PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mahdi, H; Fisher, BA; Kallberg, H; Plant, D; Malmstrom, V; Ronnelid, J; Charles, P; Ding, B; Alfredsson, L; Padyukov, L; Symmons, DPM; Venables, PJ; Klareskog, L; Lundberg, K				Mahdi, Hiba; Fisher, Benjamin A.; Kallberg, Henrik; Plant, Darren; Malmstrom, Vivianne; Ronnelid, Johan; Charles, Peter; Ding, Bo; Alfredsson, Lars; Padyukov, Leonid; Symmons, Deborah P. M.; Venables, Patrick J.; Klareskog, Lars; Lundberg, Karin			Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis	NATURE GENETICS			English	Article							HLA-DRB1 SHARED EPITOPE; INFLAMMATORY ARTHRITIS; GLYCOLYTIC ENZYME; CIGARETTE-SMOKING; ANTIBODIES; ASSOCIATION; DISEASE; COMPLEX; PROTEIN; PTPN22	Gene-environment associations are important in rheumatoid arthritis (RA) susceptibility, with an association existing between smoking, HLA-DRB1 'shared epitope' alleles, PTPN22 and antibodies to cyclic citrullinated peptides(CCP)(1,2). Here, we test the hypothesis that a subset of the anti-CCP response, with specific autoimmunity to citrullinated.-enolase(3,4), accounts for an important portion of these associations. In 1,497 individuals from three RA cohorts, antibodies to the immunodominant citrullinated alpha-enolase CEP-1 epitope(4) were detected in 43-63% of the anti-CCP-positive individuals, and this subset was preferentially linked to HLA-DRB1*04. In a case-control analysis of 1,000 affected individuals and 872 controls, the combined effect of shared epitope, PTPN22 and smoking showed the strongest association with the anti-CEP-1-positive subset (odds ratio (OR) of 37, compared to an OR of 2 for the corresponding anti-CEP-1-negative, anti-CCP-positive subset). We conclude that citrullinated alpha-enolase is a specific citrullinated autoantigen that links smoking to genetic risk factors in the development of RA.	[Fisher, Benjamin A.; Charles, Peter; Venables, Patrick J.; Lundberg, Karin] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London, England; [Mahdi, Hiba; Malmstrom, Vivianne; Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Ctr Mol Med, Rheumatol Unit, Stockholm, Sweden; [Kallberg, Henrik; Ding, Bo; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Plant, Darren; Symmons, Deborah P. M.] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester, Lancs, England; [Ronnelid, Johan] Uppsala Univ, Rudbeck Lab, Unit Clin Immunol, Uppsala, Sweden	Imperial College London; University of Oxford; Karolinska Institutet; Karolinska Institutet; University of Manchester; Uppsala University	Lundberg, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London, England.	k.lundberg@imperial.ac.uk	Ronnelid, Johan/O-2077-2019; Alfredsson, Lars/AAC-9007-2019; Fisher, Benjamin/AFO-1782-2022; Padyukov, Leonid/A-4890-2009	Alfredsson, Lars/0000-0003-1688-6697; Fisher, Benjamin/0000-0003-4631-549X; Symmons, Deborah/0000-0002-8625-1200; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186	Arthritis Research Campaign; Swedish Research Council; Swedish Council for Working Life and Social Research; Arbetsmarknadens Frs krings Aktibebolag insurance foundation; US National Institutes of Health [P60 AR047782]; FAMRI (Flight Attendants Medical Research Institute); Swedish Rheumatism Association; King Gustav V's 80-year foundation; Swedish Fund for Research; EU funded research project AutoCure; National Institute for Health Research [CL-2008-21-015] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047782] Funding Source: NIH RePORTER	Arthritis Research Campaign(Versus Arthritis); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Arbetsmarknadens Frs krings Aktibebolag insurance foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI (Flight Attendants Medical Research Institute); Swedish Rheumatism Association; King Gustav V's 80-year foundation; Swedish Fund for Research; EU funded research project AutoCure; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors wish to acknowledge M. Andersson, M. Mullazhi and M. Widhe for their input regarding the development of the anti-CEP-1 ELISA. We would also like to thank investigators and study participants from the EIRA, the NR and the NOAR studies for their contributions. This work was supported by grants from the Arthritis Research Campaign, the Swedish Research Council, the Swedish Council for Working Life and Social Research, the Arbetsmarknadens Frs krings Aktibebolag insurance foundation, the US National Institutes of Health (grant P60 AR047782), FAMRI (Flight Attendants Medical Research Institute), the Swedish Rheumatism Association, King Gustav V's 80-year foundation and the Swedish Fund for Research Without Animal Experiments. This study is part of the EU funded research project AutoCure, within the sixth framework program.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Harrison B, 1999, ARTHRITIS RHEUM, V42, P2174, DOI 10.1002/1529-0131(199910)42:10<2174::AID-ANR19>3.0.CO;2-G; HAY EM, 1993, BRIT J RHEUMATOL, V32, P443; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Kinloch A, 2008, ARTHRITIS RHEUM, V58, P2287, DOI 10.1002/art.23618; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Mahdi H, 2008, ANN RHEUM DIS, V67, pA7; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Peng JH, 2007, MOL CELL BIOCHEM, V294, P45, DOI 10.1007/s11010-006-9223-6; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Saulot V, 2002, ARTHRITIS RHEUM, V46, P1196, DOI 10.1002/art.10252; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Silman AJ, 1996, ARTHRITIS RHEUM, V39, P732, DOI 10.1002/art.1780390504; SNIR O, 2009, ARTHRITIS R IN PRESS; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Symmons DPM, 2003, CLIN EXP RHEUMATOL, V21, pS94; Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P1117, DOI 10.1002/art.21739; van Venrooij WJ, 2002, NETH J MED, V60, P383; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3	33	249	258	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1319	U84		10.1038/ng.480	http://dx.doi.org/10.1038/ng.480			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19898480				2022-12-25	WOS:000272144900014
J	Satake, W; Nakabayashi, Y; Mizuta, I; Hirota, Y; Ito, C; Kubo, M; Kawaguchi, T; Tsunoda, T; Watanabe, M; Takeda, A; Tomiyama, H; Nakashima, K; Hasegawa, K; Obata, F; Yoshikawa, T; Kawakami, H; Sakoda, S; Yamamoto, M; Hattori, N; Murata, M; Nakamura, Y; Toda, T				Satake, Wataru; Nakabayashi, Yuko; Mizuta, Ikuko; Hirota, Yushi; Ito, Chiyomi; Kubo, Michiaki; Kawaguchi, Takahisa; Tsunoda, Tatsuhiko; Watanabe, Masahiko; Takeda, Atsushi; Tomiyama, Hiroyuki; Nakashima, Kenji; Hasegawa, Kazuko; Obata, Fumiya; Yoshikawa, Takeo; Kawakami, Hideshi; Sakoda, Saburo; Yamamoto, Mitsutoshi; Hattori, Nobutaka; Murata, Miho; Nakamura, Yusuke; Toda, Tatsushi			Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease	NATURE GENETICS			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; ALPHA-SYNUCLEIN; TAU GENE; MUTATIONS; LRRK2; SUSCEPTIBILITY; CLONING; DEMENTIA; CALCIUM	To identify susceptibility variants for Parkinson's disease (PD), we performed a genome-wide association study (GWAS) and two replication studies in a total of 2,011 cases and 18,381 controls from Japan. We identified a new susceptibility locus on 1q32 (P = 1.52 x 10(-12)) and designated this as PARK16, and we also identified BST1 on 4p15 as a second new risk locus (P = 3.94 x 10(-9)). We also detected strong associations at SNCA on 4q22 (P = 7.35 x 10(-17)) and LRRK2 on 12q12 (P = 2.72 x 10(-8)), both of which are implicated in autosomal dominant forms of parkinsonism. By comparing results of a GWAS performed on individuals of European ancestry, we identified PARK16, SNCA and LRRK2 as shared risk loci for PD and BST1 and MAPT as loci showing population differences. Our results identify two new PD susceptibility loci, show involvement of autosomal dominant parkinsonism loci in typical PD and suggest that population differences contribute to genetic heterogeneity in PD.	[Satake, Wataru; Nakabayashi, Yuko; Mizuta, Ikuko; Hirota, Yushi; Ito, Chiyomi; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 657, Japan; [Satake, Wataru; Nakabayashi, Yuko; Mizuta, Ikuko; Hirota, Yushi; Ito, Chiyomi; Toda, Tatsushi] Osaka Univ, Grad Sch Med, Div Clin Genet, Suita, Osaka, Japan; [Satake, Wataru; Sakoda, Saburo] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Kubo, Michiaki; Kawaguchi, Takahisa; Tsunoda, Tatsuhiko; Nakamura, Yusuke] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Watanabe, Masahiko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Neurol, Tsukuba, Ibaraki, Japan; [Takeda, Atsushi] Tohoku Univ, Grad Sch Med, Div Neurol, Sendai, Miyagi 980, Japan; [Tomiyama, Hiroyuki; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Nakashima, Kenji] Tottori Univ, Fac Med, Dept Neurol, Yonago, Tottori 683, Japan; [Hasegawa, Kazuko] Sagamihara Natl Hosp, Dept Neurol, Sagamihara, Kanagawa, Japan; [Obata, Fumiya] Kitasato Univ, Grad Sch Med Sci, Div Clin Immunol, Sagamihara, Kanagawa 228, Japan; [Yoshikawa, Takeo] RIKEN, Brain Sci Inst, Saitama, Japan; [Kawakami, Hideshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Epidemiol, Hiroshima, Japan; [Yamamoto, Mitsutoshi] Kagawa Prefectural Cent Hosp, Dept Neurol, Takamatsu, Kagawa, Japan; [Murata, Miho] Natl Ctr Hosp Neurol & Psychiat, Dept Neurol, Kodaira, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Ind Sci, Ctr Human Genome, Tokyo, Japan	Kobe University; Osaka University; Osaka University; RIKEN; University of Tsukuba; Tohoku University; Juntendo University; Tottori University; Kitasato University; RIKEN; Hiroshima University; National Center for Neurology & Psychiatry - Japan; University of Tokyo	Toda, T (corresponding author), Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 657, Japan.	toda@med.kobe-u.ac.jp	Yoshikawa, Takeo/F-9599-2019; Kawakami, Hideshi/ABE-4077-2021; Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014; Kawakami, Hideshi/A-2086-2009; Hattori, Nobutaka/ACR-0069-2022; Perry, George/A-8611-2009	Kawakami, Hideshi/0000-0002-1405-0901; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Kawakami, Hideshi/0000-0002-1405-0901; Perry, George/0000-0002-6547-0172; Toda, Tatsushi/0000-0002-0717-1123; Mizuta, Ikuko/0000-0002-2775-2507	Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Global COE program and KAKENHI [17019044, 19590990]; Ministry of Education, Culture, Sports, Science and Technology of Japan; 'the Research Committee for the Neurodegenerative Diseases'; Research on Measures for Intractable Diseases and Research [H19-Genome-Ippan-001]; Ministry of Health, Labor and Welfare of Japan	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Global COE program and KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 'the Research Committee for the Neurodegenerative Diseases'; Research on Measures for Intractable Diseases and Research; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We are grateful to the individuals with PD who participated in this study. We also thank T. Takeshima and E. Ohta for PD samples, H. Inoko and K. Tokunaga for control samples, M. Kanagawa and K. Ura for editing, K. Yasuno and R. Ashida for analyses, and K. Yamada for genotyping. We appreciate all the volunteers and participating institutions of BioBank Japan for samples. This work was supported by a grant from Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); by the Global COE program and KAKENHI (17019044 and 19590990), both from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by the Grant-in-Aid for 'the Research Committee for the Neurodegenerative Diseases' of the Research on Measures for Intractable Diseases and Research Grant (H19-Genome-Ippan-001), all from the Ministry of Health, Labor and Welfare of Japan.	Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Biskup S, 2005, ANN NEUROL, V58, P905, DOI 10.1002/ana.20664; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GARRUTO RM, 1985, NEUROLOGY, V35, P193, DOI 10.1212/WNL.35.2.193; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Healy DG, 2004, J NEUROL NEUROSUR PS, V75, P962, DOI 10.1136/jnnp.2003.026203; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Ostvold AC, 2001, EUR J BIOCHEM, V268, P2430, DOI 10.1046/j.1432-1327.2001.02120.x; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shimizu F, 1997, CYTOGENET CELL GENET, V77, P261, DOI 10.1159/000134591; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Skipper L, 2005, HUM MOL GENET, V14, P3549, DOI 10.1093/hmg/ddi376; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Uldry M, 2001, EMBO J, V20, P4467, DOI 10.1093/emboj/20.16.4467; Warner TT, 2003, ANN NEUROL, V53, pS16, DOI 10.1002/ana.10487; Webb A, 2008, ARCH NEUROL-CHICAGO, V65, P1473, DOI 10.1001/archneur.65.11.1473; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	42	978	1006	1	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1303	U61		10.1038/ng.485	http://dx.doi.org/10.1038/ng.485			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19915576				2022-12-25	WOS:000272144900011
J	Pushkarev, D; Neff, NF; Quake, SR				Pushkarev, Dmitry; Neff, Norma F.; Quake, Stephen R.			Single-molecule sequencing of an individual human genome	NATURE BIOTECHNOLOGY			English	Article								Recent advances in high-throughput DNA sequencing technologies have enabled order-of-magnitude improvements in both cost and throughput. Here we report the use of single-molecule methods to sequence an individual human genome. We aligned billions of 24- to 70-bp reads ( 32 bp average) to similar to 90% of the National Center for Biotechnology Information (NCBI) reference genome, with 28x average coverage. Our results were obtained on one sequencing instrument by a single operator with four data collection runs. Single-molecule sequencing enabled analysis of human genomic information without the need for cloning, amplification or ligation. We determined similar to 2.8 million single nucleotide polymorphisms ( SNPs) with a false-positive rate of less than 1% as validated by Sanger sequencing and 99.8% concordance with SNP genotyping arrays. We identified 752 regions of copy number variation by analyzing coverage depth alone and validated 27 of these using digital PCR. This milestone should allow widespread application of genome sequencing to many aspects of genetics and human health, including personal genomics.	[Pushkarev, Dmitry; Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Pushkarev, Dmitry; Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu			National Science Foundation [CNS-0619926]; Bio-X2 cluster; National Institutes of Health Pioneer Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000251] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Bio-X2 cluster; National Institutes of Health Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to V. Natu and J. Coller of the Stanford Functional Genomics Facility for performing the Illumina SNP analysis, R. A. White for assistance with dPCR assays, and A. Sidow for the use of the Covaris sonicator. We acknowledge National Science Foundation award CNS-0619926 for computer resources funding the Bio-X2 cluster, and the National Institutes of Health Pioneer Award ( to S. R. Q.).	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Daines B, 2009, GENETICS, V182, P935, DOI 10.1534/genetics.109.103218; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Greenleaf WJ, 2006, SCIENCE, V313, P801, DOI 10.1126/science.1130105; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Janeway C., 2004, IMMUNOBIOLOGY; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vijg J, 2005, ANN NY ACAD SCI, V1055, P35, DOI 10.1196/annals.1323.007; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80	22	305	386	1	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2009	27	9					847	U101		10.1038/nbt.1561	http://dx.doi.org/10.1038/nbt.1561			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	493QE	19668243	Green Accepted			2022-12-25	WOS:000269751400027
J	Annicotte, JS; Blanchet, E; Chavey, C; Iankova, I; Costes, S; Assou, S; Teyssier, J; Dalle, S; Sardet, C; Fajas, L				Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Costes, Safia; Assou, Said; Teyssier, Jacques; Dalle, Stephane; Sardet, Claude; Fajas, Lluis			The CDK4-pRB-E2F1 pathway controls insulin secretion	NATURE CELL BIOLOGY			English	Article							PANCREATIC BETA-CELLS; ACTIVATED-RECEPTOR-GAMMA; SENSITIVE K+ CHANNEL; PROMOTES ADIPOGENESIS; TRANSCRIPTION; GROWTH; MICE; MASS; EXPRESSION; PROLIFERATION	CDK4-pRB-E2F1 cell-cycle regulators are robustly expressed in non-proliferating beta cells, suggesting that besides the control of beta-cell number the CDK4-pRB-E2F1 pathway has a role in beta-cell function. We show here that E2F1 directly regulates expression of Kir6.2, which is a key component of the K-ATP channel involved in the regulation of glucose-induced insulin secretion. We demonstrate, through chromatin immunoprecipitation analysis from tissues, that Kir6.2 expression is regulated at the promoter level by the CDK4-pRB-E2F1 pathway. Consistently, inhibition of CDK4, or genetic inactivation of E2F1, results in decreased expression of Kir6.2, impaired insulin secretion and glucose intolerance in mice. Furthermore we show that rescue of Kir6.2 expression restores insulin secretion in E2f1(-/-) beta cells. Finally, we demonstrate that CDK4 is activated by glucose through the insulin pathway, ultimately resulting in E2F1 activation and, consequently, increased expression of Kir6.2. In summary we provide evidence that the CDK4-pRB-E2F1 regulatory pathway is involved in glucose homeostasis, defining a new link between cell proliferation and metabolism.	[Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] INSERM, U834, F-34298 Montpellier, France; [Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] IRCM, F-34298 Montpellier, France; [Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] INSERM, U896, F-34298 Montpellier, France; [Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] Univ Montpellier 1, F-34298 Montpellier, France; [Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] CRLC Val Aurelle Paul Lamarque, F-34298 Montpellier, France; [Costes, Safia; Dalle, Stephane] CNRS, UMR5203, Inst Genom Fonct, F-34094 Montpellier, France; [Costes, Safia; Dalle, Stephane] INSERM, U661, Equipe AVENIR, F-34094 Montpellier, France; [Costes, Safia; Dalle, Stephane] Univ Montpellier 1, F-34094 Montpellier, France; [Assou, Said] Hop St Eloi, Inst Res Biotherapy, Ctr Hosp Univ, F-34295 Montpellier, France; [Sardet, Claude] Inst Genet Mol, F-34293 Montpellier, France; [Sardet, Claude] CNRS, UMR5535, F-34293 Montpellier, France; [Sardet, Claude] Univ Montpellier 2, F-34293 Montpellier, France; [Fajas, Lluis] Ctr Hosp Univ Arnaud de Villeneuve, F-34295 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Fajas, L (corresponding author), INSERM, U834, F-34298 Montpellier, France.	lluis.fajas@inserm.fr	Annicotte, Jean-Sébastien/H-4641-2018; , Costes/AAC-2820-2020; Coll, Lluis Fajas/C-8567-2014	Annicotte, Jean-Sébastien/0000-0002-2109-4849; , Costes/0000-0001-8323-1207; Chavey, Carine/0000-0002-5267-5638; Fajas, Lluis/0000-0002-1283-9503; assou, said/0000-0001-6448-7995	Agence Nationale pour la Recherche; INSERM-Association Francaise des Diabetiques; Association pour la Recherche contre le Cancer; Fondation pour la Recherche Medicale; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale pour la Recherche(French National Research Agency (ANR)); INSERM-Association Francaise des Diabetiques; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ministere de l'Enseignement Superieur et de la Recherche	We thank K. H. Kaestner (pGL3-Kir6.2-Luc), S. Seino and Y. Kurachi (pCDNA3 Kir6.2) for the gift of materials; I. Ait Arssa, M. Brissac, C. Clape, D. Greuet, C. Henriquet and S. Hure for excellent technical help; L. Le Cam. Members of the Fajas lab are acknowledged for support and discussions. This work was supported by grants from Agence Nationale pour la Recherche (ANR physio2006), INSERM-Association Francaise des Diabetiques (PNR-Diabete), Association pour la Recherche contre le Cancer, and Fondation pour la Recherche Medicale. E. B. is supported by a grant form the Ministere de l'Enseignement Superieur et de la Recherche, C. C. is supported by a grant from the Agence Nationale pour la Recherche.	Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Annicotte JS, 2006, MOL CELL BIOL, V26, P7561, DOI 10.1128/MCB.00605-06; Annicotte JS, 2003, MOL CELL BIOL, V23, P6713, DOI 10.1128/MCB.23.19.6713-6724.2003; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Fajas L, 2001, MOL CELL BIOL, V21, P2956, DOI 10.1128/MCB.21.8.2956-2966.2001; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; Miki T, 1999, J MOL ENDOCRINOL, V22, P113, DOI 10.1677/jme.0.0220113; Miki T, 2002, AM J PHYSIOL-ENDOC M, V283, pE1178, DOI 10.1152/ajpendo.00313.2002; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Rachdi L, 2006, DIABETES, V55, P3520, DOI 10.2337/db06-0861; Remedi MS, 2004, DIABETES, V53, P3159, DOI 10.2337/diabetes.53.12.3159; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Webb GC, 2000, P NATL ACAD SCI USA, V97, P5773, DOI 10.1073/pnas.100126597	29	102	105	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1017	U247		10.1038/ncb1915	http://dx.doi.org/10.1038/ncb1915			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597485	Green Accepted, Green Submitted			2022-12-25	WOS:000268593200017
J	Vincent, T; Neve, EPA; Johnson, JR; Kukalev, A; Rojo, F; Albanell, J; Pietras, K; Virtanen, I; Philipson, L; Leopold, PL; Crystal, RG; de Herreros, AG; Moustakas, A; Pettersson, RF; Fuxe, J				Vincent, Theresa; Neve, Etienne P. A.; Johnson, Jill R.; Kukalev, Alexander; Rojo, Federico; Albanell, Joan; Pietras, Kristian; Virtanen, Ismo; Philipson, Lennart; Leopold, Philip L.; Crystal, Ronald G.; Garcia de Herreros, Antonio; Moustakas, Aristidis; Pettersson, Ralf F.; Fuxe, Jonas			A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; CADHERIN GENE-EXPRESSION; ADENOVIRUS-RECEPTOR; FACTOR SNAIL; TUMOR-CELLS; CARCINOMA-CELLS; TIGHT JUNCTIONS; BREAST-CANCER; COXSACKIE; METASTASIS	Epithelial-mesenchymal transition (EMT) is essential for organogenesis and is triggered during carcinoma progression to an invasive state(1). Transforming growth factor-beta (TGF-beta) cooperates with signalling pathways, such as Ras and Wnt, to induce EMT2-5, but the molecular mechanisms are not clear. Here, we report that SMAD3 and SMAD4 interact and form a complex with SNAIL1, a transcriptional repressor and promoter of EMT6,7. The SNAIL1-SMAD3/4 complex was targeted to the gene promoters of CAR, a tight-junction protein, and E-cadherin during TGF-beta-driven EMT in breast epithelial cells. SNAIL1 and SMAD3/4 acted as co-repressors of CAR, occludin, claudin-3 and E-cadherin promoters in transfected cells. Conversely, co-silencing of SNAIL1 and SMAD4 by siRNA inhibited repression of CAR and occludin during EMT. Moreover, loss of CAR and E-cadherin correlated with nuclear co-expression of SNAIL1 and SMAD3/4 in a mouse model of breast carcinoma and at the invasive fronts of human breast cancer. We propose that activation of a SNAIL1-SMAD3/4 transcriptional complex represents a mechanism of gene repression during EMT.	[Johnson, Jill R.; Kukalev, Alexander; Philipson, Lennart; Fuxe, Jonas] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Vincent, Theresa; Neve, Etienne P. A.; Pettersson, Ralf F.] Ludwig Inst Canc Res, Stockholm Branch, S-17177 Stockholm, Sweden; [Rojo, Federico; Albanell, Joan; Garcia de Herreros, Antonio] IMIM Hosp Mar, Programa Recerca Canc, Dept Oncol, Barcelona 08003, Spain; [Virtanen, Ismo] Univ Helsinki, Inst Biomed Anat, FI-00014 Helsinki, Finland; [Leopold, Philip L.] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA; [Crystal, Ronald G.] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10065 USA; [Moustakas, Aristidis] Ludwig Inst Canc Res, Uppsala Branch, SE-75124 Uppsala, Sweden; [Vincent, Theresa] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Neve, Etienne P. A.] Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, S-17177 Stockholm, Sweden; [Rojo, Federico] Fdn Jimenez Diaz, Serv Anat Patol, E-28040 Madrid, Spain; [Albanell, Joan] Hosp del Mar, Serv Oncol Patol, Barcelona, Spain; [Johnson, Jill R.; Pietras, Kristian; Fuxe, Jonas] Karolinska Inst, Matrix Div, Dept Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Helsinki; Stevens Institute of Technology; Cornell University; Ludwig Institute for Cancer Research; Cornell University; Karolinska Institutet; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Karolinska Institutet	Fuxe, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	jonas.fuxe@ki.se	Albanell, Joan/R-9470-2019; VIncent, Theresa/HDN-9575-2022; Pietras, Kristian/ABG-2097-2021; de Herreros, A Garcia/H-3104-2014; Rojo, Federico/S-6551-2016; Fuxe, Jonas/T-4433-2017; Pietras, Kristian/ABE-8727-2020	Pietras, Kristian/0000-0001-6738-4705; de Herreros, A Garcia/0000-0001-5270-0808; Fuxe, Jonas/0000-0003-4576-9377; Rojo, Federico/0000-0001-9989-0290; Johnson, Jill/0000-0002-5149-0084	Swedish Research Council; Swedish Wenner-Gren Foundation; Swedish Childhood Cancer Foundation; International Union Against Cancer (UICC); American Cancer Society International Fellowship; National Institutes of Health (NIH) [PO1 HL59312]; Antonio Garcia de Herreros; Joan Albanell and Federico Rojo [RD06/0020/109, RD06/0020/040]; FIS [PI061513, SAF2006-00339]; Fundacio Privada Cellex; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059312] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Wenner-Gren Foundation; Swedish Childhood Cancer Foundation(European Commission); International Union Against Cancer (UICC); American Cancer Society International Fellowship(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Garcia de Herreros; Joan Albanell and Federico Rojo; FIS(Instituto de Salud Carlos III); Fundacio Privada Cellex(Foundation CELLEX); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Carl-Henrik Heldin (Ludwig Institute for Cancer Research, Uppsala Branch) and Ola Hermansson (Department of Neuroscience, Karolinska Institute, Sweden) for fruitful discussions; Clara Franc (IMIM- Hospital del Mar, Barcelona) for the initial immunohistochemical analysis of human tumors; Anita Bergstrom, Silvia Menendez and Marta Garrido for excellent technical assistance and Olov Andersson (Department of Cell and Molecular Biology, Karolinska Institute) for antibodies. Jonas Fuxe was supported by grants from the Swedish Research Council, the Swedish Wenner-Gren Foundation, the Swedish Childhood Cancer Foundation and an International Union Against Cancer (UICC), American Cancer Society International Fellowship for Beginning Investigators. Theresa Vincent was supported by the Swedish Research Council. Philip Leopold and Ronald Crystal were supported by the National Institutes of Health (NIH) by PO1 HL59312 and Antonio Garcia de Herreros, Joan Albanell and Federico Rojo by RD06/0020/109, RD06/0020/040, FIS PI061513, SAF2006-00339 and Fundacio Privada Cellex.	Anders M, 2003, CANCER RES, V63, P2088; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Frey BM, 1998, BLOOD, V91, P2781, DOI 10.1182/blood.V91.8.2781.2781_2781_2792; Hajra KM, 2002, CANCER RES, V62, P1613; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Lacher MD, 2006, CANCER RES, V66, P1648, DOI 10.1158/0008-5472.CAN-05-2328; MAHONEY KH, 1985, J LEUKOCYTE BIOL, V38, P573, DOI 10.1002/jlb.38.5.573; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsumoto K, 2005, UROLOGY, V66, P441, DOI 10.1016/j.urology.2005.02.033; MAUHIN V, 1993, NUCLEIC ACIDS RES, V21, P3951, DOI 10.1093/nar/21.17.3951; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Philipson L, 2004, CURR TOP MICROBIOL, V273, P87; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wei WZ, 1999, INT J CANCER, V81, P748, DOI 10.1002/(SICI)1097-0215(19990531)81:5<748::AID-IJC14>3.0.CO;2-6; Yamashita M, 2007, INT J CANCER, V121, P1690, DOI 10.1002/ijc.22852; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	37	492	513	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					943	U84		10.1038/ncb1905	http://dx.doi.org/10.1038/ncb1905			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597490	Green Accepted			2022-12-25	WOS:000268593200007
J	Chan, KL; Palmai-Pallag, T; Ying, SM; Hickson, ID				Chan, Kok Lung; Palmai-Pallag, Timea; Ying, Songmin; Hickson, Ian D.			Replication stress induces sister-chromatid bridging at fragile site loci in mitosis	NATURE CELL BIOLOGY			English	Article							FANCONI-ANEMIA; BLOOM-SYNDROME; RECOMBINATION; STABILITY; PATHWAYS; PROTEINS; COMPLEX; CELLS	Several inherited syndromes in humans are associated with cancer predisposition. The gene products defective in two of these disorders, BLM ( a helicase defective in Bloom's syndrome)(1) and FANC A-N ( defective in Fanconi anaemia)(2), associate in a multienzyme complex called BRAFT(3). How these proteins suppress tumorigenesis remains unclear, although both conditions are associated with chromosome instability. Here we show that the Fanconi anaemia proteins FANCD2 and FANCI specifically associate with common fragile site loci irrespective of whether the chromosome is broken. Unexpectedly, these loci are frequently interlinked through BLM-associated ultra-fine DNA bridges(4) (UFBs) even as cells traverse mitosis. Similarly to fragile site expression(5), fragile site bridging is induced after partial inhibition of DNA replication. We propose that, after replication stress, sister chromatids are interlinked by replication intermediates primarily at genetic loci with intrinsic replication difficulties, such as fragile sites. In Bloom's syndrome cells, inefficient resolution of DNA linkages at fragile sites gives rise to increased numbers of anaphase UFBs and micronuclei containing fragile site DNA. Our data have general implications concerning the contribution of fragile site loci to chromosomal instability and tumorigenesis.	[Chan, Kok Lung; Palmai-Pallag, Timea; Ying, Songmin; Hickson, Ian D.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Hickson, ID (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	ian.hickson@imm.ox.ac.uk	Hickson, Ian/AAJ-7548-2020	chan, kok-lung/0000-0002-8796-8385; Palmai-Pallag, Timea/0000-0002-7402-2144; Hickson, Ian/0000-0002-0583-566X	Cancer Research UK; Croucher Foundation (Hong Kong)	Cancer Research UK(Cancer Research UK); Croucher Foundation (Hong Kong)	We thank members of the Hickson laboratory for helpful discussions, P. McHugh and L. Wu for helpful comments on the manuscript, and P. White for preparation of the manuscript. B. Lopes, P. Jeggo, F. Esashi, A. D'Andrea, G. Brown, E. Nigg and S. Elledge kindly supplied reagents. This work was supported by Cancer Research UK. K. L. C. was supported by the Croucher Foundation (Hong Kong).	Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; DURKIN SG, 2007, P NATL ACAD SCI USA, V8, P246; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Jaco I, 2008, J CELL BIOL, V181, P885, DOI 10.1083/jcb.200803042; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	19	426	434	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					753	U120		10.1038/ncb1882	http://dx.doi.org/10.1038/ncb1882			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465922				2022-12-25	WOS:000266503700021
J	Shukla, A; Malik, M; Cataisson, C; Ho, Y; Friesen, T; Suh, KS; Yuspa, SH				Shukla, Anjali; Malik, Mariam; Cataisson, Christophe; Ho, Yan; Friesen, Travis; Suh, Kwang S.; Yuspa, Stuart H.			TGF-beta signalling is regulated by Schnurri-2-dependent nuclear translocation of CLIC4 and consequent stabilization of phospho-Smad2 and 3	NATURE CELL BIOLOGY			English	Article							CHLORIDE CHANNEL PROTEIN; ION CHANNEL; SMAD PROTEINS; EXPRESSION; GROWTH; KERATINOCYTES; TRANSCRIPTION; MTCLIC/CLIC4; APOPTOSIS; P53	CLIC4 (chloride intracellular channel 4), a multifunctional protein that traffics between the cytoplasm and nucleus, interacts with Schnurri-2, a transcription factor in the bone morphogenetic protein (BMP) signalling pathway. Here we show that transforming growth factor beta (TGF-beta) promotes the expression of CLIC4 and Schnurri-2 as well as their association in the cytoplasm and their translocation to the nucleus. In the absence of CLIC4 or Schnurri-2, TGF-beta signalling is abrogated. Direct nuclear targeting of CLIC4 enhances TGF-beta signalling and removes the requirement for Schnurri-2. Nuclear CLIC4 associates with phospho (p)-Smad2 and p-Smad3, protecting them from dephosphorylation by nuclear phosphatases. An intact TGF-beta signalling pathway is essential for CLIC4-mediated growth-arrest. These results newly identify Schnurri-2 and CLIC4 as modifiers of TGF-beta signalling through their stabilization of p-Smad2 and 3 in the nucleus.	[Shukla, Anjali; Malik, Mariam; Cataisson, Christophe; Ho, Yan; Friesen, Travis; Suh, Kwang S.; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yuspa, SH (corresponding author), NCI, Lab Canc Biol & Genet, NIH, 37 Convent Dr, Bethesda, MD 20892 USA.	yuspas@mail.nih.gov	Shukla, Anjali/G-4046-2014	, Yan/0000-0003-4980-9663	National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank L. Wakefield for critically reading the manuscript, M. Anzano for help with genotyping, C. Cheng for help with immunoprecipitation assays and colleagues for providing constructive criticism throughout the study. This work was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH.	Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Fernandez-Salas E, 1999, J BIOL CHEM, V274, P36488, DOI 10.1074/jbc.274.51.36488; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Shorning BY, 2003, DEV GENES EVOL, V213, P514, DOI 10.1007/s00427-003-0356-2; Suh KS, 2005, CURR PHARM DESIGN, V11, P2753, DOI 10.2174/1381612054546806; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Suh KS, 2007, J CELL SCI, V120, P2631, DOI 10.1242/jcs.002741; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Udagawa Y, 2000, GENES CELLS, V5, P359, DOI 10.1046/j.1365-2443.2000.00328.x; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748	25	71	71	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					777	U154		10.1038/ncb1885	http://dx.doi.org/10.1038/ncb1885			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19448624	Green Accepted			2022-12-25	WOS:000266503700024
J	Sulem, P; Gudbjartsson, DF; Rafnar, T; Holm, H; Olafsdottir, EJ; Olafsdottir, GH; Jonsson, T; Alexandersen, P; Feenstra, B; Boyd, HA; Aben, KK; Verbeek, ALM; Roeleveld, N; Jonasdottir, A; Styrkarsdottir, U; Steinthorsdottir, V; Karason, A; Stacey, SN; Gudmundsson, J; Jakobsdottir, M; Thorleifsson, G; Hardarson, G; Gulcher, J; Kong, A; Kiemeney, LA; Melbye, M; Christiansen, C; Tryggvadottir, L; Thorsteinsdottir, U; Stefansson, K				Sulem, Patrick; Gudbjartsson, Daniel F.; Rafnar, Thorunn; Holm, Hilma; Olafsdottir, Elinborg J.; Olafsdottir, Gudridur H.; Jonsson, Thorvaldur; Alexandersen, Peter; Feenstra, Bjarke; Boyd, Heather A.; Aben, Katja K.; Verbeek, Andre L. M.; Roeleveld, Nel; Jonasdottir, Aslaug; Styrkarsdottir, Unnur; Steinthorsdottir, Valgerdur; Karason, Ari; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Thorleifsson, Gudmar; Hardarson, Gudmundur; Gulcher, Jeffrey; Kong, Augustine; Kiemeney, Lambertus A.; Melbye, Mads; Christiansen, Claus; Tryggvadottir, Laufey; Thorsteinsdottir, Unnur; Stefansson, Kari			Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche	NATURE GENETICS			English	Article							INTERNATIONAL VARIABILITY; ADULT OBESITY; TWIN FAMILIES; HEIGHT; RISK; CANCER; COHORT; LOCI; MENOPAUSE; CHILDHOOD	Earlier menarche correlates with shorter adult height(1) and higher childhood body fat(2). We conducted a genome-wide association study of age at menarche (AAM) on 15,297 Icelandic women. Combined analysis with replication sets from Iceland, Denmark and the Netherlands (N = 10,040) yielded a significant association between rs314280[T] on 6q21, near the LIN28B gene, and AAM (effect = 1.2 months later per allele; P = 1.8 x 10(-14)). A second SNP within the same linkage disequilibrium (LD) block, rs314277, splits rs314280[T] into two haplotypes with different effects (0.9 months and 1.9 months per allele). These variants have been associated with greater adult height(3,4). The association with adult height did not account for the association with AAM or vice versa. Other variants, previously associated with height(3-5), did not associate significantly with AAM. Given the link between body fat and AAM, we also assessed 11 variants recently associated with higher body mass index (BMI)(6-11) and 5 of those associated with earlier AAM.	[Holm, Hilma] Emory Univ, Sch Med, Div Cardiol, Dept Internal Med, Atlanta, GA 30322 USA; [Olafsdottir, Elinborg J.; Olafsdottir, Gudridur H.; Tryggvadottir, Laufey] Iceland Canc Registry, Reykjavik, Iceland; [Jonsson, Thorvaldur] Univ Hosp, Dept Surg, Reykjavik, Iceland; [Alexandersen, Peter] Ctr Clin & Basic Res AS, Ballerup, Denmark; [Feenstra, Bjarke; Boyd, Heather A.; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Verbeek, Andre L. M.; Roeleveld, Nel; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Christiansen, Claus] Nord Biosci AS, Herlev, Denmark; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Sulem, Patrick; Gudbjartsson, Daniel F.; Rafnar, Thorunn; Holm, Hilma; Jonasdottir, Aslaug; Styrkarsdottir, Unnur; Steinthorsdottir, Valgerdur; Karason, Ari; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Thorleifsson, Gudmar; Hardarson, Gudmundur; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur] deCODE Genet, Reykjavik, Iceland	Emory University; Landspitali National University Hospital; Center Clinical & Basic Research; Statens Serum Institut; Radboud University Nijmegen; Radboud University Nijmegen; Nordic Bioscience; University of Iceland	Sulem, P (corresponding author), deCODE Genet, Reykjavik, Iceland.	patrick.sulem@decode.is; kstefans@decode.is	Kiemeney, Lambertus A./D-3357-2009; Stefansson, Kari/AAE-7187-2019; Roeleveld, Nel/B-4242-2008; Verbeek, A.L.M./H-8103-2014; Aben, Katja KH/G-9686-2016	Kiemeney, Lambertus A./0000-0002-2368-1326; Roeleveld, Nel/0000-0002-3390-4466; Verbeek, A.L.M./0000-0002-2319-5002; Aben, Katja KH/0000-0002-0214-2147; Tryggvadottir, Laufey/0000-0001-8067-9030; Feenstra, Bjarke/0000-0003-1478-649X; Gudbjartsson, Daniel/0000-0002-5222-9857; Boyd, Heather/0000-0001-6849-9985; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; melbye, mads/0000-0001-8264-6785; Kong, Augustine/0000-0001-8193-5438; Styrkarsdottir, Unnur/0000-0001-8146-8278	Danish Pharmacists' Fund; Egmont Foundation the March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Fund of the Danish Health Insurance Societies	Danish Pharmacists' Fund; Egmont Foundation the March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Fund of the Danish Health Insurance Societies	The Danish National Research Foundation has established the Danish Epidemiology Science Centre, which initiated and created the Danish National Birth Cohort. The cohort was established with the support of a major grant from this foundation. Additional support for the Danish National Birth Cohort has been obtained from the Danish Pharmacists' Fund, the Egmont Foundation the March of Dimes Birth Defects Foundation, the Augustinus Foundation and the Health Fund of the Danish Health Insurance Societies.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anderson CA, 2007, BEHAV GENET, V37, P668, DOI 10.1007/s10519-007-9163-2; Clavel-Chapelon F, 2002, BRIT J CANCER, V86, P723, DOI 10.1038/sj.bjc.6600124; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Eastell R, 2005, J ENDOCRINOL, V185, P223, DOI 10.1677/joe.1.06059; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Jordan SJ, 2005, CANCER EPIDEM BIOMAR, V14, P2045, DOI 10.1158/1055-9965.EPI-05-0085; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Morabia A, 1998, AM J EPIDEMIOL, V148, P1195, DOI 10.1093/oxfordjournals.aje.a009609; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Purdie DM, 2001, BEST PRACT RES CL OB, V15, P341, DOI 10.1053/beog.2000.0180; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; Thomas F, 2001, HUM BIOL, V73, P271, DOI 10.1353/hub.2001.0029; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; TRYGGVADOTTIR L, 1994, ANN HUM BIOL, V21, P179, DOI 10.1080/03014469400003202; van den Berg SM, 2007, BEHAV GENET, V37, P661, DOI 10.1007/s10519-007-9161-4; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	30	154	162	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					734	738		10.1038/ng.383	http://dx.doi.org/10.1038/ng.383			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19448622				2022-12-25	WOS:000266411700025
J	Hosaka, T; Ohnishi-Kameyama, M; Muramatsu, H; Murakami, K; Tsurumi, Y; Kodani, S; Yoshida, M; Fujie, A; Ochi, K				Hosaka, Takeshi; Ohnishi-Kameyama, Mayumi; Muramatsu, Hideyuki; Murakami, Kana; Tsurumi, Yasuhisa; Kodani, Shinya; Yoshida, Mitsuru; Fujie, Akihiko; Ochi, Kozo			Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12	NATURE BIOTECHNOLOGY			English	Article							COMPLETE GENOME SEQUENCE; STREPTOMYCES-COELICOLOR A3(2); ANTIBIOTIC PRODUCTION; ACTIVATION; RESISTANCE; LIVIDANS; MUTANT	We show that selection of drug-resistant bacterial mutants allows the discovery of antibacterial compounds. Mutant strains of a soil-isolated Streptomyces species that does not produce antibacterials synthesize a previously unknown class of antibacterial, which we name piperidamycin. Overall, 6% of non-Streptomyces actinomycetes species and 43% of Streptomyces species that do not produce antibacterials are activated to produce them. The antibacterial-producing mutants all carried mutations in RNA polymerase and/or the ribosomal protein S12.	[Muramatsu, Hideyuki; Murakami, Kana; Tsurumi, Yasuhisa; Fujie, Akihiko] Astellas Pharma Inc, Fermentat Res Labs, Tsukuba, Ibaraki, Japan; [Hosaka, Takeshi; Ohnishi-Kameyama, Mayumi; Kodani, Shinya; Yoshida, Mitsuru; Ochi, Kozo] Natl Food Res Inst, Tsukuba, Ibaraki 305, Japan	Astellas Pharmaceuticals; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Ochi, K (corresponding author), Shinshu Univ, Int Young Researchers Empowerment Ctr, Nagano, Japan.	kochi@affrc.go.jp	Hosaka, Takeshi/AAV-9938-2020	Hosaka, Takeshi/0000-0002-2284-1308				Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Hosaka T, 2006, MOL MICROBIOL, V61, P883, DOI 10.1111/j.1365-2958.2006.05285.x; Hu HF, 2002, J BACTERIOL, V184, P3984, DOI 10.1128/JB.184.14.3984-3991.2002; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ochi K, 2004, ADV APPL MICROBIOL, V56, P155, DOI 10.1016/S0065-2164(04)56005-7; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Oliynyk M, 2007, NAT BIOTECHNOL, V25, P447, DOI 10.1038/nbt1297; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Shima J, 1996, J BACTERIOL, V178, P7276, DOI 10.1128/jb.178.24.7276-7284.1996; Tala A, 2009, J BACTERIOL, V191, P805, DOI 10.1128/JB.01311-08; Tamehiro N, 2003, APPL ENVIRON MICROB, V69, P6412, DOI 10.1128/AEM.69.11.6412-6417.2003; Wang GJ, 2008, APPL ENVIRON MICROB, V74, P2834, DOI 10.1128/AEM.02800-07	15	172	187	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2009	27	5					462	464		10.1038/nbt.1538	http://dx.doi.org/10.1038/nbt.1538			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	444KS	19396160				2022-12-25	WOS:000265980500025
J	Ng, SB; Buckingham, KJ; Lee, C; Bigham, AW; Tabor, HK; Dent, KM; Huff, CD; Shannon, PT; Jabs, EW; Nickerson, DA; Shendure, J; Bamshad, MJ				Ng, Sarah B.; Buckingham, Kati J.; Lee, Choli; Bigham, Abigail W.; Tabor, Holly K.; Dent, Karin M.; Huff, Chad D.; Shannon, Paul T.; Jabs, Ethylin Wang; Nickerson, Deborah A.; Shendure, Jay; Bamshad, Michael J.			Exome sequencing identifies the cause of a mendelian disorder	NATURE GENETICS			English	Article							POSTAXIAL ACROFACIAL DYSOSTOSIS; ULTRACONSERVED ELEMENTS; DROSOPHILA-MELANOGASTER; RHEUMATOID-ARTHRITIS; KAPPA-B; LEFLUNOMIDE; MICE; INHIBITION; MUTATIONS; CAPTURE	We demonstrate the first successful application of exome sequencing to discover the gene for a rare mendelian disorder of unknown cause, Miller syndrome (MIM%263750). For four affected individuals in three independent kindreds, we captured and sequenced coding regions to a mean coverage of 40x and sufficient depth to call variants at similar to 97% of each targeted exome. Filtering against public SNP databases and eight HapMap exomes for genes with two previously unknown variants in each of the four individuals identified a single candidate gene, DHODH, which encodes a key enzyme in the pyrimidine de novo biosynthesis pathway. Sanger sequencing confirmed the presence of DHODH mutations in three additional families with Miller syndrome. Exome sequencing of a small number of unrelated affected individuals is a powerful, efficient strategy for identifying the genes underlying rare mendelian disorders and will likely transform the genetic analysis of monogenic traits.	[Ng, Sarah B.; Lee, Choli; Nickerson, Deborah A.; Shendure, Jay; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Buckingham, Kati J.; Bigham, Abigail W.; Tabor, Holly K.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Tabor, Holly K.] Seattle Childrens Hosp, Treuman Katz Ctr Pediat Bioeth, Seattle, WA USA; [Dent, Karin M.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Huff, Chad D.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Shannon, Paul T.] Inst Syst Biol, Seattle, WA USA; [Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Jabs, Ethylin Wang] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Institute for Systems Biology (ISB); Icahn School of Medicine at Mount Sinai; Johns Hopkins University	Bamshad, MJ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@u.washington.edu; mbamshad@u.washington.edu	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865; Jabs, Ethylin/0000-0001-8983-5466	National Heart, Lung, and Blood Institute; National Human Genome Research Institute; National Institute of Child Health and Human Development of the US National Institutes of Health; Life Sciences Discovery Fund; Washington Research Foundation; Agency for Science Technology and Research, Singapore; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Life Sciences Discovery Fund; Washington Research Foundation; Agency for Science Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the families for their participation and the Foundation of Nager and Miller Syndrome for their support. We thank M. McMillin for assistance with project coordination. We thank R. Scott, T. Cox, L. Cox, R. Jack, E. Eichler, M. Emond, G. Cooper, J. Kidd, R. Waterston and E. Wijsman for discussions. Our work was supported in part by grants from the National Heart, Lung, and Blood Institute, National Human Genome Research Institute and National Institute of Child Health and Human Development of the US National Institutes of Health, the Life Sciences Discovery Fund and the Washington Research Foundation. S. B. N. is supported by the Agency for Science Technology and Research, Singapore. A. W. B. is supported by a training fellowship from the National Human Genome Research Institute.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Bawle EV, 1998, TERATOLOGY, V57, P51, DOI 10.1002/(SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9; Breedveld FC, 2000, ANN RHEUM DIS, V59, P841, DOI 10.1136/ard.59.11.841; Brosnan ME, 2007, J NUTR, V137, p1656S, DOI 10.1093/jn/137.6.1656S; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Chen CTL, 2007, AM J HUM GENET, V80, P692, DOI 10.1086/513149; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CONNER TW, 1982, BIOCHEM GENET, V20, P607, DOI 10.1007/BF00483960; DONNAI D, 1987, J MED GENET, V24, P422, DOI 10.1136/jmg.24.7.422; FINEMAN RM, 1981, J PEDIATR-US, V98, P87, DOI 10.1016/S0022-3476(81)80546-X; Fukushima R, 2007, REPROD TOXICOL, V24, P310, DOI 10.1016/j.reprotox.2007.05.006; GENEE E, 1969, J GENET HUM, V17, P45; Grabar PB, 2009, ANN RHEUM DIS, V68, P1367, DOI 10.1136/ard.2008.099093; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Imose M, 2004, HEPATOLOGY, V40, P1160, DOI 10.1002/hep.20438; JARRY B, 1974, MOL GEN GENET, V135, P113, DOI 10.1007/BF00264779; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MILLER M, 1979, J PEDIATR-US, V95, P970, DOI 10.1016/S0022-3476(79)80285-1; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; OGLIVYSTUART AL, 1991, J MED GENET, V28, P695; PEREIRA SCS, 1992, AM J MED GENET, V44, P274, DOI 10.1002/ajmg.1320440303; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; ROBINOW M, 1986, AM J MED GENET, V25, P293, DOI 10.1002/ajmg.1320250214; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Splendore A, 2002, AM J MED GENET, V111, P324, DOI 10.1002/ajmg.10567; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775	31	1362	1451	0	231	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					30	U41		10.1038/ng.499	http://dx.doi.org/10.1038/ng.499			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	19915526	Green Accepted, Bronze			2022-12-25	WOS:000273055100013
J	Hayashi-Nishino, M; Fujita, N; Noda, T; Yamaguchi, A; Yoshimori, T; Yamamoto, A				Hayashi-Nishino, Mitsuko; Fujita, Naonobu; Noda, Takeshi; Yamaguchi, Akihito; Yoshimori, Tamotsu; Yamamoto, Akitsugu			A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation	NATURE CELL BIOLOGY			English	Article							RAT HEPATOCYTES; ISOLATION MEMBRANES; PROTEIN; DEGRADATION; TOMOGRAPHY; VACUOLES; CELLS	Autophagy is a bulk degradation process in eukaryotic cells and has fundamental roles in cellular homeostasis. The origin and source of autophagosomal membranes are long-standing questions in the field. Using electron microscopy, we show that, in mammalian culture cells, the endoplasmic reticulum ( ER) associates with early autophagic structures called isolation membranes (IMs). Overexpression of an Atg4B mutant, which causes defects in autophagosome formation, induces the accumulation of ER-IM complexes. Electron tomography revealed that the ER-IM complex appears as a subdomain of the ER that formed a cradle encircling the IM, and showed that both ER and isolation membranes are interconnected.	[Fujita, Naonobu; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Hayashi-Nishino, Mitsuko; Yamaguchi, Akihito] Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan; [Hayashi-Nishino, Mitsuko; Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Fac Biosci, Shiga 5260829, Japan	Osaka University; Osaka University	Yoshimori, T (corresponding author), Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, 3-1Yamadaoka, Suita, Osaka 5650871, Japan.	tamyoshi@biken.osaka-u.ac.jp; a_yamamoto@nagahama-i-bio.ac.jp	Yoshimori, Tamotsu/K-9626-2014; Fujita, Naonobu/A-1218-2010; Noda, Takeshi/B-7240-2008	Yoshimori, Tamotsu/0000-0001-9787-3788; Noda, Takeshi/0000-0003-3581-7961; Fujita, Naonobu/0000-0003-1914-8438	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank H. Nishioka and N. Kajimura for technical assistance with electron tomography, K. Nishino for assistance with setting up a computer and for useful comments on figure presentations, H. Omori for technical assistance with immunoelectron microscopy and K. Matsunaga and N. Taguchi for technical assistance with plasmid construction. This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; FURUNO K, 1990, EXP CELL RES, V189, P261, DOI 10.1016/0014-4827(90)90245-6; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kovacs AL, 2007, AUTOPHAGY, V3, P655, DOI 10.4161/auto.4590; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Walker S, 2008, AUTOPHAGY, V4, P1093, DOI 10.4161/auto.7141; YAMAMOTO A, 1990, J HISTOCHEM CYTOCHEM, V38, P573, DOI 10.1177/38.4.2319125; YAMAMOTO A, 1990, J HISTOCHEM CYTOCHEM, V38, P1571, DOI 10.1177/38.11.2212617; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010	22	751	781	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1433	U102		10.1038/ncb1991	http://dx.doi.org/10.1038/ncb1991			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19898463				2022-12-25	WOS:000272251300009
J	Sundstrom, JF; Vaculova, A; Smertenko, AP; Savenkov, EI; Golovko, A; Minina, E; Tiwari, BS; Rodriguez-Nieto, S; Zamyatnin, AA; Valineva, T; Saarikettu, J; Frilander, MJ; Suarez, MF; Zavialov, A; Stahl, U; Hussey, PJ; Silvennoinen, O; Sundberg, E; Zhivotovsky, B; Bozhkov, PV				Sundstrom, Jens F.; Vaculova, Alena; Smertenko, Andrei P.; Savenkov, Eugene I.; Golovko, Anna; Minina, Elena; Tiwari, Budhi S.; Rodriguez-Nieto, Salvador; Zamyatnin, Andrey A., Jr.; Valineva, Tuuli; Saarikettu, Juha; Frilander, Mikko J.; Suarez, Maria F.; Zavialov, Anton; Stahl, Ulf; Hussey, Patrick J.; Silvennoinen, Olli; Sundberg, Eva; Zhivotovsky, Boris; Bozhkov, Peter V.			Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome	NATURE CELL BIOLOGY			English	Article							COACTIVATOR PROTEIN P100; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; METACASPASES; APOPTOSIS; RNA; DNA; IDENTIFICATION; INHIBITOR; PROTEASES	Programmed cell death (PCD) is executed by proteases, which cleave diverse proteins thus modulating their biochemical and cellular functions. Proteases of the caspase family and hundreds of caspase substrates constitute a major part of the PCD degradome in animals(1,2). Plants lack close homologues of caspases, but instead possess an ancestral family of cysteine proteases, metacaspases(3,4). Although metacaspases are essential for PCD5-7, their natural substrates remain unknown(4,8). Here we show that metacaspase mcII-Pa cleaves a phylogenetically conserved protein, TSN (Tudor staphylococcal nuclease), during both developmental and stress-induced PCD. TSN knockdown leads to activation of ectopic cell death during reproduction, impairing plant fertility. Surprisingly, human TSN (also known as p100 or SND1), a multifunctional regulator of gene expression(9-15), is cleaved by caspase-3 during apoptosis. This cleavage impairs the ability of TSN to activate mRNA splicing, inhibits its ribonuclease activity and is important for the execution of apoptosis. Our results establish TSN as the first biological substrate of metacaspase and demonstrate that despite the divergence of plants and animals from a common ancestor about one billion years ago and their use of distinct PCD pathways, both have retained a common mechanism to compromise cell viability through the cleavage of the same substrate, TSN.	[Sundstrom, Jens F.; Savenkov, Eugene I.; Golovko, Anna; Minina, Elena; Tiwari, Budhi S.; Zamyatnin, Andrey A., Jr.; Stahl, Ulf; Sundberg, Eva; Bozhkov, Peter V.] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala BioCtr, SE-75007 Uppsala, Sweden; [Vaculova, Alena; Rodriguez-Nieto, Salvador; Zhivotovsky, Boris] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden; [Smertenko, Andrei P.; Hussey, Patrick J.] Univ Durham, Integrat Cell Biol Lab, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Valineva, Tuuli; Saarikettu, Juha; Silvennoinen, Olli] Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland; [Frilander, Mikko J.] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Suarez, Maria F.] Univ Malaga, Dept Biol Mol & Bioquim, Fac Ciencias, E-29071 Malaga, Spain; [Zavialov, Anton] Swedish Univ Agr Sci, Dept Mol Biol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Silvennoinen, Olli] Tampere Univ Hosp, Dept Clin Microbiol, FIN-33520 Tampere, Finland	Swedish University of Agricultural Sciences; Karolinska Institutet; Durham University; Tampere University; University of Helsinki; Universidad de Malaga; Swedish University of Agricultural Sciences; Tampere University; Tampere University Hospital	Bozhkov, PV (corresponding author), Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala BioCtr, Box 7080, SE-75007 Uppsala, Sweden.	andrei.smertenko@durham.ac.uk; peter.bozhkov@vbsg.slu.se	, Budhi S Tiwari/GSD-9696-2022; Minina, Elena/C-9888-2017; Frilander, Mikko J/B-6660-2009; Zavialov, Anton V./C-7664-2015; Zamyatnin, Andrey/D-6443-2012; Vaculová, Alena Hyršlová/H-1931-2014; Suárez, María Fernanda Valencia/F-8200-2019; Zhivotovsky, Boris/A-4346-2014; Bozhkov, Peter/K-3387-2012; Tiwari, Budhi/AFQ-0101-2022	Minina, Elena/0000-0002-2619-1859; Frilander, Mikko J/0000-0002-1732-4808; Zavialov, Anton V./0000-0001-6191-5931; Zamyatnin, Andrey/0000-0002-3046-4565; Suárez, María Fernanda Valencia/0000-0001-8987-8431; Zhivotovsky, Boris/0000-0002-2238-3482; Savenkov, Eugene/0000-0002-5802-5089; Bozhkov, Peter/0000-0002-8819-3884; Sundstrom, Jens/0000-0003-2848-5284; Smertenko, Andrei/0000-0002-5078-4881; Hyrslova Vaculova, Alena/0000-0002-0445-8807; Hussey, Patrick/0000-0002-7349-8722	Swedish Research Council; Swedish Cancer Society; Swedish Research Council for Environment; Agricultural Sciences and Spatial Planning; EC FP6 and FP7 Programs; Carl Tryggers Foundation; Pehrssons Fund; Wenner-Gren Foundation; Royal Swedish Academy of Agriculture and Forestry; Ministerio de Ciencia e Innovacion, Spain	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council for Environment(Swedish Research Council Formas); Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); EC FP6 and FP7 Programs(European Commission); Carl Tryggers Foundation; Pehrssons Fund; Wenner-Gren Foundation; Royal Swedish Academy of Agriculture and Forestry; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The authors thank: L. Filonova (Swedish University of Agricultural Sciences) for microsurgery preparations of plant embryos; G. Swardh (Swedish University of Agricultural Sciences) for Arabidopsis transformation and J. Dangl, A. Jones, C. Knorpp and S. Orrenius for comments on the manuscript. This work was supported by the Swedish Research Council (VR), the Swedish Cancer Society, the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), the EC FP6 and FP7 Programs, the Carl Tryggers Foundation, the Pehrssons Fund, the Wenner-Gren Foundation, the Royal Swedish Academy of Agriculture and Forestry and the Ministerio de Ciencia e Innovacion, Spain. A. V. is a postdoctoral fellow of the Wenner-Gren Foundation.	Bozhkov PV, 2005, CURR TOP DEV BIOL, V67, P135, DOI 10.1016/S0070-2153(05)67004-4; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Filonova LH, 2000, J CELL SCI, V113, P4399; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Howden R, 1998, GENETICS, V149, P621; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlgren Anna, 2009, J Vis Exp, DOI 10.3791/1205; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Kosec G, 2006, MOL BIOCHEM PARASIT, V145, P18, DOI 10.1016/j.molbiopara.2005.09.001; Kreuze JF, 2005, J VIROL, V79, P7227, DOI 10.1128/JVI.79.11.7227-7238.2005; Kuusk S, 2002, DEVELOPMENT, V129, P4707; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Scadden ADJ, 2007, MOL CELL, V28, P491, DOI 10.1016/j.molcel.2007.09.005; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Smertenko AP, 2003, PLANT J, V33, P813, DOI 10.1046/j.1365-313X.2003.01670.x; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; Talanian RV, 1997, J BIOL CHEM, V272, P9677; TONG X, 1995, MOL CELL BIOL, V15, P4735; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vakifahmetoglu H, 2006, ONCOGENE, V25, P5683, DOI 10.1038/sj.onc.1209569; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Valineva T, 2006, NUCLEIC ACIDS RES, V34, P3938, DOI 10.1093/nar/gkl539; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470	39	161	171	2	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1347	U198		10.1038/ncb1979	http://dx.doi.org/10.1038/ncb1979			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19820703				2022-12-25	WOS:000271425800015
J	Wiseman, RW; Karl, JA; Bimber, BN; O'Leary, CE; Lank, SM; Tuscher, JJ; Detmer, AM; Bouffard, P; Levenkova, N; Turcotte, CL; Szekeres, E; Wright, C; Harkins, T; O'Connor, DH				Wiseman, Roger W.; Karl, Julie A.; Bimber, Benjamin N.; O'Leary, Claire E.; Lank, Simon M.; Tuscher, Jennifer J.; Detmer, Ann M.; Bouffard, Pascal; Levenkova, Natalya; Turcotte, Cynthia L.; Szekeres, Edward, Jr.; Wright, Chris; Harkins, Timothy; O'Connor, David H.			Major histocompatibility complex genotyping with massively parallel pyrosequencing	NATURE MEDICINE			English	Article							CLASS-I SEQUENCES; IMMUNODEFICIENCY VIRUS-REPLICATION; RHESUS MACAQUE; CYNOMOLGUS MACAQUES; CHINESE-ORIGIN; PRIMATE MODELS; REGION; IDENTIFICATION; POLYMORPHISM; DIVERSITY	Major histocompatibility complex (MHC) genetics dictate adaptive cellular immune responses, making robust MHC genotyping methods essential for studies of infectious disease, vaccine development and transplantation. Nonhuman primates provide essential preclinical models for these areas of biomedical research. Unfortunately, given the unparalleled complexity of macaque MHCs, existing methodologies are inadequate for MHC typing of these key model animals. Here we use pyrosequencing of complementary DNA-PCR amplicons as a general approach to determine comprehensive MHC class I genotypes in nonhuman primates. More than 500 unique MHC class I sequences were resolved by sequence-based typing of rhesus, cynomolgus and pig-tailed macaques, nearly half of which have not been reported previously. The remarkable sensitivity of this approach in macaques demonstrates that pyrosequencing is viable for ultra-high-throughput MHC genotyping of primates, including humans.	[Wiseman, Roger W.; Karl, Julie A.; O'Leary, Claire E.; Lank, Simon M.; Tuscher, Jennifer J.; Detmer, Ann M.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Bimber, Benjamin N.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Wright, Chris] Univ Illinois, High Throughput Sequencing & Genotyping Unit, Urbana, IL 61801 USA; [Harkins, Timothy] Roche Appl Sci, Indianapolis, IN USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; Roche Holding	O'Connor, DH (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.	doconnor@primate.wisc.edu		Bimber, Benjamin/0000-0001-8092-3080; o'connor, david/0000-0003-2139-470X; Tuscher, Jennifer/0000-0002-8798-4545; O'Leary, Claire/0000-0001-9052-4593	US National Institute of Allergy and Infectious Diseases [HHSN266200400088C/N01-AI-40088]; Battelle Biomedical Research Center under US National Institute of Allergy and Infectious Diseases [N01-A1-30061]; US National Center for Research Resources [P51 RR000167, P40 RR019995]; US National Institutes of Health;  [RR15459-01];  [RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459, P51RR000167, P40RR019995] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096789] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Battelle Biomedical Research Center under US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Fresh blood or frozen peripheral blood mononuclear cell samples from various macaques were graciously provided by L. Picker (Oregon National Primate Research Center), P. Johnson (New England Primate Research Center), D. Read (Battelle Biomedical Research Center), N. Miller (US National Institute of Allergy and Infectious Diseases), J. Hoxie (University of Pennsylvania), J. Mankowski (Johns Hopkins University), T. Andrus (Charles River Biomedical Research Foundation, Inc.) and I. Lussier (Alpha Genesis, Inc.). L. Hetrick, A. Lane, E. Vlach and J. Thimmapuram provided outstanding emulsion PCR, pyrosequencing and informatics support at the University of Illinois at Urbana-Champaign. We thank D. Watkins and R. DeMars for insightful comments on this manuscript. This work was supported by US National Institute of Allergy and Infectious Diseases contract number HHSN266200400088C/N01-AI-40088. Some support was also provided by a subcontract from the Battelle Biomedical Research Center under US National Institute of Allergy and Infectious Diseases contract N01-A1-30061. This publication was made possible in part by grant numbers P51 RR000167 and P40 RR019995 from the US National Center for Research Resources, a component of the US National Institutes of Health to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01.	Bontrop RE, 2006, HUM IMMUNOL, V67, P388, DOI 10.1016/j.humimm.2006.03.007; Campbell KJ, 2009, IMMUNOGENETICS, V61, P177, DOI 10.1007/s00251-008-0351-x; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; Gardner MB, 2008, ILAR J, V49, P220, DOI 10.1093/ilar.49.2.220; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Haigwood NL, 2004, AIDS REV, V6, P187; Hale DA, 2005, PHILOS T R SOC B, V360, P1723, DOI 10.1098/rstb.2005.1703; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Karl JA, 2008, IMMUNOGENETICS, V60, P37, DOI 10.1007/s00251-007-0267-x; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Kulski JK, 2004, MOL BIOL EVOL, V21, P2079, DOI 10.1093/molbev/msh216; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2007, HIV MOL IMMUNOLOGY 2, P29; MARSH SGE, 2000, HLA FACTS BOOK, P3; O'Leary CE, 2009, IMMUNOGENETICS, V61, P689, DOI 10.1007/s00251-009-0397-4; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Otting N, 2008, IMMUNOGENETICS, V60, P507, DOI 10.1007/s00251-008-0311-5; Otting N, 2007, IMMUNOGENETICS, V59, P367, DOI 10.1007/s00251-007-0201-2; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Patterson JL, 2005, ILAR J, V46, P15, DOI 10.1093/ilar.46.1.15; Robinson J, 2005, NUCLEIC ACIDS RES, V33, pD523, DOI 10.1093/nar/gki032; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Watanabe A, 2007, GENOMICS, V89, P402, DOI 10.1016/j.ygeno.2006.11.002; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06	29	115	158	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1322	U123		10.1038/nm.2038	http://dx.doi.org/10.1038/nm.2038			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19820716	Green Accepted			2022-12-25	WOS:000271543700022
J	Ghiringhelli, F; Apetoh, L; Tesniere, A; Aymeric, L; Ma, YT; Ortiz, C; Vermaelen, K; Panaretakis, T; Mignot, G; Ullrich, E; Perfettini, JL; Schlemmer, F; Tasdemir, E; Uhl, M; Genin, P; Civas, A; Ryffel, B; Kanellopoulos, J; Tschopp, J; Andre, F; Lidereau, R; McLaughlin, NM; Haynes, NM; Smyth, MJ; Kroemer, G; Zitvogel, L				Ghiringhelli, Francois; Apetoh, Lionel; Tesniere, Antoine; Aymeric, Laetitia; Ma, Yuting; Ortiz, Carla; Vermaelen, Karim; Panaretakis, Theocharis; Mignot, Gregoire; Ullrich, Evelyn; Perfettini, Jean-Luc; Schlemmer, Frederic; Tasdemir, Ezgi; Uhl, Martin; Genin, Pierre; Civas, Ahmet; Ryffel, Bernhard; Kanellopoulos, Jean; Tschopp, Juerg; Andre, Fabrice; Lidereau, Rosette; McLaughlin, Nicole M.; Haynes, Nicole M.; Smyth, Mark J.; Kroemer, Guido; Zitvogel, Laurence			Activation of the NLRP3 inflammasome in dendritic cells induces IL-1 beta-dependent adaptive immunity against tumors	NATURE MEDICINE			English	Article							CALRETICULIN EXPOSURE; ALA POLYMORPHISM; P2X(7) RECEPTOR; B-CELLS; INNATE; CANCER; IDENTIFICATION; CASPASE-1; RELEASE; IL-1	The therapeutic efficacy of anticancer chemotherapies may depend on dendritic cells (DCs), which present antigens from dying cancer cells to prime tumor-specific interferon-gamma (IFN-gamma)-producing T lymphocytes. Here we show that dying tumor cells release ATP, which then acts on P2X(7) purinergic receptors from DCs and triggers the NOD-like receptor family, pyrin domain containing-3 protein (NLRP3)-dependent caspase-1 activation complex ('inflammasome'), allowing for the secretion of interleukin-1 beta (IL-1 beta). The priming of IFN-gamma-producing CD8(+) T cells by dying tumor cells fails in the absence of a functional IL-1 receptor 1 and in Nlpr3-deficient (Nlrp3(-/-)) or caspase-1-deficient (Casp-1(-/-)) mice unless exogenous IL-1 beta is provided. Accordingly, anticancer chemotherapy turned out to be inefficient against tumors established in purinergic receptor P2rx7(-/-) or Nlrp3(-/-) or Casp1(-/-) hosts. Anthracycline-treated individuals with breast cancer carrying a loss-of-function allele of P2RX7 developed metastatic disease more rapidly than individuals bearing the normal allele. These results indicate that the NLRP3 inflammasome links the innate and adaptive immune responses against dying tumor cells.	[Ghiringhelli, Francois; Apetoh, Lionel; Aymeric, Laetitia; Ma, Yuting; Ortiz, Carla; Vermaelen, Karim; Mignot, Gregoire; Ullrich, Evelyn; Andre, Fabrice; Zitvogel, Laurence] INSERM, U805, Villejuif, France; [Ghiringhelli, Francois; Apetoh, Lionel; Tesniere, Antoine; Aymeric, Laetitia; Ma, Yuting; Ortiz, Carla; Vermaelen, Karim; Panaretakis, Theocharis; Mignot, Gregoire; Ullrich, Evelyn; Perfettini, Jean-Luc; Schlemmer, Frederic; Tasdemir, Ezgi; Andre, Fabrice; Kroemer, Guido; Zitvogel, Laurence] Inst Gustave Roussy, Villejuif, France; [Ghiringhelli, Francois; Mignot, Gregoire] INSERM, AVENIR Team, CRI 866, Dijon, France; [Ghiringhelli, Francois; Mignot, Gregoire] Ctr Georges Francois Leclerc, Dijon, France; [Apetoh, Lionel; Tesniere, Antoine; Aymeric, Laetitia; Ma, Yuting; Ortiz, Carla; Vermaelen, Karim; Panaretakis, Theocharis; Ullrich, Evelyn; Perfettini, Jean-Luc; Schlemmer, Frederic; Tasdemir, Ezgi; Andre, Fabrice; Kroemer, Guido; Zitvogel, Laurence] Univ Paris Sud, Villejuif, France; [Apetoh, Lionel] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Tesniere, Antoine; Panaretakis, Theocharis; Perfettini, Jean-Luc; Schlemmer, Frederic; Tasdemir, Ezgi; Kroemer, Guido] INSERM, U848, Villejuif, France; [Ortiz, Carla] Univ Chile, Fac Ciencias Quim Farmaceut, Ctr FONDAP Estudios Mol Celula, Santiago, Chile; [Vermaelen, Karim] Ghent Univ Hosp, Dept Resp Med, Immunoregulat Lab, Ghent, Belgium; [Uhl, Martin] Inst Pasteur, INSERM, U818, F-75724 Paris, France; [Genin, Pierre; Civas, Ahmet] Univ Paris 05, CNRS, Lab Regulat Transcript & Malad Genet, UPR 2228, Paris 06, France; [Ryffel, Bernhard] CNRS, Transgenose Inst, IEM, UMR6218, F-45071 Orleans, France; [Kanellopoulos, Jean] Univ Paris, CNRS, UMR8619, Orsay, France; [Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Lidereau, Rosette] Ctr Rene Huguenin, INSERM, U735, St Cloud, France; [McLaughlin, Nicole M.; Haynes, Nicole M.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia; [Zitvogel, Laurence] CICBT507, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidad de Chile; Ghent University; Ghent University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; Peter Maccallum Cancer Center	Zitvogel, L (corresponding author), INSERM, U805, Villejuif, France.	kroemer@orange.fr; zitvogel@igr.fr	KROEMER, Guido/B-4263-2013; ANDRE, Fabrice/AAL-2683-2020; Kroemer, Guido/AAY-9859-2020; Smyth, Mark J/H-8709-2014; Mignot, Grégoire/R-4976-2017; Apetoh, Lionel/AIC-2384-2022; PERFETTINI, Jean-Luc/N-4699-2017; Apetoh, Lionel/G-3310-2014	KROEMER, Guido/0000-0002-9334-4405; ANDRE, Fabrice/0000-0001-5795-8357; Smyth, Mark J/0000-0001-7098-7240; Mignot, Grégoire/0000-0002-0682-0152; Apetoh, Lionel/0000-0002-2774-438X; PERFETTINI, Jean-Luc/0000-0002-2427-2604; Apetoh, Lionel/0000-0002-2774-438X; Genin, Pierre/0000-0002-7502-3851; Aymeric, Laetitia/0000-0001-7459-7231; Schlemmer, Frederic/0000-0003-2113-7113; Ullrich, Evelyn/0000-0001-8530-1192; ghiringhelli, francois/0000-0002-5465-8305; ZITVOGEL, laurence/0000-0003-1596-0998; Panaretakis, Theocharis/0000-0001-5754-6950	Ligue Nationale contre le Cancer; Fondation pour la Recherche Medicale; European Union; association for International cancer research; Canceropole Ile-de-France; Institut National du Cancer; Agence Nationale pour la Recherche; European Molecular Biology Organization; National Health; Association pour la recherche sur le cancer RC; National Health and Medical Research Council of Australia; Cancer Council of Victoria; China Scholarship Council; Leukemia Foundation; European Respiratory Society Fellowship [605]	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union(European Commission); association for International cancer research; Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Health; Association pour la recherche sur le cancer RC; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); China Scholarship Council(China Scholarship Council); Leukemia Foundation; European Respiratory Society Fellowship	We thank I. Couillin (CNRS) and A. Mignon (Cochin Hospital) for helpful discussion and for providing IL-1RA, R. Schreiber (Washington University School of Medicine) for monoclonal antibodies to IL-1 alpha, IL-1 beta and IL-1R, H. Yang (Feinstein Institute for Medical Research) for antibody to HMGB1, H. Yagita (School of Medicine, Juntendo University) for the N2B2 antibody to mouse TRAIL, J.-C. Guery (INSERM) for IL12rb2<SUP>-/-</SUP> mice, V. Dixit (Pennington Biomedical Research Center) for Pycard<SUP>-/-</SUP> mice, M. Albert (Pasteur Institute) for membrane-bound OVA-transfected mouse embryonic fibroblast cells, S. Forget and J. Bombled for access to the genomics platform, V. Vasseur and the Institut Gustave Roussy animal facility for breeding of transgenic mice, I. Martins for help in ATP release screening and A. Boissonnas (INSERM, Curie Institute) for providing OT1-GFP mice. We are deeply indebted to P. Arveux and S. Dabakuyo for useful help with the statistical analyses. The authors are supported by grants from the Ligue Nationale contre le Cancer (to L. Aymeric., G.K. and L.Z.), the Fondation pour la Recherche Medicale (to L. Apetoh., G.K., E.U., F.S. and L.Z.), the European Union (INFLACARE grant), the association for International cancer research (to G.K.) Canceropole Ile-de-France, Institut National du Cancer (L.Z., G.K.), Agence Nationale pour la Recherche (to G.K.), the European Molecular Biology Organization (L. Apetoh.), INSERM (A.T.), the National Health, Association pour la recherche sur le cancer RC (to G.M.), National Health and Medical Research Council of Australia, Cancer Council of Victoria, the China Scholarship Council (Y.M.) and the Leukemia Foundation (M.J.S., N.M.M. and N.M.H.). K.V. is the recipient of a European Respiratory Society Fellowship (number 605).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Blankenstein T, 2005, CURR OPIN IMMUNOL, V17, P180, DOI 10.1016/j.coi.2005.01.008; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brydges S, 2006, CURR TOP MICROBIOL, V305, P127, DOI 10.1007/3-540-29714-6_7; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Hagemann T, 2007, CANCER CELL, V12, P300, DOI 10.1016/j.ccr.2007.10.005; Hinrichs CS, 2006, CURR OPIN IMMUNOL, V18, P363, DOI 10.1016/j.coi.2006.03.009; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MCINTYRE KW, 1991, J EXP MED, V173, P931, DOI 10.1084/jem.173.4.931; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Reginato AM, 2007, CURR OPIN RHEUMATOL, V19, P134, DOI 10.1097/BOR.0b013e328040c00b; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Selzner N, 2004, CELL DEATH DIFFER, V11, pS172, DOI 10.1038/sj.cdd.4401505; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	52	1290	1336	3	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1170	U99		10.1038/nm.2028	http://dx.doi.org/10.1038/nm.2028			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19767732				2022-12-25	WOS:000270596400029
J	Gray, RS; Abitua, PB; Wlodarczyk, BJ; Szabo-Rogers, HL; Blanchard, O; Lee, I; Weiss, GS; Liu, KJ; Marcotte, EM; Wallingford, JB; Finnell, RH				Gray, Ryan S.; Abitua, Philip B.; Wlodarczyk, Bogdan J.; Szabo-Rogers, Heather L.; Blanchard, Otis; Lee, Insuk; Weiss, Greg S.; Liu, Karen J.; Marcotte, Edward M.; Wallingford, John B.; Finnell, Richard H.			The planar cell polarity effector Fuz is essential for targeted membrane trafficking, ciliogenesis and mouse embryonic development	NATURE CELL BIOLOGY			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA-TARDA; INTRAFLAGELLAR TRANSPORT PROTEIN; BARDET-BIEDL-SYNDROME; TRANSMEMBRANE PROTEIN; STRUCTURE PREDICTION; COMPLEX; MODEL; GENE; IDENTIFICATION; DYSFUNCTION	The planar cell polarity (PCP) signalling pathway is essential for embryonic development because it governs diverse cellular behaviours, and 'core PCP' proteins, such as Dishevelled and Frizzled, have been extensively characterized(1-4). By contrast, the 'PCP effector' proteins, such as Intu and Fuz, remain largely unstudied(5,6). These proteins are essential for PCP signalling, but they have never been investigated in mammals and their cell biological activities remain entirely unknown. We report here that Fuz mutant mice show neural tube defects, skeletal dysmorphologies and Hedgehog signalling defects stemming from disrupted ciliogenesis. Using bioinformatics and imaging of an in vivo mucociliary epithelium, we established a central role for Fuz in membrane trafficking, showing that Fuz is essential for trafficking of cargo to basal bodies and to the apical tips of cilia. Fuz is also essential for exocytosis in secretory cells. Finally, we identified a Rab-related small GTPase as a Fuz interaction partner that is also essential for ciliogenesis and secretion. These results are significant because they provide new insights into the mechanisms by which developmental regulatory systems such as PCP signalling interface with fundamental cellular systems such as the vesicle trafficking machinery.	[Wlodarczyk, Bogdan J.; Finnell, Richard H.] Texas A&M Hlth Sci Ctr, Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX 77030 USA; [Gray, Ryan S.; Abitua, Philip B.; Blanchard, Otis; Weiss, Greg S.; Wallingford, John B.] Univ Texas Austin, Dept Mol Cell & Dev Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Finnell, Richard H.] Texas A&M Inst Genom Med, Houston, TX 77030 USA; [Szabo-Rogers, Heather L.; Liu, Karen J.] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England; [Lee, Insuk; Weiss, Greg S.; Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Ctr Syst & Synthet Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin; University of London; King's College London; University of Texas System; University of Texas Austin	Finnell, RH (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX 77030 USA.	rfinnell@ibt.tamhsc.edu	Lee, Insuk/F-7722-2010; Gray, Ryan/G-2187-2010; Gray, Ryan/W-8366-2019; Gray, Ryan/L-3923-2019; Finnell, Richard/D-8174-2018; Liu, Karen/F-2870-2010	Gray, Ryan/0000-0001-9668-6497; Gray, Ryan/0000-0001-9668-6497; Finnell, Richard/0000-0002-5962-8754; Abitua, Philip/0000-0002-8264-0807; Marcotte, Edward/0000-0001-8808-180X; Liu, Karen/0000-0002-2483-2165; Wlodarczyk, Bogdan J./0000-0001-5249-5832	Wellcome Trust; BBSRC; NSF; NIH; Welch Foundation [F-1515]; Texas Institute for Drug and Diagnostic Development; Packard Fellowship; NIH/NIGMS; March of Dimes; Burroughs Wellcome Fund; Sandler Program for Asthma Research; Texas Advanced Research Program; Texas A& M Institute for Genomic Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104, R01GM067779] Funding Source: NIH RePORTER; BBSRC [BB/E01335X/1, BB/E013872/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E01335X/1, BB/E013872/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Texas Institute for Drug and Diagnostic Development; Packard Fellowship(The David & Lucile Packard Foundation); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Sandler Program for Asthma Research; Texas Advanced Research Program; Texas A& M Institute for Genomic Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The ES cell clone for making the Fuz mutant mouse was provided by Lexicon Pharmaceuticals. We thank P. Paukstelis for aid with structural modelling, S. Vokes for critical comments on the manuscript, and Wei H. for technical help with histology and immunostaining. Phil Abitua is supported by a Diversity Supplement from the NIH/NIGMS. This work was supported by grants to K. J. L from the Wellcome Trust and the BBSRC; to E. M. M. from the NSF, NIH, Welch Foundation (F-1515), Texas Institute for Drug and Diagnostic Development, and a Packard Fellowship; grants to J. B. W. from the NIH/NIGMS, The March of Dimes, The Burroughs Wellcome Fund, the Sandler Program for Asthma Research, and the Texas Advanced Research Program; and by grants to R. H. F. from the NIH and The Texas A& M Institute for Genomic Medicine.	Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; BILLETT FS, 1971, J ANAT, V108, P465; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chan SW, 2005, GENE, V353, P189, DOI 10.1016/j.gene.2005.04.025; Collier S, 1997, DEVELOPMENT, V124, P4029; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Dougherty GW, 2005, CELL MOTIL CYTOSKEL, V62, P141, DOI 10.1002/cm.20093; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Hagiwara H, 1997, CELL TISSUE RES, V290, P39, DOI 10.1007/s004410050905; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Karner C, 2006, SEMIN CELL DEV BIOL, V17, P194, DOI 10.1016/j.semcdb.2006.05.003; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; KIMMEL CA, 1981, STAIN TECHNOL, V56, P271, DOI 10.3109/10520298109067325; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee H, 2002, GENETICS, V160, P1535; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nagata S, 2003, DEV GENES EVOL, V213, P368, DOI 10.1007/s00427-003-0341-9; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; SNELL GD, 1948, ANAT REC, V76, P30; SOROKIN SP, 1968, J CELL SCI, V3, P207; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Wilson J.G., 1965, TERATOLOGY PRINCIPLE, P251; Yang J, 2005, EXP CELL RES, V309, P379, DOI 10.1016/j.yexcr.2005.05.026	50	155	159	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1225	U153		10.1038/ncb1966	http://dx.doi.org/10.1038/ncb1966			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767740	Green Accepted			2022-12-25	WOS:000270382000012
J	Iadecola, C				Iadecola, Costantino			Bleeding in the brain Killer waves of depolarization in subarachnoid bleed	NATURE MEDICINE			English	Editorial Material							DELAYED CEREBRAL-ISCHEMIA; PERIINFARCT DEPOLARIZATIONS; HEMORRHAGE; MANAGEMENT; PERFUSION; GLUCOSE		Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA	Cornell University	Iadecola, C (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA.	coi2001@med.cornell.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	NHLBI NIH HHS [P01 HL096571] Funding Source: Medline; NINDS NIH HHS [R37 NS034179] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL096571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034179] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Busija DW, 2008, PROG NEUROBIOL, V86, P379, DOI 10.1016/j.pneurobio.2008.09.008; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; HIJDRA A, 1986, NEUROLOGY, V36, P329, DOI 10.1212/WNL.36.3.329; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Minhas PS, 2003, NEUROSURGERY, V52, P1017, DOI 10.1227/01.NEU.0000058231.08870.1F; Nozari A, 2010, ANN NEUROL, V67, P221, DOI 10.1002/ana.21871; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stein SC, 2006, NEUROSURGERY, V59, P781, DOI 10.1227/01.NEU.0000227519.27569.45; Strong AJ, 2008, INTENS CARE MED, V34, P1169, DOI 10.1007/s00134-008-1045-4; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Takano T, 2009, J CLIN INVEST, V119, P16, DOI 10.1172/JCI38051	15	23	24	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1131	1132		10.1038/nm1009-1131	http://dx.doi.org/10.1038/nm1009-1131			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19812570				2022-12-25	WOS:000270596400020
J	Kubota, K; Anjum, R; Yu, YH; Kunz, RC; Andersen, JN; Kraus, M; Keilhack, H; Nagashima, K; Krauss, S; Paweletz, C; Hendrickson, RC; Feldman, AS; Wu, CL; Rush, J; Villen, J; Gygi, SP				Kubota, Kazuishi; Anjum, Rana; Yu, Yonghao; Kunz, Ryan C.; Andersen, Jannik N.; Kraus, Manfred; Keilhack, Heike; Nagashima, Kumiko; Krauss, Stefan; Paweletz, Cloud; Hendrickson, Ronald C.; Feldman, Adam S.; Wu, Chin-Lee; Rush, John; Villen, Judit; Gygi, Steven P.			Sensitive multiplexed analysis of kinase activities and activity-based kinase identification	NATURE BIOTECHNOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; MASS-SPECTROMETRY; DRUG DISCOVERY; PHOSPHORYLATION ANALYSIS; PHOSPHOPROTEOME ANALYSIS; SIGNALING NETWORKS; IN-VIVO; SUBSTRATE; CANCER; PEPTIDES	Constitutive activation of one or more kinase signaling pathways is a hallmark of many cancers. Here we extend the previously described mass spectrometry-based KAYAK approach by monitoring kinase activities from multiple signaling pathways simultaneously. This improved single-reaction strategy, which quantifies the phosphorylation of 90 synthetic peptides in a single mass spectrometry run, is compatible with nanogram to microgram amounts of cell lysate. Furthermore, the approach enhances kinase monospecificity through substrate competition effects, faithfully reporting the signatures of many signaling pathways after mitogen stimulation or of basal pathway activation differences across a panel of well-studied cancer cell lines. Hierarchical clustering of activities from related experiments groups peptides phosphorylated by similar kinases together and, when combined with pathway alteration using pharmacological inhibitors, distinguishes underlying differences in potency, off-target effects and genetic backgrounds. Finally, we introduce a strategy to identify the kinase, and even associated protein complex members, responsible for phosphorylation events of interest.	[Kubota, Kazuishi; Anjum, Rana; Yu, Yonghao; Kunz, Ryan C.; Villen, Judit; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Andersen, Jannik N.; Kraus, Manfred; Keilhack, Heike; Nagashima, Kumiko; Krauss, Stefan; Paweletz, Cloud] Merck Res Labs, Boston, MA USA; [Hendrickson, Ronald C.] Merck & Co Inc, Rahway, NJ 07065 USA; [Feldman, Adam S.] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Wu, Chin-Lee] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Rush, John] Cell Signaling Technol, Danvers, MA USA	Harvard University; Harvard Medical School; Merck & Company; Merck & Company; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu		Krauss, Stefan/0000-0001-6992-8091; Villen, Judit/0000-0002-1005-1739; Andersen, Jannik/0000-0003-4528-2120	National Institutes of Health (NIH) [HG3456, GM67945, GM51405]; Merck and ThermoFisher; Daiichi Sankyo Co., Ltd; Spanish Ministry of Education and Science; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM051405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck and ThermoFisher; Daiichi Sankyo Co., Ltd(Daiichi Sankyo Company Limited); Spanish Ministry of Education and Science(Spanish Government); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institutes of Health (NIH; HG3456 and GM67945) and an industry-sponsored research project to S. P. G. from Merck and ThermoFisher. K. K. was supported by Daiichi Sankyo Co., Ltd. Y.Y. was partly supported by J. Blenis through grants from the NIH (GM51405). J. V. was supported by a grant from the Spanish Ministry of Education and Science. We thank C. Zhou, S. Elledge and N. Dephoure for help with cell cycle sample preparation, J. Elias and D. Kolippakkam for bioinformatics support, M. Rodriguez-Falcon for establishing Stagetip-IMAC protocol, and S. Sando and T. Robbins for peptide purification. We appreciate the advice and encouragement of many members of the Gygi lab and Mayumi Kubota.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bilodeau MT, 2008, BIOORG MED CHEM LETT, V18, P3178, DOI 10.1016/j.bmcl.2008.04.074; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Chou TF, 2005, J BIOL CHEM, V280, P15356, DOI 10.1074/jbc.M500434200; DAILE P, 1975, NATURE, V257, P416, DOI 10.1038/257416a0; DAILE P, 1974, BIOCHEM BIOPH RES CO, V61, P852, DOI 10.1016/0006-291X(74)90234-4; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ELWOODYEN K, 2008, AM ASS CANC RES SPEC; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Gao H, 2003, J AM SOC MASS SPECTR, V14, P173, DOI 10.1016/S1044-0305(02)00867-X; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; GLASS DB, 1989, J BIOL CHEM, V264, P8802; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Houseman BT, 2002, NAT BIOTECHNOL, V20, P270, DOI 10.1038/nbt0302-270; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; KEMP BE, 1991, METHOD ENZYMOL, V200, P121; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Maly DJ, 2004, J AM CHEM SOC, V126, P9160, DOI 10.1021/ja048659i; MANNING BD, 2002, SCI STKE, pPE49; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PAN ZQ, 1993, J BIOL CHEM, V268, P20443; Parang K, 2002, FEBS LETT, V520, P156, DOI 10.1016/S0014-5793(02)02778-3; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Pi N, 2002, BIOCHEMISTRY-US, V41, P13283, DOI 10.1021/bi020457g; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Shen K, 2003, J AM CHEM SOC, V125, P16172, DOI 10.1021/ja0380401; Shults MD, 2007, CHEMBIOCHEM, V8, P933, DOI 10.1002/cbic.200600522; Sigoillot FD, 2004, INT J CANCER, V109, P491, DOI 10.1002/ijc.11717; Statsuk AV, 2008, J AM CHEM SOC, V130, P17568, DOI 10.1021/ja807066f; SUN D, 2009, COMB CHEM H IN PRESS; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335; XU Z, 2009, J BIOMOL SC IN PRESS; Yu YH, 2009, P NATL ACAD SCI USA, V106, P11606, DOI 10.1073/pnas.0905165106; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a	59	85	92	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2009	27	10					933	U98		10.1038/nbt.1566	http://dx.doi.org/10.1038/nbt.1566			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	515LO	19801977	Green Accepted			2022-12-25	WOS:000271472500024
J	Hecker, L; Vittal, R; Jones, T; Jagirdar, R; Luckhardt, TR; Horowitz, JC; Pennathur, S; Martinez, FJ; Thannickal, VJ				Hecker, Louise; Vittal, Ragini; Jones, Tamara; Jagirdar, Rajesh; Luckhardt, Tracy R.; Horowitz, Jeffrey C.; Pennathur, Subramaniam; Martinez, Fernando J.; Thannickal, Victor J.			NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury	NATURE MEDICINE			English	Article							INDUCED PULMONARY FIBROSIS; NOX-FAMILY; TRANSFORMING GROWTH-FACTOR-BETA-1; REACTIVE OXYGEN; GROWTH-FACTOR; NULL MICE; FIBROBLASTS; DISEASE; DIFFERENTIATION; INDUCTION	Members of the NADPH oxidase (NOX) family of enzymes, which catalyze the reduction of O-2 to reactive oxygen species, have increased in number during eukaryotic evolution(1,2). Seven isoforms of the NOX gene family have been identified in mammals; however, specific roles of NOX enzymes in mammalian physiology and pathophysiology have not been fully elucidated(3,4). The best established physiological role of NOX enzymes is in host defense against pathogen invasion in diverse species, including plants(5,6). The prototypical member of this family, NOX-2 (gp91(phox)), is expressed in phagocytic cells and mediates microbicidal activities(7,8). Here we report a role for the NOX4 isoform in tissue repair functions of myofibroblasts and fibrogenesis. Transforming growth factor. beta 1 (TGF-beta 1) induces NOX-4 expression in lung mesenchymal cells via SMAD-3, a receptor-regulated protein that modulates gene transcription. NOX-4-dependent generation of hydrogen peroxide (H2O2) is required for TGF-beta 1-induced myofibroblast differentiation, extracellular matrix (ECM) production and contractility. NOX-4 is upregulated in lungs of mice subjected to noninfectious injury and in cases of human idiopathic pulmonary fibrosis (IPF). Genetic or pharmacologic targeting of NOX-4 abrogates fibrogenesis in two murine models of lung injury. These studies support a function for NOX4 in tissue fibrogenesis and provide proof of concept for therapeutic targeting of NOX-4 in recalcitrant fibrotic disorders.	[Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA; [Hecker, Louise; Vittal, Ragini; Jones, Tamara; Jagirdar, Rajesh; Luckhardt, Tracy R.; Horowitz, Jeffrey C.; Martinez, Fernando J.; Thannickal, Victor J.] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Thannickal, VJ (corresponding author), Univ Alabama, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	vjthan@uab.edu	VITTAL, RAGINI/AAE-9052-2020; Jagirdar, Rajesh/AAO-2327-2021	Jagirdar, Rajesh/0000-0001-7005-7772; Horowitz, Jeffrey/0000-0002-1505-2837	US National Institutes of Health [R01 HL067967, K08 HL081059]; National Institutes of Health-sponsored Lung Tissue Research Consortium [N01 HR046162]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067967, K08HL081059] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-sponsored Lung Tissue Research Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Lambeth, Department of Biochemistry, Emory University, for providing the rabbit polyclonal antibody to NOX-4 and A. Jesaitis, Department of Microbiology, Montana State University, for the mouse monoclonal antibody to NOX-2. We thank D. Arenberg, Department of Internal Medicine, University of Michigan, for providing primary lung mesenchymal cells from human subjects with IPF (IPF-MCs). This work was supported by grants from the US National Institutes of Health R01 HL067967 ( to V. J. T.) and K08 HL081059 ( to J. C. H.) and by a National Institutes of Health-sponsored Lung Tissue Research Consortium grant, N01 HR046162 ( to F. J. M.).	Ahluwalia J, 2004, NATURE, V427, P853, DOI 10.1038/nature02356; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; QUIE PG, 1967, J CLIN INVEST, V46, P668, DOI 10.1172/JCI105568; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; ROBERTS SN, 1995, J PATHOL, V176, P309, DOI 10.1002/path.1711760313; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Thannickal VJ, 2009, AM J RESP CELL MOL, V40, P507, DOI 10.1165/rcmb.2008-0360PS; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; THRALL RS, 1982, AM REV RESPIR DIS, V126, P488; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; ZHANG K, 1994, AM J PATHOL, V145, P114	29	603	633	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1077	U133		10.1038/nm.2005	http://dx.doi.org/10.1038/nm.2005			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19701206	Green Accepted			2022-12-25	WOS:000269979200030
J	Stavreva, DA; Wiench, M; John, S; Conway-Campbell, BL; McKenna, MA; Pooley, JR; Johnson, TA; Voss, TC; Lightman, SL; Hager, GL				Stavreva, Diana A.; Wiench, Malgorzata; John, Sam; Conway-Campbell, Becky L.; McKenna, Mervyn A.; Pooley, John R.; Johnson, Thomas A.; Voss, Ty C.; Lightman, Stafford L.; Hager, Gordon L.			Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription	NATURE CELL BIOLOGY			English	Article							LIGAND-SPECIFIC DYNAMICS; CHROMATIN DYNAMICS; ANDROGEN RECEPTOR; PROMOTER; MECHANISM; EXCHANGE; CELLS; OSCILLATIONS; PULSATILITY; PROTEASOME	Studies on glucocorticoid receptor (GR) action typically assess gene responses by long-term stimulation with synthetic hormones. As corticosteroids are released from adrenal glands in a circadian and high-frequency (ultradian) mode, such treatments may not provide an accurate assessment of physiological hormone action. Here we demonstrate that ultradian hormone stimulation induces cyclic GR-mediated transcriptional regulation, or gene pulsing, both in cultured cells and in animal models. Equilibrium receptor-occupancy of regulatory elements precisely tracks the ligand pulses. Nascent RNA transcripts from GR-regulated genes are released in distinct quanta, demonstrating a profound difference between the transcriptional programs induced by ultradian and constant stimulation. Gene pulsing is driven by rapid GR exchange with response elements and by GR recycling through the chaperone machinery, which promotes GR activation and reactivation in response to the ultradian hormone release, thus coupling promoter activity to the naturally occurring fluctuations in hormone levels. The GR signalling pathway has been optimized for a prompt and timely response to fluctuations in hormone levels, indicating that biologically accurate regulation of gene targets by GR requires an ultradian mode of hormone stimulation.	[Stavreva, Diana A.; Wiench, Malgorzata; John, Sam; Johnson, Thomas A.; Voss, Ty C.; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Conway-Campbell, Becky L.; McKenna, Mervyn A.; Pooley, John R.; Lightman, Stafford L.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bristol	Hager, GL (corresponding author), NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, 41 Lib Dr, Bethesda, MD 20892 USA.	hagerg@exchange.nih.gov	Stavreva, Diana/AAW-8964-2020	Lightman, Stafford/0000-0002-8546-9646; Wiench, Malgorzata/0000-0002-0202-9881	NIH; National Cancer Institute; Center for Cancer Research; BBSRC [BB/C51297X/1]; Wellcome Trust [074112/Z/04/Z, 075548/Z/04/Z]; NATIONAL CANCER INSTITUTE [Z01BC010308, ZIABC010308] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/C51297X/1] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank T. Karpova and J. McNally for assistance, C. Zeiss Inc. for the opportunity to carry out live cell experiments on a Zeiss Duoscan microscope, D. Shatti for technical assistance with nuclear extract preparation and Y. Kershaw for assistance with the in vivo experiments. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The animal work was supported by a BBSRC grant (BB/C51297X/1) and a Wellcome Trust Programme Grant (074112/Z/04/Z) to S.L. The qPCR was performed on an Applied Biosystems 7500 System funded by a Wellcome Trust Equipment Grant (075548/Z/04/Z).	ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chadwick D., 2000, MECH BIOL SIGNIFICAN; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Conway-Campbell BL, 2007, ENDOCRINOLOGY, V148, P5470, DOI 10.1210/en.2007-0585; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Freeman BC, 2001, TRENDS BIOCHEM SCI, V26, P285, DOI 10.1016/S0968-0004(01)01834-5; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gore A. C, 2002, GNRH MASTER MOL REPR; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Kramer PR, 1999, J BIOL CHEM, V274, P28590, DOI 10.1074/jbc.274.40.28590; Lewis JG, 2005, CLIN CHIM ACTA, V359, P189, DOI 10.1016/j.cccn.2005.03.044; Lightman SL, 2006, BIOCHEM SOC T, V34, P1117, DOI 10.1042/BST0341117; Lightman S. L., 2002, Archives of Physiology and Biochemistry, V110, P90, DOI 10.1076/apab.110.1.90.899; Liu JM, 1999, MOL ENDOCRINOL, V13, P355, DOI 10.1210/me.13.3.355; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mezo G, 2008, CURR MED CHEM, V15, P2366, DOI 10.2174/092986708785909157; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; MUNCK A, 1976, J STEROID BIOCHEM, V7, P1117, DOI 10.1016/0022-4731(76)90042-X; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; QI M, 1990, MOL ENDOCRINOL, V4, P455, DOI 10.1210/mend-4-3-455; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Rothwell P, 2007, EUR J NEUROL, V14, P306; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sugaya K, 2000, J CELL SCI, V113, P2679; Thompson NM, 2003, ENDOCRINOLOGY, V144, P4859, DOI 10.1210/en.2003-0423; Vallone D, 1997, EMBO J, V16, P5310, DOI 10.1093/emboj/16.17.5310; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001	43	266	271	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1093	U111		10.1038/ncb1922	http://dx.doi.org/10.1038/ncb1922			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684579	Green Accepted			2022-12-25	WOS:000269482500010
J	Yemisci, M; Gursoy-Ozdemir, Y; Vural, A; Can, A; Topalkara, K; Dalkara, T				Yemisci, Muge; Gursoy-Ozdemir, Yasemin; Vural, Atay; Can, Alp; Topalkara, Kamil; Dalkara, Turgay			Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; FOCAL ISCHEMIA; MICROCIRCULATORY OBSTRUCTION; LEUKOCYTE ACCUMULATION; HYDROGEN-PEROXIDE; EARLY REPERFUSION; IN-VIVO; STROKE; THERAPY	Here we show that ischemia induces sustained contraction of pericytes on microvessels in the intact mouse brain. Pericytes remain contracted despite successful reopening of the middle cerebral artery after 2 h of ischemia. Pericyte contraction causes capillary constriction and obstructs erythrocyte flow. Suppression of oxidative-nitrative stress relieves pericyte contraction, reduces erythrocyte entrapment and restores microvascular patency; hence, tissue survival improves. In contrast, peroxynitrite application causes pericyte contraction. We also show that the microvessel wall is the major source of oxygen and nitrogen radicals causing ischemia and reperfusion-induced microvascular dysfunction. These findings point to a major but previously not recognized pathophysiological mechanism; ischemia and reperfusion-induced injury to pericytes may impair microcirculatory reflow and negatively affect survival by limiting substrate and drug delivery to tissue already under metabolic stress, despite recanalization of an occluded artery. Agents that can restore pericyte dysfunction and microvascular patency may increase the success of thrombolytic and neuroprotective treatments.	[Yemisci, Muge; Gursoy-Ozdemir, Yasemin; Vural, Atay; Topalkara, Kamil; Dalkara, Turgay] Hacettepe Univ, Fac Med, Dept Neurol, TR-06100 Ankara, Turkey; [Yemisci, Muge; Gursoy-Ozdemir, Yasemin; Vural, Atay; Topalkara, Kamil; Dalkara, Turgay] Hacettepe Univ, Inst Neurol Sci & Psychiat, TR-06100 Ankara, Turkey; [Can, Alp] Ankara Univ, Sch Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey	Hacettepe University; Hacettepe University; Ankara University	Dalkara, T (corresponding author), Hacettepe Univ, Fac Med, Dept Neurol, TR-06100 Ankara, Turkey.	tdalkara@hacettepe.edu.tr	Vural, Atay/K-7388-2012; Gursoy-Ozdemir, Yasemin/X-2778-2019; Yemisci, Muge/I-9928-2013; Can, Alp/AAO-5734-2020	Vural, Atay/0000-0003-3222-874X; Gursoy-Ozdemir, Yasemin/0000-0002-0860-8964; Yemisci, Muge/0000-0002-1528-1998; Dalkara, Turgay/0000-0003-3943-7819	The Turkish Academy of Sciences; Hacettepe University Research Fund [0401105001]; Scientific and Technical Research Council of Turkey [104S254]; Ankara University Biotechnology Institute [2001K120240]; Brain Research Association	The Turkish Academy of Sciences(Turkish Academy of Sciences); Hacettepe University Research Fund(Hacettepe University); Scientific and Technical Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Ankara University Biotechnology Institute(Ankara University); Brain Research Association	This work was supported by The Turkish Academy of Sciences (T. D. and Y.G.-O.), Hacettepe University Research Fund 0401105001 (T. D.), Scientific and Technical Research Council of Turkey 104S254 (Y.G.-O.), Ankara University Biotechnology Institute 2001K120240 (A. C.) and Brain Research Association (M.Y.). We are grateful to M. A. Moskowitz for his support and comments. Part of this study was presented at the Society For Neuroscience 37th Annual Meeting in San Diego, California, 2007.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Allt G, 2001, CELLS TISSUES ORGANS, V169, P1, DOI 10.1159/000047855; AMES A, 1968, AM J PATHOL, V52, P437; ANWAR M, 1988, CIRC RES, V63, P27, DOI 10.1161/01.RES.63.1.27; Balabanov R, 1998, J NEUROSCI RES, V53, P637, DOI 10.1002/(SICI)1097-4547(19980915)53:6<637::AID-JNR1>3.0.CO;2-6; Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chrissobolis S, 2006, STROKE, V37, P2174, DOI 10.1161/01.STR.0000231647.41578.df; CROWELL RM, 1972, NEUROLOGY, V22, P500, DOI 10.1212/WNL.22.5.500; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.1276; Faraci FM, 2006, J APPL PHYSIOL, V100, P739, DOI 10.1152/japplphysiol.01044.2005; FISCHER EG, 1973, ARCH NEUROL-CHICAGO, V29, P361, DOI 10.1001/archneur.1973.00490300023002; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; GARCIA JH, 1994, AM J PATHOL, V145, P728; Gibson CL, 2005, GLIA, V50, P417, DOI 10.1002/glia.20143; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Hudetz AG, 1997, MICROCIRCULATION, V4, P233, DOI 10.3109/10739689709146787; Iadecola C, 1997, J NEUROSCI, V17, P9157; Juttler E, 2006, NAT CLIN PRACT CARD, V3, P656, DOI 10.1038/ncpcardio0721; Kamouchi M, 2007, NEUROSCI LETT, V416, P12, DOI 10.1016/j.neulet.2007.01.039; Li PA, 1998, NEUROSCI LETT, V253, P191, DOI 10.1016/S0304-3940(98)00643-0; LITTLE JR, 1976, STROKE, V7, P25, DOI 10.1161/01.STR.7.1.25; LITTLE JR, 1975, MAYO CLIN PROC, V50, P264; Liu SM, 2002, J CEREBR BLOOD F MET, V22, P1222, DOI 10.1097/01.wcb.0000037998.34930.83; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Molina CA, 2005, STROKE, V36, P2311, DOI 10.1161/01.STR.0000182100.65262.46; NEWELL DW, 1995, J NEUROSCI, V15, P7702; Ohtake M, 2004, NEUROPATHOLOGY, V24, P219, DOI 10.1111/j.1440-1789.2004.00560.x; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Ritter LS, 2000, STROKE, V31, P1153, DOI 10.1161/01.STR.31.5.1153; VERDOUW PD, 1984, EUR J PHARMACOL, V102, P499, DOI 10.1016/0014-2999(84)90571-5; Wei EP, 1996, AM J PHYSIOL-HEART C, V271, pH1262, DOI 10.1152/ajpheart.1996.271.3.H1262; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002	44	459	473	4	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1031	U82		10.1038/nm.2022	http://dx.doi.org/10.1038/nm.2022			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19718040				2022-12-25	WOS:000269979200023
J	Weaver, TA; Charafeddine, AH; Agarwal, A; Turner, AP; Russell, M; Leopardi, FV; Kampen, RL; Stempora, L; Song, MQ; Larsen, CP; Kirk, AD				Weaver, Tim A.; Charafeddine, Ali H.; Agarwal, Avinash; Turner, Alexandra P.; Russell, Maria; Leopardi, Frank V.; Kampen, Robert L.; Stempora, Linda; Song, Mingqing; Larsen, Christian P.; Kirk, Allan D.			Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates	NATURE MEDICINE			English	Article							DONOR-SPECIFIC TRANSFUSION; CHRONIC PLAQUE PSORIASIS; T-CELL MEMORY; TRANSPLANTATION TOLERANCE; BARRIER; IMMUNITY	Memory T cells promote allograft rejection particularly in co-stimulation blockade-based immunosuppressive regimens. Here we show that the CD2-specific fusion protein alefacept (lymphocyte function-associated antigen-3-Ig; LFA-3-Ig) selectively eliminates memory T cells and, when combined with a co-stimulation blockade-based regimen using cytotoxic T lymphocyte antigen-4 (CTLA-4)-Ig, a CD80- and CD86-specific fusion protein, prevents renal allograft rejection and alloantibody formation in nonhuman primates. These results support the immediate translation of a regimen for the prevention of allograft rejection without the use of calcineurin inhibitors, steroids or pan-T cell depletion.	[Weaver, Tim A.; Charafeddine, Ali H.; Agarwal, Avinash; Turner, Alexandra P.; Russell, Maria; Leopardi, Frank V.; Kampen, Robert L.; Stempora, Linda; Song, Mingqing; Kirk, Allan D.] NIDDK, Transplantat Branch, US NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Weaver, Tim A.; Charafeddine, Ali H.; Leopardi, Frank V.; Kampen, Robert L.; Larsen, Christian P.; Kirk, Allan D.] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Emory University	Kirk, AD (corresponding author), NIDDK, Transplantat Branch, US NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	adkirk@emory.edu	Larsen, Christian P./B-6906-2012; Kirk, Allan D./B-6905-2012	Larsen, Christian P./0000-0001-6573-2649; Kirk, Allan/0000-0003-2004-5962	Division of Intramural Research, National Institute of Diabetes, Digestive and Kidney Disease, NIH [Z01 DK062007-06]; National Institutes of Health [1U01AI079223-01A1]; Georgia Research Alliance; McKelvey Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI079223, U19AI043900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK062007] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Diabetes, Digestive and Kidney Disease, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; McKelvey Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by the Division of Intramural Research, National Institute of Diabetes, Digestive and Kidney Disease, NIH (Z01 DK062007-06). Salary support for T. A. W. was provided by the Howard Hughes Medical Institute through the NIH Research Scholars Program. A. D. K. is supported by the National Institutes of Health (1U01AI079223-01A1), the Georgia Research Alliance and the McKelvey Foundation. We gratefully acknowledge the expert assistance of J. Bacher and the staff of the NIH Veterinary Pathology Department.	Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Girlanda R, 2008, AM J TRANSPLANT, V8, P600, DOI 10.1111/j.1600-6143.2007.02109.x; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Kirk AD, 2003, IMMUNOL REV, V196, P176, DOI 10.1046/j.1600-065X.2003.00081.x; Li YS, 1998, TRANSPLANTATION, V66, P1387, DOI 10.1097/00007890-199811270-00021; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x; Ortonne JP, 2003, EUR J DERMATOL, V13, P117; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Preston EH, 2005, AM J TRANSPLANT, V5, P1032, DOI 10.1111/j.1600-6143.2005.00796.x; Valujskikh A, 2007, J AM SOC NEPHROL, V18, P2252, DOI 10.1681/ASN.2007020151; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965	14	148	155	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					746	749		10.1038/nm.1993	http://dx.doi.org/10.1038/nm.1993			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19584865	Green Accepted			2022-12-25	WOS:000267806900026
J	He, CY; Kraft, P; Chen, C; Buring, JE; Pare, G; Hankinson, SE; Chanock, SJ; Ridker, PM; Hunter, DJ; Chasman, DI				He, Chunyan; Kraft, Peter; Chen, Constance; Buring, Julie E.; Pare, Guillaume; Hankinson, Susan E.; Chanock, Stephen J.; Ridker, Paul M.; Hunter, David J.; Chasman, Daniel I.			Genome-wide association studies identify loci associated with age at menarche and age at natural menopause	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; REPRODUCTIVE FACTORS; LINKAGE ANALYSIS; BREAST-CANCER; SCAN; RISK; REPLICATION; PROTEIN; GENES; TWIN	Age at menarche and age at natural menopause are associated with causes of substantial morbidity and mortality such as breast cancer and cardiovascular disease. We conducted a joint analysis of two genome-wide association studies of these two traits in a total of 17,438 women from the Nurses' Health Study (NHS, N = 2,287) and the Women's Genome Health Study (WGHS, N = 15,151). For age at menarche, we identified ten associated SNPs (P = 1 x 10(-7)-3 x 10(-13)) clustered at 6q21 (in or near the gene LIN28B) and 9q31.2 (in an intergenic region). For age at natural menopause, we identified 13 associated SNPs (P = 1 x 10(-7)-1 x 10(-21)) clustered at 20p12.3 (in the gene MCM8), 19q13.42 (in or near the gene BRSK1), 5q35.2 (in or near genes UIMC1 and HK3) and 6p24.2 (in the gene SYCP2L). These newly identified loci might expand understanding of the biological pathways regulating these two traits.	[He, Chunyan; Kraft, Peter; Chen, Constance; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [He, Chunyan; Kraft, Peter; Chen, Constance; Buring, Julie E.; Hankinson, Susan E.; Ridker, Paul M.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Buring, Julie E.; Pare, Guillaume; Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02115 USA; [Buring, Julie E.; Pare, Guillaume; Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Div Prevent Med, Boston, MA 02115 USA; [Pare, Guillaume; Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Hankinson, Susan E.; Hunter, David J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA; [Chanock, Stephen J.; Hunter, David J.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hunter, David J.] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	He, CY (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	che@hsph.harvard.edu	Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart, Lung, and Blood Institute [HL 043851, HL69757]; National Cancer Institute [CA 047988, CA 40356, U01-CA98233]; Donald W. Reynolds Foundation; Fondation Leducq; NATIONAL CANCER INSTITUTE [R01CA040356, U01CA098233, R37CA040356, R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, U19HL069757, U01HL069757] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Fondation Leducq(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Miletich and A. Parker as well as the technical staff at Amgen for their collaboration and scientific support in performing the genotyping for the WGHS. The NHS GWAS was performed as part of the Cancer Genetic Markers of Susceptibility initiative of the NCI. We particularly acknowledge the contributions of R. Hoover, A. Hutchinson, K. Jacobs and G. Thomas. We thank J. Chen for discussion of gene functions. We thank H. Ranu and P. Soule for assistance. The WGHS is supported by HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The NHS is supported by CA 40356 and U01-CA98233 from the National Cancer Institute. We acknowledge the study participants in the NHS and the WGHS for their contribution in making this study possible.	Anderson CA, 2008, J CLIN ENDOCR METAB, V93, P3965, DOI 10.1210/jc.2007-2568; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Cui R, 2006, J EPIDEMIOL, V16, P177, DOI 10.2188/jea.16.177; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; Guo Y, 2006, J CLIN ENDOCR METAB, V91, P1009, DOI 10.1210/jc.2005-2179; He LN, 2007, J GENET, V86, P269, DOI 10.1007/s12041-007-0034-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hooft L, 2008, CLIN ENDOCRINOL, V68, P252, DOI 10.1111/j.1365-2265.2007.03031.x; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kinoshita Y, 2008, MICROSC RES TECHNIQ, V71, P288, DOI 10.1002/jemt.20553; KVALE G, 1992, ACTA ONCOL, V31, P187, DOI 10.3109/02841869209088901; MEYER JM, 1991, AM J MED GENET, V39, P148, DOI 10.1002/ajmg.1320390207; Murabito JM, 2005, FERTIL STERIL, V84, P1674, DOI 10.1016/j.fertnstert.2005.05.046; Murabito JM, 2005, J CLIN ENDOCR METAB, V90, P3427, DOI 10.1210/jc.2005-0181; Paganini-Hill A, 2005, J WOMENS HEALTH, V14, P808, DOI 10.1089/jwh.2005.14.808; Pan F, 2008, HUM GENET, V123, P419, DOI 10.1007/s00439-008-0490-z; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rothenbuhler A, 2006, J CLIN ENDOCR METAB, V91, P3534, DOI 10.1210/jc.2006-0150; Sharma K, 2002, AM J PHYS ANTHROPOL, V117, P327, DOI 10.1002/ajpa.10055; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; van Asselt KM, 2004, AM J HUM GENET, V74, P444, DOI 10.1086/382136; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063	30	260	271	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					724	728		10.1038/ng.385	http://dx.doi.org/10.1038/ng.385			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19448621	Green Accepted, Green Published			2022-12-25	WOS:000266411700023
J	Ikeda, Y; Men, SZ; Fischer, U; Stepanova, AN; Alonso, JM; Ljung, K; Grebe, M				Ikeda, Yoshihisa; Men, Shuzhen; Fischer, Urs; Stepanova, Anna N.; Alonso, Jose M.; Ljung, Karin; Grebe, Markus			Local auxin biosynthesis modulates gradient-directed planar polarity in Arabidopsis	NATURE CELL BIOLOGY			English	Article							ROOT-HAIR INITIATION; ETHYLENE; TRANSPORT; THALIANA; GNOM; REGULATOR; PATHWAY; GROWTH; TISSUE; CTR1	The coordination of cell polarity within the plane of a single tissue layer (planar polarity) is a crucial task during development of multicellular organisms. Mechanisms underlying establishment of planar polarity, however, differ substantially between plants and animals(1-3). In Arabidopsis thaliana, planar polarity of root-hair positioning along epidermal cells is coordinated towards maximum concentration of an auxin gradient in the root tip(3-5). This gradient has been hypothesized to be sink-driven(6) and computational modelling suggests that auxin efflux carrier activity may be sufficient to generate the gradient in the absence of auxin biosynthesis in the root(7). Here, we demonstrate that the Raf-like kinase constitutive triple response1 (CTR1; refs 8, 9) acts as a concentration-dependent repressor of a biosynthesis-dependent auxin gradient that modulates planar polarity in the root tip. We analysed auxin biosynthesis and concentration gradients in a variety of root-hair-position mutants affected in CTR1 activity, auxin biosynthesis and transport. Our results reveal that planar polarity relies on influx-and efflux-carrier-mediated auxin redistribution from a local biosynthesis maximum. Thus, a local source of auxin biosynthesis contributes to gradient homeostasis during long-range coordination of cellular morphogenesis.	[Ikeda, Yoshihisa; Men, Shuzhen; Grebe, Markus] Umea Univ, Dept Plant Physiol, UPSC, SE-90187 Umea, Sweden; [Ikeda, Yoshihisa; Men, Shuzhen; Fischer, Urs; Ljung, Karin; Grebe, Markus] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, UPSC, SE-90183 Umea, Sweden; [Stepanova, Anna N.; Alonso, Jose M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	Umea University; Swedish University of Agricultural Sciences; University of North Carolina; North Carolina State University	Grebe, M (corresponding author), Umea Univ, Dept Plant Physiol, UPSC, SE-90187 Umea, Sweden.	markus.grebe@plantphys.umu.se	Ikeda, Yoshihisa/B-4614-2013; Ljung, Karin/AAE-8691-2019; Alonso, Jose M/K-6826-2014; Stepanova, Anna/P-9575-2019	Ljung, Karin/0000-0003-2901-189X; Alonso, Jose M/0000-0001-7087-1571; Stepanova, Anna/0000-0003-1018-4758; Men, Shuzhen/0000-0001-6472-6829; Grebe, Markus/0000-0001-7571-0670; Fischer, Urs/0000-0003-3642-6065	Swedish Research Council (Vetenskapsradet); Swedish Foundation for Strategic Research (SSF); EU; NSF [MCB 0519869, MCB 0315992]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); EU(European Commission); NSF(National Science Foundation (NSF))	We gratefully acknowledge M. Bennett, J. Ecker, M. Estelle, J. Friml, G. Jurgens, K. Palme, B. Scheres, R. Swarup and J. Xu for sharing published research materials used in this study. We are grateful to R. Granbom for tissue preparation and technical assistance with auxin concentration and biosynthesis-rate measurements. We thank L. Bako for valuable advice on protein kinase assays, as well as C. Bellini, R. Bhalerao, Y. Boutte, A. Claes, S. Pietra, M. Rosa and B. Sundberg for helpful comments on the manuscript. This work was supported by grants from the Swedish Research Council (Vetenskapsradet) and the Swedish Foundation for Strategic Research (SSF) to M. G., by an EU Marie-Curie International Incoming Postdoctoral Fellowship to Y. I, and by NSF grants (MCB 0519869, MCB 0315992) to J. M. A.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Grebe M, 2004, BIOESSAYS, V26, P719, DOI 10.1002/bies.20065; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ikeda Y, 2006, PLANT CELL PHYSIOL, V47, P1443, DOI 10.1093/pcp/pcl023; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Moller SG, 2001, GENE DEV, V15, P90, DOI 10.1101/gad.850101; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; ROMAN G, 1995, GENETICS, V139, P1393; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	38	131	135	0	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					731	U70		10.1038/ncb1879	http://dx.doi.org/10.1038/ncb1879			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19448626				2022-12-25	WOS:000266503700018
J	Malicdan, MCV; Noguchi, S; Hayashi, YK; Nonaka, I; Nishino, I				Malicdan, May Christine V.; Noguchi, Satoru; Hayashi, Yukiko K.; Nonaka, Ikuya; Nishino, Ichizo			Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model	NATURE MEDICINE			English	Article							INCLUSION-BODY MYOPATHY; N-ACETYLNEURAMINIC ACID; RIMMED VACUOLES; DISTAL MYOPATHY; SKELETAL-MUSCLE; KINASE GNE; EXPRESSION; ACETYLMANNOSAMINE; BIOSYNTHESIS; SIALYLATION	Distal myopathy with rimmed vacuoles (DMRV)-hereditary inclusion body myopathy (hIBM) is an adult-onset, moderately progressive autosomal recessive myopathy; eventually, affected individuals become wheelchair bound(1). It is characterized clinically by skeletal muscle atrophy and weakness, and pathologically by rimmed vacuoles, which are actually accumulations of autophagic vacuoles(2-4), scattered angular fibers and intracellular accumulation of amyloid and other proteins(5). To date, no therapy is available for this debilitating myopathy, primarily because the disease pathomechanism has been enigmatic. It is known that the disease gene underlying DMRV-hIBM is GNE, encoding glucosamine (UDP-N-acetyl)-2-epimerase and N-acetylmannosamine kinase(6-8)-two essential enzymes in sialic acid biosynthesis(9). It is still unclear, however, whether decreased sialic acid production causes muscle degeneration, as GNE has been proposed to have roles other than for sialic acid biosynthesis(10-12). By showing that muscle atrophy and weakness are completely prevented in a mouse model of DMRV-hIBM after treatment with sialic acid metabolites orally, we provide evidence that hyposialylation is indeed one of the key factors in the pathomechanism of DMRV-hIBM. These results support the notion that DMRV-hIBM can potentially be treated simply by giving sialic acids, a strategy that could be applied in clinical trials in the near future.	[Malicdan, May Christine V.; Noguchi, Satoru; Hayashi, Yukiko K.; Nonaka, Ikuya; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Malicdan, May Christine V.] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan	National Center for Neurology & Psychiatry - Japan; Kyoto University	Noguchi, S (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan.	noguchi@ncnp.go.jp	Malicdan, May Christine/F-2806-2013; Nishino, Ichizo/G-2676-2010; Malicdan, May Christine/AAK-7422-2021	Nishino, Ichizo/0000-0001-9452-112X; 	Japanese Health Sciences Foundation; Japanese National Institute of Biomedical Innovation [19A-7]; Ministry of Health Labour and Welfare in Japan; Kato Memorial Trust for Nambyo Research; Neuromuscular Disease Foundation	Japanese Health Sciences Foundation; Japanese National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Kato Memorial Trust for Nambyo Research(Kato Memorial Trust for Nambyo Research); Neuromuscular Disease Foundation	The authors acknowledge the valuable assistance offered by F. Funato and R. Hoshi in motor performance evaluation of mice, toxicology assays and sialic acid measurement. This study is supported partly by the Research on Psychiatric and Neurological Diseases and Mental Health grant from the Japanese Health Sciences Foundation; the Program for Promotion of Fundamental Studies in Health Sciences of the Japanese National Institute of Biomedical Innovation the Research Grant (19A-7) for Nervous and Mental Disorders from the Ministry of Health Labour and Welfare in Japan, the Kato Memorial Trust for Nambyo Research and the Neuromuscular Disease Foundation.	Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; Askanas V, 2006, NEUROLOGY, V66, pS39, DOI 10.1212/01.wnl.0000192128.13875.1e; ASKANAS V, 2003, MOL GENETIC BASIS NE, P501; Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; COMB DG, 1958, J AM CHEM SOC, V80, P497, DOI 10.1021/ja01535a062; CORFIELD AP, 1982, SIALIC ACIDS CHEM ME, P5; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Gagiannis D, 2007, BBA-GEN SUBJECTS, V1770, P297, DOI 10.1016/j.bbagen.2006.09.023; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Iijima R, 2004, FEBS LETT, V561, P163, DOI 10.1016/S0014-5793(04)00164-4; Ikeuchi T, 1997, ANN NEUROL, V41, P432, DOI 10.1002/ana.410410405; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Kotani K, 1994, Nihon Shokakibyo Gakkai Zasshi, V91, P154; Krause S, 2005, EXP CELL RES, V304, P365, DOI 10.1016/j.yexcr.2004.11.010; Kumamoto T, 1998, INTERNAL MED, V37, P746, DOI 10.2169/internalmedicine.37.746; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2007, AUTOPHAGY, V3, P396, DOI 10.4161/auto.4270; Malicdan MCV, 2008, PHYSIOL GENOMICS, V35, P106, DOI 10.1152/physiolgenomics.90219.2008; Malicdan MCV, 2009, METHOD ENZYMOL, V453, P379, DOI 10.1016/S0076-6879(08)04019-6; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nishino I, 2005, Acta Myol, V24, P80; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Nonaka Ikuya, 2005, Curr Neurol Neurosci Rep, V5, P61, DOI 10.1007/s11910-005-0025-0; ROBITAILLE G, 1991, J DAIRY SCI, V74, P3314, DOI 10.3168/jds.S0022-0302(91)78518-4; SCHMIDT S, 2004, METHOD MOL BIOL, V299, P408; Spuler S, 2008, ANN NEUROL, V63, P323, DOI 10.1002/ana.21309; THOMAS GH, 1985, BIOCHIM BIOPHYS ACTA, V846, P37, DOI 10.1016/0167-4889(85)90107-7; Tsuruta Y, 2001, ACTA NEUROPATHOL, V101, P579; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200	35	115	129	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					690	U127		10.1038/nm.1956	http://dx.doi.org/10.1038/nm.1956			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19448634	Green Submitted			2022-12-25	WOS:000266731600029
J	Perry, JRB; Stolk, L; Franceschini, N; Lunetta, KL; Zhai, GJ; McArdle, PF; Smith, AV; Aspelund, T; Bandinelli, S; Boerwinkle, E; Cherkas, L; Eiriksdottir, G; Estrada, K; Ferrucci, L; Folsom, AR; Garcia, M; Gudnason, V; Hofman, A; Karasik, D; Kiel, DP; Launer, LJ; van Meurs, J; Nalls, MA; Rivadeneira, F; Shuldiner, AR; Singleton, A; Soranzo, N; Tanaka, T; Visser, JA; Weedon, MN; Wilson, SG; Zhuang, V; Streeten, EA; Harris, TB; Murray, A; Spector, TD; Demerath, EW; Uitterlinden, AG; Murabito, JM				Perry, John R. B.; Stolk, Lisette; Franceschini, Nora; Lunetta, Kathryn L.; Zhai, Guangju; McArdle, Patrick F.; Smith, Albert V.; Aspelund, Thor; Bandinelli, Stefania; Boerwinkle, Eric; Cherkas, Lynn; Eiriksdottir, Gudny; Estrada, Karol; Ferrucci, Luigi; Folsom, Aaron R.; Garcia, Melissa; Gudnason, Vilmundur; Hofman, Albert; Karasik, David; Kiel, Douglas P.; Launer, Lenore J.; van Meurs, Joyce; Nalls, Michael A.; Rivadeneira, Fernando; Shuldiner, Alan R.; Singleton, Andrew; Soranzo, Nicole; Tanaka, Toshiko; Visser, Jenny A.; Weedon, Michael N.; Wilson, Scott G.; Zhuang, Vivian; Streeten, Elizabeth A.; Harris, Tamara B.; Murray, Anna; Spector, Tim D.; Demerath, Ellen W.; Uitterlinden, Andre G.; Murabito, Joanne M.			Meta-analysis of genome-wide association data identifies two loci influencing age at menarche	NATURE GENETICS			English	Article							SECULAR TRENDS; OBESITY; GIRLS; ADULTHOOD; HEIGHT; GROWTH; GENES	We conducted a meta-analysis of genome-wide association data to detect genes influencing age at menarche in 17,510 women. The strongest signal was at 9q31.2 (P = 1.7 x 10(-9)), where the nearest genes include TMEM38B, FKTN, FSD1L, TAL2 and ZNF462. The next best signal was near the LIN28B gene (rs7759938; P = 7.0 x 10(-9)), which also influences adult height. We provide the first evidence for common genetic variants influencing female sexual maturation.	[Perry, John R. B.; Stolk, Lisette; Estrada, Karol; van Meurs, Joyce; Rivadeneira, Fernando; Visser, Jenny A.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Perry, John R. B.; Nalls, Michael A.; Murray, Anna] Penn Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [Stolk, Lisette; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Franceschini, Nora] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Lunetta, Kathryn L.; Karasik, David; Kiel, Douglas P.; Murabito, Joanne M.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Lunetta, Kathryn L.; Zhuang, Vivian] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Zhai, Guangju; Cherkas, Lynn; Soranzo, Nicole; Wilson, Scott G.; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [McArdle, Patrick F.; Shuldiner, Alan R.; Streeten, Elizabeth A.] Univ Maryland, Sch Med, Div Endocrinol Diabet Clin Nutr, Baltimore, MD 21201 USA; [Smith, Albert V.; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Bandinelli, Stefania] Azienda Sanitaria Firenze, Geriatr Unit, Florence, Italy; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Ferrucci, Luigi] NIA, Clin Res Branch, Longitudinal Studies Sect, Baltimore, MD 21224 USA; [Folsom, Aaron R.; Demerath, Ellen W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Garcia, Melissa; Launer, Lenore J.; Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Karasik, David; Kiel, Douglas P.] Hebrew SeniorLife Inst Aging Res, Boston, MA USA; [Karasik, David; Kiel, Douglas P.] Harvard Univ, Sch Med, Boston, MA USA; [Nalls, Michael A.; Singleton, Andrew] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Soranzo, Nicole] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Tanaka, Toshiko] NIA, Medstar Res Inst, Baltimore, MD 21224 USA; [Wilson, Scott G.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Wilson, Scott G.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Murabito, Joanne M.] Boston Univ, Sch Med, Dept Med, Gen Internal Med Sect, Boston, MA 02118 USA	Erasmus University Rotterdam; Erasmus MC; University of Exeter; Erasmus University Rotterdam; Erasmus MC; University of North Carolina; University of North Carolina Chapel Hill; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; University of London; King's College London; University System of Maryland; University of Maryland Baltimore; Icelandic Heart Association; University of Iceland; Azienda Sanitaria di Firenze; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Western Australia; University of Western Australia; Boston University	Uitterlinden, AG (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	a.g.uitterlinden@erasmusmc.nl	Gudnason, Vilmundur/K-6885-2015; bandinelli, stefania/AAL-4570-2020; Singleton, Andrew B/C-3010-2009; Spector, Tim D/F-6533-2012; Aspelund, Thor/F-4826-2011; Aspelund, Thor/C-5983-2008; Aspelund, Thor/K-7022-2019; Launer, Lenore J/A-8218-2010; Rivadeneira, Fernando/O-5385-2015; Gudnason, Vilmundur/AAE-7126-2019; Visser, Jenny A./F-8156-2011; Smith, Albert Vernon/K-5150-2015	Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; Rivadeneira, Fernando/0000-0001-9435-9441; Gudnason, Vilmundur/0000-0001-5696-0084; Murray, Anna/0000-0002-2351-2522; Soranzo, Nicole/0000-0003-1095-3852; Smith, Albert Vernon/0000-0003-1942-5845; Demerath, Ellen/0000-0002-4585-4064; Weedon, Michael/0000-0002-6174-6135; Kiel, Douglas/0000-0001-8474-0310; Zhuang, Wei/0000-0002-9998-4753; Wilson, Scott/0000-0002-0357-1373; Murabito, Joanne/0000-0002-0192-7516; van Meurs, Joyce/0000-0001-6245-2123; Shuldiner, Alan/0000-0001-9921-4305; Karasik, David/0000-0002-8826-0530; Lunetta, Kathryn/0000-0002-9268-810X; Ballantyne, Christie/0000-0002-6432-1730	Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [M01 RR 16500, M01 RR016500-02] Funding Source: Medline; NHLBI NIH HHS [N01 HC055015, N01 HC055018, N01 HC025195, N02-HL-6-4278, N01 HC055022, U01 HL072515, N01 HC055021, N01-HC-55020, N01-HC-25195, N01-HC-55015, N01-HC-55019, N01-HC-55018, N01 HC055020, U01 HL072515-06, N01 HC055016, N01 HC055019, N01-HC-55022, N01-HC-55016, N02 HL64278, N01-HC-55021, U01 HL72515] Funding Source: Medline; NIAMS NIH HHS [R01 AR041398, R01 AR041398-15] Funding Source: Medline; NIA NIH HHS [N.1-AG-1-2111, U19 AG023122, R01 AR/AG 41398, N01 AG012100, U19 AG023122-05, R21 AG032598-02, N.1-AG-1-1, N01-AG-12100, R21 AG032598, N01-AG-5-0002, R21AG032598] Funding Source: Medline; NIDDK NIH HHS [P30 DK072488, P30 DK072488-02] Funding Source: Medline; NIMHD NIH HHS [263 MD821336, 263 MD 9164, 263 MD9164 13, 263 MD 821336] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE ON AGING [ZIAAG000965, Z01AG000015] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson CA, 2008, J CLIN ENDOCR METAB, V93, P3965, DOI 10.1210/jc.2007-2568; Anderson SE, 2003, PEDIATRICS, V111, P844, DOI 10.1542/peds.111.4.844; Bosetti C, 2001, J CLIN EPIDEMIOL, V54, P902, DOI 10.1016/S0895-4356(01)00362-6; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Gajdos ZKZ, 2008, J CLIN ENDOCR METAB, V93, P4290, DOI 10.1210/jc.2008-0981; GARN SM, 1986, AM J CLIN NUTR, V43, P879, DOI 10.1093/ajcn/43.6.879; Harris MA, 2008, J ADOLESCENT HEALTH, V43, P548, DOI 10.1016/j.jadohealth.2008.07.017; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; vanLenthe FJ, 1996, AM J CLIN NUTR, V64, P18, DOI 10.1093/ajcn/64.1.18; Wang W, 2006, INT J OBESITY, V30, P1595, DOI 10.1038/sj.ijo.0803322; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006	15	198	209	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					648	650		10.1038/ng.386	http://dx.doi.org/10.1038/ng.386			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19448620	Green Accepted, Green Submitted			2022-12-25	WOS:000266411700011
J	Kim, J; Bartel, DP				Kim, Jinkuk; Bartel, David P.			Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; MESSENGER-RNAS; MILLION SNPS; TARGET SITE; IMPACT; MOUSE; DETERMINANTS; EVOLUTION; DISEASE; GENOME	Genetic changes that help explain the differences between two individuals might create or disrupt sites complementary to microRNAs ( miRNAs)(1,2), but the extent to which such polymorphic sites influence miRNA-mediated repression is unknown. Here, we describe a method to measure mRNA allelic imbalances associated with a regulatory site found in mRNA transcribed from one allele but not found in that transcribed from the other. Applying this method, called allelic imbalance sequencing, to sites for three miRNAs (miR-1, miR-133 and miR-122) provided quantitative measurements of repression in vivo without altering either the miRNAs or their targets. A substantial fraction of polymorphic sites mediated repression in tissues that expressed the cognate miRNA, and downregulation was correlated with site type and site context. Extrapolating these results to the other broadly conserved miRNAs suggests that when comparing two mouse strains (or two human individuals), polymorphic miRNA sites cause expression of many genes (often hundreds) to differ.	[Kim, Jinkuk; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kim, Jinkuk; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Kim, Jinkuk; Bartel, David P.] MIT, Dept Biol, Cambridge, MA USA; [Kim, Jinkuk] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Kim, Jinkuk/AAJ-1999-2020		National Institutes of Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tim Harkins and the 454 Sequencing Facility for high-throughput sequencing, members of the laboratory for helpful comments on this manuscript, and T. DiCesare for illustration. Supported by a grant from the National Institutes of Health. D. P. B. is an investigator of the Howard Hughes Medical Institute.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Plagnol V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002966; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tan AC, 2008, CANCER BIOL THER, V7, P137, DOI 10.4161/cbt.7.1.5199	30	53	54	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2009	27	5					472	477		10.1038/nbt.1540	http://dx.doi.org/10.1038/nbt.1540			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	444KS	19396161	Green Accepted			2022-12-25	WOS:000265980500027
J	Barrett, JC; Lee, JC; Lees, CW; Prescott, NJ; Anderson, CA; Phillips, A; Wesley, E; Parnell, K; Zhang, H; Drummond, H; Nimmo, ER; Massey, D; Blaszczyk, K; Elliott, T; Cotterill, L; Dallal, H; Lobo, AJ; Mowat, C; Sanderson, JD; Jewell, DP; Newman, WG; Edwards, C; Ahmad, T; Mansfield, JC; Satsangi, J; Parkes, M; Mathew, CG; Donnelly, P; Peltonen, L; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Craddock, N; Deloukas, P; Duncanson, A; Jankowski, J; Markus, HS; McCarthy, MI; Palmer, CNA; Plomin, R; Rautanen, A; Sawcer, SJ; Samani, N; Trembath, RC; Viswanathan, AC; Wood, N; Spencer, CCA; Bellenguez, C; Davison, D; Freeman, C; Strange, A; Langford, C; Hunt, SE; Edkins, S; Gwilliam, R; Blackburn, H; Bumpstead, SJ; Dronov, S; Gillman, M; Gray, E; Hammond, N; Jayakumar, A; McCann, OT; Liddle, J; Perez, ML; Potter, SC; Ravindrarajah, R; Ricketts, M; Waller, M; Weston, P; Widaa, S; Whittaker, P; Attwood, AP; Stephens, J; Sambrook, J; Ouwehand, WH; McArdle, WL; Ring, SM; Strachan, DP				Barrett, Jeffrey C.; Lee, James C.; Lees, Charles W.; Prescott, Natalie J.; Anderson, Carl A.; Phillips, Anne; Wesley, Emma; Parnell, Kirstie; Zhang, Hu; Drummond, Hazel; Nimmo, Elaine R.; Massey, Dunecan; Blaszczyk, Kasia; Elliott, Timothy; Cotterill, Lynn; Dallal, Helen; Lobo, Alan J.; Mowat, Craig; Sanderson, Jeremy D.; Jewell, Derek P.; Newman, William G.; Edwards, Cathryn; Ahmad, Tariq; Mansfield, John C.; Satsangi, Jack; Parkes, Miles; Mathew, Christopher G.; Donnelly, Peter; Peltonen, Leena; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Craddock, Nicholas; Deloukas, Panos; Duncanson, Audrey; Jankowski, Janusz; Markus, Hugh S.; McCarthy, Mark I.; Palmer, Colin N. A.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Samani, Nilesh; Trembath, Richard C.; Viswanathan, Ananth C.; Wood, Nicholas; Spencer, Chris C. A.; Bellenguez, Celine; Davison, Daniel; Freeman, Colin; Strange, Amy; Langford, Cordelia; Hunt, Sarah E.; Edkins, Sarah; Gwilliam, Rhian; Blackburn, Hannah; Bumpstead, Suzannah J.; Dronov, Serge; Gillman, Matthew; Gray, Emma; Hammond, Naomi; Jayakumar, Alagurevathi; McCann, Owen T.; Liddle, Jennifer; Perez, Marc L.; Potter, Simon C.; Ravindrarajah, Radhi; Ricketts, Michelle; Waller, Matthew; Weston, Paul; Widaa, Sara; Whittaker, Pamela; Attwood, Antony P.; Stephens, Jonathan; Sambrook, Jennifer; Ouwehand, Willem H.; McArdle, Wendy L.; Ring, Susan M.; Strachan, David P.		UK IBD Genetics Consortium; Wellcome Trust Case Control Consor; Management Comm; Data Anal Grp; DNA Genotyping Data QC Informatics; Publications Comm; UK Blood Serv Controls; 1958 Birth Cohort Controls	Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; E-CADHERIN; COLORECTAL-CANCER; SEQUENCE VARIANTS; NUCLEAR FACTOR-4; RISK LOCI; GENE; EXPRESSION	Ulcerative colitis is a common form of inflammatory bowel disease with a complex etiology. As part of the Wellcome Trust Case Control Consortium 2, we performed a genome-wide association scan for ulcerative colitis in 2,361 cases and 5,417 controls. Loci showing evidence of association at P < 1 x 10(-5) were followed up by genotyping in an independent set of 2,321 cases and 4,818 controls. We find genome-wide significant evidence of association at three new loci, each containing at least one biologically relevant candidate gene, on chromosomes 20q13 (HNF4A; P = 3.2 x 10(-17)), 16q22 (CDH1 and CDH3; P = 2.8 x 10(-8)) and 7q31 (LAMB1; P = 3.0 x 10(-8)). Of note, CDH1 has recently been associated with susceptibility to colorectal cancer, an established complication of longstanding ulcerative colitis. The new associations suggest that changes in the integrity of the intestinal epithelial barrier may contribute to the pathogenesis of ulcerative colitis.	[Barrett, Jeffrey C.; Anderson, Carl A.; Peltonen, Leena; Deloukas, Panos; Langford, Cordelia; Hunt, Sarah E.; Edkins, Sarah; Gwilliam, Rhian; Blackburn, Hannah; Bumpstead, Suzannah J.; Dronov, Serge; Gillman, Matthew; Gray, Emma; Hammond, Naomi; Jayakumar, Alagurevathi; McCann, Owen T.; Liddle, Jennifer; Perez, Marc L.; Potter, Simon C.; Ravindrarajah, Radhi; Ricketts, Michelle; Waller, Matthew; Weston, Paul; Widaa, Sara; Whittaker, Pamela; Attwood, Antony P.; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Lee, James C.; Zhang, Hu; Massey, Dunecan; Parkes, Miles] Addenbrookes Hosp, Gastroenterol Res Unit, Cambridge, England; [Lees, Charles W.; Phillips, Anne; Drummond, Hazel; Nimmo, Elaine R.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Prescott, Natalie J.; Blaszczyk, Kasia; Mathew, Christopher G.; Trembath, Richard C.] Kings Coll London, Guys Hosp, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Anderson, Carl A.; Donnelly, Peter; Rautanen, Anna; Spencer, Chris C. A.; Bellenguez, Celine; Freeman, Colin; Strange, Amy] Wellcome Trust Ctr Human Genet, Oxford, England; [Wesley, Emma; Parnell, Kirstie; Ahmad, Tariq] Peninsula Coll Med & Dent, Exeter, Devon, England; [Elliott, Timothy; Sanderson, Jeremy D.] St Thomas Hosp, Dept Gastroenterol, Guys & St Thomas NHS Fdn Trust, London, England; [Cotterill, Lynn] Univ Manchester, Dept Med Genet, MAHSC, Manchester, Lancs, England; [Cotterill, Lynn; Newman, William G.] Cent Manchester NHS Fdn Trust, NIHR Biomed Res Ctr, Manchester, Lancs, England; [Dallal, Helen] S Tees Hosp NHS Trust, James Cook Univ Hosp, Dept Gastroenterol, Middlesbrough, Cleveland, England; [Lobo, Alan J.] Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Div Mol & Genet Med, Sheffield S10 2JF, S Yorkshire, England; [Jewell, Derek P.] Radcliffe Infirm, Gastroenterol Unit, Gibson Labs, Oxford OX2 6HE, England; [Edwards, Cathryn] Torbay Hosp, Endoscopy Reg Training Unit, Torquay, England; [Mansfield, John C.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Donnelly, Peter; Davison, Daniel] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Blackwell, Jenefer M.] Addenbrookes Hosp, Cambridge Inst Med Res, Genet & Infect Lab, Cambridge, England; [Bramon, Elvira] Kings Coll London, Inst Psychiat, Biomed Res Ctr Mental Hlth, Div Psychol Med & Psychiat, London WC2R 2LS, England; [Bramon, Elvira] S London & Maudsley NHS Fdn Trust, London, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Craddock, Nicholas] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales; [Duncanson, Audrey] Wellcome Trust Res Labs, Mol & Physiol Sci, London, England; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London, England; [Markus, Hugh S.] St Georges Univ London, London, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab ICDEM, Oxford OX3 7LJ, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Samani, Nilesh] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp, NHS Fdn Trust, Glaucoma Res Unit, London, England; [Viswanathan, Ananth C.] UCL, Dept Genet, Inst Ophthalmol, London, England; [Wood, Nicholas] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Attwood, Antony P.; Stephens, Jonathan; Sambrook, Jennifer; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Attwood, Antony P.; Stephens, Jonathan; Sambrook, Jennifer; Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Avon Longitudinal Study Parents & Children DNA Ba, Bristol, Avon, England; [Ring, Susan M.] Dept Social Med, ALSPAC Lab, Cambridge, England; [Strachan, David P.] St George Hosp, Div Community Hlth Sci, London, England	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Exeter; University of Plymouth; Guy's & St Thomas' NHS Foundation Trust; University of Manchester; James Cook University Hospital; University of Sheffield; Radcliffe Infirmary; University of Oxford; Newcastle University - UK; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; Trinity College Dublin; Cardiff University; University of London; Queen Mary University London; St Georges University London; University of Oxford; University of Dundee; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Cambridge; University of Bristol; St Georges University London	Barrett, JC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	barrett@sanger.ac.uk; chris.spencer@well.ox.ac.uk	Plomin, Robert/B-8911-2008; Jankowski, Janusz/H-2706-2012; Bramon, Elvira/A-9463-2011; Bellenguez, Céline/X-4004-2019; Mathew, Christopher G/G-3434-2015; Blackwell, Jenefer M/H-3015-2015; Prescott, Natalie J/F-6490-2011; Belllenguez, Céline/Y-3183-2018; Lee, James/ABD-5920-2020; Deloukas, Panos/B-2922-2013; Palmer, Colin NA/C-7053-2008; Brown, Matthew A/E-5749-2010; Bramon, Elvira/HHC-3809-2022; Wood, Nicholas W/C-2505-2009; Anderson, Carl A/B-8327-2013; Mowat, Craig/AAD-1851-2019; McCarthy, Mark/M-3763-2015	Jankowski, Janusz/0000-0003-2130-9181; Bellenguez, Céline/0000-0002-1240-7874; Mathew, Christopher G/0000-0003-4178-1838; Prescott, Natalie J/0000-0002-5901-7371; Belllenguez, Céline/0000-0002-1240-7874; Lee, James/0000-0001-5711-9385; Deloukas, Panos/0000-0001-9251-070X; Palmer, Colin NA/0000-0002-6415-6560; Brown, Matthew A/0000-0003-0538-8211; Bramon, Elvira/0000-0003-1369-5983; Wood, Nicholas W/0000-0002-9500-3348; Anderson, Carl A/0000-0003-1719-7009; Mowat, Craig/0000-0002-5021-415X; ZHANG, HU/0000-0002-3281-4661; Newman, William/0000-0002-6382-4678; Potter, Simon/0000-0003-4208-4102; Parkes, Miles/0000-0002-6467-0631; Walters, James/0000-0002-6980-4053; McCarthy, Mark/0000-0002-4393-0510; Lees, Charlie/0000-0002-0732-8215; Hunt, Sarah/0000-0002-8350-1235; Plomin, Robert/0000-0002-0756-3629; Corvin, Aiden/0000-0001-6717-4089; Trembath, Richard/0000-0003-0550-3400; Massey, Dunecan/0000-0002-7144-4579; Gillman, Matthew S./0000-0002-2340-6930; Donnelly, Peter/0000-0001-9495-3408	Wellcome Trust [083948/Z/07/Z, 068545/Z/02]; National Association for Colitis and Crohn's Disease (NACC); Medical Research Council UK; Guy's and St. Thomas' Charity; Clinical Research Facility at the Peninsular College of Medicine and Dentistry, Exeter; Torbay Hospital Medical Fund; Evelyn Trust; Wolfson-Royal Society Merit Award; UK Medical Research Council [G0601387]; Special Trustees of Moorfields National Health Service (NHS) Foundation Trust; Department of Health via the National Institute for Health Research (NIHR); Cambridge University Hospitals NHS Foundation; Central Manchester NHS Foundation Trust in partnership with the University of Manchester; Moorfields Eye Hospital in partnership with University College London Institute of Ophthalmology; Medical Research Council [G0000934]; MRC [G0800509, MC_qA137934, G0601387, G0000934, G0800383, G0800759, G0800675, G19/2, G0600329] Funding Source: UKRI; Medical Research Council [G0800759, MC_qA137934, G0800383, G9817803B, G0601387, G0600329, G0800509, G0800675, G19/2] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016, NF-SI-0507-10379] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); National Association for Colitis and Crohn's Disease (NACC); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Guy's and St. Thomas' Charity; Clinical Research Facility at the Peninsular College of Medicine and Dentistry, Exeter; Torbay Hospital Medical Fund; Evelyn Trust; Wolfson-Royal Society Merit Award(Royal Society of London); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Special Trustees of Moorfields National Health Service (NHS) Foundation Trust; Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cambridge University Hospitals NHS Foundation; Central Manchester NHS Foundation Trust in partnership with the University of Manchester; Moorfields Eye Hospital in partnership with University College London Institute of Ophthalmology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The principal funding for this study was provided by the Wellcome Trust, as part of the Wellcome Trust Case Control Consortium 2 project (083948/Z/07/Z). We thank all subjects who contributed samples and consultants and nursing staff across the UK who helped with recruitment of study subjects. We also thank S. Bertrand, J. Bryant, S. L. Clark, J. S. Conquer, T. Dibling, J. C. Eldred, S. Gamble, C. Hind, A. Wilk, C. R. Stribling and S. Taylor of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. Case collections were supported by the National Association for Colitis and Crohn's Disease (NACC), the Wellcome Trust, the Medical Research Council UK, the Guy's and St. Thomas' Charity, the Clinical Research Facility at the Peninsular College of Medicine and Dentistry, Exeter, the Torbay Hospital Medical Fund and the Evelyn Trust. P. Donnelly was supported in part by a Wolfson-Royal Society Merit Award. We also acknowledge support from the UK Medical Research Council (R. C. T., grant G0601387), the Special Trustees of Moorfields National Health Service (NHS) Foundation Trust, and the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, the Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge School of Clinical Medicine, the Central Manchester NHS Foundation Trust in partnership with the University of Manchester, and Moorfields Eye Hospital in partnership with University College London Institute of Ophthalmology. We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02, and thank W. Bodmer and B. Winney for use of the People of the British Isles DNA collection, which was funded by the Wellcome Trust.	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Anderson CA, 2009, GASTROENTEROLOGY, V136, P523, DOI 10.1053/j.gastro.2008.10.032; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barroso I, 2008, DIABETES, V57, P3161, DOI 10.2337/db08-0719; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Festen EAM, 2009, GUT, V58, P799, DOI 10.1136/gut.2008.166918; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Karayiannakis AJ, 1998, J PATHOL, V185, P413; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peignon G, 2006, J BIOL CHEM, V281, P3560, DOI 10.1074/jbc.M506360200; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rubin GP, 2000, ALIMENT PHARM THER, V14, P1553, DOI 10.1046/j.1365-2036.2000.00886.x; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Schmehl K, 2000, INT J COLORECTAL DIS, V15, P39, DOI 10.1007/s003840050006; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	34	387	393	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2009	41	12					1330	U99		10.1038/ng.483	http://dx.doi.org/10.1038/ng.483			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19915572	Green Submitted, Green Accepted			2022-12-25	WOS:000272144900016
J	Guo, XC; Keyes, WM; Papazoglu, C; Zuber, J; Li, WZ; Lowe, SW; Vogel, H; Mills, AA				Guo, Xuecui; Keyes, William M.; Papazoglu, Cristian; Zuber, Johannes; Li, Wangzhi; Lowe, Scott W.; Vogel, Hannes; Mills, Alea A.			TAp63 induces senescence and suppresses tumorigenesis in vivo	NATURE CELL BIOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; P53 HOMOLOG; TUMOR-SUPPRESSOR; ONCOGENIC RAS; P63; APOPTOSIS; CANCER; P73; DELTA-NP63-ALPHA; TRANSCRIPTION	p63 is distinct from its homologue p53 in that its role as a tumour suppressor is controversial, an issue complicated by the existence of two classes of p63 isoforms(1). Here we show that TAp63 isoforms are robust mediators of senescence that inhibit tumorigenesis in vivo. Whereas gain of TAp63 induces senescence, loss of p63 enhances sarcoma development in mice lacking p53. Using a new TAp63-specific conditional mouse model, we demonstrate that TAp63 isoforms are essential for Ras-induced senescence, and that TAp63 deficiency increases proliferation and enhances Ras-mediated oncogenesis in the context of p53 deficiency in vivo. TAp63 induces senescence independently of p53, p19(Arf) and p16(Ink4a), but requires p21(Waf/Cip1) and Rb. TAp63-mediated senescence overrides Ras-driven transformation of p53-deficient cells, preventing tumour initiation, and doxycycline-regulated expression of TAp63 activates p21(Waf/Cip1), induces senescence and inhibits progression of established tumours in vivo. Our findings demonstrate that TAp63 isoforms function as tumour suppressors by regulating senescence through p53-independent pathways. The ability of TAp63 to trigger senescence and halt tumorigenesis irrespective of p53 status identifies TAp63 as a potential target of anti-cancer therapy for human malignancies with compromised p53.	[Lowe, Scott W.; Mills, Alea A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Vogel, Hannes] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Stanford University	Mills, AA (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	mills@cshl.edu	Li, Wangzhi/A-1390-2015; Zuber, Johannes/E-7517-2011	Zuber, Johannes/0000-0001-8810-6835; Vogel, Otto Hannes/0000-0002-0960-3508; Keyes, William M./0000-0002-8917-2268	American Cancer Society Research Scholar Award; NATIONAL CANCER INSTITUTE [P01CA087497, P30CA008748] Funding Source: NIH RePORTER	American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Burgess, A. Bric, R. Dickins, P. Moody and L. Rodgers for suggestions, and L. Bianco and staff for assistance. A. A. M. and X. G. were supported by an American Cancer Society Research Scholar Award.	Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bell HS, 2007, J CLIN INVEST, V117, P1008, DOI 10.1172/JCI28920; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Gallegos JR, 2008, J BIOL CHEM, V283, P66, DOI 10.1074/jbc.M704686200; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Lee CH, 2008, MODERN PATHOL, V21, P531, DOI 10.1038/modpathol.3801023; Liefer KM, 2000, CANCER RES, V60, P4016; MacPartlin M, 2008, J BIOL CHEM, V283, P15754, DOI 10.1074/jbc.M801394200; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; QUELLE DE, 1995, CELL, V83, P993; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sunahara M, 1999, ONCOGENE, V18, P3761, DOI 10.1038/sj.onc.1202972; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2003, CANCER RES, V63, P2351; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	37	197	199	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1451	U150		10.1038/ncb1988	http://dx.doi.org/10.1038/ncb1988			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19898465	Green Accepted			2022-12-25	WOS:000272251300012
J	Eisenberg, T; Knauer, H; Schauer, A; Buttner, S; Ruckenstuhl, C; Carmona-Gutierrez, D; Ring, J; Schroeder, S; Magnes, C; Antonacci, L; Fussi, H; Deszcz, L; Hartl, R; Schraml, E; Criollo, A; Megalou, E; Weiskopf, D; Laun, P; Heeren, G; Breitenbach, M; Grubeck-Loebenstein, B; Herker, E; Fahrenkrog, B; Frohlich, KU; Sinner, F; Tavernarakis, N; Minois, N; Kroemer, G; Madeo, F				Eisenberg, Tobias; Knauer, Heide; Schauer, Alexandra; Buettner, Sabrina; Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Ring, Julia; Schroeder, Sabrina; Magnes, Christoph; Antonacci, Lucia; Fussi, Heike; Deszcz, Luiza; Hartl, Regina; Schraml, Elisabeth; Criollo, Alfredo; Megalou, Evgenia; Weiskopf, Daniela; Laun, Peter; Heeren, Gino; Breitenbach, Michael; Grubeck-Loebenstein, Beatrix; Herker, Eva; Fahrenkrog, Birthe; Froehlich, Kai-Uwe; Sinner, Frank; Tavernarakis, Nektarios; Minois, Nadege; Kroemer, Guido; Madeo, Frank			Induction of autophagy by spermidine promotes longevity	NATURE CELL BIOLOGY			English	Article							LIFE-SPAN EXTENSION; NECROTIC CELL-DEATH; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; BUDDING YEAST; REGULATES APOPTOSIS; CALORIE RESTRICTION; OXIDATIVE STRESS; GENE-EXPRESSION; MURINE SKIN	Ageing results from complex genetically and epigenetically programmed processes that are elicited in part by noxious or stressful events that cause programmed cell death. Here, we report that administration of spermidine, a natural polyamine whose intracellular concentration declines during human ageing, markedly extended the lifespan of yeast, flies and worms, and human immune cells. In addition, spermidine administration potently inhibited oxidative stress in ageing mice. In ageing yeast, spermidine treatment triggered epigenetic deacetylation of histone H3 through inhibition of histone acetyltransferases (HAT), suppressing oxidative stress and necrosis. Conversely, depletion of endogenous polyamines led to hyperacetylation, generation of reactive oxygen species, early necrotic death and decreased lifespan. The altered acetylation status of the chromatin led to significant upregulation of various autophagy-related transcripts, triggering autophagy in yeast, flies, worms and human cells. Finally, we found that enhanced autophagy is crucial for polyamine-induced suppression of necrosis and enhanced longevity.	[Eisenberg, Tobias; Knauer, Heide; Schauer, Alexandra; Buettner, Sabrina; Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Ring, Julia; Schroeder, Sabrina; Antonacci, Lucia; Fussi, Heike; Froehlich, Kai-Uwe; Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Magnes, Christoph; Sinner, Frank] Inst Med Technol & Hlth Management, Graz, Austria; [Deszcz, Luiza; Hartl, Regina; Minois, Nadege] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Deszcz, Luiza; Hartl, Regina; Minois, Nadege] Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1010 Vienna, Austria; [Schraml, Elisabeth] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Vienna, Austria; [Criollo, Alfredo; Kroemer, Guido] INSERM, U848, Villejuif, France; [Criollo, Alfredo; Kroemer, Guido] Inst Gustave Roussy, F-94805 Villejuif, France; [Criollo, Alfredo; Kroemer, Guido] Univ Paris 11, F-94805 Villejuif, France; [Megalou, Evgenia; Tavernarakis, Nektarios] Inst Mol Biol & Biotechnol, Fdn Res & Technol Hellas, Iraklion 70013, Crete, Greece; [Weiskopf, Daniela; Grubeck-Loebenstein, Beatrix] Austrian Acad Sci, Inst Biomed Ageing Res, A-6020 Innsbruck, Austria; [Laun, Peter; Heeren, Gino; Breitenbach, Michael] Salzburg Univ, Dept Cell Biol, Div Genet, A-5020 Salzburg, Austria; [Herker, Eva] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Fahrenkrog, Birthe] Univ Basel, ME Mueller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland	University of Graz; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Natural Resources & Life Sciences, Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Foundation for Research & Technology - Hellas (FORTH); Austrian Academy of Sciences; University of Innsbruck; Salzburg University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Basel	Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	kroemer@orange.fr; frank.madeo@uni-graz.at	KROEMER, Guido/B-4263-2013; Herker, Eva/B-9699-2014; Eisenberg, Tobias/AAV-7806-2021; Kroemer, Guido/AAY-9859-2020; Fahrenkrog, Birthe/D-5840-2011; Herker, Eva/AAQ-1944-2021; Tavernarakis, Nektarios/B-9684-2013	KROEMER, Guido/0000-0002-9334-4405; Herker, Eva/0000-0001-9644-2484; Tavernarakis, Nektarios/0000-0002-5253-1466; Ruckenstuhl, Christoph/0000-0002-4338-4679; Eisenberg, Tobias/0000-0003-3559-1130; Sinner, Frank Michael/0000-0002-9292-4512; Buttner, Sabrina/0000-0002-2786-8542; Fahrenkrog, Birthe/0000-0003-4080-9413; Weiskopf, Daniela/0000-0003-2968-7371; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Schraml, Elisabeth/0000-0003-0738-9883; Magnes, Christoph/0000-0002-5153-7444; Madeo, Frank/0000-0002-5070-1329; Criollo, Alfredo/0000-0002-2737-7751; Ring, Julia/0000-0003-4991-9328	Austrian Science Fund FWF (Austria) [S-9304-B05, S-9303-B05, S9302-B05, S-9301-B05]; European Commission (Brussels, Europe) [512020]; APOSYS;  [FP6 036894]	Austrian Science Fund FWF (Austria)(Austrian Science Fund (FWF)); European Commission (Brussels, Europe)(European CommissionEuropean Commission Joint Research Centre); APOSYS(European CommissionEuropean Commission Joint Research Centre); 	We thank Ulrike Potocnik, Silvia Dichtinger, Arno Absenger and Elfgard Heintz for assistance. We are grateful to the Austrian Science Fund FWF (Austria) for grant S-9304-B05 (to F. M., S. B. and D. C.-G.), grant S-9303-B05 (to K.-U. F. and H. K.), grant LIPOTOX (to F. M. and S. B.), and grant S-9301-B05 (to B. G.-L.) and to the European Commission for project TransDeath (to K.-U. F. and C. R.), project APOSYS (to F. M., T. E. and G. K.) and project Lifespan (FP6 036894 to B. G.-L.). We are grateful to the Austrian Science Fund FWF (Vienna, Austria) for grants S9302-B05 (to M. B.) and to the European Commission (Brussels, Europe) for project MIMAGE (contract no. 512020; to M. B.).	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; BALASUNDARAM D, 1991, P NATL ACAD SCI USA, V88, P5872, DOI 10.1073/pnas.88.13.5872; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; BRENNER S, 1974, GENETICS, V77, P71; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; BURHANS WC, 2009, CELL CYCLE, P8; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Chattopadhyay MK, 2006, YEAST, V23, P751, DOI 10.1002/yea.1393; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Evans E, 2000, MOL CELL, V5, P789, DOI 10.1016/S1097-2765(00)80319-6; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gianotti V, 2008, J CHROMATOGR A, V1185, P296, DOI 10.1016/j.chroma.2008.02.038; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hobbs CA, 2003, EXP CELL RES, V290, P427, DOI 10.1016/S0014-4827(03)00352-5; Hobbs CA, 2002, CANCER RES, V62, P67; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu BS, 2005, J BIOL CHEM, V280, P16659, DOI 10.1074/jbc.M414008200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MINOCHA R, 1994, J PLANT GROWTH REGUL, V13, P187, DOI 10.1007/BF00226036; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3; Schraml E, 2007, EXP GERONTOL, V42, P1072, DOI 10.1016/j.exger.2007.08.003; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Weinberger M, 2005, J CELL SCI, V118, P3543, DOI 10.1242/jcs.02477; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	76	986	1042	11	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1305	U102		10.1038/ncb1975	http://dx.doi.org/10.1038/ncb1975			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19801973	Green Published			2022-12-25	WOS:000271425800010
J	Giampieri, S; Manning, C; Hooper, S; Jones, L; Hill, CS; Sahai, E				Giampieri, Silvia; Manning, Cerys; Hooper, Steven; Jones, Louise; Hill, Caroline S.; Sahai, Erik			Localized and reversible TGF beta signalling switches breast cancer cells from cohesive to single cell motility	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; IN-VIVO; CARCINOMA CELLS; LUNG METASTASIS; MAMMARY-TUMORS; INVASION; INTRAVASATION; EXPRESSION; VIMENTIN	Here we use intravital imaging to demonstrate a reversible transition to a motile state as breast cancer cells spread. Imaging primary tumours revealed heterogeneity in cell morphology and motility. Two distinct modes of motility were observed: collective and single-celled. By monitoring the localization of Smad2 and the activity of a TGF beta-dependent reporter gene during breast cancer cell dissemination, we demonstrate that TGF beta signalling is transiently and locally activated in motile single cells. TGF beta 1 switches cells from cohesive to single cell motility through a transcriptional program involving Smad4, EGFR, Nedd9, M-RIP, FARP and RhoC. Blockade of TGF beta signalling prevented cells moving singly in vivo but did not inhibit cells moving collectively. Cells restricted to collective invasion were capable of lymphatic invasion but not blood-borne metastasis. Constitutive TGF beta signalling promoted single cell motility and intravasation but reduced subsequent growth in the lungs. Thus, transient TGF beta signalling is essential for blood-borne metastasis.	[Giampieri, Silvia; Manning, Cerys; Hooper, Steven; Sahai, Erik] CR UK London Res Inst, Tumour Cell Biol Lab, London WC2A 3PX, England; [Jones, Louise] Inst Canc Res, Tumor Biol Ctr, London EC1M 6BQ, England; [Hill, Caroline S.] CR UK London Res Inst, Dev Signalling Lab, London WC2A 3PX, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Queen Mary University London	Sahai, E (corresponding author), CR UK London Res Inst, Tumour Cell Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	erik.sahai@cancer.org.uk		Sahai, Erik/0000-0002-3932-5086; Giampieri, Silvia/0000-0001-5484-3140; Manning, Cerys/0000-0001-8656-5878; Hill, Caroline/0000-0002-8632-0480	Breast Cancer Campaign; CRUK	Breast Cancer Campaign; CRUK(Cancer Research UK)	We thank lab colleagues for advice and comments on this project. We thank members of the LRI FACS laboratory, Clare Watkins and members of the LRI Biological Resources Unit, the Paterson Institute for Cancer Research microarray facility, the LRI Bioinformatics team, Mike Howell of the LRI Developmental Signalling laboratory and Debbie Aubyn of the LRI microscopy laboratory for technical assistance. This work was funded by the Breast Cancer Campaign project grant 12May05 and CRUK.	Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Donovan J, 2000, BREAST CANCER RES, V2, P116, DOI 10.1186/bcr43; Fox SB, 1997, J MAMMARY GLAND BIOL, V2, P131, DOI 10.1023/A:1026399613946; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gilles C, 2003, CANCER RES, V63, P2658; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Mi ZY, 2004, J BIOL CHEM, V279, P46659, DOI 10.1074/jbc.M407952200; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678; Wells A, 2000, ADV CANCER RES, V78, P31; Wong C, 1999, MOL CELL BIOL, V19, P1821; Wyckoff JB, 2000, CANCER RES, V60, P2504; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	37	453	459	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1287	U49		10.1038/ncb1973	http://dx.doi.org/10.1038/ncb1973			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838175	Green Accepted			2022-12-25	WOS:000271425800008
J	Makovets, S; Blackburn, EH				Makovets, Svetlana; Blackburn, Elizabeth H.			DNA damage signalling prevents deleterious telomere addition at DNA breaks	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; REPLICATION; PATHWAYS; PHOSPHORYLATION; SUPPRESSION; ELONGATION; HELICASES; PROTEIN; ALPHA	The response to DNA damage involves regulation of several essential processes to maximize the accuracy of DNA damage repair and cell survival(1). Telomerase has the potential to interfere with repair by inappropriately adding telomeres to DNA breaks. It was unknown whether cells modulate telomerase in response to DNA damage to increase the accuracy of repair. Here, we report that telomerase action is regulated as a part of the cellular response to DNA double-strand breaks (DSBs). Using yeast, we show that the main ATR/Mec1 DNA damage signalling pathway regulates telomerase action at DSBs. After DNA damage, MEC1-RAD53-DUN1-dependent phosphorylation of the telomerase inhibitor Pif1 occurs. Using a separation of function PIF1 mutation, we show that this phosphorylation is specifically required for the Pif1-mediated telomerase inhibition that takes place at DNA breaks, but not for that at telomeres. Hence DNA damage signalling down-modulates telomerase action at DNA breaks through Pif1 phosphorylation, thus preventing aberrant healing of broken DNA ends by telomerase. These findings uncover a new regulatory mechanism that coordinates competing DNA end-processing activities and thereby promotes DNA repair accuracy and genome integrity.	[Makovets, Svetlana; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Makovets, Svetlana] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of California System; University of California San Francisco; University of Edinburgh	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	elizabeth.blackburn@ucsf.edu		Makovets, Svetlana/0000-0002-0226-2093	School of Biological Sciences, University of Edinburgh; Wellcome Trust [84637]; NIH [GM26259]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026259, R01GM026259] Funding Source: NIH RePORTER	School of Biological Sciences, University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Blackburn and Harrington laboratories for encouraging discussions and useful ideas. We also thank C. Anderson for pEHB13045 and H. Interthal and N. E. Murray for critical reading of the manuscript and helpful suggestions. We thank the laboratory of L. A. Harrington for support of S. M. since February 2008 (with funds provided by the School of Biological Sciences, University of Edinburgh, and Wellcome Trust Programme Grant 84637 to L. A. Harrington). This work was supported by NIH grant GM26259 (to E. H. B.).	Bessler JB, 2001, TRENDS CELL BIOL, V11, P60, DOI 10.1016/S0962-8924(00)01877-8; Bosco G, 1998, GENETICS, V150, P1037; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LASKO D, 1991, ANNU REV GENET, V25, P281, DOI 10.1146/annurev.ge.25.120191.001433; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Uchiki T, 2004, J BIOL CHEM, V279, P11293, DOI 10.1074/jbc.M309751200; Wagner M, 2006, GENETICS, V174, P555, DOI 10.1534/genetics.104.036905; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	23	82	90	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1383	U288		10.1038/ncb1985	http://dx.doi.org/10.1038/ncb1985			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838171	Green Accepted, Green Submitted			2022-12-25	WOS:000271425800020
J	Nistal-Villan, E; Garcia-Sastre, A				Nistal-Villan, Estanislao; Garcia-Sastre, Adolfo			New prospects for the rational design of antivirals	NATURE MEDICINE			English	Editorial Material							AVIAN INFLUENZA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; POLYMERASE; VIRUS; SUBUNIT; ENDONUCLEASE; MORTALITY; PB2		[Nistal-Villan, Estanislao; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Nistal-Villan, E (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	adolfo.garcia-sastre@mssm.edu	Nistal-Villán, Estanislao/AAM-8029-2020; Nistal-Villan, Estanislao/GWM-7994-2022	Nistal-Villán, Estanislao/0000-0003-2458-8833; Garcia-Sastre, Adolfo/0000-0002-6551-1827	NIAAA NIH HHS [HHNSN266200700010C] Funding Source: Medline	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09	15	21	23	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2009	15	11					1253	1254		10.1038/nm1109-1253	http://dx.doi.org/10.1038/nm1109-1253			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19893557	Green Accepted, Bronze			2022-12-25	WOS:000271543700012
J	Martinez, AM; Schuettengruber, B; Sakr, S; Janic, A; Gonzalez, C; Cavalli, G				Martinez, Anne-Marie; Schuettengruber, Bernd; Sakr, Samy; Janic, Ana; Gonzalez, Cayetano; Cavalli, Giacomo			Polyhomeotic has a tumor suppressor activity mediated by repression of Notch signaling	NATURE GENETICS			English	Article							POLYCOMB GROUP PROTEINS; DROSOPHILA-MELANOGASTER; IMAGINAL DISCS; CELL FATE; ASYMMETRIC DIVISION; PCG PROTEINS; STEM-CELLS; GROWTH; GENES; CANCER	Polycomb Group (PcG) proteins silence critical developmental genes and modulate cell proliferation. Using the Drosophila melanogaster eye as a model system, we show that cells with mutations in the gene locus (ph) that encodes the PcG protein Polyhomeotic (PH) overproliferate and lose both the ability to differentiate and their normal polarity. They invade the neighboring tissues and, when combined with an activated form of the Ras proto-oncogene, they trigger the formation of metastases. PcG proteins bind to multiple genes in the Notch pathway and control their transcription as well as Notch signaling. The massive cell-autonomous overproliferation of ph mutant cell clones can be rescued by ectopic expression of a dominant negative form of Notch or by RNA interference (RNAi)-mediated repression of Notch. Conversely, overexpression of ph induces a small-eye phenotype that is rescued by activation of Notch signaling. These data show that ph is a tumor suppressor locus that controls cellular proliferation by silencing multiple Notch signaling components.	[Martinez, Anne-Marie; Schuettengruber, Bernd; Sakr, Samy; Cavalli, Giacomo] CNRS, Inst Genet Humaine, Montpellier, France; [Martinez, Anne-Marie] Univ Montpellier 2, Fac Sci, Montpellier, France; [Janic, Ana; Gonzalez, Cayetano] Inst Res Biomed, Cell Div Grp, Barcelona, Spain; [Janic, Ana; Gonzalez, Cayetano] Inst Catalana Rec & Estudis Avancats, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Cavalli, G (corresponding author), CNRS, Inst Genet Humaine, Montpellier, France.	Anne-Marie.Martinez@igh.cnrs.fr; Giacomo.Cavalli@igh.cnrs.fr	martinez, Anne-marie A.M/R-2751-2017; Gonzalez, Cayetano/K-3055-2019; Janic, Ana/AAR-4783-2020; cavalli, giacomo/Z-2754-2019; Gonzalez, Cayetano/K-3933-2019; Cavalli, Giacomo/A-7958-2008	martinez, Anne-marie A.M/0000-0001-8562-7627; Gonzalez, Cayetano/0000-0002-5259-3608; Janic, Ana/0000-0002-4200-2560; cavalli, giacomo/0000-0003-3709-3469; Cavalli, Giacomo/0000-0003-3709-3469; Schuettengruber, Bernd/0000-0001-7338-4648	CNRS; Human Frontier Science Program Organization; European Union; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale; Ministere de l'Enseignement Superieur; ICREA Funding Source: Custom	CNRS(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program Organization(Human Frontier Science Program); European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ministere de l'Enseignement Superieur; ICREA(ICREA)	We are grateful to N. Azpiazu, M. Dominguez, F. Maschat, J. Treisman, L. Jan, S. Artavanis-Tsakonas, J.-M. Dura, Y.N. Jan, J. Muller, M. O'Connor, F. Schweisguth, T. Xu, the Bloomington Stock Center ( Indiana University) and the Developmental Studies Hybridoma Bank ( University of Iowa) for fly stocks and antibodies see Supplementary Acknowledgments for details). We thank C. Cazevieille, N. Lautredou and C. Duperray for technical assistance. We also thank F. Bantignies for his contribution on PC foci analysis, T. Sexton for critical reading of the manuscript and members of the Cavalli lab for discussion. G.C.'s research was supported by grants from the CNRS, the Human Frontier Science Program Organization, the European Union FP6 (Network of Excellence the Epigenome and STREP 3D Genome), the Agence Nationale de la Recherche, the Association pour la Recherche sur le Cancer, the Fondation pour la Recherche Medicale and the Ministere de l'Enseignement Superieur.	Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; Deshpande AM, 2007, ONCOGENE, V26, P1714, DOI 10.1038/sj.onc.1209988; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; DURA JM, 1987, CELL, V51, P829, DOI 10.1016/0092-8674(87)90106-1; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; HADORN E, 1978, GENETICS BIOL DROS C, V2, P557; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johnston LA, 1996, DEVELOPMENT, V122, P3519; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Negre N, 2006, METHOD ENZYMOL, V410, P316, DOI 10.1016/S0076-6879(06)10015-4; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pagliarini Raymond A, 2003, Methods Mol Biol, V223, P349; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Reynolds-Kenneally J, 2005, DEV BIOL, V285, P38, DOI 10.1016/j.ydbio.2005.05.038; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tokimasa S, 2001, EXP HEMATOL, V29, P93, DOI 10.1016/S0301-472X(00)00620-2; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wang J, 2006, DEVELOPMENT, V133, P1231, DOI 10.1242/dev.02299; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433	54	94	96	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1076	U47		10.1038/ng.414	http://dx.doi.org/10.1038/ng.414			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19749760				2022-12-25	WOS:000270330400009
J	Yeager, M; Chatterjee, N; Ciampa, J; Jacobs, KB; Gonzalez-Bosquet, J; Hayes, RB; Kraft, P; Wacholder, S; Orr, N; Berndt, S; Yu, K; Hutchinson, A; Wang, ZM; Amundadottir, L; Feigelson, HS; Thun, MJ; Diver, WR; Albanes, D; Virtamo, J; Weinstein, S; Schumacher, FR; Cancel-Tassin, G; Cussenot, O; Valeri, A; Andriole, GL; Crawford, ED; Haiman, CA; Henderson, B; Kolonel, L; Le Marchand, L; Siddiq, A; Riboli, E; Key, TJ; Kaaks, R; Isaacs, W; Isaacs, S; Wiley, KE; Gronberg, H; Wiklund, F; Stattin, P; Xu, JF; Zheng, SL; Sun, JL; Vatten, LJ; Hveem, K; Kumle, M; Tucker, M; Gerhard, DS; Hoover, RN; Fraumeni, JF; Hunter, DJ; Thomas, G; Chanock, SJ				Yeager, Meredith; Chatterjee, Nilanjan; Ciampa, Julia; Jacobs, Kevin B.; Gonzalez-Bosquet, Jesus; Hayes, Richard B.; Kraft, Peter; Wacholder, Sholom; Orr, Nick; Berndt, Sonja; Yu, Kai; Hutchinson, Amy; Wang, Zhaoming; Amundadottir, Laufey; Feigelson, Heather Spencer; Thun, Michael J.; Diver, W. Ryan; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Schumacher, Fredrick R.; Cancel-Tassin, Geraldine; Cussenot, Olivier; Valeri, Antoine; Andriole, Gerald L.; Crawford, E. David; Haiman, Christopher A.; Henderson, Brian; Kolonel, Laurence; Le Marchand, Loic; Siddiq, Afshan; Riboli, Elio; Key, Timothy J.; Kaaks, Rudolf; Isaacs, William; Isaacs, Sarah; Wiley, Kathleen E.; Gronberg, Henrik; Wiklund, Fredrik; Stattin, Par; Xu, Jianfeng; Zheng, S. Lilly; Sun, Jielin; Vatten, Lars J.; Hveem, Kristian; Kumle, Merethe; Tucker, Margaret; Gerhard, Daniela S.; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Hunter, David J.; Thomas, Gilles; Chanock, Stephen J.			Identification of a new prostate cancer susceptibility locus on chromosome 8q24	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; MULTIPLE LOCI; RISK; VARIANT; RANGE; SCAN	We report a genome-wide association study in 10,286 cases and 9,135 controls of European ancestry in the Cancer Genetic Markers of Susceptibility (CGEMS) initiative. We identify a new association with prostate cancer risk on chromosome 8q24 (rs620861, P = 1.3 x 10(-10), heterozygote OR = 1.17, 95% CI 1.10-1.24; homozygote OR = 1.33, 95% CI 1.21-1.45). This defines a new locus associated with prostate cancer susceptibility on 8q24.	[Yeager, Meredith; Hutchinson, Amy; Wang, Zhaoming] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA; [Yeager, Meredith; Chatterjee, Nilanjan; Ciampa, Julia; Gonzalez-Bosquet, Jesus; Hayes, Richard B.; Wacholder, Sholom; Orr, Nick; Berndt, Sonja; Yu, Kai; Hutchinson, Amy; Wang, Zhaoming; Amundadottir, Laufey; Albanes, Demetrius; Weinstein, Stephanie; Tucker, Margaret; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Thomas, Gilles; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD USA; [Kraft, Peter; Schumacher, Fredrick R.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Feigelson, Heather Spencer; Thun, Michael J.; Diver, W. Ryan] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Schumacher, Fredrick R.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Cancel-Tassin, Geraldine; Cussenot, Olivier; Valeri, Antoine] Hop Tenon, CeRePP, AP HP, F-75970 Paris, France; [Andriole, Gerald L.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Crawford, E. David] Univ Colorado Denver & Hlth Sci Ctr, Dept Surg, Denver, CO USA; [Haiman, Christopher A.; Henderson, Brian] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90033 USA; [Kolonel, Laurence; Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Siddiq, Afshan; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London, England; [Key, Timothy J.] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Kaaks, Rudolf] German Canc Res Ctr, Div Clin Epidemiol, DKFZ, D-6900 Heidelberg, Germany; [Isaacs, William; Isaacs, Sarah; Wiley, Kathleen E.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Gronberg, Henrik; Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Stattin, Par] Umea Univ, Dept Surg Preoperat Sci Urol & Androl, Umea, Sweden; [Xu, Jianfeng; Zheng, S. Lilly; Sun, Jielin] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Vatten, Lars J.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Kumle, Merethe] Univ Tromso, Inst Community Med, Tromso, Norway; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, DHHS, Bethesda, MD 20892 USA; [Hunter, David J.] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Sch Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; American Cancer Society; Finland National Institute for Health & Welfare; Harvard University; Harvard T.H. Chan School of Public Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Imperial College London; University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); Johns Hopkins University; Johns Hopkins Medicine; Karolinska Institutet; Umea University; Wake Forest University; Wake Forest Baptist Medical Center; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Yeager, M (corresponding author), NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA.	yeagerm@mail.nih.gov	Berndt, Sonja I/J-8423-2016; Vatten, Lars/AAF-9380-2022; Schumacher, Fredrick/R-6043-2019; Albanes, Demetrius/B-9749-2015; Hveem, Kristian/AFV-4683-2022; Amundadottir, Laufey T/L-7656-2016; Tucker, Margaret A/B-4297-2015; Yeager, Meredith/AAA-5322-2020; Weinstein, Stephanie J/P-1627-2017; Diver, Ryan/AAG-3469-2019; Vatten, Lars/AFK-2073-2022; Wang, Zhaoming/R-5527-2018	Schumacher, Fredrick/0000-0002-3073-7463; Amundadottir, Laufey T/0000-0003-1859-8971; Weinstein, Stephanie J/0000-0002-3834-1535; Diver, Ryan/0000-0002-5418-9000; Wang, Zhaoming/0000-0001-7556-3869; Siddiq, Afshan/0000-0002-9110-1434; Riboli, Elio/0000-0001-6795-6080; cussenot, olivier/0000-0002-9912-0533; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Hayes, Richard/0000-0002-0918-661X; Gonzalez Bosquet, Jesus/0000-0002-2079-4528; Jacobs, Kevin/0000-0002-4657-6473	NCI; National Institutes of Health (NIH) [HHSN261200800001E];  [CA129684];  [CA131338]; MRC [G0501019] Funding Source: UKRI; Medical Research Council [G0501019] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA129684, R01CA131338, Z01CP010152] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded in part using grants CA129684 to J.X. and CA131338 to S.L.Z. This project was funded in whole or in part with federal funds from the NCI, National Institutes of Health (NIH), under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services (DHHS), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Berndt SI, 2008, HUM MOL GENET, V17, P2665, DOI 10.1093/hmg/ddn166; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	15	179	185	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2009	41	10					1055	1057		10.1038/ng.444	http://dx.doi.org/10.1038/ng.444			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19767755	Green Accepted			2022-12-25	WOS:000270330400005
J	Li, M; Chen, WD; Papadopoulos, N; Goodman, SN; Bjerregaard, NC; Laurberg, S; Levin, B; Juhl, H; Arber, N; Moinova, H; Durkee, K; Schmidt, K; He, YP; Diehl, F; Velculescu, VE; Zhou, SB; Diaz, LA; Kinzler, KW; Markowitz, SD; Vogelstein, B				Li, Meng; Chen, Wei-dong; Papadopoulos, Nickolas; Goodman, Steven N.; Bjerregaard, Niels Christian; Laurberg, Soren; Levin, Bernard; Juhl, Hartmut; Arber, Nadir; Moinova, Helen; Durkee, Kris; Schmidt, Kerstin; He, Yiping; Diehl, Frank; Velculescu, Victor E.; Zhou, Shibin; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Markowitz, Sanford D.; Vogelstein, Bert			Sensitive digital quantification of DNA methylation in clinical samples	NATURE BIOTECHNOLOGY			English	Article							COLORECTAL-CANCER; PCR; PLASMA; MUTATIONS; MARKERS; ASSAY	Analysis of abnormally methylated genes is increasingly important in basic research and in the development of cancer biomarkers(1,2). We have developed methyl-BEAMing technology to enable absolute quantification of the number of methylated molecules in a sample. Individual DNA fragments are amplified and analyzed either by flow cytometry(3) or next-generation sequencing. We demonstrate enumeration of as few as one methylated molecule in similar to 5,000 unmethylated molecules in DNA from plasma or fecal samples. Using methylated vimentin as a biomarker in plasma samples, methyl-BEAMing detected 59% of cancer cases. In early-stage colorectal cancers, this sensitivity was four times more than that obtained by assaying serum-carcinoembryonic antigen (CEA). With stool samples, methyl-BEAMing detected 41% of cancers and 45% of advanced adenomas. In addition to diagnostic and prognostic applications, this digital quantification of rare methylation events should be applicable to preclinical assessment of new epigenetic biomarkers and quantitative analyses in epigenetic research.	[Chen, Wei-dong; Moinova, Helen; Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Chen, Wei-dong; Moinova, Helen; Markowitz, Sanford D.] Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; [Chen, Wei-dong; Moinova, Helen; Markowitz, Sanford D.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Chen, Wei-dong; Moinova, Helen; Markowitz, Sanford D.] Howard Hughes Med Inst, Cleveland, OH USA; [Li, Meng; Papadopoulos, Nickolas; Schmidt, Kerstin; He, Yiping; Diehl, Frank; Velculescu, Victor E.; Zhou, Shibin; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Med Inst, Howard Hughes Med Inst, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21205 USA; [Li, Meng; Papadopoulos, Nickolas; Schmidt, Kerstin; He, Yiping; Diehl, Frank; Velculescu, Victor E.; Zhou, Shibin; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Med Inst, Sidney Kimmel Canc Ctr, Baltimore, MD 21205 USA; [Goodman, Steven N.] Johns Hopkins Med Inst, Dept Biostat, Baltimore, MD 21205 USA; [Bjerregaard, Niels Christian; Laurberg, Soren] Aarhus Univ Hosp, Dept Surg P, DK-8000 Aarhus, Denmark; [Levin, Bernard] UTMD Anderson Canc Ctr, Houston, TX USA; [Juhl, Hartmut] Israelit Hosp, Ctr Canc Res, Hamburg, Germany; [Arber, Nadir] Tel Aviv Univ, Tel Aviv Med Ctr, IL-69978 Tel Aviv, Israel; [Arber, Nadir] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Arber, Nadir] Tel Aviv Univ, Integrated Canc Prevent Ctr, IL-69978 Tel Aviv, Israel; [Durkee, Kris] Exact Sci Corp, Marlborough, MA USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Aarhus University; University of Texas System; UTMD Anderson Cancer Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Markowitz, SD (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.	sxm10@cwru.edu	Papadopoulos, Nickolas/K-7272-2012; Velculescu, Victor/ABF-4846-2020; CHEN, WEI-DONG/F-4521-2014	Velculescu, Victor/0000-0003-1195-438X; CHEN, WEI-DONG/0000-0003-2264-5515; Arber, Nadir/0000-0001-5283-6991; Goodman, Steven/0000-0002-3872-5723; Diaz, Luis/0000-0002-7079-8914	Virginia and D. K. Ludwig Fund for Cancer Research; Miracle Foundation; Edelstein Fund; US National Colorectal Cancer Research Alliance; US National Institutes of Health [CA43460, CA62924, CA120237]; Danish Cancer Society; Danish Research Council; Institute of Experimental Clinical Research, Aarhus University; NATIONAL CANCER INSTITUTE [R01CA120237, P50CA062924, R37CA043460, R01CA043460] Funding Source: NIH RePORTER	Virginia and D. K. Ludwig Fund for Cancer Research; Miracle Foundation; Edelstein Fund; US National Colorectal Cancer Research Alliance; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cancer Society(Danish Cancer Society); Danish Research Council(Det Frie Forskningsrad (DFF)); Institute of Experimental Clinical Research, Aarhus University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Berger for helpful discussions; D. Edelstein for the help with plasma collection; and M. Whalen and L. Kasturi for expert technical assistance. This work was supported by the Virginia and D. K. Ludwig Fund for Cancer Research; the Miracle Foundation; the Edelstein Fund; the US National Colorectal Cancer Research Alliance; The US National Institutes of Health grants CA43460, CA62924 and CA120237; The Danish Cancer Society; The Danish Research Council; and The Institute of Experimental Clinical Research, Aarhus University.	Bailey VJ, 2009, GENOME RES, V19, P1455, DOI 10.1101/gr.088831.108; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Gonzalgo ML, 1997, NUCLEIC ACIDS RES, V25, P2529, DOI 10.1093/nar/25.12.2529; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Hayatsu H, 2008, MUTAT RES-REV MUTAT, V659, P77, DOI 10.1016/j.mrrev.2008.04.003; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Jahr S, 2001, CANCER RES, V61, P1659; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kahi CJ, 2008, GASTROENTEROLOGY, V135, P380, DOI 10.1053/j.gastro.2008.06.026; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lieberman David A, 2002, Clin Cornerstone, V4, P1, DOI 10.1016/S1098-3597(02)90001-3; Lo YMD, 1999, CANCER RES, V59, P3899; Moore JK, 2008, BIOTECHNIQUES, V44, P363, DOI 10.2144/000112702; Okamoto A, 2009, ORG BIOMOL CHEM, V7, P21, DOI 10.1039/b813595a; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Warnecke PM, 1997, NUCLEIC ACIDS RES, V25, P4422, DOI 10.1093/nar/25.21.4422; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zou HZ, 2007, CANCER EPIDEM BIOMAR, V16, P2686, DOI 10.1158/1055-9965.EPI-07-0518	30	254	268	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2009	27	9					858	U118		10.1038/nbt.1559	http://dx.doi.org/10.1038/nbt.1559			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	493QE	19684580	Green Accepted			2022-12-25	WOS:000269751400029
J	Greenway, SC; Pereira, AC; Lin, JC; DePalma, SR; Israel, SJ; Mesquita, SM; Ergul, E; Conta, JH; Korn, JM; McCarroll, SA; Gorham, JM; Gabriel, S; Altshuler, DM; Quintanilla-Dieck, MD; Artunduaga, MA; Eavey, RD; Plenge, RM; Shadick, NA; Weinblatt, ME; De Jager, PL; Hafler, DA; Breitbart, RE; Seidman, JG; Seidman, CE				Greenway, Steven C.; Pereira, Alexandre C.; Lin, Jennifer C.; DePalma, Steven R.; Israel, Samuel J.; Mesquita, Sonia M.; Ergul, Emel; Conta, Jessie H.; Korn, Joshua M.; McCarroll, Steven A.; Gorham, Joshua M.; Gabriel, Stacey; Altshuler, David M.; Quintanilla-Dieck, Maria de Lourdes; Artunduaga, Maria Alexandra; Eavey, Roland D.; Plenge, Robert M.; Shadick, Nancy A.; Weinblatt, Michael E.; De Jager, Philip L.; Hafler, David A.; Breitbart, Roger E.; Seidman, Jonathan G.; Seidman, Christine E.			De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot	NATURE GENETICS			English	Article							CONGENITAL HEART-DISEASE; DEPENDENT PROBE AMPLIFICATION; MUTATIONS CAUSE NOONAN; HYPERTROPHIC CARDIOMYOPATHY; CHROMOSOME 1Q21.1; ALAGILLE-SYNDROME; HUMAN GENOME; SCHIZOPHRENIA; DELETIONS; DUPLICATIONS	Tetralogy of Fallot (TOF), the most common severe congenital heart malformation, occurs sporadically, without other anomaly, and from unknown cause in 70% of cases. Through a genome-wide survey of 114 subjects with TOF and their unaffected parents, we identified 11 de novo copy number variants (CNVs) that were absent or extremely rare (<0.1%) in 2,265 controls. We then examined a second, independent TOF cohort (n = 398) for additional CNVs at these loci. We identified CNVs at chromosome 1q21.1 in 1% (5/512, P = 0.0002, OR = 22.3) of nonsyndromic sporadic TOF cases. We also identified recurrent CNVs at 3p25.1, 7p21.3 and 22q11.2. CNVs in a single subject with TOF occurred at six loci, two that encode known (NOTCH1, JAG1) disease-associated genes. Our findings predict that at least 10% (4.5-15.5%, 95% confidence interval) of sporadic nonsyndromic TOF cases result from de novo CNVs and suggest that mutations within these loci might be etiologic in other cases of TOF.	[Greenway, Steven C.; Lin, Jennifer C.; DePalma, Steven R.; Israel, Samuel J.; Korn, Joshua M.; McCarroll, Steven A.; Gorham, Joshua M.; Altshuler, David M.; Quintanilla-Dieck, Maria de Lourdes; Artunduaga, Maria Alexandra; Seidman, Jonathan G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Pereira, Alexandre C.; Mesquita, Sonia M.] Univ Sao Paulo, Sch Med, Inst Heart, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Ergul, Emel; Conta, Jessie H.; Breitbart, Roger E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Korn, Joshua M.; McCarroll, Steven A.; Gabriel, Stacey; Altshuler, David M.; Plenge, Robert M.; De Jager, Philip L.; Hafler, David A.] Broad Inst Harvard, Cambridge, MA USA; [Korn, Joshua M.; McCarroll, Steven A.; Gabriel, Stacey; Altshuler, David M.; Plenge, Robert M.; De Jager, Philip L.; Hafler, David A.] MIT, Cambridge, MA 02139 USA; [Quintanilla-Dieck, Maria de Lourdes; Artunduaga, Maria Alexandra; Eavey, Roland D.] Massachusetts Eye & Ear Infirm, Dept Otol & Laryngol, Boston, MA 02114 USA; [Plenge, Robert M.; Shadick, Nancy A.; Weinblatt, Michael E.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [De Jager, Philip L.; Hafler, David A.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Universidade de Sao Paulo; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Pereira, Alexandre/HHN-1038-2022; Greenway, Steven C/S-7777-2019; Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; DePalma, Steven/0000-0002-0381-5016	Howard Hughes Medical Institute; US National Institutes of Health; Broad Institute; Pediatric Scientist Development Program; Sarnoff Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074734] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Pediatric Scientist Development Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sarnoff Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge the participation of families. We also thank C. Sougnez and M. Parkin for technical assistance and R. Geggel for supplying TOF images. This work was supported by grants from the Howard Hughes Medical Institute (C. E. S.), US National Institutes of Health (to C. E. S., J. G. S. and R. E. B. and to the Broad Institute (National Center for Research Resources)), Pediatric Scientist Development Program (S. C. G.) and Sarnoff Cardiovascular Research Foundation (J. C. L.). Multiple sclerosis controls were genotyped in collaboration with Affymetrix, Inc.	Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Eldadah ZA, 2001, HUM MOL GENET, V10, P163, DOI 10.1093/hmg/10.2.163; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Krantz ID, 1998, AM J HUM GENET, V62, P1361, DOI 10.1086/301875; Loffredo CA, 2000, AM J MED GENET, V97, P319, DOI 10.1002/1096-8628(200024)97:4<319::AID-AJMG1283>3.0.CO;2-E; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Richards AA, 2008, PEDIATR RES, V64, P358, DOI 10.1203/PDR.0b013e31818095d0; Sato M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1921; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stern RF, 2004, BIOTECHNIQUES, V37, P399, DOI 10.2144/04373ST04; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550	38	308	322	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					931	U98		10.1038/ng.415	http://dx.doi.org/10.1038/ng.415			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19597493	Green Accepted			2022-12-25	WOS:000268432900020
J	Meier, A; Chang, JJ; Chan, ES; Pollard, RB; Sidhu, HK; Kulkarni, S; Wen, TF; Lindsay, RJ; Orellana, L; Mildvan, D; Bazner, S; Streeck, H; Alter, G; Lifson, JD; Carrington, M; Bosch, RJ; Robbins, GK; Altfeld, M				Meier, Angela; Chang, J. Judy; Chan, Ellen S.; Pollard, Richard B.; Sidhu, Harlyn K.; Kulkarni, Smita; Wen, Tom Fang; Lindsay, Robert J.; Orellana, Liliana; Mildvan, Donna; Bazner, Suzane; Streeck, Hendrik; Alter, Galit; Lifson, Jeffrey D.; Carrington, Mary; Bosch, Ronald J.; Robbins, Gregory K.; Altfeld, Marcus			Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IFN-ALPHA PRODUCTION; IMMUNE ACTIVATION; VIRAL LOAD; PROGNOSTIC VALUE; SIV INFECTION; RNA LEVELS; T-CELLS; I INTERFERON; SERUM-LEVELS	Manifestations of viral infections can differ between women and men(1), and marked sex differences have been described in the course of HIV-1 disease. HIV-1-infected women tend to have lower viral loads early in HIV-1 infection but progress faster to AIDS for a given viral load than men(2-7). Here we show substantial sex differences in the response of plasmacytoid dendritic cells (pDCs) to HIV-1. pDCs derived from women produce markedly more interferon-alpha (IFN-alpha) in response to HIV-1-encoded Toll-like receptor 7 (TLR7) ligands than pDCs derived from men, resulting in stronger secondary activation of CD8(+) T cells. In line with these in vitro studies, treatment-naive women chronically infected with HIV-1 had considerably higher levels of CD8(+) T cell activation than men after adjusting for viral load. These data show that sex differences in TLR-mediated activation of pDCs may account for higher immune activation in women compared to men at a given HIV-1 viral load and provide a mechanism by which the same level of viral replication might result in faster HIV-1 disease progression in women compared to men. Modulation of the TLR7 pathway in pDCs may therefore represent a new approach to reduce HIV-1-associated pathology.	[Meier, Angela; Chang, J. Judy; Sidhu, Harlyn K.; Wen, Tom Fang; Lindsay, Robert J.; Bazner, Suzane; Streeck, Hendrik; Alter, Galit; Altfeld, Marcus] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Chan, Ellen S.; Orellana, Liliana; Bosch, Ronald J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Pollard, Richard B.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Kulkarni, Smita; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, Frederick, MD 21701 USA; [Lifson, Jeffrey D.] NCI, Sci Applicat Int Corp Frederick, AIDS & Canc Virus Program, Frederick, MD 21701 USA; [Mildvan, Donna] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Bazner, Suzane; Robbins, Gregory K.; Altfeld, Marcus] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital	Altfeld, M (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA.	maltfeld@partners.org	Altfeld, Marcus/AAE-7306-2019; Robbins, Gregory/F-7988-2011; Orellana, Liliana/I-5249-2013	Altfeld, Marcus/0000-0001-5972-2997; Robbins, Gregory/0000-0001-7545-5817; Orellana, Liliana/0000-0003-3736-4337	US National Institutes of Health (NIH)-National Institute of Allergy Infectious Diseases [R21 AI071806, PO1 AI074415, K01AI062435]; Harvard University Center for AIDS Research; Bill & Melinda Gates Foundation; Doris Duke Charitable Foundation; German Research Society (Deutsche Forschungsgemeinschaft); National Health and Medical Research Council of Australia [519578]; National Institute of Allergy and Infectious Diseases [AI38855, AI27659, AI38858, AI25879, AI27666]; Agouron/Pfizer, Bristol Myers Squibb and GlaxoSmithKline; US National Cancer Institute (NCI), NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI062435, U01AI038855, U01AI025879, U01AI027666, U01AI027659, R21AI071806, P01AI074415, U01AI038858] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)-National Institute of Allergy Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); German Research Society (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agouron/Pfizer, Bristol Myers Squibb and GlaxoSmithKline(Pfizer); US National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Deeks, P. Hunt, B. Walker and J. Spritzler for valuable intellectual input and discussions and the ACTG 384 main study and immunology A5007 substudy teams. These studies were supported by US National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases grants to M. A. (R21 AI071806, PO1 AI074415) and G. K. R. (K01AI062435), the Harvard University Center for AIDS Research, the Bill & Melinda Gates Foundation and the Doris Duke Charitable Foundation. A. M. was supported by a fellowship from the German Research Society (Deutsche Forschungsgemeinschaft), and J. J. C. was supported by a Fellowship awarded from the National Health and Medical Research Council of Australia (519578). ACTG 384 was supported in part by National Institute of Allergy and Infectious Diseases grants AI38855, AI27659, AI38858, AI25879 and AI27666 and by Agouron/Pfizer, Bristol Myers Squibb and GlaxoSmithKline. This project has been funded in whole or in part with federal funds from the US National Cancer Institute (NCI), NIH, under Contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Support Program of the NIH, NCI, Center for Cancer Research. M. A. is a Distinguished Clinical Scientist of the Doris Duke Charitable Foundation. We thank the Mark and Lisa Schwartz Foundation and the Phillip T. and Susan M. Ragon Foundation for their support.	Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Chang JJ, 2009, BLOOD, V113, P269, DOI 10.1182/blood-2008-10-184598; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2004, J CLIN INVEST, V113, P808, DOI 10.1172/JCI200421318; Evans JS, 1997, J INFECT DIS, V175, P795, DOI 10.1086/513973; EYSTER ME, 1983, NEW ENGL J MED, V309, P583, DOI 10.1056/NEJM198309083091003; Fahey JL, 1998, AIDS, V12, P1581, DOI 10.1097/00002030-199813000-00004; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Guiducci C, 2009, J INTERN MED, V265, P43, DOI 10.1111/j.1365-2796.2008.02050.x; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Hughes GC, 2008, J IMMUNOL, V180, P2029, DOI 10.4049/jimmunol.180.4.2029; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Khatissian E, 1996, RES VIROLOGY, V147, P181, DOI 10.1016/0923-2516(96)80233-0; KROWN SE, 1991, J ACQ IMMUN DEF SYND, V4, P871; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Lyles CM, 1999, J INFECT DIS, V180, P1018, DOI 10.1086/314980; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; MILDVAN D, 1992, LANCET, V339, P453, DOI 10.1016/0140-6736(92)91058-G; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Rodriguez B, 2006, AIDS, V20, P1379, DOI 10.1097/01.aids.0000233571.51899.ab; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967	39	394	399	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					955	U161		10.1038/nm.2004	http://dx.doi.org/10.1038/nm.2004			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19597505	Green Accepted			2022-12-25	WOS:000268770400042
J	Chang, J; Wang, Z; Tang, E; Fan, ZP; McCauley, L; Franceschi, R; Guan, KL; Krebsbach, PH; Wang, CY				Chang, Jia; Wang, Zhuo; Tang, Eric; Fan, Zhipeng; McCauley, Laurie; Franceschi, Renny; Guan, Kunliang; Krebsbach, Paul H.; Wang, Cun-Yu			Inhibition of osteoblastic bone formation by nuclear factor-kappa B	NATURE MEDICINE			English	Article							NEMO/IKK-GAMMA; ACTIVATION; OSTEOCLASTOGENESIS; PATHOPHYSIOLOGY; DIFFERENTIATION; OSTEOPOROSIS; PATHWAY	An imbalance in bone formation relative to bone resorption results in the net bone loss that occurs in osteoporosis and inflammatory bone diseases. Although it is well known how bone resorption is stimulated, the molecular mechanisms that mediate impaired bone formation are poorly understood. Here we show that the time- and stage-specific inhibition of endogenous inhibitor of kappa B kinase (IKK)-nuclear factor-kappa B (NF-kappa B) in differentiated osteoblasts substantially increases trabecular bone mass and bone mineral density without affecting osteoclast activities in young mice. Moreover, inhibition of IKK-NF-kappa B in differentiated osteoblasts maintains bone formation, thereby preventing osteoporotic bone loss induced by ovariectomy in adult mice. Inhibition of IKK-NF-kappa B enhances the expression of Fos-related antigen-1 (Fra-1), an essential transcription factor involved in bone matrix formation in vitro and in vivo. Taken together, our results suggest that targeting IKK-NF-kappa B may help to promote bone formation in the treatment of osteoporosis and other bone diseases.	[Chang, Jia; Tang, Eric; Fan, Zhipeng; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90024 USA; [Chang, Jia; Tang, Eric; Fan, Zhipeng; Wang, Cun-Yu] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Wang, Zhuo; Krebsbach, Paul H.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [McCauley, Laurie; Franceschi, Renny] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [McCauley, Laurie] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Guan, Kunliang] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Guan, Kunliang] Univ Calif San Diego, Ctr Comprehens Canc, San Diego, CA 92103 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90024 USA.	cwang@dentistry.ucla.edu	Guan, Kun-Liang/ADK-7088-2022; Krebsbach, Paul H./AAC-4765-2021; McCauley, Laurie/G-4041-2012		US National Institute of Dental and Craniofacial Research [DE17684, DE019412, DE1016513, DE13848, DE018890]; US National Institute of Diabetes and Kidney Disease [DK053904]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013848, R01DE016513, R01DE019412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017684, R01DE013848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053904] Funding Source: NIH RePORTER	US National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); US National Institute of Diabetes and Kidney Disease; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Adams for valuable advice and G. Karsenty (Columbia University) for Col1a1 promoter and T. Gilmore (Boston University) for c-Rel vector. This work was supported by US National Institute of Dental and Craniofacial Research grants (DE17684, DE019412, DE1016513, DE13848 and DE018890) and US National Institute of Diabetes and Kidney Disease grants (DK053904).	Bilic-Curcic I, 2005, GENESIS, V43, P87, DOI 10.1002/gene.20156; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Harnish DC, 2006, CURR OPIN INVESTIG D, V7, P997; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Khosla S, 2005, ENDOCRIN METAB CLIN, V34, P1015, DOI 10.1016/j.ecl.2005.07.009; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LI YP, 1993, MOL CELL BIOL, V13, P3714, DOI 10.1128/MCB.13.6.3714; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pearse RN, 2006, CLIN CANCER RES, V12, p6274S, DOI 10.1158/1078-0432.CCR-06-0648; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reuther-Madrid JY, 2002, MOL CELL BIOL, V22, P8175, DOI 10.1128/MCB.22.23.8175-8183.2002; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang F, 2004, J IMMUNOL, V172, P2446, DOI 10.4049/jimmunol.172.4.2446; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	35	344	376	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					682	U120		10.1038/nm.1954	http://dx.doi.org/10.1038/nm.1954			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19448637	Green Accepted			2022-12-25	WOS:000266731600028
J	Kessenbrock, K; Krumbholz, M; Schonermarck, U; Back, W; Gross, WL; Werb, Z; Grone, HJ; Brinkmann, V; Jenne, DE				Kessenbrock, Kai; Krumbholz, Markus; Schoenermarck, Ulf; Back, Walter; Gross, Wolfgang L.; Werb, Zena; Groene, Hermann-Josef; Brinkmann, Volker; Jenne, Dieter E.			Netting neutrophils in autoimmune small-vessel vasculitis	NATURE MEDICINE			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; EXTRACELLULAR TRAPS; DNA; MYELOPEROXIDASE; CELLS	Small-vessel vasculitis (SVV) is a chronic autoinflammatory condition linked to antineutrophil cytoplasm autoantibodies (ANCAs). Here we show that chromatin fibers, so-called neutrophil extracellular traps (NETs), are released by ANCA-stimulated neutrophils and contain the targeted autoantigens proteinase-3 (PR3) and myeloperoxidase (MPO). Deposition of NETs in inflamed kidneys and circulating MPO-DNA complexes suggest that NET formation triggers vasculitis and promotes the autoimmune response against neutrophil components in individuals with SVV.	[Kessenbrock, Kai; Krumbholz, Markus; Jenne, Dieter E.] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany; [Kessenbrock, Kai; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Krumbholz, Markus] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany; [Schoenermarck, Ulf] Univ Hosp Grosshadern, Med Clin 1, Div Nephrol, Munich, Germany; [Back, Walter] Univ Heidelberg, Mannheim Clin, Dept Pathol, D-6800 Mannheim, Germany; [Gross, Wolfgang L.] Med Univ Lubeck, Univ Klinikum Schleswig Holstein, Vasculitis Ctr, Dept Rheumatol, D-23538 Lubeck, Germany; [Gross, Wolfgang L.] Rheumaklin Bad Bramstedt, Lubeck, Germany; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-6900 Heidelberg, Germany; [Brinkmann, Volker] Max Planck Inst Infect Biol, Microscopy Core Facil, Berlin, Germany	Max Planck Society; University of California System; University of California San Francisco; University of Munich; University of Munich; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Kessenbrock, K (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany.	kai.kessenbrock@ucsf.edu; djenne@neuro.mpg.de	Brinkmann, Volker/A-6015-2009; Jenne, Dieter Erich/AAP-1414-2020; Schönermarck, Ulf/AAE-6590-2020; Gross, Wolfgang Ludwig WG/C-8733-2011; Kessenbrock, Kai/B-6936-2011	Schonermarck, Ulf/0000-0002-3266-9791	Deutsche Forschungsgemeinschaft [SFB 571]; US National Institutes of Health [AI053194]; Susan G. Komen for the Cure Foundation; Alexander von Humboldt Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank W. Samtleben for providing serum samples, R. Bittner for technical assistance and E. Csernok and A. Kniepert for help with serum samples. Moreover, we are grateful to M. Sixt and E. Meinl for helpful suggestions and H. Wekerle for his constant interest and support of this work. We also thank M. Monestier (Temple University) for providing us with histone-specific monoclonal antibody and G. Koch (University of Freiburg) for the kind gift of the antibody specific for MxA. This work was funded by the Deutsche Forschungsgemeinschaft (SFB 571). It was further supported by the US National Institutes of Health (AI053194) and by fellowships from the Susan G. Komen for the Cure Foundation and the Alexander von Humboldt Foundation.	Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Harper L, 2000, AM J PATHOL, V157, P211, DOI 10.1016/S0002-9440(10)64532-4; Holdenrieder S, 2006, ANN NY ACAD SCI, V1075, P318, DOI 10.1196/annals.1368.043; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; MURAO S, 1988, P NATL ACAD SCI USA, V85, P1232, DOI 10.1073/pnas.85.4.1232; Pfister H, 2004, BLOOD, V104, P1411, DOI 10.1182/blood-2004-01-0267; Wenzel J, 2005, J PATHOL, V205, P435, DOI 10.1002/path.1721; Woltman AM, 2007, KIDNEY INT, V71, P1001, DOI 10.1038/sj.ki.5002187; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	16	1079	1149	3	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2009	15	6					623	625		10.1038/nm.1959	http://dx.doi.org/10.1038/nm.1959			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19448636	Green Accepted			2022-12-25	WOS:000266731600020
J	Khanna, H; Davis, EE; Murga-Zamalloa, CA; Estrada-Cuzcano, A; Lopez, I; den Hollander, AI; Zonneveld, MN; Othman, MI; Waseem, N; Chakarova, CF; Maubaret, C; Diaz-Font, A; MacDonald, I; Muzny, DM; Wheeler, DA; Morgan, M; Lewis, LR; Logan, CV; Tan, PL; Beer, MA; Inglehearn, CF; Lewis, RA; Jacobson, SG; Bergmann, C; Beales, PL; Attie-Bitach, T; Johnson, CA; Otto, EA; Bhattacharya, SS; Hildebrandt, F; Gibbs, RA; Koenekoop, RK; Swaroop, A; Katsanis, N				Khanna, Hemant; Davis, Erica E.; Murga-Zamalloa, Carlos A.; Estrada-Cuzcano, Alejandro; Lopez, Irma; den Hollander, Anneke I.; Zonneveld, Marijke N.; Othman, Mohammad I.; Waseem, Naushin; Chakarova, Christina F.; Maubaret, Cecilia; Diaz-Font, Anna; MacDonald, Ian; Muzny, Donna M.; Wheeler, David A.; Morgan, Margaret; Lewis, Lora R.; Logan, Clare V.; Tan, Perciliz L.; Beer, Michael A.; Inglehearn, Chris F.; Lewis, Richard A.; Jacobson, Samuel G.; Bergmann, Carsten; Beales, Philip L.; Attie-Bitach, Tania; Johnson, Colin A.; Otto, Edgar A.; Bhattacharya, Shomi S.; Hildebrandt, Friedhelm; Gibbs, Richard A.; Koenekoop, Robert K.; Swaroop, Anand; Katsanis, Nicholas			A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; LINKED RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; JOUBERT-SYNDROME; CENTROSOMAL PROTEIN; MUTATION ANALYSIS; MECKEL-SYNDROME; EARLY-ONSET; CILIARY; GENE	Despite rapid advances in the identification of genes involved in disease, the predictive power of the genotype remains limited, in part owing to poorly understood effects of second-site modifiers. Here we demonstrate that a polymorphic coding variant of RPGRIP1L (retinitis pigmentosa GTPase regulator-interacting protein-1 like), a ciliary gene mutated in Meckel-Gruber (MKS) and Joubert (JBTS) syndromes, is associated with the development of retinal degeneration in individuals with ciliopathies caused by mutations in other genes. As part of our resequencing efforts of the ciliary proteome, we identified several putative loss-of-function RPGRIP1L mutations, including one common variant, A229T. Multiple genetic lines of evidence showed this allele to be associated with photoreceptor loss in ciliopathies. Moreover, we show that RPGRIP1L interacts biochemically with RPGR, loss of which causes retinal degeneration, and that the Thr229-encoded protein significantly compromises this interaction. Our data represent an example of modification of a discrete phenotype of syndromic disease and highlight the importance of a multifaceted approach for the discovery of modifier alleles of intermediate frequency and effect.	[Khanna, Hemant; Murga-Zamalloa, Carlos A.; Estrada-Cuzcano, Alejandro; Othman, Mohammad I.; Swaroop, Anand] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Davis, Erica E.; Tan, Perciliz L.; Beer, Michael A.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Lopez, Irma; Koenekoop, Robert K.] McGill Univ, Ctr Hlth, McGill Ocular Genet Lab, Montreal, PQ, Canada; [den Hollander, Anneke I.; Zonneveld, Marijke N.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Waseem, Naushin; Chakarova, Christina F.; Maubaret, Cecilia; Bhattacharya, Shomi S.] UCL, Inst Ophthalmol, London, England; [Diaz-Font, Anna; Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London, England; [MacDonald, Ian] NEI, Ophthalm Genet & Visual Funct Branch, Bethesda, MD 20892 USA; [Muzny, Donna M.; Wheeler, David A.; Morgan, Margaret; Lewis, Lora R.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Logan, Clare V.; Inglehearn, Chris F.; Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Beer, Michael A.] Johns Hopkins Univ, Dept Biomed Engn, Sch Med, Baltimore, MD USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Jacobson, Samuel G.] Univ Penn, Sch Med, Dept Ophthalmol, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Bergmann, Carsten] Univ Aachen, Rhein Westfal TH Aachen, Dept Human Genet, D-5100 Aachen, Germany; [Attie-Bitach, Tania] Hop Necker Enfants Malad, Dept Genet, Paris, France; [Attie-Bitach, Tania] Hop Necker Enfants Malad, INSERM, U781, Paris, France; [Otto, Edgar A.; Hildebrandt, Friedhelm; Swaroop, Anand] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Hildebrandt, Friedhelm] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD USA; [Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University of Michigan System; University of Michigan; Johns Hopkins University; McGill University; Radboud University Nijmegen; University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Baylor College of Medicine; Saint James's University Hospital; University of Leeds; Johns Hopkins University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; RWTH Aachen University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Swaroop, A (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	swaroopa@nei.nih.gov; katsanis@jhmi.edu	Bhattacharya, Shom/N-2926-2016; Inglehearn, Chris/GYD-9783-2022; Hollander, Anneke den/N-4911-2014; Wheeler, David A/M-9740-2018; Murga-Zamalloa, Carlos/AAX-9387-2021; Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012; Waseem, Naushin/C-9573-2013; Estrada-Cuzcano, Alejandro/J-4365-2019; ATTIE-BITACH, Tania/K-1453-2017; Koenekoop, Robert/AAT-6676-2021; Chakarova, Christina/C-9479-2013; Beer, Michael/AFV-4282-2022	Bhattacharya, Shom/0000-0002-1601-6344; Wheeler, David A/0000-0002-9056-6299; Murga-Zamalloa, Carlos/0000-0002-2238-5066; Estrada-Cuzcano, Alejandro/0000-0001-9868-2465; ATTIE-BITACH, Tania/0000-0002-1155-3626; Beer, Michael A/0000-0001-9955-3809; Johnson, Colin/0000-0002-2979-8234; Davis, Erica/0000-0002-2412-8397; Swaroop, Anand/0000-0002-1975-1141; Logan, Clare/0000-0003-4323-1602; Otto, Edgar/0000-0002-2387-9973; Jacobson, Samuel/0000-0003-2122-169X; Katsanis, Nicholas/0000-0002-2480-0171; MacDonald, Ian/0000-0001-7472-8385	National Eye Institute [R01EY007961]; National Institute of Child Health and Development [R01HD04260]; NRSA fellowship [R01DK072301, R01DK075972, R01DK068306, R01DK064614, R01DK069274]; National Institute of Diabetes, Digestive and Kidney disorders [F32 DK079541]; Intramural program of NEI; Macular Vision Research Foundation; Foundation for Fighting Blindness; Foundation for Fighting Blindness Canada; Le Fonds de la recherche en sante du Quebec; Research to Prevent Blindness; Harold Falls Collegiate Professorship; Midwest Eye Banks and Transplantation Center; Searle Scholars Program; Deutsche Forschungsgemeinschaft [BE 3910/4-1]; UK Medical Research Council [G0700073]; NIHR Biomedical Research Centre for Ophthalmology; EU-GENORET [LSHGCT-2005-512036]; Howard Hughes Medical Institute ( HHMI); Doris Duke Distinguished Clinical Scientist (DDCF); MRC [G0801843, G0700073] Funding Source: UKRI; Medical Research Council [G0700073, G0801843] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007961, ZIAEY000473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064614, R01DK069274, R01DK068306, F32DK079541, R01DK075972, R01DK072301] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive and Kidney disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural program of NEI; Macular Vision Research Foundation; Foundation for Fighting Blindness; Foundation for Fighting Blindness Canada; Le Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Harold Falls Collegiate Professorship; Midwest Eye Banks and Transplantation Center; Searle Scholars Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre for Ophthalmology; EU-GENORET; Howard Hughes Medical Institute ( HHMI)(Howard Hughes Medical Institute); Doris Duke Distinguished Clinical Scientist (DDCF)(Doris Duke Charitable Foundation (DDCF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the individuals affected with ciliopathies and their families for their continued support and encouragement. We also thank H. Arts for critical evaluation of the manuscript. This work was supported by grants R01EY007961 from the National Eye Institute ( H. K. and A. S.), R01HD04260 from the National Institute of Child Health and Development ( N. K.), R01DK072301, R01DK075972 ( N. K.), R01DK068306, R01DK064614, R01DK069274 ( F. H.), NRSA fellowship F32 DK079541 ( E. E. D.) from the National Institute of Diabetes, Digestive and Kidney disorders, Intramural program of NEI ( A. S.), the Macular Vision Research Foundation ( N. K.), the Foundation for Fighting Blindness ( H. K., S. S. B., A. S. and N. K.), the Foundation for Fighting Blindness Canada ( R. K. K.), Le Fonds de la recherche en sante du Quebec ( FRSQ) ( R. K. K.), Research to Prevent Blindness ( A. S.), Harold Falls Collegiate Professorship ( A. S.), the Midwest Eye Banks and Transplantation Center ( H. K.), the Searle Scholars Program ( M. A. B.), the Deutsche Forschungsgemeinschaft ( DFG grant BE 3910/4-1; C. B.) the UK Medical Research Council ( grant number G0700073; C. A. J.), NIHR Biomedical Research Centre for Ophthalmology ( S. S. B.) and EU-GENORET Grant LSHGCT-2005-512036 ( S. S. B.). F. H. is an investigator of the Howard Hughes Medical Institute ( HHMI) and a Doris Duke Distinguished Clinical Scientist (DDCF).	Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; He S, 2008, VISION RES, V48, P366, DOI 10.1016/j.visres.2007.08.005; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Shu XH, 2007, HUM MUTAT, V28, P322, DOI 10.1002/humu.20461; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805	30	216	223	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					739	745		10.1038/ng.366	http://dx.doi.org/10.1038/ng.366			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19430481	Green Accepted			2022-12-25	WOS:000266411700026
J	Mullershausen, F; Zecri, F; Cetin, C; Billich, A; Guerini, D; Seuwen, K				Mullershausen, Florian; Zecri, Frederic; Cetin, Cihan; Billich, Andreas; Guerini, Danilo; Seuwen, Klaus			Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors	NATURE CHEMICAL BIOLOGY			English	Article							IMMUNOMODULATORY DRUG FTY720; SPHINGOSINE 1-PHOSPHATE RECEPTORS; CIRCULATING MATURE LYMPHOCYTES; IN-VIVO; IMMUNOSUPPRESSANT FTY720; MULTIPLE-SCLEROSIS; ADENYLATE-CYCLASE; LYMPHOID ORGANS; CELL-MIGRATION; T-CELLS	Targeting sphingosine-1-phosphate receptors with the oral immunomodulator drug FTY720 (fingolimod) has demonstrated substantial efficacy in the treatment of multiple sclerosis. The drug is phosphorylated in vivo, and most of the clinical effects of FTY720-phosphate (FTY720P) are thought to be mediated via S1P1 receptors on lymphocytes and endothelial cells, leading to sequestration of lymphocytes in secondary lymphoid organs. FTY720P was described to act as a "functional antagonist'' by promoting efficient internalization of S1P1 receptors. We demonstrate here that S1P1 receptors activated by FTY720P retain signaling activity for hours in spite of a quantitative internalization. Structural analogs of FTY720P with shorter alkyl side chains retained potency and efficacy in a functional assay but failed to promote long-lasting receptor internalization and signaling. We show that persistent signaling translates into an increased chemokinetic migration of primary human umbilical vein endothelial cells, which suggests persistent agonism as a crucial parameter in the mechanism of action of FTY720.	[Mullershausen, Florian; Seuwen, Klaus] Novartis Pharma AG, Novartis Inst BioMed Res, Dev & Mol Pathways, Basel, Switzerland; [Zecri, Frederic] Novartis Pharma AG, Novartis Inst BioMed Res, Global Discovery Chem, Basel, Switzerland; [Cetin, Cihan] Facil Adv Microscopy & Imaging, Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Billich, Andreas; Guerini, Danilo] Novartis Pharma AG, Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat, Basel, Switzerland	Novartis; Novartis; Friedrich Miescher Institute for Biomedical Research; Novartis	Mullershausen, F (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Dev & Mol Pathways, Basel, Switzerland.	florian.muellershausen@novartis.com; klaus.seuwen@novartis.com						Albert R, 2005, J MED CHEM, V48, P5373, DOI 10.1021/jm050242f; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; Chiba K, 1998, J IMMUNOL, V160, P5037; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hinterding K, 2002, TETRAHEDRON LETT, V43, P8095, DOI 10.1016/S0040-4039(02)01925-1; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Johannes L, 1998, TRENDS CELL BIOL, V8, P158, DOI 10.1016/S0962-8924(97)01209-9; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Mullershausen F, 2007, J NEUROCHEM, V102, P1151, DOI 10.1111/j.1471-4159.2007.04629.x; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pan SF, 2006, CHEM BIOL, V13, P1227, DOI 10.1016/j.chembiol.2006.09.017; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schurer SC, 2008, ACS CHEM BIOL, V3, P486, DOI 10.1021/cb800051m; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yanagawa Y, 1998, J IMMUNOL, V160, P5493; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	45	269	278	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					428	434		10.1038/nchembio.173	http://dx.doi.org/10.1038/nchembio.173			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19430484				2022-12-25	WOS:000266383800018
J	Tian, C; Xing, GC; Xie, P; Lu, KF; Nie, J; Wang, J; Li, L; Gao, M; Zhang, LQ; He, FC				Tian, Chunyan; Xing, Guichun; Xie, Ping; Lu, Kefeng; Nie, Jing; Wang, Jian; Li, Li; Gao, Mei; Zhang, Lingqiang; He, Fuchu			KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; ATAXIA-TELANGIECTASIA; CELL-SURVIVAL; P53 ACTIVITY; IN-VIVO; ATM; ACTIVATION; FAMILY; GENES; PATHWAY	Only a few p53 regulators have been shown to participate in the selective control of p53-mediated cell cycle arrest or apoptosis. How p53-mediated apoptosis is negatively regulated remains largely unclear. Here we report that Apak (ATM and p53-associated KZNF protein), a Kruppel-associated box (KRAB)-type zinc-finger protein, binds directly to p53 in unstressed cells, specifically downregulates pro-apoptotic genes, and suppresses p53-mediated apoptosis by recruiting KRAB-box-associated protein (KAP)-1 and histone deacetylase 1 (HDAC1) to attenuate the acetylation of p53. Apak inhibits p53 activity by interacting with ATM, a previously identified p53 activator. In response to stress, Apak is phosphorylated by ATM and dissociates from p53, resulting in activation of p53 and induction of apoptosis. These findings revealed Apak to be a negative regulator of p53-mediated apoptosis and showed the dual role of ATM in p53 regulation.	[Tian, Chunyan; Xing, Guichun; Xie, Ping; Lu, Kefeng; Nie, Jing; Wang, Jian; Li, Li; Gao, Mei; Zhang, Lingqiang; He, Fuchu] Beijing Inst Radiat Med, Beijing Prote Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Xie, Ping; Nie, Jing; He, Fuchu] Tsinghua Univ, Dept Biomed Sci & Biotechnol, Beijing 100084, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Academy of Military Medical Sciences - China; Tsinghua University; Fudan University	Zhang, LQ (corresponding author), Beijing Inst Radiat Med, Beijing Prote Res Ctr, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn; hefc@nic.bmi.ac.cn		Li, Li/0000-0003-2342-3658; Tian, Chunyan/0000-0003-1589-293X; Lu, Kefeng/0000-0001-8200-9380; Zhang, Lingqiang/0000-0002-9795-2141	Chinese National Basic Research Programs [2007CB914601, 2006CB910802]; Chinese National Natural Science Foundation [30621063, 30600310, 30871373]; Beijing Science and Technology NOVA Program [2007A063]	Chinese National Basic Research Programs(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology NOVA Program	We are grateful to Bert Vogelstein, Michael B. Kastan, Qimin Zhan, Wei Gu, Jiandong Chen, Yue Xiong, Shengcai Lin, Gang Pei and Weiguo Zhu for providing materials; Yi Tie, Heping Pan, Qiao Sun, Juntao Yang, Xiushan Yin, Dahu Li, Bo Dong, Shaofei Zhong, Bin Li and Yanzhi Yuan for technical assistance; and Wei Gu, Yue Xiong, Shengcai Lin, Zigang Dong, Yi Rao and Chengrong Lu for critical reading of the manuscript. This study was supported by Chinese National Basic Research Programs 2007CB914601 (L. Z.) and 2006CB910802 (F. H., L. Z.), Chinese National Natural Science Foundation Projects 30621063 (F. H.) and 30600310, 30871373 (C. T.), and the Beijing Science and Technology NOVA Program 2007A063 (L. Z.).	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Li J, 2007, BIOCHEM BIOPH RES CO, V363, P895, DOI 10.1016/j.bbrc.2007.08.180; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Li L, 2007, CELL SIGNAL, V19, P2046, DOI 10.1016/j.cellsig.2007.05.017; Liu XJ, 2008, CELL SIGNAL, V20, P230, DOI 10.1016/j.cellsig.2007.10.012; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shen ZY, 1996, GENOMICS, V37, P183, DOI 10.1006/geno.1996.0540; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2006, MOL CANCER RES, V4, P125, DOI 10.1158/1541-7786.MCR-05-0104; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang J, 2004, J BIOL CHEM, V279, P39584, DOI 10.1074/jbc.M400015200; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; Xie P, 2008, CELL SIGNAL, V20, P1671, DOI 10.1016/j.cellsig.2008.05.012; Zhang LQ, 2007, CELL SIGNAL, V19, P932, DOI 10.1016/j.cellsig.2006.11.002; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	50	81	92	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					580	U122		10.1038/ncb1864	http://dx.doi.org/10.1038/ncb1864			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19377469				2022-12-25	WOS:000265640000017
J	Lu, BC; Cebrian, C; Chi, X; Kuure, S; Kuo, R; Bates, CM; Arber, S; Hassell, J; MacNeil, L; Hoshi, M; Jain, S; Asai, N; Takahashi, M; Schmidt-Ott, KM; Barasch, J; D'Agati, V; Costantini, F				Lu, Benson C.; Cebrian, Cristina; Chi, Xuan; Kuure, Satu; Kuo, Richard; Bates, Carlton M.; Arber, Silvia; Hassell, John; MacNeil, Lesley; Hoshi, Masato; Jain, Sanjay; Asai, Naoya; Takahashi, Masahide; Schmidt-Ott, Kai M.; Barasch, Jonathan; D'Agati, Vivette; Costantini, Frank			Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis	NATURE GENETICS			English	Article							ETS TRANSCRIPTION FACTORS; URETERAL BUD; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; CELL-PROLIFERATION; NEPHRON NUMBER; EXPRESSION; RECEPTOR; MOUSE; GENE	Glial cell line-derived neurotrophic factor signaling through the Ret receptor tyrosine kinase is crucial for ureteric bud branching morphogenesis during kidney development, yet few of the downstream genes are known. Here we show that the ETS transcription factors Etv4 and Etv5 are positively regulated by Ret signaling in the ureteric bud tips. Mice lacking both Etv4 alleles and one Etv5 allele show either renal agenesis or severe hypodysplasia, whereas kidney development fails completely in double homozygotes. We identified several genes whose expression in the ureteric bud depends on Etv4 and Etv5, including Cxcr4, Myb, Met and Mmp14. Thus, Etv4 and Etv5 are key components of a gene network downstream of Ret that promotes and controls renal branching morphogenesis.	[Lu, Benson C.; Cebrian, Cristina; Chi, Xuan; Kuure, Satu; Kuo, Richard; Costantini, Frank] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA; [Bates, Carlton M.] UPMC, Childrens Hosp Pittsburgh, Div Nephrol, Pittsburgh, PA USA; [Arber, Silvia] Univ Basel, Biozentrum, Basel, Switzerland; [Hassell, John; MacNeil, Lesley] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Hoshi, Masato; Jain, Sanjay] Washington Univ, Sch Med, Div Renal, Dept Med, St Louis, MO 63110 USA; [Asai, Naoya; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Aichi, Japan; [Schmidt-Ott, Kai M.; Barasch, Jonathan] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [D'Agati, Vivette] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Basel; McMaster University; Washington University (WUSTL); Nagoya University; Columbia University; Columbia University	Costantini, F (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA.	fdc3@columbia.edu	Takahashi, Masahide/AAN-4770-2020; Cebrian, Cristina/ABE-1974-2021; Schmidt-Ott, Kai/F-4588-2011; , shkuure/AAE-2751-2019; Cebrian, Cristina/E-2185-2012; TAKAHASHI, Masahide/I-7244-2014; ASAI, Naoya/I-7377-2014	Takahashi, Masahide/0000-0002-2803-2683; Schmidt-Ott, Kai/0000-0002-7700-7142; , shkuure/0000-0002-9076-0622; Hoshi, Masato/0000-0003-2874-1807; Lu, Benson/0000-0001-7080-4897; jain, sanjay/0000-0003-2804-127X; Arber, Silvia/0000-0002-6261-250X; Cebrian, Cristina/0000-0002-1297-6591	National Kidney Foundation [DK55388, DK075578]; American Heart Association; Sigrid Juselius Foundation and Finnish Cultural Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082531, P01DK055388, R01DK075578] Funding Source: NIH RePORTER	National Kidney Foundation; American Heart Association(American Heart Association); Sigrid Juselius Foundation and Finnish Cultural Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Simonet (Amgen) for Fgf10<SUP>-/-</SUP> mice, K. Murphy (Washington University) for Etv5<SUP>tm1Kmm</SUP> mice, L. Williams and Z. Wu for technical assistance and N. Kurpios and C. Mendelsohn for critical comments on the manuscript. This work was supported by grant DK55388 (to F. C. and J. B.) and grant DK075578 (to F. C.) and by fellowships from the National Kidney Foundation (to C. C.), the American Heart Association (to X. C.) and the Sigrid Juselius Foundation and Finnish Cultural Foundation (to S. K.).	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275; Buj-Bello A, 1999, HUM MUTAT, V14, P320, DOI 10.1002/(SICI)1098-1004(199910)14:4<320::AID-HUMU7>3.0.CO;2-O; Castellone MD, 2004, ONCOGENE, V23, P5958, DOI 10.1038/sj.onc.1207790; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; Chi X, 2009, GENESIS, V47, P61, DOI 10.1002/dvg.20452; Chotteau-Lelievre A, 2003, DEV BIOL, V259, P241, DOI 10.1016/S0012-1606(03)00182-9; Colucci-D'Amato GL, 2000, J BIOL CHEM, V275, P19306, DOI 10.1074/jbc.275.25.19306; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Firnberg N, 2002, DEV BIOL, V247, P237, DOI 10.1006/dbio.2002.0696; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Gambarotta G, 1996, ONCOGENE, V13, P1911; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8; Hoy WE, 2008, CURR OPIN NEPHROL HY, V17, P258, DOI 10.1097/MNH.0b013e3282f9b1a5; Ishibe S, 2009, DEVELOPMENT, V136, P337, DOI 10.1242/dev.024463; Izumiyama Y, 2005, ONCOL REP, V13, P715; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; Kanwar YS, 1999, AM J PHYSIOL-RENAL, V277, pF934, DOI 10.1152/ajprenal.1999.277.6.F934; Koshikawa N, 2003, FASEB J, V17, P364, DOI 10.1096/fj.03-0584fje; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Maroni P, 2007, CARCINOGENESIS, V28, P267, DOI 10.1093/carcin/bgl129; Meyer TN, 2004, DEV BIOL, V275, P44, DOI 10.1016/j.ydbio.2004.07.022; Michael L, 2004, J ANAT, V204, P241, DOI 10.1111/j.0021-8782.2004.00285.x; Michael L, 2007, J ANAT, V210, P89, DOI 10.1111/j.1469-7580.2006.00670.x; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; Pohl M, 2000, AM J PHYSIOL-RENAL, V279, pF891, DOI 10.1152/ajprenal.2000.279.5.F891; Qiao J, 2001, MECH DEVELOP, V109, P123, DOI 10.1016/S0925-4773(01)00592-5; Qiao JZ, 1999, P NATL ACAD SCI USA, V96, P7330, DOI 10.1073/pnas.96.13.7330; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SANTOS OFP, 1994, DEV BIOL, V163, P525, DOI 10.1006/dbio.1994.1169; Saxen L., 1987, ORGANOGENESIS KIDNEY; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schier AF, 2003, CURR BIOL, V13, pR192, DOI 10.1016/S0960-9822(03)00122-2; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Skinner MA, 2008, AM J HUM GENET, V82, P344, DOI 10.1016/j.ajhg.2007.10.008; Sullivan J, 1997, J BIOL CHEM, V272, P1943, DOI 10.1074/jbc.272.3.1943; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Tang MJ, 2002, DEV BIOL, V243, P128, DOI 10.1006/dbio.2001.0557; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; WANG LG, 1994, CELL GROWTH DIFFER, V5, P1243; Watanabe T, 2002, AM J PATHOL, V161, P249, DOI 10.1016/S0002-9440(10)64176-4; Weaver M, 2000, DEVELOPMENT, V127, P2695; WOOLF AS, 1995, J CELL BIOL, V128, P171, DOI 10.1083/jcb.128.1.171; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	67	150	151	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1295	1302		10.1038/ng.476	http://dx.doi.org/10.1038/ng.476			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19898483	Green Accepted			2022-12-25	WOS:000272144900010
J	Smyth, JT; Petranka, JG; Boyles, RR; DeHaven, WI; Fukushima, M; Johnson, KL; Williams, JG; Putney, JW				Smyth, Jeremy T.; Petranka, John G.; Boyles, Rebecca R.; DeHaven, Wayne I.; Fukushima, Miwako; Johnson, Katina L.; Williams, Jason G.; Putney, James W., Jr.			Phosphorylation of STIM1 underlies suppression of store-operated calcium entry during mitosis	NATURE CELL BIOLOGY			English	Article							ACTIVATES CRAC CHANNELS; PLASMA-MEMBRANE; CA2+ INFLUX; MAST-CELLS; DEPLETION; KINASE; ORAI1; IDENTIFICATION; MICRODOMAINS; HOMEOSTASIS	Store-operated Ca2+ entry (SOCE) and Ca2+ release-activated Ca2+ currents (I-crac) are strongly suppressed during mitosis, the only known physiological situation in which Ca2+ store depletion is uncoupled from the activation of Ca2+ influx. We found that the endoplasmic reticulum (ER) Ca2+ sensor STIM1 failed to rearrange into near-plasma membrane puncta in mitotic cells, a critical step in the SOCE-activation pathway. We also found that STIM1 from mitotic cells is recognized by the phospho-specific MPM-2 antibody, suggesting that STIM1 is phosphorylated during mitosis. Removal of ten MPM-2 recognition sites by truncation at amino acid 482 abolished MPM-2 recognition of mitotic STIM1, and significantly rescued STIM1 rearrangement and SOCE response in mitosis. We identified Ser 486 and Ser 668 as mitosis-specific phosphorylation sites, and STIM1 containing mutations of these sites to alanine also significantly rescued mitotic SOCE. Therefore, phosphorylation of STIM1 at Ser 486 and Ser 668, and possibly other sites, underlies suppression of SOCE during mitosis.	[Smyth, Jeremy T.; Petranka, John G.; Boyles, Rebecca R.; DeHaven, Wayne I.; Fukushima, Miwako; Putney, James W., Jr.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Johnson, Katina L.; Williams, Jason G.] NIEHS, Struct Biol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Putney, JW (corresponding author), NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	putney@niehs.nih.gov	Putney, James W/F-7247-2019	Putney, James W/0000-0002-3379-4789; Boyles, Rebecca/0000-0003-0073-6854; Matsuki-Fukushima, Miwako/0000-0002-0397-0673	Intramural Program; National Institute of Environmental Health Sciences; National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090087] Funding Source: NIH RePORTER	Intramural Program; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. Tucker and H. Rutledge for assistance with confocal microscopy and C. Bortner and M. Sifre for help with flow cytometry. C. Williams and D. Miller reviewed the manuscript and offered helpful suggestions. This work was supported by the Intramural Program, National Institute of Environmental Health Sciences, National Institutes of Health.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Che SL, 1997, FEBS LETT, V413, P417, DOI 10.1016/S0014-5793(97)00948-4; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Ding M, 1997, EXP CELL RES, V231, P3, DOI 10.1006/excr.1996.3439; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; HEPLER PK, 1994, CELL CALCIUM, V16, P322, DOI 10.1016/0143-4160(94)90096-5; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; KAWASAKI T, 2009, BIOCH BIOPHYS RES CO; KREK W, 1995, METHOD ENZYMOL, V254, P114; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Preston GA, 1997, CANCER RES, V57, P537; PRESTON SF, 1991, CELL REGUL, V2, P915, DOI 10.1091/mbc.2.11.915; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Russa AD, 2008, ARCH HISTOL CYTOL, V71, P249, DOI 10.1679/aohc.71.249; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Tani D, 2007, CELL CALCIUM, V41, P249, DOI 10.1016/j.ceca.2006.07.004; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; VOLPI M, 1988, J CELL BIOL, V107, P2533, DOI 10.1083/jcb.107.6.2533; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Whitaker M, 2001, SEMIN CELL DEV BIOL, V12, P53, DOI 10.1006/scdb.2000.0217; Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; YUAN JP, 2009, NATURE CELL BIOL; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	39	127	129	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1465	U190		10.1038/ncb1995	http://dx.doi.org/10.1038/ncb1995			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19881501	Green Accepted			2022-12-25	WOS:000272251300014
J	Wakabayashi, T; Craessaerts, K; Bammens, L; Bentahir, M; Borgions, F; Herdewijn, P; Staes, A; Timmerman, E; Vandekerckhove, J; Rubinstein, E; Boucheix, C; Gevaert, K; De Strooper, B				Wakabayashi, Tomoko; Craessaerts, Katleen; Bammens, Leen; Bentahir, Mostafa; Borgions, Filip; Herdewijn, Piet; Staes, An; Timmerman, Evy; Vandekerckhove, Joel; Rubinstein, Eric; Boucheix, Claude; Gevaert, Kris; De Strooper, Bart			Analysis of the gamma-secretase interactome and validation of its association with tetraspanin-enriched microdomains	NATURE CELL BIOLOGY			English	Article							TNF-ALPHA; PRESENILIN; COMPLEX; PROTEIN; NICASTRIN; IDENTIFICATION; APH-1; ORGANIZATION; COMPONENT; FAMILY	gamma-Secretase, an aspartyl protease that belongs to the iCLiPs (intramembrane cleaving proteases) family, is a multiprotein complex that consists of presenilin (PS), nicastrin (NCT), Aph-1 and Pen-2 (ref. 1). It is responsible for generation of the beta-amyloid peptide (A beta), the primary component of senile plaques in the brains of patients with Alzheimer's disease. Although the four components are necessary and sufficient for gamma-secretase activity(2-4), additional proteins are possibly involved in its regulation. Consequently, we purified proteins associated with the active gamma-secretase complex from reconstituted PS deficient fibroblasts, using tandem affinity purification (TAP)(5) and identified a series of proteins that transiently interact with the gamma-secretase complex and are probably involved in complex maturation, membrane trafficking and, importantly, the tetraspanin web. Tetraspanins form detergent-resistant microdomains in the cell membrane and regulate cell adhesion, cell signalling and proteolysis(6,7). Association of the gamma-secretase complex with tetraspanin-enriched microdomains provides an explanation for the previously documented localization of gamma-secretase to raft-like domains(8). Thus, these studies suggest that maintenance of the integrity of tetraspanin microdomains contributes to the refinement of proteolytic activity of the gamma-secretase complex.	[Wakabayashi, Tomoko; Craessaerts, Katleen; Bammens, Leen; Bentahir, Mostafa; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Wakabayashi, Tomoko; Craessaerts, Katleen; Bammens, Leen; Bentahir, Mostafa; De Strooper, Bart] Flanders Inst Biotechnol, VIB, Dept Mol & Dev Genet, Leuven, Belgium; [Borgions, Filip; Herdewijn, Piet] Katholieke Univ Leuven, Med Chem Lab, B-3000 Leuven, Belgium; [Staes, An; Timmerman, Evy; Vandekerckhove, Joel; Gevaert, Kris] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Staes, An; Timmerman, Evy; Vandekerckhove, Joel; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Rubinstein, Eric; Boucheix, Claude] INSERM, U602, Villejuif, France; [Rubinstein, Eric; Boucheix, Claude] Univ Paris 11, Inst Andre Lwoff, Villejuif, France	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Herestr 49, B-3000 Leuven, Belgium.	bart.destrooper@med.kuleuven.be	Gevaert, Kris/AAE-4212-2019; De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019; Wakabayashi, Tomoko/GSD-1544-2022; Gevaert, Kris/H-3637-2013; Gevaert, Kris/D-6489-2017; Rubinstein, Eric/B-4650-2019	Gevaert, Kris/0000-0002-4237-0283; De Strooper, Bart/0000-0001-5455-5819; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Rubinstein, Eric/0000-0001-7623-9665; Boucheix, Claude/0000-0003-4184-7008; Staes, An/0000-0001-8767-8508; Herdewijn, Piet/0000-0003-3589-8503	Alzheimer's Association, the Fund for Scientific Research, Flanders; Katholieke Universiteit Leuven (GOA); Federal Office for Scientific Affairs, Flemisch government [P6/58]; Fund for Scientific Research-Flanders (Belgium), Ghent University [IUAP06]; Inter University Attraction Poles [IUAP06]; European Union Interaction Proteome (6th Framework Program); FWO (Fonds voor Wetenschappelijk Onderzoek); Canon Foundation in Europe; EC	Alzheimer's Association, the Fund for Scientific Research, Flanders; Katholieke Universiteit Leuven (GOA)(KU Leuven); Federal Office for Scientific Affairs, Flemisch government; Fund for Scientific Research-Flanders (Belgium), Ghent University(Ghent UniversityFWO); Inter University Attraction Poles(Belgian Federal Science Policy Office); European Union Interaction Proteome (6th Framework Program)(European Commission); FWO (Fonds voor Wetenschappelijk Onderzoek)(FWO); Canon Foundation in Europe(Canon Foundation); EC(European CommissionEuropean Commission Joint Research Centre)	We thank T. E. Golde (Mayo Clinic, FL, US) for SPPL3 cDNA, S. Aerts (VIB), E. Karran and the bioinformatics team of Elli-Lilly for helpful discussion and A. Thathiah for critical reading of the manuscript. This work was supported by a Pioneer award from the Alzheimer's Association, the Fund for Scientific Research, Flanders; Katholieke Universiteit Leuven (GOA); Federal Office for Scientific Affairs (IUAP P6/58) and a Methusalem grant from the Flemisch government. The laboratory in Ghent is supported by research grants from the Fund for Scientific Research-Flanders (Belgium), the Concerted Research Actions (GOA) from the Ghent University, the Inter University Attraction Poles (IUAP06) and the European Union Interaction Proteome (6th Framework Program). L. B. is fellow of the FWO (Fonds voor Wetenschappelijk Onderzoek) and T. W. was fellow of the Canon Foundation in Europe and Marie Curie program of the EC.	Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; HARDER T, 1994, BBA-MOL CELL RES, V1223, P375, DOI 10.1016/0167-4889(94)90098-1; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	36	102	104	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1340	U181		10.1038/ncb1978	http://dx.doi.org/10.1038/ncb1978			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838174				2022-12-25	WOS:000271425800014
J	Classen, AK; Bunker, BD; Harvey, KF; Vaccari, T; Bilder, D				Classen, Anne-Kathrin; Bunker, Brandon D.; Harvey, Kieran F.; Vaccari, Thomas; Bilder, David			A tumor suppressor activity of Drosophila Polycomb genes mediated by JAK-STAT signaling	NATURE GENETICS			English	Article							IMAGINAL DISC CELLS; GROUP PROTEINS; TRITHORAX GROUP; JAK/STAT; SCREEN; GROWTH; PATHWAY; COMPLEX; HIPPO; CYCLE	A prevailing paradigm posits that Polycomb Group (PcG) proteins maintain stem cell identity by repressing differentiation genes, and abundant evidence points to an oncogenic role for PcG proteins in human cancer(1,2). Here we show using Drosophila melanogaster that a conventional PcG complex can also have a potent tumor suppressor activity. Mutations in any core PRC1 component cause pronounced hyperproliferation of eye imaginal tissue, accompanied by deregulation of epithelial architecture. The mitogenic JAK-STAT pathway is strongly and specifically activated in mutant tissue; activation is driven by transcriptional upregulation of Unpaired (Upd, also known as Outstretched, Os) family ligands. We show here that upd genes are direct targets of PcG-mediated repression in imaginal discs. Ectopic JAK-STAT activity is sufficient to induce overproliferation, whereas reduction of JAK-STAT activity suppresses the PRC1 mutant tumor phenotype. These findings show that PcG proteins can restrict growth directly by silencing mitogenic signaling pathways, shedding light on an epigenetic mechanism underlying tumor suppression.	[Classen, Anne-Kathrin; Bunker, Brandon D.; Bilder, David] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Harvey, Kieran F.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Harvey, Kieran F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Vaccari, Thomas] Ist FIRC Oncol Mol, Milan, Italy	University of California System; University of California Berkeley; Peter Maccallum Cancer Center; University of Melbourne; IFOM - FIRC Institute of Molecular Oncology	Bilder, D (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	bilder@berkeley.edu	Classen, Anne-Kathrin/L-6164-2018; Classen, Anne-Kathrin/K-3054-2014; Vaccari, Thomas/B-1945-2015; Harvey, Kieran/AAD-5268-2022	Classen, Anne-Kathrin/0000-0001-5157-0749; Vaccari, Thomas/0000-0002-6231-7105; Harvey, Kieran/0000-0001-7845-369X; Bilder, David/0000-0002-1842-4966	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068675, R01GM090150] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068675-01, R01 GM090150, R01GM068675, R01 GM068675] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bach EA, 2003, GENETICS, V165, P1149; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Beuchle D, 2001, DEVELOPMENT, V128, P993; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Calses C, 2008, MOL CELL BIOL, V28, P1018, DOI 10.1128/MCB.01136-07; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Coelho CMA, 2005, DEVELOPMENT, V132, P5411, DOI 10.1242/dev.02148; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Ekas LA, 2006, DEVELOPMENT, V133, P4721, DOI 10.1242/dev.02675; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Janody F, 2004, GENETICS, V166, P187, DOI 10.1534/genetics.166.1.187; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Lo SM, 2009, MOL CELL BIOL, V29, P515, DOI 10.1128/MCB.01044-08; Majewski IJ, 2008, PLOS BIOL, V6, P796, DOI 10.1371/journal.pbio.0060093; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; McClure KD, 2008, MECH DEVELOP, V125, P67, DOI 10.1016/j.mod.2007.10.003; McClure KD, 2007, INT J BIOCHEM CELL B, V39, P1105, DOI 10.1016/j.biocel.2007.01.007; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Mukherjee T, 2005, ONCOGENE, V24, P2503, DOI 10.1038/sj.onc.1208487; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Parrish JZ, 2007, GENE DEV, V21, P956, DOI 10.1101/gad.1514507; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; SEHNAL F, 1993, J INSECT PHYSIOL, V39, P1051, DOI 10.1016/0022-1910(93)90129-F; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; SUN YH, 1995, GENETICS, V141, P1075; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Tseng ASK, 2007, CURR BIOL, V17, P728, DOI 10.1016/j.cub.2007.03.023; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; WU CT, 1995, GENETICS, V140, P139	54	99	101	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1150	U139		10.1038/ng.445	http://dx.doi.org/10.1038/ng.445			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19749759	Green Submitted, Green Accepted			2022-12-25	WOS:000270330400022
J	Desgrosellier, JS; Barnes, LA; Shields, DJ; Huang, M; Lau, SK; Prevost, N; Tarin, D; Shattil, SJ; Cheresh, DA				Desgrosellier, Jay S.; Barnes, Leo A.; Shields, David J.; Huang, Miller; Lau, Steven K.; Prevost, Nicolas; Tarin, David; Shattil, Sanford J.; Cheresh, David A.			An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression	NATURE MEDICINE			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION SITES; HUMAN BREAST-CANCER; CELL-MIGRATION; EXTRACELLULAR-MATRIX; HUMAN-MELANOMA; C-SRC; METASTASIS; SURVIVAL; ALPHA-V-BETA-3	Integrins regulate adhesion-dependent growth, survival and invasion of tumor cells. In particular, expression of integrin alpha(v)beta(3) is associated with progression of a variety of human tumors. Here we reveal a previously undescribed adhesion-independent role for integrin alpha(v)beta(3) in pancreatic cancer and other carcinomas. Specifically, alpha(v)beta(3) expressed in carcinoma cells enhanced anchorage-independent tumor growth in vitro and increased lymph node metastases in vivo. These effects required recruitment of c-Src to the beta(3) integrin cytoplasmic tail, leading to c-Src activation, Crk-associated substrate (CAS) phosphorylation and tumor cell survival that, unexpectedly, was independent of cell adhesion or focal adhesion kinase (FAK) activation. Pharmacological blockade of c-Src kinase activity or decreased expression of endogenous alpha(v)beta(3) integrin or c-Src not only inhibited anchorage-independent growth but also suppressed metastasis in vivo, yet these manipulations did not affect tumor cell migration or invasion. These data define an unexpected role for an integrin as a mediator of anchorage independence, suggesting that an alpha(v)beta(3)-c-Src signaling module may account for the aggressive behavior of integrin alpha(v)beta(3)-expressing tumors in humans.	[Desgrosellier, Jay S.; Barnes, Leo A.; Shields, David J.; Huang, Miller; Lau, Steven K.; Tarin, David; Cheresh, David A.] Moores Univ Calif San Diego, Ctr Canc, Dept Pathol, La Jolla, CA USA; [Prevost, Nicolas; Shattil, Sanford J.] Univ Calif San Diego, Dept Med, Div Hematol Oncol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Cheresh, DA (corresponding author), Moores Univ Calif San Diego, Ctr Canc, Dept Pathol, La Jolla, CA USA.	dcheresh@ucsd.edu	Desgrosellier, Jay S/A-8756-2008	Huang, Miller/0000-0002-3371-0100; Lau, Steven/0000-0002-6433-8735	US National Institutes of Health [CA123774, CA78045, CA45726, CA95262, CA129660, HL57900]; NATIONAL CANCER INSTITUTE [R01CA095262, R37CA050286, P01CA078045, R01CA045726, R21CA129660, F32CA123774, T32CA121938] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We wish to thank D. Stupack, L. Acevedo and S. Anand for critical reading of the manuscript. We also want to express our gratitude to M. Bouvet and A. Lowy for their help in obtaining human pancreatic tumor sections. J.S.D. was supported by a US National Institutes of Health Ruth L. Kirschstein National Research Service Award Post-doctoral Fellowship (grant CA123774). This work was supported by funding from the US National Institutes of Health grant numbers CA78045, CA45726, CA95262, CA129660 and HL57900 (to D.A.C.).	ALBELDA SM, 1990, CANCER RES, V50, P6757; Allan AL, 2006, AM J PATHOL, V169, P233, DOI 10.2353/ajpath.2006.051152; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gruber G, 2005, BRIT J CANCER, V92, P41, DOI 10.1038/sj.bjc.6602278; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Hosotani Ryo, 2002, Pancreas, V25, pe30, DOI 10.1097/00006676-200208000-00021; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Huveneers S, 2008, J BIOL CHEM, V283, P13243, DOI 10.1074/jbc.M800927200; Huveneers S, 2007, CANCER RES, V67, P2693, DOI 10.1158/0008-5472.CAN-06-3654; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; McCabe NP, 2007, ONCOGENE, V26, P6238, DOI 10.1038/sj.onc.1210429; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; NIP J, 1992, J CLIN INVEST, V90, P1406, DOI 10.1172/JCI116007; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reinmuth N, 2003, CANCER RES, V63, P2079; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Takayama S, 2005, ANTICANCER RES, V25, P79; Tsatsanis C, 2004, ANN NY ACAD SCI, V1028, P168, DOI 10.1196/annals.1322.019; Uhm JH, 1999, CLIN CANCER RES, V5, P1587; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004	49	206	217	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2009	15	10					1163	U89		10.1038/nm.2009	http://dx.doi.org/10.1038/nm.2009			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19734908	Green Accepted			2022-12-25	WOS:000270596400028
J	McCullagh, E; Farlow, J; Fuller, C; Girard, J; Lipinski-Kruszka, J; Lu, D; Noriega, T; Rollins, G; Spitzer, R; Todhunter, M; El-Samad, H				McCullagh, Emma; Farlow, Justin; Fuller, Christopher; Girard, Juliet; Lipinski-Kruszka, Joanna; Lu, Dan; Noriega, Thomas; Rollins, Geoffrey; Spitzer, Russell; Todhunter, Michael; El-Samad, Hana			Not all quiet on the noise front	NATURE CHEMICAL BIOLOGY			English	Article							GENE-EXPRESSION; SINGLE-CELL; VARIABILITY; ORIGINS; INDIVIDUALITY; PERSISTENCE; NICHE; MODEL; TIME	Phenotypic diversity exists even within isogenic populations of cells. Such nongenetic individuality may have wide implications for our understanding of many biological processes. The field of study concerned with the investigation of nongenetic individuality, also known as the 'biology of noise', is ripe with exciting scientific opportunities and challenges.	[McCullagh, Emma; Farlow, Justin; Girard, Juliet; Noriega, Thomas; Todhunter, Michael] Univ Calif San Francisco, TETRAD Grad Program, San Francisco, CA 94143 USA; [Fuller, Christopher; Lipinski-Kruszka, Joanna; Lu, Dan; Rollins, Geoffrey; Spitzer, Russell] Univ Calif San Francisco, Integrat Program Quantitat Biol, San Francisco, CA 94143 USA; [El-Samad, Hana] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McCullagh, E (corresponding author), Univ Calif San Francisco, TETRAD Grad Program, San Francisco, CA 94143 USA.	hana.el-samad@ucsf.edu		Rollins, Geoffrey/0000-0001-8038-286X; Girard, Juliet/0000-0001-8274-2136	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086379] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM086379] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; COHEN D, 1967, J THEOR BIOL, V16, P1, DOI 10.1016/0022-5193(67)90050-1; Danforth BN, 1999, P ROY SOC B-BIOL SCI, V266, P1985, DOI 10.1098/rspb.1999.0876; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Grunwald D, 2008, METHOD ENZYMOL, V448, P553, DOI 10.1016/S0076-6879(08)02627-X; Hamer RD, 2005, VISUAL NEUROSCI, V22, P417, DOI 10.1017/S0952523805224045; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Roy S, 2004, EMBO J, V23, P869, DOI 10.1038/sj.emboj.7600098; Scott SA, 2007, INT J DAIRY TECHNOL, V60, P109, DOI 10.1111/j.1471-0307.2007.00309.x; Somel M, 2006, CURR BIOL, V16, pR359, DOI 10.1016/j.cub.2006.04.024; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189	34	15	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					699	704		10.1038/nchembio.222	http://dx.doi.org/10.1038/nchembio.222			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19763097				2022-12-25	WOS:000270039900002
J	Salis, HM; Mirsky, EA; Voigt, CA				Salis, Howard M.; Mirsky, Ethan A.; Voigt, Christopher A.			Automated design of synthetic ribosome binding sites to control protein expression	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; THERMODYNAMIC PARAMETERS; TRANSLATIONAL EFFICIENCY; SECONDARY STRUCTURE; GENE NETWORKS; RNA; SEQUENCE; INITIATION; MODEL; MISMATCHES	Microbial engineering often requires fine control over protein expression-for example, to connect genetic circuits(1-7) or control flux through a metabolic pathway(8-13). To circumvent the need for trial and error optimization, we developed a predictive method for designing synthetic ribosome binding sites, enabling a rational control over the protein expression level. Experimental validation of >100 predictions in Escherichia coli showed that the method is accurate to within a factor of 2.3 over a range of 100,000-fold. The design method also correctly predicted that reusing identical ribosome binding site sequences in different genetic contexts can result in different protein expression levels. We demonstrate the method's utility by rationally optimizing protein expression to connect a genetic sensor to a synthetic circuit. The proposed forward engineering approach should accelerate the construction and systematic optimization of large genetic systems.	[Salis, Howard M.; Voigt, Christopher A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Mirsky, Ethan A.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Voigt, CA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	cavoigt@picasso.ucsf.edu	Salis, Howard M/A-2495-2008	Salis, Howard/0000-0003-0411-4390	Pew and Packard Foundations; Office of Naval Research; National Institutes of Health (NIH) [EY016546, AI067699]; NSF [BES-0547637]; TeraGrid [TG-MCB080126T]; NSF Graduate Research Fellowship; American Society for Engineering Education National Defense Science and Engineering Graduate Fellowship; NATIONAL EYE INSTITUTE [PN2EY016546, PN1EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067699, R01AI067699] Funding Source: NIH RePORTER	Pew and Packard Foundations; Office of Naval Research(Office of Naval Research); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); TeraGrid; NSF Graduate Research Fellowship(National Science Foundation (NSF)); American Society for Engineering Education National Defense Science and Engineering Graduate Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to all members of the Voigt lab for technical advice and continued support. This work is supported by the Pew and Packard Foundations, Office of Naval Research, National Institutes of Health (NIH) EY016546, NIH AI067699, NSF BES-0547637, National Science Foundation (NSF) TeraGrid TG-MCB080126T and a Sandler Family Opportunity Award. C. A. V., H. M. S., and E. A. M. are part of the NSF SynBERC Engineering Research Center (http:// www.synberc. org/). E. A. M. is supported by an NSF Graduate Research Fellowship and an American Society for Engineering Education National Defense Science and Engineering Graduate Fellowship.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Carrier TA, 1999, BIOTECHNOL PROGR, V15, P58, DOI 10.1021/bp9801143; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Christiansen ME, 2008, BIOCHEMISTRY-US, V47, P4329, DOI 10.1021/bi7020876; Chubiz LM, 2008, NUCLEIC ACIDS RES, V36, P4038, DOI 10.1093/nar/gkn354; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; David F, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/04/P04008d; de Smit MH, 2003, J MOL BIOL, V331, P737, DOI 10.1016/S0022-2836(03)00809-X; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kierzek R, 1999, BIOCHEMISTRY-US, V38, P14214, DOI 10.1021/bi991186l; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Luetke-Eversloh T, 2008, METAB ENG, V10, P69, DOI 10.1016/j.ymben.2007.12.001; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Miller S, 2008, NUCLEIC ACIDS RES, V36, P5652, DOI 10.1093/nar/gkn525; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Studer SM, 2006, MOL CELL, V22, P105, DOI 10.1016/j.molcel.2006.02.014; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	34	1148	1224	23	448	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2009	27	10					946	U112		10.1038/nbt.1568	http://dx.doi.org/10.1038/nbt.1568			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	515LO	19801975	Green Submitted, Green Accepted			2022-12-25	WOS:000271472500026
J	Mori, D; Yamada, M; Mimori-Kiyosue, Y; Shirai, Y; Suzuki, A; Ohno, S; Saya, H; Wynshaw-Boris, A; Hirotsune, S				Mori, Daisuke; Yamada, Masami; Mimori-Kiyosue, Yuko; Shirai, Yasuhito; Suzuki, Atsushi; Ohno, Shigeo; saya, Hideaki; Wynshaw-Boris, Anthony; Hirotsune, Shinji			An essential role of the aPKC-Aurora A-NDEL1 pathway in neurite elongation by modulation of microtubule dynamics	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; HIPPOCAMPAL NEURONAL POLARITY; A KINASE; CYTOPLASMIC DYNEIN; ACTIN-FILAMENTS; NERVOUS-SYSTEM; SELF-RENEWAL; ACTIVATION; SPINDLE; COMPLEX	Orchestrated remodelling of the cytoskeketon is prominent during neurite extension. In contrast with the extensive characterization of actin filament regulation, little is known about the dynamics of microtubules during neurite extension. Here we identify an atypical protein kinase C (aPKC)-Aurora A-NDEL1 pathway that is crucial for the regulation of microtubule organization during neurite extension. aPKC phosphorylates Aurora A at Thr 287 (T287), which augments interaction with TPX2 and facilitates activation of Aurora A at the neurite hillock, followed by phosphorylation of NDEL1 at S251 and recruitment. Suppression of aPKC, Aurora A or TPX2, or disruption of Well, results in severe impairment of neurite extension. Analysis of microtubule dynamics with a microtubule plus-end marker revealed that suppression of the aPKC-Aurora A-NDEL1 pathway resulted in a significant decrease in the frequency of microtubule emanation from the microtubule organizing centre (MTOC), suggesting that Aurora A acts downstream of aPKC. These findings demonstrate a surprising role of aPKC-Aurora A-NDEL1 pathway in microtubule remodelling during neurite extension.	[Mori, Daisuke; Yamada, Masami; Hirotsune, Shinji] Osaka City Univ, Dept Genet Dis Res, Grad Sch Med, Osaka 5458585, Japan; [Mimori-Kiyosue, Yuko] KAN Res Inst Inc 3F, Res Grp Cytoskeleton & Cell Motil, Kobe MI R&D Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shirai, Yasuhito] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan; [Suzuki, Atsushi; Ohno, Shigeo] Yokohama City Univ, Dept Mol Biol, Grad Sch Med Sci, Kanazawa Ku, Kanagawa 2360004, Japan; [saya, Hideaki] Keio Univ, Sch Med, Div Gene Regulat, Inst Adv Med Res, Tokyo, Japan; [Wynshaw-Boris, Anthony] UCSF Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Wynshaw-Boris, Anthony] UCSF Sch Med, Inst Human Genet, San Francisco, CA 94143 USA	Osaka Metropolitan University; Kobe University; Yokohama City University; Keio University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hirotsune, S (corresponding author), Osaka City Univ, Dept Genet Dis Res, Grad Sch Med, Asahi Machi 1-4-3 Abeno, Osaka 5458585, Japan.	shinjih@med.osaka-cu.ac.jp	Ohno, Shigeo/B-1768-2010; Mimori-Kiyosue, Yuko/K-9158-2015; Saya, Hideyuki/J-4325-2013; Shirai, Yasuhito/O-3255-2018; Mori, Daisuke/M-4952-2014	Ohno, Shigeo/0000-0002-1294-5269; Mimori-Kiyosue, Yuko/0000-0003-3513-9072; Mori, Daisuke/0000-0002-9072-2546; Saya, Hideyuki/0000-0001-6610-1902	Osaka Community Foundation; Ministry of Education, Science, Sports and Culture of Japan; Japan Spina Bifida and Hydrocephalus Research Foundation; Takeda Science Foundation; Hoh-ansha Foundation; National Institutes of Health [NS41030, HD47380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041030] Funding Source: NIH RePORTER	Osaka Community Foundation; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Spina Bifida and Hydrocephalus Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Hoh-ansha Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Yukimi Kira, Yoriko Yabunaka, Gaku Kuwabara, Toshiyuki Kawashima and Takako Takitho for technical support, and Hiromichi Nishimura and Keiko Fujimoto for mouse breeding. This work was also supported by the Osaka Community Foundation to D.M. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan to S.H. This work was also supported by the Cell Science Research Foundation, the Japan Spina Bifida and Hydrocephalus Research Foundation, the Takeda Science Foundation and the Hoh-ansha Foundation to S.H, and National Institutes of Health grants NS41030 and HD47380 to A.W.-B.	Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; DOBYNS WB, 1989, NEUROL CLIN, V7, P89, DOI 10.1016/S0733-8619(18)30830-2; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Murai KK, 2005, NEURON, V46, P161, DOI 10.1016/j.neuron.2005.04.004; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nikolic M, 2004, TRENDS CELL BIOL, V14, P1, DOI 10.1016/j.tcb.2003.10.010; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	51	94	98	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1057	U47		10.1038/ncb1919	http://dx.doi.org/10.1038/ncb1919			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19668197				2022-12-25	WOS:000269482500007
J	Shahian, T; Lee, GM; Lazic, A; Arnold, LA; Velusamy, P; Roels, CM; Guy, RK; Craik, CS				Shahian, Tina; Lee, Gregory M.; Lazic, Ana; Arnold, Leggy A.; Velusamy, Priya; Roels, Christina M.; Guy, R. Kiplin; Craik, Charles S.			Inhibition of a viral enzyme by a small-molecule dimer disruptor	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN CYTOMEGALOVIRUS PROTEASE; SIMPLEX-VIRUS TYPE-1; MECHANISM-BASED INHIBITORS; HERPESVIRUS PROTEASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; ALLOSTERIC SITE; HIV-1 PROTEASE; DIMERIZATION; DOMAIN	We identified small-molecule dimer disruptors that inhibit an essential dimeric protease of human Kaposi's sarcoma-associated herpesvirus ( KSHV) by screening an a-helical mimetic library. Next, we synthesized a second generation of low-micromolar inhibitors with improved potency and solubility. Complementary methods including size exclusion chromatography and H-1-C-13 HSQC titration using selectively labeled C-13-Met samples revealed that monomeric protease is enriched in the presence of inhibitor. H-1-N-15 HSQC titration studies mapped the inhibitor binding site to the dimer interface, and mutagenesis studies targeting this region were consistent with a mechanism where inhibitor binding prevents dimerization through the conformational selection of a dynamic intermediate. These results validate the interface of herpesvirus proteases and other similar oligomeric interactions as suitable targets for the development of small-molecule inhibitors.	[Lee, Gregory M.; Lazic, Ana; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Shahian, Tina] Univ Calif San Francisco, Grad Grp Biochem & Mol Biol, San Francisco, CA 94143 USA; [Arnold, Leggy A.; Velusamy, Priya; Roels, Christina M.; Guy, R. Kiplin] St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; St Jude Children's Research Hospital	Craik, CS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	craik@cgl.ucsf.edu	Guy, Rodney/J-7107-2013	Guy, Rodney/0000-0002-9638-2060; Arnold, Leggy/0000-0003-1411-1572	US National Institutes of Health [T32 GMO7810, AIO67423]; American Lebanese and Syrian Associated Charities; St. Jude Children's Research Hospital; University of California, San Francisco-Gladstone Institute for Virology and Immunology/Center for AIDS Research [P30-AI027763]; NATIONAL CANCER INSTITUTE [R25CA023944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067423, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250, T32GM007810] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; University of California, San Francisco-Gladstone Institute for Virology and Immunology/Center for AIDS Research(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank W. Gibson (The Johns Hopkins University School of Medicine) for providing us with the CMV protease expression plasmid and for valuable feedback on the manuscript. This work was funded by US National Institutes of Health grants T32 GMO7810 and AIO67423 (C.S.C.) and by the American Lebanese and Syrian Associated Charities and the St. Jude Children's Research Hospital (R. K. G.). We also thank the University of California, San Francisco-Gladstone Institute for Virology and Immunology/Center for AIDS Research for the Clinical Science Pilot Award (P30-AI027763 to G.M.L.).	Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bannwarth L, 2007, BIOCHEM SOC T, V35, P551, DOI 10.1042/BST0350551; Batra R, 2001, NAT STRUCT BIOL, V8, P810, DOI 10.1038/nsb0901-810; Berg T, 2003, ANGEW CHEM INT EDIT, V42, P2462, DOI 10.1002/anie.200200558; Borthwick AD, 2002, BIOORG MED CHEM LETT, V12, P1719, DOI 10.1016/S0960-894X(02)00294-9; Borthwick AD, 2002, J MED CHEM, V45, P1, DOI 10.1021/jm0102203; Borthwick AD, 1998, BIOORG MED CHEM LETT, V8, P365, DOI 10.1016/S0960-894X(98)00032-8; Brignole EJ, 2007, J VIROL, V81, P4091, DOI 10.1128/JVI.02821-06; Buisson M, 2002, J MOL BIOL, V324, P89, DOI 10.1016/S0022-2836(02)01040-9; Buisson M, 2001, J MOL BIOL, V311, P217, DOI 10.1006/jmbi.2001.4854; Chen P, 1996, CELL, V86, P835, DOI 10.1016/S0092-8674(00)80157-9; Darke PL, 1996, J BIOL CHEM, V271, P7445, DOI 10.1074/jbc.271.13.7445; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; FIELDS BN, 2006, FIELDS VIROLOGY, P3177; GAO M, 1994, J VIROL, V68, P3702, DOI 10.1128/JVI.68.6.3702-3712.1994; Gopalsamy A, 2004, J MED CHEM, V47, P1893, DOI 10.1021/jm030540h; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hoog SS, 1997, BIOCHEMISTRY-US, V36, P14023, DOI 10.1021/bi9712697; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lazic A, 2007, J MOL BIOL, V373, P913, DOI 10.1016/j.jmb.2007.07.073; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Lee SG, 2006, CHEM BIOL, V13, P421, DOI 10.1016/j.chembiol.2006.02.012; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lu F, 2006, J COMB CHEM, V8, P315, DOI 10.1021/cc050142v; Margosiak SA, 1996, BIOCHEMISTRY-US, V35, P5300, DOI 10.1021/bi952842u; Marnett AB, 2004, P NATL ACAD SCI USA, V101, P6870, DOI 10.1073/pnas.0401613101; Nomura AM, 2006, BIOCHEMISTRY-US, V45, P3572, DOI 10.1021/bi0523658; Nomura AM, 2005, NAT STRUCT MOL BIOL, V12, P1019, DOI 10.1038/nsmb1006; Ogilvie W, 1997, J MED CHEM, V40, P4113, DOI 10.1021/jm970104t; Pray TR, 2002, BIOCHEMISTRY-US, V41, P1474, DOI 10.1021/bi011753g; Pray TR, 1999, J MOL BIOL, V289, P197, DOI 10.1006/jmbi.1999.2791; PRESTON VG, 1983, J VIROL, V45, P1056, DOI 10.1128/JVI.45.3.1056-1064.1983; Qiu XY, 1996, NATURE, V383, P275, DOI 10.1038/383275a0; Qiu XY, 1997, P NATL ACAD SCI USA, V94, P2874, DOI 10.1073/pnas.94.7.2874; Reiling KK, 2000, BIOCHEMISTRY-US, V39, P12796, DOI 10.1021/bi001019h; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schmidt U, 1997, J BIOL CHEM, V272, P7732, DOI 10.1074/jbc.272.12.7732; Sheaffer AK, 2000, J VIROL, V74, P6838, DOI 10.1128/JVI.74.15.6838-6848.2000; Shieh HS, 1996, NATURE, V383, P279, DOI 10.1038/383279a0; Shimba N, 2004, J VIROL, V78, P6657, DOI 10.1128/JVI.78.12.6657-6665.2004; Tong L, 1996, NATURE, V383, P272, DOI 10.1038/383272a0; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Unal A, 1997, J VIROL, V71, P7030, DOI 10.1128/JVI.71.9.7030-7038.1997; Waxman L, 2000, ANTIVIR CHEM CHEMOTH, V11, P1; WEINHEIMER SP, 1993, J VIROL, V67, P5813, DOI 10.1128/JVI.67.10.5813-5822.1993; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003	50	67	67	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					640	646		10.1038/nchembio.192	http://dx.doi.org/10.1038/nchembio.192			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19633659	Green Submitted, Green Accepted			2022-12-25	WOS:000269093000012
J	Beaumier, CM; Harris, LD; Goldstein, S; Klatt, NR; Whitted, S; McGinty, J; Apetrei, C; Pandrea, I; Hirsch, VM; Brenchley, JM				Beaumier, Coreen M.; Harris, Levelle D.; Goldstein, Simoy; Klatt, Nichole R.; Whitted, Sonya; McGinty, John; Apetrei, Cristian; Pandrea, Ivona; Hirsch, Vanessa M.; Brenchley, Jason M.			CD4 downregulation by memory CD4(+) T cells in vivo renders African green monkeys resistant to progressive SIVagm infection	NATURE MEDICINE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; NONHUMAN PRIMATE HOSTS; SOOTY MANGABEYS; MICROBIAL TRANSLOCATION; PLASMA LIPOPOLYSACCHARIDE; AIDS PATHOGENESIS; IMMUNE ACTIVATION; CORECEPTOR USAGE; HIV-INFECTION; NATURAL HOSTS	African green monkeys (genus Chlorocebus) can be infected with species-specific simian immunodeficiency virus (SIVagm) but do not develop AIDS. These natural hosts of SIV, like sooty mangabeys, maintain high levels of SIV replication but have evolved to avoid immunodeficiency. Elucidating the mechanisms that allow natural hosts to coexist with SIV without overt disease may provide crucial information for understanding AIDS pathogenesis. Here we show that many CD4(+) T cells from African green monkeys downregulate CD4 in vivo as they enter the memory pool; that downregulation of CD4 by memory T cells is independent of SIV infection; that the CD4(-) memory T cells maintain functions that are normally attributed to CD4(+) T cells, including production of interleukin-2 (IL-2), production of IL-17, expression of forkhead box P3 and expression of CD40 ligand; that loss of CD4 expression protects these T cells from infection by SIVagm in vivo; and that these CD4(-) T cells can maintain major histocompatibility complex class II restriction. These data show that the absence of SIV-induced disease progression in natural host species may be partially explained by preservation of a subset of T cells that maintain CD4(+) T cell function while being resistant to SIV infection in vivo. (C) 2009 Nature America, Inc. All rights reserved.	[Beaumier, Coreen M.; Harris, Levelle D.; Goldstein, Simoy; Klatt, Nichole R.; Whitted, Sonya; McGinty, John; Hirsch, Vanessa M.; Brenchley, Jason M.] NIAID, Mol Microbiol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Apetrei, Cristian; Pandrea, Ivona] Tulane Natl Primate Ctr, Div Comparat Pathol, New Orleans, LA USA; [Apetrei, Cristian; Pandrea, Ivona] Tulane Natl Primate Ctr, Div Microbiol, New Orleans, LA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tulane University; Tulane University	Brenchley, JM (corresponding author), NIAID, Mol Microbiol Lab, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jbrenchl@mail.nih.gov	Apetrei, Cristian/AAG-9032-2021; Brenchley, Jason/AAC-5085-2019	Apetrei, Cristian/0000-0002-0322-7185; Brenchley, Jason/0000-0001-8357-2984	intramural National Institute of Allergy and Infectious Diseases; US National Institutes of Health program; Tulane National Primate Center [R01 AI064066, R01 AI065325, RR-00168]; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064066, R01AI065325, ZIAAI000370] Funding Source: NIH RePORTER	intramural National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane National Primate Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by the intramural National Institute of Allergy and Infectious Diseases, US National Institutes of Health program and by R01 AI064066 (I. P.), R01 AI065325 (C. A.) and RR-00168 (Tulane National Primate Center). We would like to thank the Bad Boys of Cleveland, D. Douek (Vaccine Research Center, National Institute of Allergy and Infectious Diseases, US National Institutes of Health) and D. Price (Cardiff University) for helpful discussions. We are grateful to J. E. Schmitz and R. Zahn (Harvard University) for the kind donation of microbeads coated with antibody to CD3 and CD28 for stimulation of T cells from nonhuman primates. We also appreciate the technical advice of B. Lafont and G. Mettler.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Barry AP, 2007, J IMMUNOL, V178, P8002, DOI 10.4049/jimmunol.178.12.8002; Beer BE, 2001, J VIROL, V75, P12014, DOI 10.1128/JVI.75.24.12014-12027.2001; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Boulassel MR, 2007, CLIN IMMUNOL, V124, P149, DOI 10.1016/j.clim.2007.05.005; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Chakrabarti LA, 2000, J VIROL, V74, P1209, DOI 10.1128/JVI.74.3.1209-1223.2000; Dunham R, 2006, BLOOD, V108, P209, DOI 10.1182/blood-2005-12-4897; FULTZ PN, 1989, AIDS RES HUM RETROV, V5, P397, DOI 10.1089/aid.1989.5.397; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goldstein S, 2005, J VIROL, V79, P5153, DOI 10.1128/JVI.79.8.5153-5162.2005; Goldstein S, 2000, J VIROL, V74, P11744, DOI 10.1128/JVI.74.24.11744-11753.2000; Goldstein S, 2006, J VIROL, V80, P4868, DOI 10.1128/JVI.80.10.4868-4877.2006; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Gregson JNS, 2009, AIDS, V23, P29, DOI 10.1097/QAD.0b013e3283199780; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hirsch V, 1997, J VIROL, V71, P1608, DOI 10.1128/JVI.71.2.1608-1620.1997; Hirsch VM, 2004, AIDS REV, V6, P40; HIRSCH VM, 1995, J VIROL, V69, P955, DOI 10.1128/JVI.69.2.955-967.1995; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Karube K, 2004, BRIT J HAEMATOL, V126, P81, DOI 10.1111/j.1365-2141.2004.04999.x; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Klatt NR, 2008, J CLIN INVEST, V118, P2039, DOI 10.1172/JCI33814; LI YX, 1992, J VIROL, V66, P6587, DOI 10.1128/JVI.66.11.6587-6600.1992; Ling BH, 2008, VIROLOGY, V379, P38, DOI 10.1016/j.virol.2008.06.012; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Matsunaga S, 2000, IMMUNOL LETT, V75, P47, DOI 10.1016/S0165-2478(00)00273-X; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Milush JM, 2007, J IMMUNOL, V179, P3047, DOI 10.4049/jimmunol.179.5.3047; Murayama Y, 1999, CLIN EXP IMMUNOL, V117, P504; Murayama Y, 1997, INT IMMUNOL, V9, P843, DOI 10.1093/intimm/9.6.843; Pandrea I, 2003, VIROLOGY, V317, P119, DOI 10.1016/j.virol.2003.08.015; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Pandrea I, 2008, J VIROL, V82, P5501, DOI 10.1128/JVI.02555-07; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Pandrea I, 2006, J MED PRIMATOL, V35, P194, DOI 10.1111/j.1600-0684.2006.00168.x; Pandrea I, 2006, J VIROL, V80, P4858, DOI 10.1128/JVI.80.10.4858-4867.2006; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; Papasavvas E, 2009, AIDS, V23, P369, DOI 10.1097/QAD.0b013e32831e9c76; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; RAHEMTULLA A, 1994, EUR J IMMUNOL, V24, P2213, DOI 10.1002/eji.1830240942; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Roelke ME, 2006, J WILDLIFE DIS, V42, P234, DOI 10.7589/0090-3558-42.2.234; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Sumpter B, 2007, J IMMUNOL, V178, P1680, DOI 10.4049/jimmunol.178.3.1680; Watson A, 1997, J VIROL, V71, P284, DOI 10.1128/JVI.71.1.284-290.1997; Zhang YJ, 2000, J VIROL, V74, P6893, DOI 10.1128/JVI.74.15.6893-6910.2000	55	110	110	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					879	U75		10.1038/nm.1970	http://dx.doi.org/10.1038/nm.1970			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19525963	Green Accepted			2022-12-25	WOS:000268770400031
J	Hengst, U; Deglincerti, A; Kim, HJ; Jeon, NL; Jaffrey, SR				Hengst, Ulrich; Deglincerti, Alessia; Kim, Hyung Joon; Jeon, Noo Li; Jaffrey, Samie R.			Axonal elongation triggered by stimulus-induced local translation of a polarity complex protein	NATURE CELL BIOLOGY			English	Article							MICROFLUIDIC CULTURE PLATFORM; NERVE GROWTH CONES; CELL POLARITY; MESSENGER-RNA; SONIC HEDGEHOG; NETRIN-1; GUIDANCE; NEURONS; MIDLINE; VISUALIZATION	During development, axon growth rates are precisely regulated to provide temporal control over pathfinding(1,2). The precise temporal regulation of axonal growth is a key step in the formation of functional synapses and the proper patterning of the nervous system. The rate of axonal elongation is increased by factors such as netrin-1 and nerve growth factor (NGF), which stimulate axon outgrowth using incompletely defined pathways. To clarify the mechanism of netrin-1- and NGF-stimulated axon growth, we explored the role of local protein translation. We found that intra-axonal protein translation is required for stimulated, but not basal, axon outgrowth. To identify the mechanism of translation-dependent outgrowth, we examined the PAR complex, a cytoskeleton regulator(3). We found that the PAR complex, like local translation, is required for stimulated, but not basal, outgrowth. Par3 mRNA is localized to developing axons, and NGF and netrin-1 trigger its local translation. Selective ablation of Par3 mRNA from axons abolishes the outgrowth-promoting effect of NGF. These results identify a new role for local translation and the PAR complex in axonal outgrowth.	[Hengst, Ulrich; Deglincerti, Alessia; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, Ithaca, NY 10065 USA; [Kim, Hyung Joon] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul 151742, South Korea	Cornell University; University of California System; University of California Irvine; Seoul National University (SNU)	Jaffrey, SR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, Ithaca, NY 10065 USA.	srj2003@med.cornell.edu	Hengst, Ulrich/L-1413-2014	Hengst, Ulrich/0000-0002-8061-2861; Jaffrey, Samie/0000-0003-3615-6958	National Institute of Neurological Diseases and Stroke; Klingenstein Fellowship in the Neurosciences; Irma T. Hirschl and Monique Weill-Caulier Trusts Career Scientist Award; New York State Spinal Cord Injury Research Board; Boehringer Ingelheim Fonds; Paralysis Project of America; National Institute of Mental Health [K99]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH081058, K99MH081058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Klingenstein Fellowship in the Neurosciences(Klingenstein Philanthropies); Irma T. Hirschl and Monique Weill-Caulier Trusts Career Scientist Award; New York State Spinal Cord Injury Research Board; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Paralysis Project of America; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Pawson (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Canada) for the PAR6 antibody, S. Schlesinger and A. Jeromin for Sindbis plasmids, J. Harris (University of California Irvine, USA), for preparing masters for casting microfluidic chambers and members of the Jaffrey laboratory for helpful discussions. This research was supported by the National Institute of Neurological Diseases and Stroke, a Klingenstein Fellowship in the Neurosciences, Irma T. Hirschl and Monique Weill-Caulier Trusts Career Scientist Award, the New York State Spinal Cord Injury Research Board (S. R. J.), a predoctoral fellowship from Boehringer Ingelheim Fonds (A. D.), a fellowship from the Paralysis Project of America and a Pathway to Independence Award (K99) from the National Institute of Mental Health (U. H.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; COHEN PTW, 1989, BIOCHEM J, V260, P931, DOI 10.1042/bj2600931; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Eng H, 1999, J NEUROSCI, V19, P1; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Femino AM, 2003, METHOD ENZYMOL, V361, P245; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gore BB, 2008, NEURON, V57, P501, DOI 10.1016/j.neuron.2008.01.006; Hengst U, 2007, SEMIN CELL DEV BIOL, V18, P209, DOI 10.1016/j.semcdb.2007.01.003; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; KENNEDY TE, 1994, CELL, V78, P435; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SUGANUMA M, 1990, CANCER RES, V50, P3521; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	39	137	140	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1024	U263		10.1038/ncb1916	http://dx.doi.org/10.1038/ncb1916			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19620967	Green Accepted			2022-12-25	WOS:000268593200018
J	Daly, AK; Donaldson, PT; Bhatnagar, P; Shen, YF; Pe'er, I; Floratos, A; Daly, MJ; Goldstein, DB; John, S; Nelson, MR; Graham, J; Park, BK; Dillon, JF; Bernal, W; Cordell, HJ; Pirmohamed, M; Aithal, GP; Day, CP				Daly, Ann K.; Donaldson, Peter T.; Bhatnagar, Pallav; Shen, Yufeng; Pe'er, Itsik; Floratos, Aris; Daly, Mark J.; Goldstein, David B.; John, Sally; Nelson, Matthew R.; Graham, Julia; Park, B. Kevin; Dillon, John F.; Bernal, William; Cordell, Heather J.; Pirmohamed, Munir; Aithal, Guruprasad P.; Day, Christopher P.		DILIGEN Study; Int SAE Consortium	HLA-B(star)5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin	NATURE GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; POPULATION; DISEASE; HLA; SIALYLTRANSFERASE; POLYMORPHISMS; INFLAMMATION; CLOXACILLIN; GENETICS; SAMPLE	Drug-induced liver injury (DILI) is an important cause of serious liver disease. The antimicrobial agent flucloxacillin is a common cause of DILI, but the genetic basis for susceptibility remains unclear. We conducted a genome-wide association (GWA) study using 866,399 markers in 51 cases of flucloxacillin DILI and 282 controls matched for sex and ancestry. The GWA showed an association peak in the major histocompatibility complex (MHC) region with the strongest association (P = 8.7 x 10(-33)) seen for rs2395029[G], a marker in complete linkage disequilibrium (LD) with HLA-B* 5701. Further MHC genotyping, which included 64 flucloxacillintolerant controls, confirmed the association with HLA-B*5701 (OR = 80.6, P = 9.0 x 10(-19)). The association was replicated in a second cohort of 23 cases. In HLA-B*5701 carrier cases, rs10937275 in ST6GAL1 on chromosome 3 also showed genome-wide significance (OR = 4.1, P = 1.4 x 10(-8)). These findings provide new insights the mechanism of flucloxacillin DILI and have the potential to substantially improve diagnosis of this serious disease.	[Daly, Ann K.; Donaldson, Peter T.; Bhatnagar, Pallav; Graham, Julia; Cordell, Heather J.; Day, Christopher P.] Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Daly, Ann K.; Donaldson, Peter T.; Bhatnagar, Pallav; Graham, Julia; Cordell, Heather J.; Day, Christopher P.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Shen, Yufeng; Pe'er, Itsik; Floratos, Aris] Columbia Univ, New York, NY USA; [Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA USA; [Goldstein, David B.] Duke Univ, Durham, NC USA; [John, Sally] Pfizer Inc, New London, CT USA; [Nelson, Matthew R.] GlaxoSmithKline, Res Triangle Pk, NC USA; [Park, B. Kevin; Pirmohamed, Munir] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; [Dillon, John F.] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Bernal, William] Kings Coll Hosp London, London, England; [Aithal, Guruprasad P.] Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham, England	Newcastle University - UK; Newcastle University - UK; Columbia University; Harvard University; Harvard Medical School; Duke University; Pfizer; GlaxoSmithKline; University of Liverpool; University of Dundee; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Nottingham	Daly, AK (corresponding author), Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	a.k.daly@ncl.ac.uk	Pirmohamed, Munir/H-6004-2011; Goldstein, David/AAY-8125-2020; Daly, Ann/H-3144-2011; Daly, Mark J/B-2453-2017; Dillon, John F/A-2478-2013; Day, Christopher/Z-3305-2019; Bhatnagar, Pallav/A-1280-2013	Pirmohamed, Munir/0000-0002-7534-7266; Daly, Ann/0000-0002-7321-0629; Daly, Mark J/0000-0002-0949-8752; Aithal, Guruprasad/0000-0003-3924-4830; Cordell, Heather/0000-0002-1879-5572; Dillon, John/0000-0002-2164-4476	Department of Health Funding Source: Medline	Department of Health		Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Aithal GP, 2004, HEPATOLOGY, V39, P1430, DOI 10.1002/hep.20205; BAST BJEG, 1992, J CELL BIOL, V116, P423, DOI 10.1083/jcb.116.2.423; BROWNER WS, 1989, AM J PUBLIC HEALTH, V79, P1289, DOI 10.2105/AJPH.79.9.1289; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Colombo S, 2008, J INFECT DIS, V198, P864, DOI 10.1086/591184; Daly Ann K, 2006, Methods Mol Biol, V320, P193; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Donaldson PT, 2004, GUT, V53, P599, DOI 10.1136/gut.2003.031732; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; FAIRLEY CK, 1993, BRIT MED J, V306, P233, DOI 10.1136/bmj.306.6872.233; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Grove J, 1997, HEPATOLOGY, V26, P143, DOI 10.1002/hep.510260119; Hautekeete ML, 1999, GASTROENTEROLOGY, V117, P1181, DOI 10.1016/S0016-5085(99)70404-X; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Lakehal F, 2001, CHEM RES TOXICOL, V14, P694, DOI 10.1021/tx0002435; MANN R, 2006, PHARMACOVIGILANCE; Maria VAJ, 1997, GUT, V41, P534, DOI 10.1136/gut.41.4.534; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nelson MR, 2009, PHARMACOGENOMICS J, V9, P23, DOI 10.1038/tpj.2008.4; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; O'Donohue J, 2000, GUT, V47, P717, DOI 10.1136/gut.47.5.717; OLSSON R, 1992, J HEPATOL, V15, P154, DOI 10.1016/0168-8278(92)90029-O; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Pachkoria K, 2008, J HEPATOL, V49, P107, DOI 10.1016/j.jhep.2008.03.017; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Russmann S, 2005, BRIT J CLIN PHARMACO, V60, P76, DOI 10.1111/j.1365-2125.2005.02370.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857; SUTHERLAND R, 1970, BMJ-BRIT MED J, V4, P455, DOI 10.1136/bmj.4.5733.455; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	37	710	748	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					816	U71		10.1038/ng.379	http://dx.doi.org/10.1038/ng.379			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19483685				2022-12-25	WOS:000267786200012
J	Gattinoni, L; Zhong, XS; Palmer, DC; Ji, Y; Hinrichs, CS; Yu, ZY; Wrzesinski, C; Boni, A; Cassard, L; Garvin, LM; Paulos, CM; Muranski, P; Restifo, NP				Gattinoni, Luca; Zhong, Xiao-Song; Palmer, Douglas C.; Ji, Yun; Hinrichs, Christian S.; Yu, Zhiya; Wrzesinski, Claudia; Boni, Andrea; Cassard, Lydie; Garvin, Lindsay M.; Paulos, Chrystal M.; Muranski, Pawel; Restifo, Nicholas P.			Wnt signaling arrests effector T cell differentiation and generates CD8(+) memory stem cells	NATURE MEDICINE			English	Article							BETA-CATENIN; IN-VIVO; ADOPTIVE IMMUNOTHERAPY; TRANSCRIPTION FACTORS; SELF-RENEWAL; LONG-TERM; IMMUNITY; CANCER; PROLIFERATION; MAINTENANCE	Self-renewing cell populations such as hematopoietic stem cells and memory B and T lymphocytes might be regulated by shared signaling pathways(1). The Wnt-beta-catenin pathway is an evolutionarily conserved pathway that promotes hematopoietic stem cell self-renewal and multipotency by limiting stem cell proliferation and differentiation(2,3), but its role in the generation and maintenance of memory T cells is unknown. We found that induction of Wnt-beta-catenin signaling by inhibitors of glycogen sythase kinase-3 beta or the Wnt protein family member Wnt3a arrested CD8(+) T cell development into effector cells. By blocking T cell differentiation, Wnt signaling promoted the generation of CD44(low)CD62L(high)Sca-1(high)CD122(high)Bcl-2(high) self-renewing multipotent CD8(+) memory stem cells with proliferative and antitumor capacities exceeding those of central and effector memory T cell subsets. These findings reveal a key role for Wnt signaling in the maintenance of 'stemness' in mature memory CD8(+) T cells and have major implications for the design of new vaccination strategies and adoptive immunotherapies.	[Gattinoni, Luca; Zhong, Xiao-Song; Palmer, Douglas C.; Ji, Yun; Hinrichs, Christian S.; Yu, Zhiya; Wrzesinski, Claudia; Boni, Andrea; Cassard, Lydie; Garvin, Lindsay M.; Paulos, Chrystal M.; Muranski, Pawel; Restifo, Nicholas P.] NCI, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gattinoni, L (corresponding author), NCI, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA.	gattinol@mail.nih.gov; restifo@nih.gov	Gattinoni, Luca/A-2281-2008; Restifo, Nicholas Phillip/M-6549-2019; Ji, Yun/B-7245-2009; Waldmann, Thomas/AAT-5972-2021; Palmer, Douglas/B-9454-2008; Muranski, Pawel/E-5572-2010; Restifo, Nicholas P/A-5713-2008; Restifo, Nicholas Phillip/Z-1614-2019; Hinrichs, Christian/V-9851-2019	Gattinoni, Luca/0000-0003-2239-3282; Ji, Yun/0000-0001-6340-7009; Waldmann, Thomas/0000-0003-4500-6660; Palmer, Douglas/0000-0001-5018-5734; Hinrichs, Christian/0000-0001-5597-2841; Restifo, Nicholas P./0000-0003-4229-4580	US National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research. We would like to thank S. A. Rosenberg, C. A. Klebanoff and S. Kerkar for critical review of the manuscript and A. Mixon and S. Farid of the Flow Cytometry Unit for Flow Cytometry analyses and sorting. This study was done in partial fulfillment of a PhD in Biochemistry (to D.C.P.) at the George Washington University, Washington, DC.	Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Katoh M, 2007, INT J MOL MED, V19, P529; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mizumoto K, 2007, TRENDS CELL BIOL, V17, P465, DOI 10.1016/j.tcb.2007.08.004; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schilham MW, 1998, J IMMUNOL, V161, P3984; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wrzesinski C, 2007, J CLIN INVEST, V117, P492, DOI 10.1172/JCI30414; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	40	672	698	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2009	15	7					808	U129		10.1038/nm.1982	http://dx.doi.org/10.1038/nm.1982			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19525962	Green Accepted			2022-12-25	WOS:000267806900036
J	Gutierrez, R; Lindeboom, JJ; Paredez, AR; Emons, AMC; Ehrhardt, DW				Gutierrez, Ryan; Lindeboom, Jelmer J.; Paredez, Alex R.; Emons, Anne Mie C.; Ehrhardt, David W.			Arabidopsis cortical microtubules position cellulose synthase delivery to the plasma membrane and interact with cellulose synthase trafficking compartments	NATURE CELL BIOLOGY			English	Article							PRIMARY-CELL-WALL; PLANT-CELLS; GOLGI NETWORK; ARRAYS; COMPLEXES; DIFFERENTIATION; MORPHOGENESIS; ORGANIZATION; INHIBITOR; PROTEINS	Plant cell morphogenesis relies on the organization and function of two polymer arrays separated by the plasma membrane: the cortical microtubule cytoskeleton and cellulose microfibrils in the cell wall. Studies using in vivo markers confirmed that one function of the cortical microtubule array is to drive organization of cellulose microfibrils by guiding the trajectories of active cellulose synthase (CESA) complexes in the plasma membrane, thus orienting nascent microfibrils. Here we provide evidence that cortical microtubules also position the delivery of CESA complexes to the plasma membrane and interact with small CESA-containing compartments by a mechanism that permits motility driven by microtubule depolymerization. The association of CESA compartments with cortical microtubules was greatly enhanced during osmotic stress and other treatments that limit cellulose synthesis. On recovery from osmotic stress, delivery of CESA complexes to the plasma membrane was observed in association with microtubule-tethered compartments. These results reveal multiple functions for the microtubule cortical array in organizing CESA in the cell cortex.	[Gutierrez, Ryan; Ehrhardt, David W.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Gutierrez, Ryan; Ehrhardt, David W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Lindeboom, Jelmer J.; Emons, Anne Mie C.] Wageningen Univ, Lab Plant Cell Biol, NL-6708 PB Wageningen, Netherlands; [Paredez, Alex R.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Emons, Anne Mie C.] FOM, Inst Atom & Mol Phys, Dept Biomol Syst, NL-1098 SJ Amsterdam, Netherlands	Carnegie Institution for Science; Stanford University; Wageningen University & Research; University of California System; University of California Berkeley; AMOLF	Ehrhardt, DW (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	ehrhardt@stanford.edu	Paredez, Alexander R/B-9799-2009; Paredez, Alexander/E-7171-2014	Paredez, Alexander R/0000-0002-9298-3264; Paredez, Alexander/0000-0002-9298-3264; Lindeboom, Jelmer J/0000-0003-4294-4838	National Science Foundation [0524334]; EU Commission [FP6-2004-NEST-C1-028974]	National Science Foundation(National Science Foundation (NSF)); EU Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the National Science Foundation (0524334) and the EU Commission (FP6-2004-NEST-C1-028974).	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Barton DA, 2008, PLANT CELL, V20, P982, DOI 10.1105/tpc.108.058503; Bassham DC, 2000, MOL BIOL CELL, V11, P2251, DOI 10.1091/mbc.11.7.2251; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; DeBolt S, 2007, P NATL ACAD SCI USA, V104, P5854, DOI 10.1073/pnas.0700789104; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; EMONS AM, 1985, PLANTA, V163, P350, DOI 10.1007/BF00395143; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P6918, DOI 10.1073/pnas.0801811105; HAIGLER CH, 1986, PROTOPLASMA, V134, P111, DOI 10.1007/BF01275709; HANDA S, 1983, PLANT PHYSIOL, V73, P834, DOI 10.1104/pp.73.3.834; HEATH IB, 1974, J THEOR BIOL, V48, P445, DOI 10.1016/S0022-5193(74)80011-1; HEPLER PK, 1964, J CELL BIOL, V20, P529, DOI 10.1083/jcb.20.3.529; HERTH W, 1983, PLANTA, V159, P347, DOI 10.1007/BF00393174; IRAKI NM, 1989, PLANT PHYSIOL, V91, P39, DOI 10.1104/pp.91.1.39; Kiedaisch BM, 2003, PLANTA, V217, P922, DOI 10.1007/s00425-003-1071-y; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Kirik V, 2007, J CELL SCI, V120, P4416, DOI 10.1242/jcs.024950; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; McFarlane HE, 2008, PLANTA, V227, P1363, DOI 10.1007/s00425-008-0708-2; MUELLER SC, 1980, J CELL BIOL, V84, P315, DOI 10.1083/jcb.84.2.315; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Oda Y, 2005, PLANT PHYSIOL, V137, P1027, DOI 10.1104/pp.104.052613; Paradez A, 2006, CURR OPIN PLANT BIOL, V9, P571, DOI 10.1016/j.pbi.2006.09.005; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; Rasband W, IMAGEJ; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STAEHELIN LA, 1982, DEV ORDER ITS ORIGIN, P133; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Zheng HY, 2002, PLANT PHYSIOL, V129, P530, DOI 10.1104/pp.003970	48	476	488	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					797	U43		10.1038/ncb1886	http://dx.doi.org/10.1038/ncb1886			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525940				2022-12-25	WOS:000267603100007
J	Schmidt, MHH; Bicker, F; Nikolic, I; Meister, J; Babuke, T; Picuric, S; Muller-Esterl, W; Plate, KH; Dikic, I				Schmidt, Mirko H. H.; Bicker, Frank; Nikolic, Iva; Meister, Jeannette; Babuke, Tanja; Picuric, Srdjan; Mueller-Esterl, Werner; Plate, Karl H.; Dikic, Ivan			Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal	NATURE CELL BIOLOGY			English	Article							NUCLEAR ANTIGEN-2; MAMMALIAN NOTCH; IN-VIVO; DROSOPHILA; RECEPTOR; DELTA; GENE; ACTIVATION; SERRATE; PATHWAY	Epidermal growth factor-like domain 7 (EGFL7) is a secreted factor implicated in cellular responses such as cell migration and blood vessel formation; however the molecular mechanisms underlying the effects of EGFL7 are largely unknown. Here we have identified transmembrane receptors of the Notch family as EGFL7-binding molecules. Secreted EGFL7 binds to a region in Notch involved in ligand-mediated receptor activation, thus acting as an antagonist of Notch signalling. Expression of EGFL7 in neural stem cells (NSCs) in vitro decreased Notch-specific signalling and consequently, reduced proliferation and self-renewal of NSCs. Such altered Notch signalling caused a shift in the differentiation pattern of cultured NSCs towards an excess of neurons and oligodendrocytes. We identified neurons as a source of EGFL7 in the brain, suggesting that brain-derived EGFL7 acts as an endogenous antagonist of Notch signalling that regulates proliferation and differentiation of subventricular zone-derived adult NSCs.	[Schmidt, Mirko H. H.; Babuke, Tanja; Picuric, Srdjan; Mueller-Esterl, Werner; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Schmidt, Mirko H. H.; Bicker, Frank; Nikolic, Iva; Meister, Jeannette; Plate, Karl H.] Goethe Univ Frankfurt, Sch Med, Inst Neurol, D-60528 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Mirko.Schmidt@kgu.de; Ivan.Dikic@biochem2.de	Dikic, Ivan/O-4650-2015; Schmidt, Mirko H. H./ABI-6650-2020	Dikic, Ivan/0000-0001-8156-9511; Schmidt, Mirko H. H./0000-0001-7411-8835; Nikolic, Iva/0000-0002-0141-5975	DFG; EMBO	DFG(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO))	We thank all our colleagues who provided constructs. Thanks to Julio Granados, Yonathan Lissanu Deribe and Koraljka Husnjak for initial help with the yeast two- hybrid system. Thanks to Verdon Taylor for helpful suggestions, Ruth von Laer for help with FACS analysis and Stefan Momma and David G. McEwan for comments on the manuscript. This work was financially supported by the DFG within the SFB Transregio 23, subproject A4 and the Excellence Cluster Cardiopulmonary System, by the Adolf Messer Foundation, by the Paul and Ursula Klein Foundation, and an EMBO long- term fellowship granted to M. H.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; DE SB, 1999, NATURE, V398, P518; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; Ge CH, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-48; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Levy OA, 2002, DEV NEUROSCI-BASEL, V24, P79, DOI 10.1159/000064948; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Ohuchi T, 2002, J NEUROSCI METH, V118, P1, DOI 10.1016/S0165-0270(02)00116-4; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sakai T, 1998, J VIROL, V72, P6034, DOI 10.1128/JVI.72.7.6034-6039.1998; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shimizu K, 2002, EMBO J, V21, P294, DOI 10.1093/emboj/21.3.294; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	47	107	118	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					873	U245		10.1038/ncb1896	http://dx.doi.org/10.1038/ncb1896			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19503073				2022-12-25	WOS:000267603100017
J	Zeng, SC; Xiang, T; Pandita, TK; Gonzalez-Suarez, I; Gonzalo, S; Harris, CC; Yang, Q				Zeng, Sicong; Xiang, Tao; Pandita, Tej K.; Gonzalez-Suarez, Ignacio; Gonzalo, Susana; Harris, Curtis C.; Yang, Qin			Telomere recombination requires the MUS81 endonuclease	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; HUMAN-CELLS; MAINTENANCE; RESOLUTION; SHELTERIN; BODIES; PHASE; TRF2; ALT	Telomerase-negative cancer cells maintain their telomeres through the alternative lengthening of telomeres (ALT) pathway(1-3). Although a growing body of evidence demonstrates that the ALT mechanism is a post-replicative telomere recombination process, molecular details of this pathway are largely unknown. Here we demonstrate that MUS81, a DNA structure specific recombination endonuclease, has a key role in the maintenance of telomeres in human ALT cells. We find that MUS81 specifically localizes to ALT-associated promyelocytic leukaemia (PML) nuclear bodies (APBs) and associates with telomeric DNA in ALT cells, which is enriched during the G2 phase of the cell cycle. Depletion of MUS81 results in the reduction of ALT-specific telomere recombination and leads to proliferation arrest of ALT cells. In addition, the endonuclease activity of MUS81 is required for recombination-based ALT cell survival, and the interaction of MUS81 with the telomeric repeat-binding factor TRF2 regulates this enzymatic activity, thereby maintaining telomere recombination. Thus, our results suggest that MUS81 is involved in the maintenance of ALT cell survival at least in part by homologous recombination of telomeres.	[Zeng, Sicong; Xiang, Tao; Pandita, Tej K.; Gonzalez-Suarez, Ignacio; Gonzalo, Susana; Yang, Qin] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA; [Gonzalez-Suarez, Ignacio; Gonzalo, Susana] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Harris, Curtis C.] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yang, Q (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, 4511 Forest Pk, St Louis, MO 63108 USA.	qyang@wustl.edu	Pandita, Tej K/AAM-9188-2020; Gonzalo, Susana/T-8275-2019	Gonzalo, Susana/0000-0001-9631-1206	Concern Foundation; NIH [CA10445/CA123232]; Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA129537, ZIABC005795, R01CA123232, P01CA104457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034746] Funding Source: NIH RePORTER	Concern Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. R. Reddel for ALT cells, and C. H. McGowan for wild-type and mutant MUS81 constructs, the MUS81 antibody and Mus81<SUP>+/+</SUP> and Mus81<SUP>-/-</SUP> MEFs. We thank I. Hickson and J. Roti Roti for proof-reading. This work is supported in part by grants from Concern Foundation to Q. Y. and NIH CA10445/CA123232 to T. K. P. This research was also supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Blais V, 2004, MOL BIOL CELL, V15, P552, DOI 10.1091/mbc.E03-08-0580; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; Gao H, 2003, MOL BIOL CELL, V14, P4826, DOI 10.1091/mbc.E03-05-0276; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Grobelny JV, 2000, J CELL SCI, V113, P4577; Heyer WD, 2004, CURR BIOL, V14, pR56, DOI 10.1016/j.cub.2003.12.043; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Jiang WQ, 2007, ONCOGENE, V26, P4635, DOI 10.1038/sj.onc.1210260; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Stansel RM, 2001, EMBO J, V20, P5532; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wu GK, 2000, J BIOL CHEM, V275, P30618, DOI 10.1074/jbc.C000390200; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yeager TR, 1999, CANCER RES, V59, P4175; Zhang R, 2005, CANCER RES, V65, P2526, DOI 10.1158/0008-5472.CAN-04-2421; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	33	77	79	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					616	U387		10.1038/ncb1867	http://dx.doi.org/10.1038/ncb1867			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19363487	Green Accepted			2022-12-25	WOS:000265640000020
J	Halperin, E; Stephan, DA				Halperin, Eran; Stephan, Dietrich A.			SNP imputation in association studies	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE DATA; ACCURACY; DISEASE; LOCI	Only a subset of single-nucleotide polymorphisms (SNPs) can be genotyped in genome-wide association studies. Imputation methods can infer the alleles of 'hidden' variants and use those inferences to test the hidden variants for association.	[Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA; [Halperin, Eran] Tel Aviv Univ, Dept Biotechnol, IL-69978 Tel Aviv, Israel; [Halperin, Eran] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Stephan, Dietrich A.] Navigenics, Div Genom Res, Foster City, CA USA	Tel Aviv University; Tel Aviv University	Halperin, E (corresponding author), Int Comp Sci Inst, Berkeley, CA 94704 USA.	dietrich@navigenics.com						Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Halperin E, 2009, NAT BIOTECHNOL, V27, P255, DOI 10.1038/nbt0309-255; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Kimmel G, 2008, AM J HUM GENET, V83, P675, DOI 10.1016/j.ajhg.2008.10.017; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501	14	41	42	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2009	27	4					349	351		10.1038/nbt0409-349	http://dx.doi.org/10.1038/nbt0409-349			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	430EO	19352374				2022-12-25	WOS:000264971800020
J	Starczynowski, DT; Kuchenbauer, F; Argiropoulos, B; Sung, S; Morin, R; Muranyi, A; Hirst, M; Hogge, D; Marra, M; Wells, RA; Buckstein, R; Lam, W; Humphries, RK; Karsan, A				Starczynowski, Daniel T.; Kuchenbauer, Florian; Argiropoulos, Bob; Sung, Sandy; Morin, Ryan; Muranyi, Andrew; Hirst, Martin; Hogge, Donna; Marra, Marco; Wells, Richard A.; Buckstein, Rena; Lam, Wan; Humphries, R. Keith; Karsan, Aly			Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC PROGENITOR CELLS; MICRORNA EXPRESSION PROFILES; MYELODYSPLASTIC SYNDROMES; KAPPA-B; BONE-MARROW; CHROMOSOME 5Q; CD34(+) CELLS; INTERLEUKIN-6; ACTIVATION	5q-syndrome is a subtype of myelodysplastic syndrome characterized by severe anemia and variable neutropenia but normal or high platelet counts with dysplastic megakaryocytes. We examined expression of microRNAs (miRNAs) encoded on chromosome 5q as a possible cause of haploinsufficiency. We show that deletion of chromosome 5q correlates with loss of two miRNAs that are abundant in hematopoietic stem/progenitor cells (HSPCs), miR-145 and miR-146a, and we identify Toll-interleukin-1 receptor domain-containing adaptor protein (TIRAP) and tumor necrosis factor receptor-associated factor-6 (TRAF6) as respective targets of these miRNAs. TIRAP is known to lie upstream of TRAF6 in innate immune signaling. Knockdown of miR-145 and miR-146a together or enforced expression of TRAF6 in mouse HSPCs resulted in thrombocytosis, mild neutropenia and megakaryocytic dysplasia. A subset of mice transplanted with TRAF6-expressing marrow progressed either to marrow failure or acute myeloid leukemia. Thus, inappropriate activation of innate immune signals in HSPCs phenocopies several clinical features of 5q-syndrome.	[Starczynowski, Daniel T.; Kuchenbauer, Florian; Argiropoulos, Bob; Sung, Sandy; Morin, Ryan; Muranyi, Andrew; Hirst, Martin; Hogge, Donna; Marra, Marco; Lam, Wan; Humphries, R. Keith; Karsan, Aly] British Columbia Canc Agcy, Res Ctr, Vancouver, BC V5Z 4E6, Canada; [Starczynowski, Daniel T.; Lam, Wan; Karsan, Aly] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Wells, Richard A.; Buckstein, Rena] Sunnybrook Res Inst, JD Crashley Myelodysplast Syndrome Lab, Toronto, ON, Canada; [Humphries, R. Keith] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia	Karsan, A (corresponding author), British Columbia Canc Agcy, Res Ctr, Vancouver, BC V5Z 4E6, Canada.	akarsan@bccrc.ca	Morin, Ryan/AAE-7824-2019; Marra, Marco A/B-5987-2008; Karsan, Aly/K-2067-2015; Hirst, Martin/B-7684-2016	Morin, Ryan/0000-0003-2932-7800; Marra, Marco A/0000-0001-7146-7175; Humphries, Richard/0000-0003-0540-7005; Hogge, Donna/0000-0002-5205-9982	Canadian Institutes of Health Research (CIHR) [MOP 89976]; Leukemia and Lymphoma Society of Canada; Canadian Cancer Society; Terry Fox Foundation; Stem Cell Network; Michael Smith Foundation for Health Research (MSFHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada; Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Stem Cell Network; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	We thank R. Deleeuw, R. Chari, W. Lockwood, S. Watson and E. Vucic for technical assistance and helpful discussions and M. Abbott for animal husbandry. K. Tohyama (Kawasaki Medical School) provided the MDS-L cell line. The NF-kappa B site-containing luciferase reporter plasmid was a gift from F. Jirik (University of Calgary). This work was supported by the Canadian Institutes of Health Research (CIHR; MOP 89976), Leukemia and Lymphoma Society of Canada and Canadian Cancer Society grants to A. K., a CIHR grant and a Terry Fox Foundation Program Project award to R. K. H., and a Stem Cell Network grant to M. M. D. T. S. is supported in part by CIHR and Michael Smith Foundation for Health Research (MSFHR) fellowships. M. M. and A. K. are Senior Scholars of the MSFHR.	Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bigoni R, 2001, HAEMATOLOGICA, V86, P375; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; BRANDT SJ, 1990, J CLIN INVEST, V86, P592, DOI 10.1172/JCI114749; Chen H, 2006, ONCOGENE, V25, P6520, DOI 10.1038/sj.onc.1209653; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Corral LG, 1999, J IMMUNOL, V163, P380; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Giagounidis AAN, 2006, CLIN CANCER RES, V12, P5, DOI 10.1158/1078-0432.CCR-05-1437; Gondek LP, 2008, BLOOD, V111, P1534, DOI 10.1182/blood-2007-05-092304; Hast R, 1999, LEUKEMIA RES, V23, P579, DOI 10.1016/S0145-2126(99)00042-9; HAWLEY RG, 1992, J EXP MED, V176, P1149, DOI 10.1084/jem.176.4.1149; HEROLD M, 1992, LEUKEMIA RES, V16, P585, DOI 10.1016/0145-2126(92)90006-S; Hofmann WK, 2002, BLOOD, V100, P3553, DOI 10.1182/blood.V100.10.3553; Hsu HC, 2002, ONCOLOGY-BASEL, V63, P64, DOI 10.1159/000065722; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kroef MJPL, 1997, LEUKEMIA, V11, P519, DOI 10.1038/sj.leu.2400597; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Larrivee B, 2005, J IMMUNOL, V175, P3015, DOI 10.4049/jimmunol.175.5.3015; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li X, 2004, INT J HEMATOL, V80, P140, DOI 10.1532/IJH97.NA0402; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Maratheftis CI, 2007, CLIN CANCER RES, V13, P1154, DOI 10.1158/1078-0432.CCR-06-2108; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Martinez-Ramirez A, 2005, GENE CHROMOSOME CANC, V42, P287, DOI 10.1002/gcc.20154; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; Nilsson L, 2007, BLOOD, V110, P3005, DOI 10.1182/blood-2007-03-079368; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Nimer SD, 2006, J CLIN ONCOL, V24, P2576, DOI 10.1200/JCO.2005.03.6715; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Starczynowski DT, 2008, BLOOD, V112, P3412, DOI 10.1182/blood-2007-11-122028; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takada S, 2008, LEUKEMIA, V22, P1274, DOI 10.1038/sj.leu.2405031; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; VERHOEF GEG, 1992, LEUKEMIA, V6, P1268; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang L, 2008, HAEMATOL-HEMATOL J, V93, P994, DOI 10.3324/haematol.12603	47	484	514	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					49	U84		10.1038/nm.2054	http://dx.doi.org/10.1038/nm.2054			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	19898489				2022-12-25	WOS:000273395500036
J	Natarajan, P; Liu, K; Patil, DV; Sciorra, VA; Jackson, CL; Graham, TR				Natarajan, Paramasivam; Liu, Ke; Patil, Dustin V.; Sciorra, Vicki A.; Jackson, Catherine L.; Graham, Todd R.			Regulation of a Golgi flippase by phosphoinositides and an ArfGEF	NATURE CELL BIOLOGY			English	Article							P-TYPE ATPASE; BINDING-PROTEIN HOMOLOG; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; AMINOPHOSPHOLIPID TRANSLOCASE; SACCHAROMYCES-CEREVISIAE; MEMBRANE DYNAMICS; IN-VIVO; TRAFFICKING; SECRETION; COMPLEX	The essential role for phosphatidylinositol-4-phosphate (PtdIns(4)P) in vesicle-mediated protein transport from the trans-Golgi network (TGN) was first described in the budding yeast Saccharomyces cerevisiae(1-3). However, the identity of downstream effectors of PtdIns( 4) P in this system has been elusive. Here, we show that Drs2p, a type IV P-type ATPase required for phospholipid translocase ( flippase) activity and transport vesicle budding from the TGN(4-8), is an effector of PtdIns(4) P. Drs2p-dependent flip of a fluorescent phosphatidylserine analogue across purified TGN membranes requires synthesis of PtdIns(4) P by the phosphatidylinositol-4-kinase (PI(4)K) Pik1p. PtdIns(4) P binds to a regulatory domain in the C-terminal tail of Drs2p that has homology to a split PH domain and is required for Drs2p activity. In addition, basic residues required for phosphoinositide binding overlap a previously mapped binding site for the ArfGEF Gea2p(9). ArfGEF binding to this C-terminal domain also stimulates flippase activity in TGN membrane preparations. These interactions suggest the presence of a coincidence detection system used to activate phospholipid translocation at sites of vesicle formation.	[Natarajan, Paramasivam; Liu, Ke; Patil, Dustin V.; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Sciorra, Vicki A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Jackson, Catherine L.] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Vanderbilt University; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu	Jackson, Catherine/A-3421-2013; Jackson, Catherine/T-5688-2019	Jackson, Catherine/0000-0002-0843-145X; Patil, Dustin/0000-0003-0587-0139	NIH [GM62367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062367] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ACKNOWLEDGEMENTS We thank Scott D. Emr and Anjon Audhya for yeast strains, John York for providing the GST-Inp53-Sac1 plasmid, Jonathan Goldberg for the His-Gea2p-Sec7 plasmid and our lab colleagues for comments on this manuscript. These studies were supported by NIH Grant GM62367 ( to T. R. G.)	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Liu K, 2007, MOL BIOL CELL, V18, P487, DOI 10.1091/mbc.E06-07-0592; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Muthusamy BP, 2009, MOL BIOL CELL, V20, P2920, DOI 10.1091/mbc.E08-10-1036; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2006, METHODS, V39, P163, DOI 10.1016/j.ymeth.2006.05.009; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; WALSH JP, 1991, P NATL ACAD SCI USA, V88, P9184, DOI 10.1073/pnas.88.20.9184; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2	32	89	92	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1421	U73		10.1038/ncb1989	http://dx.doi.org/10.1038/ncb1989			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19898464	Green Accepted			2022-12-25	WOS:000272251300007
J	Kurth, I; Pamminger, T; Hennings, JC; Soehendra, D; Huebner, AK; Rotthier, A; Baets, J; Senderek, J; Topaloglu, H; Farrell, SA; Nurnberg, G; Nurnberg, P; De Jonghe, P; Gal, A; Kaether, C; Timmerman, V; Hubner, CA				Kurth, Ingo; Pamminger, Torsten; Hennings, J. Christopher; Soehendra, Desiree; Huebner, Antje K.; Rotthier, Annelies; Baets, Jonathan; Senderek, Jan; Topaloglu, Haluk; Farrell, Sandra A.; Nuernberg, Gudrun; Nuernberg, Peter; De Jonghe, Peter; Gal, Andreas; Kaether, Christoph; Timmerman, Vincent; Huebner, Christian A.			Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy	NATURE GENETICS			English	Article							GENE; APPARATUS; PAIN	Hereditary sensory and autonomic neuropathy type II (HSAN II) leads to severe mutilations because of impaired nociception and autonomic dysfunction. Here we show that loss-of-function mutations in FAM134B, encoding a newly identified cis-Golgi protein, cause HSAN II. Fam134b knockdown results in structural alterations of the cis-Golgi compartment and induces apoptosis in some primary dorsal root ganglion neurons. This implicates FAM134B as critical in long-term survival of nociceptive and autonomic ganglion neurons.	[Kurth, Ingo; Soehendra, Desiree; Gal, Andreas; Huebner, Christian A.] Univ Med Ctr Hamburg Eppendorf, Dept Human Genet, Hamburg, Germany; [Pamminger, Torsten; Hennings, J. Christopher; Huebner, Antje K.; Huebner, Christian A.] Univ Jena, Dept Clin Chem, Jena, Germany; [Rotthier, Annelies; Timmerman, Vincent] Univ Antwerp VIB, Peripheral Neuropathy Grp, Dept Mol Genet, Antwerp, Belgium; [Rotthier, Annelies; Baets, Jonathan; De Jonghe, Peter; Timmerman, Vincent] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp VIB, Neurogenet Grp, Dept Mol Genet, B-2020 Antwerp, Belgium; [Senderek, Jan] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Topaloglu, Haluk] Hacettepe Univ, Fac Med, Dept Pediat Neurol, TR-06100 Ankara, Turkey; [Farrell, Sandra A.] Credit Valley Hosp, Dept Lab Med, Mississauga, ON, Canada; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Inst Genet, D-5000 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Kaether, Christoph] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hacettepe University; University of Toronto; Trillium Health Partners; Credit Valley Hospital; University of Cologne; University of Cologne; University of Cologne; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Hubner, CA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Human Genet, Hamburg, Germany.	i.kurth@uke.uni-hamburg.de; christian.huebner@med.uni-jena.de	TOPALOGLU, HALUK AYDIN/I-9318-2013; Hübner, Christian/A-2950-2017; Timmerman, Vincent/O-7283-2019; Senderek, Jan/F-8405-2015	Hübner, Christian/0000-0002-1030-4943; Timmerman, Vincent/0000-0002-2162-0933; Senderek, Jan/0000-0002-8263-1783; Kurth, Ingo/0000-0002-5642-8378	Werner-Otto-Stiftung; University of Antwerp; DFG; IZKF Jena; Fund for Scientific Research (FWO-Flanders); Universitatsklinikum Hamburg Eppendorf; Medical Foundation Queen Elisabeth (GSKE); Belgian Federal Science Policy Office (BELSPO) [P6/43]; Institute for Science and Technology (IWT); FWO-Flanders; Deutsche Forschungsgemeinschaft	Werner-Otto-Stiftung; University of Antwerp; DFG(German Research Foundation (DFG)); IZKF Jena; Fund for Scientific Research (FWO-Flanders)(FWO); Universitatsklinikum Hamburg Eppendorf; Medical Foundation Queen Elisabeth (GSKE); Belgian Federal Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); Institute for Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWO-Flanders(FWO); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to all affected individuals and their relatives who participated in the study. This work was supported by grants of the Werner-Otto-Stiftung to I. K., a Methusalem grant of the University of Antwerp and grants of the DFG and IZKF Jena to C. A. H. We thank T. Deufel for continuous support and J. Muller for help with the implementation of the lentiviral-mediated knockdown. We acknowledge the excellent technical assistance of W. Bigott, K. Kuchler and S. Vanek. This work was also supported by the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), an FFM grant of the Universitatsklinikum Hamburg Eppendorf, the Medical Foundation Queen Elisabeth (GSKE) and the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office (BELSPO). A. R. and J. B. are supported by PhD fellowships of the Institute for Science and Technology (IWT) and FWO-Flanders, respectively. J. S. is a Heisenberg fellow of the Deutsche Forschungsgemeinschaft.	Altan-Bonnet Nihal, 2007, V390, P309; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Hughes Richard, 2008, Pract Neurol, V8, P396, DOI 10.1136/jnnp.2008.162412; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Lafreniere RG, 2004, AM J HUM GENET, V74, P1064, DOI 10.1086/420795; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Tang WK, 2007, INT J MOL MED, V19, P915; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Zuchner S, 2005, J MOL MED-JMM, V83, P935, DOI 10.1007/s00109-005-0694-9	15	159	170	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1179	1181		10.1038/ng.464	http://dx.doi.org/10.1038/ng.464			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19838196				2022-12-25	WOS:000271247600009
J	Liang, Y; Vogel, JL; Narayanan, A; Peng, H; Kristie, TM				Liang, Yu; Vogel, Jodi L.; Narayanan, Aarthi; Peng, Hua; Kristie, Thomas M.			Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency	NATURE MEDICINE			English	Article							IMMEDIATE-EARLY PROMOTERS; HOST-CELL FACTOR; SIMPLEX-VIRUS; ANDROGEN-RECEPTOR; COACTIVATOR HCF-1; GENE-EXPRESSION; H3 LYSINE-4; EARLY TIMES; IN-VIVO; METHYLATION	Reversible methylation of histone tails serves as either a positive signal recognized by transcriptional assemblies or a negative signal that result in repression(1-4). Invading viral pathogens that depend upon the host cell's transcriptional apparatus are also subject to the regulatory impact of chromatin assembly and modifications(5-8). Here we show that infection by the alpha-herpesviruses, herpes simplex virus (HSV) and varicella zoster virus (VZV), results in the rapid accumulation of chromatin bearing repressive histone H3 Lys9 methylation. To enable expression of viral immediate early (IE) genes, both viruses use the cellular transcriptional coactivator host cell factor-1 (HCF-1) to recruit the lysine-specific demethylase-1 (LSD1) to the viral immediate early promoters. Depletion of LSD1 or inhibition of its activity with monoamine oxidase inhibitors (MAOIs) results in the accumulation of repressive chromatin and a block to viral gene expression. As HCF-1 is a component of the Set1 and MLL1 histone H3 Lys4 methyltransferase complexes(9,10), it thus coordinates modulation of repressive H3 Lys9 methylation levels with addition of activating H3 Lys4 trimethylation marks. Strikingly, MAOIs also block the reactivation of HSV from latency in sensory neurons, indicating that the HCF-1 complex is a crucial component of the reactivation mechanism. The results support pharmaceutical control of histone modifying enzymes as a strategy for controlling herpesvirus infections.	[Liang, Yu; Vogel, Jodi L.; Narayanan, Aarthi; Peng, Hua; Kristie, Thomas M.] NIAID, Mol Genet Sect, Viral Dis Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kristie, TM (corresponding author), NIAID, Mol Genet Sect, Viral Dis Lab, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	thomas_kristie@nih.gov			Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000712] Funding Source: NIH RePORTER	Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Skinner for expert statistical analysis of the experimental data; B. Moss, J. Yewdell, T. Pierson, J. Bennink and A. McBride for critical discussions and comments on this manuscript; members of the Molecular Genetics Section of the Laboratory of Viral Diseases for discussion, advice and technical assistance; the US National Institute of Allergy and Infectious Diseases Bld33 Animal Care Facility staff; N. Fraser (University of Pennsylvania School of Medicine) for HSV-1 strain 17, W. Ruyechan (University at Buffalo, State University of New York) for ICP8-specific sera and X. Chen (University of California at Davis) for MCF7 inducible LSD shRNA cells. These studies were supported by the Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health.	Amelio AL, 2006, J VIROL, V80, P2063, DOI 10.1128/JVI.80.4.2063-2068.2006; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Kolb G, 2008, J VIROL, V82, P9555, DOI 10.1128/JVI.01174-08; Kouzarides T, 2007, EPIGENETICS, P191; Kristie TM, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P112; Kristie TM, 1999, P NATL ACAD SCI USA, V96, P1229, DOI 10.1073/pnas.96.4.1229; Kubat NJ, 2004, J VIROL, V78, P1139, DOI 10.1128/JVI.78.3.1139-1149.2004; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lieberman PM, 2008, J CELL PHYSIOL, V216, P295, DOI 10.1002/jcp.21421; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mok HP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-228; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Neumann DM, 2007, J VIROL, V81, P13248, DOI 10.1128/JVI.01569-07; Oh J, 2008, J VIROL, V82, P3530, DOI 10.1128/JVI.00586-07; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Pesola JA, 2005, J VIROL, V79, P14516, DOI 10.1128/JVI.79.23.14516-14525.2005; Placek BJ, 2009, J VIROL, V83, P1416, DOI 10.1128/JVI.01276-08; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sawtell NM, 2006, J VIROL, V80, P38, DOI 10.1128/JVI.80.1.38-50.2006; Schmidt DMZ, 2007, BIOCHEMISTRY-US, V46, P4408, DOI 10.1021/bi0618621; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Sinclair J, 2010, BBA-GENE REGUL MECH, V1799, P286, DOI 10.1016/j.bbagrm.2009.08.001; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Whitlow Z, 2009, J VIROL, V83, P9591, DOI 10.1128/JVI.01115-09; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yang MJ, 2007, BIOCHEMISTRY-US, V46, P8058, DOI 10.1021/bi700664y; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	40	202	245	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1312	U112		10.1038/nm.2051	http://dx.doi.org/10.1038/nm.2051			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19855399	Green Accepted			2022-12-25	WOS:000271543700020
J	St John, AL; Abraham, SN				St John, Ashley L.; Abraham, Soman N.			Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines	NATURE MEDICINE			English	Article							IMMUNE-RESPONSES; TYPHIMURIUM INFECTION; LYMPHOCYTES; MACROPHAGES; EXPRESSION; CELLS; LIPOPOLYSACCHARIDE; FOLLICLES; VIRULENCE; PROMOTES	We report that infection of draining lymph nodes (DLNs) by Salmonella typhimurium results in the specific downregulation of the homeostatic chemokines CCL21 and CXCL13, which are essential for normal DLN organization and function. Our data reveal that the mechanism of this suppression is dependent on S. typhimurium LPS (sLPS). The decrease in CCL21 expression involves interaction between sLPS and CCL21-producing cells within DLNs, triggering a distinct Toll-like receptor 4 (TLR4)-mediated host signaling response. In this response, suppressor of cytokine signaling-3 (Socs3) is upregulated, which negatively regulates mothers against decapentaplegic homolog-3 (Smad3)-initiated production of CCL21. Disruption of lymph node architecture and cellular trafficking enhances S. typhimurium virulence and could represent a mechanism of immune suppression used by pathogens that primarily target lymphoid tissue.	[St John, Ashley L.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Abraham, Soman N.] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore, Singapore	Duke University; Duke University; Duke University; National University of Singapore	Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	soman.abraham@duke.edu	StJohn, Ashley/AAE-4378-2021	StJohn, Ashley/0000-0001-5098-1044	US National Institutes of Health [R01 AI35678, R01 DK077159, R01 AI50021, R37 DK50814, R21 AI056101]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074751, R01AI050021, R21AI056101, R01AI035678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077159, R21DK077307, R37DK050814] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank M. Krangel, M. Gunn, M. Kuehn, Y. He and W. Zhang for their discussions and J. Wright for the use of equipment. Salmonella strains chi 3761 and chi 8573 were a gift from R. Curtiss (Arizona State University) and M. Kuehn (Duke University). S. typhimurium SL1344 was a gift from A. Aballay (Duke University), and E. coli J96 was a gift from S. Normark (Umea University). G. Li provided technical advice. Z. Swan, C. Kunder, G. Li and A. Bickell provided critical manuscript review. This work was supported by US National Institutes of Health grants R01 AI35678, R01 DK077159, R01 AI50021, R37 DK50814 and R21 AI056101.	Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; KUMAR A, 1984, INDIAN J MED RES, V80, P270; KUMAR A, 1984, INDIAN J MED RES, V80, P557; Liu X, 2008, MOL IMMUNOL, V45, P1405, DOI 10.1016/j.molimm.2007.08.018; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Stoiber D, 1999, J IMMUNOL, V163, P2640; Uchiya K, 2005, INFECT IMMUN, V73, P5587, DOI 10.1128/IAI.73.9.5587-5594.2005; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222	24	46	47	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1259	U51		10.1038/nm.2036	http://dx.doi.org/10.1038/nm.2036			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19855398	Green Accepted			2022-12-25	WOS:000271543700013
J	Tuduri, S; Crabbe, L; Conti, C; Tourriere, H; Holtgreve-Grez, H; Jauch, A; Pantesco, V; De Vos, J; Thomas, A; Theillet, C; Pommier, Y; Tazi, J; Coquelle, A; Pasero, P				Tuduri, Sandie; Crabbe, Laure; Conti, Chiara; Tourriere, Helene; Holtgreve-Grez, Heidi; Jauch, Anna; Pantesco, Veronique; De Vos, John; Thomas, Aubin; Theillet, Charles; Pommier, Yves; Tazi, Jamal; Coquelle, Arnaud; Pasero, Philippe			Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription	NATURE CELL BIOLOGY			English	Article							SPLICING FACTOR ASF/SF2; DNA-REPLICATION; FORK PROGRESSION; SR PROTEINS; HUMAN-CELLS; ORIGIN CHOICE; FRAGILE SITES; PHOSPHORYLATION; DAMAGE; RECRUITMENT	Topoisomerase I (Top1) is a key enzyme in functioning at the interface between DNA replication, transcription and mRNA maturation. Here, we show that Top1 suppresses genomic instability in mammalian cells by preventing a conflict between transcription and DNA replication. Using DNA combing and ChIP (chromatin immunoprecipitation)-on-chip, we found that Top1-deficient cells accumulate stalled replication forks and chromosome breaks in S phase, and that breaks occur preferentially at gene-rich regions of the genome. Notably, these phenotypes were suppressed by preventing the formation of RNA-DNA hybrids (R-loops) during transcription. Moreover, these defects could be mimicked by depletion of the splicing factor ASF/SF2 (alternative splicing factor/splicing factor 2), which interacts functionally with Top1. Taken together, these data indicate that Top1 prevents replication fork collapse by suppressing the formation of R-loops in an ASF/SF2-dependent manner. We propose that interference between replication and transcription represents a major source of spontaneous replication stress, which could drive genomic instability during the early stages of tumorigenesis.	[Tuduri, Sandie; Theillet, Charles; Coquelle, Arnaud] Univ Montpellier I, IRCM, INSERM, CRLC Val Aurelle Paul Lamarque,U896, F-34298 Montpellier, France; [Tuduri, Sandie; Crabbe, Laure; Tourriere, Helene; Thomas, Aubin; Pasero, Philippe] CNRS, Inst Human Genet, UPR1142, F-34396 Montpellier, France; [Conti, Chiara; Pommier, Yves] NIH, Mol Pharmacol Lab, Bethesda, MD 20892 USA; [Holtgreve-Grez, Heidi; Jauch, Anna] Univ Heidelberg Hosp, Inst Human Genet, D-69120 Heidelberg, Germany; [Pantesco, Veronique; De Vos, John] INSERM, U847, F-34000 Montpellier, France; [Pantesco, Veronique; De Vos, John] CHU Montpellier, Inst Rech Biotherapie, Hop St Eloi, F-34000 Montpellier, France; [Pantesco, Veronique; De Vos, John] Univ Montpellier I, F-34000 Montpellier, France; [Tazi, Jamal] CNRS, Inst Mol Genet, UMR5535, F-34293 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; National Institutes of Health (NIH) - USA; Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Coquelle, A (corresponding author), Univ Montpellier I, IRCM, INSERM, CRLC Val Aurelle Paul Lamarque,U896, F-34298 Montpellier, France.	arnaud.coquelle@inserm.fr; philippe.pasero@igh.cnrs.fr	De Vos, John/A-5703-2010; Coquelle, Arnaud/AAE-5425-2020; Theillet, Charles/O-7634-2018; Pasero, Philippe/O-2340-2018; Crabbé, Laure/P-8955-2014	De Vos, John/0000-0003-1880-4130; Pasero, Philippe/0000-0001-5891-0822; Crabbé, Laure/0000-0001-7764-3600; Tazi, Jamal/0000-0002-1949-8748; Theillet, Charles/0000-0001-5555-2759	FRM (Equipe FRM); ANR; INCa; EMBO Young Investigator Programme; Ligue contre le cancer (Comite de l'Herault); ARC (Association pour la Recherche contre le Cancer); EMBO; CNRS; NATIONAL CANCER INSTITUTE [ZIABC006161] Funding Source: NIH RePORTER	FRM (Equipe FRM)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); INCa(Institut National du Cancer (INCA) France); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); Ligue contre le cancer (Comite de l'Herault); ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); EMBO(European Molecular Biology Organization (EMBO)); CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Debatisse and M. Mechali for discussions and critical comments on the manuscript, D. Durocher for communicating data before publication, J. Piette for his initial contribution to this project and E. Schwob and the DNA combing facility of Montpellier for providing silanized coverslips. Work in the P. P. laboratory is supported by FRM (Equipe FRM), ANR, INCa and the EMBO Young Investigator Programme. Work in the J. T. laboratory is supported by ANR. A. C. is supported by the Ligue contre le cancer (Comite de l'Herault), ARC (Association pour la Recherche contre le Cancer) and INCa. S. T., L. C. and H. T. were recipients of fellowships from ARC, EMBO and CNRS, respectively.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; BJORNSTI MA, 1989, CANCER RES, V49, P6318; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gilbert DM, 2007, CHROMOSOMA, V116, P341, DOI 10.1007/s00412-007-0105-9; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hann C, 1998, J BIOL CHEM, V273, P8425, DOI 10.1074/jbc.273.14.8425; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Holmes WF, 2005, J BIOL CHEM, V280, P37400, DOI 10.1074/jbc.M506995200; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Malanga M, 2008, J BIOL CHEM, V283, P19991, DOI 10.1074/jbc.M709495200; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; NICKOLOFF JA, 1990, MOL CELL BIOL, V10, P4837, DOI 10.1128/MCB.10.9.4837; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Salceda J, 2006, EMBO J, V25, P2575, DOI 10.1038/sj.emboj.7601142; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Soret J, 2003, CANCER RES, V63, P8203; Tazi J, 2005, MOL PHARMACOL, V67, P1186, DOI 10.1124/mol.104.007633; THRASH C, 1985, P NATL ACAD SCI USA, V82, P4374, DOI 10.1073/pnas.82.13.4374; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; Vieira KF, 2004, J BIOL CHEM, V279, P50350, DOI 10.1074/jbc.M408883200; Wei XY, 1998, SCIENCE, V281, P1502, DOI 10.1126/science.281.5382.1502; Widrow RJ, 1998, P NATL ACAD SCI USA, V95, P11246, DOI 10.1073/pnas.95.19.11246; Zhang CX, 2000, DEV BIOL, V222, P27, DOI 10.1006/dbio.2000.9704	54	348	355	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1315	U125		10.1038/ncb1984	http://dx.doi.org/10.1038/ncb1984			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838172	Green Submitted, Green Accepted			2022-12-25	WOS:000271425800011
J	Yang, XHR; Ng, D; Alcorta, DA; Liebsch, NJ; Sheridan, E; Li, SF; Goldstein, AM; Parry, DM; Kelley, MJ				Yang, Xiaohong R.; Ng, David; Alcorta, David A.; Liebsch, Norbert J.; Sheridan, Eamonn; Li, Sufeng; Goldstein, Alisa M.; Parry, Dilys M.; Kelley, Michael J.			T (brachyury) gene duplication confers major susceptibility to familial chordoma	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; GENOMIC REARRANGEMENTS; DISORDERS; PROTEIN; DISEASE; LOCUS	Using high-resolution array-CGH, we identified unique duplications of a region on 6q27 in four multiplex families with at least three cases of chordoma, a cancer of presumed notochordal origin. The duplicated region contains only the T (brachyury) gene, which is important in notochord development and is expressed in most sporadic chordomas. Our findings highlight the value of screening for complex genomic rearrangements in searches for cancer-susceptibility genes.	[Yang, Xiaohong R.; Ng, David; Goldstein, Alisa M.; Parry, Dilys M.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Alcorta, David A.; Li, Sufeng; Kelley, Michael J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Liebsch, Norbert J.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Sheridan, Eamonn] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Li, Sufeng; Kelley, Michael J.] Durham Vet Affairs Med Ctr, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; Harvard University; Massachusetts General Hospital; Saint James's University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Parry, DM (corresponding author), NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	parryd@mail.nih.gov	Pillay, Nischalan/F-9536-2012; Kelley, Michael/AAC-8939-2019	Kelley, Michael/0000-0001-9523-6080	US National Cancer Institute, Division of Cancer Epidemiology and Genetics; National Institutes of Health; Department of Veterans Affairs, Veterans Health Administration; Office of Research and Development, Biomedical Laboratory Research and Development program; Chordoma Foundation; NATIONAL CANCER INSTITUTE [ZIACP004410] Funding Source: NIH RePORTER	US National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development, Biomedical Laboratory Research and Development program; Chordoma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Zametkin for her outstanding skills as a research nurse; G. M. Glenn and M. L. McMaster for their careful clinical evaluations of affected individuals and family members; N. J. Patronas for reviewing the MRIs; A. Bergen and S. Chanock for SNP genotyping; K. Haque and D. Maeder for technical assistance; and, especially, the affected individuals and their families for their participation. This work was supported by the intramural research program of the US National Cancer Institute, Division of Cancer Epidemiology and Genetics, National Institutes of Health; by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development program; and by a grant from the Chordoma Foundation (M. J. K.).	Chanda B, 2008, HUM MOL GENET, V17, P3446, DOI 10.1093/hmg/ddn238; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Kelley MJ, 2001, AM J HUM GENET, V69, P454, DOI 10.1086/321982; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; MALAWER MM, 1997, SARCOMAS BONE, P844; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Yang XH, 2005, INT J CANCER, V116, P487, DOI 10.1002/ijc.21006	13	193	201	6	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1176	1178		10.1038/ng.454	http://dx.doi.org/10.1038/ng.454			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19801981	Green Accepted			2022-12-25	WOS:000271247600008
J	Begus-Nahrmann, Y; Lechel, A; Obenauf, AC; Nalapareddy, K; Peit, E; Hoffmann, E; Schlaudraff, F; Liss, B; Schirmacher, P; Kestler, H; Danenberg, E; Barker, N; Clevers, H; Speicher, MR; Rudolph, KL				Begus-Nahrmann, Yvonne; Lechel, Andre; Obenauf, Anna C.; Nalapareddy, Kodandaramireddy; Peit, Elvira; Hoffmann, Eva; Schlaudraff, Falk; Liss, Birgit; Schirmacher, Peter; Kestler, Hans; Danenberg, Esther; Barker, Nick; Clevers, Hans; Speicher, Michael R.; Rudolph, K. Lenhard			p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice	NATURE GENETICS			English	Article							DNA-DAMAGE; HUMAN FIBROBLASTS; LIFE-SPAN; CANCER; SENESCENCE; MECHANISM; RESISTANT; LENGTH; GENE; AGE	Telomere dysfunction limits the proliferative capacity of human cells and induces organismal aging by activation of p53 and p21 (refs. 1-6). Although deletion of p21 elongates the lifespan of telomere-dysfunctional mice(2), a direct analysis of p53 in telomere-related aging has been hampered by early tumor formation in p53 knockout mice(6). Here we analyzed the functional consequences of conditional p53 deletion(7). Intestinal deletion of p53 shortened the lifespan of telomere-dysfunctional mice without inducing tumor formation. In contrast to p21 deletion, the deletion of p53 impaired the depletion of chromosomal-instable intestinal stem cells in aging telomere-dysfunctional mice. These instable stem cells contributed to epithelial regeneration leading to an accumulation of chromosomal instability, increased apoptosis, altered epithelial cell differentiation and premature intestinal failure. Together, these results provide the first experimental evidence for an organ system in which p53-dependent mechanisms prevent tissue destruction in response to telomere dysfunction by depleting genetically instable stem cells.	[Begus-Nahrmann, Yvonne; Lechel, Andre; Nalapareddy, Kodandaramireddy; Peit, Elvira; Rudolph, K. Lenhard] Univ Ulm, Inst Mol Med, Ulm, Germany; [Begus-Nahrmann, Yvonne; Lechel, Andre; Nalapareddy, Kodandaramireddy; Peit, Elvira; Rudolph, K. Lenhard] Univ Ulm, Max Planck Res Dept Stem Cell Aging, Ulm, Germany; [Obenauf, Anna C.; Hoffmann, Eva; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, Graz, Austria; [Schlaudraff, Falk; Liss, Birgit] Univ Ulm, Inst Gen Physiol, Ulm, Germany; [Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Kestler, Hans] Univ Ulm, Inst Neuroinformat, Ulm, Germany; [Danenberg, Esther; Barker, Nick; Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands	Ulm University; Max Planck Society; Ulm University; Medical University of Graz; Ulm University; Ruprecht Karls University Heidelberg; Ulm University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Rudolph, KL (corresponding author), Univ Ulm, Inst Mol Med, Ulm, Germany.	lenhard.rudolph@uni-ulm.de	Barker, Nick/AAE-9833-2021; Lechel, André/AAQ-2041-2021; Barker, Nick/A-5535-2011; Speicher, Michael R/B-5362-2013; Kestler, Hans A./D-5799-2012; Barker, Nick/AAS-2774-2020	Barker, Nick/0000-0003-3566-4475; Lechel, André/0000-0003-0221-6959; Speicher, Michael R/0000-0003-0105-955X; Kestler, Hans A./0000-0002-4759-5254; Danenberg, Esther/0000-0002-1799-4457; liss, Birgit/0000-0002-6733-9207; Rudolph, Karl Lenhard/0000-0002-4839-2862; Nalapareddy, Kodandaramireddy/0000-0003-3290-5114; Obenauf, Anna/0000-0002-9556-5914	Deutsche Forschungsgemeinschaft [KFO 167, RU745/10-1]; Deutsche Krebshilfe e. V.; European Union [202230]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); European Union(European Commission)	We thank S. Robine (Institute Curie-CNRS, Paris) for providing villin-Cre-ERT2 mice and A. Berns (The Netherlands Cancer Institute, Amsterdam) for providing conditional p53 knockout mice. We thank J. Jonkers ((The Netherlands Cancer Institute, Amsterdam) for providing the BAC clones for chromosome FISH. We thank G. Schatz (German Cancer Research Center, Heidelberg) for providing selfmade Cre antibody. We thank C. Ganes for critical reading of the manuscript. This project was supported by funding from the Deutsche Forschungsgemeinschaft (KFO 167, RU745/10-1), by the Deutsche Krebshilfe e. V. (consortium grant on tumor stem cells) and by the European Union (GENINCA, Telomarker). K. L. R. and M. R. S. are both supported by the European Union (GENINCA, contract number 202230).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Chung YJ, 2004, GENOME RES, V14, P188, DOI 10.1101/gr.1878804; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Flores I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004934; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Geigl JB, 2007, NAT PROTOC, V2, P3173, DOI 10.1038/nprot.2007.476; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Nalapareddy K, 2008, EXP GERONTOL, V43, P998, DOI 10.1016/j.exger.2008.09.002; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Riboni R, 1997, CANCER GENET CYTOGEN, V95, P130, DOI 10.1016/S0165-4608(96)00248-8; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C	31	87	87	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1138	U125		10.1038/ng.426	http://dx.doi.org/10.1038/ng.426			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19718028				2022-12-25	WOS:000270330400020
J	Harold, D; Abraham, R; Hollingworth, P; Sims, R; Gerrish, A; Hamshere, ML; Pahwa, JS; Moskvina, V; Dowzell, K; Williams, A; Jones, N; Thomas, C; Stretton, A; Morgan, AR; Lovestone, S; Powell, J; Proitsi, P; Lupton, MK; Brayne, C; Rubinsztein, DC; Gill, M; Lawlor, B; Lynch, A; Morgan, K; Brown, KS; Passmore, PA; Craig, D; McGuinness, B; Todd, S; Holmes, C; Mann, D; Smith, AD; Love, S; Kehoe, PG; Hardy, J; Mead, S; Fox, N; Rossor, M; Collinge, J; Maier, W; Jessen, F; Schurmann, B; van den Bussche, H; Heuser, I; Kornhuber, J; Wiltfang, J; Dichgans, M; Frolich, L; Hampel, H; Hull, M; Rujescu, D; Goate, AM; Kauwe, JSK; Cruchaga, C; Nowotny, P; Morris, JC; Mayo, K; Sleegers, K; Bettens, K; Engelborghs, S; De Deyn, PP; Van Broeckhoven, C; Livingston, G; Bass, NJ; Gurling, H; McQuillin, A; Gwilliam, R; Deloukas, P; Al-Chalabi, A; Shaw, CE; Tsolaki, M; Singleton, AB; Guerreiro, R; Muhleisen, TW; Nothen, MM; Moebus, S; Jockel, KH; Klopp, N; Wichmann, HE; Carrasquillo, MM; Pankratz, VS; Younkin, SG; Holmans, PA; O'Donovan, M; Owen, MJ; Williams, J				Harold, Denise; Abraham, Richard; Hollingworth, Paul; Sims, Rebecca; Gerrish, Amy; Hamshere, Marian L.; Pahwa, Jaspreet Singh; Moskvina, Valentina; Dowzell, Kimberley; Williams, Amy; Jones, Nicola; Thomas, Charlene; Stretton, Alexandra; Morgan, Angharad R.; Lovestone, Simon; Powell, John; Proitsi, Petroula; Lupton, Michelle K.; Brayne, Carol; Rubinsztein, David C.; Gill, Michael; Lawlor, Brian; Lynch, Aoibhinn; Morgan, Kevin; Brown, Kristelle S.; Passmore, Peter A.; Craig, David; McGuinness, Bernadette; Todd, Stephen; Holmes, Clive; Mann, David; Smith, A. David; Love, Seth; Kehoe, Patrick G.; Hardy, John; Mead, Simon; Fox, Nick; Rossor, Martin; Collinge, John; Maier, Wolfgang; Jessen, Frank; Schuermann, Britta; van den Bussche, Hendrik; Heuser, Isabella; Kornhuber, Johannes; Wiltfang, Jens; Dichgans, Martin; Froelich, Lutz; Hampel, Harald; Huell, Michael; Rujescu, Dan; Goate, Alison M.; Kauwe, John S. K.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin; Sleegers, Kristel; Bettens, Karolien; Engelborghs, Sebastiaan; De Deyn, Peter P.; Van Broeckhoven, Christine; Livingston, Gill; Bass, Nicholas J.; Gurling, Hugh; McQuillin, Andrew; Gwilliam, Rhian; Deloukas, Panagiotis; Al-Chalabi, Ammar; Shaw, Christopher E.; Tsolaki, Magda; Singleton, Andrew B.; Guerreiro, Rita; Muehleisen, Thomas W.; Noethen, Markus M.; Moebus, Susanne; Joeckel, Karl-Heinz; Klopp, Norman; Wichmann, H-Erich; Carrasquillo, Minerva M.; Pankratz, V. Shane; Younkin, Steven G.; Holmans, Peter A.; O'Donovan, Michael; Owen, Michael J.; Williams, Julie			Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; AMYLOID-PRECURSOR-PROTEIN; APOLIPOPROTEIN-J; BETA-PROTEIN; LARGE-SCALE; SUSCEPTIBILITY LOCI; MOUSE MODEL; IN-VITRO; CLUSTERIN; BRAIN	We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD) involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 cases and 7,848 controls), we replicated the established association with the apolipoprotein E (APOE) locus (most significant SNP, rs2075650, P = 1.8 x 10(-157)) and observed genome-wide significant association with SNPs at two loci not previously associated with the disease: at the CLU (also known as APOJ) gene (rs11136000, P = 1.4 x 10(-9)) and 5. to the PICALM gene (rs3851179, P = 1.9 x 10(-8)). These associations were replicated in stage 2 (2,023 cases and 2,340 controls), producing compelling evidence for association with Alzheimer's disease in the combined dataset (rs11136000, P = 8.5 x 10(-10), odds ratio = 0.86; rs3851179, P = 1.3 x 10(-9), odds ratio = 0.86).	[Harold, Denise; Abraham, Richard; Hollingworth, Paul; Sims, Rebecca; Gerrish, Amy; Hamshere, Marian L.; Pahwa, Jaspreet Singh; Moskvina, Valentina; Dowzell, Kimberley; Williams, Amy; Jones, Nicola; Thomas, Charlene; Stretton, Alexandra; Morgan, Angharad R.; Holmans, Peter A.; O'Donovan, Michael; Owen, Michael J.; Williams, Julie] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Dept Psychol Med & Neurol,Sch Med, Cardiff, S Glam, Wales; [Lovestone, Simon] Kings Coll London, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, S London & Maudsley Natl Hlth Serv Fdn Trust, London WC2R 2LS, England; [Powell, John; Proitsi, Petroula; Lupton, Michelle K.] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Rubinsztein, David C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Gill, Michael; Lawlor, Brian; Lynch, Aoibhinn] St James Hosp, Mercers Inst Res Aging, Dublin 8, Ireland; [Gill, Michael; Lawlor, Brian; Lynch, Aoibhinn] Trinity Coll Dublin, Dublin, Ireland; [Morgan, Kevin; Brown, Kristelle S.] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England; [Passmore, Peter A.; Craig, David; McGuinness, Bernadette; Todd, Stephen] Queens Univ Belfast, Ageing Grp, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Holmes, Clive] Univ Southampton, Div Clin Neurosci, Sch Med, Southampton, Hants, England; [Mann, David] Univ Manchester, Clin Neurosci Res Grp, Greater Manchester Neurosci Ctr, Salford, Lancs, England; [Smith, A. David] Univ Oxford, John Radcliffe Hosp, Oxford Project Investigate Memory & Ageing, Oxford OX3 9DU, England; [Love, Seth; Kehoe, Patrick G.] Univ Bristol, Dementia Res Grp, Inst Clin Neurosci, Frenchay Hosp, Bristol, Avon, England; [Hardy, John] Inst Neurol, Dept Mol Neurosci Ctr, London WC1N 3BG, England; [Hardy, John] Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England; [Mead, Simon; Collinge, John] UCL Inst Neurol, MRC, Prion Unit, London, England; [Fox, Nick; Rossor, Martin] UCL Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat Dis, London, England; [Maier, Wolfgang; Jessen, Frank; Schuermann, Britta] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [van den Bussche, Hendrik] Univ Med Ctr Hamburg Eppendorf, Inst Primary Med Care, Hamburg, Germany; [Heuser, Isabella] Charite, Dept Psychiat, Berlin, Germany; [Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany; [Wiltfang, Jens] Univ Duisburg Essen, Dept Psychiat & Psychotherapy, Landschaftsverband Rheinland Hosp Essen, Essen, Germany; [Dichgans, Martin] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dichgans, Martin] Klinikum Univ Munchen, Dept Neurol, Munich, Germany; [Froelich, Lutz] Heidelberg Univ, Dept Geriatr Psychiat, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany; [Hampel, Harald] Univ Dublin Trinity Coll, Discipline Psychiat, Sch Med, Dublin 2, Ireland; [Hampel, Harald] Univ Dublin Trinity Coll, Inst Neurosci, Lab Neuroimaging & Biomarker Res, Dublin 2, Ireland; [Hampel, Harald; Rujescu, Dan] Univ Munich, Dept Psychiat, Alzheimer Mem Ctr, D-8000 Munich, Germany; [Hampel, Harald; Rujescu, Dan] Univ Munich, Dept Psychiat, Geriatr Psychiat Branch, D-8000 Munich, Germany; [Huell, Michael] Univ Freiburg, Ctr Geriatr Med, Sch Med, Freiburg, Germany; [Huell, Michael] Univ Freiburg, Sect Gerontopsychiat & Neuropsychol, Sch Med, Freiburg, Germany; [Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Sleegers, Kristel; Bettens, Karolien; Van Broeckhoven, Christine] VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium; [Sleegers, Kristel; Bettens, Karolien; Engelborghs, Sebastiaan; De Deyn, Peter P.; Van Broeckhoven, Christine] Inst Born Bunge, Antwerp, Belgium; [Sleegers, Kristel; Bettens, Karolien; Engelborghs, Sebastiaan; De Deyn, Peter P.; Van Broeckhoven, Christine] Univ Antwerp, B-2020 Antwerp, Belgium; [Engelborghs, Sebastiaan; De Deyn, Peter P.] Ziekenhuis Netwerk Antwerpen Middelheim, Memory Clin, Antwerp, Belgium; [Engelborghs, Sebastiaan; De Deyn, Peter P.] Ziekenhuis Netwerk Antwerpen Middelheim, Dept Neurol, Antwerp, Belgium; [Livingston, Gill; Bass, Nicholas J.; Gurling, Hugh; McQuillin, Andrew] UCL, Dept Mental Hlth Sci, London, England; [Gwilliam, Rhian; Deloukas, Panagiotis] Wellcome Trust Sanger Inst, Cambridge, England; [Al-Chalabi, Ammar; Shaw, Christopher E.] Kings Coll London, MRC, Ctr Neurodegenerat Res, Dept Clin Neurosci,Inst Psychiat, London WC2R 2LS, England; [Tsolaki, Magda] Aristotle Univ Thessaloniki, Dept Neurol 3, GR-54006 Thessaloniki, Greece; [Singleton, Andrew B.; Guerreiro, Rita] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, D-5300 Bonn, Germany; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Moebus, Susanne; Joeckel, Karl-Heinz] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Klopp, Norman; Wichmann, H-Erich] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Carrasquillo, Minerva M.; Younkin, Steven G.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Pankratz, V. Shane] Mayo Clin & Mayo Fdn, Div Biomed Stat & Informat, Rochester, MN 55905 USA	Cardiff University; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; University of Cambridge; University of Cambridge; Trinity College Dublin; Trinity College Dublin; University of Nottingham; Queens University Belfast; University of Southampton; University of Manchester; University of Oxford; University of Bristol; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg; University of Duisburg Essen; University of Munich; University of Munich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Trinity College Dublin; Trinity College Dublin; University of Munich; University of Munich; University of Freiburg; University of Freiburg; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brigham Young University; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of London; University College London; Wellcome Trust Sanger Institute; University of London; King's College London; Aristotle University of Thessaloniki; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bonn; University of Bonn; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Mayo Clinic; Mayo Clinic	Williams, J (corresponding author), Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Dept Psychol Med & Neurol,Sch Med, Cardiff, S Glam, Wales.	owenmj@cardiff.ac.uk; williamsj@cardiff.ac.uk	Kornhuber, Johannes/B-9613-2014; Livingston, G/C-7081-2008; Hardy, John/C-2451-2009; McGuinness, Bernadette/A-4056-2010; Love, Seth/E-6545-2012; Holmans, Peter/F-4518-2015; Jessen, Frank/E-7655-2012; Smith, Anthony D./A-4233-2010; Todd, Stephen/AAF-6729-2020; O'Donovan, Michael C/P-7005-2018; Todd, Stephen/A-4299-2009; passmore, anthony/C-9824-2009; McGuinness, Bernadette/AAH-2755-2021; Guerreiro, Rita J L/A-1327-2011; Nöthen, Markus/B-2027-2009; Kauwe, John/AAC-6646-2021; Fox, Nick C/B-1319-2009; Brayne, Carol/AAA-4285-2020; Singleton, Andrew B/C-3010-2009; Mead, Simon/E-9414-2011; Van Broeckhoven, Christine/G-8362-2017; Wichmann, Heinz Erich/AAA-5695-2022; Goldsmith, Seraphina P/M-7829-2013; Morris, John C/A-1686-2012; Heath, Simon C/J-4138-2012; Rujescu, Dan/GRS-3875-2022; Kauwe, John/B-2034-2009; Fox, Nick C/AAE-1849-2021; Powell, John F/G-4412-2011; Al-Chalabi, Ammar/E-5361-2010; Hüll, Michael/F-2618-2012; Gurling, Hugh M/A-5029-2010; Rossor, Martin/C-1598-2008; Rubinsztein, David C/C-3472-2011; Frölich, Lutz/AAA-6940-2019; , beccie/AAM-3770-2021; McQuillin, Andrew/C-1623-2008; Cruz e Silva, Odete/AAH-5595-2020; Lovestone, Simon/E-8725-2010; Jessen, Frank/AAK-6170-2020; Dichgans, Martin/HCH-3247-2022; Van Broeckhoven, Christine/M-7853-2019; Sander-Effron, Samuel/AAX-2231-2020; Cruchaga, Carlos/ABF-4065-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Deloukas, Panos/B-2922-2013; Kehoe, Patrick/P-8760-2018	Kornhuber, Johannes/0000-0002-8096-3987; Hardy, John/0000-0002-3122-0423; Holmans, Peter/0000-0003-0870-9412; Smith, Anthony D./0000-0002-1095-6722; O'Donovan, Michael C/0000-0001-7073-2379; McGuinness, Bernadette/0000-0002-7028-5633; Nöthen, Markus/0000-0002-8770-2464; Kauwe, John/0000-0001-8641-2468; Fox, Nick C/0000-0002-6660-657X; Brayne, Carol/0000-0001-5307-663X; Mead, Simon/0000-0002-4326-1468; Van Broeckhoven, Christine/0000-0003-0183-7665; Goldsmith, Seraphina P/0000-0003-4379-988X; Heath, Simon C/0000-0002-9550-0897; Kauwe, John/0000-0001-8641-2468; Fox, Nick C/0000-0002-6660-657X; Powell, John F/0000-0001-6124-439X; Al-Chalabi, Ammar/0000-0002-4924-7712; Frölich, Lutz/0000-0003-1494-0813; , beccie/0000-0002-3885-1199; McQuillin, Andrew/0000-0003-1567-2240; Dichgans, Martin/0000-0002-0654-387X; Van Broeckhoven, Christine/0000-0003-0183-7665; Cruchaga, Carlos/0000-0002-0276-2899; Deloukas, Panos/0000-0001-9251-070X; Hampel, Harald/0000-0003-0894-8982; Moebus, Susanne/0000-0002-0072-5410; Harold, Denise/0000-0001-5195-0143; Gerrish, Amy/0000-0002-5982-1685; Williams, Julie/0000-0002-4069-0259; Todd, Stephen/0000-0002-2312-9195; Love, Seth/0000-0001-8683-3625; Shaw, Christopher/0000-0003-0251-0146; Rossor, Martin/0000-0001-8215-3120; Morgan, Kevin/0000-0002-8217-2396; Denning, Nicola/0000-0001-8467-7382; Guerreiro, Rita/0000-0001-5879-3486; Goate, Alison/0000-0002-0576-2472; Escott-Price, Valentina/0000-0003-1784-5483; Kehoe, Patrick/0000-0002-7542-1139; Gill, Michael/0000-0003-0206-5337; Tsolaki, Magda/0000-0002-2072-8010; Holmes, Clive/0000-0003-1999-6912; Wiltfang, Jens/0000-0003-1492-5330; Lupton, Michelle/0000-0002-7274-7299; Lovestone, Simon/0000-0003-0473-4565; Livingston, Gill/0000-0001-6741-5516	Wellcome Trust; Medical Research Council (MRC, UK); Alzheimer's Research Trust (ART); Welsh Assembly Government; Mercer's Institute for Research on Ageing; South West Dementia Brain Bank; Charles Wolfson Charitable Trust; Motor Neurone Disease Association; US National Institutes of Health (NIH); Barnes Jewish Foundation; Charles and Joanne Knight Alzheimer's Research Initiative; Robert and Clarice Smith and Abigail Van Buren AD Research Program; UCL Hospital/UCL Biomedical Centre; Lundbeck; German Federal Ministry of Education and Research (BMBF); Competence Network Dementia and Competence Network Degenerative Dementia; Alfried Krupp von Bohlen und Halbach-Stiftung; Helmholtz Zentrum Munchen; German National Genome Research Network; Munich Center of Health Sciences; Heinz Nixdorf Foundation; US National Institute of Neurological Disorders and Stroke; National Institute on Aging (NIA); IRP; Department of Health and Human Services [Z01 AG000950-06]; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International; VIB Genetic Service Facility; Biobank of the Institute Born-Bunge; Special Research Fund of the University of Antwerp; Fund for Scientific Research-Flanders; Foundation for Alzheimer Research; Belgian Federal Science Policy Office; MRC [G0600974, MC_U123160651, G0900688, G0801418, G0300429, MC_U123192748, G0601846, G0701075] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000950] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-RF2007-3, ART-NCG2008A-1, ART-BIG2009-1] Funding Source: researchfish; Medical Research Council [MC_U123192748, G0900688, G0300429, G0801418, G0801418B, G0601846, G0701075, G0600974, MC_U123160651] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust (ART); Welsh Assembly Government; Mercer's Institute for Research on Ageing; South West Dementia Brain Bank; Charles Wolfson Charitable Trust; Motor Neurone Disease Association; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes Jewish Foundation; Charles and Joanne Knight Alzheimer's Research Initiative; Robert and Clarice Smith and Abigail Van Buren AD Research Program; UCL Hospital/UCL Biomedical Centre; Lundbeck(Lundbeck Corporation); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Competence Network Dementia and Competence Network Degenerative Dementia; Alfried Krupp von Bohlen und Halbach-Stiftung; Helmholtz Zentrum Munchen(Helmholtz Association); German National Genome Research Network; Munich Center of Health Sciences; Heinz Nixdorf Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); IRP; Department of Health and Human Services; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); VIB Genetic Service Facility; Biobank of the Institute Born-Bunge; Special Research Fund of the University of Antwerp; Fund for Scientific Research-Flanders(FWO); Foundation for Alzheimer Research; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the individuals and families who took part in this research. Cardiff University was supported by the Wellcome Trust, Medical Research Council (MRC, UK), Alzheimer's Research Trust (ART) and the Welsh Assembly Government. ART supported sample collections at the Institute of Psychiatry, the South West Dementia Bank and the Universities of Cambridge, Nottingham, Manchester and Belfast. The Belfast group acknowledges support from the Alzheimer's Society, Ulster Garden Villages, Northern Ireland Research and Development Office and the Royal College of Physicians-Dunhill Medical Trust. The MRC and Mercer's Institute for Research on Ageing supported the Trinity College group. The South West Dementia Brain Bank acknowledges support from Bristol Research into Alzheimer's and Care of the Elderly. The Charles Wolfson Charitable Trust supported the Oxford Project to Investigate Memory and Ageing (OPTIMA) group. A. A.-C. and C. E. S. thank the Motor Neurone Disease Association and MRC for support. D. C. R. is a Wellcome Trust Senior Clinical Research Fellow. Washington University was funded by US National Institutes of Health (NIH) grants, the Barnes Jewish Foundation and the Charles and Joanne Knight Alzheimer's Research Initiative. The Mayo GWAS was supported by NIH grants, the Robert and Clarice Smith and Abigail Van Buren AD Research Program, and the Palumbo Professorship in AD Research. Patient recruitment for the MRC Prion Unit/University College London Department of Neurodegenerative Disease collection was supported by the UCL Hospital/UCL Biomedical Centre. London and the South East Region (LASER)-AD was funded by Lundbeck. The Bonn group was supported by the German Federal Ministry of Education and Research (BMBF), Competence Network Dementia and Competence Network Degenerative Dementia, and by the Alfried Krupp von Bohlen und Halbach-Stiftung. The Kooperative gesundheitsforschung in der region Augsburg (KORA) F4 studies were financed by Helmholtz Zentrum Munchen, the German Research Center for Environmental Health, BMBF, the German National Genome Research Network and the Munich Center of Health Sciences. The Heinz Nixdorf Recall cohort was funded by the Heinz Nixdorf Foundation (G. Schmidt, chairman) and BMBF. Coriell Cell Repositories is supported by the US National Institute of Neurological Disorders and Stroke and the Intramural Research Program (IRP) of the National Institute on Aging (NIA). Work on this sample was supported in part by the IRP of the NIA, National Institutes of Health, Department of Health and Human Services; Z01 AG000950-06. We acknowledge use of DNA from the 1958 Birth Cohort collection, funded by the MRC and the Wellcome Trust, which was genotyped by the Wellcome Trust Case Control Consortium and the Type-1 Diabetes Genetics Consortium, sponsored by the US National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development and Juvenile Diabetes Research Foundation International. The Antwerp site was supported by the VIB Genetic Service Facility, the Biobank of the Institute Born-Bunge, the Special Research Fund of the University of Antwerp, the Fund for Scientific Research-Flanders, the Foundation for Alzheimer Research and the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office. K. S. is a postdoctoral fellow and K. B. a PhD fellow (Fund for Scientific Research-Flanders). We thank R. Brown, J. Landers, D.; Warden, D Lehmann, N. Leigh, J. Uphill, J. Beck, T. Campbell, S. Klier, G. Adamson, J. Wyatt, M. L. Perez, T. Meitinger, P. Lichtner, G. Eckstein, N. Graff-Radford, R. Petersen, D. Dickson, G. Fischer, H. Bickel, H. Jahn, H. Kaduszkiewicz, C. Luckhaus, S. Riedel-Heller, S. Wolf, S. Weyerer, the Helmholtz Zentrum Munchen genotyping staff, E. Reiman, TGEN and the NIMH AD Genetics Initiative. We thank Advanced Research Computing @ Cardiff (ARCCA), which facilitated data analysis.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; AMOUYEL P, 2009, NAT GENET       0906, DOI DOI 10.1038/NG.439; Avramopoulos D, 2009, GENOME MED, V1, DOI 10.1186/gm34; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Boggs LN, 1996, J NEUROCHEM, V67, P1324; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; Giannakopoulos P, 1998, ACTA NEUROPATHOL, V95, P387, DOI 10.1007/s004010050815; GOLABEK A, 1995, NEUROSCI LETT, V191, P79, DOI 10.1016/0304-3940(95)11565-7; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; JENNE DE, 1992, TRENDS BIOCHEM SCI, V17, P154, DOI 10.1016/0968-0004(92)90325-4; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Tycko B, 1996, HUM GENET, V98, P430, DOI 10.1007/s004390050234; Yao PJ, 2005, J COMP NEUROL, V481, P58, DOI 10.1002/cne.20362; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; ZLOKOVIC BV, 1994, BIOCHEM BIOPH RES CO, V205, P1431, DOI 10.1006/bbrc.1994.2825; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	58	2003	2059	13	342	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1088	U61		10.1038/ng.440	http://dx.doi.org/10.1038/ng.440			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19734902	Green Accepted, Green Submitted			2022-12-25	WOS:000270330400011
J	van Es, MA; Veldink, JH; Saris, CGJ; Blauw, HM; van Vught, PWJ; Birve, A; Lemmens, R; Schelhaas, HJ; Groen, EJN; Huisman, MHB; van der Kooi, AJ; de Visser, M; Dahlberg, C; Estrada, K; Rivadeneira, F; Hofman, A; Zwarts, MJ; van Doormaal, PTC; Rujescu, D; Strengman, E; Giegling, I; Muglia, P; Tomik, B; Slowik, A; Uitterlinden, AG; Hendrich, C; Waibel, S; Meyer, T; Ludolph, AC; Glass, JD; Purcell, S; Cichon, S; Nothen, MM; Wichmann, HE; Schreiber, S; Vermeulen, SHHM; Kiemeney, LA; Wokke, JHJ; Cronin, S; McLaughlin, RL; Hardiman, O; Fumoto, K; Pasterkamp, RJ; Meininger, V; Melki, J; Leigh, PN; Shaw, CE; Landers, JE; Al-Chalabi, A; Brown, RH; Robberecht, W; Andersen, PM; Ophoff, RA; van den Berg, LH				van Es, Michael A.; Veldink, Jan H.; Saris, Christiaan G. J.; Blauw, Hylke M.; van Vught, Paul W. J.; Birve, Anna; Lemmens, Robin; Schelhaas, Helenius J.; Groen, Ewout J. N.; Huisman, Mark H. B.; van der Kooi, Anneke J.; de Visser, Marianne; Dahlberg, Caroline; Estrada, Karol; Rivadeneira, Fernando; Hofman, Albert; Zwarts, Machiel J.; van Doormaal, Perry T. C.; Rujescu, Dan; Strengman, Eric; Giegling, Ina; Muglia, Pierandrea; Tomik, Barbara; Slowik, Agnieszka; Uitterlinden, Andre G.; Hendrich, Corinna; Waibel, Stefan; Meyer, Thomas; Ludolph, Albert C.; Glass, Jonathan D.; Purcell, Shaun; Cichon, Sven; Noethen, Markus M.; Wichmann, H-Erich; Schreiber, Stefan; Vermeulen, Sita H. H. M.; Kiemeney, Lambertus A.; Wokke, John H. J.; Cronin, Simon; McLaughlin, Russell L.; Hardiman, Orla; Fumoto, Katsumi; Pasterkamp, R. Jeroen; Meininger, Vincent; Melki, Judith; Leigh, P. Nigel; Shaw, Christopher E.; Landers, John E.; Al-Chalabi, Ammar; Brown, Robert H., Jr.; Robberecht, Wim; Andersen, Peter M.; Ophoff, Roel A.; van den Berg, Leonard H.			Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							FRONTOTEMPORAL DEMENTIA; CONFERS SUSCEPTIBILITY; CHROMOSOME 9P; POPULATION; DISEASE; VARIANTS; RELEASE; LINKAGE; HAPMAP; DESIGN	We conducted a genome-wide association study among 2,323 individuals with sporadic amyotrophic lateral sclerosis (ALS) and 9,013 control subjects and evaluated all SNPs with P < 1.0 x 10(-4) in a second, independent cohort of 2,532 affected individuals and 5,940 controls. Analysis of the genome-wide data revealed genome-wide significance for one SNP, rs12608932, with P = 1.30 x 10(-9). This SNP showed robust replication in the second cohort (P = 1.86 x 10(-6)), and a combined analysis over the two stages yielded P = 2.53 x 10(-14). The rs12608932 SNP is located at 19p13.3 and maps to a haplotype block within the boundaries of UNC13A, which regulates the release of neurotransmitters such as glutamate at neuromuscular synapses. Follow-up of additional SNPs showed genome-wide significance for two further SNPs (rs2814707, with P = 7.45 x 10(-9), and rs3849942, with P = 1.01 x 10(-8)) in the combined analysis of both stages. These SNPs are located at chromosome 9p21.2, in a linkage region for familial ALS with frontotemporal dementia found previously in several large pedigrees.	[Wokke, John H. J.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Birve, Anna; Dahlberg, Caroline; Andersen, Peter M.] Umea Univ Hosp, Inst Clin Neurosci, S-90185 Umea, Sweden; [Lemmens, Robin; Robberecht, Wim] Katholieke Univ Leuven VIB, Vesalius Res Ctr, Leuven, Belgium; [Lemmens, Robin; Robberecht, Wim] Univ Leuven, Dept Neurol, Univ Hosp Leuven, Louvain, Belgium; [Schelhaas, Helenius J.; Zwarts, Machiel J.] Radboud Univ Nijmegen, Dept Neurology Clin Neurophysiol, Donders Inst Brain Cognit & Behav, Ctr Neurosci,Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van der Kooi, Anneke J.; de Visser, Marianne] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Estrada, Karol; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Genet Lab, Rotterdam, Netherlands; [Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Rujescu, Dan; Giegling, Ina] Univ Munich, Dept Psychiat, Div Mol & Clin Neurobiol, D-8000 Munich, Germany; [Strengman, Eric; Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Strengman, Eric; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Utrecht, Netherlands; [Muglia, Pierandrea] GlaxoSmithKline R&D, Med Genet, Verona, Italy; [Tomik, Barbara; Slowik, Agnieszka] Jagiellonian Univ, Dept Neurol, Krakow, Poland; [Hendrich, Corinna; Waibel, Stefan; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Meyer, Thomas] Humboldt Univ, Dept Neurol, Charite Univ Hosp, Berlin, Germany; [Glass, Jonathan D.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Purcell, Shaun] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, D-5300 Bonn, Germany; [Wichmann, H-Erich] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany; [Vermeulen, Sita H. H. M.] Radboud Univ Nijmegen, Dept Epidemiol Biostat & HTA, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Cronin, Simon] Royal Coll Surgeons Ireland, Dept Clin Neurol Sci, Dublin 2, Ireland; [Cronin, Simon; McLaughlin, Russell L.; Hardiman, Orla] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [McLaughlin, Russell L.; Hardiman, Orla] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Fumoto, Katsumi; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Meininger, Vincent] Hop La Pitie Salpetriere, Dept Neurol, AP HP, Paris, France; [Melki, Judith] Hadassah Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel; [Leigh, P. Nigel; Shaw, Christopher E.; Al-Chalabi, Ammar] Kings Coll London, Dept Clin Neurosci, MRC, Ctr Neurodegenerat Res,Inst Psychiat, London WC2R 2LS, England; [Landers, John E.; Brown, Robert H., Jr.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Landers, John E.; Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	Utrecht University; Utrecht University Medical Center; Umea University; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Munich; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; GlaxoSmithKline; Jagiellonian University; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Emory University; Harvard University; Massachusetts General Hospital; University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Kiel; University of Kiel; Radboud University Nijmegen; Radboud University Nijmegen; Royal College of Surgeons - Ireland; Trinity College Dublin; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hebrew University of Jerusalem; University of London; King's College London; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles	van den Berg, LH (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	R.A.Ophoff@umcutrecht.nl; L.H.vandenBerg@umcutrecht.nl	van+Es, Michael/AAC-5772-2021; Giegling, Ina/ABA-3677-2021; Muglia, Pierandrea/ABD-9235-2020; Schelhaas, Helenius Jurgen/E-2815-2010; Saris, C.G.J./L-4623-2015; Rivadeneira, Fernando/O-5385-2015; Cichon, Sven/B-9618-2014; Rujescu, Dan/GRS-3875-2022; Hardiman, Orla/Y-3441-2019; Al-Chalabi, Ammar/E-5361-2010; Groen, Ewout JN/L-5081-2016; Vermeulen, Sita H./L-4716-2015; Kiemeney, Lambertus A./D-3357-2009; Wichmann, Heinz Erich/AAA-5695-2022; Cichon, Sven/H-8803-2013; Leigh, Peter/AAD-5638-2019; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Nöthen, Markus/B-2027-2009	Muglia, Pierandrea/0000-0002-3973-8606; Rivadeneira, Fernando/0000-0001-9435-9441; Cichon, Sven/0000-0002-9475-086X; Hardiman, Orla/0000-0003-2610-1291; Al-Chalabi, Ammar/0000-0002-4924-7712; Groen, Ewout JN/0000-0002-2330-9444; Vermeulen, Sita H./0000-0003-4913-8601; Kiemeney, Lambertus A./0000-0002-2368-1326; Cichon, Sven/0000-0002-9475-086X; Nöthen, Markus/0000-0002-8770-2464; Meyer, Thomas/0000-0002-2736-7350; Veldink, Jan/0000-0001-5572-9657; Lemmens, Robin/0000-0002-4948-5956; Pasterkamp, Jeroen/0000-0003-1631-6440; Ingre, Caroline/0000-0001-5327-7204; McLaughlin, Russell/0000-0003-3915-2135; van der Kooi, Anneke/0000-0002-5261-5512; van Es, Michael/0000-0002-7709-5883; Shaw, Christopher/0000-0003-0251-0146; Landers, John/0000-0001-8084-5043	Prinses Beatrix Fonds; VSB fonds; Kersten Foundation; Netherlands ALS Foundation; Adessium Foundation; Brain Foundation of The Netherlands; Netherlands Organisation for Scientific Research (NWO) investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93015]; Netherlands Genomics Initiative/NWO [050-060-810]; National Institute for Mental Health (R.A.O.); Erasmus Medical Center; Erasmus University, Rotterdam; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; Muscular Dystrophy Association USA; Health Research Board of Ireland; Irish Motor Neuron Disease Research Foundation; Swedish Brain Research Foundation; Hallstens Research Foundation; Swedish Medical Society; Bjorklund Foundation for ALS Research; Swedish Association for the Neurologically; Belgian Federal Science Policy Office; Polish Ministry of Science and Higher Education [N N402 083934, N402 092 32/3216]; Association pour la Recherche sur la SLA; Association Reseau SLA Ile de France; Motor Neurone Disease Association of Great Britain and Ireland; Medical Research Council (UK); Wellcome Trust; Psychiatry Research Trust; ALS Therapy Alliance; Angel Fund; ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institute of Neurological Disorders and Stroke [NS050557]; Medical Research Council [G0600974, G0500289B, G0500289, G0900688] Funding Source: researchfish; MRC [G0600974, G0900688, G0500289] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050557] Funding Source: NIH RePORTER	Prinses Beatrix Fonds; VSB fonds; Kersten Foundation; Netherlands ALS Foundation; Adessium Foundation; Brain Foundation of The Netherlands; Netherlands Organisation for Scientific Research (NWO) investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative/NWO(Netherlands Organization for Scientific Research (NWO)); National Institute for Mental Health (R.A.O.)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Erasmus Medical Center; Erasmus University, Rotterdam; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Muscular Dystrophy Association USA(Muscular Dystrophy Association); Health Research Board of Ireland; Irish Motor Neuron Disease Research Foundation; Swedish Brain Research Foundation; Hallstens Research Foundation; Swedish Medical Society; Bjorklund Foundation for ALS Research; Swedish Association for the Neurologically; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Association pour la Recherche sur la SLA; Association Reseau SLA Ile de France; Motor Neurone Disease Association of Great Britain and Ireland; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Psychiatry Research Trust; ALS Therapy Alliance; Angel Fund; ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals and their families who participated in this project; the study staff, general practitioners and pharmacists; P. Arp, M. Jhamai, M. Moorhouse, M. Verkerk and S. Bervoets for their help in creating the GWAS database; D. B. Goldstein for his contribution to the genotyping and analysis of the control sample from the German schizophrenia study; and N. Freimer for critical comments and reading of the manuscript. This project was supported by the Prinses Beatrix Fonds, VSB fonds, H. Kersten and M. Kersten (Kersten Foundation), The Netherlands ALS Foundation, and J. R. van Dijk and the Adessium Foundation (L.H.v.d.B.). J. H. V. was supported by the Brain Foundation of The Netherlands. The generation and management of GWAS genotype data for the Rotterdam Study was supported by The Netherlands Organisation for Scientific Research (NWO) investments (no. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (RIDE; 014-93015)and the Netherlands Genomics Initiative/NWO (project no. 050-060-810). The controls from the Dutch schizophrenia GWAS were genotyped with the support of the National Institute for Mental Health (R.A.O.). The Rotterdam study was funded by Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Health Research and Development; RIDE; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. The Irish studies were funded by the Muscular Dystrophy Association USA (S. C., O.H.), the Health Research Board of Ireland (O.H.) and the Irish Motor Neuron Disease Research Foundation. In Sweden, this project was supported by the Swedish Brain Research Foundation, the Hallstens Research Foundation, the Swedish Medical Society, the Bjorklund Foundation for ALS Research and the Swedish Association for the Neurologically Disabled (P. M. A.). W. R. was supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders and by the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office. The Polish study was partially funded by the Polish Ministry of Science and Higher Education (nos. N N402 083934 and N402 092 32/3216). In France, this study was funded by the Association pour la Recherche sur la SLA and the Association Reseau SLA Ile de France. We thank the Motor Neurone Disease Association of Great Britain and Ireland, the Medical Research Council (UK), the Wellcome Trust and the Psychiatry Research Trust (Tim Perkins Fund and Charcot Fund). Support was also provided by the ALS Therapy Alliance, Project ALS, the Angel Fund, the Pierre L. de Bourgknecht ALS Research Foundation, the Al-Athel ALS Research Foundation, the ALS Family Charitable Foundation and the National Institute of Neurological Disorders and Stroke (NS050557). R. H. B. is a cofounder of AviTx, which targets development of therapies.	Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Chio A, 2009, HUM MOL GENET, V18, P1524, DOI 10.1093/hmg/ddp059; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Graham AJ, 1997, J NEUROL NEUROSUR PS, V62, P562, DOI 10.1136/jnnp.62.6.562; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raaphorst J, 2009, AMYOTROPH LATERAL SC, V29, P1, DOI DOI 10.1080/17482960802645008; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Valdmanis PN, 2007, ARCH NEUROL-CHICAGO, V64, P240, DOI 10.1001/archneur.64.2.240; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Varoqueaux F, 2005, MOL CELL BIOL, V25, P5973, DOI 10.1128/MCB.25.14.5973-5984.2005; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226	33	261	267	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1083	U53		10.1038/ng.442	http://dx.doi.org/10.1038/ng.442			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19734901				2022-12-25	WOS:000270330400010
J	Han, YG; Kim, HJ; Dlugosz, AA; Ellison, DW; Gilbertson, RJ; Alvarez-Buylla, A				Han, Young-Goo; Kim, Hong Joo; Dlugosz, Andrzej A.; Ellison, David W.; Gilbertson, Richard J.; Alvarez-Buylla, Arturo			Dual and opposing roles of primary cilia in medulloblastoma development	NATURE MEDICINE			English	Article							INTRAFLAGELLAR TRANSPORT; CEREBELLAR DEVELOPMENT; REPRESSOR FUNCTIONS; MOUSE MODEL; HEDGEHOG; PROLIFERATION; MORPHOGENESIS; DISRUPTION; EXPRESSION; EXPANSION	Recent work has shown that primary cilia are essential for Hedgehog (Hh) signaling during mammalian development(1-9). It is also known that aberrant Hh signaling can lead to cancer(10), but the role of primary cilia in oncogenesis is not known. Cerebellar granule neuron precursors (GNPs) can give rise to medulloblastomas, the most common malignant brain tumor in children(11). The primary cilium and Hh signaling are required for GNP proliferation(8,12-15). We asked whether primary cilia in GNPs have a role in medulloblastoma growth in mice. Genetic ablation of primary cilia blocked medulloblastoma formation when this tumor was driven by a constitutively active Smoothened protein (Smo), an upstream activator of Hh signaling. In contrast, removal of cilia was required for medulloblastoma growth by a constitutively active glioma-associated oncogene family zinc finger-2 (GLI2), a downstream transcription factor. Thus, primary cilia are either required for or inhibit medulloblastoma formation, depending on the initiating oncogenic event. Remarkably, the presence or absence of cilia was associated with specific variants of human medulloblastomas; primary cilia were found in medulloblastomas with activation in HH or WNT signaling but not in most medulloblastomas in other distinct molecular subgroups. Primary cilia could serve as a diagnostic tool and provide new insights into the mechanism of tumorigenesis.	[Han, Young-Goo; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Han, Young-Goo; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Kim, Hong Joo] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; [Dlugosz, Andrzej A.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Dlugosz, Andrzej A.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; St Jude Children's Research Hospital	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Ellison, David/N-4806-2018; Han, Young-Goo/N-2664-2018; Gilbertson, Richard James/ABE-1346-2021	Han, Young-Goo/0000-0002-4008-294X; Gilbertson, Richard James/0000-0001-7539-9472; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Kim, Hong Joo/0000-0002-9157-1612	Mark Linder/American Brain Tumor Association Fellowship; US National Institutes of Health [NS28478, HD32116, P30 DK063720]; Goldhirsh Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087837, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478, R01NS028478, R29NS028478] Funding Source: NIH RePORTER	Mark Linder/American Brain Tumor Association Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldhirsh Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. S. Goldstein at the University of California-San Diego for providing us with Kif3a<SUP>fl/fl</SUP> mice; D. Rowitch at UCSF for SmoM2<SUP>fl/+</SUP> mice; B. Yoder at the University of Alabama-Birmingham for Ift88<SUP>fl/fl</SUP> mice; C. Cowdrey and the Neurological Surgery Tissue Bank at UCSF for human medulloblastoma samples; R. Segal and C. Stiles at Harvard University for Zic-specific and Olig2- specific antibodies; and A. Ruiz i Altaba at University of Geneva Medical School for Gli1 cDNA. We thank S. Wong, J. Reiter, D. Cano and S. Cervantes-Roldan for sharing unpublished data. We thank S. Vandenberg for helping with assessing the tumor types; J. Morris, K. Blaschke and M. Sachs for helping with quantitative RT-PCR; R. Romero for technical assistance; and D. Rowitch, J. Reiter, S Wong, R. Ihrie, S. Nader and T. Nguyen for comments on the manuscript. Y.-G.H. was, in part, supported by Mark Linder/American Brain Tumor Association Fellowship. The work was supported by grants from the US National Institutes of Health (NS28478 and HD32116), John G Bowes Research Fund and a grant from the Goldhirsh Foundation to A.A.-B. Confocal microscopy at Diabetes & Endocrinology Research Center. Microscopy and Imaging Core was supported by an US National Institutes of Health grant P30 DK063720.	Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dahmane N, 1999, DEVELOPMENT, V126, P3089; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Lam CW, 1999, ONCOGENE, V18, P833, DOI 10.1038/sj.onc.1202360; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	40	278	287	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1062	U114		10.1038/nm.2020	http://dx.doi.org/10.1038/nm.2020			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19701203	Green Accepted, Green Submitted			2022-12-25	WOS:000269979200027
J	Lee, YS; Pressman, S; Andress, AP; Kim, K; White, JL; Cassidy, JJ; Li, X; Lubell, K; Lim, DH; Cho, IS; Nakahara, K; Preall, JB; Bellare, P; Sontheimer, EJ; Carthew, RW				Lee, Young Sik; Pressman, Sigal; Andress, Arlise P.; Kim, Kevin; White, Jamie L.; Cassidy, Justin J.; Li, Xin; Lubell, Kim; Lim, Do Hwan; Cho, Ik Sang; Nakahara, Kenji; Preall, Jonathan B.; Bellare, Priya; Sontheimer, Erik J.; Carthew, Richard W.			Silencing by small RNAs is linked to endosomal trafficking	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNAS; DROSOPHILA; BIOGENESIS; MICRORNAS; COMPLEXES; PROTEIN; MECHANISMS; ORGANELLES; DEFICIENT; UBIQUITIN	Small RNAs direct RNA-induced silencing complexes (RISCs) to regulate stability and translation of mRNAs(1,2). RISCs associated with target mRNAs often accumulate in discrete cytoplasmic foci known as GW-bodies(3). However, RISC proteins can associate with membrane compartments such as the Golgi and endoplasmic reticuium(4). Here, we show that GW-bodies are associated with late endosomes (multivesicular bodies, MVBs). Blocking the maturation of MVBs into lysosomes by loss of the tethering factor HPS4 (ref. 5) enhances short interfering RNA (siRNA)- and micro RNA (miRNA)-mediated silencing in Drosophila melanogaster and humans. It also triggers over-accumulation of GW-bodies. Blocking MVB formation by ESCRT (endosomal sorting complex required for transport)6 depletion results in impaired miRNA silencing and loss of GW-bodies. These results indicate that active RISCs are physically and functionally coupled to MVBs. We further show that MVBs promote the competence of RISCs in loading small RNAs. We suggest that the recycling of RISCs is promoted by MVBs, resulting in RISCs more effectively engaging with small RNA effectors and possibly target RNAs. It may provide a means to enhance the dynamics of RNA silencing in the cytoplasm.	[Lee, Young Sik; Pressman, Sigal; Andress, Arlise P.; Kim, Kevin; White, Jamie L.; Cassidy, Justin J.; Li, Xin; Lubell, Kim; Nakahara, Kenji; Preall, Jonathan B.; Bellare, Priya; Sontheimer, Erik J.; Carthew, Richard W.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60201 USA; [Lee, Young Sik; Lim, Do Hwan; Cho, Ik Sang] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136713, South Korea; [Li, Xin] NYU, Dept Biol, New York, NY 10003 USA; [Bellare, Priya] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Northwestern University; Korea University; New York University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Lee, YS (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60201 USA.	ys-lee@korea.ac.kr; r-carthew@northwestern.edu	Lim, Dohwan/ABA-2685-2020; Li, Xin/D-3421-2013; Nakahara, Kenji/F-5780-2012	Li, Xin/0000-0002-3428-3569; Nakahara, Kenji/0000-0002-9541-3208; Lim, Do-Hwan/0000-0002-2054-1416; Sontheimer, Erik/0000-0002-0881-0310	FRAXA; CMBD; National Institutes of Health [GM072830, GM77581, GM68743]; Korean BioGreen 21 Program [2007030103403]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068743, R01GM072830, R01GM077581] Funding Source: NIH RePORTER	FRAXA; CMBD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Cagan, H. Folsch, P. Sharp, G. J. Hannon, Q. Liu, X. Wang, C. Horvath, G. Goshima, V. Helfand, M. Lowe, I. Hariharan, D. Bilder, J. Treisman, M. Siomi and J. Pham for reagents; H. Folsch, I. Fields, A. Komuro, and D. Harris for help with some of the experiments; H. Jiang for help with statistics and the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for fly strains and antibodies. Y.S.L. was supported by a FRAXA postdoctoral Fellowship; J.J.C. was supported by the CMBD Training Grant and J.B.P. was supported by a Presidential Fellowship. This work was also supported by grants from the National Institutes of Health to E.J.S. (GM072830) and R.W.C. (GM77581, GM68743), and from a grant from the Korean BioGreen 21 Program to Y.S.L. (20070301034036).	Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fielenbach N, 2007, DEV CELL, V12, P443, DOI 10.1016/j.devcel.2007.01.018; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207; Kinch LN, 2006, PROTEIN SCI, V15, P2669, DOI 10.1110/ps.062419006; Kujala P, 2001, J VIROL, V75, P3873, DOI 10.1128/JVI.75.8.3873-3884.2001; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Lin MD, 2008, DEV BIOL, V322, P276, DOI 10.1016/j.ydbio.2008.07.033; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Nguyen T, 2007, J INVEST DERMATOL, V127, P421, DOI 10.1038/sj.jid.5700566; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	33	262	277	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1150	U243		10.1038/ncb1930	http://dx.doi.org/10.1038/ncb1930			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684574	Green Accepted			2022-12-25	WOS:000269482500018
J	Song, HL; Ramus, SJ; Tyrer, J; Bolton, KL; Gentry-Maharaj, A; Wozniak, E; Anton-Culver, H; Chang-Claude, J; Cramer, DW; DiCioccio, R; Dork, T; Goode, EL; Goodman, MT; Schildkraut, JM; Sellers, T; Baglietto, L; Beckmann, MW; Beesley, J; Blaakaer, J; Carney, ME; Chanock, S; Chen, ZH; Cunningham, JM; Dicks, E; Doherty, JA; Durst, M; Ekici, AB; Fenstermacher, D; Fridley, BL; Giles, G; Gore, ME; De Vivo, I; Hillemanns, P; Hogdall, C; Hogdall, E; Iversen, ES; Jacobs, IJ; Jakubowska, A; Li, D; Lissowska, J; Lubinski, J; Lurie, G; McGuire, V; McLaughlin, J; Medrek, K; Moorman, PG; Moysich, K; Narod, S; Phelan, C; Pye, C; Risch, H; Runnebaum, IB; Severi, G; Southey, M; Stram, DO; Thiel, FC; Terry, KL; Tsai, YY; Tworoger, SS; Van Den Berg, DJ; Vierkant, RA; Wang-Gohrke, S; Webb, PM; Wilkens, LR; Wu, AH; Yang, HN; Brewster, W; Ziogas, A; Houlston, R; Tomlinson, I; Whittemore, AS; Rossing, MA; Ponder, BAJ; Pearce, CL; Ness, RB; Menon, U; Kjaer, SK; Gronwald, J; Garcia-Closas, M; Fasching, PA; Easton, DF; Chenevix-Trench, G; Berchuck, A; Pharoah, PDP; Gayther, SA				Song, Honglin; Ramus, Susan J.; Tyrer, Jonathan; Bolton, Kelly L.; Gentry-Maharaj, Aleksandra; Wozniak, Eva; Anton-Culver, Hoda; Chang-Claude, Jenny; Cramer, Daniel W.; DiCioccio, Richard; Doerk, Thilo; Goode, Ellen L.; Goodman, Marc T.; Schildkraut, Joellen M.; Sellers, Thomas; Baglietto, Laura; Beckmann, Matthias W.; Beesley, Jonathan; Blaakaer, Jan; Carney, Michael E.; Chanock, Stephen; Chen, Zhihua; Cunningham, Julie M.; Dicks, Ed; Doherty, Jennifer A.; Duerst, Matthias; Ekici, Arif B.; Fenstermacher, David; Fridley, Brooke L.; Giles, Graham; Gore, Martin E.; De Vivo, Immaculata; Hillemanns, Peter; Hogdall, Claus; Hogdall, Estrid; Iversen, Edwin S.; Jacobs, Ian J.; Jakubowska, Anna; Li, Dong; Lissowska, Jolanta; Lubinski, Jan; Lurie, Galina; McGuire, Valerie; McLaughlin, John; Medrek, Krzysztof; Moorman, Patricia G.; Moysich, Kirsten; Narod, Steven; Phelan, Catherine; Pye, Carole; Risch, Harvey; Runnebaum, Ingo B.; Severi, Gianluca; Southey, Melissa; Stram, Daniel O.; Thiel, Falk C.; Terry, Kathryn L.; Tsai, Ya-Yu; Tworoger, Shelley S.; Van Den Berg, David J.; Vierkant, Robert A.; Wang-Gohrke, Shan; Webb, Penelope M.; Wilkens, Lynne R.; Wu, Anna H.; Yang, Hannah; Brewster, Wendy; Ziogas, Argyrios; Houlston, Richard; Tomlinson, Ian; Whittemore, Alice S.; Rossing, Mary Anne; Ponder, Bruce A. J.; Pearce, Celeste Leigh; Ness, Roberta B.; Menon, Usha; Kjaer, Susanne Krueger; Gronwald, Jacek; Garcia-Closas, Montserrat; Fasching, Peter A.; Easton, Douglas F.; Chenevix-Trench, Georgia; Berchuck, Andrew; Pharoah, Paul D. P.; Gayther, Simon A.		Australian Canc Ovarian Study; Australian Ovarian Canc Study Grp; Ovarian Canc Assoc Consortium	A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2	NATURE GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; BASAL-CELL CARCINOMA; PROSTATE-CANCER; BREAST-CANCER; COLORECTAL-CANCER; INVASIVE OVARIAN; PARP INHIBITORS; CANDIDATE SNPS; MULTIPLE LOCI; RISK	Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explain less than half the excess familial risk(1). We performed a genome-wide association study (GWAS) to identify common ovarian cancer susceptibility alleles. We evaluated 507,094 SNPs genotyped in 1,817 cases and 2,353 controls from the UK and similar to 2 million imputed SNPs. We genotyped the 22,790 top ranked SNPs in 4,274 cases and 4,809 controls of European ancestry from Europe, USA and Australia. We identified 12 SNPs at 9p22 associated with disease risk (P < 10(-8)). The most significant SNP (rs3814113; P = 2.5 x 10(-17)) was genotyped in a further 2,670 ovarian cancer cases and 4,668 controls, confirming its association (combined data odds ratio (OR) - 0.82, 95% confidence interval (CI) 0.79-0.86, P-trend = 5.1 x 10(-19)). The association differs by histological subtype, being strongest for serous ovarian cancers (OR 0.77, 95% CI 0.73-0.81, Ptrend 4.1 x 10(-21)).	[Song, Honglin; Tyrer, Jonathan; Bolton, Kelly L.; Dicks, Ed; Pye, Carole; Ponder, Bruce A. J.; Pharoah, Paul D. P.] Univ Cambridge, Canc Res UK Dept Oncol, Strangeways Res Lab, Cambridge, England; [Ramus, Susan J.; Gentry-Maharaj, Aleksandra; Wozniak, Eva; Jacobs, Ian J.; Menon, Usha; Gayther, Simon A.] UCL, Dept Gynaecol Oncol, Inst Womens Hlth, London, England; [Bolton, Kelly L.; Chanock, Stephen; Yang, Hannah] NIH, Div Canc Epidemiol & Genet, Rockville, MD USA; [Anton-Culver, Hoda; Li, Dong; Ziogas, Argyrios] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Cramer, Daniel W.; Terry, Kathryn L.] Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [DiCioccio, Richard] Dept Canc Genet, Buffalo, NY USA; [DiCioccio, Richard] Gilda Radner Familial Ovarian Canc Registry, Buffalo, NY USA; [Doerk, Thilo; Hillemanns, Peter] Hannover Med Sch, Clin Obstet & Gynaecol, D-3000 Hannover, Germany; [Goode, Ellen L.; Cunningham, Julie M.; Fridley, Brooke L.; Vierkant, Robert A.] Mayo Clin, Coll Med, Rochester, MN USA; [Goodman, Marc T.; Carney, Michael E.; Lurie, Galina; Wilkens, Lynne R.] Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96813 USA; [Schildkraut, Joellen M.; Moorman, Patricia G.; Berchuck, Andrew] Duke Univ, Med Ctr, Ctr Comprehens Canc, Durham, NC 27710 USA; [Sellers, Thomas; Chen, Zhihua; Fenstermacher, David; Phelan, Catherine; Tsai, Ya-Yu] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Baglietto, Laura; Hillemanns, Peter] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Baglietto, Laura; Giles, Graham; Severi, Gianluca] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; [Beckmann, Matthias W.; Thiel, Falk C.; Fasching, Peter A.] Univ Hosp Erlangen, Dept Gynecol & Obstet, Erlangen, Germany; [Beesley, Jonathan; Webb, Penelope M.; Chenevix-Trench, Georgia] PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld, Australia; [Blaakaer, Jan; Garcia-Closas, Montserrat] Skejby Univ Hosp, Dept Obstet & Gynaecol, Aarhus, Denmark; [Doherty, Jennifer A.; Rossing, Mary Anne] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA; [Duerst, Matthias; Runnebaum, Ingo B.] Univ Hosp Jena, Dept Obstet & Gynaecol, Jena, Germany; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Gore, Martin E.] Royal Marsden Hosp, Gynecol Oncol Unit, London SW3 6JJ, England; [De Vivo, Immaculata; Tworoger, Shelley S.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [De Vivo, Immaculata; Tworoger, Shelley S.] Harvard Univ, Sch Med, Boston, MA USA; [Hogdall, Claus] Rigshosp, Gynaecol Clin, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; [Hogdall, Estrid; Kjaer, Susanne Krueger] Danish Canc Soc, Dept Viruses Hormones & Canc, Inst Canc Epidemiol, Copenhagen, Denmark; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Jakubowska, Anna; Lubinski, Jan; Medrek, Krzysztof; Gronwald, Jacek] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Lissowska, Jolanta] M Sklodowska Curie Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [McGuire, Valerie] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [McLaughlin, John] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Moysich, Kirsten] Roswell Pk Canc Ctr, Buffalo, NY USA; [Narod, Steven] Ctr Res Womens Hlth, Toronto, ON, Canada; [Risch, Harvey] Yale Univ, New Haven, CT USA; [Southey, Melissa] Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, Melbourne, Vic, Australia; [Stram, Daniel O.; Van Den Berg, David J.; Wu, Anna H.; Pearce, Celeste Leigh] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynaecol, Ulm, Germany; [Brewster, Wendy] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Australian Canc Ovarian Study; Australian Ovarian Canc Study Grp] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Populat & Funct Genet Lab, Oxford, England; [Houlston, Richard; Ovarian Canc Assoc Consortium] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Easton, Douglas F.] Univ Cambridge, CR UK Genet Epidemiol Unit, Strangeways Res Lab, Cambridge, England	Cancer Research UK; University of Cambridge; University of London; University College London; National Institutes of Health (NIH) - USA; University of California System; University of California Irvine; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Brigham & Women's Hospital; Hannover Medical School; Mayo Clinic; Cancer Research Center of Hawaii; University of Hawaii System; Duke University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Cancer Council Victoria; University of Melbourne; University of Erlangen Nuremberg; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Aarhus University; Fred Hutchinson Cancer Center; Friedrich Schiller University of Jena; University of Erlangen Nuremberg; Royal Marsden NHS Foundation Trust; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rigshospitalet; University of Copenhagen; Danish Cancer Society; Duke University; Pomeranian Medical University; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Stanford University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Roswell Park Cancer Institute; Yale University; University of Melbourne; University of Southern California; Ulm University; University of North Carolina; University of North Carolina Chapel Hill; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; University of Oxford; Wellcome Centre for Human Genetics; University of London; Institute of Cancer Research - UK; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Cambridge	Pharoah, PDP (corresponding author), Univ Cambridge, Canc Res UK Dept Oncol, Strangeways Res Lab, Cambridge, England.	paul1@srl.cam.ac.uk	Jakubowska, Anna/O-8050-2014; Garcia-Closas, Montserrat/F-3871-2015; Narod, Steven A/AAA-6112-2022; Baglietto, Laura/AAB-9051-2019; McLaughlin, John R/E-4577-2013; Dörk, Thilo/J-8620-2012; Menon, Usha/C-4716-2008; Van Den Berg, David J/G-8598-2017; Webb, Penelope/D-5736-2013; Gronwald, Jacek/A-4576-2017; Garcia-Closas, Montserrat/AAZ-6930-2021; Jacobs, Ian J/F-1743-2013; Severi, Gianluca/H-3774-2018; Lissowska, Jolanta/AAH-3252-2020; Bowtell, David/H-1007-2016; Vierkant, Robert/AAP-4927-2020; Chenevix-Trench, Georgia/AAV-2014-2020; Fasching, Peter A/ABH-9912-2020; Pharoah, Paul/V-6658-2019; Fridley, Brooke L/D-8315-2015; Severi, Gianluca/Q-1824-2019; Ekici, Arif B/C-3971-2013; Ramus, Susan/AAG-8352-2019	Jakubowska, Anna/0000-0002-5650-0501; Garcia-Closas, Montserrat/0000-0003-1033-2650; Dörk, Thilo/0000-0002-9458-0282; Menon, Usha/0000-0003-3708-1732; Van Den Berg, David J/0000-0002-5404-5218; Webb, Penelope/0000-0003-0733-5930; Gronwald, Jacek/0000-0002-3643-2871; Garcia-Closas, Montserrat/0000-0003-1033-2650; Jacobs, Ian J/0000-0002-8112-4624; Severi, Gianluca/0000-0001-7157-419X; Lissowska, Jolanta/0000-0003-2695-5799; Bowtell, David/0000-0001-9089-7525; Vierkant, Robert/0000-0001-6242-5221; Chenevix-Trench, Georgia/0000-0002-1878-2587; Fasching, Peter A/0000-0003-4885-8471; Pharoah, Paul/0000-0001-8494-732X; Fridley, Brooke L/0000-0001-7739-7956; Severi, Gianluca/0000-0001-7157-419X; Ekici, Arif B/0000-0001-6099-7066; Ramus, Susan/0000-0003-0005-7798; Baglietto, Laura/0000-0002-8193-7529; Beesley, Jonathan/0000-0003-1942-325X; Southey, Melissa/0000-0002-6313-9005; Hogdall, Claus/0000-0002-5959-8874; Bolton, Kelly/0000-0001-6584-3357; Hogdall, Estrid/0000-0003-4689-5658; Lubinski, Jan/0000-0003-2931-3003; Jacobs, Ian/0000-0002-5005-2672; Tworoger, Shelley/0000-0002-6986-7046; Kjaer, Susanne/0000-0002-8347-1398; Houlston, Richard/0000-0002-5268-0242; Goodman, Marc/0000-0002-4839-3021; Giles, Graham/0000-0003-4946-9099	DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055424] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA114343, R01CA058860, P50CA105009, R01CA112523, R01CA058598, K07CA092044, R01CA087538, P30CA016056, R01CA122443, R01CA061107, ZIACP010126, U01CA058860, R01CA054419, P50CA136393] Funding Source: NIH RePORTER; Cancer Research UK [10124, 11021, 10119, 10118, A10124, A10119, A8339, 11022, A6187] Funding Source: Medline; Medical Research Council [G0801875, G0000934] Funding Source: Medline; NCI NIH HHS [R01CA114343, R01 CA058860, N01 PC035137, R01 CA87538, R01 CA058598, R01 CA054419, R01 CA122443, R01-CA-122443, P30 CA016056, K07 CA092044, K07 CA092044-04, R01 CA61107, P50 CA105009, CA-92044, R01 CA114343-03, R01 CA054419-15, CA-58860, R01 CA058598-10, U01 CA058860, R01 CA122443-02, N01-CN-55424, R01 CA087538-05, R01 CA112523-04, N01PC35137, R01 CA114343, P50 CA136393, R01 CA112523, P30 CA016056-33, R01-CA- 58598, CA71766, P50 CA105009-05, N01-PC-35137, CA16056, R01 CA087538, R01 CA058860-14] Funding Source: Medline; Department of Health Funding Source: Medline; The Francis Crick Institute [10124, 10119] Funding Source: researchfish; MRC [G0000934, G0801875] Funding Source: UKRI	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health; The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antoniou Antonis C, 2006, Future Oncol, V2, P257, DOI 10.2217/14796694.2.2.257; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Domanska K, 2007, INT J GYNECOL CANCER, V17, P789, DOI 10.1111/j.1525-1438.2007.00875.x; Drew Y, 2008, ANN NY ACAD SCI, V1138, P136, DOI 10.1196/annals.1414.020; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Gayther SA, 2007, CANCER RES, V67, P3027, DOI 10.1158/0008-5472.CAN-06-3261; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; O'Driscoll L, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-74; Pearce CL, 2009, BRIT J CANCER, V100, P412, DOI 10.1038/sj.bjc.6604820; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Pharoah PDP, 2002, BEST PRACT RES CL OB, V16, P449, DOI 10.1053/beog.2002.0296; Quaye L, 2008, CLIN CANCER RES, V14, P5833, DOI 10.1158/1078-0432.CCR-08-0819; Ramus SJ, 2008, INT J CANCER, V123, P380, DOI 10.1002/ijc.23448; Romano RA, 2004, GENOMICS, V83, P821, DOI 10.1016/j.ygeno.2003.11.009; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schildkraut JM, 2009, CANCER RES, V69, P2349, DOI 10.1158/0008-5472.CAN-08-2902; Song HL, 2008, CANCER RES, V68, P8837, DOI 10.1158/0008-5472.CAN-08-2363; Song HL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000268; Song HL, 2009, HUM MOL GENET, V18, P2297, DOI 10.1093/hmg/ddp138; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Vanhoutteghem A, 2004, P NATL ACAD SCI USA, V101, P3468, DOI 10.1073/pnas.0400268101; Vanhoutteghem A, 2007, GENOMICS, V89, P44, DOI 10.1016/j.ygeno.2006.07.006; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	40	232	236	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					996	U60		10.1038/ng.424	http://dx.doi.org/10.1038/ng.424			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19648919	Green Accepted, Green Submitted			2022-12-25	WOS:000269382100011
J	Feuerer, M; Herrero, L; Cipolletta, D; Naaz, A; Wong, J; Nayer, A; Lee, J; Goldfine, AB; Benoist, C; Shoelson, S; Mathis, D				Feuerer, Markus; Herrero, Laura; Cipolletta, Daniela; Naaz, Afia; Wong, Jamie; Nayer, Ali; Lee, Jongsoon; Goldfine, Allison B.; Benoist, Christophe; Shoelson, Steven; Mathis, Diane			Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; DENDRITIC CELLS; MACROPHAGES; ACTIVATION; EXPRESSION; ABLATION; BETA; MICE; GENE	Obesity is accompanied by chronic, low-grade inflammation of adipose tissue, which promotes insulin resistance and type-2 diabetes. These findings raise the question of how fat inflammation can escape the powerful armamentarium of cells and molecules normally responsible for guarding against a runaway immune response. CD4(+) Foxp3(+) T regulatory (T-reg) cells with a unique phenotype were highly enriched in the abdominal fat of normal mice, but their numbers were strikingly and specifically reduced at this site in insulin-resistant models of obesity. Loss-of-function and gain-of-function experiments revealed that these T-reg cells influenced the inflammatory state of adipose tissue and, thus, insulin resistance. Cytokines differentially synthesized by fat-resident regulatory and conventional T cells directly affected the synthesis of inflammatory mediators and glucose uptake by cultured adipocytes. These observations suggest that harnessing the anti-inflammatory properties of T-reg cells to inhibit elements of the metabolic syndrome may have therapeutic potential. (C) 2009 Nature America, Inc. All rights reserved.	[Cipolletta, Daniela] European Sch Mol Med, Naples, Italy; [Feuerer, Markus; Herrero, Laura; Cipolletta, Daniela; Naaz, Afia; Wong, Jamie; Nayer, Ali; Lee, Jongsoon; Goldfine, Allison B.; Benoist, Christophe; Shoelson, Steven; Mathis, Diane] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Joslin Diabetes Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	Mathis, D (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	dm@hms.harvard.edu	Herrero, Laura/D-4011-2014; Eckhardt, Erik/G-1567-2010; Lee, Jongsoon/AAG-1674-2020	Herrero, Laura/0000-0003-4244-4673; Lee, Jongsoon/0000-0002-0891-5059	Young Chair funds; US National Institutes of Health [DK51729, DK73547, T32 DK7260]; Adler Chair funds; Joslin's National Institutes of Diabetes and Digestive and Kidney Diseases-funded Diabetes and Endocrinology Research Center core facilities; German Research Foundation [FE 801/1-1]; Charles A. King Trust Postdoctoral Fellowship; Ministry of Science of Spain; European School of Molecular Medicine, respectively; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051729, T32DK007260, R37DK051729, R01DK073547] Funding Source: NIH RePORTER	Young Chair funds; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adler Chair funds; Joslin's National Institutes of Diabetes and Digestive and Kidney Diseases-funded Diabetes and Endocrinology Research Center core facilities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); German Research Foundation(German Research Foundation (DFG)); Charles A. King Trust Postdoctoral Fellowship; Ministry of Science of Spain(Spanish Government); European School of Molecular Medicine, respectively; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Littman (New York University) for the DTR construct, L. Roser and K. Hattori for assistance with mice, S. Rudensky (Memorial Sloan Kettering Cancer Center) for providing us with Foxp3<SUP>DTR</SUP> mice, J. LaVecchio and G. Buruzala for flow cytometry and J. Hill, J. Perez and R. Melamed for help with the microarray analysis. This work was supported by Young Chair funds to D. M. and C. B., by the US National Institutes of Health (DK51729 and DK73547) and Adler Chair funds to S. S. and by Joslin's National Institutes of Diabetes and Digestive and Kidney Diseases-funded Diabetes and Endocrinology Research Center core facilities. Postdoctoral fellowship support for M. F. was from the German Research Foundation (Emmy-Noether Fellowship, FE 801/1-1) and the Charles A. King Trust Postdoctoral Fellowship, and for L. H. from the Ministry of Science of Spain. J. W. and D. C. were supported by predoctoral fellowships from the US National Institutes of Health (T32 DK7260) and the European School of Molecular Medicine, respectively.	Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Bluher M, 2005, EXP CLIN ENDOCR DIAB, V113, P534, DOI 10.1055/s-2005-872851; Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Miyake Y, 2007, J IMMUNOL, V178, P5001, DOI 10.4049/jimmunol.178.8.5001; Murphy TJ, 2005, J IMMUNOL, V174, P2957, DOI 10.4049/jimmunol.174.5.2957; Nguyen LT, 2007, ARTHRITIS RHEUM-US, V56, P509, DOI 10.1002/art.22272; Nolan KF, 2004, J IMMUNOL, V172, P2201, DOI 10.4049/jimmunol.172.4.2201; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Scarpelli D, 2006, DIABETES, V55, P1529, DOI 10.2337/db06-0047; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thorburn J, 2003, CLIN CANCER RES, V9, P861; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	58	1445	1500	1	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					930	U137		10.1038/nm.2002	http://dx.doi.org/10.1038/nm.2002			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19633656	Green Accepted			2022-12-25	WOS:000268770400038
J	Kazlauskas, RJ; Bornscheuer, UT				Kazlauskas, Romas J.; Bornscheuer, Uwe T.			Finding better protein engineering strategies	NATURE CHEMICAL BIOLOGY			English	Article							DIRECTED EVOLUTION; SATURATION MUTAGENESIS; ENZYME EVOLUTION; DRIFT	Protein improvement strategies today involve widely varying combinations of rational design with random mutagenesis and screening. To make further progress-defined as making subsequent protein engineering problems easier to solve-protein engineers must critically compare these strategies and eliminate less effective ones.	[Kazlauskas, Romas J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Kazlauskas, Romas J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [Bornscheuer, Uwe T.] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Dept Biotechnol & Enzyme Catalysis, Greifswald, Germany	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Ernst Moritz Arndt Universitat Greifswald	Kazlauskas, RJ (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.	rjk@umn.edu; uwe.bornscheuer@uni-greifswald.de	Bornscheuer, Uwe T/C-4612-2012	Bornscheuer, Uwe T/0000-0003-0685-2696; Kazlauskas, Romas/0000-0002-3570-2411				Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-17; Carr R, 2005, CHEMBIOCHEM, V6, P637, DOI 10.1002/cbic.200400329; Chen-Goodspeed M, 2001, BIOCHEMISTRY-US, V40, P1332, DOI 10.1021/bi001549d; DeSantis G, 2003, J AM CHEM SOC, V125, P11476, DOI 10.1021/ja035742h; ESCHENMOSER A, 1977, SCIENCE, V196, P1410, DOI 10.1126/science.867037; ESTELL DA, 1985, J BIOL CHEM, V260, P6518; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Gray KA, 2006, CURR OPIN CHEM BIOL, V10, P141, DOI 10.1016/j.cbpa.2006.02.035; Gupta RD, 2008, NAT METHODS, V5, P939, DOI 10.1038/nmeth.1262; LUTZ S, 2009, PROTEIN ENG HDB; McCarthy Alice, 2003, Chem Biol, V10, P893; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Neylon C, 2004, NUCLEIC ACIDS RES, V32, P1448, DOI 10.1093/nar/gkh315; Qian Z, 2005, J AM CHEM SOC, V127, P13466, DOI 10.1021/ja053932h; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746; REETZ MT, 2008, J CHEMBIOCHEM, V9, P2260; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Whittle E, 2001, J BIOL CHEM, V276, P21500, DOI 10.1074/jbc.M102129200; WOODWARD R B, 1973, Pure and Applied Chemistry, V33, P145, DOI 10.1351/pac197333010145	23	159	161	3	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					526	529		10.1038/nchembio0809-526	http://dx.doi.org/10.1038/nchembio0809-526			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19620988				2022-12-25	WOS:000268209200004
J	Thomas, C				Thomas, Clare			Roadblocks in HIV research: five questions	NATURE MEDICINE			English	Article							VACCINE	What are the most important questions that the HIV field needs to answer to make progress? Nature Medicine asked this question to a group of HIV researchers to identify some of the key roadblocks in HIV research.										Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; *COORD COMM GLOB H, 2004, PLOS MED, V2, pE25; Enquist LW, 2009, J VIROL, V83, P5296, DOI 10.1128/JVI.00151-09; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Willyard C, 2009, NAT MED, V15, P126, DOI 10.1038/nm0209-126	10	30	30	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					855	859		10.1038/nm0809-855	http://dx.doi.org/10.1038/nm0809-855			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19661992				2022-12-25	WOS:000268770400025
J	Fisch, KM; Gurgui, C; Heycke, N; van der Sar, SA; Anderson, SA; Webb, VL; Taudien, S; Platzer, M; Rubio, BK; Robinson, SJ; Crews, P; Piel, J				Fisch, Katja M.; Gurgui, Cristian; Heycke, Nina; van der Sar, Sonia A.; Anderson, Sally A.; Webb, Victoria L.; Taudien, Stefan; Platzer, Matthias; Rubio, Brent K.; Robinson, Sarah J.; Crews, Phillip; Piel, Joern			Polyketide assembly lines of uncultivated sponge symbionts from structure-based gene targeting	NATURE CHEMICAL BIOLOGY			English	Article							ZEALAND MARINE SPONGE; BACTERIAL SYMBIONT; NATURAL-PRODUCTS; SYNTHASE GENES; BIOSYNTHESIS; IDENTIFICATION; METABOLITES; CLUSTER; PATHWAY; ACYLTRANSFERASE	There is increasing evidence that uncultivated bacterial symbionts are the true producers of numerous bioactive compounds isolated from marine sponges. The localization and heterologous expression of biosynthetic genes could clarify this issue and provide sustainable supplies for a wide range of pharmaceuticals. However, identification of genes in the usually highly complex symbiont communities remains a challenging task. For polyketides, one of the most important groups of sponge-derived drug candidates, we have developed a general strategy that allows one to rapidly access biosynthetic gene clusters based on chemical moieties. Using this method, we targeted polyketide synthase genes from two different sponge metagenomes. We have obtained from a sponge-bacterial association a complete pathway for the rare and potent antitumor agent psymberin from Psammocinia aff. bulbosa. The data support the symbiont hypothesis and provide insights into natural product evolution in previously inaccessible bacteria.	[Fisch, Katja M.; Gurgui, Cristian; Heycke, Nina; van der Sar, Sonia A.; Piel, Joern] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-5300 Bonn, Germany; [Anderson, Sally A.; Webb, Victoria L.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Taudien, Stefan; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Rubio, Brent K.; Robinson, Sarah J.; Crews, Phillip] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of Bonn; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of California System; University of California Santa Cruz	Piel, J (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, D-5300 Bonn, Germany.	joern.piel@uni-bonn.de	Fisch, Katja/B-8467-2018		US National Science Foundation; German Research Foundation [PI 430/6-1, NSF-CHE-0617056]; Alexander von Humboldt Research Fellowship [SFB 624, SPP 1152]	US National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Alexander von Humboldt Research Fellowship(Alexander von Humboldt Foundation)	We thank M. Page for assistance with collecting M. hentscheli of known chemotypes and S. Brady for advice on metagenomic library construction. This work was supported by a collaborative grant from the US National Science Foundation and the German Research Foundation to J. P. (PI 430/6-1) and P. C. (NSF-CHE-0617056), by grants from the German Research Foundation to J. P. (SFB 624 and SPP 1152) and by an Alexander von Humboldt Research Fellowship to S. A. v. d. S.	Bewley CA, 1998, ANGEW CHEM INT EDIT, V37, P2163, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2162::AID-ANIE2162>3.0.CO;2-2; Blunt JW, 2008, NAT PROD REP, V25, P35, DOI 10.1039/b701534h; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Cichewicz RH, 2004, ORG LETT, V6, P1951, DOI 10.1021/ol049503q; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Esquenazi E, 2008, MOL BIOSYST, V4, P562, DOI 10.1039/b720018h; Fieseler L, 2007, APPL ENVIRON MICROB, V73, P2144, DOI 10.1128/AEM.02260-06; Flatt P, 2005, MAR BIOL, V147, P761, DOI 10.1007/s00227-005-1614-9; Gu LC, 2007, SCIENCE, V318, P970, DOI 10.1126/science.1148790; Gu LC, 2006, J AM CHEM SOC, V128, P9014, DOI 10.1021/ja0626382; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hrvatin S, 2007, J MICROBIOL METH, V68, P434, DOI 10.1016/j.mimet.2006.09.009; Jiang X, 2007, ORG LETT, V9, P227, DOI 10.1021/ol062656o; Johnson TA, 2007, J MED CHEM, V50, P3795, DOI 10.1021/jm070410z; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kim TK, 2006, ENVIRON MICROBIOL, V8, P1460, DOI 10.1111/j.1462-2920.2006.01040.x; Konig GM, 2006, CHEMBIOCHEM, V7, P229, DOI 10.1002/cbic.200500087; Menche D, 2008, J AM CHEM SOC, V130, P14234, DOI 10.1021/ja804194c; Newman DJ, 2004, J NAT PROD, V67, P1216, DOI 10.1021/np040031y; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; NORTHCOTE PT, 1991, TETRAHEDRON LETT, V32, P6411, DOI 10.1016/0040-4039(91)80182-6; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Paul GK, 2002, J NAT PROD, V65, P59, DOI 10.1021/np0103766; PERRY NB, 1988, J AM CHEM SOC, V110, P4850, DOI 10.1021/ja00222a067; Pettit GR, 2004, J MED CHEM, V47, P1149, DOI 10.1021/jm030207d; Piel J, 2004, ENVIRON MICROBIOL, V6, P921, DOI 10.1111/j.1462-2920.2004.00531.x; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2004, CHEMBIOCHEM, V5, P93, DOI 10.1002/cbic.200300782; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Piel J, 2004, J BACTERIOL, V186, P1280, DOI 10.1128/JB.186.5.1280-1286.2004; Robinson SJ, 2007, J NAT PROD, V70, P1002, DOI 10.1021/np070171i; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Schmidt EW, 2005, TRENDS BIOTECHNOL, V23, P437, DOI 10.1016/j.tibtech.2005.07.002; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Simmons TL, 2008, P NATL ACAD SCI USA, V105, P4587, DOI 10.1073/pnas.0709851105; Sipkema D, 2005, MAR BIOTECHNOL, V7, P142, DOI 10.1007/s10126-004-0405-5; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor MW, 2007, ISME J, V1, P187, DOI 10.1038/ismej.2007.32; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Wenzel SC, 2007, NAT PROD REP, V24, P1211, DOI 10.1039/b706416k; West LM, 2000, J ORG CHEM, V65, P445, DOI 10.1021/jo991296y	48	140	143	1	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					494	501		10.1038/nchembio.176	http://dx.doi.org/10.1038/nchembio.176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19448639				2022-12-25	WOS:000267266100015
J	Henneke, M; Diekmann, S; Ohlenbusch, A; Kaiser, J; Engelbrecht, V; Kohlschutter, A; Kratzner, R; Madruga-Garrido, M; Mayer, M; Opitz, L; Rodriguez, D; Ruschendorf, F; Schumacher, J; Thiele, H; Thoms, S; Steinfeld, R; Nurnberg, P; Gartner, J				Henneke, Marco; Diekmann, Simone; Ohlenbusch, Andreas; Kaiser, Jens; Engelbrecht, Volkher; Kohlschuetter, Alfried; Kraetzner, Ralph; Madruga-Garrido, Marcos; Mayer, Michele; Opitz, Lennart; Rodriguez, Diana; Rueschendorf, Franz; Schumacher, Johannes; Thiele, Holger; Thoms, Sven; Steinfeld, Robert; Nuernberg, Peter; Gaertner, Jutta			RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection	NATURE GENETICS			English	Article							EPITHELIAL OVARIAN-CANCER; TUMOR-SUPPRESSOR GENE; HUMAN MEMBER; RNASET2; 6Q27; REGION; FAMILY; RIBONUCLEASES; CLONING	Congenital cytomegalovirus brain infection without symptoms at birth can cause a static encephalopathy with characteristic patterns of brain abnormalities. Here we show that loss-of-function mutations in the gene encoding the RNASET2 glycoprotein lead to cystic leukoencephalopathy, an autosomal recessive disorder with an indistinguishable clinical and neuroradiological phenotype. Congenital cytomegalovirus infection and RNASET2 deficiency may both interfere with brain development and myelination through angiogenesis or RNA metabolism.	[Henneke, Marco; Diekmann, Simone; Ohlenbusch, Andreas; Kaiser, Jens; Kraetzner, Ralph; Thoms, Sven; Steinfeld, Robert; Gaertner, Jutta] Univ Gottingen, Dept Pediat & Pediat Neurol, Gottingen, Germany; [Engelbrecht, Volkher] Hosp St Marien, Inst Diagnost & Intervent Radiol, Amberg, Germany; [Kohlschuetter, Alfried] Univ Med Ctr, Dept Pediat, Hamburg, Germany; [Madruga-Garrido, Marcos] Univ Hosp Virgen del Rocio, Dept Neuropediat, Seville, Spain; [Mayer, Michele; Rodriguez, Diana] Armand Trousseau Hosp, Dept Neuropediat, AP HP, Paris, France; [Opitz, Lennart] Univ Gottingen, DNA Microarray Facil, Gottingen, Germany; [Rodriguez, Diana] INSERM, UMR S546, Paris, France; [Rodriguez, Diana] Univ Paris 06, Paris, France; [Rueschendorf, Franz] Max Delbruck Ctr Mol Med, Berlin, Germany; [Schumacher, Johannes] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Schumacher, Johannes] NIH, Bethesda, MD 20892 USA; [Thiele, Holger; Nuernberg, Peter] Univ Cologne, CCG, D-5000 Cologne 41, Germany; [Thiele, Holger; Nuernberg, Peter] Univ Cologne, Inst Genet, D-5000 Cologne 41, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-5000 Cologne 41, Germany	University of Gottingen; St. Marien Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Virgen del Rocio University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Gottingen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Bonn; National Institutes of Health (NIH) - USA; University of Cologne; University of Cologne; University of Cologne	Gartner, J (corresponding author), Univ Gottingen, Dept Pediat & Pediat Neurol, Gottingen, Germany.	gaertnj@med.uni-goettingen.de	Thiele, Holger/ABE-6792-2020; Rodriguez, Diana/GVR-7668-2022; Kohlschütter, Alfried/ABE-3495-2021; Thoms, Sven/B-5763-2013; Kohlschütter, Alfried/ABH-5710-2020; Schumacher, Johannes/F-4970-2015; Thoms, Sven/K-4530-2019	Thiele, Holger/0000-0002-0169-998X; Kohlschütter, Alfried/0000-0002-2700-0401; Schumacher, Johannes/0000-0001-9217-6457; Thoms, Sven/0000-0003-3018-6363; Steinfeld, Robert/0000-0003-0956-6601	Deutsche Forschungsgemeinschaft [GA354/6-1]; Bundesministerium fur Bildung and Forschung (BMBF) through the German Leukodystrophy Network	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung and Forschung (BMBF) through the German Leukodystrophy Network(Federal Ministry of Education & Research (BMBF))	We thank the subjects and their families for participating in the study, C. Becker, L. Florin, M. Grapp, R. Hitt, J. Landgrebe and G. Nurnberg for expert technical assistance, and A. Fuchs, T. V. O. Hansen, R. Sedlmeier, O. Shoseyov and G. Tretter for collaborative efforts. This work has been supported by the Deutsche Forschungsgemeinschaft Grant GA354/6-1 (J. G. and M. H.) and the Bundesministerium fur Bildung and Forschung (BMBF) through the German Leukodystrophy Network (M. H. and J. S.).	Acquati F, 2005, INT J ONCOL, V26, P1159; Acquati F, 2001, ONCOGENE, V20, P980, DOI 10.1038/sj.onc.1204178; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; Henneke M, 2005, NEUROLOGY, V64, P1411, DOI 10.1212/01.WNL.0000158472.82823.01; Irie M, 1999, PHARMACOL THERAPEUT, V81, P77, DOI 10.1016/S0163-7258(98)00035-7; Ishii KJ, 2005, INT J CANCER, V117, P517, DOI 10.1002/ijc.21402; KNIPE DM, 2007, FIELDS VIROLOGY, pCH69; Liu Y, 2002, ONCOGENE, V21, P387, DOI 10.1038/sj.onc.1205067; Monti L, 2008, ONCOL RES, V17, P69, DOI 10.3727/096504008784523658; Smirnoff P, 2006, CANCER-AM CANCER SOC, V107, P2760, DOI 10.1002/cncr.22327; Trubia M, 1997, GENOMICS, V42, P342, DOI 10.1006/geno.1997.4679; VANDERKNAAP MS, 2005, J MAGN RESON, pCH85	15	99	103	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					773	775		10.1038/ng.398	http://dx.doi.org/10.1038/ng.398			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19525954				2022-12-25	WOS:000267786200005
J	Kyrpides, NC				Kyrpides, Nikos C.			Fifteen years of microbial genomics: meeting the challenges and fulfilling the dream	NATURE BIOTECHNOLOGY			English	Article							BIOLOGY	As we approach the completed sequencing of 1,000 microbial genomes, the field of microbial genomics is poised at a crossroads. The future holds great promise for far-reaching advancements in microbiology as well as in diverse, related sciences. But realizing that potential will require meeting the challenges that have accompanied the rapid development of the underlying technology and the exponential growth of data. New technologies provide unprecedented opportunities but also call for conceptual shifts. Experience gained in the first decade of genomics can guide the improved approaches now needed for the selection of genome sequencing projects and their funding, for genome publication and annotation, as well as for data analysis and access. Equipped with these new tools and policies, microbiologists will have a unique opportunity for unprecedented exploration of our microbial planet.	US DOE, Genome Biol Program, Joint Genome Inst, Walnut Creek, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Kyrpides, NC (corresponding author), US DOE, Genome Biol Program, Joint Genome Inst, Walnut Creek, CA USA.	nckyrpides@lbl.gov	Kyrpides, Nikos C./A-6305-2014	Kyrpides, Nikos C./0000-0002-6131-0462				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armengaud J, 2009, CURR OPIN MICROBIOL, V12, P292, DOI 10.1016/j.mib.2009.03.005; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Galperin MY, 2009, NUCLEIC ACIDS RES, V37, pD1, DOI 10.1093/nar/gkn942; Garrity GM, 2008, OMICS, V12, P157, DOI 10.1089/omi.2008.A2B2; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J., 2007, NEW SCI METAGENOMICS, DOI 10.17226/11902; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hugenholtz P, 2002, GENOME BIOL, V3; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P551, DOI 10.1111/j.1462-2920.2009.01888.x; Huss JW, 2008, PLOS BIOL, V6, P1398, DOI 10.1371/journal.pbio.0060175; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Kyrpides NC, 1999, MOL MICROBIOL, V32, P886, DOI 10.1046/j.1365-2958.1999.01380.x; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Markowitz VM, 2007, CURR OPIN BIOTECH, V18, P267, DOI 10.1016/j.copbio.2007.04.005; Mons B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r89; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Oehmen C, 2006, IEEE T PARALL DISTR, V17, P740, DOI 10.1109/TPDS.2006.112; Parkhill J, 2008, TRENDS MICROBIOL, V16, P510, DOI 10.1016/j.tim.2008.08.003; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; Stanhope MJ, 2001, NATURE, V411, P940, DOI 10.1038/35082058; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woese C, 1999, ASM NEWS, V65, P260; Woese CR, 1998, CURR BIOL, V8, pR781, DOI 10.1016/S0960-9822(07)00498-8; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	35	67	69	0	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2009	27	7					627	632		10.1038/nbt.1552	http://dx.doi.org/10.1038/nbt.1552			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	469OF	19587669				2022-12-25	WOS:000267908500019
J	Muchamuel, T; Basler, M; Aujay, MA; Suzuki, E; Kalim, KW; Lauer, C; Sylvain, C; Ring, ER; Shields, J; Jiang, J; Shwonek, P; Parlati, F; Demo, SD; Bennett, MK; Kirk, CJ; Groettrup, M				Muchamuel, Tony; Basler, Michael; Aujay, Monette A.; Suzuki, Erika; Kalim, Khalid W.; Lauer, Christoph; Sylvain, Catherine; Ring, Eileen R.; Shields, Jamie; Jiang, Jing; Shwonek, Peter; Parlati, Francesco; Demo, Susan D.; Bennett, Mark K.; Kirk, Christopher J.; Groettrup, Marcus			A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis	NATURE MEDICINE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; T-CELL REPERTOIRE; IRREVERSIBLE INHIBITOR; VIRUS-INFECTION; TNF-ALPHA; INDUCTION; EXPRESSION; BORTEZOMIB; TOLERANCE; RESPONSES	The immunoproteasome, a distinct class of proteasome found predominantly in monocytes and lymphocytes, is known to shape the antigenic repertoire presented on class I major histocompatibility complexes (MHC-I). However, a specific role for the immunoproteasome in regulating other facets of immune responses has not been established. We describe here the characterization of PR-957, a selective inhibitor of low-molecular mass polypeptide-7 (LMP7, encoded by Psmb8), the chymotrypsin-like subunit of the immunoproteasome. PR-957 blocked presentation of LMP7-specific, MHC-I-restricted antigens in vitro and in vivo. Selective inhibition of LMP7 by PR-957 blocked production of interleukin-23 (IL-23) by activated monocytes and interferon-gamma and IL-2 by T cells. In mouse models of rheumatoid arthritis, PR-957 treatment reversed signs of disease and resulted in reductions in cellular infiltration, cytokine production and autoantibody levels. These studies reveal a unique role for LMP7 in controlling pathogenic immune responses and provide a therapeutic rationale for targeting LMP7 in autoimmune disorders.	[Muchamuel, Tony; Aujay, Monette A.; Suzuki, Erika; Sylvain, Catherine; Ring, Eileen R.; Shields, Jamie; Jiang, Jing; Shwonek, Peter; Parlati, Francesco; Demo, Susan D.; Bennett, Mark K.; Kirk, Christopher J.] Proteolix Inc, San Francisco, CA USA; [Basler, Michael; Groettrup, Marcus] Univ Constance, Biotechnol Inst Thurgau, Kreuzlingen, Switzerland; [Basler, Michael; Kalim, Khalid W.; Lauer, Christoph; Groettrup, Marcus] Univ Constance, Div Immunol, Dept Biol, D-7750 Constance, Germany	University of Konstanz	Kirk, CJ (corresponding author), Proteolix Inc, San Francisco, CA USA.	ckirk@proteolix.com; Marcus.Groettrup@uni-konstanz.de	Groettrup, Marcus/AAT-2623-2020	Basler, Michael/0000-0002-9428-2349; Muchamuel, Tony/0000-0002-4143-3086	German National Science Foundation [GR 1517/4-2]; Swiss National Science Foundation [31003A_ 119699]; Graduate School Chemical Biology	German National Science Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Graduate School Chemical Biology	We thank R. Deshaies for discussion and comments. We thank N. Shastri (University of California-Berkeley) for providing T cell hybridomas and V. Cerundulo (University of Oxford) for the contribution of recombinant vaccinia viruses. We acquired P14 (transgenic line 318) and RIP-GP mice from M. van den Broek, University Hospital Zurich. Psmb8<SUP>-/-</SUP> gene-targeted mice were obtained from J. Monaco, University of Cincinnati. We thank J. Mattar (Rheumatology, Ueberlingen-Nussdorf) for the collection of blood from individuals with rheumatoid arthritis and L. Klotz and P. Knolle for instructions on the TH17 differentiation assay. U. Beck is achnowledged for excellent technical assistance. This work was funded by the German National Science Foundation grant GR 1517/4-2 and the Swiss National Science Foundation grant 31003A_ 119699. K. W. K. holds a fellowship of the Graduate School Chemical Biology at University of Constance (KoRS-CB).	Basler M, 2004, J IMMUNOL, V173, P3925, DOI 10.4049/jimmunol.173.6.3925; Basler M, 2007, EUR J IMMUNOL, V37, P896, DOI 10.1002/eji.200636372; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Caudill CM, 2006, J IMMUNOL, V176, P4075, DOI 10.4049/jimmunol.176.7.4075; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; De M, 2003, J BIOL CHEM, V278, P6153, DOI 10.1074/jbc.M209292200; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Frausto RF, 2007, J NEUROIMMUNOL, V192, P124, DOI 10.1016/j.jneuroim.2007.09.024; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; Ho YK, 2007, CHEM BIOL, V14, P419, DOI 10.1016/j.chembiol.2007.03.008; Kagari T, 2002, J IMMUNOL, V169, P1459, DOI 10.4049/jimmunol.169.3.1459; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Naujokat C, 2007, IMMUNOLOGY, V120, P120, DOI 10.1111/j.1365-2567.2006.02487.x; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Palmowski MJ, 2006, J IMMUNOL, V177, P983, DOI 10.4049/jimmunol.177.2.983; Palombella VJ, 1998, P NATL ACAD SCI USA, V95, P15671, DOI 10.1073/pnas.95.26.15671; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Qureshi N, 2003, J IMMUNOL, V171, P1515, DOI 10.4049/jimmunol.171.3.1515; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Schwartz AL, 1999, ANNU REV MED, V50, P57; SHENK KD, 2008, Patent No. 20070293465; Strehl B, 2006, J IMMUNOL, V177, P6238, DOI 10.4049/jimmunol.177.9.6238; VAN KL, 1994, IMMUNITY, V1, P533; Williams RO, 2000, J IMMUNOL, V165, P7240, DOI 10.4049/jimmunol.165.12.7240; ZANELLI E, 1993, IMMUNOGENETICS, V38, P400, DOI 10.1007/BF00184520	40	436	473	2	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					781	U12		10.1038/nm.1978	http://dx.doi.org/10.1038/nm.1978			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19525961	Green Submitted			2022-12-25	WOS:000267806900031
J	Okuzumi, T; Fiedler, D; Zhang, C; Gray, DC; Aizenstein, B; Hoffman, R; Shokat, KM				Okuzumi, Tatsuya; Fiedler, Dorothea; Zhang, Chao; Gray, Daniel C.; Aizenstein, Brian; Hoffman, Randy; Shokat, Kevan M.			Inhibitor hijacking of Akt activation	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE-B; CANCER DRUG DISCOVERY; IN-VIVO; INSULIN; TYROSINE; AKT/PKB; PHOSPHORYLATION; PATHWAY; BINDING; GROWTH	The kinase Akt plays a central role as a regulator of multiple growth factor input signals, thus making it an attractive anticancer drug target. A-443654 is an ATP-competitive Akt inhibitor. Unexpectedly, treatment of cells with A-443654 causes paradoxical hyperphosphorylation of Akt at its two regulatory sites (Thr308 and Ser473). We explored whether inhibitor-induced hyperphosphorylation of Akt by A-443654 is a consequence of disrupted feedback regulation at a pathway level or whether it is a direct consequence of inhibitor binding to the ATP binding site of Akt. Catalytically inactive mutants of Akt revealed that binding of an inhibitor to the ATP site of Akt is sufficient to directly cause hyperphosphorylation of the kinase in the absence of any pathway feedback effects. We conclude that ATP-competitive Akt inhibitors impart regulatory phosphorylation of their target kinase Akt. These results provide new insights into both natural regulation of Akt activation and Akt inhibitors entering the clinic.	[Okuzumi, Tatsuya; Fiedler, Dorothea; Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Okuzumi, Tatsuya; Fiedler, Dorothea; Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Gray, Daniel C.] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA; [Aizenstein, Brian; Hoffman, Randy] Invitrogen Corp, Cell Syst Div, Discovery Assays & Serv, SelectScreen Serv, Madison, WI USA; [Shokat, Kevan M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Thermo Fisher Scientific; University of California System; University of California Berkeley	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	shokat@cmp.ucsf.edu			University of California; US National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER	University of California(University of California System); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank B. Houseman (University of California, San Francisco) for PIK90 synthesis. We thank A. Dar, M. Feldman, A. Garske and A. Statsuk for helpful comments on the manuscript. T. O. was supported by Ajinomoto Co., Inc. D. C. G. is supported by a training grant from the University of California Systemwide Biotechnology Research & Education Program GREAT (Graduate Research and Education in Adaptive bio- Technology) and by a US National Institutes of Health Chemistry and Chemical Biology Training Grant. D. F. thanks the Ernst Schering Stiftung for funding.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Davies TG, 2007, J MOL BIOL, V367, P882, DOI 10.1016/j.jmb.2007.01.004; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Exelixis, 2005, [No title captured], Patent No. [WO2005117909, 2005117909]; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Heerding DA, 2008, J MED CHEM, V51, P5663, DOI 10.1021/jm8004527; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Miller AL, 2009, J IMMUNOL, V182, P988, DOI 10.4049/jimmunol.182.2.988; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shor Audrey C, 2008, Cancer Control, V15, P47; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200	50	226	235	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					484	493		10.1038/nchembio.183	http://dx.doi.org/10.1038/nchembio.183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19465931	Green Accepted, Green Submitted			2022-12-25	WOS:000267266100014
J	Ray, D; Kazan, H; Chan, ET; Castillo, LP; Chaudhry, S; Talukder, S; Blencowe, BJ; Morris, Q; Hughes, TR				Ray, Debashish; Kazan, Hilal; Chan, Esther T.; Castillo, Lourdes Pena; Chaudhry, Sidharth; Talukder, Shaheynoor; Blencowe, Benjamin J.; Morris, Quaid; Hughes, Timothy R.			Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins	NATURE BIOTECHNOLOGY			English	Article							UNIVERSAL DNA MICROARRAYS; MESSENGER-RNA; SAM DOMAIN; IDENTIFICATION; SEQUENCE; DISTINCT; SUBSETS; COMPACT; NUCLEAR; FAMILY	Metazoan genomes encode hundreds of RNA-binding proteins (RBPs) but RNA-binding preferences for relatively few RBPs have been well defined(1). Current techniques for determining RNA targets, including in vitro selection and RNA co-immunoprecipitation(2-5), require significant time and labor investment. Here we introduce RNAcompete, a method for the systematic analysis of RNA binding specificities that uses a single binding reaction to determine the relative preferences of RBPs for short RNAs that contain a complete range of k-mers in structured and unstructured RNA contexts. We tested RNAcompete by analyzing nine diverse RBPs (HuR, Vts1, FUSIP1, PTB, U1A, SF2/ASF, SLM2, RBM4 and YB1). RNAcompete identified expected and previously unknown RNA binding preferences. Using in vitro and in vivo binding data, we demonstrate that preferences for individual 7-mers identified by RNAcompete are a more accurate representation of binding activity than are conventional motif models. We anticipate that RNAcompete will be a valuable tool for the study of RNA-protein interactions.	[Ray, Debashish; Castillo, Lourdes Pena; Talukder, Shaheynoor; Blencowe, Benjamin J.; Morris, Quaid; Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Kazan, Hilal; Morris, Quaid] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Chan, Esther T.; Chaudhry, Sidharth; Blencowe, Benjamin J.; Morris, Quaid; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada.	quaid.morris@utoronto.ca; t.hughes@utoronto.ca	Kazan, Hilal/B-2247-2014; Morris, Quaid/ABE-8343-2020	Pena Castillo, Lourdes/0000-0002-0643-2547; Morris, Quaid/0000-0002-2760-6999; Chan, Esther/0000-0002-2406-2623	CIHR [MOP-49451, MOP-14609, MOP-93671]; Natural Sciences and Engineering Research Council operating; Canadian Foundation of Innovation	CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council operating; Canadian Foundation of Innovation(Canada Foundation for Innovation)	We are grateful to C. Smibert, H. Lipshitz, F. Sicheri, M. Kekis and T. Babak for helpful commentary. Bacterial expression plasmids for the N-terminal arm of U1A, the Vts1 SAM domain, full-length PTB and YB1 were generously provided by C. Lutz (Univ. of Medicine and Dentistry of New Jersey), C. Smibert (Univ. of Toronto), M. Garcia-Blanco (Duke Univ.) and K. Kohno (Univ. of Occupational and Environmental Health, Kitakyushu, Japan). This work was supported by grants to T. R. H., B.J.B. and Q. M. from CIHR (MOP-49451, MOP-14609, MOP-93671), by Natural Sciences and Engineering Research Council operating and Canadian Foundation of Innovation grants to Q. M., Genome Canada through the Ontario Genomics Institute and the Ontario Research Fund. D. R. was supported in part by a National Science and Engineering Research Council of Canada (NSERC) postdoctoral fellowship.	Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Aviv T, 2006, NAT STRUCT MOL BIOL, V13, P168, DOI 10.1038/nsmb1053; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Dong JJ, 2009, RNA BIOL, V6, P59, DOI 10.4161/rna.6.1.7458; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; GAO FB, 1994, P NATL ACAD SCI USA, V91, P11207, DOI 10.1073/pnas.91.23.11207; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hiller M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl544; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Ohno G, 2008, GENE DEV, V22, P360, DOI 10.1101/gad.1620608; Perez I, 1997, BIOCHEMISTRY-US, V36, P11881, DOI 10.1021/bi9711745; Philippakis AA, 2008, J COMPUT BIOL, V15, P655, DOI 10.1089/cmb.2007.0114; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; TSAI DE, 1991, NUCLEIC ACIDS RES, V19, P4931, DOI 10.1093/nar/19.18.4931; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018	38	312	320	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2009	27	7					667	U135		10.1038/nbt.1550	http://dx.doi.org/10.1038/nbt.1550			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	469OF	19561594				2022-12-25	WOS:000267908500025
J	Rice, GI; Bond, J; Asipu, A; Brunette, RL; Manfield, IW; Carr, IM; Fuller, JC; Jackson, RM; Lamb, T; Briggs, TA; Ali, M; Gornall, H; Couthard, LR; Aeby, A; Attard-Montalto, SP; Bertini, E; Bodemer, C; Brockmann, K; Brueton, LA; Corry, PC; Desguerre, I; Fazzi, E; Cazorla, AG; Gener, B; Hamel, BCJ; Heiberg, A; Hunter, M; van der Knaap, MS; Kumar, R; Lagae, L; Landrieu, PG; Lourenco, CM; Marom, D; McDermott, MF; van der Merwe, W; Orcesi, S; Prendiville, JS; Rasmussen, M; Shalev, SA; Soler, DM; Shinawi, M; Spiegel, R; Tan, TY; Vanderver, A; Wakeling, EL; Wassmer, E; Whittaker, E; Lebon, P; Stetson, DB; Bonthron, DT; Crow, YJ				Rice, Gillian I.; Bond, Jacquelyn; Asipu, Aruna; Brunette, Rebecca L.; Manfield, Iain W.; Carr, Ian M.; Fuller, Jonathan C.; Jackson, Richard M.; Lamb, Teresa; Briggs, Tracy A.; Ali, Manir; Gornall, Hannah; Couthard, Lydia R.; Aeby, Alec; Attard-Montalto, Simon P.; Bertini, Enrico; Bodemer, Christine; Brockmann, Knut; Brueton, Louise A.; Corry, Peter C.; Desguerre, Isabelle; Fazzi, Elisa; Cazorla, Angels Garcia; Gener, Blanca; Hamel, Ben C. J.; Heiberg, Arvid; Hunter, Matthew; van der Knaap, Marjo S.; Kumar, Ram; Lagae, Lieven; Landrieu, Pierre G.; Lourenco, Charles M.; Marom, Daphna; McDermott, Michael F.; van der Merwe, William; Orcesi, Simona; Prendiville, Julie S.; Rasmussen, Magnhild; Shalev, Stavit A.; Soler, Doriette M.; Shinawi, Marwan; Spiegel, Ronen; Tan, Tiong Y.; Vanderver, Adeline; Wakeling, Emma L.; Wassmer, Evangeline; Whittaker, Elizabeth; Lebon, Pierre; Stetson, Daniel B.; Bonthron, David T.; Crow, Yanick J.			Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GAMMA-INDUCED PROTEIN; CONGENITAL INFECTION; EXONUCLEASE TREX1; VIRUS-INFECTION; INTERFERON; DOMAIN; AUTOIMMUNITY; GENES	Aicardi-Goutieres syndrome is a mendelian mimic of congenital infection and also shows overlap with systemic lupus erythematosus at both a clinical and biochemical level. The recent identification of mutations in TREX1 and genes encoding the RNASEH2 complex and studies of the function of TREX1 in DNA metabolism have defined a previously unknown mechanism for the initiation of autoimmunity by interferon-stimulatory nucleic acid. Here we describe mutations in SAMHD1 as the cause of AGS at the AGS5 locus and present data to show that SAMHD1 may act as a negative regulator of the cell-intrinsic antiviral response.	[Rice, Gillian I.; Gornall, Hannah; Crow, Yanick J.] Univ Manchester, Acad Unit Med Genet, Manchester, Lancs, England; [Rice, Gillian I.; Bond, Jacquelyn; Asipu, Aruna; Carr, Ian M.; Briggs, Tracy A.; Ali, Manir; Couthard, Lydia R.; McDermott, Michael F.; Bonthron, David T.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Brunette, Rebecca L.; Stetson, Daniel B.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Manfield, Iain W.; Fuller, Jonathan C.; Jackson, Richard M.] Univ Leeds, Astbury Ctr Struct Mol Biol, JIF Ctr Biomol Interact, Leeds, W Yorkshire, England; [Lamb, Teresa] St James Univ Hosp, Ashley Wing, Yorkshire Reg Genet Serv, DNA Lab, Leeds, W Yorkshire, England; [Aeby, Alec] Erasme Hosp ULB, Dept Paediat Neurol, Brussels, Belgium; [Attard-Montalto, Simon P.; Soler, Doriette M.] Mater Dei Hosp, Sch Med, Dept Paediat, Tal Qroqq, Malta; [Bertini, Enrico] Bambino Gesu Pediat Hosp, Unit Mol Med & Neuromuscular Disorders, Rome, Italy; [Bodemer, Christine] Univ Paris 05, Dept Dermatol, Paris, France; [Brockmann, Knut] Univ Gottingen, Gottingen, Germany; [Brueton, Louise A.] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; [Corry, Peter C.] St Lukes Hosp, Bradford Child Dev Ctr, Bradford BD5 0NA, W Yorkshire, England; [Desguerre, Isabelle] Hop Necker Enfants Malad, APHP, Paris, France; [Fazzi, Elisa; Orcesi, Simona] IRCCS Inst Neurol C Mondino Fdn, Dept Child Neurol & Psychiat, Pavia, Italy; [Cazorla, Angels Garcia] Hosp St Joan de Deu, Dept Neurol, Barcelona, Spain; [Gener, Blanca] Hosp Cruces, Dept Paediat, Clin Genet Unit, Baracaldo, Vizcaya, Spain; [Hamel, Ben C. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Heiberg, Arvid] Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway; [Hunter, Matthew] Royal Childrens Hosp, Victorian Clin Genet Serv, Parkville, Vic 3052, Australia; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat & Child Neurol, Amsterdam, Netherlands; [Kumar, Ram] Alder Hey Childrens NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England; [Lagae, Lieven] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium; [Landrieu, Pierre G.] CHU Paris Sud Hosp, Pediat Neurol Dept, Le Kremlin Bicetre, France; [Lourenco, Charles M.] Univ Sao Paulo, Sch Med Ribeirao Preto, Neurogenet Unit, Med Genet Serv,Hosp Clin Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil; [Marom, Daphna] Rabin Med Ctr, Raphael Recanati Genet Inst, Petah Tiqwa, Israel; [Prendiville, Julie S.] British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada; [Rasmussen, Magnhild] Univ Hosp, Rikshosp, Dept Paediat, Oslo, Norway; [Shalev, Stavit A.; Spiegel, Ronen] Technion Israel Inst Technol, Afula & Rappaport Fac Med, HaEmek Med Ctr, Genet Inst, Haifa, Israel; [Shinawi, Marwan] Baylor Coll Med, Dept Mol & Human Genet T619, Houston, TX 77030 USA; [Tan, Tiong Y.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Genet Hlth Serv Victoria,Murdoch Childrens Res In, Parkville, Vic 3052, Australia; [Vanderver, Adeline] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Wakeling, Emma L.] NW London Hosp NHS Trust, Kennedy Galton Ctr, Harrow, Middx, England; [Wassmer, Evangeline] Birmingham Childrens Hosp, Dept Neurol, Birmingham, W Midlands, England; [Whittaker, Elizabeth] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Lebon, Pierre] Univ Paris 05, Hop Cochin St Vincent de Paul, Paris, France	University of Manchester; Saint James's University Hospital; University of Leeds; University of Washington; University of Washington Seattle; University of Leeds; Saint James's University Hospital; Universite Libre de Bruxelles; IRCCS Bambino Gesu; UDICE-French Research Universities; Universite Paris Cite; University of Gottingen; Birmingham Women's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Fondazione Casimiro Mondino; University of Barcelona; Hospital Universitario Cruces; Radboud University Nijmegen; University of Oslo; National Hospital Norway; Royal Children's Hospital Melbourne; Vrije Universiteit Amsterdam; Alder Hey Children's NHS Foundation Trust; KU Leuven; University Hospital Leuven; UDICE-French Research Universities; Universite Paris Saclay; Universidade de Sao Paulo; Rabin Medical Center; BC Childrens Hospital; University of British Columbia; University of Oslo; National Hospital Norway; Technion Israel Institute of Technology; Baylor College of Medicine; Royal Children's Hospital Melbourne; University of Melbourne; Children's National Health System; University of Birmingham; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Crow, YJ (corresponding author), Univ Manchester, Acad Unit Med Genet, Manchester, Lancs, England.	yanickcrow@mac.com	Wassmer, Evangeline/K-5467-2019; Crow, Yanick J/N-6120-2014; Fazzi, Elisa/J-6076-2016; Lourenço, Charles M/O-2731-2013; orcesi, simona/J-6030-2016; McDermott, Michael/S-8490-2019; Vanderver, Adeline/CAG-5072-2022; Hunter, Matthew/S-7150-2019; Rice, Gillian I/G-3128-2015; McDermott, Michael Francis/GZM-5330-2022; Tan, Tiong Yang/AAV-6563-2020; Bertini, Enrico/A-2284-2014; Gener, Blanca/E-4310-2012; Ali, Manir/ABE-5251-2020; Bertini, Enrico/ABG-1278-2020	Crow, Yanick J/0000-0001-7211-7564; Fazzi, Elisa/0000-0003-4805-7906; orcesi, simona/0000-0001-8947-9342; McDermott, Michael/0000-0002-1015-0745; Hunter, Matthew/0000-0002-2475-6545; Rice, Gillian I/0000-0002-4223-0571; Tan, Tiong Yang/0000-0001-8455-7778; Bertini, Enrico/0000-0001-9276-4590; Ali, Manir/0000-0003-3204-3788; Vanderver, Adeline/0000-0002-6290-6751; Johnson, Lydia/0000-0002-2122-3479; Aeby, Alec/0000-0002-7516-665X; Hunter, Matthew/0000-0002-7659-1404; Fuller, Jonathan/0000-0001-8801-149X; Wakeling, Emma/0000-0001-5712-0044; Whittaker, Elizabeth/0000-0002-7944-8793; shinawi, Marwan/0000-0003-1329-4100; Manfield, Iain/0000-0003-3765-0325; Bonthron, David/0000-0001-8132-8179	BDF Newlife; Royal Society; Wellcome Trust VIP; National Institutes for Health Research Manchester Biomedical Research Centre; International AicardiGoutie` res syndrome Association (IAGSA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER	BDF Newlife; Royal Society(Royal Society of London); Wellcome Trust VIP(Wellcome Trust); National Institutes for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); International AicardiGoutie` res syndrome Association (IAGSA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the participating families with Aicardi-Goutieres syndrome for the use of genetic samples and clinical information. We thank all clinicians for contributing samples not included in the current manuscript. We thank C. Ponting and E. Morrison for helpful discussions and R. Smith for technical support in preparing images. This work was supported by BDF Newlife, the Royal Society, a Wellcome Trust VIP award to G. I. R., the National Institutes for Health Research Manchester Biomedical Research Centre, and the International AicardiGoutie` res syndrome Association (IAGSA).	Aicardi J, 2000, NEUROPEDIATRICS, V31, P113, DOI 10.1055/s-2000-7533; Alarcon-Riquelme ME, 2006, NAT GENET, V38, P866, DOI 10.1038/ng0806-866; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bhoj VG, 2008, CELL, V134, P569, DOI 10.1016/j.cell.2008.08.010; Coscoy L, 2007, CELL, V131, P836, DOI 10.1016/j.cell.2007.11.012; Crow MK, 2007, CURR TOP MICROBIOL, V316, P359; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; Crow YJ, 2008, DEV MED CHILD NEUROL, V50, P410, DOI 10.1111/j.1469-8749.2008.02062.x; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; Dale RC, 2000, NEUROPEDIATRICS, V31, P155, DOI 10.1055/s-2000-7492; De Laet C, 2005, NEUROPEDIATRICS, V36, P399, DOI 10.1055/s-2005-873058; DUSSAIX E, 1985, ACTA NEUROL SCAND, V71, P504; Farrugia R, 2007, MOL GENET METAB, V90, P277, DOI 10.1016/j.ymgme.2006.10.013; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Liao WP, 2008, PROTEOMICS, V8, P2640, DOI 10.1002/pmic.200700954; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Oussenko IA, 2002, J BACTERIOL, V184, P6250, DOI 10.1128/JB.184.22.6250-6259.2002; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; QIAO F, 2005, SCI STKE, V7, pRE7; Rasmussen M, 2005, NEUROPEDIATRICS, V36, P40, DOI 10.1055/s-2004-830532; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zhao DC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-114; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	30	499	525	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					829	U89		10.1038/ng.373	http://dx.doi.org/10.1038/ng.373			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19525956	Green Accepted			2022-12-25	WOS:000267786200015
J	Weraarpachai, W; Antonicka, H; Sasarman, F; Seeger, J; Schrank, B; Kolesar, JE; Lochmuller, H; Chevrette, M; Kaufman, BA; Horvath, R; Shoubridge, EA				Weraarpachai, Woranontee; Antonicka, Hana; Sasarman, Florin; Seeger, Juergen; Schrank, Bertold; Kolesar, Jill E.; Lochmueller, Hanns; Chevrette, Mario; Kaufman, Brett A.; Horvath, Rita; Shoubridge, Eric A.			Mutation in TACO1, encoding a translational activator of COX I, results in cytochrome c oxidase deficiency and late-onset Leigh syndrome	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; EXPRESSION; PROTEINS; GENE; BIOGENESIS; MULTIPLE; DEFECT; CELLS; SURF1	Defects in mitochondrial translation are among the most common causes of mitochondrial disease(1), but the mechanisms that regulate mitochondrial translation remain largely unknown. In the yeast Saccharomyces cerevisiae, all mitochondrial mRNAs require specific translational activators, which recognize sequences in 5' UTRs and mediate translation(2). As mammalian mitochondrial mRNAs do not have significant 5' UTRs(3), alternate mechanisms must exist to promote translation. We identified a specific defect in the synthesis of the mitochondrial DNA (mtDNA)-encoded COX I subunit in a pedigree segregating late-onset Leigh syndrome and cytochrome c oxidase (COX) deficiency. We mapped the defect to chromosome 17q by functional complementation and identified a homozygous single-base-pair insertion in CCDC44, encoding a member of a large family of hypothetical proteins containing a conserved DUF28 domain. CCDC44, renamed TACO1 for translational activator of COX I, shares a notable degree of structural similarity with bacterial homologs(4), and our findings suggest that it is one of a family of specific mammalian mitochondrial translational activators.	[Weraarpachai, Woranontee; Sasarman, Florin; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Weraarpachai, Woranontee; Antonicka, Hana; Sasarman, Florin; Kolesar, Jill E.; Kaufman, Brett A.; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Seeger, Juergen] Deutsch Klin Diagnost GmbH, Dept Pediat, Wiesbaden, Germany; [Schrank, Bertold] Deutsch Klin Diagnost GmbH, Dept Neurol, Wiesbaden, Germany; [Lochmueller, Hanns; Horvath, Rita] Univ Munich, Friedrich Baur Inst, Munich, Germany; [Chevrette, Mario] McGill Univ, Dept Surg, Div Urol, Montreal, PQ H3A 2T5, Canada; [Chevrette, Mario] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; University of Munich; McGill University; McGill University	Shoubridge, EA (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	eric@ericpc.mni.mcgill.ca	Kolesar, Jill/AAA-9727-2020; Horvath, Rita/AAY-7042-2020	Kolesar, Jill/0000-0003-1802-6439; Antonicka, Hana/0000-0002-2525-2867; Lochmuller, Hanns/0000-0003-2324-8001; Horvath, Rita/0000-0002-9841-170X	Canadian Institutes of Health Research; International Scholar of the Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft [HO 2505/2-1]; Medical Research Council [G0601943B] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); International Scholar of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the contribution of the individuals who cared for the study subjects and the technical assistance of I. Kaus, S. Mueller- Ziermann and A. Zimmermann. We thank T. Johns for help with immunocytochemistry and the cell culture. This work was supported in part by a grant from the Canadian Institutes of Health Research to E. A. S. E. A. S. is an International Scholar of the Howard Hughes Medical Institute. R. H. is supported by the Deutsche Forschungsgemeinschaft HO 2505/2-1	Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Barclay BJ, 2001, ENVIRON MOL MUTAGEN, V38, P153, DOI 10.1002/em.1066; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; BOULET L, 1992, AM J HUM GENET, V51, P1187; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Gagnon A, 2006, GENE CHROMOSOME CANC, V45, P220, DOI 10.1002/gcc.20281; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Liang HH, 2008, J BACTERIOL, V190, P6217, DOI 10.1128/JB.00428-08; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Shin DH, 2002, P NATL ACAD SCI USA, V99, P7980, DOI 10.1073/pnas.132241399; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zhang Xu-hong, 2008, Asian Journal of Ecotoxicology, V3, P9; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	27	200	206	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					833	U96		10.1038/ng.390	http://dx.doi.org/10.1038/ng.390			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19503089				2022-12-25	WOS:000267786200016
J	Wignall, SM; Villeneuve, AM				Wignall, Sarah M.; Villeneuve, Anne M.			Lateral microtubule bundles promote chromosome alignment during acentrosomal oocyte meiosis	NATURE CELL BIOLOGY			English	Article							MEIOTIC SPINDLE FORMATION; CAENORHABDITIS-ELEGANS; KINASE AIR-2; FUNCTIONAL-ANALYSIS; MITOTIC SPINDLE; KINETOCHORE; KINESIN; SEGREGATION; MECHANISMS; ATTACHMENT	Although centrosomes serve to organize microtubules in most cell types, oocyte spindles form and mediate meiotic chromosome segregation in their absence. Here, we used high-resolution imaging of both bipolar and experimentally generated monopolar spindles in Caenorhabditis elegans to reveal a surprising organization of microtubules and chromosomes within acentrosomal structures. We found that homologous chromosome pairs (bivalents) are surrounded by microtubule bundles running along their sides, whereas microtubule density is extremely low at chromosome ends despite a high concentration of kinetochore proteins at those regions. Furthermore, we found that the chromokinesin KLP-19 (kinesin-like protein 19) is targeted to a ring around the centre of each bivalent and provides a polar ejection force that is required for congression. Together, these observations create a new picture of chromosome-microtubule association in acentrosomal spindles and reveal a mechanism by which metaphase alignment can be achieved using this organization. Specifically, we propose that ensheathment by lateral microtubule bundles places spatial constraints on the chromosomes, thereby promoting biorientation, and that localized motors mediate movement along these bundles, thereby promoting alignment.	[Wignall, Sarah M.; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Wignall, Sarah M.; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Wignall, SM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.	swignall@stanford.edu; villen@cmgm.stanford.edu	Wignall, Sadie/AHD-0715-2022	Wignall, Sadie/0000-0001-9828-9356	NIGMS NIH HHS [R01 GM053804-11, R01 GM053804-10, R01 GM053804-13, R01 GM053804, R01 GM053804-14, R01 GM53804, R01 GM053804-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053804] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Boleti H, 1996, CELL, V84, P49, DOI 10.1016/S0092-8674(00)80992-7; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; Cullen CF, 2005, J CELL BIOL, V171, P593, DOI 10.1083/jcb.200508127; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Howe M, 2001, J CELL BIOL, V153, P1227, DOI 10.1083/jcb.153.6.1227; Jang JK, 2007, GENETICS, V177, P267, DOI 10.1534/genetics.107.076091; Jang JK, 2005, MOL BIOL CELL, V16, P4684, DOI 10.1091/mbc.E04-11-0964; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; MAINS PE, 1990, GENETICS, V126, P593; Mazumdar M, 2005, TRENDS CELL BIOL, V15, P349, DOI 10.1016/j.tcb.2005.05.006; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; MERDES A, 1990, EUR J CELL BIOL, V53, P313; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Powers J, 2004, J CELL BIOL, V166, P991, DOI 10.1083/jcb.200403036; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Segbert C, 2003, MOL BIOL CELL, V14, P4458, DOI 10.1091/mbc.E03-05-0283; Skold HN, 2005, J CELL SCI, V118, P1745, DOI 10.1242/jcs.02304; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Srayko M, 2000, GENE DEV, V14, P1072; Stiernagle Theresa, 2006, WormBook, P1; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643	45	102	104	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					839	U135		10.1038/ncb1891	http://dx.doi.org/10.1038/ncb1891			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525937	Green Accepted			2022-12-25	WOS:000267603100012
J	Dennis, MK; Burai, R; Ramesh, C; Petrie, WK; Alcon, SN; Nayak, TK; Bologa, CG; Leitao, A; Brailoiu, E; Deliu, E; Dun, NJ; Sklar, LA; Hathaway, HJ; Arterburn, JB; Oprea, TI; Prossnitz, ER				Dennis, Megan K.; Burai, Ritwik; Ramesh, Chinnasamy; Petrie, Whitney K.; Alcon, Sara N.; Nayak, Tapan K.; Bologa, Cristian G.; Leitao, Andrei; Brailoiu, Eugen; Deliu, Elena; Dun, Nae J.; Sklar, Larry A.; Hathaway, Helen J.; Arterburn, Jeffrey B.; Oprea, Tudor I.; Prossnitz, Eric R.			In vivo effects of a GPR30 antagonist	NATURE CHEMICAL BIOLOGY			English	Article							TAIL SUSPENSION TEST; ESTROGEN-RECEPTOR GPR30; CENTRAL-NERVOUS-SYSTEM; BREAST-CANCER CELLS; G-PROTEIN; G-PROTEIN-COUPLED-RECEPTOR-30 GPR30; GENE-EXPRESSION; RAT; PROLIFERATION; MICE	Estrogen is central to many physiological processes throughout the human body. We have previously shown that the G protein-coupled receptor GPR30 (also known as GPER), in addition to classical nuclear estrogen receptors (ER alpha and ER beta), activates cellular signaling pathways in response to estrogen. In order to distinguish between the actions of classical estrogen receptors and GPR30, we have previously characterized G-1 (1), a selective agonist of GPR30. To complement the pharmacological properties of G-1, we sought to identify an antagonist of GPR30 that displays similar selectivity against the classical estrogen receptors. Here we describe the identification and characterization of G15 (2), a G-1 analog that binds to GPR30 with high affinity and acts as an antagonist of estrogen signaling through GPR30. In vivo administration of G15 revealed that GPR30 contributes to both uterine and neurological responses initiated by estrogen. The identification of this antagonist will accelerate the evaluation of the roles of GPR30 in human physiology.	[Dennis, Megan K.; Petrie, Whitney K.; Alcon, Sara N.; Nayak, Tapan K.; Hathaway, Helen J.; Prossnitz, Eric R.] Univ New Mexico, Dept Cell Biol & Physiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Burai, Ritwik; Ramesh, Chinnasamy; Arterburn, Jeffrey B.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; [Bologa, Cristian G.; Leitao, Andrei; Oprea, Tudor I.] Univ New Mexico, Div Biocomp, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Brailoiu, Eugen; Deliu, Elena; Dun, Nae J.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA; [Sklar, Larry A.; Hathaway, Helen J.; Arterburn, Jeffrey B.; Oprea, Tudor I.; Prossnitz, Eric R.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Sklar, Larry A.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; New Mexico State University; University of New Mexico; University of New Mexico's Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of New Mexico; University of New Mexico; University of New Mexico's Health Sciences Center	Prossnitz, ER (corresponding author), Univ New Mexico, Dept Cell Biol & Physiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	jarterbu@nmsu.edu; toprea@salud.unm.edu; eprossnitz@salud.unm.edu	Oprea, Tudor I/A-5746-2011; Bologa, Cristian G/A-7952-2010; Leitao, Andrei/B-7942-2012; Prossnitz, Eric/I-4599-2019; BOLOGA, CRISTINA/T-8927-2017; Deliu, Elena/O-7379-2019; Prossnitz, Eric R./B-4543-2008	Oprea, Tudor I/0000-0002-6195-6976; Bologa, Cristian G/0000-0003-2232-4244; Leitao, Andrei/0000-0002-6601-6609; Prossnitz, Eric/0000-0001-9190-8302; Nayak, Tapan/0000-0002-3706-6092; Dennis, Megan/0000-0002-8986-5021	NIH [CA118743, CA127731, R37 NS18710, HL90804]; Oxnard and Stranahan Foundations; University of New Mexico Center for Molecular Discovery [NIH U54 MH084690]; New Mexico Tobacco Settlement fund; New Mexico Cowboys for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA118743, R01CA127731] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690, U54MH074425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS018710] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxnard and Stranahan Foundations; University of New Mexico Center for Molecular Discovery; New Mexico Tobacco Settlement fund; New Mexico Cowboys for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants CA118743 and CA127731 (to E. R. P.), by grants from the Oxnard and Stranahan Foundations (to E. R. P.), by the University of New Mexico Center for Molecular Discovery (NIH U54 MH084690; to L. A. S.) by the New Mexico Tobacco Settlement fund (to T. I. O.), by the New Mexico Cowboys for Cancer Research (to J. B. A.) and by NIH grants R37 NS18710 (to N. J. D.) and HL90804 (to E. B.). Flow cytometry data and confocal images in this study were generated in the Flow Cytometry and Fluorescence Microscopy Facilities, which received support from the University of New Mexico Health Sciences Center and the University of New Mexico Cancer Center (as detailed at http://hsc.unm.edu/crtc/microscopy/facility.html). In vivo data were generated with the support of the University of New Mexico Cancer Center Animal Models & Imaging Core.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Balla Tamas, 2002, Sci STKE, V2002, ppl3, DOI 10.1126/stke.2002.125.pl3; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Diel P, 2004, MOL CELL ENDOCRINOL, V221, P21, DOI 10.1016/j.mce.2004.04.006; Dun SL, 2009, J NEUROSCI RES, V87, P1610, DOI 10.1002/jnr.21980; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Epperson CN, 1999, PSYCHOSOM MED, V61, P676, DOI 10.1097/00006842-199909000-00010; Estrada-Camarena E, 2003, NEUROPSYCHOPHARMACOL, V28, P830, DOI 10.1038/sj.npp.1300097; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Frasor J, 2003, ENDOCRINOLOGY, V144, P3159, DOI 10.1210/en.2002-0143; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Genazzani AR, 1999, MATURITAS, V31, P103, DOI 10.1016/S0378-5122(98)00112-1; GRUNERT G, 1986, J ENDOCRINOL, V110, P103, DOI 10.1677/joe.0.1100103; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; KOBAYASHI S, 1995, SYNTHESIS-STUTTGART, P1195; Kuhn J, 2008, EUR J NEUROSCI, V27, P1700, DOI 10.1111/j.1460-9568.2008.06131.x; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; Noel SD, 2009, MOL ENDOCRINOL, V23, P349, DOI 10.1210/me.2008-0299; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Owens JW, 2002, CRIT REV TOXICOL, V32, P445, DOI 10.1080/20024091064291; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Pang Y, 2008, ENDOCRINOLOGY, V149, P3410, DOI 10.1210/en.2007-1663; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prossnitz ER, 2008, TRENDS PHARMACOL SCI, V29, P116, DOI 10.1016/j.tips.2008.01.001; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Ramirez S, 2003, CYTOM PART A, V53A, P55, DOI 10.1002/cyto.a.10035; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; STERU L, 1987, PROG NEURO-PSYCHOPH, V11, P659; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Teng J, 2008, ENDOCRINOLOGY, V149, P4024, DOI 10.1210/en.2007-1669; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P18350, DOI 10.1073/pnas.0608861103; Wang C, 2008, ENDOCRINOLOGY, V149, P4452, DOI 10.1210/en.2008-0441; Wang C, 2008, MOL ENDOCRINOL, V22, P636, DOI 10.1210/me.2007-0359; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; WILLNER P, 1990, PHARMACOL THERAPEUT, V45, P425, DOI 10.1016/0163-7258(90)90076-E	42	393	435	3	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					421	427		10.1038/nchembio.168	http://dx.doi.org/10.1038/nchembio.168			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19430488	Green Accepted			2022-12-25	WOS:000266383800017
J	Eguchi, A; Meade, BR; Chang, YC; Fredrickson, CT; Willert, K; Puri, N; Dowdy, SF				Eguchi, Akiko; Meade, Bryan R.; Chang, Yung-Chi; Fredrickson, Craig T.; Willert, Karl; Puri, Nitin; Dowdy, Steven F.			Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; DOUBLE-STRANDED-RNA; CELLULAR UPTAKE; IN-VIVO; MACROPINOCYTOSIS; THERAPEUTICS; INTERFERENCE; DISEASE; GENE	RNA interference (RNAi) induced by short interfering RNA (siRNA) allows for discovery research and large-scale screening(1-5); however, owing to their size and anionic charge, siRNAs do not readily enter cells(4,5). Current approaches do not deliver siRNAs into a high percentage of primary cells without cytotoxicity. Here we report an efficient siRNA delivery approach that uses a peptide transduction domain-double-stranded RNA-binding domain (PTD-DRBD) fusion protein. DRBDs bind to siRNAs with high avidity, masking the siRNA's negative charge and allowing PTD-mediated cellular uptake. PTD-DRBD-delivered siRNA induced rapid RNAi in a large percentage of various primary and transformed cells, including T cells, human umbilical vein endothelial cells and human embryonic stem cells. We observed no cytotoxicity, minimal off-target transcriptional changes and no induction of innate immune responses. Thus, PTD-DRBD-mediated siRNA delivery allows efficient gene silencing in difficult-to-transfect primary cell types.	[Eguchi, Akiko; Meade, Bryan R.; Dowdy, Steven F.] UCSD, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Eguchi, Akiko; Meade, Bryan R.; Fredrickson, Craig T.; Willert, Karl; Dowdy, Steven F.] UCSD, Sch Med, Dept Cellular & Mol Med, La Jolla, CA USA; [Eguchi, Akiko] Japan Soc Promot Sci, Tokyo, Japan; [Chang, Yung-Chi] UCSD, Sch Med, Dept Pediat, La Jolla, CA USA; [Puri, Nitin] Life Technol, Austin, TX USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Japan Society for the Promotion of Science; University of California System; University of California San Diego; Thermo Fisher Scientific	Dowdy, SF (corresponding author), UCSD, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu	Eguchi, Akiko/E-3086-2010		Leukemia & Lymphoma Society; Elsa U. Pardee Foundation; Howard Hughes Medical Institute; California Institute for Regenerative Medicine	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Elsa U. Pardee Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	We thank V. Nizet (UCSD) for PBMCs. The hES cell line HUES9 was kindly provided by D. Melton (HHMI, Harvard University). A. E. was funded by a Japan Society for the Promotion of Science Research Fellowships for Young Scientists. This work was supported by a Specialized Center of Research grant from the Leukemia & Lymphoma Society (S. F. D.), the Elsa U. Pardee Foundation (S. F. D.), the Howard Hughes Medical Institute (S. F. D.) and the California Institute for Regenerative Medicine (S. F. D.).	Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Meade BR, 2008, ADV DRUG DELIVER REV, V60, P530, DOI 10.1016/j.addr.2007.10.004; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Turner JJ, 2007, BLOOD CELL MOL DIS, V38, P1, DOI 10.1016/j.bcmd.2006.10.003; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174	20	276	302	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2009	27	6					567	U110		10.1038/nbt.1541	http://dx.doi.org/10.1038/nbt.1541			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	458AC	19448630	Green Accepted			2022-12-25	WOS:000266980500027
J	Guernsey, DL; Jiang, H; Campagna, DR; Evans, SC; Ferguson, M; Kellogg, MD; Lachance, M; Matsuoka, M; Nightingale, M; Rideout, A; Saint-Amant, L; Schmidt, PJ; Orr, A; Bottomley, SS; Fleming, MD; Ludman, M; Dyack, S; Fernandez, CV; Samuels, ME				Guernsey, Duane L.; Jiang, Haiyan; Campagna, Dean R.; Evans, Susan C.; Ferguson, Meghan; Kellogg, Mark D.; Lachance, Mathieu; Matsuoka, Makoto; Nightingale, Mathew; Rideout, Andrea; Saint-Amant, Louis; Schmidt, Paul J.; Orr, Andrew; Bottomley, Sylvia S.; Fleming, Mark D.; Ludman, Mark; Dyack, Sarah; Fernandez, Conrad V.; Samuels, Mark E.			Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEOME; DEFECTS	The sideroblastic anemias are a heterogeneous group of congenital and acquired hematological disorders whose morphological hallmark is the presence of ringed sideroblasts-bone marrow erythroid precursors containing pathologic iron deposits within mitochondria. Here, by positional cloning, we define a previously unknown form of autosomal recessive nonsyndromic congenital sideroblastic anemia, associated with mutations in the gene encoding the erythroid specific mitochondrial carrier family protein SLC25A38, and demonstrate that SLC25A38 is important for the biosynthesis of heme in eukaryotes.	[Samuels, Mark E.] Univ Montreal, CHU Ste Justine, Ctr Rech, Montreal, PQ, Canada; [Guernsey, Duane L.; Jiang, Haiyan; Evans, Susan C.; Matsuoka, Makoto; Nightingale, Mathew] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Campagna, Dean R.; Schmidt, Paul J.; Fleming, Mark D.] Childrens Hosp Boston, Dept Pathol, Boston, MA USA; [Campagna, Dean R.; Schmidt, Paul J.; Fleming, Mark D.] Harvard Univ, Sch Med, Boston, MA USA; [Ferguson, Meghan; Rideout, Andrea] IWK Hlth Ctr, Maritime Med Genet Serv, Halifax, NS, Canada; [Kellogg, Mark D.] Childrens Hosp Boston, Dept Lab Med, Boston, MA USA; [Lachance, Mathieu; Saint-Amant, Louis] Univ Montreal, Dept Pathol, GRSNC, Montreal, PQ H3C 3J7, Canada; [Orr, Andrew] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS B3K 6R8, Canada; [Bottomley, Sylvia S.] Univ Oklahoma, Coll Med, Hematol Oncol Sect, Dept Med, Oklahoma City, OK 73190 USA; [Ludman, Mark; Dyack, Sarah] IWK Hlth Ctr, Div Med Genet, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Fernandez, Conrad V.] IWK Hlth Ctr, Div Hematol & Oncol, Dept Pediat, Halifax, NS B3K 6R8, Canada	Universite de Montreal; Dalhousie University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Dalhousie University; Harvard University; Boston Children's Hospital; Universite de Montreal; Dalhousie University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Dalhousie University; Dalhousie University	Samuels, ME (corresponding author), Univ Montreal, CHU Ste Justine, Ctr Rech, Montreal, PQ, Canada.	mark.e.samuels@umontreal.ca	Dyack, Sarah/AAD-4347-2020	Nightingale, Mat/0000-0003-1465-7911; Ludman, Mark/0000-0002-9658-6784; Orr, Andrew/0000-0002-9388-9034; Fleming, Mark/0000-0003-0948-4024; Fernandez, Conrad/0000-0002-0746-8306; Kellogg, Mark/0000-0003-1868-2153	Nova Scotia Health Research Foundation; Nova Scotia Research and Innovation Trust; IWK Health Centre Foundation; Dalhousie University; Capital Health Research Fund; Fonds de la Recherche en Santede Quebec; NIH [K01 DK074410, R01 DK080011]; US Department of Veterans Affairs; University of Oklahoma Health Sciences Center Provost's Fund; Oklahoma Center for Advancement of Science and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK074410, R01DK080011] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation; Nova Scotia Research and Innovation Trust; IWK Health Centre Foundation; Dalhousie University; Capital Health Research Fund; Fonds de la Recherche en Santede Quebec(Fonds de la Recherche en Sante du Quebec); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); University of Oklahoma Health Sciences Center Provost's Fund; Oklahoma Center for Advancement of Science and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge the participation of all the families with this genetic disorder. We thank P. Drapeau for advice on zebrafish physiology and experimentation and P. Wise and E. Wasson for expert technical assistance. The following agencies provided funding for this project: Genome Canada (M. E. S.), Genome Atlantic (M. E. S.), Nova Scotia Health Research Foundation (M. E. S.), Nova Scotia Research and Innovation Trust (M. E. S.), IWK Health Centre Foundation (M. E. S.), Dalhousie University (M. E. S.), Capital Health Research Fund (M. E. S.), Fonds de la Recherche en Santede Quebec (L. S.- A.), NIH K01 DK074410 (P. J. S.) and NIH R01 DK080011 (M. D. F.), The US Department of Veterans Affairs (S. S. B.), University of Oklahoma Health Sciences Center Provost's Fund (S. S. B.), and the Oklahoma Center for Advancement of Science and Technology (S. S. B.).	BOTTOMLEY SS, 1995, J BIOENERG BIOMEMBR, V27, P161, DOI 10.1007/BF02110031; Bottomley Sylvia S, 2006, Curr Hematol Rep, V5, P41; Camaschella C, 2008, BRIT J HAEMATOL, V143, P27, DOI 10.1111/j.1365-2141.2008.07290.x; Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5; Fleming MD, 2002, SEMIN HEMATOL, V39, P270, DOI 10.1053/shem.2002.35637; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; LESUISSE E, 1995, ANAL BIOCHEM, V226, P375, DOI 10.1006/abio.1995.1239; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f	14	176	186	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					651	653		10.1038/ng.359	http://dx.doi.org/10.1038/ng.359			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19412178				2022-12-25	WOS:000266411700012
J	Herrero-Mendez, A; Almeida, A; Fernandez, E; Maestre, C; Moncada, S; Bolanos, JP				Herrero-Mendez, Angel; Almeida, Angeles; Fernandez, Emilio; Maestre, Carolina; Moncada, Salvador; Bolanos, Juan P.			The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1	NATURE CELL BIOLOGY			English	Article							NITRIC-OXIDE; QUANTITATIVE-DETERMINATION; FRUCTOSE 2,6-BISPHOSPHATE; GLUCOSE-METABOLISM; RNA INTERFERENCE; PROTEIN-KINASE; RAT-BRAIN; PATHWAY; TISSUES; CELLS	Neurons are known to have a lower glycolytic rate than astrocytes and when stressed they are unable to upregulate glycolysis(1) because of low Pfkfb3 (6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-3) activity(2). This enzyme generates fructose-2,6- bisphosphate (F2,6P(2))(3), the most potent activator of 6-phosphofructo-1-kinase (Pfk1; ref. 4), a master regulator of glycolysis(5). Here, we show that Pfkfb3 is absent from neurons in the brain cortex and that Pfkfb3 in neurons is constantly subject to proteasomal degradation by the action of the E3 ubiquitin ligase(6), anaphase-promoting complex/cyclosome (APC/C)-Cdh1. By contrast, astrocytes have low APC/C-Cdh1 activity and therefore Pfkfb3 is present in these cells. Upregulation of Pfkfb3 by either inhibition of Cdh1 or overexpression of Pfkfb3 in neurons resulted in the activation of glycolysis. This, however, was accompanied by a marked decrease in the oxidation of glucose through the pentose phosphate pathway (a metabolic route involved in the regeneration of reduced glutathione(7))resulting in oxidative stress and apoptotic death. Thus, by actively downregulating glycolysis by APC/C-Cdh1, neurons use glucose to maintain their antioxidant status at the expense of its utilization for bioenergetic purposes.	[Herrero-Mendez, Angel; Almeida, Angeles; Fernandez, Emilio; Maestre, Carolina; Bolanos, Juan P.] Univ Salamanca, Dept Bioquim & Biol Mol, Inst Neurociencias Castilla & Leon, Salamanca 37007, Spain; [Almeida, Angeles; Maestre, Carolina] Hosp Univ Salamanca, Unidad Invest, Inst Estudios Ciencias Salud Castilla & Leon, Salamanca 37007, Spain; [Moncada, Salvador] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of Salamanca; University of Salamanca; University of London; University College London	Bolanos, JP (corresponding author), Univ Salamanca, Dept Bioquim & Biol Mol, Inst Neurociencias Castilla & Leon, Salamanca 37007, Spain.	s.moncada@ucl.ac.uk; jbolanos@usal.es	ALMEIDA, ANGELES/B-4727-2017; 2009, Secribsal/A-1266-2012; Maestre, Carolina/A-9662-2014; Bolaños, Juan Pedro/M-9518-2019	ALMEIDA, ANGELES/0000-0003-0485-8904; Maestre, Carolina/0000-0003-2480-8082; Bolaños, Juan Pedro/0000-0002-3949-6862	Ministerio de Ciencia e Innovacion [SAF2007-61492, CSD2007-00020]; Instituto de Salud Carlos-III [FIS06/0794]; Junta de Castilla y Leon [SA066A07]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos-III(Instituto de Salud Carlos IIIEuropean Commission); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Ministerio de Ciencia e Innovacion (SAF2007-61492 and Consolider-Ingenio CSD2007-00020, Spain), Instituto de Salud Carlos-III (FIS06/0794 and Renevas), and Junta de Castilla y Leon (SA066A07 and Red de Terapia Celular y Medicina Regenerativa). We would like to thank H. Yamano for valuable help with the APC/C-Cdh1 activity assays, Carmela Gomez-Rodriguez for immunohistochemistry experiments, M. Resch for technical assistance and A. Higgs for critical evaluation of this paper.	Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; BenYoseph O, 1996, J NEUROCHEM, V66, P2329; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886; COHEN SS, 1950, BIOL BULL, V99, P369; Gutmann I, 1974, METHOD ENZYMAT AN, P1464; HAMMERSTEDT RH, 1973, ANAL BIOCHEM, V56, P292, DOI 10.1016/0003-2697(73)90192-9; HOTHERSALL JS, 1979, ARCH BIOCHEM BIOPHYS, V198, P478, DOI 10.1016/0003-9861(79)90522-8; HUANG M, 1982, J BIOL CHEM, V257, P1358; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; KATZ J, 1965, J BIOL CHEM, V240; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; LARRABEE MG, 1990, BIOCHEM J, V272, P127, DOI 10.1042/bj2720127; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MICHAL G, 1985, METHOD ENZYMAT AN, P191; NOGALES PG, 2003, J BIOL CHEM, V278, P864; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Pfleger CM, 2000, GENE DEV, V14, P655; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Riera L, 2003, FEBS LETT, V550, P23, DOI 10.1016/S0014-5793(03)00808-1; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; THAUER RK, 1970, ANAL BIOCHEM, V38, P461, DOI 10.1016/0003-2697(70)90471-9; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Watanabe F, 1997, J NEUROCHEM, V69, P1	35	531	535	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					747	U105		10.1038/ncb1881	http://dx.doi.org/10.1038/ncb1881			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19448625				2022-12-25	WOS:000266503700020
J	Khan, AA; Betel, D; Miller, ML; Sander, C; Leslie, CS; Marks, DS				Khan, Aly A.; Betel, Doron; Miller, Martin L.; Sander, Chris; Leslie, Christina S.; Marks, Debora S.			Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs	NATURE BIOTECHNOLOGY			English	Article							TARGET MESSENGER-RNAS; DOUBLE-STRANDED-RNA; IN-VIVO; EXPRESSION; CANCER; SIRNAS; MICE; SPECIFICITY	Transfection of small RNAs (such as small interfering RNAs (siRNAs) and microRNAs (miRNAs)) into cells typically lowers expression of many genes. Unexpectedly, increased expression of genes also occurs. We investigated whether this upregulation results from a saturation effect-that is, competition among the transfected small RNAs and the endogenous pool of miRNAs for the intracellular machinery that processes small RNAs. To test this hypothesis, we analyzed genome-wide transcript responses from 151 published transfection experiments in seven different human cell types. We show that targets of endogenous miRNAs are expressed at significantly higher levels after transfection, consistent with impaired effectiveness of endogenous miRNA repression. This effect exhibited concentration and temporal dependence. Notably, the profile of endogenous miRNAs can be largely inferred by correlating miRNA sites with gene expression changes after transfections. The competition and saturation effects have practical implications for miRNA target prediction, the design of siRNA and short hairpin RNA (shRNA) genomic screens and siRNA therapeutics.	[Khan, Aly A.; Betel, Doron; Miller, Martin L.; Sander, Chris; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Khan, Aly A.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Miller, Martin L.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Marks, Debora S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Memorial Sloan Kettering Cancer Center; Columbia University; University of Copenhagen; Harvard University; Harvard Medical School	Leslie, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA.	cleslie@cbio.mskcc.org; deboramarks@gmail.com	Sander, Chris/H-1452-2011; Miller, Martin/D-4660-2009; Califano, Andrea/F-7239-2012	Sander, Chris/0000-0001-6059-6270; Betel, Doron/0000-0002-8006-7752; Miller, Martin L/0000-0003-3161-8690	National Institutes of Health (NIH) [CA124380]; NIH [CA121852]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA124380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Stroustrup, Y. Merbl, G. Altan-Bonnet, A. Arvey and N. Gauthier for useful discussions. This work was supported in part by National Institutes of Health (NIH) grant CA124380 and NIH grant CA121852.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Burchard J, 2009, RNA, V15, P308, DOI 10.1261/rna.1326809; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Fabani MM, 2008, RNA, V14, P336, DOI 10.1261/rna.844108; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gruber J, 2005, J CELL SCI, V118, P689, DOI 10.1242/jcs.01652; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; John M, 2007, NATURE, V449, P745, DOI 10.1038/nature06179; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Leachman SA, 2008, J DERMATOL SCI, V51, P151, DOI 10.1016/j.jdermsci.2008.04.003; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Lupberger Joachim, 2008, J Hepatol, V48, P523, DOI 10.1016/j.jhep.2007.12.007; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Oates AC, 2000, DEV BIOL, V224, P20, DOI 10.1006/dbio.2000.9761; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Robbins M, 2008, HUM GENE THER, V19, P991, DOI 10.1089/hum.2008.131; Rossi J, 2008, NAT MED, V14, P611, DOI 10.1038/nm0608-611; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shibata MA, 2008, CANCER GENE THER, V15, P776, DOI 10.1038/cgt.2008.43; Stenvang J, 2008, BIOCHEM SOC T, V36, P1197, DOI 10.1042/BST0361197; Stewart CK, 2008, BIOCHEM BIOPH RES CO, V370, P113, DOI 10.1016/j.bbrc.2008.03.041; Tam W, 2008, J MOL DIAGN, V10, P411, DOI 10.2353/jmoldx.2008.080067; Vankoningsloo S, 2008, FEBS J, V275, P2738, DOI 10.1111/j.1742-4658.2008.06415.x; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wargelius A, 1999, BIOCHEM BIOPH RES CO, V263, P156, DOI 10.1006/bbrc.1999.1343	52	354	382	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2009	27	6					549	U92		10.1038/nbt.1543	http://dx.doi.org/10.1038/nbt.1543			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	458AC	19465925	Green Accepted			2022-12-25	WOS:000266980500024
J	Levy, D; Ehret, GB; Rice, K; Verwoert, GC; Launer, LJ; Dehghan, A; Glazer, NL; Morrison, AC; Johnson, AD; Aspelund, T; Aulchenko, Y; Lumley, T; Kottgen, A; Vasan, RS; Rivadeneira, F; Eiriksdottir, G; Guo, XQ; Arking, DE; Mitchell, GF; Mattace-Raso, FUS; Smith, AV; Taylor, K; Scharpf, RB; Hwang, SJ; Sijbrands, EJG; Bis, J; Harris, TB; Ganesh, SK; O'Donnell, CJ; Hofman, A; Rotter, JI; Coresh, J; Benjamin, EJ; Uitterlinden, AG; Heiss, G; Fox, CS; Witteman, JCM; Boerwinkle, E; Wang, TJ; Gudnason, V; Larson, MG; Chakravarti, A; Psaty, BM; van Duijn, CM				Levy, Daniel; Ehret, Georg B.; Rice, Kenneth; Verwoert, Germaine C.; Launer, Lenore J.; Dehghan, Abbas; Glazer, Nicole L.; Morrison, Alanna C.; Johnson, Andrew D.; Aspelund, Thor; Aulchenko, Yurii; Lumley, Thomas; Koettgen, Anna; Vasan, Ramachandran S.; Rivadeneira, Fernando; Eiriksdottir, Gudny; Guo, Xiuqing; Arking, Dan E.; Mitchell, Gary F.; Mattace-Raso, Francesco U. S.; Smith, Albert V.; Taylor, Kent; Scharpf, Robert B.; Hwang, Shih-Jen; Sijbrands, Eric J. G.; Bis, Joshua; Harris, Tamara B.; Ganesh, Santhi K.; O'Donnell, Christopher J.; Hofman, Albert; Rotter, Jerome I.; Coresh, Josef; Benjamin, Emelia J.; Uitterlinden, Andre G.; Heiss, Gerardo; Fox, Caroline S.; Witteman, Jacqueline C. M.; Boerwinkle, Eric; Wang, Thomas J.; Gudnason, Vilmundur; Larson, Martin G.; Chakravarti, Aravinda; Psaty, Bruce M.; van Duijn, Cornelia M.			Genome-wide association study of blood pressure and hypertension	NATURE GENETICS			English	Article							GENETIC-VARIANTS; COMMON VARIANTS; SUSCEPTIBILITY; HEART; MUTATIONS; DISEASE; EXPRESSION; BURDEN; RISK	Blood pressure is a major cardiovascular disease risk factor. To date, few variants associated with interindividual blood pressure variation have been identified and replicated. Here we report results of a genome-wide association study of systolic (SBP) and diastolic (DBP) blood pressure and hypertension in the CHARGE Consortium (n = 29,136), identifying 13 SNPs for SBP, 20 for DBP and 10 for hypertension at P < 4 x 10(-7). The top ten loci for SBP and DBP were incorporated into a risk score; mean BP and prevalence of hypertension increased in relation to the number of risk alleles carried. When ten CHARGE SNPs for each trait were included in a joint meta-analysis with the Global BPgen Consortium (n = 34,433), four CHARGE loci attained genome-wide significance (P < 5 x 10(-8)) for SBP (ATP2B1, CYP17A1, PLEKHA7, SH2B3), six for DBP (ATP2B1, CACNB2, CSK-ULK3, SH2B3, TBX3-TBX5, ULK4) and one for hypertension (ATP2B1). Identifying genes associated with blood pressure advances our understanding of blood pressure regulation and highlights potential drug targets for the prevention or treatment of hypertension.	[Levy, Daniel; Johnson, Andrew D.; Vasan, Ramachandran S.; Hwang, Shih-Jen; O'Donnell, Christopher J.; Benjamin, Emelia J.; Fox, Caroline S.; Wang, Thomas J.; Larson, Martin G.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Levy, Daniel; Johnson, Andrew D.; Hwang, Shih-Jen; O'Donnell, Christopher J.; Fox, Caroline S.] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Ehret, Georg B.; Arking, Dan E.; Ganesh, Santhi K.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Ehret, Georg B.] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland; [Rice, Kenneth; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Verwoert, Germaine C.; Dehghan, Abbas; Aulchenko, Yurii; Rivadeneira, Fernando; Mattace-Raso, Francesco U. S.; Hofman, Albert; Uitterlinden, Andre G.; Witteman, Jacqueline C. M.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Mattace-Raso, Francesco U. S.] Erasmus MC, Dept Internal Med, Geriatr Med Sect, Rotterdam, Netherlands; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Dermog & Biometry, Bethesda, MD 20892 USA; [Glazer, Nicole L.; Bis, Joshua] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Glazer, Nicole L.; Bis, Joshua] Univ Washington, Dept Med, Seattle, WA USA; [Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Koettgen, Anna; Coresh, Josef; Chakravarti, Aravinda] Johns Hopkins Univ, Dept Epidemiol & Med, Baltimore, MD USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Cardiol, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Prevent Med, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Epidemiol Sect, Boston, MA USA; [Guo, Xiuqing; Taylor, Kent; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA USA; [Scharpf, Robert B.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Ganesh, Santhi K.] NHGRI, Vasc Biol Sect, Bethesda, MD 20892 USA; [Heiss, Gerardo] Carolina Cardiovasc Biol Ctr, Chapel Hill, NC USA; [Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of Geneva; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; Icelandic Heart Association; University of Iceland; Johns Hopkins University; Boston University; Boston University; Boston University; Boston University; Cedars Sinai Medical Center; Cardiovascular Engineering; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Levy, D (corresponding author), Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA.	levyd@nhlbi.nih.gov; c.vanduijn@erasmusmc.nl	Gudnason, Vilmundur/AAE-7126-2019; Raso, Francesco Mattace-/L-2541-2015; Rivadeneira, Fernando/O-5385-2015; EHRET, Georg B/A-9532-2009; Dehghan, Abbas/ABE-7377-2020; Aspelund, Thor/K-7022-2019; Rice, Kenneth M/A-4150-2013; Kottgen, Anna/D-2920-2012; Levy, Daniel/ABF-6873-2021; Gudnason, Vilmundur/K-6885-2015; Smith, Albert Vernon/K-5150-2015; Hwang, Shih-Jen/HGU-5826-2022; Aspelund, Thor/F-4826-2011; Ramachandran, Vasan/Y-2527-2019; Launer, Lenore J/A-8218-2010; Levy, Daniel/ABB-2752-2021; Aspelund, Thor/C-5983-2008; Aulchenko, Yurii/M-8270-2013; Rotter, Jerome/AAY-6598-2021; Johnson, Andrew D/G-6520-2013; Sijbrands, Eric/A-1065-2009; Benjamin, Emelia/E-7103-2011; Dehghan, Abbas/B-9896-2008	Gudnason, Vilmundur/0000-0001-5696-0084; Rivadeneira, Fernando/0000-0001-9435-9441; EHRET, Georg B/0000-0002-5730-0675; Aspelund, Thor/0000-0002-7998-5433; Rice, Kenneth M/0000-0001-5779-4495; Levy, Daniel/0000-0003-1843-8724; Gudnason, Vilmundur/0000-0001-5696-0084; Smith, Albert Vernon/0000-0003-1942-5845; Ramachandran, Vasan/0000-0001-7357-5970; Aspelund, Thor/0000-0002-7998-5433; Aulchenko, Yurii/0000-0002-7899-1575; Johnson, Andrew D/0000-0001-6369-5178; Sijbrands, Eric/0000-0001-8857-7389; Wang, Thomas/0000-0003-4063-6508; Van Duijn, Cornelia/0000-0002-2374-9204; Glazer, Nicole/0000-0002-6397-609X; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336; Morrison, Alanna/0000-0001-6381-4296; Dehghan, Abbas/0000-0001-6403-016X; Mattace-Raso, Francesco/0000-0002-1688-6497; Ballantyne, Christie/0000-0002-6432-1730	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, ZIAHL006001, N01HC55021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007420, ZIAAG007380, ZIAAG007270] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [UL1 RR025005-01, UL1 RR025005, UL1RR025005] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402, U01 HG004402-01, U01HG004402] Funding Source: Medline; NHLBI NIH HHS [R37 HL051021-10, R01 HL087652, N01 HC055018, N01-HC-55016, N01 HC015103, N01HC55021, N01HC55022, N01-HC-85082, N01 HC055019, N01-HC-55018, U10HL054512, R01 HL086694-01A1, N01 HC055022, R01 HL059367, N01-HC-85081, N01-HC-55022, N01 HC075150, U01 HL080295, N01-HC-85084, U10 HL054512, N01 HC055016, N01 HC-55222, N01-HC-55019, U10 HL054512-05, R01HL086694, N01-HC-55015, N01-HC-25195, R01 HL086694, N01HC55222, N01 HC055222, N01-HC-55021, N01 HC085086, R01 HL059367-02, N01HC55018, N01-HC-75150, N01-HC-85085, N01-HC-55020, N01-HC-85080, R01HL59367, R01HL087641, N01HC55016, N01 HC025195, R37 HL051021-15, R37 HL051021, N01 HC045133, N01HC85079, N01 HC085079, N01 HC035129, R01 HL087641, N01HC55019, R01 HL087641-01, R37HL051021, N01 HC055021, N01HC55020, N01-HC-85079, N01-HC-85086, N01HC55015, R37 HL051021-13, R01 HL087652-01, R37 HL051021-14, R37 HL051021-06, N02 HL64278, R37 HL051021-12, N01HC75150, N01HC25195, U01 HL080295-01, N01HC85086, N01 HC055020, N01-HC-85083, R37 HL051021-11, N01 HC055015, N02-HL-6-4278] Funding Source: Medline; NIA NIH HHS [N01AG12100, N01 AG012100] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491-029004, P30 DK063491-019004, P30 DK063491-049004, P30 DK063491-039004, P30 DK063491] Funding Source: Medline; PHS HHS [HHSN268200625226C] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Costa-Santos M, 2004, J CLIN ENDOCR METAB, V89, P49, DOI 10.1210/jc.2003-031021; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; Koivukoski L, 2004, HUM MOL GENET, V13, P2325, DOI 10.1093/hmg/ddh237; Lao QZ, 2008, J BIOL CHEM, V283, P15577, DOI 10.1074/jbc.M802035200; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Li Y, 2006, AM J HUM GENET S, VS79, P2290; LIFTON RP, 1995, P NATL ACAD SCI USA, V92, P8545, DOI 10.1073/pnas.92.19.8545; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monteith GR, 1997, BIOCHEM BIOPH RES CO, V230, P344, DOI 10.1006/bbrc.1996.5956; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Pande J, 2006, AM J PHYSIOL-CELL PH, V290, pC1341, DOI 10.1152/ajpcell.00573.2005; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sayeski PP, 2003, EXP CELL RES, V287, P339, DOI 10.1016/S0014-4827(03)00154-X; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Senn S, 2007, STAT MED, V26, P1417, DOI 10.1002/sim.2639; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Vogel V, 1999, CLIN SCI, V97, P91, DOI 10.1042/CS19980369; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Yang J, 2006, J CLIN ENDOCR METAB, V91, P3619, DOI 10.1210/jc.2005-2283	47	964	1007	0	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					677	687		10.1038/ng.384	http://dx.doi.org/10.1038/ng.384			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19430479	Green Submitted, Green Accepted			2022-12-25	WOS:000266411700016
J	Newton-Cheh, C; Johnson, T; Gateva, V; Tobin, MD; Bochud, M; Coin, L; Najjar, SS; Zhao, JH; Heath, SC; Eyheramendy, S; Papadakis, K; Voight, BF; Scott, LJ; Zhang, F; Farrall, M; Tanaka, T; Wallace, C; Chambers, JC; Khaw, KT; Nilsson, P; van der Harst, P; Polidoro, S; Grobbee, DE; Onland-Moret, NC; Bots, ML; Wain, LV; Elliott, KS; Teumer, A; Luan, J; Lucas, G; Kuusisto, J; Burton, PR; Hadley, D; McArdle, WL; Brown, M; Dominiczak, A; Newhouse, SJ; Samani, NJ; Webster, J; Zeggini, E; Beckmann, JS; Bergmann, S; Lim, N; Song, K; Vollenweider, P; Waeber, G; Waterworth, DM; Yuan, X; Groop, L; Orho-Melander, M; Allione, A; Di Gregorio, A; Guarrera, S; Panico, S; Ricceri, F; Romanazzi, V; Sacerdote, C; Vineis, P; Barroso, I; Sandhu, MS; Luben, RN; Crawford, GJ; Jousilahti, P; Perola, M; Boehnke, M; Bonnycastle, LL; Collins, FS; Jackson, AU; Mohlke, KL; Stringham, HM; Valle, TT; Willer, CJ; Bergman, RN; Morken, MA; Doring, A; Gieger, C; Illig, T; Meitinger, T; Org, E; Pfeufer, A; Wichmann, HE; Kathiresan, S; Marrugat, J; O'Donnell, CJ; Schwartz, SM; Siscovick, DS; Subirana, I; Freimer, NB; Hartikainen, AL; McCarthy, MI; O'Reilly, PF; Peltonen, L; Pouta, A; de Jong, PE; Snieder, H; van Gilst, WH; Clarke, R; Goel, A; Hamsten, A; Peden, JF; Seedorf, U; Syvanen, AC; Tognoni, G; Lakatta, EG; Sanna, S; Scheet, P; Schlessinger, D; Scuteri, A; Dorr, M; Ernst, F; Felix, SB; Homuth, G; Lorbeer, R; Reffelmann, T; Rettig, R; Volker, U; Galan, P; Gut, IG; Hercberg, S; Lathrop, GM; Zelenika, D; Deloukas, P; Soranzo, N; Williams, FM; Zhai, G; Salomaa, V; Laakso, M; Elosua, R; Forouhi, NG; Volzke, H; Uiterwaal, CS; van der Schouw, YT; Numans, ME; Matullo, G; Navis, G; Berglund, G; Bingham, SA; Kooner, JS; Connell, JM; Bandinelli, S; Ferrucci, L; Watkins, H; Spector, TD; Tuomilehto, J; Altshuler, D; Strachan, DP; Laan, M; Meneton, P; Wareham, NJ; Uda, M; Jarvelin, MR; Mooser, V; Melander, O; Loos, RJF; Elliott, P; Abecasis, GR; Caulfield, M; Munroe, PB				Newton-Cheh, Christopher; Johnson, Toby; Gateva, Vesela; Tobin, Martin D.; Bochud, Murielle; Coin, Lachlan; Najjar, Samer S.; Zhao, Jing Hua; Heath, Simon C.; Eyheramendy, Susana; Papadakis, Konstantinos; Voight, Benjamin F.; Scott, Laura J.; Zhang, Feng; Farrall, Martin; Tanaka, Toshiko; Wallace, Chris; Chambers, John C.; Khaw, Kay-Tee; Nilsson, Peter; van der Harst, Pim; Polidoro, Silvia; Grobbee, Diederick E.; Onland-Moret, N. Charlotte; Bots, Michiel L.; Wain, Louise V.; Elliott, Katherine S.; Teumer, Alexander; Luan, Jian'an; Lucas, Gavin; Kuusisto, Johanna; Burton, Paul R.; Hadley, David; McArdle, Wendy L.; Brown, Morris; Dominiczak, Anna; Newhouse, Stephen J.; Samani, Nilesh J.; Webster, John; Zeggini, Eleftheria; Beckmann, Jacques S.; Bergmann, Sven; Lim, Noha; Song, Kijoung; Vollenweider, Peter; Waeber, Gerard; Waterworth, Dawn M.; Yuan, Xin; Groop, Leif; Orho-Melander, Marju; Allione, Alessandra; Di Gregorio, Alessandra; Guarrera, Simonetta; Panico, Salvatore; Ricceri, Fulvio; Romanazzi, Valeria; Sacerdote, Carlotta; Vineis, Paolo; Barroso, Ines; Sandhu, Manjinder S.; Luben, Robert N.; Crawford, Gabriel J.; Jousilahti, Pekka; Perola, Markus; Boehnke, Michael; Bonnycastle, Lori L.; Collins, Francis S.; Jackson, Anne U.; Mohlke, Karen L.; Stringham, Heather M.; Valle, Timo T.; Willer, Cristen J.; Bergman, Richard N.; Morken, Mario A.; Doering, Angela; Gieger, Christian; Illig, Thomas; Meitinger, Thomas; Org, Elin; Pfeufer, Arne; Wichmann, H. Erich; Kathiresan, Sekar; Marrugat, Jaume; O'Donnell, Christopher J.; Schwartz, Stephen M.; Siscovick, David S.; Subirana, Isaac; Freimer, Nelson B.; Hartikainen, Anna-Liisa; McCarthy, Mark I.; O'Reilly, Paul F.; Peltonen, Leena; Pouta, Anneli; de Jong, Paul E.; Snieder, Harold; van Gilst, Wiek H.; Clarke, Robert; Goel, Anuj; Hamsten, Anders; Peden, John F.; Seedorf, Udo; Syvanen, Ann-Christine; Tognoni, Giovanni; Lakatta, Edward G.; Sanna, Serena; Scheet, Paul; Schlessinger, David; Scuteri, Angelo; Doerr, Marcus; Ernst, Florian; Felix, Stephan B.; Homuth, Georg; Lorbeer, Roberto; Reffelmann, Thorsten; Rettig, Rainer; Voelker, Uwe; Galan, Pilar; Gut, Ivo G.; Hercberg, Serge; Lathrop, G. Mark; Zelenika, Diana; Deloukas, Panos; Soranzo, Nicole; Williams, Frances M.; Zhai, Guangju; Salomaa, Veikko; Laakso, Markku; Elosua, Roberto; Forouhi, Nita G.; Volzke, Henry; Uiterwaal, Cuno S.; van der Schouw, Yvonne T.; Numans, Mattijs E.; Matullo, Giuseppe; Navis, Gerjan; Berglund, Goran; Bingham, Sheila A.; Kooner, Jaspal S.; Connell, John M.; Bandinelli, Stefania; Ferrucci, Luigi; Watkins, Hugh; Spector, Tim D.; Tuomilehto, Jaakko; Altshuler, David; Strachan, David P.; Laan, Maris; Meneton, Pierre; Wareham, Nicholas J.; Uda, Manuela; Jarvelin, Marjo-Riitta; Mooser, Vincent; Melander, Olle; Loos, Ruth J. F.; Elliott, Paul; Abecasis, Goncalo R.; Caulfield, Mark; Munroe, Patricia B.		Wellcome Trust Case Control Consor	Genome-wide association study identifies eight loci associated with blood pressure	NATURE GENETICS			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; COMMON VARIANTS; CELL-DIFFERENTIATION; BARTTERS-SYNDROME; PUBLIC-HEALTH; RISK; MUTATIONS; HYPERTENSION; POLYMORPHISM; METAANALYSIS	Elevated blood pressure is a common, heritable cause of cardiovascular disease worldwide. To date, identification of common genetic variants influencing blood pressure has proven challenging. We tested 2.5 million genotyped and imputed SNPs for association with systolic and diastolic blood pressure in 34,433 subjects of European ancestry from the Global BPgen consortium and followed up findings with direct genotyping (N <= 71,225 European ancestry, N <= 12,889 Indian Asian ancestry) and in silico comparison (CHARGE consortium, N 29,136). We identified association between systolic or diastolic blood pressure and common variants in eight regions near the CYP17A1 (P = 7 x 10(-24)), CYP1A2 (P = 1 x 10(-23)), FGF5 (P = 1 x 10(-21)), SH2B3 (P = 3 x 10(-18)), MTHFR (P = 2 x 10(-13)), c10orf107 (P = 1 x 10(-9)), ZNF652 (P = 5 x 10(-9)) and PLCD3 (P = 1 x 10(-8)) genes. All variants associated with continuous blood pressure were associated with dichotomous hypertension. These associations between common variants and blood pressure and hypertension offer mechanistic insights into the regulation of blood pressure and may point to novel targets for interventions to prevent cardiovascular disease.	[Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Newton-Cheh, Christopher; Voight, Benjamin F.; Kathiresan, Sekar; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Voight, Benjamin F.; Crawford, Gabriel J.; Kathiresan, Sekar; Altshuler, David] Harvard & Massachusetts Inst Technol, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; [Johnson, Toby; Beckmann, Jacques S.; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Johnson, Toby; Bochud, Murielle] CHU Vaudois, Univ Inst Social & Preventat Med, CH-1011 Lausanne, Switzerland; [Johnson, Toby; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Gateva, Vesela; Scott, Laura J.; Boehnke, Michael; Jackson, Anne U.; Stringham, Heather M.; Willer, Cristen J.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Gateva, Vesela; Scott, Laura J.; Boehnke, Michael; Jackson, Anne U.; Stringham, Heather M.; Willer, Cristen J.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Tobin, Martin D.; Wain, Louise V.; Burton, Paul R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Tobin, Martin D.; Wain, Louise V.; Burton, Paul R.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Coin, Lachlan; Chambers, John C.; Vineis, Paolo; O'Reilly, Paul F.; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Najjar, Samer S.; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Zhao, Jing Hua; Luan, Jian'an; Sandhu, Manjinder S.; Forouhi, Nita G.; Wareham, Nicholas J.; Loos, Ruth J. F.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Zhao, Jing Hua; Khaw, Kay-Tee; Barroso, Ines; Sandhu, Manjinder S.; Luben, Robert N.; Deloukas, Panos; Bingham, Sheila A.; Wareham, Nicholas J.; Loos, Ruth J. F.] Cambridge Genet Energy Metab GEM Consortium, Cambridge, England; [Heath, Simon C.; Gut, Ivo G.; Lathrop, G. Mark; Zelenika, Diana] Ctr Natl Genotypage, Evry, France; [Eyheramendy, Susana] Pontificia Univ Catolica Chile, Fac Matemat, Santiago, Chile; [Eyheramendy, Susana; Doering, Angela; Gieger, Christian; Illig, Thomas; Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Papadakis, Konstantinos; Hadley, David; Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Zhang, Feng; Soranzo, Nicole; Williams, Frances M.; Zhai, Guangju; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Farrall, Martin; Goel, Anuj; Peden, John F.; Watkins, Hugh] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Farrall, Martin; Elliott, Katherine S.; Zeggini, Eleftheria; McCarthy, Mark I.; Goel, Anuj; Watkins, Hugh] Wellcome Trust Ctr Human Genet, Oxford, England; [Tanaka, Toshiko] Medstar Res Inst, Baltimore, MD USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Wallace, Chris; Newhouse, Stephen J.; Caulfield, Mark; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Genome Ctr, London, England; [Wallace, Chris] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 2QQ, England; [Khaw, Kay-Tee; Sandhu, Manjinder S.; Luben, Robert N.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Nilsson, Peter; Orho-Melander, Marju; Berglund, Goran; Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden; [van der Harst, Pim; van Gilst, Wiek H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Polidoro, Silvia; Di Gregorio, Alessandra; Guarrera, Simonetta; Ricceri, Fulvio; Romanazzi, Valeria; Vineis, Paolo; Matullo, Giuseppe] ISI Fdn Inst Sci Interchange, Turin, Italy; [Grobbee, Diederick E.; Onland-Moret, N. Charlotte; Bots, Michiel L.; Uiterwaal, Cuno S.; van der Schouw, Yvonne T.; Numans, Mattijs E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Onland-Moret, N. Charlotte] Univ Med Ctr Utrecht, Dept Med Genet DBG, Complex Genet Sect, Utrecht, Netherlands; [Teumer, Alexander; Ernst, Florian; Homuth, Georg; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Lucas, Gavin; Marrugat, Jaume; Subirana, Isaac; Elosua, Roberto] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, ALSPAC Lab, Bristol, Avon, England; [Brown, Morris] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Dominiczak, Anna; Connell, John M.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Webster, John] Aberdeen Royal Infirm, Aberdeen, Scotland; [Zeggini, Eleftheria; Barroso, Ines; Peltonen, Leena; Deloukas, Panos; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge, England; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Lim, Noha; Song, Kijoung; Waterworth, Dawn M.; Yuan, Xin; Mooser, Vincent] GlaxoSmithKline, Div Genet, King Of Prussia, PA USA; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Groop, Leif] Univ Hosp, Diabet & Endocrinol Res Unit, Dept Clin Sci, Malmo, Sweden; [Groop, Leif] Lund Univ, Malmo, Sweden; [Di Gregorio, Alessandra; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Sacerdote, Carlotta; Peltonen, Leena] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Sacerdote, Carlotta; Peltonen, Leena] Ctr Canc Epidemiol & Prevent CPO Piemonte, Turin, Italy; [Jousilahti, Pekka; Perola, Markus; Salomaa, Veikko] Natl Inst Welf & Hlth, Helsinki, Finland; [Perola, Markus] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland; [Bonnycastle, Lori L.; Collins, Francis S.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Valle, Timo T.; Morken, Mario A.; Tuomilehto, Jaakko] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet Unit, Helsinki, Finland; [Bergman, Richard N.] Univ So Calif, Sch Med, Los Angeles, CA USA; [Meitinger, Thomas; Pfeufer, Arne] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas; Pfeufer, Arne] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Org, Elin; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Wichmann, H. Erich] Univ Munich, IBE, Chair Epidemiol, Munich, Germany; [O'Donnell, Christopher J.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [O'Donnell, Christopher J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [O'Donnell, Christopher J.] Framingham Heart Study & Natl Heart Lung & Bloo, Framingham, MA USA; [Schwartz, Stephen M.; Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Schwartz, Stephen M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Subirana, Isaac; Elosua, Roberto] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Freimer, Nelson B.] Univ Calif Los Angeles, Gonda Ctr, Ctr Neurobehav Genet, Los Angeles, CA USA; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Publ Hlth Inst KTL, Dept Child & Adolescent Hlth, Oulu, Finland; [de Jong, Paul E.; Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Med, Div Nephrol, Groningen, Netherlands; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Clarke, Robert] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Hamsten, Anders] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med Solna,Atherosclerosis Res Unit, Stockholm, Sweden; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Tognoni, Giovanni] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Chieti, Italy; [Sanna, Serena; Uda, Manuela] CNR, Inst Neurogenet & Neurofarmacol, Cagliari, Italy; [Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Schlessinger, David] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Scuteri, Angelo] IRCCS, INRCA, Unita Operat Geriatria, Rome, Italy; [Doerr, Marcus; Felix, Stephan B.; Reffelmann, Thorsten] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med B, Greifswald, Germany; [Lorbeer, Roberto; Navis, Gerjan] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Rettig, Rainer] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, Greifswald, Germany; [Galan, Pilar; Hercberg, Serge] Univ Paris 13, Inst Natl Rech Agron, Inst Natl Sante & Rech Med, U557, Bobigny, France; [Bingham, Sheila A.] Wellcome Trust Res Labs, MRC Dunn Human Nutr Unit, Cambridge, England; [Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Bandinelli, Stefania] ASF, Geriatr Rehabil Unit, Florence, Italy; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Meneton, Pierre] Fac Med Paris Descartes, Inst Natl Sante & Rech Med, U872, Paris, France; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Seedorf, Udo] Univ Munster, Leibniz Inst Arterioskleroseforsch, Munster, Germany	University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Leicester; University of Leicester; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; CEA; UDICE-French Research Universities; Universite Paris Saclay; Pontificia Universidad Catolica de Chile; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; University of London; King's College London; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; Queen Mary University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Lund University; Skane University Hospital; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Ernst Moritz Arndt Universitat Greifswald; University of Eastern Finland; University of Bristol; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Glasgow; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Aberdeen; Wellcome Trust Sanger Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Lund University; Skane University Hospital; Lund University; University of Turin; University of Naples Federico II; University of Turin; Finland National Institute for Health & Welfare; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of North Carolina; University of North Carolina Chapel Hill; Finland National Institute for Health & Welfare; University of Southern California; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Tartu; University of Munich; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of California System; University of California Los Angeles; University of Oulu; University of Oxford; University of Oxford; Finland National Institute for Health & Welfare; University of Groningen; University of Groningen; University of Oxford; University of Oxford; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consiglio Nazionale delle Ricerche (CNR); University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); IRCCS INRCA; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Wellcome Trust Sanger Institute; Imperial College London; University of Helsinki; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oulu; University of Oulu; University of Munster	Abecasis, GR (corresponding author), Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	cnewtoncheh@chgr.mgh.harvard.edu; goncalo@umich.edu; m.j.caulfield@qmul.ac.uk; p.b.munroe@qmul.ac.uk	Loos, Ruth/GON-5877-2022; van der Schouw, Yvonne T./F-8327-2014; Voight, Benjamin/F-1775-2011; Pilar, Galan/F-2908-2017; Coin, Lachlan/O-4976-2019; sanna, serena/H-3009-2019; Polidoro, Silvia/GYJ-3517-2022; Ricceri, Fulvio/I-9910-2018; Onland-Moret, N. Charlotte/G-9185-2011; Loos, Ruth J F/Q-2862-2016; HERCBERG, Serge/B-4429-2008; Dörr, Marcus/F-1919-2010; Brown, Matthew A/E-5749-2010; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Grobbee, Diederick/C-7651-2014; Wichmann, Heinz Erich/AAA-5695-2022; eyre, stephen/K-3776-2017; Lakatta, Edward G/AAL-1447-2020; Burton, Paul R/H-7527-2016; Teumer, Alexander/S-7438-2019; Beckmann, Jacques S/A-9772-2008; Panico, Salvatore/K-6506-2016; Coin, Lachlan JM/A-9001-2014; Deloukas, Panos/B-2922-2013; bandinelli, stefania/AAL-4570-2020; Org, Elin/AAJ-9631-2021; Spector, Tim D/F-6533-2012; Altshuler, David M/A-4476-2009; Guarrera, Simonetta/AAB-8482-2022; Dominiczak, Anna F/P-9390-2017; O'Donovan, Michael C/P-7005-2018; Laan, Maris/A-4100-2011; Mathew, Christopher G/G-3434-2015; van Gilst, Wiek H/C-3828-2008; Timpson, Nicholas John/O-7548-2015; Heath, Simon C/J-4138-2012; Newhouse, Stephen J/C-9330-2011; Lim, Noha/ABA-2509-2020; Breen, Gerome/Y-2706-2019; Serge, Hercberg/F-3038-2017; van Gilst, Wiek/R-1806-2019; Khaw, Kay-Tee/AAZ-3209-2021; Abecasis, Goncalo R/B-7840-2010; Dominiczak, Anna F/D-2262-2009; Bochud, Murielle/A-3981-2010; Luben, Robert N/H-5519-2015; Hinks, Anne/E-1853-2015; Meneton, Pierre/T-1216-2019; Worthington, Jane/M-9770-2014; Matullo, Giuseppe/K-6383-2016; Meitinger, Thomas/O-1318-2015; Pfeufer, Arne/B-6634-2013; Colaus, PsyColaus/K-6607-2013; Attrill, Lauren/V-1688-2018; Gut, Ivo/ABF-3188-2020; Lucas, Gavin/D-4346-2012; Hadley, David/I-6902-2012; Uda, Manuela/AAC-2645-2019; Prescott, Natalie/F-6490-2011; dobson, richard/C-9269-2011; Barton, Anne/N-2053-2014; Evans, David/H-6325-2013; McCarthy, Mark/M-3763-2015	van der Schouw, Yvonne T./0000-0002-4605-435X; Pilar, Galan/0000-0003-1706-3107; Coin, Lachlan/0000-0002-4300-455X; sanna, serena/0000-0002-3768-1749; Ricceri, Fulvio/0000-0001-8749-9737; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Loos, Ruth J F/0000-0002-8532-5087; HERCBERG, Serge/0000-0002-3168-1350; Dörr, Marcus/0000-0001-7471-475X; Brown, Matthew A/0000-0003-0538-8211; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Grobbee, Diederick/0000-0003-4472-4468; eyre, stephen/0000-0002-1251-6974; Teumer, Alexander/0000-0002-8309-094X; Beckmann, Jacques S/0000-0002-9741-1900; Panico, Salvatore/0000-0002-5498-8312; Coin, Lachlan JM/0000-0002-4300-455X; Deloukas, Panos/0000-0001-9251-070X; Altshuler, David M/0000-0002-7250-4107; Dominiczak, Anna F/0000-0003-4913-3608; O'Donovan, Michael C/0000-0001-7073-2379; Laan, Maris/0000-0002-8519-243X; Mathew, Christopher G/0000-0003-4178-1838; Timpson, Nicholas John/0000-0002-7141-9189; Heath, Simon C/0000-0002-9550-0897; Newhouse, Stephen J/0000-0002-1843-9842; Breen, Gerome/0000-0003-2053-1792; Serge, Hercberg/0000-0002-3168-1350; van Gilst, Wiek/0000-0003-2968-8585; Bochud, Murielle/0000-0002-5727-0218; Luben, Robert N/0000-0002-5088-6343; Hinks, Anne/0000-0001-8843-3967; Worthington, Jane/0000-0003-0544-042X; Matullo, Giuseppe/0000-0003-0674-7757; Gut, Ivo/0000-0001-7219-632X; Uda, Manuela/0000-0002-4890-6456; Zeggini, Eleftheria/0000-0003-4238-659X; Kirov, George/0000-0002-3427-3950; Hall, Alistair/0000-0003-0306-7887; Jones, Lisa/0000-0002-5122-8334; Watkins, Hugh/0000-0002-5287-9016; Lango Allen, Hana/0000-0002-7803-8688; O'Reilly, Paul/0000-0001-7515-0845; Seedorf, Udo/0000-0003-4652-5358; Sacerdote, Carlotta/0000-0002-8008-5096; Johnson, Toby/0000-0002-5998-3270; Symmons, Deborah/0000-0002-8625-1200; Willer, Cristen/0000-0001-5645-4966; Meitinger, Thomas/0000-0002-8838-8403; Org, Elin/0000-0001-8688-9717; Forouhi, Nita/0000-0002-5041-248X; Prescott, Natalie/0000-0002-5901-7371; Bergman, Richard/0000-0003-1539-4471; dobson, richard/0000-0003-4224-9245; Soranzo, Nicole/0000-0003-1095-3852; Lucas, Gavin/0000-0003-4166-9416; Bergmann, Sven/0000-0002-6785-9034; Melander, Olle/0000-0002-2581-484X; Bishop, Tim/0000-0002-8752-8785; Barton, Anne/0000-0003-3316-2527; SCUTERI, ANGELO/0000-0003-4784-5441; Wallace, Chris/0000-0001-9755-1703; Lakatta, Edward/0000-0002-4772-0035; Williams, Frances/0000-0002-2998-2744; Hattersley, Andrew/0000-0001-5620-473X; Lees, Charlie/0000-0002-0732-8215; Munroe, Patricia/0000-0002-4176-2947; Tobin, Martin/0000-0002-3596-7874; Newport, Melanie/0000-0002-8946-7525; Barrett, Jenny/0000-0002-1720-7724; s, hema/0000-0002-3440-9475; Dunger, Professor David/0000-0002-2566-9304; Evans, David/0000-0003-0663-4621; Volker, Uwe/0000-0002-5689-3448; Grozeva, Detelina/0000-0003-3239-8415; Bruce, Ian/0000-0003-3047-500X; Polidoro, Silvia/0000-0003-2968-0575; Young, Allan/0000-0003-2291-6952; Barroso, Ines/0000-0001-5800-4520; Voight, Benjamin/0000-0002-6205-9994; Lindgren, Cecilia/0000-0002-4903-9374; Goel, Anuj/0000-0003-2307-4021; Lee, Kathryn/0000-0001-6848-4767; Elliott, Paul/0000-0002-7511-5684; Org, Elin/0000-0003-1451-9375; Parkes, Miles/0000-0002-6467-0631; Wain, Louise/0000-0003-4951-1867; Allione, Alessandra/0000-0001-9599-309X; Gieger, Christian/0000-0001-6986-9554; Thomson, Wendy/0000-0002-9022-5179; McCarthy, Mark/0000-0002-4393-0510; Eyheramendy, Susana/0000-0003-4723-9660; Abecasis, Goncalo/0000-0003-1509-1825; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Cummings, Fraser/0000-0002-9659-3247; Weedon, Michael/0000-0002-6174-6135; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Caulfield, Mark/0000-0001-9295-3594; Waeber, Gerard/0000-0003-4193-788X; Simmonds, Matt/0000-0003-3154-3510; Marrugat, Jaume/0000-0003-3320-554X	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD013107] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL080025, R01HL087679, R01HL087676, R01HL056931, K23HL083102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062370, R01DK072193, U01DK062418, U01DK062370, R56DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000799, ZIAAG000015, ZIAAG000675, ZIAAG000965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER; British Heart Foundation [FS/05/061/19501, PG02/128, SP/04/002] Funding Source: Medline; Cancer Research UK [10589] Funding Source: Medline; Intramural NIH HHS [Z01 HG000024] Funding Source: Medline; Medical Research Council [MC_U105630924, G0800675, MC_U137686857, MC_U106188470, 85374, G0600329, G9521010, G0701863, G0400874, G0000934, G0401527, G9521010D, G0800759, MC_QA137934, G0801056, G0501942] Funding Source: Medline; NCRR NIH HHS [U54RR020278, U54 RR020278] Funding Source: Medline; NHGRI NIH HHS [1Z01HG000024] Funding Source: Medline; NHLBI NIH HHS [R01 HL087676, K23 HL080025, R01HL056931, R01 HL056931-04, K23HL083102, K23 HL080025-04, R01 HL056931-02, R01HL087676, K23 HL083102, R01 HL056931-03, R01HL087679, R01 HL087679, K23HL80025] Funding Source: Medline; NIA NIH HHS [N01AG-916413, N01-AG-1-2109, N01AG-821336] Funding Source: Medline; NICHD NIH HHS [N01-HD-1-3107] Funding Source: Medline; NIDA NIH HHS [U54DA021519, U54 DA021519] Funding Source: Medline; NIDDK NIH HHS [DK072193, R01 DK072193, U01DK062418, U01 DK062418, R01 DK062370, R56 DK062370, U01 DK062370, DK062370] Funding Source: Medline; NIEHS NIH HHS [P30 ES007033, P30ES007033] Funding Source: Medline; NIMHD NIH HHS [263MD821336, 263MD916413] Funding Source: Medline; NIMH NIH HHS [RL1 MH083268, RL1MH083268] Funding Source: Medline; PHS HHS [263-MA-410953] Funding Source: Medline; Wellcome Trust [077016, 061858, 090532, 077016/Z/05/Z, 088885, 068545/Z/02, 070191/Z/03/Z, 076113, 089061, 076113/B/04/Z, 077011, 079557, 079895, WT088885/Z/09/Z] Funding Source: Medline; Chief Scientist Office [CZB/4/540] Funding Source: Medline; MRC [G0000934, G0801056, G0501942, MC_U105630924, G0701863, MC_U137686857, G0800759, G0600329, G9521010, G0800675, MC_qA137934, MC_U106188470, G0400874] Funding Source: UKRI; Medical Research Council [MC_qA137934, G0801056B] Funding Source: researchfish	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 1978, J Chronic Dis, V31, P651; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Du YH, 2008, CIRCULATION, V117, P1045, DOI 10.1161/CIRCULATIONAHA.107.748236; DYER AR, 1994, AM J EPIDEMIOL, V139, P927, DOI 10.1093/oxfordjournals.aje.a117099; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HAVLIK RJ, 1979, AM J EPIDEMIOL, V110, P304, DOI 10.1093/oxfordjournals.aje.a112815; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin RM, 2003, J CLIN ENDOCR METAB, V88, P5739, DOI 10.1210/jc.2003-030988; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Newhouse SJ, 2005, HUM MOL GENET, V14, P1805, DOI 10.1093/hmg/ddi187; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Qian XQ, 2007, EUR J HUM GENET, V15, P1239, DOI 10.1038/sj.ejhg.5201914; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Sohda S, 1997, J MED GENET, V34, P525, DOI 10.1136/jmg.34.6.525; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vatner SF, 2005, CIRC RES, V96, P705, DOI 10.1161/01.RES.0000164184.63158.6c; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Watanabe M, 2002, CIRC RES, V91, P382, DOI 10.1161/01.RES.0000033593.05545.7B; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; WHO, 2002, RED RISKS PROM HLTH; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zheng JS, 2003, CIRCULATION, V108, P1238, DOI 10.1161/01.CIR.0000089082.40285.C3	49	872	910	1	129	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					666	676		10.1038/ng.361	http://dx.doi.org/10.1038/ng.361			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19430483	Green Submitted, Green Accepted			2022-12-25	WOS:000266411700015
J	Perez, JT; Pham, AM; Lorini, MH; Chua, MA; Steel, J; tenOever, BR				Perez, Jasmine T.; Pham, Alissa M.; Lorini, Maria H.; Chua, Mark A.; Steel, John; tenOever, Benjamin R.			MicroRNA-mediated species-specific attenuation of influenza A virus	NATURE BIOTECHNOLOGY			English	Article							NS1 PROTEIN; SMALL RNA; EXPRESSION; REPLICATION; IMMUNITY; RESCUE; SYSTEM	Influenza A virus leads to yearly epidemics and sporadic pandemics. Present prophylactic strategies focus on egg-grown, live, attenuated influenza vaccines (LAIVs), in which attenuation is generated by conferring temperature sensitivity onto the virus. Here we describe an alternative approach to attenuating influenza A virus based on microRNA-mediated gene silencing. By incorporating nonavian microRNA response elements (MREs) into the open-reading frame of the viral nucleoprotein, we generate reassortant LAIVs for H1N1 and H5N1 that are attenuated in mice but not in eggs. MRE-based LAIVs show a greater than two-log reduction in mortality compared with control viruses lacking MREs and elicit a diverse antibody response. This approach might be combined with existing LAIVs to increase attenuation and improve vaccine safety.	[Perez, Jasmine T.; Pham, Alissa M.; tenOever, Benjamin R.] Mt Sinai Sch Med, Microbiol Grad Sch Training Program, New York, NY USA; [Lorini, Maria H.; Steel, John; tenOever, Benjamin R.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Chua, Mark A.; tenOever, Benjamin R.] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	tenOever, BR (corresponding author), Mt Sinai Sch Med, Microbiol Grad Sch Training Program, New York, NY USA.	benjamin.tenoever@mssm.edu			US Army Research Laboratory; US Army Research Office [54677-LS-YIP]; National Institutes of Health [AI007647-09]; Pew Charitable Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007647] Funding Source: NIH RePORTER	US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This material is based upon work supported in part by the US Army Research Laboratory and the US Army Research Office under grant number 54677-LS-YIP. J.T.P. is supported by the NYU-MSSM Mechanisms of Virus-Host Interactions National Institutes of Health T32 training grant (no. AI007647-09). B.R.t. is supported in part by the Pew Charitable Funds. We thank A. Garcia-Sastre for giving us polyclonal A/PR/8/34 (MSSM, NY); G. Sen for ISG54 (Cleveland Clinic, OH, USA); A. Fernandez-Sesma (MSSM, NY) for primary human dendritic cell RNA; A. Tarakhovsky (Rockefeller University, NY) and D. O'Carroll (EMBL, Monterotondo, Italy) for Dicer-/- murine fibroblasts; E. Makeyev (Nanyang Technological University, Singapore) for firefly luciferase constructs containing miR-124 MREs and control SV40 3' UTRs; and P. Palese (MSSM, NY) for pPol-I driven nucleoprotein vector, monoclonal nucleoprotein and A/PR/8/34 NS1. We thank members of the Palese and Garcia-Sastre labs for advice, reagents and comments during the course of this work.	Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; Edge RE, 2008, MOL THER, V16, P1437, DOI 10.1038/mt.2008.130; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hoffmann HH, 2008, ANTIVIR RES, V80, P124, DOI 10.1016/j.antiviral.2008.05.008; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kok KH, 2006, J GEN VIROL, V87, P2639, DOI 10.1099/vir.0.81764-0; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Neumann G, 2005, P NATL ACAD SCI USA, V102, P16825, DOI 10.1073/pnas.0505587102; Palese P., 2006, FIELDS VIROLOGY, P1648; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; REED LJ, 1938, AM J HYG, V27; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SHAPIRO GI, 1988, J VIROL, V62, P2285, DOI 10.1128/JVI.62.7.2285-2290.1988; Stohr K, 2003, VACCINE, V21, P1744, DOI 10.1016/S0264-410X(03)00065-3; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172	30	122	138	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2009	27	6					572	U117		10.1038/nbt.1542	http://dx.doi.org/10.1038/nbt.1542			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	458AC	19483680				2022-12-25	WOS:000266980500028
J	Brandt, DT; Baarlink, C; Kitzing, TM; Kremmer, E; Ivaska, J; Nollau, P; Grosse, R				Brandt, Dominique T.; Baarlink, Christian; Kitzing, Thomas M.; Kremmer, Elisabeth; Ivaska, Johanna; Nollau, Peter; Grosse, Robert			SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta(1)-integrin	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; SRF ACTIVITY; MIGRATION; INTEGRIN; DYNAMICS; DIA1; BETA-1-INTEGRIN; COACTIVATOR; METASTASIS; MECHANISMS	Gene expression reprogramming governs cellular processes such as proliferation, differentiation and cell migration through the complex and tightly regulated control of transcriptional cofactors that exist in multiprotein complexes. Here we describe SCAI (suppressor of cancer cell invasion), a novel and highly conserved protein that regulates invasive cell migration through three-dimensional matrices. SCAI acts on the RhoA-Dia1 signal transduction pathway and localizes in the nucleus, where it binds and inhibits the myocardin-related transcription factor MAL by forming a ternary complex with serum response factor (SRF). Genomewide expression analysis surprisingly reveals that one of the strongest upregulated genes after suppression of SCAI is beta(1)-integrin. Decreased levels of SCAI are tightly correlated with increased invasive cell migration, and SCAI is downregulated in several human tumours. Functional analysis of the beta(1)-integrin gene strongly argues that SCAI is a novel transcriptional cofactor that controls gene expression downstream of Dia1 to dictate changes in cell invasive behaviour.	[Brandt, Dominique T.; Baarlink, Christian; Kitzing, Thomas M.; Grosse, Robert] Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Ivaska, Johanna] VTT Tech Res Ctr Finland, FIN-20520 Turku, Finland; [Ivaska, Johanna] Univ Turku, FIN-20520 Turku, Finland; [Nollau, Peter] Univ Med Ctr Hamburg Eppendorf, Ctr Clin Pathol, Dept Clin Chem, D-20246 Hamburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; VTT Technical Research Center Finland; University of Turku; University of Hamburg; University Medical Center Hamburg-Eppendorf	Grosse, R (corresponding author), Univ Heidelberg, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	robert.grosse@pharma.uni-heidelberg.de		Ivaska, Johanna/0000-0002-6295-6556; Grosse, Robert/0000-0002-3380-5273	Emmy Noether Program of the Deutsche Forschungsgemeinschaft [GR 2111/1-3]; Wilhelm Sander-Stiftung [2008.020.1]; CHS Foundation; EMBO Young Investigator Program; Academy of Finland; European Research Council	Emmy Noether Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; CHS Foundation; EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	We thank B. Di Ventura and W. Birchmeier for critical reading, and R. Treisman and T. Worzfeld for stimulating discussions. We are grateful to A. Ripperger, K. Reeck and G. Streichert for technical assistance, and U. Engel at the Nikon Imaging Center for imaging advice. This work was funded by the Emmy Noether Program of the Deutsche Forschungsgemeinschaft (GR 2111/1-3) and the Wilhelm Sander-Stiftung (2008.020.1) to R. G. R. G. is a member of the excellence cluster Cellular Networks and supported by the CHS Foundation. J. I. is supported by the EMBO Young Investigator Program, Academy of Finland, and the European Research Council.	Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Freddie CT, 2007, NUCLEIC ACIDS RES, V35, P5203, DOI 10.1093/nar/gkm528; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Spessotto P, 2003, J BIOL CHEM, V278, P6160, DOI 10.1074/jbc.M208322200; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Worzfeld T, 2004, EUR J NEUROSCI, V19, P2622, DOI 10.1111/j.0953-816X.2004.03401.x; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05	32	99	108	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					557	U83		10.1038/ncb1862	http://dx.doi.org/10.1038/ncb1862			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19350017				2022-12-25	WOS:000265640000015
J	Pellegrini, M; Calzascia, T; Elford, AR; Shahinian, A; Lin, AE; Dissanayake, D; Dhanji, S; Nguyen, LT; Gronski, MA; Morre, M; Assouline, B; Lahl, K; Sparwasser, T; Ohashi, PS; Mak, TW				Pellegrini, Marc; Calzascia, Thomas; Elford, Alisha R.; Shahinian, Arda; Lin, Amy E.; Dissanayake, Dilan; Dhanji, Salim; Nguyen, Linh T.; Gronski, Matthew A.; Morre, Michel; Assouline, Brigitte; Lahl, Katharina; Sparwasser, Tim; Ohashi, Pamela S.; Mak, Tak W.			Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; E3 UBIQUITIN LIGASE; TGF-BETA; CBL-B; TRANSGENIC MICE; NEGATIVE REGULATION; IMMUNE-RESPONSE; CUTTING EDGE; IN-VITRO; INTERLEUKIN-7	Identifying key factors that enhance immune responses is crucial for manipulating immunity to tumors. We show that after a vaccine-induced immune response, adjuvant interleukin-7 (IL-7) improves antitumor responses and survival in an animal model. The improved immune response is associated with increased IL-6 production and augmented T helper type 17 cell differentiation. Furthermore, IL-7 modulates the expression of two ubiquitin ligases: Casitas B-lineage lymphoma b (Cbl-b), a negative regulator of T cell activation, is repressed, and SMAD-specific E3 ubiquitin protein ligase-2 (Smurf2) is enhanced, which antagonizes transforming growth factor-beta signaling. Notably, we show that although short term IL-7 therapy potently enhances vaccine-mediated immunity, in the absence of vaccination it is inefficient in promoting antitumor immune responses, despite inducing homeostatic proliferation of T cells. The ability of adjuvant IL-7 to antagonize inhibitory networks at the cellular and molecular level has major implications for immunotherapy in the treatment of tumors.	[Pellegrini, Marc; Calzascia, Thomas; Elford, Alisha R.; Shahinian, Arda; Lin, Amy E.; Dissanayake, Dilan; Dhanji, Salim; Nguyen, Linh T.; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Pellegrini, Marc; Calzascia, Thomas; Lin, Amy E.; Dissanayake, Dilan; Dhanji, Salim; Nguyen, Linh T.; Ohashi, Pamela S.; Mak, Tak W.] Univ Toronto, Dept Med Biophys & Immunol, Toronto, ON, Canada; [Gronski, Matthew A.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA USA; [Morre, Michel; Assouline, Brigitte] Cytheris Inc, Issy Les Moulineaux, France; [Lahl, Katharina] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, Inst Infect Immunol, Hanover, NH USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Virginia; Technical University of Munich	Ohashi, PS (corresponding author), Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.	pohashi@uhnres.utoronto.ca	Sparwasser, Tim D/AAA-4306-2022; Pellegrini, Marc/F-7670-2014; Lahl, Katharina/AAA-1909-2021; Sparwasser, Tim/AAF-7085-2019; Lin, Amy Erica/ABG-4745-2020	Lahl, Katharina/0000-0003-4919-331X; Sparwasser, Tim/0000-0001-5645-902X; Lin, Amy Erica/0000-0002-0554-2832; Pellegrini, Marc/0000-0003-3627-3126; Calzascia, Thomas/0000-0001-8225-6744; Gronski, Matthew/0000-0003-4779-5720; Ohashi, Pamela S./0000-0003-2915-9317; Dissanayake, Dilan/0000-0003-4270-7015	Canadian Institute for Health; Ontario Institute for Cancer Research; Terry Fox Cancer Foundation National Cancer Institute of Canada; Boninchi Foundation (Geneva, Switzerland); National Cancer Institute of Canada; Cancer Research Institute (New York)	Canadian Institute for Health(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research; Terry Fox Cancer Foundation National Cancer Institute of Canada; Boninchi Foundation (Geneva, Switzerland); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Cancer Research Institute (New York)	E. Deenick and R. Kalaf assisted with the injection of mice. M. Nikpour assisted with statistical analyses. This work was supported by a Canadian Institute for Health Research grant and funding from the Ontario Institute for Cancer Research to P. S. O. and a Terry Fox Cancer Foundation National Cancer Institute of Canada grant to T. W. M. T. C. was supported by the Boninchi Foundation (Geneva, Switzerland) and is a Research Fellow of The Terry Fox Foundation through an award from the National Cancer Institute of Canada. M. P. holds an Irvington Institute Fellowship with the Cancer Research Institute (New York). P. S. O. holds a Canada Research Chair in autoimmunity and tumor immunity.	AOKI T, 1992, P NATL ACAD SCI USA, V89, P3850, DOI 10.1073/pnas.89.9.3850; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Bellone M, 2008, TRENDS IMMUNOL, V29, P235, DOI 10.1016/j.it.2008.02.003; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; CAYEUX S, 1995, EUR J IMMUNOL, V25, P2325, DOI 10.1002/eji.1830250831; Chiang JY, 2007, J CLIN INVEST, V117, P1029, DOI 10.1172/JCI29472; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Fry TJ, 2001, BLOOD, V97, P1525, DOI 10.1182/blood.V97.6.1525; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Lin AE, 2007, CURR OPIN IMMUNOL, V19, P665, DOI 10.1016/j.coi.2007.10.002; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; LYNCH DH, 1994, J EXP MED, V179, P31, DOI 10.1084/jem.179.1.31; Martin-Orozco N, 2006, J EXP MED, V203, P817, DOI 10.1084/jem.20060219; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Miller PW, 2000, HUM GENE THER, V11, P53, DOI 10.1089/10430340050016157; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nanjappa SG, 2008, J CLIN INVEST, V118, P1027, DOI 10.1172/JCI32020; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Prendergast GC, 2007, CANCER RES, V67, P3500, DOI 10.1158/0008-5472.CAN-06-4626; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Tripathi P, 2007, J IMMUNOL, V178, P4027, DOI 10.4049/jimmunol.178.7.4027; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Wohlfert EA, 2004, J IMMUNOL, V173, P1059, DOI 10.4049/jimmunol.173.2.1059; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	55	158	168	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2009	15	5					528	536		10.1038/nm.1953	http://dx.doi.org/10.1038/nm.1953			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19396174				2022-12-25	WOS:000265889300031
J	Razani, B; Semenkovich, CF				Razani, Babak; Semenkovich, Clay F.			Getting away from glucose: stop sugarcoating diabetes	NATURE MEDICINE			English	Editorial Material							AUTOPHAGY; DISEASE; STRESS; ROLES	Type 2 diabetes is often viewed as a disorder of glucose metabolism. But many factors come into play in this condition, with obesity a prime risk factor and cardiovascular disease a major result. In Bedside to Bench, Babak Razani and Clay Semenkovich examine the linkages between diabetes and cardiovascular disease. They call for new research approaches in the wake of clinical trials showing that lowering glucose levels does not decrease cardiovascular events in people with type 2 diabetes. In Bench to Bedside, Steven Shoelson and Allison Goldfine examine how type 2 diabetes and other disorders can stem from obesity-and its effect on inflammation. These authors take a look at two recent studies showing how obesity perturbs inflammatory gene networks.	[Razani, Babak; Semenkovich, Clay F.] Washington Univ, Dept Med, St Louis, MO 63130 USA; [Semenkovich, Clay F.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Razani, B (corresponding author), Washington Univ, Dept Med, St Louis, MO 63130 USA.	csemenko@wustl.edu		Semenkovich, Clay/0000-0003-1163-1871; Razani, Babak/0000-0002-7172-9240				[Anonymous], 1982, Diabetes, V31 Suppl 5, P1; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Doria A, 2008, JAMA-J AM MED ASSOC, V300, P2389, DOI 10.1001/jama.2008.649; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	15	6	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2009	15	4					372	373		10.1038/nm0409-372	http://dx.doi.org/10.1038/nm0409-372			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19350008				2022-12-25	WOS:000264937200018
J	Kawakami, T; Ohta, A; Ohuchi, M; Ashigai, H; Murakami, H; Suga, H				Kawakami, Takashi; Ohta, Atsushi; Ohuchi, Masaki; Ashigai, Hiroshi; Murakami, Hiroshi; Suga, Hiroaki			Diverse backbone-cyclized peptides via codon reprogramming	NATURE CHEMICAL BIOLOGY			English	Article							TRUNCATED ALPHA-DEFENSINS; LIGATION; PROTEINS; BIOSYNTHESIS; EXPRESSION; LIBRARIES; TERMINUS; SYSTEM	We report a methodology for the ribosomal synthesis of backbone-cyclized peptides involving genetic code reprogramming to introduce one or more nonproteinogenic amino acids. Expression of linear peptides bearing a cysteine-proline dipeptide sequence followed by glycolic acid results in self-rearrangement to a C-terminal diketopiperadine-thioester, which non-enzymatically generates a cyclized peptide. We demonstrate the ribosomal synthesis of several naturally occurring backbone-cyclized peptides and a library based on a bicyclic scaffold, and we identify bioactive sequences by screening and deconvolution.	[Kawakami, Takashi; Ohta, Atsushi; Ashigai, Hiroshi; Suga, Hiroaki] Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Tokyo, Japan; [Ohuchi, Masaki; Suga, Hiroaki] Univ Tokyo, Dept Adv Interdisciplinary Studies, Grad Sch Engn, Tokyo, Japan; [Murakami, Hiroshi; Suga, Hiroaki] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Suga, H (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Tokyo, Japan.	hsuga@rcast.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [16101007, 20-664, 19-1722]; Japanese Industrial Science and Technology Program in the New Energy and Industrial Technology Development Organization (NEDO)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Industrial Science and Technology Program in the New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (16101007) and a research and development project of the Japanese Industrial Science and Technology Program in the New Energy and Industrial Technology Development Organization (NEDO) to H. S. T. K. and A. O. are supported by JSPS Research Fellowships for young scientists (20-664 and 19-1722, respectively).	Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Forster AC, 2003, P NATL ACAD SCI USA, V100, P6353, DOI 10.1073/pnas.1132122100; Goto Y, 2008, ACS CHEM BIOL, V3, P120, DOI 10.1021/cb700233t; Kawakami T, 2008, CHEM BIOL, V15, P32, DOI 10.1016/j.chembiol.2007.12.008; Kawakami T, 2008, J AM CHEM SOC, V130, P16861, DOI 10.1021/ja806998v; Kawakami T, 2007, CHEM LETT, V36, P76, DOI 10.1246/cl.2007.76; Kimura RH, 2006, ANGEW CHEM INT EDIT, V45, P973, DOI 10.1002/anie.200503882; King RW, 1997, SCIENCE, V277, P973, DOI 10.1126/science.277.5328.973; Kohli RM, 2003, CHEM COMMUN, P297, DOI 10.1039/b208333g; Korsinczky MLJ, 2004, CURR PROTEIN PEPT SC, V5, P351, DOI 10.2174/1389203043379594; LADNER RC, 1995, TRENDS BIOTECHNOL, V13, P426, DOI 10.1016/S0167-7799(00)88997-0; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Ohta A, 2008, CURR OPIN CHEM BIOL, V12, P159, DOI 10.1016/j.cbpa.2007.12.009; Ohta A, 2007, CHEM BIOL, V14, P1315, DOI 10.1016/j.chembiol.2007.10.015; Ohuchi M, 2007, CURR OPIN CHEM BIOL, V11, P537, DOI 10.1016/j.cbpa.2007.08.011; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rungpragayphan S, 2003, FEBS LETT, V540, P147, DOI 10.1016/S0014-5793(03)00251-5; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1; Ueno S, 2007, INT J BIOL SCI, V3, P365; Wang W, 2006, J BIOL CHEM, V281, P32755, DOI 10.1074/jbc.M603614200; Whyte AC, 2000, J NAT PROD, V63, P1006, DOI 10.1021/np000103v	25	106	115	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					888	890		10.1038/nchembio.259	http://dx.doi.org/10.1038/nchembio.259			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19915537				2022-12-25	WOS:000271756900010
J	Shinawi, M; Schaaf, CP; Bhatt, SS; Xia, ZL; Patel, A; Cheung, SW; Lanpher, B; Nagl, S; Herding, HS; Nevinny-Stickel, C; Immken, LL; Patel, GS; German, JR; Beaudet, AL; Stankiewicz, P				Shinawi, Marwan; Schaaf, Christian P.; Bhatt, Samarth S.; Xia, Zhilian; Patel, Ankita; Cheung, Sau Wai; Lanpher, Brendan; Nagl, Sandra; Herding, Heinrich Stephan; Nevinny-Stickel, Claudia; Immken, LaDonna L.; Patel, Gayle Simpson; German, Jennifer Ruth; Beaudet, Arthur L.; Stankiewicz, Pawel			A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes	NATURE GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; MENTAL-RETARDATION; INCREASE RISK; GENE CHRNA7; SCHIZOPHRENIA; MICRODELETIONS; DUPLICATIONS; DISORDERS; SEIZURES; LOCUS	We report a recurrent 680-kb deletion within chromosome 15q13.3 in ten individuals, from four unrelated families, with neurodevelopmental phenotypes including developmental delay, mental retardation and seizures. This deletion likely resulted from nonallelic homologous recombination between low-copy repeats on the normal and inverted region of chromosome 15q13.3. Although this deletion also affects OTUD7A, accumulated data suggest that haploinsufficiency of CHRNA7 is causative for the majority of neurodevelopmental phenotypes in the 15q13.3 microdeletion syndrome.	[Shinawi, Marwan; Schaaf, Christian P.; Bhatt, Samarth S.; Xia, Zhilian; Patel, Ankita; Cheung, Sau Wai; German, Jennifer Ruth; Beaudet, Arthur L.; Stankiewicz, Pawel] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lanpher, Brendan] Vanderbilt Univ, Div Genet & Genom Med, Nashville, TN USA; [Nagl, Sandra; Nevinny-Stickel, Claudia] Med Versorgungszentrum Humane Genet, Munich, Germany; [Stankiewicz, Pawel] Inst Mother & Child Hlth, Dept Med Genet, Warsaw, Poland	Baylor College of Medicine; Vanderbilt University	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	abeaudet@bcm.edu	Stankiewicz, Paweł/AAP-7906-2021; Patel, Ankita/D-3247-2013; Bhatt, Samarth/H-2892-2019; Schaaf, Christian P/AAJ-7318-2021	Stankiewicz, Paweł/0000-0002-6456-7490; Bhatt, Samarth/0000-0001-5706-4572; Schaaf, Christian P/0000-0002-2148-7490; shinawi, Marwan/0000-0003-1329-4100	US National Institutes of Health [HD-037283, M01-RR00188]; Mental Retardation and Developmental Disabilities Research Center [HD-024064]; Rare Disease Clinical Research Consortia [RR-019478]; William Stamps Farish Fund; Polish Ministry of Science and Higher Education [R13-0005-04/2008]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, R01HD037283] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019478, M01RR000188] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mental Retardation and Developmental Disabilities Research Center; Rare Disease Clinical Research Consortia; William Stamps Farish Fund; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank all families who participated in this study; C. Carvalho, W. Gu, J. R. Lupski, C. Shaw and M. Strivens for helpful discussion; and P. Eng, Z. Ou and M. Suzuki for technical assistance. A. L. B. was supported by US National Institutes of Health grants HD-037283, M01-RR00188 (General Clinical Research Center), HD-024064 (Mental Retardation and Developmental Disabilities Research Center) and RR-019478 (Rare Disease Clinical Research Consortia) and by generous support from the William Stamps Farish Fund. P. S. was supported in part by grant R13-0005-04/2008 from the Polish Ministry of Science and Higher Education.	Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Broide RS, 2002, MOL PHARMACOL, V61, P695, DOI 10.1124/mol.61.3.695; Dibbens LM, 2009, HUM MOL GENET, V18, P3626, DOI 10.1093/hmg/ddp311; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Leonard S, 2006, BIOL PSYCHIAT, V60, P115, DOI 10.1016/j.biopsych.2006.03.054; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Makoff AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r114; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Taske NL, 2002, EPILEPSY RES, V49, P157, DOI 10.1016/S0920-1211(02)00027-X; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412	15	145	147	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1269	1271		10.1038/ng.481	http://dx.doi.org/10.1038/ng.481			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19898479	Green Accepted			2022-12-25	WOS:000272144900005
J	Cordeddu, V; Di Schiavi, E; Pennacchio, LA; Ma'ayan, A; Sarkozy, A; Fodale, V; Cecchetti, S; Cardinale, A; Martin, J; Schackwitz, W; Lipzen, A; Zampino, G; Mazzanti, L; Digilio, MC; Martinelli, S; Flex, E; Lepri, F; Bartholdi, D; Kutsche, K; Ferrero, GB; Anichini, C; Selicorni, A; Rossi, C; Tenconi, R; Zenker, M; Merlo, D; Dallapiccola, B; Iyengar, R; Bazzicalupo, P; Gelb, BD; Tartaglia, M				Cordeddu, Viviana; Di Schiavi, Elia; Pennacchio, Len A.; Ma'ayan, Avi; Sarkozy, Anna; Fodale, Valentina; Cecchetti, Serena; Cardinale, Alessio; Martin, Joel; Schackwitz, Wendy; Lipzen, Anna; Zampino, Giuseppe; Mazzanti, Laura; Digilio, Maria C.; Martinelli, Simone; Flex, Elisabetta; Lepri, Francesca; Bartholdi, Deborah; Kutsche, Kerstin; Ferrero, Giovanni B.; Anichini, Cecilia; Selicorni, Angelo; Rossi, Cesare; Tenconi, Romano; Zenker, Martin; Merlo, Daniela; Dallapiccola, Bruno; Iyengar, Ravi; Bazzicalupo, Paolo; Gelb, Bruce D.; Tartaglia, Marco			Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair	NATURE GENETICS			English	Article							INTERACTION DATABASE; C-ELEGANS; RAS; PTPN11; PHOSPHATASE; NETWORK; SUR-8	N-myristoylation is a common form of co-translational protein fatty acylation resulting from the attachment of myristate to a required N-terminal glycine residue(1,2). We show that aberrantly acquired N-myristoylation of SHOC2, a leucine-rich repeat-containing protein that positively modulates RAS-MAPK signal flow(3-6), underlies a clinically distinctive condition of the neuro-cardio-facial-cutaneous disorders family. Twenty-five subjects with a relatively consistent phenotype previously termed Noonan-like syndrome with loose anagen hair (MIM607721)(7) shared the 4A>G missense change in SHOC2 (producing an S2G amino acid substitution) that introduces an N-myristoylation site, resulting in aberrant targeting of SHOC2 to the plasma membrane and impaired translocation to the nucleus upon growth factor stimulation. Expression of SHOC2(S2G) in vitro enhanced MAPK activation in a cell typespecific fashion. Induction of SHOC2(S2G) in Caenorhabditis elegans engendered protruding vulva, a neomorphic phenotype previously associated with aberrant signaling. These results document the first example of an acquired N-terminal lipid modification of a protein causing human disease.	[Cordeddu, Viviana; Fodale, Valentina; Martinelli, Simone; Flex, Elisabetta; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Di Schiavi, Elia; Bazzicalupo, Paolo] CNR, Ist Genet & Biofis A Buzzati Traverso, Naples, Italy; [Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Pennacchio, Len A.; Martin, Joel; Schackwitz, Wendy; Lipzen, Anna] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Ma'ayan, Avi; Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, SBCNY, New York, NY USA; [Sarkozy, Anna; Lepri, Francesca; Dallapiccola, Bruno] San Giovanni Rotondo & Ist Mendel, Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Rome, Italy; [Fodale, Valentina; Dallapiccola, Bruno] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Cecchetti, Serena; Merlo, Daniela] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Cardinale, Alessio; Merlo, Daniela] IRCCS San Raffaele Pisana, Rome, Italy; [Zampino, Giuseppe] Univ Cattolica Sacro Cuore, Ist Clin Pediat, Rome, Italy; [Mazzanti, Laura] Univ Bologna, Dipartimento Pediat, Bologna, Italy; [Digilio, Maria C.] Bambino Gesu Pediat Hosp, Sez Genet Med, Rome, Italy; [Bartholdi, Deborah] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Kutsche, Kerstin] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Ferrero, Giovanni B.] Univ Turin, Dipartimento Pediat, Turin, Italy; [Anichini, Cecilia] Univ Siena, Dipartimento Pediat Ostetr & Med Riproduz, I-53100 Siena, Italy; [Selicorni, Angelo] Fdn Policlin Milano, IRCCS, Clin Pediat 1, Milan, Italy; [Rossi, Cesare] St Orsola Marcello Malpighi Hosp, Unita Operat Genet Med, Bologna, Italy; [Tenconi, Romano] Univ Padua, Dipartimento Pediat, I-35128 Padua, Italy; [Zenker, Martin] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-8520 Erlangen, Germany; [Gelb, Bruce D.] Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genom Sci, New York, NY USA	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Icahn School of Medicine at Mount Sinai; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; Istituto Superiore di Sanita (ISS); IRCCS San Raffaele Pisana; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Bologna; IRCCS Bambino Gesu; University of Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Turin; University of Siena; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Padua; University of Erlangen Nuremberg; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	bruce.gelb@mssm.edu; mtartaglia@iss.it	Cecchetti, Serena/N-1061-2015; Ferrero, Giovanni Battista/K-5265-2018; Tartaglia, Marco/K-2955-2018; Rossi, Cesare/AAC-2083-2022; Merlo, Daniela/K-7986-2016; Flex, Elisabetta/A-5958-2017; Digilio, Maria Cristina/AAI-2434-2019; cordeddu, viviana/A-5612-2016; Lepri, Francesca Romana/AAA-6115-2020; cordeddu, viviana/J-2272-2014; Zampino, Giuseppe/AAC-2152-2019; Ma'ayan, Avi/AAG-3131-2019; Schackwitz, Wendy/GXH-9536-2022; Martinelli, Simone/J-9432-2018; Di Schiavi, Elia/B-8046-2015; Dallapiccola, Bruno/K-8692-2016	Cecchetti, Serena/0000-0002-3601-176X; Ferrero, Giovanni Battista/0000-0002-3793-5788; Tartaglia, Marco/0000-0001-7736-9672; Rossi, Cesare/0000-0003-1826-615X; Merlo, Daniela/0000-0003-4240-5762; Flex, Elisabetta/0000-0002-6802-1356; cordeddu, viviana/0000-0001-7159-7383; Ma'ayan, Avi/0000-0002-6904-1017; Martinelli, Simone/0000-0002-5843-419X; Di Schiavi, Elia/0000-0002-8179-6666; mazzanti, laura/0000-0002-7670-6494; Lepri, Francesca Romana/0000-0001-5331-0473; Martin, Joel/0000-0001-9511-6441; Pennacchio, Len/0000-0002-8748-3732; Schackwitz, Wendy/0000-0002-3013-9180; Lipzen, Anna/0000-0003-2293-9329; Dallapiccola, Bruno/0000-0002-5031-1013	TelethonItaly [GGP07115]; Convenzione Italia- USA; NIH [HL71207, HD01294, HL074728]; SBCNY [P50GM071558]; German Research Foundation ( DFG) [ZE 524/ 4- 1]; IRCCS- CSS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074728, R01HL071207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM054508] Funding Source: NIH RePORTER	TelethonItaly(Fondazione Telethon); Convenzione Italia- USA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBCNY; German Research Foundation ( DFG)(German Research Foundation (DFG)); IRCCS- CSS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to the affected individuals and families who participated in the study, the physicians who referred the subjects, A. Fire ( Stanford University School of Medicine, Stanford, California) and J. D. McGhee ( University of Calgary, Calgary, Canada) for plasmids, and C. Ramoni, S. Venanzi and T. Squatriti ( Istituto Superiore di Sanita`, Rome, Italy) and the Open Laboratory ( IGB- CNR, Naples, Italy) for experimental support. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center ( University of Minnesota, Minneapolis, Minnesota), funded by the US National Institutes of Health ( NIH) National Center for Research Resources. We also thank M. C. Silengo ( Universita` di Torino, Turin, Italy), S. Spranger ( Praxis fuer Humangenetik, Bremen, Germany), I. M. Gaspar ( Egas Moniz Hospital, Lisbon, Portugal) and D. R. Bertola ( HC/ FMUSP, Sa ~ o Paulo, Brazil) for their contribution in DNA sampling and valuable clinical assistance. This research was funded by grants from TelethonItaly ( GGP07115) and ` Convenzione Italia- USA- malattie rare' to M. T., the NIH ( HL71207, HD01294 and HL074728) to B. D. G., SBCNY ( P50GM071558) to A. M. and R. I. the German Research Foundation ( DFG) ( ZE 524/ 4- 1) to M. Z. and IRCCS- CSS ( Ricerca Corrente 2009) to F. L.	ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Duerr Janet S, 2006, WormBook, P1; Eisenmann DM, 2000, GENETICS, V156, P1097; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kishore RS, 2002, DEV BIOL, V241, P339, DOI 10.1006/dbio.2001.0513; Li WQ, 2000, GENE DEV, V14, P895; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Mazzanti L, 2003, AM J MED GENET A, V118A, P279, DOI 10.1002/ajmg.a.10923; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Sarkozy A., 2009, V17, P55; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M., 2009, V17, P20; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; TOSTI A, 1991, DERMATOLOGICA, V182, P247; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; VACHON L, 1987, MOL PHARMACOL, V31, P159; VANDERBURGT I, 1994, AM J MED GENET, V53, P187, DOI 10.1002/ajmg.1320530213; VORON DA, 1976, AM J MED, V60, P447, DOI 10.1016/0002-9343(76)90764-6; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239	36	279	293	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1022	U95		10.1038/ng.425	http://dx.doi.org/10.1038/ng.425			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19684605	Green Accepted, Green Published			2022-12-25	WOS:000269382100016
J	Li, XX; Dawe, RK				Li, Xuexian; Dawe, R. Kelly			Fused sister kinetochores initiate the reductional division in meiosis I	NATURE CELL BIOLOGY			English	Article							CHROMOSOME SEGREGATION; MONOPOLAR ATTACHMENT; FUNCTIONAL GENOMICS; DROSOPHILA MEI-S332; CHROMATID COHESION; HOMOLOG; CENTROMERE; SHUGOSHIN; DIFFERENTIATION; ORIENTATION	During meiosis I the genome is reduced to the haploid content by a coordinated reductional division event. Homologous chromosomes align, recombine and segregate while the sister chromatids co-orient and move to the same pole(1,2). Several data suggest that sister kinetochores co-orient early in metaphase I and that sister chromatid cohesion (which requires Rec8 and Shugoshin) supports monopolar orientation. Nevertheless, it is unclear how the sister kinetochores function as single unit during this period. A gene (monopolin)(3) with a co-orienting role was identified in Saccharomyces cerevisiae; however, it does not have the same function in fission yeast(4) and no similar genes have been found in other species. Here we pursue this issue using knockdown mutants of the core kinetochore protein MIS12 (minichromosome instability 12). MIS12 binds to base of the NDC80 complex, which in turn binds directly to microtubuies(5-7). In maize plants with systemically reduced levels of MIS12, a visible MIS12-NDC80 bridge between sister kinetochores at meiosis I is broken. Kinetochores separate and orient randomly in metaphase 1, causing chromosomes to stall in anaphase due to normal cohesion, marked by Shugoshin, between the chromatids. The data establish that sister kinetochores in meiosis I are fused by a shared microtubule-binding face and that this direct linkage is required for reductional division.	[Li, Xuexian; Dawe, R. Kelly] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Dawe, R. Kelly] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dawe, RK (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	kelly@plantbio.uga.edu			National Science Foundation [0421671]	National Science Foundation(National Science Foundation (NSF))	We thank X. Zhang for her support and help with RT-PCR and image analysis, H. Tang for help with statistics, R. Wang for providing Shugoshin antibodies, A. Luce for technical support and C. Topp and L. Kanizay for helpful comments. This study was supported by a grant from the National Science Foundation to R.K.D. (0421671).	Brar GA, 2008, NAT REV GENET, V9, P899, DOI 10.1038/nrg2454; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; COUNCE SJ, 1973, CHROMOSOMA, V44, P231, DOI 10.1007/BF00329119; Dawe RK, 1999, PLANT CELL, V11, P1227, DOI 10.1105/tpc.11.7.1227; Dawe RK, 1998, ANNU REV PLANT PHYS, V49, P371, DOI 10.1146/annurev.arplant.49.1.371; Du Y, 2007, CHROMOSOME RES, V15, P767, DOI 10.1007/s10577-007-1160-z; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Golubovskaya IN, 2006, J CELL SCI, V119, P3306, DOI 10.1242/jcs.03054; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hamant O, 2005, CURR BIOL, V15, P948, DOI 10.1016/j.cub.2005.04.049; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2007, EMBO J, V26, P4475, DOI 10.1038/sj.emboj.7601880; Heyting C, 1996, CURR OPIN CELL BIOL, V8, P389, DOI 10.1016/S0955-0674(96)80015-9; KERREBROCK AW, 1992, GENETICS, V130, P827; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; McGinnis K, 2007, PLANT PHYSIOL, V143, P1441, DOI 10.1104/pp.106.094334; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Paliulis LV, 2000, J CELL BIOL, V150, P1223, DOI 10.1083/jcb.150.6.1223; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Sato H, 2005, CHROMOSOME RES, V13, P827, DOI 10.1007/s10577-005-1016-3; Stoop-Myer C, 1999, NAT CELL BIOL, V1, pE125, DOI 10.1038/12956; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zhang XL, 2005, PLANT CELL, V17, P572, DOI 10.1105/tpc.104.028522; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	32	67	71	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1103	U122		10.1038/ncb1923	http://dx.doi.org/10.1038/ncb1923			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684578				2022-12-25	WOS:000269482500011
J	Edgington, LE; Berger, AB; Blum, G; Albrow, VE; Paulick, MG; Lineberry, N; Bogyo, M				Edgington, Laura E.; Berger, Alicia B.; Blum, Galia; Albrow, Victoria E.; Paulick, Margot G.; Lineberry, Neil; Bogyo, Matthew			Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes	NATURE MEDICINE			English	Article							FLUOROCHROME-LABELED INHIBITORS; DEATH IN-VIVO; CELL-DEATH; ANNEXIN-V; DNA FRAGMENTATION; TUMOR RESPONSE; ACTIVATION; CHEMOTHERAPY; PEPTIDE; VISUALIZATION	Imaging agents that enable direct visualization and quantification of apoptosis in vivo have great potential value for monitoring chemotherapeutic response as well as for early diagnosis and disease monitoring. We describe here the development of fluorescently labeled activity-based probes (ABPs) that covalently label active caspases in vivo. We used these probes to monitor apoptosis in the thymi of mice treated with dexamethasone as well as in tumor-bearing mice treated with the apoptosis-inducing monoclonal antibody Apomab (Genentech). Caspase ABPs provided direct readouts of the kinetics of apoptosis in live mice, whole organs and tissue extracts. The probes produced a maximum fluorescent signal that could be monitored noninvasively and that coincided with the peak in caspase activity, as measured by gel analysis. Overall, these studies demonstrate that caspase-specific ABPs have the potential to be used for noninvasive imaging of apoptosis in both preclinical and clinical settings.	[Edgington, Laura E.; Berger, Alicia B.; Bogyo, Matthew] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Blum, Galia; Albrow, Victoria E.; Paulick, Margot G.; Bogyo, Matthew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Lineberry, Neil] Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA; [Bogyo, Matthew] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Bogyo, M (corresponding author), Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA.	mbogyo@stanford.edu		Bogyo, Matthew/0000-0003-3753-4412; Edgington-Mitchell, Laura/0000-0002-6810-6149	US National Institutes of Health [U54 RR020843, R01 EB005011]; Public Health Services [CA09302]; US National Cancer Institute; Department of Health and Human Services.; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health and Human Services.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We would like to thank G. Salvesen from the Burnham Institute for Medical Research for the kind gift of recombinant caspases and for creative input on the project. We thank B. Sloane, Wayne State University, for the kind gift of cathepsin antibodies and C. Watts of the University of Dundee for the kind gift of legumain antibodies. We thank R. Weimer for critical discussion of the data and help with protocols for the use of Apomab. We thank A. Fan and D. Felsher for assistance with the MYC mouse model. We thank the Molecular Imaging Program at Stanford and the Stanford Small Animal Imaging Facility for assistance with noninvasive imaging studies. This work was funded by US National Institutes of Health grants U54 RR020843 and R01 EB005011 (to M. B.). M. G. P. was supported by Public Health Services grant CA09302, awarded by the US National Cancer Institute, Department of Health and Human Services.	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Aloya R, 2006, APOPTOSIS, V11, P2089, DOI 10.1007/s10495-006-0282-7; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Bauer C, 2005, J NUCL MED, V46, P1066; Bedner E, 2000, EXP CELL RES, V259, P308, DOI 10.1006/excr.2000.4955; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; Blankenberg FG, 2006, NAT PROTOC, V1, P108, DOI 10.1038/nprot.2006.17; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Bullok K, 2005, J MED CHEM, V48, P5404, DOI 10.1021/jm050008p; Cohen A, 2009, CELL RES, V19, P625, DOI 10.1038/cr.2009.17; Cohen J J, 1992, Semin Immunol, V4, P363; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Hofstra L, 2000, LANCET, V356, P209, DOI 10.1016/S0140-6736(00)02482-X; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Laxman B, 2002, P NATL ACAD SCI USA, V99, P16551, DOI 10.1073/pnas.252644499; Lee A, 2001, ORG LETT, V3, P3707, DOI 10.1021/ol0166496; Methot N, 2004, J BIOL CHEM, V279, P27905, DOI 10.1074/jbc.M400247200; Ntziachristos V, 2004, P NATL ACAD SCI USA, V101, P12294, DOI 10.1073/pnas.0401137101; Odaka C, 2002, CELL DEATH DIFFER, V9, P104, DOI 10.1038/sj/cdd/4400941; Petrovsky A, 2003, CANCER RES, V63, P1936; Pozarowski P, 2003, CYTOM PART A, V55A, P50, DOI 10.1002/cyto.a.10074; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Rottey S, 2006, J NUCL MED, V47, P1813; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Schellenberger EA, 2003, NEOPLASIA, V5, P187, DOI 10.1016/S1476-5586(03)80050-7; Sexton KB, 2007, CELL DEATH DIFFER, V14, P727, DOI 10.1038/sj.cdd.4402074; Sexton KB, 2007, BIOORG MED CHEM LETT, V17, P649, DOI 10.1016/j.bmcl.2006.10.100; Smolewski P, 2001, CYTOMETRY, V44, P73, DOI 10.1002/1097-0320(20010501)44:1<73::AID-CYTO1084>3.0.CO;2-S; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Vermeersch H, 2004, NUCL MED COMMUN, V25, P259, DOI 10.1097/00006231-200403000-00008; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Zavitsanou K, 2007, J MOL HISTOL, V38, P313, DOI 10.1007/s10735-007-9104-7; Zhou D, 2006, BIOORG MED CHEM LETT, V16, P5041, DOI 10.1016/j.bmcl.2006.07.045	35	225	232	7	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					967	U177		10.1038/nm.1938	http://dx.doi.org/10.1038/nm.1938			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19597506	Green Accepted			2022-12-25	WOS:000268770400044
J	Kokubu, C; Horie, K; Abe, K; Ikeda, R; Mizuno, S; Uno, Y; Ogiwara, S; Ohtsuka, M; Isotani, A; Okabe, M; Imai, K; Takeda, J				Kokubu, Chikara; Horie, Kyoji; Abe, Koichiro; Ikeda, Ryuji; Mizuno, Sumi; Uno, Yoshihiro; Ogiwara, Sanae; Ohtsuka, Masato; Isotani, Ayako; Okabe, Masaru; Imai, Kenji; Takeda, Junji			A transposon-based chromosomal engineering method to survey a large cis-regulatory landscape in mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; SLEEPING-BEAUTY TRANSPOSON; ENHANCER ANALYSIS; MAMMALIAN-CELLS; GENE-EXPRESSION; ES CELLS; ELEMENTS; SYSTEM; REGION; COMPLEMENTATION	A large cis-regulatory landscape is a common feature of vertebrate genomes, particularly at key developmental gene loci with finely tuned expression patterns. Existing genetic tools for surveying large genomic regions of interest spanning over hundreds of kilobases are limited. Here we propose a chromosomal engineering strategy exploiting the local hopping trait of the Sleeping Beauty transposon in the mouse genome. We generated embryonic stem cells with a targeted integration of the transposon vector, carrying an enhancer-detecting lacZ reporter and loxP cassette, into the developmentally critical Pax1 gene locus, followed by efficient local transpositions, nested deletion formation and derivation of embryos by tetraploid complementation. Comparative reporter expression analysis among different insertion/deletion embryos substantially facilitated long-range cis-regulatory element mapping in the genomic neighborhood and demonstrated the potential of the transposon-based approach as a versatile tool for exploration of defined genomic intervals of functional or clinical relevance, such as disease-associated microdeletions.	[Kokubu, Chikara; Mizuno, Sumi; Takeda, Junji] Osaka Univ, Ctr Adv Sci & Innovat, Osaka, Japan; [Kokubu, Chikara; Horie, Kyoji; Ikeda, Ryuji; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan; [Abe, Koichiro; Ogiwara, Sanae; Ohtsuka, Masato; Imai, Kenji] Tokai Univ, Sch Med, Div Basic Med Sci & Mol Med, Dept Mol Life Sci, Kanagawa 2591100, Japan; [Isotani, Ayako; Okabe, Masaru] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan	Osaka University; Osaka University; Tokai University; Osaka University	Kokubu, C (corresponding author), Osaka Univ, Ctr Adv Sci & Innovat, Osaka, Japan.	ckokubu@mr-envi.med.osaka-u.ac.jp; takeda@mr-envi.med.osaka-u.ac.jp	Isotani, Ayako/A-9929-2009; Isotani, Ayako/D-4564-2017; Okabe, Masaru/B-6917-2015	Isotani, Ayako/0000-0002-4720-2318; Isotani, Ayako/0000-0002-4720-2318; Ohtsuka, Masato/0000-0002-6952-4238; Okabe, Masaru/0000-0002-0803-9044; Horie, Kyoji/0000-0001-9036-8180				Bejerano G, 2005, NAT METHODS, V2, P535, DOI 10.1038/nmeth0705-535; Bilodeau M, 2007, NAT METHODS, V4, P263, DOI 10.1038/NMETH1011; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Garrison BS, 2007, MOL CELL BIOL, V27, P8824, DOI 10.1128/MCB.00498-07; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Geurts AM, 2006, PLOS GENET, V2, P1413, DOI 10.1371/journal.pgen.0020156; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Ikeda R, 2007, MOL CELL BIOL, V27, P1665, DOI 10.1128/MCB.01500-06; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kokubu C, 2003, GENETICS, V165, P299; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Menke DB, 2008, DEVELOPMENT, V135, P2543, DOI 10.1242/dev.017384; MorinKensicki EM, 1997, DEVELOPMENT, V124, P159; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Santagati F, 2003, GENETICS, V165, P235; Sasaki H, 1996, GENES CELLS, V1, P59, DOI 10.1046/j.1365-2443.1996.04004.x; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Su H, 2000, NAT GENET, V24, P92, DOI 10.1038/71756; VALANCIUS V, 1991, MOL CELL BIOL, V11, P4389, DOI 10.1128/MCB.11.9.4389; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2007, MOL BIOL EVOL, V24, P784, DOI 10.1093/molbev/msl205; WATANABE S, 1995, BIOCHEM BIOPH RES CO, V213, P130, DOI 10.1006/bbrc.1995.2107; Wilm B, 1998, P NATL ACAD SCI USA, V95, P8692, DOI 10.1073/pnas.95.15.8692; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060	44	45	49	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2009	41	8					946	U121		10.1038/ng.397	http://dx.doi.org/10.1038/ng.397			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19633672				2022-12-25	WOS:000268432900023
J	Labrijn, AF; Buijsse, AO; van den Bremer, ETJ; Verwilligen, AYW; Bleeker, WK; Thorpe, SJ; Killestein, J; Polman, CH; Aalberse, RC; Schuurman, J; van de Winkel, JGJ; Parren, PWHI				Labrijn, Aran F.; Buijsse, Antonio Ortiz; van den Bremer, Ewald T. J.; Verwilligen, Annemiek Y. W.; Bleeker, Wim K.; Thorpe, Susan J.; Killestein, Joep; Polman, Chris H.; Aalberse, Rob C.; Schuurman, Janine; van de Winkel, Jan G. J.; Parren, Paul W. H. I.			Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo	NATURE BIOTECHNOLOGY			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PLACEBO-CONTROLLED TRIAL; ACUTE MYELOID-LEUKEMIA; MONOCLONAL-ANTIBODY; MULTIPLE-SCLEROSIS; CYTOKINE STORM; HUMAN CD4; T-CELLS; PHASE-I; NATALIZUMAB	Two humanized IgG4 antibodies, natalizumab and gemtuzumab, are approved for human use, and several others, like TGN1412, are or have been in clinical development. Although IgG4 antibodies can dynamically exchange half-molecules(1), Fab-arm exchange with therapeutic antibodies has not been demonstrated in humans. Here, we show that natalizumab exchanges Fab arms with endogenous human IgG4 in natalizumab-treated individuals. Gemtuzumab, in contrast, contains an IgG4 core-hinge mutation that blocks Fab-arm exchange to undetectable levels both in vitro and in a mouse model. The ability of IgG4 therapeutics to recombine with endogenous IgG4 may affect their pharmacokinetics and pharmacodynamics. Although pharmacokinetic modeling lessens concerns about undesired cross-linking under normal conditions, unpredictability remains and mutations that completely prevent Fab-arm exchange in vivo should be considered when designing therapeutic IgG4 antibodies.	[Labrijn, Aran F.; Buijsse, Antonio Ortiz; van den Bremer, Ewald T. J.; Verwilligen, Annemiek Y. W.; Bleeker, Wim K.; Schuurman, Janine; van de Winkel, Jan G. J.; Parren, Paul W. H. I.] Genmab, Utrecht, Netherlands; [Thorpe, Susan J.] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Killestein, Joep; Polman, Chris H.] VU Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Aalberse, Rob C.] Sanquin Res AMC Landsteiner Lab, Dept Immunopathol, Amsterdam, Netherlands; [van de Winkel, Jan G. J.] Univ Med Ctr, Immunotherapy Lab, Dept Immunol, Utrecht, Netherlands	Genmab; National Institute for Biological Standards & Control; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center	Parren, PWHI (corresponding author), Genmab, Utrecht, Netherlands.	p.parren@genmab.com	Thorpe, Susan J/E-1808-2013	Killestein, Joep/0000-0002-6347-5957; Parren, Paul/0000-0002-4365-3859; Labrijn, Aran Frank/0000-0001-9239-8439				ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; AUCOUTURIER P, 1987, IMMUNOL LETT, V16, P55, DOI 10.1016/0165-2478(87)90061-7; Bleeker WK, 2004, J IMMUNOL, V173, P4699, DOI 10.4049/jimmunol.173.7.4699; Bloom JW, 1997, PROTEIN SCI, V6, P407; Bross PF, 2001, CLIN CANCER RES, V7, P1490; Burton DR, 2007, SCIENCE, V317, P1507, DOI 10.1126/science.1148905; Calabrese LH, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2008.097972; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gordon FH, 2001, GASTROENTEROLOGY, V121, P268, DOI 10.1053/gast.2001.26260; HANKE T, 2007, Patent No. 20070122410; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Labrijn AF, 2008, CURR OPIN IMMUNOL, V20, P479, DOI 10.1016/j.coi.2008.05.010; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; MAJOR EO, 2001, FIELDS VIROLOGY, P2175; Murphy SL, 2009, J MED VIROL, V81, P65, DOI 10.1002/jmv.21360; Newman R, 2001, CLIN IMMUNOL, V98, P164, DOI 10.1006/clim.2000.4975; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Reddy MP, 2000, J IMMUNOL, V164, P1925, DOI 10.4049/jimmunol.164.4.1925; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Sheremata WA, 1999, NEUROLOGY, V52, P1072, DOI 10.1212/WNL.52.5.1072; Sievers EL, 1999, BLOOD, V93, P3678, DOI 10.1182/blood.V93.11.3678; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Sterry W, 2009, J DTSCH DERMATOL GES, V7, P5, DOI 10.1111/j.1610-0387.2008.06993.x; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	30	206	288	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2009	27	8					767	U122		10.1038/nbt.1553	http://dx.doi.org/10.1038/nbt.1553			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	480YY	19620983				2022-12-25	WOS:000268774500028
J	Ohyama, K; Shinohara, H; Ogawa-Ohnishi, M; Matsubayashi, Y				Ohyama, Kentaro; Shinohara, Hidefumi; Ogawa-Ohnishi, Mari; Matsubayashi, Yoshikatsu			A glycopeptide regulating stem cell fate in Arabidopsis thaliana	NATURE CHEMICAL BIOLOGY			English	Article							HYDROXYPROLINE ARABINOSIDES; MERISTEM; CLAVATA3; PEPTIDE; SHOOT; CLV3; MS; CONSERVATION; GENES	The secreted peptide gene CLAVATA3 (CLV3) regulates stem cell fate in the shoot apical meristem in Arabidopsis thaliana plants, but the molecular structure of the active mature CLV3 peptide is controversial. Here, using nano-LC-MS/MS analysis of apoplastic peptides of A. thaliana plants overexpressing CLV3, we show that CLV3 is a 13-amino-acid arabinosylated glycopeptide. Post-translational arabinosylation of CLV3 is critical for its biological activity and high-affinity binding to its receptor CLV1.	[Ohyama, Kentaro; Shinohara, Hidefumi; Ogawa-Ohnishi, Mari; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsubayashi, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	matsu@agr.nagoya-u.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019	Matsubayashi, Yoshikatsu/0000-0002-2669-2119; Ogawa-Ohnishi, Mari/0000-0002-7581-2607	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19060010, 18687003]; Japan Society for the Promotion of Science [19GS0315]; Bio-oriented Technology Research Advancement Institution (BRAIN)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bio-oriented Technology Research Advancement Institution (BRAIN)	This research was supported by a Grant-in-Aid for Scientific Research for Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (No. 19060010), a Grant-in-Aid for Young Scientists from MEXT (No. 18687003), a Grant-in-Aid for Creative Scientific Research from the Japan Society for the Promotion of Science (No. 19GS0315) and the Program of Basic Research Activities for Innovative Biosciences from the Bio-oriented Technology Research Advancement Institution (BRAIN). We thank the Radioisotope Research Center of Nagoya University for instrumental support in radioisotope experiments.	AKIYAMA Y, 1976, AGR BIOL CHEM TOKYO, V40, P2343, DOI 10.1080/00021369.1976.10862409; AKIYAMA Y, 1980, AGR BIOL CHEM TOKYO, V44, P2487, DOI 10.1080/00021369.1980.10864347; ASHFORD D, 1982, BIOCHEM J, V201, P199, DOI 10.1042/bj2010199; Bollig K, 2007, CARBOHYD RES, V342, P2557, DOI 10.1016/j.carres.2007.08.008; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Cock JM, 2001, PLANT PHYSIOL, V126, P939, DOI 10.1104/pp.126.3.939; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Fiers M, 2006, PLANT PHYSIOL, V141, P1284, DOI 10.1104/pp.106.080671; Fletcher JC, 2000, CURR OPIN PLANT BIOL, V3, P23, DOI 10.1016/S1369-5266(99)00033-3; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Ni J, 2006, PLANT PHYSIOL, V140, P726, DOI 10.1104/pp.105.072678; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ohyama K, 2008, PLANT J, V55, P152, DOI 10.1111/j.1365-313X.2008.03464.x; Sassaki GL, 2005, CARBOHYD RES, V340, P731, DOI 10.1016/j.carres.2005.01.020; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Seitz O, 2000, CHEMBIOCHEM, V1, P215	17	295	314	8	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					578	580		10.1038/nchembio.182	http://dx.doi.org/10.1038/nchembio.182			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19525968				2022-12-25	WOS:000268209200015
J	Stacey, SN; Sulem, P; Masson, G; Gudjonsson, SA; Thorleifsson, G; Jakobsdottir, M; Sigurdsson, A; Gudbjartsson, DF; Sigurgeirsson, B; Benediktsdottir, KR; Thorisdottir, K; Ragnarsson, R; Scherer, D; Hemminki, K; Rudnai, P; Gurzau, E; Koppova, K; Botella-Estrada, R; Soriano, V; Juberias, P; Saez, B; Gilaberte, Y; Fuentelsaz, V; Corredera, C; Grasa, M; Hoiom, V; Lindblom, A; Bonenkamp, JJ; van Rossum, MM; Aben, KKH; de Vries, E; Santinami, M; Di Mauro, MG; Maurichi, A; Wendt, J; Hochleitner, P; Pehamberger, H; Gudmundsson, J; Magnusdottir, DN; Gretarsdottir, S; Holm, H; Steinthorsdottir, V; Frigge, ML; Blondal, T; Saemundsdottir, J; Bjarnason, H; Kristjansson, K; Bjornsdottir, G; Okamoto, I; Rivoltini, L; Rodolfo, M; Kiemeney, LA; Hansson, J; Nagore, E; Mayordomo, JI; Kumar, R; Karagas, MR; Nelson, HH; Gulcher, JR; Rafnar, T; Thorsteinsdottir, U; Olafsson, JH; Kong, A; Stefansson, K				Stacey, Simon N.; Sulem, Patrick; Masson, Gisli; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Jakobsdottir, Margret; Sigurdsson, Asgeir; Gudbjartsson, Daniel F.; Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Scherer, Dominique; Hemminki, Kari; Rudnai, Peter; Gurzau, Eugene; Koppova, Kvetoslava; Botella-Estrada, Rafael; Soriano, Virtudes; Juberias, Pablo; Saez, Berta; Gilaberte, Yolanda; Fuentelsaz, Victoria; Corredera, Cristina; Grasa, Matilde; Hoiom, Veronica; Lindblom, Annika; Bonenkamp, Johannes J.; van Rossum, Michelle M.; Aben, Katja K. H.; de Vries, Esther; Santinami, Mario; Di Mauro, Maria G.; Maurichi, Andrea; Wendt, Judith; Hochleitner, Pia; Pehamberger, Hubert; Gudmundsson, Julius; Magnusdottir, Droplaug N.; Gretarsdottir, Solveig; Holm, Hilma; Steinthorsdottir, Valgerdur; Frigge, Michael L.; Blondal, Thorarinn; Saemundsdottir, Jona; Bjarnason, Hjordis; Kristjansson, Kristleifur; Bjornsdottir, Gyda; Okamoto, Ichiro; Rivoltini, Licia; Rodolfo, Monica; Kiemeney, Lambertus A.; Hansson, Johan; Nagore, Eduardo; Mayordomo, Jose I.; Kumar, Rajiv; Karagas, Margaret R.; Nelson, Heather H.; Gulcher, Jeffrey R.; Rafnar, Thorunn; Thorsteinsdottir, Unnur; Olafsson, Jon H.; Kong, Augustine; Stefansson, Kari			New common variants affecting susceptibility to basal cell carcinoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EPIDERMOLYSIS-BULLOSA SIMPLEX; GENETIC-DETERMINANTS; PIGMENTATION; MELANOMA; FAMILY; CANCER; KERATINS; INK4/ARF; LOCUS	In a follow-up to our previously reported genome-wide association study of cutaneous basal cell carcinoma (BCC)(1), we describe here several new susceptibility variants. SNP rs11170164, encoding a G138E substitution in the keratin 5 (KRT5) gene, affects risk of BCC (OR = 1.35, P = 2.1 x 10(-9)). A variant at 9p21 near CDKN2A and CDKN2B also confers susceptibility to BCC (rs2151280[C]; OR = 1.19, P = 6.9 x 10(-9)), as does rs157935[T] at 7q32 near the imprinted gene KLF14 (OR = 1.23, P = 5.7 x 10(-10)). The effect of rs157935[T] is dependent on the parental origin of the risk allele. None of these variants were found to be associated with melanoma or fair-pigmentation traits. A melanoma-and pigmentation-associated variant in the SLC45A2 gene, L374F, is associated with risk of both BCC and squamous cell carcinoma. Finally, we report conclusive evidence that rs401681[C] in the TERT-CLPTM1L locus confers susceptibility to BCC but protects against melanoma.	[Stacey, Simon N.; Sulem, Patrick; Masson, Gisli; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Jakobsdottir, Margret; Sigurdsson, Asgeir; Gudbjartsson, Daniel F.; Gudmundsson, Julius; Magnusdottir, Droplaug N.; Gretarsdottir, Solveig; Holm, Hilma; Steinthorsdottir, Valgerdur; Frigge, Michael L.; Blondal, Thorarinn; Saemundsdottir, Jona; Bjarnason, Hjordis; Kristjansson, Kristleifur; Bjornsdottir, Gyda; Gulcher, Jeffrey R.; Rafnar, Thorunn; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Sigurgeirsson, Bardur; Thorisdottir, Kristin; Olafsson, Jon H.] Univ Iceland, Landspitali, Dept Dermatol, Reykjavik, Iceland; [Benediktsdottir, Kristrun R.; Olafsson, Jon H.] Univ Iceland, Landspitali, Dept Pathol, Reykjavik, Iceland; [Thorisdottir, Kristin; Ragnarsson, Rafn; Olafsson, Jon H.] Univ Iceland, Landspitali, Dept Plast Surg, Reykjavik, Iceland; [Scherer, Dominique; Hemminki, Kari; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Rudnai, Peter] Natl Inst Environm Hlth, Budapest, Hungary; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca, Ro Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, Banska Bystrica, Slovakia; [Botella-Estrada, Rafael; Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain; [Soriano, Virtudes] Inst Valenciano Oncol, Dept Oncol, Valencia, Spain; [Juberias, Pablo; Fuentelsaz, Victoria; Corredera, Cristina; Grasa, Matilde] Univ Hosp, Div Dermatol, Zaragoza, Spain; [Saez, Berta; Mayordomo, Jose I.] Nanotechnol Inst Aragon, Hlth Sci Inst, Zaragoza, Spain; [Gilaberte, Yolanda] San Jorge Gen Hosp, Div Dermatol, Huesca, Spain; [Hoiom, Veronica; Hansson, Johan] Karolinska Univ Hosp Solna, Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden; [Lindblom, Annika] Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Bonenkamp, Johannes J.] Radboud Univ Nijmegen, Dept Surg, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Rossum, Michelle M.] Radboud Univ Nijmegen, Dept Dermatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol Biostat & Hlth Technol Assessment, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Comprehens Canc Ctr IKO, Nijmegen, Netherlands; [de Vries, Esther] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Santinami, Mario; Maurichi, Andrea] Fdn IRCCS, Ist Nazl Tumori, Melanoma & Sarcoma Surg Unit, Milan, Italy; [Di Mauro, Maria G.] Fdn IRCCS, Ist Nazl Tumori, Dept Immunohematol & Transfus Med, Milan, Italy; [Wendt, Judith; Hochleitner, Pia; Pehamberger, Hubert; Okamoto, Ichiro] Med Univ Vienna, Div Gen Dermatol, Dept Dermatol, Vienna, Austria; [Rivoltini, Licia; Rodolfo, Monica] Fdn IRCCS, Ist Nazl Tumori, Immunotherapy Human Tumours Unit, Milan, Italy; [Rodolfo, Monica] Fdn IRCCS, Ist Nazl Tumori, Melanoma Genet Grp, Milan, Italy; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza, Spain; [Karagas, Margaret R.] Dartmouth Med Sch, Epidemiol & Biostat Sect, Dept Community & Family Med, Lebanon, NH USA; [Karagas, Margaret R.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA; [Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Div Epidemiol & Community Hlth, Minneapolis, MN USA	University of Iceland; University of Iceland; University of Iceland; Helmholtz Association; German Cancer Research Center (DKFZ); Instituto Valenciano De Oncologia; Instituto Valenciano De Oncologia; Miguel Servet University Hospital; Hospital Universidad San Jorge; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Medical University of Vienna; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Radboud University Nijmegen; Miguel Servet University Hospital; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of Minnesota System; University of Minnesota Twin Cities	Stacey, SN (corresponding author), deCODE Genet, Reykjavik, Iceland.	simon.stacey@decode.is; kari.stefansson@decode.is	Nagore, Eduardo/Z-2126-2019; Rossum, M.M./L-4614-2015; Stefansson, Kari/AAE-7187-2019; Di Mauro, Maria Gaetana/AAB-1869-2021; Maurichi, Andrea/AAX-5020-2020; Gilaberte, Yolanda/K-6416-2019; Sigurgeirsson, Bárður/B-6130-2011; Bonenkamp, J.J./L-4213-2015; Maurichi, Andrea/E-7030-2017; Aben, Katja KH/G-9686-2016; Sigurgeirsson, Bardur/AAP-7755-2020; rodolfo, monica/H-2671-2012; Kiemeney, Lambertus A./D-3357-2009; de Vries, Esther/A-6603-2009; Kumar, Rajiv/H-6431-2019; Mayordomo, Jose/K-3453-2013; Santinami, Mario/I-3795-2017; Höiom, Veronica/F-4153-2012; rivoltini, licia/I-2450-2012	Nagore, Eduardo/0000-0003-3433-8707; Di Mauro, Maria Gaetana/0000-0002-2200-9060; Maurichi, Andrea/0000-0002-6503-5373; Maurichi, Andrea/0000-0002-6503-5373; Aben, Katja KH/0000-0002-0214-2147; rodolfo, monica/0000-0002-9196-0298; Kiemeney, Lambertus A./0000-0002-2368-1326; de Vries, Esther/0000-0002-5560-2258; Kumar, Rajiv/0000-0002-6093-0395; Santinami, Mario/0000-0001-8436-4757; rivoltini, licia/0000-0002-2409-6225; Bjornsdottir, Gyda/0000-0002-8100-0306; Nelson, Heather/0000-0003-1901-9513; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Gurzau, Eugen/0000-0002-8688-6118; Kong, Augustine/0000-0001-8193-5438; Saez, Berta/0000-0003-0753-1165; Gilaberte, Yolanda/0000-0001-8034-3617; Gudbjartsson, Daniel/0000-0002-5222-9857; Sigurgeirsson, Bardur/0000-0002-9733-9742	NCI NIH HHS [R01CA57494, R01CA082354, R01 CA057494-16, R01 CA082354, R01 CA057494] Funding Source: Medline; NIEHS NIH HHS [T32 ES007155] Funding Source: Medline; PHS HHS [T32E007155] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057494, R01CA082354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007155] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bataille V, 2007, CANCER EPIDEM BIOMAR, V16, P1499, DOI 10.1158/1055-9965.EPI-07-0152; CHAN YM, 1993, P NATL ACAD SCI USA, V90, P7414, DOI 10.1073/pnas.90.15.7414; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kowalewski C, 2007, INT J MOL MED, V20, P75; Lin J, 2008, BRIT J DERMATOL, V159, P286, DOI 10.1111/j.1365-2133.2008.08682.x; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shurman D, 2006, EUR J DERMATOL, V16, P132; Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Uitto J, 2007, EXP CELL RES, V313, P1995, DOI 10.1016/j.yexcr.2007.03.029; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	251	257	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					909	U69		10.1038/ng.412	http://dx.doi.org/10.1038/ng.412			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19578363	Green Accepted			2022-12-25	WOS:000268432900016
J	Iwaki, M; Iwane, AH; Shimokawa, T; Cooke, R; Yanagida, T				Iwaki, Mitsuhiro; Iwane, Atsuko H.; Shimokawa, Tetsuya; Cooke, Roger; Yanagida, Toshio			Brownian search-and-catch mechanism for myosin-VI steps	NATURE CHEMICAL BIOLOGY			English	Article							HAND-OVER-HAND; ACTIN; WALKS; BINDING; MUSCLE; TRANSLOCATION; PROCESSIVITY; CONTRACTION; DYNAMICS; MOTORS	The cargo transporter myosin-VI processively walks along actin filaments using its two heads. Here we use single-molecule nanometry to show that the strong binding by myosin heads to actin is greatly accelerated (similar to 30-fold) when backward strain is applied to weakly bound heads during the actin search. We propose that the myosin head searches for the forward actin target by Brownian motion and catches the actin in a strain-dependent manner.	[Iwaki, Mitsuhiro; Iwane, Atsuko H.; Yanagida, Toshio] Osaka Univ, Grad Sch Med, Osaka, Japan; [Iwaki, Mitsuhiro; Iwane, Atsuko H.; Shimokawa, Tetsuya; Yanagida, Toshio] Osaka Univ, Soft Biosyst Grp, Labs Nanobiol, Grad Sch Frontier Biosci, Osaka, Japan; [Cooke, Roger] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; [Cooke, Roger] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Osaka University; Osaka University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yanagida, T (corresponding author), Osaka Univ, Grad Sch Med, Osaka, Japan.	yanagida@phys1.med.osaka-u.ac.jp	Yanagida, Toshio/D-1919-2009; Iwaki, Mitsuhiro/X-8924-2019	Iwaki, Mitsuhiro/0000-0002-8893-1103; Iwane, Atsuko/0000-0003-2641-2268	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [21570159] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Nishikawa, H. Takagi and Y. Togashi for valuable discussion; P. Karagiannis for reading the manuscript; and colleagues of the Yanagida laboratory for comments and discussion. The work was supported by the Yuragi Project and Grant-in-Aid for Scientific Research on Innovative Areas of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and by the Soft Nanomachine Project of the Japan Science and Technology Agency (JST).	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Astumian RD, 2001, SCI AM, V285, P56, DOI 10.1038/scientificamerican0701-56; BRENNER B, 1991, P NATL ACAD SCI USA, V88, P10490, DOI 10.1073/pnas.88.23.10490; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; GEEVES MA, 1991, BIOCHEM J, V274, P1; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Iwaki M, 2006, BIOPHYS J, V90, P3643, DOI 10.1529/biophysj.105.075721; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Menetrey J, 2007, CELL, V131, P300, DOI 10.1016/j.cell.2007.08.027; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Shiroguchi K, 2007, SCIENCE, V316, P1208, DOI 10.1126/science.1140468; Sun YJ, 2007, MOL CELL, V28, P954, DOI 10.1016/j.molcel.2007.10.029; Sweeney HL, 2007, EMBO J, V26, P2682, DOI 10.1038/sj.emboj.7601720; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; YOUNT RG, 1995, BIOPHYS J S, V68, P44	22	51	51	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					403	405		10.1038/nchembio.171	http://dx.doi.org/10.1038/nchembio.171			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19430485				2022-12-25	WOS:000266383800014
J	Jang, ACC; Chang, YC; Bai, JW; Montell, D				Jang, Anna C. -C.; Chang, Yu-Chiuan; Bai, Jianwu; Montell, Denise			Border-cell migration requires integration of spatial and temporal signals by the BTB protein Abrupt	NATURE CELL BIOLOGY			English	Article							DROSOPHILA ECDYSONE-RECEPTOR; GENE-FUNCTION; P450 ENZYME; MELANOGASTER; METAMORPHOSIS; ECR; OOGENESIS; MICRORNA; BEHAVIOR; PATHWAY	During development, elaborate patterns of cell differentiation and movement must occur in the correct locations and at the proper times. Developmental timing has been studied less than spatial pattern formation, and the mechanisms integrating the two are poorly understood. Border-cell migration in the Drosophila ovary occurs specifically at stage 9. Timing of the migration is regulated by the steroid hormone ecdysone, whereas spatial patterning of the migratory population requires localized activity of the JAK-STAT pathway. Ecdysone signalling is patterned spatially as well as temporally, although the mechanisms are not well understood. In stage 9 egg chambers, ecdysone signalling is highest in anterior follicle cells including the border cells. We identify the gene abrupt as a repressor of ecdysone signalling and border-cell migration. Abrupt protein is normally lost from border-cell nuclei during stage 9, in response to JAK-STAT activity. This contributes to the spatial pattern of the ecdysone response. Abrupt attenuates ecdysone signalling by means of a direct interaction with the basic helix-loop-helix (bHLH) domain of the P160 ecdysone receptor coactivator Taiman (Tai). Taken together, these findings provide a molecular mechanism by which spatial and temporal cues are integrated.	[Jang, Anna C. -C.; Chang, Yu-Chiuan; Montell, Denise] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Bai, Jianwu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02175 USA	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School	Montell, D (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	dmontell@jhmi.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046425, R01GM073164] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM46425, R01 GM046425, R01 GM073164, R01 GM73164, R01 GM073164-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Banerjee I, 2007, J NEUROENDOCRINOL, V19, P831, DOI 10.1111/j.1365-2826.2007.01598.x; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Carney GE, 2000, GENETICS, V154, P1203; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Doe CQ, 2006, CELL, V127, P254, DOI 10.1016/j.cell.2006.10.008; Frasch M, 2008, GENE DEV, V22, P1572, DOI 10.1101/gad.1690608; Freeman MR, 1999, DEVELOPMENT, V126, P4591; Gaziova I, 2004, DEVELOPMENT, V131, P2715, DOI 10.1242/dev.01143; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Hackney JF, 2007, DEV DYNAM, V236, P1213, DOI 10.1002/dvdy.21140; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Kozlova T, 2002, DEVELOPMENT, V129, P1739; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Riddiford Lynn M., 1993, P899; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 2002, TRENDS CELL BIOL, V12, P325, DOI 10.1016/S0962-8924(02)02311-5; RUBENSTEIN EC, 1982, J EXP ZOOL, V223, P305, DOI 10.1002/jez.1402230313; Schubiger M, 2003, MECH DEVELOP, V120, P909, DOI 10.1016/S0925-4773(03)00134-5; SCHWARTZ MB, 1989, INSECT BIOCHEM, V19, P243, DOI 10.1016/0020-1790(89)90068-1; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Starz-Gaiano M, 2008, DEV CELL, V14, P726, DOI 10.1016/j.devcel.2008.03.005; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Xi RW, 2003, DEV CELL, V4, P167, DOI 10.1016/S1534-5807(02)00412-4; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Yao JG, 2005, EMBO J, V24, P2602, DOI 10.1038/sj.emboj.7600725; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	55	76	77	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					569	U100		10.1038/ncb1863	http://dx.doi.org/10.1038/ncb1863			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19350016	Green Accepted			2022-12-25	WOS:000265640000016
J	Kirino, Y; Kim, N; de Planell-Saguer, M; Khandros, E; Chiorean, S; Klein, PS; Rigoutsos, I; Jongens, TA; Mourelatos, Z				Kirino, Yohei; Kim, Namwoo; de Planell-Saguer, Mariangels; Khandros, Eugene; Chiorean, Stephanie; Klein, Peter S.; Rigoutsos, Isidore; Jongens, Thomas A.; Mourelatos, Zissimos			Arginine methylation of Piwi proteins catalysed by dPRMT5 is required for Ago3 and Aub stability	NATURE CELL BIOLOGY			English	Article							SPLICEOSOMAL SM PROTEINS; SELFISH GENETIC ELEMENTS; DROSOPHILA-MELANOGASTER; INTERACTING RNAS; METHYLTRANSFERASE CAPSULEEN; TRANSPOSON CONTROL; CELL-FORMATION; TUDOR DOMAINS; 3' TERMINI; GERMLINE	Piwi family proteins are essential for germline development and bind piwi-interacting RNAs (piRNAs)(1-3). The grandchildless gene aub of Drosophila melanogaster encodes the piRNA-binding protein Aubergine (Aub), which is essential for formation of primordial germ cells (PGCs)(4). Here we report that Piwi family proteins of mouse, Xenopus laevis and Drosophila contain symmetrical dimethylarginines (sDMAs). We found that Piwi proteins are expressed in Xenopus oocytes and we identified numerous Xenopus piRNAs. We report that the Drosophila homologue of protein methyltransferase 5 (dPRMT5, csul/ dart5), which is also the product of a grandchildless gene(5,6), is required for arginine methylation of Drosophila Piwi, Ago3 and Aub proteins in vivo. Loss of dPRMT5 activity led to a reduction in the levels of piRNAs, Ago3 and Aub proteins, and accumulation of retrotransposons in the Drosophila ovary. Our studies explain the relationship between aub and dPRMT5 (csul/ dart5) genes by demonstrating that dPRMT5 is the enzyme that methylates Aub. Our findings underscore the significance of sDMA modification of Piwi proteins in the germline and suggest an interacting pathway of genes that are required for piRNA function and PGC specification.	[Kirino, Yohei; Kim, Namwoo; de Planell-Saguer, Mariangels; Khandros, Eugene; Mourelatos, Zissimos] Univ Penn, Dept Pathol & Lab Med, Div Neuropathol, Sch Med, Philadelphia, PA 19104 USA; [Chiorean, Stephanie; Jongens, Thomas A.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Rigoutsos, Isidore] IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; International Business Machines (IBM)	Mourelatos, Z (corresponding author), Univ Penn, Dept Pathol & Lab Med, Div Neuropathol, Sch Med, Philadelphia, PA 19104 USA.	mourelaz@uphs.upenn.edu	Rigoutsos, Isidore/C-5381-2012	Kirino, Yohei/0000-0001-5232-4742; Kim, Namwoo/0000-0002-1684-5417; Rigoutsos, Isidore/0000-0003-1529-8631; Mourelatos, Zissimos/0000-0002-9852-1845	Human Frontier Science Program [GM76621, GM0720777, NS056070, UL1RR024134]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056070, R01NS046573] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to M. C. Siomi, H. Siomi, K. Saito, G. Dreyfuss for antibodies; to J. Anne for csul flies; to S. Kuramochi-Miyagawa and T. Nakano for Miwi and Mili cDNA constructs; to Rebecca Beerman for help with fly methodology; to Y. Kawamura for immunofluorescence protocols and to members of the Mourelatos lab for discussions. Mass spectrometry was performed at the Proteomics Core Facility (University of Pennsylvania) and at the Proteomics Resource of the Keck Foundation (Yale University). Illumina sequencing was performed at the Functional Genomics Core of the University of Pennsylvania. Protein production was at the Protein Expression Core of the Wistar Institute. We apologize to colleagues whose studies were not cited because of space limitations. This work was supported by a Human Frontier Science Program Long Term Fellowship to Y. K., and NIH grants to T. A. J. (NS046573), P. S. K. (GM76621) and Z. M.(GM0720777, NS056070, UL1RR024134). Z. M. also received ITMAT-PENN and URF-PENN.	Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Bossi Elena, 2007, V375, P107; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; DREYFUSS G, 1984, J CELL BIOL, V99, pA233, DOI 10.1083/jcb.99.6.1997; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kiriakidou M, 2005, METH MOL B, V309, P295; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Siomi MC, 2008, FEBS LETT, V582, P2473, DOI 10.1016/j.febslet.2008.06.018; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	52	175	194	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					652	U478		10.1038/ncb1872	http://dx.doi.org/10.1038/ncb1872			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19377467	Green Accepted			2022-12-25	WOS:000265640000025
J	Cohen-Chalamish, S; Hasson, A; Weinberg, D; Namer, LS; Banai, Y; Osman, F; Kaempfer, R				Cohen-Chalamish, Smadar; Hasson, Anat; Weinberg, Dahlia; Namer, Lise Sarah; Banai, Yona; Osman, Farhat; Kaempfer, Raymond			Dynamic refolding of IFN-gamma mRNA enables it to function as PKR activator and translation template	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE PKR; CONTROLS GENE-EXPRESSION; DOUBLE-STRANDED-RNA; INTERFERON-GAMMA; BINDING; RIBOSWITCHES; REGULATORS; BIOLOGY; DOMAIN	Interferon-gamma mRNA activates the RNA-dependent protein kinase PKR, which in turn strongly attenuates translation of interferon-gamma mRNA. Unlike riboswitches restricted to noncoding regions, the interferon-gamma RNA domain that activates PKR comprises the 5' UTR and 26 translated codons. Extensive interferon-gamma coding sequence is thus dedicated to activating PKR and blocking interferon-gamma synthesis. This implies that the PKR activator is disrupted by ribosomes during translation initiation and must refold promptly to restore PKR activation. The activator structure harbors an essential kink-turn, probably to allow formation of a pseudoknot that is critical for PKR activation. Three indispensable short helices, bordered by orientation-sensitive base pairs, align with the pseudoknot stem, generating RNA helix of sufficient length to activate PKR. Through gain-of-function mutations, we show that the RNA activator can adopt alternative conformations that activate PKR. This flexibility promotes efficient refolding of interferon-gamma mRNA, which is necessary for its dual function as translation template and activator of PKR, and which thus prevents overexpression of this inflammatory cytokine.	[Cohen-Chalamish, Smadar; Hasson, Anat; Weinberg, Dahlia; Namer, Lise Sarah; Banai, Yona; Osman, Farhat; Kaempfer, Raymond] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Kaempfer, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.	kaempfer@hebrew.edu		Kaempfer, Raymond/0000-0002-5865-4619	Israel Science Foundation; German Research Foundation (DFG)	Israel Science Foundation(Israel Science Foundation); German Research Foundation (DFG)(German Research Foundation (DFG))	We thank E. Westhof for valuable suggestions and V. Bafna for bioinformatic analysis of the rodent IFN-gamma genes. We thank A. Billiau (Catholic University of Leuven) for porcine IFN-gamma cDNA. This work was supported by grants from the Israel Science Foundation and the German Research Foundation (DFG).	Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Circle DA, 1997, RNA, V3, P438; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gerez L, 1997, CLIN EXP IMMUNOL, V109, P296, DOI 10.1046/j.1365-2249.1997.4471345.x; Guerrier-Takada C, 2002, RNA, V8, P290, DOI 10.1017/S1355838202027954; Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911; Kaempfer R, 2003, EMBO REP, V4, P1043, DOI 10.1038/sj.embor.7400005; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Reyes A, 2000, MOL BIOL EVOL, V17, P979, DOI 10.1093/oxfordjournals.molbev.a026379; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Strobel SA, 2004, RNA, V10, P1852, DOI 10.1261/rna.7141504; Suess B, 2004, NUCLEIC ACIDS RES, V32, P1610, DOI 10.1093/nar/gkh321; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; VANDENBROECK K, 1991, BIOCHEM BIOPH RES CO, V180, P1408, DOI 10.1016/S0006-291X(05)81353-1; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Zheng XF, 2004, RNA, V10, P1934, DOI 10.1261/rna.7150804	33	56	56	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					896	903		10.1038/nchembio.234	http://dx.doi.org/10.1038/nchembio.234			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19801993				2022-12-25	WOS:000271756900012
J	Chen, YH; Chang, M; Davidson, BL				Chen, Yong Hong; Chang, Michael; Davidson, Beverly L.			Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy	NATURE MEDICINE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; ADENOASSOCIATED VIRUS; MOUSE MODEL; GENE; EVOLUTION; VECTORS; PHENOTYPES; LIBRARIES; TROPISM	The brain vasculature forms an immense network such that most neural cells are in contact with a microvessel. Here we tested the hypothesis that endothelia lining these vessels can be harnessed to create a cellular reservoir of enzyme replacement therapy to diseased brain. As a model system, we used mice with central nervous system (CNS) deficits due to lysosomal storage disease (LSD mice). The basic premise of this work is that recombinant enzyme expressed in, and secreted from, the vascular endothelia will be endocytosed by underlying neurons and glia, decreasing neuropathology. We screened a phage library in vivo by panning to identify peptides that bound the vascular endothelia in diseased and wild-type mice. Epitopes binding diseased brain were distinct from those panned from normal brain. Moreover, different epitopes were identified in two distinct LSD disease models, implying a unique vascular signature imparted by the disease state. Presentation of these epitopes on the capsid of adeno-associated virus (AAV) expanded the biodistribution of intravenously injected AAV from predominantly liver to include the CNS. Peripheral injection of the epitope-modified AAVs expressing the enzymes lacking in LSD mice reconstituted enzyme activity throughout the brain and improved disease phenotypes in two distinct disease models.	[Chen, Yong Hong; Davidson, Beverly L.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Chang, Michael; Davidson, Beverly L.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Davidson, Beverly L.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Davidson, BL (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	beverly-davidson@uiowa.edu		Davidson, Beverly/0000-0002-3715-6290	US National Institutes of Health [HD33531, NS34568, DK54759]; Batten Disease Research and Support Association; Roy J. Carver Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034568] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Batten Disease Research and Support Association; Roy J. Carver Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Liu and J. Wilson for technical assistance and the Central Microscopy Research Facility at the University of Iowa. We thank C. Stein and P. Staber for reading of the manuscript. We thank W. Sly, St. Louis University, for goat antibody to beta-glucuronidase. This work was supported by the US National Institutes of Health (grants HD33531, NS34568 and DK54759), the Batten Disease Research and Support Association and the Roy J. Carver Trust.	Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Grifman M, 2001, MOL THER, V3, P964, DOI 10.1006/mthe.2001.0345; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Koerber JT, 2006, NAT PROTOC, V1, P701, DOI 10.1038/nprot.2006.93; Liu GM, 2005, J NEUROSCI, V25, P9321, DOI 10.1523/JNEUROSCI.2936-05.2005; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Perabo L, 2006, J VIROL, V80, P7265, DOI 10.1128/JVI.00076-06; Sleat DE, 2004, J NEUROSCI, V24, P9117, DOI 10.1523/JNEUROSCI.2729-04.2004; Song L, 2003, IN VITRO CELL DEV-AN, V39, P313; Vogler C, 2001, PEDIATR RES, V49, P342, DOI 10.1203/00006450-200103000-00007; Work LM, 2006, MOL THER, V13, P683, DOI 10.1016/j.ymthe.2005.11.013	12	131	155	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1215	U145		10.1038/nm.2025	http://dx.doi.org/10.1038/nm.2025			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19749771	Green Accepted			2022-12-25	WOS:000270596400035
J	Yazawa, M; Sadaghiani, AM; Hsueh, B; Dolmetsch, RE				Yazawa, Masayuki; Sadaghiani, Amir M.; Hsueh, Brian; Dolmetsch, Ricardo E.			Induction of protein-protein interactions in live cells using light	NATURE BIOTECHNOLOGY			English	Article							IN-VIVO; ARABIDOPSIS; FKF1; ACTIVATION; GIGANTEA; BINDING; RAC1; GENE; SYSTEM; SIGNAL	Protein-protein interactions are essential for many cellular processes. We have developed a technology called light-activated dimerization (LAD) to artificially induce protein hetero- and homodimerization in live cells using light. Using the FKF1 and GIGANTEA (GI) proteins of Arabidopsis thaliana, we have generated protein tags whose interaction is controlled by blue light. We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1 to the plasma membrane and induce the local formation of lamellipodia in response to focal illumination. We also generated a light-activated transcription factor by fusing domains of GI and FKF1 to the DNA binding domain of Gal4 and the transactivation domain of VP16, respectively, showing that this technology is easily adapted to other systems. These studies set the stage for the development of light-regulated signaling molecules for controlling receptor activation, synapse formation and other signaling events in organisms.	[Yazawa, Masayuki; Sadaghiani, Amir M.; Hsueh, Brian; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu			National Institutes of Health Pioneer Award; Simons Foundation; Japan Society for the Promotion of Science; Stanford Institutes of Medicine Summer Research Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	National Institutes of Health Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Stanford Institutes of Medicine Summer Research Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank T. Imaizumi (Scripps Research Institute) for providing FKF1 and GI plasmids; T.-S. Tseng and W. R. Briggs (Carnegie Institution, Stanford University) for providing phototropin plasmids; Y. Gotoh (University of Tokyo) for providing plasmids encoding human Rac1 mutants; and M. Endo and S. Sugano for helpful advice. This study is supported by an National Institutes of Health Pioneer Award, the Simons Foundation and by gifts from L. Miller, B. and F. Horowitz and M. MCafferey to R. E. D., the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad to M. Y. and Stanford Institutes of Medicine Summer Research Program to B. H.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; LIU M, 2005, NUCL ACIDS S SER OXF, V49, P283; Magee T, 1999, CELL, V98, P9, DOI 10.1016/S0092-8674(00)80601-7; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; XU XM, 1994, J BIOL CHEM, V269, P23569; Zikihara K, 2006, BIOCHEMISTRY-US, V45, P10828, DOI 10.1021/bi0607857	29	306	324	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2009	27	10					941	U105		10.1038/nbt.1569	http://dx.doi.org/10.1038/nbt.1569			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	515LO	19801976				2022-12-25	WOS:000271472500025
J	Wang, K; Saito, M; Bisikirska, BC; Alvarez, MJ; Lim, WK; Rajbhandari, P; Shen, Q; Nemenman, I; Basso, K; Margolin, AA; Klein, U; Dalla-Favera, R; Califano, A				Wang, Kai; Saito, Masumichi; Bisikirska, Brygida C.; Alvarez, Mariano J.; Lim, Wei Keat; Rajbhandari, Presha; Shen, Qiong; Nemenman, Ilya; Basso, Katia; Margolin, Adam A.; Klein, Ulf; Dalla-Favera, Riccardo; Califano, Andrea			Genome-wide identification of post-translational modulators of transcription factor activity in human B cells	NATURE BIOTECHNOLOGY			English	Article							C-MYC; EXPRESSION PROFILES; REGULATORY NETWORKS; PROTEIN; BCL6; BINDING; CYCLE; TRANSDUCTION; DISCOVERY; CHROMATIN	The ability of a transcription factor (TF) to regulate its targets is modulated by a variety of genetic and epigenetic mechanisms, resulting in highly context-dependent regulatory networks. However, high-throughput methods for the identification of proteins that affect TF activity are still largely unavailable. Here we introduce an algorithm, modulator inference by network dynamics (MINDy), for the genome-wide identification of post-translational modulators of TF activity within a specific cellular context. When used to dissect the regulation of MYC activity in human B lymphocytes, the approach inferred novel modulators of MYC function, which act by distinct mechanisms, including protein turnover, transcription complex formation and selective enzyme recruitment. MINDy is generally applicable to study the post-translational modulation of mammalian TFs in any cellular context. As such it can be used to dissect context-specific signaling pathways and combinatorial transcriptional regulation.	[Wang, Kai; Lim, Wei Keat; Margolin, Adam A.; Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Wang, Kai; Bisikirska, Brygida C.; Alvarez, Mariano J.; Lim, Wei Keat; Rajbhandari, Presha; Nemenman, Ilya; Margolin, Adam A.; Califano, Andrea] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [Saito, Masumichi; Shen, Qiong; Basso, Katia; Klein, Ulf; Dalla-Favera, Riccardo; Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY USA; [Saito, Masumichi; Shen, Qiong; Basso, Katia; Klein, Ulf; Dalla-Favera, Riccardo; Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol & Genet & Dev, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.	califano@c2b2.columbia.edu		Wang, Kai/0000-0003-0567-3004; Nemenman, Ilya/0000-0003-3024-4244; Califano, Andrea/0000-0003-4742-3679	US National Cancer Institute [R01CA109755]; National Institute of Allergy and Infectious Diseases [R01AI066116]; National Centers for Biomedical Computing NIH Roadmap Initiative [U54CA121852]; National Institute for General Medical Sciences [R21GM080216]; IBM; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA109755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM080216] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Centers for Biomedical Computing NIH Roadmap Initiative; National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); IBM(International Business Machines (IBM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Cancer Institute (R01CA109755), the National Institute of Allergy and Infectious Diseases (R01AI066116) and the National Centers for Biomedical Computing NIH Roadmap Initiative (U54CA121852). I.N. was supported in part by the National Institute for General Medical Sciences (R21GM080216). A. A. M. was supported by an IBM PhD fellowship.	Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Matsuoka Y, 2008, CANCER SCI, V99, P309, DOI 10.1111/j.1349-7006.2007.00689.x; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Molkentin JD, 1996, MOL CELL BIOL, V16, P3814; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Patel JH, 2007, J BIOL CHEM, V282, P5, DOI 10.1074/jbc.M609138200; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Thomas MC, 2006, ELEMENTS INFORM THEO; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	49	176	178	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2009	27	9					829	U84		10.1038/nbt.1563	http://dx.doi.org/10.1038/nbt.1563			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	493QE	19741643	Green Accepted			2022-12-25	WOS:000269751400025
J	Xu, D; Esko, JD				Xu, Ding; Esko, Jeffrey D.			A Golgi-on-a-chip for glycan synthesis	NATURE CHEMICAL BIOLOGY			English	News Item							HEPARAN-SULFATE BIOSYNTHESIS; BINDING	One of the primary functions of the Golgi apparatus is the assembly of glycans on macromolecules destined for secretion or the plasma membrane. A recent study describes the first step toward an artificial Golgi, based on a microfluidic chip and magnetic nanoparticles.	[Xu, Ding; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Xu, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu	Xu, Ding/B-2493-2009	Xu, Ding/0000-0001-9380-2712				ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; Martin JG, 2009, J AM CHEM SOC, V131, P11041, DOI 10.1021/ja903038d; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Varki A., 2009, ESSENTIALS GLYCOBIOL; Watson MWL, 2006, ANAL CHEM, V78, P7877, DOI 10.1021/ac0613378	11	9	9	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					612	613		10.1038/nchembio0909-612	http://dx.doi.org/10.1038/nchembio0909-612			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19690535				2022-12-25	WOS:000269093000007
J	Fan, ZP; Yamaza, T; Lee, JS; Yu, JH; Wang, SL; Fan, GP; Shi, ST; Wang, CY				Fan, Zhipeng; Yamaza, Takayoshi; Lee, Janice S.; Yu, Jinhua; Wang, Songlin; Fan, Guoping; Shi, Songtao; Wang, Cun-Yu			BCOR regulates mesenchymal stem cell function by epigenetic mechanisms	NATURE CELL BIOLOGY			English	Article							DOMAIN-CONTAINING PROTEINS; CARDIO-DENTAL SYNDROME; HISTONE DEMETHYLATION; TRANSCRIPTION FACTOR; COREPRESSOR; DIFFERENTIATION; EXPRESSION; DEFECTS; COMPLEX; REGENERATION	The BCL-6 co-repressor (BCOR) represses gene transcription by interacting with BCL-6 (refs 1, 2). BCOR mutation is responsible for oculo-facio-cardio-dental (OFCD) syndrome, which is characterized by canine teeth with extremely long roots, congenital cataracts, craniofacial defects and congenital heart disease(3-5). Here we show that BCOR mutation increased the osteo-dentinogenic potential of mesenchymal stem cells (MSCs) isolated from a patient with OFCD, providing a molecular explanation for abnormal root growth. AP-2 alpha was identified as a repressive target of BCOR, and BCOR mutation resulted in abnormal activation of AP-2 alpha. Gain- and loss-of-function assays suggest that AP-2 alpha is a key factor that mediates the increased osteo-dentinogenic capacity of MSCs. Moreover, we found that BCOR maintained tissue homeostasis and gene silencing through epigenetic mechanisms. BCOR mutation increased histone H3K4 and H3K36 methylation in MSCs, thereby reactivating transcription of silenced target genes. By studying a rare human genetic disease, we have unravelled an epigenetic mechanism for control of human adult stem cell function.	[Fan, Zhipeng; Yu, Jinhua; Wang, Cun-Yu] Univ Calif Los Angeles, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA; [Yamaza, Takayoshi; Shi, Songtao] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Lee, Janice S.] Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, San Francisco, CA 94143 USA; [Wang, Songlin] Capital Med Univ, Sch Stomatol, Mol Lab Gene Therapy & Tooth Regenerat, Beijing 100050, Peoples R China; [Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Southern California; University of California System; University of California San Francisco; Capital Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, CY (corresponding author), Univ Calif Los Angeles, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu		Yamaza, Takayoshi/0000-0001-7055-3370; Yu, Jinhua/0000-0003-4874-9910; Fan, Guoping/0000-0001-5235-6410; Fan, Zhipeng/0000-0003-0629-3476	National Institute of Dental and Craniofacial Research [R01DE1016513, R01DE017684, R21DE017632]; Shapiro Family Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019412, R01DE016513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE017632, R01DE017684] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Shapiro Family Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institute of Dental and Craniofacial Research Grants (R01DE1016513 and R01DE017684) to C. Y. W. (R21DE017632) and S. S., and the Shapiro Family Charitable Foundation. We thank Vivian Bardwell for reagents.	ARTHUR A, 2008, STEM CELLS; Brewer S, 2004, DEV BIOL, V267, P135, DOI 10.1016/j.ydbio.2003.10.039; Butler WT, 2003, CONNECT TISSUE RES, V44, P171, DOI 10.1080/03008200390152287; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Hedera P, 2003, AM J MED GENET A, V123A, P261, DOI 10.1002/ajmg.a.20444; Horn D, 2005, EUR J HUM GENET, V13, P563, DOI 10.1038/sj.ejhg.5201391; Huynh KD, 2000, GENE DEV, V14, P1810; Jahagirdar BN, 2005, STEM CELL REV, V1, P53, DOI 10.1385/SCR:1:1:053; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; MacDougall M, 2006, AM J MED GENET A, V140A, P2536, DOI 10.1002/ajmg.a.31359; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Oberoi S, 2005, AM J MED GENET A, V136A, P275, DOI 10.1002/ajmg.a.30811; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Scheller EL, 2008, J DENT RES, V87, P126, DOI 10.1177/154405910808700206; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schulze BRB, 1999, AM J MED GENET, V82, P429, DOI 10.1002/(SICI)1096-8628(19990219)82:5<429::AID-AJMG13>3.0.CO;2-S; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi Songtao, 2004, Biotechnol Genet Eng Rev, V21, P133; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wamstad JA, 2007, GENE EXPR PATTERNS, V7, P550, DOI 10.1016/j.modgep.2007.01.006; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; West-Mays JA, 2002, DEV BIOL, V245, P13, DOI 10.1006/dbio.2002.0624; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596	35	185	196	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1002	U215		10.1038/ncb1913	http://dx.doi.org/10.1038/ncb1913			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19578371	Green Accepted			2022-12-25	WOS:000268593200015
J	Nishimura, S; Manabe, I; Nagasaki, M; Eto, K; Yamashita, H; Ohsugi, M; Otsu, M; Hara, K; Ueki, K; Sugiura, S; Yoshimura, K; Kadowaki, T; Nagai, R				Nishimura, Satoshi; Manabe, Ichiro; Nagasaki, Mika; Eto, Koji; Yamashita, Hiroshi; Ohsugi, Mitsuru; Otsu, Makoto; Hara, Kazuo; Ueki, Kohjiro; Sugiura, Seiryo; Yoshimura, Kotaro; Kadowaki, Takashi; Nagai, Ryozo			CD8(+) effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity	NATURE MEDICINE			English	Article							INSULIN-RESISTANCE; AUTOIMMUNE-DISEASE; MICE; ACCUMULATION; INFILTRATION; ADIPOCYTES; ACTIVATION	Inflammation is increasingly regarded as a key process underlying metabolic diseases in obese individuals. In particular, obese adipose tissue shows features characteristic of active local inflammation. At present, however, little is known about the sequence of events that comprises the inflammatory cascade or the mechanism by which inflammation develops. We found that large numbers of CD8(+) effector T cells infiltrated obese epididymal adipose tissue in mice fed a high-fat diet, whereas the numbers of CD4(+) helper and regulatory T cells were diminished. The infiltration by CD8(+) T cells preceded the accumulation of macrophages, and immunological and genetic depletion of CD8(+) T cells lowered macrophage infiltration and adipose tissue inflammation and ameliorated systemic insulin resistance. Conversely, adoptive transfer of CD8(+) T cells to CD8-deficient mice aggravated adipose inflammation. Coculture and other in vitro experiments revealed a vicious cycle of interactions between CD8(+) T cells, macrophages and adipose tissue. Our findings suggest that obese adipose tissue activates CD8(+) T cells, which, in turn, promote the recruitment and activation of macrophages in this tissue. These results support the notion that CD8(+) T cells have an essential role in the initiation and propagation of adipose inflammation.	[Nishimura, Satoshi; Manabe, Ichiro; Nagasaki, Mika; Yamashita, Hiroshi; Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Nishimura, Satoshi; Manabe, Ichiro] Univ Tokyo, Grad Sch Med, Nanobioengn Educ Program, Tokyo, Japan; [Nishimura, Satoshi; Manabe, Ichiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Manabe, Ichiro; Ueki, Kohjiro; Kadowaki, Takashi; Nagai, Ryozo] Univ Tokyo, Comprehens Ctr Educ & Res Chem Biol Dis, Tokyo, Japan; [Nagasaki, Mika] Univ Tokyo, Computat Diagnost Radiol & Prevent Med, Tokyo, Japan; [Eto, Koji; Otsu, Makoto] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo, Japan; [Ohsugi, Mitsuru; Hara, Kazuo; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo, Japan; [Sugiura, Seiryo] Univ Tokyo, Grad Sch Frontier Sci, Dept Human & Engineered Environm Studies, Tokyo, Japan; [Yoshimura, Kotaro] Univ Tokyo, Grad Sch Med, Dept Plast Surg, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Nishimura, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	snishi-tky@umin.ac.jp; manabe-tky@umin.ac.jp	Manabe, Ichiro/AAE-5105-2021; Manabe, Ichiro/E-1529-2014; Eckhardt, Erik/G-1567-2010; Yoshimura, Kotaro/C-8524-2009	Otsu, Makoto/0000-0002-9769-0217; Yoshimura, Kotaro/0000-0002-7152-5475	Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research; Translational Systems Biology and Medicine Initiative; Global Centers of Excellence program; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [21390321] Funding Source: KAKEN	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Translational Systems Biology and Medicine Initiative; Global Centers of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We gratefully acknowledge A. Matsuoka, X. Yingda, E. Magoshi, M. Hayashi, K. Wakabayashi, M. Tajima and Y. Yamazaki for excellent technical assistance. This study was supported by Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (S. N.), Grants-in-Aid for Scientific Research (I. M., R. N.) and grants for Translational Systems Biology and Medicine Initiative (R. N., T. K.) and Global Centers of Excellence program (R. N., T. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a research grant from the National Institute of Biomedical Innovation (R.N.)	Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mahajan D, 2006, J AM SOC NEPHROL, V17, P2731, DOI 10.1681/ASN.2005080842; Miller R, 2006, J INTERF CYTOK RES, V26, P787, DOI 10.1089/jir.2006.26.787; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Taams LS, 2005, HUM IMMUNOL, V66, P222, DOI 10.1016/j.humimm.2004.12.006; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	22	1528	1573	5	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					914	U116		10.1038/nm.1964	http://dx.doi.org/10.1038/nm.1964			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19633658				2022-12-25	WOS:000268770400036
J	Tuupanen, S; Turunen, M; Lehtonen, R; Hallikas, O; Vanharanta, S; Kivioja, T; Bjorklund, M; Wei, GH; Yan, J; Niittymaki, I; Mecklin, JP; Jarvinen, H; Ristimaki, A; Di-Bernardo, M; East, P; Carvajal-Carmona, L; Houlston, RS; Tomlinson, I; Palin, K; Ukkonen, E; Karhu, A; Taipale, J; Aaltonen, LA				Tuupanen, Sari; Turunen, Mikko; Lehtonen, Rainer; Hallikas, Outi; Vanharanta, Sakari; Kivioja, Teemu; Bjorklund, Mikael; Wei, Gonghong; Yan, Jian; Niittymaki, Iina; Mecklin, Jukka-Pekka; Jarvinen, Heikki; Ristimaki, Ari; Di-Bernardo, Mariachiara; East, Phil; Carvajal-Carmona, Luis; Houlston, Richard S.; Tomlinson, Ian; Palin, Kimmo; Ukkonen, Esko; Karhu, Auli; Taipale, Jussi; Aaltonen, Lauri A.			The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BETA-CATENIN; PROSTATE-CANCER; SUSCEPTIBILITY LOCUS; GENETIC-VARIATION; COLON-CANCER; RISK; ELEMENTS; VARIANTS; SCAN	Homozygosity for the G allele of rs6983267 at 8q24 increases colorectal cancer (CRC) risk B1.5 fold. We report here that the risk allele G shows copy number increase during CRC development. Our computer algorithm, Enhancer Element Locator (EEL), identified an enhancer element that contains rs6983267. The element drove expression of a reporter gene in a pattern that is consistent with regulation by the key CRC pathway Wnt. rs6983267 affects a binding site for the Wnt-regulated transcription factor TCF4, with the risk allele G showing stronger binding in vitro and in vivo. Genome-wide ChIP assay revealed the element as the strongest TCF4 binding site within 1 Mb of MYC. An unambiguous correlation between rs6983267 genotype and MYC expression was not detected, and additional work is required to scrutinize all possible targets of the enhancer. Our work provides evidence that the common CRC predisposition associated with 8q24 arises from enhanced responsiveness to Wnt signaling.	[Tuupanen, Sari; Lehtonen, Rainer; Vanharanta, Sakari; Niittymaki, Iina; Karhu, Auli; Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Turunen, Mikko; Hallikas, Outi; Kivioja, Teemu; Bjorklund, Mikael; Wei, Gonghong; Yan, Jian; Taipale, Jussi] Univ Helsinki, Inst Biomed, Genome Scale Biol Res Program, Helsinki, Finland; [Kivioja, Teemu; Palin, Kimmo; Ukkonen, Esko] Univ Helsinki, Dept Comp Sci, SF-00510 Helsinki, Finland; [Mecklin, Jukka-Pekka] Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland; [Jarvinen, Heikki] Univ Helsinki Hosp, Dept Surg 2, Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Ristimaki, Ari] Helsinki Univ Cent Hosp, HUSLAB, Dept Pathol, Helsinki, Finland; [Ristimaki, Ari] Helsinki Univ Cent Hosp, Haartman Inst, Helsinki, Finland; [Ristimaki, Ari] Univ Oulu, Dept Pathol, Oulu, Finland; [Ristimaki, Ari] Oulu Univ Hosp, Oulu, Finland; [Di-Bernardo, Mariachiara; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [East, Phil; Carvajal-Carmona, Luis; Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Oxford, England	University of Helsinki; University of Helsinki; University of Helsinki; Central Finland Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of London; Institute of Cancer Research - UK; University of Oxford; Wellcome Centre for Human Genetics	Aaltonen, LA (corresponding author), Univ Helsinki, Dept Med Genet, Haartmaninkatu 3, Helsinki, Finland.	jussi.taipale@helsinki.fi; lauri.aaltonen@helsinki.fi	Palin, Kimmo/ABG-5710-2020; Bjørklund, Geir/B-7319-2014; Björklund, Mikael/D-3362-2009; Mecklin, Jukka-Pekka/AAC-9650-2019; Carvajal-Carmona, Luis G/B-3882-2010; Wei, Gonghong/C-6263-2014; Yan, Jian/B-2631-2018; Aaltonen, Lauri/A-5375-2010; Bjorklund, Mikael/AAA-2894-2020; Mecklin, Jukka-Pekka/AAB-5378-2020	Palin, Kimmo/0000-0002-4621-6128; Bjørklund, Geir/0000-0003-2632-3935; Björklund, Mikael/0000-0002-2176-681X; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Yan, Jian/0000-0002-1267-2870; Aaltonen, Lauri/0000-0001-6839-4286; Mecklin, Jukka-Pekka/0000-0003-4895-2249; Turunen, Mikko/0000-0001-5134-1559; Lehtonen, Rainer Juhani/0000-0002-8343-0318; East, Philip/0000-0001-5801-5713; Karhu, Auli/0000-0002-7927-0796; Ukkonen, Esko/0000-0002-5978-1505; Houlston, Richard/0000-0002-5268-0242; Wei, Gong-Hong/0000-0001-6546-9334				Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BADIS G, 2009, SCIENCE         0514, DOI DOI 10.1126/SCIENCE.1162327; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Berndt SI, 2008, HUM MOL GENET, V17, P2665, DOI 10.1093/hmg/ddn166; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gruber SB, 2007, CANCER BIOL THER, V6, P1143, DOI 10.4161/cbt.6.7.4704; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hallikas O, 2006, NAT PROTOC, V1, P215, DOI 10.1038/nprot.2006.33; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Li L, 2008, CANCER EPIDEM BIOMAR, V17, P339, DOI 10.1158/1055-9965.EPI-07-0713; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Miller C, 1998, DEVELOPMENT, V125, P3201; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Palin K, 2006, NAT PROTOC, V1, P368, DOI 10.1038/nprot.2006.56; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schafmayer C, 2009, INT J CANCER, V124, P75, DOI 10.1002/ijc.23872; SMYTH GK, 2005, BIOINFORMATICS COMPU; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Turunen MM, 2007, NUCLEIC ACIDS RES, V35, P2734, DOI 10.1093/nar/gkm179; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	54	394	407	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					885	U37		10.1038/ng.406	http://dx.doi.org/10.1038/ng.406			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19561604				2022-12-25	WOS:000268432900011
J	Addona, TA; Abbatiello, SE; Schilling, B; Skates, SJ; Mani, DR; Bunk, DM; Spiegelman, CH; Zimmerman, LJ; Ham, AJL; Keshishian, H; Hall, SC; Allen, S; Blackman, RK; Borchers, CH; Buck, C; Cardasis, HL; Cusack, MP; Dodder, NG; Gibson, BW; Held, JM; Hiltke, T; Jackson, A; Johansen, EB; Kinsinger, CR; Li, J; Mesri, M; Neubert, TA; Niles, RK; Pulsipher, TC; Ransohoff, D; Rodriguez, H; Rudnick, PA; Smith, D; Tabb, DL; Tegeler, TJ; Variyath, AM; Vega-Montoto, LJ; Wahlander, A; Waldemarson, S; Wang, M; Whiteaker, JR; Zhao, L; Anderson, NL; Fisher, SJ; Liebler, DC; Paulovich, AG; Regnier, FE; Tempst, P; Carr, SA				Addona, Terri A.; Abbatiello, Susan E.; Schilling, Birgit; Skates, Steven J.; Mani, D. R.; Bunk, David M.; Spiegelman, Clifford H.; Zimmerman, Lisa J.; Ham, Amy-Joan L.; Keshishian, Hasmik; Hall, Steven C.; Allen, Simon; Blackman, Ronald K.; Borchers, Christoph H.; Buck, Charles; Cardasis, Helene L.; Cusack, Michael P.; Dodder, Nathan G.; Gibson, Bradford W.; Held, Jason M.; Hiltke, Tara; Jackson, Angela; Johansen, Eric B.; Kinsinger, Christopher R.; Li, Jing; Mesri, Mehdi; Neubert, Thomas A.; Niles, Richard K.; Pulsipher, Trenton C.; Ransohoff, David; Rodriguez, Henry; Rudnick, Paul A.; Smith, Derek; Tabb, David L.; Tegeler, Tony J.; Variyath, Asokan M.; Vega-Montoto, Lorenzo J.; Wahlander, Asa; Waldemarson, Sofia; Wang, Mu; Whiteaker, Jeffrey R.; Zhao, Lei; Anderson, N. Leigh; Fisher, Susan J.; Liebler, Daniel C.; Paulovich, Amanda G.; Regnier, Fred E.; Tempst, Paul; Carr, Steven A.			Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma	NATURE BIOTECHNOLOGY			English	Article							MASS-SPECTROMETRIC QUANTITATION; ABSOLUTE QUANTIFICATION; ISOTOPE-DILUTION; BIOMARKER DISCOVERY; PEPTIDE STANDARDS; SERUM; ASSAYS; LC/MS/MS; PROTEOME; LIMITS	Verification of candidate biomarkers relies upon specific, quantitative assays optimized for selective detection of target proteins, and is increasingly viewed as a critical step in the discovery pipeline that bridges unbiased biomarker discovery to preclinical validation. Although individual laboratories have demonstrated that multiple reaction monitoring (MRM) coupled with isotope dilution mass spectrometry can quantify candidate protein biomarkers in plasma, reproducibility and transferability of these assays between laboratories have not been demonstrated. We describe a multilaboratory study to assess reproducibility, recovery, linear dynamic range and limits of detection and quantification of multiplexed, MRM-based assays, conducted by NCI-CPTAC. Using common materials and standardized protocols, we demonstrate that these assays can be highly reproducible within and across laboratories and instrument platforms, and are sensitive to low lg/ml protein concentrations in unfractionated plasma. We provide data and benchmarks against which individual laboratories can compare their performance and evaluate new technologies for biomarker verification in plasma.	[Addona, Terri A.; Abbatiello, Susan E.; Mani, D. R.; Keshishian, Hasmik; Blackman, Ronald K.; Carr, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Schilling, Birgit; Cusack, Michael P.; Gibson, Bradford W.; Held, Jason M.] Buck Inst Age Res, Novato, CA USA; [Skates, Steven J.; Pulsipher, Trenton C.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Bunk, David M.; Dodder, Nathan G.; Rudnick, Paul A.] Natl Inst Stand & Technol, Chem Sci & Technol Lab, Gaithersburg, MD 20899 USA; [Spiegelman, Clifford H.; Variyath, Asokan M.; Vega-Montoto, Lorenzo J.] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Zimmerman, Lisa J.; Ham, Amy-Joan L.; Li, Jing; Tabb, David L.; Liebler, Daniel C.] Vanderbilt Univ, Nashville, TN USA; [Hall, Steven C.; Allen, Simon; Johansen, Eric B.; Niles, Richard K.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Borchers, Christoph H.; Jackson, Angela; Smith, Derek] Univ Victoria, Genome BC Prote Ctr, Victoria, BC, Canada; [Buck, Charles; Regnier, Fred E.] Purdue Univ, W Lafayette, IN 47907 USA; [Cardasis, Helene L.; Neubert, Thomas A.; Wahlander, Asa] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY USA; [Cardasis, Helene L.; Neubert, Thomas A.; Wahlander, Asa] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Hiltke, Tara; Kinsinger, Christopher R.; Mesri, Mehdi; Rodriguez, Henry] NCI, NIH, Bethesda, MD 20892 USA; [Ransohoff, David] Univ N Carolina, Chapel Hill, NC USA; [Tegeler, Tony J.; Wang, Mu] Monarch Life Sci, Indianapolis, IN USA; [Wang, Mu] Indiana Univ, Sch Med, Indianapolis, IN USA; [Whiteaker, Jeffrey R.; Zhao, Lei; Paulovich, Amanda G.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Anderson, N. Leigh] Plasma Proteome Inst, Washington, DC USA; [Tempst, Paul] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Buck Institute for Research on Aging; Harvard University; Massachusetts General Hospital; National Institute of Standards & Technology (NIST) - USA; Texas A&M University System; Texas A&M University College Station; Vanderbilt University; University of California System; University of California San Francisco; University of Victoria; Purdue University System; Purdue University; Purdue University West Lafayette Campus; New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University-Purdue University Indianapolis; Fred Hutchinson Cancer Center; Memorial Sloan Kettering Cancer Center	Carr, SA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.	scarr@broad.mit.edu	Dodder, Nathan/C-7971-2015; Vega-Montoto, Lorenzo/B-9035-2017; Waldemarson, Sofia/C-6377-2012; Carr, Steven A./AAH-8366-2019; BORCHERS, Christoph/U-5964-2019	Dodder, Nathan/0000-0001-5913-1767; Vega-Montoto, Lorenzo/0000-0002-4096-1100; Mani, D. R./0000-0003-3914-133X; Held, Jason/0000-0001-8024-2736; Jackson, Angela/0000-0002-0943-6287; Tabb, David/0000-0001-7223-578X; Tempst, Paul/0000-0002-6680-3987; Liebler, Daniel/0000-0002-7873-3031	NCI NIH HHS [U24 CA126480-01, U24 CA126485, U24 CA126476, U24 CA126480, U24 CA126476-03] Funding Source: Medline; PHS HHS [U24 126479, U24 126477, U24 126480] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA126476, U24CA126480, U24CA126485] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguiar M, 2006, ANAL BIOCHEM, V354, P175, DOI 10.1016/j.ab.2006.03.037; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; ARMBRUSTER DA, 1994, CLIN CHEM, V40, P1233; Barnidge DR, 2004, J PROTEOME RES, V3, P644, DOI 10.1021/pr049963d; Barnidge DR, 2003, ANAL CHEM, V75, P445, DOI 10.1021/ac026154+; Barr JR, 1996, CLIN CHEM, V42, P1676; Berna M, 2008, ANAL CHEM, V80, P561, DOI 10.1021/ac702311m; Berna MJ, 2007, ANAL CHEM, V79, P4199, DOI 10.1021/ac070051f; Burkitt WI, 2008, ANAL BIOCHEM, V376, P242, DOI 10.1016/j.ab.2008.02.010; CURRIE LA, 1968, ANAL CHEM, V40, P593; FDA, 2018, BIOANALYTICAL METHOD; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hoofnagle AN, 2008, CLIN CHEM, V54, P1796, DOI 10.1373/clinchem.2008.109652; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Kuhn E, 2004, PROTEOMICS, V4, P1175, DOI 10.1002/pmic.200300670; Kuhn E, 2009, CLIN CHEM, V55, P1108, DOI 10.1373/clinchem.2009.123935; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Labugger R, 2003, CLIN CHEM, V49, P873, DOI 10.1373/49.6.873; Lavagnini I, 2007, MASS SPECTROM REV, V26, P1, DOI 10.1002/mas.20100; Linnet K, 2004, CLIN CHEM, V50, P732, DOI 10.1373/clinchem.2003.029983; Nicol GR, 2008, MOL CELL PROTEOMICS, V7, P1974, DOI 10.1074/mcp.M700476-MCP200; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Paulovich AG, 2008, PROTEOM CLIN APPL, V2, P1386, DOI 10.1002/prca.200780174; R Core Team, 2022, R LANG ENV STAT COMP; Randriamiharisoa, 1993, ALGORITHMS ROUTINES; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sapin R, 2007, CLIN CHEM, V53, P810, DOI 10.1373/clinchem.2006.084012; Slev PR, 2006, AM J CLIN PATHOL, V125, P752, DOI 10.1309/G6X6PR7526FAKV0E; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vial J, 2003, CHROMATOGRAPHIA, V57, pS303, DOI 10.1007/BF02492120; Whiteaker JR, 2007, J PROTEOME RES, V6, P3962, DOI 10.1021/pr070202v; WHITEAKER JR, 2007, J PROTEOME RES, V6, P3875; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Xu X, 2007, NAT PROTOC, V2, P1350, DOI 10.1038/nprot.2007.176; Zorn ME, 1997, ANAL CHEM, V69, P3069, DOI 10.1021/ac970082i	38	812	833	5	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2009	27	7					633	U85		10.1038/nbt.1546	http://dx.doi.org/10.1038/nbt.1546			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	469OF	19561596	Green Accepted, Green Published			2022-12-25	WOS:000267908500020
J	Lehar, J; Krueger, AS; Avery, W; Heilbut, AM; Johansen, LM; Price, ER; Rickles, RJ; Short, GF; Staunton, JE; Jin, XW; Lee, MS; Zimmermann, GR; Borisy, AA				Lehar, Joseph; Krueger, Andrew S.; Avery, William; Heilbut, Adrian M.; Johansen, Lisa M.; Price, E. Roydon; Rickles, Richard J.; Short, Glenn F., III; Staunton, Jane E.; Jin, Xiaowei; Lee, Margaret S.; Zimmermann, Grant R.; Borisy, Alexis A.			Synergistic drug combinations tend to improve therapeutically relevant selectivity	NATURE BIOTECHNOLOGY			English	Article							MULTICOMPONENT THERAPEUTICS; NETWORK; SYSTEMS; ROBUSTNESS; DISCOVERY; THERAPY; CELLS; MODEL; YEAST; CATECHOLAMINES	Drug combinations are a promising strategy to overcome the compensatory mechanisms and unwanted off-target effects that limit the utility of many potential drugs. However, enthusiasm for this approach is tempered by concerns that the therapeutic synergy of a combination will be accompanied by synergistic side effects. Using large scale simulations of bacterial metabolism and 94,110 multi-dose experiments relevant to diverse diseases, we provide evidence that synergistic drug combinations are generally more specific to particular cellular contexts than are single agent activities. We highlight six combinations whose selective synergy depends on multitarget drug activity. For one anti-inflammatory example, we show how such selectivity is achieved through differential expression of the drugs' targets in cell types associated with therapeutic, but not toxic, effects and validate its therapeutic relevance in a rat model of asthma. The context specificity of synergistic combinations creates many opportunities for therapeutically relevant selectivity and enables improved control of complex biological systems.	[Lehar, Joseph; Avery, William; Heilbut, Adrian M.; Johansen, Lisa M.; Price, E. Roydon; Rickles, Richard J.; Short, Glenn F., III; Staunton, Jane E.; Jin, Xiaowei; Lee, Margaret S.; Zimmermann, Grant R.; Borisy, Alexis A.] CombinatoRx Inc, Cambridge, MA USA; [Lehar, Joseph; Krueger, Andrew S.] Boston Univ Bioinformat Bioengn, Boston, MA USA	Zalicus Inc; Boston University	Lehar, J (corresponding author), CombinatoRx Inc, Cambridge, MA USA.	jlehar@combinatorx.com; aborisy@combinatorx.com	Heilbut, Adrian M/J-9427-2012	Heilbut, Adrian M/0000-0002-8169-7967	NIAID NIH HHS [U01 AI61345, U01 AI061345, U01 AI061345-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061345] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Araujo RP, 2005, BIOSYSTEMS, V80, P57, DOI 10.1016/j.biosystems.2004.10.002; BERENBAUM MC, 1985, J THEOR BIOL, V114, P413, DOI 10.1016/S0022-5193(85)80176-4; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Farr M, 1995, BRIT J RHEUMATOL, V34, P100; FILLIBEN JJ, 2005, ENG STAT HDB, V2007; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; HOLM S, 1979, SCAND J STAT, V6, P65; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hughes B, 2008, NAT REV DRUG DISCOV, V7; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kassouf W, 2005, CANCER RES, V65, P10524, DOI 10.1158/0008-5472.CAN-05-1536; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kvien TK, 2008, ANN RHEUM DIS, V67, P942, DOI 10.1136/ard.2007.074401; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Loewe S., 1928, ERGEBN PHYSL, V27, P47, DOI [10.1007/BF02322290, DOI 10.1007/BF02322290]; Okamoto M, 1998, AIDS RES HUM RETROV, V14, P1239, DOI 10.1089/aid.1998.14.1239; Press W.H., 1997, NUMER RECIPES C; Qiu YH, 2005, J NEUROIMMUNOL, V167, P45, DOI 10.1016/j.jneuroim.2005.06.007; Radhakrishnan ML, 2008, J CHEM INF MODEL, V48, P1055, DOI 10.1021/ci700452r; Salicru AN, 2007, BRAIN BEHAV IMMUN, V21, P913, DOI 10.1016/j.bbi.2007.02.006; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schacke Heike, 2005, Curr Opin Investig Drugs, V6, P503; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sharom JR, 2004, CURR OPIN CHEM BIOL, V8, P81, DOI 10.1016/j.cbpa.2003.12.007; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Virmani R, 2004, CORONARY ARTERY DIS, V15, P313, DOI 10.1097/00019501-200409000-00003; Yang K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.60; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Zarraga IGE, 2007, J AM COLL CARDIOL, V49, P1, DOI 10.1016/j.jacc.2006.10.003; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; Zimmermann GR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2602	49	636	704	8	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2009	27	7					659	U116		10.1038/nbt.1549	http://dx.doi.org/10.1038/nbt.1549			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	469OF	19581876	Green Accepted			2022-12-25	WOS:000267908500023
J	Matsuura, M; Saikawa, Y; Inui, K; Nakae, K; Igarashi, M; Hashimoto, K; Nakata, M				Matsuura, Masanori; Saikawa, Yoko; Inui, Kosei; Nakae, Koichi; Igarashi, Masayuki; Hashimoto, Kimiko; Nakata, Masaya			Identification of the toxic trigger in mushroom poisoning	NATURE CHEMICAL BIOLOGY			English	Article							RUSSULA-SUBNIGRICANS HONGO; RHABDOMYOLYSIS; ACID	We have isolated the small, highly strained carboxylic acid cycloprop-2-ene carboxylic acid from the Asian toxic mushroom Russula subnigricans. This compound is responsible for fatal rhabdomyolysis, a new type of mushroom poisoning that is indicated by an increase in serum creatine phosphokinase activity in mice. We found that polymerization of the compound at high concentrations via ene reaction abolishes its toxicity.	[Hashimoto, Kimiko] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 607, Japan; [Matsuura, Masanori; Saikawa, Yoko; Nakata, Masaya] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Inui, Kosei] Ishihara Sangyo Kaisha Ltd, Shiga, Japan; [Nakae, Koichi; Igarashi, Masayuki] Microbial Chem Res Ctr, Bioact Mol Res Grp, Shinagawa Ku, Tokyo, Japan	Kyoto Pharmaceutical University; Keio University; Ishihara Sangyo Kaisha Ltd	Hashimoto, K (corresponding author), Kyoto Pharmaceut Univ, Yamashina Ku, 5 Nakauchi Cho, Kyoto 607, Japan.	kimikoh@mb.kyoto-phu.ac.jp	Nakata, Masaya/C-4916-2014; Igarashi, Masayuki/AAG-1628-2020					AVERBUKH Z, 1989, HUM TOXICOL, V8, P345, DOI 10.1177/096032718900800502; Bedry R, 2001, NEW ENGL J MED, V345, P798, DOI 10.1056/NEJMoa010581; BRESLOW R, 1963, J AM CHEM SOC, V85, P2729, DOI 10.1021/ja00901a012; Chodorowski Zygmunt, 2002, Przegl Lek, V59, P386; FATTORUSSO E, 1975, TETRAHEDRON, V31, P1715, DOI 10.1016/0040-4020(75)85092-7; Imazeki R, 1989, COLORED ILLUSTRATION, V2, P47; KUSANO G, 1987, CHEM PHARM BULL, V35, P3482; KUSANO G, 1997, SHINKEI SEISHIN YAKU, V19, P251; Lee PT, 2001, AM J KIDNEY DIS, V38, DOI 10.1053/ajkd.2001.27725; Nieminen P, 2008, FOOD CHEM TOXICOL, V46, P781, DOI 10.1016/j.fct.2007.10.014; Nieminen P, 2006, EXP BIOL MED, V231, P221; Nieminen P, 2009, FOOD CHEM TOXICOL, V47, P70, DOI 10.1016/j.fct.2008.10.009; NUNN JR, 1952, J CHEM SOC, P313, DOI 10.1039/jr9520000313; OHTA T, 1995, TETRAHEDRON LETT, V36, P5223; PENN AS, 1994, MYOLOGY, V2; Rubin M, 2006, SYNTHESIS-STUTTGART, P1221, DOI 10.1055/s-2006-926404; SALAUN J, 1995, CURR MED CHEM, V2, P511; TAKAHASHI A, 1992, CHEM PHARM BULL, V40, P3185, DOI 10.1248/cpb.40.3185; TAKAHASHI A, 1993, CHEM PHARM BULL, V41, P1726, DOI 10.1248/cpb.41.1726; UEDA T, 2003, POISONOUS FUNGI JAPA, V14, P46; Yan N, 2008, J ORG CHEM, V73, P4283, DOI 10.1021/jo800042w	21	47	57	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					465	467		10.1038/nchembio.179	http://dx.doi.org/10.1038/nchembio.179			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19465932				2022-12-25	WOS:000267266100011
J	Nishimura, Y; Shimojima, M; Tano, Y; Miyamura, T; Wakita, T; Shimizu, H				Nishimura, Yorihiro; Shimojima, Masayuki; Tano, Yoshio; Miyamura, Tatsuo; Wakita, Takaji; Shimizu, Hiroyuki			Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71	NATURE MEDICINE			English	Article							CYNOMOLGUS MONKEYS; MOLECULAR-BASIS; INFECTION; EXPRESSION; EVOLUTION; MOUSE; ENCEPHALOMYELITIS; ENCEPHALITIS; OUTBREAK	Enterovirus 71 (EV71) is a major causative agent of hand, foot and mouth disease (HFMD), a common febrile disease occurring mainly in young children. Although clinical manifestations of HFMD are usually mild and self limiting, a severe EV71 outbreak can lead to a diverse array of neurological diseases. Identification of the specific cellular receptors is crucial for elucidating the mechanism of early virus-host interactions and the pathogenesis of enteroviruses(1). Here we identify human P-selectin glycoprotein ligand-1 (PSGL-1; CD162), a sialomucin membrane protein expressed on leukocytes that has a major role in early stages of inflammation(2-4), as a functional receptor for EV71 using an expression cloning method by panning(5). The N-terminal region of PSGL-1 binds specifically to EV71. Stable PSGL-1 expression allowed EV71 entry and replication, and development of cytopathic effects in nonsusceptible mouse L929 cells. Five out of eight EV71 strains bound soluble PSGL-1 and used intact PSGL-1 as the primary receptor for infection of Jurkat T cells. Three other EV71 strains did not use PSGL-1, suggesting the presence of strain-specific replication of EV71 in leukocytes. EV71 replicated in nonleukocyte cell lines in a PSGL-1-independent manner, indicating the presence of alternative receptor(s) for EV71. The identification of PSGL-1 as a receptor for EV71 sheds new light on a role for PSGL-1-positive leukocytes in cell tropism and pathogenesis during the course of HFMD and other EV71-mediated diseases.	[Nishimura, Yorihiro; Tano, Yoshio; Miyamura, Tatsuo; Wakita, Takaji; Shimizu, Hiroyuki] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan; [Shimojima, Masayuki] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Inst Med Sci,Minato Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo	Shimizu, H (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan.	hshimizu@nih.go.jp	Shimizu, Hiroyuki/AAU-9621-2020	Shimizu, Hiroyuki/0000-0002-2987-2377				[Anonymous], 2008, Wkly Epidemiol Rec, V83, P169; Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang SC, 2004, J NEUROVIROL, V10, P338, DOI 10.1080/13550280490521032; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chen LC, 2006, J MED VIROL, V78, P780, DOI 10.1002/jmv.20623; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Kitamura T, 2000, METH MOL B, V134, P143; Kung CM, 2007, J MED VIROL, V79, P60, DOI 10.1002/jmv.20761; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Nagata N, 2002, J MED VIROL, V67, P207, DOI 10.1002/jmv.2209; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Rossmann MG, 2002, TRENDS MICROBIOL, V10, P324, DOI 10.1016/S0966-842X(02)02383-1; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Shimojimaa M, 2003, ANAL BIOCHEM, V315, P138, DOI 10.1016/S0003-2697(02)00708-X; Snapp KR, 1998, BLOOD, V91, P154, DOI 10.1182/blood.V91.1.154.154_154_164; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Thatte A, 2002, J LEUKOCYTE BIOL, V72, P470; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wong KT, 2008, J NEUROPATH EXP NEUR, V67, P162, DOI 10.1097/nen.0b013e318163a990	29	297	354	2	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					794	U14		10.1038/nm.1961	http://dx.doi.org/10.1038/nm.1961			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19543284				2022-12-25	WOS:000267806900033
J	Rapley, EA; Turnbull, C; Al Olama, AA; Dermitzakis, ET; Linger, R; Huddart, RA; Renwick, A; Hughes, D; Hines, S; Seal, S; Morrison, J; Nsengimana, J; Deloukas, P; Rahman, N; Bishop, DT; Easton, DF; Stratton, MR				Rapley, Elizabeth A.; Turnbull, Clare; Al Olama, Ali Amin; Dermitzakis, Emmanouil T.; Linger, Rachel; Huddart, Robert A.; Renwick, Anthony; Hughes, Deborah; Hines, Sarah; Seal, Sheila; Morrison, Jonathan; Nsengimana, Jeremie; Deloukas, Panagiotis; Rahman, Nazneen; Bishop, D. Timothy; Easton, Douglas F.; Stratton, Michael R.		Uk Testicular Canc Collaboration	A genome-wide association study of testicular germ cell tumor	NATURE GENETICS			English	Article							CANCER; SUSCEPTIBILITY; TESTIS; RISK	We conducted a genome-wide association study for testicular germ cell tumor (TGCT), genotyping 307,666 SNPs in 730 cases and 1,435 controls from the UK and replicating associations in a further 571 cases and 1,806 controls. We found strong evidence for susceptibility loci on chromosome 5 (per allele OR = 1.37 (95% CI = 1.19-1.58), P = 3 x 10(-13)), chromosome 6 (OR = 1.50 (95% CI = 1.28-1.75), P = 10(-13)) and chromosome 12 (OR = 2.55 (95% CI = 2.05-3.19), P = 10(-31)). KITLG, encoding the ligand for the receptor tyrosine kinase KIT, which has previously been implicated in the pathogenesis of TGCT and the biology of germ cells, may explain the association on chromosome 12.	[Rapley, Elizabeth A.; Turnbull, Clare; Linger, Rachel; Renwick, Anthony; Hughes, Deborah; Hines, Sarah; Seal, Sheila; Rahman, Nazneen; Stratton, Michael R.] Inst Canc Res, Sect Canc Genet, Surrey, England; [Al Olama, Ali Amin; Morrison, Jonathan; Easton, Douglas F.] Strangeways Res Lab, Genet Epidemiol Unit, Canc Res UK, Cambridge CB1 4RN, England; [Dermitzakis, Emmanouil T.; Deloukas, Panagiotis; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton, England; [Huddart, Robert A.] Inst Canc Res, Acad Radiotherapy Unit, Surrey, England; [Nsengimana, Jeremie; Bishop, D. Timothy] Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England	University of London; Institute of Cancer Research - UK; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK; University of Leeds	Stratton, MR (corresponding author), Inst Canc Res, Sect Canc Genet, Surrey, England.	mrs@sanger.ac.uk	Nsengimana, Jeremie/AAP-3185-2020; Turnbull, Clare/AAA-6596-2019; Rahman, Nazneen/B-8890-2012; Dermitzakis, Emmanouil/B-7687-2013; Nsengimana, Jeremie/AGK-5625-2022; Pillay, Nischalan/F-9536-2012; Deloukas, Panos/B-2922-2013; Rahman, Nazneen/D-2802-2013	Deloukas, Panos/0000-0001-9251-070X; Bishop, Tim/0000-0002-8752-8785; Rahman, Nazneen/0000-0003-4376-0440; Turnbull, Clare/0000-0002-1734-5772; huddart, robert/0000-0003-3604-1990	Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; Institute of Cancer Research, Cancer Research UK; Wellcome Trust; Cancer Research UK [10589, 11022, 10118] Funding Source: researchfish; Medical Research Council [G0700491] Funding Source: researchfish; MRC [G0000934, G0700491] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Institute of Cancer Research, Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank the individuals with TGCT and the clinicians involved in their care for participation in this study. We would like to thank D. Dudakia, J. Pugh, H. McDonald and J. Marke for subject recruitment and database entry for the TGCT collections. We acknowledge NHS funding to the NIHR Biomedical Research Centre. We acknowledge use of DNA from the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. D. F. E. is a Principal Research Fellow of Cancer Research UK, and the study was supported by the Institute of Cancer Research, Cancer Research UK and the Wellcome Trust.	Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; BOLDAJIPOUR B, 2007, SCI STKE, pPE16; BOSL GJB, 2005, CANC PRINCIPLES PRAC; Crockford GP, 2006, HUM MOL GENET, V15, P443, DOI 10.1093/hmg/ddi459; Dong CH, 2001, INT J CANCER, V92, P144; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Ferlay J., 2004, GLOBOCAN 2002 CANC I; FORMAN D, 1992, BRIT J CANCER, V65, P255, DOI 10.1038/bjc.1992.51; Gori S, 2005, CRIT REV ONCOL HEMAT, V53, P141, DOI 10.1016/j.critrevonc.2004.05.006; Heaney JD, 2008, CANCER RES, V68, P5193, DOI 10.1158/0008-5472.CAN-08-0779; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Holzik M. F. L., 2004, Lancet Oncology, V5, P363, DOI 10.1016/S1470-2045(04)01493-7; McIntyre A, 2008, GENE CHROMOSOME CANC, V47, P547, DOI 10.1002/gcc.20562; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Rashid HH, 2004, UROL ONCOL-SEMIN ORI, V22, P285, DOI 10.1016/S1078-1439(03)00177-7; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Sasaki A, 2003, CELL CYCLE, V2, P281, DOI 10.4161/cc.2.4.418; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Yan W, 2000, MOL ENDOCRINOL, V14, P682, DOI 10.1210/me.14.5.682	20	248	257	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					807	U59		10.1038/ng.394	http://dx.doi.org/10.1038/ng.394			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19483681	Green Accepted, Green Published			2022-12-25	WOS:000267786200010
J	Kilarski, WW; Samolov, B; Petersson, L; Kvanta, A; Gerwins, P				Kilarski, Witold W.; Samolov, Branka; Petersson, Ludvig; Kvanta, Anders; Gerwins, Par			Biomechanical regulation of blood vessel growth during tissue vascularization	NATURE MEDICINE			English	Article							GRANULATION-TISSUE; INTUSSUSCEPTIVE ANGIOGENESIS; ENDOTHELIAL-CELLS; CROSS-LINKING; IN-VIVO; PROLIFERATION; MYOFIBROBLASTS; CONTRACTION; MECHANISMS; PHENOTYPE	Formation of new vessels in granulation tissue during wound healing has been assumed to occur solely through sprouting angiogenesis. In contrast, we show here that neovascularization can be accomplished by nonangiogenic expansion of preexisting vessels. Using neovascularization models based on the chick chorioallantoic membrane and the healing mouse cornea, we found that tissue tension generated by activated fibroblasts or myofibroblasts during wound contraction mediated and directed translocation of the vasculature. These mechanical forces pulled vessels from the preexisting vascular bed as vascular loops with functional circulation that expanded as an integral part of the growing granulation tissue through vessel enlargement and elongation. Blockade of vascular endothelial growth factor receptor-2 confirmed that biomechanical forces were sufficient to mediate the initial vascular growth independently of endothelial sprouting or proliferation. The neovascular network was further remodeled by splitting, sprouting and regression of individual vessels. This model explains the rapid appearance of large functional vessels in granulation tissue during wound healing.	[Kilarski, Witold W.; Petersson, Ludvig; Gerwins, Par] Uppsala Univ, Ctr Biomed, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Samolov, Branka; Kvanta, Anders] Karolinska Inst, Dept Clin Neurosci, Sect Ophthalmol & Vis, Stockholm, Sweden; [Gerwins, Par] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Sect Radiol, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Uppsala University; Uppsala University Hospital	Kilarski, WW (corresponding author), Swiss Fed Inst Technol, Lab Mechanobiol & Morphogenesis, CH-1015 Lausanne, Switzerland.	witold.kilarski@epfl.ch; par.gerwins@imbim.uu.se	Kilarski, Witold W./G-8673-2012; Kilarski, Witold/AAA-1843-2019	Kilarski, Witold W./0000-0003-0734-4749; 	Goran Gustafsson Foundation; Swedish Cancer Foundation [4422-B04O5XAB]; Swedish Research Council [K2005-31X-15348-01A, 2006-13828-37891-37]; Children's Cancer Foundation of Sweden [04/037]; Lions Cancer Research Foundation in Uppsala; Magnus Bergvall Foundation; King Gustaf V's 80-Year Foundation; Uppsala Foundation for Medical Research; Crown Princess Margareta Foundation; Edwin Jordan Foundation; Karolinska Institute research grants; Stiftelsen Synframjandets Forskningsfond; St. Erik Eye Hospital Research Foundation; Sigvard and Marianne Bernadotte Research Foundation for Children's Eye Care	Goran Gustafsson Foundation; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Children's Cancer Foundation of Sweden(Swedish Cancer Society); Lions Cancer Research Foundation in Uppsala; Magnus Bergvall Foundation; King Gustaf V's 80-Year Foundation; Uppsala Foundation for Medical Research; Crown Princess Margareta Foundation; Edwin Jordan Foundation; Karolinska Institute research grants(Karolinska Institutet); Stiftelsen Synframjandets Forskningsfond; St. Erik Eye Hospital Research Foundation; Sigvard and Marianne Bernadotte Research Foundation for Children's Eye Care	We thank M. Aronsson for help with cornea experiments, J. Kilarska for help with image processing and analysis and K. Kullander and N. Rabe for help with microscopy of whole-mount corneas. We also thank M. Swartz for allowing us to use her laboratory to perform gel contraction and image analysis and A. Bikfalvi for comments. This study was supported by grants to P. G. from the Goran Gustafsson Foundation, the Swedish Cancer Foundation (project 4422-B04O5XAB), the Swedish Research Council (project K2005-31X-15348-01A), the Children's Cancer Foundation of Sweden (project 04/037), Lions Cancer Research Foundation in Uppsala, the Magnus Bergvall Foundation, King Gustaf V's 80-Year Foundation and Uppsala Foundation for Medical Research, by grants to A. K. from the Crown Princess Margareta Foundation (KMA), the Edwin Jordan Foundation, Karolinska Institute research grants, Stiftelsen Synframjandets Forskningsfond, and Swedish Research Council (project 2006-13828-37891-37) and by grants to B. S. from St. Erik Eye Hospital Research Foundation, Sigvard and Marianne Bernadotte Research Foundation for Children's Eye Care and Stiftelsen Synframjandets Forskningsfond.	Augustin HG, 1998, TRENDS PHARMACOL SCI, V19, P216, DOI 10.1016/S0165-6147(98)01211-5; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; BARNHILL R, 1982, MICROVASC RES, V23, P129; Burri PH, 2002, MOL ASPECTS MED, V23, pS1; Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203; Clark ER, 1918, AM J ANAT, V23, P37, DOI 10.1002/aja.1000230103; Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3; Dor Y, 2003, TRENDS CELL BIOL, V13, P131, DOI 10.1016/S0962-8924(03)00022-9; DUDAR TE, 1983, MICROVASC RES, V25, P1, DOI 10.1016/0026-2862(83)90040-7; Dvorak HF, 2003, AM J PATHOL, V162, P1747, DOI 10.1016/S0002-9440(10)64309-X; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; GABBIANI G, 1972, J EXP MED, V135, P719, DOI 10.1084/jem.135.4.719; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gschwandtner ME, 2001, MICROVASC RES, V62, P226, DOI 10.1006/mvre.2001.2330; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; JUNGHANS BM, 1989, CORNEA, V8, P141; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kilarski WW, 2005, LAB INVEST, V85, P643, DOI 10.1038/labinvest.3700255; Kilarski WW, 2003, EXP CELL RES, V291, P70, DOI 10.1016/S0014-4827(03)00374-4; Korff T, 1999, J CELL SCI, V112, P3249; Kumar V., 2004, ROBBINS COTRAN PATHO; Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9; Lockhart AC, 2003, WOUND REPAIR REGEN, V11, P306, DOI 10.1046/j.1524-475X.2003.11411.x; Lorena D, 2002, WOUND REPAIR REGEN, V10, P86, DOI 10.1046/j.1524-475X.2002.00201.x; Lusimbo WS, 2000, ANAT REC, V259, P25, DOI 10.1002/(SICI)1097-0185(20000501)259:1<25::AID-AR3>3.0.CO;2-Y; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; McClain SA, 1996, AM J PATHOL, V149, P1257; MORRISON JC, 1995, INVEST OPHTH VIS SCI, V36, P751; MUTHUKKARUPPAN V, 1979, SCIENCE, V205, P1416, DOI 10.1126/science.472760; Patan S, 2001, CIRC RES, V89, P723, DOI 10.1161/hh2001.097870; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Rendell MS, 1998, J SURG RES, V80, P373, DOI 10.1006/jsre.1998.5463; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rogers P A, 1998, Angiogenesis, V2, P287, DOI 10.1023/A:1009222030539; Samolov B, 2005, EXP EYE RES, V80, P159, DOI 10.1016/j.exer.2004.08.023; Scherer SS, 2008, PLAST RECONSTR SURG, V122, P786, DOI 10.1097/PRS.0b013e31818237ac; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; SHOLLEY MM, 1984, LAB INVEST, V51, P624; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Thurston G, 2000, MICROCIRCULATION, V7, P67, DOI 10.1038/sj.mn.7300155; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; Vosseler S, 2005, CANCER RES, V65, P1294, DOI 10.1158/0008-5472.CAN-03-3986; WESTERHAUSEN A, 1990, J BIOL CHEM, V265, P13995; WOODLEY DT, 1991, J INVEST DERMATOL, V97, P580, DOI 10.1111/1523-1747.ep12481920	54	164	171	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2009	15	6					657	U145		10.1038/nm.1985	http://dx.doi.org/10.1038/nm.1985			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19483693				2022-12-25	WOS:000266731600025
J	Krishnamoorthy, G; Saxena, A; Mars, LT; Domingues, HS; Mentele, R; Ben-Nun, A; Lassmann, H; Dornmair, K; Kurschus, FC; Liblau, RS; Wekerle, H				Krishnamoorthy, Gurumoorthy; Saxena, Amit; Mars, Lennart T.; Domingues, Helena S.; Mentele, Reinhard; Ben-Nun, Avraham; Lassmann, Hans; Dornmair, Klaus; Kurschus, Florian C.; Liblau, Roland S.; Wekerle, Hartmut			Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN; MICE; INDUCTION; BINDING; BRAIN; RAT; MOG	We describe here the paradoxical development of spontaneous experimental autoimmune encephalomyelitis (EAE) in transgenic mice expressing a myelin oligodendrocyte glycoprotein (MOG)-specific T cell antigen receptor (TCR) in the absence of MOG. We report that in Mog-deficient mice (Mog(-/-)), the autoimmune response by transgenic T cells is redirected to a neuronal cytoskeletal self antigen, neurofilament-M (NF-M). Although components of radically different protein classes, the cross-reacting major histocompatibility complex I-A(b)-restricted epitope sequences of MOG(35-55) and NF-M18-30 share essential TCR contact positions. This pattern of cross-reaction is not specific to the transgenic TCR but is also commonly seen in MOG(35-55)-I-A(b)-reactive T cells. We propose that in the C57BL/6 mouse, MOG and NF-M response components add up to overcome the general resistance of this strain to experimental induction of autoimmunity. Similar cumulative responses against more than one autoantigen may have a role in spontaneously developing human autoimmune diseases.	[Krishnamoorthy, Gurumoorthy; Domingues, Helena S.; Dornmair, Klaus; Kurschus, Florian C.; Wekerle, Hartmut] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany; [Saxena, Amit; Mars, Lennart T.; Liblau, Roland S.] Univ Toulouse 3, INSERM, U563, F-31062 Toulouse, France; [Domingues, Helena S.] Univ Coimbra, Ctr Neurosci & Cell Biol, Program Expt Biol & Biomed, Coimbra, Portugal; [Mentele, Reinhard; Dornmair, Klaus] Univ Munich, Univ Hosp Grosshadern, Inst Clin Neuroimmunol, Munich, Germany; [Mentele, Reinhard] Max Planck Inst Biochem, Dept Prot Analyt, D-82152 Martinsried, Germany; [Ben-Nun, Avraham] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	Max Planck Society; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universidade de Coimbra; University of Munich; Max Planck Society; Weizmann Institute of Science; Medical University of Vienna	Wekerle, H (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany.	hwekerle@neuro.mpg.de	Lassmann, Hans/Z-2269-2019; Domingues, Sofia/A-9842-2011; Kurschus, Florian/B-2838-2014; Mars, Lennart T/K-7593-2014; Krishnamoorthy, Gurumoorthy/O-1650-2013; Liblau, Roland/J-3530-2014; Kurschus, Florian C./AAP-9777-2020; Saxena, Amit/J-4119-2012	Lassmann, Hans/0000-0001-8617-5052; Domingues, Sofia/0000-0003-1230-2682; Mars, Lennart T/0000-0001-7997-1974; Krishnamoorthy, Gurumoorthy/0000-0002-7798-6707; Kurschus, Florian C./0000-0001-7550-0681; LIBLAU, Roland/0000-0001-5477-5475	Deutsche Forschungsgemeinschaft (Sonderforschungsbereiche (SFB) 571; Max Planck Society; Portuguese Fundacao para a Ciencia ea Tecnologia (FCT) [SFRH/BD/15885/2005]; EU Project Neuropromise [PL 018637]; Israel Science Foundation; National Multiple Sclerosis Society of New York [RG3195B8/2]; Alexander von Humboldt Prize Awardee	Deutsche Forschungsgemeinschaft (Sonderforschungsbereiche (SFB) 571(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Portuguese Fundacao para a Ciencia ea Tecnologia (FCT)(Portuguese Foundation for Science and Technology); EU Project Neuropromise; Israel Science Foundation(Israel Science Foundation); National Multiple Sclerosis Society of New York(National Multiple Sclerosis Society); Alexander von Humboldt Prize Awardee(Alexander von Humboldt Foundation)	Mog<SUP>Cre/Cre</SUP>, Nefm<SUP>-/-</SUP>, 2D2 and Mog<SUP>-/-</SUP> mice were generously provided by A. Waisman (Johannes Gutenberg University of Mainz), J.-P. Julien (Laval University), V. K. Kuchroo (Harvard Medical School) and D. Pham-Dinh (INSERM UMR 546). We thank F. Lottspeich for granting us permission to use his mass spectrometer. We thank L. Penner and I. Arnold-Ammer for technical support. This project was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereiche (SFB) 571, Projects A1 and B6) and the Max Planck Society. H. S. D. is supported by a PhD fellowship (Portuguese Fundacao para a Ciencia ea Tecnologia (FCT) program SFRH/BD/15885/2005). Part of the study (conducted by H. W., R. L. and H. L.) was funded by the EU Project Neuropromise (PL 018637), and A. B.-N. was supported by the Israel Science Foundation and the National Multiple Sclerosis Society of New York (RG3195B8/2). A. B.-N. is an Alexander von Humboldt Prize Awardee.	ABROMSONLEEMAN S, 1993, J NEUROIMMUNOL, V45, P89, DOI 10.1016/0165-5728(93)90168-X; AMOR S, 1994, J IMMUNOL, V153, P4349; Bartos A, 2007, J NEUROL, V254, P20, DOI 10.1007/s00415-006-0185-0; Ben-Nun A, 2006, EUR J IMMUNOL, V36, P478, DOI 10.1002/eji.200535363; Berger T, 1997, LAB INVEST, V76, P355; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; CHANTRY A, 1989, J BIOL CHEM, V264, P21603; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Goebels N, 2000, BRAIN, V123, P508, DOI 10.1093/brain/123.3.508; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Huizinga R, 2007, J NEUROPATH EXP NEUR, V66, P295, DOI 10.1097/nen.0b013e318040ad5c; Jacomy H, 1999, J NEUROCHEM, V73, P972, DOI 10.1046/j.1471-4159.1999.0730972.x; KELLY BM, 1992, J CELL BIOL, V118, P397, DOI 10.1083/jcb.118.2.397; KOJIMA K, 1994, J EXP MED, V180, P817, DOI 10.1084/jem.180.3.817; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; Petersen TR, 2004, EUR J IMMUNOL, V34, P165, DOI 10.1002/eji.200324669; Stefferl A, 2000, J IMMUNOL, V165, P2859, DOI 10.4049/jimmunol.165.5.2859; Wekerle H, 2006, CURR TOP MICROBIOL, V305, P25, DOI 10.1007/3-540-29714-6_2; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8	23	114	120	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					626	U142		10.1038/nm.1975	http://dx.doi.org/10.1038/nm.1975			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19483694				2022-12-25	WOS:000266731600021
J	Ootani, A; Li, XN; Sangiorgi, E; Ho, QT; Ueno, H; Toda, S; Sugihara, H; Fujimoto, K; Weissman, IL; Capecchi, MR; Kuo, CJ				Ootani, Akifumi; Li, Xingnan; Sangiorgi, Eugenio; Ho, Quoc T.; Ueno, Hiroo; Toda, Shuji; Sugihara, Hajime; Fujimoto, Kazuma; Weissman, Irving L.; Capecchi, Mario R.; Kuo, Calvin J.			Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche	NATURE MEDICINE			English	Article							MOUSE SMALL-INTESTINE; PROGENITOR CELLS; TISSUE; DIFFERENTIATION; RENEWAL; SIGNALS; NEUROGENIN-3; MAINTENANCE; HOMEOSTASIS; DISRUPTION	The in vitro analysis of intestinal epithelium has been hampered by a lack of suitable culture systems. Here we describe robust long-term methodology for small and large intestinal culture, incorporating an air-liquid interface and underlying stromal elements. These cultures showed prolonged intestinal epithelial expansion as sphere-like organoids with proliferation and multilineage differentiation. The Wnt growth factor family positively regulates proliferation of the intestinal epithelium in vivo. Accordingly, culture growth was inhibited by the Wnt antagonist Dickkopf-1 (Dkk1) and markedly stimulated by a fusion protein between the Wnt agonist R-spondin-1 and immunoglobulin Fc (RSpo1-Fc). Furthermore, treatment with the gamma-secretase inhibitor dibenzazepine and neurogenin-3 overexpression induced goblet cell and enteroendocrine cell differentiation, respectively, consistent with endogenous Notch signaling and lineage plasticity. Epithelial cells derived from both leucine-rich repeat-containing G protein-coupled receptor-5-positive (Lgr5(+)) and B lymphoma moloney murine leukemia virus insertion region homolog-1-positive (Bmi1(+)) lineages, representing putative intestinal stem cell (ISC) populations, were present in vitro and were expanded by treatment with RSpo1-Fc; this increased number of Lgr5(+) cells upon RSpo1-Fc treatment was subsequently confirmed in vivo. Our results indicate successful long-term intestinal culture within a microenvironment accurately recapitulating the Wnt- and Notch-dependent ISC niche.	[Ootani, Akifumi; Li, Xingnan; Ho, Quoc T.; Kuo, Calvin J.] Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Sangiorgi, Eugenio; Capecchi, Mario R.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Sangiorgi, Eugenio; Capecchi, Mario R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT USA; [Ueno, Hiroo; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Toda, Shuji; Sugihara, Hajime] Saga Med Sch, Dept Pathol, Saga, Japan; [Fujimoto, Kazuma] Saga Med Sch, Dept Internal Med, Saga, Japan	Stanford University; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Stanford University; Saga University; Saga University	Ootani, A (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA.	aootani@stanford.edu; cjkuo@stanford.edu	Sangiorgi, Eugenio/AAP-9836-2020	Sangiorgi, Eugenio/0000-0001-9079-9175; Kuo, Calvin/0000-0002-7427-5985	NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527, R01DK085720, R01DK069989, P30DK056339] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA086065, R01 CA86065-06] Funding Source: Medline; NIDDK NIH HHS [P30 DK056339, R01 DK069989-01, R01 DK069989, U01 DK085527-02, R01 DK085720, R01 DK069989-05, P30 DK56339, U01 DK085527, R01 DK085720-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abud HE, 2005, EXP CELL RES, V303, P252, DOI 10.1016/j.yexcr.2004.10.006; Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BINGMANN D, 1982, EXP BRAIN RES, V48, P89; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Booth C, 1999, EXP CELL RES, V249, P359, DOI 10.1006/excr.1999.4483; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Kaeffer B, 2002, IN VITRO CELL DEV-AN, V38, P123; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lopez-Diaz L, 2007, DEV BIOL, V309, P298, DOI 10.1016/j.ydbio.2007.07.015; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Ootani A, 2003, AM J PATHOL, V162, P1905, DOI 10.1016/S0002-9440(10)64324-6; Pageot LP, 2000, MICROSC RES TECHNIQ, V49, P394; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Perreault N, 1998, EXP CELL RES, V245, P34, DOI 10.1006/excr.1998.4221; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; Schonhoff SE, 2004, DEV BIOL, V270, P443, DOI 10.1016/j.ydbio.2004.03.013; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Strater J, 1996, GASTROENTEROLOGY, V110, P1776, DOI 10.1053/gast.1996.v110.pm8964403; Toda S, 2002, BIOCHEM BIOPH RES CO, V294, P906, DOI 10.1016/S0006-291X(02)00561-2; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; WILLIAMS ED, 1992, AM J PATHOL, V141, P773; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006	40	567	600	3	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					1	U140		10.1038/nm.1951	http://dx.doi.org/10.1038/nm.1951			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19398967	Green Accepted, Green Submitted			2022-12-25	WOS:000266731600031
J	Machnik, A; Neuhofer, W; Jantsch, J; Dahlmann, A; Tammela, T; Machura, K; Park, JK; Beck, FX; Muller, DN; Derer, W; Goss, J; Ziomber, A; Dietsch, P; Wagner, H; van Rooijen, N; Kurtz, A; Hilgers, KF; Alitalo, K; Eckardt, KU; Luft, FC; Kerjaschki, D; Titze, J				Machnik, Agnes; Neuhofer, Wolfgang; Jantsch, Jonathan; Dahlmann, Anke; Tammela, Tuomas; Machura, Katharina; Park, Joon-Keun; Beck, Franz-Xaver; Mueller, Dominik N.; Derer, Wolfgang; Goss, Jennifer; Ziomber, Agata; Dietsch, Peter; Wagner, Hubertus; van Rooijen, Nico; Kurtz, Armin; Hilgers, Karl F.; Alitalo, Kari; Eckardt, Kai-Uwe; Luft, Friedrich C.; Kerjaschki, Dontscho; Titze, Jens			Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; OSMOTICALLY INACTIVE NA+; TUMOR LYMPHANGIOGENESIS; INTERSTITIAL FLOW; SODIUM-BALANCE; DOCA-SALT; VEGF-C; RATS; HYPERTENSION; MICE	In salt-sensitive hypertension, the accumulation of Na(+) in tissue has been presumed to be accompanied by a commensurate retention of water to maintain the isotonicity of body fluids. We show here that a high-salt diet (HSD) in rats leads to interstitial hypertonic Na(+) accumulation in skin, resulting in increased density and hyperplasia of the lymphcapillary network. The mechanisms underlying these effects on lymphatics involve activation of tonicity-responsive enhancer binding protein (TonEBP) in mononuclear phagocyte system (MPS) cells infiltrating the interstitium of the skin. TonEBP binds the promoter of the gene encoding vascular endothelial growth factor-C (VEGF-C, encoded by Vegfc) and causes VEGF-C secretion by macrophages. MPS cell depletion or VEGF-C trapping by soluble VEGF receptor-3 blocks VEGF-C signaling, augments interstitial hypertonic volume retention, decreases endothelial nitric oxide synthase expression and elevates blood pressure in response to HSD. Our data show that TonEBP-VEGF-C signaling in MPS cells is a major determinant of extracellular volume and blood pressure homeostasis and identify VEGFC as an osmosensitive, hypertonicity-driven gene intimately involved in salt-induced hypertension.	[Machnik, Agnes; Jantsch, Jonathan; Dahlmann, Anke; Goss, Jennifer; Ziomber, Agata; Hilgers, Karl F.; Eckardt, Kai-Uwe; Titze, Jens] Univ Erlangen Nurnberg, D-8520 Erlangen, Germany; [Neuhofer, Wolfgang; Beck, Franz-Xaver] Univ Munich, Dept Physiol, D-8000 Munich, Germany; [Jantsch, Jonathan] Univ Clin Erlangen, Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany; [Tammela, Tuomas; Alitalo, Kari] Biomedicum Helsinki, Lab Mol Canc Biol, Helsinki, Finland; [Machura, Katharina; Kurtz, Armin] Univ Regensburg, Inst Physiol, Regensburg, Germany; [Park, Joon-Keun] Hannover Med Sch, Dept Med, Div Nephrol, Hannover, Germany; [Mueller, Dominik N.; Luft, Friedrich C.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Mueller, Dominik N.; Luft, Friedrich C.] Fac Med Charite, Expt & Clin Res Ctr, Berlin, Germany; [Derer, Wolfgang; Luft, Friedrich C.] HELIOS Klinikum Berlin Brandenburg, Berlin, Germany; [Dietsch, Peter] Inst Biochem, Berlin, Germany; [Wagner, Hubertus] Max Rubner Inst, Dept Safety & Qual Meat, Kulmbach, Germany; [van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Kerjaschki, Dontscho] Med Univ Vienna, Dept Pathol, Vienna, Austria	University of Erlangen Nuremberg; University of Munich; University of Erlangen Nuremberg; University of Helsinki; University of Regensburg; Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; Vrije Universiteit Amsterdam; Medical University of Vienna		jtitze@molmed.uni-erlangen.de	Titze, Jens/GXV-1636-2022; Alitalo, Kari K/J-5013-2014; Schröder, Agnes/AHC-9286-2022; Van Rooijen, Nico/Z-1578-2019	Alitalo, Kari K/0000-0002-7331-0902; /0000-0003-3675-6961; Luft, Friedrich/0000-0002-8635-1199; Titze, Jens/0000-0001-8463-8404; Muller, Dominik N/0000-0003-3650-5644	Interdisziplinares Zentrum fur klinische Forschung Erlangen [TP B13]; Bundesministerium fur Bildung und Forschung - Forschung unter Weltraumbedingungen [50WB0620]; Deutsche Forschungsgemeinschaft [Ti345/2]; sixth Framework Integrated Project Lymphangiogenomics [LSGH-2004-503573]; EuReGene	Interdisziplinares Zentrum fur klinische Forschung Erlangen; Bundesministerium fur Bildung und Forschung - Forschung unter Weltraumbedingungen(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); sixth Framework Integrated Project Lymphangiogenomics(European Commission); EuReGene	This work was supported in part by grants from the Interdisziplinares Zentrum fur klinische Forschung Erlangen (TP B13), from the Bundesministerium fur Bildung und Forschung - Forschung unter Weltraumbedingungen (50WB0620), and from the Deutsche Forschungsgemeinschaft (Ti345/2) to J. T., from the sixth Framework Integrated Project Lymphangiogenomics (LSGH-2004-503573) to D. K., and from a Fresenius Nephro-Core Stipend to A. Z. F. C. L. and D. N. M. were supported by EuReGene; D. N. M. is a Helmholtz fellow. We thank N. Rakova for translating Russian articles and E. Prell, M. Klewer and B. Hausknecht for their technical assistance. We thank P. Uhrin (Department of Vascular Biology and Thrombosis Research, Medical University of Vienna) for the Swiss-129Sv mice and H. M. Kwon (Department of Medicine, University of Maryland) for pCMV-Tag2-TonEBP.	Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; Ahmad S, 2006, CIRC RES, V99, P715, DOI 10.1161/01.RES.0000243989.46006.b9; Boardman KC, 2003, CIRC RES, V92, P801, DOI 10.1161/01.RES.0000065621.69843.49; Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790; Fukuda S, 2004, CIRC RES, V95, P100, DOI 10.1161/01.RES.0000133677.77465.38; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Goldman J, 2007, AM J PHYSIOL-HEART C, V292, pH2176, DOI 10.1152/ajpheart.01011.2006; GUYTON AC, 1972, ANN BIOMED ENG, V1, P254, DOI 10.1007/BF02584211; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Heer M, 2000, AM J PHYSIOL-RENAL, V278, pF585, DOI 10.1152/ajprenal.2000.278.4.F585; Jantsch J, 2008, J IMMUNOL METHODS, V337, P71, DOI 10.1016/j.jim.2008.04.004; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Kang KT, 2007, HYPERTENSION, V49, P893, DOI 10.1161/01.HYP.0000259669.40991.1e; Karpanen T, 2001, CANCER RES, V61, P1786; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Konovchuk V. N., 1992, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V78, P42; Laitinen M, 1998, HUM GENE THER, V9, P1481, DOI 10.1089/hum.1998.9.10-1481; Leonard AM, 2006, AM J HYPERTENS, V19, P1264, DOI 10.1016/j.amjhyper.2006.05.025; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lohela M, 2008, AM J PATHOL, V173, P1891, DOI 10.2353/ajpath.2008.080378; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; Neuhofer W, 2005, ANNU REV PHYSIOL, V67, P531, DOI 10.1146/annurev.physiol.67.031103.154456; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Obst M, 2004, KIDNEY INT, V65, P2268, DOI 10.1111/j.1523-1755.2004.00646.x; Pitts RF, 1974, PHYSL KIDNEY BODY FL, P11; Rutkowski JM, 2006, AM J PHYSIOL-HEART C, V291, pH1402, DOI 10.1152/ajpheart.00038.2006; Schafflhuber M, 2007, AM J PHYSIOL-RENAL, V292, pF1490, DOI 10.1152/ajprenal.00300.2006; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Titze J, 2005, AM J PHYSIOL-RENAL, V289, pF793, DOI 10.1152/ajprenal.00096.2005; Titze J, 2004, AM J PHYSIOL-HEART C, V287, pH203, DOI 10.1152/ajpheart.01237.2003; Titze J, 2003, AM J PHYSIOL-RENAL, V285, pF1108, DOI 10.1152/ajprenal.00200.2003; Titze J, 2002, AM J KIDNEY DIS, V40, P508, DOI 10.1053/ajkd.2002.34908; TOLINS JP, 1994, KIDNEY INT, V46, P230, DOI 10.1038/ki.1994.264; Trzewik J, 2001, FASEB J, V15, P1711, DOI 10.1096/fj.01-0067com; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Ziomber A, 2008, AM J PHYSIOL-RENAL, V295, pF1752, DOI 10.1152/ajprenal.00531.2007	40	664	680	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2009	15	5					545	552		10.1038/nm.1960	http://dx.doi.org/10.1038/nm.1960			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19412173				2022-12-25	WOS:000265889300033
J	Trapnell, C; Salzberg, SL				Trapnell, Cole; Salzberg, Steven L.			How to map billions of short reads onto genomes	NATURE BIOTECHNOLOGY			English	Article								Mapping the vast quantities of short sequence fragments produced by next-generation sequencing platforms is a challenge. What programs are available and how do they work?	[Trapnell, Cole; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Trapnell, C (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	cole@cs.umd.edu; salzberg@umd.edu	Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432	NIGMS NIH HHS [R01 GM083873-06, R01 GM083873] Funding Source: Medline; NLM NIH HHS [R01 LM006845, R01 LM006845-09, R01 LM006845-10] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509	10	179	222	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2009	27	5					455	457		10.1038/nbt0509-455	http://dx.doi.org/10.1038/nbt0509-455			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	444KS	19430453	Green Accepted			2022-12-25	WOS:000265980500023
J	Wu, JQ; Guo, JY; Tang, W; Yang, CS; Freel, CD; Chen, C; Nairn, AC; Kornbluth, S				Wu, Judy Qiju; Guo, Jessie Yanxiang; Tang, Wanli; Yang, Chih-Sheng; Freel, Christopher D.; Chen, Chen; Nairn, Angus C.; Kornbluth, Sally			PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE INHIBITOR-1; ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; M-PHASE; MITOSIS; CDC14; CALCINEURIN; EXTRACTS; KINASE; ACTIVATION	Loss of cell division cycle 2 (Cdc2, also known as Cdk1) activity after cyclin B degradation is necessary, but not sufficient, for mitotic exit. Proteins phosphorylated by Cdc2 and downstream mitotic kinases must be dephosphorylated. We report here that protein phosphatase-1 (PP1) is the main catalyst of mitotic phosphoprotein dephosphorylation. Suppression of PP1 during early mitosis is maintained through dual inhibition by Cdc2 phosphorylation and the binding of inhibitor-1. Protein kinase A (PKA) phosphorylates inhibitor-1, mediating binding to PP1. As Cdc2 levels drop after cyclin B degradation, auto-dephosphorylation of PP1 at its Cdc2 phosphorylation site (Thr 320) allows partial PP1 activation. This promotes PP1-regulated dephosphorylation at the activating site of inhibitor-1 (Thr 35) followed by dissociation of the inhibitor-1-PP1 complex and then full PP1 activation to promote mitotic exit. Thus, Cdc2 both phosphorylates multiple mitotic substrates and inhibits their PP1-mediated dephosphorylation.	[Wu, Judy Qiju; Guo, Jessie Yanxiang; Tang, Wanli; Yang, Chih-Sheng; Freel, Christopher D.; Chen, Chen; Kornbluth, Sally] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Duke University; Yale University	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kornb001@mc.duke.edu		Nairn, Angus/0000-0002-7075-0195	NIH [RO1 GM67225, DA10044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants to S. K. (RO1 GM67225) and A. C. N. (DA10044).	Amon A, 2008, FEBS J, V275, P5774, DOI 10.1111/j.1742-4658.2008.06693.x; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; Bianchi M, 2001, BIOCHEM BIOPH RES CO, V280, P1, DOI 10.1006/bbrc.2000.4067; Bibbb JA, 2001, J BIOL CHEM, V276, P14490, DOI 10.1074/jbc.M007197200; Casaletto JB, 2005, J CELL BIOL, V169, P61, DOI 10.1083/jcb.200411056; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Che SL, 1998, FEBS LETT, V424, P225, DOI 10.1016/S0014-5793(98)00158-6; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; DOONAN JH, 1989, CELL, V57, P987, DOI 10.1016/0092-8674(89)90337-1; El-Armouche A, 2006, BIOCHEM BIOPH RES CO, V346, P700, DOI 10.1016/j.bbrc.2006.05.182; GUSTAFSON EL, 1991, J COMP NEUROL, V310, P170, DOI 10.1002/cne.903100204; Higuchi E, 2000, EUR J PHARMACOL, V408, P107, DOI 10.1016/S0014-2999(00)00767-6; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nishiyama T, 2007, NATURE, V449, P341, DOI 10.1038/nature06136; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Trautmann S, 2002, CURR BIOL, V12, pR733, DOI 10.1016/S0960-9822(02)01250-2; Wolfe BA, 2006, DEV CELL, V11, P423, DOI 10.1016/j.devcel.2006.07.016; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045	30	178	178	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					644	U451		10.1038/ncb1871	http://dx.doi.org/10.1038/ncb1871			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19396163	Green Accepted			2022-12-25	WOS:000265640000024
J	Schellenberger, V; Wang, CW; Geething, NC; Spink, BJ; Campbell, A; To, W; Scholle, MD; Yin, Y; Yao, Y; Bogin, O; Cleland, JL; Silverman, J; Stemmer, WPC				Schellenberger, Volker; Wang, Chia-wei; Geething, Nathan C.; Spink, Benjamin J.; Campbell, Andrew; To, Wayne; Scholle, Michael D.; Yin, Yong; Yao, Yi; Bogin, Oren; Cleland, Jeffrey L.; Silverman, Joshua; Stemmer, Willem P. C.			A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner	NATURE BIOTECHNOLOGY			English	Article							POLY(ETHYLENE GLYCOL); PEGYLATION; FUSION; PHARMACOKINETICS; ATTACHMENT; ANTIBODIES; EXENDIN-4; GENERATE; ANIMALS; POLYMER	Increasing the in vivo residence times of protein therapeutics could decrease their dosing frequencies. We show that genetic fusion of an unstructured recombinant polypeptide of 864 amino acids, called XTEN, to a peptide or protein provides an apparently generic approach to extend plasma half-life. Allometric scaling suggests that a fusion of XTEN to the exenatide peptide should increase exenatide half-life in humans from 2.4 h to a projected time of 139 h. We confirmed the biological activity of the exenatide-XTEN fusion in mice. As extended stability might exacerbate undesirable side effects in some cases, we show that truncating the XTEN sequence can regulate plasma half-life. XTEN lacks hydrophobic amino acid residues that often contribute to immunogenicity and complicate manufacture. Based on data on XTEN fusions to exenatide, glucagon, GFP and human growth hormone, we expect that XTEN will enable dosing of otherwise rapidly cleared protein drugs at up to monthly intervals in humans.	[Schellenberger, Volker; Wang, Chia-wei; Geething, Nathan C.; Spink, Benjamin J.; Campbell, Andrew; To, Wayne; Scholle, Michael D.; Yin, Yong; Yao, Yi; Bogin, Oren; Silverman, Joshua; Stemmer, Willem P. C.] Amunix Inc, Mountain View, CA USA; [Cleland, Jeffrey L.] Versartis Inc, Mountain View, CA USA		Stemmer, WPC (corresponding author), Amunix Inc, Mountain View, CA USA.	pstemmer@amunix.com	Wang, Chia Wei/GXF-9984-2022		National Institute of General Medical Sciences [R44GM079873]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM079873] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The size exclusion chromatography-multi-angle light scattering analysis was conducted by E. Folta-Stogniew at the W. M. Keck Foundation Biotechnology Resource Laboratory. The mass spectrometry was performed at MDS Analytical Technologies by A. Booy. The Macrocap Q resin was kindly provided by J. Lundberg from GE Healthcare. The project described was supported by award number R44GM079873 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Ai G, 2008, INT J PHARM, V353, P56, DOI 10.1016/j.ijpharm.2007.11.016; Alvarez P, 2004, J BIOL CHEM, V279, P3375, DOI 10.1074/jbc.M311356200; [Anonymous], 2009, BYETT PACK INS; Baggio LL, 2004, DIABETES, V53, P2492, DOI 10.2337/diabetes.53.9.2492; Bendele A, 1998, TOXICOL SCI, V42, P152, DOI 10.1093/toxsci/42.2.152; CHEZ RA, 1974, AM J OBSTET GYNECOL, V120, P690, DOI 10.1016/0002-9378(74)90612-7; Cindric M, 2007, J PHARMACEUT BIOMED, V44, P388, DOI 10.1016/j.jpba.2007.02.036; Dhalluin C, 2005, BIOCONJUGATE CHEM, V16, P504, DOI 10.1021/bc049781+; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; *E LILL CO, 2009, GLUC PACK INS; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gaertner HF, 1996, BIOCONJUGATE CHEM, V7, P38, DOI 10.1021/bc950074d; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; He XH, 1999, LIFE SCI, V65, P355, DOI 10.1016/S0024-3205(99)00257-X; Huang LH, 2009, ANAL CHEM, V81, P567, DOI 10.1021/ac801711u; Huang YS, 2008, J PEPT SCI, V14, P588, DOI 10.1002/psc.942; Kochendoerfer G, 2003, EXPERT OPIN BIOL TH, V3, P1253, DOI 10.1517/eobt.3.8.1253.21285; Mahmood I, 2007, ADV DRUG DELIVER REV, V59, P1177, DOI 10.1016/j.addr.2007.05.015; *MERCK CO INC, 2009, ELSPAR PACK INS; RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309; Ryan SM, 2008, EXPERT OPIN DRUG DEL, V5, P371, DOI [10.1517/17425247.5.4.371, 10.1517/17425247.5.4.371 ]; Schlapschy M, 2007, PROTEIN ENG DES SEL, V20, P273, DOI 10.1093/protein/gzm020; Shaunak S, 2006, NAT CHEM BIOL, V2, P312, DOI 10.1038/nchembio786; Shiffman M L, 2001, Curr Gastroenterol Rep, V3, P30, DOI 10.1007/s11894-001-0038-z; SINIGAGLIA F, 1995, J EXP MED, V181, P449, DOI 10.1084/jem.181.2.449; Sroda K, 2005, CELL MOL BIOL LETT, V10, P37; TUCKER M, 2007, PEDIAT NEWS, V41, P58; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x	29	275	423	8	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1186	U155		10.1038/nbt.1588	http://dx.doi.org/10.1038/nbt.1588			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	19915550				2022-12-25	WOS:000272708300037
J	Parsons, J; Castaldi, MP; Dutta, S; Dibrov, SM; Wyles, DL; Hermann, T				Parsons, Jerod; Castaldi, M. Paola; Dutta, Sanjay; Dibrov, Sergey M.; Wyles, David L.; Hermann, Thomas			Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA	NATURE CHEMICAL BIOLOGY			English	Article							TRANSLATION INITIATION; REPLICATION	The internal ribosome entry site (IRES), a highly conserved structured element of the hepatitis C virus (HCV) genomic RNA, is an attractive target for antiviral drugs. Here we show that benzimidazole inhibitors of the HCV replicon act by conformational induction of a widened interhelical angle in the IRES subdomain IIa, which facilitates the undocking of subdomain IIb from the ribosome and ultimately leads to inhibition of IRES-driven translation in HCV-infected cells.	[Parsons, Jerod; Castaldi, M. Paola; Dutta, Sanjay; Dibrov, Sergey M.; Hermann, Thomas] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wyles, David L.] Univ Calif San Diego, Div Infect Dis, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hermann, T (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	tch@ucsd.edu	Hermann, Thomas/L-4311-2019	Hermann, Thomas/0000-0002-9855-1593; Parsons, Jerod/0000-0002-4184-343X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072012, K08AI069989] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI069989, K08 AI069989-02, R01 AI072012, R01AI72012] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; BROWN EA, 1992, NUCLEIC ACIDS RES, V20, P5041, DOI 10.1093/nar/20.19.5041; Dibrov SM, 2007, ANGEW CHEM INT EDIT, V46, P226, DOI 10.1002/anie.200603807; Hermann T, 2005, CURR OPIN STRUC BIOL, V15, P355, DOI 10.1016/j.sbi.2005.05.001; Hermann T, 2000, ANGEW CHEM INT EDIT, V39, P1891; Ji H, 2004, P NATL ACAD SCI USA, V101, P16990, DOI 10.1073/pnas.0407402101; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Lukavsky PJ, 2009, VIRUS RES, V139, P166, DOI 10.1016/j.virusres.2008.06.004; Lukavsky PJ, 2003, NAT STRUCT BIOL, V10, P1033, DOI 10.1038/nsb1004; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Seth PP, 2005, J MED CHEM, V48, P7099, DOI 10.1021/jm050815o; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Wyles DL, 2007, J VIROL, V81, P3005, DOI 10.1128/JVI.02083-06	17	109	114	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2009	5	11					823	825		10.1038/nchembio.217	http://dx.doi.org/10.1038/nchembio.217			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	508FQ	19767736	Green Accepted			2022-12-25	WOS:000270915000011
J	Pechhold, S; Stouffer, M; Walker, G; Martel, R; Seligmann, B; Hang, Y; Stein, R; Harlan, DM; Pechhold, K				Pechhold, Susanne; Stouffer, Melissa; Walker, Gregory; Martel, Ralph; Seligmann, Bruce; Hang, Yan; Stein, Roland; Harlan, David M.; Pechhold, Klaus			Transcriptional analysis of intracytoplasmically stained, FACS-purified cells by high-throughput, quantitative nuclease protection	NATURE BIOTECHNOLOGY			English	Article							BETA-CELLS; ALPHA-CELLS; INSULIN-SECRETION; GENE-EXPRESSION; MOUSE; PANCREAS; ISLETS; MAFA; DIFFERENTIATION; PROLIFERATION	Analyzing specialized cells in heterogeneous tissues is crucial for understanding organ function in health and disease. Thus far, however, there has been no convenient method for studying gene expression in cells purified by fluorescence-activated cell sorting (FACS) using intracellular markers. Here we show that the quantitative nuclease protection assay (qNPA) enables transcriptional analysis of intracytoplasmically stained cells sorted by FACS. Applying the method to mouse pancreatic islet-cell subsets, we detected both expected and unknown lineage-specific gene expression patterns. Some beta cells from pregnant animals were found to express Mafb, previously observed only in immature beta cells during embryonic development. The four 'housekeeping' genes tested were expressed in purified islet-cell subpopulations with a notable variability, dependent on both cell lineage and developmental stage. Application of qNPA to intracellularly stained, FACS-sorted cells should be broadly applicable to the analysis of gene expression in subpopulations of any heterogeneous tissue, including tumors.	[Pechhold, Susanne; Walker, Gregory; Harlan, David M.; Pechhold, Klaus] NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA; [Stouffer, Melissa; Martel, Ralph; Seligmann, Bruce] High Throughput Genom Inc, Tucson, AZ USA; [Hang, Yan; Stein, Roland] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Pechhold, K (corresponding author), NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA.	KlausP@intra.NIDDK.NIH.gov		Stouffer, Melissa/0000-0002-7092-0246	US National Institutes of Health (NIH); National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK); NIH [DK042502]; Juvenile Diabetes Research Foundation [1-2008-595]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK042502, ZIADK055113, R01DK090570] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors like to thank A. Franks for mouse colony management and S. Wank, O. Gavrilova and L. Weinstein for critically reading the manuscript and making helpful suggestions. This research was supported in part by the Intramural Research Program of the US National Institutes of Health (NIH), National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), and NIH DK042502, Juvenile Diabetes Research Foundation 1-2008-595 to R.	Ahn YB, 2007, DIABETOLOGIA, V50, P334, DOI 10.1007/s00125-006-0536-5; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Frericks M, 2008, BBA-GENE REGUL MECH, V1779, P830, DOI 10.1016/j.bbagrm.2008.08.007; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Lee SJ, 2002, CRIT REV EUKAR GENE, V12, P297, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.40; Linden E, 1997, CYTOMETRY, V27, P92, DOI 10.1002/(SICI)1097-0320(19970101)27:1<92::AID-CYTO12>3.0.CO;2-N; MARCINKIEWICZ M, 1994, ENDOCRINOLOGY, V135, P1651, DOI 10.1210/en.135.4.1651; Martel RR, 2002, ASSAY DRUG DEV TECHN, V1, P61, DOI 10.1089/154065802761001310; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Mellitzer G, 2004, MOL ENDOCRINOL, V18, P2765, DOI 10.1210/me.2004-0243; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; NEERMANARBEZ M, 1994, BIOCHEM J, V300, P57, DOI 10.1042/bj3000057; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Pechhold K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004827; Pechhold K, 2009, DIABETES, V58, P1175, DOI 10.2337/db08-0616; Sambrook J, 2001, MOL CLONING LAB MANU, P51; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Tornehave D, 2008, J HISTOCHEM CYTOCHEM, V56, P841, DOI 10.1369/jhc.2008.951319; Wang J, 2003, P NATL ACAD SCI USA, V100, P12660, DOI 10.1073/pnas.1735286100; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171	30	40	40	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2009	27	11					1038	U106		10.1038/nbt.1579	http://dx.doi.org/10.1038/nbt.1579			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	516EM	19838197	Green Accepted			2022-12-25	WOS:000271524700025
J	van Diepen, MT; Parsons, M; Downes, CP; Leslie, NR; Hindges, R; Eickholt, BJ				van Diepen, Michiel T.; Parsons, Maddy; Downes, C. Peter; Leslie, Nicholas R.; Hindges, Robert; Eickholt, Britta J.			MyosinV controls PTEN function and neuronal cell size	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR PTEN; UNCONVENTIONAL MYOSIN; EPITHELIAL-CELLS; IN-VIVO; BRAIN; PHOSPHORYLATION; MEMBRANE; MORPHOGENESIS; STABILITY; DISEASE	The tumour suppressor PTEN can inhibit cell proliferation and migration as well as control cell growth, in different cell types(1). PTEN functions predominately as a lipid phosphatase, converting PtdIns(3,4,5)P-3 to PtdIns(4,5)P-2, thereby antagonizing PI(3) K (phosphoinositide 3-kinase) and its established downstream effector pathways(2). However, much is unclear concerning the mechanisms that regulate PTEN movement to the cell membrane, which is necessary for its activity towards PtdIns(3,4,5)P-3 (refs 3-5). Here we show a requirement for functional motor proteins in the control of PI3K signalling, involving a previously unknown association between PTEN and myosinV. FRET (Forster resonance energy transfer) measurements revealed that PTEN interacts directly with myosinV, which is dependent on PTEN phosphorylation mediated by CK2 and/or GSK3. Inactivation of myosinV transport function in neurons increased cell size, which, in line with known attributes of PTEN-loss(6,7), required PI(3) K and mTor. Our data demonstrate a myosin-based transport mechanism that regulates PTEN function, providing new insights into the signalling networks regulating cell growth.	[van Diepen, Michiel T.; Hindges, Robert; Eickholt, Britta J.] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Downes, C. Peter; Leslie, Nicholas R.] Univ Dundee, Div Mol Physiol, Coll Life Sci, Dundee DD1 5EH, Scotland	University of London; King's College London; University of London; King's College London; University of Dundee	Eickholt, BJ (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, New Hunts House, London SE1 1UL, England.	britta.J.eickholt@kcl.ac.uk	Parsons, Maddy/B-2203-2013; Leslie, Nicholas/D-2699-2009; Eickholt, Britta/C-5337-2009; Hindges, Robert/C-5344-2009	Parsons, Maddy/0000-0002-2021-8379; Hindges, Robert/0000-0003-0095-7913; LESLIE, Nicholas/0000-0001-5131-0541; van Diepen, Michiel/0000-0001-8156-4294; Eickholt, Britta/0000-0001-7873-8687	Biotechnology and Biological Science Research Council [BB/C514307/1]; MRC [G9403619]; MRC [G0801865] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C514307/1] Funding Source: researchfish; Medical Research Council [G9403619, G0801865] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biotechnology and Biological Science Research Council to B. J. E. (BB/C514307/1), an MRC program grant to C. P. D. (G9403619). M. P. is a Royal Society University Research Fellow. We thank J. Hammer III for providing the myosinVa cDNA, C. Sutherland for the GSK3 inhibitor CT99021, E. Blanc for help with statistical analyses and F. Gertler for comments on the manuscript.	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Brown JR, 2002, BIOL BULL, V203, P210, DOI 10.2307/1543401; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rodriguez OC, 2002, J CELL SCI, V115, P991; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sanal O, 2000, J NEUROL, V247, P570, DOI 10.1007/s004150070162; Spittaels K, 2002, NEUROSCIENCE, V113, P797, DOI 10.1016/S0306-4522(02)00236-1; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	29	71	71	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1191	U55		10.1038/ncb1961	http://dx.doi.org/10.1038/ncb1961			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767745	Green Accepted			2022-12-25	WOS:000270382000007
J	Cobos-Correa, A; Trojanek, JB; Diemer, S; Mall, MA; Schultz, C				Cobos-Correa, Amanda; Trojanek, Johanna B.; Diemer, Stefanie; Mall, Marcus A.; Schultz, Carsten			Membrane-bound FRET probe visualizes MMP12 activity in pulmonary inflammation	NATURE CHEMICAL BIOLOGY			English	Article							MACROPHAGE METALLOELASTASE; MATRIX METALLOPROTEINASE-12; ACTIVATION; INHIBITORS; EMPHYSEMA; ELASTASE; CELLS; MICE	MMP12 is a metalloproteinase implicated in inflammation. To monitor its activity, we synthesized a membrane-targeted reporter (LaRee1) based on Foerster resonance energy transfer (FRET). Unlike existing sensors, LaRee1 detects MMP12 activity by loss of FRET plus internalization of the lipidated fragment. In bronchoalveolar lavages from a mouse model of pulmonary inflammation, LaRee1 detected MMP12 activity at the surface of activated macrophages. LaRee1 may become a powerful tool for monitoring lung disease.	[Cobos-Correa, Amanda; Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Cobos-Correa, Amanda; Diemer, Stefanie; Mall, Marcus A.; Schultz, Carsten] European Mol Biol Lab, Mol Med Partnership Unit, Heidelberg, Germany; [Trojanek, Johanna B.; Diemer, Stefanie] Univ Heidelberg, Pediat Pulmonol & Cyst Fibrosis Ctr, Dept Pediat 3, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Schultz, C (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	marcus.mall@med.uni-heidelberg.de; schultz@embl.de	Mall, Marcus A./AAA-1498-2022	Mall, Marcus A./0000-0002-4057-2199; Schultz, Carsten/0000-0002-5824-2171; Trojanek, Joanna/0000-0002-3200-735X	European Union [LSHG-CT-2003-503259, MEXT-2004-013666]	European Union(European Commission)	We thank M. Gutierrez (EMBL) for RAW 264.7 macrophages, O. Gallego (EMBL) for liposomes, H. Stichnoth (EMBL) for tissue culture, S. Hirtz for genotyping, S. Schubert for discussions and mouse work and J.R. Harkema (Michigan State University) for providing particulate matter (PM10). This work was supported in part by grants from the European Union (LSHG-CT-2003-503259 to C.S. and MEXT-2004-013666 to M.A.M.).	Bachoual R, 2007, CHEM RES TOXICOL, V20, P1426, DOI 10.1021/tx700093j; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Churg A, 2003, AM J RESP CRIT CARE, V167, P1083, DOI 10.1164/rccm.200212-1396OC; Churg A, 2002, AM J RESP CELL MOL, V27, P368, DOI 10.1165/rcmb.4791; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; DORING G, 1994, AM J RESP CRIT CARE, V150, pS114; Gaggar A, 2007, AM J PHYSIOL-LUNG C, V293, pL96, DOI 10.1152/ajplung.00492.2006; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Lanone S, 2002, J CLIN INVEST, V110, P463, DOI 10.1172/JCI200214136; Lombard C, 2005, BIOCHIMIE, V87, P265, DOI 10.1016/j.biochi.2005.01.007; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Ouyang MX, 2008, J BIOL CHEM, V283, P17740, DOI 10.1074/jbc.M709872200; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vos CMP, 2003, J NEUROIMMUNOL, V138, P106, DOI 10.1016/S0165-5728(03)00036-5; Yang J, 2007, BBA-MOL CELL RES, V1773, P400, DOI 10.1016/j.bbamcr.2006.11.002	21	86	93	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					628	630		10.1038/nchembio.196	http://dx.doi.org/10.1038/nchembio.196			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19648933				2022-12-25	WOS:000269093000010
J	Bennett, BD; Kimball, EH; Gao, M; Osterhout, R; Van Dien, SJ; Rabinowitz, JD				Bennett, Bryson D.; Kimball, Elizabeth H.; Gao, Melissa; Osterhout, Robin; Van Dien, Stephen J.; Rabinowitz, Joshua D.			Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							TANDEM MASS-SPECTROMETRY; FREE-ENERGY MAPS; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; INTRACELLULAR METABOLITES; CELLULAR METABOLITES; NITROGEN; EXTRACTS; PATHWAY; MODELS	Absolute metabolite concentrations are critical to a quantitative understanding of cellular metabolism, as concentrations impact both the free energies and rates of metabolic reactions. Here we use LC-MS/MS to quantify more than 100 metabolite concentrations in aerobic, exponentially growing Escherichia coli with glucose, glycerol or acetate as the carbon source. The total observed intracellular metabolite pool was approximately 300 mM. A small number of metabolites dominate the metabolome on a molar basis, with glutamate being the most abundant. Metabolite concentration exceeds K-m for most substrate-enzyme pairs. An exception is lower glycolysis, where concentrations of intermediates are near the K-m of their consuming enzymes and all reactions are near equilibrium. This may facilitate efficient flux reversibility given thermodynamic and osmotic constraints. The data and analyses presented here highlight the ability to identify organizing metabolic principles from systems-level absolute metabolite concentration data.	[Bennett, Bryson D.; Kimball, Elizabeth H.; Gao, Melissa; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Bennett, Bryson D.; Kimball, Elizabeth H.; Gao, Melissa; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Osterhout, Robin; Van Dien, Stephen J.] Genomat Inc, San Diego, CA USA	Princeton University; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	joshr@princeton.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	US National Science Foundation; Arnold and Mabel Beckman Foundation; US National Institutes of Health [P50 GM071508]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Arnold and Mabel Beckman Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to B. Cravatt for the suggestion that metabolite concentrations be compared to the Km of consuming enzymes. We thank the US National Science Foundation (CAREER Award), the Arnold and Mabel Beckman Foundation, the US National Institutes of Health (Center for Quantitative Biology grant P50 GM071508) and the American Heart Association for their financial support.	ALBERTY RA, 1969, J BIOL CHEM, V244, P3290; ASNIS RE, 1953, J BIOL CHEM, V203, P153; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Benov L, 2003, BBA-GEN SUBJECTS, V1622, P128, DOI 10.1016/S0304-4165(03)00134-X; Birkemeyer C, 2005, TRENDS BIOTECHNOL, V23, P28, DOI 10.1016/j.tibtech.2004.12.001; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Coulier L, 2006, ANAL CHEM, V78, P6573, DOI 10.1021/ac0607616; EASTERBY JS, 1986, BIOCHEM J, V233, P871, DOI 10.1042/bj2330871; EDGAR JR, 1978, J BIOL CHEM, V253, P6348; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; FREEDBERG WB, 1971, J BACTERIOL, V108, P137, DOI 10.1128/JB.108.1.137-144.1971; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ikeda TP, 1996, J MOL BIOL, V259, P589, DOI 10.1006/jmbi.1996.0342; Jamshidi N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.8; Karp PD, 2007, NUCLEIC ACIDS RES, V35, P7577, DOI 10.1093/nar/gkm740; Kimball E, 2006, ANAL BIOCHEM, V358, P273, DOI 10.1016/j.ab.2006.07.038; Kummel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-512; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Mashego MR, 2004, BIOTECHNOL BIOENG, V85, P620, DOI 10.1002/bit.10907; Maskow T, 2005, BIOTECHNOL BIOENG, V92, P223, DOI 10.1002/bit.20572; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; MILLER RE, 1972, J BIOL CHEM, V247, P7407; Neidhardt F.C., 1987, ESCHERICHIA COLI SAL, VI; Oldiges M, 2004, BIOTECHNOL PROGR, V20, P1623, DOI 10.1021/bp0498746; Piazza M, 2008, J THEOR BIOL, V251, P628, DOI 10.1016/j.jtbi.2007.12.009; POWELL JT, 1978, EUR J BIOCHEM, V87, P391, DOI 10.1111/j.1432-1033.1978.tb12388.x; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; ROSENBERG H, 1982, J BACTERIOL, V149, P123, DOI 10.1128/JB.149.1.123-130.1982; Seifar RM, 2008, J CHROMATOGR A, V1187, P103, DOI 10.1016/j.chroma.2008.02.008; SHIKAMA K, 1971, ARCH BIOCHEM BIOPHYS, V147, P311, DOI 10.1016/0003-9861(71)90338-9; SHIKAMA K, 1973, ARCH BIOCHEM BIOPHYS, V157, P457, DOI 10.1016/0003-9861(73)90662-0; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; TRUNIGER V, 1994, J BACTERIOL, V176, P1796, DOI 10.1128/jb.176.6.1796-1800.1994; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Villas-Boas SG, 2007, ANAL BIOCHEM, V370, P87, DOI 10.1016/j.ab.2007.06.028; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816; Zamboni N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-199	47	1209	1223	13	287	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					593	599		10.1038/nchembio.186	http://dx.doi.org/10.1038/nchembio.186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19561621	Green Accepted			2022-12-25	WOS:000268209200018
J	Khadaroo, B; Teixeira, MT; Luciano, P; Eckert-Boulet, N; Germann, SM; Simon, MN; Gallina, I; Abdallah, P; Gilson, E; Geli, V; Lisby, M				Khadaroo, Basheer; Teixeira, M. Teresa; Luciano, Pierre; Eckert-Boulet, Nadine; Germann, Susanne M.; Simon, Marie Noelle; Gallina, Irene; Abdallah, Pauline; Gilson, Eric; Geli, Vincent; Lisby, Michael			The DNA damage response at eroded telomeres and tethering to the nuclear pore complex	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DYSFUNCTIONAL TELOMERES; YEAST TELOMERES; BINDING PROTEIN; KU HETERODIMER; S-PHASE; G-TAILS; REPAIR; COLOCALIZATION	The ends of linear eukaryotic chromosomes are protected by telomeres, which serve to ensure proper chromosome replication and to prevent spurious recombination at chromosome ends. In this study, we show by single cell analysis that in the absence of telomerase, a single short telomere is sufficient to induce the recruitment of checkpoint and recombination proteins. Notably, a DNA damage response at eroded telomeres starts many generations before senescence and is characterized by the recruitment of Cdc13 (cell division cycle 13), replication protein A, DNA damage checkpoint proteins and the DNA repair protein Rad52 into a single focus. Moreover, we show that eroded telomeres, although remaining at the nuclear periphery, move to the nuclear pore complex. Our results link the DNA damage response at eroded telomeres to changes in subnuclear localization and suggest the existence of collapsed replication forks at eroded telomeres.	[Khadaroo, Basheer; Luciano, Pierre; Simon, Marie Noelle; Geli, Vincent] Univ Aix Marseille 2, CNRS, Unite Propre Rech 3081, F-13402 Marseille 20, France; [Teixeira, M. Teresa; Abdallah, Pauline] Univ Lyon 1, Ecole Normale Super, CNRS, UMR 5239,Lab Biol Mol Cellule, F-69364 Lyon 07, France; [Eckert-Boulet, Nadine; Germann, Susanne M.; Gallina, Irene; Lisby, Michael] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; University of Copenhagen	Geli, V (corresponding author), Univ Aix Marseille 2, CNRS, Unite Propre Rech 3081, F-13402 Marseille 20, France.	geli@ibsm.cnrs-mrs.fr	Germann, Susanne Manuela/K-9062-2014; Teixeira, Maria Teresa/A-2100-2011; Lisby, Michael/K-9814-2014	Germann, Susanne Manuela/0000-0002-4737-8452; Teixeira, Maria Teresa/0000-0002-9466-7951; Lisby, Michael/0000-0002-4830-5247; Gallina, Irene/0000-0002-3741-9038	The Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation; Deutscher Akademischer Austausch Dienst; Lundbeck Foundation; LNNC; Lebanese National council for Scientific Research; Association pour la Recherche sur le Cancer	The Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation(Villum Fonden); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Lundbeck Foundation(Lundbeckfonden); LNNC; Lebanese National council for Scientific Research; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank members of the Geli, Gilson and Lisby laboratories for helpful discussions concerning this work, A. Nicolas, X. Zhao, R. Rothstein, B. Palancade, V. Lundblad and R. Wellinger for sharing reagents and for fruitful discussions, S. Larose and R. Wellinger, who engineered the pTet-off-TLC1 construct, and S. Brill for the anti-RPA antibody. This work was supported by The Danish Agency for Science, Technology and Innovation (M. L.), the Villum Kann Rasmussen Foundation (M. L.), the Deutscher Akademischer Austausch Dienst (S. M. G.) and the Lundbeck Foundation (N. E. B.). The Agence Nationale de la Recherche (ANR programme blanc) and the Ligue Nationale Contre le Cancer (LNCC, equipes labelisees) supported V. G. and E. G. laboratories; B. K. is a recipient of a fellowship from the LNNC and P. A. is supported by the Lebanese National council for Scientific Research (CNRSL) and the Association pour la Recherche sur le Cancer (ARC).	Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003; Bhattacharyya MK, 2006, TRENDS BIOCHEM SCI, V31, P114, DOI 10.1016/j.tibs.2005.12.001; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Grandin N, 2005, BIOL CELL, V97, P799, DOI 10.1042/BC20040526; Hackett JA, 2003, MOL CELL BIOL, V23, P8450, DOI 10.1128/MCB.23.23.8450-8461.2003; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Le S, 1999, GENETICS, V152, P143; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Negrini S, 2007, GENE DEV, V21, P292, DOI 10.1101/gad.400907; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Sherman F., 1986, METHODS YEAST GENETI; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V	31	143	145	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					980	U161		10.1038/ncb1910	http://dx.doi.org/10.1038/ncb1910			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597487				2022-12-25	WOS:000268593200012
J	Clavaguera, F; Bolmont, T; Crowther, RA; Abramowski, D; Frank, S; Probst, A; Fraser, G; Stalder, AK; Beibel, M; Staufenbiel, M; Jucker, M; Goedert, M; Tolnay, M				Clavaguera, Florence; Bolmont, Tristan; Crowther, R. Anthony; Abramowski, Dorothee; Frank, Stephan; Probst, Alphonse; Fraser, Graham; Stalder, Anna K.; Beibel, Martin; Staufenbiel, Matthias; Jucker, Mathias; Goedert, Michel; Tolnay, Markus			Transmission and spreading of tauopathy in transgenic mouse brain	NATURE CELL BIOLOGY			English	Article							PAIRED HELICAL FILAMENTS; TAU-PROTEIN; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; INTRACEREBRAL INFUSION; PARKINSONS-DISEASE; MICE; PATHOLOGY; DEMENTIA; PHOSPHORYLATION	Hyperphosphorylated tau makes up the filamentous intracellular inclusions of several neurodegenerative diseases, including Alzheimer's disease(1). In the disease process, neuronal tau inclusions first appear in the transentorhinal cortex from where they seem to spread to the hippocampal formation and neocortex(2). Cognitive impairment becomes manifest when inclusions reach the hippocampus, with abundant neocortical tau inclusions and extracellular beta-amyloid deposits being the defining pathological hallmarks of Alzheimer's disease. An abundance of tau inclusions, in the absence of beta-amyloid deposits, defines Pick's disease, progressive supranuclear palsy, corticobasal degeneration and other diseases(1). Tau mutations cause familial forms of frontotemporal dementia, establishing that tau protein dysfunction is sufficient to cause neurodegeneration and dementia(3-5). Thus, transgenic mice expressing mutant (for example, P301S) human tau in nerve cells show the essential features of tauopathies, including neurodegeneration and abundant filaments made of hyperphosphorylated tau protein(6,8). By contrast, mouse lines expressing single isoforms of wild-type human tau do not produce tau filaments or show neurodegeneration(7,8). Here we have used tau-expressing lines to investigate whether experimental tauopathy can be transmitted. We show that injection of brain extract from mutant P301S tau-expressing mice into the brain of transgenic wild-type tau-expressing animals induces assembly of wild-type human tau into filaments and spreading of pathology from the site of injection to neighbouring brain regions.	[Clavaguera, Florence; Frank, Stephan; Probst, Alphonse; Tolnay, Markus] Univ Basel, Inst Pathol, Dept Neuropathol, Basel, Switzerland; [Bolmont, Tristan; Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Crowther, R. Anthony; Fraser, Graham; Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Abramowski, Dorothee; Beibel, Martin; Staufenbiel, Matthias] Novartis Inst Biomed Res, Basel, Switzerland; [Stalder, Anna K.] Univ Basel Hosp, CH-4031 Basel, Switzerland	University of Basel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; MRC Laboratory Molecular Biology; Novartis; University of Basel	Tolnay, M (corresponding author), Univ Basel, Inst Pathol, Dept Neuropathol, Basel, Switzerland.	mg@mrc-lmb.cam.ac.uk; mtolnay@uhbs.ch			MRC [MC_U105184319, MC_U105184291] Funding Source: UKRI; Alzheimers Research UK [ART-PG2004A-5] Funding Source: researchfish; Medical Research Council [MC_U105184291, MC_U105184319, U.1051.02.002(78792)] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen B, 2002, J NEUROSCI, V22, P9340; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Boutajangout A, 2004, NEUROBIOL DIS, V15, P47, DOI 10.1016/j.nbd.2003.09.007; BRAAK H, 1988, STAIN TECHNOL, V63, P197, DOI 10.3109/10520298809107184; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Frank S, 2008, ACTA NEUROPATHOL, V115, P39, DOI 10.1007/s00401-007-0291-9; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; MERCKEN M, 1992, J NEUROCHEM, V58, P548, DOI 10.1111/j.1471-4159.1992.tb09754.x; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257; Yoshida H, 2006, J NEUROCHEM, V99, P154, DOI 10.1111/j.1471-4159.2006.04052.x	35	1198	1241	1	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					909	U325		10.1038/ncb1901	http://dx.doi.org/10.1038/ncb1901			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19503072	Green Accepted			2022-12-25	WOS:000267603100022
J	Popovich, P; McTigue, D				Popovich, Phillip; McTigue, Dana			Beware the immune system in spinal cord injury	NATURE MEDICINE			English	Editorial Material							PREVENTIVE ANTIBACTERIAL THERAPY; CENTRAL-NERVOUS-SYSTEM; ACUTE ISCHEMIC-STROKE; INFLAMMATION; INFECTIONS; TRIAL; SCI		[Popovich, Phillip; McTigue, Dana] Ctr Brain & Spinal Cord Repair, Columbus, OH USA		Popovich, P (corresponding author), Ctr Brain & Spinal Cord Repair, Columbus, OH USA.	phillip.popovich@osumc.edu; dana.mctigue@osumc.edu	Popovich, Phillip/C-9187-2009	Popovich, Phillip/0000-0003-1329-7395				Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; Dziedzic T, 2007, J NEUROL SCI, V252, P53, DOI 10.1016/j.jns.2006.10.007; GRIS D, 2008, EXP NEUROL; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; McColl BW, 2009, NEUROSCIENCE, V158, P1049, DOI 10.1016/j.neuroscience.2008.08.019; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Teeling JL, 2009, NEUROSCIENCE, V158, P1062, DOI 10.1016/j.neuroscience.2008.07.031	15	49	49	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2009	15	7					736	737		10.1038/nm0709-736	http://dx.doi.org/10.1038/nm0709-736			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19584863				2022-12-25	WOS:000267806900024
J	Rice, BW; Contag, CH				Rice, Bradley W.; Contag, Christopher H.			The importance of being red	NATURE BIOTECHNOLOGY			English	Editorial Material							GREEN FLUORESCENT PROTEIN; GENE-EXPRESSION; MARKER; TISSUE		[Rice, Bradley W.] Caliper Life Sci, Alameda, CA USA; [Contag, Christopher H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Program Photomed, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Program Mol Imaging, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Rice, BW (corresponding author), Caliper Life Sci, Alameda, CA USA.	ccontag@stanford.edu		Contag, Christopher/0000-0002-1011-8278				CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chishima T, 1997, CANCER RES, V57, P2042; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Rasmussen JC, 2009, CURR OPIN BIOTECH, V20, P74, DOI 10.1016/j.copbio.2009.01.009; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Takada T, 1997, NAT BIOTECHNOL, V15, P458, DOI 10.1038/nbt0597-458; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Zacharakis G, 2006, MOL IMAGING, V5, P153, DOI 10.2310/7290.2006.00018; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	12	25	25	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2009	27	7					624	625		10.1038/nbt0709-624	http://dx.doi.org/10.1038/nbt0709-624			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	469OF	19587667				2022-12-25	WOS:000267908500018
J	Ghezzi, D; Goffrini, P; Uziel, G; Horvath, R; Klopstock, T; Lochmuller, H; D'Adamo, P; Gasparini, P; Strom, TM; Prokisch, H; Invernizzi, F; Ferrero, I; Zeviani, M				Ghezzi, Daniele; Goffrini, Paola; Uziel, Graziella; Horvath, Rita; Klopstock, Thomas; Lochmueller, Hanns; D'Adamo, Pio; Gasparini, Paolo; Strom, Tim M.; Prokisch, Holger; Invernizzi, Federica; Ferrero, Ileana; Zeviani, Massimo			SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy	NATURE GENETICS			English	Article							FLAVOPROTEIN GENE; MUTATIONS; PARAGANGLIOMA; DEFICIENCY; SUCCINATE	We report mutations in SDHAF1, encoding a new LYR-motif protein, in infantile leukoencephalopathy with defective succinate dehydrogenase (SDH, complex II). Disruption of the yeast homolog or expression of variants corresponding to human mutants caused SDH deficiency and failure of OXPHOS-dependent growth, whereas SDH activity and amount were restored in mutant fibroblasts proportionally with re-expression of the wild-type gene. SDHAF1 is the first bona fide SDH assembly factor reported in any organism.	[Ghezzi, Daniele; Invernizzi, Federica; Zeviani, Massimo] Fdn IRCCS Neurol Inst C Besta, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy; [Goffrini, Paola; Ferrero, Ileana] Univ Parma, Dept Genet Anthropol Evolut, I-43100 Parma, Italy; [Uziel, Graziella] Fdn IRCCS Neurol Inst C Besta, Dept Child Neurol, Milan, Italy; [Horvath, Rita] Univ Newcastle, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Horvath, Rita; Klopstock, Thomas; Lochmueller, Hanns] Univ Munich, Friedrich Baur Inst, Munich, Germany; [Lochmueller, Hanns] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [D'Adamo, Pio; Gasparini, Paolo] Univ Trieste, IRCCS Burlo Garofolo, Dept Med Genet, Trieste, Italy; [Strom, Tim M.; Prokisch, Holger] Helmholtz Zentrum, Inst Human Genet, Munich, Germany	University of Parma; Newcastle University - UK; University of Munich; Newcastle University - UK; IRCCS Burlo Garofolo; University of Trieste; Helmholtz Association	Zeviani, M (corresponding author), Fdn IRCCS Neurol Inst C Besta, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy.	zeviani@istituto-besta.it	Prokisch, Holger/N-8964-2013; Ghezzi, Daniele/J-7873-2016; Horvath, Rita/AAY-7042-2020; d'Adamo, Adamo Pio/G-4064-2011; Gasparini, Paolo/B-6173-2014; Invernizzi, Federica/J-9849-2016; Goffrini, Paola/C-3860-2015; Zeviani, Massimo/AAU-2632-2021; Zeviani, Massimo/K-2891-2014	Ghezzi, Daniele/0000-0002-6564-3766; d'Adamo, Adamo Pio/0000-0001-9367-4909; Invernizzi, Federica/0000-0001-8072-0152; Goffrini, Paola/0000-0002-8650-4765; Zeviani, Massimo/0000-0002-9067-5508; Prokisch, Holger/0000-0003-2379-6286; Lochmuller, Hanns/0000-0003-2324-8001; Gasparini, Paolo/0000-0002-0859-0856; Horvath, Rita/0000-0002-9841-170X	Pierfranco and Luisa Mariani Foundation Italy; Fondazione Telethon-Italy [GGP07019]; Italian Ministry of University and Research [RBLA038RMA]; Impulse and Networking Fund of the Helmholtz Alliance for Mental Health in an Ageing Society [HA-215]; Deutsche Forschungsgemeinschaft [HO 2505/ 2-1]; MIUR [2006069034_ 003]; German ministry of education and research (BMBF, Bonn, Germany) [01GM0862]; Medical Research Council [G0601943B] Funding Source: researchfish	Pierfranco and Luisa Mariani Foundation Italy; Fondazione Telethon-Italy(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Impulse and Networking Fund of the Helmholtz Alliance for Mental Health in an Ageing Society; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MIUR(Ministry of Education, Universities and Research (MIUR)); German ministry of education and research (BMBF, Bonn, Germany)(Federal Ministry of Education & Research (BMBF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Pierfranco and Luisa Mariani Foundation Italy, Fondazione Telethon-Italy grant number GGP07019, the Italian Ministry of University and Research (FIRB 2003-project RBLA038RMA), The Impulse and Networking Fund of the Helmholtz Alliance for Mental Health in an Ageing Society, HA-215, Deutsche Forschungsgemeinschaft HO 2505/ 2-1 and MIUR grant 2006069034_ 003. T. K. and H. P. are members of the German network for mitochondrial disorders (mitoNET, 01GM0862), funded by the German ministry of education and research (BMBF, Bonn, Germany).	Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brockmann K, 2002, ANN NEUROL, V52, P38, DOI 10.1002/ana.10232; Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001; Cardol P, 2004, BBA-BIOENERGETICS, V1658, P212, DOI 10.1016/j.bbabio.2004.06.001; Klanner C, 2000, FEBS LETT, V470, P365, DOI 10.1016/S0014-5793(00)01322-3; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Van Coster R, 2003, AM J MED GENET A, V120A, P13, DOI 10.1002/ajmg.a.10202; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Ye Z, 2000, BIOCHEM BIOPH RES CO, V275, P223, DOI 10.1006/bbrc.2000.3282	15	177	187	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					654	656		10.1038/ng.378	http://dx.doi.org/10.1038/ng.378			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19465911				2022-12-25	WOS:000266411700013
J	Carver, BS; Tran, J; Gopalan, A; Chen, Z; Shaikh, S; Carracedo, A; Alimonti, A; Nardella, C; Varmeh, S; Scardino, PT; Cordon-Cardo, C; Gerald, W; Pandolfi, PP				Carver, Brett S.; Tran, Jennifer; Gopalan, Anuradha; Chen, Zhenbang; Shaikh, Safa; Carracedo, Arkaitz; Alimonti, Andrea; Nardella, Caterina; Varmeh, Shohreh; Scardino, Peter T.; Cordon-Cardo, Carlos; Gerald, William; Pandolfi, Pier Paolo			Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate	NATURE GENETICS			English	Article							GENE FUSIONS; INTRAEPITHELIAL NEOPLASIA; TUMORIGENESIS; SUPPRESSION; MIGRATION; INVASION; TMPRSS2; CXCR4; CELLS	Chromosomal translocations involving the ERG locus are frequent events in human prostate cancer pathogenesis; however, the biological role of aberrant ERG expression is controversial(1). Here we show that aberrant expression of ERG is a progression event in prostate tumorigenesis. We find that prostate cancer specimens containing the TMPRSS2-ERG rearrangement are significantly enriched for loss of the tumor suppressor PTEN. In concordance with these findings, transgenic overexpression of ERG in mouse prostate tissue promotes marked acceleration and progression of high-grade prostatic intraepithelial neoplasia ( HGPIN) to prostatic adenocarcinoma in a Pten heterozygous background. In vitro overexpression of ERG promotes cell migration, a property necessary for tumorigenesis, without affecting proliferation. ADAMTS1 and CXCR4, two candidate genes strongly associated with cell migration, were upregulated in the presence of ERG overexpression. Thus, ERG has a distinct role in prostate cancer progression and cooperates with PTEN haploinsufficiency to promote progression of HGPIN to invasive adenocarcinoma.	[Carver, Brett S.; Tran, Jennifer; Chen, Zhenbang; Carracedo, Arkaitz; Alimonti, Andrea; Nardella, Caterina; Varmeh, Shohreh; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; [Carver, Brett S.; Shaikh, Safa; Scardino, Peter T.] Mem Sloan Kettering Canc Ctr, Div Urol, Dept Surg, New York, NY USA; [Gopalan, Anuradha; Gerald, William; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA; [Chen, Zhenbang; Carracedo, Arkaitz; Alimonti, Andrea; Nardella, Caterina; Varmeh, Shohreh; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol & Med,Canc Genet Program, Boston, MA 02215 USA; [Cordon-Cardo, Carlos] Columbia Univ, Dept Pathol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Columbia University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011; Alimonti, Andrea/J-4150-2012	Carracedo, Arkaitz/0000-0001-5957-1260; Alimonti, Andrea/0000-0002-9362-2313; Nardella, Caterina/0000-0002-1901-7916	US National Institutes of Health [R01-CA82328, R01-CA84292, P50-CA92629]; Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE [P50CA092629, R01CA082328, U01CA084292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD004038] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We are grateful to all members of the Pandolfi laboratory and C. Sawyers and his group for stimulating discussions regarding our study project. We thank P. Romanienko and W. Mark from our genetically engineered mouse core facility for their assistance in generating and genotyping our prostate-specific ERG mouse model. We also thank S. Hayward (Vanderbilt-Ingram Cancer Center) for providing us with the BPH-1 cells used for our experiments, R. Lester at our animal facility for caring for our mice on a daily basis and L. DiSantis for her editorial support. This work was funded through grants from the US National Institutes of Health (R01-CA82328, R01-CA84292, P50-CA92629) and Memorial Sloan Kettering Cancer Center Research in Therapeutics Program in Prostate Cancer award to B. S. C. and P. P. P.	Arya M, 2007, TUMOR BIOL, V28, P123, DOI 10.1159/000102979; Arya Manit, 2004, J Exp Ther Oncol, V4, P291; Bettendorf O, 2008, GENE CHROMOSOME CANC, V47, P565, DOI 10.1002/gcc.20560; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; Hart CA, 2005, BRIT J CANCER, V92, P503, DOI 10.1038/sj.bjc.6602325; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hermans KG, 2008, CANCER RES, V68, P3094, DOI 10.1158/0008-5472.CAN-08-0198; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Krampert M, 2005, J BIOL CHEM, V280, P23844, DOI 10.1074/jbc.M412212200; Leversha MA, 2001, METH MOL B, V175, P109; Maroni P, 2007, CARCINOGENESIS, V28, P267, DOI 10.1093/carcin/bgl129; Mosquera JM, 2008, CLIN CANCER RES, V14, P3380, DOI 10.1158/1078-0432.CCR-07-5194; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tu JJ, 2007, MODERN PATHOL, V20, P921, DOI 10.1038/modpathol.3800903; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; XING Y, 2008, CANCER BIOL THER, V7, P1840; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96	26	483	492	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					619	624		10.1038/ng.370	http://dx.doi.org/10.1038/ng.370			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19396168	Green Accepted			2022-12-25	WOS:000265575600026
J	Huang, J; Huen, MSY; Kim, H; Leung, CCY; Glover, JNM; Yu, XC; Chen, JJ				Huang, Jun; Huen, Michael S. Y.; Kim, Hongtae; Leung, Charles Chung Yun; Glover, J. N. Mark; Yu, Xiaochun; Chen, Junjie			RAD18 transmits DNA damage signalling to elicit homologous recombination repair	NATURE CELL BIOLOGY			English	Article							DEFECTIVE POSTREPLICATION REPAIR; DOUBLE-STRAND BREAKS; ONCOGENIC TRANSLOCATIONS; UBIQUITIN STRUCTURES; GENOMIC INSTABILITY; RAD51L2 RAD51C; PROTEIN; BRCA1; CHECKPOINT; CELLS	To maintain genome stability, cells respond to DNA damage by activating signalling pathways that govern cell-cycle checkpoints and initiate DNA repair. Cell-cycle checkpoint controls should connect with DNA repair processes, however, exactly how such coordination occurs in vivo is largely unknown. Here we describe a new role for the E3 ligase RAD18 as the integral component in translating the damage response signal to orchestrate homologous recombination repair (HRR). We show that RAD18 promotes homologous recombination in a manner strictly dependent on its ability to be recruited to sites of DNA breaks and that this recruitment relies on a well-defined DNA damage signalling pathway mediated by another E3 ligase, RNF8. We further demonstrate that RAD18 functions as an adaptor to facilitate homologous recombination through direct interaction with the recombinase RAD51C. Together, our data uncovers RAD18 as a key factor that orchestrates HRR through surveillance of the DNA damage signal.	[Huang, Jun; Huen, Michael S. Y.; Kim, Hongtae; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Leung, Charles Chung Yun; Glover, J. N. Mark] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	Yale University; University of Alberta	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	Junjie.chen@yale.edu	Huen, Michael Shing Yan/E-9862-2010		National Institutes of Health; Anna Fuller Fund Fellowship; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA130899, R01CA132755, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna Fuller Fund Fellowship; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Shiomi for HCT116 RAD18<SUP>-/-</SUP> cells, M. Yamaizumi for RAD18<SUP>-/-</SUP> MEFs, S. Akira for UBC13-deficient cells, H. Nagasawa for IRS3 and V79 cells, M. Jasin for U2OS cells with DR-GFP integration and pCBASce plasmids, B. P. Chen for NU7441 and J. Groenendyk for helping with the BIAcore system. J. C would like to thank all colleagues for discussions and technical assistance, and J. Wood for proofreading. This work was supported by grants from the National Institutes of Health to J. C., M. S. Y. H. is supported by the Anna Fuller Fund Fellowship and J. C. is a recipient of an Era of Hope Scholar award from the Department of Defense ( a member of the Mayo Clinic Breast SPORE program).	Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hinz JM, 2003, CARCINOGENESIS, V24, P249, DOI 10.1093/carcin/24.2.249; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Lukas J, 2004, CELL, V118, P666, DOI 10.1016/j.cell.2004.09.006; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Petrini JHJ, 2007, SCIENCE, V316, P1138, DOI 10.1126/science.1143700; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Reynolds J, 2004, NAT CELL BIOL, V6, P184, DOI 10.1038/ncb0304-184a; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yoshimura A, 2006, DNA REPAIR, V5, P1307, DOI 10.1016/j.dnarep.2006.05.045; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	53	217	227	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					592	U155		10.1038/ncb1865	http://dx.doi.org/10.1038/ncb1865			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19396164	Green Accepted			2022-12-25	WOS:000265640000018
J	Willand, N; Dirie, B; Carette, X; Bifani, P; Singhal, A; Desroses, M; Leroux, F; Willery, E; Mathys, V; Deprez-Poulain, R; Delcroix, G; Frenois, F; Aumercier, M; Locht, C; Villeret, V; Deprez, B; Baulard, AR				Willand, Nicolas; Dirie, Bertrand; Carette, Xavier; Bifani, Pablo; Singhal, Amit; Desroses, Matthieu; Leroux, Florence; Willery, Eve; Mathys, Vanessa; Deprez-Poulain, Rebecca; Delcroix, Guy; Frenois, Frederic; Aumercier, Marc; Locht, Camille; Villeret, Vincent; Deprez, Benoit; Baulard, Alain R.			Synthetic EthR inhibitors boost antituberculous activity of ethionamide	NATURE MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; MOLECULAR-PROPERTIES; DRUG; ACTIVATION; REPRESSOR; PHARMACOKINETICS; THIACETAZONE; PYRAZINAMIDE; INFECTION	The side effects associated with tuberculosis therapy bring with them the risk of noncompliance and subsequent drug resistance. Increasing the therapeutic index of antituberculosis drugs should thus improve treatment effectiveness. Several antituberculosis compounds require in situ metabolic activation to become inhibitory. Various thiocarbamide-containing drugs, including ethionamide, are activated by the mycobacterial monooxygenase EthA, the production of which is controlled by the transcriptional repressor EthR. Here we identify drug-like inhibitors of EthR that boost the bioactivation of ethionamide. Compounds designed and screened for their capacity to inhibit EthR-DNA interaction were co-crystallized with EthR. We exploited the three-dimensional structures of the complexes for the synthesis of improved analogs that boosted the ethionamide potency in culture more than tenfold. In Mycobacterium tuberculosis-infected mice, one of these analogs, BDM31343, enabled a substantially reduced dose of ethionamide to lessen the mycobacterial load as efficiently as the conventional higher-dose treatment. This provides proof of concept that inhibiting EthR improves the therapeutic index of thiocarbamide derivatives, which should prompt reconsideration of their use as first-line drugs.	[Willand, Nicolas; Dirie, Bertrand; Carette, Xavier; Desroses, Matthieu; Leroux, Florence; Willery, Eve; Deprez-Poulain, Rebecca; Delcroix, Guy; Frenois, Frederic; Aumercier, Marc; Locht, Camille; Villeret, Vincent; Deprez, Benoit; Baulard, Alain R.] Inst Pasteur, Lille, France; [Willand, Nicolas; Dirie, Bertrand; Desroses, Matthieu; Leroux, Florence; Deprez-Poulain, Rebecca; Deprez, Benoit] INSERM, U761, F-59045 Lille, France; [Willand, Nicolas; Dirie, Bertrand; Desroses, Matthieu; Leroux, Florence; Deprez-Poulain, Rebecca; Deprez, Benoit] Univ Lille Nord France, Fac Pharm Lille, Lille, France; [Willand, Nicolas; Dirie, Bertrand; Carette, Xavier; Desroses, Matthieu; Leroux, Florence; Willery, Eve; Deprez-Poulain, Rebecca; Frenois, Frederic; Aumercier, Marc; Locht, Camille; Villeret, Vincent; Deprez, Benoit; Baulard, Alain R.] Inst Federat Rech 142 Mol & Cellular Med, Lille, France; [Willand, Nicolas; Carette, Xavier; Desroses, Matthieu; Leroux, Florence; Willery, Eve; Deprez-Poulain, Rebecca; Deprez, Benoit; Baulard, Alain R.] Pole Rech Interdisciplinaire Medicament, Lille, France; [Carette, Xavier; Willery, Eve; Locht, Camille; Baulard, Alain R.] INSERM, U629, F-59045 Lille, France; [Bifani, Pablo; Singhal, Amit; Mathys, Vanessa] Inst Pasteur, Brussels, Belgium; [Frenois, Frederic; Aumercier, Marc; Villeret, Vincent] Univ Lille Nord France, CNRS, UMR 8161, Inst Pasteur Lille, Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Baulard, AR (corresponding author), Inst Pasteur, Lille, France.	alain.baulard@pasteur-lille.fr	Locht, Camille/L-3516-2018; nicolas, Willand/A-5322-2012; deprez, benoit/G-6749-2012; Deprez-Poulain, Rebecca/A-5444-2015; Baulard, Alain R/E-6830-2017; Leroux, Florence/R-8155-2017; Willand, Pr Nicolas/A-5653-2019	deprez, benoit/0000-0002-2777-4538; Deprez-Poulain, Rebecca/0000-0002-3318-5297; Baulard, Alain R/0000-0002-0150-5241; Leroux, Florence/0000-0003-0554-873X; Willand, Pr Nicolas/0000-0002-0784-0462; Singhal, Amit/0000-0003-3913-8798; Aumercier, Marc/0000-0002-0370-3452; Desroses, Matthieu/0000-0003-4152-3855; Villeret, Vincent/0000-0003-4504-056X; Carette, Xavier/0000-0003-4490-5752; Bifani, Pablo/0000-0001-9651-6439; Locht, Camille/0000-0001-7295-7336	INSERM; Universite de Lille 2 Droit et Sante; Institut Pasteur de Lille; CNRS; Region Nord-Pas de Calais; Ministere delegue a la Recherche et aux Nouvelles Technologies; European Union [FEDER OBJ2-4.1-2006/3-n1297/9360]; l'Agence Nationale de la Recherche, France [ANR-06-EMPB-033]; Ministere de la Recherche; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Lille 2 Droit et Sante; Institut Pasteur de Lille; CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Ministere delegue a la Recherche et aux Nouvelles Technologies; European Union(European Commission); l'Agence Nationale de la Recherche, France(French National Research Agency (ANR)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are indebted to G. Mahieu for his invaluable help with the synergistic experiments on M. tuberculosis, P. Rucktooa for crystal structure acquisitions and manipulations, F. Demirkaya for technical support, M. Flipo for support in chemical synthesis, M. Cynamon for sharing experimental data about ethionamide sensitivity in mice and S. Delaroche for data formatting. We thank H. Gras for critical reading of the manuscript and F. Jean, C. Desruelle and V. Dewailly for grants management. Nuclear magnetic resonance spectra acquisitions were done at the Laboratoire d'Application de Resonance Magnetique Nucleaire, Lille. This work was supported by INSERM, Universite de Lille 2 Droit et Sante, Institut Pasteur de Lille, CNRS, the Region Nord-Pas de Calais, Ministere delegue a la Recherche et aux Nouvelles Technologies and the European Union (FEDER OBJ2-4.1-2006/3-n1297/9360), l'Agence Nationale de la Recherche, France (ANR-06-EMPB-033). We are indebted to the European Synchrotron Radiation Facility for beam-time allocation (through the Block Allocation Group BAG MX-485) for this project. X. C. is a recipient of a doctoral fellowship from Institut Pasteur de Lille and the Region Nord-Pas de Calais. B. D. is a recipient of a doctoral fellowship of the Ministere de la Recherche. M. A. and V. V. are researchers from the CNRS.	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baulard AR, 2000, J BIOL CHEM, V275, P28326; Boshoff HIM, 2000, J BACTERIOL, V182, P5479, DOI 10.1128/JB.182.19.5479-5485.2000; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Dover LG, 2004, J MOL BIOL, V340, P1095, DOI 10.1016/j.jmb.2004.06.003; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Fajardo TT, 2006, AM J TROP MED HYG, V74, P457, DOI 10.4269/ajtmh.2006.74.457; Frenois F, 2006, TUBERCULOSIS, V86, P110, DOI 10.1016/j.tube.2005.07.005; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; HASTINGS R C, 1988, Clinical Microbiology Reviews, V1, P330; HOLDINESS MR, 1987, MED TOXICOL ADV DRUG, V2, P33, DOI 10.1007/BF03259859; HOLDINESS MR, 1984, CLIN PHARMACOKINET, V9, P511, DOI 10.2165/00003088-198409060-00003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kasim NA, 2004, MOL PHARMACEUT, V1, P85, DOI 10.1021/mp034006h; Kordulakova J, 2007, ANTIMICROB AGENTS CH, V51, P3824, DOI 10.1128/AAC.00433-07; LEES AW, 1964, CHEST, V45, P247; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Qian L, 2006, CHEM RES TOXICOL, V19, P443, DOI 10.1021/tx050328b; Schaaf HS, 2007, EUR J CLIN MICROBIOL, V26, P203, DOI 10.1007/s10096-007-0257-9; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Tomioka H, 2006, CURR PHARM DESIGN, V12, P4047, DOI 10.2174/138161206778743646; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Vieth M, 2004, J MED CHEM, V47, P224, DOI 10.1021/jm030267j; WEINSTEIN HJ, 1962, AM REV RESPIR DIS, V86, P576; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WILSON TM, 1995, MOL MICROBIOL, V15, P1009, DOI 10.1111/j.1365-2958.1995.tb02276.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; ZHANG Y, 2005, MYCOBACTERIUM TUBERC, P115; Zhu M, 2002, TUBERCULOSIS, V82, P91, DOI 10.1054/tube.2002.0330	41	136	146	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2009	15	5					537	544		10.1038/nm.1950	http://dx.doi.org/10.1038/nm.1950			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19412174				2022-12-25	WOS:000265889300032
J	Ross, CJD; Katzov-Eckert, H; Dube, MP; Brooks, B; Rassekh, SR; Barhdadi, A; Feroz-Zada, Y; Visscher, H; Brown, AMK; Rieder, MJ; Rogers, PC; Phillips, MS; Carleton, BC; Hayden, MR				Ross, Colin J. D.; Katzov-Eckert, Hagit; Dube, Marie-Pierre; Brooks, Beth; Rassekh, S. Rod; Barhdadi, Amina; Feroz-Zada, Yassamin; Visscher, Henk; Brown, Andrew M. K.; Rieder, Michael J.; Rogers, Paul C.; Phillips, Michael S.; Carleton, Bruce C.; Hayden, Michael R.		CPNDS Consortium	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy	NATURE GENETICS			English	Article							CATECHOL-O-METHYLTRANSFERASE; INDIVIDUAL SENSITIVITY; OTOTOXICITY; MERCAPTOPURINE; POLYMORPHISMS; THERAPY; PHARMACOGENOMICS	Cisplatin is a widely used and effective chemotherapeutic agent, although its use is restricted by the high incidence of irreversible ototoxicity associated with it(1). In children, cisplatin ototoxicity is a serious and pervasive problem, affecting more than 60% of those receiving cisplatin(2-5) and compromising language and cognitive development. Candidate gene studies have previously reported associations of cisplatin ototoxicity with genetic variants in the genes encoding glutathione S-transferases and megalin(6-8). We report association analyses for 220 drug-metabolism genes in genetic susceptibility to cisplatin-induced hearing loss in children. We genotyped 1,949 SNPs in these candidate genes in an initial cohort of 54 children treated in pediatric oncology units, with replication in a second cohort of 112 children recruited through a national surveillance network for adverse drug reactions in Canada. We identified genetic variants in TPMT (rs12201199, P value = 0.00022, OR = 17.0, 95% CI 2.3-125.9) and COMT (rs9332377, P value = 0.00018, OR = 5.5, 95% CI 1.9-15.9) associated with cisplatin-induced hearing loss in children.	[Ross, Colin J. D.; Katzov-Eckert, Hagit; Visscher, Henk; Hayden, Michael R.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; [Ross, Colin J. D.; Katzov-Eckert, Hagit; Visscher, Henk; Carleton, Bruce C.; Hayden, Michael R.] Childrens & Womens Hlth Res Ctr British Columbia, Child & Family Res Inst, Vancouver, BC, Canada; [Dube, Marie-Pierre; Barhdadi, Amina; Feroz-Zada, Yassamin; Brown, Andrew M. K.; Phillips, Michael S.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Dube, Marie-Pierre; Barhdadi, Amina; Feroz-Zada, Yassamin; Brown, Andrew M. K.; Phillips, Michael S.] Univ Montreal, Montreal, PQ, Canada; [Brooks, Beth] British Columbia Childrens Hosp, Dept Speech Pathol & Audiol, Vancouver, BC V6H 3V4, Canada; [Rassekh, S. Rod; Rogers, Paul C.] British Columbia Childrens Hosp, Dept Pediat, Div Pediat Hematol Oncol Bone & Marrow Tranplant, Vancouver, BC V6H 3V4, Canada; [Brown, Andrew M. K.; Phillips, Michael S.] Genome Quebec Pharmacogenom Ctr, Montreal, PQ, Canada; [Rieder, Michael J.] Childrens Hosp, Dept Paediat, London Hlth Sci Ctr, London, England; [Carleton, Bruce C.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Carleton, Bruce C.] Univ British Columbia, Dept Paediat, Pharmaceut Outcomes Programme, Vancouver, BC, Canada	University of British Columbia; Child & Family Research Institute; Universite de Montreal; Universite de Montreal; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of British Columbia	Hayden, MR (corresponding author), Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada.	mrh@cmmt.ubc.ca	Rassekh, Shahrad Rod/G-5301-2010; Dubé, Marie-Pierre/B-9364-2008; Rogers, Paul/AAV-6876-2021; Rieder, Michael J/L-2397-2013; Hayden, Michael R/D-8581-2011; Visscher, Henk/B-5442-2013	Rassekh, Shahrad Rod/0000-0001-8005-2641; Dubé, Marie-Pierre/0000-0001-8442-4393; Rogers, Paul/0000-0002-1182-9231; Hayden, Michael R/0000-0001-5159-1419; Wasserman, Wyeth/0000-0001-6098-6412; Carleton, Bruce/0000-0002-4485-4054; Visscher, Henk/0000-0001-8407-2893; Ross, Colin/0000-0003-1476-7037	Genome Canada; Genome British Columbia; Child and Family Research Institute; University of British Columbia Faculty of Pharmaceutical Sciences; Canadian Institutes of Health Research; Canada Foundation for Innovation; Canada Gene Cure Foundation; Canadian Society of Clinical Pharmacology; BC Clinical Genomics Network; C17 Research Network and Childhood Cancer Foundation Candlelighters Canada; Michael Smith Foundation for Health Research, Health Canada, Pfizer, Eli Lilly, Merck Frosst and Janssen-Ortho; Genome Canada Applied Health Research Program	Genome Canada(Genome Canada); Genome British Columbia; Child and Family Research Institute; University of British Columbia Faculty of Pharmaceutical Sciences; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Gene Cure Foundation; Canadian Society of Clinical Pharmacology; BC Clinical Genomics Network; C17 Research Network and Childhood Cancer Foundation Candlelighters Canada; Michael Smith Foundation for Health Research, Health Canada, Pfizer, Eli Lilly, Merck Frosst and Janssen-Ortho(Eli LillyMichael Smith Foundation for Health ResearchPfizer); Genome Canada Applied Health Research Program(Genome Canada)	We especially want to acknowledge the study participants and their families for their participation in the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) network; this work could not have been done without your help and support. We also want to acknowledge the support of the CPNDS active ADR surveillance consortium, as well as S. Langlois and B. Casey (Supplementary Note). The study was funded by Genome Canada, and additional funding was also provided by Genome British Columbia, Child and Family Research Institute, University of British Columbia Faculty of Pharmaceutical Sciences, Canadian Institutes of Health Research, Canada Foundation for Innovation, Canada Gene Cure Foundation, Canadian Society of Clinical Pharmacology, BC Clinical Genomics Network, C17 Research Network and Childhood Cancer Foundation Candlelighters Canada, Michael Smith Foundation for Health Research, Health Canada, Pfizer, Eli Lilly, Merck Frosst and Janssen-Ortho. This work was funded as part of the peer-reviewed Genome Canada Applied Health Research Program; the pharmaceutical industry partners had no formal or informal role in this program of research.	Ahmed ZM, 2008, NAT GENET, V40, P1335, DOI 10.1038/ng.245; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; BLAKLEY BW, 1994, ARCH OTOLARYNGOL, V120, P541; BROCK P, 1991, BRIT J CANCER, V63, P159, DOI 10.1038/bjc.1991.35; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Coradini PP, 2007, J PEDIAT HEMATOL ONC, V29, P355, DOI 10.1097/MPH.0b013e318059c220; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Du X, 2008, P NATL ACAD SCI USA, V105, P14609, DOI 10.1073/pnas.0807219105; Ekborn A, 2000, HEARING RES, V140, P38, DOI 10.1016/S0378-5955(99)00190-2; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Knight KRG, 2005, J CLIN ONCOL, V23, P8588, DOI 10.1200/JCO.2004.00.5355; KRYNETSKI EY, 1995, MOL PHARMACOL, V47, P1141; Kushner BH, 2006, CANCER-AM CANCER SOC, V107, P417, DOI 10.1002/cncr.22004; Li Y, 2004, EUR J CANCER, V40, P2445, DOI 10.1016/j.ejca.2003.08.009; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nelson MR, 2009, PHARMACOGENOMICS J, V9, P23, DOI 10.1038/tpj.2008.4; Ochoa B, 2009, ARCH MED RES, V40, P54, DOI 10.1016/j.arcmed.2008.10.006; Oldenburg J, 2007, J CLIN ONCOL, V25, P708, DOI 10.1200/JCO.2006.08.9599; Peters U, 2000, ANTI-CANCER DRUG, V11, P639, DOI 10.1097/00001813-200009000-00007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Riedemann L, 2008, PHARMACOGENOMICS J, V8, P23, DOI 10.1038/sj.tpj.6500455; Ross CJD, 2007, ANN NY ACAD SCI, V1110, P177, DOI 10.1196/annals.1423.020; Shord SS, 2006, ANTI-CANCER DRUG, V17, P207, DOI 10.1097/00001813-200602000-00013; Ujiie S, 2008, PHARMACOGENET GENOM, V18, P887, DOI 10.1097/FPC.0b013e3283097328; VISSCHER H, 2009, PHARMACOGENOMIC 0804, DOI DOI 10.1038/TPJ.2009.36; Weinshilboum RM, 2006, CELL MOL NEUROBIOL, V26, P539, DOI 10.1007/s10571-006-9095-z; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003	33	224	240	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1345	U118		10.1038/ng.478	http://dx.doi.org/10.1038/ng.478			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19898482				2022-12-25	WOS:000272144900019
J	Wilcox, AJ; Laney, JD				Wilcox, Alexander J.; Laney, Jeffrey D.			A ubiquitin-selective AAA-ATPase mediates transcriptional switching by remodelling a repressor-promoter DNA complex	NATURE CELL BIOLOGY			English	Article							YEAST MAT-ALPHA-2 REPRESSOR; SACCHAROMYCES-CEREVISIAE; IN-VIVO; MCM1 PROTEIN; LIVING CELLS; DEGRADATION; ALPHA-2; REGULATOR; HOMEODOMAIN; PROTEASOME	Switches between different phenotypes and their underlying states of gene transcription occur as cells respond to intrinsic developmental cues or adapt to changing environmental conditions. Post-translational modification of the master regulatory transcription factors that define the initial phenotype is a common strategy to direct such transitions. Emerging evidence indicates that the modification of key transcription factors by the small polypeptide ubiquitin has a central role in many of these transitions(1,2). However, the molecular mechanisms by which ubiquitylation regulates the switching of promoters between active and inactive states are largely unknown. Ubiquitylation of the yeast transcriptional repressor alpha(2) is necessary to evoke the transition between mating-types(3), and here we dissect the impact of this modification on alpha(2) dynamics at its target promoters. Ubiquitylation of alpha(2) does not alter DNA occupancy by depleting the existing pool of the transcription factor, despite its well-characterized function in directing repressor turnover. Rather, alpha(2) ubiquitylation has a direct role in the rapid removal of the repressor from its DNA targets. This disassembly of alpha(2) from DNA depends on the ubiquitin-selective AAA-ATPase Cdc48. Our findings expand the functional targets of Cdc48 to include active transcriptional regulatory complexes in the nucleus. These data reveal an ubiquitin-dependent extraction pathway for dismantling transcription factor-DNA complexes and provide an archetype for the regulation of transcriptional switching events by ubiquitylation.	[Wilcox, Alexander J.; Laney, Jeffrey D.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Laney, JD (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box G-L2, Providence, RI 02912 USA.	jeffrey_laney@brown.edu		Wilcox, Allen/0000-0002-3376-1311	National Institutes of Health [GM71764]; March of Dimes; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Y. Xie and M. Hochstrasser for sharing data and reagents in advance of publication, for providing strains and plasmids and for many discussions. We thank R. Hampton and S. Jentsch for providing strains, R. Whitaker and R. Reenan for the sequencing of cdc48 alleles, J. Mead and D. Vershon for the His-tagged alpha 2 construct, S. Gregory and A. Dahlberg for their help with the footprinting experiments, and T. Serio for numerous discussions. Our ideas were also shaped by discussions with K. Wilkinson and R. Deshaies. The manuscript was improved by comments from T. Serio, J. Bender, Y. Xie, M. Hochstrasser, R. Reenan and A. DeSimone. This work was supported by a grant from the National Institutes of Health (GM71764 to J. D. L.) and by a Basil O'Connor Starter Scholar Research Award from the March of Dimes.	ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Dennis AP, 2005, J STEROID BIOCHEM, V93, P139, DOI 10.1016/j.jsbmb.2004.12.015; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; DESHAIES R, 1995, CURR OPIN CELL BIOL, V7, P781, DOI 10.1016/0955-0674(95)80061-1; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; GANTER B, 1993, J MOL BIOL, V234, P975, DOI 10.1006/jmbi.1993.1652; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gregory PD, 1998, METHODS, V15, P295, DOI 10.1006/meth.1998.0633; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; Laney JD, 2006, MOL CELL BIOL, V26, P371, DOI 10.1128/MCB.26.1.371-380.2006; Laney JD, 2003, GENE DEV, V17, P2259, DOI 10.1101/gad.1115703; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mead J, 1996, MOL CELL BIOL, V16, P2135; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; RICHTERRUOFF B, 1994, FEBS LETT, V354, P50, DOI 10.1016/0014-5793(94)01085-4; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; VERSHON AK, 1993, CELL, V72, P105, DOI 10.1016/0092-8674(93)90054-T; VERSHON AK, 1995, GENE DEV, V9, P182, DOI 10.1101/gad.9.2.182; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhong HL, 1999, GENOME RES, V9, P1040, DOI 10.1101/gr.9.11.1040; Zhong HL, 1997, J BIOL CHEM, V272, P8402, DOI 10.1074/jbc.272.13.8402	41	51	52	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1481	U218		10.1038/ncb1997	http://dx.doi.org/10.1038/ncb1997			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19915556	Green Accepted			2022-12-25	WOS:000272251300016
J	Chan, EM; Ratanasirintrawoot, S; Park, IH; Manos, PD; Loh, YH; Huo, HG; Miller, JD; Hartung, O; Rho, J; Ince, TA; Daley, GQ; Schlaeger, TM				Chan, Elayne M.; Ratanasirintrawoot, Sutheera; Park, In-Hyun; Manos, Philip D.; Loh, Yuin-Han; Huo, Hongguang; Miller, Justine D.; Hartung, Odelya; Rho, Junsung; Ince, Tan A.; Daley, George Q.; Schlaeger, Thorsten M.			Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; GENERATION; FIBROBLASTS; EXPRESSION; SYSTEM	Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells by enforced expression of transcription factors. Using serial live imaging of human fibroblasts undergoing reprogramming, we identified distinct colony types that morphologically resemble embryonic stem (ES) cells yet differ in molecular phenotype and differentiation potential. By analyzing expression of pluripotency markers, methylation at the OCT4 and NANOG promoters and differentiation into teratomas, we determined that only one colony type represents true iPS cells, whereas the others represent reprogramming intermediates. Proviral silencing and expression of TRA-1-60, DNMT3B and REX1 can be used to distinguish the fully reprogrammed state, whereas alkaline phosphatase, SSEA-4, GDF3, hTERT and NANOG are insufficient as markers. We also show that reprogramming using chemically defined medium favors formation of fully reprogrammed over partially reprogrammed colonies. Our data define molecular markers of the fully reprogrammed state and highlight the need for rigorous characterization and standardization of putative iPS cells.	[Chan, Elayne M.; Ratanasirintrawoot, Sutheera; Park, In-Hyun; Manos, Philip D.; Loh, Yuin-Han; Huo, Hongguang; Miller, Justine D.; Hartung, Odelya; Rho, Junsung; Daley, George Q.; Schlaeger, Thorsten M.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Chan, Elayne M.; Ratanasirintrawoot, Sutheera; Park, In-Hyun; Manos, Philip D.; Loh, Yuin-Han; Huo, Hongguang; Miller, Justine D.; Hartung, Odelya; Rho, Junsung; Daley, George Q.; Schlaeger, Thorsten M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chan, Elayne M.; Park, In-Hyun; Loh, Yuin-Han; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ratanasirintrawoot, Sutheera; Manos, Philip D.; Huo, Hongguang; Miller, Justine D.; Hartung, Odelya; Daley, George Q.; Schlaeger, Thorsten M.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Ince, Tan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Daley, George Q.; Schlaeger, Thorsten M.] Harvard Stem Cell Inst, Cambridge, MA USA; [Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Daley, George Q.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; schlaeger@enders.tch.harvard.edu	Loh, Yuin-Han/E-1096-2014	Loh, Yuin-Han/0000-0002-4715-6454; Ince, Tan/0000-0003-0315-6425; Schlaeger, Thorsten/0000-0002-1599-9908; Ratanasirintrawoot, Sutheera/0000-0002-0641-5106	National Institutes of Health (NIH); Burroughs Wellcome Fund; Leukemia and Lymphoma Society; Harvard Stem Cell Institute; Agency of Science, Technology and Research International Fellowship; Institute of Medical Biology, Singapore; Canadian Institutes of Health Research; Breast Cancer Research Foundation, NY; Department of Defense; Congressionally Directed Medical Research Programs (CDMRPs); Breast Cancer Research Program (BCRP)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Harvard Stem Cell Institute; Agency of Science, Technology and Research International Fellowship; Institute of Medical Biology, Singapore; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Breast Cancer Research Foundation, NY; Department of Defense(United States Department of Defense); Congressionally Directed Medical Research Programs (CDMRPs)(United States Department of Defense); Breast Cancer Research Program (BCRP)	G. Q. D. was supported by grants from the National Institutes of Health (NIH), the NIH Director's Pioneer Award of the NIH Roadmap for Medical Research, and private funds contributed to the Harvard Stem Cell Institute and the Children's Hospital Stem Cell Program. G. Q. D. is a recipient of Clinical Scientist Awards in Translational Research from the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society, and is an investigator of the Howard Hughes Medical Institute. T. M. S. was supported by the Harvard Stem Cell Institute and the Children's Hospital Stem Cell Program. Y.-H. L. is funded by the Agency of Science, Technology and Research International Fellowship and the Institute of Medical Biology, Singapore. E. M. C. was funded by The Canadian Institutes of Health Research. T. A. I. was supported by Breast Cancer Research Foundation, NY, and Department of Defense, Congressionally Directed Medical Research Programs (CDMRPs) and Breast Cancer Research Program (BCRP). We thank T. Woo (BWH) for her assistance with immnuhistopathological stains of the teratoma sections.	Apati A, 2008, BBA-BIOMEMBRANES, V1778, P2700, DOI 10.1016/j.bbamem.2008.08.010; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	22	365	412	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2009	27	11					1033	U100		10.1038/nbt.1580	http://dx.doi.org/10.1038/nbt.1580			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	516EM	19826408				2022-12-25	WOS:000271524700024
J	Chen, GL; Subbarao, K				Chen, Grace L.; Subbarao, Kanta			Attacking the flu Neutralizing antibodies may lead to 'universal' vaccine	NATURE MEDICINE			English	Editorial Material							INFLUENZA-A VIRUS; AVIAN INFLUENZA; UNITED-STATES; H5N1; EPITOPE; CELLS; HEMAGGLUTININS; H1; H2	Flu remains a major killer because of imperfect vaccines and widespread resistance to existing antivirals-problems particularly acute during a pandemic. New findings at the bedside and at the bench could lead to improvements on both fronts. Grace Chen and Kanta Subbarao discuss the implications of research identifying human antibodies than can neutralize a range of viral subtypes. The findings may help lead to a 'universal' vaccine against these diverse and rapidly evolving viruses. Estanislao Nistal-Villan and Adolfo Garcia-Sastre examine two recent studies that reveal the crystal structure of a promising viral drug target, the unique endonuclease domain of the viral polymerase. The findings open the door to the rational design of new influenza virus inhibitors.	[Chen, Grace L.; Subbarao, Kanta] NIAID, Infect Dis Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chen, GL (corresponding author), NIAID, Infect Dis Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA.	ksubbarao@niaid.nih.gov		Subbarao, Kanta/0000-0003-1713-3056	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000933] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000933-06] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Smirnov YA, 1999, ACTA VIROL, V43, P237; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574	13	28	30	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2009	15	11					1251	1252		10.1038/nm1109-1251	http://dx.doi.org/10.1038/nm1109-1251			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19893556	Green Accepted			2022-12-25	WOS:000271543700011
J	Dupres, V; Alsteens, D; Wilk, S; Hansen, B; Heinisch, JJ; Dufrene, YF				Dupres, Vincent; Alsteens, David; Wilk, Sabrina; Hansen, Benjamin; Heinisch, Juergen J.; Dufrene, Yves F.			The yeast Wsc1 cell surface sensor behaves like a nanospring in vivo	NATURE CHEMICAL BIOLOGY			English	Article							ATOMIC-FORCE MICROSCOPY; SINGLE-MOLECULAR RECOGNITION; SACCHAROMYCES-CEREVISIAE; INTEGRITY; PROTEIN; RECEPTOR; DOMAINS; MID2; SPECTROSCOPY; PATHWAYS	Here we report on in vivo measurement of the mechanical behavior of a cell surface sensor using single-molecule atomic force microscopy. We focus on the yeast wall stress component sensor Wsc1, a plasma membrane protein that is thought to function as a rigid probe of the cell wall status. We first map the distribution of individual histidine-tagged sensors on living yeast cells by scanning the cell surface with atomic force microscopy tips carrying nitrilotriacetate groups. We then show that Wsc1 behaves like a linear nanospring that is capable of resisting high mechanical force and of responding to cell surface stress. Both a genomic pmt4 deletion and the insertion of a stretch of glycines in Wsc1 result in substantial alterations in protein spring properties, supporting the important role of glycosylation at the extracellular serine/threonine-rich region.	[Dupres, Vincent; Alsteens, David; Dufrene, Yves F.] Catholic Univ Louvain, Unite Chim Interfaces, B-3000 Louvain, Belgium; [Wilk, Sabrina; Hansen, Benjamin; Heinisch, Juergen J.] Univ Osnabruck, Fachbereich Biol Chem, AG Genet, D-4500 Osnabruck, Germany	Universite Catholique Louvain; University Osnabruck	Dufrene, YF (corresponding author), Catholic Univ Louvain, Unite Chim Interfaces, B-3000 Louvain, Belgium.	juergen.heinisch@biologie.uni-osnabrueck.de; yves.dufrene@uclouvain.be	Alsteens, David A/F-2669-2014; Dupres, Vincent/GLQ-5321-2022; Alsteens, David/AAU-5475-2020; Heinisch, Juergen J./G-3801-2017	Alsteens, David A/0000-0001-9229-113X; Dupres, Vincent/0000-0002-1970-3633; Alsteens, David/0000-0001-9229-113X; Dufrene, Yves/0000-0002-7289-4248	Belgian National Foundation for Scientific Research (FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Federal Office for Scientific, Technical and Cultural Affairs; Deutsche Forschungsgemeinschaft [SFB431]	Belgian National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Federal Office for Scientific, Technical and Cultural Affairs; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Belgian National Foundation for Scientific Research (FNRS), the Universite catholique de Louvain (Fonds Speciaux de Recherche), the Region wallonne, the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), and the Research Department of the Communaute francaise de Belgique (Concerted Research Action). Work at the University of Osnabruck was funded by the Deutsche Forschungsgemeinschaft within the framework of the SFB431.	Ahimou FO, 2003, YEAST, V20, P25, DOI 10.1002/yea.923; ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Dubreuil RR, 2006, J MEMBRANE BIOL, V211, P151, DOI 10.1007/s00232-006-0863-y; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Heinisch JJ, 2008, EXPERT OPIN DRUG DIS, V3, P931, DOI 10.1517/17460441.3.8.931; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Julien MA, 2007, AM J PHYSIOL-CELL PH, V292, pC517, DOI 10.1152/ajpcell.00093.2006; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; KOCH Y, 1980, CAN J MICROBIOL, V26, P965, DOI 10.1139/m80-164; Krieg M, 2008, ANGEW CHEM INT EDIT, V47, P9775, DOI 10.1002/anie.200803552; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Law R, 2003, BIOPHYS J, V85, P3286, DOI 10.1016/S0006-3495(03)74747-X; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Lodder AL, 1999, GENETICS, V152, P1487; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Piao HL, 2007, MOL BIOL CELL, V18, P57, DOI 10.1091/mbc.e06-08-0721; Powell CD, 2003, MICROBIOL-SGM, V149, P3129, DOI 10.1099/mic.0.25940-0; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rodicio R, 2008, FUNGAL GENET BIOL, V45, P422, DOI 10.1016/j.fgb.2007.07.009; Schlierf M, 2005, J MOL BIOL, V354, P497, DOI 10.1016/j.jmb.2005.09.070; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Straede A, 2007, YEAST, V24, P321, DOI 10.1002/yea.1478; Straede A, 2007, FEBS LETT, V581, P4495, DOI 10.1016/j.febslet.2007.08.027; Verbelen C, 2007, J MOL RECOGNIT, V20, P490, DOI 10.1002/jmr.833; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003	36	112	116	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2009	5	11					857	862		10.1038/nchembio.220	http://dx.doi.org/10.1038/nchembio.220			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	508FQ	19767735				2022-12-25	WOS:000270915000016
J	Meacham, CE; Ho, EE; Dubrovsky, E; Gertler, FB; Hemann, MT				Meacham, Corbin E.; Ho, Emily E.; Dubrovsky, Esther; Gertler, Frank B.; Hemann, Michael T.			In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression	NATURE GENETICS			English	Article							RETROVIRAL INSERTIONAL MUTAGENESIS; TUMOR SUPPRESSORS; TRANSGENIC MICE; GENE DISCOVERY; CANCER GENES; CELL LINES; RAC; ACTIVATION; MIGRATION; ONCOGENE	Mouse models have markedly improved our understanding of cancer development and tumor biology. However, these models have shown limited efficacy as tractable systems for unbiased genetic experimentation. Here, we report the adaptation of loss-of-function screening to mouse models of cancer. Specifically, we have been able to introduce a library of shRNAs into individual mice using transplantable E mu-myc lymphoma cells. This approach has allowed us to screen nearly 1,000 genetic alterations in the context of a single tumor-bearing mouse. These experiments have identified a central role for regulators of actin dynamics and cell motility in lymphoma cell homeostasis in vivo. Validation experiments confirmed that these proteins represent bona fide lymphoma drug targets. Additionally, suppression of two of these targets, Rac2 and twinfilin, potentiated the action of the front-line chemotherapeutic vincristine, suggesting a critical relationship between cell motility and tumor relapse in hematopoietic malignancies.	[Meacham, Corbin E.; Ho, Emily E.; Dubrovsky, Esther; Gertler, Frank B.; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hemann, MT (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hemann@mit.edu			US National Institutes of Health [RO1 CA128803-01]; MIT Department of Biology training; Integrated Cancer Biology Program [1-U54-CA112967]; NATIONAL CANCER INSTITUTE [R01CA128803, U54CA112967] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Department of Biology training; Integrated Cancer Biology Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank E. van Veen for help with motility assays, C. Whittaker and J. Pritchard for bioinformatic processing of sequencing data, H. Thompson for expert technical assistance, and members of the Hemann laboratory for helpful advice and discussions. M. T. H. is a Rita Allen Fellow and the Latham Family Career Development Assistant Professor of Biology and is supported by US National Institutes of Health RO1 CA128803-01. C. E. M. is supported by the MIT Department of Biology training grant, and E. E. H. and E. D. were supported by MIT's UROP program. Additional funding was provided by the Integrated Cancer Biology Program grant 1-U54-CA112967 to F. B. G. and M. T. H.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16490, DOI 10.1073/pnas.0806578105; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Smith LG, 2004, CURR BIOL, V14, pR109, DOI 10.1016/j.cub.2004.01.016; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Tani N, 2001, NEUROSCI RES, V39, P247, DOI 10.1016/S0168-0102(00)00213-3; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	32	103	104	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1133	U118		10.1038/ng.451	http://dx.doi.org/10.1038/ng.451			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19783987	Green Accepted, Green Submitted			2022-12-25	WOS:000270330400019
J	Saito, A; Hino, SI; Murakami, T; Kanemoto, S; Kondo, S; Saitoh, M; Nishimura, R; Yoneda, T; Furuichi, T; Ikegawa, S; Ikawa, M; Okabe, M; Imaizumi, K				Saito, Atsushi; Hino, Shin-ichiro; Murakami, Tomohiko; Kanemoto, Soshi; Kondo, Shinichi; Saitoh, Masahiro; Nishimura, Riko; Yoneda, Toshiyuki; Furuichi, Tatsuya; Ikegawa, Shiro; Ikawa, Masahito; Okabe, Masaru; Imaizumi, Kazunori			Regulation of endoplasmic reticulum stress response by a BBF2H7-mediated Sec23a pathway is essential for chondrogenesis	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR; CREB/ATF-FAMILY; MATRIX PROTEIN; ER STRESS; CLEAVAGE; MEMBER; OASIS	Many tissues have a specific signal transduction system for endoplasmic reticulum (ER) dysfunction; however, the mechanisms underlying the ER stress response in cartilage remain unclear. BBF2H7 (BBF2 human homologue on chromosome 7), an ER-resident basic leucine zipper transcription factor, is activated in response to ER stress(1) and is highly expressed in chondrocytes. In this study, we generated Bbf2h7(-/-) ice to assess the in vivo function of BBF2H7. The mice showed severe chondrodysplasia and died by suffocation shortly after birth because of an immature chest cavity. The cartilage showed a lack of typical columnar structure in the proliferating zone and a decrease in the size of the hypertrophic zone, resulting in a significant reduction of extracellular matrix proteins. Interestingly, proliferating chondrocytes showed abnormally expanded ER, containing aggregated type II collagen (Col2) and cartilage oligomeric matrix protein (COMP). We identified Sec23a, which encodes a coat protein complex II component responsible for protein transport from the ER to the Golgi(2,3), as a target of BBF2H7, which directly bound to a CRE-like sequence in the promoter region of Sec23a to activate its transcription. When Sec23a was introduced to Bbf2h7(-/-) chondrocytes, the impaired transport and secretion of cartilage matrix proteins was totally restored, indicating that by activating protein secretion the BBF2H7-Sec23a pathway has a crucial role in chondrogenesis. Our findings provide a new link by which ER stress is converted to signalling for the activation of ER-to-Golgi trafficking.	[Saito, Atsushi; Hino, Shin-ichiro; Murakami, Tomohiko; Kanemoto, Soshi; Kondo, Shinichi; Imaizumi, Kazunori] Miyazaki Univ, Div Mol & Cellular Biol, Dept Anat, Fac Med, Miyazaki 8891692, Japan; [Saitoh, Masahiro; Nishimura, Riko; Yoneda, Toshiyuki] Osaka Univ, Dept Mol & Cellular Biochem, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Furuichi, Tatsuya; Ikegawa, Shiro] RIKEN, Lab Bone & Joint Dis, Ctr Genom Med, Minato Ku, Tokyo 1088639, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	University of Miyazaki; Osaka University; RIKEN; Osaka University; Osaka University	Imaizumi, K (corresponding author), Miyazaki Univ, Div Mol & Cellular Biol, Dept Anat, Fac Med, 5200 Kihara, Miyazaki 8891692, Japan.	imaizumi@med.miyazaki-u.ac.jp	ikawa, masahito/A-5315-2009; Ikegawa, Shiro/N-6895-2015; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Ikegawa, Shiro/0000-0003-0316-2147; Okabe, Masaru/0000-0002-0803-9044; Nishimura, Riko/0000-0001-7279-8363				Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; Cremer MA, 1998, J MOL MED, V76, P275, DOI 10.1007/s001090050217; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Hata K, 2008, J CLIN INVEST, V118, P3098, DOI 10.1172/JCI31373; HEATHER P, 2001, MOL CELL, V7, P1153; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Nagamori I, 2006, GENES CELLS, V11, P1161, DOI 10.1111/j.1365-2443.2006.01013.x; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Paccaud JP, 1996, MOL BIOL CELL, V7, P1535, DOI 10.1091/mbc.7.10.1535; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Woods A, 2007, ENDOCRINOLOGY, V148, P5030, DOI 10.1210/en.2007-0695; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	26	154	162	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1197	U73		10.1038/ncb1962	http://dx.doi.org/10.1038/ncb1962			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767744				2022-12-25	WOS:000270382000008
J	Yoshikawa, Y; Ogawa, M; Hain, T; Yoshida, M; Fukumatsu, M; Kim, M; Mimuro, H; Nakagawa, I; Yanagawa, T; Ishii, T; Kakizuka, A; Sztul, E; Chakraborty, T; Sasakawa, C				Yoshikawa, Yuko; Ogawa, Michinaga; Hain, Torsten; Yoshida, Mitsutaka; Fukumatsu, Makoto; Kim, Minsoo; Mimuro, Hitomi; Nakagawa, Ichiro; Yanagawa, Toru; Ishii, Tetsuro; Kakizuka, Akira; Sztul, Elizabeth; Chakraborty, Trinad; Sasakawa, Chihiro			Listeria monocytogenes ActA-mediated escape from autophagic recognition	NATURE CELL BIOLOGY			English	Article							DEFENSE-MECHANISM; CELL-DEATH; PROTEIN; P62; REPLICATION; DEGRADATION; VACUOLES; COMPLEX; SURFACE	Autophagy degrades unnecessary organelles and misfolded protein aggregates(1), as well as cytoplasm-invading bacteria(2). Nevertheless, the bacteria Listeria monocytogenes efficiently escapes autophagy(3,4). We show here that recruitment of the Arp2/3 complex and Ena/VASP, via the bacterial ActA protein, to the bacterial surface disguises the bacteria from autophagic recognition, an activity that is independent of the ability to mediate bacterial motility. L. monocytogenes expressing ActA mutants that lack the ability to recruit the host proteins initially underwent ubiquitylation, followed by recruitment of p62 (also known as SQSTM1) and LC3, before finally undergoing autophagy. The ability of ActA to mediate protection from ubiquitylation was further demonstrated by generating aggregate-prone GFP-ActA-Q79C and GFP ActA-170* chimaeras, consisting of GFP (green fluorescent protein), the ActA protein and segments of polyQ(5) or Golgi membrane protein GCP170 (ref. 6). GFP-ActA-Q79C and GFP-ActA-170* formed aggregates in the host cell cytoplasm, however, these ActA-containing aggregates were not targeted for association with ubiquitin and p62. Our findings indicate that ActA-mediated host protein recruitment is a unique bacterial disguise tactic to escape from autophagy.	[Yoshikawa, Yuko; Ogawa, Michinaga; Fukumatsu, Makoto; Mimuro, Hitomi; Sasakawa, Chihiro] Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Hain, Torsten; Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, D-35392 Giessen, Germany; [Yoshida, Mitsutaka] Juntendo Univ, Div Ultrastruct Res, Biomed Res Ctr, Grad Sch Med,Bunkyo Ku, Tokyo 1138421, Japan; [Kim, Minsoo; Nakagawa, Ichiro; Sasakawa, Chihiro] Univ Tokyo, Dept Infect Dis Control, Int Res Ctr Infect Dis, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Yanagawa, Toru; Ishii, Tetsuro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Kyoto 6068501, Japan; [Sztul, Elizabeth] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Sasakawa, Chihiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Justus Liebig University Giessen; Juntendo University; University of Tokyo; University of Tsukuba; Kyoto University; University of Alabama System; University of Alabama Birmingham; Japan Science & Technology Agency (JST)	Sasakawa, C (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Yanagawa, Toru/GYU-6448-2022	Yanagawa, Toru/0000-0003-0868-2563; Kim, Minsoo/0000-0001-8536-8653	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; German Ministry of Education and Research; EU	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	We thank all members of the Sasakawa laboratory for discussions and technical advice and A. Amend and N. Schlarenko for help with the generation of several ActA mutants. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to M. O. and C. S, the Special Coordination Funds for Promoting Science from the Japan Science and Technology Agency to C. S, and the ERA-NET Pathogenomics Network funded by the German Ministry of Education and Research and the EU to T. H. and T. C.	Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Footer MJ, 2008, J BIOL CHEM, V283, P23852, DOI 10.1074/jbc.M803448200; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pistor S, 2000, J CELL SCI, V113, P3277; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Van Troys M, 2008, BIOCHEM BIOPH RES CO, V375, P194, DOI 10.1016/j.bbrc.2008.07.152; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	31	325	336	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1233	U175		10.1038/ncb1967	http://dx.doi.org/10.1038/ncb1967			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19749745				2022-12-25	WOS:000270382000013
J	Dassie, JP; Liu, XY; Thomas, GS; Whitaker, RM; Thiel, KW; Stockdale, KR; Meyerholz, DK; McCaffrey, AP; McNamara, JO; Giangrande, PH				Dassie, Justin P.; Liu, Xiu-ying; Thomas, Gregory S.; Whitaker, Ryan M.; Thiel, Kristina W.; Stockdale, Katie R.; Meyerholz, David K.; McCaffrey, Anton P.; McNamara, James O., II; Giangrande, Paloma H.			Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors	NATURE BIOTECHNOLOGY			English	Article							SMALL INTERFERING RNA; IN-VIVO DELIVERY; HUMAN PROSTATE-CANCER; FACTOR-IXA ACTIVITY; BREAST-CANCER; CELLS; GROWTH; THERAPEUTICS; MODEL; NANOPARTICLES	Prostate cancer cells expressing prostate-specific membrane antigen (PSMA) have been targeted with RNA aptamer-small interfering (si) RNA chimeras, but therapeutic efficacy in vivo was demonstrated only with intratumoral injection. Clinical translation of this approach will require chimeras that are effective when administered systemically and are amenable to chemical synthesis. To these ends, we enhanced the silencing activity and specificity of aptamer-siRNA chimeras by incorporating modifications that enable more efficient processing of the siRNA by the cellular machinery. These included adding 2-nucleotide 3'-overhangs and optimizing the thermodynamic profile and structure of the duplex to favor processing of the siRNA guide strand. We also truncated the aptamer portion of the chimeras to facilitate large-scale chemical synthesis. The optimized chimeras resulted in pronounced regression of PSMA-expressing tumors in athymic mice after systemic administration. Anti-tumor activity was further enhanced by appending a polyethylene glycol moiety, which increased the chimeras' circulating half-life.	[Dassie, Justin P.; Liu, Xiu-ying; Thomas, Gregory S.; Whitaker, Ryan M.; Thiel, Kristina W.; Stockdale, Katie R.; McCaffrey, Anton P.; McNamara, James O., II; Giangrande, Paloma H.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Dassie, Justin P.; Thomas, Gregory S.; McCaffrey, Anton P.; Giangrande, Paloma H.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Giangrande, Paloma H.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Giangrande, PH (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	paloma-giangrande@uiowa.edu	Dong, Ping/H-4011-2016; Meyerholz, David/J-8131-2019	Meyerholz, David/0000-0003-1552-3253; Thiel, Kristina/0000-0001-8295-864X; McNamara, James/0000-0003-4091-618X	National Institutes of Health (NIH); Ladies Auxiliary to the Veterans of Foreign Wars postdoctoral fellowship; American Cancer Society Institutional Research; Lymphoma SPORE Developmental Research Award; NATIONAL CANCER INSTITUTE [R01CA138503, P50CA097274] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ladies Auxiliary to the Veterans of Foreign Wars postdoctoral fellowship; American Cancer Society Institutional Research(American Cancer Society); Lymphoma SPORE Developmental Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Henry ( Department of Molecular Physiology and Biophysics, University of Iowa) for supplying PC-3 and 22Rv1(1.7) luciferase-positive cells, A. Klingelhutz ( Department of Microbiology, University of Iowa) for providing immortalized human fibroblasts, J. Houtman ( Department of Immunology, University of Iowa) for help with flow cytometry, and R. Sousa ( Department of Biochemistry, University of Texas Health Science Center) for providing a plasmid encoding a mutant T7 RNA polymerase. We are also thankful to M. Behlke for help with the manuscript. J. P. D. is supported by an National Institutes of Health (NIH) graduate student training grant to the Molecular and Cellular Biology Program ( University of Iowa), K. W. T. is supported by a Ladies Auxiliary to the Veterans of Foreign Wars postdoctoral fellowship, J. O. M. and A. P. M. are supported by the NIH. This research was supported by an American Cancer Society Institutional Research Grant and a Lymphoma SPORE Developmental Research Award to P. H. G.	Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Blow N, 2007, NATURE, V450, P1117, DOI 10.1038/4501117a; Boomer RM, 2005, OLIGONUCLEOTIDES, V15, P183, DOI 10.1089/oli.2005.15.183; Bozza M, 2006, BIOCHEMISTRY-US, V45, P7639, DOI 10.1021/bi0521442; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Chan MY, 2008, CIRCULATION, V117, P2865, DOI 10.1161/CIRCULATIONAHA.107.745687; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Girvan AC, 2006, MOL CANCER THER, V5, P1790, DOI 10.1158/1535-7163.MCT-05-0361; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Judge A, 2008, HUM GENE THER, V19, P111, DOI 10.1089/hum.2007.179; Katz Barrett, 2006, Int Ophthalmol Clin, V46, P141, DOI 10.1097/01.iio.0000212130.91136.31; Keck K, 2009, MOL THER, V17, P538, DOI 10.1038/mt.2008.273; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Lupold SE, 2002, CANCER RES, V62, P4029; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Meade BR, 2007, ADV DRUG DELIVER REV, V59, P134, DOI 10.1016/j.addr.2007.03.004; Mendenhall WM, 2008, AM J CLIN ONCOL-CANC, V31, P496, DOI 10.1097/COC.0b013e31816d1ca6; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Peer D, 2007, P NATL ACAD SCI USA, V104, P4095, DOI 10.1073/pnas.0608491104; Pille JY, 2006, HUM GENE THER, V17, P1019, DOI 10.1089/hum.2006.17.1019; Potvin K, 2008, CAN J UROL, V15, P14; Reagan-Shaw S, 2005, FASEB J, V19, P611, DOI 10.1096/fj.04-2910fje; Reagan-Shaw S, 2005, IUBMB LIFE, V57, P677, DOI 10.1080/15216540500305910; Reich S, 2003, MOL VIS, V9, P210; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Rozema DB, 2007, P NATL ACAD SCI USA, V104, P12982, DOI 10.1073/pnas.0703778104; Sano M, 2008, NUCLEIC ACIDS RES, V36, P5812, DOI 10.1093/nar/gkn584; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Zhou JH, 2008, MOL THER, V16, P1481, DOI 10.1038/mt.2008.92	48	438	483	6	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2009	27	9					839	U95		10.1038/nbt.1560	http://dx.doi.org/10.1038/nbt.1560			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	493QE	19701187	Green Accepted			2022-12-25	WOS:000269751400026
J	Molina, G; Vogt, A; Bakan, A; Dai, WX; de Oliveira, PQ; Znosko, W; Smithgall, TE; Bahar, I; Lazo, JS; Day, BW; Tsang, M				Molina, Gabriela; Vogt, Andreas; Bakan, Ahmet; Dai, Weixiang; de Oliveira, Pierre Queiroz; Znosko, Wade; Smithgall, Thomas E.; Bahar, Ivet; Lazo, John S.; Day, Billy W.; Tsang, Michael			Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages	NATURE CHEMICAL BIOLOGY			English	Article							CATALYTIC ACTIVATION; CRYSTAL-STRUCTURE; MICROARRAY ANALYSIS; GENETIC ALGORITHM; IN-VIVO; FGF; MAP; PHOSPHATASE; IDENTIFICATION; DOMAIN	The dual-specificity phosphatase 6 (Dusp6) functions as a feedback regulator of fibroblast growth factor (FGF) signaling to limit the activity of extracellular signal-regulated kinases (ERKs) 1 and 2. We have identified a small-molecule inhibitor of Dusp6 (E)-2-benzylidene-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one (BCI)-using a transgenic zebrafish chemical screen. BCI treatment blocked Dusp6 activity and enhanced FGF target gene expression in zebrafish embryos. Docking simulations predicted an allosteric binding site for BCI within the phosphatase domain. In vitro studies supported a model in which BCI inhibits Dusp6 catalytic activation by ERK2 substrate binding. We used BCI treatment at varying developmental stages to uncover a temporal role for Dusp6 in restricting cardiac progenitors and controlling heart organ size. This study highlights the power of in vivo zebrafish chemical screens to identify new compounds targeting Dusp6, a component of the FGF signaling pathway that has eluded traditional high-throughput in vitro screens.	[Molina, Gabriela; Znosko, Wade; Smithgall, Thomas E.; Tsang, Michael] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Vogt, Andreas; de Oliveira, Pierre Queiroz; Lazo, John S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Vogt, Andreas; Smithgall, Thomas E.; Bahar, Ivet; Lazo, John S.] Univ Pittsburgh, Pittsburgh Mol Lib Screening Ctr, Pittsburgh, PA USA; [Bakan, Ahmet; Bahar, Ivet] Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA USA; [Dai, Weixiang; Day, Billy W.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Day, Billy W.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tsang, M (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	tsang@pitt.edu	Tsang, Michael W/I-9305-2014; Tsang, Michael/AAG-9338-2020; TSANG, Michael/E-2758-2013; Tsang, Michael/ABV-0504-2022; Bahar, Ivet/AAH-2921-2020	Tsang, Michael W/0000-0001-7123-0063; TSANG, Michael/0000-0001-6384-2422; Tsang, Michael/0000-0001-7123-0063; Day, Billy/0000-0001-6208-9950	US National Heart, Lung, and Blood Institute [R01HL088016]; NIH [HD053287, CA52995, MH074411, CA78039]; Fiske Drug Discovery Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053287] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U19CA052995, U01CA052995, P01CA078039] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074411] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007994] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fiske Drug Discovery Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank N. Hukriede, M. Rebagliati and I. Dawid for critical reading of the manuscript. We thank M. S. Poslusney for assistance in the syntheses. We thank R. Schultz (Developmental Therapeutics Program, US National Cancer Institute) for providing the National Cancer Institute diversity set and samples of individual compounds. The project described was supported in part by award number R01HL088016 to M. T. from the US National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health (NIH). This work was also supported by NIH grants HD053287, CA52995, MH074411 and CA78039, and by the Fiske Drug Discovery Fund.	Abraira VE, 2007, J NEUROSCI, V27, P4273, DOI 10.1523/JNEUROSCI.3477-06.2007; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bakan A, 2008, CURR MED CHEM, V15, P2536, DOI 10.2174/092986708785909003; Brown JL, 2008, P NATL ACAD SCI USA, V105, P12337, DOI 10.1073/pnas.0805589105; CALLAHAN JF, 1999, Patent No. 9965495; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dowd S, 1998, J CELL SCI, V111, P3389; Ducruet AP, 2005, ANNU REV PHARMACOL, V45, P725, DOI 10.1146/annurev.pharmtox.45.120403.100040; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Jeong DG, 2007, PROTEINS, V66, P253, DOI 10.1002/prot.21224; Jeong DG, 2006, J MOL BIOL, V360, P946, DOI 10.1016/j.jmb.2006.05.059; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Lazo JS, 2006, BIOORGAN MED CHEM, V14, P5643, DOI 10.1016/j.bmc.2006.04.036; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marques SR, 2008, DEV BIOL, V321, P397, DOI 10.1016/j.ydbio.2008.06.033; Maves L, 2002, DEVELOPMENT, V129, P3825; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Qian F, 2005, DEV DYNAM, V233, P1163, DOI 10.1002/dvdy.20444; Reifers F, 1998, DEVELOPMENT, V125, P2381; Reifers F, 2000, DEVELOPMENT, V127, P225; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; TSANG M, 2004, SCI STKE, pPE17, DOI DOI 10.1126/STKE.2282004PE17; Vogt A, 2005, PHARMACOL THERAPEUT, V107, P212, DOI 10.1016/j.pharmthera.2005.03.002; Vogt A, 2007, METHODS, V42, P268, DOI 10.1016/j.ymeth.2007.02.006; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Yelon D, 2001, DEV DYNAM, V222, P552, DOI 10.1002/dvdy.1243; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	50	178	185	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					680	687		10.1038/nchembio.190	http://dx.doi.org/10.1038/nchembio.190			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19578332	Green Accepted			2022-12-25	WOS:000269093000017
J	Papaemmanuil, E; Hosking, FJ; Vijayakrishnan, J; Price, A; Olver, B; Sheridan, E; Kinsey, SE; Lightfoot, T; Roman, E; Irving, JAE; Allan, JM; Tomlinson, IP; Taylor, M; Greaves, M; Houlston, RS				Papaemmanuil, Elli; Hosking, Fay J.; Vijayakrishnan, Jayaram; Price, Amy; Olver, Bianca; Sheridan, Eammon; Kinsey, Sally E.; Lightfoot, Tracy; Roman, Eve; Irving, Julie A. E.; Allan, James M.; Tomlinson, Ian P.; Taylor, Malcolm; Greaves, Mel; Houlston, Richard S.			Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FAMILY; CANCER; IKAROS; GENE; DIFFERENTIATION; PROTEINS; DELETION; MEMBERS; GROWTH	To identify risk variants for childhood acute lymphoblastic leukemia (ALL), we conducted a genome-wide association study of two case-control series, analyzing the genotypes with respect to 291,423 tagging SNPs in a total of 907 ALL cases and 2,398 controls. We identified risk loci for ALL at 7p12.2 (IKZF1, rs4132601, odds ratio (OR) = 1.69, P = 1.20 x 10(-19)), 10q21.2 (ARID5B, rs7089424, OR = 1.65, P = 6.69 x 10(-19)) and 14q11.2 (CEBPE, rs2239633, OR = 1.34, P = 2.88 x 10(-7)). The 10q21.2 (ARID5B) risk association appears to be selective for the subset of B-cell precursor ALL with hyperdiploidy. These data show that common low-penetrance susceptibility alleles contribute to the risk of developing childhood ALL and provide new insight into disease causation of this specific hematological cancer. Notably, all three risk variants map to genes involved in transcriptional regulation and differentiation of B-cell progenitors.	[Papaemmanuil, Elli; Hosking, Fay J.; Vijayakrishnan, Jayaram; Price, Amy; Olver, Bianca; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Sheridan, Eammon] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Kinsey, Sally E.] St James Hosp, Dept Paediat & Adolescent Oncol & Haematol, Leeds LS9 7TF, W Yorkshire, England; [Lightfoot, Tracy; Roman, Eve] Univ York, Epidemiol & Genet Unit, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Irving, Julie A. E.; Allan, James M.] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England; [Tomlinson, Ian P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Taylor, Malcolm] Univ Manchester, St Marys Hosp, Canc Immunogenet Grp, Sch Canc Sci, Manchester M13 0JH, Lancs, England; [Greaves, Mel] Inst Canc Res, Sect Haematooncol, Surrey, England	University of London; Institute of Cancer Research - UK; Saint James's University Hospital; Saint James's University Hospital; University of York - UK; Newcastle University - UK; University of Oxford; Wellcome Centre for Human Genetics; University of Manchester; University of London; Institute of Cancer Research - UK	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk	Allan, James/B-4448-2009	Hosking, Fay/0000-0002-1101-039X; Roman, Eve/0000-0001-7603-3704; Houlston, Richard/0000-0002-5268-0242; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Allan, James/0000-0002-7580-5087	Cancer Research UK [C1298/A8362] Funding Source: Medline; Medical Research Council [G0000934] Funding Source: Medline; Blood Cancer UK [13027] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Blood Cancer UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akasaka T, 2007, BLOOD, V109, P3451, DOI 10.1182/blood-2006-08-041012; Boulton A, 2000, BRIT J CANCER, V82, P1073; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang LW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r38; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Couto E, 2005, BRIT J CANCER, V93, P1307, DOI 10.1038/sj.bjc.6602867; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hemminki K, 2002, LEUKEMIA, V16, P297, DOI 10.1038/sj.leu.2402351; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hodgson S.V., 2007, PRACTICAL GUIDE HUMA, V3rd; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Pettiti D, 1994, METAANALYSIS DECISIO; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Stiller CA, 1996, BRIT MED BULL, V52, P682; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95	25	346	360	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1006	U73		10.1038/ng.430	http://dx.doi.org/10.1038/ng.430			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19684604	Green Accepted			2022-12-25	WOS:000269382100013
J	Aghamohammadzadeh, S; Ayscough, KR				Aghamohammadzadeh, Soheil; Ayscough, Kathryn R.			Differential requirements for actin during yeast and mammalian endocytosis	NATURE CELL BIOLOGY			English	Article							PPZ PROTEIN PHOSPHATASES; CELL POLARITY; CYTOSKELETON; INVAGINATION; RECRUITMENT; PATHWAY	Key features of clathrin-mediated endocytosis have been conserved across evolution. However, endocytosis in Saccharomyces cerevisiae is completely dependent on a functional actin cytoskeleton, whereas actin appears to be less critical in mammalian cell endocytosis. We reveal that the fundamental requirement for actin in the early stages of yeast endocytosis is to provide a strong framework to support the force generation needed to direct the invaginating plasma membrane into the cell against turgor pressure. By providing osmotic support, pressure differences across the plasma membrane were removed and this reduced the requirement for actin-bundling proteins in normal endocytosis. Conversely, increased turgor pressure in specific yeast mutants correlated with a decreased rate of endocytic patch invagination.	[Aghamohammadzadeh, Soheil; Ayscough, Kathryn R.] Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Ayscough, KR (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	ayscough@sheffield.ac.uk			BBSRC; MRC [G0601600]; Wellcome Trust [GR077544AIA]; Medical Research Council [G0601600] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank V. Allan, E. Smythe and S. Winder for discussions and critical reading of the manuscript, L. Yenush (Universidad Politecnica de Valencia, Spain) for yeast strains. K. R. A. is a senior non-clinical MRC Fellow (G0601600). S. A. is supported by a BBSRC studentship. The light microscopy-imaging centre at the University of Sheffield was funded by a grant from the Wellcome Trust (GR077544AIA).	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; DULIC V, 1991, METHOD ENZYMOL, V194, P697; Gheorghe DM, 2008, J BIOL CHEM, V283, P15037, DOI 10.1074/jbc.M710332200; Kaiser C., 1994, METHODS YEAST GENETI; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kayingo G, 2001, ARCH MICROBIOL, V177, P29, DOI 10.1007/s00203-001-0358-2; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Whitacre JL, 2001, GENETICS, V157, P533; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920	14	150	153	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1039	U283		10.1038/ncb1918	http://dx.doi.org/10.1038/ncb1918			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597484	Green Accepted			2022-12-25	WOS:000268593200020
J	Silvera, D; Arju, R; Darvishian, F; Levine, PH; Zolfaghari, L; Goldberg, J; Hochman, T; Formenti, SC; Schneider, RJ				Silvera, Deborah; Arju, Rezina; Darvishian, Farbod; Levine, Paul H.; Zolfaghari, Ladan; Goldberg, Judith; Hochman, Tsivia; Formenti, Silvia C.; Schneider, Robert J.			Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer	NATURE CELL BIOLOGY			English	Article							MAMMARY EPITHELIAL-CELLS; INITIATION-FACTOR EIF-4E; E-CADHERIN EXPRESSION; TRANSLATION INITIATION; RHOC-GTPASE; PROLIFERATION; P120-CATENIN; PROTEIN; EMBOLI; MODEL	Inflammatory breast cancer (IBC) is the most lethal form of primary breast cancer(1). IBC lethality derives from generation of tumour emboli, which are non-adherent cell clusters that rapidly spread by a form of continuous invasion known as passive metastasis(2-5). In most cancers, expression of E-cadherin, an epithelial marker, is indicative of low metastatic potential(6,7). In IBC, E-cadherin is overexpressed(8) and supports formation of tumour emboli by promoting tumour cell interactions rather than adherence to stroma(2,3,9). E-cadherin, a surface component of adherens junctions, is anchored by interaction with p120 catenin (p120). We show that the unique pathogenic properties of IBC result in part from overexpression of the translation initiation factor eIF4GI in most IBCs. eIF4GI reprograms the protein synthetic machinery for increased translation of mRNAs with internal ribosome entry sites (IRESs) that promote IBC tumour cell survival and formation of tumour emboli. Overexpression of eIF4GI promotes formation of IBC tumour emboli by enhancing translation of IRES-containing p120 mRNAs. These findings provide a new understanding of translational control in the development of advanced breast cancer.	[Silvera, Deborah; Arju, Rezina; Schneider, Robert J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Darvishian, Farbod] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Levine, Paul H.; Zolfaghari, Ladan] George Washington Univ, Sch Publ Hlth, Washington, DC 20037 USA; [Goldberg, Judith; Hochman, Tsivia] NYU, Dept Environm Med, Sch Med, Div Biostat, New York, NY 10016 USA; [Formenti, Silvia C.] NYU, Sch Med, Dept Radiat Oncol, New York, NY 10016 USA; [Formenti, Silvia C.; Schneider, Robert J.] NYU, Sch Med, Inst Canc, New York, NY 10016 USA	New York University; New York University; George Washington University; New York University; New York University; New York University	Schneider, RJ (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Robert.schneider@nyumc.org		Schneider, Robert/0000-0001-5807-5564; Goldberg, Judith D./0000-0003-3758-6976	US Department of Defence [W81XWH-06-1-0629]; Breast Cancer Research Foundation [15-C6000-33141]; NY State Breast Cancer Research Fund; Breast Cancer Discovery Fund	US Department of Defence(United States Department of Defense); Breast Cancer Research Foundation; NY State Breast Cancer Research Fund; Breast Cancer Discovery Fund	We thank I. Mohr and members of the Schneider lab for their comments on the manuscript. This study was supported by the US Department of Defence Breast Cancer Center of Excellence Research Program (W81XWH-06-1-0629), the Breast Cancer Research Foundation (15-C6000-33141; R. J. S. and S. C. F.), Shifrin and Myers, the NY State Breast Cancer Research Fund (D. S.) and the Breast Cancer Discovery Fund.	Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Bauer C, 2002, INT J CANCER, V98, P181, DOI 10.1002/ijc.10180; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brooks PC, 1999, METH MOL B, V129, P257; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Colpaert CG, 2003, BRIT J CANCER, V88, P718, DOI 10.1038/sj.bjc.6600807; Comtesse N, 2007, INT J CANCER, V120, P2538, DOI 10.1002/ijc.22585; Cuesta R, 2000, GENE DEV, V14, P1460; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gong Y, 2008, SEMIN ONCOL, V35, P33, DOI 10.1053/j.seminoncol.2007.11.014; Ignatoski KMW, 1999, ENDOCRINOLOGY, V140, P3615, DOI 10.1210/en.140.8.3615; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lerebours F, 2005, BREAST CANCER RES, V7, P52, DOI 10.1186/bcr997; LIOTTA LA, 1976, CANCER RES, V36, P889; McClusky DR, 2005, ANN SURG, V242, P584, DOI 10.1097/01.sla.0000184224.55949.90; MIYAGI Y, 1995, CANCER LETT, V91, P247, DOI 10.1016/0304-3835(95)03737-H; MOORE DH, 1992, GYNECOL ONCOL, V47, P44, DOI 10.1016/0090-8258(92)90073-R; Parker C, 2001, BRIT J CANCER, V85, P1958, DOI 10.1054/bjoc.2001.2178; Portera CC, 2006, BREAST CANCER RES TR, V100, pS177; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Rosenwald IB, 2001, CANCER-AM CANCER SOC, V92, P2164, DOI 10.1002/1097-0142(20011015)92:8<2164::AID-CNCR1559>3.0.CO;2-A; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tomlinson JS, 2001, CANCER RES, V61, P5231; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; van Golen KL, 2000, CANCER RES, V60, P5832; van Golen KL, 2000, NEOPLASIA, V2, P418, DOI 10.1038/sj.neo.7900115; Wheelock MJ, 2001, J MAMMARY GLAND BIOL, V6, P275, DOI 10.1023/A:1011319507155; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440	34	171	175	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					903	U312		10.1038/ncb1900	http://dx.doi.org/10.1038/ncb1900			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525934				2022-12-25	WOS:000267603100021
J	Naim, V; Rosselli, F				Naim, Valeria; Rosselli, Filippo			The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE RESPONSE; HISTONE H2AX; COMMON PATHWAY; BLOOM-SYNDROME; FRAGILE SITES; ANEMIA; INSTABILITY; CELLS; MONOUBIQUITINATION; CHECKPOINT	Loss-of-function of caretaker genes characterizes a group of cancer predisposition diseases that feature cellular hypersensitivity to DNA damage and chromosome fragility; this group includes Fanconi anaemia and Bloom syndrome(1-3). The products of the 13 FANC genes(4) (mutated in Fanconi anaemia), which constitute the 'FANC' pathway, and BLM (the RecQ helicase mutated in Bloom syndrome) are thought to collaborate during the S phase of the cell cycle, preventing chromosome instability. Recently, BLM has been implicated in the completion of sister chromatid separation during mitosis, a complex process in which precise regulation and execution is crucial to preserve genomic stability. Here we show for the first time a role for the FANC pathway in chromosome segregation during mitotic cell division. FANCD2, a key component of the pathway, localizes to discrete spots on mitotic chromosomes. FANCD2 chromosomal localization is responsive to replicative stress and specifically targets aphidicolin (APH)-induced chromatid gaps and breaks. Our data indicate that the FANC pathway is involved in rescuing abnormal anaphase and telophase (ana-telophase) cells, limiting aneuploidy and reducing chromosome instability in daughter cells. We further address a cooperative role for the FANC pathway and BLM in preventing micronucleation, through FANC-dependent targeting of BLM to non-centromeric abnormal structures induced by replicative stress. We reveal new crosstalk between FANC and BLM proteins, extending their interaction beyond the S-phase rescue of damaged DNA(5-6) to the safeguarding of chromosome stability during mitosis.	[Naim, Valeria; Rosselli, Filippo] Univ Paris 11, CNRS, FRE2939, Inst Gustave Roussy,CEA LRC43V, F-94805 Villejuif, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Rosselli, F (corresponding author), Univ Paris 11, CNRS, FRE2939, Inst Gustave Roussy,CEA LRC43V, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	rosselli@igr.fr	Naim, Valeria/ABD-1533-2021; Filippo, Rosselli/AAO-6393-2020	Filippo, Rosselli/0000-0003-1080-5745; Naim, Valeria/0000-0002-2149-8712	La Ligue Contre le Cancer; Electricite de France (EDF); Institut Nationale pour le Cancer (INCa); INCa-Lilly	La Ligue Contre le Cancer(Ligue nationale contre le cancer); Electricite de France (EDF)(Electricite de France (EDF)); Institut Nationale pour le Cancer (INCa)(Institut National du Cancer (INCA) France); INCa-Lilly	~We thank all the past and present members of F. Rosselli's team for technical support and helpful discussions, J. Soulier and D. Briot for the FA-C complemented cell lines, E. Nigg for the anti-PICH antibody, Y. Lecluse for FACS analysis, A. Jalil for help with confocal microscopy and P. Kannouche for providing materials and technical advice. This work was supported by grants from La Ligue Contre le Cancer (Equipe Labellisee 2006 and 2009), Electricite de France (EDF) and Institut Nationale pour le Cancer (INCa) to F. R., and a fellowship from INCa-Lilly to V. N.	Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; FUNDIA A, 1994, HEREDITAS, V120, P47, DOI 10.1111/j.1601-5223.1994.00047.x; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kinzler KW, 1997, NATURE, V386, P763; Maluf SW, 2001, CANCER GENET CYTOGEN, V124, P71, DOI 10.1016/S0165-4608(00)00322-8; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2004, CELL CYCLE, V3, P179; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; PORFIRIO B, 1991, HUM GENET, V86, P256; ROSIN MP, 1985, HUM GENET, V71, P187, DOI 10.1007/BF00284570; Suzuki M, 2006, RADIAT RES, V165, P269, DOI 10.1667/RR3508.1; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Walpita D, 1999, P NATL ACAD SCI USA, V96, P5622, DOI 10.1073/pnas.96.10.5622; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; WILLINGALETHEUNE J, 1989, J CELL SCI, V93, P651	31	241	245	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					761	U127		10.1038/ncb1883	http://dx.doi.org/10.1038/ncb1883			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465921				2022-12-25	WOS:000266503700022
J	Sato, T; Onai, N; Yoshihara, H; Arai, F; Suda, T; Ohteki, T				Sato, Taku; Onai, Nobuyuki; Yoshihara, Hiroki; Arai, Fumio; Suda, Toshio; Ohteki, Toshiaki			Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion	NATURE MEDICINE			English	Article							OSTEOBLASTIC NICHE; DENDRITIC CELLS; IFN-ALPHA/BETA; IRF-2; VIVO; PROLIFERATION; INDUCTION; EXPANSION; RESPONSES; BETA	Type I interferons (IFNs), a family of cytokines, orchestrate numerous biological and cellular processes(1-3). Although it is well known that type I IFNs are essential for establishing the host antiviral state(4), their role in hematopoietic homeostasis has not been studied. Here we show that type I IFNs induce proliferation and exhaustion in hematopoietic stem cells (HSCs) and that interferon regulatory factor-2 (IRF2), a transcriptional suppressor of type I IFN signaling(5,6), preserves the self-renewal and multilineage differentiation capacity of HSCs. HSCs were substantially less abundant in the bone marrow of Irf2(-/-) as compared to Irf2(+/-) mice. Irf2(-/-) HSCs showed enhanced cell cycling status and failed to produce hematopoietic cells in competitive repopulation assays, and the reconstituting capacity of Irf2(-/-) HSCs was restored by disabling type I IFN signaling in these cells. In wild-type mice, injection of poly(I:C), an inducer of type I IFN signaling, or IFN-alpha induced HSC proliferation, and chronic type I IFN signaling further reduced the number of quiescent HSCs. Notably, combined poly(I:C) and 5-fluorouracil (5-FU) treatment allowed exogenous HSC engraftment and hematopoietic reconstitution in WT mice. Our findings provide insight into the molecular basis for the maintenance of HSC quiescence and may lead to improvements in bone marrow transplantation and type I IFN-based therapies for viral infection and cancer.	[Sato, Taku; Onai, Nobuyuki; Ohteki, Toshiaki] Akita Univ, Grad Sch Med, Dept Immunol, Akita 010, Japan; [Sato, Taku; Onai, Nobuyuki; Ohteki, Toshiaki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Yoshihara, Hiroki; Arai, Fumio; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat, Tokyo, Japan; [Ohteki, Toshiaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Biodefense Res, Tokyo, Japan	Akita University; Japan Science & Technology Agency (JST); Keio University; Tokyo Medical & Dental University (TMDU)	Ohteki, T (corresponding author), Akita Univ, Grad Sch Med, Dept Immunol, Akita 010, Japan.	ohteki.bre@mri.tmd.ac.jp	Suda, Toshio/H-6761-2013; Arai, Fumio/J-5241-2013	Suda, Toshio/0000-0001-7540-1771; Arai, Fumio/0000-0003-1936-4907; Yoshihara, Hiroki/0000-0001-5128-4515; Onai, Nobuyuki/0000-0003-2246-4917	Ministry of Education, Science, Sports and Culture of Japan; Global Center of Excellence (COE) Program	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence (COE) Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (to T. Sato), a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan (T.O.) and a Grant-in-Aid for the Global Center of Excellence (COE) Program.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Honda K, 2004, P NATL ACAD SCI USA, V101, P2416, DOI 10.1073/pnas.0307336101; Huttmann A, 2001, EXP HEMATOL, V29, P1109, DOI 10.1016/S0301-472X(01)00684-1; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; LERNER C, 1990, EXP HEMATOL, V18, P114; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Mizutani T, 2008, EXP HEMATOL, V36, P255, DOI 10.1016/j.exphem.2007.11.004; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	27	307	313	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					696	U133		10.1038/nm.1973	http://dx.doi.org/10.1038/nm.1973			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19483695				2022-12-25	WOS:000266731600030
J	Seeberger, PH				Seeberger, Peter H.			Chemical glycobiology: why now?	NATURE CHEMICAL BIOLOGY			English	Article							OLIGOSACCHARIDES; CHEMISTRY	Understanding the structure and function of carbohydrates remains a key challenge for chemical biologists. Developments in carbohydrate synthesis and analysis together with the advent of high-throughput methods such as carbohydrate microarrays have helped shed light on the function of glycoconjugates. Similarly, consortia have provided technology platforms and focus to a burgeoning field. Now, recruitment of scientists from related fields and further integration of chemistry and biology to achieve technical goals are needed for rapid advancements.	[Seeberger, Peter H.] Inst Colloid & Interface, Dept Biomol Syst, Potsdam, Germany; [Seeberger, Peter H.] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany	Free University of Berlin	Seeberger, PH (corresponding author), Inst Colloid & Interface, Dept Biomol Syst, Potsdam, Germany.	peter.seeberger@mpikg.mpg.de						[Anonymous], CARBOHYDRATE CHEM; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Kunz H, 2002, ANGEW CHEM INT EDIT, V41, P4439, DOI 10.1002/1521-3773(20021202)41:23<4439::AID-ANIE4439>3.0.CO;2-6; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; SCHMIDT RR, 1986, ANGEW CHEM INT EDIT, V25, P212, DOI 10.1002/anie.198602121; Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899; Seeberger PH, 2007, NATURE, V446, P1046, DOI 10.1038/nature05819; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 1999, ESSENTIALS GLYCOBIOL; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; von der Lieth CW, 2004, J CARBOHYD CHEM, V23, P277, DOI 10.1081/CAR-200030093	14	63	63	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					368	372		10.1038/nchembio0609-368	http://dx.doi.org/10.1038/nchembio0609-368			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19448600				2022-12-25	WOS:000266383800004
J	Wang, SP; Wang, WL; Chang, YL; Wu, CT; Chao, YC; Kao, SH; Yuan, A; Lin, CW; Yang, SC; Chan, WK; Li, KC; Hong, TM; Yang, PC				Wang, Shu-Ping; Wang, Wen-Lung; Chang, Yih-Leong; Wu, Chen-Tu; Chao, Yu-Chih; Kao, Shih-Han; Yuan, Ang; Lin, Chung-Wu; Yang, Shuenn-Chen; Chan, Wing-Kai; Li, Ker-Chau; Hong, Tse-Ming; Yang, Pan-Chyr			p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTORS SNAIL; E-CADHERIN EXPRESSION; REPRESSES E-CADHERIN; PROGNOSTIC-SIGNIFICANCE; BREAST-CANCER; MOUSE MODEL; CARCINOMA; METASTASIS; MUTATION; ADHESION	The tumour suppressor p53 is known to prevent cancer progression by inhibiting proliferation and inducing apoptosis of tumour cells. Slug, an invasion promoter, exerts its effects by repressing E-cadherin transcription. Here we show that wild-type p53 (wtp53) suppresses cancer invasion by inducing Slug degradation, whereas mutant p53 may stabilize Slug protein. In non-small-cell lung cancer (NSCLC), mutation of p53 correlates with low MDM2, high Slug and low E-cadherin expression. This expression profile is associated with poor overall survival and short metastasis-free survival in patients with NSCLC. wtp53 upregulates MDM2 and forms a wtp53-MDM2-Slug complex that facilitates MDM2-mediated Slug degradation. Downregulation of Slug by wtp53 or MDM2 enhances E-cadherin expression and represses cancer cell invasiveness. In contrast, mutant p53 inactivates Slug degradation and leads to Slug accumulation and increased cancer cell invasiveness. Our findings indicate that wtp53 and p53 mutants may differentially control cancer invasion and metastasis through the p53-MDM2-Slug pathway.	[Yuan, Ang; Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 10043, Taiwan; [Wang, Shu-Ping; Wang, Wen-Lung; Chao, Yu-Chih] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Dept Pathol, Taipei 10764, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan; [Kao, Shih-Han] Natl Taiwan Univ, Coll Med, Grad Inst Mol Biol, Taipei 10043, Taiwan; [Lin, Chung-Wu] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10043, Taiwan; [Yang, Shuenn-Chen; Yang, Pan-Chyr] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chan, Wing-Kai] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 10043, Taiwan; [Li, Ker-Chau] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Hong, Tse-Ming] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10043, Taiwan	National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Cheng Kung University; National Taiwan University	Yang, PC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 10043, Taiwan.	pcyang@ntu.edu.tw	Yang, Pan-Chyr/B-8808-2009; Wang, Shu-Ping/S-4379-2018; Li, Ker-Chau/AAQ-4886-2021	Wang, Shu-Ping/0000-0002-5895-1269; WU, CHEN-TU/0000-0001-8458-4119; LIN, CHUNG-WU/0000-0001-5042-0503; CHANG, YIH-LEONG/0000-0001-5309-0554; YANG, PAN-CHYR/0000-0001-6330-6048; Chan, Wing-Kai/0000-0002-5328-548X; YUAN, ANG/0000-0002-5664-1339	National Science Council; Department of Health, Executive Yuan of the Republic of China, through the National Research Program for Genomic Medicine [DOH94-TD-G-111-020, DOH95-TD-G-111-010, DOH96-TD-G-111-009, DOH97-TD-G-111-018, DOH98-TD-G-111-007, NSC97-3112-B-002-033, NSC97-2314-B-002-146-MY3]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan of the Republic of China, through the National Research Program for Genomic Medicine	We thank H. K. Sytwu (Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan) for providing the plasmids for the lentivirus infection system, Pei-Fang Hung and Lu-Kai Wang for technical assistance, and Pei-Ying Lin for English language editing. This work was supported by the National Science Council and Department of Health, Executive Yuan of the Republic of China, through the National Research Program for Genomic Medicine Grants (DOH94-TD-G-111-020, DOH95-TD-G-111-010, DOH96-TD-G-111-009, DOH97-TD-G-111-018, DOH98-TD-G-111-007, NSC97-3112-B-002-033 and NSC97-2314-B-002-146-MY3). shRNA constructs were obtained from the National RNAi Core Facility at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, Taipei, Taiwan.	Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bermejo-Rodriguez C, 2006, GENOMICS, V87, P113, DOI 10.1016/j.ygeno.2005.09.014; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Bukholm IK, 1997, VIRCHOWS ARCH, V431, P317, DOI 10.1007/s004280050105; Cano A, 1996, INT J CANCER, V65, P254; Chang YL, 2007, CLIN CANCER RES, V13, P52, DOI 10.1158/1078-0432.CCR-06-1743; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hajra KM, 2002, CANCER RES, V62, P1613; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Havrilesky L, 2003, J CLIN ONCOL, V21, P3814, DOI 10.1200/JCO.2003.11.052; HENNIG G, 1995, ONCOGENE, V11, P475; HSIAO M, 1994, AM J PATHOL, V145, P702; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Levrero M, 2000, J CELL SCI, V113, P1661; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; Manfredi JJ, 2003, MOL CELL, V11, P552, DOI 10.1016/S1097-2765(03)00106-0; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Ravi R, 2000, GENE DEV, V14, P34; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Travis WD., 2004, TRAVIS WB WHO CLASSI; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yuan A, 2002, J CLIN ONCOL, V20, P900, DOI 10.1200/JCO.20.4.900	50	369	379	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					694	U22		10.1038/ncb1875	http://dx.doi.org/10.1038/ncb1875			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19448627				2022-12-25	WOS:000266503700014
J	Judson, RL; Babiarz, JE; Venere, M; Blelloch, R				Judson, Robert L.; Babiarz, Joshua E.; Venere, Monica; Blelloch, Robert			Embryonic stem cell-specific microRNAs promote induced pluripotency	NATURE BIOTECHNOLOGY			English	Article							DNA METHYLATION; MOUSE; GENERATION; CLUSTER	This report demonstrates that introduction of microRNAs (miRNAs) specific to embryonic stem cells enhances the production of mouse induced pluripotent stem (iPS) cells. The miRNAs miR-291-3p, miR-294 and miR-295 increase the efficiency of reprogramming by Oct4, Sox2 and Klf4, but not by these factors plus cMyc. cMyc binds the promoter of the miRNAs, suggesting that they are downstream effectors of cMyc during reprogramming. However, unlike cMyc, the miRNAs induce a homogeneous population of iPS cell colonies.	[Blelloch, Robert] Univ Calif San Francisco, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, Ctr Reprod Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blelloch, R (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, Ctr Reprod Sci, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu			NINDS NIH HHS [K08 NS048118-01A1, R01 NS057221-01A1, K08 NS048118-03, F32 NS058042, F32 NS058042-02, K08 NS048118-04, K08 NS048118-02, F32NS058042, K08 NS048118, R01 NS057221, R01 NS057221-02, K08 NS48118] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057221, F32NS058042, K08NS048118] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250	17	532	594	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2009	27	5					459	461		10.1038/nbt.1535	http://dx.doi.org/10.1038/nbt.1535			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	444KS	19363475	Green Accepted			2022-12-25	WOS:000265980500024
J	Asano, K; Matsushita, T; Umeno, J; Hosono, N; Takahashi, A; Kawaguchi, T; Matsumoto, T; Matsui, T; Kakuta, Y; Kinouchi, Y; Shimosegawa, T; Hosokawa, M; Arimura, Y; Shinomura, Y; Kiyohara, Y; Tsunoda, T; Kamatani, N; Iida, M; Nakamura, Y; Kubo, M				Asano, Kouichi; Matsushita, Tomonaga; Umeno, Junji; Hosono, Naoya; Takahashi, Atsushi; Kawaguchi, Takahisa; Matsumoto, Takayuki; Matsui, Toshiyuki; Kakuta, Yoichi; Kinouchi, Yoshitaka; Shimosegawa, Tooru; Hosokawa, Masayo; Arimura, Yoshiaki; Shinomura, Yasuhisa; Kiyohara, Yutaka; Tsunoda, Tatsuhiko; Kamatani, Naoyuki; Iida, Mitsuo; Nakamura, Yusuke; Kubo, Michiaki			A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; CONGENITAL CHLORIDE DIARRHEA; COPY NUMBER VARIATION; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; RISK-FACTORS; VARIANTS; GENE; AUTOIMMUNITY; DEFINES	Ulcerative colitis is one of the principal forms of inflammatory bowel disease with complex manifestations. Although previous studies have indicated that there is a genetic contribution to the pathogenesis of ulcerative colitis, the genes influencing susceptibility to the disease have not been fully determined. To identify genetic factors conferring risk of ulcerative colitis, here we conducted a two-stage genome-wide association study and subsequent replication study using 1,384 Japanese individuals with ulcerative colitis and 3,057 control subjects. In addition to the expected strong association with the major histocompatibility complex (MHC) region, we identified three new susceptibility loci: the immunoglobulin receptor gene FCGR2A (rs1801274, P = 1.56 x 10(-12)), a locus on chromosome 13q12 (rs17085007, P = 6.64 x 10(-8)) and the glycoprotein gene SLC26A3 (rs2108225, P = 9.50 x 10(-8)). rs1801274 is a nonsynonymous SNP of FCGR2A that is reported to have a critical effect on receptor binding affinity for IgG and to be associated with other autoimmune diseases. Our findings provide insight into the molecular pathogenesis of ulcerative colitis.	[Asano, Kouichi; Matsushita, Tomonaga; Umeno, Junji; Hosono, Naoya; Kubo, Michiaki] RIKEN, Yokohama Inst, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Asano, Kouichi; Matsushita, Tomonaga; Umeno, Junji; Matsumoto, Takayuki; Iida, Mitsuo; Kubo, Michiaki] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Fukuoka 812, Japan; [Asano, Kouichi; Kiyohara, Yutaka; Kubo, Michiaki] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Yokohama Inst, Ctr Genom Med, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Kawaguchi, Takahisa; Tsunoda, Tatsuhiko] RIKEN, Yokohama Inst, Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa, Japan; [Matsui, Toshiyuki] Fukuoka Univ, Chikushi Hosp, Dept Gastroenterol, Fukuoka 81401, Japan; [Kakuta, Yoichi; Kinouchi, Yoshitaka; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan; [Hosokawa, Masayo; Arimura, Yoshiaki; Shinomura, Yasuhisa] Sapporo Med Univ, Sch Med, Dept Internal Med 1, Sapporo, Hokkaido, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	RIKEN; Kyushu University; Kyushu University; RIKEN; RIKEN; Fukuoka University; Tohoku University; Sapporo Medical University; University of Tokyo	Kubo, M (corresponding author), RIKEN, Yokohama Inst, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan.	mkubo@src.riken.jp	Tsunoda, Tatsuhiko/K-2061-2014; Kakuta, Yoichi/H-5046-2019; Kubo, Michiaki/N-7947-2015	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Kakuta, Yoichi/0000-0002-7042-009X; 	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank all of the patients who participated in this study. We are grateful to F. Hirai, K. Aoyagi, T. Fuchigami, M. Miyazaki, S. Yada, M. Esaki, H. Koga, S. Nakamura, S. Motoya, M. Nomura and T. Sonoda for collecting samples. We thank R. Nakamichi and T. Morizono for help with statistical analysis; participants of the Midosuji and other related Rotary Clubs, Hisayama residents and staff of the Division of Health and Welfare of Hisayama for cooperation in this study; and K. Ashikawa, H. Amitani and other staff of the Laboratory for Genotyping Development, Center for Genomic Medicine, for contributions to this study. This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology.	Alizadeh BZ, 2007, HUM MOL GENET, V16, P2552, DOI 10.1093/hmg/ddm194; Anderson CA, 2009, GASTROENTEROLOGY, V136, P523, DOI 10.1053/j.gastro.2008.10.032; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; FUTAMI S, 1995, DIGEST DIS SCI, V40, P814, DOI 10.1007/BF02064985; Gill RK, 2007, J CLIN INVEST, V117, P428, DOI 10.1172/JCI29625; Halme L, 2006, WORLD J GASTROENTERO, V12, P3668, DOI 10.3748/wjg.v12.i23.3668; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Hosono N, 2008, HUM MUTAT, V29, P182, DOI 10.1002/humu.20609; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Salmon JE, 1996, J CLIN INVEST, V97, P1348, DOI 10.1172/JCI118552; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z; Yang HY, 1998, AM J PHYSIOL-GASTR L, V275, pG1445, DOI 10.1152/ajpgi.1998.275.6.G1445	33	195	207	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1325	U92		10.1038/ng.482	http://dx.doi.org/10.1038/ng.482			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19915573				2022-12-25	WOS:000272144900015
J	Faiella, M; Andreozzi, C; de Rosales, RTM; Pavone, V; Maglio, O; Nastri, F; DeGrado, WF; Lombardi, A				Faiella, Marina; Andreozzi, Concetta; de Rosales, Rafael Torres Martin; Pavone, Vincenzo; Maglio, Ornella; Nastri, Flavia; DeGrado, William F.; Lombardi, Angela			An artificial di-iron oxo-protein with phenol oxidase activity	NATURE CHEMICAL BIOLOGY			English	Article							DE-NOVO DESIGN; COMPUTATIONAL DESIGN; BINDING SITES; METALLOPROTEINS; HELIX; REACTIVITY; MECHANISM; ENZYMES; MODEL; DFSC	Here we report the de novo design and NMR structure of a four-helical bundle di-iron protein with phenol oxidase activity. The introduction of the cofactor-binding and phenol-binding sites required the incorporation of residues that were detrimental to the free energy of folding of the protein. Sufficient stability was, however, obtained by optimizing the sequence of a loop distant from the active site.	[Faiella, Marina; Andreozzi, Concetta; de Rosales, Rafael Torres Martin; Pavone, Vincenzo; Maglio, Ornella; Nastri, Flavia; Lombardi, Angela] Univ Naples Federico 2, Dept Chem, Naples, Italy; [DeGrado, William F.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Naples Federico II; University of Pennsylvania	Lombardi, A (corresponding author), Univ Naples Federico 2, Dept Chem, Complesso Univ Monte S Angelo, Naples, Italy.	wdegrado@mail.med.upenn.edu; alombard@unina.it	Maglio, Ornella/F-1162-2016; Pavone, Vincenzo/D-1688-2011; Nastri, Flavia/D-2811-2011; Lombardi, Angela/D-2778-2011; Torres Martin de Rosales, Rafael/A-7375-2008	Maglio, Ornella/0000-0002-7829-1907; Pavone, Vincenzo/0000-0001-6432-0802; Nastri, Flavia/0000-0002-3390-9822; Lombardi, Angela/0000-0002-2013-3009; Andreozzi, Concetta/0000-0001-6324-5599; Torres Martin de Rosales, Rafael/0000-0003-0431-0535	Italian Ministry of University and Scientific Research [PRIN 2007KAWXCL]; European Commission [HPMD-GH-01-00113-03]; US National Institutes of Health [GM54616]; US National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054616, R01GM054616] Funding Source: NIH RePORTER	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Trifuoggi for metal content analysis. This work was supported by the Italian Ministry of University and Scientific Research (PRIN 2007KAWXCL), the European Commission (Marie Curie Fellowship HPMD-GH-01-00113-03 to R. T. M. R.), the US National Institutes of Health (GM54616) and the US National Science Foundation (grant from the Materials Research Science and Engineering Center to the Laboratory for Research on the Structure of Matter at the University of Pennsylvania).	Bell CB, 2009, BIOCHEMISTRY-US, V48, P59, DOI 10.1021/bi8016087; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Bolon DN, 2002, CURR OPIN CHEM BIOL, V6, P125, DOI 10.1016/S1367-5931(02)00303-4; BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935; Calhoun JR, 2008, J AM CHEM SOC, V130, P9188, DOI 10.1021/ja801657y; CORBETT JF, 1972, J CHEM SOC PERK T 2, P1531, DOI 10.1039/p29720001531; DeGrado WF, 1999, ANNU REV BIOCHEM, V68, P779, DOI 10.1146/annurev.biochem.68.1.779; DeGrado WF, 2003, ANGEW CHEM INT EDIT, V42, P417, DOI 10.1002/anie.200390127; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; JOHNSSON K, 1993, NATURE, V365, P530, DOI 10.1038/365530a0; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Koder RL, 2006, DALTON T, P3045, DOI 10.1039/b514972j; Koval IA, 2006, CHEM SOC REV, V35, P814, DOI 10.1039/b516250p; Lahr SJ, 2005, J MOL BIOL, V346, P1441, DOI 10.1016/j.jmb.2004.12.016; Lombardi A, 2000, P NATL ACAD SCI USA, V97, P6298, DOI 10.1073/pnas.97.12.6298; Lu Y, 2001, CHEM REV, V101, P3047, DOI 10.1021/cr0000574; Maglio O, 2005, J BIOL INORG CHEM, V10, P539, DOI 10.1007/s00775-005-0002-8; Maglio O, 2003, P NATL ACAD SCI USA, V100, P3772, DOI 10.1073/pnas.0730771100; Maglio O, 2007, CR CHIM, V10, P703, DOI 10.1016/j.crci.2007.03.010; Razkin J, 2008, CHEMBIOCHEM, V9, P1975, DOI 10.1002/cbic.200800057; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Summa CM, 2002, J MOL BIOL, V321, P923, DOI 10.1016/S0022-2836(02)00589-2; VINCENT JB, 1990, CHEM REV, V90, P1447, DOI 10.1021/cr00106a004	25	144	145	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					882	884		10.1038/nchembio.257	http://dx.doi.org/10.1038/nchembio.257			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19915535	Green Accepted			2022-12-25	WOS:000271756900008
J	Cho, BK; Zengler, K; Qiu, Y; Park, YS; Knight, EM; Barrett, CL; Gao, Y; Palsson, BO				Cho, Byung-Kwan; Zengler, Karsten; Qiu, Yu; Park, Young Seoub; Knight, Eric M.; Barrett, Christian L.; Gao, Yuan; Palsson, Bernhard O.			The transcription unit architecture of the Escherichia coli genome	NATURE BIOTECHNOLOGY			English	Article							RNA-POLYMERASE; ACCURATE MASS; ANNOTATION; PROTEOMICS; PROTEIN; K-12; RECONSTRUCTION; EXPRESSION; INITIATION; NETWORKS	Bacterial genomes are organized by structural and functional elements, including promoters, transcription start and termination sites, open reading frames, regulatory noncoding regions, untranslated regions and transcription units. Here, we iteratively integrate high-throughput, genome-wide measurements of RNA polymerase binding locations and mRNA transcript abundance, 5' sequences and translation into proteins to determine the organizational structure of the Escherichia coli K-12 MG1655 genome. Integration of the organizational elements provides an experimentally annotated transcription unit architecture, including alternative transcription start sites, 5' untranslated region, boundaries and open reading frames of each transcription unit. A total of 4,661 transcription units were identified, representing an increase of >530% over current knowledge. This comprehensive transcription unit architecture allows for the elucidation of condition-specific uses of alternative sigma factors at the genome scale. Furthermore, the transcription unit architecture provides a foundation on which to construct genome-scale transcriptional and translational regulatory networks.	[Cho, Byung-Kwan; Zengler, Karsten; Qiu, Yu; Park, Young Seoub; Knight, Eric M.; Barrett, Christian L.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Gao, Yuan] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Gao, Yuan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA USA	University of California System; University of California San Diego; Virginia Commonwealth University; Virginia Commonwealth University	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	bpalsson@ucsd.edu	Cho, Byung-Kwan/C-1830-2011; Gao, Yuan/E-1706-2011	Zengler, Karsten/0000-0002-8062-3296; Palsson, Bernhard/0000-0003-2357-6785	US National Institutes of Health [GM062791]; Office of Science (BER), US Department of Energy [DE-FC02-02ER63446]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057089, R01GM062791] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science (BER), US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Derek Lovley at the University of Massachusetts, Amherst for his insightful discussion and Marc Abrams for editing the manuscript. Proteomics experiments were performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. This work was supported by the US National Institutes of Health Grant GM062791 and by the Office of Science (BER), US Department of Energy, cooperative agreement DE-FC02-02ER63446.	Ansong Charles, 2008, Briefings in Functional Genomics & Proteomics, V7, P50, DOI 10.1093/bfgp/eln010; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Cho BK, 2007, CURR OPIN BIOTECH, V18, P360, DOI 10.1016/j.copbio.2007.07.002; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Graham RL, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-26; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Halasz G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r59; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Kaberdin VR, 2006, FEMS MICROBIOL REV, V30, P967, DOI 10.1111/j.1574-6976.2006.00043.x; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; POWER J, 1967, GENETICS, V55, P557; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Rudd KE, 2000, NUCLEIC ACIDS RES, V28, P60, DOI 10.1093/nar/28.1.60; Sabatti C, 2002, NUCLEIC ACIDS RES, V30, P2886, DOI 10.1093/nar/gkf388; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Xia QW, 2007, PROTEOMICS, V7, P2904, DOI 10.1002/pmic.200700267; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	36	199	201	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2009	27	11					1043	U115		10.1038/nbt.1582	http://dx.doi.org/10.1038/nbt.1582			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	516EM	19881496	Green Accepted			2022-12-25	WOS:000271524700026
J	Gierasch, LM; Gershenson, A				Gierasch, Lila M.; Gershenson, Anne			Post-reductionist protein science, or putting Humpty Dumpty back together again	NATURE CHEMICAL BIOLOGY			English	Article							BIOCHEMICAL NETWORKS; MOLECULAR-BIOLOGY; ESCHERICHIA-COLI; ORGANIZATION; CELLS; COMPLEXES		[Gierasch, Lila M.; Gershenson, Anne] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu; gershenson@biochem.umass.edu	Gierasch, Lila M/D-1494-2009	Gershenson, Anne/0000-0003-3124-9610	NIH HHS [DP1 OD000945, DP1 OD000945-04] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000945] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adilakshmi T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl291; Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bader S, 2008, FEBS LETT, V582, P1220, DOI 10.1016/j.febslet.2008.02.015; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Durek P, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-100; Elcock AH, 2006, PLOS COMPUT BIOL, V2, P824, DOI 10.1371/journal.pcbi.0020098; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gutstein HB, 2008, MASS SPECTROM REV, V27, P316, DOI 10.1002/mas.20161; Hoenger A, 2009, CURR OPIN CELL BIOL, V21, P89, DOI 10.1016/j.ceb.2008.12.003; Ignatova Z, 2007, BIOPOLYMERS, V88, P157, DOI 10.1002/bip.20665; Kempner ES, 2003, CELL MOTIL CYTOSKEL, V56, P219, DOI 10.1002/cm.10145; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; MCCONKEY EH, 1982, P NATL ACAD SCI-BIOL, V79, P3236, DOI 10.1073/pnas.79.10.3236; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Pielak GJ, 2009, BIOCHEMISTRY-US, V48, P226, DOI 10.1021/bi8018948; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Remy Ingrid, 2004, Methods Mol Biol, V261, P411; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; Srere PA, 2000, TRENDS BIOCHEM SCI, V25, P150, DOI 10.1016/S0968-0004(00)01550-4; Stein M, 2007, CURR OPIN STRUC BIOL, V17, P166, DOI 10.1016/j.sbi.2007.03.014; Sykes MT, 2009, ANNU REV BIOPHYS, V38, P197, DOI 10.1146/annurev.biophys.050708.133615; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Wilt BA, 2009, ANNU REV NEUROSCI, V32, P435, DOI 10.1146/annurev.neuro.051508.135540; Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640; Zhang JS, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.48; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	35	87	88	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2009	5	11					774	777		10.1038/nchembio.241	http://dx.doi.org/10.1038/nchembio.241			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	508FQ	19841622	Green Accepted			2022-12-25	WOS:000270915000002
J	Tan, C; Marguet, P; You, LC				Tan, Cheemeng; Marguet, Philippe; You, Lingchong			Emergent bistability by a growth-modulating positive feedback circuit	NATURE CHEMICAL BIOLOGY			English	Article							T7 RNA-POLYMERASE; ESCHERICHIA-COLI; GENE-EXPRESSION; SYNTHETIC BIOLOGY; LAC OPERON; CELL; SWITCH; NETWORKS; PROMOTER; BACTERIA	Synthetic gene circuits are often engineered by considering the host cell as an invariable 'chassis'. Circuit activation, however, may modulate host physiology, which in turn can substantially impact circuit behavior. We illustrate this point by a simple circuit consisting of mutant T7 RNA polymerase (T7 RNAP*) that activates its own expression in the bacterium Escherichia coli. Although activation by the T7 RNAP* is noncooperative, the circuit caused bistable gene expression. This counterintuitive observation can be explained by growth retardation caused by circuit activation, which resulted in nonlinear dilution of T7 RNAP* in individual bacteria. Predictions made by models accounting for such effects were verified by further experimental measurements. Our results reveal a new mechanism of generating bistability and underscore the need to account for host physiology modulation when engineering gene circuits.	[Tan, Cheemeng; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Marguet, Philippe] Duke Univ, Dept Biochem, Durham, NC 27706 USA; [You, Lingchong] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA	Duke University; Duke University; Duke University	You, LC (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	you@duke.edu		Tan, Cheemeng/0000-0003-1049-1192	US National Science Foundation [BES-0625213]; US National Institutes of Health [1P50GM081883]; DuPont Young Professorship; David and Lucile Packard Fellowship; Medtronic Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081883] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DuPont Young Professorship; David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); Medtronic Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Salehi, G. Yao, J. Wong, H. Song, T. J. Lee, Q. Wang, J. Niemi, I. Molineux, M. Wall and W. Studier for discussions or comments; M. Cook for assistance with flow cytometry; W. Thompson, E. Soderblom and L. Dubois for assistance with mass spectrometry; M. Elowitz (California Institute of Technology), R. Weiss (Princeton University) and Y. Yokobayashi (University of California, Davis) for plasmids and bacterial strains; and T. Hwa for discussions and for sharing unpublished results. This work was partially supported by the US National Science Foundation (BES-0625213), the US National Institutes of Health (1P50GM081883), a DuPont Young Professorship (L.Y.), a David and Lucile Packard Fellowship (L.Y.) and a Medtronic Fellowship (C.T.).	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chin JW, 2006, NAT CHEM BIOL, V2, P304, DOI 10.1038/nchembio789; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dreisigmeyer DW, 2008, IET SYST BIOL, V2, P293, DOI 10.1049/iet-syb:20080095; DUBENDORFF JW, 1991, J MOL BIOL, V219, P61, DOI 10.1016/0022-2836(91)90857-3; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Hancock V, 2007, INFECT IMMUN, V75, P966, DOI 10.1128/IAI.01748-06; Haseltine EL, 2008, APPL ENVIRON MICROB, V74, P437, DOI 10.1128/AEM.01688-07; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; Lim HN, 2007, NAT GENET, V39, P269, DOI 10.1038/ng1956; Lu T, 2004, SYSTEMS BIOL, V1, P121, DOI 10.1049/sb:20045016; Marguet P, 2007, J R SOC INTERFACE, V4, P607, DOI 10.1098/rsif.2006.0206; MARTIN CT, 1987, BIOCHEMISTRY-US, V26, P2690, DOI 10.1021/bi00384a006; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PERETTI SW, 1987, BIOTECHNOL BIOENG, V29, P316, DOI 10.1002/bit.260290305; Pruss BM, 1997, J BACTERIOL, V179, P3818; Rosenfeld N, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100185; Santillan M, 2007, BIOPHYS J, V92, P3830, DOI 10.1529/biophysj.106.101717; Savageau MA, 2001, CHAOS, V11, P142, DOI 10.1063/1.1349892; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Tan CM, 2007, MOL BIOSYST, V3, P343, DOI 10.1039/b618473c; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; You LC, 2002, J BACTERIOL, V184, P1888, DOI 10.1128/JB.184.7.1888-1894.2002	50	226	231	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2009	5	11					842	848		10.1038/nchembio.218	http://dx.doi.org/10.1038/nchembio.218			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	508FQ	19801994	Green Accepted			2022-12-25	WOS:000270915000014
J	Hockemeyer, D; Soldner, F; Beard, C; Gao, Q; Mitalipova, M; DeKelver, RC; Katibah, GE; Amora, R; Boydston, EA; Zeitler, B; Meng, XD; Miller, JC; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD; Jaenisch, R				Hockemeyer, Dirk; Soldner, Frank; Beard, Caroline; Gao, Qing; Mitalipova, Maisam; DeKelver, Russell C.; Katibah, George E.; Amora, Ranier; Boydston, Elizabeth A.; Zeitler, Bryan; Meng, Xiangdong; Miller, Jeffrey C.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.; Jaenisch, Rudolf			Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; SOMATIC-CELLS; ELECTROPORATION; IDENTIFICATION; PLURIPOTENCY; INTEGRATION; DISEASE; LOCUS; LINE	Realizing the full potential of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) requires efficient methods for genetic modification. However, techniques to generate cell type-specific lineage reporters, as well as reliable tools to disrupt, repair or overexpress genes by gene targeting, are inefficient at best and thus are not routinely used. Here we report the highly efficient targeting of three genes in human pluripotent cells using zinc-finger nuclease (ZFN)-mediated genome editing. First, using ZFNs specific for the OCT4 (POU5F1) locus, we generated OCT4-eGFP reporter cells to monitor the pluripotent state of hESCs. Second, we inserted a transgene into the AAVS1 locus to generate a robust drug-inducible overexpression system in hESCs. Finally, we targeted the PITX3 gene, demonstrating that ZFNs can be used to generate reporter cells by targeting non-expressed genes in hESCs and hiPSCs.	[Hockemeyer, Dirk; Soldner, Frank; Beard, Caroline; Gao, Qing; Mitalipova, Maisam; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA USA; [DeKelver, Russell C.; Katibah, George E.; Amora, Ranier; Boydston, Elizabeth A.; Zeitler, Bryan; Meng, Xiangdong; Miller, Jeffrey C.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Sangamo Therapeutics, Inc.	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Hockemeyer, Dirk/0000-0002-5598-5092; Costa, Elizabeth/0000-0001-8365-0436; Gregory, Philip/0000-0001-9249-2468	Merck Fellow of the Life Science Research Foundation; US National Institutes of Health [R37-CA084198, RO1-CA087869, RO1-HD045022]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R37CA084198, R01CA087869] Funding Source: NIH RePORTER	Merck Fellow of the Life Science Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Alagappan, P. Xu and E. Cook for technical support and J. Dausman, R. Flannery and D. Fu for their help with animal husbandry and processing of teratomas. We thank all the members of the Jaenisch laboratory for helpful discussions and comments on the manuscript. D. H. is a Merck Fellow of the Life Science Research Foundation. R. J. was supported by US National Institutes of Health grants R37-CA084198, RO1-CA087869 and RO1-HD045022: and by the Howard Hughes Medical Institute. Requests for ZFNs should be directed to F. D. U. (furnov@sangamo.com).	Bibikova M, 2002, GENETICS, V161, P1169; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Klug A, 2005, P JPN ACAD B-PHYS, V81, P87, DOI 10.2183/pjab.81.87; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	31	770	900	0	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2009	27	9					851	U110		10.1038/nbt.1562	http://dx.doi.org/10.1038/nbt.1562			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	493QE	19680244	Green Accepted			2022-12-25	WOS:000269751400028
J	Furnham, N; Garavelli, JS; Apweiler, R; Thornton, JM				Furnham, Nicholas; Garavelli, John S.; Apweiler, Rolf; Thornton, Janet M.			Missing in action: enzyme functional annotations in biological databases	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN FUNCTION; SEQUENCES; GENES; WIKI	Annotations of enzyme function provide critical starting points for generating and testing biological hypotheses, but the quality of functional annotations is hindered by uncertain assignments for uncharacterized sequences and by the relative sparseness of validated experimental data. Given the relentless increase in genomic data, new thinking and validation methods are urgently needed to provide high confidence in enzyme functional assignments.	[Furnham, Nicholas; Garavelli, John S.; Apweiler, Rolf; Thornton, Janet M.] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England	European Molecular Biology Laboratory (EMBL)	Furnham, N (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	nickf@ebi.ac.uk		Thornton, Janet/0000-0003-0824-4096; Garavelli, John/0000-0002-4131-735X; Furnham, Nicholas/0000-0002-7532-1269; Apweiler, Rolf/0000-0001-7078-200X				Andorf C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-284; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audit B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S3; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chiang RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000142; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; CORNISHBOWDEN A, 1984, EUR J BIOCHEM, V138, P9, DOI 10.1111/j.1432-1033.1984.tb07877.x; Degtyarenko Kirill, 2007, In Silico Biology, V7, pS45; Favia AD, 2008, J MOL BIOL, V375, P855, DOI 10.1016/j.jmb.2007.10.065; Fontana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004619; George RA, 2005, P NATL ACAD SCI USA, V102, P12299, DOI 10.1073/pnas.0504833102; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Johnston JM, 2003, J BACTERIOL, V185, P4057, DOI 10.1128/JB.185.14.4057-4065.2003; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kretschmann E, 2001, BIOINFORMATICS, V17, P920, DOI 10.1093/bioinformatics/17.10.920; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Martz E, 2009, BIOPOLYMERS, V92, P76, DOI 10.1002/bip.21126; Nagano N, 2005, NUCLEIC ACIDS RES, V33, pD407, DOI 10.1093/nar/gki080; Naumoff DG, 2004, MICROBIOL-SGM, V150, P3908, DOI 10.1099/mic.0.27640-0; Naumoff DG, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-52; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Seffernick JL, 2001, J BACTERIOL, V183, P2405, DOI 10.1128/JB.183.8.2405-2410.2001; Shrager J, 2003, BIOINFORMATICS, V19, P1934, DOI 10.1093/bioinformatics/btg277; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Valencia A, 2005, CURR OPIN STRUC BIOL, V15, P267, DOI 10.1016/j.sbi.2005.05.010; Watson JD, 2007, J MOL BIOL, V367, P1511, DOI 10.1016/j.jmb.2007.01.063	28	39	39	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					521	525		10.1038/nchembio0809-521	http://dx.doi.org/10.1038/nchembio0809-521			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19620987				2022-12-25	WOS:000268209200003
J	Gudbjartsson, DF; Holm, H; Gretarsdottir, S; Thorleifsson, G; Walters, GB; Thorgeirsson, G; Gulcher, J; Mathiesen, EB; Njolstad, I; Nyrnes, A; Wilsgaard, T; Hald, EM; Hveem, K; Stoltenberg, C; Kucera, G; Stubblefield, T; Carter, S; Roden, D; Ng, MCY; Baum, L; So, WY; Wong, KS; Chan, JCN; Gieger, C; Wichmann, HE; Gschwendtner, A; Dichgans, M; Kuhlenbaumer, G; Berger, K; Ringelstein, EB; Bevan, S; Markus, HS; Kostulas, K; Hillert, J; Sveinbjornsdottir, S; Valdimarsson, EM; Lochen, ML; Ma, RCW; Darbar, D; Kong, A; Arnar, DO; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Holm, Hilma; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Walters, G. Bragi; Thorgeirsson, Gudmundur; Gulcher, Jeffrey; Mathiesen, Ellisiv B.; Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Hald, Erin M.; Hveem, Kristian; Stoltenberg, Camilla; Kucera, Gayle; Stubblefield, Tanya; Carter, Shannon; Roden, Dan; Ng, Maggie C. Y.; Baum, Larry; So, Wing Yee; Wong, Ka Sing; Chan, Juliana C. N.; Gieger, Christian; Wichmann, H-Erich; Gschwendtner, Andreas; Dichgans, Martin; Kuhlenbaeumer, Gregor; Berger, Klaus; Ringelstein, E. Bernd; Bevan, Steve; Markus, Hugh S.; Kostulas, Konstantinos; Hillert, Jan; Sveinbjornsdottir, Sigurlaug; Valdimarsson, Einar M.; Lochen, Maja-Lisa; Ma, Ronald C. W.; Darbar, Dawood; Kong, Augustine; Arnar, David O.; Thorsteinsdottir, Unnur; Stefansson, Kari			A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke	NATURE GENETICS			English	Article							CHROMOSOME 4Q25; ATBF1; RISK; METAANALYSIS; PROTEIN	We expanded our genome-wide association study on atrial fibrillation (AF) in Iceland, which previously identified risk variants on 4q25, and tested the most significant associations in samples from Iceland, Norway and the United States. A variant in the ZFHX3 gene on chromosome 16q22, rs7193343-T, associated significantly with AF (odds ratio OR = 1.21, P = 1.4 x 10(-10)). This variant also associated with ischemic stroke (OR = 1.11, P = 0.00054) and cardioembolic stroke (OR = 1.22, P = 0.00021) in a combined analysis of five stroke samples.	[Gudbjartsson, Daniel F.; Holm, Hilma; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Walters, G. Bragi; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCode Genet, Reykjavik, Iceland; [Holm, Hilma] Emory Univ, Sch Med, Div Cardiol, Dept Internal Med, Atlanta, GA 30322 USA; [Thorleifsson, Gudmar; Arnar, David O.] Landspitali Univ Hosp, Div Cardiol, Dept Internal Med, Reykjavik, Iceland; [Thorleifsson, Gudmar; Arnar, David O.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Mathiesen, Ellisiv B.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Mathiesen, Ellisiv B.] Univ Hosp N Norway, Dept Neurol, Tromso, Norway; [Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Lochen, Maja-Lisa] Univ Tromso, Inst Community Med, Tromso, Norway; [Nyrnes, Audhild] Univ Hosp N Norway, Dept Geriatr, Tromso, Norway; [Hald, Erin M.; Lochen, Maja-Lisa] Univ Hosp N Norway, Dept Cardiol, Tromso, Norway; [Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Stoltenberg, Camilla] Norwegian Inst Publ Hlth, Oslo, Norway; [Kucera, Gayle; Stubblefield, Tanya; Carter, Shannon; Roden, Dan; Darbar, Dawood] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Ng, Maggie C. Y.; Baum, Larry; So, Wing Yee; Wong, Ka Sing; Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Gieger, Christian; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Epidemiol, Neuherberg, Germany; [Gschwendtner, Andreas; Dichgans, Martin] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; [Kuhlenbaeumer, Gregor] Univ Kiel, Inst Expt Med, Kiel, Germany; [Berger, Klaus] Inst Epidemiol & Social Med, Munster, Germany; [Ringelstein, E. Bernd] Univ Munster, Dept Neurol, Munster, Germany; [Ringelstein, E. Bernd] Univ Munster, Leibniz Inst Atherosclerosis Res, Munster, Germany; [Bevan, Steve; Markus, Hugh S.] St Georges Univ London, London, England; [Kostulas, Konstantinos; Hillert, Jan] Karolinska Univ Hosp Huddinge, Dept Neurol, Stockholm, Sweden; [Sveinbjornsdottir, Sigurlaug; Valdimarsson, Einar M.] Landspitali Univ Hosp, Dept Neurol, Reykjavik, Iceland	Emory University; Landspitali National University Hospital; University of Iceland; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH); Vanderbilt University; Chinese University of Hong Kong; Prince of Wales Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Kiel; University of Munster; University of Munster; St Georges University London; Karolinska Institutet; Karolinska University Hospital; Landspitali National University Hospital	Gudbjartsson, DF (corresponding author), DeCode Genet, Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Darbar, Dawood/C-9079-2015; Stoltenberg, Camilla/G-5090-2017; Kuhlenbäumer, Gregor/A-5110-2009; Ma, Ronald/C-2788-2009; Wichmann, Heinz Erich/AAA-5695-2022; Dichgans, Martin/HCH-3247-2022; Stefansson, Kari/AAE-7187-2019; Chan, Juliana/B-7918-2016; Roden, Dan/ABD-5412-2021; Hveem, Kristian/AFV-4683-2022; Wong, Ka Sing Lawrence/N-3434-2015; Baum, Lawrence/B-1005-2013; Njolstad, Inger/X-3784-2019; Walters, G. Bragi/L-4215-2013	Darbar, Dawood/0000-0002-4103-5977; Ma, Ronald/0000-0002-1227-803X; Dichgans, Martin/0000-0002-0654-387X; Chan, Juliana/0000-0003-1325-1194; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Baum, Lawrence/0000-0002-5345-9355; Walters, G. Bragi/0000-0002-5415-6487; Gudbjartsson, Daniel/0000-0002-5222-9857; Gieger, Christian/0000-0001-6986-9554; Kong, Augustine/0000-0001-8193-5438; Lochen, Maja-Lisa/0000-0002-8532-6573; Bevan, Steve/0000-0003-0490-6830	US National Institutes of Health [HL075266, U01 HL65962]; American Heart Association [0940116N]; German Federal Ministry of Education and Research [01GI9909/3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962, K23HL075266] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by US National Institutes of Health grants HL075266 and U01 HL65962 and American Heart Association grant 0940116N. Case ascertainment in the West Germany region (Westphalia) was part of the German Competence Net Stroke, which was supported by the German Federal Ministry of Education and Research (01GI9909/3). In the Dortmund Health Study (controls, West Germany) blood collection was done through funds of the Institute of Epidemiology and Social Medicine University of Muenster, the collection of sociodemographic and clinical variables was supported by the German Migraine & Headache Society (DMKG) and by unrestricted grants of equal share from Astra Zeneca, Berlin Chemie, Boots Healthcare, Glaxo-Smith-Kline, McNeil Pharma, MSD Sharp & Dohme and Pfizer to the University of Muenster.	Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Lip GYH, 2006, HEART, V92, P155, DOI 10.1136/hrt.2005.066944; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Qi Y, 2008, P NATL ACAD SCI USA, V105, P2481, DOI 10.1073/pnas.0712196105	11	349	361	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					876	878		10.1038/ng.417	http://dx.doi.org/10.1038/ng.417			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19597491	Green Accepted			2022-12-25	WOS:000268432900007
J	Jin, CY; Zang, CZ; Wei, G; Cui, KR; Peng, WQ; Zhao, KJ; Felsenfeld, G				Jin, Chunyuan; Zang, Chongzhi; Wei, Gang; Cui, Kairong; Peng, Weiqun; Zhao, Keji; Felsenfeld, Gary			H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions	NATURE GENETICS			English	Article							GENOME-WIDE; SACCHAROMYCES-CEREVISIAE; HISTONE MODIFICATIONS; GENE-EXPRESSION; HUMAN-CELLS; CHROMATIN; H2A.Z; H3.3; IDENTIFICATION; OCCUPANCY	To understand how chromatin structure is organized by different histone variants, we have measured the genome-wide distribution of nucleosome core particles (NCPs) containing the histone variants H3.3 and H2A.Z in human cells. We find that a special class of NCPs containing both variants is enriched at 'nucleosome-free regions' of active promoters, enhancers and insulator regions. We show that preparative methods used previously in studying nucleosome structure result in the loss of these unstable double-variant NCPs. It seems likely that this instability facilitates the access of transcription factors to promoters and other regulatory sites in vivo. Other combinations of variants have different distributions, consistent with distinct roles for histone variants in the modulation of gene expression.	[Wei, Gang; Cui, Kairong; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Jin, Chunyuan; Felsenfeld, Gary] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); George Washington University	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov; gary.felsenfeld@nih.gov	Wei, Gang/A-3291-2011; /AAI-2516-2019; Jin, Chunyuan/GRX-9623-2022; Zang, Chongzhi/D-1445-2011	Zang, Chongzhi/0000-0003-4812-3627; Peng, Weiqun/0000-0001-5521-9091	Intramural Research Programs of the National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036149] Funding Source: NIH RePORTER	Intramural Research Programs of the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Tagami, Y. Nakatani and G. Almouzni for H3.3- Flag cells, T. Roh, D. E. Schones and P. Khil for Solexa pipeline analysis and S. Sharmeen and G. Poy for Solexa sequencing. We also acknowledge members of the Felsenfeld laboratory for criticism of the manuscript. This research was supported by the Intramural Research Programs of the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; ZANG C, 2009, BIOINFORMATICS  0608, DOI DOI 10.1093/BIOINFORMATICS/BTP340; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	38	544	554	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					941	U112		10.1038/ng.409	http://dx.doi.org/10.1038/ng.409			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19633671	Green Accepted			2022-12-25	WOS:000268432900022
J	Chiang, EY; Kolumam, GA; Yu, X; Francesco, M; Ivelja, S; Peng, I; Gribling, P; Shu, J; Lee, WP; Refino, CJ; Balazs, M; Paler-Martinez, A; Nguyen, A; Young, J; Barck, KH; Carano, RAD; Ferrando, R; Diehl, L; Chatterjea, D; Grogan, JL				Chiang, Eugene Y.; Kolumam, Ganesh A.; Yu, Xin; Francesco, Michelle; Ivelja, Sinisa; Peng, Ivan; Gribling, Peter; Shu, Jean; Lee, Wyne P.; Refino, Canio J.; Balazs, Mercedesz; Paler-Martinez, Andres; Nguyen, Allen; Young, Judy; Barck, Kai H.; Carano, Richard A. D.; Ferrando, Ron; Diehl, Lauri; Chatterjea, Devavani; Grogan, Jane L.			Targeted depletion of lymphotoxin-alpha-expressing T(H)1 and T(H)17 cells inhibits autoimmune disease	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; COLLAGEN-INDUCED ARTHRITIS; T-CELL; B-CELL; SURFACE LYMPHOTOXIN; IL-17-DEFICIENT MICE; HUMORAL RESPONSES; TH17 CELLS; INFLAMMATION; IL-17	Uncontrolled T helper type 1 (T(H)1) and T(H)17 cells are associated with autoimmune responses. We identify surface lymphotoxin-alpha (LT-alpha) as common to T(H)0, T(H)1 and T(H)17 cells and employ a unique strategy to target these subsets using a depleting monoclonal antibody (mAb) directed to surface LT-alpha. Depleting LT-alpha-specific mAb inhibited T cell-mediated models of delayed-type hypersensitivity and experimental autoimmune encephalomyelitis. In collagen-induced arthritis (CIA), preventive and therapeutic administration of LT-alpha-specific mAb inhibited disease, and immunoablated T cells expressing interleukin-17 (IL-17), interferon-gamma and tumor necrosis factor-alpha (TNF-alpha), whereas decoy lymphotoxin-beta receptor (LT-beta R) fusion protein had no effect. A mutation in the Fc tail, rendering the antibody incapable of Fc gamma receptor binding and antibody-dependent cellular cytotoxicity activity, abolished all in vivo effects. Efficacy in CIA was preceded by a loss of rheumatoid-associated cytokines IL-6, IL-1 beta and TNF-alpha within joints. These data indicate that depleting LT-alpha-expressing lymphocytes with LT-alpha-specific mAb may be beneficial in the treatment of autoimmune disease.	[Chiang, Eugene Y.; Kolumam, Ganesh A.; Yu, Xin; Francesco, Michelle; Ivelja, Sinisa; Peng, Ivan; Gribling, Peter; Shu, Jean; Lee, Wyne P.; Refino, Canio J.; Balazs, Mercedesz; Paler-Martinez, Andres; Chatterjea, Devavani; Grogan, Jane L.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Nguyen, Allen; Young, Judy] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Barck, Kai H.; Carano, Richard A. D.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Ferrando, Ron; Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Grogan, JL (corresponding author), Genentech Inc, Dept Immunol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	jgrogan@gene.com						Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Chabaud M, 2001, ARTHRITIS RES, V3, P168, DOI 10.1186/ar294; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Drayton DL, 2003, J EXP MED, V197, P1153, DOI 10.1084/jem.20021761; Dunussi-Joannopoulos K, 2005, BLOOD, V106, P2235, DOI 10.1182/blood-2004-11-4547; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fava RA, 2003, J IMMUNOL, V171, P115, DOI 10.4049/jimmunol.171.1.115; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Gommerman JL, 2003, J CLIN INVEST, V112, P755, DOI 10.1172/JCI200318648; Gramaglia I, 1999, J IMMUNOL, V162, P1333; Han SH, 2005, ARTHRITIS RHEUM-US, V52, P3202, DOI 10.1002/art.21341; Jungbeck M, 2008, MOL IMMUNOL, V45, P34, DOI 10.1016/j.molimm.2007.05.007; Katschke KJ, 2007, J EXP MED, V204, P1319, DOI 10.1084/jem.20070432; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liepinsh DJ, 2006, MOL CELL BIOL, V26, P4214, DOI 10.1128/MCB.01751-05; Locksley RM, 2008, IMMUNITY, V28, P437, DOI 10.1016/j.immuni.2008.03.009; Lubberts E, 2002, INFLAMM RES, V51, P102, DOI 10.1007/BF02684010; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Miossec P, 2007, ARTHRITIS RHEUM-US, V56, P2111, DOI 10.1002/art.22733; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Panayi GS, 2006, NAT CLIN PRACT RHEUM, V2, P58, DOI 10.1038/ncprheum0094; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Summers-DeLuca LE, 2007, J EXP MED, V204, P1071, DOI 10.1084/jem.20061968; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Wang JS, 2006, J CLIN INVEST, V116, P414, DOI 10.1172/JCI26631; WARE CF, 1992, J IMMUNOL, V149, P3881; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8; Weyand CM, 2007, J RHEUMATOL, V34, P9; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	135	141	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					766	U10		10.1038/nm.1984	http://dx.doi.org/10.1038/nm.1984			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19561618				2022-12-25	WOS:000267806900029
J	Schulze-Topphoff, U; Prat, A; Prozorovski, T; Siffrin, V; Paterka, M; Herz, J; Bendix, I; Ifergan, I; Schadock, I; Mori, MA; Van Horssen, J; Schrotter, F; Smorodchenko, A; Han, MH; Bader, M; Steinman, L; Aktas, O; Zipp, F				Schulze-Topphoff, Ulf; Prat, Alexandre; Prozorovski, Timour; Siffrin, Volker; Paterka, Magdalena; Herz, Josephine; Bendix, Ivo; Ifergan, Igal; Schadock, Ines; Mori, Marcelo A.; Van Horssen, Jack; Schroetter, Friederike; Smorodchenko, Alina; Han, May Htwe; Bader, Michael; Steinman, Lawrence; Aktas, Orhan; Zipp, Frauke			Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system	NATURE MEDICINE			English	Article							ACTIVE MULTIPLE-SCLEROSIS; AUTOIMMUNE ENCEPHALOMYELITIS; NEURONAL DAMAGE; CELLS; EXPRESSION; LESIONS; MICE; NEUROINFLAMMATION; IMMUNOTHERAPY; INFLAMMATION	Previous proteomic and transcriptional analyses of multiple sclerosis lesions(1-3) revealed modulation of the renin-angiotensin and the opposing kallikrein-kinin pathways. Here we identify kinin receptor B1 (Bdkrb1) as a specific modulator of immune cell entry into the central nervous system (CNS). We demonstrate that the Bdkrb1 agonist R838 (Sar-[D-Phe]des-Arg(9)-bradykinin) markedly decreases the clinical symptoms of experimental autoimmune encephalomyelitis (EAE) in SJL mice(4-6), whereas the Bdkrb1 antagonist R715 (Ac-Lys-[D-beta Nal(7), Ile(8)]des-Arg(9)-bradykinin) resulted in earlier onset and greater severity of the disease. Bdkrb1-deficient (Bdkrb1(-/-)) C57BL/6 mice(7) immunized with a myelin oligodendrocyte glycoprotein fragment, MOG(35-55), showed more severe disease with enhanced CNS-immune cell infiltration. The same held true for mixed bone marrow-chimeric mice reconstituted with Bdkrb1(-/-) T lymphocytes, which showed enhanced T helper type 17 (T(H)17) cell invasion into the CNS. Pharmacological modulation of Bdkrb1 revealed that in vitro migration of human T(H)17 lymphocytes across blood-brain barrier endothelium is regulated by this receptor. Taken together, these results suggest that the kallikrein-kinin system is involved in the regulation of CNS inflammation, limiting encephalitogenic T lymphocyte infiltration into the CNS, and provide evidence that Bdkrb1 could be a new target for the treatment of chronic inflammatory diseases such as multiple sclerosis.	[Schulze-Topphoff, Ulf; Prozorovski, Timour; Siffrin, Volker; Paterka, Magdalena; Herz, Josephine; Bendix, Ivo; Schroetter, Friederike; Smorodchenko, Alina; Aktas, Orhan; Zipp, Frauke] Charite, Cecilie Vogt Klin, Max Delbrueck Ctr Mol Med, Berlin, Germany; [Schulze-Topphoff, Ulf; Prozorovski, Timour; Siffrin, Volker; Paterka, Magdalena; Herz, Josephine; Bendix, Ivo; Schroetter, Friederike; Smorodchenko, Alina; Aktas, Orhan; Zipp, Frauke] NeuroCure Res Ctr, Berlin, Germany; [Prat, Alexandre; Ifergan, Igal] Ctr Hosp Univ Montreal, Neuroimmunol Res Lab, Montreal, PQ, Canada; [Schadock, Ines; Mori, Marcelo A.; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Van Horssen, Jack] Vrije Univ Amsterdam, Univ Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Han, May Htwe; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universite de Montreal; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Vrije Universiteit Amsterdam; Stanford University	Zipp, F (corresponding author), Charite, Cecilie Vogt Klin, Max Delbrueck Ctr Mol Med, Berlin, Germany.	frauke.zipp@charite.de	Smorodchenko, Alina/ABB-2411-2020; Smorodchenko, Alina/AAU-2854-2020; Bader, Michael/K-2124-2013; Mori, Marcelo A/R-2881-2018; Aktas, Orhan/B-7623-2009; Ifergan, Igal/AAI-9734-2020; Zipp, Frauke/C-9968-2015; Smorodchenko, Alina/D-1880-2010; Siffrin, Volker/AAR-3632-2021; Ifergan, Igal/AAR-7849-2021	Mori, Marcelo A/0000-0001-7112-5263; Aktas, Orhan/0000-0002-2020-9210; Zipp, Frauke/0000-0002-1231-1928; Ifergan, Igal/0000-0003-2945-2580; Bader, Michael/0000-0003-4780-4164; Siffrin, Volker/0000-0002-1532-2868; Smorodchenko, Alina/0000-0003-1415-1531; Bendix, Ivo/0000-0002-9751-3640; Schadock, Ines/0000-0002-6717-6276; van Horssen, Jack/0000-0003-4078-7402	Deutsche Forschungsgemeinschaft [SFB-TRR 43, GRK 1258/1, SFB 650]; Heinrich und Erna Schaufler-Stiftung; European Cooperation in Science and Technology (COST); Will Foundation; Multiple Sclerosis Society of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinrich und Erna Schaufler-Stiftung; European Cooperation in Science and Technology (COST)(European Cooperation in Science and Technology (COST)); Will Foundation; Multiple Sclerosis Society of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Deutsche Forschungsgemeinschaft to O.A. (SFB-TRR 43) and F.Z. (GRK 1258/1, SFB-TRR 43, SFB 650), from the Heinrich und Erna Schaufler-Stiftung to O. A., by European Cooperation in Science and Technology (COST), by the Will Foundation and by a grant from the Multiple Sclerosis Society of Canada to A. P. A. P. is a Donald Paty Career Scientist from the Multiple Sclerosis Society of Canada. We thank T. Hohnstein and N. Nowakowski for expert technical assistance and A. Noon for reading the manuscript as a native speaker.	Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Betti M, 2006, ANN ONCOL, V17, P235; Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Cayla C, 2007, FASEB J, V21, P1689, DOI 10.1096/fj.06-7175com; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; Dos Santos AC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-49; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hoffmann O, 2007, J CLIN INVEST, V117, P2004, DOI 10.1172/JCI30356; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Kursar M, 2005, J EXP MED, V201, P1447, DOI 10.1084/jem.20041204; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Nitsch R, 2004, J NEUROSCI, V24, P2458, DOI 10.1523/JNEUROSCI.4703-03.2004; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Prat A, 1999, NEUROLOGY, V53, P2087, DOI 10.1212/WNL.53.9.2087; Prat A, 2000, J NEUROPATH EXP NEUR, V59, P896, DOI 10.1093/jnen/59.10.896; Prat A, 2005, ARCH NEUROL-CHICAGO, V62, P795, DOI 10.1001/archneur.62.5.795; Rohnelt RK, 1997, INT IMMUNOL, V9, P435, DOI 10.1093/intimm/9.3.435; Schmaier AH, 2002, J CLIN INVEST, V109, P1007, DOI 10.1172/JCI200215490; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502	29	104	107	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					788	793		10.1038/nm.1980	http://dx.doi.org/10.1038/nm.1980			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19561616	Green Accepted			2022-12-25	WOS:000267806900032
J	Chung, SM; Parker, JB; Bianchet, M; Amzel, LM; Stivers, JT				Chung, Suhman; Parker, Jared B.; Bianchet, Mario; Amzel, L. Mario; Stivers, James T.			Impact of linker strain and flexibility in the design of a fragment-based inhibitor	NATURE CHEMICAL BIOLOGY			English	Article							URACIL DNA GLYCOSYLASE; DRUG DISCOVERY; HUMAN DUTPASE; BINDING; EXPRESSION; PROTEIN; ENTROPY; LIGANDS; COMPLEX; UNG2	The linking together of molecular fragments that bind to adjacent sites on an enzyme can lead to high-affinity inhibitors. Ideally, this strategy would use linkers that do not perturb the optimal binding geometries of the fragments and do not have excessive conformational flexibility that would increase the entropic penalty of binding. In reality, these aims are seldom realized owing to limitations in linker chemistry. Here we systematically explore the energetic and structural effects of rigid and flexible linkers on the binding of a fragment-based inhibitor of human uracil DNA glycosylase. Analysis of the free energies of binding in combination with cocrystal structures shows that the flexibility and strain of a given linker can have a substantial impact on binding affinity even when the binding fragments are optimally positioned. Such effects are not apparent from inspection of structures and underscore the importance of linker optimization in fragment-based drug discovery efforts.	[Chung, Suhman; Parker, Jared B.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Bianchet, Mario; Amzel, L. Mario] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Stivers, JT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	jstivers@jhmi.edu	Bianchet, Mario a/K-2131-2015	Bianchet, Mario a/0000-0001-9032-7549; Amzel, L. Mario/0000-0002-0129-9572	US National Institutes of Health [GM56834-12, GM066895]; Ruth L. Kirschstein National Research Service Award [F31 GM083623]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066895, R01GM056834, F31GM083623] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants GM56834-12 to J. T. S. and GM066895 to L. M. A. and by a Ruth L. Kirschstein National Research Service Award (F31 GM083623) to J. B. P. The content of the publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does the mention of trade names, commercial products or organizations imply endorsement by the US Government.	Babaoglu K, 2006, NAT CHEM BIOL, V2, P720, DOI 10.1038/nchembio831; Baltas M, 1996, TETRAHEDRON, V52, P14865, DOI 10.1016/0040-4020(96)00919-2; Bohm HJ, 1998, J COMPUT AID MOL DES, V12, P309, DOI 10.1023/A:1007999920146; BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; Erlanson DA, 2004, ANNU REV BIOPH BIOM, V33, P199, DOI 10.1146/annurev.biophys.33.110502.140409; Erlanson DA, 2006, CURR OPIN BIOTECH, V17, P643, DOI 10.1016/j.copbio.2006.10.007; FINKELSTEIN AV, 1989, PROTEIN ENG, V3, P1, DOI 10.1093/protein/3.1.1; Fleischmann J, 2002, J MED VIROL, V68, P568, DOI 10.1002/jmv.10234; Fleischmann J, 1999, INT J CANCER, V84, P614, DOI 10.1002/(SICI)1097-0215(19991222)84:6<614::AID-IJC13>3.0.CO;2-P; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Hagen L, 2006, EXP CELL RES, V312, P2666, DOI 10.1016/j.yexcr.2006.06.015; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jiang YL, 2005, J AM CHEM SOC, V127, P17412, DOI 10.1021/ja055846n; Jiang YL, 2006, BIOORGAN MED CHEM, V14, P5666, DOI 10.1016/j.bmc.2006.04.022; Krosky DJ, 2006, NUCLEIC ACIDS RES, V34, P5872, DOI 10.1093/nar/gkl747; Maly DJ, 2000, P NATL ACAD SCI USA, V97, P2419, DOI 10.1073/pnas.97.6.2419; Murray CW, 2002, J COMPUT AID MOL DES, V16, P741, DOI 10.1023/A:1022446720849; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Priet S, 2006, CURR HIV RES, V4, P31, DOI 10.2174/157016206775197673; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Xiao GY, 1999, PROTEINS, V35, P13	25	88	89	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					407	413		10.1038/nchembio.163	http://dx.doi.org/10.1038/nchembio.163			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19396178	Green Accepted			2022-12-25	WOS:000266383800015
J	Strauss, SH; Tan, HM; Boerjan, W; Sedjo, R				Strauss, Steven H.; Tan, Huimin; Boerjan, Wout; Sedjo, Roger			Strangled at birth? Forest biotech and the Convention on Biological Diversity	NATURE BIOTECHNOLOGY			English	Article							CARTAGENA; BIOSAFETY; GENOMICS; TREES; RISK; DOMESTICATION; CONTAINMENT; PROTOCOL; SYSTEMS; GENES	Against the Cartagena Protocol and widespread scientific support for a case-by-case approach to regulation, the Convention on Biological Diversity has become a platform for imposing broad restrictions on research and development of all types of transgenic trees.	[Strauss, Steven H.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Tan, Huimin] Carnegie Mellon Univ, Heinz Sch Publ Policy & Management, Pittsburgh, PA 15213 USA; [Boerjan, Wout] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Boerjan, Wout] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium; [Sedjo, Roger] Resources Future Inc, Washington, DC 20036 USA	Oregon State University; Carnegie Mellon University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Resources for the Future	Strauss, SH (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.	steve.strauss@oregonstate.edu	Boerjan, Wout/Y-4158-2019	Boerjan, Wout/0000-0003-1495-510X				*A FOX INT ENV RES, 2006, BIOS REG SOURC; Batista R, 2008, P NATL ACAD SCI USA, V105, P3640, DOI 10.1073/pnas.0707881105; Baudo MM, 2006, PLANT BIOTECHNOL J, V4, P369, DOI 10.1111/j.1467-7652.2006.00193.x; Boerjan W, 2005, CURR OPIN BIOTECH, V16, P159, DOI 10.1016/j.copbio.2005.03.003; Brunner AM, 2004, TRENDS PLANT SCI, V9, P49, DOI 10.1016/j.tplants.2003.11.006; Brunner AM, 2007, TREE GENET GENOMES, V3, P75, DOI 10.1007/s11295-006-0067-8; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Catchpole GS, 2005, P NATL ACAD SCI USA, V102, P14458, DOI 10.1073/pnas.0503955102; Cheng KC, 2008, J AGR FOOD CHEM, V56, P3057, DOI 10.1021/jf073505i; Conko G, 2003, TRANSGENIC RES, V12, P639, DOI 10.1023/B:TRAG.0000005157.45046.8e; *CONV BIOL DIV, 2009, PART CONV BIOD; *CONV BIOL DIV ALL, 2008, NO GE TREES NO CAS C; *COP CBD, FOR BIOL DIV IMPL PR; *COP CBD, REP SUBS BOD SCI TEC; De Greef W, 2004, NAT BIOTECHNOL, V22, P811, DOI 10.1038/nbt0704-811; Doty SL, 2007, P NATL ACAD SCI USA, V104, P16816, DOI 10.1073/pnas.0703276104; El-Lakany M. H., 2004, Unasylva (English ed.), V55, P45; Farnum P, 2007, TREE GENET GENOMES, V3, P119, DOI 10.1007/s11295-006-0063-z; *FOOD AGR ORG UN, 2004, PREL REV BIOT FOR IN; *GLOB IND COAL, 2007, COMP ENV RISK ASS GU; *GLOB JUST EC PROJ, 2008, GJEP STOP GE TREES C; Grattapaglia D, 2008, NEW PHYTOL, V179, P911, DOI 10.1111/j.1469-8137.2008.02503.x; Hoenicka H, 2006, TREES-STRUCT FUNCT, V20, P131, DOI 10.1007/s00468-005-0023-5; Hu WJ, 1999, NAT BIOTECHNOL, V17, P808, DOI 10.1038/11758; HUMPHREYS D, 2005, BIOTECHNOLOGY FOREST; *I SCI SOC, 2005, GM TREES LOST CHIN F; *INF SYST BIOT, FIELD TRIAL DAT; International Service for the Acquisition of Agri-Biotech Applications, GLOB STAT COMM BIOT; Jaffe G, 2005, J PUBLIC AFF, V5, P299, DOI 10.1002/pa.30; Johnston S., 2008, INT FUNDED TRAINING; KALAITZANDONAKE.N, 2006, REGULATION, V29, P18; Kinderlerer, 2008, COLLECTION BIOSAFETY, V4, P12; Lang C., 2008, WORLD RAINFOREST MOV; Linacre NA, 2004, ECOL MODEL, V179, P247, DOI 10.1016/j.ecolmodel.2003.11.011; MARCHANT GE, 2005, ARBITARY CAPRICIOUS; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Merkle SA, 2007, TREE GENET GENOMES, V3, P111, DOI 10.1007/s11295-006-0050-4; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Morris J, 2002, TOXICOLOGY, V181, P127, DOI 10.1016/S0300-483X(02)00268-8; Petermann Anne, 2005, INT STATUS GENETICAL; Ramessar K, 2007, TRANSGENIC RES, V16, P261, DOI 10.1007/s11248-007-9083-1; Richardson DM, 2006, MANAG FOR ECOSYST, V9, P169; ROBISCHON M, 2006, FIELD TRIALS TRANSGE; *SAF GMO, 2007, DEL REL GEN MOD TREE; Schwartz Jason, 2006, N Y U ENV LAW J, V14, P421; SLAVOV GT, 2004, GENE FLOW FOREST TRE; Smouse PE, 2007, TREE GENET GENOMES, V3, P141, DOI 10.1007/s11295-006-0075-8; Strauss S, 1999, NAT BIOTECHNOL, V17, P1145, DOI 10.1038/70652; Strauss SH, 2003, SCIENCE, V300, P61, DOI 10.1126/science.1079514; Strauss SH, 2001, J FOREST, V99, P4; *SUBS BOD SCI TECH, 2008, POT ENV CULT SOC IMP; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; *UN ENV PROGR, 2008, POT ENV CULT SOC IMP; *USDA, 2008, POL STAT REG REL PER; van Frankenhuyzen K, 2004, CAN J FOREST RES, V34, P1163, DOI [10.1139/X04-024, 10.1139/x04-024]; Voesenek LACJ, 2008, SCIENCE, V320, P880, DOI 10.1126/science.1158720; Watanabe KN, 2004, NAT BIOTECHNOL, V22, P1207, DOI 10.1038/nbt1004-1207b; Wei H, 2007, MOL BREEDING, V19, P69, DOI 10.1007/s11032-006-9045-y; Yin XY, 2008, NEW PHYTOL, V179, P629, DOI 10.1111/j.1469-8137.2008.02424.x	59	40	42	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2009	27	6					519	527		10.1038/nbt0609-519	http://dx.doi.org/10.1038/nbt0609-519			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	458AC	19513052	Bronze			2022-12-25	WOS:000266980500017
J	Effraim, PR; Wang, JN; Englander, MT; Avins, J; Leyh, TS; Gonzalez, RL; Cornish, VW				Effraim, Philip R.; Wang, Jiangning; Englander, Michael T.; Avins, Josh; Leyh, Thomas S.; Gonzalez, Ruben L., Jr.; Cornish, Virginia W.			Natural amino acids do not require their native tRNAs for efficient selection by the ribosome	NATURE CHEMICAL BIOLOGY			English	Article							ELONGATION-FACTOR TU; SITE-SPECIFIC INCORPORATION; PEPTIDE-BOND FORMATION; GENETIC-CODE; PROTEIN-STRUCTURE; GTP HYDROLYSIS; IN-VITRO; EF-TU; TRANSLATION; FIDELITY	The involvement of tRNA structural elements beyond the anticodon in aminoacyl-tRNA (aa-tRNA) selection by the ribosome has revealed that substrate recognition is considerably more complex than originally envisioned in the adaptor hypothesis. By combining recent breakthroughs in aa-tRNA synthesis and mechanistic and structural studies of protein synthesis, we have investigated whether aa-tRNA recognition further extends to the amino acid, which would explain various translation disorders exhibited by misacylated tRNAs. Contrary to expectation, we find that natural amino acids misacylated onto natural but non-native tRNAs are selected with efficiencies very similar to those of their correctly acylated counterparts. Despite this, small but reproducible differences in selection indeed demonstrate that the translational machinery is sensitive to the amino acid-tRNA pairing. These results suggest either that the ribosome is an exquisite sensor of natural versus unnatural amino acid-tRNA pairings and/or that aa-tRNA selection is not the primary step governing the amino acid specificity of the ribosome.	[Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Effraim, Philip R.; Wang, Jiangning; Englander, Michael T.; Avins, Josh; Gonzalez, Ruben L., Jr.; Cornish, Virginia W.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Effraim, Philip R.; Englander, Michael T.] Columbia Univ, Integrated Program Cellular Mol & Biomed Sci, New York, NY 10027 USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University; Columbia University	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	leyh@aecom.yu.edu; rlg2118@columbia.edu; vc114@columbia.edu			Columbia University; Burroughs Wellcome Fund [CABS 1004856]; US National Institutes of Health [RO1 GM54469]; Columbia University College of Physicians and Surgeons' MD/PhD Program [T32 GM07367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084288, R01GM090126, R01GM054469, T32GM007367] Funding Source: NIH RePORTER	Columbia University; Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University College of Physicians and Surgeons' MD/PhD Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds to V. W. C. and R. L. G. Jr. from Columbia University and by grants to R. L. G. Jr. from the Burroughs Wellcome Fund (CABS 1004856) and T. S. L. from the US National Institutes of Health (RO1 GM54469). P. R. E. was supported by Columbia University College of Physicians and Surgeons' MD/PhD Program (US National Institutes of Health Institutional Training Grant T32 GM07367). We thank Y.-M. Hou and M. Dupasquier (both at Thomas Jefferson University) for the kind gift of a nucleotidyl transferase overexpression strain, D. Tirrell (California Institute of Technology) for the gift of a phenylalanyl-tRNA synthetase overexpressing strain and N. Prywes (Columbia University) for cloning and purifying alanyl-tRNA synthetase as well as aiding in tRNAAla purification. We also thank H. Suga, R. Green, H. Zaher and L. G. Dickson for helpful discussions and advice. Finally, we are indebted to V. Mondol and S. Das for managing the Cornish and Gonzalez laboratories, respectively.	Asahara H, 2005, BIOCHEMISTRY-US, V44, P11254, DOI 10.1021/bi050204y; Beringer M, 2008, RNA, V14, P795, DOI 10.1261/rna.980308; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; CHAPEVILLE F, 1962, P NATL ACAD SCI USA, V48, P1086, DOI 10.1073/pnas.48.6.1086; Cload ST, 1996, CHEM BIOL, V3, P1033, DOI 10.1016/S1074-5521(96)90169-6; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; CORNISH VW, 1994, P NATL ACAD SCI USA, V91, P2910, DOI 10.1073/pnas.91.8.2910; CORNISH VW, 1995, ANGEW CHEM INT EDIT, V34, P621, DOI 10.1002/anie.199506211; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; CRICK FHC, 1963, PROG NUCLEIC ACID RE, V1, P163, DOI 10.1016/S0079-6603(08)60642-X; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Dale T, 2009, NUCLEIC ACIDS RES, V37, P1202, DOI 10.1093/nar/gkn1040; Dedkova LM, 2006, BIOCHEMISTRY-US, V45, P15541, DOI 10.1021/bi060986a; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Dougherty DA, 2000, CURR OPIN CHEM BIOL, V4, P645, DOI 10.1016/S1367-5931(00)00148-4; ELLMAN JA, 1992, SCIENCE, V255, P197, DOI 10.1126/science.1553546; Forster AC, 2003, P NATL ACAD SCI USA, V100, P6353, DOI 10.1073/pnas.1132122100; Gonzalez RL, 2007, RNA, V13, P2091, DOI 10.1261/rna.499407; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; HIRSH D, 1971, J MOL BIOL, V58, P459, DOI 10.1016/0022-2836(71)90363-9; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee TH, 2007, P NATL ACAD SCI USA, V104, P13661, DOI 10.1073/pnas.0705988104; Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Murakami H, 2009, NAT STRUCT MOL BIOL, V16, P353, DOI 10.1038/nsmb.1580; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ohta A, 2007, CHEM BIOL, V14, P1315, DOI 10.1016/j.chembiol.2007.10.015; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Rodnina MV, 2001, TRENDS BIOCHEM SCI, V26, P124, DOI 10.1016/S0968-0004(00)01737-0; Rothman DM, 2005, J AM CHEM SOC, V127, P846, DOI 10.1021/ja043875c; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; SPRINZL M, 1989, NUCLEIC ACIDS RES, V1, pR1; Subtelny AO, 2008, J AM CHEM SOC, V130, P6131, DOI 10.1021/ja710016v; Tan ZP, 2004, J AM CHEM SOC, V126, P12752, DOI 10.1021/ja0472174; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Wang JY, 2006, J AM CHEM SOC, V128, P8738, DOI 10.1021/ja062666k; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582	50	28	29	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					947	953		10.1038/nchembio.255	http://dx.doi.org/10.1038/nchembio.255			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19915542	Green Accepted			2022-12-25	WOS:000271756900018
J	Okamoto, SI; Pouladi, MA; Talantova, M; Yao, DD; Xia, P; Ehrnhoefer, DE; Zaidi, R; Clemente, A; Kaul, M; Graham, RK; Zhang, DX; Chen, HSV; Tong, G; Hayden, MR; Lipton, SA				Okamoto, Shu-ichi; Pouladi, Mahmoud A.; Talantova, Maria; Yao, Dongdong; Xia, Peng; Ehrnhoefer, Dagmar E.; Zaidi, Rameez; Clemente, Arjay; Kaul, Marcus; Graham, Rona K.; Zhang, Dongxian; Chen, H-S Vincent; Tong, Gary; Hayden, Michael R.; Lipton, Stuart A.			Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin	NATURE MEDICINE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; YAC128 MOUSE MODEL; IN-VIVO; MEDIATED EXCITOTOXICITY; AGGREGATION; DYSFUNCTION; MEMANTINE; NEUROPROTECTION; ABNORMALITIES; ACTIVATION	Huntington's disease is caused by an expanded CAG repeat in the gene encoding huntingtin (HTT), resulting in loss of striatal and cortical neurons. Given that the gene product is widely expressed, it remains unclear why neurons are selectively targeted. Here we show the relationship between synaptic and extrasynaptic activity, inclusion formation of mutant huntingtin protein (mtHtt) and neuronal survival. Synaptic N-methyl-d-aspartate-type glutamate receptor (NMDAR) activity induces mtHtt inclusions via a T complex-1 (TCP-1) ring complex (TRiC)-dependent mechanism, rendering neurons more resistant to mtHtt-mediated cell death. In contrast, stimulation of extrasynaptic NMDARs increases the vulnerability of mtHtt-containing neurons to cell death by impairing the neuroprotective cyclic AMP response element-binding protein (CREB)-peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) cascade and increasing the level of the small guanine nucleotide-binding protein Rhes, which is known to sumoylate and disaggregate mtHtt. Treatment of transgenic mice expressing a yeast artificial chromosome containing 128 CAG repeats (YAC128) with low-dose memantine blocks extrasynaptic (but not synaptic) NMDARs and ameliorates neuropathological and behavioral manifestations. By contrast, high-dose memantine, which blocks both extrasynaptic and synaptic NMDAR activity, decreases neuronal inclusions and worsens these outcomes. Our findings offer a rational therapeutic approach for protecting susceptible neurons in Huntington's disease.	[Okamoto, Shu-ichi; Talantova, Maria; Yao, Dongdong; Xia, Peng; Zaidi, Rameez; Clemente, Arjay; Kaul, Marcus; Zhang, Dongxian; Chen, H-S Vincent; Tong, Gary; Lipton, Stuart A.] Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA; [Pouladi, Mahmoud A.; Ehrnhoefer, Dagmar E.; Graham, Rona K.; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Chen, H-S Vincent] Univ Calif San Diego, Div Cardiol, La Jolla, CA 92093 USA; [Tong, Gary; Lipton, Stuart A.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of British Columbia; University of California System; University of California San Diego; University of California System; University of California San Diego	Lipton, SA (corresponding author), Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA.	mrh@cmmt.ubc.ca; slipton@burnham.org	Graham, Rona K/R-7358-2018; Ehrnhoefer, Dagmar/B-7231-2008; Tong, Gary/AAC-9426-2022; Hayden, Michael R/D-8581-2011; Pouladi, Mahmoud A/B-8743-2016; Kaul, Marcus/AAS-8955-2020; Ehrnhöfer, Dagmar/O-2514-2016	Graham, Rona K/0000-0003-3722-6241; Ehrnhoefer, Dagmar/0000-0003-3411-5415; Hayden, Michael R/0000-0001-5159-1419; Pouladi, Mahmoud A/0000-0002-9030-0976; Ehrnhöfer, Dagmar/0000-0003-3411-5415; Lipton, Stuart/0000-0002-3490-1259	US National Institutes of Health [P01 HD29587, P01 ES016738, R01 EY09024, R01 EY05477, R01 NS41207]; Ellison Medical Foundation; National Institutes of Health [P30 NS057096]; Canadian Institute of Health Research; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; Huntington Society of Canada; Huntington's Disease Society of America, CHDI Foundation, Inc.; HighQ Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009024, R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041207, P30NS057096] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Huntington Society of Canada; Huntington's Disease Society of America, CHDI Foundation, Inc.; HighQ Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. A. Ross (Johns Hopkins University School of Medicine) and L. M. Ellerby (Buck Institute for Age Research) for N-terminal and full-length constructs of huntingtin, T. F. Newmeyer and H. Fang (Burnham Institute for Medical Research) for preparing primary neuronal cultures, X.-J.Li (Emory University School of Medicine) for providing the EM48 antibody and E. Bossy-Wetzel, Y.S. Choo, W. Zago and T. Nakamura for assistance or discussion. This work was supported in part by US National Institutes of Health grants P01 HD29587, P01 ES016738, R01 EY09024, R01 EY05477 and R01 NS41207 and a Senior Scholar Award in Aging Research from the Ellison Medical Foundation (S. A. L.). Additional support was provided by the National Institutes of Health Blueprint Grant for La Jolla Interdisciplinary Neuroscience Center Cores P30 NS057096. M. A. P. was supported by the Canadian Institute of Health Research and the Michael Smith Foundation for Health Research. M. R. H. was supported by grants from the Canadian Institutes of Health Research, the Huntington Society of Canada, the Huntington's Disease Society of America, CHDI Foundation, Inc., and the HighQ Foundation.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Beister A, 2004, J NEURAL TRANSM-SUPP, P117; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Heng MY, 2009, J NEUROSCI, V29, P3200, DOI 10.1523/JNEUROSCI.5599-08.2009; Hesselink MB, 1999, PHARMACEUT RES, V16, P637, DOI 10.1023/A:1018856020583; King MA, 2008, J NEUROSCI, V28, P14401, DOI 10.1523/JNEUROSCI.4751-08.2008; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Pickett J, 2006, NAT REV NEUROSCI, V7, P832, DOI 10.1038/nrn2034; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	43	326	329	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2009	15	12					1407	U8		10.1038/nm.2056	http://dx.doi.org/10.1038/nm.2056			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	527YS	19915593	Green Accepted, Green Submitted			2022-12-25	WOS:000272407800021
J	Chambers, JC; Zhang, WH; Li, Y; Sehmi, J; Wass, MN; Zabaneh, D; Hoggart, C; Bayele, H; McCarthy, MI; Peltonen, L; Freimer, NB; Srai, SK; Maxwell, PH; Sternberg, MJE; Ruokonen, A; Abecasis, G; Jarvelin, MR; Scott, J; Elliott, P; Kooner, JS				Chambers, John C.; Zhang, Weihua; Li, Yun; Sehmi, Joban; Wass, Mark N.; Zabaneh, Delilah; Hoggart, Clive; Bayele, Henry; McCarthy, Mark I.; Peltonen, Leena; Freimer, Nelson B.; Srai, Surjit K.; Maxwell, Patrick H.; Sternberg, Michael J. E.; Ruokonen, Aimo; Abecasis, Goncalo; Jarvelin, Marjo-Riitta; Scott, James; Elliott, Paul; Kooner, Jaspal S.			Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels	NATURE GENETICS			English	Article							SERINE-PROTEASE MATRIPTASE-2; IRON-DEFICIENCY; EXPRESSION	We carried out a genome-wide association study of hemoglobin levels in 16,001 individuals of European and Indian Asian ancestry. The most closely associated SNP (rs855791) results in nonsynonymous (V736A) change in the serine protease domain of TMPRSS6 and a blood hemoglobin concentration 0.13 (95% CI 0.09-0.17) g/dl lower per copy of allele A (P = 1.6 x 10(-13)). Our findings suggest that TMPRSS6, a regulator of hepcidin synthesis and iron handling, is crucial in hemoglobin level maintenance.	[Chambers, John C.; Zhang, Weihua; Zabaneh, Delilah; Hoggart, Clive; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Li, Yun; Abecasis, Goncalo] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sehmi, Joban; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Wass, Mark N.; Sternberg, Michael J. E.] Univ London Imperial Coll Sci Technol & Med, Struct Bioinformat Grp, London, England; [Bayele, Henry; Srai, Surjit K.] UCL, Dept Biol Mol & Struct, London, England; [McCarthy, Mark I.] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Oxford NIHR Biomed Res Ctr, Oxford, England; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Maxwell, Patrick H.] UCL, Div Med, London, England; [Ruokonen, Aimo] Univ Hosp Oulu, Dept Clin Chem, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland	Imperial College London; University of Michigan System; University of Michigan; Imperial College London; Imperial College London; University of London; University College London; University of Oxford; University of Oxford; Wellcome Trust Sanger Institute; University of California System; University of California Los Angeles; University of London; University College London; University of Oulu; University of Oulu	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England.	john.chambers@ic.ac.uk; j.kooner@ic.ac.uk	Wass, Mark/H-3398-2019; Srai, Kaila/AAE-7039-2021; zhang, weihua/GXV-1334-2022; Wass, Mark N/F-5540-2010; Maxwell, Patrick H/C-5557-2008; Abecasis, Goncalo R/B-7840-2010; McCarthy, Mark/M-3763-2015	Wass, Mark/0000-0001-5428-6479; Maxwell, Patrick H/0000-0002-0338-2679; Abecasis, Goncalo/0000-0003-1509-1825; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; McCarthy, Mark/0000-0002-4393-0510; Sternberg, Michael/0000-0002-1884-5445; Elliott, Paul/0000-0002-7511-5684	British Heart Foundation [SP/04/002]; Wellcome Trust; Academy of Finland [104781, 120315]; University Hospital Oulu, Biocenter, University of Oulu, Finland; National Heart, Lung, and Blood Institute (US) [5R01HL087679-02, 1RL1MH083268-01]; ENGAGE; Medical Research Council (UK) [G0500539, G0600705]; Wellcome Trust (UK) [GR069224]; Research Council UK; Academy of Finland and Biocentrum Helsinki;  [HEALTH-F4-2007-201413]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; BBSRC [BB/F020481/1] Funding Source: UKRI; MRC [G0601966, G0600705, G0700931, G0801056] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020481/1] Funding Source: researchfish; Medical Research Council [G0601966, G0801056, G0600705, G0801056B, G0700931] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); University Hospital Oulu, Biocenter, University of Oulu, Finland; National Heart, Lung, and Blood Institute (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ENGAGE; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (UK)(Wellcome Trust); Research Council UK(UK Research & Innovation (UKRI)); Academy of Finland and Biocentrum Helsinki(Academy of Finland); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the participants and research teams involved in LOLIPOP and NFBC1966, including P. Rantakallio, O. Tornwall and M. Jussila. The LOLIPOP study was supported by the British Heart Foundation (SP/04/002) and the Wellcome Trust. NFBC1966 was supported by the Academy of Finland (project grants 104781, 120315 and Center of Excellence in Complex Disease Genetics), University Hospital Oulu, Biocenter, University of Oulu, Finland, National Heart, Lung, and Blood Institute (US) grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, the Medical Research Council (UK) (studentship grant G0500539, centre grant G0600705), the Wellcome Trust (UK) (project grant GR069224) and the Research Council UK fellowship. We thank the National Public Health Institute, Biomedicum Helsinki, Finland, supported financially by the Academy of Finland and Biocentrum Helsinki, for DNA extraction, sample quality controls, biobank upkeep and aliquotting.	Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Beutler E, 2003, BRIT J HAEMATOL, V120, P887, DOI 10.1046/j.1365-2141.2003.04215.x; deBenoist B, 2008, WORLDWIDE PREVALENCE; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramsay AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P569, DOI 10.2741/2702; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Weatherall DJ, 2000, LANCET, V355, P1169, DOI 10.1016/S0140-6736(00)02073-0	15	178	184	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2009	41	11					1170	1172		10.1038/ng.462	http://dx.doi.org/10.1038/ng.462			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19820698	Green Accepted, Green Published			2022-12-25	WOS:000271247600006
J	Zoltowski, BD; Vaccaro, B; Crane, BR				Zoltowski, Brian D.; Vaccaro, Brian; Crane, Brian R.			Mechanism-based tuning of a LOV domain photoreceptor	NATURE CHEMICAL BIOLOGY			English	Article							BLUE-LIGHT PHOTORECEPTOR; INDUCED STRUCTURAL-CHANGES; S-H GROUP; CHLAMYDOMONAS-REINHARDTII; CLOSTRIDIUM-BEIJERINCKII; ADIANTUM PHYTOCHROME3; NEUROSPORA-CRASSA; PHOTOTROPIN; PROTEIN; PHOTOCYCLE	Phototropin-like LOV domains form a cysteinyl-flavin adduct in response to blue light but show considerable variation in output signal and the lifetime of the photo-adduct signaling state. Mechanistic studies of the slow-cycling fungal LOV photoreceptor Vivid (VVD) reveal the importance of reactive cysteine conformation, flavin electronic environment and solvent accessibility for adduct scission and thermal reversion. Proton inventory, pH effects, base catalysis and structural studies implicate flavin N-5 deprotonation as rate-determining for recovery. Substitutions of active site residues Ile74, Ile85, Met135 and Met165 alter photoadduct lifetimes by over four orders of magnitude in VVD, and similar changes in other LOV proteins show analogous effects. Adduct state decay rates also correlate with changes in conformational and oligomeric properties of the protein necessary for signaling. These findings link natural sequence variation of LOV domains to function and provide a means to design broadly reactive light-sensitive probes.	[Zoltowski, Brian D.; Vaccaro, Brian; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bc69@cornell.edu	Vaccaro, Brian/F-8526-2017		US National Institutes of Health [R01-GM079679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079679] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. Vaidya for help with kinetic studies, K. Gardner (University of Texas Southwestern) for supplying the AsLOV2 expression clone, J. Widom for help with mutagenesis and protein expression, and the Cornell High Energy Synchrotron for access to data collection facilities. This work was supported by US National Institutes of Health grant R01-GM079679.	Alexandre MTA, 2008, PHYS CHEM CHEM PHYS, V10, P6693, DOI 10.1039/b810040c; Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Dittrich M, 2005, J PHYS CHEM B, V109, P13006, DOI 10.1021/jp050943o; Domratcheva T, 2006, J CHEM THEORY COMPUT, V2, P1565, DOI 10.1021/ct0600114; Druhan LJ, 1998, BIOCHEMISTRY-US, V37, P9668, DOI 10.1021/bi980770b; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Ishikita H, 2007, J BIOL CHEM, V282, P25240, DOI 10.1074/jbc.M702788200; Iwata T, 2002, J AM CHEM SOC, V124, P11840, DOI 10.1021/ja020834c; Iwata T, 2003, BIOCHEMISTRY-US, V42, P8183, DOI 10.1021/bi0345135; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Kennis JTM, 2004, J AM CHEM SOC, V126, P4512, DOI 10.1021/ja031840r; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; LAMB JS, J MOL BIOL IN PRESS; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nakasone Y, 2008, J MOL BIOL, V383, P904, DOI 10.1016/j.jmb.2008.08.074; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Sato Y, 2005, J AM CHEM SOC, V127, P1088, DOI 10.1021/ja0436897; Sato Y, 2007, BIOCHEMISTRY-US, V46, P10258, DOI 10.1021/bi701022v; Schleicher E, 2004, J AM CHEM SOC, V126, P11067, DOI 10.1021/ja049553q; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Shrode LB, 2001, FUNGAL GENET BIOL, V32, P169, DOI 10.1006/fgbi.2001.1264; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; VENKATASUBBAN KS, 1984, CRC CR REV BIOCH MOL, V17, P1, DOI 10.3109/10409238409110268; YAGI K, 1980, BIOCHEMISTRY-US, V19, P1553, DOI 10.1021/bi00549a003; Yamamoto A, 2008, BIOCHEMISTRY-US, V47, P922, DOI 10.1021/bi701851v; Yoshida Y, 2004, J BIOL CHEM, V279, P6986, DOI 10.1074/jbc.M310060200; Zikihara K, 2006, BIOCHEMISTRY-US, V45, P10828, DOI 10.1021/bi0607857; Zoltowski BD, 2008, BIOCHEMISTRY-US, V47, P7012, DOI 10.1021/bi8007017; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	49	203	208	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2009	5	11					827	834		10.1038/nchembio.210	http://dx.doi.org/10.1038/nchembio.210			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	508FQ	19718042	Green Accepted			2022-12-25	WOS:000270915000012
J	Tanaka, Y; Nishida, N; Sugiyama, M; Kurosaki, M; Matsuura, K; Sakamoto, N; Nakagawa, M; Korenaga, M; Hino, K; Hige, S; Ito, Y; Mita, E; Tanaka, E; Mochida, S; Murawaki, Y; Honda, M; Sakai, A; Hiasa, Y; Nishiguchi, S; Koike, A; Sakaida, I; Imamura, M; Ito, K; Yano, K; Masaki, N; Sugauchi, F; Izumi, N; Tokunaga, K; Mizokami, M				Tanaka, Yasuhito; Nishida, Nao; Sugiyama, Masaya; Kurosaki, Masayuki; Matsuura, Kentaro; Sakamoto, Naoya; Nakagawa, Mina; Korenaga, Masaaki; Hino, Keisuke; Hige, Shuhei; Ito, Yoshito; Mita, Eiji; Tanaka, Eiji; Mochida, Satoshi; Murawaki, Yoshikazu; Honda, Masao; Sakai, Akito; Hiasa, Yoichi; Nishiguchi, Shuhei; Koike, Asako; Sakaida, Isao; Imamura, Masatoshi; Ito, Kiyoaki; Yano, Koji; Masaki, Naohiko; Sugauchi, Fuminaka; Izumi, Namiki; Tokunaga, Katsushi; Mizokami, Masashi			Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C	NATURE GENETICS			English	Article							PLUS RIBAVIRIN; COMBINATION THERAPY; VIROLOGICAL RESPONSE; 1B	The recommended treatment for patients with chronic hepatitis C, pegylated interferon-alpha (PEG-IFN-alpha) plus ribavirin (RBV), does not provide sustained virologic response (SVR) in all patients. We report a genome-wide association study (GWAS) to null virological response (NVR) in the treatment of patients with hepatitis C virus (HCV) genotype 1 within a Japanese population. We found two SNPs near the gene IL28B on chromosome 19 to be strongly associated with NVR (rs12980275, P = 1.93 x 10(-13), and rs8099917, 3.11 x 10(-15)). We replicated these associations in an independent cohort (combined P values, 2.84 x 10(-27) (OR = 17.7; 95% CI = 10.0-31.3) and 2.68 x 10(-32) (OR = 27.1; 95% CI = 14.6-50.3), respectively). Compared to NVR, these SNPs were also associated with SVR (rs12980275, P = 3.99 x 10(-24), and rs8099917, P = 1.11 x 10(-27)). In further fine mapping of the region, seven SNPs (rs8105790, rs11881222, rs8103142, rs28416813, rs4803219, rs8099917 and rs7248668) located in the IL28B region showed the most significant associations (P = 5.52 x 10(-28)-2.68 x 10(-32); OR = 22.3-27.1). Real-time quantitative PCR assays in peripheral blood mononuclear cells showed lower IL28B expression levels in individuals carrying the minor alleles (P = 0.015).	[Tanaka, Yasuhito; Sugiyama, Masaya; Matsuura, Kentaro; Sugauchi, Fuminaka; Mizokami, Masashi] Nagoya City Univ, Grad Sch Med Sci, Dept Clin Mol Informat Med, Nagoya, Aichi, Japan; [Nishida, Nao; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Kurosaki, Masayuki; Izumi, Namiki] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Tokyo, Japan; [Sakamoto, Naoya; Nakagawa, Mina] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Korenaga, Masaaki; Hino, Keisuke] Kawasaki Med Coll, Div Hepatol & Pancreatol, Kurashiki, Okayama, Japan; [Hige, Shuhei] Hokkaido Univ, Dept Internal Med, Grad Sch Med, Sapporo, Hokkaido, Japan; [Ito, Yoshito] Kyoto Prefectural Univ Med, Kyoto, Japan; [Mita, Eiji] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan; [Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 390, Japan; [Mochida, Satoshi] Saitama Med Univ, Div Gastroenterol & Hepatol, Saitama, Japan; [Murawaki, Yoshikazu] Tottori Univ, Fac Med, Dept Internal Med 2, Yonago, Tottori 683, Japan; [Honda, Masao; Sakai, Akito] Kanazawa Univ, Dept Gastroenterol, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Hiasa, Yoichi] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Nishiguchi, Shuhei] Hyogo Coll Med, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Koike, Asako] Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo 185, Japan; [Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan; [Imamura, Masatoshi; Ito, Kiyoaki; Yano, Koji; Masaki, Naohiko; Mizokami, Masashi] Japan Konodai Hosp, Int Med Ctr, Res Ctr Hepatitis & Immunol, Ichikawa, Japan	Nagoya City University; University of Tokyo; Tokyo Medical & Dental University (TMDU); Kawasaki Medical School; Hokkaido University; Kyoto Prefectural University of Medicine; Osaka National Hospital; Shinshu University; Saitama Medical University; Tottori University; Kanazawa University; Ehime University; Hyogo College of Medicine; Hitachi Limited; Yamaguchi University	Mizokami, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Clin Mol Informat Med, Nagoya, Aichi, Japan.	mmizokami@imcjk2.hosp.go.jp	Sakamoto, Naoya/G-2734-2012; Hiasa, Yoichi/ABD-2759-2021; Korenaga, Masaaki/AAE-7479-2020; Nakagawa, Mina/AAO-4589-2020; nakagawa, mina/AAH-8088-2020	Sakamoto, Naoya/0000-0003-0061-059X; Hiasa, Yoichi/0000-0003-4117-339X; Tanaka, Yasuhito/0000-0002-2473-6966	Ministry of Health, Labour, and Welfare of Japan [H19-kannen-013]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant-in-aid from the Ministry of Health, Labour, and Welfare of Japan (H19-kannen-013). This study is based on 15 multicenter hospitals throughout Japan, in the Hokkaido area (Hokkaido University Hospital), Kanto area (Saitama University Hospital; Konodai Hospital; Musashino Red Cross Hospital; Tokyo Medical and Dental University Hospital), Koshin area (Shinshu University Hospital; Kanazawa University Hospital), Tokai area (Nagoya City University Hospital), Kinki area (Kyoto Prefectural University of Medicine Hospital; National Hospital Organization Osaka National Hospital; Hyogo College of Medicine Hospital) and Chugoku/Shikoku area (Tottori University Hospital; Ehime University Hospital; Yamaguchi University Hospital; Kawasaki Medical College Hospital). We thank Y. Uehara-Shibata, Y. Ogasawara, Y. Ishibashi and M. Yamaoka-Sageshima (Tokyo University) for technical assistance; A. Matsumoto (Shinshu), K. Naiki (Saitama), K. Nishimura (Kyoto), H. Enomoto (Hyogo), K. Oyama (Tottori) and the Ochanomizu Liver Conference Study Group for collecting samples; M. Watanabe (Tokyo Medical and Dental University), S. Kaneko (Kanazawa University) and M. Onji (Ehime University) for their advice throughout the study; and H. Ito (Aichi Cancer Center) for conducting statistical analyses.	Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Bruno S, 2004, J HEPATOL, V41, P474, DOI 10.1016/j.jhep.2004.05.012; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Kim WR, 2002, MICROBES INFECT, V4, P1219, DOI 10.1016/S1286-4579(02)01649-0; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Matsuyama N, 2003, HEPATOL RES, V25, P221, DOI 10.1016/S1386-6346(02)00269-3; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Miyagawa T, 2008, J HUM GENET, V53, P886, DOI 10.1007/s10038-008-0322-y; NISHIDA N, 2006, GASTROENTEROLOGY, V131, P1887; Nishida N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-431; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Sezaki H, 2009, DIGEST DIS SCI, V54, P1317, DOI 10.1007/s10620-008-0500-y; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Tsukada H, 2009, GASTROENTEROLOGY, V136, P1796, DOI 10.1053/j.gastro.2009.01.061; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674	24	1821	1934	0	159	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1105	U81		10.1038/ng.449	http://dx.doi.org/10.1038/ng.449			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19749757				2022-12-25	WOS:000270330400014
J	Wu, SG; Rhee, KJ; Albesiano, E; Rabizadeh, S; Wu, XQ; Yen, HR; Huso, DL; Brancati, FL; Wick, E; McAllister, F; Housseau, F; Pardoll, DM; Sears, CL				Wu, Shaoguang; Rhee, Ki-Jong; Albesiano, Emilia; Rabizadeh, Shervin; Wu, Xinqun; Yen, Hung-Rong; Huso, David L.; Brancati, Frederick L.; Wick, Elizabeth; McAllister, Florencia; Housseau, Franck; Pardoll, Drew M.; Sears, Cynthia L.			A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses	NATURE MEDICINE			English	Article							ENTEROTOXIGENIC BACTEROIDES-FRAGILIS; COLITIS-ASSOCIATED CANCER; TUMOR MICROENVIRONMENT; COLORECTAL-CANCER; APC(MIN/+) MICE; MOUSE MODEL; INFLAMMATION; INFECTION; STAT3; IMMUNITY	The intestinal flora may promote colon tumor formation. Here we explore immunologic mechanisms of colonic carcinogenesis by a human colonic bacterium, enterotoxigenic Bacteroides fragilis (ETBF). ETBF that secretes B. fragilis toxin (BFT) causes human inflammatory diarrhea but also asymptomatically colonizes a proportion of the human population. Our results indicate that whereas both ETBF and nontoxigenic B. fragilis (NTBF) chronically colonize mice, only ETBF triggers colitis and strongly induces colonic tumors in multiple intestinal neoplasia (Min) mice. ETBF induces robust, selective colonic signal transducer and activator of transcription-3 (Stat3) activation with colitis characterized by a selective T helper type 17 (T(H)17) response distributed between CD4(+) T cell receptor-alpha beta (TCR alpha beta)(+) and CD4(-)8(-)TCR gamma alpha(+) T cells. Antibody-mediated blockade of interleukin-17 (IL-17) as well as the receptor for IL-23, a key cytokine amplifying T(H)17 responses, inhibits ETBF-induced colitis, colonic hyperplasia and tumor formation. These results show a Stat3- and T(H)17-dependent pathway for inflammation-induced cancer by a common human commensal bacterium, providing new mechanistic insight into human colon carcinogenesis.	[Wu, Shaoguang; Rhee, Ki-Jong; Wu, Xinqun; Brancati, Frederick L.; McAllister, Florencia; Pardoll, Drew M.; Sears, Cynthia L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Albesiano, Emilia; Wu, Xinqun; Yen, Hung-Rong; McAllister, Florencia; Housseau, Franck; Pardoll, Drew M.; Sears, Cynthia L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Albesiano, Emilia; Wu, Xinqun; Yen, Hung-Rong; McAllister, Florencia; Housseau, Franck; Pardoll, Drew M.; Sears, Cynthia L.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Yen, Hung-Rong] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Yen, Hung-Rong] Chang Gung Mem Hosp, Ctr Tradit Chinese Med, Tao Yuan, Taiwan; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Wick, Elizabeth] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Chang Gung University; Chang Gung Memorial Hospital; Johns Hopkins University; Johns Hopkins University	Sears, CL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	fhousse1@jhmi.edu; csears@jhmi.edu	Sears, Cynthia L/AAJ-6704-2020; Yen, Hung-Rong/M-1373-2013	Sears, Cynthia L/0000-0003-4059-1661; Yen, Hung-Rong/0000-0002-0131-1658; Rhee, Ki-Jong/0000-0001-5130-2728	Crohn's and Colitis Foundation [RO1 DK45496, RO1 DK080817]; US National Institutes of Health; Special Projects of Research Excellence [CA62924, R24 DK64388, RR00171]; Institutional Training for Pediatricians [5 T32 HD44355]; Clinical Pharmacology [2 T32GM066691];  [F32 DK079509]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044355] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064388, R01DK045496, R01DK080817, F32DK079509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066691] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Special Projects of Research Excellence; Institutional Training for Pediatricians; Clinical Pharmacology; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Crohn's and Colitis Foundation through a Senior Investigator Award (to C. L. S.) and a Research Fellowship Award (to K.-J.R.), RO1 DK45496 (to C. L. S.), RO1 DK080817 (to C. L. S.), US National Institutes of Health grants (to D. M. P.), Special Projects of Research Excellence grant CA62924, R24 DK64388 (to M. Donowitz, the principal investigator of this grant that provided resource support to this project), RR00171 grant (to D. L. H.), Institutional Training for Pediatricians 5 T32 HD44355 (to G. Dover, the principal investigator of this grant that provided partial salary support to S. R.), Clinical Pharmacology Training Program 2 T32GM066691 (to T. Shapiro, the principal investigator of this grant that provided salary support to F. M.) and F32 DK079509 (to S. R.). This work was also supported by gifts from B. Schwartz, W. and B. Topercer, D. Needle, B. Swartz and the Commonwealth Foundation. D. M. P. is a Januey scholar and holds the Abeloff Chair in Oncology at Johns Hopkins University. We thank J. Wolfe for her assistance with some experiments; L. Myers (formerly Montana State University) for ETBF strain 86-5443-2-2; B. Vogelstein and K. Kinzler (Johns Hopkins University School of Medicine) for Min mice and E. Jaffee (Johns Hopkins University School of Medicine) for GK1.5 antibody.	Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hope ME, 2005, FEMS MICROBIOL LETT, V244, P1, DOI 10.1016/j.femsle.2005.01.029; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Nagamine CM, 2008, INFECT IMMUN, V76, P2758, DOI 10.1128/IAI.01604-07; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Niess JH, 2008, J IMMUNOL, V180, P559, DOI 10.4049/jimmunol.180.1.559; Poutahidis T, 2007, CARCINOGENESIS, V28, P2614, DOI 10.1093/carcin/bgm180; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rao VP, 2006, CANCER RES, V66, P57, DOI 10.1158/0008-5472.CAN-05-3445; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Sears CL, 2008, CLIN INFECT DIS, V47, P797, DOI 10.1086/591130; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	46	1076	1135	7	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1016	U64		10.1038/nm.2015	http://dx.doi.org/10.1038/nm.2015			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19701202	Green Accepted			2022-12-25	WOS:000269979200021
J	Pomerantz, MM; Ahmadiyeh, N; Jia, L; Herman, P; Verzi, MP; Doddapaneni, H; Beckwith, CA; Chan, JA; Hills, A; Davis, M; Yao, KL; Kehoe, SM; Lenz, HJ; Haiman, CA; Yan, CL; Henderson, BE; Frenkel, B; Barretina, J; Bass, A; Tabernero, J; Baselga, J; Regan, MM; Manak, JR; Shivdasani, R; Coetzee, GA; Freedman, ML				Pomerantz, Mark M.; Ahmadiyeh, Nasim; Jia, Li; Herman, Paula; Verzi, Michael P.; Doddapaneni, Harshavardhan; Beckwith, Christine A.; Chan, Jennifer A.; Hills, Adam; Davis, Matt; Yao, Keluo; Kehoe, Sarah M.; Lenz, Heinz-Josef; Haiman, Christopher A.; Yan, Chunli; Henderson, Brian E.; Frenkel, Baruch; Barretina, Jordi; Bass, Adam; Tabernero, Josep; Baselga, Jose; Regan, Meredith M.; Manak, J. Robert; Shivdasani, Ramesh; Coetzee, Gerhard A.; Freedman, Matthew L.			The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer	NATURE GENETICS			English	Article							WIDE ASSOCIATION SCAN; CHROMOSOME 8Q24; BETA-CATENIN; GENOME; ACTIVATION; ENHANCERS; PROSTATE; APC	An inherited variant on chromosome 8q24, rs6983267, is significantly associated with cancer pathogenesis. We present evidence that the region harboring this variant is a transcriptional enhancer, that the alleles of rs6983267 differentially bind transcription factor 7-like 2 (TCF7L2) and that the risk region physically interacts with the MYC protooncogene. These data provide strong support for a biological mechanism underlying this non-protein-coding risk variant.	[Pomerantz, Mark M.; Ahmadiyeh, Nasim; Herman, Paula; Verzi, Michael P.; Beckwith, Christine A.; Hills, Adam; Davis, Matt; Yao, Keluo; Kehoe, Sarah M.; Barretina, Jordi; Bass, Adam; Shivdasani, Ramesh; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ahmadiyeh, Nasim] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Jia, Li; Yan, Chunli; Coetzee, Gerhard A.] USC, Keck Sch Med, Dept Urol, Los Angeles, CA USA; [Doddapaneni, Harshavardhan; Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Chan, Jennifer A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 1N4, Canada; [Lenz, Heinz-Josef; Haiman, Christopher A.; Henderson, Brian E.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Frenkel, Baruch] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Tabernero, Josep; Baselga, Jose] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol, Catalonia, Spain; [Regan, Meredith M.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Freedman, Matthew L.] Broad Inst Harvard, Cambridge, MA USA; [Freedman, Matthew L.] MIT, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Southern California; University of Southern California Keck Hospital; University of Iowa; University of Calgary; University of Southern California; University of Southern California; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Freedman, ML (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	freedman@broad.mit.edu	Davis, Matt/F-9045-2012; li, jia/GVT-7587-2022; Jia, li/GPW-8015-2022; coetzee, Gerhard/AAT-6203-2020; Coetzee, Gerhard/AAG-8439-2019; Tabernero, Josep/AAG-5026-2019; Barretina, Jordi/A-7192-2013	Tabernero, Josep/0000-0002-2495-8139; Barretina, Jordi/0000-0002-3478-4080; Ahmadiyeh, Nasim/0000-0002-4028-6539; /0000-0003-4914-1157; doddapaneni, harshavardhan/0000-0002-2433-633X; Manak, John/0000-0002-6562-7694; Coetzee, Gerhard/0000-0001-8820-8364	National Institutes of Health [R01 CA129435, R01 CA109147]; Mayer Foundation; H. L. Snyder Medical Foundation; Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE [5P50CA90381]; Prostate Cancer Foundation; Whittier Foundation; American Cancer Society Institutional Research [IRG -58-007-48]; American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE [K08CA134931, R01CA109147, P50CA090381, R01CA136924, R01CA129435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayer Foundation; H. L. Snyder Medical Foundation; Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE; Prostate Cancer Foundation; Whittier Foundation; American Cancer Society Institutional Research(American Cancer Society); American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M. L. F. is a Howard Hughes Medical Institute Physician-Scientist Early Career Awardee and is a recipient of a 2006 Doris Duke Clinical Scientist Development Award. This work was supported by grants from the US National Institutes of Health (R01 CA129435 to M. L. F. and R01 CA109147 to G. A. C.), the Mayer Foundation (to M. L. F.), the H. L. Snyder Medical Foundation (to M. L. F.), the Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (National Cancer Institute Grant No. 5P50CA90381), the Prostate Cancer Foundation (to G. A. C. and to M. M. P.), the Whittier Foundation (to G. A. C.), the American Cancer Society Institutional Research Grant (IRG -58-007-48 to L. J.) and the American Society of Clinical Oncology (to M. M. P.). We also acknowledge M. A. Brown for his support and guidance.	Barker N, 2000, ADV CANCER RES, V77, P1; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Miele A, 2006, CURR PROTOC MOL BIOL; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Polakis P, 2000, GENE DEV, V14, P1837; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	15	511	529	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					882	884		10.1038/ng.403	http://dx.doi.org/10.1038/ng.403			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19561607	Green Accepted			2022-12-25	WOS:000268432900010
J	Shete, S; Hosking, FJ; Robertson, LB; Dobbins, SE; Sanson, M; Malmer, B; Simon, M; Marie, Y; Boisselier, B; Delattre, JY; Hoang-Xuan, K; El Hallani, S; Idbaih, A; Zelenika, D; Andersson, U; Henriksson, R; Bergenheim, AT; Feychting, M; Lonn, S; Ahlbom, A; Schramm, J; Linnebank, M; Hemminki, K; Kumar, R; Hepworth, SJ; Price, A; Armstrong, G; Liu, YH; Gu, XJ; Yu, R; Lau, C; Schoemaker, M; Muir, K; Swerdlow, A; Lathrop, M; Bondy, M; Houlston, RS				Shete, Sanjay; Hosking, Fay J.; Robertson, Lindsay B.; Dobbins, Sara E.; Sanson, Marc; Malmer, Beatrice; Simon, Matthias; Marie, Yannick; Boisselier, Blandine; Delattre, Jean-Yves; Hoang-Xuan, Khe; El Hallani, Soufiane; Idbaih, Ahmed; Zelenika, Diana; Andersson, Ulrika; Henriksson, Roger; Bergenheim, A. Tommy; Feychting, Maria; Lonn, Stefan; Ahlbom, Anders; Schramm, Johannes; Linnebank, Michael; Hemminki, Kari; Kumar, Rajiv; Hepworth, Sarah J.; Price, Amy; Armstrong, Georgina; Liu, Yanhong; Gu, Xiangjun; Yu, Robert; Lau, Ching; Schoemaker, Minouk; Muir, Kenneth; Swerdlow, Anthony; Lathrop, Mark; Bondy, Melissa; Houlston, Richard S.			Genome-wide association study identifies five susceptibility loci for glioma	NATURE GENETICS			English	Article							NERVOUS-SYSTEM TUMORS; BIRTH-WEIGHT; GENE-EXPRESSION; BREAST-CANCER; RETINOIC ACID; RISK; POPULATION; GLIOBLASTOMA; DELETION; 8Q24	To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide association studies by genotyping 550K tagging SNPs in a total of 1,878 cases and 3,670 controls, with validation in three additional independent series totaling 2,545 cases and 2,953 controls. We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)). These data show that common low-penetrance susceptibility alleles contribute to the risk of developing glioma and provide insight into disease causation of this primary brain tumor.	[Hosking, Fay J.; Robertson, Lindsay B.; Dobbins, Sara E.; Price, Amy; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Shete, Sanjay; Armstrong, Georgina; Liu, Yanhong; Gu, Xiangjun; Yu, Robert; Bondy, Melissa] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Sanson, Marc; Marie, Yannick; Boisselier, Blandine; Delattre, Jean-Yves; Hoang-Xuan, Khe; El Hallani, Soufiane; Idbaih, Ahmed] UPMC, GH Pitie Salpetriere, AP HP, Serv Neurol Mazarin, Paris, France; [Sanson, Marc; Marie, Yannick; Boisselier, Blandine; Delattre, Jean-Yves; Hoang-Xuan, Khe; El Hallani, Soufiane; Idbaih, Ahmed] UPMC, GH Pitie Salpetriere, AP HP, INSERM,UMR 975, Paris, France; [Malmer, Beatrice; Andersson, Ulrika; Henriksson, Roger] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Sanson, Marc; Schramm, Johannes] Neurochirurg Univ Klin Bonn, Bonn, Germany; [Zelenika, Diana; Lathrop, Mark] IG CEA, Ctr Natl Genotypage, Evry, France; [Bergenheim, A. Tommy] Umea Univ, Dept Clin Neurosci, Umea, Sweden; [Feychting, Maria; Ahlbom, Anders] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Lonn, Stefan] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Linnebank, Michael] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Hemminki, Kari; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Hepworth, Sarah J.] Univ Leeds, Fac Med & Hlth, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [Lau, Ching] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Schoemaker, Minouk; Swerdlow, Anthony] Inst Canc Res, Epidemiol Sect, Sutton, Surrey, England; [Muir, Kenneth] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Queens Med Ctr, Nottingham, England; [Lathrop, Mark] Fdn Jean Dausett CEPH, Paris, France	University of London; Institute of Cancer Research - UK; University of Texas System; UTMD Anderson Cancer Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Umea University; University of Bonn; CEA; UDICE-French Research Universities; Universite Paris Saclay; Umea University; Karolinska Institutet; Karolinska Institutet; University of Zurich; University Zurich Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Leeds; Baylor College of Medicine; Texas Children's Cancer Center; University of London; Institute of Cancer Research - UK; University of Nottingham	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	mbondy@mdanderson.org; Richard.houlston@icr.ac.uk	LIU, YANHONG/A-1495-2010; Hoang-Xuan, Khe/O-7527-2017; BOISSELIER, Blandine/K-4377-2015; Simon, Matthias/F-3046-2014; Henriksson, Roger/AAI-8608-2020; Kumar, Rajiv/H-6431-2019; Idbaih, Ahmed/N-8746-2017	Kumar, Rajiv/0000-0002-6093-0395; Idbaih, Ahmed/0000-0001-5290-1204; Hosking, Fay/0000-0002-1101-039X; Houlston, Richard/0000-0002-5268-0242; Swerdlow, Anthony/0000-0001-5550-4159; Schoemaker, Minouk/0000-0001-8403-2234; Fleming, Sarah/0000-0002-7655-4806	Cancer Research UK [C1298/A8362] Funding Source: Medline; Medical Research Council [G0000934] Funding Source: Medline; NCI NIH HHS [T32 CA096520, 5R01 CA070917, R01 CA070917, 5R01 CA119215, R01 CA119215] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0000934] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [T32CA096520, R01CA070917, R01CA119215] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arakawa Y, 2005, ACTA NEUROPATHOL, V109, P294, DOI 10.1007/s00401-004-0956-6; Bahuau M, 1998, CANCER RES, V58, P2298; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bille C, 2005, AM J EPIDEMIOL, V161, P1047, DOI 10.1093/aje/kwi132; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Cardis E, 2007, EUR J EPIDEMIOL, V22, P647, DOI 10.1007/s10654-007-9152-z; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Das A, 2007, NEUROCHEM RES, V32, P2167, DOI 10.1007/s11064-007-9413-y; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ferrie JE, 2006, INT J EPIDEMIOL, V35, P1532, DOI 10.1093/ije/dyl184; Guo C, 1999, ONCOGENE, V18, P4948, DOI 10.1038/sj.onc.1202887; Hallmans G, 2003, SCAND J PUBLIC HEALT, V31, P18, DOI 10.1080/14034950310001432; Harder T, 2008, AM J EPIDEMIOL, V168, P366, DOI 10.1093/aje/kwn144; Hemminki K, 2003, CANCER EPIDEM BIOMAR, V12, P1137; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jiang MR, 2008, BBA-MOL CELL RES, V1783, P1055, DOI 10.1016/j.bbamcr.2008.02.007; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Randerson-Moor JA, 2001, HUM MOL GENET, V10, P55, DOI 10.1093/hmg/10.1.55; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Simon M, 2006, ONCOL REP, V16, P127; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wager M, 2008, BRIT J CANCER, V98, P1830, DOI 10.1038/sj.bjc.6604378; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yin W, 2006, ONCOGENE, V25, P3735, DOI 10.1038/sj.onc.1209410	37	615	628	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					899	U54		10.1038/ng.407	http://dx.doi.org/10.1038/ng.407			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19578367	Green Accepted			2022-12-25	WOS:000268432900013
J	Kanetsky, PA; Mitra, N; Vardhanabhuti, S; Li, MY; Vaughn, DJ; Letrero, R; Ciosek, SL; Doody, DR; Smith, LM; Weaver, J; Albano, A; Chen, C; Starr, JR; Rader, DJ; Godwin, AK; Reilly, MP; Hakonarson, H; Schwartz, SM; Nathanson, KL				Kanetsky, Peter A.; Mitra, Nandita; Vardhanabhuti, Saran; Li, Mingyao; Vaughn, David J.; Letrero, Richard; Ciosek, Stephanie L.; Doody, David R.; Smith, Lauren M.; Weaver, JoEllen; Albano, Anthony; Chen, Chu; Starr, Jacqueline R.; Rader, Daniel J.; Godwin, Andrew K.; Reilly, Muredach P.; Hakonarson, Hakon; Schwartz, Stephen M.; Nathanson, Katherine L.			Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TUMOR SUSCEPTIBILITY; FACTOR-RECEPTOR; PROLIFERATION; PIGMENTATION; ACTIVATION; FERTILITY; MIGRATION; ETIOLOGY; HUMANS	Testicular germ cell tumors (TGCT) have been expected to have a strong underlying genetic component. We conducted a genome-wide scan among 277 TGCT cases and 919 controls and found that seven markers at 12p22 within KITLG (c-KIT ligand) reached genome-wide significance (P < 5.0 x 10 (-8) in discovery). In independent replication, TGCT risk was increased threefold per copy of the major allele at rs3782179 and rs4474514 (OR = 3.08, 95% CI = 2.29-4.13; OR = 3.07, 95% CI 2.29-4.13, respectively). We found associations with rs4324715 and rs6897876 at 5q31.3 near SPRY4 (sprouty 4; P < 5.0 x 10(-6) in discovery). In independent replication, risk of TGCT was increased nearly 40% per copy of the major allele (OR = 1.37, 95% CI = 1.14-1.64; OR = 1.39, 95% CI = 1.16-1.66, respectively). All of the genotypes were associated with both seminoma and nonseminoma TGCT subtypes. These results demonstrate that common genetic variants affect TGCT risk and implicate KITLG and SPRY4 as genes involved in TGCT susceptibility.	[Kanetsky, Peter A.; Mitra, Nandita; Vaughn, David J.; Letrero, Richard; Ciosek, Stephanie L.; Nathanson, Katherine L.] Univ Penn, Sch Med, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA; [Vaughn, David J.] Univ Penn, Sch Med, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA; [Letrero, Richard; Ciosek, Stephanie L.; Smith, Lauren M.; Nathanson, Katherine L.] Univ Penn, Sch Med, Div Med Genet, Dept Med, Philadelphia, PA 19104 USA; [Kanetsky, Peter A.; Mitra, Nandita; Vardhanabhuti, Saran; Li, Mingyao] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Dept Med, Philadelphia, PA 19104 USA; [Doody, David R.; Starr, Jacqueline R.; Schwartz, Stephen M.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Weaver, JoEllen; Godwin, Andrew K.] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Albano, Anthony; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Albano, Anthony; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Chen, Chu; Starr, Jacqueline R.; Schwartz, Stephen M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Starr, Jacqueline R.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Fred Hutchinson Cancer Center; Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Nathanson, KL (corresponding author), Univ Penn, Sch Med, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA.	knathans@mail.med.upenn.edu		Nathanson, Katherine/0000-0002-6740-0901; Starr, Jacqueline/0000-0002-3039-2311; Reilly, Muredach/0000-0002-3035-9386; Doody, David/0000-0003-2291-6493	NCI NIH HHS [P30 CA006927, R01 CA085914-02, R01 CA085914-06, R01 CA085914-07, R01 CA114478, R01 CA085914-01, R01 CA085914-08, P30 CA006927-41, R01 CA085914-02S1, R01 CA085914-03, R01 CA085914-05, R01 CA085914-10, R01 CA114478-01A2, R01 CA085914-09, R01 CA085914-04, R01 CA085914] Funding Source: Medline; NIEHS NIH HHS [P30 ES007033-15, P30 ES007033] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA085914, R01CA114478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Crockford GP, 2006, HUM MOL GENET, V15, P443, DOI 10.1093/hmg/ddi459; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frolov A, 2003, MOL CANCER THER, V2, P699; Heaney JD, 2008, CANCER RES, V68, P5193, DOI 10.1158/0008-5472.CAN-08-0779; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rapley EA, 2000, NAT GENET, V24, P197, DOI 10.1038/72877; Richiardi L, 2005, CANCER EPIDEM BIOMAR, V14, P2557, DOI 10.1158/1055-9965.EPI-05-0409; Ries L MD, 2008, SEER CANC STAT REV 1; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Starr JR, 2005, CANCER EPIDEM BIOMAR, V14, P2183, DOI 10.1158/1055-9965.EPI-04-0749; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Zama AM, 2005, BIOL REPROD, V73, P639, DOI 10.1095/biolreprod.105.042846	30	256	262	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					811	U65		10.1038/ng.393	http://dx.doi.org/10.1038/ng.393			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19483682	Green Accepted			2022-12-25	WOS:000267786200011
J	Lipson, D; Raz, T; Kieu, A; Jones, DR; Giladi, E; Thayer, E; Thompson, JF; Letovsky, S; Milos, P; Causey, M				Lipson, Doron; Raz, Tal; Kieu, Alix; Jones, Daniel R.; Giladi, Eldar; Thayer, Edward; Thompson, John F.; Letovsky, Stan; Milos, Patrice; Causey, Marie			Quantification of the yeast transcriptome by single-molecule sequencing	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; START SITES; RNA-SEQ; GENOME; SAGE; MPSS; ARRAYS; BIAS	We present single-molecule sequencing digital gene expression (smsDGE), a high-throughput, amplification-free method for accurate quantification of the full range of cellular polyadenylated RNA transcripts using a Helicos Genetic Analysis system. smsDGE involves a reverse-transcription and polyA-tailing sample preparation procedure followed by sequencing that generates a single read per transcript. We applied smsDGE to the transcriptome of Saccharomyces cerevisiae strain DBY746, using 6 of the available 50 channels in a single sequencing run, yielding on average 12 million aligned reads per channel. Using spiked-in RNA, accurate quantitative measurements were obtained over four orders of magnitude. High correlation was demonstrated across independent flow-cell channels, instrument runs and sample preparations. Transcript counting in smsDGE is highly efficient due to the representation of each transcript molecule by a single read. This efficiency, coupled with the high throughput enabled by the single-molecule sequencing platform, provides an alternative method for expression profiling.	[Lipson, Doron; Raz, Tal; Kieu, Alix; Jones, Daniel R.; Giladi, Eldar; Thayer, Edward; Thompson, John F.; Letovsky, Stan; Milos, Patrice; Causey, Marie] Helicos Biosci Corp, Cambridge, MA USA		Raz, T (corresponding author), Helicos Biosci Corp, Cambridge, MA USA.	traz@helicosbio.com		Jones, Daniel/0000-0001-8108-0169; Thompson, John/0000-0001-8568-3311				BOWERS J, NAT METHODS IN PRESS; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Chen JF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-77; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Gilchrist MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-403; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hashimoto S, 2004, NAT BIOTECHNOL, V22, P1146, DOI 10.1038/nbt998; Hene L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-333; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Siddiqui AS, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl404; So AP, 2006, BIOTECHNOL BIOENG, V94, P54, DOI 10.1002/bit.20805; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	25	134	146	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2009	27	7					652	U105		10.1038/nbt.1551	http://dx.doi.org/10.1038/nbt.1551			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	469OF	19581875				2022-12-25	WOS:000267908500022
J	Rajan, A; Tien, AC; Haueter, CM; Schulze, KL; Bellen, HJ				Rajan, Akhila; Tien, An-Chi; Haueter, Claire M.; Schulze, Karen L.; Bellen, Hugo J.			The Arp2/3 complex and WASp are required for apical trafficking of Delta into microvilli during cell fate specification of sensory organ precursors	NATURE CELL BIOLOGY			English	Article							ALDRICH-SYNDROME PROTEIN; DROSOPHILA-MELANOGASTER; ENDOCYTIC PATHWAY; NOTCH ACTIVATION; FOLLICLE CELLS; NUMB PROTEIN; ACTIN; DIVISION; LINEAGE; GENE	Cell fate decisions mediated by the Notch signalling pathway require direct cell-cell contact between adjacent cells. In Drosophila melanogaster, an external sensory organ (ESO) develops from a single sensory organ precursor (SOP) and its fate specification is governed by differential Notch activation. Here we show that mutations in actin-related protein-3 (Arp3) compromise Notch signalling, leading to a fate transformation of the ESO. Our data reveal that during ESO fate specification, most endocytosed vesicles containing the ligand Delta traffic to a prominent apical actin-rich structure (ARS) formed in the SOP daughter cells. Using immunohistochemistry and transmission electron microscopy (TEM) analyses, we show that the ARS contains numerous microvilli on the apical surface of SOP progeny. In Arp2/3 and WASp mutants, the surface area of the ARS is substantially reduced and there are significantly fewer microvilli. More importantly, trafficking of Delta-positive vesicles from the basal area to the apical portion of the ARS is severely compromised. Our data indicate that WASp-dependent Arp2/3 actin polymerization is crucial for apical presentation of Delta, providing a mechanistic link between actin polymerization and Notch signalling.	[Rajan, Akhila; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Tien, An-Chi; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Haueter, Claire M.; Schulze, Karen L.; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu		Bellen, Hugo/0000-0001-5992-5989	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD024064-21S1, P30 HD024064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; deCelis JF, 1996, DEVELOPMENT, V122, P359; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Dollar G, 2002, DEVELOPMENT, V129, P517; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Emery G, 2006, CURR OPIN CELL BIOL, V18, P407, DOI 10.1016/j.ceb.2006.06.009; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Galletta BJ, 2008, PLOS BIOL, V6, P72, DOI 10.1371/journal.pbio.0060001; Gho M, 1999, DEVELOPMENT, V126, P3573; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HEINTZELMAN MB, 1992, CURR TOP DEV BIOL, V26, P93, DOI 10.1016/S0070-2153(08)60442-1; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Imai K, 2003, CURR OPIN ALLERGY CL, V3, P427, DOI 10.1097/01.all.0000104452.09202.9c; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2001, DEV BIOL, V231, P217, DOI 10.1006/dbio.2000.0124; Larsen CW, 2003, DEVELOPMENT, V130, P5625, DOI 10.1242/dev.00867; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; Majstoravich S, 2004, BLOOD, V104, P1396, DOI 10.1182/blood-2004-02-0437; Manning L, 1999, DEVELOPMENT, V126, P2063; MAUPIN P, 1983, J CELL BIOL, V96, P51, DOI 10.1083/jcb.96.1.51; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; MORGAN NS, 1995, DEV BIOL, V172, P51, DOI 10.1006/dbio.1995.0005; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Parks AL, 2000, DEVELOPMENT, V127, P1373; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sun JJ, 2007, DEV CELL, V12, P431, DOI 10.1016/j.devcel.2007.02.003; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tal T, 2002, DEV BIOL, V243, P260, DOI 10.1006/dbio.2002.0571; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yip MLR, 1997, DEVELOPMENT, V124, P2129; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100	75	78	78	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					815	U82		10.1038/ncb1888	http://dx.doi.org/10.1038/ncb1888			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543274	Green Accepted			2022-12-25	WOS:000267603100009
J	Wang, SQ; Tsarouhas, V; Xylourgidis, N; Sabri, N; Tiklova, K; Nautiyal, N; Gallio, M; Samakovlis, C				Wang, Shenqiu; Tsarouhas, Vasilios; Xylourgidis, Nikos; Sabri, Nafiseh; Tiklova, Katarina; Nautiyal, Naumi; Gallio, Marco; Samakovlis, Christos			The tyrosine kinase Stitcher activates Grainy head and epidermal wound healing in Drosophila	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR; CELL-MIGRATION; GROWTH; TISSUE; BINDING; REPAIR; GFP; TRANSFORMATION; MORPHOGENESIS; PROTEINS	Epidermal injury initiates a cascade of inflammation, epithelial remodelling and integument repair at wound sites. The regeneration of the extracellular barrier and damaged tissue repair rely on the precise orchestration of epithelial responses triggered by the injury(1,2). Grainy head (Grh) transcription factors induce gene expression to crosslink the extracellular barrier in wounded flies and mice(3,4). However, the activation mechanisms and functions of Grh factors in re-epithelialization remain unknown. Here we identify stitcher (stit), a new Grh target in Drosophila melanogaster. stit encodes a Ret-family receptor tyrosine kinase required for efficient epidermal wound healing. Live imaging analysis reveals that Stit promotes actin cable assembly during wound re-epithelialization. Stit activation also induces extracellular signal-regulated kinase (ERK) phosphorylation along with the Grh-dependent expression of stit and barrier repair genes at the wound sites. The transcriptional stimulation of stit on injury triggers a positive feedback loop increasing the magnitude of epithelial responses. Thus, Stit activation upon wounding coordinates cytoskeletal rearrangements and the level of Grh-mediated transcriptional wound responses.	[Wang, Shenqiu; Tsarouhas, Vasilios; Xylourgidis, Nikos; Sabri, Nafiseh; Tiklova, Katarina; Nautiyal, Naumi; Gallio, Marco; Samakovlis, Christos] Stockholm Univ, Wenner Gren Inst, Dept Dev Biol, S-10691 Stockholm, Sweden	Stockholm University	Samakovlis, C (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Dev Biol, S-10691 Stockholm, Sweden.	christos@devbio.su.se	Tsarouhas, Vasilios/AAG-8226-2020	Tsarouhas, Vasilios/0000-0002-2933-1351; Gallio, Marco/0000-0003-2132-0639				Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fang XH, 2005, J BIOL CHEM, V280, P28451, DOI 10.1074/jbc.M504400200; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Gabay L, 1997, DEVELOPMENT, V124, P3535; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harden N, 2005, SCIENCE, V308, P364, DOI 10.1126/science.1112050; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Ostrowski S, 2002, GENETICS, V161, P171; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Stramer B, 2005, CURR BIOL, V15, pR425, DOI 10.1016/j.cub.2005.05.034; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; UV AE, 1994, MOL CELL BIOL, V14, P4020, DOI 10.1128/MCB.14.6.4020; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; WENCZAK BA, 1992, J CLIN INVEST, V90, P2392, DOI 10.1172/JCI116130; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	43	55	55	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					890	U282		10.1038/ncb1898	http://dx.doi.org/10.1038/ncb1898			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525935				2022-12-25	WOS:000267603100019
J	De Schutter, K; Lin, YC; Tiels, P; Van Hecke, A; Glinka, S; Weber-Lehmann, J; Rouze, P; Van de Peer, Y; Callewaert, N				De Schutter, Kristof; Lin, Yao-Cheng; Tiels, Petra; Van Hecke, Annelies; Glinka, Sascha; Weber-Lehmann, Jacqueline; Rouze, Pierre; Van de Peer, Yves; Callewaert, Nico			Genome sequence of the recombinant protein production host Pichia pastoris	NATURE BIOTECHNOLOGY			English	Article							TRANSFER-RNA GENES; EXPRESSION; YEAST; GLYCOSYLATION; PREDICTION; IDENTIFICATION; ALGORITHM; ACCURACY; PROMOTER; FEATURES	The methylotrophic yeast Pichia pastoris is widely used for the production of proteins and as a model organism for studying peroxisomal biogenesis and methanol assimilation. P. pastoris strains capable of human-type N-glycosylation are now available, which increases the utility of this organism for biopharmaceutical production. Despite its biotechnological importance, relatively few genetic tools or engineered strains have been generated for P. pastoris. To facilitate progress in these areas, we present the 9.43 Mbp genomic sequence of the GS115 strain of P. pastoris. We also provide manually curated annotation for its 5,313 protein-coding genes.	[De Schutter, Kristof; Tiels, Petra; Van Hecke, Annelies; Callewaert, Nico] VIB, Dept Mol Biomed Res, Unit Mol Glycobiol, Ghent, Belgium; [De Schutter, Kristof] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Lin, Yao-Cheng; Rouze, Pierre; Van de Peer, Yves] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Lin, Yao-Cheng; Rouze, Pierre; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium; [Tiels, Petra; Van Hecke, Annelies; Callewaert, Nico] Univ Ghent, Dept Biochem & Microbiol, L ProBE, Unit Mol Glycobiol, B-9000 Ghent, Belgium; [Glinka, Sascha; Weber-Lehmann, Jacqueline] Eurofins MWG Operon, Ebersberg, Germany	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Callewaert, N (corresponding author), VIB, Dept Mol Biomed Res, Unit Mol Glycobiol, Ghent, Belgium.	Nico.Callewaert@dmbr.vib-UGent.be	LIN, Yao-Cheng/B-4394-2008; Van de Peer, Yves/D-4388-2009; De Schutter, Kristof/B-9371-2009; De Schutter, Kristof/E-5400-2018; Van de Peer, Yves/AAE-7666-2019	LIN, Yao-Cheng/0000-0002-9390-795X; Van de Peer, Yves/0000-0003-4327-3730; De Schutter, Kristof/0000-0003-2366-0557; Van de Peer, Yves/0000-0003-4327-3730; Van Hecke, Annelies/0000-0002-3010-8034; Callewaert, Nico/0000-0003-2069-6917	Marie Curie Excellence Grant [EU-FP6]; BioMaGNet [IUA P6/25]; Fund for Scientific Research-Flanders (FWO); EU [FP6]	Marie Curie Excellence Grant(European Commission); BioMaGNet; Fund for Scientific Research-Flanders (FWO)(FWO); EU(European Commission)	This research was supported by a Marie Curie Excellence Grant to N.C. (EU-FP6), IUA P6/25 (BioMaGNet) and by the Fund for Scientific Research-Flanders (FWO). Y.-C.L. is supported by the EVOLTREE (EU-FP6) fellowship. Contributions towards the sequencing cost were received from VIB and from Research Corporation Technologies. We thank Lieven Sterck and Kenny Billiau for setup and maintenance of the BOGAS annotation portal and Cindy Martens for the Dollo parsimony analysis. We thank Mark Veugelers and Jo Bury for continuous support of this project.	Bobrowicz P, 2004, GLYCOBIOLOGY, V14, P757, DOI 10.1093/glycob/cwh104; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Dalle F, 2003, INFECT IMMUN, V71, P7061, DOI 10.1128/IAI.71.12.7061-7068.2003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Foissac S, 2008, CURR BIOINFORM, V3, P87, DOI 10.2174/157489308784340702; Friberg M, 2004, YEAST, V21, P1083, DOI 10.1002/yea.1150; Gasser B, 2007, APPL ENVIRON MICROB, V73, P6499, DOI 10.1128/AEM.01196-07; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Hani J, 1998, NUCLEIC ACIDS RES, V26, P689, DOI 10.1093/nar/26.3.689; Hardy E, 2000, J BIOTECHNOL, V77, P157, DOI 10.1016/S0168-1656(99)00201-1; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Hu SY, 2006, PROTEIN EXPRES PURIF, V47, P249, DOI 10.1016/j.pep.2005.11.014; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marthey S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-456; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; Mogelsvang S, 2003, MOL BIOL CELL, V14, P2277, DOI 10.1091/mbc.E02-10-0697; Ohi H, 1998, YEAST, V14, P895, DOI 10.1002/(SICI)1097-0061(199807)14:10<895::AID-YEA288>3.0.CO;2-9; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pinheiro M, 2006, METHOD INFORM MED, V45, P163, DOI 10.1055/s-0038-1634061; Pop M, 2004, GENOME RES, V14, P149; Potgieter TI, 2009, J BIOTECHNOL, V139, P318, DOI 10.1016/j.jbiotec.2008.12.015; Prabha L, 2009, PROTEIN EXPRES PURIF, V64, P155, DOI 10.1016/j.pep.2008.10.021; Ratner M, 2009, NAT BIOTECHNOL, V27, P299, DOI 10.1038/nbt0409-299; Rossignol T, 2008, NUCLEIC ACIDS RES, V36, pD557, DOI 10.1093/nar/gkm1010; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmid R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-180; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen SG, 1998, GENE, V216, P93, DOI 10.1016/S0378-1119(98)00315-1; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Trimble RB, 2004, GLYCOBIOLOGY, V14, P265, DOI 10.1093/glycob/cwh036; TSCHOPP JF, 1987, NUCLEIC ACIDS RES, V15, P3859, DOI 10.1093/nar/15.9.3859; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; Wang K, 2009, FUNGAL GENET BIOL, V46, pS14, DOI 10.1016/j.fgb.2008.09.010; Watanabe H, 2001, PHARMACEUT RES, V18, P1775, DOI 10.1023/A:1013391001141; Weiss HM, 1998, METH MOL B, V103, P227	54	353	476	13	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2009	27	6					561	+		10.1038/nbt.1544	http://dx.doi.org/10.1038/nbt.1544			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	458AC	19465926	hybrid			2022-12-25	WOS:000266980500026
J	Fichelson, P; Moch, C; Ivanovitch, K; Martin, C; Sidor, CM; Lepesant, JA; Bellaiche, Y; Huynh, JR				Fichelson, Pierre; Moch, Clara; Ivanovitch, Kenzo; Martin, Charlotte; Sidor, Clara M.; Lepesant, Jean-Antoine; Bellaiche, Yohanns; Huynh, Jean-Rene			Live-imaging of single stem cells within their niche reveals that a U3snoRNP component segregates asymmetrically and is required for self-renewal in Drosophila	NATURE CELL BIOLOGY			English	Article							OOCYTE SPECIFICATION; GERMLINE CYST; GENE; OVARY; DIVISION; TRANSCRIPTION; PROTEIN; PROLIFERATION; MELANOGASTER; MECHANISMS	Stem cells generate self-renewing and differentiating progeny over many rounds of asymmetric divisions. How stem cell growth rate and size are maintained over time remains unknown. We isolated mutations in a Drosophila melanogaster gene, wicked (wcd), which induce premature differentiation of germline stem cells (GSCs). Wcd is a member of the U3 snoRNP complex required for pre-ribosomal RNA maturation. This general function of Wcd contrasts with its specific requirement for GSC self-renewal. However, live imaging of GSCs within their niche revealed a pool of Wcd-forming particles that segregate asymmetrically into the GSCs on mitosis, independently of the Dpp signal sent by the niche. A fraction of Wcd also segregated asymmetrically in dividing larval neural stem cells (NSCs). In the absence of Wcd, NSCs became smaller and produced fewer neurons. Our results show that regulation of ribosome synthesis is a crucial parameter for stem cell maintenance and function.	[Fichelson, Pierre; Moch, Clara; Ivanovitch, Kenzo; Sidor, Clara M.; Lepesant, Jean-Antoine; Huynh, Jean-Rene] Univ Paris 07, CNRS, Inst Jacques Monod, F-75251 Paris 05, France; [Fichelson, Pierre; Ivanovitch, Kenzo; Sidor, Clara M.; Lepesant, Jean-Antoine] Univ Paris 06, CNRS, Inst Jacques Monod, F-75251 Paris 05, France; [Moch, Clara; Martin, Charlotte; Bellaiche, Yohanns; Huynh, Jean-Rene] Inst Curie, UMR 144, F-75248 Paris 05, France; [Fichelson, Pierre; Ivanovitch, Kenzo] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; [Fichelson, Pierre; Ivanovitch, Kenzo] UCL, Dept Anat & Dev Biol, Cell Biol Unit, London WC1E 6BT, England; [Sidor, Clara M.] London Res Inst, Canc Res UK, London WC2A 3PX, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of London; University College London; University of London; University College London; Cancer Research UK	Huynh, JR (corresponding author), Inst Curie, Dept Genet & Dev Biol, U934, UMR3215, 26 Rue Ulm, F-75248 Paris 05, France.	jean-rene.huynh@curie.fr	ivanovitch, kenzo/K-2343-2013; ivanovitch, kenzo/AAE-3214-2022	ivanovitch, kenzo/0000-0003-4706-7686; ivanovitch, kenzo/0000-0003-4706-7686; Sidor, Clara/0000-0002-2125-8858; Moch, Clara/0000-0002-8674-3440; HUYNH, Jean-Rene/0000-0002-4078-399X	Arthritis Research UK [3802] Funding Source: Medline; Medical Research Council Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bolivar J, 2006, DEV DYNAM, V235, P2969, DOI 10.1002/dvdy.20967; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fichelson Pierre, 2007, Prog Mol Subcell Biol, V45, P97; Frank DJ, 2002, DEVELOPMENT, V129, P399; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Gho M, 1999, DEVELOPMENT, V126, P3573; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; Godfrey AC, 2006, RNA, V12, P396, DOI 10.1261/rna.2270406; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Hong A, 2003, DEVELOPMENT, V130, P1235, DOI 10.1242/dev.00352; Huynh J.-R., 2006, FUSOME CELL CELL COM; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; KAI T, 2005, DEV BIOL; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Lanzotti DJ, 2004, MOL BIOL CELL, V15, P1112, DOI 10.1091/mbc.E03-09-0649; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; LONG EO, 1980, J MOL BIOL, V138, P873, DOI 10.1016/0022-2836(80)90070-4; MaalOe O, 1966, CONTROL MACROMOLECUL; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; NEUMULLER RA, 2008, NATURE; Page SL, 2000, GENETICS, V155, P1757; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	53	61	62	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					685	U11		10.1038/ncb1874	http://dx.doi.org/10.1038/ncb1874			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19430468				2022-12-25	WOS:000266503700013
J	Chew, J; Biswas, S; Shreeram, S; Humaidi, M; Wong, ET; Dhillion, MK; Teo, H; Hazra, A; Fang, CC; Lopez-Collazo, E; Bulavin, DV; Tergaonkar, V				Chew, Joanne; Biswas, Subhra; Shreeram, Sathyavageeswaran; Humaidi, Mahathir; Wong, Ee Tsin; Dhillion, Manprit Kaur; Teo, Hsiangling; Hazra, Amit; Fang, Cheok Chit; Lopez-Collazo, Eduardo; Bulavin, Dmitry V.; Tergaonkar, Vinay			WIP1 phosphatase is a negative regulator of NF-kappa B signalling	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE; P65 SUBUNIT; ACTIVATION; KINASE; PHOSPHORYLATION; PATHWAY; P38; IKK; P53; DEGRADATION	Post-translational modifications of NF-kappa B through phosphorylations enhance its transactivation potential. Much is known about the kinases that phosphorylate NF-kappa B, but little is known about the phosphatases that dephosphorylate it. By using a genome-scale siRNA screen, we identified the WIP1 phosphatase as a negative regulator of NF-kappa B signalling. WIP1-mediated regulation of NF-kappa B occurs in both a p38-dependent and independent manner. Overexpression of WIP1 resulted in decreased NF-kappa B activation in a dose-dependent manner, whereas WIP1 knockdown resulted in increased NF-kappa B function. We show that WIP1 is a direct phosphatase of Ser 536 of the p65 subunit of NF-kappa B. Phosphorylation of Ser 536 is known to be essential for the transactivation function of p65, as it is required for recruitment of the transcriptional co-activator p300. WIP1-mediated regulation of p65 regulated binding of NF-kappa B to p300 and hence chromatin remodelling. Consistent with our results, mice lacking WIP1 showed enhanced inflammation. These results provide the first genetic proof that a phosphatase directly regulates NF-kappa B signalling in vivo.	[Chew, Joanne; Humaidi, Mahathir; Wong, Ee Tsin; Teo, Hsiangling; Hazra, Amit; Tergaonkar, Vinay] Inst Mol & Cell Biol, Lab NF B signalling, Singapore 138673, Singapore; [Shreeram, Sathyavageeswaran; Bulavin, Dmitry V.] Inst Mol & Cell Biol, Cell Cycle Control & Tumorigenesis Grp, Singapore 138673, Singapore; [Fang, Cheok Chit] Inst Mol & Cell Biol, Lab Cell Cycle Control, Singapore 138673, Singapore; [Biswas, Subhra; Dhillion, Manprit Kaur] ASTAR, Biomed Sci Inst, Singapore Immunol Network, Singapore 138648, Singapore; [Tergaonkar, Vinay] Hosp Univ La Paz, Unidad Invest, Madrid 28046, Spain; [Tergaonkar, Vinay] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Hospital Universitario La Paz; National University of Singapore	Tergaonkar, V (corresponding author), Inst Mol & Cell Biol, Lab NF B signalling, 61 Biopolis Dr, Singapore 138673, Singapore.	vinayt@imcb.a-star.edu.sg	; Lopez-Collazo, Eduardo/U-6634-2018	Sathyavageeswaran, Shreeram/0000-0002-6111-1818; Teo, Hsiang Ling/0000-0002-3849-809X; Lopez-Collazo, Eduardo/0000-0003-1957-877X				Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dey A, 2007, CELL CYCLE, V6, P2178, DOI 10.4161/cc.6.17.4643; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Schito ML, 2006, J IMMUNOL, V176, P4818, DOI 10.4049/jimmunol.176.8.4818; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; SINGH S, 1995, J BIOL CHEM, V270, P10631, DOI 10.1074/jbc.270.18.10631; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	40	130	140	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					659	U493		10.1038/ncb1873	http://dx.doi.org/10.1038/ncb1873			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19377466				2022-12-25	WOS:000265640000026
J	Fan, AC; Deb-Basu, D; Orban, MW; Gotlib, JR; Natkunam, Y; O'Neill, R; Padua, RA; Xu, LW; Taketa, D; Shirer, AE; Beer, S; Yee, AX; Voehringer, DW; Felsher, DW				Fan, Alice C.; Deb-Basu, Debabrita; Orban, Mathias W.; Gotlib, Jason R.; Natkunam, Yasodha; O'Neill, Roger; Padua, Rose-Ann; Xu, Liwen; Taketa, Daryl; Shirer, Amy E.; Beer, Shelly; Yee, Ada X.; Voehringer, David W.; Felsher, Dean W.			Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens	NATURE MEDICINE			English	Article							HUMAN FOLLICULAR LYMPHOMA; CHRONIC MYELOID-LEUKEMIA; NON-HODGKINS-LYMPHOMA; B-CELL LYMPHOMA; C-MYC ONCOGENE; BCR-ABL; PROTEIN EXPRESSION; PROGNOSTIC-SIGNIFICANCE; BCL-2 GENE; K562 CELLS	Current methods of protein detection are insensitive to detecting subtle changes in oncoprotein activation that underlie key cancer signaling processes. The requirement for large numbers of cells precludes serial tumor sampling for assessing a response to therapeutics. Therefore, we have developed a nanofluidic proteomic immunoassay (NIA) to quantify total and low-abundance protein isoforms in nanoliter volumes. Our method can quantify amounts of MYC oncoprotein and B cell lymphoma protein-2 (BCL2) in Burkitt's and follicular lymphoma; identify changes in activation of extracellular signal-related kinases-1 (ERK1) and ERK2, mitogen-activated kinase-1 (MEK), signal transducer and activator of transcription protein-3 (STAT3) and STAT5, c-Jun N-terminal kinase (JNK) and caspase-3 in imatinib-treated chronic myelogeneous leukemia (CML) cells; measure an unanticipated change in the phosphorylation of an ERK2 isomer in individuals with CML who responded to imatinib; and detect a decrease in STAT3 and STAT5 phosphorylation in individuals with lymphoma who were treated with atorvastatin. Therefore, we have described a new and highly sensitive method for determining oncoprotein expression and phosphorylation in clinical specimens for the development of new therapeutics for cancer.	[Fan, Alice C.; Orban, Mathias W.; Xu, Liwen; Shirer, Amy E.; Beer, Shelly; Yee, Ada X.; Felsher, Dean W.] Stanford Univ, Sch Med, Div Oncol, Dept Med, Stanford, CA 94305 USA; [Fan, Alice C.; Orban, Mathias W.; Xu, Liwen; Shirer, Amy E.; Beer, Shelly; Yee, Ada X.; Felsher, Dean W.] Stanford Univ, Sch Med, Div Oncol, Dept Pathol, Stanford, CA 94305 USA; [Deb-Basu, Debabrita; O'Neill, Roger; Taketa, Daryl; Voehringer, David W.] Cell Biosci, Palo Alto, CA USA; [Gotlib, Jason R.] Stanford Univ, Sch Med, Div Hematol, Stanford Canc Ctr,Dept Med, Stanford, CA 94305 USA; [Padua, Rose-Ann] Hop St Louis, INSERM, Inst Univ Hematol, U718, Paris, France	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Felsher, DW (corresponding author), Stanford Univ, Sch Med, Div Oncol, Dept Med, Stanford, CA 94305 USA.	dfelsher@stanford.edu	Natkunam, Yasodha/L-5454-2015; Padua, Rose Ann/GVT-5961-2022; Orban, Mathias/AAS-8461-2020; PADUA, Rose Ann/E-8621-2019; Yee, Ada/GRX-9171-2022	Natkunam, Yasodha/0000-0002-9816-1018; Orban, Mathias/0000-0001-7846-8808; PADUA, Rose Ann/0000-0001-9964-7864; 	US National Cancer Institute [CA89305, CA034233, P01 CA034233]; NIH/NCI ICMIC [P50]; Burroughs Welcome Fund; Damon Runyon Foundation; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [T32CA009151, R01CA089305, P01CA034233] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI ICMIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome Fund(Burroughs Wellcome Fund); Damon Runyon Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript is dedicated to the memory of Roger O'Neill. This work was supported, in part, by the US National Cancer Institute grants CA89305, CA034233, P01 CA034233, NIH/NCI ICMIC P50, Burroughs Welcome Fund, the Damon Runyon Foundation (to D. W. F.), and the Leukemia and Lymphoma Society (to D. W. F. and A. C. F.). We thank the members of the Felsher laboratory for their helpful suggestions. We thank W.- K. Weng (Stanford Bone Marrow Transplantation Division) for providing access to previously banked tumor samples and the Stanford Hematology Division Tissue Bank for the use of samples.	Barrans SL, 2002, BLOOD, V99, P1136, DOI 10.1182/blood.V99.4.1136; Bordeleau L, 2000, SEMIN ONCOL, V27, P42, DOI 10.1053/sonc.2000.20440; Brozik A, 2006, ANN NY ACAD SCI, V1090, P344, DOI 10.1196/annals.1378.038; Calvo KR, 2008, BLOOD, V112, P3818, DOI 10.1182/blood-2008-02-138933; Camacho FI, 2003, AM J SURG PATHOL, V27, P762, DOI 10.1097/00000478-200306000-00006; Colomo L, 2003, BLOOD, V101, P78, DOI 10.1182/blood-2002-04-1286; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 2005, CANCER CELL, V8, P177, DOI 10.1016/j.ccr.2005.08.005; Dierlamm J, 1996, BLOOD, V87, P299; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Felsher DW, 2003, NAT REV CANCER, V3, P375, DOI 10.1038/nrc1070; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Ferry JA, 2006, ONCOLOGIST, V11, P375, DOI 10.1634/theoncologist.11-4-375; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Gascoyne RD, 1997, BLOOD, V90, P244; Ghaffari S, 1999, LEUKEMIA, V13, P1200, DOI 10.1038/sj.leu.2401467; Giuriato S, 2004, SEMIN CANCER BIOL, V14, P3, DOI 10.1016/j.semcancer.2003.11.002; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Harris H, 2004, NATURE, V427, P201, DOI 10.1038/427201a; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Johnson NA, 2008, GENE CHROMOSOME CANC, V47, P1038, DOI 10.1002/gcc.20606; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Karlsson A, 2003, BLOOD, V101, P2797, DOI 10.1182/blood-2002-10-3091; Kohmura K, 2004, J CELL PHYSIOL, V198, P370, DOI 10.1002/jcp.10426; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; MITANI S, 1988, CANCER, V62, P2085, DOI 10.1002/1097-0142(19881115)62:10<2085::AID-CNCR2820621003>3.0.CO;2-R; O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; Shachaf CM, 2007, BLOOD, V110, P2674, DOI 10.1182/blood-2006-09-048033; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; WENNBORG AD, 1991, EUR J CANCER, V27, P1643, DOI 10.1016/0277-5379(91)90436-H	40	96	107	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2009	15	5					566	571		10.1038/nm.1903	http://dx.doi.org/10.1038/nm.1903			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19363496	Green Accepted			2022-12-25	WOS:000265889300036
J	Wierzbicki, AT; Ream, TS; Haag, JR; Pikaard, CS				Wierzbicki, Andrzej T.; Ream, Thomas S.; Haag, Jeremy R.; Pikaard, Craig S.			RNA polymerase V transcription guides ARGONAUTE4 to chromatin	NATURE GENETICS			English	Article							DIRECTED DNA METHYLATION; PROCESSING CENTER; ARABIDOPSIS; SIRNA; IV; PROTEIN	Retrotransposons and repetitive DNA elements in eukaryotes are silenced by small RNA-directed heterochromatin formation. In Arabidopsis, this process involves 24-nt siRNAs that bind to ARGONAUTE4 (AGO4) and facilitate the targeting of complementary loci(1,2) via unknown mechanisms. Nuclear RNA polymerase V (Pol V) is an RNA silencing enzyme recently shown to generate noncoding transcripts at loci silenced by 24-nt siRNAs(3). We show that AGO4 physically interacts with these Pol V transcripts and is thereby recruited to the corresponding chromatin. We further show that DEFECTIVE IN MERISTEM SILENCING3 (DMS3), a structural maintenance of chromosomes (SMC) hinge-domain protein(4), functions in the assembly of Pol V transcription initiation or elongation complexes. Collectively, our data suggest that AGO4 is guided to target loci through base-pairing of associated siRNAs with nascent Pol V transcripts.	[Wierzbicki, Andrzej T.; Ream, Thomas S.; Haag, Jeremy R.; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	US National Institutes of Health [GM077590]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our work is supported by US National Institutes of Health grant GM077590. The content of the paper is the sole responsibility of the authors and does not necessarily reflect the views of the NIH. We thank T. Blevins (Washington University, St. Louis), S. Jacobsen (University of California, Los Angeles) and T. Jenuwein (Max Planck Institute of Immunobiology) for providing reagents.	Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Haag JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004110; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2005, EMBO REP, V6, P649, DOI 10.1038/sj.embor.7400446; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Peric-Hupkes D, 2008, CELL, V132, P925, DOI 10.1016/j.cell.2008.03.001; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	21	310	330	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					630	634		10.1038/ng.365	http://dx.doi.org/10.1038/ng.365			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19377477	Green Accepted			2022-12-25	WOS:000265575600028
J	Tsvetkov, P; Reuven, N; Shaul, Y				Tsvetkov, Peter; Reuven, Nina; Shaul, Yosef			The nanny model for IDPs	NATURE CHEMICAL BIOLOGY			English	Article							UNSTRUCTURED PROTEINS; DEGRADATION; PROTEASOME; DISORDER	Intrinsically disordered proteins (IDPs) are subject to ubiquitin-independent degradation, a default and passive process. We describe here a model wherein a group of 'nanny' proteins function to protect newly synthesized IDPs from degradation by default, thereby insuring their maturation into important regulatory molecules.	[Tsvetkov, Peter; Reuven, Nina; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tsvetkov, P (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yosef.shaul@weizmann.ac.il; yosef.shaul@weizmann.ac.il	Reuven, Nina/AAM-8711-2020; Tsvetkov, Peter/J-9878-2019; Tsvetkov, Peter/D-6458-2011	Reuven, Nina/0000-0003-1569-3818; Tsvetkov, Peter/0000-0002-7577-2342; 				Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Bloom J, 2004, CELL CYCLE, V3, P138; Boyd NF, 2003, BRIT J CANCER, V89, P1672, DOI 10.1038/sj.bjc.6601314; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Errami A, 1996, MOL CELL BIOL, V16, P1519; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Hegyi H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000017; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Ongkeko WM, 1999, CURR BIOL, V9, P829, DOI 10.1016/S0960-9822(99)80367-4; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; TSVETKOV P, CELL DEATH IN PRESS; Tsvetkov P, 2008, PROTEINS, V70, P1357, DOI 10.1002/prot.21614; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	23	86	88	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2009	5	11					778	781		10.1038/nchembio.233	http://dx.doi.org/10.1038/nchembio.233			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	508FQ	19841623				2022-12-25	WOS:000270915000003
J	Ruzankina, Y; Schoppy, DW; Asare, A; Clark, CE; Vonderheide, RH; Brown, EJ				Ruzankina, Yaroslava; Schoppy, David W.; Asare, Amma; Clark, Carolyn E.; Vonderheide, Robert H.; Brown, Eric J.			Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53	NATURE GENETICS			English	Article							EARLY EMBRYONIC LETHALITY; CELL-CYCLE; P53; TUMORIGENESIS; SENESCENCE; PATHWAY; LEADS; DEFICIENCY; ACTIVATION; PHENOTYPES	Trp53 loss of function has previously been shown to rescue tissue maintenance and developmental defects resulting from DNA damage or DNA-repair gene mutations(1-12). Here, we report that p53 deficiency severely exacerbates tissue degeneration caused by mosaic deletion of the essential genome maintenance regulator Atr. Combined loss of Atr and p53 (Trp53(-/-)Atr(mKO)) led to severe defects in hair follicle regeneration, localized inflammation (Mac1(+)Gr1(+) infiltrates), accelerated deterioration of the intestinal epithelium and synthetic lethality in adult mice. Tissue degeneration in Trp53(-/-)Atr(mKO) mice was characterized by the accumulation of cells maintaining high levels of DNA damage. Moreover, the elevated frequency of these damaged cells in both progenitor and downstream compartments in Trp53(-/-)Atr(mKO) skin coincided with delayed compensatory tissue renewal from residual ATR-expressing cells. Together, our results indicate that the combined loss of Atr and Trp53 in adult mice leads to the accumulation of highly damaged cells, which, consequently, impose a barrier to regeneration from undamaged progenitors.	[Ruzankina, Yaroslava; Schoppy, David W.; Asare, Amma; Clark, Carolyn E.; Vonderheide, Robert H.; Brown, Eric J.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Brown, EJ (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.	brownej@mail.med.upenn.edu		Asare, Amma/0000-0002-4865-6864	US National Institute on Aging [R01AG027376, F30AG034027]; Abramson Family Cancer Research Institute; NATIONAL INSTITUTE ON AGING [R01AG027376, F30AG034027] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Abramson Family Cancer Research Institute; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are indebted to G. Beatty, K. Cimprich, G. Cotsarelis and A. Bhandoola for reagents, protocols and helpful advice, and J. Wang and other members of the AFCRI Histology Core for tissue processing. These studies were supported by the US National Institute on Aging (R01AG027376 and F30AG034027) and the Abramson Family Cancer Research Institute.	Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Botchkarev VA, 2000, CANCER RES, V60, P5002; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wlodarski P, 1998, BLOOD, V91, P2998, DOI 10.1182/blood.V91.8.2998.2998_2998_3006; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Xu Y, 1998, MOL CELL BIOL, V18, P4385, DOI 10.1128/MCB.18.7.4385; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	33	84	85	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1144	U132		10.1038/ng.441	http://dx.doi.org/10.1038/ng.441			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19718024	Green Accepted			2022-12-25	WOS:000270330400021
J	Zhou, YD; Lee, S; Jin, Z; Wright, M; Smith, SEP; Anderson, MP				Zhou, Yu-Dong; Lee, Sanghoon; Jin, Zhe; Wright, Moriah; Smith, Stephen E. P.; Anderson, Matthew P.			Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy	NATURE MEDICINE			English	Article							LONG-TERM POTENTIATION; DENTATE GRANULE CELLS; NMDA-RECEPTORS; HIPPOCAMPAL-FORMATION; CHROMOSOMAL GENES; AUDITORY FEATURES; GYRUS; RAT; LGI1; MUTATIONS	A subset of central glutamatergic synapses are coordinately pruned and matured by unresolved mechanisms during postnatal development. We report that the human epilepsy gene LGI1, encoding leucine-rich, glioma-inactivated protein-1 and mutated in autosomal dominant lateral temporal lobe epilepsy (ADLTE), mediates this process in hippocampus. We created transgenic mice either expressing a truncated mutant LGI1 (835delC) found in ADLTE or overexpressing a wild-type LGI1. We discovered that the normal postnatal maturation of presynaptic and postsynaptic functions was arrested by the 835delC mutant LGI1, and contrastingly, was magnified by excess wild-type LGI1. Concurrently, mutant LGI1 inhibited dendritic pruning and increased the spine density to markedly increase excitatory synaptic transmission. Inhibitory transmission, by contrast, was unaffected. Furthermore, mutant LGI1 promoted epileptiform discharge in vitro and kindling epileptogenesis in vivo with partial gamma-aminobutyric acid(A) (GABA(A)) receptor blockade. Thus, LGI1 represents a human gene mutated to promote epilepsy through impaired postnatal development of glutamatergic circuits.	[Zhou, Yu-Dong; Lee, Sanghoon; Jin, Zhe; Smith, Stephen E. P.; Anderson, Matthew P.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Zhou, Yu-Dong; Lee, Sanghoon; Jin, Zhe; Smith, Stephen E. P.; Anderson, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Zhou, Yu-Dong; Lee, Sanghoon; Jin, Zhe; Smith, Stephen E. P.; Anderson, Matthew P.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Wright, Moriah] Tufts Univ, Sch Med, Boston, MA 02111 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Tufts University	Anderson, MP (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.	mpanders@bidmc.harvard.edu		Zhou, Yu-Dong/0000-0002-6364-3869; Anderson, Matthew/0000-0003-4602-1811	US National Institute of Neurological Disorders and Stroke [R01 NS057444, K02 NS054674-03]; Nancy Lurie Marks Family Foundation; Autism Speaks/US National Alliance for Autism Research; Beth Israel Deaconess Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS054674, R03NS052521, R01NS057444] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Nancy Lurie Marks Family Foundation; Autism Speaks/US National Alliance for Autism Research; Beth Israel Deaconess Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C.B. Saper, J.S. Flier, D.K. Simon, G.D. Rosen, M.R. Kasten and M.W. Anderson for comments and suggestions, and G.D. Rosen for help on the Neurolucida system. This work was supported in part by the US National Institute of Neurological Disorders and Stroke R01 NS057444 (M.P.A.), US National Institute of Neurological Disorders and Stroke K02 NS054674-03 (M.P.A.), the Nancy Lurie Marks Family Foundation (M.P.A.), Autism Speaks/US National Alliance for Autism Research (M.P.A.) and Beth Israel Deaconess Medical Center.	Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bermingham JR, 2006, NAT NEUROSCI, V9, P76, DOI 10.1038/nn1598; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Buckmaster PS, 1997, J NEUROPHYSIOL, V77, P2685, DOI 10.1152/jn.1997.77.5.2685; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; CUDMORE SB, 1991, J NEUROCHEM, V57, P1240, DOI 10.1111/j.1471-4159.1991.tb08285.x; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Grosse G, 2000, J NEUROSCI, V20, P1869; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; Lozovaya NA, 2004, J PHYSIOL-LONDON, V558, P451, DOI 10.1113/jphysiol.2004.063792; Meiri N, 1997, P NATL ACAD SCI USA, V94, P4430, DOI 10.1073/pnas.94.9.4430; Meiri N, 1998, P NATL ACAD SCI USA, V95, P15037, DOI 10.1073/pnas.95.25.15037; Min MY, 1998, P NATL ACAD SCI USA, V95, P4702, DOI 10.1073/pnas.95.8.4702; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Ottman R, 2004, NEUROLOGY, V62, P1120, DOI 10.1212/01.WNL.0000120098.39231.6E; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Rahimi O, 2007, PROG BRAIN RES, V163, P167, DOI 10.1016/S0079-6123(07)63010-6; RIHN LL, 1990, DEV BRAIN RES, V54, P115, DOI 10.1016/0165-3806(90)90071-6; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Sirerol-Piquer MS, 2006, HUM MOL GENET, V15, P3436, DOI 10.1093/hmg/ddl421; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Thompson CL, 2002, MOL BRAIN RES, V102, P55, DOI 10.1016/S0169-328X(02)00183-3; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Tovar KR, 1999, J NEUROSCI, V19, P4180; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Velisek L, 2006, MODELS OF SEIZURES AND EPILEPSY, P127, DOI 10.1016/B978-012088554-1/50013-X; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wu C, 2008, J NEUROSCI METH, V171, P126, DOI 10.1016/j.jneumeth.2008.03.001; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001	43	135	136	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1208	U140		10.1038/nm.2019	http://dx.doi.org/10.1038/nm.2019			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19701204	Green Accepted			2022-12-25	WOS:000270596400034
J	Albuquerque, RJC; Hayashi, T; Cho, WG; Kleinman, ME; Dridi, S; Takeda, A; Baffi, JZ; Yamada, K; Kaneko, H; Green, MG; Chappell, J; Wilting, J; Weich, HA; Yamagami, S; Amano, S; Mizuki, N; Alexander, JS; Peterson, ML; Brekken, RA; Hirashima, M; Capoor, S; Usui, T; Ambati, BK; Ambati, J				Albuquerque, Romulo J. C.; Hayashi, Takahiko; Cho, Won Gil; Kleinman, Mark E.; Dridi, Sami; Takeda, Atsunobu; Baffi, Judit Z.; Yamada, Kiyoshi; Kaneko, Hiroki; Green, Martha G.; Chappell, Joe; Wilting, Joerg; Weich, Herbert A.; Yamagami, Satoru; Amano, Shiro; Mizuki, Nobuhisa; Alexander, Jonathan S.; Peterson, Martha L.; Brekken, Rolf A.; Hirashima, Masanori; Capoor, Seema; Usui, Tomohiko; Ambati, Balamurali K.; Ambati, Jayakrishna			Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth	NATURE MEDICINE			English	Article							PROMOTES TUMOR-METASTASIS; VEGF-C; CORNEAL LYMPHANGIOGENESIS; NODE METASTASIS; TRANSGENIC MICE; CELLS; ANGIOGENESIS; BINDING; EXPRESSION; MOUSE	Disruption of the precise balance of positive and negative molecular regulators of blood and lymphatic vessel growth can lead to myriad diseases. Although dozens of natural inhibitors of hemangiogenesis have been identified, an endogenous selective inhibitor of lymphatic vessel growth has not to our knowledge been previously described. We report the existence of a splice variant of the gene encoding vascular endothelial growth factor receptor-2 (Vegfr-2) that encodes a secreted form of the protein, designated soluble Vegfr-2 (sVegfr-2), that inhibits developmental and reparative lymphangiogenesis by blocking Vegf-c function. Tissue-specific loss of sVegfr-2 in mice induced, at birth, spontaneous lymphatic invasion of the normally alymphatic cornea and hyperplasia of skin lymphatics without affecting blood vasculature. Administration of sVegfr-2 inhibited lymphangiogenesis but not hemangiogenesis induced by corneal suture injury or transplantation, enhanced corneal allograft survival and suppressed lymphangioma cellular proliferation. Naturally occurring sVegfr-2 thus acts as a molecular uncoupler of blood and lymphatic vessels; modulation of sVegfr-2 might have therapeutic effects in treating lymphatic vascular malformations, transplantation rejection and, potentially, tumor lymphangiogenesis and lymphedema.	[Albuquerque, Romulo J. C.; Cho, Won Gil; Kleinman, Mark E.; Dridi, Sami; Takeda, Atsunobu; Baffi, Judit Z.; Yamada, Kiyoshi; Kaneko, Hiroki; Green, Martha G.; Capoor, Seema; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA; [Albuquerque, Romulo J. C.; Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Hayashi, Takahiko; Mizuki, Nobuhisa] Yokohama City Univ, Dept Ophthalmol, Yokohama, Kanagawa 232, Japan; [Chappell, Joe] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Wilting, Joerg] Univ Gottingen, Dept Anat & Cell Biol, Gottingen, Germany; [Weich, Herbert A.] Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany; [Yamagami, Satoru; Amano, Shiro; Usui, Tomohiko] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; [Alexander, Jonathan S.] Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Peterson, Martha L.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Hirashima, Masanori] Kobe Univ, Grad Sch Med, Div Vasc Biol, Dept Physiol & Cell Biol, Kobe, Hyogo 657, Japan; [Ambati, Balamurali K.] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Dept Ophthalmol, Salt Lake City, UT USA	University of Kentucky; University of Kentucky; Yokohama City University; University of Kentucky; University of Gottingen; Helmholtz Association; Helmholtz-Center for Infection Research; University of Tokyo; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas; Kobe University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA.	jamba2@email.uky.edu	Hayashi, Takahiko/ABB-7168-2020; Kaneko, Hiroki/O-7695-2015; Dridi, Sami/Q-8207-2019; Hirashima, Masanori/ABC-9204-2021; Kaneko, Hiroki/AHA-2461-2022	Hayashi, Takahiko/0000-0001-8704-680X; Kaneko, Hiroki/0000-0003-0731-6465; Hirashima, Masanori/0000-0002-0190-4381; Kaneko, Hiroki/0000-0003-0731-6465; Peterson, Martha/0000-0002-7214-421X; Kleinman, Mark/0000-0001-8557-7949	US National Institutes of Health; National Eye Institute [EY015422, EY018350, EY018836, EY017182, EY017950]; Research to Prevent Blindness; University of Kentucky University Research Professorship; Fight for Sight; Japan Society for the Promotion of Science for Young Scientists; US Department of Defense; Doris Duke Distinguished Clinical Scientist; Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R01EY018836, R01EY017182, R01EY018350, RC1EY020442, R01EY020672, R21EY019778, R01EY015422, R01EY017950] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); University of Kentucky University Research Professorship; Fight for Sight; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US Department of Defense(United States Department of Defense); Doris Duke Distinguished Clinical Scientist(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank R. Ashery-Padan (Tel Aviv University), P. Gruss (Max Planck Institute) and D. C. Beebe (Washington University) for LeCre mice, R. K. Nordeen (University of Colorado) for Cre plasmid, K. Miyazono (University of Tokyo) for pVegf-c and J.L. Arbiser (Emory University) and C. D. Kontos (Duke University) for endothelial cell lines; R. King, L. Xu, M. McConnell, K. Emerson, A. Blanford, M. Baker, S. Furlow, M. LaFalce and C. Long for technical assistance; and R. Mohan, F. Cambi, S. Bondada, M. Detmar, M. W. Fannon, T. V. Getchell, R. K. Jain, T. S. Khurana, B. J. Raisler, J. E. Springer, P. A. Pearson, C. W. Vander Kooi, J. G. Woodward, A. M. Rao, G. S. Rao, K. Ambati and L. Garcia for valuable discussions. This work was supported by US National Institutes of Health and National Eye Institute grants EY015422, EY018350 and EY018836 to J. A. and EY017182 and EY017950 to B. K. A.; a Research to Prevent Blindness Lew R. Wassermann Merit Award (J. A.); Physician Scientist Awards (J. A., B. K. A.); a Medical Student Fellowship (R. J. C. A.); a departmental unrestricted grant ( J. A.); a University of Kentucky University Research Professorship (J. A.); Fight for Sight (R. J. C. A.); Japan Society for the Promotion of Science for Young Scientists (A. T.); a VA Merit Award (B. K. A.); and the US Department of Defense (B. K. A.). J. A. is also supported by the Doris Duke Distinguished Clinical Scientist Award and the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and is the Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; Bernatchez PN, 2002, J CELL BIOCHEM, V85, P629, DOI 10.1002/jcb.10155; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Brakenhielm E, 2007, INT J CANCER, V121, P2153, DOI 10.1002/ijc.22900; Brideau G, 2007, CANCER RES, V67, P11528, DOI 10.1158/0008-5472.CAN-07-1458; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen L, 2004, NAT MED, V10, P813, DOI 10.1038/nm1078; Cursiefen C, 2003, CORNEA, V22, P273, DOI 10.1097/00003226-200304000-00021; Cursiefen C, 2002, INVEST OPHTH VIS SCI, V43, P2127; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Ebos JML, 2004, MOL CANCER RES, V2, P315; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Fenwick A, 2006, SCIENCE, V313, P1077, DOI 10.1126/science.1127184; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; Hamrah P, 2004, EXP EYE RES, V79, P553, DOI 10.1016/j.exer.2004.06.028; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Huang HY, 2001, LAB INVEST, V81, P1729, DOI 10.1038/labinvest.3780386; Huang XM, 1998, BIOCHEM BIOPH RES CO, V252, P643, DOI 10.1006/bbrc.1998.9717; Jeltsch M, 2006, J BIOL CHEM, V281, P12187, DOI 10.1074/jbc.M511593200; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2006, AM J PATHOL, V169, P708, DOI 10.2353/ajpath.2006.051200; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Kojima T, 2008, FEBS LETT, V582, P2515, DOI 10.1016/j.febslet.2008.06.014; Kubo H, 2002, P NATL ACAD SCI USA, V99, P8868, DOI 10.1073/pnas.062040199; Liu Y, 2002, J EXP MED, V195, P259, DOI 10.1084/jem.20010838; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Norgall S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-105; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Rajakumar A, 2009, PLACENTA, V30, P25, DOI 10.1016/j.placenta.2008.10.006; Roeckl W, 1998, EXP CELL RES, V241, P161, DOI 10.1006/excr.1998.4039; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Streilein JW, 1996, INVEST OPHTH VIS SCI, V37, P413; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wilting J, 2007, NOVART FDN SYMP, V283, P227; Wilting J, 2007, NOVART FDN SYMP, V283, P238; WILTING J, 2007, NOVART FDN SYMP, V238, P220; Yamagami S, 2001, INVEST OPHTH VIS SCI, V42, P1293; Yoon Y, 2003, J CLIN INVEST, V111, P717, DOI 10.1172/JCI200315830	62	264	280	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1023	U74		10.1038/nm.2018	http://dx.doi.org/10.1038/nm.2018			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19668192	Green Accepted			2022-12-25	WOS:000269979200022
J	Han, Y; Moreira, IS; Urizar, E; Weinstein, H; Javitch, JA				Han, Yang; Moreira, Irina S.; Urizar, Eneko; Weinstein, Harel; Javitch, Jonathan A.			Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; 4TH TRANSMEMBRANE SEGMENT; ALPHA FUSION PROTEINS; OPIOID RECEPTOR; D2 RECEPTOR; CONFORMATIONAL-CHANGES; THYROTROPIN RECEPTOR; AMINO-ACIDS; BINDING; TRANSACTIVATION	A major obstacle to understanding the functional importance of dimerization between class A G protein-coupled receptors (GPCRs) has been the methodological limitation in achieving control of the identity of the components comprising the signaling unit. We have developed a functional complementation assay that enables such control, and we demonstrate it here for the human dopamine D2 receptor. The minimal signaling unit, two receptors and a single G protein, is maximally activated by agonist binding to a single protomer, which suggests an asymmetrical activated dimer. Inverse agonist binding to the second protomer enhances signaling, whereas agonist binding to the second protomer blunts signaling. Ligand-independent constitutive activation of the second protomer also inhibits signaling. Thus, GPCR dimer function can be modulated by the activity state of the second protomer, which for a heterodimer may be altered in pathological states. Our new methodology also makes possible the characterization of signaling from a defined heterodimer unit.	[Han, Yang; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Han, Yang; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Han, Yang; Urizar, Eneko; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Moreira, Irina S.; Weinstein, Harel] Cornell Univ, Dept Physiol & Biophys, Weill Cornell Med Coll, New York, NY 10021 USA; [Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; Cornell University; Cornell University; Columbia University	Javitch, JA (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 630 W 168th St, New York, NY 10032 USA.	jaj2@columbia.edu	WEINSTEIN, HAREL/O-8245-2019; Moreira, Irina/AAU-6975-2021; Moreira, Irina S/K-4711-2012	WEINSTEIN, HAREL/0000-0003-3473-9818; Moreira, Irina/0000-0003-2970-5250; Moreira, Irina S/0000-0003-2970-5250; Javitch, Jonathan/0000-0001-7395-2967	US National Institutes of Health [DA022413, MH054137, DA012923]; Lieber Center; European Molecular Biology Organization; David A. Cofrin Center for Biomedical Information (Institute for Computational Biomedicine, Weill Cornell Medical College of Cornell University); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, P01DA012923] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lieber Center; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); David A. Cofrin Center for Biomedical Information (Institute for Computational Biomedicine, Weill Cornell Medical College of Cornell University); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Gales for discussion and comments on the manuscript. Plasmids encoding apo-aequorin were a gift from V. Dupriez (Euroscreen). This work was supported in part by US National Institutes of Health grants DA022413 and MH054137 (to J.A.J.) and DA012923 (to H. W.), by the Lieber Center for Schizophrenia Research and Treatment, and by a European Molecular Biology Organization long-term fellowship (to E. U.). Computational resources of the David A. Cofrin Center for Biomedical Information (Institute for Computational Biomedicine, Weill Cornell Medical College of Cornell University) are gratefully acknowledged.	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; Carrillo JJ, 2003, J BIOL CHEM, V278, P42578, DOI 10.1074/jbc.M306165200; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Costagliola S, 1999, THYROID, V9, P995, DOI 10.1089/thy.1999.9.995; Damian M, 2008, J BIOL CHEM, V283, P21084, DOI 10.1074/jbc.M710419200; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Javitch JA, 2000, BIOCHEMISTRY-US, V39, P12190, DOI 10.1021/bi001069m; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kota P, 2006, P NATL ACAD SCI USA, V103, P3054, DOI 10.1073/pnas.0510982103; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Lee TW, 1999, BIOCHEMISTRY-US, V38, P13801, DOI 10.1021/bi9908282; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; Molinari P, 2003, J BIOL CHEM, V278, P15778, DOI 10.1074/jbc.M300731200; MORO O, 1993, J BIOL CHEM, V268, P22273; Neve KA, 2001, MOL PHARMACOL, V60, P373, DOI 10.1124/mol.60.2.373; Niv MY, 2006, J COMPUT AID MOL DES, V20, P437, DOI 10.1007/s10822-006-9061-3; Parenty G, 2008, BIOCHEM J, V412, P245, DOI 10.1042/BJ20071689; Pascal G, 2005, MOL PHARMACOL, V68, P905, DOI 10.1124/mol.105.013847; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Simpson MM, 1999, MOL PHARMACOL, V56, P1116, DOI 10.1124/mol.56.6.1116; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; STRADER CD, 1987, J BIOL CHEM, V262, P16439; STRADER CD, 1988, J BIOL CHEM, V263, P3050; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; van Dijk ADJ, 2005, PROTEINS, V60, P232, DOI 10.1002/prot.20563; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wenzel-Seifert K, 1998, BIOCHEM J, V334, P519, DOI 10.1042/bj3340519; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wilson J, 2001, J NEUROCHEM, V77, P493, DOI 10.1046/j.1471-4159.2001.00233.x; Xu W, 1999, FEBS LETT, V447, P318, DOI 10.1016/S0014-5793(99)00316-6	51	296	299	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					688	695		10.1038/nchembio.199	http://dx.doi.org/10.1038/nchembio.199			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19648932	Green Accepted			2022-12-25	WOS:000269093000018
J	Jacoby, M; Cox, JJ; Gayral, S; Hampshire, DJ; Ayub, M; Blockmans, M; Pernot, E; Kisseleva, MV; Compere, P; Schiffmann, SN; Gergely, F; Riley, JH; Perez-Morga, D; Woods, CG; Schurmans, S				Jacoby, Monique; Cox, James J.; Gayral, Stephanie; Hampshire, Daniel J.; Ayub, Mohammed; Blockmans, Marianne; Pernot, Eileen; Kisseleva, Marina V.; Compere, Philippe; Schiffmann, Serge N.; Gergely, Fanni; Riley, John H.; Perez-Morga, David; Woods, C. Geoffrey; Schurmans, Stephane			INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse	NATURE GENETICS			English	Article							INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE; POLYCYSTIC KIDNEY-DISEASE; FIBROBLASTS; DISORDERS; PROTEINS; NETWORK; BIOLOGY	The primary cilium is an antenna-like structure that protrudes from the cell surface of quiescent/ differentiated cells and participates in extracellular signal processing(1-3). Here, we report that mice deficient for the lipid 5-phosphatase Inpp5e develop a multiorgan disorder associated with structural defects of the primary cilium. In ciliated mouse embryonic fibroblasts, Inpp5e is concentrated in the axoneme of the primary cilium. Inpp5e inactivation did not impair ciliary assembly but altered the stability of pre-established cilia after serum addition. Blocking phosphoinositide 3-kinase (PI3K) activity or ciliary platelet-derived growth factor receptor a (PDGFRa) restored ciliary stability. In human INPP5E, we identified a mutation affecting INPP5E ciliary localization and cilium stability in a family with MORM syndrome, a condition related to Bardet-Biedl syndrome. Together, our results show that INPP5E plays an essential role in the primary cilium by controlling ciliary growth factor and PI3K signaling and stability, and highlight the consequences of INPP5E dysfunction.	[Jacoby, Monique; Gayral, Stephanie; Blockmans, Marianne; Pernot, Eileen; Schurmans, Stephane] Univ Libre Bruxelles, IRIBHM, IBMM, Gosselies, Belgium; [Cox, James J.; Woods, C. Geoffrey] Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Cambridge, England; [Hampshire, Daniel J.] Univ Sheffield, Acad Unit Haematol, Henry Wellcome Labs Med Res, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Ayub, Mohammed] St Lukes Hosp, Middlesbrough, Cleveland, England; [Kisseleva, Marina V.] Washington Univ, Sch Med, Div Hematol, St Louis, MO USA; [Compere, Philippe] Univ Liege, Inst Chim, Liege, Belgium; [Schiffmann, Serge N.] Univ Libre Bruxelles, Neurophysiol Lab, Brussels, Belgium; [Gergely, Fanni] Univ Cambridge, Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Riley, John H.] GSK Resp Med Dev Ctr, Uxbridge, Middx, England; [Perez-Morga, David] Univ Libre Bruxelles, Mol Parasitol Lab, IBMM, Gosselies, Belgium	Universite Libre de Bruxelles; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Sheffield; Washington University (WUSTL); University of Liege; Universite Libre de Bruxelles; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; GlaxoSmithKline; Universite Libre de Bruxelles	Schurmans, S (corresponding author), Univ Libre Bruxelles, IRIBHM, IBMM, Gosselies, Belgium.	cw347@cam.ac.uk; sschurma@ulb.ac.be	Hampshire, Daniel/Q-3540-2019; woods, christopher g/A-1361-2010; Cox, James/R-1910-2016	Gayral, Stephanie/0000-0001-6276-3917; Gergely, Fanni/0000-0002-2441-8095; Perez-Morga, David/0000-0002-7168-1865; Schiffmann, Serge/0000-0002-0118-9816	American Heart Association [0730350N]; US National Institutes of Health [HL16634]; Wellcome Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016634, R01HL016634] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C. Erneux, C. Moreau, F. Fontaine and L. Cuvelier for discussions and technical help, S. J. Elledge for the recombineering reagents, A. de Kerchove d'Exaerde for help with the design of the oligonucleotide probes, A. Nagy for the R1 ES cells, A. P. McMahon for the CAGG- Cre- ERTM mice and E. Golemis for hTERT- RPE1 cells. This work was supported by the Fonds de la Recherche Scientifique- FNRS ( FRS- FNRS; to S. G. and S. S.), the Fonds pour la Formation a` la Recherche dans l'Industrie et dans l'Agriculture ( FRIA; to M. J., M. B. and E. P.), the Fonds de la Recherche Scientifique Me ' dicale ( FRSM; to S. S. and S. N. S.), the Fondation Rose et Jean Hoguet ( to E. P.), Action de Recherches Concerte ' e de la Communaute ' Franc, aise de Belgique ( to S. N. S., S. S. and M. B.), The Queen Elisabeth Medical Fundation ( to S. N. S.), the Fonds David et Alice Van Buuren ( to M. J.), the Royal Society and Cancer Research UK ( to F. G.), the American Heart Association ( 0730350N; to M. V. K.), the US National Institutes of Health ( HL16634; to M. V. K.) and the Wellcome Trust ( to J. J. C. and C. G. W).	Adams M, 2008, J MED GENET, V45, P257, DOI 10.1136/jmg.2007.054999; Anderson CT, 2008, ANAT REC, V291, P1074, DOI 10.1002/ar.20754; Asano T, 1999, BIOCHEM BIOPH RES CO, V261, P188, DOI 10.1006/bbrc.1999.0998; Astle MV, 2007, BIOCHEM SOC SYMP, V74, P161, DOI 10.1042/BSS2007c15; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; Blero D, 2007, PFLUG ARCH EUR J PHY, V455, P31, DOI 10.1007/s00424-007-0304-5; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; DeSmedt F, 1996, J BIOL CHEM, V271, P10419, DOI 10.1074/jbc.271.17.10419; Hampshire DJ, 2006, EUR J HUM GENET, V14, P543, DOI 10.1038/sj.ejhg.5201577; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Kong AM, 2000, J BIOL CHEM, V275, P24052, DOI 10.1074/jbc.M000874200; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Phillips CL, 2004, J AM SOC NEPHROL, V15, P1744, DOI 10.1097/01.ASN.0000131520.07008.B3; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Vandeput F, 2006, CELL SIGNAL, V18, P2193, DOI 10.1016/j.cellsig.2006.05.010; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797	25	242	250	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1027	U102		10.1038/ng.427	http://dx.doi.org/10.1038/ng.427			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19668215				2022-12-25	WOS:000269382100017
J	Kritzer, JA; Hamamichi, S; McCaffery, JM; Santagata, S; Naumann, TA; Caldwell, KA; Caldwell, GA; Lindquist, S				Kritzer, Joshua A.; Hamamichi, Shusei; McCaffery, J. Michael; Santagata, Sandro; Naumann, Todd A.; Caldwell, Kim A.; Caldwell, Guy A.; Lindquist, Susan			Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN DISULFIDE-ISOMERASE; PARKINSONS-DISEASE; CAENORHABDITIS-ELEGANS; INTERACTOME NETWORK; CHEMICAL GENETICS; DRUG DISCOVERY; SPLIT-INTEIN; INHIBITORS; LIBRARIES; MAP	Phage display has demonstrated the utility of cyclic peptides as general protein ligands but cannot access proteins inside eukaryotic cells. Expanding a new chemical genetics tool, we describe the first expressed library of head-to-tail cyclic peptides in yeast (Saccharomyces cerevisiae). We applied the library to selections in a yeast model of alpha-synuclein toxicity that recapitulates much of the cellular pathology of Parkinson's disease. From a pool of 5 million transformants, we isolated two related cyclic peptide constructs that specifically reduced the toxicity of human alpha-synuclein. These expressed cyclic peptide constructs also prevented dopaminergic neuron loss in an established Caenorhabditis elegans Parkinson's model. This work highlights the speed and efficiency of using libraries of expressed cyclic peptides for forward chemical genetics in cellular models of human disease.	[Kritzer, Joshua A.; Santagata, Sandro; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hamamichi, Shusei; Caldwell, Kim A.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [McCaffery, J. Michael] Johns Hopkins Univ, Integrated Imaging Ctr, Baltimore, MD USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Santagata, Sandro] Harvard Univ, Sch Med, Boston, MA USA; [Naumann, Todd A.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Alabama System; University of Alabama Tuscaloosa; Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu		Caldwell, Guy/0000-0002-8283-9090; Caldwell, Kim/0000-0003-1580-6122; Santagata, Sandro/0000-0002-7528-9668	US National Institute of Neurological Disorders and Stroke (NINDS) [R21]; National Institute on Aging; American Parkinson Disease Association; Michael J. Fox Foundation; US National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038372, R21NS060957] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Parkinson Disease Association; Michael J. Fox Foundation; US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Benkovic (Pennsylvania State University) for plasmids, E. Spooner for mass spectrometry assistance and N. Azubuine for preparation of media. This work was supported by a National Research Service Award fellowship from the US National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (J.A.K.), an R21 grant from NINDS (S.L. and J.A.K.) and the Morris K. Udall Centers of Excellence for Parkinson's Disease Research (S. L.) Parkinson's disease research in the Caldwell Lab (G.A.C, K.A.C., S.H.) was supported by the American Parkinson Disease Association, Michael J. Fox Foundation and US National Institute of Environmental Health Sciences.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Bickle MBT, 2006, NAT PROTOC, V1, P1066, DOI 10.1038/nprot.2006.32; BRENNER S, 1974, GENETICS, V77, P71; Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Cabrele C, 2002, CHEM BIOL, V9, P731, DOI 10.1016/S1074-5521(02)00152-7; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Cheng L, 2007, PROTEIN SCI, V16, P1535, DOI 10.1110/ps.072933007; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Evans TC, 2002, CHEM REV, V102, P4869, DOI 10.1021/cr9601369; Ghosh I, 2001, J BIOL CHEM, V276, P24051, DOI 10.1074/jbc.M011049200; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Horswill AR, 2005, CELL CYCLE, V4, P552, DOI 10.4161/cc.4.4.1585; Horswill AR, 2004, P NATL ACAD SCI USA, V101, P15591, DOI 10.1073/pnas.0406999101; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Kersteen EA, 2003, ANTIOXID REDOX SIGN, V5, P413, DOI 10.1089/152308603768295159; Kinsella TM, 2002, J BIOL CHEM, V277, P37512, DOI 10.1074/jbc.M206162200; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Naumann TA, 2005, BIOTECHNOL BIOENG, V92, P820, DOI 10.1002/bit.20644; Nilsson LO, 2005, PROTEIN PEPTIDE LETT, V12, P795, DOI 10.2174/0929866054864247; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Scott CP, 2001, CHEM BIOL, V8, P801, DOI 10.1016/S1074-5521(01)00052-7; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Tavassoli A, 2005, ANGEW CHEM INT EDIT, V44, P2760, DOI 10.1002/anie.200500417; Tavassoli A, 2007, NAT PROTOC, V2, P1126, DOI 10.1038/nprot.2007.152; Tavassoli A, 2008, ACS CHEM BIOL, V3, P757, DOI 10.1021/cb800193n; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020; YOCUM RR, 1984, MOL CELL BIOL, V4, P1985, DOI 10.1128/MCB.4.10.1985; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	48	112	120	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					655	663		10.1038/nchembio.193	http://dx.doi.org/10.1038/nchembio.193			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19597508	Green Accepted, Green Submitted			2022-12-25	WOS:000269093000014
J	Schwarz, K; Iolascon, A; Verissimo, F; Trede, NS; Horsley, W; Chen, W; Paw, BH; Hopfner, KP; Holzmann, K; Russo, R; Esposito, MR; Spano, D; De Falco, L; Heinrich, K; Joggerst, B; Rojewski, MT; Perrotta, S; Denecke, J; Pannicke, U; Delaunay, J; Pepperkok, R; Heimpel, H				Schwarz, Klaus; Iolascon, Achille; Verissimo, Fatima; Trede, Nikolaus S.; Horsley, Wyatt; Chen, Wen; Paw, Barry H.; Hopfner, Karl-Peter; Holzmann, Karlheinz; Russo, Roberta; Esposito, Maria Rosaria; Spano, Daniela; De Falco, Luigia; Heinrich, Katja; Joggerst, Brigitte; Rojewski, Markus T.; Perrotta, Silverio; Denecke, Jonas; Pannicke, Ulrich; Delaunay, Jean; Pepperkok, Rainer; Heimpel, Hermann			Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II	NATURE GENETICS			English	Article							TRANSPORT; COMPLEX; TRAFFICKING; PROTEINS; VESICLES	Congenital dyserythropoietic anemias (CDAs) are phenotypically and genotypically heterogeneous diseases(1-4). CDA type II (CDAII) is the most frequent CDA. It is characterized by ineffective erythropoiesis and by the presence of bi- and multinucleated erythroblasts in bone marrow, with nuclei of equal size and DNA content, suggesting a cytokinesis disturbance(5). Other features of the peripheral red blood cells are protein and lipid dysglycosylation and endoplasmic reticulum double-membrane remnants(4,6). Development of other hematopoietic lineages is normal. Individuals with CDAII show progressive splenomegaly, gallstones and iron overload potentially with liver cirrhosis or cardiac failure. Here we show that the gene encoding the secretory COPII component SEC23B is mutated in CDAII. Short hairpin RNA (shRNA)-mediated suppression of SEC23B expression recapitulates the cytokinesis defect. Knockdown of zebrafish sec23b also leads to aberrant erythrocyte development. Our results provide in vivo evidence for SEC23B selectivity in erythroid differentiation and show that SEC23A and SEC23B, although highly related paralogous secretory COPII components, are nonredundant in erythrocyte maturation.	[Schwarz, Klaus; Heinrich, Katja; Rojewski, Markus T.; Pannicke, Ulrich] Univ Ulm, Inst Transfus Med, Ulm, Germany; [Schwarz, Klaus; Rojewski, Markus T.] German Red Cross Blood Serv Baden Wuerttemberg He, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany; [Iolascon, Achille; Russo, Roberta; Esposito, Maria Rosaria; Spano, Daniela; De Falco, Luigia] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy; [Iolascon, Achille; Russo, Roberta; Esposito, Maria Rosaria; Spano, Daniela; De Falco, Luigia] CEINGE Adv Biotechnol, Naples, Italy; [Verissimo, Fatima; Joggerst, Brigitte; Pepperkok, Rainer] European Mol Biol Lab, Heidelberg, Germany; [Trede, Nikolaus S.; Horsley, Wyatt] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Trede, Nikolaus S.; Horsley, Wyatt] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Chen, Wen; Paw, Barry H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA; [Chen, Wen; Paw, Barry H.] Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; [Hopfner, Karl-Peter] Univ Munich, Ctr Integrated Prot Sci, Munich, Germany; [Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Dept Chem & Biochem, Munich, Germany; [Holzmann, Karlheinz] Univ Hosp Ulm, Chip Facil ZKF, Ulm, Germany; [Perrotta, Silverio] Univ Naples 2, Dept Pediat, Naples, Italy; [Denecke, Jonas] Univ Rostock, Dept Pediat, Rostock, Germany; [Delaunay, Jean] Hop Bicetre, INSERM, U779, F-94275 Le Kremlin Bicetre, France; [Heimpel, Hermann] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany	Ulm University; University of Naples Federico II; CEINGE Biotecnologie Avanzate; European Molecular Biology Laboratory (EMBL); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Munich; University of Munich; Ulm University; Universita della Campania Vanvitelli; University of Rostock; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Ulm University	Schwarz, K (corresponding author), Univ Ulm, Inst Transfus Med, Ulm, Germany.	klaus.schwarz@uni-ulm.de; iolascon@ceinge.unina.it	Pannicke, Ulrich/D-7348-2014; De Falco, Luigia/AFT-1424-2022; de Falco, Luigia/J-7306-2016; Iolascon, Achille/A-4461-2014; Russo, Roberta/A-4441-2014; Hopfner, Karl-Peter/B-6864-2014; Russo, Roberta/O-7108-2019; Esposito, Maria Rosaria/Y-3138-2018	de Falco, Luigia/0000-0002-0553-2087; Russo, Roberta/0000-0002-3624-7721; Hopfner, Karl-Peter/0000-0002-4528-8357; Russo, Roberta/0000-0002-3624-7721; Paw, Barry/0000-0002-0492-1419; Pepperkok, Rainer/0000-0002-9762-3583; iolascon, achille/0000-0002-9558-0356; Rojewski, Markus/0000-0003-4265-0442; Perrotta, Silverio/0000-0001-6149-6845; Spano, Daniela/0000-0003-3567-6492; Esposito, Maria Rosaria/0000-0001-6749-9991	Telethon [GGP09044] Funding Source: Medline	Telethon(Fondazione Telethon)		Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CROOKSTON JH, 1972, BRIT J HAEMAT      S, V23, P83; Denecke J, 2008, GLYCOCONJUGATE J, V25, P375, DOI 10.1007/s10719-007-9089-1; Denecke J, 2009, BBA-MOL BASIS DIS, V1792, P915, DOI 10.1016/j.bbadis.2008.12.005; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Gasparini P, 1997, AM J HUM GENET, V61, P1112, DOI 10.1086/301609; HEIMPEL H, 1968, HELV MED ACTA, V34, P103; Heimpel H, 2003, BLOOD, V102, P4576, DOI 10.1182/blood-2003-02-0613; Heimpel H, 2006, DISORDERS HOMEOSTASI, P120; Iolascon A, 2000, HAEMATOLOGICA, V85, P673; Iolascon A, 1996, HAEMATOLOGICA, V81, P543; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Paw BH, 2003, NAT GENET, V34, P59, DOI 10.1038/ng1137; Penalver E, 1999, J BACTERIOL, V181, P2555; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; QUEISSER W, 1971, ACTA HAEMATOL-BASEL, V45, P65, DOI 10.1159/000208608; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Ronzoni L, 2008, BLOOD CELL MOL DIS, V40, P148, DOI 10.1016/j.bcmd.2007.07.006; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Wickramasinghe SN, 2000, CURR OPIN HEMATOL, V7, P71, DOI 10.1097/00062752-200003000-00001	33	196	203	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					936	U105		10.1038/ng.405	http://dx.doi.org/10.1038/ng.405			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19561605				2022-12-25	WOS:000268432900021
J	Shichita, T; Sugiyama, Y; Ooboshi, H; Sugimori, H; Nakagawa, R; Takada, I; Iwaki, T; Okada, Y; Iida, M; Cua, DJ; Iwakura, Y; Yoshimura, A				Shichita, Takashi; Sugiyama, Yuki; Ooboshi, Hiroaki; Sugimori, Hiroshi; Nakagawa, Ryusuke; Takada, Ichiro; Iwaki, Toru; Okada, Yasunori; Iida, Mitsuo; Cua, Daniel J.; Iwakura, Yoichiro; Yoshimura, Akihiko			Pivotal role of cerebral interleukin-17-producing gamma delta T cells in the delayed phase of ischemic brain injury	NATURE MEDICINE			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; AUTOIMMUNE ENCEPHALOMYELITIS; INTERFERON-GAMMA; FOCAL ISCHEMIA; BARRIER DISRUPTION; ESCHERICHIA-COLI; ARTERY OCCLUSION; IL-17 PRODUCTION; NERVOUS-SYSTEM; INFLAMMATION	Lymphocyte recruitment and activation have been implicated in the progression of cerebral ischemia-reperfusion (I/R) injury, but the roles of specific lymphocyte subpopulations and cytokines during stroke remain to be clarified. Here we demonstrate that the infiltration of T cells into the brain, as well as the cytokines interleukin-23 (IL-23) and IL-17, have pivotal roles in the evolution of brain infarction and accompanying neurological deficits. Blockade of T cell infiltration into the brain by the immunosuppressant FTY720 reduced I/R-induced brain damage. The expression of IL-23, which was derived mostly from infiltrated macrophages, increased on day 1 after I/R, whereas IL-17 levels were elevated after day 3, and this induction of IL-17 was dependent on IL-23. These data, together with analysis of mice genetically disrupted for IL-17 and IL-23, suggest that IL-23 functions in the immediate stage of I/R brain injury, whereas IL-17 has an important role in the delayed phase of I/R injury during which apoptotic neuronal death occurs in the penumbra. Intracellular cytokine staining revealed that gamma delta T lymphocytes, but not CD4(+) helper T cells, were a major source of IL-17. Moreover, depletion of gamma delta T lymphocytes ameliorated the I/R injury. We propose that T lymphocytes, including gamma delta T lymphocytes, could be a therapeutic target for mitigating the inflammatory events that amplify the initial damage in cerebral ischemia.	[Shichita, Takashi; Sugiyama, Yuki; Nakagawa, Ryusuke; Takada, Ichiro; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo, Japan; [Shichita, Takashi] Kyushu Univ, Grad Sch Med Sci, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 812, Japan; [Shichita, Takashi; Ooboshi, Hiroaki; Sugimori, Hiroshi; Iida, Mitsuo] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Ooboshi, Hiroaki] Med & Dent Hosp, Fukuoka Dent Coll, Dept Internal Med, Fukuoka, Japan; [Iwaki, Toru] Kyushu Univ, Grad Sch Med Sci, Dept Neuropathol, Fukuoka 812, Japan; [Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Shijuku Ku, Tokyo 160, Japan; [Cua, Daniel J.] Schering Plough SpA, Dept Immunol, Palo Alto, CA USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Tokyo, Japan; [Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Keio University; Kyushu University; Kyushu University; Fukuoka Dental College (FDC); Kyushu University; Keio University; Merck & Company; Schering Plough Corporation; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013; Iwakura, Yoichiro/E-5457-2011; Okada, Yasunori/B-5550-2014	Iwakura, Yoichiro/0000-0002-9934-5775; Okada, Yasunori/0000-0001-9208-4755	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [NIBIO, 07-4]; Naito Foundation; Astellas Foundation for Research on Metabolic Disorders.	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Naito Foundation(Naito Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders.	We thank S. Hamano for TCR gamma delta-specific antibody hybridoma, T. Yoshioka, N. Shiino and M. Asakawa for technical assistance, E. Ishikawa and H. Noguchi for technical support for human ischemic brain section, T. Kobayashi for discussion and technical help and N. Soma for manuscript preparation. This study was supported by special Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO, 07-4), the Naito Foundation and the Astellas Foundation for Research on Metabolic Disorders.	Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; CharriautMarlangue C, 1996, J CEREBR BLOOD F MET, V16, P186, DOI 10.1097/00004647-199603000-00002; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Gaudinski MR, 2008, STROKE, V39, P2765, DOI 10.1161/STROKEAHA.107.512269; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Ifergan I, 2008, BRAIN, V131, P785, DOI 10.1093/brain/awm295; JANDER S, 1995, J CEREBR BLOOD F MET, V15, P42, DOI 10.1038/jcbfm.1995.5; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Lambertsen KL, 2004, J NEUROPATH EXP NEUR, V63, P942, DOI 10.1093/jnen/63.9.942; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li GZ, 2005, SCAND J IMMUNOL, V62, P481, DOI 10.1111/j.1365-3083.2005.01683.x; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakamura R, 2008, J IMMUNOL, V181, P2071, DOI 10.4049/jimmunol.181.3.2071; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Sacco RL, 2007, LANCET, V369, P331, DOI 10.1016/S0140-6736(07)60155-X; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shimosegawa E, 2005, ANN NEUROL, V57, P495, DOI 10.1002/ana.20427; Sugimori H, 2004, BRAIN RES PROTOC, V13, P189, DOI 10.1016/j.brainresprot.2004.06.001; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	33	607	643	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					946	U150		10.1038/nm.1999	http://dx.doi.org/10.1038/nm.1999			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19648929				2022-12-25	WOS:000268770400040
J	Nichols, J; Jones, K; Phillips, JM; Newland, SA; Roode, M; Mansfield, W; Smith, A; Cooke, A				Nichols, Jennifer; Jones, Kenneth; Phillips, Jenny M.; Newland, Stephen A.; Roode, Mila; Mansfield, William; Smith, Austin; Cooke, Anne			Validated germline-competent embryonic stem cell lines from nonobese diabetic mice	NATURE MEDICINE			English	Article							NOD MOUSE; RAT BLASTOCYSTS; GROUND-STATE; PLURIPOTENCY; TRANSMISSION; DERIVATION	Nonobese diabetic (NOD) mice provide an excellent model of type 1 diabetes. The genetic contribution to this disease is complex, with more than 20 loci implicated in diabetes onset. One of the challenges for researchers using the NOD mouse model (and, indeed, other models of spontaneous autoimmune disease) has been the high density of sequence variation within candidate chromosomal segments. Furthermore, the scope for analyzing many putative disease loci via gene targeting has been hampered by the lack of NOD embryonic stem (ES) cells. We describe here the derivation of NOD ES cell lines capable of generating chimeric mice after stable genetic modification. These NOD ES cell lines also show efficient germline transmission, with offspring developing diabetes. The availability of these cells will not only enable the dissection of closely linked loci and the role they have in the onset of type 1 diabetes but also facilitate the generation of new transgenics.	[Phillips, Jenny M.; Newland, Stephen A.; Cooke, Anne] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Nichols, Jennifer; Jones, Kenneth; Roode, Mila; Mansfield, William; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QP, England; [Nichols, Jennifer; Jones, Kenneth; Roode, Mila] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QP, England; [Mansfield, William; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QP, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Cooke, A (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	ac@mole.bio.cam.ac.uk	Mallat, Ziad/D-4041-2012; Cooke, Anne/E-8709-2012; Cooke, Anne/S-4763-2019	Mallat, Ziad/0000-0003-0443-7878; Cooke, Anne/0000-0003-3327-6081; Nichols, Jennifer/0000-0002-8650-1388; Smith, Austin/0000-0002-3029-4682	Medical Research Council [G0300723B] Funding Source: researchfish; MRC [G0601174, G9806702] Funding Source: UKRI; Medical Research Council [G0601174, G9806702] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Arai S, 2004, EXP DIABESITY RES, V5, P219, DOI 10.1080/15438600490486877; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Brook FA, 2003, DIABETES, V52, P205, DOI 10.2337/diabetes.52.1.205; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; Nagafuchi S, 1999, FEBS LETT, V455, P101, DOI 10.1016/S0014-5793(99)00801-7; Redondo MJ, 2001, RECENT PROG HORM RES, V56, P69, DOI 10.1210/rp.56.1.69; Serreze DV, 2001, CURR DIRECT AUTOIMMU, V4, P31; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Yang W, 2009, STEM CELLS, V27, P383, DOI 10.1634/stemcells.2008-0974; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	19	157	164	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					814	U135		10.1038/nm.1996	http://dx.doi.org/10.1038/nm.1996			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19491843				2022-12-25	WOS:000267806900037
J	Tang, CJC; Fu, RH; Wu, KS; Hsu, WB; Tang, TK				Tang, Chieh-Ju C.; Fu, Ru-Huei; Wu, Kuo-Sheng; Hsu, Wen-Bin; Tang, K. Tang			CPAP is a cell-cycle regulated protein that controls centriole length	NATURE CELL BIOLOGY			English	Article							COILED-COIL PROTEIN; CENTROSOME DUPLICATION; C-ELEGANS; CAENORHABDITIS-ELEGANS; KEN BOX; PROCENTRIOLE; RECRUITMENT; BIOGENESIS; MECHANISMS; INTERACTS	Centriole duplication involves the growing of a procentriole (progeny centriole) next to the proximal end of each preexisting centriole (parental centriole). The molecular mechanisms that regulate procentriole elongation remain obscure. We show here that expression of the centriolar protein CPAP (centrosomal P4.1-associated protein) is carefully regulated during the cell cycle, with the protein being degraded in late mitosis. Depletion of CPAP inhibited centrosome duplication, whereas excess CPAP induced the formation of elongated procentriole-like structures (PLSs), which contain stable microtubules and several centriolar proteins. Ultrastructural analysis revealed that these structures are similar to procentrioles with elongated microtubules. Overexpression of a CPAP mutant (CPAP-377EE) that does not bind to tubulin dimers significantly inhibited the formation of CPAP-induced PLSs. Together, these results suggest that CPAP is a new regulator of centriole length and its intrinsic tubulin-dimer binding activity is required for procentriole elongation.	[Tang, Chieh-Ju C.; Fu, Ru-Huei; Wu, Kuo-Sheng; Hsu, Wen-Bin; Tang, K. Tang] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Wu, Kuo-Sheng] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Tang, TK (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.	tktang@ibms.sinica.edu.tw	Tang, Tang K./S-7012-2018	Tang, Tang K./0000-0002-3660-0695; Fu, Ru-Huei/0000-0001-9367-1759				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Chen CY, 2006, BIOCHEM BIOPH RES CO, V342, P1203, DOI 10.1016/j.bbrc.2006.02.089; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; KOHLMAIER G, 2004, CURR BIOL IN PRESS; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Paoletti A, 1996, J CELL SCI, V109, P3089; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; SCHMIDT TI, CURR BIOL IN PRESS; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	35	201	203	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					825	U103		10.1038/ncb1889	http://dx.doi.org/10.1038/ncb1889			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19503075				2022-12-25	WOS:000267603100010
J	Chau, TA; McCully, ML; Brintnell, W; An, G; Kasper, KJ; Vines, ED; Kubes, P; Haeryfar, SMM; McCormick, JK; Cairns, E; Heinrichs, DE; Madrenas, J				Chau, Thu A.; McCully, Michelle L.; Brintnell, William; An, Gary; Kasper, Katherine J.; Vines, Enrique D.; Kubes, Paul; Haeryfar, S. M. Mansour; McCormick, John K.; Cairns, Ewa; Heinrichs, David E.; Madrenas, Joaquin			Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome	NATURE MEDICINE			English	Article							METHICILLIN-RESISTANT; BACTERIAL SUPERANTIGENS; LIPOTEICHOIC ACID; UNITED-STATES; LETHAL SHOCK; AUREUS; INTERLEUKIN-10; INDUCTION; IL-10; PREVALENCE	Staphylococcal superantigens are pyrogenic exotoxins that cause massive T cell activation leading to toxic shock syndrome and death. Despite the strong adaptive immune response induced by these toxins, infections by superantigen-producing staphylococci are very common clinical events. We hypothesized that this may be partly a result of staphylococcal strains having developed strategies that downregulate the T cell response to these toxins. Here we show that the human interleukin-2 response to staphylococcal superantigens is inhibited by the simultaneous presence of bacteria. Such a downregulatory effect is the result of peptidoglycan-embedded molecules binding to Toll-like receptor 2 and inducing interleukin-10 production and apoptosis of antigen-presenting cells. We corroborated these findings in vivo by showing substantial prevention of mortality after simultaneous administration of staphylococcal enterotoxin B with either heat-killed staphylococci or Staphylococcus aureus peptidoglycan in mouse models of superantigen-induced toxic shock syndrome.	[Chau, Thu A.; McCully, Michelle L.; Madrenas, Joaquin] Robarts Res Inst, FOCIS Ctr Clin Immunol & Immunotherapeut, London, ON N6A 5C1, Canada; [McCully, Michelle L.; Kasper, Katherine J.; Vines, Enrique D.; Haeryfar, S. M. Mansour; McCormick, John K.; Cairns, Ewa; Heinrichs, David E.; Madrenas, Joaquin] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Brintnell, William; Cairns, Ewa; Madrenas, Joaquin] Univ Western Ontario, Dept Med, London, ON, Canada; [An, Gary] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Kubes, Paul] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada; [McCormick, John K.] Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Northwestern University; Feinberg School of Medicine; University of Calgary; Western University (University of Western Ontario)	Madrenas, J (corresponding author), Robarts Res Inst, FOCIS Ctr Clin Immunol & Immunotherapeut, London, ON N6A 5C1, Canada.	madrenas@robarts.ca	Madrenas, Quim/P-5008-2019; Cairns, Ewa/G-3284-2011; McCormick, John/E-4232-2015; McCully, Michelle/A-7705-2013; Heinrichs, David/ABD-5702-2021	McCully, Michelle/0000-0003-1543-3629; McCormick, John/0000-0003-3742-7289; An, Gary/0000-0003-4549-9004; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research; Kidney Foundation of Canada; Canadian Institutes of Health Research New Investigator Award; Calder Foundation; Tier I Canada Research Chair in Immunobiology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Calder Foundation; Tier I Canada Research Chair in Immunobiology	We thank K. C. Kain and Z. Lu (University Health Network, Toronto) for providing mice to harvest cells for in vitro experiments and the members of the Madrenas laboratory for helpful discussions and ideas. The human B lymphoblastoid cell line LG2 was provided by E. Long (US National Institutes of Health). This work was supported by grants from the Canadian Institutes of Health Research and the Kidney Foundation of Canada. J.K.M. is a recipient of a Canadian Institutes of Health Research New Investigator Award, E. C. is a recipient of an award from the Calder Foundation and J.M. holds a Tier I Canada Research Chair in Immunobiology.	Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Annane D, 2004, EXPERT OPIN PHARMACO, V5, P1701, DOI 10.1517/14656566.5.8.1701; AOKI Y, 1995, BLOOD, V86, P1420, DOI 10.1182/blood.V86.4.1420.bloodjournal8641420; BEAN AGD, 1993, INFECT IMMUN, V61, P4937, DOI 10.1128/IAI.61.11.4937-4939.1993; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; BUELENS C, 1995, EUR J IMMUNOL, V25, P2668, DOI 10.1002/eji.1830250940; Bueno Clara, 2007, Chem Immunol Allergy, V93, P161, DOI 10.1159/000100894; Bueno C, 2006, IMMUNITY, V25, P67, DOI 10.1016/j.immuni.2006.04.012; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P421; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chuang Yu-Yu, 2005, Paediatr Drugs, V7, P11, DOI 10.2165/00148581-200507010-00002; Criado G, 2004, J IMMUNOL, V172, P222, DOI 10.4049/jimmunol.172.1.222; Dale SE, 2004, J BACTERIOL, V186, P8356, DOI 10.1128/JB.186.24.8356-8362.2004; DAVIS JP, 1980, NEW ENGL J MED, V303, P1429, DOI 10.1056/NEJM198012183032501; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Faulkner L, 2005, J IMMUNOL, V175, P6870, DOI 10.4049/jimmunol.175.10.6870; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Guo H, 2008, IMMUNOL CELL BIOL, V86, P271, DOI 10.1038/sj.icb.7100158; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Haslinger-Loffler B, 2006, KIDNEY INT, V70, P1089, DOI 10.1038/sj.ki.5001710; Holtfreter S, 2006, J INFECT DIS, V193, P1275, DOI 10.1086/503048; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; Jankovic D, 2007, NAT IMMUNOL, V8, P1281, DOI 10.1038/ni1207-1281; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kanauchi O, 2005, CURR PHARM DESIGN, V11, P1047, DOI 10.2174/1381612053381675; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; KRAKAUER T, 1995, J INFECT DIS, V172, P988, DOI 10.1093/infdis/172.4.988; Kuehnert MJ, 2005, EMERG INFECT DIS, V11, P868; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Llewelyn M, 2002, LANCET INFECT DIS, V2, P156, DOI 10.1016/S1473-3099(02)00222-0; Madsen K, 2006, J CLIN GASTROENTEROL, V40, P232, DOI 10.1097/00004836-200603000-00014; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Mempel M, 2003, EUR J CLIN MICROBIOL, V22, P306, DOI 10.1007/s10096-003-0928-0; Nakagawa Y, 2003, J INFECT DIS, V188, P1284, DOI 10.1086/379036; Nashev D, 2004, FEMS MICROBIOL LETT, V233, P45, DOI 10.1016/j.femsle.2004.01.032; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Parsonnet J, 2005, J CLIN MICROBIOL, V43, P4628, DOI 10.1128/JCM.43.9.4628-4634.2005; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Schmitz FJ, 1997, EUR J EPIDEMIOL, V13, P699, DOI 10.1023/A:1007357206672; Sebulsky MT, 2004, J BIOL CHEM, V279, P53152, DOI 10.1074/jbc.M409793200; Sing A, 2002, J EXP MED, V196, P1017, DOI 10.1084/jem.20020908; Stiles BG, 1999, INFECT IMMUN, V67, P1521, DOI 10.1128/IAI.67.3.1521-1525.1999; Stuyt RJL, 2001, INFECT IMMUN, V69, P5025, DOI 10.1128/IAI.69.8.5025-5030.2001; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Teft WA, 2007, J IMMUNOL, V179, P3631, DOI 10.4049/jimmunol.179.6.3631; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Venet F, 2006, J IMMUNOL, V177, P6540, DOI 10.4049/jimmunol.177.9.6540; Wang JE, 2000, INFECT IMMUN, V68, P3965, DOI 10.1128/IAI.68.7.3965-3970.2000; WILLEMS F, 1994, EUR J IMMUNOL, V24, P1007, DOI 10.1002/eji.1830240435; Young MH, 2006, EXPERT OPIN BIOL TH, V6, P155, DOI 10.1517/14712598.6.2.155	60	105	107	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					641	U143		10.1038/nm.1965	http://dx.doi.org/10.1038/nm.1965			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19465927				2022-12-25	WOS:000266731600023
J	Fink, G; Hajdo, L; Skowronek, KJ; Reuther, C; Kasprzak, AA; Diez, S				Fink, Gero; Hajdo, Lukasz; Skowronek, Krzysztof J.; Reuther, Cordula; Kasprzak, Andrzej A.; Diez, Stefan			The mitotic kinesin-14 Ncd drives directional microtubule-microtubule sliding	NATURE CELL BIOLOGY			English	Article							CROSS-LINKS MICROTUBULES; MOTOR PROTEIN; DROSOPHILA; EG5; IDENTIFICATION; MOVEMENT; SPINDLES; MEIOSIS; MUTANTS	During mitosis and meiosis, the bipolar spindle facilitates chromosome segregation through microtubule sliding as well as microtubule growth and shrinkage(1). Kinesin-14, one of the motors involved, causes spindle collapse in the absence of kinesin-5 (refs 2, 3), participates in spindle assembly(4) and modulates spindle length(5). However, the molecular mechanisms underlying these activities are not known. Here, we report that Drosophila melanogaster kinesin-14 (Ncd) alone causes sliding of anti-parallel microtubules but locks together (that is, statically crosslinks) those that are parallel. Using single molecule imaging we show that Ncd diffuses along microtubules in a tail-dependent manner and switches its orientation between sliding microtubules. Our results show that kinesin-14 causes sliding and expansion of an anti-parallel microtubule array by dynamic interactions through the motor domain on the one side and the tail domain on the other. This mechanism accounts for the roles of kinesin-14 in spindle organization.	[Fink, Gero; Reuther, Cordula; Diez, Stefan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Hajdo, Lukasz; Skowronek, Krzysztof J.; Kasprzak, Andrzej A.] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Hajdo, Lukasz] Univ Lodz, Dept Gen Biophys, PL-90237 Lodz, Poland; [Skowronek, Krzysztof J.] Int Inst Mol & Cell Biol, PL-02093 Warsaw, Poland	Max Planck Society; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Lodz; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Diez, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	diez@mpi-cbg.de	Skowronek, Krzysztof/G-2855-2010; Diez, Stefan/E-8172-2010; Kasprzak, Andrzej A. A/R-4476-2016	Skowronek, Krzysztof/0000-0001-9973-7085; Diez, Stefan/0000-0002-0750-8515; Kasprzak, Andrzej A. A/0000-0002-3602-5379; Reuther, Cordula/0000-0002-3787-4022	German Federal Ministry of Education and Research [03 N 8712]; Polish Network for Mechanisms of Cell Motility [2 P04C 131 29]; Max-Planck-Society; Boehringer Ingelheim Foundation	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Polish Network for Mechanisms of Cell Motility; Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	We acknowledge the members of the Kasprzak and the Diez labs for comments on the manuscript as well as C. Brauer and D. Naumburger for technical support. We thank C. Leduc, B. Nitzsche, C. Gell and J. Howard for fruitful discussion, F. Ruhnow for help with the microtubule tracking, as well as S. Bajer and E. Kocik for help with FPLC experiments. This work was supported by the German Federal Ministry of Education and Research (Grant 03 N 8712), the Polish Network for Mechanisms of Cell Motility, the Grant 2 P04C 131 29 and the Max-Planck-Society. G. Fink was supported by a fellowship from the Boehringer Ingelheim Foundation	Brust-Mascher I, 2002, MOL BIOL CELL, V13, P3967, DOI 10.1091/mbc.02-05-0069; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; CHANDRA R, 1993, J BIOL CHEM, V268, P9005; Cheerambathur DK, 2008, J CELL BIOL, V182, P429, DOI 10.1083/jcb.200804100; ENDOW SA, 1994, J CELL SCI, V107, P859; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; HATSUMI M, 1992, J CELL SCI, V101, P547; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HOYT MA, 1993, GENETICS, V135, P35; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; HYMAN AA, 1991, J CELL SCI, P125; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; KIMBLE M, 1983, J CELL SCI, V62, P301; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Oladipo A, 2007, MOL BIOL CELL, V18, P3601, DOI 10.1091/mbc.e06-12-1085; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Segbert C, 2003, MOL BIOL CELL, V14, P4458, DOI 10.1091/mbc.E03-05-0283; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3	35	152	153	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					717	U47		10.1038/ncb1877	http://dx.doi.org/10.1038/ncb1877			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19430467				2022-12-25	WOS:000266503700016
J	Goldenson, D				Goldenson, Dianna			A day late and a few million dollars short	NATURE BIOTECHNOLOGY			English	Editorial Material								The pitfalls of seeking and obtaining a patent term extension.	Darby & Darby, New York, NY USA		Goldenson, D (corresponding author), Darby & Darby, New York, NY USA.	dgoldenson@darbylaw.com						[Anonymous], 2008, US Patent, Patent No. [5,674,860, 5674860]; *ASTRAZENECA PLC, 2009, 4 QUART FULL YEAR RE; 2009, PFIZER REPOTS 4 QUAT	3	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2009	27	6					538	542		10.1038/nbt0609-538	http://dx.doi.org/10.1038/nbt0609-538			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	458AC	19513055				2022-12-25	WOS:000266980500020
J	Shen, JH; Yu, WM; Brotto, M; Scherman, JA; Guo, CY; Stoddard, C; Nosek, TM; Valdivia, HH; Qu, CK				Shen, Jinhua; Yu, Wen-Mei; Brotto, Marco; Scherman, Joseph A.; Guo, Caiying; Stoddard, Christopher; Nosek, Thomas M.; Valdivia, Hector H.; Qu, Cheng-Kui			Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca2+ homeostasis	NATURE CELL BIOLOGY			English	Article							OPERATED CALCIUM-CHANNEL; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; MICE LACKING; ACTIVATION; INHIBITOR; MOUSE; THAPSIGARGIN; DYSFUNCTION; FATIGUE	The intracellular Ca2+ concentration ([Ca2+](i)) in skeletal muscles must be rapidly regulated during the excitation-contraction-relaxation process(1). However, the signalling components involved in such rapid Ca2+ movement are not fully understood. Here we report that mice deficient in the newly identified PtdInsP (phosphatidylinositol phosphate) phosphatase MIP/MTMR14 (muscle-specific inositol phosphatase) show muscle weakness and fatigue. Muscles isolated from MIP/MTMR14(-/-) mice produced less contractile force, had markedly prolonged relaxation and showed exacerbated fatigue relative to normal muscles. Further analyses revealed that MIP/MTMR14 deficiency resulted in spontaneous Ca2+ leakage from the internal store - the sarcoplasmic reticulum. This was attributed to decreased metabolism (dephosphorylation) and the subsequent accumulation of MIP/MTMR14 substrates, especially PtdIns(3,5)P-2 and PtdIns (3,4)P-2. Furthermore, we found that PtdIns(3,5)P-2 and PtdIns(3,4)P-2 bound to, and directly activated, the Ca2+ release channel (ryanodine receptor 1, RyR1) of the sarcoplasmic reticulum. These studies provide the first evidence that finely controlled PtdInsP levels in muscle cells are essential for maintaining Ca2+ homeostasis and muscle performance.	[Shen, Jinhua; Yu, Wen-Mei; Qu, Cheng-Kui] Case Western Reserve Univ, Dept Med, Ctr Stem Cell & Regenerat Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Brotto, Marco] Univ Missouri, Sch Nursing & Med, Kansas City, MO 64108 USA; [Scherman, Joseph A.; Valdivia, Hector H.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; [Guo, Caiying; Stoddard, Christopher] Univ Connecticut, Ctr Hlth, Gene Targeting & Transgen Facil, Farmington, CT 06030 USA; [Nosek, Thomas M.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; University of Missouri System; University of Missouri Kansas City; University of Wisconsin System; University of Wisconsin Madison; University of Connecticut; Case Western Reserve University	Qu, CK (corresponding author), Case Western Reserve Univ, Dept Med, Ctr Stem Cell & Regenerat Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	cxq6@case.edu		Nosek, Thomas/0000-0001-6466-9035	NIH [HL068212, HL082670, HL55438]; American Heart Association [0535555N]; Case Center for Transdisciplinary Research on Energetics and Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL082670, R01HL055438, R01HL068212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Case Center for Transdisciplinary Research on Energetics and Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to D. Chess, M. Chandler, T. Stefan, J. Jacobberger, L. Brotto, N. Wiesleder and J. Ma for technical assistance and helpful discussions. Motor function tests were performed by the Case Western Reserve University Rodent Behavior Core. This work was supported by NIH grants (HL068212 and HL082670) to C. K. Q. and (HL55438) H. H. V., an American Heart Association grant (0535555N) to M. B. and a pilot grant from the Case Center for Transdisciplinary Research on Energetics and Cancer to T. M. N., C. K. Q. and M. B.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Amran MS, 2003, CARDIOVASC DRUG REV, V21, P255; Bartolommei G, 2006, J BIOL CHEM, V281, P9547, DOI 10.1074/jbc.M510550200; Benkusky NA, 2004, BIOCHEM BIOPH RES CO, V322, P1280, DOI 10.1016/j.bbrc.2004.08.033; Bhogal MS, 1998, ANN NY ACAD SCI, V853, P260, DOI 10.1111/j.1749-6632.1998.tb08274.x; BOGO V, 1981, NEUROTOXICOLOGY, V2, P765; Brotto MAD, 2002, EXP PHYSIOL, V87, P77, DOI 10.1113/eph8702224; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; DEAN RL, 1981, EXP AGING RES, V7, P427, DOI 10.1080/03610738108259823; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; ISHII T, 1994, P NATL ACAD SCI USA, V91, P6103, DOI 10.1073/pnas.91.13.6103; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Min J, 2007, NAT CHEM BIOL, V3, P55, DOI 10.1038/nchembio833; Morgan EE, 2006, AM J PHYSIOL-HEART C, V290, pH1899, DOI 10.1152/ajpheart.01014.2005; Nagaraj RY, 2000, PHYSIOL GENOMICS, V4, P43, DOI 10.1152/physiolgenomics.2000.4.1.43; Niswender KD, 2003, J HISTOCHEM CYTOCHEM, V51, P275, DOI 10.1177/002215540305100302; Nosek TM, 2000, PHYSIOL GENOMICS, V4, P25, DOI 10.1152/physiolgenomics.2000.4.1.25; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Rennison JH, 2007, AM J PHYSIOL-HEART C, V292, pH1498, DOI 10.1152/ajpheart.01021.2006; Shin DW, 2003, J BIOL CHEM, V278, P3286, DOI 10.1074/jbc.M209045200; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; Toth A, 1998, AM J PHYSIOL-HEART C, V275, pH1652, DOI 10.1152/ajpheart.1998.275.5.H1652; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005; Zhu XS, 2004, J BIOL CHEM, V279, P26588, DOI 10.1074/jbc.M403284200; Zhu XS, 2004, CELL CALCIUM, V35, P165, DOI 10.1016/j.ceca.2003.09.002	37	72	73	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					769	U141		10.1038/ncb1884	http://dx.doi.org/10.1038/ncb1884			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465920	Green Accepted			2022-12-25	WOS:000266503700023
J	Ngo, JT; Champion, JA; Mahdavi, A; Tanrikulu, IC; Beatty, KE; Connor, RE; Yoo, TH; Dieterich, DC; Schuman, EM; Tirrell, DA				Ngo, John T.; Champion, Julie A.; Mahdavi, Alborz; Tanrikulu, I. Caglar; Beatty, Kimberly E.; Connor, Rebecca E.; Yoo, Tae Hyeon; Dieterich, Daniela C.; Schuman, Erin M.; Tirrell, David A.			Cell-selective metabolic labeling of proteins	NATURE CHEMICAL BIOLOGY			English	Article							NEWLY SYNTHESIZED PROTEINS; NONCANONICAL AMINO-ACIDS; MAMMALIAN-CELLS; BACTERIAL-CELLS; IDENTIFICATION; PROTEOMICS; CHEMISTRY	Metabolic labeling of proteins with the methionine surrogate azidonorleucine can be targeted exclusively to specified cells through expression of a mutant methionyl-tRNA synthetase (MetRS). In complex cellular mixtures, proteins made in cells that express the mutant synthetase can be tagged with affinity reagents (for detection or enrichment) or fluorescent dyes (for imaging). Proteins made in cells that do not express the mutant synthetase are neither labeled nor detected.	[Ngo, John T.; Champion, Julie A.; Mahdavi, Alborz; Tanrikulu, I. Caglar; Beatty, Kimberly E.; Connor, Rebecca E.; Yoo, Tae Hyeon; Tirrell, David A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Dieterich, Daniela C.; Schuman, Erin M.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Tirrell, DA (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	tirrell@caltech.edu	Schuman, Erin M/D-6204-2011	Beatty, Kimberly/0000-0002-2303-8779; Tanrikulu, Ismet Caglar/0000-0002-7165-0399; Dieterich, Daniela C./0000-0002-9880-1214; Ngo, John/0000-0003-3508-1915	US National Institutes of Health [R21 DA020589, R01 GM62523]; US Army Research Office Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA020589] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Research Office Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We gratefully acknowledge the US National Institutes of Health (R21 DA020589 and R01 GM62523) and the US Army Research Office Institute for Collaborative Biotechnologies for support of this work. We thank K. Boulware for assistance in generating the three-dimensional movie of infected macrophages. E. M. S. is an investigator of the Howard Hughes Medical Institute.	Beatty KE, 2005, J AM CHEM SOC, V127, P14150, DOI 10.1021/ja054643W; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Beynon RJ, 2005, MOL CELL PROTEOMICS, V4, P857, DOI 10.1074/mcp.R400010-MCP200; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Lewis WG, 2002, ANGEW CHEM INT EDIT, V41, P1053, DOI 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4; Link AJ, 2006, P NATL ACAD SCI USA, V103, P10180, DOI 10.1073/pnas.0601167103; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Yoo TH, 2007, ANGEW CHEM INT EDIT, V46, P5340, DOI 10.1002/anie.200700779; Zhang CG, 2005, EXPERT REV PROTEOMIC, V2, P187, DOI 10.1586/14789450.2.2.187	14	125	126	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					715	717		10.1038/nchembio.200	http://dx.doi.org/10.1038/nchembio.200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19668194	Green Accepted			2022-12-25	WOS:000270039900006
J	Nguyen, H; Merrill, BJ; Polak, L; Nikolova, M; Rendl, M; Shaver, TM; Pasolli, HA; Fuchs, E				Nguyen, Hoang; Merrill, Bradley J.; Polak, Lisa; Nikolova, Maria; Rendl, Michael; Shaver, Timothy M.; Pasolli, H. Amalia; Fuchs, Elaine			Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia	NATURE GENETICS			English	Article							HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; STEM-CELLS; TRANSIENT ACTIVATION; MOUSE EPIDERMIS; SELF-RENEWAL; DIFFERENTIATION; MAINTENANCE; REGULATOR; TRIGGER	Single-layered embryonic skin either stratifies to form epidermis or responds to Wnt signaling (stabilized beta-catenin) to form hair follicles. Postnatally, stem cells continue to differentially use Wnt signaling in long-term tissue homeostasis. We have discovered that embryonic progenitor cells and postnatal hair follicle stem cells coexpress Tcf3 and Tcf4, which can act as transcriptional activators or repressors. Using loss-of-function studies and transcriptional analyses, we uncovered consequences to the absence of Tcf3 and Tcf4 in skin that only partially overlap with those caused by beta-catenin deficiency. We established roles for Tcf3 and Tcf4 in long-term maintenance and wound repair of both epidermis and hair follicles, suggesting that Tcf proteins have both Wnt-dependent and Wnt-independent roles in lineage determination.	[Nguyen, Hoang; Merrill, Bradley J.; Polak, Lisa; Nikolova, Maria; Rendl, Michael; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA; [Shaver, Timothy M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Shaver, Timothy M.] Baylor Coll Med, Stem Cell & Regenerat Med Ctr, Houston, TX 77030 USA	Howard Hughes Medical Institute; Rockefeller University; Baylor College of Medicine; Baylor College of Medicine	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Pasolli, Hilda Amalia/0000-0003-3899-3530; Shaver, Timothy/0000-0002-3210-3691; Rendl, Michael/0000-0001-6326-620X	National Institutes of Health; Howard Hughes Medical Institute; National Institutes of Health [R01-AR31737]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Clevers for providing Tcf4 knockout mice, Fuchs lab members for their help and critical discussions of the work and N. Stokes for assistance in the Comparative Biosciences Center animal facility at Rockefeller University. E. F. is an Investigator of the Howard Hughes Medical Institute. H. N. was the recipient of a Ruth Kirschstein postdoctoral fellowship from the National Institutes of Health. This work was supported by the Howard Hughes Medical Institute and a grant from the National Institutes of Health (R01-AR31737).	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Alonso L, 2005, J CELL BIOL, V170, P559, DOI 10.1083/jcb.200504131; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Niemann C, 2002, DEVELOPMENT, V129, P95; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034	32	162	169	2	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1068	U38		10.1038/ng.431	http://dx.doi.org/10.1038/ng.431			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19718027	Green Accepted			2022-12-25	WOS:000270330400008
J	Fujita, K; Mondal, AM; Horikawa, I; Nguyen, GH; Kumamoto, K; Sohn, JJ; Bowman, ED; Mathe, EA; Schetter, AJ; Pine, SR; Ji, H; Vojtesek, B; Bourdon, JC; Lane, DP; Harris, CC				Fujita, Kaori; Mondal, Abdul M.; Horikawa, Izumi; Nguyen, Giang H.; Kumamoto, Kensuke; Sohn, Jane J.; Bowman, Elise D.; Mathe, Ewy A.; Schetter, Aaron J.; Pine, Sharon R.; Ji, Helen; Vojtesek, Borivoj; Bourdon, Jean-Christophe; Lane, David P.; Harris, Curtis C.			p53 isoforms Delta 133p53 and p53 beta are endogenous regulators of replicative cellular senescence	NATURE CELL BIOLOGY			English	Article							ONCOGENE-INDUCED SENESCENCE; HUMAN-COLON; DNA-DAMAGE; DOWNSTREAM TARGET; EXPRESSION; MIR-34A; CANCER; GENE; APOPTOSIS; CELLS	The finite proliferative potential of normal human cells leads to replicative cellular senescence, which is a critical barrier to tumour progression in vivo(1-3). We show that the human p53 isoforms Delta 133p53 and p53 beta(4) function in an endogenous regulatory mechanism for p53-mediated replicative senescence. Induced p53 beta and diminished Delta 133p53 were associated with replicative senescence, but not oncogene-induced senescence, in normal human fibroblasts. The replicatively senescent fibroblasts also expressed increased levels of miR-34a, a p53-induced microRNA(5-9), the antisense inhibition of which delayed the onset of replicative senescence. The siRNA (short interfering RNA)-mediated knockdown of endogenous Delta 133p53 induced cellular senescence, which was attributed to the regulation of p21(WAF1) and other p53 transcriptional target genes. In overexpression experiments, whereas p53 beta cooperated with full-length p53 to accelerate cellular senescence, Delta 133p53 repressed miR-34a expression and extended the cellular replicative lifespan, providing a functional connection of this microRNA to the p53 isoform-mediated regulation of senescence. The senescence-associated signature of p53 isoform expression (that is, elevated p53 beta and reduced Delta 133p53) was observed in vivo in colon adenomas with senescent phenotypes(10,11). The increased Delta 133p53 and decreased p53 beta isoform expression found in colon carcinoma may signal an escape from the senescence barrier during the progression from adenoma to carcinoma.	[Fujita, Kaori; Mondal, Abdul M.; Horikawa, Izumi; Nguyen, Giang H.; Kumamoto, Kensuke; Sohn, Jane J.; Bowman, Elise D.; Mathe, Ewy A.; Schetter, Aaron J.; Pine, Sharon R.; Ji, Helen; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Nguyen, Giang H.] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20814 USA; [Vojtesek, Borivoj] Masaryk Mem Canc Inst, Brno 65653, Czech Republic; [Bourdon, Jean-Christophe; Lane, David P.] Univ Dundee, Ninewells Hosp, Dept Surg & Mol Oncol, Inserm European Associated Lab, Dundee DD1 9SY, Scotland; [Lane, David P.] Inst Mol & Cell Biol, Singapore 138673, Singapore	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; Masaryk Memorial Cancer Institute; University of Dundee; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Harris, CC (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, 37 Convent Dr, Bethesda, MD 20892 USA.	curtis_harris@nih.gov	JC, Bourdon/A-4439-2008; Mathe, Ewy/L-1616-2019	JC, Bourdon/0000-0003-4623-9386; Lane, David/0000-0003-0551-3545; Mathe, Ewy/0000-0003-4491-8107	NIH, National Cancer Institute (NCI); Grant Agency of the Czech Republic (GACR) [301/08/1468]; Internal Grant Agency of Health of Czech Republic (IGA MZ CR) [NS/9812-4]; Breast Cancer Campaign, Cancer-Research UK (CRUK); Institut National de la Same et de la Recherche Medicale (Inserm); NATIONAL CANCER INSTITUTE [ZIABC005795, ZIABC005480, Z01BC010878, Z01BC005480] Funding Source: NIH RePORTER	NIH, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grant Agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); Internal Grant Agency of Health of Czech Republic (IGA MZ CR); Breast Cancer Campaign, Cancer-Research UK (CRUK)(Cancer Research UK); Institut National de la Same et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Serrano, M. Tainsky, M. Oshimura, G. Hannon, T. de Lange and J. Khan for cells and reagents, X. Wang for helpful discussions, E. Spillare for continuous support and E. Michalova for technical assistance. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute (NCI). B.V. was supported by the grants from the Grant Agency of the Czech Republic (GACR; number 301/08/1468) and the Internal Grant Agency of Health of Czech Republic (IGA MZ CR; number NS/9812-4). J.C.B. was supported by Breast Cancer Campaign, Cancer-Research UK (CRUK) and the Institut National de la Same et de la Recherche Medicale (Inserm). D.L. is a Gibb fellow of CRUK. H. J. participated in the NIH Summer Internship Program.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; AUTRUP H, 1980, CARCINOGENESIS, V1, P375, DOI 10.1093/carcin/1.5.375; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; COSTA A, 1995, J PATHOL, V176, P45, DOI 10.1002/path.1711760108; Dai CY, 2000, GASTROENTEROLOGY, V119, P929, DOI 10.1053/gast.2000.17952; Gjoerup OV, 2007, P NATL ACAD SCI USA, V104, P8334, DOI 10.1073/pnas.0703164104; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; HORIKAWA I, 1995, HUM MOL GENET, V4, P313, DOI 10.1093/hmg/4.2.313; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; O'Sullivan J, 2006, CANCER EPIDEM BIOMAR, V15, P573, DOI 10.1158/1055-9965.EPI-05-0542; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tang X, 2007, ONCOGENE, V26, P7302, DOI 10.1038/sj.onc.1210542; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yang Q, 2007, CANCER RES, V67, P11677, DOI 10.1158/0008-5472.CAN-07-1390; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	44	228	233	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1135	U208		10.1038/ncb1928	http://dx.doi.org/10.1038/ncb1928			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19701195	Green Accepted			2022-12-25	WOS:000269482500016
J	Ro, H; Dawid, IB				Ro, Hyunju; Dawid, Igor B.			Organizer restriction through modulation of Bozozok stability by the E3 ubiquitin ligase Lnx-like	NATURE CELL BIOLOGY			English	Article							NUMB PROTEIN-X; HOMEOBOX GENE; ANTERIOR NEUROECTODERM; PATTERN-FORMATION; DORSAL ORGANIZER; XENOPUS EMBRYOS; BETA-CATENIN; ZEBRAFISH; PATHWAY; AXIS	The organizer anchors the primary embryonic axis, and balance between dorsal (organizer) and ventral domains is fundamental to body patterning. LNX (ligand of Numb protein-X) is a RING finger and four PDZ domain-containing E3 ubiquitin ligase(1,2). LNX serves as a binding platform and may have a role in cell fate determination, but its in vivo functions are unknown(1-5). Here we show that Lnx-l (Lnx-like) functions as a critical regulator of dorso-ventral axis formation in zebrafish. Depletion of Lnx-l using specific antisense morpholinos (MOs) caused strong embryonic dorsalization. We identified Bozozok (Boz, also known as Dharma or Nieuwkoid) as a binding partner and substrate of Lnx-l. Boz is a homeodomain-containing transcriptional repressor induced by canonical Wnt signalling that is critical for dorsal organizer formation (6-12). Lnx-l induced K48-linked polyubiquitylation of Boz, leading to its proteasomal degradation in human 293T cells and in zebrafish embryos. Dorsalization induced by Boz overexpression was suppressed by raising the level of Lnx-l, but Lnx-l failed to counteract dorsalization caused by mutant Boz lacking a critical motif for Lnx-l binding. Furthermore, dorsalization induced by depletion of Lnx-l was alleviated by attenuation of Boz expression. We conclude that Lnx-l modulates Boz activity to prevent the invasion of ventral regions of the embryo by organizer tissue. These studies introduce a ubiquitin ligase, Lnx-l, as a balancing modulator of axial patterning in the zebrafish embryo.	[Ro, Hyunju; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Genet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dawid, IB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Genet Lab, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov		Ro, Hyunju/0000-0002-0829-9639	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001002, ZIAHD008809] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Rath and J. Gonzales for help with fish maintenance, and S.-Y. Choi for helpful comments. This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health.	Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Fekany K, 1999, DEVELOPMENT, V126, P1427; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Gonzalez EM, 2000, GENE DEV, V14, P3087, DOI 10.1101/gad.852400; Kansaku A, 2006, ONCOGENE, V25, P5071, DOI 10.1038/sj.onc.1209468; Kawahara A, 2000, GENESIS, V28, P58, DOI 10.1002/1526-968X(200010)28:2<58::AID-GENE30>3.0.CO;2-N; Kawahara A, 2000, P NATL ACAD SCI USA, V97, P12121, DOI 10.1073/pnas.97.22.12121; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Koos DS, 1998, CURR BIOL, V8, P1199, DOI 10.1016/S0960-9822(07)00509-X; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Leung TC, 2003, DEVELOPMENT, V130, P3639, DOI 10.1242/dev.00558; Leung TC, 2003, DEV DYNAM, V228, P424, DOI 10.1002/dvdy.10408; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Melby AE, 2000, DEV BIOL, V224, P275, DOI 10.1006/dbio.2000.9780; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Ro H, 2004, MOL CELLS, V17, P373; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ryu SL, 2001, DEV BIOL, V231, P397, DOI 10.1006/dbio.2000.0150; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Shimizu T, 2002, MECH DEVELOP, V118, P125, DOI 10.1016/S0925-4773(02)00243-5; Sirotkin HI, 2000, DEVELOPMENT, V127, P2583; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Solnica-Krezel L, 2001, INT J DEV BIOL, V45, P299; Weiss A, 2007, FEBS LETT, V581, P5131, DOI 10.1016/j.febslet.2007.09.062; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zhu ZL, 2002, DEV CELL, V3, P557, DOI 10.1016/S1534-5807(02)00270-8	32	26	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1121	U165		10.1038/ncb1926	http://dx.doi.org/10.1038/ncb1926			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19668196	Green Accepted			2022-12-25	WOS:000269482500014
J	Phillips, CM; Meng, XD; Zhang, L; Chretien, JH; Urnov, FD; Dernburg, AF				Phillips, Carolyn M.; Meng, Xiangdong; Zhang, Lei; Chretien, Jacqueline H.; Urnov, Fyodor D.; Dernburg, Abby F.			Identification of chromosome sequence motifs that mediate meiotic pairing and synapsis in C. elegans	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; X-CHROMOSOME; RECOMBINATION; MEIOSIS; PROTEINS; COMPLEX; GENOME; MECHANISMS; MAP	Caenorhabditis elegans chromosomes contain specialized regions called pairing centres, which mediate homologous pairing and synapsis during meiosis. Four related proteins, ZIM-1, 2, 3 and HIM-8, associate with these sites and are required for their essential functions. Here we show that short sequence elements enriched in the corresponding chromosome regions selectively recruit these proteins in vivo. In vitro analysis using SELEX indicates that the binding specificity of each protein arises from a combination of two zinc fingers and an adjacent domain. Insertion of a cluster of recruiting motifs into a chromosome lacking its endogenous pairing centre is sufficient to restore homologous pairing, synapsis, crossover recombination and segregation. These findings help to illuminate how chromosome sites mediate essential aspects of meiotic chromosome dynamics.	[Phillips, Carolyn M.; Chretien, Jacqueline H.; Dernburg, Abby F.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Meng, Xiangdong; Zhang, Lei; Urnov, Fyodor D.] Sangamo BioSci, Pt Richmond Tech Ctr, Richmond, CA 94804 USA; [Chretien, Jacqueline H.; Dernburg, Abby F.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Dernburg, Abby F.] Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA USA	University of California System; University of California Berkeley; Sangamo Therapeutics, Inc.; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Dernburg, AF (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 470 Stanley Hall,MC 3220, Berkeley, CA 94720 USA.	afdernburg@lbl.gov	Phillips, Carolyn/E-8305-2011	Phillips, Carolyn/0000-0002-6228-6468; Dernburg, Abby/0000-0001-8037-1079	NSF; Burroughs Wellcome Career Award [1000950]; NIH [R01 GM065591]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065591] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NSF Predoctoral Fellowship (C. M. P.) and by Burroughs Wellcome Career Award 1000950 and NIH R01 GM065591 (A. F. D.). We are grateful to Anne Villeneuve for SYP-1 antibodies, Barbara Meyer, Kevin Corbett and Ed Rebar for valuable suggestions, to members of the Meyer lab for assistance with the extrachromosomal array assay and to members of the Dernburg lab and anonymous referees for helpful comments on the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; HERMAN RK, 1989, GENETICS, V121, P723; HODGKIN J, 1979, GENETICS, V91, P67; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kelly WG, 2002, DEVELOPMENT, V129, P479; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; MCKIM KS, 1988, GENETICS, V120, P987; MCKIM KS, 1993, GENETICS, V134, P749; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Nicoll M, 1997, NATURE, V388, P200, DOI 10.1038/40645; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Phillips CM, 2006, DEV CELL, V11, P817, DOI 10.1016/j.devcel.2006.09.020; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Sanford C, 2001, NUCLEIC ACIDS RES, V29, P2920, DOI 10.1093/nar/29.14.2920; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; VILLENEUVE AM, 1994, GENETICS, V136, P887; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; ZETKA M, 1995, TRENDS GENET, V11, P27, DOI 10.1016/S0168-9525(00)88983-0; ZETKA MC, 1992, GENETICS, V131, P321	30	87	93	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					934	U66		10.1038/ncb1904	http://dx.doi.org/10.1038/ncb1904			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19620970	Green Accepted, Green Submitted			2022-12-25	WOS:000268593200006
J	Bok, JW; Chiang, YM; Szewczyk, E; Reyes-Domingez, Y; Davidson, AD; Sanchez, JF; Lo, HC; Watanabe, K; Strauss, J; Oakley, BR; Wang, CCC; Keller, NP				Bok, Jin Woo; Chiang, Yi-Ming; Szewczyk, Edyta; Reyes-Domingez, Yazmid; Davidson, Ashley D.; Sanchez, James F.; Lo, Hsien-Chun; Watanabe, Kenji; Strauss, Joseph; Oakley, Berl R.; Wang, Clay C. C.; Keller, Nancy P.			Chromatin-level regulation of biosynthetic gene clusters	NATURE CHEMICAL BIOLOGY			English	Article							HISTONE H3; SECONDARY METABOLISM; CHEMICAL DIVERSITY; ASPERGILLUS; SEQUENCE; METHYLATION; COMPASS	Loss-of-function Aspergillus nidulans CclA, a Bre2 ortholog involved in histone H3 lysine 4 methylation, activated the expression of cryptic secondary metabolite clusters in A. nidulans. One new cluster generated monodictyphenone, emodin and emodin derivatives, whereas a second encoded two anti-osteoporosis polyketides, F9775A and F9775B. Modification of the chromatin landscape in fungal secondary metabolite clusters allows for a simple technological means to express silent fungal secondary metabolite gene clusters.	[Chiang, Yi-Ming; Sanchez, James F.; Lo, Hsien-Chun; Watanabe, Kenji; Wang, Clay C. C.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Bok, Jin Woo; Keller, Nancy P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Bok, Jin Woo; Keller, Nancy P.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Chiang, Yi-Ming] Chia Nan Univ Pharm & Sci, Grad Inst Pharmaceut Sci, Tainan, Taiwan; [Szewczyk, Edyta; Davidson, Ashley D.; Oakley, Berl R.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Reyes-Domingez, Yazmid; Strauss, Joseph] Univ Vienna, Fungal Genom Unit, Austrian Res Ctr & BOKU, Vienna, Austria; [Wang, Clay C. C.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Keller, Nancy P.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Southern California; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Chia Nan University of Pharmacy & Science; University System of Ohio; Ohio State University; University of Vienna; University of Southern California; University of Wisconsin System; University of Wisconsin Madison	Wang, CCC (corresponding author), Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	clayw@usc.edu; npkeller@wisc.edu	Watanabe, Kenji/N-2012-2015; Bok, Jin Woo/F-7140-2010; Keller, Nancy P./ABC-5911-2021; Szewczyk, Edyta/AAF-4715-2020; Wang, Clay/ABG-9056-2021	Watanabe, Kenji/0000-0002-0463-4831; Strauss, Joseph/0000-0003-0474-6267; Szewczyk, Edyta/0000-0002-2054-5855; Oakley, Berl/0000-0002-3046-8240; Wang, Clay/0000-0003-2955-7569	US National Science Foundation [MCB-0236393]; National Institutes of Health [GM084077]; Austrian Science Fund (FWF) [GM031837, P19731-B11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031837, P01GM084077] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by the US National Science Foundation grant MCB-0236393 to N. P. K., National Institutes of Health grant GM084077 to N. P. K., B. R. O. and C. C. C. W., and GM031837 to B. R. O. Work in Vienna was supported by grant P19731-B11 from the Austrian Science Fund (FWF) to J. S.	Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Bok JW, 2006, CHEM BIOL, V13, P31, DOI 10.1016/j.chembiol.2005.10.008; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Brown DW, 1996, P NATL ACAD SCI USA, V93, P14873, DOI 10.1073/pnas.93.25.14873; Couch RD, 2004, J BIOTECHNOL, V108, P171, DOI 10.1016/j.jbiotec.2003.10.021; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Krick A, 2007, J NAT PROD, V70, P353, DOI 10.1021/np060505o; Lu P, 2005, MOL GENET GENOMICS, V273, P207, DOI 10.1007/s00438-005-1132-y; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; Pelaez F, 2005, MYCOLOGY S, V22, P49; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; Rohlfs M, 2007, BIOL LETTERS, V3, P523, DOI 10.1098/rsbl.2007.0338; Roze LV, 2007, MOL MICROBIOL, V66, P713, DOI 10.1111/j.1365-2958.2007.05952.x; Sato S., 1999, Japanese patent application, Patent No. [JP11001480, 11001480]; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shwab EK, 2007, EUKARYOT CELL, V6, P1656, DOI 10.1128/EC.00186-07; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Wood A, 2005, BIOCHEM CELL BIOL, V83, P460, DOI 10.1139/O05-116; Wu YX, 2007, LIFE SCI, V81, P1332, DOI 10.1016/j.lfs.2007.08.040	25	273	324	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					462	464		10.1038/nchembio.177	http://dx.doi.org/10.1038/nchembio.177			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19448638	Green Accepted			2022-12-25	WOS:000267266100010
J	Edwards, AM; Bountra, C; Kerr, DJ; Willson, TM				Edwards, Aled M.; Bountra, Chas; Kerr, David J.; Willson, Timothy M.			Open access chemical and clinical probes to support drug discovery	NATURE CHEMICAL BIOLOGY			English	Article							ORPHAN NUCLEAR RECEPTORS; SUBSTANCE-P; SYNOVIAL-FLUID; PAIN; BRADYKININ; INHIBITORS; ARTHRITIS; GENOMICS	Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.	[Edwards, Aled M.] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Bountra, Chas] Univ Oxford, Struct Genom Consortium, Oxford, England; [Kerr, David J.] Qatar Fdn, Sidra Med & Res Ctr, Doha, Qatar; [Willson, Timothy M.] GlaxoSmithKline, Discovery Med Chem, Res Triangle Pk, NC USA	University of Toronto; Structural Genomics Consortium; University of Oxford; Qatar Foundation (QF); Sidra Medical & Research Center; GlaxoSmithKline	Edwards, AM (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	aled.edwards@utoronto.ca	feinstein, doug/M-9414-2019	Edwards, Aled/0000-0002-4782-6016	Canadian Institutes of Health Research Funding Source: Medline; Wellcome Trust Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Babenko V, 1999, EUR J PAIN-LONDON, V3, P93, DOI 10.1053/eujp.1998.0103; Boyce S, 2000, PROG PAIN RES MANAG, V16, P313; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Edwards A, 2009, ANNU REV BIOCHEM, V78, P541, DOI 10.1146/annurev.biochem.78.070907.103305; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Garnier JP, 2008, HARVARD BUS REV, V86, P68; Gharat LA, 2008, EXPERT OPIN THER PAT, V18, P159, DOI 10.1517/13543776.18.2.159; Gunthorpe MJ, 2009, DRUG DISCOV TODAY, V14, P56, DOI 10.1016/j.drudis.2008.11.005; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; JENSEN K, 1991, CEPHALALGIA, V11, P175, DOI 10.1046/j.1468-2982.1991.1104175.x; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MARSHALL KW, 1990, ARTHRITIS RHEUM, V33, P87; MENKES CJ, 1993, J RHEUMATOL, V20, P714; Neeli H, 2008, CARDIOL CLIN, V26, P537, DOI 10.1016/j.ccl.2008.06.005; Newman RH, 2008, NAT CHEM BIOL, V4, P382, DOI 10.1038/nchembio0708-382; PEDERSENBJERGAARD U, 1989, PEPTIDES, V10, P1147, DOI 10.1016/0196-9781(89)90006-5; Rupniak Nadia M. J., 1999, P135; SALT TE, 1983, NEUROSCIENCE, V10, P1083, DOI 10.1016/0306-4522(83)90101-X; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; VONEULER US, 1985, NEUROTRANSMITTERS AC, P143; Weigelt J, 2008, CURR OPIN CHEM BIOL, V12, P32, DOI 10.1016/j.cbpa.2008.01.045; Willson TM, 2002, MOL ENDOCRINOL, V16, P1135, DOI 10.1210/me.16.6.1135; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	26	85	85	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					436	440		10.1038/nchembio0709-436	http://dx.doi.org/10.1038/nchembio0709-436			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19536100				2022-12-25	WOS:000267266100002
J	Oprea, TI; Bologa, CG; Boyer, S; Curpan, RF; Glen, RC; Hopkins, AL; Lipinski, CA; Marshall, GR; Martin, YC; Ostopovici-Halip, L; Rishton, G; Ursu, O; Vaz, RJ; Waller, C; Waldmann, H; Sklar, LA				Oprea, Tudor I.; Bologa, Cristian G.; Boyer, Scott; Curpan, Ramona F.; Glen, Robert C.; Hopkins, Andrew L.; Lipinski, Christopher A.; Marshall, Garland R.; Martin, Yvonne C.; Ostopovici-Halip, Liliana; Rishton, Gilbert; Ursu, Oleg; Vaz, Roy J.; Waller, Chris; Waldmann, Herbert; Sklar, Larry A.			A crowdsourcing evaluation of the NIH chemical probes	NATURE CHEMICAL BIOLOGY			English	Article							DRUG DISCOVERY; LEAD DISCOVERY; LIBRARIES; PREDICTION; DESIGN; IDENTIFICATION; CANDIDATES	Between 2004 and 2008, the US National Institutes of Health Molecular Libraries and Imaging initiative pilot phase funded 10 high-throughput screening centers, resulting in the deposition of 691 assays into PubChem and the nomination of 64 chemical probes. We crowdsourced the Molecular Libraries and Imaging initiative output to 11 experts, who expressed medium or high levels of confidence in 48 of these 64 probes.	[Oprea, Tudor I.; Bologa, Cristian G.; Curpan, Ramona F.; Ostopovici-Halip, Liliana; Ursu, Oleg; Sklar, Larry A.] Univ New Mexico, Sch Med, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Boyer, Scott] AstraZeneca R&D, Global Safety Assessment, Molndal, Sweden; [Curpan, Ramona F.; Ostopovici-Halip, Liliana] Acad Romana, Inst Chem, Timisoara, Romania; [Glen, Robert C.] Unilever Ctr Mol Sci Informat, Dept Chem, Cambridge, England; [Hopkins, Andrew L.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland; [Lipinski, Christopher A.] Melior Discovery, Waterford, CT USA; [Marshall, Garland R.] Washington Univ, Ctr Computat Biol, St Louis, MO USA; [Rishton, Gilbert] Calif State Univ, Channel Islands Alzheimers Inst, Camarillo, CA USA; [Vaz, Roy J.] Sanofi Aventis Pharmaceut, Bridgewater, NJ USA; [Waller, Chris] Pfizer Inc, Pfizer Global R&D, Chem Informat, Groton, CT 06340 USA; [Waldmann, Herbert] Max Planck Inst Mol Physiol, Abt Chem Biol 4, D-44139 Dortmund, Germany; [Waldmann, Herbert] Tech Univ Dortmund, Fac Chem, Dortmund, Germany	University of New Mexico; AstraZeneca; Romanian Academy of Sciences; Institute of Chemistry, Timisoara; University of Cambridge; University of Dundee; Washington University (WUSTL); Sanofi-Aventis; Pfizer; Max Planck Society; Dortmund University of Technology	Oprea, TI (corresponding author), Univ New Mexico, Sch Med, Ctr Mol Discovery, Albuquerque, NM 87131 USA.	toprea@salud.unm.edu; lskar@salud.unm.edu	Oprea, Tudor I/A-5746-2011; Martin, Yvonne/AAD-6019-2019; Bologa, Cristian G/A-7952-2010; BOLOGA, CRISTINA/T-8927-2017; Curpan, Ramona Florentina/GZL-2499-2022; Waldmann, Herbert/B-7406-2017; Hopkins, Andrew/H-5138-2011	Oprea, Tudor I/0000-0002-6195-6976; Bologa, Cristian G/0000-0003-2232-4244; Curpan, Ramona Florentina/0000-0003-0268-7291; Waldmann, Herbert/0000-0002-9606-7247; Halip, Liliana/0000-0002-2600-0186; Marshall, Garland/0000-0002-3098-0332; Hopkins, Andrew/0000-0003-1977-018X; Lipinski, Christopher/0000-0001-7355-7254	NIMH NIH HHS [U54 MH084690, 1U54MH084690, U54 MH074425] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074425, U54MH084690] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Ajay, 1998, J MED CHEM, V41, P3314, DOI 10.1021/jm970666c; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; Chesbrough H., 2003, OPEN INNOVATION NEW; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Hopkins AL, 2006, ANNU REP MED CHEM, V41, P425, DOI 10.1016/S0065-7743(06)41029-0; Howe J., 2006, WIRED MAG, V14; Howe J., 2008, CROWDSOURCING WHY PO; Inglese J, 2007, NAT CHEM BIOL, V3, P438, DOI 10.1038/nchembio0807-438; Kaiser J, 2008, SCIENCE, V321, P764, DOI 10.1126/science.321.5890.764; Keseru GM, 2009, NAT REV DRUG DISCOV, V8, P203, DOI 10.1038/nrd2796; Kramer JA, 2007, NAT REV DRUG DISCOV, V6, P636, DOI 10.1038/nrd2378; LEO AJ, 1993, CHEM REV, V93, P1281, DOI 10.1021/cr00020a001; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Norinder U, 2002, ADV DRUG DELIVER REV, V54, P291, DOI 10.1016/S0169-409X(02)00005-4; Oprea TI, 2004, CURR OPIN CHEM BIOL, V8, P349, DOI 10.1016/j.cbpa.2004.06.008; Oprea TI, 2002, J BRAZIL CHEM SOC, V13, P811, DOI 10.1590/S0103-50532002000600013; Polanyi M, 1974, PERSONAL KNOWLEDGE P, V2; Rishton GM, 2008, CURR OPIN CHEM BIOL, V12, P340, DOI 10.1016/j.cbpa.2008.02.008; Rishton GM, 1997, DRUG DISCOV TODAY, V2, P382, DOI 10.1016/S1359-6446(97)01083-0; Roche O, 2002, J MED CHEM, V45, P137, DOI 10.1021/jm010934d; Sadowski J, 1998, J MED CHEM, V41, P3325, DOI 10.1021/jm9706776; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Tetko IV, 2001, J CHEM INF COMP SCI, V41, P1407, DOI 10.1021/ci010368v; VAZ R, 2008, ANTITARGETS; Young SM, 2005, J BIOMOL SCREEN, V10, P374, DOI 10.1177/1087057105274532	29	97	97	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					441	447		10.1038/nchembio0709-441	http://dx.doi.org/10.1038/nchembio0709-441			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19536101	Green Accepted			2022-12-25	WOS:000267266100003
J	Lewis, MA; Quint, E; Glazier, AM; Fuchs, H; De Angelis, MH; Langford, C; van Dongen, S; Abreu-Goodger, C; Piipari, M; Redshaw, N; Dalmay, T; Moreno-Pelayo, MA; Enright, AJ; Steel, KP				Lewis, Morag A.; Quint, Elizabeth; Glazier, Anne M.; Fuchs, Helmut; De Angelis, Martin Hrabe; Langford, Cordelia; van Dongen, Stijn; Abreu-Goodger, Cei; Piipari, Matias; Redshaw, Nick; Dalmay, Tamas; Angel Moreno-Pelayo, Miguel; Enright, Anton J.; Steel, Karen P.			An ENU-induced mutation of miR-96 associated with progressive hearing loss in mice	NATURE GENETICS			English	Article							OUTER HAIR CELL; INNER-EAR; STEREOCILIA DEFECTS; MICRORNA TARGETS; GENE-EXPRESSION; MUTANT MICE; MOUSE; DIFFERENTIATION; ORGAN; IMPAIRMENT	Progressive hearing loss is common in the human population, but little is known about the molecular basis. We report a new N-ethyl-N-nitrosurea (ENU)-induced mouse mutant, diminuendo, with a single base change in the seed region of Mirn96. Heterozygotes show progressive loss of hearing and hair cell anomalies, whereas homozygotes have no cochlear responses. Most microRNAs are believed to downregulate target genes by binding to specific sites on their mRNAs, so mutation of the seed should lead to target gene upregulation. Microarray analysis revealed 96 transcripts with significantly altered expression in homozygotes; notably, Slc26a5, Ocm, Gfi1, Ptprq and Pitpnm1 were downregulated. Hypergeometric P-value analysis showed that hundreds of genes were upregulated in mutants. Different genes, with target sites complementary to the mutant seed, were downregulated. This is the first microRNA found associated with deafness, and diminuendo represents a model for understanding and potentially moderating progressive hair cell degeneration in hearing loss more generally.	[Lewis, Morag A.; Glazier, Anne M.; Langford, Cordelia; van Dongen, Stijn; Abreu-Goodger, Cei; Piipari, Matias; Steel, Karen P.] Wellcome Trust Sanger Inst, Hinxton, England; [Quint, Elizabeth; Steel, Karen P.] Inst Hearing Res, MRC, Nottingham, England; [Fuchs, Helmut; De Angelis, Martin Hrabe] GSF Natl Res Ctr Environm & Hlth, Munich, Germany; [Redshaw, Nick; Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Angel Moreno-Pelayo, Miguel] Hosp Ramon & Cajal, Unidad Genet Mol, E-28034 Madrid, Spain; [Angel Moreno-Pelayo, Miguel] ISCIII, CIBERER, Madrid, Spain	Wellcome Trust Sanger Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of East Anglia; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Steel, KP (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	kps@sanger.ac.uk	Enright, Anton/F-3094-2011; Dalmay, Tamas/E-1377-2011; Orton, Elizabeth/AAI-1377-2021; Abreu-Goodger, Cei/A-1268-2010; Orton, Elizabeth/J-6550-2013; de Angelis, Martin Hrabe/F-5531-2012; Fuchs, Helmut/M-7347-2014	Enright, Anton/0000-0002-6090-3100; Dalmay, Tamas/0000-0003-1492-5429; Orton, Elizabeth/0000-0002-2531-8846; Abreu-Goodger, Cei/0000-0001-8302-9893; de Angelis, Martin Hrabe/0000-0002-7898-2353; Fuchs, Helmut/0000-0002-5143-2677; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098; Piipari, Matias/0000-0002-3283-4136	Deafness Research UK; Wellcome Trust; Medical Research Council (UK); EC [CT-97-2715, LSHG-CT-2004-512063]; Spanish Ministerio de Ciencia y Tecnologia [SAF2005-06355]; Spanish Fondo de Investigaciones Sanitarias [FIS PI-051942, G03/203, CP03/00014, PI08/0045]; NGFN (Germany); MRC [MC_qA137918, G0300212] Funding Source: UKRI; Medical Research Council [G0300212, MC_qA137918] Funding Source: researchfish	Deafness Research UK; Wellcome Trust(Wellcome Trust); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); NGFN (Germany); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Ellis, K. James and R. Andrews for assistance with the microarrays, H. Williams for help with the quantitative RT-PCR, A. Rodriguez for helpful discussions on miRNAs, A. Taylor for help with bioinformatics, S. Rose, M. Drummond, K. Hawker and A. Lucas for help with mapping the mutation, F. Zhu for her work on Gfi1 and Ptprq, R. Lacey and D. Savage for animal care, A. El-Amraoui and C. Petit for the anti-MyRIP antibody, G. Richardson for the anti-Ptprq antibody, and A. Rzadzinska for high-resolution scanning electron microscopy analysis. This work was supported by Deafness Research UK, the Wellcome Trust, Medical Research Council (UK), EC (CT-97-2715, LSHG-CT-2004-512063), Spanish Ministerio de Ciencia y Tecnologia (SAF2005-06355), Spanish Fondo de Investigaciones Sanitarias (FIS PI-051942; G03/203, CP03/00014, PI08/0045), NGFN (Germany), and charitable donations from individuals affected by deafness.	BOCK GR, 1983, ACTA OTO-LARYNGOL, V96, P39, DOI 10.3109/00016488309132873; Bosman EA, 2009, DEV BIOL, V328, P285, DOI 10.1016/j.ydbio.2009.01.030; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Enright AJ, 2004, GENOME BIOL, V5; Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Holme RH, 2002, HEARING RES, V169, P13, DOI 10.1016/S0378-5955(02)00334-9; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kiyota T, 2008, DEV BIOL, V315, P579, DOI 10.1016/j.ydbio.2007.12.013; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mueller KL, 2002, J NEUROSCI, V22, P9368; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Rhodes CR, 2004, MAMM GENOME, V15, P686, DOI 10.1007/s00335-004-2344-x; Sakaguchi N, 1998, J HISTOCHEM CYTOCHEM, V46, P29, DOI 10.1177/002215549804600105; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Spiden SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000238; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200	30	224	246	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					614	618		10.1038/ng.369	http://dx.doi.org/10.1038/ng.369			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19363478	Green Submitted, Green Accepted			2022-12-25	WOS:000265575600025
J	Rybak, A; Fuchs, H; Hadian, K; Smirnova, L; Wulczyn, EA; Michel, G; Nitsch, R; Krappmann, D; Wulczyn, FG				Rybak, Agnieszka; Fuchs, Heiko; Hadian, Kamyar; Smirnova, Lena; Wulczyn, Ellery A.; Michel, Geert; Nitsch, Robert; Krappmann, Daniel; Wulczyn, F. Gregory			The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; POSTTRANSCRIPTIONAL REGULATION; NEURONAL DIFFERENTIATION; RNA INTERFERENCE; REGULATORY RNA; SELF-RENEWAL; RING FINGER; MICRORNA; EXPRESSION; BRAIN	The let-7 miRNA and its target gene Lin-28 interact in a regulatory circuit controlling pluripotency. We investigated an additional let-7 target, mLin41 (mouse homologue of lin-41), as a potential contributor to this circuit. We demonstrate the presence of mLin41 protein in several stem cell niches, including the embryonic ectoderm, epidermis and male germ line. mLin41 colocalized to cytoplasmic foci with P-body markers and the miRNA pathway proteins Ago2, Mov10 and Tnrc6b. In co-precipitation assays, mLin41 interacted with Dicer and the Argonaute proteins Ago1, Ago2 and Ago4. Moreover, we show that mLin41 acts as an E3 ubiquitin ligase in an auto-ubiquitylation assay and that mLin41 mediates ubiquitylation of Ago2 in vitro and in vivo. Overexpression and depletion of mLin41 led to inverse changes in the level of Ago2 protein, implicating mLin41 in the regulation of Ago2 turnover. mLin41 interfered with silencing of target mRNAs for let-7 and miR-124, at least in part by antagonizing Ago2. Furthermore, mLin41 cooperated with the pluripotency factor Lin-28 in suppressing let-7 activity, revealing a dual control mechanism regulating let-7 in stem cells.	[Rybak, Agnieszka; Fuchs, Heiko; Wulczyn, Ellery A.; Wulczyn, F. Gregory] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Smirnova, Lena] Ctr Alternat Methods Animals Expt, Fed Inst Risk Assessment, Unit 37, Berlin, Germany; [Michel, Geert] Charite, Transgene Facil, Forsch Einrichtung Expt Med, D-13353 Berlin, Germany; [Nitsch, Robert] Univ Med Mainz, Inst Microscop Anat & Neurobiol, D-55128 Mainz, Germany; [Hadian, Kamyar; Krappmann, Daniel] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Toxicol, Neuherberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Federal Institute for Risk Assessment; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wulczyn, FG (corresponding author), Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany.	gregory.wulczyn@charite.de	Nitsch, Robert/AAI-9129-2021; Hadian, Kamyar/B-6314-2013; Krappmann, Daniel/ABF-4038-2021; Krappmann, Daniel/AAT-4354-2021; Fuchs, Helmut/M-7347-2014	Hadian, Kamyar/0000-0001-8727-2575; Krappmann, Daniel/0000-0001-7640-3234; Krappmann, Daniel/0000-0001-7640-3234; Fuchs, Helmut/0000-0002-5143-2677; Fuchs, Heiko/0000-0001-9142-4084; Rybak-Wolf, Agnieszka/0000-0002-1192-5290; Michel, Geert/0000-0002-3518-1185	Humboldt University Graduate [238, 1123]; SFB [665]	Humboldt University Graduate; SFB(Austrian Science Fund (FWF))	The authors would like to thank members of the Robert Nitsch laboratories, in particular Vincenzo Catanzariti for assistance with figure preparation, and Ari Liebkowsky, Elisa Cuevas, Eleonora Franzoni and Junko Toraiwa for critical reading of the manuscript. Christian Hagemeier kindly provided tissue-specific cDNAs used in preliminary work. Michele Salanova ( testis) and Sven Hendrix and Ruth Schmidt-Ulrich (skin) helped with methods and interpretation of immunohistochemistry results. Nicola Brandt and Kristin Franke generously provided cultured hippocampal neurons. We acknowledge the laboratory support of Brita Scholte. L. S. and A. R. were fellows of the Humboldt University Graduate Schools 238 and 1123, respectively. Additional support was provided by SFB grant 665 to F. G. W. and R. N.	Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Diederichs S, 2008, P NATL ACAD SCI USA, V105, P9284, DOI 10.1073/pnas.0800803105; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanamoto T, 2006, DEV DYNAM, V235, P1142, DOI 10.1002/dvdy.20712; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Lancman JJ, 2005, DEV DYNAM, V234, P948, DOI 10.1002/dvdy.20591; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Loedige I, 2009, CELL, V136, P818, DOI 10.1016/j.cell.2009.02.030; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rodriguez A, 1996, GENETICS, V143, P929; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schulman BRM, 2008, CELL CYCLE, V7, P3935; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; TOKUMARU S, 2008, CARCINOGENESIS; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Xu C, 2004, ASIAN J ANDROL, V6, P217; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	49	162	167	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1411	U58		10.1038/ncb1987	http://dx.doi.org/10.1038/ncb1987			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19898466				2022-12-25	WOS:000272251300006
J	Yang, YL; Xu, YQ; Straight, P; Dorrestein, PC				Yang, Yu-Liang; Xu, Yuquan; Straight, Paul; Dorrestein, Pieter C.			Translating metabolic exchange with imaging mass spectrometry	NATURE CHEMICAL BIOLOGY			English	Article							STREPTOMYCES-COELICOLOR; BACILLUS-SUBTILIS; NONRIBOSOMAL PEPTIDES; PRODUCT; IDENTIFICATION; MEGACOMPLEX	Metabolic exchange between an organism and the environment, including interactions with neighboring organisms, is important for processes of organismal development. Here we develop and use thin-layer agar natural product MALDI-TOF imaging mass spectrometry of intact bacterial colonies grown on top of the MALDI target plate to study an interaction between two species of bacteria and provide direct evidence that Bacillus subtilis silences the defensive arsenal of Streptomyces coelicolor.	[Yang, Yu-Liang; Xu, Yuquan; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Straight, Paul] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dorrestein, PC (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	paul_straight@tamu.edu; pdorrest@ucsd.edu	Xu, Yuquan/F-9789-2013; Dorrestein, Pieter/D-5012-2012; Dorrestein, Pieter/ABF-2930-2020; Yang, Yu-Liang/A-8229-2008	Straight, Paul/0000-0003-2460-8240	Beckman Foundation; Texas AM University;  [NIHGM086283]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086283] Funding Source: NIH RePORTER	Beckman Foundation; Texas AM University; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge M. Burkart (University of California, San Diego) for S. coelicolor A3(2). The funding was provided by the Beckman Foundation, the annotation of the cyclic peptides in this study was supported by NIHGM086283 (P. C. D.) and P. S. acknowledges financial support from Texas A&M University.	BABASAKI K, 1985, J BIOCHEM, V98, P585, DOI 10.1093/oxfordjournals.jbchem.a135315; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Chen K, 2008, J AM SOC MASS SPECTR, V19, P1856, DOI 10.1016/j.jasms.2008.08.002; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Corre C, 2008, P NATL ACAD SCI USA, V105, P17510, DOI 10.1073/pnas.0805530105; Esquenazi E, 2008, MOL BIOSYST, V4, P562, DOI 10.1039/b720018h; Gross H, 2007, APPL MICROBIOL BIOT, V75, P267, DOI 10.1007/s00253-007-0900-5; Grunewald J, 2004, BIOCHEMISTRY-US, V43, P2915, DOI 10.1021/bi036140d; Hagelin G, 2007, INT J MASS SPECTROM, V268, P254, DOI 10.1016/j.ijms.2007.05.011; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Leenders F, 1999, RAPID COMMUN MASS SP, V13, P943; Liu WT, 2009, ANAL CHEM, V81, P4200, DOI 10.1021/ac900114t; Ng J, 2009, NAT METHODS, V6, P596, DOI 10.1038/nmeth.1350; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Seeley EH, 2008, P NATL ACAD SCI USA, V105, P18126, DOI 10.1073/pnas.0801374105; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Simmons TL, 2008, P NATL ACAD SCI USA, V105, P4587, DOI 10.1073/pnas.0709851105; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Stein T, 2008, RAPID COMMUN MASS SP, V22, P1146, DOI 10.1002/rcm.3481; Straight PD, 2007, P NATL ACAD SCI USA, V104, P305, DOI 10.1073/pnas.0609073103; Straight PD, 2006, J BACTERIOL, V188, P4918, DOI 10.1128/JB.00162-06; Vaidyanathan S, 2008, ANAL CHEM, V80, P1942, DOI 10.1021/ac701921e; WRIGHT LF, 1976, J GEN MICROBIOL, V96, P289, DOI 10.1099/00221287-96-2-289	25	179	180	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					885	887		10.1038/nchembio.252	http://dx.doi.org/10.1038/nchembio.252			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19915536	Green Accepted			2022-12-25	WOS:000271756900009
J	Bass, AJ; Watanabe, H; Mermel, CH; Yu, SY; Perner, S; Verhaak, RG; Kim, SY; Wardwell, L; Tamayo, P; Gat-Viks, I; Ramos, AH; Woo, MS; Weir, BA; Getz, G; Beroukhim, R; O'Kelly, M; Dutt, A; Rozenblatt-Rosen, O; Dziunycz, P; Komisarof, J; Chirieac, LR; LaFargue, CJ; Scheble, V; Wilbertz, T; Ma, CQ; Rao, S; Nakagawa, H; Stairs, DB; Lin, L; Giordano, TJ; Wagner, P; Minna, JD; Gazdar, AF; Zhu, CQ; Brose, MS; Cecconello, I; Ribeiro, U; Marie, SK; Dahl, O; Shivdasani, RA; Tsao, MS; Rubin, MA; Wong, KK; Regev, A; Hahn, WC; Beer, DG; Rustgi, AK; Meyerson, M				Bass, Adam J.; Watanabe, Hideo; Mermel, Craig H.; Yu, Soyoung; Perner, Sven; Verhaak, Roel G.; Kim, So Young; Wardwell, Leslie; Tamayo, Pablo; Gat-Viks, Irit; Ramos, Alex H.; Woo, Michele S.; Weir, Barbara A.; Getz, Gad; Beroukhim, Rameen; O'Kelly, Michael; Dutt, Amit; Rozenblatt-Rosen, Orit; Dziunycz, Piotr; Komisarof, Justin; Chirieac, Lucian R.; LaFargue, Christopher J.; Scheble, Veit; Wilbertz, Theresia; Ma, Changqing; Rao, Shilpa; Nakagawa, Hiroshi; Stairs, Douglas B.; Lin, Lin; Giordano, Thomas J.; Wagner, Patrick; Minna, John D.; Gazdar, Adi F.; Zhu, Chang Qi; Brose, Marcia S.; Cecconello, Ivan; Ribeiro, Ulysses, Jr.; Marie, Suely K.; Dahl, Olav; Shivdasani, Ramesh A.; Tsao, Ming-Sound; Rubin, Mark A.; Wong, Kwok K.; Regev, Aviv; Hahn, William C.; Beer, David G.; Rustgi, Anil K.; Meyerson, Matthew			SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas	NATURE GENETICS			English	Article							GENE; EXPRESSION; CANCER; REVEALS; ADENOCARCINOMAS; DIFFERENTIATION; IDENTIFICATION; AMPLIFICATION; DEPENDENCY; CONSISTENT	Lineage-survival oncogenes are activated by somatic DNA alterations in cancers arising from the cell lineages in which these genes play a role in normal development(1,2). Here we show that a peak of genomic amplification on chromosome 3q26.33 found in squamous cell carcinomas (SCCs) of the lung and esophagus contains the transcription factor gene SOX2, which is mutated in hereditary human esophageal malformations(3), is necessary for normal esophageal squamous development(4), promotes differentiation and proliferation of basal tracheal cells(5) and cooperates in induction of pluripotent stem cells(6-8). SOX2 expression is required for proliferation and anchorage-independent growth of lung and esophageal cell lines, as shown by RNA interference experiments. Furthermore, ectopic expression of SOX2 here cooperated with FOXE1 or FGFR2 to transform immortalized tracheobronchial epithelial cells. SOX2-driven tumors show expression of markers of both squamous differentiation and pluripotency. These characteristics identify SOX2 as a lineage-survival oncogene in lung and esophageal SCC.	[Bass, Adam J.; Watanabe, Hideo; Mermel, Craig H.; Yu, Soyoung; Verhaak, Roel G.; Kim, So Young; Wardwell, Leslie; Ramos, Alex H.; Woo, Michele S.; Weir, Barbara A.; Beroukhim, Rameen; Dutt, Amit; Rozenblatt-Rosen, Orit; Dziunycz, Piotr; Komisarof, Justin; Shivdasani, Ramesh A.; Wong, Kwok K.; Hahn, William C.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bass, Adam J.; Beroukhim, Rameen; Shivdasani, Ramesh A.; Wong, Kwok K.; Hahn, William C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bass, Adam J.; Watanabe, Hideo; Mermel, Craig H.; Yu, Soyoung; Verhaak, Roel G.; Kim, So Young; Wardwell, Leslie; Ramos, Alex H.; Woo, Michele S.; Weir, Barbara A.; Beroukhim, Rameen; Dutt, Amit; Rozenblatt-Rosen, Orit; Hahn, William C.; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Bass, Adam J.; Watanabe, Hideo; Mermel, Craig H.; Verhaak, Roel G.; Tamayo, Pablo; Gat-Viks, Irit; Ramos, Alex H.; Woo, Michele S.; Weir, Barbara A.; Getz, Gad; Beroukhim, Rameen; O'Kelly, Michael; Dutt, Amit; Regev, Aviv; Hahn, William C.; Meyerson, Matthew] Broad Inst, Cambridge, MA USA; [Perner, Sven; LaFargue, Christopher J.; Wagner, Patrick; Rubin, Mark A.] Cornell Univ, Dept Pathol, Weill Med Coll, New York, NY 10021 USA; [Perner, Sven; Scheble, Veit; Wilbertz, Theresia] Univ Tubingen Hosp, Inst Pathol, Ctr Comprehens Canc, Tubingen, Germany; [Chirieac, Lucian R.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ma, Changqing; Rao, Shilpa; Nakagawa, Hiroshi; Stairs, Douglas B.; Brose, Marcia S.; Rustgi, Anil K.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Nakagawa, Hiroshi; Stairs, Douglas B.; Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Lin, Lin; Beer, David G.] Univ Michigan, Dept Surg, Thorac Surg Sect, Ann Arbor, MI 48109 USA; [Giordano, Thomas J.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Minna, John D.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Zhu, Chang Qi; Tsao, Ming-Sound] Univ Hlth Network, Toronto, ON, Canada; [Zhu, Chang Qi; Tsao, Ming-Sound] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Brose, Marcia S.] Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA; [Cecconello, Ivan; Ribeiro, Ulysses, Jr.; Marie, Suely K.] Univ Sao Paulo, Sch Med, Bauru, SP, Brazil; [Dahl, Olav] Univ Bergen, Sect Oncol, Bergen, Norway; [Rustgi, Anil K.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cornell University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Pennsylvania; Universidade de Sao Paulo; University of Bergen; University of Pennsylvania	Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Verhaak, Roel/ABE-7058-2020; Marie, Suely Kazue Nagahashi/D-1870-2012; Ribeiro, Ulysses/G-5942-2012; Meyerson, Matthew L/E-7123-2012; Chirieac, Lucian R./AAD-2030-2019; Rozenblatt-Rosen, Orit/HDN-4182-2022; Tsao, Ming Sound/AFQ-7332-2022; Wagner, Patrick/AAZ-7790-2021; Tsao, Ming-Sound/M-3503-2017; Mermel, Craig/AAZ-7322-2020; Cecconello, Ivan/A-3918-2013; Dutt, Amit/I-1911-2013	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Ribeiro, Ulysses/0000-0003-1711-7347; Tsao, Ming Sound/0000-0002-9160-5405; Mermel, Craig/0000-0002-0816-3395; Cecconello, Ivan/0000-0002-3535-4170; Dutt, Amit/0000-0002-1119-4774; Zhu, ChangQi/0000-0002-9992-0258; Rubin, Mark/0000-0002-8321-9950; LaFargue, Christopher/0000-0001-6473-8061; Giordano, Thomas/0000-0003-0641-8873	Ruth L. Kirschstein NRSA; KWF Kankerbestrijding; US Department of Defense; National Cancer Institute [K08CA134931, P50CA70907, R33CA128625, R01CA071606-12, P01CA098101-05, R01CA109038, P50CA90578]; Genentech, Inc.; Sara Thomas Monopoli Lung Cancer Research Fund; Seaman Corporation Fund for Lung Cancer Research; NATIONAL CANCER INSTITUTE [T32CA009172, K08CA134931, P30CA016520, R33CA128625, P50CA070907, P01CA098101, R01CA109038, R01CA154365, P50CA090578, R01CA071606, P20CA090578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KWF Kankerbestrijding(KWF Kankerbestrijding); US Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genentech, Inc.(Roche HoldingGenentech); Sara Thomas Monopoli Lung Cancer Research Fund; Seaman Corporation Fund for Lung Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Francis, J. Cho, A. Schinzel, R. Firestein, I. Guney and J. Boehm for technical advice and discussions. A. J. B. is supported by the Harvard Clinical Investigator Training Program and American Society of Clinical Oncology. H. W. is supported by a Ruth L. Kirschstein NRSA T32 institutional training grant. R. G. V. is supported by the KWF Kankerbestrijding. The Morphology, Molecular Biology and Cell Culture Core of 5P01CA098101-05 (A. K. R.) provided tissue processing for this project. This work was supported by US Department of Defense VITAL grant (J. D. M, A. F. G.) and by National Cancer Institute grants K08CA134931 (A. J. B.), P50CA70907 (J. D. M, A. F. G.), R33CA128625 (W. C. H.), R01CA071606-12 (D. G. B.), P01CA098101-05 (A. K. R.) and R01CA109038 and P50CA90578 (M. M.). Funding for lung SCC SNP arrays was provided by Genentech, Inc. Funding was provided by the Sara Thomas Monopoli Lung Cancer Research Fund and the Seaman Corporation Fund for Lung Cancer Research.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chen XX, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-1; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Dathan N, 2002, DEV DYNAM, V224, P450, DOI 10.1002/dvdy.10118; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Huber W, 2004, BIOINFORMATICS, V20, P1651, DOI 10.1093/bioinformatics/bth133; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Massion PP, 2003, CANCER RES, V63, P7113; Pack SD, 1999, GENE CHROMOSOME CANC, V25, P160, DOI 10.1002/(SICI)1098-2264(199906)25:2<160::AID-GCC12>3.0.CO;2-U; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Williamson KA, 2006, HUM MOL GENET, V15, P1413, DOI 10.1093/hmg/ddl064; Woenckhaus J, 2002, J PATHOL, V198, P335, DOI 10.1002/path.1207; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	701	738	2	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1238	U105		10.1038/ng.465	http://dx.doi.org/10.1038/ng.465			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19801978	Green Accepted, Green Submitted			2022-12-25	WOS:000271247600018
J	Gateva, V; Sandling, JK; Hom, G; Taylor, KE; Chung, SA; Sun, X; Ortmann, W; Kosoy, R; Ferreira, RC; Nordmark, G; Gunnarsson, I; Svenungsson, E; Padyukov, L; Sturfelt, G; Jonsen, A; Bengtsson, AA; Rantapaa-Dahlqvist, S; Baechler, EC; Brown, EE; Alarcon, GS; Edberg, JC; Ramsey-Goldman, R; McGwin, G; Reveille, JD; Vila, LM; Kimberly, RP; Manzi, S; Petri, MA; Lee, A; Gregersen, PK; Seldin, MF; Ronnblom, L; Criswell, LA; Syvanen, AC; Behrens, TW; Graham, RR				Gateva, Vesela; Sandling, Johanna K.; Hom, Geoff; Taylor, Kimberly E.; Chung, Sharon A.; Sun, Xin; Ortmann, Ward; Kosoy, Roman; Ferreira, Ricardo C.; Nordmark, Gunnel; Gunnarsson, Iva; Svenungsson, Elisabet; Padyukov, Leonid; Sturfelt, Gunnar; Jonsen, Andreas; Bengtsson, Anders A.; Rantapaa-Dahlqvist, Solbritt; Baechler, Emily C.; Brown, Elizabeth E.; Alarcon, Graciela S.; Edberg, Jeffrey C.; Ramsey-Goldman, Rosalind; McGwin, Gerald, Jr.; Reveille, John D.; Vila, Luis M.; Kimberly, Robert P.; Manzi, Susan; Petri, Michelle A.; Lee, Annette; Gregersen, Peter K.; Seldin, Michael F.; Ronnblom, Lars; Criswell, Lindsey A.; Syvanen, Ann-Christine; Behrens, Timothy W.; Graham, Robert R.			A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; COMMON VARIANTS; POLYMORPHISMS; MULTIPLE; PATHOGENESIS; METAANALYSIS; CLEC16A; LINKAGE	Genome-wide association studies have recently identified at least 15 susceptibility loci for systemic lupus erythematosus (SLE). To confirm additional risk loci, we selected SNPs from 2,466 regions that showed nominal evidence of association to SLE (P < 0.05) in a genome-wide study and genotyped them in an independent sample of 1,963 cases and 4,329 controls. This replication effort identified five new SLE susceptibility loci (P < 5 x 10(-8)): TNIP1 (odds ratio (OR) = 1.27), PRDM1 (OR = 1.20), JAZF1 (OR = 1.20), UHRF1BP1 (OR = 1.17) and IL10 (OR = 1.19). We identified 21 additional candidate loci with P <= 1 x 10(-5). A candidate screen of alleles previously associated with other autoimmune diseases suggested five loci (P < 1 x 10(-3)) that may contribute to SLE: IFIH1, CFB, CLEC16A, IL12B and SH2B3. These results expand the number of confirmed and candidate SLE susceptibility loci and implicate several key immunologic pathways in SLE pathogenesis.	[Gateva, Vesela; Hom, Geoff; Sun, Xin; Ortmann, Ward; Ferreira, Ricardo C.; Behrens, Timothy W.; Graham, Robert R.] Genentech Inc, Immunol Biomarkers Grp, San Francisco, CA 94080 USA; [Nordmark, Gunnel; Ronnblom, Lars] Uppsala Univ, Dept Med Sci, Rheumatol Sect, Uppsala, Sweden; [Taylor, Kimberly E.; Chung, Sharon A.; Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA USA; [Kosoy, Roman; Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Gunnarsson, Iva; Svenungsson, Elisabet; Padyukov, Leonid] Karolinska Univ Hosp, Dept Med, Karolinska Inst, Rheumatol Unit, Stockholm, Sweden; [Sturfelt, Gunnar; Jonsen, Andreas; Bengtsson, Anders A.] Univ Lund Hosp, Dept Clin Sci, Rheumatol Sect, S-22185 Lund, Sweden; [Rantapaa-Dahlqvist, Solbritt] Umea Univ Hosp, Dept Rheumatol, S-90185 Umea, Sweden; [Baechler, Emily C.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Brown, Elizabeth E.; Alarcon, Graciela S.; Edberg, Jeffrey C.; McGwin, Gerald, Jr.; Kimberly, Robert P.] Univ Alabama Birmingham, Birmingham, AL USA; [Ramsey-Goldman, Rosalind] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Reveille, John D.] Univ Texas Houston Hlth Sci Ctr, Houston, TX USA; [Vila, Luis M.] Univ Puerto Rico, San Juan, PR 00936 USA; [Manzi, Susan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Lee, Annette; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA	Roche Holding; Genentech; Uppsala University; University of California System; University of California San Francisco; University of California System; University of California Davis; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Umea University; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Puerto Rico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Northwell Health	Graham, RR (corresponding author), Genentech Inc, Immunol Biomarkers Grp, San Francisco, CA 94080 USA.	graham.robert@gene.com	Gillespie, Emily/N-1265-2013; Sandling, Johanna/AAG-6376-2019; Sandling, Johanna K/B-2973-2016; Padyukov, Leonid/A-4890-2009	Gillespie, Emily/0000-0001-5261-3931; Sandling, Johanna/0000-0003-1382-2321; Sandling, Johanna K/0000-0003-1382-2321; Padyukov, Leonid/0000-0003-2950-5670; Ferreira, Ricardo C./0000-0001-5733-3285; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Kimberly, Robert/0000-0002-5330-3086; Svenungsson, Elisabet/0000-0003-3396-3244	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, UL1RR025005, UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002175, R01AR044804, R01AR043727] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000079, UL1 RR025741, UL1RR025005, UL1 RR025005, 5 M01 RR-00079, UL1 RR025005-01] Funding Source: Medline; NIAMS NIH HHS [R01 AR043727, R01 AR044804-01A1, R01 AR043727-03, R01 AR44804, K24 AR02175, R01 AR43727, K24 AR002175, K24 AR002175-01A1] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Awata T, 2009, J CLIN ENDOCR METAB, V94, P231, DOI 10.1210/jc.2008-0718; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Diveu C, 2008, CURR OPIN IMMUNOL, V20, P663, DOI 10.1016/j.coi.2008.09.003; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Graham DSC, 2008, NAT GENET, V40, P83, DOI 10.1038/ng.2007.47; Graham RR, 2009, J INTERN MED, V265, P680, DOI 10.1111/j.1365-2796.2009.02096.x; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kozyrev SV, 2008, NAT GENET, V40, P484, DOI 10.1038/ng0408-484; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nath SK, 2005, HUM GENET, V118, P225, DOI 10.1007/s00439-005-0044-6; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Sawalha AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001727; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Sutherland A, 2007, J CLIN ENDOCR METAB, V92, P3338, DOI 10.1210/jc.2007-0173; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489; Zoledziewska M, 2009, GENES IMMUN, V10, P15, DOI 10.1038/gene.2008.84	47	621	638	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1228	U93		10.1038/ng.468	http://dx.doi.org/10.1038/ng.468			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19838195	Green Accepted			2022-12-25	WOS:000271247600016
J	Al Olama, AA; Kote-Jarai, Z; Giles, GG; Guy, M; Morrison, J; Severi, G; Leongamornlert, DA; Tymrakiewicz, M; Jhavar, S; Saunders, E; Hopper, JL; Southey, MC; Muir, KR; English, DR; Dearnaley, DP; Ardern-Jones, AT; Hall, AL; O'Brien, LT; Wilkinson, RA; Sawyer, E; Lophatananon, A; Horwich, A; Huddart, RA; Khoo, VS; Parker, CC; Woodhouse, CJ; Thompson, A; Christmas, T; Ogden, C; Cooper, C; Donovan, JL; Hamdy, FC; Neal, DE; Eeles, RA; Easton, DF				Al Olama, Ali Amin; Kote-Jarai, Zsofia; Giles, Graham G.; Guy, Michelle; Morrison, Jonathan; Severi, Gianluca; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Jhavar, Sameer; Saunders, Ed; Hopper, John L.; Southey, Melissa C.; Muir, Kenneth R.; English, Dallas R.; Dearnaley, David P.; Ardern-Jones, Audrey T.; Hall, Amanda L.; O'Brien, Lynne T.; Wilkinson, Rosemary A.; Sawyer, Emma; Lophatananon, Artitaya; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Cooper, Colin; Donovan, Jenny L.; Hamdy, Freddie C.; Neal, David E.; Eeles, Rosalind A.; Easton, Douglas F.		British Assoc Urol Surg Section On; UK Prostate Testing Canc Treatment	Multiple loci on 8q24 associated with prostate cancer susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RISK LOCUS; COLORECTAL-CANCER; RS6983267; AMERICANS; VARIANTS; MYC	Previous studies have identified multiple loci on 8q24 associated with prostate cancer risk. We performed a comprehensive analysis of SNP associations across 8q24 by genotyping tag SNPs in 5,504 prostate cancer cases and 5,834 controls. We confirmed associations at three previously reported loci and identified additional loci in two other linkage disequilibrium blocks (rs1006908: per-allele OR = 0.87, P = 7.9 x 10(-8); rs620861: OR = 0.90, P = 4.8 x 10(-8)). Eight SNPs in five linkage disequilibrium blocks were independently associated with prostate cancer susceptibility.	[Al Olama, Ali Amin; Morrison, Jonathan; Easton, Douglas F.] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge, England; [Kote-Jarai, Zsofia; Guy, Michelle; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Jhavar, Sameer; Saunders, Ed; Dearnaley, David P.; Hall, Amanda L.; O'Brien, Lynne T.; Wilkinson, Rosemary A.; Sawyer, Emma; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Cooper, Colin; Eeles, Rosalind A.] Inst Canc Res, Surrey, England; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Giles, Graham G.; Severi, Gianluca; Hopper, John L.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Muir, Kenneth R.; Lophatananon, Artitaya] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham, England; [Dearnaley, David P.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Neal, David E.] Royal Marsden Natl Hlth Serv Fdn Trust, Surrey, England; [Donovan, Jenny L.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Neal, David E.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England	Cancer Research UK; University of Cambridge; University of London; Institute of Cancer Research - UK; Cancer Council Victoria; University of Melbourne; University of Melbourne; University of Nottingham; Royal Marsden NHS Foundation Trust; University of Bristol; University of Oxford; Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Easton, DF (corresponding author), Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge, England.	douglas@srl.cam.ac.uk	Severi, Gianluca/H-3774-2018; Severi, Gianluca/Q-1824-2019; Griffiths, TR Leyshon/K-7433-2019; Dearnaley, David P/J-2318-2014; English, Dallas/AAH-5005-2019	Severi, Gianluca/0000-0001-7157-419X; Severi, Gianluca/0000-0001-7157-419X; Griffiths, TR Leyshon/0000-0002-3879-0664; Dearnaley, David P/0000-0002-3954-2806; English, Dallas/0000-0001-7828-8188; Rogers, Paul/0000-0003-2593-2595; huddart, robert/0000-0003-3604-1990; Clarke, Noel/0000-0001-7776-8059; Saunders, Ed/0000-0003-4343-3570; Southey, Melissa/0000-0002-6313-9005; Leongamornlert, Daniel/0000-0002-3486-3168; McLaren, Duncan/0000-0002-9862-4158; Hamdy, Freddie/0000-0003-2627-2154; Evans, Gareth/0000-0002-8482-5784; Bancroft, Elizabeth/0000-0002-5482-5660; Hickish, Tamas/0000-0001-6770-7279; Eeles, Rosalind/0000-0002-3698-6241; Neal, David/0000-0002-6033-5086; Adeyoju, Adebanji/0000-0003-4010-5985; van As, Nicholas/0000-0001-6829-8788; Giles, Graham/0000-0003-4946-9099	MRC [G0501019, G0500966] Funding Source: UKRI; Cancer Research UK [C1287/A10118, 10118, C5047/A10692, C16913/A6135, C5047/A7357, 10588, C16913/A6835, 11022, C5047/A3354] Funding Source: Medline; Medical Research Council [G0501019, G0500966] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Robbins C, 2007, GENOME RES, V17, P1717, DOI 10.1101/gr.6782707; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169	15	226	230	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1058	1060		10.1038/ng.452	http://dx.doi.org/10.1038/ng.452			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19767752				2022-12-25	WOS:000270330400006
J	Day, JW; Ottaway, N; Patterson, JT; Gelfanov, V; Smiley, D; Gidda, J; Findeisen, H; Bruemmer, D; Drucker, DJ; Chaudhary, N; Holland, J; Hembree, J; Abplanalp, W; Grant, E; Ruehl, J; Wilson, H; Kirchner, H; Lockie, SH; Hofmann, S; Woods, SC; Nogueiras, R; Pfluger, PT; Perez-Tilve, D; DiMarchi, R; Tschop, MH				Day, Jonathan W.; Ottaway, Nickki; Patterson, James T.; Gelfanov, Vasily; Smiley, David; Gidda, Jas; Findeisen, Hannes; Bruemmer, Dennis; Drucker, Daniel J.; Chaudhary, Nilika; Holland, Jenna; Hembree, Jazzminn; Abplanalp, William; Grant, Erin; Ruehl, Jennifer; Wilson, Hilary; Kirchner, Henriette; Lockie, Sarah Haas; Hofmann, Susanna; Woods, Stephen C.; Nogueiras, Ruben; Pfluger, Paul T.; Perez-Tilve, Diego; DiMarchi, Richard; Tschoep, Matthias H.			A new glucagon and GLP-1 co-agonist eliminates obesity in rodents	NATURE CHEMICAL BIOLOGY			English	Article							SECONDARY STRUCTURE ANALYSES; FOOD-INTAKE; ADIPOSE-TISSUE; PEPTIDE-1; OXYNTOMODULIN; WEIGHT; OVERWEIGHT; EFFICACY; INSULIN; SAFETY	We report the efficacy of a new peptide with agonism at the glucagon and GLP-1 receptors that has potent, sustained satiation-inducing and lipolytic effects. Selective chemical modification to glucagon resulted in a loss of specificity, with minimal change to inherent activity. The structural basis for the co-agonism appears to be a combination of local positional interactions and a change in secondary structure. Two co-agonist peptides differing from each other only in their level of glucagon receptor agonism were studied in rodent obesity models. Administration of PEGylated peptides once per week normalized adiposity and glucose tolerance in diet-induced obese mice. Reduction of body weight was achieved by a loss of body fat resulting from decreased food intake and increased energy expenditure. These preclinical studies indicate that when full GLP-1 agonism is augmented with an appropriate degree of glucagon receptor activation, body fat reduction can be substantially enhanced without any overt adverse effects.	[Day, Jonathan W.; Patterson, James T.; Gelfanov, Vasily; Smiley, David; DiMarchi, Richard] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Ottaway, Nickki; Chaudhary, Nilika; Holland, Jenna; Hembree, Jazzminn; Abplanalp, William; Grant, Erin; Ruehl, Jennifer; Wilson, Hilary; Kirchner, Henriette; Lockie, Sarah Haas; Woods, Stephen C.; Nogueiras, Ruben; Pfluger, Paul T.; Perez-Tilve, Diego; Tschoep, Matthias H.] Univ Cincinnati, Dept Psychiat, Obes Res Ctr, Cincinnati, OH USA; [Gidda, Jas] Marcadia Biotech, Carmel, IN USA; [Findeisen, Hannes; Bruemmer, Dennis] Univ Kentucky, Coll Med, Div Endocrinol & Mol Med, Lexington, KY USA; [Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Dept Med, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Hofmann, Susanna; Tschoep, Matthias H.] Univ Cincinnati, Div Endocrinol, Cincinnati, OH USA	Indiana University System; Indiana University Bloomington; University System of Ohio; University of Cincinnati; University of Kentucky; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University System of Ohio; University of Cincinnati	DiMarchi, R (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	rdimarch@indiana.edu	Tschoep, Matthias H/I-5443-2014; Drucker, Daniel J/A-4092-2010; Pfluger, Paul/B-4889-2010; Lockie, Sarah/M-1415-2019; Hofmann, Susanna/F-2654-2014; Kirchner, Henriette/D-6699-2011; Pfluger, Paul T/A-3770-2019; Nogueiras, Ruben/AAS-9427-2021	Hofmann, Susanna/0000-0001-7682-5840; Pfluger, Paul T/0000-0002-8118-7588; Nogueiras, Ruben/0000-0002-9976-9930; Gelfanov, Vasily/0000-0001-5216-5227; Patterson, James/0000-0001-6006-7184; Perez-Tilve, Diego/0000-0002-0351-4133; Lockie, Sarah/0000-0002-3833-4714; Tschoep, Matthias/0000-0002-4744-371X				Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Baggio LL, 2004, GASTROENTEROLOGY, V127, P546, DOI 10.1053/j.gastro.2004.04.063; BILLINGTON CJ, 1987, AM J PHYSIOL, V252, pR160, DOI 10.1152/ajpregu.1987.252.1.R160; CHAN EK, 1984, EXP MOL PATHOL, V40, P320, DOI 10.1016/0014-4800(84)90049-2; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Cohen MA, 2003, J CLIN ENDOCR METAB, V88, P4696, DOI 10.1210/jc.2003-030421; Cvetkovic RS, 2007, DRUGS, V67, P935, DOI 10.2165/00003495-200767060-00008; DAVIDSON IWF, 1960, AM J CLIN NUTR, V8, P540, DOI 10.1093/ajcn/8.5.540; Geary N, 1998, SATIATION: FROM GUT TO BRAIN, P164; GEARY N, 1992, AM J PHYSIOL, V262, pR975, DOI 10.1152/ajpregu.1992.262.6.R975; GEARY N, 1990, NEUROSCI BIOBEHAV R, V14, P323, DOI 10.1016/S0149-7634(05)80042-9; GOODRIDG.AG, 1965, COMP BIOCHEM PHYSIOL, V16, P367, DOI 10.1016/0010-406X(65)90303-8; Griffen L, 1998, ARCH INTERN MED, V158, P102, DOI 10.1001/archinte.158.1.102; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; HECKEMEYER CM, 1983, ENDOCRINOLOGY, V113, P270, DOI 10.1210/endo-113-1-270; HJORTH SA, 1994, J BIOL CHEM, V269, P30121; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Neovius M, 2008, INT J OBESITY, V32, P1752, DOI 10.1038/ijo.2008.189; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; ORSKOV C, 1992, DIABETOLOGIA, V35, P701; Roth JD, 2008, P NATL ACAD SCI USA, V105, P7257, DOI 10.1073/pnas.0706473105; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALTER JM, 1960, AM J CLIN NUTR, V8, P535, DOI 10.1093/ajcn/8.5.535; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Small CJ, 2004, TRENDS ENDOCRIN MET, V15, P259, DOI 10.1016/j.tem.2004.06.002; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Woods SC, 2006, PHILOS T R SOC B, V361, P1219, DOI 10.1098/rstb.2006.1858; Wynne K, 2005, DIABETES, V54, P2390, DOI 10.2337/diabetes.54.8.2390	34	398	488	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					749	757		10.1038/nchembio.209	http://dx.doi.org/10.1038/nchembio.209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19597507				2022-12-25	WOS:000270039900013
J	Roepke, TK; King, EC; Reyna-Neyra, A; Paroder, M; Purtell, K; Koba, W; Fine, E; Lerner, DJ; Carrasco, N; Abbott, GW				Roepke, Torsten K.; King, Elizabeth C.; Reyna-Neyra, Andrea; Paroder, Monika; Purtell, Kerry; Koba, Wade; Fine, Eugene; Lerner, Daniel J.; Carrasco, Nancy; Abbott, Geoffrey W.			Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis	NATURE MEDICINE			English	Article							LONG QT SYNDROME; FAMILIAL ATRIAL-FIBRILLATION; CARDIAC POTASSIUM CURRENT; GASTRIC-ACID-SECRETION; LANGE-NIELSEN-SYNDROME; OF-FUNCTION MUTATION; SUBCLINICAL HYPOTHYROIDISM; TARGETED DISRUPTION; IODIDE TRANSPORTER; SERUM THYROTROPIN	Thyroid dysfunction is a global health concern, causing defects including neurodevelopmental disorders, dwarfism and cardiac arrhythmia. Here, we show that the potassium channel subunits KCNQ1 and KCNE2 form a thyroid-stimulating hormone-stimulated, constitutively active, thyrocyte K+ channel required for normal thyroid hormone biosynthesis. Targeted disruption of Kcne2 in mice impaired thyroid iodide accumulation up to eightfold, impaired maternal milk ejection, halved milk tetraiodothyronine (T-4) content and halved litter size. Kcne2-deficient mice had hypothyroidism, dwarfism, alopecia, goiter and cardiac abnormalities including hypertrophy, fibrosis, and reduced fractional shortening. The alopecia, dwarfism and cardiac abnormalities were alleviated by triiodothyronine (T-3) and T-4 administration to pups, by supplementing dams with T-4 before and after they gave birth or by feeding the pups exclusively from Kcne2(+/+) dams; conversely, these symptoms were elicited in Kcne2(+/+) pups by feeding exclusively from Kcne2(-/-) dams. These data provide a new potential therapeutic target for thyroid disorders and raise the possibility of an endocrine component to previously identified KCNE2- and KCNQ1-linked human cardiac arrhythmias.	[Roepke, Torsten K.; King, Elizabeth C.; Purtell, Kerry; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Dept Med, Greenberg Div Cardiol, New York, NY 10021 USA; [Roepke, Torsten K.; King, Elizabeth C.; Purtell, Kerry; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Reyna-Neyra, Andrea; Paroder, Monika; Carrasco, Nancy] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Koba, Wade; Fine, Eugene] Albert Einstein Coll Med, Dept Nucl Med, M Donald Blaufox MicroPet Lab Mol Imaging, Bronx, NY 10467 USA; [Lerner, Daniel J.] CV Ingenu, San Francisco, CA USA; [Carrasco, Nancy] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	Cornell University; Cornell University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Abbott, GW (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, Greenberg Div Cardiol, New York, NY 10021 USA.	gwa2001@med.cornell.edu	Carrasco, Nancy/AAH-1053-2019; Reyna-Neyra, Andrea/F-5621-2013	Carrasco, Nancy/0000-0003-4137-6162; Abbott, Geoffrey/0000-0003-4552-496X	US National Heart, Lung, and Blood Institute [HL079275]; American Heart Association [0855756D]; US National Institute of Diabetes and Digestive and Kidney Diseases [DK41544]; US National Cancer Institute [CA098390]; US National Institutes of Health [5T32GM002788]; NATIONAL CANCER INSTITUTE [R01CA098390] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.W.A. is supported by the US National Heart, Lung, and Blood Institute (HL079275) and the American Heart Association (0855756D). N.C. is supported by the US National Institute of Diabetes and Digestive and Kidney Diseases (DK41544) and the US National Cancer Institute (CA098390). M.P. is supported by US National Institutes of Health Medical Scientist Training Grant 5T32GM002788. We are grateful for expert technical assistance from S. Backovic, L. Cohen-Gould, G.J.-S. Abbott, K. La Perle, the Molecular Cytology Core Facility of Memorial Sloan-Kettering Cancer Center and C. Basson and J. Chen (WCMC Center for Molecular Cardiology Small Animal Physiology Core Facility). We also thank T. Denecke for interpreting the radiographs and B. Abbott for critical reading of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Bakiner O, 2008, MED PRIN PRACT, V17, P390, DOI 10.1159/000141503; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Burman KD, 2006, CLIN DERMATOL, V24, P247, DOI 10.1016/j.clindermatol.2006.04.010; Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Ehrlich JR, 2005, CARDIOVASC RES, V67, P520, DOI 10.1016/j.cardiores.2005.03.007; Elso CM, 2004, HUM MOL GENET, V13, P2813, DOI 10.1093/hmg/ddh307; FORFAR JC, 1979, AM J CARDIOL, V44, P9, DOI 10.1016/0002-9149(79)90243-1; FUKUDA H, 1980, ENDOCRINOLOGY, V107, P1711, DOI 10.1210/endo-107-6-1711; GAVIN LA, 1991, MED CLIN N AM, V75, P179, DOI 10.1016/S0025-7125(16)30478-3; GLUECK CJ, 1991, CLIN CHIM ACTA, V201, P113, DOI 10.1016/0009-8981(91)90032-8; Gnat D, 2003, CLIN CHEM, V49, P186, DOI 10.1373/49.1.186; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Gruters A, 2004, EUR J ENDOCRINOL, V151, pU39, DOI 10.1530/eje.0.151U039; HAGGERTY JJ, 1990, INT J PSYCHIAT MED, V20, P193, DOI 10.2190/ADLY-1UU0-1A8L-HPXY; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Hapon MB, 2003, REPRODUCTION, V126, P371, DOI 10.1530/rep.0.1260371; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Imaizumi M, 2001, ENDOCRINOLOGY, V142, P823, DOI 10.1210/en.142.2.823; Kasatkina E P, 2006, Neurosci Behav Physiol, V36, P619, DOI 10.1007/s11055-006-0066-0; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Levy S, 1998, J CARDIOVASC ELECTR, V9, pS78; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; NAKAZAWA HK, 1982, AM J MED, V72, P903, DOI 10.1016/0002-9343(82)90850-6; ODDIE TH, 1966, J CLIN ENDOCR METAB, V26, P1293, DOI 10.1210/jcem-26-12-1293; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Opazo MC, 2008, ENDOCRINOLOGY, V149, P5097, DOI 10.1210/en.2008-0560; Palagiano A, 2006, Minerva Ginecol, V58, P471; PALLAS D, 1991, J ENDOCRINOL INVEST, V14, P743, DOI 10.1007/BF03347907; Quevedo-Corona L, 2000, LIFE SCI, V66, P2013, DOI 10.1016/S0024-3205(00)00528-2; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Shiels HA, 2008, J EXP BIOL, V211, P2005, DOI 10.1242/jeb.003145; Song L, 2006, BRAIN RES, V1101, P59, DOI 10.1016/j.brainres.2006.05.027; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Tang YD, 2005, CIRCULATION, V112, P3122, DOI 10.1161/CIRCULATIONAHA.105.572883; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Temple J, 2005, CIRC RES, V97, P62, DOI 10.1161/01.RES.0000173047.42236.88; Tester DJ, 2007, J AM COLL CARDIOL, V49, P240, DOI 10.1016/j.jacc.2006.10.010; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; van Wassenaer AG, 2002, CLIN ENDOCRINOL, V56, P621, DOI 10.1046/j.1365-2265.2002.01526.x; vanTol BL, 2007, AM J PHYSIOL-CELL PH, V293, pC1010, DOI 10.1152/ajpcell.00071.2007; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342	55	101	104	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1186	U117		10.1038/nm.2029	http://dx.doi.org/10.1038/nm.2029			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19767733	Green Submitted, Green Accepted			2022-12-25	WOS:000270596400031
J	Rung, J; Cauchi, S; Albrechtsen, A; Shen, LS; Rocheleau, G; Cavalcanti-Proenca, C; Bacot, F; Balkau, B; Belisle, A; Borch-Johnsen, K; Charpentier, G; Dina, C; Durand, E; Elliott, P; Hadjadj, S; Jarvelin, MR; Laitinen, J; Lauritzen, T; Marre, M; Mazur, A; Meyre, D; Montpetit, A; Pisinger, C; Posner, B; Poulsen, P; Pouta, A; Prentki, M; Ribel-Madsen, R; Ruokonen, A; Sandbaek, A; Serre, D; Tichet, J; Vaxillaire, M; Wojtaszewski, JFP; Vaag, A; Hansen, T; Polychronakos, C; Pedersen, O; Froguel, P; Sladek, R				Rung, Johan; Cauchi, Stephane; Albrechtsen, Anders; Shen, Lishuang; Rocheleau, Ghislain; Cavalcanti-Proenca, Christine; Bacot, Francois; Balkau, Beverley; Belisle, Alexandre; Borch-Johnsen, Knut; Charpentier, Guillaume; Dina, Christian; Durand, Emmanuelle; Elliott, Paul; Hadjadj, Samy; Jaervelin, Marjo-Riitta; Laitinen, Jaana; Lauritzen, Torsten; Marre, Michel; Mazur, Alexander; Meyre, David; Montpetit, Alexandre; Pisinger, Charlotta; Posner, Barry; Poulsen, Pernille; Pouta, Anneli; Prentki, Marc; Ribel-Madsen, Rasmus; Ruokonen, Aimo; Sandbaek, Anelli; Serre, David; Tichet, Jean; Vaxillaire, Martine; Wojtaszewski, Jorgen F. P.; Vaag, Allan; Hansen, Torben; Polychronakos, Constantin; Pedersen, Oluf; Froguel, Philippe; Sladek, Robert			Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR SUBSTRATE-1 GENE; MUSCLE GLYCOGEN-SYNTHASE; SUSCEPTIBILITY LOCI; BETA-CELL; RISK LOCI; DISRUPTION; MICE; POLYMORPHISM; METAANALYSIS	Genome-wide association studies have identified common variants that only partially explain the genetic risk for type 2 diabetes (T2D). Using genome-wide association data from 1,376 French individuals, we identified 16,360 SNPs nominally associated with T2D and studied these SNPs in an independent sample of 4,977 French individuals. We then selected the 28 best hits for replication in 7,698 Danish subjects and identified 4 SNPs showing strong association with T2D, one of which (rs2943641, P = 9.3 x 10(-12), OR = 1.19) was located adjacent to the insulin receptor substrate 1 gene (IRS1). Unlike previously reported T2D risk loci, which predominantly associate with impaired beta cell function, the C allele of rs2943641 was associated with insulin resistance and hyperinsulinemia in 14,358 French, Danish and Finnish participants from population-based cohorts; this allele was also associated with reduced basal levels of IRS1 protein and decreased insulin induction of IRS1-associated phosphatidylinositol-3-OH kinase activity in human skeletal muscle biopsies.	[Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Borch-Johnsen, Knut; Poulsen, Pernille; Ribel-Madsen, Rasmus; Vaag, Allan; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rung, Johan; Shen, Lishuang; Rocheleau, Ghislain; Bacot, Francois; Belisle, Alexandre; Mazur, Alexander; Montpetit, Alexandre; Serre, David; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Cauchi, Stephane; Cavalcanti-Proenca, Christine; Dina, Christian; Durand, Emmanuelle; Meyre, David; Vaxillaire, Martine; Froguel, Philippe] CNRS, UMR 8090, Inst Biol, Lille, France; [Cauchi, Stephane; Cavalcanti-Proenca, Christine; Dina, Christian; Durand, Emmanuelle; Meyre, David; Vaxillaire, Martine; Froguel, Philippe] Univ Lille 2, Inst Pasteur, Lille, France; [Albrechtsen, Anders] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Rocheleau, Ghislain; Polychronakos, Constantin; Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Balkau, Beverley] INSERM, U780, Villejuif, France; [Balkau, Beverley] Univ Paris Sud, Orsay, France; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, Corbeil Essonnes, France; [Elliott, Paul; Jaervelin, Marjo-Riitta; Pouta, Anneli] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Hadjadj, Samy] Univ Poitiers, Poitiers Hosp, Ctr Invest Clin INSERM 0801, Unite Format & Rech,INSERM U927, Poitiers, France; [Jaervelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jaervelin, Marjo-Riitta] Natl Publ Hlth Inst, Dept Child & Adolescent Hlth, Helsinki, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Helsinki, Finland; [Lauritzen, Torsten; Sandbaek, Anelli] Univ Aarhus, Dept Gen Practice, Aarhus C, Denmark; [Marre, Michel] Bichat Claude Bernard Univ Hosp, Dept Endocrinol Diabetol & Nutr, AP HP, Paris, France; [Marre, Michel] Univ Paris 07, INSERM, U695, Paris, France; [Marre, Michel] Diderot Univ, Paris, France; [Pisinger, Charlotta] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Posner, Barry] McGill Univ, Fac Med, Dept Med, Montreal, PQ, Canada; [Posner, Barry] McGill Univ, Polypeptide Hormone Lab, Montreal, PQ, Canada; [Posner, Barry] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Prentki, Marc] Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Mol Nutr Unit, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Ruokonen, Aimo] Univ Oulu, Dept Clin Chem, Oulu, Finland; [Tichet, Jean] Inst Interreg Sante, La Riche, France; [Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Copenhagen Muscle Res Ctr, Inst Exercise & Sport Sci, Copenhagen NV, Denmark; [Vaag, Allan] Lund Univ, Unit Diabet & Endocrinol, Dept Clin Sci, Malmo Univ Hosp, Malmo, Sweden; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense M, Denmark; [Polychronakos, Constantin] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3A 2T5, Canada; [Pedersen, Oluf] Univ Copenhagen, Dept Biomed Sci, Copenhagen N, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus C, Denmark; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Genom Med, London, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Genom Med, London, England	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Copenhagen; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier Sud Francilien; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Finnish Institute of Occupational Health; Aarhus University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Oulu; University of Copenhagen; Lund University; Skane University Hospital; University of Southern Denmark; McGill University; University of Copenhagen; Aarhus University; Imperial College London; Imperial College London	Pedersen, O (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	oluf@hagedorn.dk; phillipe.froguel@good.ibl.fr; robert.sladek@mcgill.ca	Albrechtsen, Anders/K-4281-2013; Pedersen, Oluf/Z-1731-2019; Shen, Lishuang/B-3040-2013; Dina, Christian R/D-3535-2015; Sladek, Robert/R-2391-2019; Meyre, David/D-7315-2011; Wojtaszewski, Jørgen FP/P-6583-2014; Pedersen, Oluf/AAG-8015-2020; FROGUEL, Philippe/O-6799-2017	Albrechtsen, Anders/0000-0001-7306-031X; Pedersen, Oluf/0000-0002-3321-3972; Dina, Christian R/0000-0002-7722-7348; Sladek, Robert/0000-0002-2730-1204; Meyre, David/0000-0003-4850-7444; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; FROGUEL, Philippe/0000-0003-2972-0784; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Pisinger, Charlotta/0000-0002-7970-3168; Vaag, Allan Arthur/0000-0002-3690-2191; Elliott, Paul/0000-0002-7511-5684; wojtaszewski, jorgen/0000-0001-8185-3408; Marre, Michel/0000-0002-3071-1837; Shen, Lishuang/0000-0002-0436-0199; Rung, Johan/0000-0001-5875-8429; Polychronakos, Constantin/0000-0002-7624-6635	Genome Canada; Genome Quebec; Canada Foundation for Innovation; French Government (Agence Nationale de la Recherche); French Region of Nord Pas De Calais (Contrat de Projets Etat-Region); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries; Lilly; Novartis Pharma; Sanofi-Aventis; Institut National de la Sante et de la Recherche Medicale (INSERM); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; Fondation de France; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Office National Interprofessionnel des Vins; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche and Topcon; Oulu University Hospital, Finland; Academy of Finland; European Commission [QLG1-CT-2000-01643]; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction; Prevention and Care (LUCAMP); European Union [LSHM-CT-2004-512013, LSHM-CT-2004-005272, LSHM-CT-2006-518153]; Danish Diabetes Association; Danish Agency for Science, Technology and Innovation [271-06-0539]; Canadian Chair in diabetes and metabolism; Fonds de la recherche en sante du Quebec; Montreal General Hospital Foundation; Medical Research Council [G0801056, G0600331, G0801056B] Funding Source: researchfish; MRC [G0600331, G0801056] Funding Source: UKRI	Genome Canada(Genome Canada); Genome Quebec; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); French Government (Agence Nationale de la Recherche)(French National Research Agency (ANR)); French Region of Nord Pas De Calais (Contrat de Projets Etat-Region)(Region Hauts-de-France); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries; Lilly(Eli Lilly); Novartis Pharma; Sanofi-Aventis(Sanofi-Aventis); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; Fondation de France(Fondation de France); Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Office National Interprofessionnel des Vins; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche and Topcon; Oulu University Hospital, Finland; Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction; Prevention and Care (LUCAMP); European Union(European Commission); Danish Diabetes Association; Danish Agency for Science, Technology and Innovation; Canadian Chair in diabetes and metabolism; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Montreal General Hospital Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Genome Canada, Genome Quebec and the Canada Foundation for Innovation. This work was also supported by the French Government (Agence Nationale de la Recherche), the French Region of Nord Pas De Calais (Contrat de Projets Etat-Region), and the following charities: Association Francaise des Diabetiques, Programme National de Recherche sur le Diabete and Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques. The D. E. S. I. R. study has been supported by the Caisse Nationale d'Assurance Maladie des Travailleurs Salaries, Lilly, Novartis Pharma and Sanofi-Aventis, Institut National de la Sante et de la Recherche Medicale (INSERM) (Reseaux en Sante Publique, Interactions entre les determinants de la sante), Association Diabete Risque Vasculaire, Federation Francaise de Cardiologie, Fondation de France, Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques, Office National Interprofessionnel des Vins, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche and Topcon. The D. E. S. I. R. Study Group: INSERM U780: B. Balkau, P. Ducimetiere, E. Eschwege; INSERM U367: F. Alhenc-Gelas; Centre Hospitalier Universitaire D'Angers: Y. Gallois, A. Girault; Bichat Hospital: F. Fumeron, M. Marre; Medical Examination Services: Alencon, Angers, Caen, Chateauroux, Cholet, Le Mans and Tours; Research Institute for General Medicine: J. Cogneau; General practitioners of the region; Cross-Regional Institute for Health: C. Born, E. Caces, M. Cailleau, J. G. Moreau, F. Rakotozafy, J. Tichet, S. Vol. The NFBC 1986 study has been supported by the Oulu University Hospital, Finland, the Academy of Finland and the European Commission (Framework 5 award QLG1-CT-2000-01643). The Danish study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP), the European Union (EUGENE2) grant LSHM-CT-2004-512013, EXGENESIS grant LSHM-CT-2004-005272, the Danish Diabetes Association and the Danish Agency for Science, Technology and Innovation, grant no. 271-06-0539. This study was supported in part by a grant from the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European Community). M. P. is the recipient of a Canadian Chair in diabetes and metabolism. R. S. is a Chercheur-boursier of the Fonds de la recherche en sante du Quebec and the recipient of an MGH One Hundred and Seventy-Fifth Anniversary Award from Research Institute of the Montreal General Hospital Foundation. We thank L. Peltonen-Palotie for her contribution in DNA extraction and distribution; M. Deweider and F. Allegaert for the DNA bank management; R. Frechette, V. Catudal, D. Vincent, A. Forman, I.-L. Wantzin, T. Lorentzen, M. Stendal, M. H. Kristensen, T. Brunt and A. L. Nielsen for their technical or management assistance. Large-scale computations were performed using the Consortium Laval, Universite du Quebec, McGill and Eastern Quebec supercomputer facility. We are sincerely indebted to all subjects who participated in this study.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Almind K, 1996, J CLIN INVEST, V97, P2569, DOI 10.1172/JCI118705; ALMIND K, 1993, LANCET, V342, P828, DOI 10.1016/0140-6736(93)92694-O; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Aston-Mourney K, 2008, DIABETOLOGIA, V51, P540, DOI 10.1007/s00125-008-0930-2; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; CLAUSEN JO, 1995, LANCET, V346, P397, DOI 10.1016/S0140-6736(95)92779-4; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Florez JC, 2007, DIABETOLOGIA, V50, P1209, DOI 10.1007/s00125-007-0657-5; Florez JC, 2004, DIABETES, V53, P3313, DOI 10.2337/diabetes.53.12.3313; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jellema A, 2003, DIABETOLOGIA, V46, P990, DOI 10.1007/s00125-003-1126-4; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Poulsen P, 2005, DIABETES, V54, P1289, DOI 10.2337/diabetes.54.5.1289; Poulsen P, 2005, DIABETES, V54, P275, DOI 10.2337/diabetes.54.1.275; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2004, DIABETES, V53, P3319, DOI 10.2337/diabetes.53.12.3319; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	324	332	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1110	U89		10.1038/ng.443	http://dx.doi.org/10.1038/ng.443			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19734900				2022-12-25	WOS:000270330400015
J	Caruso, R; Botti, E; Sarra, M; Esposito, M; Stolfi, C; Diluvio, L; Giustizieri, ML; Pacciani, V; Mazzotta, A; Campione, E; MacDonald, TT; Chimenti, S; Pallone, F; Costanzo, A; Monteleone, G				Caruso, Roberta; Botti, Elisabetta; Sarra, Massimiliano; Esposito, Maria; Stolfi, Carmine; Diluvio, Laura; Giustizieri, Maria Laura; Pacciani, Valentina; Mazzotta, Annamaria; Campione, Elena; MacDonald, Thomas T.; Chimenti, Sergio; Pallone, Francesco; Costanzo, Antonio; Monteleone, Giovanni			Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis	NATURE MEDICINE			English	Article							INFLAMMATION	T cells are crucial mediators of the skin damage in psoriasis. We here show that interleukin-21 (IL-21), a T cell-derived cytokine, is highly expressed in the skin of individuals with psoriasis, stimulates human keratinocytes to proliferate and causes epidermal hyperplasia when injected intradermally into mice. In the human psoriasis xenograft mouse model, blockade of IL-21 activity resolves inflammation and reduces keratinocyte proliferation. Blocking IL-21 may represent a new therapeutic strategy in psoriasis.	[Caruso, Roberta; Sarra, Massimiliano; Stolfi, Carmine; Pallone, Francesco; Monteleone, Giovanni] Univ Roma Tor Vergata, Gastroenterol Unit, Dept Internal Med, Rome, Italy; [Botti, Elisabetta; Esposito, Maria; Diluvio, Laura; Giustizieri, Maria Laura; Pacciani, Valentina; Mazzotta, Annamaria; Campione, Elena; Chimenti, Sergio; Costanzo, Antonio] Univ Roma Tor Vergata, Dermatol Unit, Dept Internal Med, Rome, Italy; [MacDonald, Thomas T.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England	University of Rome Tor Vergata; University of Rome Tor Vergata; University of London; Queen Mary University London	Monteleone, G (corresponding author), Univ Roma Tor Vergata, Gastroenterol Unit, Dept Internal Med, Rome, Italy.	GiMonteleone@Med.uniroma2.it	Costanzo, Antonio/GZG-2433-2022; Costanzo, Antonio/D-3896-2012; Stolfi, Carmine/J-4524-2019; Campione, Elena/AAJ-4264-2021; Caruso, Roberta/AAA-7661-2020; Diluvio, Laura/AAM-7371-2020	Costanzo, Antonio/0000-0001-9697-2557; Campione, Elena/0000-0001-7447-6798; Diluvio, Laura/0000-0003-1844-9052; Stolfi, Carmine/0000-0002-6354-2443	Fondazione Umberto di Mario and Giuliani SpA, Milan, Italy	Fondazione Umberto di Mario and Giuliani SpA, Milan, Italy	This work received support from the Fondazione Umberto di Mario and Giuliani SpA, Milan, Italy. It is dedicated to the memory of A. Ribuffo, the Master of the Roman University School of Dermatology.	Caprioli F, 2008, J IMMUNOL, V180, P1800, DOI 10.4049/jimmunol.180.3.1800; Hobbs RM, 2004, J INVEST DERMATOL, V123, P503, DOI 10.1111/j.0022-202X.2004.23225.x; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Monteleone G, 2008, TRENDS IMMUNOL, V29, P290, DOI 10.1016/j.it.2008.02.008; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	9	149	163	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1013	1015		10.1038/nm.1995	http://dx.doi.org/10.1038/nm.1995			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19684581				2022-12-25	WOS:000269979200020
J	Newton, GL; Rawat, M; La Clair, JJ; Jothivasan, VK; Budiarto, T; Hamilton, CJ; Claiborne, A; Helmann, JD; Fahey, RC				Newton, Gerald L.; Rawat, Mamta; La Clair, James J.; Jothivasan, Vishnu Karthik; Budiarto, Tanya; Hamilton, Chris J.; Claiborne, Al; Helmann, John D.; Fahey, Robert C.			Bacillithiol is an antioxidant thiol produced in Bacilli	NATURE CHEMICAL BIOLOGY			English	Article							A-DISULFIDE REDUCTASE; STAPHYLOCOCCUS-AUREUS; SUBTILIS; MYCOTHIOL; BIOSYNTHESIS; PURIFICATION; THIOREDOXIN; EXPRESSION; ANTHRACIS; COMPLEX	Glutathione is a nearly ubiquitous, low-molecular-mass thiol and antioxidant, but it is conspicuously absent from most Gram-positive bacteria. We identify here the structure of bacillithiol, a newly described and abundant thiol produced by Bacillus species, Staphylococcus aureus and Deinococcus radiodurans. Bacillithiol is the alpha-anomeric glycoside of L-cysteinyl-D-glucosamine with L-malic acid and most probably functions as an antioxidant. Bacillithiol, like the structurally similar mycothiol, may serve as a substitute for glutathione.	[Newton, Gerald L.; La Clair, James J.; Budiarto, Tanya; Fahey, Robert C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Rawat, Mamta] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; [Jothivasan, Vishnu Karthik; Hamilton, Chris J.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England; [Claiborne, Al] Wake Forest Univ, Sch Med, Struct Biol Ctr, Winston Salem, NC 27109 USA; [Helmann, John D.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	University of California System; University of California San Diego; California State University System; California State University Fresno; University of East Anglia; Wake Forest University; Cornell University	Fahey, RC (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	rcfahey@ucsd.edu	hamilton, chris/C-5651-2009	Helmann, John/0000-0002-3832-3249	US National Science Foundation [MCB0235705, MCB0640616]; US National Institutes of Health [AI49174, AI072133, GM061223-05A, GM35394]; The University of East Anglia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072133, R01AI049174, R21AI049174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035394] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The University of East Anglia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Upton for technical assistance. This work was supported by grants from the US National Science Foundation to R. C. F. (MCB0235705) and J.D.H. (MCB0640616); from the US National Institutes of Health to R. C. F. (AI49174 and AI072133), to M. R. (GM061223-05A) and to A. C. (GM35394); and from The University of East Anglia to V.K.J.	delCardayre SB, 1998, J BIOL CHEM, V273, P5752, DOI 10.1074/jbc.273.10.5752; delCardayre SB, 1998, J BIOL CHEM, V273, P5744, DOI 10.1074/jbc.273.10.5744; Fahey R.C., 1983, P251; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; FAHEY RC, 1991, ADV ENZYMOL RAMB, V64, P1; HELD KD, 1994, RADIAT RES, V139, P15, DOI 10.2307/3578727; HERMANSSON K, 1990, PHYTOCHEMISTRY, V29, P513, DOI 10.1016/0031-9422(90)85107-Q; HOCH JA, 1978, J BACTERIOL, V133, P265, DOI 10.1128/JB.133.1.265-269.1978; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lithgow JK, 2004, J BACTERIOL, V186, P1579, DOI 10.1128/JB.186.6.1579-1590.2004; Meister A, 1989, GLUTATHIONE CHEM BIO, P367; Mostertz J, 2008, PROTEOMICS, V8, P2676, DOI 10.1002/pmic.200701015; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; NEWTON GL, 1995, EUR J BIOCHEM, V230, P821; Nicely NI, 2007, BIOCHEMISTRY-US, V46, P3234, DOI 10.1021/bi062299p; Patel MP, 1999, BIOCHEMISTRY-US, V38, P11827, DOI 10.1021/bi991025h; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; Rotzoll N, 2005, J AGR FOOD CHEM, V53, P4149, DOI 10.1021/jf050056i; Soonsanga S, 2008, MOL MICROBIOL, V68, P978, DOI 10.1111/j.1365-2958.2008.06200.x; Wallen JR, 2008, BIOCHEMISTRY-US, V47, P5182, DOI 10.1021/bi8002204	22	205	210	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					625	627		10.1038/nchembio.189	http://dx.doi.org/10.1038/nchembio.189			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19578333	Green Accepted			2022-12-25	WOS:000269093000009
J	Kwon, C; Qian, L; Cheng, P; Nigam, V; Arnold, J; Srivastava, D				Kwon, Chulan; Qian, Li; Cheng, Paul; Nigam, Vishal; Arnold, Joshua; Srivastava, Deepak			A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; SMOOTH-MUSCLE; HEART FIELD; DIFFERENTIATION; BETA; MULTIPOTENT; EXPRESSION; MYOCARDIN; PROTEIN; DEC1	Regulation of multipotent cardiac progenitor cell (CPC) expansion and subsequent differentiation into cardiomyocytes, smooth muscle or endothelial cells is a fundamental aspect of basic cardiovascular biology and cardiac regenerative medicine. However, the mechanisms governing these decisions remain unclear. Here, we show that Wnt/beta-catenin signalling, which promotes expansion of CPCs1-3, is negatively regulated by Notch1-mediated control of phosphorylated beta-catenin accumulation within CPCs, and that Notch1 activity in CPCs is required for their differentiation. Notch1 positively, and beta-catenin negatively, regulated expression of the cardiac transcription factors, Isl1, Myocd and Smyd1. Surprisingly, disruption of Isl1, normally expressed transiently in CPCs before their differentiation(4), resulted in expansion of CPCs in vivo and in an embryonic stem (ES) cell system. Furthermore, Isl1 was required for CPC differentiation into cardiomyocyte and smooth muscle cells, but not endothelial cells. These findings reveal a regulatory network controlling CPC expansion and cell fate that involves unanticipated functions of beta-catenin, Notch1 and Isl1 that may be leveraged for regenerative approaches involving CPCs.	[Kwon, Chulan] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kwon, C (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	ckwon@gladstone.ucsf.edu; dsrivastava@gladstone.ucsf.edu		Nigam, Vishal/0000-0002-9652-8146; Cheng, Paul/0000-0003-3429-2702	American Heart Association (AHA); California Institute for Regenerative Medicine (CIRM); NHLBI/NIH; CIRM; NIH/NCRR [C06 RR018928]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R13HD046201] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, R01HL057181, R01HL080592, K99HL092234, P50HL061033, R01HL062591] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CIRM(California Institute for Regenerative Medicine); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank R. Kopan (Washington Univeristy, St. Louis, MO) and M. M. Taketo (Kyoto University, Kyoto, Japan) for providing Notch1<SUP>flox</SUP> and beta-catenin/loxP(ex3)<SUP>loxP</SUP> mice, respectively. The authors thank G. Howard and S. Ordway for editorial assistance, R. F. Yeh for statistical analyses, K. Cordes for graphical assistance, B. Taylor for manuscript and figure preparation and Srivastava lab members for helpful discussions. C. K. was supported by a fellowship from the American Heart Association (AHA) and California Institute for Regenerative Medicine (CIRM); D. S. was an Established Investigator of the AHA and was supported by grants from NHLBI/NIH and CIRM. This work was also supported by NIH/NCRR grant (C06 RR018928) to the Gladstone Institutes.	Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Cohen ED, 2007, J CLIN INVEST, V117, P1794, DOI 10.1172/JCI31731; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Kwon C, 2004, DEVELOPMENT, V131, P2681, DOI 10.1242/dev.01127; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rones MS, 2000, DEVELOPMENT, V127, P3865; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Votin V, 2005, J CELL SCI, V118, P5699, DOI 10.1242/jcs.02679; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999	34	180	188	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					951	U96		10.1038/ncb1906	http://dx.doi.org/10.1038/ncb1906			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19620969	Green Accepted			2022-12-25	WOS:000268593200008
J	Thorleifsson, G; Holm, H; Edvardsson, V; Walters, GB; Styrkarsdottir, U; Gudbjartsson, DF; Sulem, P; Halldorsson, BV; de Vegt, F; d'Ancona, FCH; den Heijer, M; Franzson, L; Christiansen, C; Alexandersen, P; Rafnar, T; Kristjansson, K; Sigurdsson, G; Kiemeney, LA; Bodvarsson, M; Indridason, OS; Palsson, R; Kong, A; Thorsteinsdottir, U; Stefansson, K				Thorleifsson, Gudmar; Holm, Hilma; Edvardsson, Vidar; Walters, G. Bragi; Styrkarsdottir, Unnur; Gudbjartsson, Daniel F.; Sulem, Patrick; Halldorsson, Bjarni V.; de Vegt, Femmie; d'Ancona, Frank C. H.; den Heijer, Martin; Franzson, Leifur; Christiansen, Claus; Alexandersen, Peter; Rafnar, Thorunn; Kristjansson, Kristleifur; Sigurdsson, Gunnar; Kiemeney, Lambertus A.; Bodvarsson, Magnus; Indridason, Olafur S.; Palsson, Runolfur; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density	NATURE GENETICS			English	Article							RECESSIVE DEAFNESS DFNB29; RISK-FACTORS; RENAL STONE; NEPHROLITHIASIS; DISEASE; JUNCTION; OSTEOPOROSIS; MUTATIONS; FRACTURES; STABILITY	Kidney stone disease is a common condition. To search for sequence variants conferring risk of kidney stones, we conducted a genome-wide association study in 3,773 cases and 42,510 controls from Iceland and The Netherlands. We discovered common, synonymous variants in the CLDN14 gene that associate with kidney stones (OR = 1.25 and P = 4.0 x 10(-12) for rs219780[C]). Approximately 62% of the general population is homozygous for rs219780[C] and is estimated to have 1.64 times greater risk of developing the disease compared to noncarriers. The CLDN14 gene is expressed in the kidney and regulates paracellular permeability at epithelial tight junctions. The same variants were also found to associate with reduced bone mineral density at the hip (P = 0.00039) and spine (P = 0.0077).	[Thorleifsson, Gudmar; Holm, Hilma; Walters, G. Bragi; Styrkarsdottir, Unnur; Gudbjartsson, Daniel F.; Sulem, Patrick; Halldorsson, Bjarni V.; Rafnar, Thorunn; Kristjansson, Kristleifur; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Holm, Hilma] Emory Univ, Sch Med, Div Cardiol, Dept Internal Med, Atlanta, GA 30322 USA; [Edvardsson, Vidar] Univ Iceland, Dept Pediat, Landspitali Univ Hosp, Reykjavik, Iceland; [Halldorsson, Bjarni V.] Reykjavik Univ, Reykjavik, Iceland; [de Vegt, Femmie; den Heijer, Martin; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [d'Ancona, Frank C. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Franzson, Leifur] Univ Iceland, Landspitali Univ Hosp, Dept Genet & Mol Med, Reykjavik, Iceland; [Christiansen, Claus] Nord Biosci AS, Herlev, Denmark; [Alexandersen, Peter] Ctr Clin & Basic Res AS, Ballerup, Denmark; [Sigurdsson, Gunnar] Univ Iceland, Landspitali Univ Hosp, Div Endocrinol & Metab, Reykjavik, Iceland; [Bodvarsson, Magnus; Indridason, Olafur S.; Palsson, Runolfur] Univ Iceland, Landspitali Univ Hosp, Div Nephrol, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	Emory University; Landspitali National University Hospital; University of Iceland; Reykjavik University; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Landspitali National University Hospital; University of Iceland; Nordic Bioscience; Center Clinical & Basic Research; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; University of Iceland; University of Iceland	Thorleifsson, G (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	gudmar.thorleifsson@decode.is; kstefans@decode.is	Edvardsson, Vidar O/M-3306-2015; Martens, Frank/B-7868-2018; D'Ancona, F.C.H./L-4259-2015; de Vegt, F./L-4704-2015; Kiemeney, Lambertus A./D-3357-2009; Walters, G. Bragi/L-4215-2013; Stefansson, Kari/AAE-7187-2019; den Heijer, Martin/J-8036-2015	Edvardsson, Vidar O/0000-0002-4204-9342; Martens, Frank/0000-0002-5883-7116; de Vegt, F./0000-0001-8728-3397; Kiemeney, Lambertus A./0000-0002-2368-1326; Walters, G. Bragi/0000-0002-5415-6487; Kong, Augustine/0000-0001-8193-5438; den Heijer, Martin/0000-0003-3620-5617; Styrkarsdottir, Unnur/0000-0001-8146-8278; Gudbjartsson, Daniel/0000-0002-5222-9857; Halldorsson, Bjarni/0000-0003-0756-0767				Angelow S, 2006, J PHYSIOL-LONDON, V571, P15, DOI 10.1113/jphysiol.2005.099135; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Asplin JR, 2003, KIDNEY INT, V63, P662, DOI 10.1046/j.1523-1755.2003.00763.x; Bagger YZ, 2007, OSTEOPOROSIS INT, V18, P505, DOI 10.1007/s00198-006-0255-2; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Edvardsson V, 2005, PEDIATR NEPHROL, V20, P940, DOI 10.1007/s00467-005-1861-5; Elkouby-Naor L, 2008, CELL TISSUE RES, V333, P427, DOI 10.1007/s00441-008-0621-9; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goldfarb DS, 2005, KIDNEY INT, V67, P1053, DOI 10.1111/j.1523-1755.2005.00170.x; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsdottir SL, 2005, J CLIN DENSITOM, V8, P80, DOI 10.1385/JCD:8:1:080; Hess B, 1997, NEPHROL DIAL TRANSPL, V12, P1362, DOI 10.1093/ndt/12.7.1362; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lemann J, 2003, AM J PHYSIOL-RENAL, V285, pF811, DOI 10.1152/ajprenal.00115.2003; LEVY FL, 1995, AM J MED, V98, P50, DOI 10.1016/S0002-9343(99)80080-1; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Polito C, 2000, PEDIATR NEPHROL, V14, P1102; Rice J., 1995, MATH STAT DATA ANAL; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Stechman MJ, 2007, ANN NY ACAD SCI, V1116, P461, DOI 10.1196/annals.1402.030; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tefekli A, 2003, UROL INT, V70, P273, DOI 10.1159/000070134; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Trinchieri A, 1999, J UROLOGY, V162, P27, DOI 10.1097/00005392-199907000-00007; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; Uyguner O, 2003, CLIN GENET, V64, P65, DOI 10.1034/j.1399-0004.2003.00101.x; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Zhang HP, 2006, HUM MOL GENET, V15, P807, DOI 10.1093/hmg/ddl024	43	198	212	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					926	U92		10.1038/ng.404	http://dx.doi.org/10.1038/ng.404			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19561606				2022-12-25	WOS:000268432900019
J	Zhang, F; Khajavi, M; Connolly, AM; Towne, CF; Batish, SD; Lupski, JR				Zhang, Feng; Khajavi, Mehrdad; Connolly, Anne M.; Towne, Charles F.; Batish, Sat Dev; Lupski, James R.			The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans	NATURE GENETICS			English	Article							BREAK-INDUCED REPLICATION; STRUCTURAL VARIATION; COPY-NUMBER; FINE-SCALE; DUPLICATIONS; ARCHITECTURE; DISORDERS; GENES	We recently proposed a DNA replication-based mechanism of fork stalling and template switching (FoSTeS) to explain the complex genomic rearrangements associated with a dysmyelinating central nervous system disorder in humans(1). The FoSTeS mechanism has been further generalized and molecular mechanistic details have been provided in the microhomology-mediated break-induced replication (MMBIR) model that may underlie many structural variations in genomes from all domains of life(2). Here we provide evidence that human genomic rearrangements ranging in size from several megabases to a few hundred base pairs can be generated by FoSTeS/MMBIR. Furthermore, we show that FoSTeS/MMBIR-mediated rearrangements can occur mitotically and can result in duplication or triplication of individual genes or even rearrangements of single exons. The FoSTeS/MMBIR mechanism can explain both the gene duplication-divergence hypothesis(3) and exon shuffling(4), suggesting an important role in both genome and single-gene evolution.	[Zhang, Feng; Khajavi, Mehrdad; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Connolly, Anne M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Towne, Charles F.; Batish, Sat Dev] Athena Diagnost Inc, Worcester, MA USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Connolly, Anne/GYD-3128-2022; Zhang, Feng/C-7735-2009	Zhang, Feng/0000-0003-4556-8276; Connolly, Anne/0000-0002-9193-2457	Charcot Marie Tooth Association and the National Institute of Neurological Disorders and Stroke (NINDS, NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	Charcot Marie Tooth Association and the National Institute of Neurological Disorders and Stroke (NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all participating subjects and families for their kind cooperation in the study. We also thank W. Bi, W. Gu, J. A. Lee and P. Stankiewicz for their critical reviews and C. M. B. Carvalho and M. A. Withers for their assistance. This work was supported in part by the Charcot Marie Tooth Association and the National Institute of Neurological Disorders and Stroke (NINDS, NIH).	Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chen JM, 2005, HUM MUTAT, V26, P125, DOI 10.1002/humu.20202; Doco-Fenzy M, 2008, AM J MED GENET A, V146A, P917, DOI 10.1002/ajmg.a.32195; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jones JM, 2000, HUM MOL GENET, V9, P821, DOI 10.1093/hmg/9.5.821; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Lupski JR, 2005, PERIPHERAL NEUROPATH, P1659, DOI DOI 10.1016/B978-0-7216-9491-7.50073-9; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Ohno S., 1970, EVOLUTION GENE DUPLI; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Rijk AAF, 1999, P NATL ACAD SCI USA, V96, P8074, DOI 10.1073/pnas.96.14.8074; Vissers LELM, 2007, HUM GENET, V121, P697, DOI 10.1007/s00439-007-0359-6; ZHANG F, TRENDS GENE IN PRESS	35	297	303	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					849	U115		10.1038/ng.399	http://dx.doi.org/10.1038/ng.399			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19543269	Green Accepted			2022-12-25	WOS:000267786200019
J	Tomida, S; Mamiya, T; Sakamaki, H; Miura, M; Aosaki, T; Masuda, M; Niwa, M; Kameyama, T; Kobayashi, J; Iwaki, Y; Imai, S; Ishikawa, A; Abe, K; Yoshimura, T; Nabeshima, T; Ebihara, S				Tomida, Shigeru; Mamiya, Takayoshi; Sakamaki, Hirotake; Miura, Masami; Aosaki, Toshihiko; Masuda, Masao; Niwa, Minae; Kameyama, Tsutomu; Kobayashi, Junya; Iwaki, Yuka; Imai, Saki; Ishikawa, Akira; Abe, Kuniya; Yoshimura, Takashi; Nabeshima, Toshitaka; Ebihara, Shizufumi			Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests	NATURE GENETICS			English	Article							PREPULSE INHIBITION; MICE LACKING; QTL ANALYSIS; RECEPTOR; DEPRESSION; MODEL; GABA; DISSECTION; PLASTICITY; ATTENTION	The tail suspension test (TST) and forced swimming test (FST) are widely used for assessing antidepressant activity and depression-like behavior. We found that CS mice show negligible immobility in inescapable situations. Quantitative trait locus (QTL) mapping using CS and C57BL/6J mice revealed significant QTLs on chromosomes 4 (FST) and 5 (TST and FST). To identify the quantitative trait gene on chromosome 5, we narrowed the QTL interval to 0.5 Mb using several congenic and subcongenic strains. Ubiquitin-specific peptidase 46 (Usp46) with a lysine codon deletion was located in this region. This deletion affected nest building, muscimol-induced righting reflex and anti-immobility effects of imipramine. The muscimol-induced current in the hippocampal CA1 pyramidal neurons and hippocampal expression of the 67-kDa isoform of glutamic acid decarboxylase were significantly decreased in the Usp46 mutant mice compared to control mice. These phenotypes were rescued in transgenic mice with bacterial artificial chromosomes containing wild-type Usp46. Thus, Usp46 affects the immobility in the TST and FST, and it is implicated in the regulation of GABA action.	[Tomida, Shigeru; Sakamaki, Hirotake; Kobayashi, Junya; Iwaki, Yuka; Imai, Saki; Yoshimura, Takashi; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mamiya, Takayoshi; Niwa, Minae; Nabeshima, Toshitaka] Meijo Univ, Fac Pharm, Dept Chem Pharmacol, Tempaku Ku, Nagoya, Aichi 468, Japan; [Miura, Masami; Aosaki, Toshihiko; Masuda, Masao] Tokyo Metropolitan Inst Gerontol, Neural Circuits Dynam Res Grp, Itabashi Ku, Tokyo, Japan; [Kameyama, Tsutomu] Japan Inst Psychopharmacol, Higashi Ku, Nagoya, Aichi, Japan; [Ishikawa, Akira] Nagoya Univ, Grad Sch Bioagr Sci, Div Appl Genet & Physiol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Abe, Kuniya] RIKEN, Bioresource Ctr, Technol & Dev Team Mammalian Cellular Dynam, Tsukuba, Ibaraki, Japan	Nagoya University; Meijo University; Tokyo Metropolitan Institute of Gerontology; Nagoya University; RIKEN	Ebihara, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	ebihara@agr.nagoya-u.ac.jp	Niwa, Minae/AAV-2639-2021; Yoshimura, Takashi/C-8306-2012; Niwa, Minae/G-5469-2011; Ishikawa, Akira/I-6856-2014	Niwa, Minae/0000-0002-8784-7815; Yoshimura, Takashi/0000-0001-7018-9652; Niwa, Minae/0000-0002-8784-7815; Ishikawa, Akira/0000-0002-8275-4230	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the late M. Ukai (Meijo University) for his helpful suggestions and for providing the facilities for the behavioral experiments, A. Yoshiki (RIKEN BRC) for his useful suggestions regarding the rescue experiment with transgenic mice, S. Yasuo (Johann Wolfgang Goethe-University Frankfurt) for her guidance on the in situ hybridization experiment, RIKEN BRC for providing the mice and the Nagoya University Radio-isotope Center for allowing us to use their facilities. This research was supported in part by a Grant-in-Aid for Scientific Research to S. E. and by the Academic Frontier Project for Private Universities (2007-2011) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. M and T. N.	Abe H, 1999, J COMP PHYSIOL A, V184, P243, DOI 10.1007/s003590050322; Abe H, 2007, AM J PHYSIOL-REG I, V292, pR607, DOI 10.1152/ajpregu.00331.2006; Abe K, 2004, GENOME RES, V14, P2439, DOI 10.1101/gr.2899304; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Belknap JK, 2001, BEHAV GENET, V31, P5, DOI 10.1023/A:1010249607128; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; CHURCHILL GA, 1994, GENETICS, V138, P963; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Crowley JJ, 2006, NEUROPSYCHOPHARMACOL, V31, P2433, DOI 10.1038/sj.npp.1301065; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DeLorey TM, 2008, BEHAV BRAIN RES, V187, P207, DOI 10.1016/j.bbr.2007.09.009; Ebihara S, 2003, BRAIN RES, V980, P121, DOI 10.1016/S0006-8993(03)02947-0; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Galeotti N, 2003, NEUROPSYCHOPHARMACOL, V28, P888, DOI 10.1038/sj.npp.1300111; Ishikawa A, 2005, GENET RES, V85, P127, DOI 10.1017/S001667230500738X; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kuwahara M, 1999, BLOOD, V94, P1149, DOI 10.1182/blood.V94.4.1149.416k18_1149_1155; Lad HV, 2007, MAMM GENOME, V18, P482, DOI 10.1007/s00335-007-9029-1; Liang J, 2007, J NEUROSCI, V27, P12367, DOI 10.1523/JNEUROSCI.2786-07.2007; Liu GX, 2007, NEUROPSYCHOPHARMACOL, V32, P1531, DOI 10.1038/sj.npp.1301281; Liu XQ, 2007, BIOL PSYCHIAT, V62, P81, DOI 10.1016/j.biopsych.2006.08.017; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Mamiya T, 2004, BIOL PHARM BULL, V27, P1041, DOI 10.1248/bpb.27.1041; Mamiya T, 1998, BRAIN RES, V783, P236, DOI 10.1016/S0006-8993(97)01406-6; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; MEIER E, 1987, NEUROTROPHIC ACTIVIT, P139; Miura M, 2007, J NEUROSCI, V27, P9721, DOI 10.1523/JNEUROSCI.2993-07.2007; Miyamoto Y, 2002, J NEUROSCI, V22, P2335, DOI 10.1523/JNEUROSCI.22-06-02335.2002; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Solberg LC, 2004, MAMM GENOME, V15, P648, DOI 10.1007/s00335-004-2326-z; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Suzuki T, 2001, MAMM GENOME, V12, P272, DOI 10.1007/s003350010280; Turri MG, 2001, CURR BIOL, V11, P725, DOI 10.1016/S0960-9822(01)00206-8; Ukai M, 2004, EUR J PHARMACOL, V492, P183, DOI 10.1016/j.ejphar.2004.03.066; Ukai M, 1998, PHARMACOL BIOCHEM BE, V61, P247, DOI 10.1016/S0091-3057(98)00093-8; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Yoshikawa T, 2002, GENOME RES, V12, P357, DOI 10.1101/gr.222602; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7	49	71	80	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					688	695		10.1038/ng.344	http://dx.doi.org/10.1038/ng.344			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19465912				2022-12-25	WOS:000266411700017
J	Hu, JX; Matsui, M; Gagnon, KT; Schwartz, JC; Gabillet, S; Arar, K; Wu, J; Bezprozvanny, I; Corey, DR				Hu, Jiaxin; Matsui, Masayuki; Gagnon, Keith T.; Schwartz, Jacob C.; Gabillet, Sylvie; Arar, Khalil; Wu, Jun; Bezprozvanny, Ilya; Corey, David R.			Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs	NATURE BIOTECHNOLOGY			English	Article							ANTISENSE OLIGONUCLEOTIDES; DISEASE; MOUSE; MODEL; INTERFERENCE; THERAPY	Expanded trinucleotide repeats(1) cause many neurological diseases. These include Machado-Joseph disease (MJD)(2) and Huntington's disease (HD)(3), which are caused by expanded CAG repeats within an allele of the ataxin-3 (ATXN3) and huntingtin (HTT) genes, respectively. Silencing expression of these genes is a promising therapeutic strategy, but indiscriminate inhibition of both the mutant and wild-type alleles may lead to toxicity, and allele-specific approaches have required polymorphisms that differ among individuals. We report that peptide nucleic acid and locked nucleic acid antisense oligomers that target CAG repeats can preferentially inhibit mutant ataxin-3 and HTT protein expression in cultured cells. Duplex RNAs were less selective than single-stranded oligomers. The activity of the peptide nucleic acids does not involve inhibition of transcription, and differences in mRNA secondary structure or the number of oligomer binding sites may be important. Antisense oligomers that discriminate between wild-type and mutant genes on the basis of repeat length may offer new options for developing treatments for MJD, HD and related hereditary diseases.	[Hu, Jiaxin; Matsui, Masayuki; Gagnon, Keith T.; Schwartz, Jacob C.; Corey, David R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol & Biochem, Dallas, TX 75390 USA; [Wu, Jun; Bezprozvanny, Ilya] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Gabillet, Sylvie; Arar, Khalil] SIGMA Aldrich Genopole Campus, Evry, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Merck KGaA; MilliporeSigma	Corey, DR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol & Biochem, Dallas, TX 75390 USA.	david.corey@utsouthwestern.edu	Schwartz, Jacob/J-6477-2012	Schwartz, Jacob/0000-0002-5205-564X	High-Q Foundation; US National Institutes of Health [NIGMS 60642, 73042]; NINDS [RO1NS056224]; NIBIB [EB 05556]; Welch Foundation [I-1244, I-1336]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB005556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073042, R01GM060642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056224] Funding Source: NIH RePORTER	High-Q Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the High-Q Foundation, the US National Institutes of Health (NIGMS 60642 and 73042 to D. R. C.; NINDS RO1NS056224 to I. B.; NIBIB EB 05556 to J. C. S.), and the Robert A. Welch Foundation (I-1244 and I-1336) and Ataxia MJD research project. We thank B. Janowski for helpful comments and Y. Li for help maintaining the YAC128 mouse colony.	Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Boado RJ, 2000, J PHARMACOL EXP THER, V295, P239; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Corey DR, 2007, NAT CHEM BIOL, V3, P8, DOI 10.1038/nchembio0107-8; COREY DR, 1995, J AM CHEM SOC, V117, P9373, DOI 10.1021/ja00141a038; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; De Souza EB, 2009, NEUROPSYCHOPHARMACOL, V34, P142, DOI 10.1038/npp.2008.115; Denovan-Wright EM, 2006, GENE THER, V13, P525, DOI 10.1038/sj.gt.3302664; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hu JX, 2007, BIOCHEMISTRY-US, V46, P7581, DOI 10.1021/bi700230a; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Knudsen H, 1996, NUCLEIC ACIDS RES, V24, P494, DOI 10.1093/nar/24.3.494; KOCH T, 2008, THERAPEUTIC OLIGONUC, P103; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Marin VL, 2005, J AM CHEM SOC, V127, P8032, DOI 10.1021/ja051102y; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 2007, SEMIN NEUROL, V27, P133, DOI 10.1055/s-2007-971172; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x	35	192	206	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2009	27	5					478	484		10.1038/nbt.1539	http://dx.doi.org/10.1038/nbt.1539			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	444KS	19412185	Green Accepted			2022-12-25	WOS:000265980500028
J	Renkawitz, J; Schumann, K; Weber, M; Lammermann, T; Pflicke, H; Piel, M; Polleux, J; Spatz, JP; Sixt, M				Renkawitz, Joerg; Schumann, Kathrin; Weber, Michele; Laemmermann, Tim; Pflicke, Holger; Piel, Matthieu; Polleux, Julien; Spatz, Joachim P.; Sixt, Michael			Adaptive force transmission in amoeboid cell migration	NATURE CELL BIOLOGY			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; RETROGRADE FLOW; DENDRITIC CELLS; LEADING-EDGE; F-ACTIN; GROWTH; LAMELLIPODIA; MECHANISMS; LOCOMOTION; MOTILITY	The leading front of a cell can either protrude as an actin-free membrane bleb that is inflated by actomyosin-driven contractile forces, or as an actin-rich pseudopodium, a site where polymerizing actin filaments push out the membrane(1-3). Pushing filaments can only cause the membrane to protrude if the expanding actin network experiences a retrograde counter-force, which is usually provided by transmembrane receptors of the integrin family(4). Here we show that chemotactic dendritic cells mechanically adapt to the adhesive properties of their substrate by switching between integrin-mediated and integrin-independent locomotion. We found that on engaging the integrin-actin clutch, actin polymerization was entirely turned into protrusion, whereas on disengagement actin underwent slippage and retrograde flow. Remarkably, accelerated retrograde flow was balanced by an increased actin polymerization rate; therefore, cell shape and protrusion velocity remained constant on alternating substrates. Due to this adaptive response in polymerization dynamics, tracks of adhesive substrate did not dictate the path of the cells. Instead, directional guidance was exclusively provided by a soluble gradient of chemoattractant, which endowed these 'amoeboid' cells with extraordinary flexibility, enabling them to traverse almost every type of tissue.	[Renkawitz, Joerg; Schumann, Kathrin; Weber, Michele; Laemmermann, Tim; Pflicke, Holger; Sixt, Michael] Max Planck Inst Biochem, Hofschneider Grp Leukocyte Migrat, D-82152 Martinsried, Germany; [Polleux, Julien] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Piel, Matthieu] Inst Curie, CNRS, UMR144, F-75231 Paris, France; [Polleux, Julien; Spatz, Joachim P.] Max Planck Inst Met Res, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany	Max Planck Society; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Max Planck Society	Sixt, M (corresponding author), Max Planck Inst Biochem, Hofschneider Grp Leukocyte Migrat, D-82152 Martinsried, Germany.	sixt@biochem.mpg.de	Renkawitz, Jörg/AAD-5932-2022; Spatz, Joachim P/A-1107-2017; Lämmermann, Tim/AAD-7453-2022; Schumann, Kathrin/HHZ-8041-2022; Sixt, Michael/F-3925-2010	Renkawitz, Jörg/0000-0003-2856-3369; Spatz, Joachim P/0000-0003-3419-9807; Weber, Michele/0000-0003-2056-3751; Sixt, Michael/0000-0002-6620-9179; Schumann, Kathrin/0000-0002-0993-3910	German Research Foundation; Peter Hans Hofschneider Foundation; Max Planck Society; Alexander von Humboldt Foundation	German Research Foundation(German Research Foundation (DFG)); Peter Hans Hofschneider Foundation; Max Planck Society(Max Planck Society); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank S. Cremer for statistical analysis, K. Hirsch for technical assistance, D. Critchley for talin1-deficient mice and R. F ssler for integrin-deficient mice, discussions and critical reading of the manuscript. This work was supported by the German Research Foundation, the Peter Hans Hofschneider Foundation for Experimental Biomedicine, the Max Planck Society, the Alexander von Humboldt Foundation and the allergology programme of the Landesstiftung Baden-Wurttemberg.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; HEIT B, 2003, SCI STKE, pPL5; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; KUCIK DF, 1991, J CELL BIOL, V114, P1029, DOI 10.1083/jcb.114.5.1029; KUCIK DF, 1990, J CELL BIOL, V111, P1617, DOI 10.1083/jcb.111.4.1617; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; LEE J, 1990, SCIENCE, V247, P1229, DOI 10.1126/science.2315695; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Malawista SE, 1997, P NATL ACAD SCI USA, V94, P11577, DOI 10.1073/pnas.94.21.11577; McGrath JL, 2003, CURR BIOL, V13, P329, DOI 10.1016/S0960-9822(03)00051-4; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; RUTHERFORD MS, 1992, J LEUKOCYTE BIOL, V51, P69, DOI 10.1002/jlb.51.1.69; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200	28	203	203	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1438	U121		10.1038/ncb1992	http://dx.doi.org/10.1038/ncb1992			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19915557	Green Published			2022-12-25	WOS:000272251300010
J	Ganesh, SK; Zakai, NA; van Rooij, FJA; Soranzo, N; Smith, AV; Nalls, MA; Chen, MH; Kottgen, A; Glazer, NL; Dehghan, A; Kuhnel, B; Aspelund, T; Yang, Q; Tanaka, T; Jaffe, A; Bis, JCM; Verwoert, GC; Teumer, A; Fox, CS; Guralnik, JM; Ehret, GB; Rice, K; Felix, JF; Rendon, A; Eiriksdottir, G; Levy, D; Patel, KV; Boerwinkle, E; Rotter, JI; Hofman, A; Sambrook, JG; Hernandez, DG; Zheng, G; Bandinelli, S; Singleton, AB; Coresh, J; Lumley, T; Uitterlinden, AG; vanGils, JM; Launer, LJ; Cupples, LA; Oostra, BA; Zwaginga, JJ; Ouwehand, WH; Thein, SL; Meisinger, C; Deloukas, P; Nauck, M; Spector, TD; Gieger, C; Gudnason, V; van Duijn, CM; Psaty, BM; Ferrucci, L; Chakravarti, A; Greinacher, A; O'Donnell, CJ; Witteman, JCM; Furth, S; Cushman, M; Harris, TB; Lin, JP				Ganesh, Santhi K.; Zakai, Neil A.; van Rooij, Frank J. A.; Soranzo, Nicole; Smith, Albert V.; Nalls, Michael A.; Chen, Ming-Huei; Kottgen, Anna; Glazer, Nicole L.; Dehghan, Abbas; Kuhnel, Brigitte; Aspelund, Thor; Yang, Qiong; Tanaka, Toshiko; Jaffe, Andrew; Bis, Joshua C. M.; Verwoert, Germaine C.; Teumer, Alexander; Fox, Caroline S.; Guralnik, Jack M.; Ehret, Georg B.; Rice, Kenneth; Felix, Janine F.; Rendon, Augusto; Eiriksdottir, Gudny; Levy, Daniel; Patel, Kushang V.; Boerwinkle, Eric; Rotter, Jerome I.; Hofman, Albert; Sambrook, Jennifer G.; Hernandez, Dena G.; Zheng, Gang; Bandinelli, Stefania; Singleton, Andrew B.; Coresh, Josef; Lumley, Thomas; Uitterlinden, Andre G.; vanGils, Janine M.; Launer, Lenore J.; Cupples, L. Adrienne; Oostra, Ben A.; Zwaginga, Jaap-Jan; Ouwehand, Willem H.; Thein, Swee-Lay; Meisinger, Christa; Deloukas, Panos; Nauck, Matthias; Spector, Tim D.; Gieger, Christian; Gudnason, Vilmundur; van Duijn, Cornelia M.; Psaty, Bruce M.; Ferrucci, Luigi; Chakravarti, Aravinda; Greinacher, Andreas; O'Donnell, Christopher J.; Witteman, Jacqueline C. M.; Furth, Susan; Cushman, Mary; Harris, Tamara B.; Lin, Jing-Ping			Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; HEMOGLOBIN CONCENTRATION; HEMOCHROMATOSIS GENE; HEREDITARY HEMOCHROMATOSIS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; FETAL-HEMOGLOBIN; CELIAC-DISEASE; C-MYB	Measurements of erythrocytes within the blood are important clinical traits and can indicate various hematological disorders. We report here genome-wide association studies (GWAS) for six erythrocyte traits, including hemoglobin concentration (Hb), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and red blood cell count (RBC). We performed an initial GWAS in cohorts of the CHARGE Consortium totaling 24,167 individuals of European ancestry and replication in additional independent cohorts of the HaemGen Consortium totaling 9,456 individuals. We identified 23 loci significantly associated with these traits in a meta-analysis of the discovery and replication cohorts (combined P values ranging from 5 x 10(-8) to 7 x 10(-86)). Our findings include loci previously associated with these traits (HBS1L-MYB, HFE, TMPRSS6, TFR2, SPTA1) as well as new associations (EPO, TFRC, SH2B3 and 15 other loci). This study has identified new determinants of erythrocyte traits, offering insight into common variants underlying variation in erythrocyte measures.	[Ganesh, Santhi K.] NHGRI, Div Intramural Res, Bethesda, MD 20892 USA; [Ganesh, Santhi K.; Fox, Caroline S.; Levy, Daniel] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [Ganesh, Santhi K.; Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Zakai, Neil A.; Cushman, Mary] Univ Vermont, Dept Med, Burlington, VT USA; [Zakai, Neil A.; Cushman, Mary] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [van Rooij, Frank J. A.; Dehghan, Abbas; Verwoert, Germaine C.; Felix, Janine F.; Hofman, Albert; Uitterlinden, Andre G.; Oostra, Ben A.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Rooij, Frank J. A.; Dehghan, Abbas; Verwoert, Germaine C.; Felix, Janine F.; Hofman, Albert; Uitterlinden, Andre G.; Oostra, Ben A.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] NCHA, NGI, Leiden, Netherlands; [Soranzo, Nicole; Ouwehand, Willem H.; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Soranzo, Nicole; Cupples, L. Adrienne; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Smith, Albert V.; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Hernandez, Dena G.] NIA, Intramural Res Program, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Chen, Ming-Huei; Yang, Qiong; Fox, Caroline S.; Levy, Daniel; Cupples, L. Adrienne; O'Donnell, Christopher J.] NHLBIs Framingham Heart Study, Framingham, MA USA; [Chen, Ming-Huei] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Kottgen, Anna; Jaffe, Andrew; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Glazer, Nicole L.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Glazer, Nicole L.; Bis, Joshua C. M.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Kuhnel, Brigitte; Meisinger, Christa; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA; [Tanaka, Toshiko] MedStar Res Inst, Hyattsville, MD USA; [Verwoert, Germaine C.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Guralnik, Jack M.; Patel, Kushang V.; Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Ehret, Georg B.] Univ Hosp Geneva, Ctr Cardiol, Geneva, Switzerland; [Rice, Kenneth; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rendon, Augusto; Sambrook, Jennifer G.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Rendon, Augusto; Sambrook, Jennifer G.; Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Zheng, Gang; Lin, Jing-Ping] NHLBI, Off Biostat Res, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Bandinelli, Stefania] Geriatr Unit ASF, Florence, Italy; [Uitterlinden, Andre G.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Zwaginga, Jaap-Jan] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Zwaginga, Jaap-Jan] Sanquin Res, Dept Expt Immunohematol, Amsterdam, Netherlands; [Thein, Swee-Lay] Kings Coll London, Dept Haematol, London WC2R 2LS, England; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Klin Chem & Lab Med, Greifswald, Germany; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA; [Greinacher, Andreas] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Furth, Susan] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of Vermont; University of Vermont; Erasmus University Rotterdam; Erasmus MC; Wellcome Trust Sanger Institute; University of London; King's College London; Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Framingham Heart Study; Boston University; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Iceland; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam; Erasmus MC; Ernst Moritz Arndt Universitat Greifswald; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Geneva; University of Washington; University of Washington Seattle; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Texas System; University of Texas Health Science Center Houston; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; Ernst Moritz Arndt Universitat Greifswald; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Ernst Moritz Arndt Universitat Greifswald; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Medicine	Ganesh, SK (corresponding author), NHGRI, Div Intramural Res, Bethesda, MD 20892 USA.	ganeshs@mail.nih.gov; odonnellc@mail.nih.gov	Levy, Daniel/ABB-2752-2021; Dehghan, Abbas/ABE-7377-2020; Kottgen, Anna/D-2920-2012; Rice, Kenneth M/A-4150-2013; Rotter, Jerome/AAY-6598-2021; bandinelli, stefania/AAL-4570-2020; Jaffe, Andrew/GPF-5693-2022; EHRET, Georg B/A-9532-2009; Teumer, Alexander/S-7438-2019; Meisinger, Christine/B-5358-2014; Singleton, Andrew B/C-3010-2009; Aspelund, Thor/K-7022-2019; Aspelund, Thor/F-4826-2011; Spector, Tim D/F-6533-2012; Launer, Lenore J/A-8218-2010; Deloukas, Panos/B-2922-2013; van Rooij, Frank/AAI-3997-2020; Gudnason, Vilmundur/K-6885-2015; Yang, Qiong/G-5438-2014; Levy, Daniel/ABF-6873-2021; Aspelund, Thor/C-5983-2008; Smith, Albert Vernon/K-5150-2015; Gudnason, Vilmundur/AAE-7126-2019; Dehghan, Abbas/B-9896-2008	Rice, Kenneth M/0000-0001-5779-4495; Jaffe, Andrew/0000-0001-6886-1454; EHRET, Georg B/0000-0002-5730-0675; Teumer, Alexander/0000-0002-8309-094X; Aspelund, Thor/0000-0002-7998-5433; Deloukas, Panos/0000-0001-9251-070X; van Rooij, Frank/0000-0002-8600-9852; Gudnason, Vilmundur/0000-0001-5696-0084; Levy, Daniel/0000-0003-1843-8724; Aspelund, Thor/0000-0002-7998-5433; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Rendon, Augusto/0000-0001-8994-0039; Glazer, Nicole/0000-0002-6397-609X; Gieger, Christian/0000-0001-6986-9554; Cupples, L. Adrienne/0000-0003-0273-7965; Felix, Janine/0000-0002-9801-5774; van Gils, Janine/0000-0003-2429-7462; Chen, Ming-Huei/0000-0003-3551-8726; Dehghan, Abbas/0000-0001-6403-016X; Meisinger, Christa/0000-0002-9026-6544; Van Duijn, Cornelia/0000-0002-2374-9204; Soranzo, Nicole/0000-0003-1095-3852	Medical Research Council [G0000111] Funding Source: Medline; NHLBI NIH HHS [R01 HL086694-02, R01 HL086694-03, R01 HL086694-01A1, R01 HL086694] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491-039004, P30 DK063491, P30 DK063491-029004, P30 DK063491-019004, K24 DK078737, P30 DK063491-05, P30 DK063491-049004, U01 DK066174] Funding Source: Medline; MRC [G0000111] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001, R01HL086694, ZIAHL006094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK078737, U01DK066174, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000, ZIAAG001050] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; de Simone G, 2005, HYPERTENSION, V45, P625, DOI 10.1161/01.HYP.0000157526.07977.ec; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; ELWOOD PC, 1974, LANCET, V1, P891; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; GAGNON DR, 1994, AM HEART J, V127, P674, DOI 10.1016/0002-8703(94)90679-3; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HAMOSH A, ONLINE MENDELIAN INH; HAVLIK RJ, 1980, CIRCULATION, V61, P710, DOI 10.1161/01.CIR.61.4.710; Higgs DR, 2008, P NATL ACAD SCI USA, V105, P11595, DOI 10.1073/pnas.0806633105; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Iliadou A, 2007, J MED GENET, V44, P24, DOI 10.1136/jmg.2006.043521; Jongmans M, 2005, AM J MED GENET A, V134A, P165, DOI 10.1002/ajmg.a.30598; Kalidas K, 2005, J HUM GENET, V50, P21, DOI 10.1007/s10038-004-0212-x; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; LETCHER RL, 1983, HYPERTENSION, V5, P757, DOI 10.1161/01.HYP.5.5.757; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lin JP, 2007, AM J HEMATOL, V82, P605, DOI 10.1002/ajh.20868; Lin JP, 2005, J MED GENET, V42, P75, DOI 10.1136/jmg.2004.021097; MARCHESI SL, 1987, J CLIN INVEST, V80, P191, DOI 10.1172/JCI113047; Martins PD, 2007, ARTERIOSCL THROM VAS, V27, P1023, DOI 10.1161/ATVBAHA.107.140442; McLaren CE, 2007, AM J HEMATOL, V82, P898, DOI 10.1002/ajh.20937; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; OTT EO, 1974, STROKE, V5, P330, DOI 10.1161/01.STR.5.3.330; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Roest M, 1999, CIRCULATION, V100, P1268, DOI 10.1161/01.CIR.100.12.1268; Roetto A, 2002, BLOOD CELL MOL DIS, V29, P465, DOI 10.1006/bcmd.2002.0585; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sharp DS, 1996, CIRCULATION, V93, P1677, DOI 10.1161/01.CIR.93.9.1677; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Swinkels DW, 2008, NEPHROL DIAL TRANSPL, V23, P250, DOI 10.1093/ndt/gfn267; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; TELL GS, 1994, HYPERTENSION, V23, P59, DOI 10.1161/01.HYP.23.1.59; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tong ZZ, 2008, P NATL ACAD SCI USA, V105, P6998, DOI 10.1073/pnas.0800454105; Tuomainen TP, 1999, CIRCULATION, V100, P1274, DOI 10.1161/01.CIR.100.12.1274; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; WANNAMETHEE G, 1994, THROMB HAEMOSTASIS, V72, P58; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; WELLS RE, 1962, J CLIN INVEST, V41, P1591, DOI 10.1172/JCI104617; WHITFIELD J B, 1985, Genetic Epidemiology, V2, P133, DOI 10.1002/gepi.1370020204; Yang XL, 2007, J TURBUL, V8, P1, DOI 10.1080/14685240701194107; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zeng S M, 2001, J Gend Specif Med, V4, P35; Zeng She Min, 2003, J Gend Specif Med, V6, P36	65	280	287	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1191	U48		10.1038/ng.466	http://dx.doi.org/10.1038/ng.466			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19862010	Green Submitted, Green Accepted			2022-12-25	WOS:000271247600011
J	Lawson, C				Lawson, Charles			The role of patents in biodiversity conservation	NATURE BIOTECHNOLOGY			English	Editorial Material								Patents may not establish clear property and use rights and this may promote biodiversity destruction and decline. What is needed are schemes for patents to suit conservation and sustainable-use objectives.	Griffith Univ, Griffith Law Sch, Australian Ctr Intellectual Property Agr, Parkwood, Qld, Australia	Griffith University	Lawson, C (corresponding author), Griffith Univ, Griffith Law Sch, Australian Ctr Intellectual Property Agr, Gold Coast Campus, Parkwood, Qld, Australia.	c.lawson@griffith.edu.au						Janssen J, 1999, GLOBAL ENVIRON CHANG, V9, P313, DOI 10.1016/S0959-3780(99)00025-4; Lawson Charles, 2004, PROMETHEUS, V22, P355; *ORG EC COOP DEV, 1994, MAN ENV ROL EC INSTR, P73; Organisation for Economic Co-operation and Development, 2003, HARN MARK BIOD CONS, p[18, 109]; *SECR CONV BIOL DI, 1993, UN TREAT SER; *WORLD TRAD ORG, 1929, AGR TRAD REL ASP INT; 2002, 6 M C PART CONV BIOL, P60	7	6	6	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2009	27	11					994	996		10.1038/nbt1109-994	http://dx.doi.org/10.1038/nbt1109-994			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	516EM	19898449	Green Published			2022-12-25	WOS:000271524700016
J	Mullighan, CG; Collins-Underwood, JR; Phillips, LAA; Loudin, MG; Liu, W; Zhang, JH; Ma, J; Coustan-Smith, E; Harvey, RC; Willman, CL; Mikhail, FM; Meyer, J; Carroll, AJ; Williams, RT; Cheng, JJ; Heerema, NA; Basso, G; Pession, A; Pui, CH; Raimondi, SC; Hunger, SP; Downing, JR; Carroll, WL; Rabin, KR				Mullighan, Charles G.; Collins-Underwood, J. Racquel; Phillips, Letha A. A.; Loudin, Michael G.; Liu, Wei; Zhang, Jinghui; Ma, Jing; Coustan-Smith, Elaine; Harvey, Richard C.; Willman, Cheryl L.; Mikhail, Fady M.; Meyer, Julia; Carroll, Andrew J.; Williams, Richard T.; Cheng, Jinjun; Heerema, Nyla A.; Basso, Giuseppe; Pession, Andrea; Pui, Ching-Hon; Raimondi, Susana C.; Hunger, Stephen P.; Downing, James R.; Carroll, William L.; Rabin, Karen R.			Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia	NATURE GENETICS			English	Article							THYMIC STROMAL LYMPHOPOIETIN; DOWN-SYNDROME; CELL DEVELOPMENT; COMPETING RISK; MUTATIONS; RECEPTOR; GENE; JAK2; EXPRESSION; CYTOKINE	Aneuploidy and translocations are hallmarks of B-progenitor acute lymphoblastic leukemia (ALL), but many individuals with this cancer lack recurring chromosomal alterations. Here we report a recurring interstitial deletion of the pseudoautosomal region 1 of chromosomes X and Y in B-progenitor ALL that juxtaposes the first, noncoding exon of P2RY8 with the coding region of CRLF2. We identified the P2RY8-CRLF2 fusion in 7% of individuals with B-progenitor ALL and 53% of individuals with ALL associated with Down syndrome. CRLF2 alteration was associated with activating JAK mutations, and expression of human P2RY8-CRLF2 together with mutated mouse Jak2 resulted in constitutive Jak-Stat activation and cytokine-independent growth of Ba/F3 cells overexpressing interleukin-7 receptor alpha. Our findings indicate that these two genetic lesions together contribute to leukemogenesis in B-progenitor ALL.	[Mullighan, Charles G.; Collins-Underwood, J. Racquel; Phillips, Letha A. A.; Cheng, Jinjun; Raimondi, Susana C.; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Loudin, Michael G.; Rabin, Karen R.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Liu, Wei] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Zhang, Jinghui] NCI, Ctr Biomed Informat & Informat Technol, NIH, Rockville, MD USA; [Ma, Jing] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Coustan-Smith, Elaine; Williams, Richard T.; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Harvey, Richard C.; Willman, Cheryl L.] Univ New Mexico, Canc Res Facil, Univ New Mexico Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Mikhail, Fady M.; Carroll, Andrew J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Meyer, Julia; Carroll, William L.] NYU, New York Univ Canc Inst, Langone Med Ctr, New York, NY USA; [Heerema, Nyla A.] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Dept Pathol, Columbus, OH 43210 USA; [Basso, Giuseppe] Univ Padua, Dept Pediat, Padua, Italy; [Pession, Andrea] Univ Bologna, Dept Pediat, Hematol & Oncol Unit Lalla Seragnoli, Bologna, Italy; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Childrens Hosp, Sect Pediat Hematol Oncol & Bone Marrow Transplan, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Childrens Hosp, Ctr Canc & Blood Disorders, Aurora, CO USA	St Jude Children's Research Hospital; Baylor College of Medicine; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of New Mexico; University of Alabama System; University of Alabama Birmingham; New York University; NYU Langone Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Padua; University of Bologna; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Mullighan, CG (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.mullighan@stjude.org	Zhang, Jing/HII-4294-2022; Zhang, Jing/GWZ-7332-2022; Pession, Andrea/O-3200-2013; Mullighan, Charles/H-3253-2011; Raimondi, Susana C/N-8166-2018; Downing, James R./N-8102-2018; Meyer, Julia/ABD-4452-2021; Pui, Ching-Hon/N-8076-2018	Pession, Andrea/0000-0002-0379-9562; Mullighan, Charles/0000-0002-1871-1850; Pui, Ching-Hon/0000-0003-0303-5658; BASSO, GIUSEPPE/0000-0002-2634-9302; Harvey, Richard/0000-0002-4904-9767	National Cancer Institute Cancer Center [P30 CA021765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; a Bear Necessities Pediatric Research Foundation; Children's Cancer Research Foundation; National Institutes of Health [CA90433-06]; NATIONAL CANCER INSTITUTE [K12CA090433, U10CA098543, U01CA157937, U10CA098413, P30CA021765] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); a Bear Necessities Pediatric Research Foundation; Children's Cancer Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Wang and D. Naeve (Functional Genomics Laboratory, Hartwell Center, St. Jude Children's Research Hospital) for conducting array-CGH analysis; E. Walker and J. Morris (CACT Laboratory, Hartwell Center) for conducting SNP microarrays; S. Tate, J. Armstrong and K. Rakestraw (St. Jude Hartwell Center Sequencing Core) for conducting sequencing; the St. Jude Flow Cytometry Core; John Gray and the St. Jude Vector Core for lentiviral reagents and methods; the St. Jude Tissue Resources Laboratory for providing primary patient samples; S. Nutt for providing the MSCV-mIL7R-IRES-hCD4 retroviral vector; G. P. Nolan, Stanford University, for the Eco Phoenix packaging cells (http://www.stanford.edu/group/nolan); and M. Smith and K. Dobbin for gene expression studies of CRLF2. This work was supported by National Cancer Institute Cancer Center Support Grant P30 CA021765, the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital, a Bear Necessities Pediatric Research Foundation grant (to K. R. R.), a Children's Cancer Research Foundation grant (to K. R. R.) and National Institutes of Health Pediatric Oncology Clinical Research Training Grant CA90433-06 (to K. R. R.).	Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Forestier E, 2008, BLOOD, V111, P1575, DOI 10.1182/blood-2007-09-114231; Fujiwara SI, 2007, LEUKEMIA LYMPHOMA, V48, P978, DOI 10.1080/10428190701225882; Gaikwad A, 2009, BRIT J HAEMATOL, V144, P930, DOI 10.1111/j.1365-2141.2008.07552.x; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Kearney L, 2009, BLOOD, V113, P646, DOI 10.1182/blood-2008-08-170928; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Parrish YK, 2009, J IMMUNOL, V182, P4255, DOI 10.4049/jimmunol.0800489; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pounds S, 2009, BIOINFORMATICS, V25, P315, DOI 10.1093/bioinformatics/btn624; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rochman Y, 2008, CURR OPIN PHARMACOL, V8, P249, DOI 10.1016/j.coph.2008.03.002; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storlazzi CT, 2007, LEUKEMIA, V21, P2221, DOI 10.1038/sj.leu.2404784; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Whitlock JA, 2006, BRIT J HAEMATOL, V135, P595, DOI 10.1111/j.1365-2141.2006.06337.x; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	33	414	422	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1243	U111		10.1038/ng.469	http://dx.doi.org/10.1038/ng.469			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19838194	Green Accepted			2022-12-25	WOS:000271247600019
J	Bumpus, SB; Evans, BS; Thomas, PM; Ntai, I; Kelleher, NL				Bumpus, Stefanie B.; Evans, Bradley S.; Thomas, Paul M.; Ntai, Ioanna; Kelleher, Neil L.			A proteomics approach to discovering natural products and their biosynthetic pathways	NATURE BIOTECHNOLOGY			English	Article							TANDEM MASS-SPECTROMETRY; ADENYLATION DOMAINS; BACILLUS-CEREUS; CARRIER DOMAINS; GENE-CLUSTER; POLYKETIDE; ZWITTERMICIN; SYNTHETASES; SEQUENCE; PROTEIN	Many natural products with antibiotic, anticancer and antifungal properties are synthesized by nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs)(1). Although genome sequencing has revealed the diversity of these enzymes, identifying new products and their biosynthetic pathways remains challenging(2). By taking advantage of the size of these enzymes (often > 2,000 amino acids) and unique marker ions derived from their common phosphopantetheinyl cofactor, we adapted mass spectrometry-based proteomics to selectively detect NRPS and PKS gene clusters in microbial proteomes without requiring genome sequence information. We detected known NRPS systems in members of the genera Bacillus and Streptomyces, and screened 22 environmental isolates to uncover production of unknown natural products from the hybrid NRPS-PKS zwittermicin A biosynthetic gene cluster(3). We also discovered an NRPS cluster that generates a seven-residue lipopeptide. This 'protein-first' strategy complements bioassay- and sequence-based approaches by finding expressed gene clusters that produce new natural products.	[Bumpus, Stefanie B.; Thomas, Paul M.; Ntai, Ioanna; Kelleher, Neil L.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Evans, Bradley S.; Kelleher, Neil L.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Bumpus, Stefanie B.; Evans, Bradley S.; Thomas, Paul M.; Ntai, Ioanna; Kelleher, Neil L.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kelleher, NL (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	kelleher@scs.uiuc.edu	Thomas, Paul M/A-6233-2011; Ntai, Ioanna/G-2697-2012; Evans, Bradley S/M-2842-2013	Thomas, Paul M/0000-0003-2887-4765; Evans, Bradley S/0000-0002-1207-9006	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM077596, R01GM067725] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM 077596-03, R01 GM067725-07, R01 GM067725, P01 GM077596, P01 GM077596-030004, R01 GM 067725-07] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Brakhage Axel A., 2008, V66; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Dorrestein PC, 2006, NAT PROD REP, V23, P893, DOI 10.1039/b511400b; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Hathout Y, 2000, J NAT PROD, V63, P1492, DOI 10.1021/np000169q; Kevany BM, 2009, APPL ENVIRON MICROB, V75, P1144, DOI 10.1128/AEM.02518-08; Knappe TA, 2008, J AM CHEM SOC, V130, P11446, DOI 10.1021/ja802966g; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; MATTEO CC, 1975, BIOTECHNOL BIOENG, V17, P129, DOI 10.1002/bit.260170111; Meier JL, 2008, J AM CHEM SOC, V130, P5443, DOI 10.1021/ja711263w; Meluzzi D, 2008, BIOORG MED CHEM LETT, V18, P3107, DOI 10.1016/j.bmcl.2007.10.104; Mercer AC, 2007, NAT PROD REP, V24, P750, DOI 10.1039/b603921a; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; Rogers EW, 2008, ANGEW CHEM INT EDIT, V47, P8086, DOI 10.1002/anie.200801561; Schley C, 2006, J PROTEOME RES, V5, P2760, DOI 10.1021/pr0602489; Silo-Suh LA, 1998, CURR MICROBIOL, V37, P6; STEIN T, 1994, FEBS LETT, V340, P39, DOI 10.1016/0014-5793(94)80169-X; Steller S, 2004, BIOCHEMISTRY-US, V43, P11331, DOI 10.1021/bi0493416; TRAVERS RS, 1987, APPL ENVIRON MICROB, V53, P1263, DOI 10.1128/AEM.53.6.1263-1266.1987; Weinstein M. J., 1978, ANTIBIOTICS ISOLATIO; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784; Zerikly M, 2009, CHEMBIOCHEM, V10, P625, DOI 10.1002/cbic.200800389	31	106	109	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2009	27	10					951	U120		10.1038/nbt.1565	http://dx.doi.org/10.1038/nbt.1565			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	515LO	19767731	Green Accepted			2022-12-25	WOS:000271472500027
J	del Zoppo, GJ				del Zoppo, Gregory J.			Bleeding in the brain Amyloid-beta may keep clots away	NATURE MEDICINE			English	Editorial Material							SERINE PROTEINASE-INHIBITORS; PROTEASE NEXIN-II; PRECURSOR; COAGULATION; ISCHEMIA		Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	del Zoppo, GJ (corresponding author), Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA.	grgdlzop@u.washington.edu			NINDS NIH HHS [R37 NS038710, R37 NS038710-09, R01 NS053716-05, R01 NS053716] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038710, R01NS053716] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; CORRALRODRIGUEZ MA, 2009, INSECT BIOCHEM MOLEC, V39, P1; Milner R, 2008, STROKE, V39, P191, DOI 10.1161/STROKEAHA.107.486134; OKADA Y, 1994, STROKE, V25, P1847, DOI 10.1161/01.STR.25.9.1847; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; SCHMAIER AH, 1993, J CLIN INVEST, V92, P2540, DOI 10.1172/JCI116863; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Tagaya M, 2001, J CEREBR BLOOD F MET, V21, P835, DOI 10.1097/00004647-200107000-00009; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; VANNOSTRAND WE, 1989, NATURE, V341, P546; Xu F, 2007, STROKE, V38, P2598, DOI 10.1161/STROKEAHA.106.480103; Xu F, 2009, J NEUROSCI, V29, P5666, DOI 10.1523/JNEUROSCI.0095-09.2009	12	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1132	1133		10.1038/nm1009-1132	http://dx.doi.org/10.1038/nm1009-1132			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19812571	Green Accepted			2022-12-25	WOS:000270596400021
J	Kim, TW; Guan, SH; Sun, Y; Deng, ZP; Tang, WQ; Shang, JX; Sun, Y; Burlingame, AL; Wang, ZY				Kim, Tae-Wuk; Guan, Shenheng; Sun, Yu; Deng, Zhiping; Tang, Wenqiang; Shang, Jian-Xiu; Sun, Ying; Burlingame, Alma L.; Wang, Zhi-Yong			Brassinosteroid signal transduction from cell-surface receptor kinases to nuclear transcription factors	NATURE CELL BIOLOGY			English	Article							TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; PROTEIN-KINASE; PLANT-GROWTH; ARABIDOPSIS; BRI1; BZR1; FAMILY; GSK3; MECHANISMS	Brassinosteroid (BR) regulates gene expression and plant development through a receptor kinase-mediated signal transduction pathway(1). Despite the identification of many components of this pathway, it remains unclear how the BR signal is transduced from the cell surface to the nucleus(2). Here we describe a complete BR signalling pathway by elucidating key missing steps. We show that phosphorylation of BSK1 (BR-signalling kinase 1) by the BR receptor kinase BRI1 (BR-insensitive 1) promotes BSK1 binding to the BSU1 (BRI1 suppressor 1) phosphatase, and BSU1 inactivates the GSK3-like kinase BIN2 (BR-insensitive 2) by dephosphorylating a conserved phospho-tyrosine residue (pTyr 200). Mutations that affect phosphorylation/dephosphorylation of BIN2 pTyr200 (bin2-1, bin2-Y200F and quadruple loss-of-function of BSU1-related phosphatases) support an essential role for BSU1-mediated BIN2 dephosphorylation in BR-dependent plant growth. These results demonstrate direct sequential BR activation of BRI1, BSK1 and BSU1, and inactivation of BIN2, leading to accumulation of unphosphorylated BZR (brassinazole resistant) transcription factors in the nucleus. This study establishes a fully connected BR signalling pathway and provides new insights into the mechanism of GSK3 regulation.	[Kim, Tae-Wuk; Sun, Yu; Deng, Zhiping; Tang, Wenqiang; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Guan, Shenheng; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Shang, Jian-Xiu; Sun, Ying] Hebei Normal Univ, Inst Mol Cell Biol, Shijiazhuang 050016, Hebei, Peoples R China	Carnegie Institution for Science; University of California System; University of California San Francisco; Hebei Normal University	Wang, ZY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; Tang, Wenqiang/0000-0002-2972-5748; Deng, zhiping/0000-0001-9663-3088	NIH [R01GM066258]; National Science Foundation [0724688]; US Department of Energy [DE-FG02-08ER15973]; Herman Frasch Foundation; National Center for Research Resources; NIH NCRR [RR01614, RR012961, RR019934]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019934, S10RR012961, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Herman Frasch Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Chory for providing the bsu1-D seeds and BSU1 cDNA clone and D. Bhaya and K. Barton for comments on the manuscript. Research was supported by grants from NIH (R01GM066258), the National Science Foundation (0724688), the US Department of Energy (DE-FG02-08ER15973) and the Herman Frasch Foundation. The UCSF Mass Spectrometry Facility is supported by the Biomedical Research Technology Program of the National Center for Research Resources, NIH NCRR (RR01614, RR012961 and RR019934).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BELKHADIR Y, 2006, SCI STKE, pCM5; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Deng ZP, 2007, MOL CELL PROTEOMICS, V6, P2058, DOI 10.1074/mcp.M700123-MCP200; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Johnson KL, 2005, CURR OPIN PLANT BIOL, V8, P648, DOI 10.1016/j.pbi.2005.09.007; Kim L, 2002, DEV CELL, V3, P523, DOI 10.1016/S1534-5807(02)00269-1; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; MacKintosh C, 1996, FEBS LETT, V397, P235, DOI 10.1016/S0014-5793(96)01175-1; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Peng P, 2008, MOL PLANT, V1, P338, DOI 10.1093/mp/ssn001; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, P NATL ACAD SCI USA, V99, P10191, DOI 10.1073/pnas.152337599; Zhou A, 2004, PLANT J, V40, P399, DOI 10.1111/j.1365-313X.2004.02214.x	40	441	470	12	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1254	U233		10.1038/ncb1970	http://dx.doi.org/10.1038/ncb1970			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19734888	Green Accepted			2022-12-25	WOS:000270382000016
J	Ishihara, N; Nomura, M; Jofuku, A; Kato, H; Suzuki, SO; Masuda, K; Otera, H; Nakanishi, Y; Nonaka, I; Goto, YI; Taguchi, N; Morinaga, H; Maeda, M; Takayanagi, R; Yokota, S; Mihara, K				Ishihara, Naotada; Nomura, Masatoshi; Jofuku, Akihiro; Kato, Hiroki; Suzuki, Satoshi O.; Masuda, Keiji; Otera, Hidenori; Nakanishi, Yae; Nonaka, Ikuya; Goto, Yu-ichi; Taguchi, Naoko; Morinaga, Hidetaka; Maeda, Maki; Takayanagi, Ryoichi; Yokota, Sadaki; Mihara, Katsuyoshi			Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice	NATURE CELL BIOLOGY			English	Article							DYNAMIN-RELATED PROTEIN; CYTOCHROME-C RELEASE; FUSION; OPA1; MORPHOLOGY; MEMBRANE; DIVISION; GTPASE; IDENTIFICATION; REVEALS	Mitochondrial morphology is dynamically controlled by a balance between fusion and fission. The physiological importance of mitochondrial fission in vertebrates is less clearly defined than that of mitochondrial fusion. Here we show that mice lacking the mitochondrial fission GTPase Drp1 have developmental abnormalities, particularly in the forebrain, and die after embryonic day 12.5. Neural cell-specific (NS) Drp1(-/-) mice die shortly after birth as a result of brain hypoplasia with apoptosis. Primary culture of NS-Drp1(-/-) mouse forebrain showed a decreased number of neurites and defective synapse formation, thought to be due to aggregated mitochondria that failed to distribute properly within the cell processes. These defects were reflected by abnormal forebrain development and highlight the importance of Drp1-dependent mitochondrial fission within highly polarized cells such as neurons. Moreover, Drp1(-/-) murine embryonic fibroblasts and embryonic stem cells revealed that Drp1 is required for a normal rate of cytochrome c release and caspase activation during apoptosis, although mitochondrial outer membrane permeabilization, as examined by the release of Smac/Diablo and Tim8a, may occur independently of Drp1 activity.	[Jofuku, Akihiro; Kato, Hiroki; Otera, Hidenori; Mihara, Katsuyoshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; [Ishihara, Naotada; Maeda, Maki] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Nomura, Masatoshi; Nakanishi, Yae; Morinaga, Hidetaka; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Suzuki, Satoshi O.] Kyushu Univ, Grad Sch Med Sci, Dept Neuropathol, Fukuoka 8128582, Japan; [Masuda, Keiji] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Fukuoka 8128582, Japan; [Nonaka, Ikuya; Goto, Yu-ichi] Natl Inst Neurosci, Dept Mental Retardat & Birth Dev Res, Kodaira, Tokyo 1878502, Japan; [Taguchi, Naoko] Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Yokota, Sadaki] Nagasaki Int Univ, Sasebo 8593298, Japan	Kyushu University; Tokyo Medical & Dental University (TMDU); Kyushu University; Kyushu University; Kyushu University; National Center for Neurology & Psychiatry - Japan; Osaka University; Nagasaki International University	Mihara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan.	mihara@cell.med.kyushu-u.ac.jp	Kato, Hiroki/N-3495-2019; Suzuki, Satoshi O/H-8367-2019; Kato, Hiroki/L-2346-2013	Kato, Hiroki/0000-0002-6529-659X; Suzuki, Satoshi O/0000-0002-0742-5680; Kato, Hiroki/0000-0002-3292-2160; Ishihara, Naotada/0000-0002-6305-7149	Ministry of Education, Science, and Culture of Japan; Human Frontier Science Program; Core Research from Evolutional Science and Technology; Takeda Science Foundation	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Core Research from Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Dr Toshihiko Oka, Dr Noboru Mizushima, Dr Akira Kondo and members of the Mihara laboratory for productive discussions. We also thank Dr Richard Youle and Dr Atsushi Tanaka for critical reading of the manuscript and for advice. This work was supported by grants from the Ministry of Education, Science, and Culture of Japan, from the Human Frontier Science Program, from Core Research from Evolutional Science and Technology, and from the Takeda Science Foundation.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kato H, 2006, J CELL SCI, V119, P2342, DOI 10.1242/jcs.02951; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; KOPPENOL WH, 1978, BIOCHIM BIOPHYS ACTA, V503, P499, DOI 10.1016/0005-2728(78)90149-4; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Uesaka N, 2007, J NEUROSCI, V27, P5215, DOI 10.1523/JNEUROSCI.4685-06.2007; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	54	709	730	5	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					958	U114		10.1038/ncb1907	http://dx.doi.org/10.1038/ncb1907			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19578372				2022-12-25	WOS:000268593200009
J	Korpal, M; Yan, J; Lu, X; Xu, SW; Lerit, DA; Kang, YB				Korpal, Manav; Yan, Jun; Lu, Xin; Xu, Shuwa; Lerit, Dorothy A.; Kang, Yibin			Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis	NATURE MEDICINE			English	Article							RECEPTOR-TYPE-I; TGF-BETA; ORAL IBANDRONATE; TUMOR; DISEASE; CELLS; VIVO; INHIBITORS; MICE; BISPHOSPHONATES	Although the transforming growth factor-beta (TGF-beta) pathway has been implicated in breast cancer metastasis, its in vivo dynamics and temporal-spatial involvement in organ-specific metastasis have not been investigated. Here we engineered a xenograft model system with a conditional control of the TGF-beta-SMAD signaling pathway and a dual-luciferase reporter system for tracing both metastatic burden and TGF-beta signaling activity in vivo. Strong TGF-beta signaling in osteolytic bone lesions is suppressed directly by genetic and pharmacological disruption of the TGF-beta-SMAD pathway and indirectly by inhibition of osteoclast function with bisphosphonates. Notably, disruption of TGF-beta signaling early in metastasis can substantially reduce metastasis burden but becomes less effective when bone lesions are well established. Our in vivo system for real-time manipulation and detection of TGF-beta signaling provides a proof of principle for using similar strategies to analyze the in vivo dynamics of other metastasis-associated signaling pathways and will expedite the development and characterization of therapeutic agents.	[Korpal, Manav; Yan, Jun; Lu, Xin; Xu, Shuwa; Lerit, Dorothy A.; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kang, Yibin] Canc Inst New Jersey, Breast Canc Program, New Brunswick, NJ USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ykang@princeton.edu	lu, xuemin/A-8741-2011	Kang, Yibin/0000-0002-1626-6730; Yan, Jun/0000-0002-5641-5710	Department of Defense Era of Hope Scholar Award; American Cancer Society; Susan G. Komen Foundation; New Jersey Commission on Cancer Research; Department of Defense Breast Cancer Research Program.	Department of Defense Era of Hope Scholar Award(United States Department of Defense); American Cancer Society(American Cancer Society); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); New Jersey Commission on Cancer Research; Department of Defense Breast Cancer Research Program.(United States Department of Defense)	We thank members of the Kang laboratory for insightful discussions and technical suggestions, J. Yingling (Eli Lilly and Company) for the TGF-beta receptor I kinase inhibitor and suggestions for the manuscript, S. Gambhir (Stanford University) for triple-reporter plasmids, R. Agami (The Netherlands Cancer Institute) for pRS-GFP, T. Guise and K. Mohammad for technical advice in bone histology and G. Hu for statistical support. Y. K. is a Champalimaud Investigator funded by a Department of Defense Era of Hope Scholar Award and grants from the American Cancer Society, the Susan G. Komen Foundation and the New Jersey Commission on Cancer Research. M. K. is supported by a predoctoral fellowship from the Department of Defense Breast Cancer Research Program.	Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Body JJ, 2004, BRIT J CANCER, V90, P1133, DOI 10.1038/sj.bjc.6601663; Coleman R, 2007, BREAST, V16, pS21, DOI 10.1016/j.breast.2007.10.006; Coleman RE, 1997, CANCER, V80, P1686, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1686::AID-CNCR20>3.3.CO;2-T; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Deroose CM, 2007, J NUCL MED, V48, P295; Diel IJ, 1998, NEW ENGL J MED, V339, P357, DOI 10.1056/NEJM199808063390601; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; El-Abdaimi K, 2003, INT J ONCOL, V22, P883; Fritz V, 2007, BONE, V40, P1032, DOI 10.1016/j.bone.2006.11.026; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Hoffman RM, 2009, CLIN EXP METASTAS, V26, P345, DOI 10.1007/s10585-008-9205-z; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Li HY, 2008, J MED CHEM, V51, P2302, DOI 10.1021/jm701199p; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; Tjuvajev JG, 2003, CANCER CELL, V3, P327, DOI 10.1016/S1535-6108(03)00082-5; Tripathy D, 2004, ANN ONCOL, V15, P743, DOI 10.1093/annonc/mdh173; van der Pluijm G, 2005, CANCER RES, V65, P7682, DOI 10.1158/0008-5472.CAN-04-4188; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	35	159	167	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					960	U169		10.1038/nm.1943	http://dx.doi.org/10.1038/nm.1943			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19597504				2022-12-25	WOS:000268770400043
J	Bahlo, M; Booth, DR; Broadley, SA; Brown, MA; Foote, SJ; Griffiths, LR; Kilpatrick, TJ; Lechner-Scott, J; Moscato, P; Perreau, VM; Rubio, JP; Scott, RJ; Stankovich, J; Stewart, GJ; Taylor, BV; Wiley, J; Clarke, G; Cox, MB; Csurhes, PA; Danoy, P; Drysdale, K; Field, J; Foote, SJ; Greer, JM; Griffiths, LR; Hadler, J; McMorran, BJ; Jensen, CJ; Johnson, LJ; McCallum, R; Merriman, M; Merriman, T; Pryce, K; Tajouri, L; Wilkins, EJ; Browning, BL; Browning, SR; Perera, D; Butzkueven, H; Carroll, WM; Chapman, C; Kermode, AG; Marriott, M; Mason, D; Heard, RN; Pender, MP; Slee, M; Tubridy, N; Willoughby, E				Bahlo, Melanie; Booth, David R.; Broadley, Simon A.; Brown, Matthew A.; Foote, Simon J.; Griffiths, Lyn R.; Kilpatrick, Trevor J.; Lechner-Scott, Jeanette; Moscato, Pablo; Perreau, Victoria M.; Rubio, Justin P.; Scott, Rodney J.; Stankovich, Jim; Stewart, Graeme J.; Taylor, Bruce V.; Wiley, James; Clarke, Glynnis; Cox, Mathew B.; Csurhes, Peter A.; Danoy, Patrick; Drysdale, Karen; Field, Judith; Foote, Simon J.; Greer, Judith M.; Guru, Preethi; Hadler, Johanna; McMorran, Brendan J.; Jensen, Cathy J.; Johnson, Laura J.; McCallum, Ruth; Merriman, Marilyn; Merriman, Tony; Pryce, Karen; Tajouri, Lotfi; Wilkins, Ella J.; Browning, Brian L.; Browning, Sharon R.; Perera, Devindri; Butzkueven, Helmut; Carroll, William M.; Chapman, Caron; Kermode, Allan G.; Marriott, Mark; Mason, Deborah; Heard, Robert N.; Pender, Michael P.; Slee, Mark; Tubridy, Niall; Willoughby, Ernest		Australia & New Zealand Multiple S	Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20	NATURE GENETICS			English	Article							RHEUMATOID-ARTHRITIS; DIAGNOSTIC-CRITERIA; CD40; POLYMORPHISM; GUIDELINES; INDUCTION; INFERENCE; ANTIBODY; MODELS; LIGAND	To identify multiple sclerosis (MS) susceptibility loci, we conducted a genome-wide association study (GWAS) in 1,618 cases and used shared data for 3,413 controls. We performed replication in an independent set of 2,256 cases and 2,310 controls, for a total of 3,874 cases and 5,723 controls. We identified risk-associated SNPs on chromosome 12q13-14 (rs703842, P = 5.4 x 10(-11); rs10876994, P = 2.7 x 10(-10); rs12368653, P = 1.0 x 10(-7)) and upstream of CD40 on chromosome 20q13 (rs6074022, P = 1.3 x 10(-7); rs1569723, P = 2.9 x 10(-7)). Both loci are also associated with other autoimmune diseases(1-5). We also replicated several known MS associations (HLA-DR15, P = 7.0 x 10(-184); CD58, P = 9.6 x 10(-8); EVI5-RPL5, P = 2.5 x 10(-6); IL2RA, P = 7.4 x 10(-6); CLEC16A, P = 1.1 x 10(-4); IL7R, P = 1.3 x 10(-3); TYK2, P = 3.5 x 10(-3)) and observed a statistical interaction between SNPs in EVI5-RPL5 and HLA-DR15 (P = 0.001).	[Rubio, Justin P.; Field, Judith; Jensen, Cathy J.; Johnson, Laura J.; Wilkins, Ella J.; Butzkueven, Helmut] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia; [Bahlo, Melanie] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Booth, David R.; Stewart, Graeme J.] Westmead Millenium Inst, Westmead, NSW, Australia; [Broadley, Simon A.] Griffith Univ, Sch Med, Nathan, Qld 4111, Australia; [Brown, Matthew A.; Hadler, Johanna; Pryce, Karen] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Brown, Matthew A.] Univ Oxford, Nuffield Dept Orthopaed Surg, Botnar Res Ctr, Oxford, England; [Stankovich, Jim; Taylor, Bruce V.; Drysdale, Karen; Foote, Simon J.; Guru, Preethi; McMorran, Brendan J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Griffiths, Lyn R.; Tajouri, Lotfi] Griffith Univ, Genom Res Ctr, Nathan, Qld 4111, Australia; [Kilpatrick, Trevor J.; Perreau, Victoria M.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Kilpatrick, Trevor J.] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Lechner-Scott, Jeanette; Scott, Rodney J.] John Hunter Hosp, Hunter New England Hlth Serv, Newcastle, NSW, Australia; [Lechner-Scott, Jeanette; Moscato, Pablo; Cox, Mathew B.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Moscato, Pablo; Scott, Rodney J.; Cox, Mathew B.] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Wiley, James] Nepean Hosp, Dept Med, Penrith, NSW, Australia; [Clarke, Glynnis] Univ Otago, Christchurch Sch Med & Hlth Sci, Christchurch, New Zealand; [Csurhes, Peter A.; Greer, Judith M.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld 4072, Australia; [McCallum, Ruth; Merriman, Marilyn; Merriman, Tony] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Browning, Brian L.; Browning, Sharon R.] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Carroll, William M.; Kermode, Allan G.] Sir Charles Gairdner Hosp, Nedlands, WA, Australia; [Carroll, William M.; Kermode, Allan G.] Australian Neuromuscular Res Inst, Nedlands, WA, Australia; [Chapman, Caron] Barwon Hlth, Geelong, Vic, Australia; [Mason, Deborah] Canterbury Dist Hlth Board, Christchurch, New Zealand; [Pender, Michael P.] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia; [Pender, Michael P.] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia; [Slee, Mark] Flinders Univ S Australia, Dept Neurol, Sch Med, Adelaide, SA 5001, Australia; [Tubridy, Niall] St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland; [Willoughby, Ernest] Auckland Dist Hlth Board, Auckland, New Zealand	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Sydney; Westmead Institute for Medical Research; Griffith University; University of Queensland; University of Oxford; University of Tasmania; Menzies Institute for Medical Research; Griffith University; University of Melbourne; Royal Melbourne Hospital; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Nepean Hospital; University of Sydney; University of Otago; University of Queensland; University of Otago; University of Auckland; University of Western Australia; University of Western Australia; University of Queensland; Royal Brisbane & Women's Hospital; Flinders University South Australia; University College Dublin; Saint Vincent's University Hospital; Auckland District Health Board	Rubio, JP (corresponding author), Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia.	justin.rubio@florey.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Csurhes, Peter A/F-1510-2010; Brown, Matthew A/E-5749-2010; Greer, Judith/C-4945-2009; Scott, Rodney J/B-2827-2013; Browning, Sharon/B-1530-2008; Perera, Devindri/V-8796-2019; Pender, Michael P/F-4110-2010; Browning, Brian L/A-1178-2010; Slee, Mark/J-4731-2015; Foote, Simon J/F-2802-2013; Kermode, Allan/G-3568-2019	Csurhes, Peter A/0000-0002-6626-301X; Brown, Matthew A/0000-0003-0538-8211; Greer, Judith/0000-0003-4440-4309; Scott, Rodney J/0000-0001-7724-3404; Browning, Sharon/0000-0001-7251-9715; Browning, Brian L/0000-0001-6454-6633; Slee, Mark/0000-0003-4323-2453; Kermode, Allan/0000-0002-4476-4016; Butzkueven, Helmut/0000-0003-3940-8727; Bahlo, Melanie/0000-0001-5132-0774; Topless, Ruth/0000-0002-9343-8911; Kilpatrick, Trevor/0000-0003-3999-085X; Merriman, Tony/0000-0003-0844-8726; Foote, Simon/0000-0002-9142-2107; Pender, Michael/0000-0003-3792-3768; Stankovich, Jim/0000-0001-9344-7749; Wiley, James/0000-0001-9421-4154; Field, Judith/0000-0002-7089-0999; Griffiths, Lyn/0000-0002-6774-5475; Moscato, Pablo/0000-0003-2570-5966; RUBIO, JUSTIN/0000-0003-3750-917X	The National Health and Medical Research Council of Australia (NHMRC); NHMRC Principal Research Fellow; John Hunter Hospital Charitable Trust Fund; Macquarie Bank	The National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Principal Research Fellow(National Health and Medical Research Council (NHMRC) of Australia); John Hunter Hospital Charitable Trust Fund; Macquarie Bank	We thank individuals with MS in Australia and New Zealand for supporting this research. We are grateful to M. Tanner for database management and J. Wright and C. Remediakis from Multiple Sclerosis Research Australia (MSRA) for expediting this research. J. P. R. and M. B. are supported by Career Development Awards from The National Health and Medical Research Council of Australia (NHMRC). M. A. B. is an NHMRC Principal Research Fellow. H. B. is an NHMRC Peter Doherty Postdoctoral Fellow. J. F. is an MSRA Post-doctoral Fellow. M. B. C. is supported by a grant from the John Hunter Hospital Charitable Trust Fund and a special grant from Macquarie Bank. Replication genotyping was conducted at the Murdoch	Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bailey R, 2007, DIABETES, V56, P2616, DOI 10.2337/db07-0652; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cantorna MT, 1998, J NUTR, V128, P68, DOI 10.1093/jn/128.1.68; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; DURIE FH, 1994, IMMUNOL TODAY, V15, P406, DOI 10.1016/0167-5699(94)90269-0; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; ISHIDA T, 1995, J IMMUNOL, V155, P5527; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Marzo N, 2008, J IMMUNOL, V180, P1189, DOI 10.4049/jimmunol.180.2.1189; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Satoh J, 2006, J NEUROIMMUNOL, V174, P108, DOI 10.1016/j.jneuroim.2006.02.004; Sekine C, 2008, J IMMUNOL, V180, P1954, DOI 10.4049/jimmunol.180.3.1954; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8	35	394	403	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					824	U84		10.1038/ng.396	http://dx.doi.org/10.1038/ng.396			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19525955				2022-12-25	WOS:000267786200014
J	Heinis, C; Rutherford, T; Freund, S; Winter, G				Heinis, Christian; Rutherford, Trevor; Freund, Stephan; Winter, Greg			Phage-encoded combinatorial chemical libraries based on bicyclic peptides	NATURE CHEMICAL BIOLOGY			English	Article							MESSENGER-RNA DISPLAY; FILAMENTOUS PHAGE; ESCHERICHIA-COLI; VARIABLE DOMAINS; PROTEIN SURFACES; BINDING; SELECTION; DNA; MACROCYCLES; EVOLUTION	Here we describe a phage strategy for the selection of ligands based on bicyclic or linear peptides attached covalently to an organic core. We designed peptide repertoires with three reactive cysteine residues, each spaced apart by several random amino acid residues, and we fused the repertoires to the phage gene-3-protein. Conjugation with tris-(bromomethyl) benzene via the reactive cysteines generated repertoires of peptide conjugates with two peptide loops anchored to a mesitylene core. Iterative affinity selections yielded several enzyme inhibitors; after further mutagenesis and selection, we were able to chemically synthesize a lead inhibitor (PK15; K(i) = 1.5 nM) specific to human plasma kallikrein that efficiently interrupted the intrinsic coagulation pathway in human plasma tested ex vivo. This approach offers a powerful means of generating and selecting bicyclic macrocycles (or if cleaved, linear derivatives thereof) as ligands poised at the interface of small-molecule drugs and biologics.	[Heinis, Christian; Winter, Greg] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Rutherford, Trevor; Freund, Stephan] MRC, Ctr Prot Engn, Cambridge, England	MRC Laboratory Molecular Biology; University of Cambridge	Heinis, C (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Lausanne, Switzerland.	christian.heinis@epfl.ch; winter@mrc-lmb.cam.ac.uk			Swiss National Science Foundation (SNSF); Novartis Foundation; MRC [MC_U105115240] Funding Source: UKRI; Medical Research Council [MC_U105115240] Funding Source: researchfish	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Jones (Laboratory of Molecular Biology, Cambridge, UK) for expert laboratory advice, L. Judd (Centre for Protein Engineering, Cambridge, UK) for media preparation, A. Jaulent (Centre for Protein Engineering, Cambridge, UK) for peptide purification, and F. Begum (Laboratory of Molecular Biology, Cambridge, UK) and S.- Y. Peak- Chew (Laboratory of Molecular Biology, Cambridge, UK) for mass spectrometric analysis. We also thank I. Kather and F. X. Schmid from the University of Bayreuth for the engineered phage with disulfide- free gene- 3- protein. C. H. was supported by the Swiss National Science Foundation (SNSF) and the Novartis Foundation (formerly Ciba- Geigy Jubilee Foundation).	Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; BARBAS CF, 1995, NAT MED, V1, P837, DOI 10.1038/nm0895-837; BHASKARAN R, 1992, BIOPOLYMERS, V32, P1599, DOI 10.1002/bip.360321203; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; BRENNER S, 1992, P NATL ACAD SCI USA, V89, P5381, DOI 10.1073/pnas.89.12.5381; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cremlyn R. J., 1996, INTRO ORGANOSULFUR C; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Doyon JB, 2003, J AM CHEM SOC, V125, P12372, DOI 10.1021/ja036065u; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Gartner ZJ, 2004, SCIENCE, V305, P1601, DOI 10.1126/science.1102629; Halpin DR, 2004, PLOS BIOL, V2, P1022, DOI 10.1371/journal.pbio.0020174; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Huang LL, 2003, J BIOL CHEM, V278, P15532, DOI 10.1074/jbc.M212934200; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; Huser J., 2006, HIGH THROUGHPUT SCRE, V35; JACKSON DY, 1994, SCIENCE, V266, P243, DOI 10.1126/science.7939659; Jespers L, 2004, PROTEIN ENG DES SEL, V17, P709, DOI 10.1093/protein/gzh083; Jespers L. S. A. T., 1995, PCT International Patent, Patent No. [WO 95/01438, 9501438]; Kather I, 2005, J MOL BIOL, V354, P666, DOI 10.1016/j.jmb.2005.09.086; KEMP DS, 1985, J ORG CHEM, V50, P5834, DOI 10.1021/jo00350a077; Lerner RA, 2006, ANGEW CHEM INT EDIT, V45, P8106, DOI 10.1002/anie.200603381; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Litovchick A, 2008, P NATL ACAD SCI USA, V105, P15293, DOI 10.1073/pnas.0805837105; Mannocci L, 2008, P NATL ACAD SCI USA, V105, P17670, DOI 10.1073/pnas.0805130105; MARKS JD, 1992, J BIOL CHEM, V267, P16007; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Melacini G, 1997, BIOCHEMISTRY-US, V36, P1233, DOI 10.1021/bi962497o; Melkko S, 2004, NAT BIOTECHNOL, V22, P568, DOI 10.1038/nbt961; Millward SW, 2007, ACS CHEM BIOL, V2, P625, DOI 10.1021/cb7001126; Nygren PA, 2004, J IMMUNOL METHODS, V290, P3, DOI 10.1016/j.jim.2004.04.006; POHL E, 1995, ACTA CRYSTALLOGR D, V51, P48, DOI 10.1107/S0907444994006104; Sandman KE, 2000, J AM CHEM SOC, V122, P960, DOI 10.1021/ja992462m; Sandman KE, 2000, NUCLEIC ACIDS RES, V28, P755, DOI 10.1093/nar/28.3.755; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; TIMMERMAN P, 2006, Patent No. 2006078161; Timmerman P., 2004, WO, Patent No. [/2004/077062, 2004077062]; Tse BN, 2008, J AM CHEM SOC, V130, P15611, DOI 10.1021/ja805649f; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Ulrich Henning, 2005, Med Chem, V1, P199; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wessjohann LA, 2005, MOL DIVERS, V9, P171, DOI 10.1007/s11030-005-1314-x; Woiwode TF, 2003, CHEM BIOL, V10, P847, DOI 10.1016/j.chembiol.2003.08.005; WOOD SP, 1986, SCIENCE, V232, P633, DOI 10.1126/science.3008332	45	468	520	5	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					502	507		10.1038/nchembio.184	http://dx.doi.org/10.1038/nchembio.184			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19483697				2022-12-25	WOS:000267266100016
J	Shen, A; Lupardus, PJ; Albrow, VE; Guzzetta, A; Powers, JC; Garcia, KC; Bogyo, M				Shen, Aimee; Lupardus, Patrick J.; Albrow, Victoria E.; Guzzetta, Andrew; Powers, James C.; Garcia, K. Christopher; Bogyo, Matthew			Mechanistic and structural insights into the proteolytic activation of Vibrio cholerae MARTX toxin	NATURE CHEMICAL BIOLOGY			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; AUTOPROCESSING RTX TOXIN; CYSTEINE PROTEASE DOMAIN; VIRULENCE; IDENTIFICATION; VULNIFICUS; INHIBITORS; CLEAVAGE; MICE; CYTOTOXICITY	MARTX toxins modulate the virulence of a number of Gram-negative Vibrio species. This family of toxins is defined by the presence of a cysteine protease domain (CPD), which proteolytically activates the Vibrio cholerae MARTX toxin. Although recent structural studies of the CPD have uncovered a new allosteric activation mechanism, the mechanism of CPD substrate recognition or toxin processing is unknown. Here we show that interdomain cleavage of MARTX(Vc) enhances effector domain function. We also identify the first small-molecule inhibitors of this protease domain and present the 2.35-angstrom structure of the CPD bound to one of these inhibitors. This structure, coupled with biochemical and mutational studies of the toxin, reveals the molecular basis of CPD substrate specificity and underscores the evolutionary relationship between the CPD and the clan CD caspase proteases. These studies are likely to prove valuable for devising new antitoxin strategies for a number of bacterial pathogens.	[Shen, Aimee; Albrow, Victoria E.; Guzzetta, Andrew; Bogyo, Matthew] Stanford Sch Med, Dept Pathol, Stanford, CA USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Sch Med, Dept Mol & Cellular Biol, Stanford, CA USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Sch Med, Howard Hughes Med Inst, Stanford, CA USA; [Powers, James C.] Georgia Inst Technol, Dept Chem, Atlanta, GA 30332 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University System of Georgia; Georgia Institute of Technology	Bogyo, M (corresponding author), Stanford Sch Med, Dept Pathol, Stanford, CA USA.	ashen2@stanford.edu; mbogyo@stanford.edu		Shen, Aimee/0000-0002-9786-5742; Bogyo, Matthew/0000-0003-3753-4412	US National Institutes of Health National Technology Center [U54-RR020843]; Human Frontier Science Program [RGP0024/2006-C]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	US National Institutes of Health National Technology Center; Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	M. B. is supported by the Burroughs Wellcome Foundation, the Searle Scholars Program, the US National Institutes of Health National Technology Center for Networks and Pathways (grant U54-RR020843) and the Human Frontier Science Program ( grant RGP0024/2006-C).	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Asgian JL, 2002, J MED CHEM, V45, P4958, DOI 10.1021/jm025581c; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Bedard KM, 2004, MICROBES INFECT, V6, P702, DOI 10.1016/j.micinf.2004.03.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganesan R, 2006, BIOCHEMISTRY-US, V45, P9059, DOI 10.1021/bi060364p; Giesemann T, 2008, J MED MICROBIOL, V57, P690, DOI 10.1099/jmm.0.47742-0; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Lee BC, 2008, INFECT IMMUN, V76, P1509, DOI 10.1128/IAI.01503-07; Lee JH, 2007, J MICROBIOL, V45, P146; Li L, 2008, INFECT IMMUN, V76, P2620, DOI 10.1128/IAI.01308-07; Liu M, 2007, INFECT IMMUN, V75, P3282, DOI 10.1128/IAI.00045-07; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Rahman MH, 2008, DNA CELL BIOL, V27, P347, DOI 10.1089/dna.2008.0737; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563	36	63	65	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					469	478		10.1038/nchembio.178	http://dx.doi.org/10.1038/nchembio.178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19465933	Green Accepted			2022-12-25	WOS:000267266100012
J	Leonard, E; Runguphan, W; O'Connor, S; Prather, KJ				Leonard, Effendi; Runguphan, Weerawat; O'Connor, Sarah; Prather, Kristala Jones			Opportunities in metabolic engineering to facilitate scalable alkaloid production	NATURE CHEMICAL BIOLOGY			English	Article							ROSEUS HAIRY ROOTS; STEREOCONTROLLED TOTAL-SYNTHESIS; TRANSGENIC CELL-LINE; CATHARANTHUS-ROSEUS; STRICTOSIDINE SYNTHASE; ESCHERICHIA-COLI; NATURAL-PRODUCTS; OPIUM POPPY; TRYPTOPHAN DECARBOXYLASE; SECONDARY METABOLITES	cNumerous drugs and drug precursors in the current pharmacopoeia originate from plant sources. The limited yield of some bioactive compounds in plant tissues, however, presents a significant challenge for large-scale drug development. Metabolic engineering has facilitated the development of plant cell and tissue systems as alternative production platforms that can be scaled up in a controlled environment. Nevertheless, effective metabolic engineering approaches and the predictability of genetic transformations are often obscured due to the myriad cellular complexities. Progress in systems biology has aided the understanding of genome-wide interconnectivities in plant-based systems. In parallel, the bottom-up assembly of plant biosynthetic pathways in microorganisms demonstrated the possibilities of a new means of production. In this Perspective, we discuss the opportunities and challenges of implementing metabolic engineering in various platforms for the synthesis of natural and unnatural plant alkaloids.	[Leonard, Effendi; Prather, Kristala Jones] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Runguphan, Weerawat; O'Connor, Sarah] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Leonard, E (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	kljp@mit.edu	Runguphan, Weerawat/GSM-9179-2022; O'Connor, Sarah Ellen/X-2893-2019; O'Connor, Sarah/O-5850-2016	Runguphan, Weerawat/0000-0001-5707-3516; O'Connor, Sarah/0000-0003-0356-6213	US National Science Foundation/Synthetic Biology Engineering Research Center [0540879]; MIT Energy Initiative [6917278]; US National Institutes of Health [GM074820]; US National Science Foundation [MCB-0719120]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074820] Funding Source: NIH RePORTER	US National Science Foundation/Synthetic Biology Engineering Research Center(National Science Foundation (NSF)); MIT Energy Initiative; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for the constructive discussion and contribution of M. Tackett (Whitehead Institute for Biomedical Research and Department of Biology, MIT). Research in the Prather laboratory is supported by the US National Science Foundation/Synthetic Biology Engineering Research Center (SynBERC; grant no. 0540879) and the MIT Energy Initiative (grant no. 6917278). Research in the O'Connor laboratory is funded by the US National Institutes of Health (GM074820) and the US National Science Foundation (MCB-0719120).	Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; AMER MA, 1981, PHYTOCHEMISTRY, V20, P2569, DOI 10.1016/0031-9422(81)83096-8; Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; BASER KHC, 1979, PHYTOCHEMISTRY, V18, P512, DOI 10.1016/S0031-9422(00)81909-3; Beghyn T, 2008, CHEM BIOL DRUG DES, V72, P3, DOI 10.1111/j.1747-0285.2008.00673.x; Bernhardt P, 2007, CHEM BIOL, V14, P888, DOI 10.1016/j.chembiol.2007.07.008; BHADRA R, 1993, BIOTECHNOL BIOENG, V41, P581, DOI 10.1002/bit.260410511; Canel C, 1998, PLANTA, V205, P414, DOI 10.1007/s004250050338; CARVALHO A, 1965, NATURE, V205, P314, DOI 10.1038/205314a0; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Chen QH, 2008, J SEP SCI, V31, P2211, DOI 10.1002/jssc.200800055; Chen S, 2006, CHEM BIOL, V13, P1137, DOI 10.1016/j.chembiol.2006.10.009; Costantino L, 2006, CURR MED CHEM, V13, P65, DOI 10.2174/092986706775197944; Datta A, 1997, PHYTOCHEMISTRY, V46, P135, DOI 10.1016/S0031-9422(97)00165-9; De Luca V, 2000, TRENDS PLANT SCI, V5, P168, DOI 10.1016/S1360-1385(00)01575-2; EVANS BE, 1988, J MED CHEM, V31, P2235, DOI 10.1021/jm00120a002; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; FILNER P, 1969, SCIENCE, V165, P358, DOI 10.1126/science.165.3891.358; Frick S, 2007, METAB ENG, V9, P169, DOI 10.1016/j.ymben.2006.10.004; Gamborg OL, 2002, IN VITRO CELL DEV-PL, V38, P84, DOI 10.1079/IVP2001281; Gantet P, 2002, TRENDS PHARMACOL SCI, V23, P563, DOI 10.1016/S0165-6147(02)02098-9; Geerlings A, 2001, APPL MICROBIOL BIOT, V56, P420, DOI 10.1007/s002530100663; Hagel JM, 2008, PLANT PHYSIOL, V147, P1805, DOI 10.1104/pp.108.120493; Hartmann T, 2004, PLANTA, V219, P1, DOI 10.1007/s00425-004-1249-y; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hong SB, 2006, J BIOTECHNOL, V122, P28, DOI 10.1016/j.jbiotec.2005.08.008; Horton DA, 2003, CHEM REV, V103, P893, DOI 10.1021/cr020033s; Hughes EH, 2004, METAB ENG, V6, P268, DOI 10.1016/j.ymben.2004.03.002; Hughes EH, 2004, BIOTECHNOL BIOENG, V86, P718, DOI 10.1002/bit.20081; JOHNSON EL, 1994, ANN BOT-LONDON, V73, P645, DOI 10.1006/anbo.1994.1081; Kalant H, 1997, ADDICTION, V92, P267; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kosalec I, 2009, WORLD J MICROB BIOT, V25, P145, DOI 10.1007/s11274-008-9860-x; Kuboyama T, 2004, P NATL ACAD SCI USA, V101, P11966, DOI 10.1073/pnas.0401323101; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Larkin PJ, 2007, PLANT BIOTECHNOL J, V5, P26, DOI 10.1111/j.1467-7652.2006.00212.x; Leonard E, 2008, MOL PHARM, V5, P257, DOI 10.1021/mp7001472; Leonard E, 2007, APPL ENVIRON MICROB, V73, P7246, DOI 10.1128/AEM.01411-07; Leonard E, 2007, APPL ENVIRON MICROB, V73, P3877, DOI 10.1128/AEM.00200-07; Liscombe DK, 2008, CURR OPIN BIOTECH, V19, P173, DOI 10.1016/j.copbio.2008.02.012; Loris EA, 2007, CHEM BIOL, V14, P979, DOI 10.1016/j.chembiol.2007.08.009; Ma XY, 2006, PLANT CELL, V18, P907, DOI 10.1105/tpc.105.038018; MacLean D, 2000, J COMB CHEM, V2, P562, DOI 10.1021/cc000071u; Magnotta M, 2007, PHYTOCHEMISTRY, V68, P1922, DOI 10.1016/j.phytochem.2007.04.037; MAPLESTONE RA, 1992, GENE, V115, P151, DOI 10.1016/0378-1119(92)90553-2; Maresh JJ, 2008, J AM CHEM SOC, V130, P710, DOI 10.1021/ja077190z; Mateus L, 2000, PHYTOCHEMISTRY, V54, P517, DOI 10.1016/S0031-9422(00)00134-5; MCCALLEY DV, 1990, ANALYST, V115, P1355, DOI 10.1039/an9901501355; McCoy E, 2006, BIOORG MED CHEM LETT, V16, P2475, DOI 10.1016/j.bmcl.2006.01.098; Mccoy E, 2006, J AM CHEM SOC, V128, P14276, DOI 10.1021/ja066787w; Mccoy Elizabeth, 2008, V65; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Miyazaki T, 2007, ORG LETT, V9, P4737, DOI 10.1021/ol702040y; Morgan JA, 2000, J BIOTECHNOL, V79, P137, DOI 10.1016/S0168-1656(00)00221-2; Morgan JA, 2002, METAB ENG, V4, P257, DOI 10.1006/mben.2002.0224; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Ogita S, 2003, NATURE, V423, P823, DOI 10.1038/423823a; PAKRASHI SC, 1955, J AM CHEM SOC, V77, P6687, DOI 10.1021/ja01629a111; Peebles CAM, 2009, METAB ENG, V11, P76, DOI 10.1016/j.ymben.2008.09.002; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Rischer H, 2006, TRENDS BIOTECHNOL, V24, P102, DOI 10.1016/j.tibtech.2006.01.009; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Runguphan W, 2009, NAT CHEM BIOL, V5, P151, DOI 10.1038/nchembio.141; Sato F, 2001, P NATL ACAD SCI USA, V98, P367, DOI 10.1073/pnas.011526398; SAUNDERS JW, 1979, PLANT PHYSIOL, V64, P236, DOI 10.1104/pp.64.2.236; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Shanks JV, 1998, BIOTECHNOL BIOENG, V58, P333, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3&lt;333::AID-BIT35&gt;3.0.CO;2-A; Shanks JV, 1999, CURR OPIN BIOTECH, V10, P151, DOI 10.1016/S0958-1669(99)80026-3; Sriram G, 2004, METAB ENG, V6, P116, DOI 10.1016/j.ymben.2004.02.003; Sriram G, 2007, PHYTOCHEMISTRY, V68, P2243, DOI 10.1016/j.phytochem.2007.04.009; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; STAFFORD AM, 1998, PLANT CELL CULTURE V; Touno K, 2005, PLANT PHYSIOL BIOCH, V43, P101, DOI 10.1016/j.plaphy.2005.01.004; Uchida K, 2006, ORG LETT, V8, P5311, DOI 10.1021/ol062112m; Uefuji H, 2005, PLANT MOL BIOL, V59, P221, DOI 10.1007/s11103-005-8520-x; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; Vazquez-Flota FA, 2000, PHYTOCHEMISTRY, V55, P531, DOI 10.1016/S0031-9422(00)00221-1; Verpoorte R, 2000, TRANSGENIC RES, V9, P323, DOI 10.1023/A:1008966404981; Whitmer S, 1998, PLANT PHYSIOL, V116, P853, DOI 10.1104/pp.116.2.853; Whitmer S, 2002, J BIOTECHNOL, V96, P193, DOI 10.1016/S0168-1656(02)00027-5; Wiedenfeld H, 1997, PLANT CELL TISS ORG, V49, P213, DOI 10.1023/A:1005704429339; WILLIAMS DH, 1989, J NAT PROD, V52, P1189, DOI 10.1021/np50066a001; WITHERUP KM, 1990, J NAT PROD, V53, P1249, DOI 10.1021/np50071a017; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Yokoshima S, 2002, J AM CHEM SOC, V124, P2137, DOI 10.1021/ja0177049; Yukimune Y, 1996, NAT BIOTECHNOL, V14, P1129, DOI 10.1038/nbt0996-1129; YUN DJ, 1992, P NATL ACAD SCI USA, V89, P11799, DOI 10.1073/pnas.89.24.11799; Zhang L, 2004, P NATL ACAD SCI USA, V101, P6786, DOI 10.1073/pnas.0401391101; [No title captured]	96	101	113	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2009	5	5					292	300		10.1038/nchembio.160	http://dx.doi.org/10.1038/nchembio.160			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	436PT	19377455	Green Submitted			2022-12-25	WOS:000265427000009
J	Little, SC; Mullins, MC				Little, Shawn C.; Mullins, Mary C.			Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis	NATURE CELL BIOLOGY			English	Article							SERINE/THREONINE KINASE RECEPTOR; SPEMANNS ORGANIZER; ZEBRAFISH EMBRYO; BMP ACTIVITY; SIGNALS; DORSAL; BMP2B/SWIRL; CHORDIN; XENOPUS; BMP7/SNAILHOUSE	Patterning the embryonic dorsoventral axis of both vertebrates and invertebrates requires signalling through bone morphogenetic proteins (BMPs)(1). Although a well-studied process, the identity of the physiologically relevant BMP signalling complex in the Drosophila melanogaster embryo is controversial(2,3), is generally inferred from cell culture studies and has not been investigated in vertebrates. Here, we demonstrate that dorsoventral patterning in zebrafish, Danio rerio, requires two classes of non-redundant type I BMP receptors, Alk3/6 and Alk8 (activin-like kinases 3/6 and 8). We show, under physiological conditions in the embryo, that these two type I receptor classes form a complex in a manner that depends on Bmp2 and Bmp7. We found that both Bmp2-7 heterodimers, as well as Bmp2 and Bmp7 homodimers, form in the embryo. However, only recombinant ligand heterodimers can activate BMP signalling in the early embryo, whereas a combination of Bmp2 and Bmp7 homodimers cannot. We propose that only heterodimers, signalling through two distinct classes of type I receptor, possess sufficient receptor affinity in an environment of extracellular antagonists to elicit the signalling response required for dorsoventral patterning.	[Little, Shawn C.; Mullins, Mary C.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Mullins, MC (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 1211 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	mullins@mail.med.upenn.edu		Little, Shawn/0000-0002-2815-3696	NIH [GM56326, 5 T32 GM07229-28, 2 T32 HD007516-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM056326, R01GM056326, T32GM007229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Whitman for the Alk4(KR) HA construct; L. Jing and M. Granato for Myc-tagged Unplugged/ MuSK; B. Holloway and J. Tucker for technical advice; S. Lu for technical support; J. Xie and the UPenn zebrafish core facility for wild-type embryos and S. DiNardo, T. Gupta, F. Marlow and L. Kapp for comments on the manuscript. This work was funded by NIH grants to M. C. M. (GM56326) and to S. C. L. (5 T32 GM07229-28 and 2 T32 HD007516-05).	AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Bauer H, 2001, DEVELOPMENT, V128, P849; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Imai Y, 2001, GENESIS, V30, P160, DOI 10.1002/gene.1055; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Nikaido M, 1999, DEVELOPMENT, V126, P181; Nikaido M, 1999, MECH DEVELOP, V82, P219, DOI 10.1016/S0925-4773(99)00023-4; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; SAMPATH TK, 1990, J BIOL CHEM, V265, P13198; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Schmid B, 2000, DEVELOPMENT, V127, P957; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Suzuki A, 1997, DEV BIOL, V189, P112, DOI 10.1006/dbio.1997.8652; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yelick PC, 1998, DEV DYNAM, V211, P352, DOI 10.1002/(SICI)1097-0177(199804)211:4<352::AID-AJA6>3.0.CO;2-G; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	46	177	181	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					637	U439		10.1038/ncb1870	http://dx.doi.org/10.1038/ncb1870			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19377468	Green Accepted			2022-12-25	WOS:000265640000023
J	Tarpey, PS; Smith, R; Pleasance, E; Whibley, A; Edkins, S; Hardy, C; O'Meara, S; Latimer, C; Dicks, E; Menzies, A; Stephens, P; Blow, M; Greenman, C; Xue, YL; Tyler-Smith, C; Thompson, D; Gray, K; Andrews, J; Barthorpe, S; Buck, G; Cole, J; Dunmore, R; Jones, D; Maddison, M; Mironenko, T; Turner, R; Turrell, K; Varian, J; West, S; Widaa, S; Wray, P; Teague, J; Butler, A; Jenkinson, A; Jia, MM; Richardson, D; Shepherd, R; Wooster, R; Tejada, MI; Martinez, F; Carvill, G; Goliath, R; de Brouwer, APM; van Bokhoven, H; Van Esch, H; Chelly, J; Raynaud, M; Ropers, HH; Abidi, FE; Srivastava, AK; Cox, J; Luo, Y; Mallya, U; Moon, J; Parnau, J; Mohammed, S; Tolmie, JL; Shoubridge, C; Corbett, M; Gardner, A; Haan, E; Rujirabanjerd, S; Shaw, M; Vandeleur, L; Fullston, T; Easton, DF; Boyle, J; Partington, M; Hackett, A; Field, M; Skinner, C; Stevenson, RE; Bobrow, M; Turner, G; Schwartz, CE; Gecz, J; Raymond, FL; Futreal, PA; Stratton, MR				Tarpey, Patrick S.; Smith, Raffaella; Pleasance, Erin; Whibley, Annabel; Edkins, Sarah; Hardy, Claire; O'Meara, Sarah; Latimer, Calli; Dicks, Ed; Menzies, Andrew; Stephens, Phil; Blow, Matt; Greenman, Chris; Xue, Yali; Tyler-Smith, Chris; Thompson, Deborah; Gray, Kristian; Andrews, Jenny; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Dunmore, Rebecca; Jones, David; Maddison, Mark; Mironenko, Tatiana; Turner, Rachel; Turrell, Kelly; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Teague, Jon; Butler, Adam; Jenkinson, Andrew; Jia, Mingming; Richardson, David; Shepherd, Rebecca; Wooster, Richard; Tejada, M. Isabel; Martinez, Francisco; Carvill, Gemma; Goliath, Rene; de Brouwer, Arjan P. M.; van Bokhoven, Hans; Van Esch, Hilde; Chelly, Jamel; Raynaud, Martine; Ropers, Hans-Hilger; Abidi, Fatima E.; Srivastava, Anand K.; Cox, James; Luo, Ying; Mallya, Uma; Moon, Jenny; Parnau, Josef; Mohammed, Shehla; Tolmie, John L.; Shoubridge, Cheryl; Corbett, Mark; Gardner, Alison; Haan, Eric; Rujirabanjerd, Sinitdhorn; Shaw, Marie; Vandeleur, Lucianne; Fullston, Tod; Easton, Douglas F.; Boyle, Jackie; Partington, Michael; Hackett, Anna; Field, Michael; Skinner, Cindy; Stevenson, Roger E.; Bobrow, Martin; Turner, Gillian; Schwartz, Charles E.; Gecz, Jozef; Raymond, F. Lucy; Futreal, P. Andrew; Stratton, Michael R.			A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation	NATURE GENETICS			English	Article							HUMAN GENOME; PROTEIN EVOLUTION; CANCER GENOMES; DNA-SEQUENCE; MUTATIONS; SELECTION; GENETICS; DISEASE; GENES; CONSERVATION	Large-scale systematic resequencing has been proposed as the key future strategy for the discovery of rare, disease-causing sequence variants across the spectrum of human complex disease. We have sequenced the coding exons of the X chromosome in 208 families with X-linked mental retardation (XLMR), the largest direct screen for constitutional disease-causing mutations thus far reported. The screen has discovered nine genes implicated in XLMR, including SYP, ZNF711 and CASK reported here, confirming the power of this strategy. The study has, however, also highlighted issues confronting whole-genome sequencing screens, including the observation that loss of function of 1% or more of X-chromosome genes is compatible with apparently normal existence.	[Tarpey, Patrick S.; Smith, Raffaella; Pleasance, Erin; Edkins, Sarah; Hardy, Claire; O'Meara, Sarah; Latimer, Calli; Dicks, Ed; Menzies, Andrew; Stephens, Phil; Blow, Matt; Greenman, Chris; Xue, Yali; Tyler-Smith, Chris; Gray, Kristian; Andrews, Jenny; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Dunmore, Rebecca; Jones, David; Maddison, Mark; Mironenko, Tatiana; Turner, Rachel; Turrell, Kelly; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Teague, Jon; Butler, Adam; Jenkinson, Andrew; Jia, Mingming; Richardson, David; Shepherd, Rebecca; Wooster, Richard; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge, England; [Whibley, Annabel; Cox, James; Luo, Ying; Mallya, Uma; Moon, Jenny; Parnau, Josef; Bobrow, Martin; Raymond, F. Lucy] Cambridge Inst Med Res, Cambridge, England; [Thompson, Deborah; Easton, Douglas F.] Strangeways Res Lab, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 4RN, England; [Tejada, M. Isabel] Hosp Cruces, Mol Genet Lab, Bizkaia, Spain; [Martinez, Francisco] Hosp Univ La Fe, Unidad Genet & Diagnost Prenatal, Valencia, Spain; [Carvill, Gemma; Goliath, Rene] Univ S Africa, Fac Hlth Sci, Human Genet Res Unit, MRC, ZA-0001 Pretoria, South Africa; [de Brouwer, Arjan P. M.; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Van Esch, Hilde] Katholieke Univ Leuven Hosp, Ctr Human Genet, Leuven, Belgium; [Chelly, Jamel] Univ Paris 05, Inst Cochin, INSERM, CNRS,Unite 567,UMR 8104, Paris, France; [Raynaud, Martine] Ctr Hosp Reg Univ Tours, INSERM, U930, Serv Genet, Tours, France; [Ropers, Hans-Hilger] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Abidi, Fatima E.; Srivastava, Anand K.; Skinner, Cindy; Stevenson, Roger E.; Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Mohammed, Shehla] Guys Hosp, London SE1 9RT, England; [Tolmie, John L.] Yorkhill Hosp, Inst Med Genet, Glasgow, Lanark, Scotland; [Shoubridge, Cheryl; Corbett, Mark; Gardner, Alison; Haan, Eric; Rujirabanjerd, Sinitdhorn; Shaw, Marie; Vandeleur, Lucianne; Fullston, Tod; Gecz, Jozef] Womens & Childrens Hosp, Adelaide, SA, Australia; [Boyle, Jackie; Partington, Michael; Hackett, Anna; Field, Michael; Turner, Gillian] GOLD Serv, Waratah, NSW, Australia; [Gecz, Jozef] Univ Adelaide, Adelaide, SA, Australia; [Stratton, Michael R.] Inst Canc Res, Surrey, England	Wellcome Trust Sanger Institute; University of Cambridge; Cancer Research UK; University of Cambridge; Hospital Universitario Cruces; Hospital Universitari i Politecnic La Fe; University of South Africa; Radboud University Nijmegen; KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Greenwood Genetic Center; Guy's & St Thomas' NHS Foundation Trust; University of Glasgow; Womens & Childrens Hospital Australia; University of Adelaide; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Martinez, Francisco/A-2543-2009; Van+Esch, Hilde/AAU-5688-2020; Bokhoven, J.H.L.M. van van/H-8015-2014; Whibley, Annabel/P-2509-2017; Blow, Matthew/G-6369-2012; van Bokhoven, Hans/D-8764-2012; Cox, James/R-1910-2016; Gecz, Jozef/X-3469-2019; Corbett, Mark/A-8063-2010; TEJADA, Maria-Isabel/O-5051-2019; Chelly, Jamel/J-7528-2015; Raynaud, Martine/R-9811-2019; Whibley, Annabel/G-2836-2011; M Isabel, Tejada/E-2394-2012; de Brouwer, Arjan PM/P-5949-2015; Shoubridge, Cheryl/A-1571-2016	Martinez, Francisco/0000-0002-0589-2584; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Whibley, Annabel/0000-0003-1878-7705; Blow, Matthew/0000-0002-8844-9149; Gecz, Jozef/0000-0002-7884-6861; Corbett, Mark/0000-0001-9298-3072; TEJADA, Maria-Isabel/0000-0002-7334-1864; Chelly, Jamel/0000-0002-0939-8719; Raynaud, Martine/0000-0002-6888-6480; Shoubridge, Cheryl/0000-0002-0157-3084; Richardson, David/0000-0003-0247-9118; Van Esch, Hilde/0000-0002-9604-5726; Buck, Gemma/0000-0001-5289-1050; Gray, Kristian/0000-0002-7035-7107; Jenkinson, Andrew/0000-0002-0703-6984	European Community's Seventh Framework Programme-the GEN2PHEN Project; New South Wales Department of Health; Australian NHMRC; SMILE foundation; WCH Foundation; D. Harwood, EU (EURO-MRX) [QLG3-CT-2002-01810]; US National Institutes of Health [HD26202]; South Carolina Department of Disabilities and Special Needs (SCDDSN); Action Medical Research; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; Cancer Research UK [10118, 11022] Funding Source: researchfish	European Community's Seventh Framework Programme-the GEN2PHEN Project(European Commission); New South Wales Department of Health; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); SMILE foundation; WCH Foundation; D. Harwood, EU (EURO-MRX); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Department of Disabilities and Special Needs (SCDDSN); Action Medical Research; Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cancer Research UK(Cancer Research UK)	We would like to express our gratitude to the many families with members with mental retardation or learning disability who agreed to participate in these studies performed by the IGOLD consortium. We would also like to thank many clinicians and researchers, including J. T. den Dunnen, L. Holloway, M. May, B. Kerr, J. Erikson, R. Smith, E. Fraser, P. Hodgins, I. Wilkinson, A. J. Gardener, D. Amor, D. Anderson, M. Edwards, V. J. Ajith, A. Barnicoat, P. Beales, K. Becker, A. Brady, C. Brewer, J. Christodoulou, J. Clayton- Smith, T. Cole, A. Collins, J. Cook, J. Craig, S. Davies, H. Dawkins, M. Delatycki, D. Donnai, M. Edwards, F. Essop, D. Fitzpatrick, F. Flinter, B. Franco, A. Fryer, T. Homfray, S. Garcia, C. Gardiner, R. Gardner, C. Garrett, R. Gibbons, A. Green, P. Guilbert, D. Halliday, B. Hamel, P. Harper, E. Hobson, S. Holder, E. Holinski- Feder, H. Hughes, J. Hurst, F. Kavalier, B. Kerr, U. Kini, T. Kleefstra, F. Kooy, K. Lachlan, W. Lam, M. Lees, S. Lindsay, C. Longman, S. Lynch, S. Mansour, C. Mercel, J. McGaughran, V. Murday, J. Nelson, G. Neri, R. Newbury-Ecob, C. Owens, M. Patton, M. Porteous, S. Price, A. Proctor, O. Quarrell, N. Rahman, W. Reardon, E. Rosser, F. Stewart, H. Stewart, S. Tompkins, D. Trump, B. de Vries, T. Webb, D. Wellesley, D. Williams, L. Wilson, R. Winter, N. Wood, and J. Yates, who referred families for research, and N. Rahman for comments on the manuscript. The work was supported by the European Community's Seventh Framework Programme-the GEN2PHEN Project, the New South Wales Department of Health, the Australian NHMRC, the SMILE foundation, the WCH Foundation, D. Harwood, EU grant QLG3-CT-2002-01810 (EURO-MRX), US National Institutes of Health (HD26202) to C. E. S., the South Carolina Department of Disabilities and Special Needs (SCDDSN), Action Medical Research and the Wellcome Trust.	Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; BAIRD PA, 1985, AM J MENT DEF, V89, P323; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; de Brouwer APM, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9482; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Dicks E, 2007, BIOINFORMATICS, V23, P1689, DOI 10.1093/bioinformatics/btm152; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LAXOVA R, 1977, AM J MED GENET, V1, P75, DOI 10.1002/ajmg.1320010109; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; McCandless SE, 2004, AM J HUM GENET, V74, P121, DOI 10.1086/381053; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Osada N, 2007, MOL BIOL EVOL, V24, P1622, DOI 10.1093/molbev/msm080; Polder JJ, 2002, J INTELL DISABIL RES, V46, P168, DOI 10.1046/j.1365-2788.2002.00384.x; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sakharkar Meena Kishore, 2004, Front Biosci, V9, P3262, DOI 10.2741/1478; SCHREPPERS-TIJDINK G A J, 1988, Journal de Genetique Humaine, V36, P425; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013; WHO, 1992, ICD 10 CLASS MENT BE, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P	42	439	458	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					535	543		10.1038/ng.367	http://dx.doi.org/10.1038/ng.367			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19377476	Green Accepted			2022-12-25	WOS:000265575600014
J	Manosas, M; Spiering, MM; Zhuang, ZH; Benkovic, SJ; Croquette, V				Manosas, Maria; Spiering, Michelle M.; Zhuang, Zhihao; Benkovic, Stephen J.; Croquette, Vincent			Coupling DNA unwinding activity with primer synthesis in the bacteriophage T4 primosome	NATURE CHEMICAL BIOLOGY			English	Article							REPLICATION APPARATUS; ACCESSORY PROTEINS; PRIMASE-HELICASE; SINGLE-MOLECULE; T4; POLYMERASE; GENE-41; TEMPLATE; COMPLEX; FORK	The unwinding and priming activities of the bacteriophage T4 primosome, which consists of a hexameric helicase (gp41) translocating 5' to 3' and an oligomeric primase (gp61) synthesizing primers 5' to 3', have been investigated on DNA hairpins manipulated by a magnetic trap. We find that the T4 primosome continuously unwinds the DNA duplex while allowing for primer synthesis through a primosome disassembly mechanism or a new DNA looping mechanism. A fused gp61-gp41 primosome unwinds and primes DNA exclusively via the DNA looping mechanism. Other proteins within the replisome control the partitioning of these two mechanisms by disfavoring primosome disassembly, thereby increasing primase processivity. In contrast to T4, priming in bacteriophage T7 and Escherichia coli involves discrete pausing of the primosome and dissociation of the primase from the helicase, respectively. Thus nature appears to use several strategies to couple the disparate helicase and primase activities within primosomes.	[Spiering, Michelle M.; Zhuang, Zhihao; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Manosas, Maria; Croquette, Vincent] Univ Paris Diderot, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS, Paris, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sjb1@psu.edu; vincent.croquette@lps.ens.fr	Spiering, Michelle M/B-8789-2016	Croquette, Vincent/0000-0003-1400-0039; Manosas Castejon, Maria/0000-0001-8001-4055	Human Frontier Science Program; BioNanoSwitch CEE; US National Institutes of Health [GM013306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); BioNanoSwitch CEE; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Lionnet for initial discussions and D. Bensimon for critical reading of the manuscript. This work was supported by a Human Frontier Science Program grant (to V. C. and S. J. B.), a BioNanoSwitch CEE grant (to V. C.) and US National Institutes of Health grant GM013306 (to S. J. B.).	BARRY J, 1994, J BIOL CHEM, V269, P33049; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; CHA TA, 1986, J BIOL CHEM, V261, P7001; CHA TA, 1990, BIOCHEMISTRY-US, V29, P1791, DOI 10.1021/bi00459a018; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; HINTON DM, 1987, J BIOL CHEM, V262, P10873; HUANG CC, 1981, J BIOL CHEM, V256, P4087; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Jing D, 2004, ELECTROPHORESIS, V25, P2439, DOI 10.1002/elps.200405994; Jing DH, 1999, J BIOL CHEM, V274, P27287, DOI 10.1074/jbc.274.38.27287; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; Khopde S, 2002, BIOCHEMISTRY-US, V41, P14820, DOI 10.1021/bi026711m; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; LIU CC, 1981, J BIOL CHEM, V256, P2813; MORRIS CF, 1975, P NATL ACAD SCI USA, V72, P4800, DOI 10.1073/pnas.72.12.4800; Nelson SW, 2008, J BIOL CHEM, V283, P22838, DOI 10.1074/jbc.M802762200; NOSSAL NG, 1979, J BIOL CHEM, V254, P6026; Raney KD, 1996, J BIOL CHEM, V271, P14074, DOI 10.1074/jbc.271.24.14074; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4725; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4732; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Trakselis MA, 2003, J BIOL CHEM, V278, P49839, DOI 10.1074/jbc.M307405200; Valentine AM, 2001, BIOCHEMISTRY-US, V40, P15074, DOI 10.1021/bi0108554; Vanloock MS, 2001, J MOL BIOL, V311, P951, DOI 10.1006/jmbi.2001.4932; WERNER R, 1968, J MOL BIOL, V33, P679, DOI 10.1016/0022-2836(68)90313-6; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yang JS, 2005, J BIOL CHEM, V280, P25416, DOI 10.1074/jbc.M501847200; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Zhang ZQ, 2005, P NATL ACAD SCI USA, V102, P3254, DOI 10.1073/pnas.0500327102	31	71	73	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					904	912		10.1038/nchembio.236	http://dx.doi.org/10.1038/nchembio.236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19838204	Green Accepted			2022-12-25	WOS:000271756900013
J	Wang, XS; Prensner, JR; Chen, GA; Cao, Q; Han, B; Dhanasekaran, SM; Ponnala, R; Cao, XH; Varambally, S; Thomas, DG; Giordano, TJ; Beer, DG; Palanisamy, N; Sartor, MA; Omenn, GS; Chinnaiyan, AM				Wang, Xiao-Song; Prensner, John R.; Chen, Guoan; Cao, Qi; Han, Bo; Dhanasekaran, Saravana M.; Ponnala, Rakesh; Cao, Xuhong; Varambally, Sooryanarayana; Thomas, Dafydd G.; Giordano, Thomas J.; Beer, David G.; Palanisamy, Nallasivam; Sartor, Maureen A.; Omenn, Gilbert S.; Chinnaiyan, Arul M.			An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer	NATURE BIOTECHNOLOGY			English	Article							PROSTATE-CANCER; LYMPHOBLASTIC-LEUKEMIA; PATHWAY; GENOME; DISCOVERY; RESOURCE; CELLS; JAK2; PI3K	Cancer genomes contain many aberrant gene fusions-a few that drive disease and many more that are nonspecific passengers. We developed an algorithm (the concept signature or 'ConSig' score) that nominates biologically important fusions from high-throughput data by assessing their association with 'molecular concepts' characteristic of cancer genes, including molecular interactions, pathways and functional annotations. Copy number data supported candidate fusions and suggested a breakpoint principle for intragenic copy number aberrations in fusion partners. By analyzing lung cancer transcriptome sequencing and genomic data, we identified a novel R3HDM2-NFE2 fusion in the H1792 cell line. Lung tissue microarrays revealed 2 of 76 lung cancer patients with genomic rearrangement at the NFE2 locus, suggesting recurrence. Knockdown of NFE2 decreased proliferation and invasion of H1792 cells. Together, these results present a systematic analysis of gene fusions in cancer and describe key characteristics that assist in new fusion discovery.	[Wang, Xiao-Song; Sartor, Maureen A.; Omenn, Gilbert S.; Chinnaiyan, Arul M.] CCMB, Natl Ctr Integrat Biomed Informat, Ann Arbor, MI USA; [Wang, Xiao-Song; Prensner, John R.; Cao, Qi; Han, Bo; Dhanasekaran, Saravana M.; Ponnala, Rakesh; Cao, Xuhong; Varambally, Sooryanarayana; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Michigan Ctr Translat Pathol, Ann Arbor, MI USA; [Wang, Xiao-Song; Prensner, John R.; Cao, Qi; Han, Bo; Dhanasekaran, Saravana M.; Cao, Xuhong; Varambally, Sooryanarayana; Thomas, Dafydd G.; Giordano, Thomas J.; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chen, Guoan; Beer, David G.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Omenn, GS (corresponding author), CCMB, Natl Ctr Integrat Biomed Informat, Ann Arbor, MI USA.	gomenn@umich.edu; arul@umich.edu	Palanisamy, Nallasivam/ABC-8844-2020; Chen, Guoan/J-9140-2018; Cao, Qi/A-5517-2010; Sartor, Maureen/L-2902-2019	Palanisamy, Nallasivam/0000-0002-0633-9772; Chen, Guoan/0000-0001-5608-6761; Cao, Qi/0000-0002-5140-3681; Giordano, Thomas/0000-0003-0641-8873; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Prensner, John/0000-0002-7024-636X; Varambally, Sooryanarayana/0000-0002-2277-1127; Omenn, Gilbert S./0000-0002-8976-6074	National Institutes of Health NIH [U01 CA111275, DOD W81XWH-09-2-0014]; National Institutes of Health Cancer Biology Training [CA009676-18]; University of Michigan; Doris Duke Foundation; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009676, U01CA111275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Biology Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank F. Mitelman for offering the fusion genes list from the Mitelman database; T. W. Glover for the important comments for improving the manuscript; J. Granger for help with editing the manuscript; S. Qin for useful discussions about biostatistics; NCIBI colleagues L. Ke and A. Ade for helping in the implementation of tools and technologies; C. Yang for the guidance in drug informatics; Z. Hu from Boston University for help with network visualization. This work was supported by the National Institutes of Health (NIH; U54 DA021519) and a National Institutes of Health Cancer Biology Training Grant (CA009676-18 to J. R. P). J. R. P. is a Fellow of the University of Michigan Medical Scientist Training Program. A. M. C. is supported by NIH early detection network U01 CA111275, DOD W81XWH-09-2-0014, the Doris Duke Foundation and the American Cancer Society.	Bashir A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000051; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chen CC, 2007, ENDOCR-RELAT CANCER, V14, P513, DOI 10.1677/ERC-06-0027; Chen GJ, 2007, J CELL BIOCHEM, V101, P1492, DOI 10.1002/jcb.21265; Drexler HG, 2000, LEUKEMIA LYMPHOMA CE; Fuhrer DK, 1996, BIOCHEM BIOPH RES CO, V224, P289, DOI 10.1006/bbrc.1996.1023; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hu ZJ, 2007, NUCLEIC ACIDS RES, V35, pW625, DOI 10.1093/nar/gkm295; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; RICHARD W, 2009, OVERALL EXPT CHARACT; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Vantler M, 2006, FEBS LETT, V580, P6769, DOI 10.1016/j.febslet.2006.11.034; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Walz C, 2008, LEUKEMIA, V22, P1320, DOI 10.1038/leu.2008.133; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	30	58	65	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2009	27	11					1005	U73		10.1038/nbt.1584	http://dx.doi.org/10.1038/nbt.1584			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	516EM	19881495	Green Accepted			2022-12-25	WOS:000271524700021
J	Klamt, F; Zdanov, S; Levine, RL; Pariser, A; Zhang, YQ; Zhang, BL; Yu, LR; Veenstra, TD; Shacter, E				Klamt, Fabio; Zdanov, Stephanie; Levine, Rodney L.; Pariser, Ashley; Zhang, Yaqin; Zhang, Baolin; Yu, Li-Rong; Veenstra, Timothy D.; Shacter, Emily			Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin	NATURE CELL BIOLOGY			English	Article							HYPOCHLOROUS ACID; CELL-DEATH; PERMEABILITY TRANSITION; HYDROGEN-PEROXIDE; MITOCHONDRIAL PERMEABILITY; LYMPHOMA-CELLS; STRESS; CYSTEINE; CANCER; CHLORAMINES	Physiological oxidants that are generated by activated phagocytes comprise the main source of oxidative stress during inflammation(1,2). Oxidants such as taurine chloramine (TnCl) and hydrogen peroxide (H2O2) can damage proteins and induce apoptosis, but the role of specific protein oxidation in this process has not been defined. We found that the actin-binding protein cofilin is a key target of oxidation. When oxidation of this single regulatory protein is prevented, oxidant-induced apoptosis is inhibited. Oxidation of cofilin causes it to lose its affinity for actin and to translocate to the mitochondria, where it induces swelling and cytochrome c release by mediating opening of the permeability transition pore (PTP). This occurs independently of Bax activation and requires both oxidation of cofilin Cys residues and dephosphorylation at Ser 3. Knockdown of endogenous cofilin using targeted siRNA inhibits oxidant-induced apoptosis, which is restored by re-expression of wild-type cofilin but not by cofilin containing Cys to Ala mutations. Exposure of cofilin to TnCl results in intramolecular disulphide bonding and oxidation of Met residues to Met sulphoxide, but only Cys oxidation causes cofilin to induce mitochondrial damage.	[Klamt, Fabio; Zdanov, Stephanie; Pariser, Ashley; Zhang, Yaqin; Zhang, Baolin; Shacter, Emily] US FDA, Biochem Lab, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Klamt, Fabio] Univ Fed Rio Grande do Sul, Ctr Oxidat Stress Res, Dept Biochem, ICBS, BR-90035003 Porto Alegre, RS, Brazil; [Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Yu, Li-Rong] US FDA, Ctr Prote, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Yu, Li-Rong; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21702 USA	US Food & Drug Administration (FDA); Universidade Federal do Rio Grande do Sul; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Shacter, E (corresponding author), US FDA, Biochem Lab, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA.	emily.shacter@fda.hhs.gov	Zdanov, Stephanie/G-2524-2012; Levine, Rodney L/D-9885-2011	Yu, Li-Rong/0000-0001-6084-991X; Pariser, Ashley/0000-0002-7993-6316	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HL000225-31] Funding Source: Medline; NCI NIH HHS [N01-CO-12400, N01CO12400] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Englert RP, 2002, J BIOL CHEM, V277, P20518, DOI 10.1074/jbc.M200212200; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kang DK, 2003, J BIOL CHEM, V278, P14857, DOI 10.1074/jbc.M300616200; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z; Klamt F, 2005, BBA-GEN SUBJECTS, V1726, P14, DOI 10.1016/j.bbagen.2005.07.016; Klamt F, 2005, J BIOL CHEM, V280, P21346, DOI 10.1074/jbc.M501170200; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; Levine RL, 2006, RAPID COMMUN MASS SP, V20, P1828, DOI 10.1002/rcm.2519; Mannherz HG, 2005, EUR J CELL BIOL, V84, P503, DOI 10.1016/j.ejcb.2004.11.008; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Prutz WA, 1996, ARCH BIOCHEM BIOPHYS, V332, P110, DOI 10.1006/abbi.1996.0322; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Senturker S, 2002, ARCH BIOCHEM BIOPHYS, V397, P262, DOI 10.1006/abbi.2001.2681; Shacter E, 2000, BLOOD, V96, P307, DOI 10.1182/blood.V96.1.307.013k47_307_313; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; Yu LR, 2004, MOL CELL PROTEOMICS, V3, P896, DOI 10.1074/mcp.M400034-MCP200; Zhu BB, 2006, CANCER RES, V66, P8640, DOI 10.1158/0008-5472.CAN-06-1443	38	173	178	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1241	U193		10.1038/ncb1968	http://dx.doi.org/10.1038/ncb1968			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19734890	Green Accepted			2022-12-25	WOS:000270382000014
J	Yan, ZH; Garg, SK; Kipnis, J; Banerjee, R				Yan, Zhonghua; Garg, Sanjay K.; Kipnis, Jonathan; Banerjee, Ruma			Extracellular redox modulation by regulatory T cells	NATURE CHEMICAL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; THIOL/DISULFIDE REDOX; DENDRITIC CELLS; GLUTATHIONE; PROLIFERATION; ACTIVATION; SUSCEPTIBILITY; LYMPHOCYTES; EXCHANGE; THIOLS	We demonstrate that the mechanism of redox remodeling during mouse T-cell activation involves secretion of glutathione by dendritic cells and its subsequent cleavage to cysteine. Extracellular cysteine accumulation results in a lower redox potential, which is conducive to proliferation, and changes the net redox status of exofacial protein domains. Regulatory T cells inhibit this redox metabolite signaling pathway, which represents a previously unrecognized mechanism for immunosuppression of effector T cells.	[Yan, Zhonghua; Garg, Sanjay K.; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Kipnis, Jonathan] Univ Virginia, Dept Neurosci, Charlottesville, VA USA	University of Michigan System; University of Michigan; University of Virginia	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X	US National Institutes of Health [DK64959, NIH5P60 DK20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK064959, P60DK020572] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from the US National Institutes of Health (DK64959 and NIH5P60 DK20572).	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Blakytny R, 2006, INT J BIOCHEM CELL B, V38, P1363, DOI 10.1016/j.biocel.2006.01.017; DROGE W, 1991, AM J MED, V91, pS140, DOI 10.1016/0002-9343(91)90297-B; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; ISHII T, 1987, J CELL PHYSIOL, V133, P330, DOI 10.1002/jcp.1041330217; Jonas CR, 2002, FREE RADICAL BIO MED, V33, P1499, DOI 10.1016/S0891-5849(02)01081-X; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; MESSINA JP, 1989, J IMMUNOL, V143, P1974; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Ramirez A, 2007, AM J PHYSIOL-LUNG C, V293, pL972, DOI 10.1152/ajplung.00010.2007; Sahaf B, 2005, ARCH BIOCHEM BIOPHYS, V434, P26, DOI 10.1016/j.abb.2004.11.015; Sahaf B, 2003, P NATL ACAD SCI USA, V100, P4001, DOI 10.1073/pnas.2628032100; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yoshimura S, 2001, INT IMMUNOL, V13, P675, DOI 10.1093/intimm/13.5.675	25	112	113	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					721	723		10.1038/nchembio.212	http://dx.doi.org/10.1038/nchembio.212			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19718041	Green Accepted			2022-12-25	WOS:000270039900008
J	Clark, MA; Acharya, RA; Arico-Muendel, CC; Belyanskaya, SL; Benjamin, DR; Carlson, NR; Centrella, PA; Chiu, CH; Creaser, SP; Cuozzo, JW; Davie, CP; Ding, Y; Franklin, GJ; Franzen, KD; Gefter, ML; Hale, SP; Hansen, NJV; Israel, DI; Jiang, JW; Kavarana, MJ; Kelley, MS; Kollmann, CS; Li, F; Lind, K; Mataruse, S; Medeiros, PF; Messer, JA; Myers, P; O'Keefe, H; Oliff, MC; Rise, CE; Satz, AL; Skinner, SR; Svendsen, JL; Tang, LJ; van Vloten, K; Wagner, RW; Yao, G; Zhao, BG; Morgan, BA				Clark, Matthew A.; Acharya, Raksha A.; Arico-Muendel, Christopher C.; Belyanskaya, Svetlana L.; Benjamin, Dennis R.; Carlson, Neil R.; Centrella, Paolo A.; Chiu, Cynthia H.; Creaser, Steffen P.; Cuozzo, John W.; Davie, Christopher P.; Ding, Yun; Franklin, G. Joseph; Franzen, Kurt D.; Gefter, Malcolm L.; Hale, Steven P.; Hansen, Nils J. V.; Israel, David I.; Jiang, Jinwei; Kavarana, Malcolm J.; Kelley, Michael S.; Kollmann, Christopher S.; Li, Fan; Lind, Kenneth; Mataruse, Sibongile; Medeiros, Patricia F.; Messer, Jeffrey A.; Myers, Paul; O'Keefe, Heather; Oliff, Matthew C.; Rise, Cecil E.; Satz, Alexander L.; Skinner, Steven R.; Svendsen, Jennifer L.; Tang, Lujia; van Vloten, Kurt; Wagner, Richard W.; Yao, Gang; Zhao, Baoguang; Morgan, Barry A.			Design, synthesis and selection of DNA-encoded small-molecule libraries	NATURE CHEMICAL BIOLOGY			English	Article							CHEMICAL LIBRARIES; RNA DISPLAY; LIGANDS; EVOLUTION; DISCOVERY; PHAGE	Biochemical combinatorial techniques such as phage display, RNA display and oligonucleotide aptamers have proven to be reliable methods for generation of ligands to protein targets. Adapting these techniques to small synthetic molecules has been a long-sought goal. We report the synthesis and interrogation of an 800-million-member DNA-encoded library in which small molecules are covalently attached to an encoding oligonucleotide. The library was assembled by a combination of chemical and enzymatic synthesis, and interrogated by affinity selection. We describe methods for the selection and deconvolution of the chemical display library, and the discovery of inhibitors for two enzymes: Aurora A kinase and p38 MAP kinase.	[Clark, Matthew A.; Acharya, Raksha A.; Arico-Muendel, Christopher C.; Belyanskaya, Svetlana L.; Benjamin, Dennis R.; Carlson, Neil R.; Centrella, Paolo A.; Chiu, Cynthia H.; Creaser, Steffen P.; Cuozzo, John W.; Davie, Christopher P.; Ding, Yun; Franklin, G. Joseph; Franzen, Kurt D.; Gefter, Malcolm L.; Hale, Steven P.; Hansen, Nils J. V.; Israel, David I.; Jiang, Jinwei; Kavarana, Malcolm J.; Kelley, Michael S.; Kollmann, Christopher S.; Li, Fan; Lind, Kenneth; Mataruse, Sibongile; Medeiros, Patricia F.; Messer, Jeffrey A.; Myers, Paul; O'Keefe, Heather; Oliff, Matthew C.; Rise, Cecil E.; Satz, Alexander L.; Skinner, Steven R.; Svendsen, Jennifer L.; Tang, Lujia; van Vloten, Kurt; Wagner, Richard W.; Yao, Gang; Morgan, Barry A.] GlaxoSmithKline, Mol Discovery Res Boston, Waltham, MA USA; [Zhao, Baoguang] GlaxoSmithKline, Computat & Struct Chem, King Of Prussia, PA USA	GlaxoSmithKline; GlaxoSmithKline	Morgan, BA (corresponding author), GlaxoSmithKline, Mol Discovery Res Boston, Waltham, MA USA.	barry.a.morgan@gsk.com		Messer, Jeffrey/0000-0001-6636-9642; Cuozzo, John/0000-0002-6229-0395				Barbas Carlos F. Iii, 1993, Current Opinion in Biotechnology, V4, P526, DOI 10.1016/0958-1669(93)90072-5; BRENNER S, 1992, P NATL ACAD SCI USA, V89, P5381, DOI 10.1073/pnas.89.12.5381; Buller F, 2008, BIOORG MED CHEM LETT, V18, P5926, DOI 10.1016/j.bmcl.2008.07.038; BURNS CJ, 2005, Patent No. 2005054230; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Frankel A, 2003, CURR OPIN STRUC BIOL, V13, P506, DOI 10.1016/S0959-440X(03)00110-6; Gartner ZJ, 2002, ANGEW CHEM INT EDIT, V41, P1796, DOI 10.1002/1521-3773(20020517)41:10<1796::AID-ANIE1796>3.0.CO;2-Z; Halpin DR, 2004, PLOS BIOL, V2, P1031, DOI 10.1371/journal.pbio.0020175; Hansen MH, 2009, J AM CHEM SOC, V131, P1322, DOI 10.1021/ja808558a; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; Kinoshita Y, 1995, Nucleic Acids Symp Ser, P201; Leftheris K, 2004, J MED CHEM, V47, P6283, DOI 10.1021/jm049521d; Li XY, 2004, ANGEW CHEM INT EDIT, V43, P4848, DOI 10.1002/anie.200400656; Mannocci L, 2008, P NATL ACAD SCI USA, V105, P17670, DOI 10.1073/pnas.0805130105; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Melkko S, 2004, NAT BIOTECHNOL, V22, P568, DOI 10.1038/nbt961; Melkko S, 2007, DRUG DISCOV TODAY, V12, P465, DOI 10.1016/j.drudis.2007.04.007; Morgan B., 2007, Patent No. [WO2007053358, 2007053358]; Mortlock A, 2005, CURR TOP MED CHEM, V5, P805, DOI 10.2174/1568026054637719; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Western EC, 2003, J ORG CHEM, V68, P6767, DOI 10.1021/jo034289p; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Wrenn SJ, 2007, J AM CHEM SOC, V129, P13137, DOI 10.1021/ja073993a	25	432	455	3	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					647	654		10.1038/nchembio.211	http://dx.doi.org/10.1038/nchembio.211			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19648931				2022-12-25	WOS:000269093000013
J	Echtermeyer, F; Bertrand, J; Dreier, R; Meinecke, I; Neugebauer, K; Fuerst, M; Lee, YJ; Song, YW; Herzog, C; Theilmeier, G; Pap, T				Echtermeyer, Frank; Bertrand, Jessica; Dreier, Rita; Meinecke, Ingmar; Neugebauer, Katja; Fuerst, Martin; Lee, Yun Jong; Song, Yeong Wook; Herzog, Christine; Theilmeier, Gregor; Pap, Thomas			Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis	NATURE MEDICINE			English	Article							ARTICULAR-CARTILAGE; AGGRECAN DEGRADATION; KNEE-JOINTS; IN-VITRO; METALLOPROTEINASE; KINASE; MICE; EXPRESSION; EXPLANTS; DELETION	Aggrecan cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 5 (ADAMTS-5) is crucial for the breakdown of cartilage matrix during osteoarthritis(1,2), a degenerative joint disease that leads to the progressive destruction of articular structures. The mechanisms of ADAMTS-5 activation and their links to the pathogenesis of osteoarthritis remain poorly understood, but syndecans have been shown to be involved in the activation of ADAMTS-4 (ref. 3). Here we show that syndecan-4 is specifically induced in type X collagen-producing chondrocytes both in human osteoarthritis and in murine models of the disease. The loss of syndecan-4 in genetically modified mice and intra-articular injections of syndecan-4-specific antibodies into wild-type mice protect from proteoglycan loss and thereby prevent osteoarthritic cartilage damage in a surgically induced model of osteoarthritis. The occurrence of less severe osteoarthritis-like cartilage destruction in both syndecan-4-deficient mice and syndecan-4-specific antibody-treated wild-type mice results from a marked decrease in ADAMTS-5 activity. Syndecan-4 controls the activation of ADAMTS-5 through direct interaction with the protease and through regulating mitogen-activated protein kinase (MAPK)-dependent synthesis of matrix metalloproteinase-3 (MMP-3). Our data suggest that strategies aimed at the inhibition of syndecan-4 will be of great value for the treatment of cartilage damage in osteoarthritis.	[Echtermeyer, Frank; Herzog, Christine; Theilmeier, Gregor] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany; [Dreier, Rita] Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, Munster, Germany; [Meinecke, Ingmar] Univ Hosp Munster, Dept Trauma Hand & Reconstruct Surg, Munster, Germany; [Fuerst, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Orthoped Surg, Hamburg, Germany; [Lee, Yun Jong; Song, Yeong Wook] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Bertrand, Jessica; Meinecke, Ingmar; Neugebauer, Katja; Pap, Thomas] Univ Hosp Munster, Inst Expt Musculoskeletal Med, Munster, Germany	Hannover Medical School; University of Munster; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; Seoul National University (SNU); University of Munster	Echtermeyer, F (corresponding author), Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany.	echtermeyer.frank@mh-hannover.de; Thomas.pap@uni-muenster.de	Song, Yeong-Wook/J-2765-2012	Bertrand, Jessica/0000-0001-9511-4999	German Research Foundation; Deutsche Forschungsgemeinschaft [Pa689/7-1, Th667/6-1]; Collaborative Research Centres [SFB 492]; Deutsche Arthrosehilfe [p77-a117-Ruther-EP2-fuer1-knie-ko-49k-2006-7];  [B18];  [B19]	German Research Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Centres; Deutsche Arthrosehilfe; ; 	We would like to thank A. Forsberg, S. Niehues, S. Ecklebe and K. Reher for technical assistance. This work was supported by the German Research Foundation ( Deutsche Forschungsgemeinschaft; Pa689/7-1 to T. P. and F. E. and Th667/6-1 to G. T. and C. H.), the Collaborative Research Centres (SFB 492; project B18 to R. D. and B19 to T. P.) and Deutsche Arthrosehilfe e.V (p77-a117-Ruther-EP2-fuer1-knie-ko-49k-2006-7 to M. F.).	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Barre PE, 2000, OSTEOARTHR CARTILAGE, V8, P34, DOI 10.1053/joca.1999.0286; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139; Brooks PM, 2006, CLIN RHEUMATOL, V25, P778, DOI 10.1007/s10067-006-0240-3; Clements KM, 2003, ARTHRITIS RHEUM-US, V48, P3452, DOI 10.1002/art.11355; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Molteni A, 1999, BONE, V24, P337, DOI 10.1016/S8756-3282(98)00191-4; Ostergaard K, 1999, ANN RHEUM DIS, V58, P208, DOI 10.1136/ard.58.4.208; Pap G, 1998, PATHOL RES PRACT, V194, P41, DOI 10.1016/S0344-0338(98)80010-1; Pattoli MA, 2005, J PHARMACOL EXP THER, V315, P382, DOI 10.1124/jpet.105.087569; Poole AR, 2003, BIOCHEM SOC SYMP, V70, P115, DOI 10.1042/bss0700115; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tortorella MD, 2005, ARCH BIOCHEM BIOPHYS, V444, P34, DOI 10.1016/j.abb.2005.09.018; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200	29	245	255	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2009	15	9					1072	U127		10.1038/nm.1998	http://dx.doi.org/10.1038/nm.1998			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19684582				2022-12-25	WOS:000269979200029
J	Jandial, R; Snyder, EY				Jandial, Rahul; Snyder, Evan Y.			On guard against cancer	NATURE MEDICINE			English	Editorial Material							CELLS; MODEL; IDENTIFICATION; NEURONS; BRAIN		[Jandial, Rahul; Snyder, Evan Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Jandial, Rahul] Div Neurosurg, Duarte, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Jandial, R (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	esnyder@burnham.org						Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Keller C, 2005, CANCER RES, V65, P7530, DOI 10.1158/0008-5472.CAN-05-0477; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Singh SK, 2003, CANCER RES, V63, P5821; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	13	29	30	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					999	1001		10.1038/nm0909-999	http://dx.doi.org/10.1038/nm0909-999			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19734873				2022-12-25	WOS:000269979200016
J	Mueller, EG				Mueller, Eugene G.			Se-ing into selenocysteine biosynthesis	NATURE CHEMICAL BIOLOGY			English	News Item							MECHANISM; SYNTHASE	A cocrystal structure of the enzyme that synthesizes selenocysteine reveals the elegantly simple recognition mechanism for the tRNA molecule for this '21(st) amino acid'. The structure resolves some mechanistic questions and allows for comparison of the tRNA-dependent synthesis of cysteine and selenocysteine.	Univ Louisville, Dept Chem, Louisville, KY 40292 USA	University of Louisville	Mueller, EG (corresponding author), Univ Louisville, Dept Chem, Louisville, KY 40292 USA.	eugene.mueller@louisville.edu						Araiso Y, 2008, NUCLEIC ACIDS RES, V36, P1187, DOI 10.1093/nar/gkm1122; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; Hauenstein SI, 2008, J BIOL CHEM, V283, P22007, DOI 10.1074/jbc.M801839200; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	7	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					611	612		10.1038/nchembio0909-611	http://dx.doi.org/10.1038/nchembio0909-611			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19690534				2022-12-25	WOS:000269093000006
J	Trevino, LR; Yang, WJ; French, D; Hunger, SP; Carroll, WL; Devidas, M; Willman, C; Neale, G; Downing, J; Raimondi, SC; Pui, CH; Evans, WE; Relling, MV				Trevino, Lisa R.; Yang, Wenjian; French, Deborah; Hunger, Stephen P.; Carroll, William L.; Devidas, Meenakshi; Willman, Cheryl; Neale, Geoffrey; Downing, James; Raimondi, Susana C.; Pui, Ching-Hon; Evans, William E.; Relling, Mary V.			Germline genomic variants associated with childhood acute lymphoblastic leukemia	NATURE GENETICS			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; MINIMAL RESIDUAL DISEASE; DNA-BINDING PROPERTIES; IKAROS GENE ENCODES; NATIONAL-INSTITUTE; BIPOLAR DISORDER; WIDE ANALYSIS; IN-VIVO; POLYMORPHISMS; EXPRESSION	Using the Affymetrix 500K Mapping array and publicly available genotypes, we identified 18 SNPs whose allele frequency differed significantly(P < 1 x 10(-5)) between pediatric acute lymphoblastic leukemia (ALL) cases (n = 317) and non-ALL controls (n = 17,958). Two SNPs in ARID5B not only differed between ALL and non-ALL groups (rs10821936, P = 1.4 x 10(-15), odds ratio (OR) = 1.91; rs10994982, P = 5.7 x 10(-9), OR = 1.62) but also distinguished B-hyperdiploid ALL from other subtypes (rs10821936, P = 1.62 x 10(-5), OR = 2.17; rs10994982, P = 0.003, OR 1.72). These ARID5B SNPs also distinguished B-hyperdiploid ALL from other subtypes in an independent validation cohort (n 124 children with ALL; P 0.003 and P = 0.0008, OR 2.45 and 2.86, respectively) and were associated with methotrexate accumulation and gene expression pattern in leukemic lymphoblasts. We conclude that germline variants affect susceptibility to, and characteristics of, specific ALL subtypes.	[Trevino, Lisa R.; Yang, Wenjian; French, Deborah; Neale, Geoffrey; Downing, James; Raimondi, Susana C.; Pui, Ching-Hon; Evans, William E.; Relling, Mary V.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Hunger, Stephen P.] Univ Colorado, Denver, CO 80202 USA; [Carroll, William L.] NYU, Med Ctr, New York, NY 10016 USA; [Devidas, Meenakshi] Univ Florida, Gainesville, FL USA; [Willman, Cheryl] Univ New Mexico, Albuquerque, NM 87131 USA	St Jude Children's Research Hospital; University of Colorado System; University of Colorado Denver; New York University; State University System of Florida; University of Florida; University of New Mexico	Relling, MV (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	mary.relling@stjude.org	Relling, Mary/N-5032-2018; Raimondi, Susana C/N-8166-2018; Devidas, Meenakshi/H-1170-2019; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012	Devidas, Meenakshi/0000-0002-1099-3478; Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322	NATIONAL CANCER INSTITUTE [R01CA078224, U10CA098543, U01CA157937, R01CA036401, U10CA098413, U10CA029139, R37CA036401, P30CA021765, R01CA051001, R29CA051001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374, U01GM061393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061675, R01MH059548, U01MH079470, R01MH059588, R01MH059567, R01MH081800, R01MH059586, U01MH079469, R01MH059553, R01MH060068, R01MH059533, R01MH059571, Z01MH002810, R01MH059534, U01MH046276, R01MH060879, R01MH060870, R01MH059556, R01MH059535, R01MH067257, R01MH059545, R01MH059587, R01MH059566, R01MH059565, U01MH046318] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 MH002810] Funding Source: Medline; NCI NIH HHS [P30 CA021765-259006, CA 21765, U10 CA098413-07, CA 078224, R01 CA051001-15, R01 CA078224-10, R01 CA036401, U10 CA098543-07, U01 CA157937, R01 CA078224, R01 CA051001, P30 CA021765, U10 CA098543, CA 51001, R37 CA036401, CA 36401, U10 CA029139-22, U10 CA098413, R37 CA036401-24] Funding Source: Medline; NHLBI NIH HHS [U01 HL65899, U01 HL065899, U01 HL065899-07] Funding Source: Medline; NIGMS NIH HHS [U01 GM061393, U01 GM061393-100007, U01 GM061374-07, U01 GM61393, U01 GM061374, U01GM61374] Funding Source: Medline; NIMH NIH HHS [R01 MH059586, R01 MH059587, R01 MH059533, R01 MH059553, R01 MH060068, R01 MH061675, R01 MH059556, R01 MH059566, U01 MH079469, R01 MH059535, R01 MH059588, U01 MH046318, R01 MH059545, R01 MH060879, U01 MH046276, R01 MH067257, R01 MH060870, R01 MH081800, U01 MH079470, R01 MH059567, R01 MH059565, R01 MH059571, R01 MH059534, R01 MH059548] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Borowitz MJ, 2003, LEUKEMIA, V17, P1566, DOI 10.1038/sj.leu.2403001; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell PJ, 2009, NAT GENET, V41, P385, DOI 10.1038/ng0409-385; Chang LW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r38; Chen HC, 2008, EUR J CANCER PREV, V17, P251, DOI 10.1097/CEJ.0b013e3282b72093; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; FABRE G, 1983, CANCER RES, V43, P4648; Greaves M, 2002, BRIT MED J, V324, P283, DOI 10.1136/bmj.324.7332.283; GREAVES MF, 1988, LEUKEMIA, V2, P120; Healy J, 2007, BLOOD, V109, P683, DOI 10.1182/blood-2006-02-003236; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; Kim MS, 2008, HUM PATHOL, V39, P1059, DOI 10.1016/j.humpath.2007.11.013; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; Mathonnet G, 2003, BRIT J HAEMATOL, V123, P45, DOI 10.1046/j.1365-2141.2003.04551.x; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Molnar A, 1996, J IMMUNOL, V156, P585; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Paulsson K, 2005, GENE CHROMOSOME CANC, V44, P113, DOI 10.1002/gcc.20222; Perera FP, 1997, SCIENCE, V278, P1068, DOI 10.1126/science.278.5340.1068; Pritchard JK, 2000, GENETICS, V155, P945; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Schnakenberg E, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-23; Sobti RC, 2008, BIOMARKERS, V13, P282, DOI [10.1080/13547500701843437, 10.1080/13547500701843437 ]; Stanulla M, 2000, BLOOD, V95, P1222, DOI 10.1182/blood.V95.4.1222.004k20_1222_1228; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; SYNOLD TW, 1994, J CLIN INVEST, V94, P1996, DOI 10.1172/JCI117552; Urayama KY, 2007, CANCER EPIDEM BIOMAR, V16, P1172, DOI 10.1158/1055-9965.EPI-07-0007; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298; Wilsker D, 2004, NUCLEIC ACIDS RES, V32, P1345, DOI 10.1093/nar/gkh277; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Ziino O, 2006, HAEMATOLOGICA, V91, P139	47	357	371	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1001	U67		10.1038/ng.432	http://dx.doi.org/10.1038/ng.432			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19684603	Green Accepted			2022-12-25	WOS:000269382100012
J	Abdallah, P; Luciano, P; Runge, KW; Lisby, M; Geli, V; Gilson, E; Teixeira, MT				Abdallah, Pauline; Luciano, Pierre; Runge, Kurt W.; Lisby, Michael; Geli, Vincent; Gilson, Eric; Teixeira, M. Teresa			A two-step model for senescence triggered by a single critically short telomere	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; DNA-DAMAGE; LENGTH; PATHWAY; MMS1; RECOMBINATION; MAINTENANCE; ELONGATION; PROTEINS	Telomeres protect chromosome ends from fusion and degradation(1). In the absence of a specific telomere elongation mechanism, their DNA shortens progressively with every round of replication, leading to replicative senescence(2). Here, we show that telomerase-deficient cells bearing a single, very short telomere senesce earlier, demonstrating that the length of the shortest telomere is a major determinant of the onset of senescence. We further show that Mec1p-ATR specifically recognizes the single, very short telomere causing the accelerated senescence. Strikingly, before entering senescence, cells divide for several generations despite complete erosion of their shortened telomeres. This pre-senescence growth requires RAD52 (radiation sensitive) and MMS1 (methyl methane sulfonate sensitive), and there is no evidence for major intertelomeric recombination. We propose that, in the absence of telomerase, a very short telomere is first maintained in a pre-signalling state by a RAD52-MMS1-dependent pathway and then switches to a signalling state leading to senescence through a Mec1p-dependent checkpoint.	[Abdallah, Pauline; Gilson, Eric; Teixeira, M. Teresa] Univ Lyon 1, CNRS, Ecole Normale Super, UMR 5239,LBMC, F-69364 Lyon 07, France; [Luciano, Pierre; Geli, Vincent] Univ Aix Marseille 2, Unite Propre Rech 3081, CNRS, F-13402 Marseille 20, France; [Runge, Kurt W.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Lisby, Michael] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Cleveland Clinic Foundation; University of Copenhagen	Gilson, E (corresponding author), Univ Lyon 1, CNRS, Ecole Normale Super, UMR 5239,LBMC, 46 Allee Italie, F-69364 Lyon 07, France.	eric.gilson@ens-lyon.fr	Lisby, Michael/K-9814-2014; Teixeira, Maria Teresa/A-2100-2011; Runge, Kurt/AAW-9308-2021	Lisby, Michael/0000-0002-4830-5247; Teixeira, Maria Teresa/0000-0002-9466-7951; Runge, Kurt/0000-0001-8492-0530	La Ligue Contre le Cancer; INCa; The Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019960] Funding Source: NIH RePORTER	La Ligue Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); The Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation(Villum Fonden); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Wellinger and L. Rudolph for fruitful suggestions, G. Yvert and C. Lopes for advice in statistical analysis and A. Jacquier for sharing unpublished material. We also thank T. Petes, M. P. Longhese and S. Marcand for strains and plasmids. P. A. gratefully acknowledges the financial support of the Lebanese National council for Scientific Research (CNRSL) and the Association pour la Recherche sur le Cancer (ARC). This work was supported by La Ligue Contre le Cancer (E. G. and V. G., equipes labellisees), the INCa programmes TELINCA and TELOFUN ( E. G. and V. G.), The Danish Agency for Science, Technology and Innovation (M. L.), the Villum Kann Rasmussen Foundation (M. L.) and the National Institutes of Health (K. R.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arneric M, 2007, EMBO REP, V8, P1080, DOI 10.1038/sj.embor.7401082; Bianchi A, 2007, GENE DEV, V21, P1726, DOI 10.1101/gad.438907; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Duro E, 2008, DNA REPAIR, V7, P811, DOI 10.1016/j.dnarep.2008.01.007; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hryciw T, 2002, MOL GENET GENOMICS, V266, P848, DOI 10.1007/s00438-001-0605-x; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Longhese MP, 2000, GENETICS, V155, P1577; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Mallory JC, 2000, P NATL ACAD SCI USA, V97, P13749, DOI 10.1073/pnas.250475697; Mantiero D, 2007, EMBO REP, V8, P380, DOI 10.1038/sj.embor.7400911; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Sadaie M, 2003, GENE DEV, V17, P2271, DOI 10.1101/gad.1112103; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tresaugues L, 2006, J MOL BIOL, V359, P1170, DOI 10.1016/j.jmb.2006.04.050; Ui A, 2007, BIOCHEM BIOPH RES CO, V356, P1031, DOI 10.1016/j.bbrc.2007.03.088; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	35	120	124	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					988	U174		10.1038/ncb1911	http://dx.doi.org/10.1038/ncb1911			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597486	Green Accepted			2022-12-25	WOS:000268593200013
J	Carpenter, MK; Frey-Vasconcells, J; Rao, MS				Carpenter, Melissa K.; Frey-Vasconcells, Joyce; Rao, Mahendra S.			Developing safe therapies from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							PARKINSONS-DISEASE; GENE-EXPRESSION; HUMAN ES; LINES; TRANSPLANTATION; GENERATION; SURVIVAL; DIFFERENTIATION; TUMORS; INACTIVATION	Translation of human pluripotent stem cells into cell therapies will require the development of standardized tests for product consistency, stability, tumorigenicity, toxicity and immunogenicity.	[Carpenter, Melissa K.] Carpenter Grp, San Diego, CA USA; [Frey-Vasconcells, Joyce] Pharmanet Consulting, Princeton, NJ USA; [Rao, Mahendra S.] Invitrogen Corp, Frederick, MD USA	Thermo Fisher Scientific	Carpenter, MK (corresponding author), Carpenter Grp, San Diego, CA USA.	m_carpenter@mac.com						Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; ANDREWS PW, 1988, BIOCHIM BIOPHYS ACTA, V948, P17, DOI 10.1016/0304-419X(88)90003-0; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; BACH FH, 1968, LANCET, V2, P1364; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; Condic ML, 2008, STEM CELLS, V26, P2753, DOI 10.1634/stemcells.2008-0421; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Flynn CM, 2007, BLOOD, V109, P2688, DOI 10.1182/blood-2006-07-021980; GATTI RA, 1968, LANCET, V2, P1366; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; KLEPPNER SR, 1995, J COMP NEUROL, V357, P618, DOI 10.1002/cne.903570410; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Martin-Ibanez R, 2008, HUM REPROD, V23, P2744, DOI 10.1093/humrep/den316; Mostert MMC, 1996, CANCER GENET CYTOGEN, V87, P95, DOI 10.1016/0165-4608(95)00233-2; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pannetier M, 2007, TRENDS BIOTECHNOL, V25, P556, DOI 10.1016/j.tibtech.2007.09.003; Preti RA, 2005, NAT BIOTECHNOL, V23, P801, DOI 10.1038/nbt0705-801; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rao M, 2008, STEM CELLS DEV, V17, P1, DOI 10.1089/scd.2008.0013; Rao MS, 2006, LANCET, V367, P650, DOI 10.1016/S0140-6736(06)68261-5; Ravindran G, 2008, BIOCHEM BIOPH RES CO, V373, P258, DOI 10.1016/j.bbrc.2008.06.022; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Shih CC, 2007, STEM CELLS DEV, V16, P893, DOI 10.1089/scd.2007.0070; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Sun BW, 2006, HUM MOL GENET, V15, P65, DOI 10.1093/hmg/ddi427; Sun XF, 2008, HUM REPROD, V23, P2185, DOI 10.1093/humrep/den137; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ulbright TM, 2005, MODERN PATHOL, V18, pS61, DOI 10.1038/modpathol.3800310; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu H, 2006, PEDIATR RES, V59, p21R, DOI 10.1203/01.pdr.0000203565.76028.2a; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	77	95	97	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2009	27	7					606	613		10.1038/nbt0709-606	http://dx.doi.org/10.1038/nbt0709-606			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	469OF	19587662				2022-12-25	WOS:000267908500014
J	Fawcett, JW; Curt, A				Fawcett, James W.; Curt, Armin			Rehabilitation in a plastic environment	NATURE MEDICINE			English	Editorial Material							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; RECOVERY; RATS; REGENERATION; EXERCISE; STROKE; IMPACT; TRIAL; NOGO	People with damage to the central nervous system often undergo rehabilitation therapy. James Fawcett and Armin Curt examine how such therapy might work in conjunction with experimental approaches that increase the ability of neurons to form new connections. They discuss how animal studies raise questions about how to test such approaches in people in a field where firm data are already hard to come by. Phillip Popovich and Dana McTigue take a look at a specific type of nervous system damage spinal cord injury-and argue that the role of the immune system is underappreciated. They also suggest that one common therapy, application of glucocorticoids, might actually exacerbate the condition.	[Curt, Armin] Univ Hosp Balgrist, Spinal Cord Injury Ctr, Zurich, Switzerland; [Fawcett, James W.] Univ Cambridge, Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England	University of Zurich; University of Cambridge	Fawcett, JW (corresponding author), Univ Cambridge, Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England.	jf108@cam.ac.uk		Fawcett, James/0000-0002-7990-4568	Medical Research Council [G9828345] Funding Source: Medline; MRC [G9828345] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Dietz V, 2009, BRAIN RES BULL, V78, pI, DOI 10.1016/S0361-9230(08)00410-3; Dobkin B, 2007, NEUROREHAB NEURAL RE, V21, P25, DOI 10.1177/1545968306295556; Dunlop SA, 2008, TRENDS NEUROSCI, V31, P410, DOI 10.1016/j.tins.2008.05.004; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; GARCIAALIAS G, NAT NEUROSC IN PRESS; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Harvey LA, 2009, SPINAL CORD, V47, P184, DOI 10.1038/sc.2008.100; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; Montour-Proulx I, 2004, J CHILD NEUROL, V19, P935, DOI 10.1177/08830738040190120501; SMITH R, 2009, J NEUROTRAUMA   0128, DOI DOI 10.1089/NEU.2008-0829; Tawashy AE, 2009, SPINAL CORD, V47, P301, DOI 10.1038/sc.2008.120; Valent LJ, 2008, ARCH PHYS MED REHAB, V89, P1016, DOI 10.1016/j.apmr.2007.10.034; Vega SR, 2008, NEUROSCIENCE, V153, P1064, DOI 10.1016/j.neuroscience.2008.03.037; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057	17	21	22	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					735	736		10.1038/nm0709-735	http://dx.doi.org/10.1038/nm0709-735			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19584862				2022-12-25	WOS:000267806900023
J	Peng, G; Yim, EK; Dai, H; Jackson, AP; van der Burgt, I; Pan, MR; Hu, RZ; Li, KY; Lin, SY				Peng, Guang; Yim, Eun-Kyoung; Dai, Hui; Jackson, Andrew P.; van der Burgt, Ineke; Pan, Mei-Ren; Hu, Ruozhen; Li, Kaiyi; Lin, Shiaw-Yih			BRIT1/MCPH1 links chromatin remodelling to DNA damage response	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; PROTEIN; REPAIR; COMPLEX; ATM; MICROCEPHALIN; PATHWAY; MECHANISM; INO80	To detect and repair damaged DNA, DNA-damage-response proteins need to overcome the barrier of condensed chromatin to gain access to DNA lesions(1). ATP-dependent chromatin remodelling is one of the fundamental mechanisms used by cells to relax chromatin in DNA repair(2,3). However, the mechanism mediating their recruitment to DNA lesions remains largely unknown. BRIT1 (also known as MCPH1) is an early DNA-damage- response protein that is mutated in human primary microcephaly(4-8). Here we report a previously unknown function of BRIT1 as a regulator of the ATP-dependent chromatin remodelling complex SWI-SNF in DNA repair. After damage to DNA, BRIT1 increases its interaction with SWI-SNF through ATM/ ATR-dependent phosphorylation on the BAF170 subunit. This increase in binding affinity provides a means by which SWI-SNF can be specifically recruited to and maintained at DNA lesions. Loss of BRIT1 causes impaired chromatin relaxation as a result of decreased association of SWI-SNF with chromatin. This explains the decreased recruitment of repair proteins to DNA lesions and the reduced efficiency of repair in BRIT1-deficient cells, resulting in impaired cell survival after DNA damage. Our findings therefore identify BRIT1 as a key molecule that links chromatin remodelling with response to DNA damage in the control of DNA repair, and its dysfunction contributes to human disease.	[Peng, Guang; Yim, Eun-Kyoung; Dai, Hui; Pan, Mei-Ren; Hu, Ruozhen; Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA; [Jackson, Andrew P.] Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [van der Burgt, Ineke] Univ Med Ctr Nijmegen, Dept Human Genet, Nijmegen, Netherlands; [Li, Kaiyi] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Edinburgh; Radboud University Nijmegen; Baylor College of Medicine	Lin, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA.	sylin@mdanderson.org	Jackson, Andrew P/D-3442-2009; Pan, Mei-Ren/I-2021-2013	Jackson, Andrew P/0000-0002-8739-2646; 	National Cancer Institute [R01CA112291]; American Cancer Society Research Scholar Award; NATIONAL CANCER INSTITUTE [R01CA112291] Funding Source: NIH RePORTER; Medical Research Council [MC_U127580972] Funding Source: researchfish; MRC [MC_U127580972] Funding Source: UKRI	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Rosenberg, X. Shen and F. Meric- Bernstam for critical reading of the manuscript; S. Deming for proofreading it; M. Jasin for reagents; E. Griffith for identifying the mutation in the MCPH no. 2 cell line; and the core facilities of the M. D. Anderson Cancer Center for mass spectrometry and fluorescence-activated cell sorting. This work was supported by a grant from the National Cancer Institute ( R01CA112291) and an American Cancer Society Research Scholar Award to S. Y. L.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Teraoka H, 1996, EXP CELL RES, V222, P218, DOI 10.1006/excr.1996.0027; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	35	154	159	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					865	U221		10.1038/ncb1895	http://dx.doi.org/10.1038/ncb1895			40	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525936	Green Accepted			2022-12-25	WOS:000267603100016
J	Gondry, M; Sauguet, L; Belin, P; Thai, R; Amouroux, R; Tellier, C; Tuphile, K; Jacquet, M; Braud, S; Courcon, M; Masson, C; Dubois, S; Lautru, S; Lecoq, A; Hashimoto, S; Genet, R; Pernodet, JL				Gondry, Muriel; Sauguet, Ludovic; Belin, Pascal; Thai, Robert; Amouroux, Rachel; Tellier, Carine; Tuphile, Karine; Jacquet, Mickael; Braud, Sandrine; Courcon, Marie; Masson, Cedric; Dubois, Steven; Lautru, Sylvie; Lecoq, Alain; Hashimoto, Shin-ichi; Genet, Roger; Pernodet, Jean-Luc			Cyclodipeptide synthases are a family of tRNA-dependent peptide bond-forming enzymes	NATURE CHEMICAL BIOLOGY			English	Article							COLLISION-INDUCED DISSOCIATION; PROTEIN TRANSFERASE; GENE-CLUSTER; ASPERGILLUS-FUMIGATUS; MASS-SPECTRA; IN-VIVO; BIOSYNTHESIS; STREPTOMYCES; ALBONOURSIN; SYNTHETASE	Cyclodipeptides and their derivatives belong to the diketopiperazine (DKP) family, which is comprised of a broad array of natural products that exhibit useful biological properties. In the few known DKP biosynthetic pathways, nonribosomal peptide synthetases (NRPSs) are involved in the synthesis of cyclodipeptides that constitute the DKP scaffold, except in the albonoursin (1) pathway. Albonoursin, or cyclo(alpha,beta-dehydroPhe-alpha,beta-dehydroLeu), is an antibacterial DKP produced by Streptomyces noursei. In this pathway, the formation of the cyclo(Phe-Leu) (2) intermediate is catalyzed by AlbC, a small protein unrelated to NRPSs. We demonstrated that AlbC uses aminoacyl-tRNAs as substrates to catalyze the formation of the DKP peptide bonds. Moreover, several other bacterial proteins, presenting moderate similarity to AlbC, also use aminoacyl-tRNAs to synthesize various cyclodipeptides. Therefore, AlbC and these related proteins belong to a newly defined family of enzymes that we have named cyclodipeptide synthases (CDPSs).	[Gondry, Muriel; Sauguet, Ludovic; Belin, Pascal; Thai, Robert; Amouroux, Rachel; Tellier, Carine; Jacquet, Mickael; Braud, Sandrine; Courcon, Marie; Masson, Cedric; Dubois, Steven; Lecoq, Alain; Genet, Roger] Inst Biol & Technol Saclay, Serv Ingn Mol Prot, Gif Sur Yvette, France; [Amouroux, Rachel; Tellier, Carine; Tuphile, Karine; Braud, Sandrine; Lautru, Sylvie; Pernodet, Jean-Luc] Univ Paris 11, CNRS, Unite Mixte Rech 8621, Inst Genet & Microbiol, F-91405 Orsay, France; [Hashimoto, Shin-ichi] Kyowa Hakko Bio Co Ltd, Tech Res Labs, Hofu, Yamaguchi, Japan	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Kyowa Hakko Bio Co., Ltd.	Gondry, M (corresponding author), Inst Biol & Technol Saclay, Serv Ingn Mol Prot, Gif Sur Yvette, France.	muriel.gondry@cea.fr; jean-luc.pernodet@igmors.u-psud.fr	Lautru, Sylvie/AAJ-1199-2020; Pernodet, Jean-Luc/A-4074-2015	Lautru, Sylvie/0000-0002-7935-704X; Gondry, Muriel/0000-0003-0398-3404; Pernodet, Jean-Luc/0000-0002-6129-7093; Thai, Robert/0000-0001-9438-4225; COURCON, Marie/0000-0001-7152-1768	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Universite Paris-Sud 11; Pole de Recherche et d'Enseignement Superieur UniverSud Paris; Kyowa Hakko Bio Co. Ltd.	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Sud 11; Pole de Recherche et d'Enseignement Superieur UniverSud Paris; Kyowa Hakko Bio Co. Ltd.	We thank C. Olaizola and M. Bahut for technical assistance, S. Zinn-Justin and J. Baillon for helpful discussion, and M. Moutiez for the critical reading of the manuscript. We are indebted to M. Springer (Institut de Biologie Physico-Chimique) for the plasmid pBI and to F. Doucet-Populaire (Universite Paris Descartes), T. Msadek (Pasteur Institute), A. Bolotin (Institut National de la Recherche Agronomique), T. Baba (Juntendo University) and E. Krin (Pasteur Institute) for the gifts of bacterial strains and bacterial genomic DNAs. This study was supported by Commissariat a l'Energie Atomique, Centre National de la Recherche Scientifique, Universite Paris-Sud 11, Pole de Recherche et d'Enseignement Superieur UniverSud Paris and Kyowa Hakko Bio Co. Ltd. L. S. is a recipient of a doctoral fellowship from Commissariat a l'Energie Atomique.	Abramochkin G, 1996, J BIOL CHEM, V271, P22901, DOI 10.1074/jbc.271.37.22901; ABRAMOCHKIN G, 1995, J BIOL CHEM, V270, P20621, DOI 10.1074/jbc.270.35.20621; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15029, DOI 10.1021/bi061845b; BELIN P, 1950, P NATL ACAD IN PRESS; Chen YH, 2004, EUR FOOD RES TECHNOL, V218, P589, DOI 10.1007/s00217-004-0901-x; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; FALICK AM, 1993, J AM SOC MASS SPECTR, V4, P882, DOI 10.1016/1044-0305(93)87006-X; FUKUSHIMA K, 1973, J ANTIBIOT, V26, P175, DOI 10.7164/antibiotics.26.175; Gardiner DM, 2004, MOL MICROBIOL, V53, P1307, DOI 10.1111/j.1365-2958.2004.04215.x; Gondry M, 2001, EUR J BIOCHEM, V268, P1712, DOI 10.1046/j.1432-1033.2001.02038.x; Gruenewald S, 2004, APPL ENVIRON MICROB, V70, P3282, DOI 10.1128/AEM.70.6.3282-3291.2004; Healy FG, 2000, MOL MICROBIOL, V38, P794, DOI 10.1046/j.1365-2958.2000.02170.x; IANG MR, 2006, IND BIOTECHNOL, V2, P66; Jeedigunta S, 2000, TETRAHEDRON, V56, P3303, DOI 10.1016/S0040-4020(00)00249-0; JOHNSON RS, 1987, ANAL CHEM, V59, P2621, DOI 10.1021/ac00148a019; Kanoh K, 1999, BIOSCI BIOTECH BIOCH, V63, P1130, DOI 10.1271/bbb.63.1130; Kanzaki H, 1999, J MOL CATAL B-ENZYM, V6, P265, DOI 10.1016/S1381-1177(98)00079-4; Kohn Harold, 2005, Current Drug Targets - Infectious Disorders, V5, P273, DOI 10.2174/1568005054880136; Lautru S, 2002, CHEM BIOL, V9, P1355, DOI 10.1016/S1074-5521(02)00285-5; Loria R, 2008, ANTON LEEUW INT J G, V94, P3, DOI 10.1007/s10482-008-9240-4; Mainardi JL, 2008, FEMS MICROBIOL REV, V32, P386, DOI 10.1111/j.1574-6976.2007.00097.x; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104; RajBhandary UL, 2008, P NATL ACAD SCI USA, V105, P5285, DOI 10.1073/pnas.0801193105; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schultz AW, 2008, J AM CHEM SOC, V130, P4507, DOI 10.1021/ja711188x; Schwarzer D, 2001, CHEM BIOL, V8, P997, DOI 10.1016/S1074-5521(01)00068-0; Stark T, 2005, J AGR FOOD CHEM, V53, P7222, DOI 10.1021/jf051313m; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; UFFEN RL, 1972, J BACTERIOL, V11, P86, DOI 10.1128/JB.111.1.86-93.1972; Villet R, 2007, NUCLEIC ACIDS RES, V35, P6870, DOI 10.1093/nar/gkm778; Walzel B, 1997, CHEM BIOL, V4, P223, DOI 10.1016/S1074-5521(97)90292-1; Waring P, 1996, GEN PHARMACOL, V27, P1311, DOI 10.1016/S0306-3623(96)00083-3; Watanabe K, 2007, NATURE, V449, P867, DOI 10.1038/nature06167; Williams DE, 1998, TETRAHEDRON LETT, V39, P9579, DOI 10.1016/S0040-4039(98)02277-1	39	163	175	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					414	420		10.1038/nchembio.175	http://dx.doi.org/10.1038/nchembio.175			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19430487				2022-12-25	WOS:000266383800016
J	Nesbitt, WS; Westein, E; Tovar-Lopez, FJ; Tolouei, E; Mitchell, A; Fu, J; Carberry, J; Fouras, A; Jackson, SP				Nesbitt, Warwick S.; Westein, Erik; Tovar-Lopez, Francisco Javier; Tolouei, Elham; Mitchell, Arnan; Fu, Jia; Carberry, Josie; Fouras, Andreas; Jackson, Shaun P.			A shear gradient-dependent platelet aggregation mechanism drives thrombus formation	NATURE MEDICINE			English	Article							ADHESIVE INTERACTIONS; IN-VIVO; ACTIVATION; MODEL; FLOW; IDENTIFICATION; TRANSLOCATION	Platelet aggregation at sites of vascular injury is essential for hemostasis and arterial thrombosis. It has long been assumed that platelet aggregation and thrombus growth are initiated by soluble agonists generated at sites of vascular injury. By using high-resolution intravital imaging techniques and hydrodynamic analyses, we show that platelet aggregation is primarily driven by changes in blood flow parameters (rheology), with soluble agonists having a secondary role, stabilizing formed aggregates. We find that in response to vascular injury, thrombi initially develop through the progressive stabilization of discoid platelet aggregates. Analysis of blood flow dynamics revealed that discoid platelets preferentially adhere in low-shear zones at the downstream face of forming thrombi, with stabilization of aggregates dependent on the dynamic restructuring of membrane tethers. These findings provide insight into the prothrombotic effects of disturbed blood flow parameters and suggest a fundamental reinterpretation of the mechanisms driving platelet aggregation and thrombus growth.	[Nesbitt, Warwick S.; Westein, Erik; Fu, Jia; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Tovar-Lopez, Francisco Javier; Mitchell, Arnan] RMIT Univ, Sch Elect & Comp Engn, Microelect & Mat Technol Ctr, Melbourne, Vic, Australia; [Tolouei, Elham; Carberry, Josie] Monash Univ, Dept Mech Engn, Clayton, Vic 3168, Australia; [Fouras, Andreas] Monash Univ, Div Biol Engn, Clayton, Vic, Australia	Monash University; Royal Melbourne Institute of Technology (RMIT); Monash University; Monash University	Nesbitt, WS (corresponding author), Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia.	warwick.nesbitt@med.monash.edu.au; shaun.jackson@med.monash.edu.au	Jackson, Shaun P/E-9633-2011; Tovar, Francisco/AGG-3400-2022; Carberry, Josie/E-9321-2010; Mitchell, Arnan/C-5017-2008; Fouras, Andreas/A-9410-2008	Carberry, Josie/0000-0002-4463-641X; Mitchell, Arnan/0000-0002-2463-2956; Fouras, Andreas/0000-0002-8933-1759; Nesbitt, Warwick/0000-0001-5644-7053; Tolouei, Elham/0000-0002-3595-0060; Jackson, Shaun/0000-0002-4750-1991; Tovar-Lopez, Francisco J/0000-0001-8578-7786	National Health and Medical Research Council of Australia; Australian Research Council; National Heart Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by project funding from the National Health and Medical Research Council of Australia and the Australian Research Council. E. W. was supported by the National Heart Foundation of Australia.	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; DINTENFASS L, 1964, ANGIOLOGY, V15, P333, DOI 10.1177/000331976401500802; Dopheide SM, 2002, BLOOD, V99, P159, DOI 10.1182/blood.V99.1.159; Dubois C, 2007, J CLIN INVEST, V117, P953, DOI 10.1172/JCI30537; ECKSTEIN EC, 1988, MICROVASC RES, V36, P31, DOI 10.1016/0026-2862(88)90036-2; Edmondson KE, 2005, BIOPHYS J, V89, P3603, DOI 10.1529/biophysj.105.066134; Fouras A, 1998, EXP FLUIDS, V25, P409, DOI 10.1007/s003480050248; Fouras A, 2008, EXP FLUIDS, V44, P317, DOI 10.1007/s00348-007-0404-1; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Giuliano S, 2003, BIOCHEM J, V372, P163, DOI 10.1042/BJ20020868; Goncalves I, 2005, J BIOL CHEM, V280, P15430, DOI 10.1074/jbc.M410235200; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Kulkarni S, 2000, J CLIN INVEST, V105, P783, DOI 10.1172/JCI7569; Kulkarni Suhasini, 2004, Methods Mol Biol, V272, P165; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Maxwell MJ, 2007, BLOOD, V109, P566, DOI 10.1182/blood-2006-07-028282; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; MUSTARD JF, 1962, AM J MED, V33, P621, DOI 10.1016/0002-9343(62)90243-7; MUSTARD JF, 1966, THROMB DIATH HAEMOST, VS, P131; Nesbitt WS, 2003, J CELL BIOL, V160, P1151, DOI 10.1083/jcb.200207119; Nesbitt WS, 2002, J BIOL CHEM, V277, P2965, DOI 10.1074/jbc.M110070200; Rosen ED, 2001, AM J PATHOL, V158, P1613, DOI 10.1016/S0002-9440(10)64117-X; Ruggeri ZM, 2007, THROMB RES, V120, pS5, DOI 10.1016/j.thromres.2007.03.011; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Schoenwaelder SM, 2007, J BIOL CHEM, V282, P28648, DOI 10.1074/jbc.M704358200; SCHOEPHOERSTER RT, 1993, ARTERIOSCLER THROMB, V13, P1806, DOI 10.1161/01.ATV.13.12.1806; STEIN PD, 1974, CIRC RES, V35, P608, DOI 10.1161/01.RES.35.4.608; Sturgeon SA, 2008, EUR J PHARMACOL, V587, P209, DOI 10.1016/j.ejphar.2008.03.017; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; van Gestel MA, 2002, J VASC RES, V39, P534, DOI 10.1159/000067208; Versteeg H.K., 2007, INTRO COMPUTATIONAL; VIRCHOW R, 1856, MEIDINGER SOHN, P219; WANG SK, 1992, BIORHEOLOGY, V29, P353; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Yap CL, 2000, J BIOL CHEM, V275, P41377, DOI 10.1074/jbc.M005590200; YOGANATHAN AP, 1978, CIRCULATION, V58, P70, DOI 10.1161/01.CIR.58.1.70	44	592	609	3	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					665	U146		10.1038/nm.1955	http://dx.doi.org/10.1038/nm.1955			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19465929				2022-12-25	WOS:000266731600026
J	Phalke, S; Nickel, O; Walluscheck, D; Hortig, F; Onorati, MC; Reuter, G				Phalke, Sameer; Nickel, Olaf; Walluscheck, Diana; Hortig, Frank; Onorati, Maria Cristina; Reuter, Gunter			Retrotransposon silencing and telomere integrity in somatic cells of Drosophila depends on the cytosine-5 methyltransferase DNMT2	NATURE GENETICS			English	Article							DNA METHYLATION; HETEROCHROMATIN FORMATION; DE-NOVO; MELANOGASTER; HOMOLOG; 5-METHYLCYTOSINE; TRNA(ASP); GERMLINE; REPEATS; PATHWAY	Here we show that the cytosine-5 methyltransferase DNMT2 controls retrotransposon silencing in Drosophila somatic cells. In Drosophila, significant DNMT2-dependent DNA methylation occurs during early embryogenesis. Suppression of white gene silencing by Mt2 (Dnmt2) null mutations in variegated P[w(+)] element insertions identified functional targets of DNMT2. The enzyme controls DNA methylation at retrotransposons in early embryos and initiates histone H4K20 trimethylation catalyzed by the SUV4-20 methyltransferase. In somatic cells, loss of DNMT2 eliminates H4K20 trimethylation at retrotransposons and impairs maintenance of retrotransposon silencing. In Dnmt2 and Suv4-20 null genotypes, retrotransposons are strongly overexpressed in somatic but not germline cells, where retrotransposon silencing depends on an RNAi mechanism. DNMT2 also controls integrity of chromosome 2R and 3R telomeres. In Dnmt2 null strains, we found stable loss of the subtelomeric clusters of defective Invader4 elements. Together, these results demonstrate a previously unappreciated role of DNA methylation in retrotransposon silencing and telomere integrity in Drosophila.	[Phalke, Sameer; Nickel, Olaf; Walluscheck, Diana; Hortig, Frank; Reuter, Gunter] Univ Halle Wittenberg, Inst Biol Dev Genet, Halle, Germany; [Onorati, Maria Cristina] Univ Palermo, Inst Telethon Dulbecco, Dipartimento Sci Biochim Policlin, Palermo, Italy	Martin Luther University Halle Wittenberg; University of Palermo	Reuter, G (corresponding author), Univ Halle Wittenberg, Inst Biol Dev Genet, Halle, Germany.	reuter@genetik.uni-halle.de	Nickel, Olaf/AAB-5506-2022					Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; ELGIN SCR, 2006, EPIGENETICS POSITION; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; Meehan RR, 2001, GENE DEV, V15, P3231, DOI 10.1101/gad.954901; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Seum C, 2007, PLOS GENET, V3, P709, DOI 10.1371/journal.pgen.0030076; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tang LY, 2003, J BIOL CHEM, V278, P33613, DOI 10.1074/jbc.C300255200; Tweedie S, 1999, NAT GENET, V23, P389, DOI 10.1038/70490; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Yan QS, 2003, EMBO J, V22, P5154, DOI 10.1093/emboj/cdg493	31	146	153	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					696	702		10.1038/ng.360	http://dx.doi.org/10.1038/ng.360			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19412177				2022-12-25	WOS:000266411700018
J	Hicks, GR; Raikhel, NV				Hicks, Glenn R.; Raikhel, Natasha V.			Opportunities and challenges in plant chemical biology	NATURE CHEMICAL BIOLOGY			English	Article							CONFER RESISTANCE; AUXIN TRANSPORT; ARABIDOPSIS; MUTATIONS; GENOMICS; IDENTIFICATION; GRAVITROPISM; HERBICIDE; INHIBITOR; MEMBRANE	Chemical biology is beginning to enhance our understanding of diverse cellular processes in plants, including endomembrane trafficking, hormone transport and cell wall biosynthesis. To reach its potential requires the development of a community-wide infrastructure of technology and expertise. We present some of the opportunities and challenges in this emerging branch of plant biology and offer some suggestions for enhancing the approach to the benefit of the community at large.	[Hicks, Glenn R.; Raikhel, Natasha V.] Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Hicks, Glenn R.; Raikhel, Natasha V.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Hicks, GR (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	nraikhel@ucr.edu						Blackwell HE, 2003, PLANT PHYSIOL, V133, P448, DOI 10.1104/pp.103.031138; Borevitz JO, 2004, ANNU REV GENOM HUM G, V5, P443, DOI 10.1146/annurev.genom.5.061903.180017; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dai XH, 2005, P NATL ACAD SCI USA, V102, P3129, DOI 10.1073/pnas.0500185102; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; DeBolt S, 2007, P NATL ACAD SCI USA, V104, P5854, DOI 10.1073/pnas.0700789104; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Drakakaki G, 2009, PLANT SIGNAL BEHAV, V4, P57, DOI 10.4161/psb.4.1.7314; Feraru E, 2008, PLANT PHYSIOL, V147, P1553, DOI 10.1104/pp.108.121756; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Girke T, 2005, PLANT PHYSIOL, V138, P573, DOI 10.1104/pp.105.062687; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mitsopoulos G, 2004, CURR OPIN CHEM BIOL, V8, P26, DOI 10.1016/j.cbpa.2003.11.002; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Peterson RT, 2008, NAT CHEM BIOL, V4, P635, DOI 10.1038/nchembio1108-635; ROBERT S, 2009, ARABIDOPSIS BOOK; Robert S, 2008, P NATL ACAD SCI USA, V105, P8464, DOI 10.1073/pnas.0711650105; Rojas-Pierce M, 2007, CHEM BIOL, V14, P1366, DOI 10.1016/j.chembiol.2007.10.014; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Surpin M, 2004, NAT REV MOL CELL BIO, V5, P100, DOI 10.1038/nrm1311; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Walsh TA, 2007, PLANT PHYSIOL, V144, P1292, DOI 10.1104/pp.107.099705; Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969; Zhao Y, 2007, NAT CHEM BIOL, V3, P716, DOI 10.1038/nchembio.2007.32	30	45	49	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2009	5	5					268	272		10.1038/nchembio0509-268	http://dx.doi.org/10.1038/nchembio0509-268			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	436PT	19377447				2022-12-25	WOS:000265427000002
J	Wu, C; Ivars, F; Anderson, P; Hallmann, R; Vestweber, D; Nilsson, P; Robenek, H; Tryggvason, K; Song, J; Korpos, E; Loser, K; Beissert, S; Georges-Labouesse, E; Sorokin, LM				Wu, Chuan; Ivars, Fredrik; Anderson, Per; Hallmann, Rupert; Vestweber, Dietmar; Nilsson, Per; Robenek, Horst; Tryggvason, Karl; Song, Jian; Korpos, Eva; Loser, Karin; Beissert, Stefan; Georges-Labouesse, Elisabeth; Sorokin, Lydia M.			Endothelial basement membrane laminin alpha 5 selectively inhibits T lymphocyte extravasation into the brain	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL-ADHESION; LEUKOCYTE EXTRAVASATION; G-PROTEIN; IN-VIVO; MIGRATION; EXPRESSION; INTEGRIN; BARRIER; ANTIGEN	Specific inhibition of the entry of encephalitogenic T lymphocytes into the central nervous system in multiple sclerosis would provide a means of inhibiting disease without compromising innate immune responses. We show here that targeting lymphocyte interactions with endothelial basement membrane laminins provides such a possibility. In mouse experimental autoimmune encephalomyelitis, T lymphocyte extravasation correlates with sites expressing laminin alpha 4 and small amounts of laminin alpha 5. In mice lacking laminin alpha 4, laminin alpha 5 is ubiquitously expressed along the vascular tree, resulting in marked and selective reduction of T lymphocyte infiltration into the brain and reduced disease susceptibility and severity. Vessel phenotype and immune response were not affected in these mice. Rather, laminin alpha 5 directly inhibited integrin alpha(6)beta(1)-mediated migration of T lymphocytes through laminin alpha 4. The data indicate that T lymphocytes use mechanisms distinct from other immune cells to penetrate the endothelial basement membrane barrier, permitting specific targeting of this immune cell population.	[Wu, Chuan; Hallmann, Rupert; Song, Jian; Korpos, Eva; Sorokin, Lydia M.] Univ Munster, Inst Physiol Chem & Pathobiochem, D-4400 Munster, Germany; [Ivars, Fredrik; Anderson, Per] Lund Univ, Immunol Sect, Dept Expt Med Sci, Lund, Sweden; [Vestweber, Dietmar] Max Planck Inst Mol Biomed, Munster, Germany; [Robenek, Horst] Univ Munster, Leibniz Inst Arterosclerosis Res, D-4400 Munster, Germany; [Tryggvason, Karl] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Loser, Karin; Beissert, Stefan] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Georges-Labouesse, Elisabeth] Inst Genet & Biol Mol & Cellulaire, Strasbourg, France	University of Munster; Lund University; Max Planck Society; University of Munster; Karolinska Institutet; University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm)	Sorokin, LM (corresponding author), Univ Munster, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-4400 Munster, Germany.	sorokin@uni-muenster.de	Song, Jian/Q-5216-2018; Korpos, Eva/AAF-6988-2021; Wu, Chuan/H-6379-2013	Song, Jian/0000-0002-2459-7046; Vestweber, Dietmar/0000-0002-3517-732X; Sorokin, Lydia/0000-0001-7704-7921; Wu, Chuan/0000-0003-2288-353X; Anderson, Per/0000-0002-0958-7990; , Jian/0000-0003-2159-9190	German [SFB293 A14, B8, A1, SFB492 Z3]; Swedish Research Councils [K2005-06X-14184-04A, 621-2001-2142]; Alfred Osterlunds Foundation; Knut and Alice Wallenbergs Foundation [KAW 2002.0056]; Crafoord Foundation; Greta; Johan Kocks Foundation; Interdisciplinary Clinical Research Center [Lo2/017/07]	German; Swedish Research Councils(Swedish Research Council); Alfred Osterlunds Foundation; Knut and Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation); Crafoord Foundation; Greta; Johan Kocks Foundation; Interdisciplinary Clinical Research Center	This work was supported by the German (SFB293 A14, B8, A1; SFB492 Z3) and Swedish Research Councils (K2005-06X-14184-04A, 621-2001-2142), Alfred Osterlunds Foundation, Knut and Alice Wallenbergs Foundation (KAW 2002.0056), the Crafoord Foundation, the Greta and Johan Kocks Foundation and the Interdisciplinary Clinical Research Center (IZKF; Lo2/017/07) in Munster, Germany. We thank M. Sixt for initial studies on Lama4<SUP>-/-</SUP> mice, J. Eble (Frankfurt University) for recombinant integrin alpha<INF>6</INF>beta<INF>1</INF>, A. Sonnenberg (Division of Cell Biology, The Netherlands Cancer Institute) for GoH3, A. De Arcangelis for tissue collection, G. Roos for technical assistance and F. Kiefer and R. Bohmer for assistance with confocal microscopy.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Alt C, 2002, EUR J IMMUNOL, V32, P2133, DOI 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; Bixel MG, 2007, BLOOD, V109, P5327, DOI 10.1182/blood-2006-08-043109; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; ENGELHARDT B, 1997, ADHESION MOL CHEMOKI, P173; Engelhardt B, 2008, CURR PHARM DESIGN, V14, P1555, DOI 10.2174/138161208784705432; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; FORD AL, 1995, J IMMUNOL, V154, P4309; Frieser M, 1997, EUR J BIOCHEM, V246, P727, DOI 10.1111/j.1432-1033.1997.t01-1-00727.x; Fujiwara H, 2004, EXP CELL RES, V292, P67, DOI 10.1016/j.yexcr.2003.08.010; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; Geberhiwot T, 2001, J CELL SCI, V114, P423; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Gimond C, 1998, J CELL BIOL, V143, P253, DOI 10.1083/jcb.143.1.253; Glabinski AR, 1995, BRAIN BEHAV IMMUN, V9, P315, DOI 10.1006/brbi.1995.1030; Gorfu G, 2008, J LEUKOCYTE BIOL, V84, P701, DOI 10.1189/jlb.0108048; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hoshi O, 2004, ARCH HISTOL CYTOL, V67, P107, DOI 10.1679/aohc.67.107; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Nasdala I, 2002, J BIOL CHEM, V277, P16294, DOI 10.1074/jbc.M111999200; Ohashi K. L., 1996, Microcirculation (Philadelphia), V3, P199, DOI 10.3109/10739689609148289; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Rehder D, 2006, EXP CELL RES, V312, P3389, DOI 10.1016/j.yexcr.2006.07.004; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Sixt M, 2001, J BIOL CHEM, V276, P18878, DOI 10.1074/jbc.M010898200; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Thompson RD, 2001, BLOOD, V97, P1854, DOI 10.1182/blood.V97.6.1854; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Toft-Hansen H, 2006, J IMMUNOL, V177, P7242, DOI 10.4049/jimmunol.177.10.7242; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Wakelin MW, 1996, J EXP MED, V184, P229, DOI 10.1084/jem.184.1.229; Wang JM, 2006, J BIOL CHEM, V281, P213, DOI 10.1074/jbc.M505061200; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Yadav R, 2003, THROMB HAEMOSTASIS, V90, P598, DOI 10.1160/TH03-04-0220; Yurchenco PD, 2002, METHOD CELL BIOL, V69, P111, DOI 10.1016/S0091-679X(02)69010-7	42	177	186	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2009	15	5					519	527		10.1038/nm.1957	http://dx.doi.org/10.1038/nm.1957			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19396173				2022-12-25	WOS:000265889300030
J	Ruiz, A; Gonzalez, A; Munoz, I; Serrano, R; Abrie, JA; Strauss, E; Arino, J				Ruiz, Amparo; Gonzalez, Asier; Munoz, Ivan; Serrano, Raquel; Abrie, J. Albert; Strauss, Erick; Arino, Joaquin			Moonlighting proteins Hal3 and Vhs3 form a heteromeric PPCDC with Ykl088w in yeast CoA biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							AFFECTING DNA-SYNTHESIS; COENZYME-A; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHARACTERIZATION; SALT TOLERANCE; PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE; FUNCTIONAL-CHARACTERIZATION; INHIBITORY SUBUNIT; REGULATORY SUBUNIT; ESCHERICHIA-COLI	Unlike most other organisms, the essential five-step coenzyme A biosynthetic pathway has not been fully resolved in yeast. Specifically, the genes encoding the phosphopantothenoylcysteine decarboxylase (PPCDC) activity still remain unidentified. Sequence homology analyses suggest three candidates-Ykl088w, Hal3 and Vhs3-as putative PPCDC enzymes in Saccharomyces cerevisiae. Notably, Hal3 and Vhs3 have been characterized as negative regulatory subunits of the Ppz1 protein phosphatase. Here we show that YKL088w does not encode a third Ppz1 regulatory subunit, and that the essential roles of Ykl088w and the Hal3 and Vhs3 pair are complementary, cannot be interchanged and can be attributed to PPCDC-related functions. We demonstrate that while known eukaryotic PPCDCs are homotrimers, the active yeast enzyme is a heterotrimer that consists of Ykl088w and Hal3/Vhs3 monomers that separately provides two essential catalytic residues. Our results unveil Hal3 and Vhs3 as moonlighting proteins involved in both CoA biosynthesis and protein phosphatase regulation.	[Ruiz, Amparo; Gonzalez, Asier; Munoz, Ivan; Serrano, Raquel; Arino, Joaquin] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Gonzalez, Asier; Arino, Joaquin] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Abrie, J. Albert; Strauss, Erick] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa	Autonomous University of Barcelona; Autonomous University of Barcelona; Stellenbosch University	Arino, J (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain.	joaquin.arino@uab.es	Ruiz, Amparo/AAZ-2317-2021; Arino, Joaquin/D-3756-2011; Zhang, Ning/F-1387-2014; Strauss, Erick/G-1783-2010; González, Asier/A-7064-2012	Ruiz, Amparo/0000-0002-3947-4540; Arino, Joaquin/0000-0002-6774-2987; Strauss, Erick/0000-0002-9898-8226; Arino Carmona, Joaquin/0000-0002-0390-4270; Munoz Munoz, Ivan/0000-0002-1606-5445	Ministerio de Educacion y Ciencia, Spain [BFU2005-06388-C4-04-BMC, BFU2008-04188-C03-01]; Fondo Europeo de Desarrollo Regional; National Research Foundation, South Africa [FA2007041600013]; Ajut de Suport a les Activitats dels Grups de Recerca [2009SGR-1091]; Spanish Ministry of Education and Science; National Research Foundation (South Africa) [HS2007-0022]; Ministerio de Educacion y Ciencia (Spain)	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Fondo Europeo de Desarrollo Regional(European Commission); National Research Foundation, South Africa(National Research Foundation - South Africa); Ajut de Suport a les Activitats dels Grups de Recerca; Spanish Ministry of Education and Science(Spanish Government); National Research Foundation (South Africa)(National Research Foundation - South Africa); Ministerio de Educacion y Ciencia (Spain)(Spanish Government)	Thanks are given to B. Weiss (Emory University School of Medicine) for E. coli strain BW369, to A. Osterman (Burnham Institute for Medical Research) for the human PPCDC cDNA and to R. Serrano (Instituto de Biologia Molecular y Celular de Plantas, Universidad Politecnica de Valencia-Consejo Superior de Investigaciones Cientificas) and P. Sanz (Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Cientificas) for diverse constructs and plasmids. We thank H. Ceulemans, E. Simon, A. Barcelo and A. Vivo for their contribution in different phases of the project. The excellent technical assistance of A. Vilalta, M. J. Alvarez and M. Robledo is acknowledged. This work was supported by grants BFU2005-06388-C4-04-BMC and BFU2008-04188-C03-01 to J. A. (Ministerio de Educacion y Ciencia, Spain and Fondo Europeo de Desarrollo Regional) and grant FA2007041600013 to E. S. (National Research Foundation, South Africa). J. A. is recipient of an "Ajut de Suport a les Activitats dels Grups de Recerca" (2009SGR-1091, Generalitat de Catalunya). A. G. was recipient of a fellowship from the Spanish Ministry of Education and Science. J. A. and E. S. are recipients of a Spain/South Africa Research Cooperation grant (HS2007-0022) from the National Research Foundation (South Africa) and the Ministerio de Educacion y Ciencia (Spain). J. A. dedicates this paper to the memory of his father.	Adams A, 1997, METHODS YEAST GENETI; Albert A, 2000, STRUCTURE, V8, P961, DOI 10.1016/S0969-2126(00)00187-8; Arino J, 2002, EUR J BIOCHEM, V269, P1072, DOI 10.1046/j.0014-2956.2002.02753.x; Begley TP, 2001, VITAM HORM, V61, P157; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; Bucovaz ET, 1997, BIOCHIMIE, V79, P787, DOI 10.1016/S0300-9084(97)86938-6; BUCOVAZ ET, 1980, MOL CELL BIOCHEM, V30, P7, DOI 10.1007/BF00215301; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; Clotet J, 1999, MOL CELL BIOL, V19, P2408; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; COSTIGAN C, 1994, MOL CELL BIOL, V14, P2391, DOI 10.1128/MCB.14.4.2391; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; de Nadal E, 1998, P NATL ACAD SCI USA, V95, P7357, DOI 10.1073/pnas.95.13.7357; de Nadal E, 2001, J BIOL CHEM, V276, P14829, DOI 10.1074/jbc.M010824200; DICOMO CJ, 1995, GENETICS, V139, P95; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hernandez-Acosta P, 2002, J BIOL CHEM, V277, P20490, DOI 10.1074/jbc.M201557200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kupke T, 2000, J BIOL CHEM, V275, P31838, DOI 10.1074/jbc.M004273200; Kupke T, 2006, J BIOL CHEM, V281, P5435, DOI 10.1074/jbc.M510056200; Kupke T, 2003, J BIOL CHEM, V278, P38229, DOI 10.1074/jbc.M306321200; Kupke T, 2001, J BIOL CHEM, V276, P19190, DOI 10.1074/jbc.M100776200; LEE KS, 1993, MOL CELL BIOL, V13, P5843, DOI 10.1128/MCB.13.9.5843; Mercer AC, 2007, NAT PROD REP, V24, P750, DOI 10.1039/b603921a; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; MEYER CR, 1988, PLANT PHYSIOL, V86, P325, DOI 10.1104/pp.86.2.325; Munoz I, 2004, J BIOL CHEM, V279, P42619, DOI 10.1074/jbc.M405656200; Munoz I, 2003, YEAST, V20, P157, DOI 10.1002/yea.938; Olzhausen J, 2009, CURR GENET, V55, P163, DOI 10.1007/s00294-009-0234-1; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; POSAS F, 1995, J BIOL CHEM, V270, P13036, DOI 10.1074/jbc.270.22.13036; Ruiz A, 2004, J BIOL CHEM, V279, P34421, DOI 10.1074/jbc.M400572200; Ruiz A, 2003, EUKARYOT CELL, V2, P937, DOI 10.1128/EC.2.5.937-948.2003; SPITZER ED, 1988, J BACTERIOL, V170, P872, DOI 10.1128/jb.170.2.872-876.1988; SPITZER ED, 1985, J BACTERIOL, V164, P994, DOI 10.1128/JB.164.3.994-1003.1985; Steinbacher S, 2003, J MOL BIOL, V327, P193, DOI 10.1016/S0022-2836(03)00092-5; Strauss E, 2004, BIOCHEMISTRY-US, V43, P15520, DOI 10.1021/bi048340a; Strauss E, 2003, BIOORG MED CHEM LETT, V13, P339, DOI 10.1016/S0960-894X(02)01018-1; Strauss E, 2001, J AM CHEM SOC, V123, P6449, DOI 10.1021/ja016020y; Strauss E, 2001, J BIOL CHEM, V276, P13513, DOI 10.1074/jbc.C100033200; TRECO DA, 1998, CURRENT PROTOCOLS MO; Ye YZ, 2005, BIOINFORMATICS, V21, pI478, DOI 10.1093/bioinformatics/bti1052; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920	50	44	48	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					920	928		10.1038/nchembio.243	http://dx.doi.org/10.1038/nchembio.243			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19915539	Green Accepted			2022-12-25	WOS:000271756900015
J	Han, JW; Zheng, HF; Cui, Y; Sun, LD; Ye, DQ; Hu, Z; Xu, JH; Cai, ZM; Huang, W; Zhao, GP; Xie, HF; Fang, H; Lu, QJ; Xu, JH; Li, XP; Pan, YF; Deng, DQ; Zeng, FQ; Ye, ZZ; Zhang, XY; Wang, QW; Hao, F; Ma, L; Zuo, XB; Zhou, FS; Du, WH; Cheng, YL; Yang, JQ; Shen, SK; Li, J; Sheng, YJ; Zuo, XX; Zhu, WF; Gao, F; Zhang, PL; Guo, Q; Li, B; Gao, M; Xiao, FL; Quan, C; Zhang, C; Zhang, Z; Zhu, KJ; Li, Y; Hu, DY; Lu, WS; Huang, JL; Liu, SX; Li, H; Ren, YQ; Wang, ZX; Yang, CJ; Wang, PG; Zhou, WM; Lv, YM; Zhang, AP; Zhang, SQ; Lin, D; Li, Y; Low, HQ; Shen, M; Zhai, ZF; Wang, Y; Zhang, FY; Yang, S; Liu, JJ; Zhang, XJ				Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Xu, Jin-Hua; Cai, Zhi-Ming; Huang, Wei; Zhao, Guo-Ping; Xie, Hong-Fu; Fang, Hong; Lu, Qian-Jin; Xu, Jian-Hua; Li, Xiang-Pei; Pan, Yun-Feng; Deng, Dan-Qi; Zeng, Fan-Qin; Ye, Zhi-Zhong; Zhang, Xiao-Yan; Wang, Qing-Wen; Hao, Fei; Ma, Li; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Zuo, Xiao-Xia; Zhu, Wei-Fang; Gao, Fei; Zhang, Pei-Lian; Guo, Qing; Li, Bo; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Huang, Jian-Lin; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Li, Yi; Low, Hui Qi; Shen, Min; Zhai, Zhi-Fang; Wang, Ying; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun			Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus	NATURE GENETICS			English	Article							GENE; VARIANTS; ITGAM; EPIDEMIOLOGY; EXPRESSION; PSORIASIS; SCAN; SLE; PXK	We performed a genome-wide association study (GWAS) of systemic lupus erythematosus (SLE) in a Chinese Han population by genotyping 1,047 cases and 1,205 controls using Illumina Human610-Quad BeadChips and replicating 78 SNPs in two additional cohorts (3,152 cases and 7,050 controls). We identified nine new susceptibility loci (ETS1, IKZF1, RASGRP3, SLC15A4, TNIP1, 7q11.23, 10q11.22, 11q23.3 and 16p11.2; 1.77 x 10(-25) <= P-combined <= 2.77 x 10(-8)) and confirmed seven previously reported loci (BLK, IRF5, STAT4, TNFAIP3, TNFSF4, 6q21 and 22q11.21; 5.17 x 10(-42) <= P-combined <= 5.18 x 10(-12)). Comparison with previous GWAS findings highlighted the genetic heterogeneity of SLE susceptibility between Chinese Han and European populations. This study not only advances our understanding of the genetic basis of SLE but also highlights the value of performing GWAS in diverse ancestral populations.	[Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Xu, Jin-Hua; Zhang, Xue-Jun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Cai, Zhi-Ming; Wang, Qing-Wen] Peking Univ, Shenzhen Hosp, Dept Rheumatol, Shenzhen, Guangdong, Peoples R China; [Huang, Wei; Zhao, Guo-Ping; Shen, Min; Wang, Ying] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China; [Xie, Hong-Fu; Zuo, Xiao-Xia] Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Fang, Hong; Zhu, Wei-Fang] Zhejiang Univ, Dept Dermatol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Qian-Jin; Gao, Fei] Cent S Univ, Epigenet Res Ctr, Dept Dermatol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Xu, Jian-Hua] Anhui Med Univ, Dept Rheumatol, Hosp 1, Hefei, Anhui, Peoples R China; [Li, Xiang-Pei] Anhui Med Univ, Dept Rheumatol, Affiliated Prov Hosp, Hefei, Anhui, Peoples R China; [Pan, Yun-Feng; Huang, Jian-Lin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Dan-Qi; Zhang, Pei-Lian] Kunming Med Univ, Affiliated Hosp 2, Dept Dermatol, Kunming, Yunnan, Peoples R China; [Zeng, Fan-Qin; Guo, Qing] Sun Yat Sen Univ, Dept Dermatol, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China; [Ye, Zhi-Zhong; Li, Bo] Shenzhen Fourth Peoples Hosp, Dept Rheumatol, Shenzhen, Guangdong, Peoples R China; [Zhang, Xiao-Yan; Ma, Li] China Japan Friendship Hosp, Dept Dermatol, Beijing, Peoples R China; [Hao, Fei; Zhai, Zhi-Fang] Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China; [Li, Yi; Low, Hui Qi] Genome Inst Singapore, Singapore, Singapore	Anhui Medical University; Anhui Medical University; Anhui Medical University; Fudan University; Peking University; Central South University; Zhejiang University; Central South University; Anhui Medical University; Anhui Medical University; Sun Yat Sen University; Kunming Medical University; Sun Yat Sen University; China-Japan Friendship Hospital; Army Medical University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China.	liuj3@gis.a-star.edu.sg; ayzxj@vip.sina.com	Zhang, Fengyu/M-1396-2019; Zhu, Kunju/AAN-5264-2020; SHENG, Yu/GXZ-8269-2022; Zheng, Houfeng/K-4424-2012; Liu, Jianjun/AAK-4989-2020; Cui, Yong/AAF-9300-2020; Chen, Gang/G-2722-2010	Zhang, Fengyu/0000-0001-8504-0770; Zhu, Kunju/0000-0002-3649-209X; Zheng, Houfeng/0000-0001-5681-8598; Liu, Jianjun/0000-0002-3255-3019; Zhao, Guo-Ping/0000-0002-7621-6620	National Natural Science Foundation [30972727, 30530670, 30830089]; Anhui Provincial Special Scientific Program [2007-7]; Anhui Skin Genetic Study Innovative Research Team Program [TD200701]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Anhui Provincial Special Scientific Program; Anhui Skin Genetic Study Innovative Research Team Program	We thank all study participants. This study was funded by the National Natural Science Foundation (30972727), the Key Project of National Natural Science Foundation (30530670 and 30830089), the Anhui Provincial Special Scientific Program (2007-7) and the Anhui Skin Genetic Study Innovative Research Team Program (TD200701).	Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Graham DSC, 2008, NAT GENET, V40, P83, DOI 10.1038/ng.2007.47; Graham RR, 2009, J INTERN MED, V265, P680, DOI 10.1111/j.1365-2796.2009.02096.x; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; HOPKINSON ND, 1994, ANN RHEUM DIS, V53, P675, DOI 10.1136/ard.53.10.675; Ke YH, 2001, SCI CHINA SER C, V44, P225, DOI 10.1007/BF02879329; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lau CS, 2006, LUPUS, V15, P715, DOI 10.1177/0961203306072311; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi YY, 2004, GENOME RES, V14, P1345, DOI 10.1101/gr.1758204; Wang J, 2007, ARCH DERMATOL RES, V298, P485, DOI 10.1007/s00403-006-0719-4; Wojcik H, 2007, EUR J IMMUNOL, V37, P1022, DOI 10.1002/eji.200637026; Yang W, 2009, GENES IMMUN, V10, P219, DOI 10.1038/gene.2009.1; Zeng QY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2368; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	28	729	778	2	247	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1234	U98		10.1038/ng.472	http://dx.doi.org/10.1038/ng.472			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19838193				2022-12-25	WOS:000271247600017
J	Eeles, RA; Kote-Jarai, Z; Al Olama, AA; Giles, GG; Guy, M; Severi, G; Muir, K; Hopper, JL; Henderson, BE; Haiman, CA; Schleutker, J; Hamdy, FC; Neal, DE; Donovan, JL; Stanford, JL; Ostrander, EA; Ingles, SA; John, EM; Thibodeau, SN; Schaid, D; Park, JY; Spurdle, A; Clements, J; Dickinson, JL; Maier, C; Vogel, W; Dork, T; Rebbeck, TR; Cooney, KA; Cannon-Albright, L; Chappuis, PO; Hutter, P; Zeegers, M; Kaneva, R; Zhang, HW; Lu, YJ; Foulkes, WD; English, DR; Leongamornlert, DA; Tymrakiewicz, M; Morrison, J; Ardern-Jones, AT; Hall, AL; O'Brien, LT; Wilkinson, RA; Saunders, EJ; Page, EC; Sawyer, EJ; Edwards, SM; Dearnaley, DP; Horwich, A; Huddart, RA; Khoo, VS; Parker, CC; Van As, N; Woodhouse, CJ; Thompson, A; Christmas, T; Ogden, C; Cooper, CS; Southey, MC; Lophatananon, A; Liu, JF; Kolonel, LN; Le Marchand, L; Wahlfors, T; Tammela, TL; Auvinen, A; Lewis, SJ; Cox, A; FitzGerald, LM; Koopmeiners, JS; Karyadi, DM; Kwon, EM; Stern, MC; Corral, R; Joshi, AD; Shahabi, A; McDonnell, SK; Sellers, TA; Pow-Sang, J; Chambers, S; Aitken, J; Gardiner, RA; Batra, J; Kedda, MA; Lose, F; Polanowski, A; Patterson, B; Serth, J; Meyer, A; Luedeke, M; Stefflova, K; Ray, AM; Lange, EM; Farnham, J; Khan, H; Slavov, C; Mitkova, A; Cao, GW; Easton, DF				Eeles, Rosalind A.; Kote-Jarai, Zsofia; Al Olama, Ali Amin; Giles, Graham G.; Guy, Michelle; Severi, Gianluca; Muir, Kenneth; Hopper, John L.; Henderson, Brian E.; Haiman, Christopher A.; Schleutker, Johanna; Hamdy, Freddie C.; Neal, David E.; Donovan, Jenny L.; Stanford, Janet L.; Ostrander, Elaine A.; Ingles, Sue A.; John, Esther M.; Thibodeau, Stephen N.; Schaid, Daniel; Park, Jong Y.; Spurdle, Amanda; Clements, Judith; Dickinson, Joanne L.; Maier, Christiane; Vogel, Walther; Doerk, Thilo; Rebbeck, Timothy R.; Cooney, Kathleen A.; Cannon-Albright, Lisa; Chappuis, Pierre O.; Hutter, Pierre; Zeegers, Maurice; Kaneva, Radka; Zhang, Hong-Wei; Lu, Yong-Jie; Foulkes, William D.; English, Dallas R.; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Morrison, Jonathan; Ardern-Jones, Audrey T.; Hall, Amanda L.; O'Brien, Lynne T.; Wilkinson, Rosemary A.; Saunders, Edward J.; Page, Elizabeth C.; Sawyer, Emma J.; Edwards, Stephen M.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Cooper, Colin S.; Southey, Melissa C.; Lophatananon, Artitaya; Liu, Jo-Fen; Kolonel, Laurence N.; Le Marchand, Loic; Wahlfors, Tiina; Tammela, Teuvo L.; Auvinen, Anssi; Lewis, Sarah J.; Cox, Angela; FitzGerald, Liesel M.; Koopmeiners, Joseph S.; Karyadi, Danielle M.; Kwon, Erika M.; Stern, Mariana C.; Corral, Roman; Joshi, Amit D.; Shahabi, Ahva; McDonnell, Shannon K.; Sellers, Thomas A.; Pow-Sang, Julio; Chambers, Suzanne; Aitken, Joanne; Gardiner, R. A. (Frank); Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity; Polanowski, Andrea; Patterson, Briony; Serth, Juergen; Meyer, Andreas; Luedeke, Manuel; Stefflova, Klara; Ray, Anna M.; Lange, Ethan M.; Farnham, Jim; Khan, Humera; Slavov, Chavdar; Mitkova, Atanaska; Cao, Guangwen; Easton, Douglas F.		British Assoc Urological Surg; UK ProtecT Study Collaborators; PRACTICAL Consortium	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study	NATURE GENETICS			English	Article							AUSTRALIAN CASE-CONTROL; MULTIPLE; RISK; VARIANTS; ANTIGEN	Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To identify common PrCa susceptibility alleles, we previously conducted a genome-wide association study in which 541,129 SNPs were genotyped in 1,854 PrCa cases with clinically detected disease and in 1,894 controls. We have now extended the study to evaluate promising associations in a second stage in which we genotyped 43,671 SNPs in 3,650 PrCa cases and 3,940 controls and in a third stage involving an additional 16,229 cases and 14,821 controls from 21 studies. In addition to replicating previous associations, we identified seven new prostate cancer susceptibility loci on chromosomes 2, 4, 8, 11 and 22 (with P = 1.6 x 10(-8) to P = 2.7 x 10(-33)).	[Eeles, Rosalind A.; Kote-Jarai, Zsofia; Guy, Michelle; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Hall, Amanda L.; O'Brien, Lynne T.; Wilkinson, Rosemary A.; Saunders, Edward J.; Page, Elizabeth C.; Sawyer, Emma J.; Edwards, Stephen M.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Cooper, Colin S.] Inst Canc Res, Surrey, England; [Eeles, Rosalind A.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Page, Elizabeth C.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris] Royal Marsden Natl Hlth Serv Fdn Trust, Surrey, England; [Eeles, Rosalind A.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Page, Elizabeth C.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris] Royal Marsden Natl Hlth Serv Fdn Trust, London, England; [Al Olama, Ali Amin; Morrison, Jonathan; Easton, Douglas F.] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Dept Publ Hlth & Primary Care, Strangeways Lab, Cambridge, England; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Giles, Graham G.; Severi, Gianluca; Hopper, John L.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; [Muir, Kenneth; Lophatananon, Artitaya; Liu, Jo-Fen] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham, England; [Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Schleutker, Johanna; Wahlfors, Tiina] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Neal, David E.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Donovan, Jenny L.; Lewis, Sarah J.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Stanford, Janet L.; FitzGerald, Liesel M.; Koopmeiners, Joseph S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; [Ostrander, Elaine A.; Karyadi, Danielle M.; Kwon, Erika M.] NHGRI, NIH, Bethesda, MD 20892 USA; [John, Esther M.] No Calif Canc Ctr, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Thibodeau, Stephen N.; Schaid, Daniel; McDonnell, Shannon K.] Mayo Clin, Rochester, MN USA; [Park, Jong Y.; Sellers, Thomas A.; Pow-Sang, Julio] Univ S Florida, H Lee Moffitt Canc Ctr, Div Canc Prevent & Control, Tampa, FL 33682 USA; [Spurdle, Amanda; Lose, Felicity] Queensland Inst Med Res, Mol Canc Epidemiol Lab, Brisbane, Qld 4006, Australia; [Clements, Judith; Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Clements, Judith; Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity] Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4001, Australia; [Clements, Judith; Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Dickinson, Joanne L.; Polanowski, Andrea; Patterson, Briony] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Maier, Christiane; Vogel, Walther; Luedeke, Manuel] Inst Human Genet & Anthropol, Ulm, Germany; [Doerk, Thilo] Hannover Med Sch, Clin Obstet, D-3000 Hannover, Germany; [Doerk, Thilo] Hannover Med Sch, Clin Gynaecol, D-3000 Hannover, Germany; [Rebbeck, Timothy R.; Stefflova, Klara] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.; Stefflova, Klara] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Cooney, Kathleen A.; Ray, Anna M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Cooney, Kathleen A.; Ray, Anna M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Cannon-Albright, Lisa; Farnham, Jim] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Chappuis, Pierre O.] Univ Hosp Geneva, Div Med Genet, Geneva, Switzerland; [Chappuis, Pierre O.] Univ Hosp Geneva, Div Oncol, Geneva, Switzerland; [Hutter, Pierre] Inst Cent Hop Valaisans, Div Med Genet, Sion, Switzerland; [Zeegers, Maurice; Khan, Humera] Univ Birmingham, Unit Genet Epidemiol, Dept Publ Hlth Epidemiol & Biostat, Sch Med, Birmingham B15 2TT, W Midlands, England; [Zeegers, Maurice] Maastricht Univ, Dept Complex Genet, Cluster Genet & Cell Biol, Nutr & Toxicol Res Inst,Med Ctr, Maastricht, Netherlands; [Kaneva, Radka; Mitkova, Atanaska] Med Univ Sofia, Mol Med Ctr, Sofia, Bulgaria; [Kaneva, Radka; Mitkova, Atanaska] Med Univ Sofia, Dept Chem & Biochem, Sofia, Bulgaria; [Zhang, Hong-Wei; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Lu, Yong-Jie] Univ London, Inst Canc, Barts & London Sch Med & Dent, London, England; [Foulkes, William D.] McGill Univ, Program Canc Genet, Montreal, PQ, Canada; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Lophatananon, Artitaya] Chulabhorn Canc Res Ctr, Bangkok, Thailand; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Tammela, Teuvo L.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Tammela, Teuvo L.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Auvinen, Anssi] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; [Cox, Angela] Univ Sheffield, Inst Canc Studies, Sheffield, S Yorkshire, England; [Koopmeiners, Joseph S.] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Chambers, Suzanne; Aitken, Joanne] Canc Council Queensland, Viertel Ctr Res Canc Control, Brisbane, Qld, Australia; [Aitken, Joanne] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Gardiner, R. A. (Frank)] Univ Queensland, Dept Surg, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Serth, Juergen] Hannover Med Sch, Urol Clin, D-3000 Hannover, Germany; [Serth, Juergen] Hannover Med Sch, Clin Urol Oncol, D-3000 Hannover, Germany; [Meyer, Andreas] Hannover Med Sch, Dept Radiat Oncol, D-3000 Hannover, Germany; [Lange, Ethan M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Slavov, Chavdar] Med Univ Sofia, Dept Urol, Alexandrovska Univ Hosp, Sofia, Bulgaria	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cancer Research UK; University of Cambridge; Cancer Council Victoria; University of Melbourne; University of Nottingham; University of Southern California; Tampere University; University of Oxford; Cancer Research UK; CRUK Cambridge Institute; University of Bristol; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Tasmania; Menzies Institute for Medical Research; Hannover Medical School; Hannover Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of Geneva; University of Geneva; University of Birmingham; Maastricht University; Medical University Sofia; Medical University Sofia; Naval Medical University; University of London; Queen Mary University London; McGill University; University of Melbourne; Chulabhorn Research Institute; Chulabhorn Royal Academy; Chulabhorn Hospital; Cancer Research Center of Hawaii; University of Hawaii System; Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Sheffield; University of Washington; University of Washington Seattle; Cancer Council Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of North Carolina; University of North Carolina Chapel Hill; Medical University Sofia	Eeles, RA (corresponding author), Inst Canc Res, Surrey, England.	rosalind.eeles@icr.ac.uk	Kaneva, Radka P/AGS-5076-2022; Severi, Gianluca/H-3774-2018; Kaneva, Radka P/V-6535-2017; Severi, Gianluca/Q-1824-2019; Auvinen, Anssi/AAL-2111-2020; Dearnaley, David P/J-2318-2014; Griffiths, TR Leyshon/K-7433-2019; Gardiner, Robert/G-2096-2010; Batra, Jyotsna/B-4130-2011; Rebbeck, Timothy/GLU-8348-2022; O'Mara, Tracy/M-7508-2016; English, Dallas/AAH-5005-2019; Auvinen, Anssi/AAD-9311-2020; Foulkes, William D./AAR-9586-2021; Aitken, Joanne F/C-5289-2009; Spurdle, Amanda B/A-4978-2011; Chambers, Suzanne K/H-5957-2012; Thomson, Russell J/H-5653-2012; Dörk, Thilo/J-8620-2012; Dickinson, Joanne/J-7728-2014; Kaneva, Radka/AAT-5322-2021; Chambers, Suzanne K/C-5508-2009; Wahlfors, Tiina/U-7635-2018	Kaneva, Radka P/0000-0002-1437-1393; Severi, Gianluca/0000-0001-7157-419X; Kaneva, Radka P/0000-0002-1437-1393; Severi, Gianluca/0000-0001-7157-419X; Auvinen, Anssi/0000-0003-1125-4818; Dearnaley, David P/0000-0002-3954-2806; Griffiths, TR Leyshon/0000-0002-3879-0664; Rebbeck, Timothy/0000-0002-4799-1900; O'Mara, Tracy/0000-0002-5436-3232; English, Dallas/0000-0001-7828-8188; Foulkes, William D./0000-0001-7427-4651; Spurdle, Amanda B/0000-0003-1337-7897; Chambers, Suzanne K/0000-0003-2369-6111; Thomson, Russell J/0000-0003-4949-4120; Dörk, Thilo/0000-0002-9458-0282; McLaren, Duncan/0000-0002-9862-4158; Polanowski, Andrea/0000-0002-9612-220X; Eeles, Rosalind/0000-0002-3698-6241; Dickinson, Joanne/0000-0003-4621-1703; Lewis, Sarah/0000-0003-4311-6890; Cox, Angela/0000-0002-5138-1099; Clarke, Noel/0000-0001-7776-8059; Southey, Melissa/0000-0002-6313-9005; Barsi, Klara/0000-0001-9338-0468; Neal, David/0000-0002-6033-5086; Lu, Yong-Jie/0000-0001-6174-6621; van As, Nicholas/0000-0001-6829-8788; Wahlfors, Tiina/0000-0002-3910-796X; Hamdy, Freddie/0000-0003-2627-2154; Saunders, Ed/0000-0003-4343-3570; Adeyoju, Adebanji/0000-0003-4010-5985; Aitken, Joanne Frances/0000-0001-6859-2186; Giles, Graham/0000-0003-4946-9099; albright, lisa/0000-0003-2602-3668; Karyadi, Danielle/0000-0003-4164-5625; Surowy, Harald/0000-0002-3595-9188; Cornford, Philip/0000-0002-7146-9258; Ostrander, Elaine/0000-0001-6075-9738; Clements, Judith/0000-0001-6026-1964; Cooney, Kathleen/0000-0003-3831-6943; McDonnell, Shannon/0000-0001-6201-369X; Farnham, James/0000-0002-8213-949X; Schleutker, Johanna/0000-0002-1863-0305; batra, Jyotsna/0000-0003-4646-6247; Bancroft, Elizabeth/0000-0002-5482-5660; Lose, Felicity/0000-0001-8337-3547; Alexander, Kimberly/0000-0003-3906-2412; Leongamornlert, Daniel/0000-0002-3486-3168; Rogers, Paul/0000-0003-2593-2595; Hickish, Tamas/0000-0001-6770-7279; Mitev, Vanyo/0000-0001-7528-590X; FitzGerald, Liesel/0000-0002-6882-2698; Evans, Gareth/0000-0002-8482-5784; huddart, robert/0000-0003-3604-1990	Cancer Research UK [C5047/A7357, C5047/A3354, 10118, 10588, C16913/A6835, C1287/A10118, C16913/A6135, C5047/A10692, C522/A8649, 11022] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G0501019, G0500966] Funding Source: Medline; NCI NIH HHS [P50 CA069568-12, CA63464, U01 CA089600-04, U01 CA089600, CA56678, N01-PC-35141, R01 CA128813-02, R01 CA084979-05, R01 CA084979, R01 CA072818-09, CA97186, R37 CA054281-17, CA54281, R01 CA056678-05, R01CA84979, R01 CA128813, P50 CA097186-08, P50 CA097186, R01 CA072818, CA92579, R01 CA063464, N01 PC035141, P50 CA105641, R01 CA092579-05, R01CA128813, R01 CA063464-10, P50 CA105641-05, R01 CA092579, P50 CA069568, R37 CA054281] Funding Source: Medline; NCRR NIH HHS [M01 RR00064, M01 RR000064-41] Funding Source: Medline; NIGMS NIH HHS [T32 GM007814] Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G0501019, G0500966] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA092579, R01CA054281, R37CA054281, R01CA072818, P50CA069568, U01CA089600, R01CA128813, U01CA063464, R01CA063464, P50CA097186, R01CA056678, R01CA084979, P50CA105641] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn J, 2008, NAT GENET, V40, P1032, DOI 10.1038/ng0908-1032; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Donovan J, 2003, Health Technol Assess, V7, P1; Eeles R, 2008, NAT GENET, V40, P1035, DOI 10.1038/ng0908-1035; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Giles GG, 2002, CANCER EPIDEM BIOMAR, V11, P549; Giles GG, 2001, ANN ONCOL, V12, P761, DOI 10.1023/A:1011131105617; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Severi G, 2003, J NATL CANCER I, V95, P818, DOI 10.1093/jnci/95.11.818; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Witte JS, 2009, NAT REV GENET, V10, P77, DOI 10.1038/nrg2507; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	17	334	345	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1116	U97		10.1038/ng.450	http://dx.doi.org/10.1038/ng.450			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19767753	Green Accepted, Green Submitted			2022-12-25	WOS:000270330400016
J	Gonfloni, S; Di Tella, L; Caldarola, S; Cannata, SM; Klinger, FG; Di Bartolomeo, C; Mattei, M; Candi, E; De Felici, M; Melino, G; Cesareni, G				Gonfloni, Stefania; Di Tella, Lucia; Caldarola, Sara; Cannata, Stefano M.; Klinger, Francesca G.; Di Bartolomeo, Claudia; Mattei, Maurizio; Candi, Eleonora; De Felici, Massimo; Melino, Gerry; Cesareni, Gianni			Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death	NATURE MEDICINE			English	Article							C-ABL ACTIVATION; DNA-DAMAGE; APOPTOTIC RESPONSE; TYROSINE KINASE; GENOTOXIC STRESS; REGULATES P73; P63; P53; PHOSPHORYLATION; CHECKPOINTS	Germ cells are sensitive to genotoxins, and ovarian failure and infertility are major side effects of chemotherapy in young patients with cancer. Here we describe the c-Abl-TAp63 pathway activated by chemotherapeutic DNA-damaging drugs in model human cell lines and in mouse oocytes and its role in cell death. In cell lines, upon cisplatin treatment, c-Abl phosphorylates TAp63 on specific tyrosine residues. Such modifications affect p63 stability and induce a p63-dependent activation of proapoptotic promoters. Similarly, in oocytes, cisplatin rapidly promotes TAp63 accumulation and eventually cell death. Treatment with the c-Abl kinase inhibitor imatinib counteracts these cisplatin-induced effects. Taken together, these data support a model in which signals initiated by DNA double-strand breaks are detected by c-Abl, which, through its kinase activity, modulates the p63 transcriptional output. Moreover, they suggest a new use for imatinib, aimed at preserving oocytes of the follicle reserve during chemotherapeutic treatments.	[Gonfloni, Stefania; Di Tella, Lucia; Caldarola, Sara; Cannata, Stefano M.; Di Bartolomeo, Claudia; Mattei, Maurizio; Cesareni, Gianni] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Klinger, Francesca G.; De Felici, Massimo] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Rome, Italy; [Candi, Eleonora; Melino, Gerry] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy; [Melino, Gerry] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Leicester	Gonfloni, S (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Italy.	stefania.gonfloni@uniroma2.it	Mattei, Maurizio/AAC-1303-2019; De Felici, Massimo/J-4845-2018; Klinger, Francesca Gioia/AAO-5349-2021; Cesareni, Gianni/AAW-1382-2020	Mattei, Maurizio/0000-0002-0814-8873; Klinger, Francesca Gioia/0000-0001-6744-0850; De Felici, Massimo/0000-0001-8479-8264; GONFLONI, STEFANIA/0000-0002-9392-4258	Associazione Italiana per la Ricerca sul Cancro; EU; EPISTEM; Medical Research Council [MC_U132670600] Funding Source: researchfish; MRC [MC_U132670600] Funding Source: UKRI	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); EU(European Commission); EPISTEM; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Mazzeo for critical suggestions and support. We thank G. Superti-Furga for critical reading of the manuscript. We thank R. Sacco for help in preparing some figures. We thank S. Bernardini, M. Angelini, A.M. Lena, A. Gamboi-Miraglia, M. Ranalli and G. Palmieri for technical advice. This work was supported by Associazione Italiana per la Ricerca sul Cancro to S.G. and G.C., and the EU integrated projects Interaction Proteome to G.C. and EPISTEM to G.M.	Agami R, 1999, NATURE, V399, P809; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; BLOMMAERT FA, 1995, NUCLEIC ACIDS RES, V23, P1300, DOI 10.1093/nar/23.8.1300; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; De Felici M, 2004, HUM REPROD UPDATE, V10, P197, DOI 10.1093/humupd/dmh020; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Gong JG, 1999, NATURE, V399, P806; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jones EV, 2007, BIOCHEM J, V405, P617, DOI 10.1042/BJ20061778; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KATOH MA, 1990, MUTAT RES, V230, P205, DOI 10.1016/0027-5107(90)90058-C; Kharbanda S, 2000, MOL CELL BIOL, V20, P4979, DOI 10.1128/MCB.20.14.4979-4989.2000; Kharbanda S, 1995, J BIOL CHEM, V270, P30278, DOI 10.1074/jbc.270.51.30278; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Machuy N, 2004, CELL DEATH DIFFER, V11, P290, DOI 10.1038/sj.cdd.4401336; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Melino G, 2006, CELL CYCLE, V5, P1735; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tsai KKC, 2003, CANCER RES, V63, P3418; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	35	240	248	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2009	15	10					1179	U107		10.1038/nm.2033	http://dx.doi.org/10.1038/nm.2033			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19783996				2022-12-25	WOS:000270596400030
J	Prickett, TD; Agrawal, NS; Wei, XM; Yates, KE; Lin, JC; Wunderlich, JR; Cronin, JC; Cruz, P; Rosenberg, SA; Samuels, Y				Prickett, Todd D.; Agrawal, Neena S.; Wei, Xiaomu; Yates, Kristin E.; Lin, Jimmy C.; Wunderlich, John R.; Cronin, Julia C.; Cruz, Pedro; Rosenberg, Steven A.; Samuels, Yardena		NISC Comparative Sequencing Progra	Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; CANCER; INHIBITOR; KINASES; BREAST; ACTIVATION; RESISTANCE; LAPATINIB; PATHWAYS	Tyrosine phosphorylation is important in signaling pathways underlying tumorigenesis. We performed a mutational analysis of the protein tyrosine kinase (PTK) gene family in cutaneous metastatic melanoma. We identified 30 somatic mutations affecting the kinase domains of 19 PTKs and subsequently evaluated the entire coding regions of the genes encoding these 19 PTKs for somatic mutations in 79 melanoma samples. We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas. We examined seven missense mutations in the most commonly altered PTK gene, ERBB4, and found that they resulted in increased kinase activity and transformation ability. Melanoma cells expressing mutant ERBB4 had reduced cell growth after shRNA-mediated knockdown of ERBB4 or treatment with the ERBB inhibitor lapatinib. These studies could lead to personalized therapeutics specifically targeting the kinases that are mutationally altered in individual melanomas.	[Prickett, Todd D.; Agrawal, Neena S.; Wei, Xiaomu; Yates, Kristin E.; Cronin, Julia C.; Samuels, Yardena] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Lin, Jimmy C.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Wunderlich, John R.; Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Cruz, Pedro] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [NISC Comparative Sequencing Progra] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Samuels, Y (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	samuelsy@mail.nih.gov		Samuels, Yardena/0000-0002-3349-7266	National Human Genome Research Institute; National Cancer Institute; National Institutes of Health, USA; NATIONAL CANCER INSTITUTE [ZICBC010905, ZIABC010984] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200337] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank B. Vogelstein, T. Waldman, D. Bell, P. Meltzer, L. Brody, G. Merlino, S. Gutkind and I. Cardenas-Navia for their helpful comments on the manuscript; members of the NISC Comparative Sequencing Program for generating the sequence data analyzed here; and S. Anderson and M. Kirby for assistance with FACS analysis. This work supported by the Intramural Research Programs of the National Human Genome Research Institute and National Cancer Institute, National Institutes of Health, USA.	Allen LF, 2003, SEMIN ONCOL, V30, P65, DOI 10.1053/j.seminoncol.2003.08.009; Bhangale TR, 2006, NAT GENET, V38, P1457, DOI 10.1038/ng1925; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Chappell DB, 1999, CANCER RES, V59, P59; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Frey MR, 2009, GASTROENTEROLOGY, V136, P217, DOI 10.1053/j.gastro.2008.09.023; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heymach JV, 2006, CLIN CANCER RES, V12, p4441S, DOI 10.1158/1078-0432.CCR-06-0286; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; McHugh LA, 2009, INT J ONCOL, V34, P1155, DOI 10.3892/ijo_00000244; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shih LY, 2004, CLIN CANCER RES, V10, P1326, DOI 10.1158/1078-0432.CCR-0835-03; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774	30	260	271	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1127	U112		10.1038/ng.438	http://dx.doi.org/10.1038/ng.438			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19718025	Green Accepted			2022-12-25	WOS:000270330400018
J	Suppiah, V; Moldovan, M; Ahlenstiel, G; Berg, T; Weltman, M; Abate, ML; Bassendine, M; Spengler, U; Dore, GJ; Powell, E; Riordan, S; Sheridan, D; Smedile, A; Fragomeli, V; Muller, T; Bahlo, M; Stewart, GJ; Booth, DR; George, J				Suppiah, Vijayaprakash; Moldovan, Max; Ahlenstiel, Golo; Berg, Thomas; Weltman, Martin; Abate, Maria Lorena; Bassendine, Margaret; Spengler, Ulrich; Dore, Gregory J.; Powell, Elizabeth; Riordan, Stephen; Sheridan, David; Smedile, Antonina; Fragomeli, Vincenzo; Mueller, Tobias; Bahlo, Melanie; Stewart, Graeme J.; Booth, David R.; George, Jacob		Hepatitis C Study	IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy	NATURE GENETICS			English	Article							GENE-EXPRESSION; PLUS RIBAVIRIN; IFN-LAMBDA; III IFN; REPLICATION; OPINION; STRATIFICATION; COMBINATION; INFECTION; IL-28	Hepatitis C virus (HCV) infects 3% of the world's population. Treatment of chronic HCV consists of a combination of PEGylated interferon-alpha (PEG-IFN-alpha) and ribavirin (RBV). To identify genetic variants associated with HCV treatment response, we conducted a genome-wide association study of sustained virological response (SVR) to PEG-IFN-alpha/RBV combination therapy in 293 Australian individuals with genotype 1 chronic hepatitis C, with validation in an independent replication cohort consisting of 555 individuals. We report an association to SVR within the gene region encoding interleukin 28B (IL28B, also called IFN lambda 3; rs8099917 combined P = 9.25 x 10(-9), OR = 1.98, 95% CI = 1.57-2.52). IL28B contributes to viral resistance and is known to be upregulated by interferons and by RNA virus infection. These data suggest that host genetics may be useful for the prediction of drug response, and they also support the investigation of the role of IL28B in the treatment of HCV and in other diseases treated with IFN-alpha.	[Suppiah, Vijayaprakash; George, Jacob] Univ Sydney, Storr Liver Unit, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Suppiah, Vijayaprakash; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Inst Immunol & Allergy Res, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Moldovan, Max; Bahlo, Melanie] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3010, Australia; [Ahlenstiel, Golo; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany; [Berg, Thomas; Mueller, Tobias] Univ Med Berlin, Med Klin MS Hepatol & Gastroenterol, Charite, D-13353 Berlin, Germany; [Weltman, Martin; Fragomeli, Vincenzo] Nepean Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW, Australia; [Abate, Maria Lorena; Smedile, Antonina] Univ Turin, Dept Internal Med, Liver Physiopathol Lab, Turin, Italy; [Bassendine, Margaret; Sheridan, David] Univ Newcastle, Liver Res Grp, Inst Cellular Med, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Dore, Gregory J.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Dore, Gregory J.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Powell, Elizabeth] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Woolloongabba, Qld 4102, Australia; [Powell, Elizabeth] Univ Queensland, Sch Med, Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [Riordan, Stephen] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research; University of Melbourne; Walter & Eliza Hall Institute; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Nepean Hospital; University of Turin; Newcastle University - UK; University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; University of Queensland	George, J (corresponding author), Univ Sydney, Storr Liver Unit, Westmead Millennium Inst, Sydney, NSW 2006, Australia.	j.george@usyd.edu.au	Suppiah, Vijay/D-4174-2011; Dore, Gregory John/ABD-5665-2021; Powell, Elizabeth/B-4455-2011; Ahlenstiel, Golo/U-1990-2017; Moldovan, Max/H-7108-2014; George, jacob/P-1496-2014	Suppiah, Vijay/0000-0001-5496-935X; Dore, Gregory John/0000-0002-4741-2622; Powell, Elizabeth/0000-0001-5008-8061; Ahlenstiel, Golo/0000-0003-0026-1457; Moldovan, Max/0000-0001-9680-8474; Bahlo, Melanie/0000-0001-5132-0774; Sheridan, David/0000-0001-5100-814X; Mueller, Tobias/0000-0003-3426-5421; Berg, Thomas/0000-0003-0003-6241	National Health and Medical Research Council [402577]; Robert W. Storr Bequest; National Health and Medical Research Council Career Development Award fellowship; German Competence Network for Viral Hepatitis; German Ministry of Education and Research [01 KI 0437]; EU [LSHM-CT-2004-503359]; BMBF [01KI0411]; Medical Research Council UK [G0502028]; MRC [G0502028] Funding Source: UKRI; Medical Research Council [G0502028] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Robert W. Storr Bequest; National Health and Medical Research Council Career Development Award fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Competence Network for Viral Hepatitis; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EU(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S., D. R. B., G. J. S. and J. G. were supported by National Health and Medical Research Council Project grant 402577 and the Robert W. Storr Bequest to the University of Sydney. M. Bahlo has a National Health and Medical Research Council Career Development Award fellowship. T. B. is supported by the German Competence Network for Viral Hepatitis (Hep-Net), funded by the German Ministry of Education and Research (BMBF, grant number 01 KI 0437), the EU-Vigilanz network of excellence combating viral resistance (VIRGIL, project number LSHM-CT-2004-503359), and the BMBF project Host and viral determinants for susceptibility and resistance to hepatitis C virus infection (FKZ: 01KI0411; project B). D. S. and M. Bassendine are funded by a Medical Research Council UK project grant G0502028. We would like to thank all subjects for their valuable participation in this study.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; DAVID M, 2002, BIOTECHNIQUES    OCT, pS58; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Fox BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004933; Fried MW, 2000, AM J GASTROENTEROL, V95, P3225, DOI 10.1111/j.1572-0241.2000.03433.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Saito A, 2002, J HUM GENET, V47, P360, DOI 10.1007/s100380200050; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Selzner N, 2008, J HEPATOL, V49, P494, DOI 10.1016/j.jhep.2008.07.006; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Siren J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Tan H, 2005, J INTERF CYTOK RES, V25, P632, DOI 10.1089/jir.2005.25.632; Taylor MW, 2007, J VIROL, V81, P3391, DOI 10.1128/JVI.02640-06; Taylor MW, 2004, J INTERF CYTOK RES, V24, P107, DOI 10.1089/107999004322813354; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Weiss ST, 2008, NAT REV DRUG DISCOV, V7, P568, DOI 10.1038/nrd2520; World Health Organization, 164 WHO; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x; Zhu HZ, 2003, J VIROL, V77, P5493, DOI 10.1128/JVI.77.9.5493-5498.2003	50	1557	1659	0	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1100	U74		10.1038/ng.447	http://dx.doi.org/10.1038/ng.447			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19749758				2022-12-25	WOS:000270330400013
J	Vakoc, BJ; Lanning, RM; Tyrrell, JA; Padera, TP; Bartlett, LA; Stylianopoulos, T; Munn, LL; Tearney, GJ; Fukumura, D; Jain, RK; Bouma, BE				Vakoc, Benjamin J.; Lanning, Ryan M.; Tyrrell, James A.; Padera, Timothy P.; Bartlett, Lisa A.; Stylianopoulos, Triantafyllos; Munn, Lance L.; Tearney, Guillermo J.; Fukumura, Dai; Jain, Rakesh K.; Bouma, Brett E.			Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging	NATURE MEDICINE			English	Article							COHERENCE TOMOGRAPHY; LYMPHATIC METASTASIS; GROWTH; ANGIOGENESIS; VASCULATURE; FLOW; NORMALIZATION; ARCHITECTURE; SENSITIVITY; PRESSURE	Intravital multiphoton microscopy has provided powerful mechanistic insights into health and disease and has become a common instrument in the modern biological laboratory. The requisite high numerical aperture and exogenous contrast agents that enable multiphoton microscopy, however, limit the ability to investigate substantial tissue volumes or to probe dynamic changes repeatedly over prolonged periods. Here we introduce optical frequency domain imaging (OFDI) as an intravital microscopy that circumvents the technical limitations of multiphoton microscopy and, as a result, provides unprecedented access to previously unexplored, crucial aspects of tissue biology. Using unique OFDI-based approaches and entirely intrinsic mechanisms of contrast, we present rapid and repeated measurements of tumor angiogenesis, lymphangiogenesis, tissue viability and both vascular and cellular responses to therapy, thereby demonstrating the potential of OFDI to facilitate the exploration of physiological and pathological processes and the evaluation of treatment strategies.	[Lanning, Ryan M.; Tyrrell, James A.; Padera, Timothy P.; Stylianopoulos, Triantafyllos; Munn, Lance L.; Fukumura, Dai; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA; [Vakoc, Benjamin J.; Bartlett, Lisa A.; Tearney, Guillermo J.; Bouma, Brett E.] Harvard Univ, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Vakoc, Benjamin J.; Bouma, Brett E.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Vakoc, Benjamin J.; Lanning, Ryan M.; Tearney, Guillermo J.; Bouma, Brett E.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Tearney, Guillermo J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Jain, RK (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA.	jain@steele.mgh.harvard.edu; bouma@helix.mgh.harvard.edu	Padera, Timothy/R-2982-2019; Lanning, Ryan/GSM-9167-2022; Munn, Lance L/L-3950-2016; Jain, Rakesh K/I-1384-2017; Stylianopoulos, Triantafyllos/AGF-9544-2022; Tyrrell, James/A-6359-2010	Padera, Timothy/0000-0002-3453-9384; Munn, Lance L/0000-0003-0698-7232; Jain, Rakesh K/0000-0001-7571-3548; Stylianopoulos, Triantafyllos/0000-0002-3093-1696; 	US National Institutes of Health [P01-CA080124, R01-CA085140, R01-CA115767, R01 CA126642, R33-CA125560, K25-CA127465, K99-CA137167, R01-CA096915]; US Department of Defense Breast Cancer Research Program fellowship [W81XWH-06-1-0436]; NATIONAL CANCER INSTITUTE [K25CA127465, K99CA137167, R01CA126642, T32CA073479, R01CA085140, P01CA080124, R01CA096915, R33CA125560, R24CA085140, R00CA137167, R01CA115767] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense Breast Cancer Research Program fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Baish for insightful input regarding fractal analysis. We also thank J. Kahn and S. Roberge for preparation of animal models, P. Huang for animal care and colony maintenance, and E. di Tomaso and C. Smith for histological preparations. We thank Genentech for supplying the MDA-MB-361HK mammary carcinoma cells and J. B. Little of the Harvard School for Public Health for HSTS26T. This research was funded in part by US National Institutes of Health grants P01-CA080124, R01-CA085140, R01-CA115767, R01 CA126642, R33-CA125560, K25-CA127465, K99-CA137167, and R01-CA096915. R.M.L. is supported in part by US Department of Defense Breast Cancer Research Program fellowship W81XWH-06-1-0436.	Arbiser JL, 1999, AM J PATHOL, V155, P723, DOI 10.1016/S0002-9440(10)65171-1; Baish JW, 2000, CANCER RES, V60, P3683; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen ZP, 1997, OPT LETT, V22, P64, DOI 10.1364/OL.22.000064; Collins HA, 2008, NAT PHOTONICS, V2, P420, DOI 10.1038/nphoton.2008.100; Gazit Y, 1997, MICROCIRCULATION-LON, V4, P395, DOI 10.3109/10739689709146803; GAZIT Y, 1995, PHYS REV LETT, V75, P2428, DOI 10.1103/PhysRevLett.75.2428; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Isaka N, 2004, CANCER RES, V64, P4400, DOI 10.1158/0008-5472.CAN-04-0752; Izatt JA, 1997, OPT LETT, V22, P1439, DOI 10.1364/OL.22.001439; Jain R. K., 2005, LIVE CELL IMAGING LA, P435; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; LEUNIG M, 1992, CANCER RES, V52, P6553; MASTERS BR, 2008, HDB BIOMEDICAL NONLI, P735; Padera TP, 2008, MOL CANCER THER, V7, P2272, DOI 10.1158/1535-7163.MCT-08-0182; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Sharma M, 2007, BIOTECHNOL LETT, V29, P273, DOI 10.1007/s10529-006-9232-2; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tyrrell JA, 2007, IEEE T MED IMAGING, V26, P223, DOI 10.1109/TMI.2006.889722; Vakoc BJ, 2005, OPT EXPRESS, V13, P5483, DOI 10.1364/OPEX.13.005483; Wang RKK, 2007, OPT EXPRESS, V15, P11402, DOI 10.1364/OE.15.011402; YUAN F, 1994, CANCER RES, V54, P4564; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450; Yun SH, 2003, OPT EXPRESS, V11, P2953, DOI 10.1364/OE.11.002953; Zhao YH, 2000, OPT LETT, V25, P114, DOI 10.1364/OL.25.000114	28	538	551	2	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1219	U151		10.1038/nm.1971	http://dx.doi.org/10.1038/nm.1971			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19749772	Green Accepted, Green Submitted			2022-12-25	WOS:000270596400036
J	Liu, J; Divoux, A; Sun, J; Zhang, J; Clement, K; Glickman, JN; Sukhova, GK; Wolters, PJ; Du, J; Gorgun, CZ; Doria, A; Libby, P; Blumberg, RS; Kahn, BB; Hotamisligil, GS; Shi, GP				Liu, Jian; Divoux, Adeline; Sun, Jiusong; Zhang, Jie; Clement, Karine; Glickman, Jonathan N.; Sukhova, Galina K.; Wolters, Paul J.; Du, Juan; Gorgun, Cem Z.; Doria, Alessandro; Libby, Peter; Blumberg, Richard S.; Kahn, Barbara B.; Hotamisligil, Goekhan S.; Shi, Guo-Ping			Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; TUMOR-GROWTH; CATHEPSIN-S; ANGIOGENESIS; INFLAMMATION; EXPRESSION; RESPONSES; ACCUMULATION; INFILTRATION; DEPRIVATION	Although mast cell functions have classically been related to allergic responses(1-3), recent studies indicate that these cells contribute to other common diseases such as multiple sclerosis, rheumatoid arthritis, atherosclerosis, aortic aneurysm and cancer(4-8). This study presents evidence that mast cells also contribute to diet-induced obesity and diabetes. For example, white adipose tissue (WAT) from obese humans and mice contain more mast cells than WAT from their lean counterparts. Furthermore, in the context of mice on a Western diet, genetically induced deficiency of mast cells, or their pharmacological stabilization, reduces body weight gain and levels of inflammatory cytokines, chemokines and proteases in serum and WAT, in concert with improved glucose homeostasis and energy expenditure. Mechanistic studies reveal that mast cells contribute to WAT and muscle angiogenesis and associated cell apoptosis and cathepsin activity. Adoptive transfer experiments of cytokine-deficient mast cells show that these cells, by producing interleukin-6 (IL-6) and interferon-c (IFN-gamma), contribute to mouse adipose tissue cysteine protease cathepsin expression, apoptosis and angiogenesis, thereby promoting diet-induced obesity and glucose intolerance. Our results showing reduced obesity and diabetes in mice treated with clinically available mast cell-stabilizing agents suggest the potential of developing new therapies for these common human metabolic disorders.	[Liu, Jian; Sun, Jiusong; Zhang, Jie; Glickman, Jonathan N.; Sukhova, Galina K.; Du, Juan; Libby, Peter; Blumberg, Richard S.; Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Liu, Jian; Sun, Jiusong; Zhang, Jie; Glickman, Jonathan N.; Sukhova, Galina K.; Du, Juan; Doria, Alessandro; Libby, Peter; Blumberg, Richard S.; Kahn, Barbara B.; Shi, Guo-Ping] Harvard Univ, Sch Med, Boston, MA USA; [Divoux, Adeline; Clement, Karine] Inst Natl Sante & Rech Med, U872, Paris, France; [Clement, Karine] Univ Paris 06, Cordeliers Res Ctr, Paris, France; [Clement, Karine] Hop La Pitie Salpetriere, AP HP, Dept Nutr, Paris, France; [Wolters, Paul J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Gorgun, Cem Z.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Doria, Alessandro] Joslin Diabet Ctr, Sect Genet & Epidemiol, Boston, MA 02215 USA; [Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center	Shi, GP (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	gshi@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021; Wolters, Paul/A-7181-2009; Eckhardt, Erik/G-1567-2010; Doria, Alessandro/H-9157-2018; Clément, karine/R-1120-2017	Libby, Peter/0000-0002-1502-502X; Doria, Alessandro/0000-0002-3830-4304; 	American Heart Association [0840118N]; US National Institutes of Health [HL60942, HL67283, HL81090, HL88547, HL34636, DK57521, DK56116, DK52539, DK64360]; Programme Hospitalier de Recherche Clinique; Assistance Publique des Hopitaux de Paris [AOR 02076]; French National Agency of Research [NdegreesANR05-PCOD-030-02]; Commission of the European Communities; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075026, R01HL034636, R01HL088547, R01HL067283, R01HL060942, R37HL034636, R01HL081090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539, R37DK044319, P30DK057521, P30DK040561, P01DK056116] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programme Hospitalier de Recherche Clinique; Assistance Publique des Hopitaux de Paris; French National Agency of Research(French National Research Agency (ANR)); Commission of the European Communities(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Rizkalla and C. Poitou, who contributed to the clinical investigation program. We also thank B. Spiegelman and R. K. Gupta for their help with the 3T3-L1 culture. This study was supported partially by the Established Investigator Award from the American Heart Association (0840118N) (to G.-P. S.) and by US National Institutes of Health grants HL60942, HL67283, HL81090, HL88547 (G.-P. S.), HL34636 (P. L.), DK57521, DK56116 (B. B. K.) and DK52539 and DK64360 (G. S. H.). The clinical work was supported by the Programme Hospitalier de Recherche Clinique, Assistance Publique des Hopitaux de Paris (AOR 02076), a grant from French National Agency of Research (RIOMA program N degrees ANR05-PCOD-030-02), and by the Commission of the European Communities (ADAPT project) (to K. C.).	Bingham CO, 2000, J ALLERGY CLIN IMMUN, V105, pS527, DOI 10.1016/S0091-6749(00)90056-3; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; DUTTLINGER R, 1995, P NATL ACAD SCI USA, V92, P3754, DOI 10.1073/pnas.92.9.3754; EIGEN H, 1987, J ALLERGY CLIN IMMUN, V80, P612, DOI 10.1016/0091-6749(87)90016-9; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; GALLI SJ, 1987, AM J PATHOL, V127, P191; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hadigan C, 1999, J CLIN ENDOCR METAB, V84, P1932, DOI 10.1210/jc.84.6.1932; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Koban M, 2005, AM J PHYSIOL-ENDOC M, V289, pE68, DOI 10.1152/ajpendo.00543.2004; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Paterson WG, 1998, AM J PHYSIOL-GASTR L, V274, pG385, DOI 10.1152/ajpgi.1998.274.2.G385; Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Santone DJ, 2008, AM J PHYSIOL-HEART C, V294, pH2456, DOI 10.1152/ajpheart.00925.2007; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Serna H, 2006, J PHARMACOL EXP THER, V319, P1104, DOI 10.1124/jpet.106.104620; SHI GP, 1992, J BIOL CHEM, V267, P7258; Shin HY, 2004, LIFE SCI, V74, P2877, DOI 10.1016/j.lfs.2003.10.026; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yang M, 2007, NAT CELL BIOL, V9, P970, DOI 10.1038/ncb1623	35	547	578	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					940	U144		10.1038/nm.1994	http://dx.doi.org/10.1038/nm.1994			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19633655	Green Submitted, Green Accepted			2022-12-25	WOS:000268770400039
J	Erkizan, HV; Kong, YL; Merchant, M; Schlottmann, S; Barber-Rotenberg, JS; Yuan, LS; Abaan, OD; Chou, TH; Dakshanamurthy, S; Brown, ML; Uren, A; Toretsky, JA				Erkizan, Hayriye V.; Kong, Yali; Merchant, Melinda; Schlottmann, Silke; Barber-Rotenberg, Julie S.; Yuan, Linshan; Abaan, Ogan D.; Chou, Tsu-hang; Dakshanamurthy, Sivanesan; Brown, Milton L.; Uren, Aykut; Toretsky, Jeffrey A.			A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma	NATURE MEDICINE			English	Article							PRIMITIVE NEUROECTODERMAL TUMOR; POLYMERASE-II; A INTERACTS; CELLS; TRANSCRIPTION; CANCER; FUSION; MODEL; GENE; IDENTIFICATION	Many sarcomas and leukemias carry nonrandom chromosomal translocations encoding tumor-specific mutant fusion transcription factors that are essential to their molecular pathogenesis. Ewing's sarcoma family tumors (ESFTs) contain a characteristic t(11;22) translocation leading to expression of the oncogenic fusion protein EWS-FLI1. EWS-FLI1 is a disordered protein that precludes standard structure-based small-molecule inhibitor design. EWS-FLI1 binding to RNA helicase A (RHA) is important for its oncogenic function. We therefore used surface plasmon resonance screening to identify compounds that bind EWS-FLI1 and might block its interaction with RHA. YK-4-279, a derivative of the lead compound from the screen, blocks RHA binding to EWS-FLI1, induces apoptosis in ESFT cells and reduces the growth of ESFT orthotopic xenografts. These findings provide proof of principle that inhibiting the interaction of mutant cancer-specific transcription factors with the normal cellular binding partners required for their oncogenic activity provides a promising strategy for the development of uniquely effective, tumor-specific anticancer agents.	[Erkizan, Hayriye V.; Kong, Yali; Schlottmann, Silke; Barber-Rotenberg, Julie S.; Yuan, Linshan; Abaan, Ogan D.; Dakshanamurthy, Sivanesan; Brown, Milton L.; Uren, Aykut; Toretsky, Jeffrey A.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; [Merchant, Melinda; Chou, Tsu-hang] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Toretsky, Jeffrey A.] Georgetown Univ, Dept Pediat, Washington, DC 20057 USA	Georgetown University; Memorial Sloan Kettering Cancer Center; Georgetown University	Toretsky, JA (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA.	jat42@georgetown.edu	ERKIZAN, HAYRIYE VERDA/C-2341-2011; Dakshanamurthy, Sivanesan/CAF-4258-2022	Dakshanamurthy, Sivanesan/0000-0003-3681-4121	Children's Cancer Foundation of Baltimore; Go4theGoal Foundation; Foundation of Denver; Liddy Shriver Sarcoma Initiative; Amschwand Sarcoma Cancer Foundation; Burroughs-Wellcome Clinical Scientist Award; US National Institutes of Health [R01CA138212, R01CA133662, P30 CA051008]; Georgetown University Medical Center Drug Discovery Program; NATIONAL CANCER INSTITUTE [R01CA138212, R01CA088004, P01CA047179, T32CA009686, P30CA051008, R01CA133662] Funding Source: NIH RePORTER	Children's Cancer Foundation of Baltimore; Go4theGoal Foundation; Foundation of Denver; Liddy Shriver Sarcoma Initiative; Amschwand Sarcoma Cancer Foundation; Burroughs-Wellcome Clinical Scientist Award(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown University Medical Center Drug Discovery Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was generously supported by the Children's Cancer Foundation of Baltimore (J.T. and A.U.), Go4theGoal Foundation (J.T.), Dani's Foundation of Denver (J.T.), the Liddy Shriver Sarcoma Initiative (J.T.), the Amschwand Sarcoma Cancer Foundation (J.T.), the Burroughs-Wellcome Clinical Scientist Award in Translational Research (J.T.), US National Institutes of Health grants R01CA138212 (J.T.) and R01CA133662 (J.T.), and the Georgetown University Medical Center Drug Discovery Program. US National Institutes of Health support is through the Cancer Center Support Grant P30 CA051008 for use of Flow Cytometry and Cell Sorting, Biacore Molecular Interaction, Tissue Culture and microscopy core facilities and grant P01 CA47179 (M. M.). We would like to thank S. Metallo for training in fluorescence polarization. Also, T. Cripe and L. Whitesell provided critical review of our manuscript. We also thank S. Lessnick from Hunstamn Cancer Institute, for providing NROB1 reporter plasmid, J.V. Frangioni from Beth Israel Deaconess Medical Center for providing pG, pGN and pGC vectors, O. Delattre from INSERM France for providing the A673 shEWS-FLI1 cell line, and R. Schlegel, Lombardi Comprehensive Cancer Center, for providing HFK and HEC cell lines. We thank the Developmental Therapeutics Program of the US National Cancer Institute for providing the Diversity set of compounds for screening. This article is dedicated to our patients who have fought but succumbed to ESFT.	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Bhalla J, 2006, MOL CELL PROTEOMICS, V5, P1212, DOI 10.1074/mcp.M500315-MCP200; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; FRANGIONI JV, 1993, J CELL SCI, V105, P481; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Knoop LL, 2001, J BIOL CHEM, V276, P22317, DOI 10.1074/jbc.M008950200; Kovar H, 2003, SEMIN CANCER BIOL, V13, P275, DOI 10.1016/S1044-579X(03)00041-5; Lee CG, 1998, P NATL ACAD SCI USA, V95, P13709, DOI 10.1073/pnas.95.23.13709; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Myohanen S, 2001, J BIOL CHEM, V276, P1634, DOI 10.1074/jbc.M004481200; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Ng KP, 2007, P NATL ACAD SCI USA, V104, P479, DOI 10.1073/pnas.0607007104; Palermo CM, 2008, LEUKEMIA RES, V32, P633, DOI 10.1016/j.leukres.2007.08.002; Petermann R, 1998, ONCOGENE, V17, P603, DOI 10.1038/sj.onc.1201964; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Poppe B, 2004, BLOOD, V103, P229, DOI 10.1182/blood-2003-06-2163; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Sanchez G, 2008, P NATL ACAD SCI USA, V105, P6004, DOI 10.1073/pnas.0710748105; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Tetsuka T, 2004, EUR J BIOCHEM, V271, P3741, DOI 10.1111/j.1432-1033.2004.04314.x; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Uren A, 2005, CANCER RES, V65, P6199, DOI 10.1158/0008-5472.CAN-05-0455; Uren A, 2004, BIOCHEMISTRY-US, V43, P13579, DOI 10.1021/bi048776q; Valineva T, 2006, NUCLEIC ACIDS RES, V34, P3938, DOI 10.1093/nar/gkl539; Voss SD, 2002, ANAL BIOCHEM, V308, P364, DOI 10.1016/S0003-2697(02)00268-3; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Zhong XL, 2004, J BIOL CHEM, V279, P17134, DOI 10.1074/jbc.M311057200	40	296	320	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					750	U8		10.1038/nm.1983	http://dx.doi.org/10.1038/nm.1983			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19584866	Green Accepted			2022-12-25	WOS:000267806900027
J	Midwood, K; Sacre, S; Piccinini, AM; Inglis, J; Trebaul, A; Chan, E; Drexler, S; Sofat, N; Kashiwagi, M; Orend, G; Brennan, F; Foxwell, B				Midwood, Kim; Sacre, Sandra; Piccinini, Anna M.; Inglis, Julia; Trebaul, Annette; Chan, Emma; Drexler, Stefan; Sofat, Nidhi; Kashiwagi, Masahide; Orend, Gertraud; Brennan, Fionula; Foxwell, Brian			Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease	NATURE MEDICINE			English	Article							GROUP BOX CHROMOSOMAL-PROTEIN-1; ANTIGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX; TOLL-LIKE-RECEPTOR-4; EXPRESSION; RECOGNITION; CARTILAGE; CYTOKINE; MODEL	Although there have been major advances in the treatment of rheumatoid arthritis with the advent of biological agents, the mechanisms that drive cytokine production and sustain disease chronicity remain unknown. Tenascin-C (encoded by Tnc) is an extracellular matrix glycoprotein specifically expressed at areas of inflammation and tissue damage in inflamed rheumatoid joints. Here we show that mice that do not express tenascin-C show rapid resolution of acute joint inflammation and are protected from erosive arthritis. Intra-articular injection of tenascin-C promotes joint inflammation in vivo in mice, and addition of exogenous tenascin-C induces cytokine synthesis in explant cultures from inflamed synovia of individuals with rheumatoid arthritis. Moreover, in human macrophages and fibroblasts from synovia of individuals with rheumatoid arthritis, tenascin-C induces synthesis of proinflammatory cytokines via activation of Toll-like receptor 4 (TLR4). Thus, we have identified tenascin-C as a novel endogenous activator of TLR4-mediated immunity that mediates persistent synovial inflammation and tissue destruction in arthritic joint disease.	[Midwood, Kim; Sacre, Sandra; Piccinini, Anna M.; Inglis, Julia; Trebaul, Annette; Chan, Emma; Drexler, Stefan; Sofat, Nidhi; Kashiwagi, Masahide; Brennan, Fionula; Foxwell, Brian] Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, Fac Med, London, England; [Orend, Gertraud] Univ Strasbourg, INSERM U682, Strasbourg, France	Imperial College London; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Midwood, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, Fac Med, London, England.	k.midwood@imperial.ac.uk	Sofat, Nidhi/AAQ-7358-2020; Sacre, Sandra/AAE-2297-2020; Orend, Gertraud/E-8446-2015	Sofat, Nidhi/0000-0002-6963-6475; Sacre, Sandra/0000-0003-1665-1142; Orend, Gertraud/0000-0003-2522-1195; Piccinini, Anna Maria/0000-0002-7588-0415	Arthritis Research Campaign; The Kennedy Institute of Rheumatology Trustees; UK Medical Research Council New Investigators Research Grant; UK National Institute for Health Research Biomedical Research Centre; Institut National du Cancer-Institut National de la Sante et de la Recherche Medicale; Contrat d'interface with the Hospital Hautepierre; MRC [G0700108] Funding Source: UKRI; Medical Research Council [G0700108] Funding Source: researchfish	Arthritis Research Campaign(Versus Arthritis); The Kennedy Institute of Rheumatology Trustees; UK Medical Research Council New Investigators Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Institut National du Cancer-Institut National de la Sante et de la Recherche Medicale; Contrat d'interface with the Hospital Hautepierre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This paper is dedicated to B. Foxwell, an inspirational colleague and a good friend, who will be sadly missed. We thank R. Best for processing tissue, D. Essex for immunohistology and C. ffrench-Constant (University of Edinburgh) for the gift of the Tnc<SUP>-/-</SUP> mice. This work was funded by the Arthritis Research Campaign, The Kennedy Institute of Rheumatology Trustees and a UK Medical Research Council New Investigators Research Grant awarded to K. M. We are also grateful for support from the UK National Institute for Health Research Biomedical Research Centre funding scheme. G.O. was supported by Institut National du Cancer-Institut National de la Sante et de la Recherche Medicale and a Contrat d'interface with the Hospital Hautepierre.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Amin K, 2001, RESP MED, V95, P904, DOI 10.1053/rmed.2001.1174; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; BRENNAN FM, 1989, LANCET, V2, P244; Brentano F, 2005, CELL IMMUNOL, V233, P90, DOI 10.1016/j.cellimm.2005.04.018; CHEVALIER X, 1994, ARTHRITIS RHEUM, V37, P1013, DOI 10.1002/art.1780370706; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Choe JY, 2003, J EXP MED, V197, P537, DOI 10.1084/jem.20021850; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; CUTOLO M, 1992, J RHEUMATOL, V19, P1439; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Gondokaryono SP, 2007, J LEUKOCYTE BIOL, V82, P657, DOI 10.1189/jlb.1206730; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gutowski NJ, 1999, NEUROPATH APPL NEURO, V25, P207; Hasegawa M, 2007, J ORTHOP RES, V25, P563, DOI 10.1002/jor.20366; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; KEYSTONE EC, 1977, ARTHRITIS RHEUM, V20, P1396, DOI 10.1002/art.1780200714; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Lee EK, 2005, INT IMMUNOL, V17, P325, DOI 10.1093/intimm/dxh212; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MCCACHREN SS, 1992, ARTHRITIS RHEUM, V35, P1185, DOI 10.1002/art.1780351011; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; Pullerits R, 2003, ARTHRITIS RHEUM, V48, P1693, DOI 10.1002/art.11028; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Sacre SM, 2008, J IMMUNOL, V181, P8002, DOI 10.4049/jimmunol.181.11.8002; SALTER DM, 1993, BRIT J RHEUMATOL, V32, P780; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SIRI A, 1991, NUCLEIC ACIDS RES, V19, P525, DOI 10.1093/nar/19.3.525; Smolen JS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1969; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Van Lent PL, 2006, ARTHRITIS RHEUM-US, V54, P3868, DOI 10.1002/art.22253; Vanags D, 2006, LANCET, V368, P855, DOI 10.1016/S0140-6736(06)69210-6; Williams RO, 2007, CURR OPIN PHARMACOL, V7, P412, DOI 10.1016/j.coph.2007.06.001	42	521	537	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					774	U11		10.1038/nm.1987	http://dx.doi.org/10.1038/nm.1987			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19561617				2022-12-25	WOS:000267806900030
J	Goldfine, AB; Shoelson, SE; Aguirre, V				Goldfine, Allison B.; Shoelson, Steven E.; Aguirre, Vincent			Expansion and contraction Treating diabetes with bariatric surgery	NATURE MEDICINE			English	Editorial Material							Y GASTRIC BYPASS; WEIGHT-LOSS; MORTALITY	Bariatric surgery is not only one of the most immediate and effective ways to slim down: recent clinical data show that certain procedures are also particularly good at quelling type 2 diabetes. In "Bedside to Bench," Allison Goldfine, Steven Shoelson and Vincent Aguirre outline how researchers can better understand these new clinical findings at the mechanistic level. In the accompanying "Bench to Bedside," Jorge Plutzky takes a look how proper regulation of the storage of fatty acids helps maintain their effectiveness as signaling molecules and reins in their potential pathological effects. Such research is leading to new ways of thinking about how to combat type 2 diabetes.	[Goldfine, Allison B.; Shoelson, Steven E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Goldfine, Allison B.; Shoelson, Steven E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Aguirre, Vincent] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Aguirre, Vincent] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldfine, AB (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA.	allison.goldfine@joslin.harvard.edu		Goldfine, Allison/0000-0002-0345-1048				Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Aguirre V, 2008, OBESITY, V16, P2585, DOI 10.1038/oby.2008.502; Borg CM, 2006, BRIT J SURG, V93, P210, DOI 10.1002/bjs.5227; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Cummings David E., 2004, Journal of Clinical Endocrinology & Metabolism, V89, P2608, DOI 10.1210/jc.2004-0433; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309; Goldfine ABM, 2006, CURR OPIN ENDOCRINOL, V13, P419; Morinigo R, 2006, J CLIN ENDOCR METAB, V91, P1735, DOI 10.1210/jc.2005-0904; Rodriguez-Grunert L, 2008, SURG OBES RELAT DIS, V4, P55, DOI 10.1016/j.soard.2007.07.012; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schauer PR, 2003, ANN SURG, V238, P484; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Vetter ML, 2009, ANN INTERN MED, V150, P94, DOI 10.7326/0003-4819-150-2-200901200-00007	15	25	25	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					616	617		10.1038/nm0609-616	http://dx.doi.org/10.1038/nm0609-616			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19498374				2022-12-25	WOS:000266731600018
J	Jaglin, XH; Poirier, K; Saillour, Y; Buhler, E; Tian, GL; Bahi-Buisson, N; Fallet-Bianco, C; Phan-Dinh-Tuy, F; Kong, XP; Bomont, P; Castelnau-Ptakhine, L; Odent, S; Loget, P; Kossorotoff, M; Snoeck, I; Plessis, G; Parent, P; Beldjord, C; Cardoso, C; Represa, A; Flint, J; Keays, DA; Cowan, NJ; Chelly, J				Jaglin, Xavier Hubert; Poirier, Karine; Saillour, Yoann; Buhler, Emmanuelle; Tian, Guoling; Bahi-Buisson, Nadia; Fallet-Bianco, Catherine; Phan-Dinh-Tuy, Francoise; Kong, Xiang Peng; Bomont, Pascale; Castelnau-Ptakhine, Laetitia; Odent, Sylvie; Loget, Philippe; Kossorotoff, Manoelle; Snoeck, Irina; Plessis, Ghislaine; Parent, Philippe; Beldjord, Cherif; Cardoso, Carlos; Represa, Alfonso; Flint, Jonathan; Keays, David Anthony; Cowan, Nicholas Justin; Chelly, Jamel			Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria	NATURE GENETICS			English	Article							ALPHA-TUBULIN; NEURONAL MIGRATION; RNA INTERFERENCE; EXPRESSION; CHAPERONIN; SEQUENCES; SPECTRUM	Polymicrogyria is a relatively common but poorly understood defect of cortical development characterized by numerous small gyri and a thick disorganized cortical plate lacking normal lamination. Here we report de novo mutations in a beta-tubulin gene, TUBB2B, in four individuals and a 27-gestational-week fetus with bilateral asymmetrical polymicrogyria. Neuropathological examination of the fetus revealed an absence of cortical lamination associated with the presence of ectopic neuronal cells in the white matter and in the leptomeningeal spaces due to breaches in the pial basement membrane. In utero RNAi-based inactivation demonstrates that TUBB2B is required for neuronal migration. We also show that two disease-associated mutations lead to impaired formation of tubulin heterodimers. These observations, together with previous data, show that disruption of microtubule-based processes underlies a large spectrum of neuronal migration disorders that includes not only lissencephaly and pachygyria, but also polymicrogyria malformations.	[Tian, Guoling; Kong, Xiang Peng; Cowan, Nicholas Justin] NYU, Dept Biochem, Med Ctr, New York, NY 10016 USA; [Jaglin, Xavier Hubert; Poirier, Karine; Saillour, Yoann; Bahi-Buisson, Nadia; Phan-Dinh-Tuy, Francoise; Castelnau-Ptakhine, Laetitia; Chelly, Jamel] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France; [Jaglin, Xavier Hubert; Poirier, Karine; Saillour, Yoann; Bahi-Buisson, Nadia; Phan-Dinh-Tuy, Francoise; Castelnau-Ptakhine, Laetitia; Chelly, Jamel] INSERM, U567, Paris, France; [Buhler, Emmanuelle] INSERM, U901, Plateforme Postgenom INMED, F-13258 Marseille, France; [Bahi-Buisson, Nadia; Kossorotoff, Manoelle] Hop Necker Enfants Malad, Serv Neurol Pediat, Dept Pediat, AP HP, Paris, France; [Fallet-Bianco, Catherine] Hop St Anne, Serv Anat Pathol, F-75674 Paris, France; [Bomont, Pascale; Cardoso, Carlos; Represa, Alfonso] INSERM, Inst Neurobiol Mediterrane, U901, F-13258 Marseille, France; [Odent, Sylvie] Hop Sud, CHU Rennes, Serv Genet Med, Rennes, France; [Loget, Philippe] CHU Pontchaillou, Dept Anat & Cytopathol, Rennes, France; [Snoeck, Irina] Locatie Juliana Kinderziekenhusi Poliklin, The Hague, Netherlands; [Plessis, Ghislaine] CHU Hop Clemenceau, Serv Genet, Caen, France; [Parent, Philippe] CHU Hop Morvan, Dept Pediat & Genet Med, Brest, France; [Beldjord, Cherif] CHU Hop Cochin, Lab Biochim & Genet Mol, Paris, France; [Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Keays, David Anthony] Inst Mol Pathol, A-1030 Vienna, Austria	New York University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; CHU Rennes; CHU de Caen NORMANDIE; CHU Brest; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Wellcome Centre for Human Genetics; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Cowan, NJ (corresponding author), NYU, Dept Biochem, Med Ctr, New York, NY 10016 USA.	nicholas.cowan@med.nyu.edu; jamel.chelly@inserm.fr	Represa, Alfonso/M-7383-2016; Bomont, Pascale/GLS-8721-2022; Fallet-Bianco, Catherine/AAP-7390-2020; Bomont, Pascale L/Y-5517-2018; POIRIER, Karine/N-3009-2018; Cardoso, Carlos/H-4520-2016; Cardoso, Carlos/M-2767-2019; Chelly, Jamel/J-7528-2015	Represa, Alfonso/0000-0002-5096-8939; Bomont, Pascale/0000-0001-7216-3261; Bomont, Pascale L/0000-0001-7216-3261; POIRIER, Karine/0000-0002-7928-2906; Cardoso, Carlos/0000-0003-1914-9553; Cardoso, Carlos/0000-0003-1914-9553; Chelly, Jamel/0000-0002-0939-8719; Saillour, Yoann/0000-0002-5110-9239; Kong, Xiang-Peng/0000-0001-5773-2681; Flint, Jonathan/0000-0002-9427-4429	AP-HP; INSERM; FRM; ANR [A05183KS, ANR-06-NEURO-008-01, RPV06055ASA]; Ministere de l'Enseignement Superieur et de la Recherche,; Universite Paris Descartes; EMBO [ASTF 66.00-2008]	AP-HP; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FRM(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche,(Estonian Research CouncilEuropean Commission); Universite Paris Descartes; EMBO(European Molecular Biology Organization (EMBO))	We thank F. Francis for her helpful comments and critical readings of the manuscript, the subjects and their parents who contributed in this study and all the colleagues who provided clinical and imaging information. We thank R. Guerrini for providing us helpful advice. We are grateful to E. Leguern for allowing K. P. to develop this project and all the members of Cochin Institute genomic platform, Cochin Hospital Cell Bank, and Isabelle Souville for their technical assistance. This work was supported by funding from AP-HP, INSERM, FRM ( funding within the frame of the Programme EQUIPEs FRM 2007) and ANR ( ANR Neuro 2005, project A05183KS and ANR-06-NEURO-008-01 contract number RPV06055ASA). X. H. J. is supported by a PhD fellowship of the Ministere de l'Enseignement Superieur et de la Recherche, by a grant for mobility from Universite Paris Descartes and an EMBO short-term fellowship ( ASTF 66.00-2008) for his work in NYU the Medical Center. K. P. is a post-doctoral researcher supported by FRM ( Fondation pour la Recherche Medicale).	Bahi-Buisson N, 2008, J MED GENET, V45, P647, DOI 10.1136/jmg.2008.058073; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; CLEVELAND DW, 1978, CELL, V15, P1021, DOI 10.1016/0092-8674(78)90286-6; Cowan NJ, 2002, ADV PROTEIN CHEM, V59, P73; Dutcher SK, 2001, CURR OPIN CELL BIOL, V13, P49, DOI 10.1016/S0955-0674(00)00173-3; GAO M, 1992, MOL CELL BIOL, V12, P1330, DOI 10.1128/MCB.12.3.1330; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; LITTLE M, 1988, COMP BIOCHEM PHYS B, V90, P655, DOI 10.1016/0305-0491(88)90320-3; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; TIAN GL, 1995, J BIOL CHEM, V270, P23910, DOI 10.1074/jbc.270.41.23910; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian G, 2008, MOL BIOL CELL, V19, P1152, DOI 10.1091/mbc.E07-09-0861; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	28	259	265	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					746	752		10.1038/ng.380	http://dx.doi.org/10.1038/ng.380			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19465910	Green Accepted, Green Submitted			2022-12-25	WOS:000266411700027
J	Huggett, B; Scott, C				Huggett, Brady; Scott, Christopher			Gilead's deal of a lifetime	NATURE BIOTECHNOLOGY			English	Article																		Danzon PM, 2007, MANAG DECIS ECON, V28, P307, DOI 10.1002/mde.1343; LIM TM, 2006, THESIS CRANFIELD U	2	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2009	27	5					423	423		10.1038/nbt0509-423	http://dx.doi.org/10.1038/nbt0509-423			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	444KS	19430443				2022-12-25	WOS:000265980500016
J	Kamatani, Y; Wattanapokayakit, S; Ochi, H; Kawaguchi, T; Takahashi, A; Hosono, N; Kubo, M; Tsunoda, T; Kamatani, N; Kumada, H; Puseenam, A; Sura, T; Daigo, Y; Chayama, K; Chantratita, W; Nakamura, Y; Matsuda, K				Kamatani, Yoichiro; Wattanapokayakit, Sukanya; Ochi, Hidenori; Kawaguchi, Takahisa; Takahashi, Atsushi; Hosono, Naoya; Kubo, Michiaki; Tsunoda, Tatsuhiko; Kamatani, Naoyuki; Kumada, Hiromitsu; Puseenam, Aekkachai; Sura, Thanyachai; Daigo, Yataro; Chayama, Kazuaki; Chantratita, Wasun; Nakamura, Yusuke; Matsuda, Koichi			A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians	NATURE GENETICS			English	Article							VIRUS-INFECTION; SURFACE-ANTIGEN; RECEPTOR GENE; SUSCEPTIBILITY; POLYMORPHISMS; POPULATION; ALLELES; MARKERS	Chronic hepatitis B is a serious infectious liver disease that often progresses to liver cirrhosis and hepatocellular carcinoma; however, clinical outcomes after viral exposure vary enormously among individuals(1). Through a two-stage genome-wide association study using 786 Japanese chronic hepatitis B cases and 2,201 controls, we identified a significant association of chronic hepatitis B with 11 SNPs in a region including HLA-DPA1 and HLA-DPB1. We validated these associations by genotyping two SNPs from the region in three additional Japanese and Thai cohorts consisting of 1,300 cases and 2,100 controls (combined P = 6.34 x 10(-39) and 2.31 x 10(-38), OR = 0.57 and 0.56, respectively). Subsequent analyses revealed risk haplotypes (HLA-DPA1*0202-DPB1*0501 and HLA-DPA1*0202-DPB1*0301, OR = 1.45 and 2.31, respectively) and protective haplotypes (HLA-DPA1*0103-DPB1*0402 and HLA-DPA1*0103-DPB1*0401, OR = 0.52 and 0.57, respectively). Our findings show that genetic variants in the HLA-DP locus are strongly associated with risk of persistent infection with hepatitis B virus.	[Kamatani, Yoichiro; Daigo, Yataro; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Kamatani, Yoichiro; Daigo, Yataro] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo, Japan; [Wattanapokayakit, Sukanya] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Med Genet Sect, Nonthaburi, Thailand; [Ochi, Hidenori; Kawaguchi, Takahisa; Takahashi, Atsushi; Hosono, Naoya; Kubo, Michiaki; Tsunoda, Tatsuhiko; Kamatani, Naoyuki; Chayama, Kazuaki; Nakamura, Yusuke] RIKEN, Ctr Genom Med, Kanagawa, Japan; [Ochi, Hidenori; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Programs Biomed Res, Dept Med & Mol Sci,Div Frontier Med Sci, Hiroshima, Japan; [Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Puseenam, Aekkachai; Sura, Thanyachai] Mahidol Univ, Ramathidi Hosp, Fac Med, Dept Med, Bangkok 10700, Thailand; [Chantratita, Wasun] Mahidol Univ, Ramathidi Hosp, Fac Med, Virol & Mol Microbiol Unit,Dept Pathol, Bangkok 10700, Thailand	University of Tokyo; University of Tokyo; Ministry of Public Health - Thailand; RIKEN; Hiroshima University; Toranomon Hospital; Mahidol University; Mahidol University	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	yusuke@ims.u-tokyo.ac.jp	Kamatani, Yoichiro/N-5513-2015; Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014; Matsuda, Koichi/D-4597-2011	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Chayama, Kazuaki/0000-0002-5530-5341; Daigo, Yataro/0000-0002-0915-3025; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Tokunaga for useful advice of on HLA-DP genotyping and interpretation, and technical staff of Laboratory for Genotyping Development at RIKEN for SNP genotyping at the first and second stages of the GWAS. We are also grateful to members of Hiroshima Liver Study Group and The Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government.	Ahn SH, 2000, HEPATOLOGY, V31, P1371, DOI 10.1053/jhep.2000.7988; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; Ben-Ari Z, 2003, AM J GASTROENTEROL, V98, P144, DOI 10.1111/j.1572-0241.2003.07179.x; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Deng GH, 2004, HEPATOLOGY, V40, P318, DOI 10.1002/hep.20318; Fontenot AP, 2000, P NATL ACAD SCI USA, V97, P12717, DOI 10.1073/pnas.220430797; Frodsham AJ, 2005, TRANSPL IMMUNOL, V14, P183, DOI 10.1016/j.trim.2005.03.006; Frodsham AJ, 2006, P NATL ACAD SCI USA, V103, P9148, DOI 10.1073/pnas.0602800103; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; JUNG MC, 1995, J VIROL, V69, P3358, DOI 10.1128/JVI.69.6.3358-3368.1995; Kobayashi M, 2002, J MED VIROL, V68, P522, DOI 10.1002/jmv.10239; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; LASKUS T, 1992, J HEPATOL, V15, P174, DOI 10.1016/0168-8278(92)90032-K; LIN TM, 1989, ANTICANCER RES, V9, P737; Mineta M, 1996, INT IMMUNOL, V8, P525, DOI 10.1093/intimm/8.4.525; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saito A, 2002, J HUM GENET, V47, P360, DOI 10.1007/s100380200050; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SHEEN IS, 1994, J INFECT DIS, V170, P358, DOI 10.1093/infdis/170.2.358; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; VANDERZWAN A, 2002, TECHNICAL MANUAL GEN	25	398	429	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					591	595		10.1038/ng.348	http://dx.doi.org/10.1038/ng.348			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19349983				2022-12-25	WOS:000265575600021
J	Geraldes, P; Hiraoka-Yamamoto, J; Matsumoto, M; Clermont, A; Leitges, M; Marette, A; Aiello, LP; Kern, TS; King, GL				Geraldes, Pedro; Hiraoka-Yamamoto, Junko; Matsumoto, Motonobu; Clermont, Allen; Leitges, Michael; Marette, Andre; Aiello, Lloyd P.; Kern, Timothy S.; King, George L.			Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy	NATURE MEDICINE			English	Article							PROTEIN-KINASE-C; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; MOTH-EATEN MICE; TYROSINE-PHOSPHATASE; FACTOR RECEPTOR; GLUCOSE; EXPRESSION; INDUCTION; RATS	Cellular apoptosis induced by hyperglycemia occurs in many vascular cells and is crucial for the initiation of diabetic pathologies. In the retina, pericyte apoptosis and the formation of acellular capillaries, the most specific vascular pathologies attributed to hyperglycemia, is linked to the loss of platelet-derived growth factor (PDGF)-mediated survival actions owing to unknown mechanisms. Here we show that hyperglycemia persistently activates protein kinase C-delta (PKC-delta, encoded by Prkcd) and p38 alpha mitogen-activated protein kinase (MAPK) to increase the expression of a previously unknown target of PKC-delta signaling, Src homology-2 domain-containing phosphatase-1 (SHP-1), a protein tyrosine phosphatase. This signaling cascade leads to PDGF receptor-beta dephosphorylation and a reduction in downstream signaling from this receptor, resulting in pericyte apoptosis independently of nuclear factor-kappa B (NF-kappa B) signaling. We observed increased PKC-delta activity and an increase in the number of acellular capillaries in diabetic mouse retinas, which were not reversible with insulin treatment that achieved normoglycemia. Unlike diabetic age-matched wild-type mice, diabetic Prkcd(-/-) mice did not show activation of p38 alpha MAPK or SHP-1, inhibition of PDGF signaling in vascular cells or the presence of acellular capillaries. We also observed PKC-delta, p38 alpha MAPK and SHP-1 activation in brain pericytes and in the renal cortex of diabetic mice. These findings elucidate a new signaling pathway by which hyperglycemia can induce PDGF resistance and increase vascular cell apoptosis to cause diabetic vascular complications.	[Geraldes, Pedro; Hiraoka-Yamamoto, Junko; Matsumoto, Motonobu; Clermont, Allen; Aiello, Lloyd P.; King, George L.] Joslin Diabet Ctr, Dianne Nunnally Hoppes Lab Diabet Complicat, Boston, MA 02215 USA; [Aiello, Lloyd P.] Joslin Diabet Ctr, Beetham Eye Inst, Boston, MA 02215 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Marette, Andre] Univ Laval, Dept Anat & Physiol, Quebec City, PQ, Canada; [Aiello, Lloyd P.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [King, George L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Joslin Diabetes Center, Inc.; University of Oslo; Laval University; Harvard University; Harvard Medical School; Case Western Reserve University; Harvard University; Harvard Medical School	King, GL (corresponding author), Joslin Diabet Ctr, Dianne Nunnally Hoppes Lab Diabet Complicat, Boston, MA 02215 USA.	george.king@joslin.harvard.edu	Marette, Andre/E-9342-2013; Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995; Marette, Andre/0000-0003-3950-5973	US National Eye Institute [5R01EY016150-02]; Canadian Institute of Health Research [165453]; NATIONAL EYE INSTITUTE [R01EY016150] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Prkcd<SUP>-/-</SUP> mice were provided by M. Leitges (University of Oslo). Adenoviral vectors expressing dominant-negative p38 alpha and p38 beta MAPK were generously provided by Y. Wang (University of California, Los Angeles). Adenoviral vector expressing dominant-negative of SHP-1 (Ad-DN SHP-1) was generously provided by A. Marette (University of Laval). P. G. is a recipient of awards from the Juvenile Diabetes Research Foundation. This study was supported by the US National Eye Institute (grant 5R01EY016150-02 to G. L. K.) and by the Canadian Institute of Health Research (grant 165453) to A. M. We thank W.-C. Li and S. Bonner-Weir for the technical support on confocal microscopy imaging.	Aiello LP, 2005, DIABETES, V54, P2188; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Bhattacharya Resham, 2008, J Mol Signal, V3, P8, DOI 10.1186/1750-2187-3-8; BIGNON JS, 1994, CLIN IMMUNOL IMMUNOP, V73, P168, DOI 10.1006/clin.1994.1185; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; KERN TS, 1994, CURR EYE RES, V13, P863, DOI 10.3109/02713689409015087; KING GL, 1987, DIABETES, V36, P1460, DOI 10.2337/diabetes.36.12.1460; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; KUWABARA T, 1963, ARCH OPHTHALMOL-CHIC, V69, P492, DOI 10.1001/archopht.1963.00960040498013; Leitges M, 2001, J CLIN INVEST, V108, P1505; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lorenzi M, 2001, DIABETOLOGIA, V44, P791, DOI 10.1007/s001250100544; Lyons BL, 2006, INVEST OPHTH VIS SCI, V47, P1201, DOI 10.1167/iovs.05-1161; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Nakase K, 2009, J LEUKOCYTE BIOL, V85, P165, DOI 10.1189/jlb.0608383; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Peter PS, 2007, J CLIN INVEST, V117, P1335, DOI 10.1172/JCI29576; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Ryer EJ, 2005, J BIOL CHEM, V280, P35310, DOI 10.1074/jbc.M507187200; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Suzuma K, 2002, P NATL ACAD SCI USA, V99, P721, DOI 10.1073/pnas.022644499; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Yokota T, 2003, DIABETES, V52, P838, DOI 10.2337/diabetes.52.3.838; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	44	282	298	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1298	U133		10.1038/nm.2052	http://dx.doi.org/10.1038/nm.2052			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19881493	Green Submitted, Green Accepted			2022-12-25	WOS:000271543700018
J	Pathania, R; Zlitni, S; Barker, C; Das, R; Gerritsma, DA; Lebert, J; Awuah, E; Melacini, G; Capretta, FA; Brown, ED				Pathania, Ranjana; Zlitni, Soumaya; Barker, Courtney; Das, Rahul; Gerritsma, David A.; Lebert, Julie; Awuah, Emilia; Melacini, Giuseppe; Capretta, Fred A.; Brown, Eric D.			Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting	NATURE CHEMICAL BIOLOGY			English	Article							DIFFERENCE NMR-SPECTROSCOPY; INDUCED HAPLOINSUFFICIENCY; OUTER-MEMBRANE; D-CYCLOSERINE; DRUG EFFLUX; BIOSYNTHESIS; DISCOVERY; PROTEINS; BINDING; ALANINE	One of the most significant hurdles to developing new chemical probes of biological systems and new drugs to treat disease is that of understanding the mechanism of action of small molecules discovered with cell-based small-molecule screening. Here we have assembled an ordered, high-expression clone set of all of the essential genes from Escherichia coli and used it to systematically screen for suppressors of growth inhibitory compounds. Using this chemical genomic approach, we demonstrate that the targets of well-known antibiotics can be identified as high copy suppressors of chemical lethality. This approach led to the discovery of MAC13243, a molecule that belongs to a new chemical class and that has a unique mechanism and promising activity against multidrug-resistant Pseudomonas aeruginosa. We show that MAC13243 inhibits the function of the LolA protein and represents a new chemical probe of lipoprotein targeting in bacteria with promise as an antibacterial lead with Gram-negative selectivity.	[Pathania, Ranjana; Zlitni, Soumaya; Barker, Courtney; Melacini, Giuseppe; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Pathania, Ranjana; Zlitni, Soumaya; Barker, Courtney; Gerritsma, David A.; Lebert, Julie; Awuah, Emilia; Capretta, Fred A.; Brown, Eric D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Das, Rahul; Gerritsma, David A.; Lebert, Julie; Awuah, Emilia; Melacini, Giuseppe; Capretta, Fred A.] McMaster Univ, Dept Chem, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	ebrown@mcmaster.ca	Das, Rahul/AAU-5123-2020; Capretta, Alfredo/G-2195-2011; Zlitni, Soumaya/C-1370-2013	Das, Rahul/0000-0001-7841-8229; Pathania, Ranjana/0000-0002-7965-8176	Canadian Institutes of Health Research [MOP-81330]; Canada Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank B. Wanner and H. Mori of Purdue University and the Nara Institute, respectively, for providing the ordered genomic library (ASKA library) used in these studies and for inspiring discussion. We thank H. Zgurskaya at University of Oklahoma for the polyclonal antibodies against TolC, we thank D. Andrews at McMaster University for the YidC antibodies and we thank G. Wright at McMaster University for the clinical isolates of P. aeruginosa. This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP-81330) and by a Canada Research Chair award to E. D. B.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; Brown ED, 2005, CHEM REV, V105, P759, DOI 10.1021/cr030116o; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chalker AF, 2002, PHARMACOL THERAPEUT, V95, P1, DOI 10.1016/S0163-7258(02)00222-X; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Elkins CA, 2002, J BACTERIOL, V184, P6490, DOI 10.1128/JB.184.23.6490-6499.2002; Ford C. W., 2001, Current Drug Targets - Infectious Disorders, V1, P181, DOI 10.2174/1568005014606099; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; HITCHINGS GEORGE H., 1965, ADVANCE ENZYMOL, V27, P417; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; LAMBERT MP, 1972, J BACTERIOL, V110, P978, DOI 10.1128/JB.110.3.978-987.1972; LaPlante KL, 2004, EXPERT OPIN PHARMACO, V5, P2321, DOI 10.1517/14656566.5.11.2321; Li XM, 2004, CHEM BIOL, V11, P1423, DOI 10.1016/j.chembiol.2004.08.014; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Meyer B, 2004, E SCHERING RES FDN W, V44, P149; *NAT COMM CLIN LAB, 2000, METH DIL ANT SUSC TE; NEUHAUS FC, 1964, BIOCHEMISTRY-US, V3, P471, DOI 10.1021/bi00892a001; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rice LB, 2006, BIOCHEM PHARMACOL, V71, P991, DOI 10.1016/j.bcp.2005.09.018; ROOD JI, 1980, GENE, V8, P255, DOI 10.1016/0378-1119(80)90003-7; Tajima T, 1998, FEBS LETT, V439, P51, DOI 10.1016/S0014-5793(98)01334-9; TOKUDA H, 2004, BIOCH BIOPHYS ACTA, V1694; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	33	92	95	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2009	5	11					849	856		10.1038/nchembio.221	http://dx.doi.org/10.1038/nchembio.221			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	508FQ	19783991				2022-12-25	WOS:000270915000015
J	Chandra, M; Sachdeva, A; Silverman, SK				Chandra, Madhavaiah; Sachdeva, Amit; Silverman, Scott K.			DNA-catalyzed sequence-specific hydrolysis of DNA	NATURE CHEMICAL BIOLOGY			English	Article							IN-VITRO SELECTION; ZN2+-DEPENDENT DEOXYRIBOZYMES; STRANDED-DNA; RNA; CLEAVAGE; COMPLEXES; ENZYME; SITE; LINKAGES; RIBOZYME	Deoxyribozymes (DNA catalysts) have been reported for cleavage of RNA phosphodiester linkages, but cleaving peptide or DNA phosphodiester linkages is much more challenging. Using in vitro selection, here we identified deoxyribozymes that sequence-specifically hydrolyze DNA with multiple turnover and with a rate enhancement of 10(8) (possibly as high as 10(14)). The new DNA catalysts require both Mn2+ and Zn2+, which is noteworthy because many natural DNA nucleases are bimetallic protein enzymes.	[Chandra, Madhavaiah; Sachdeva, Amit; Silverman, Scott K.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Silverman, SK (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	scott@scs.illinois.edu	Singh, Pramod K./F-1379-2016	Singh, Pramod K./0000-0002-3155-6621; Silverman, Scott/0000-0001-8166-3460	US National Institutes of Health [GM065966]; US Defense Threat Reduction Agency [BRBAA08-l-2-0001]; David and Lucile Packard Foundation; US National Institutes of Health; Ruth L. Kirschstein National Research Service Award [T32 GM070421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065966, T32GM070421] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health (GM065966), the US Defense Threat Reduction Agency (BRBAA08-l-2-0001) and the David and Lucile Packard Foundation. A. S. was partially supported by the US National Institutes of Health (National Institute of General Medical Sciences) under the Ruth L. Kirschstein National Research Service Award T32 GM070421. We thank D. Ghosh and P. Bevilacqua (Pennsylvania State University) for independently verifying the cleavage activity of the 10MD5 deoxyribozyme with an all-DNA substrate. We thank L. A. Furgerson Ihnken and W. van der Donk for expert assistance with and access to the ESI mass spectrometer for the 18O-water experiment.	Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Carmi N, 2001, BIOORGAN MED CHEM, V9, P2589, DOI 10.1016/S0968-0896(01)00035-9; DAI XC, 1995, SCIENCE, V267, P237, DOI 10.1126/science.7809628; Flynn-Charlebois A, 2003, J AM CHEM SOC, V125, P2444, DOI 10.1021/ja028774y; Hoadley KA, 2005, BIOCHEMISTRY-US, V44, P9217, DOI 10.1021/bi050146g; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Komiyama M, 2008, NAT PROTOC, V3, P655, DOI 10.1038/nprot.2008.7; Kost DM, 2008, ORG BIOMOL CHEM, V6, P4391, DOI 10.1039/b813566e; Liu XQ, 2008, CHEM COMMUN, P380, DOI 10.1039/b713445b; Mancin F, 2005, CHEM COMMUN, P2540, DOI 10.1039/b418164f; Mancin F, 2007, NEW J CHEM, V31, P800, DOI 10.1039/b703556j; Pradeepkumar PI, 2008, ANGEW CHEM INT EDIT, V47, P1753, DOI 10.1002/anie.200703676; Radzicka A, 1996, J AM CHEM SOC, V118, P6105, DOI 10.1021/ja954077c; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schlosser K, 2008, NUCLEIC ACIDS RES, V36, P4768, DOI 10.1093/nar/gkn396; Schroeder GK, 2006, P NATL ACAD SCI USA, V103, P4052, DOI 10.1073/pnas.0510879103; Shan S, 2001, BIOCHEMISTRY-US, V40, P5161, DOI 10.1021/bi002887h; Shell TA, 2007, INORG CHEM, V46, P8120, DOI 10.1021/ic701231d; Silverman SK, 2008, CHEM COMMUN, P3467, DOI 10.1039/b807292m; Silverman SK, 2005, NUCLEIC ACIDS RES, V33, P6151, DOI 10.1093/nar/gki930; SILVERMAN SK, 2009, WILEY ENCY CHEM BIOL; WADA T, 1994, J AM CHEM SOC, V116, P9901, DOI 10.1021/ja00101a011; Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b; Williams NH, 1999, ACCOUNTS CHEM RES, V32, P485, DOI 10.1021/ar9500877	26	127	131	1	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					718	720		10.1038/nchembio.201	http://dx.doi.org/10.1038/nchembio.201			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19684594	Green Accepted			2022-12-25	WOS:000270039900007
J	Rajabian, T; Gavicherla, B; Heisig, M; Muller-Altrock, S; Goebel, W; Gray-Owen, SD; Ireton, K				Rajabian, Tina; Gavicherla, Balramakrishna; Heisig, Martin; Mueller-Altrock, Stefanie; Goebel, Werner; Gray-Owen, Scott D.; Ireton, Keith			The bacterial virulence factor InlC perturbs apical cell junctions and promotes cell-to-cell spread of Listeria	NATURE CELL BIOLOGY			English	Article							ACTIN-BASED MOTILITY; LEUCINE-RICH REPEAT; MONOCYTOGENES; PROTEINS; DOMAINS; FAMILY; TUBA; PATHOGENESIS; CYTOSKELETON; INTERNALINS	Several pathogenic bacteria, including Listeria monocytogenes, use an F-actin motility process to spread between mammalian cells1. Actin 'comet tails' propel Listeria through the cytoplasm, resulting in bacteria-containing membrane protrusions that are internalized by neighbouring cells. The mechanism by which Listeria overcomes cortical tension to generate protrusions is unknown. Here, we identify bacterial and host proteins that directly regulate protrusions. We show that efficient spreading between polarized epithelial cells requires the secreted Listeria virulence protein InlC (internalin C). We next identify the mammalian adaptor protein Tuba as a ligand of InlC. InlC binds to a carboxy-terminal SH3 domain in Tuba, which normally engages the human actin regulatory protein N-WASP(2). InlC promotes protrusion formation by inhibiting Tuba and N-WASP activity, probably by impairing binding of N-WASP to the Tuba SH3 domain. Tuba and N-WASP are known to control the structure of apical junctions in epithelial cells(3). We demonstrate that, by inhibiting Tuba and N-WASP, InlC makes taut apical junctions become slack. Experiments with myosin II inhibitors indicate that InlC-mediated perturbation of apical junctions accounts for the role of this bacterial protein in protrusion formation. Collectively, our results suggest that InlC promotes bacterial dissemination by relieving cortical tension, thereby enhancing the ability of motile bacteria to deform the plasma membrane into protrusions.	[Rajabian, Tina; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Gavicherla, Balramakrishna; Ireton, Keith] Univ Cent Florida, Dept Mol Biol & Microbiol, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Heisig, Martin] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, D-97078 Wurzburg, Germany; [Mueller-Altrock, Stefanie; Goebel, Werner] Univ Wurzburg, Bioctr Microbiol, D-97074 Wurzburg, Germany	University of Toronto; State University System of Florida; University of Central Florida; University of Wurzburg; University of Wurzburg	Ireton, K (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kireton@mail.ucf.edu	McDivitt, Tina Rajabian/HGC-5127-2022; Gray-Owen, Scott/AFL-7380-2022; Gray-Owen, Scott/AAG-7337-2022	Gray-Owen, Scott D./0000-0002-1477-3616	Canadian Institutes of Health Research (CIHR) [MT-15497, MOP-15499]; National Institutes of Health [1R21AI076881-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076881] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Brumell, H. Sarantis, A. Wilde and R. Collins for reviewing the manuscript, N. Freitag, T. Otani, E. Leung and K. Nemec for advice on assays or protein purification and Y. Shen for help with plasmid construction. This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (MT-15497) and National Institutes of Health (1R21AI076881-01) to K. I., and a CIHR grant (MOP-15499) to S. D. G.	Auerbuch V, 2003, MOL MICROBIOL, V49, P1361, DOI 10.1046/j.1365-2958.2003.03639.x; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Engelbrecht F, 1996, MOL MICROBIOL, V21, P823, DOI 10.1046/j.1365-2958.1996.541414.x; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kovacs EM, 2006, J CELL SCI, V119, P2715, DOI 10.1242/jcs.03005; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Monack DM, 2001, CELL MICROBIOL, V3, P633, DOI 10.1046/j.1462-5822.2001.00143.x; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; PETERSON MD, 1992, J CELL SCI, V102, P581; Pust S, 2005, EMBO J, V24, P1287, DOI 10.1038/sj.emboj.7600595; RIENTO K, 2003, NATURE REV MOL CELL, V4, P456; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Sechi AS, 1997, J CELL BIOL, V137, P155, DOI 10.1083/jcb.137.1.155; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Sun H, 2005, CELL MICROBIOL, V7, P443, DOI 10.1111/j.1462-5822.2004.00475.x; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; WUENSCHER MD, 1991, MOL GEN GENET, V228, P177, DOI 10.1007/BF00282463	28	126	130	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1212	U104		10.1038/ncb1964	http://dx.doi.org/10.1038/ncb1964			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767742	Green Accepted			2022-12-25	WOS:000270382000010
J	Zhao, BH; Takami, M; Yamada, A; Wang, XG; Koga, T; Hu, XY; Tamura, T; Ozato, K; Choi, YW; Ivashkiv, LB; Takayanagi, H; Kamijo, R				Zhao, Baohong; Takami, Masamichi; Yamada, Atsushi; Wang, Xiaogu; Koga, Takako; Hu, Xiaoyu; Tamura, Tomohiko; Ozato, Keiko; Choi, Yongwon; Ivashkiv, Lionel B.; Takayanagi, Hiroshi; Kamijo, Ryutaro			Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis	NATURE MEDICINE			English	Article							SEQUENCE-BINDING-PROTEIN; TOLL-LIKE RECEPTORS; NF-KAPPA-B; DENDRITIC CELLS; KEY REGULATOR; CROSS-TALK; IFN-GAMMA; C-FOS; DIFFERENTIATION; ACTIVATION	Bone metabolism results from a balance between osteoclast-driven bone resorption and osteoblast-mediated bone formation. Diseases such as periodontitis and rheumatoid arthritis are characterized by increased bone destruction due to enhanced osteoclastogenesis(1,2). Here we report that interferon regulatory factor-8 (IRF-8), a transcription factor expressed in immune cells, is a key regulatory molecule for osteoclastogenesis. IRF-8 expression in osteoclast precursors was downregulated during the initial phase of osteoclast differentiation induced by receptor activator of nuclear factor-kappa B ligand (RANKL), which is encoded by the Tnfsf11 gene. Mice deficient in Irf8 showed severe osteoporosis, owing to increased numbers of osteoclasts, and also showed enhanced bone destruction after lipopolysaccharide (LPS) administration. Irf8(-/-) osteoclast precursors underwent increased osteoclastogenesis in response to RANKL and tumor necrosis factor-alpha (TNF-alpha). IRF-8 suppressed osteoclastogenesis by inhibiting the function and expression of nuclear factor of activated T cells c1 (NFATc1). Our results show that IRF-8 inhibits osteoclast formation under physiological and pathological conditions and suggest a model where downregulation of inhibitory factors such as IRF-8 contributes to RANKL-mediated osteoclastogenesis.	[Zhao, Baohong; Takami, Masamichi; Yamada, Atsushi; Wang, Xiaogu; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 142, Japan; [Zhao, Baohong; Hu, Xiaoyu; Ivashkiv, Lionel B.] Hosp Special Surg, Arthritis & Tissue Degenerat Program, New York, NY 10021 USA; [Koga, Takako; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Dept Cell Signaling, Grad Sch, Bunkyo Ku, Tokyo, Japan; [Koga, Takako; Takayanagi, Hiroshi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Tokyo, Japan; [Hu, Xiaoyu; Ivashkiv, Lionel B.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Tamura, Tomohiko; Ozato, Keiko] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; [Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Ivashkiv, Lionel B.] Cornell Univ, Grad Program Immunol & Microbial Pathogenesis, Weill Grad Sch Med Sci, New York, NY 10021 USA	Showa University; Tokyo Medical & Dental University (TMDU); Cornell University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Pennsylvania; Cornell University	Takami, M (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 142, Japan.	takami@dent.showa-u.ac.jp	Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998; Takami, Masamichi/0000-0002-4506-3975	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science [20390474]; US National Institutes of Health [AR053843, DE19381, DE019420, AR46713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713, R01AR053843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019420, R01DE019381] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to M. Asagiri for technical assistance. We thank T. Kitamura ( University of Tokyo) for providing the retrovirus expression system. We also thank A. Mochizuki and all members of the Department of Biochemistry, School of Dentistry, Showa University for valuable discussions. This work is supported in part by the High-Tech Research Center Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan, 2005-2009, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science ( 20390474 to M. T.) and by grants from the US National Institutes of Health (AR053843 and DE19381 to Y. C. and DE019420 and AR46713 to L. B. I.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Kantakamalakul W, 1999, J IMMUNOL, V162, P7417; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Lee SK, 2006, CURR OPIN RHEUMATOL, V18, P411, DOI 10.1097/01.bor.0000231911.42666.78; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Marecki S, 2000, CELL BIOCHEM BIOPHYS, V33, P127, DOI 10.1385/CBB:33:2:127; Mochizuki A, 2006, J IMMUNOL, V177, P4360, DOI 10.4049/jimmunol.177.7.4360; Nelson N, 1996, J IMMUNOL, V156, P3711; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	29	220	227	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1066	U121		10.1038/nm.2007	http://dx.doi.org/10.1038/nm.2007			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19718038	Green Accepted			2022-12-25	WOS:000269979200028
J	Bishop, DT; Demenais, F; Iles, MM; Harland, M; Taylor, JC; Corda, E; Randerson-Moor, J; Aitken, JF; Avril, MF; Azizi, E; Bakker, B; Bianchi-Scarra, G; Bressac-de Paillerets, B; Calista, D; Cannon-Albright, LA; Chin-A-Woeng, T; Debniak, T; Galore-Haskel, G; Ghiorzo, P; Gut, I; Hansson, J; Hocevar, M; Hoiom, V; Hopper, JL; Ingvar, C; Kanetsky, PA; Kefford, RF; Landi, MT; Lang, J; Lubinski, J; Mackie, R; Malvehy, J; Mann, GJ; Martin, NG; Montgomery, GW; van Nieuwpoort, FA; Novakovic, S; Olsson, H; Puig, S; Weiss, M; van Workum, W; Zelenika, D; Brown, KM; Goldstein, AM; Gillanders, EM; Boland, A; Galan, P; Elder, DE; Gruis, NA; Hayward, NK; Lathrop, GM; Barrett, JH; Bishop, JAN				Bishop, D. Timothy; Demenais, Florence; Iles, Mark M.; Harland, Mark; Taylor, John C.; Corda, Eve; Randerson-Moor, Juliette; Aitken, Joanne F.; Avril, Marie-Francoise; Azizi, Esther; Bakker, Bert; Bianchi-Scarra, Giovanna; Bressac-de Paillerets, Brigitte; Calista, Donato; Cannon-Albright, Lisa A.; Chin-A-Woeng, Thomas; Debniak, Tadeusz; Galore-Haskel, Gilli; Ghiorzo, Paola; Gut, Ivo; Hansson, Johan; Hocevar, Marko; Hoiom, Veronica; Hopper, John L.; Ingvar, Christian; Kanetsky, Peter A.; Kefford, Richard F.; Landi, Maria Teresa; Lang, Julie; Lubinski, Jan; Mackie, Rona; Malvehy, Josep; Mann, Graham J.; Martin, Nicholas G.; Montgomery, Grant W.; van Nieuwpoort, Frans A.; Novakovic, Srdjan; Olsson, Hakan; Puig, Susana; Weiss, Marjan; van Workum, Wilbert; Zelenika, Diana; Brown, Kevin M.; Goldstein, Alisa M.; Gillanders, Elizabeth M.; Boland, Anne; Galan, Pilar; Elder, David E.; Gruis, Nelleke A.; Hayward, Nicholas K.; Lathrop, G. Mark; Barrett, Jennifer H.; Bishop, Julia A. Newton			Genome-wide association study identifies three loci associated with melanoma risk	NATURE GENETICS			English	Article							CUTANEOUS MALIGNANT-MELANOMA; SUN EXPOSURE; PHENOTYPIC CHARACTERISTICS; FAMILY-HISTORY; MC1R VARIANTS; CDKN2A; GENES; MUTATIONS; WOMEN; SUSCEPTIBILITY	We report a genome-wide association study of melanoma conducted by the GenoMEL consortium based on 317K tagging SNPs for 1,650 selected cases and 4,336 controls, with replication in an additional two cohorts (1,149 selected cases and 964 controls from GenoMEL, and a population-based case-control study in Leeds of 1,163 cases and 903 controls). The genome-wide screen identified five loci with genotyped or imputed SNPs reaching P < 5 x 10(-7). Three of these loci were replicated: 16q24 encompassing MC1R (combined P = 2.54 x 10(-27) for rs258322), 11q14-q21 encompassing TYR (P = 2.41 x 10(-14) for rs1393350) and 9p21 adjacent to MTAP and flanking CDKN2A (P = 4.03 x 10(-7) for rs7023329). MC1R and TYR are associated with pigmentation, freckling and cutaneous sun sensitivity, well-recognized melanoma risk factors. Common variants within the 9p21 locus have not previously been associated with melanoma. Despite wide variation in allele frequency, these genetic variants show notable homogeneity of effect across populations of European ancestry living at different latitudes and show independent association to disease risk.	[Bishop, D. Timothy; Iles, Mark M.; Harland, Mark; Taylor, John C.; Randerson-Moor, Juliette; Barrett, Jennifer H.; Bishop, Julia A. Newton] St James Univ Hosp, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Canc Res UK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England; [Demenais, Florence; Corda, Eve] Fdn Jean Dausset CEPH, INSERM, U946, F-75010 Paris, France; [Aitken, Joanne F.] Canc Council, Viertel Ctr Res Canc Control, Brisbane, Qld, Australia; [Avril, Marie-Francoise] Hop Cochin, AP HP, Fac Paris 5, Serv Dermatol, F-75674 Paris, France; [Azizi, Esther; Galore-Haskel, Gilli] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Dept Dermatol, IL-52621 Tel Hashomer, Israel; [Bakker, Bert; Weiss, Marjan] Leiden Univ, Dept Clin Genet, Ctr Human & Clin Genet, Med Ctr, Leiden, Netherlands; [Bianchi-Scarra, Giovanna; Ghiorzo, Paola] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; [Bressac-de Paillerets, Brigitte] CNRS, Inst Canc Gustave Roussy, Serv Genet, FRE 2939, Villejuif, France; [Calista, Donato] Maurizio Bufalini Hosp, Dermatol Unit, Cesena, Italy; [Cannon-Albright, Lisa A.] Univ Utah, Salt Lake City, UT USA; [Chin-A-Woeng, Thomas; van Workum, Wilbert] ServiceXS, NL-2333 BZ Leiden, Netherlands; [Debniak, Tadeusz; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Szczecin, Poland; [Gut, Ivo; Zelenika, Diana; Boland, Anne; Lathrop, G. Mark] Ctr Natl Genotypage, Inst Genom, Commissariat Energie Atorn, Evry, France; [Hansson, Johan; Hoiom, Veronica] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hocevar, Marko; Novakovic, Srdjan] Inst Oncol Ljubljana, Ljubljana, Slovenia; [Hopper, John L.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt MEGA Epidemiol, Melbourne, Vic 3010, Australia; [Ingvar, Christian; Olsson, Hakan] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden; [Kanetsky, Peter A.] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kefford, Richard F.; Mann, Graham J.] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Kefford, Richard F.; Mann, Graham J.] Melanoma Inst Australia, Westmead, NSW, Australia; [Landi, Maria Teresa; Goldstein, Alisa M.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Lang, Julie; Mackie, Rona] Univ Glasgow, Dept Med Genet, Glasgow G12 8QQ, Lanark, Scotland; [Mackie, Rona] Univ Glasgow, Dept Publ Hlth & Hlth Policy, Glasgow G12 8QQ, Lanark, Scotland; [Malvehy, Josep; Puig, Susana] Hosp Clin Barcelona, Melanoma Unit, Dept Dermatol, IDIBAPS, E-08036 Barcelona, Spain; [Malvehy, Josep; Puig, Susana] CIBER Enfermedades Raras, Barcelona, Spain; [Martin, Nicholas G.; Montgomery, Grant W.; Hayward, Nicholas K.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [van Nieuwpoort, Frans A.; Gruis, Nelleke A.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Brown, Kevin M.] Translat Genom Res Inst, Melanoma Genom Lab, Phoenix, AZ USA; [Gillanders, Elizabeth M.] NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA; [Galan, Pilar] CRNH Idf, INSERM, INRA, CNAM,UMR U557,U1125, Bobigny, France; [Elder, David E.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Cancer Research UK; Saint James's University Hospital; University of Leeds; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Genoa; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Ospedale Maurizio Bufalini; Utah System of Higher Education; University of Utah; Pomeranian Medical University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Institute of Oncology - Slovenia; University of Melbourne; Lund University; Skane University Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Sydney; Westmead Institute for Medical Research; Melanoma Institute Australia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Glasgow; University of Glasgow; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; QIMR Berghofer Medical Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pennsylvania	Bishop, DT (corresponding author), St James Univ Hosp, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Canc Res UK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England.	d.t.bishop@leeds.ac.uk	Montgomery, Grant W/B-7148-2008; Mann, Graham J/G-4758-2014; hayward, nicholas k/C-1367-2015; Calista, Donato/AAM-1567-2020; Scarrà, Giovanna Bianchi/G-8933-2014; Bakker, Egbert/D-3525-2009; Weiss, Marjan M/AAN-4979-2020; Puig, Susana/AAB-2091-2020; Paillerets, Brigitte Bressac-de/D-8954-2018; Ingvar, Christian/AAE-9841-2019; Ghiorzo, Paola/CAG-0673-2022; Pilar, Galan/F-2908-2017; Höiom, Veronica/F-4153-2012; Gut, Ivo/ABF-3188-2020; Demenais, Florence/G-3298-2013; Aitken, Joanne F/C-5289-2009; hayward, nick/AAV-8802-2020	Montgomery, Grant W/0000-0002-4140-8139; Mann, Graham J/0000-0003-1301-405X; hayward, nicholas k/0000-0003-4760-1033; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Bakker, Egbert/0000-0002-2843-7357; Weiss, Marjan M/0000-0002-0936-1406; Puig, Susana/0000-0003-1337-9745; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Ghiorzo, Paola/0000-0002-3651-8173; Pilar, Galan/0000-0003-1706-3107; Gut, Ivo/0000-0001-7219-632X; Demenais, Florence/0000-0001-8361-0936; Novakovic, Srdjan/0000-0002-8888-4810; Aitken, Joanne Frances/0000-0001-6859-2186; Martin, Nicholas/0000-0003-4069-8020; Newton-Bishop, Julia/0000-0001-9147-6802; Iles, Mark/0000-0002-2603-6509; Bishop, Tim/0000-0002-8752-8785; Kefford, Richard/0000-0001-9251-9229; Barrett, Jenny/0000-0002-1720-7724; Olsson, Hakan/0000-0002-8794-9635; Randerson-Moor, Juliette/0000-0003-0303-0072; albright, lisa/0000-0003-2602-3668; Gruis, Nelleke/0000-0002-5210-9150; malvehy, josep/0000-0002-6998-914X	Cancer Research UK [C588/A4994, A4994, 10589] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R01 ROI CA83115, R0-1 CA 83115, R01 CA102422, CA88363, R01 CA5558, R01 CA083115, R01 CA083115-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102422, R01CA088363, R01CA083115] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bataille V, 1996, BRIT J CANCER, V73, P1605, DOI 10.1038/bjc.1996.302; Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Berwick M, 2006, CANCER EPIDEM BIOMAR, V15, P1520, DOI 10.1158/1055-9965.EPI-06-0270; Bishop JAN, 2000, J INVEST DERMATOL, V114, P28, DOI 10.1046/j.1523-1747.2000.00823.x; Borg A, 2000, J NATL CANCER I, V92, P1260, DOI 10.1093/jnci/92.15.1260; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cannon-Albright L A, 1991, Important Adv Oncol, P39; Chang YM, 2009, INT J CANCER, V124, P420, DOI 10.1002/ijc.23869; Chaudru V, 2004, JNCI-J NATL CANCER I, V96, P785, DOI 10.1093/jnci/djh136; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Debniak T, 2008, EUR J CANCER, V44, P110, DOI 10.1016/j.ejca.2007.10.006; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Holland EA, 1995, ONCOGENE, V11, P2289; Holland EA, 1999, GENE CHROMOSOME CANC, V25, P339, DOI 10.1002/(SICI)1098-2264(199908)25:4<339::AID-GCC5>3.0.CO;2-H; Hollenbeak CS, 2005, CANCER, V104, P1962, DOI 10.1002/cncr.21404; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P934, DOI 10.1093/oxfordjournals.aje.a117360; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; Kanetsky PA, 2006, CANCER RES, V66, P9330, DOI 10.1158/0008-5472.CAN-06-1634; Landi MT, 2004, J MED GENET, V41, P557, DOI 10.1136/jmg.2003.016907; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Naldi L, 2005, ANN EPIDEMIOL, V15, P545, DOI 10.1016/j.annepidem.2004.10.005; Newton-Bishop JA, 1999, BRIT J CANCER, V80, P295, DOI 10.1038/sj.bjc.6690354; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pastorino L, 2008, PIGM CELL MELANOMA R, V21, P700, DOI 10.1111/j.1755-148X.2008.00512.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peric B, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-86; Platz A, 1997, J NATL CANCER I, V89, P697, DOI 10.1093/jnci/89.10.697; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Puig S, 2005, J CLIN ONCOL, V23, P3043, DOI 10.1200/JCO.2005.08.034; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Titus-Ernstoff L, 2005, INT J CANCER, V116, P144, DOI 10.1002/ijc.21001; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375	42	341	346	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					920	U85		10.1038/ng.411	http://dx.doi.org/10.1038/ng.411			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19578364	Green Accepted			2022-12-25	WOS:000268432900018
J	Dueber, JE; Wu, GC; Malmirchegini, GR; Moon, TS; Petzold, CJ; Ullal, AV; Prather, KLJ; Keasling, JD				Dueber, John E.; Wu, Gabriel C.; Malmirchegini, G. Reza; Moon, Tae Seok; Petzold, Christopher J.; Ullal, Adeeti V.; Prather, Kristala L. J.; Keasling, Jay D.			Synthetic protein scaffolds provide modular control over metabolic flux	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; BIFUNCTIONAL ENZYME; MEVALONATE PATHWAY; SUBSTRATE; 1,3-PROPANEDIOL; EXPRESSION; GLYCEROL; SWITCH	Engineered metabolic pathways constructed from enzymes heterologous to the production host often suffer from flux imbalances, as they typically lack the regulatory mechanisms characteristic of natural metabolism. In an attempt to increase the effective concentration of each component of a pathway of interest, we built synthetic protein scaffolds that spatially recruit metabolic enzymes in a designable manner. Scaffolds bearing interaction domains from metazoan signaling proteins specifically accrue pathway enzymes tagged with their cognate peptide ligands. The natural modularity of these domains enabled us to optimize the stoichiometry of three mevalonate biosynthetic enzymes recruited to a synthetic complex and thereby achieve 77-fold improvement in product titer with low enzyme expression and reduced metabolic load. One of the same scaffolds was used to triple the yield of glucaric acid, despite high titers (0.5 g/I) without the synthetic complex. These strategies should prove generalizeable to other metabolic pathways and programmable for fine-tuning pathway flux.	[Dueber, John E.; Wu, Gabriel C.; Malmirchegini, G. Reza; Keasling, Jay D.] Univ Calif Berkeley, Calif Inst Quantitat Biomed Res QB3, Berkeley, CA 94720 USA; [Dueber, John E.; Wu, Gabriel C.; Keasling, Jay D.] Univ Calif Berkeley, SynBERC, Berkeley, CA 94720 USA; [Moon, Tae Seok; Prather, Kristala L. J.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Moon, Tae Seok; Prather, Kristala L. J.] MIT, SynBERC, Cambridge, MA 02139 USA; [Petzold, Christopher J.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Petzold, Christopher J.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Ullal, Adeeti V.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dueber, JE (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biomed Res QB3, Berkeley, CA 94720 USA.	jdueber@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Petzold, Christopher/0000-0002-8270-5228; Moon, Tae Seok/0000-0001-8373-9051	UC Berkeley; QB3 Institute; National Science Foundation (NSF); Synthetic Biology Engineering Research Center [EEC-0540879]; NSF [CBET-0756801]; Bill and Melinda Gates Foundation; Joint BioEnergy Institute; Office of Naval Research Young Investigator Program [N000140510656]	UC Berkeley; QB3 Institute; National Science Foundation (NSF)(National Science Foundation (NSF)); Synthetic Biology Engineering Research Center; NSF(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Joint BioEnergy Institute; Office of Naval Research Young Investigator Program(Office of Naval Research)	We thank A. Arkin, J. Dietrich, E. Dueber, L. Katz, and W. Whitaker for comments and discussion during the preparation of the manuscript. We also thank members of the Dueber and Keasling labs for experimental help and discussions. This work was supported by funding from UC Berkeley QB3 Institute (J. E. D.), National Science Foundation (NSF) Synthetic Biology Engineering Research Center grant no. EEC-0540879 (J. E. D., J. D. K, K. L. J. P., T. S. M.), NSF grant no. CBET-0756801 (J. E. D.), the Bill and Melinda Gates Foundation (J. D. K), Joint BioEnergy Institute (J. D. K.), the Office of Naval Research Young Investigator Program grant no. N000140510656 (K. L. J. P. and T. S. M.).	Barbirato F, 1996, APPL ENVIRON MICROB, V62, P1448, DOI 10.1128/AEM.62.4.1448-1451.1996; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; BULOW L, 1985, BIO-TECHNOL, V3, P821, DOI 10.1038/nbt0985-821; BULOW L, 1987, EUR J BIOCHEM, V163, P443, DOI 10.1111/j.1432-1033.1987.tb10889.x; Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Dueber JE, 2007, NAT BIOTECHNOL, V25, P660, DOI 10.1038/nbt1308; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Harcum SW, 1999, APPL BIOCHEM BIOTECH, V80, P23, DOI 10.1385/ABAB:80:1:23; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Howard PL, 2003, P NATL ACAD SCI USA, V100, P11267, DOI 10.1073/pnas.1934711100; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Lee SK, 2005, J BACTERIOL, V187, P2793, DOI 10.1128/JB.187.8.2793-2800.2005; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Moon TS, 2009, APPL ENVIRON MICROB, V75, P589, DOI 10.1128/AEM.00973-08; MOSBACH K, 1970, ACTA CHEM SCAND, V24, P2093, DOI 10.3891/acta.chem.scand.24-2093; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Spivey HO, 1999, METHODS, V19, P306, DOI 10.1006/meth.1999.0858; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Werpy T., 2004, TOP VALUE ADDED CHEM, VI; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Zhu MM, 2002, BIOTECHNOL PROGR, V18, P694, DOI 10.1021/bp020281+	38	857	933	23	597	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2009	27	8					753	U107		10.1038/nbt.1557	http://dx.doi.org/10.1038/nbt.1557			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	480YY	19648908				2022-12-25	WOS:000268774500026
J	Plantier, JC; Leoz, M; Dickerson, JE; De Oliveira, F; Cordonnier, F; Lemee, V; Damond, F; Robertson, DL; Simon, F				Plantier, Jean-Christophe; Leoz, Marie; Dickerson, Jonathan E.; De Oliveira, Fabienne; Cordonnier, Francois; Lemee, Veronique; Damond, Florence; Robertson, David L.; Simon, Francois			A new human immunodeficiency virus derived from gorillas	NATURE MEDICINE			English	Article							HIV-1	We have identified a new human immunodeficiency virus in a Cameroonian woman. It is closely related to gorilla simian immunodeficiency virus (SIVgor) and shows no evidence of recombination with other HIV-1 lineages. This new virus seems to be the prototype of a new HIV-1 lineage that is distinct from HIV-1 groups M, N and O. We propose to designate it HIV-1 group	[Plantier, Jean-Christophe; Leoz, Marie; De Oliveira, Fabienne; Lemee, Veronique] Univ Rouen, Fac Med Pharm, CHU Rouen,Lab Associe,Equipe Accueil EA2656, Ctr Natl Reference Virus Immunodeficience Humaine, F-76821 Mont St Aignan, France; [Dickerson, Jonathan E.; Robertson, David L.] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Cordonnier, Francois] Hop Louis Mourier, F-92701 Colombes, France; [Damond, Florence] Hop Bichat Claude Bernard, F-75877 Paris, France; [Simon, Francois] Univ Paris Diderot, Hop St Louis, Inst Natl Sante & Rech Med, U941,Fac Med, Paris, France	CHU de Rouen; Universite de Rouen Normandie; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Plantier, JC (corresponding author), Univ Rouen, Fac Med Pharm, CHU Rouen,Lab Associe,Equipe Accueil EA2656, Ctr Natl Reference Virus Immunodeficience Humaine, F-76821 Mont St Aignan, France.	jean-christophe.plantier@univ-rouen.fr		PLANTIER, Jean-Christophe/0000-0001-6417-4083	Institut de Veille Sanitaire; Agence Nationale de Recherches sur le Sida et les Hepatites; Rouen University Hospital, France; Wellcome Trust studentship	Institut de Veille Sanitaire; Agence Nationale de Recherches sur le Sida et les Hepatites; Rouen University Hospital, France; Wellcome Trust studentship(Wellcome Trust)	We thank H. Ichou for field assistance and all the staff of the Rouen Virology Laboratory. Funding was provided by Institut de Veille Sanitaire, Agence Nationale de Recherches sur le Sida et les Hepatites and Rouen University Hospital, France. J.E.D. is supported by a Wellcome Trust studentship.	Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gueudin M, 2004, JAIDS-J ACQ IMM DEF, V36, P639, DOI 10.1097/00126334-200405010-00014; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Takehisa J, 2009, J VIROL, V83, P1635, DOI 10.1128/JVI.02311-08; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wain LV, 2007, MOL BIOL EVOL, V24, P1853, DOI 10.1093/molbev/msm110	9	323	338	0	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					871	872		10.1038/nm.2016	http://dx.doi.org/10.1038/nm.2016			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19648927				2022-12-25	WOS:000268770400028
J	Hansen, CG; Bright, NA; Howard, G; Nichols, BJ				Hansen, Carsten G.; Bright, Nicholas A.; Howard, Gillian; Nichols, Benjamin J.			SDPR induces membrane curvature and functions in the formation of caveolae	NATURE CELL BIOLOGY			English	Article							DEPRIVATION-RESPONSE-GENE; TRANSCRIPT RELEASE FACTOR; COILED-COIL PROTEIN; SHIGA TOXIN; INDEPENDENT ENDOCYTOSIS; SERUM STARVATION; BINDING PROTEIN; POLYMERASE-I; PATHWAYS; CELLS	Caveolae are plasma membrane invaginations with a characteristic flask-shaped morphology. They function in diverse cellular processes, including endocytosis. The mechanism by which caveolae are generated is not fully understood, but both caveolin proteins and PTRF (polymerase I and transcript release factor, also known as cavin) are important. Here we show that loss of SDPR (serum deprivation protein response) causes loss of caveolae. SDPR binds directly to PTRF and recruits PTRF to caveolar membranes. Overexpression of SDPR, unlike PTRF, induces deformation of caveolae and extensive tubulation of the plasma membrane. The B-subunit of Shiga toxin (STB) also induces membrane tubulation and these membrane tubes also originate from caveolae. STB colocalizes extensively with both SDPR and caveolin 1. Loss of caveolae reduces the propensity of STB to induce membrane tubulation. We conclude that SDPR is a membrane-curvature-inducing component of caveolae, and that STB-induced membrane tubulation is facilitated by caveolae.	[Hansen, Carsten G.; Howard, Gillian; Nichols, Benjamin J.] MRC LMB, Cambridge CB2 0QH, England; [Bright, Nicholas A.] Univ Cambridge, Cambridge Inst Med Res, Addenbrookes Hosp, Cambridge CB2 0XY, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Nichols, BJ (corresponding author), MRC LMB, Hills Rd, Cambridge CB2 0QH, England.	ben@mrc-lmb.cam.ac.uk		Hansen, Carsten/0000-0003-0746-7482	MRC; Cowi Foundation; Ulla og Mogens Andersens Fond; Oticon Fonden; Julie Von Mullens Fond; Fuhrmann-Fonden; Krista og Viggo Petersen's Fond; Reinholdt W Jorck og Hustrus Fond; Niels Bohr Fond; MRC [MC_U105178778] Funding Source: UKRI; Medical Research Council [G9310915, MC_U105178778] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cowi Foundation; Ulla og Mogens Andersens Fond; Oticon Fonden; Julie Von Mullens Fond; Fuhrmann-Fonden; Krista og Viggo Petersen's Fond; Reinholdt W Jorck og Hustrus Fond; Niels Bohr Fond; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. Riento, H. Pelham and S. Munro for comments on the manuscript. C. G. H. is supported by the MRC, Cowi Foundation, Ulla og Mogens Andersens Fond, Oticon Fonden, Julie Von Mullens Fond, Fuhrmann-Fonden, Krista og Viggo Petersen's Fond, Reinholdt W Jorck og Hustrus Fond, Christian og Ottilia Brorsons Rejselegat for Yngre Videnskabsmoend-og Kvinder, Niels Bohr Fond and Henry Shaw's Legat. N. A. B. is supported by the MRC.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; BURGENER R, 1990, BIOCHEM J, V269, P729, DOI 10.1042/bj2690729; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; GUSTINCICH S, 1993, CELL GROWTH DIFFER, V4, P753; Gustincich S, 1999, GENOMICS, V57, P120, DOI 10.1006/geno.1998.5733; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Izumi Y, 1997, J BIOL CHEM, V272, P7381, DOI 10.1074/jbc.272.11.7381; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Razani B, 2001, J BIOL CHEM, V276, P38121; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Sandvig K, 2004, INT J MED MICROBIOL, V293, P483, DOI 10.1078/1438-4221-00294; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stan RV, 2002, MICROSC RES TECHNIQ, V57, P350, DOI 10.1002/jemt.10089; Tagawa M, 2008, AM J PHYSIOL-CELL PH, V295, pC490, DOI 10.1152/ajpcell.00188.2008; Vinten J, 2001, CELL TISSUE RES, V305, P99, DOI 10.1007/s004410100389; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	39	194	198	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					807	U60		10.1038/ncb1887	http://dx.doi.org/10.1038/ncb1887			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525939	Green Accepted			2022-12-25	WOS:000267603100008
J	Luce, K; Osiewacz, HD				Luce, Karin; Osiewacz, Heinz D.			Increasing organismal healthspan by enhancing mitochondrial protein quality control	NATURE CELL BIOLOGY			English	Article							ASCOMYCETE PODOSPORA-ANSERINA; LIFE-SPAN; LON PROTEASE; DNA REARRANGEMENTS; OXIDATIVE STRESS; RESPIRATORY CHAINS; FUNGAL; GENES; SENESCENCE; EXPRESSION	Degradation of damaged proteins by members of the protein quality control system is of fundamental importance in maintaining cellular homeostasis. In mitochondria, organelles which both generate and are targets of reactive oxygen species (ROS), a number of membrane bound and soluble proteases are essential components of this system. Here we describe the regulation of Podospora anserina LON (PaLON) levels, an AAA(+) family serine protease localized in the matrix fraction of mitochondria. Constitutive overexpression of PaLon results in transgenic strains of the fungal ageing model P. anserina showing increased ATP-dependent serine protease activity. These strains display lower levels of carbonylated (aconitase) and carboxymethylated proteins, reduced secretion of hydrogen peroxide and a higher resistance against exogenous oxidative stress. Moreover, they are characterized by an extended lifespan without impairment of vital functions such as respiration, growth and fertility. The reported genetic manipulation proved to be a successful intervention in organismal ageing and it led to an increase in the healthy lifespan, the healthspan, of P. anserina.	[Luce, Karin; Osiewacz, Heinz D.] Univ Frankfurt, Fac Biosci & Cluster Excellence Macromol Complexe, Inst Mol Biosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Osiewacz, HD (corresponding author), Univ Frankfurt, Fac Biosci & Cluster Excellence Macromol Complexe, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	osiewacz@bio.uni-frankfurt.de	Osiewacz, Heinz D./D-3454-2011		Deutsche Forschungsgemeinschaft; European Commission [FP6-518230]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	was supported by a grant from the Deutsche Forschungsgemeinschaft. Part of the work of H. D. O. was supported by the European Commission ( FP6-518230; Proteomage).	Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x; Borghouts C, 1997, P NATL ACAD SCI USA, V94, P10768, DOI 10.1073/pnas.94.20.10768; Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Esser K., 1974, BACTERIA BACTERIOPHA, P531; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010; Hamann A, 2005, CURR GENET, V48, P270, DOI 10.1007/s00294-005-0018-1; Hamann A, 2007, MOL MICROBIOL, V65, P948, DOI 10.1111/j.1365-2958.2007.05839.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Jung C, 2000, ANAL BIOCHEM, V286, P214, DOI 10.1006/abio.2000.4813; Krause F, 2004, J BIOL CHEM, V279, P26453, DOI 10.1074/jbc.M402756200; KUCK U, 1985, CURR GENET, V9, P373, DOI 10.1007/BF00421608; Kunstmann B, 2008, AGING CELL, V7, P651, DOI 10.1111/j.1474-9726.2008.00412.x; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; OSIEWACZ HD, 1994, CURR GENET, V26, P87, DOI 10.1007/BF00326309; OSIEWACZ HD, 1992, AGING-CLIN EXP RES, V4, P273, DOI 10.1007/BF03324108; OSIEWACZ HD, 1991, APPL MICROBIOL BIOT, V35, P38; Osiewacz HD, 2002, AGEING RES REV, V1, P425, DOI 10.1016/S1568-1637(02)00010-7; Osiewacz HD, 2000, ANN NY ACAD SCI, V908, P31; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Scheckhuber Christian Q., 2008, Biotechnology Journal, V3, P781, DOI 10.1002/biot.200800010; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004; SUZUKI CK, 1994, SCIENCE, V264, P891, DOI 10.1126/science.8178144; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	38	111	118	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					852	U168		10.1038/ncb1893	http://dx.doi.org/10.1038/ncb1893			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543272				2022-12-25	WOS:000267603100014
J	Simard, JR; Kluter, S; Grutter, C; Getlik, M; Rabiller, M; Rode, HB; Rauh, D				Simard, Jeffrey R.; Klueter, Sabine; Gruetter, Christian; Getlik, Matthaeus; Rabiller, Matthias; Rode, Haridas B.; Rauh, Daniel			A new screening assay for allosteric inhibitors of cSrc	NATURE CHEMICAL BIOLOGY			English	Article							P38 MAP KINASE; PHARMACOPHORE APPROACH; BINDING-SITE; PROTEIN; CONFORMATION; CANCER; SRC; RESISTANCE; COMPOUND	Targeting kinases outside the highly conserved ATP pocket is thought to be a promising strategy for overcoming bottlenecks in kinase inhibitor research, such as limited selectivity and drug resistance. Here we report the development and application of a direct binding assay to detect small molecules that stabilize the inactive conformation of the tyrosine kinase cSrc. Protein X-ray crystallography validated the assay results and confirmed an exclusively allosteric binding mode.	[Simard, Jeffrey R.; Klueter, Sabine; Gruetter, Christian; Getlik, Matthaeus; Rabiller, Matthias; Rode, Haridas B.; Rauh, Daniel] Max Planck Soc, Chem Genom Ctr, Dortmund, Germany	Max Planck Society	Rauh, D (corresponding author), Max Planck Soc, Chem Genom Ctr, Dortmund, Germany.	daniel.rauh@cgc.mpg.de	Rauh, Daniel/G-1595-2013	Rauh, Daniel/0000-0002-1970-7642	German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus) [BMBF 01GS08102]; Schering Plough; Bayer-Schering Pharma; Merck-Serono; Bayer CropScience	German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus)(Federal Ministry of Education & Research (BMBF)); Schering Plough(Merck & CompanySchering Plough Corporation); Bayer-Schering Pharma(Bayer AG); Merck-Serono(Merck & Company); Bayer CropScience(Bayer AG)	We thank the Dortmund Protein Facility for cloning, expressing and purifying the chicken cSrc and human p38a mutant variants for labeling. We thank M. Weyand, W. Blanckenfeldt, E. Hofmann, I. Vetter and beamline scientists at the Swiss Light Source of the Paul Scherrer Institute for expert assistance during data collection. We thank P. Janning for her assistance with the HPLC and MS analysis of the fluorescent-labeled and unlabeled cSrc, and we thank H. Waldmann and K. Shokat for helpful discussions. J. R. S. was funded by the Alexander von Humboldt Foundation. This work was supported by the German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus) (grant number BMBF 01GS08102). Schering Plough, Bayer-Schering Pharma, Merck-Serono and Bayer CropScience are thanked for financial support.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Annis DA, 2004, J AM CHEM SOC, V126, P15495, DOI 10.1021/ja048365x; Backes AC, 2008, EXPERT OPIN DRUG DIS, V3, P1409, DOI 10.1517/17460440802579975; Backes AC, 2008, EXPERT OPIN DRUG DIS, V3, P1427, DOI 10.1517/17460440802580106; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Dar AC, 2008, CHEM BIOL, V15, P1015, DOI 10.1016/j.chembiol.2008.09.007; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Dumas J, 2000, BIOORG MED CHEM LETT, V10, P2051, DOI 10.1016/S0960-894X(00)00272-9; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Jacobs MD, 2008, PROTEINS, V70, P1451, DOI 10.1002/prot.21633; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Michalczyk A, 2008, BIOORGAN MED CHEM, V16, P3482, DOI 10.1016/j.bmc.2008.02.053; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Regan J, 2003, J MED CHEM, V46, P4676, DOI 10.1021/jm030121k; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	21	106	114	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					394	396		10.1038/nchembio.162	http://dx.doi.org/10.1038/nchembio.162			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19396179				2022-12-25	WOS:000266383800011
J	Jeffreys, AJ; Neumann, R				Jeffreys, Alec J.; Neumann, Rita			The rise and fall of a human recombination hot spot	NATURE GENETICS			English	Article							HOTSPOT CONVERSION PARADOX; HUMAN GENOME; MEIOTIC RECOMBINATION; MARKER ASSOCIATION; GENE CONVERSION; DNA-SEQUENCES; CROSSOVER; CHIMPANZEES; PATTERNS; REGIONS	Human meiotic crossovers mainly cluster into narrow hot spots(1) that profoundly influence patterns of haplotype diversity(2) and that may also affect genome instability(3) and sequence evolution(4-6). Hot spots also seem to be ephemeral(7-9), but processes of hot-spot activation and their subsequent evolutionary dynamics remain unknown. We now analyze the life cycle of a recombination hot spot. Sperm typing revealed a polymorphic hot spot that was activated in cis by a single base change, providing evidence for a primary sequence determinant necessary, though not sufficient, to activate recombination. This activating mutation occurred roughly 70,000 y ago and has persisted to the present, most likely fortuitously through genetic drift despite its systematic elimination by biased gene conversion. Nonetheless, this self-destructive conversion will eventually lead to hot-spot extinction. These findings define a subclass of highly transient hot spots and highlight the importance of understanding hot-spot turnover and how it influences haplotype diversity.	[Jeffreys, Alec J.; Neumann, Rita] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Jeffreys, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	ajj@le.ac.uk			Medical Research Council; Wellcome Trust [081227/Z/06/Z]; Royal Society; Louis-Jeantet Foundation; MRC [G0601068] Funding Source: UKRI; Medical Research Council [G0601068] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Louis-Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Blower and volunteers for providing semen samples, T. E. King and P. Balaresque for DNA samples, A. Webb for bioinformatics support, colleagues for helpful discussions, and the Medical Research Council, the Wellcome Trust (ref. 081227/Z/06/Z), the Royal Society and the Louis-Jeantet Foundation for funding support.	Arndt PF, 2005, J MOL EVOL, V60, P748, DOI 10.1007/s00239-004-0222-5; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Dreszer TR, 2007, GENOME RES, V17, P1420, DOI 10.1101/gr.6395807; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; HUDSON RR, 1985, GENETICS, V111, P147; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morton N. E., 1982, OUTLINE GENETIC EPID; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Peters AD, 2008, GENETICS, V178, P1579, DOI 10.1534/genetics.107.084061; Pineda-Krch M, 2005, GENETICS, V169, P2319, DOI 10.1534/genetics.104.034363; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	29	49	49	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					625	629		10.1038/ng.346	http://dx.doi.org/10.1038/ng.346			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19349985	Green Accepted			2022-12-25	WOS:000265575600027
J	Nelson, AL; Reichert, JM				Nelson, Aaron L.; Reichert, Janice M.			Development trends for therapeutic antibody fragments	NATURE BIOTECHNOLOGY			English	Article							SINGLE-CHAIN-FV; MONOCLONAL-ANTIBODY; ESCHERICHIA-COLI; FAB FRAGMENTS; DOMAIN ANTIBODIES; FC-RECEPTOR; LOCALIZATION; MOLECULES; MELANOMA; TUMORS	Although fewer antibody fragments have entered the clinic than full-length monoclonal antibodies, proof-of-concept studies for these therapeutics remain the main hurdle.	[Nelson, Aaron L.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Reichert, Janice M.] Tufts Ctr Study Drug Dev, Boston, MA USA	Tufts University	Nelson, AL (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	janice.reichert@tufts.edu		Reichert, Janice/0000-0003-0400-1951				ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582; AREND WP, 1975, CLIN EXP IMMUNOL, V22, P502; BETTER M, 1988, SCIENCE, V240, P1041, DOI 10.1126/science.3285471; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; CUMBER AJ, 1992, J IMMUNOL, V149, P120; *DATAMONITOR, 2007, MON ANT REP 2; FUJIMORI K, 1989, CANCER RES, V49, P5656; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; HUMPHREYS A, 2008, MEDADNEWS, V27, P12; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; INBAR D, 1972, P NATL ACAD SCI USA, V69, P2659, DOI 10.1073/pnas.69.9.2659; JAIN RK, 1988, CANCER RES, V48, P7022; JAIN RK, 1987, CANCER RES, V47, P3039; JAIN RK, 1990, CANCER RES S, V50, P814; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; KING DJ, 1994, CANCER RES, V54, P6176; LARSON SM, 1983, J CLIN INVEST, V72, P2101, DOI 10.1172/JCI111175; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Maggon K, 2007, CURR MED CHEM, V14, P1978; NEUWELT EA, 1988, CANCER RES, V48, P4725; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sanz L, 2005, ACTA PHARMACOL SIN, V26, P641, DOI 10.1111/j.1745-7254.2005.00135.x; SCHOTT ME, 1992, CANCER RES, V52, P6413; SHIMBA N, 1995, FEBS LETT, V360, P247, DOI 10.1016/0014-5793(95)00113-N; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Steinbrook R, 2006, NEW ENGL J MED, V355, P1409, DOI 10.1056/NEJMp068185; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; YOKOTA T, 1992, CANCER RES, V52, P3402	36	221	245	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2009	27	4					331	337		10.1038/nbt0409-331	http://dx.doi.org/10.1038/nbt0409-331			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	430EO	19352366				2022-12-25	WOS:000264971800014
J	Atsumi, S; Higashide, W; Liao, JC				Atsumi, Shota; Higashide, Wendy; Liao, James C.			Direct photosynthetic recycling of carbon dioxide to isobutyraldehyde	NATURE BIOTECHNOLOGY			English	Article							VARIABILIS ATCC 29413; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; ENHANCES PHOTOSYNTHESIS; HYDROGEN-PRODUCTION; ESCHERICHIA-COLI; LIGHT-INTENSITY; CYANOBACTERIA; EXPRESSION; GENE; PHOTOPRODUCTION	Global climate change has stimulated efforts to reduce CO2 emissions. One approach to addressing this problem is to recycle CO2 directly into fuels or chemicals using photosynthesis. Here we genetically engineered Synechococcus elongatus PCC7942 to produce isobutyraldehyde and isobutanol directly from CO2 and increased productivity by overexpression of ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco). Isobutyraldehyde is a precursor for the synthesis of other chemicals, and isobutanol can be used as a gasoline substitute. The high vapor pressure of isobutyraldehyde allows in situ product recovery and reduces product toxicity. The engineered strain remained active for 8 d and produced isobutyraldehyde at a higher rate than those reported for ethanol(1), hydrogen(2) or lipid(3) production by cyanobacteria or algae. These results underscore the promise of direct bioconversion of CO2 into fuels and chemicals, which bypasses the need for deconstruction of biomass.	[Atsumi, Shota; Higashide, Wendy; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA; [Liao, James C.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA.	liaoj@seas.ucla.edu		Liao, James/0000-0002-4580-7276; Atsumi, Shota/0000-0002-5782-4196	US Department of Energy (DOE) [DE-FG02-07ER64490]; UCLA-DOE Institute	US Department of Energy (DOE)(United States Department of Energy (DOE)); UCLA-DOE Institute	This work was supported in part by US Department of Energy (DOE) grant DE-FG02-07ER64490 and the UCLA-DOE Institute for Genomics and Proteomics. We thank S. S. Golden (University of California, San Diego) for S. elongatus PCC7942 and pAM2991, F. R. Tabita (Ohio State University, Columbus) for the rbcLS plasmid and L. A. Sherman (Purdue University) for helpful advice.	Andersson CR, 2000, METHOD ENZYMOL, V305, P527; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6; BUSTOS SA, 1992, MOL GEN GENET, V232, P221, DOI 10.1007/BF00280000; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; CIOFFI EA, 1980, ANAL BIOCHEM, V104, P485, DOI 10.1016/0003-2697(80)90104-9; de la Plaza M, 2004, FEMS MICROBIOL LETT, V238, P367, DOI 10.1016/j.femsle.2004.07.057; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; Dubbs JM, 2004, FEMS MICROBIOL REV, V28, P353, DOI 10.1016/j.femsre.2004.01.002; Dutta D, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-36; Energy Information Administration, 2009, INT EN OUTL 2009; GOLDEN SS, 1987, METHOD ENZYMOL, V153, P215; Happe T, 2000, J BACTERIOL, V182, P1624, DOI 10.1128/JB.182.6.1624-1631.2000; Huntley M. E., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P573, DOI 10.1007/s11027-006-7304-1; Ikawa M, 1997, HYDROBIOLOGIA, V356, P143, DOI 10.1023/A:1003103726520; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; KIRITANI K, 1966, J BIOL CHEM, V241, P2042; Laurinavichene T, 2004, J BIOTECHNOL, V114, P143, DOI 10.1016/j.jbiotec.2004.05.012; Ma WM, 2005, J APPL PHYCOL, V17, P273, DOI 10.1007/s10811-005-4850-y; Miyagawa Y, 2001, NAT BIOTECHNOL, V19, P965, DOI 10.1038/nbt1001-965; PHLIPS EJ, 1983, APPL ENVIRON MICROB, V45, P1212, DOI 10.1128/AEM.45.4.1212-1220.1983; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; Sulzenbacher G, 2004, J MOL BIOL, V342, P489, DOI 10.1016/j.jmb.2004.07.034; Suzuki Y, 2007, PLANT CELL PHYSIOL, V48, P626, DOI 10.1093/pcp/pcm035; Tavano CL, 2006, CURR OPIN MICROBIOL, V9, P625, DOI 10.1016/j.mib.2006.10.005; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Tsygankov AA, 1999, BIOTECHNOL BIOENG, V64, P709, DOI 10.1002/(SICI)1097-0290(19990920)64:6<709::AID-BIT10>3.0.CO;2-C; Tyo KE, 2006, APPL ENVIRON MICROB, V72, P3412, DOI 10.1128/AEM.72.5.3412-3417.2006; Wahlund TM, 1996, AM CHEM SOC DIV FUEL, V41, P1403; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; WHITMAN W, 1976, BIOCHEM BIOPH RES CO, V71, P1034, DOI 10.1016/0006-291X(76)90758-0; Whitney SM, 2001, P NATL ACAD SCI USA, V98, P14738, DOI 10.1073/pnas.261417298; WOODROW IE, 1988, ANNU REV PLANT PHYS, V39, P533, DOI 10.1146/annurev.pp.39.060188.002533; Yang YT, 2000, BIOTECHNOL BIOENG, V69, P150, DOI 10.1002/(SICI)1097-0290(20000720)69:2<150::AID-BIT4>3.0.CO;2-N	36	590	661	19	362	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1177	U142		10.1038/nbt.1586	http://dx.doi.org/10.1038/nbt.1586			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	19915552				2022-12-25	WOS:000272708300035
J	Woo, CW; Cui, DY; Arellano, J; Dorweiler, B; Harding, H; Fitzgerald, KA; Ron, D; Tabas, I				Woo, Connie W.; Cui, Dongying; Arellano, Jerry; Dorweiler, Bernhard; Harding, Heather; Fitzgerald, Katherine A.; Ron, David; Tabas, Ira			Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; IN-VIVO; TRANSLATION; CELLS; CHOP; EXPRESSION; APOPTOSIS; PHOSPHORYLATION; REINITIATION	The endoplasmic reticulum ( ER) unfolded protein response (UPR) restores equilibrium to the ER, but prolonged expression of the UPR effector CHOP (GADD153) is cytotoxic. We found that CHOP expression induced by ER stress was suppressed by prior engagement of toll-like receptor (TLR) 3 or 4 through a TRIF-dependent pathway. TLR engagement did not suppress phosphorylation of PERK or eIF-2 alpha, which are upstream of CHOP, but phospho-eIF-2 alpha failed to promote translation of the CHOP activator ATF4. In mice subjected to systemic ER stress, pretreatment with low dose lipopolysaccharide (LPS), a TLR4 ligand, suppressed CHOP expression and apoptosis in splenic macrophages, renal tubule cells and hepatocytes, and prevented renal dysfunction and hepatosteatosis. This protective effect of LPS did not occur in Trif(-/-) mice or in wildtype mice in which CHOP expression was genetically restored. Thus, TRIF-mediated signals from TLRs selectively attenuate translational activation of ATF4 and its downstream target gene CHOP. We speculate that this mechanism evolved to promote survival of TLR-expressing cells that experience prolonged levels of physiological ER stress in the course of the host response to invading pathogens.	[Woo, Connie W.; Cui, Dongying; Arellano, Jerry; Dorweiler, Bernhard; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Woo, Connie W.; Cui, Dongying; Arellano, Jerry; Dorweiler, Bernhard; Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Woo, Connie W.; Cui, Dongying; Arellano, Jerry; Dorweiler, Bernhard; Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Harding, Heather; Ron, David] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Dept Cardiothorac & Vasc Surg, Mainz, Germany	Columbia University; Columbia University; Columbia University; New York University; University of Massachusetts System; University of Massachusetts Worcester; Johannes Gutenberg University of Mainz	Tabas, I (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	iat1@columbia.edu	Fitzgerald, Katherine/ABE-6317-2020; Woo, Connie/AAX-2588-2020	Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636; Fitzgerald, Kate/0000-0003-3175-609X; Woo, Connie Wai Hong/0000-0002-9574-9828	German Research Foundation; NIH [HL75662, HL57560, DK47119, ES08681]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, R01HL057560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047119, R29DK047119, R01DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a German Research Foundation Grant ( B. D.), NIH grants HL75662, HL57560 ( I. T.), DK47119 and ES08681( D. R.). We thank Alice Prince and Vincent Racaniello ( Columbia University) for helpful discussions related to the high-dose LPS mouse experiments and biological effects of TRIF signalling, respectively.	Boelens J, 2007, IN VIVO, V21, P215; DUKSIN D, 1982, EUR J BIOCHEM, V129, P77, DOI 10.1111/j.1432-1033.1982.tb07022.x; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Feng HP, 2001, BLOOD, V97, P3505, DOI 10.1182/blood.V97.11.3505; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hiramatsu N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl515; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kitamura M, 2008, CLIN EXP NEPHROL, V12, P317, DOI 10.1007/s10157-008-0060-7; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma T, 2008, EUR SURG RES, V41, P219, DOI 10.1159/000135631; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Skalet AH, 2005, J BIOL CHEM, V280, P39762, DOI 10.1074/jbc.M502640200; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Yamaguchi Y, 2008, J BIOL CHEM, V283, P17020, DOI 10.1074/jbc.M802466200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	41	220	232	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1473	U203		10.1038/ncb1996	http://dx.doi.org/10.1038/ncb1996			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19855386	Green Accepted			2022-12-25	WOS:000272251300015
J	Jacobs, KB; Yeager, M; Wacholder, S; Craig, D; Kraft, P; Hunter, DJ; Paschal, J; Manolio, TA; Tucker, M; Hoover, RN; Thomas, GD; Chanock, SJ; Chatterjee, N				Jacobs, Kevin B.; Yeager, Meredith; Wacholder, Sholom; Craig, David; Kraft, Peter; Hunter, David J.; Paschal, Justin; Manolio, Teri A.; Tucker, Margaret; Hoover, Robert N.; Thomas, Gilles D.; Chanock, Stephen J.; Chatterjee, Nilanjan			A new statistic and its power to infer membership in a genome-wide association study using genotype frequencies	NATURE GENETICS			English	Article								Aggregate results from genome-wide association studies (GWAS)(1-3), such as genotype frequencies for cases and controls, were until recently often made available on public websites(4,5) because they were thought to disclose negligible information concerning an individual's participation in a study. Homer et al.(6) recently suggested that a method for forensic detection of an individual's contribution to an admixed DNA sample could be applied to aggregate GWAS data. Using a likelihood-based statistical framework, we developed an improved statistic that uses genotype frequencies and individual genotypes to infer whether a specific individual or any close relatives participated in the GWAS and, if so, what the participant's phenotype status is. Our statistic compares the logarithm of genotype frequencies, in contrast to that of Homer et al.(6), which is based on differences in either SNP probe intensity or allele frequencies. We derive the theoretical power of our test statistics and explore the empirical performance in scenarios with varying numbers of randomly chosen or top-associated SNPs.	[Jacobs, Kevin B.; Yeager, Meredith] NCI, Core Genotyping Facil, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Jacobs, Kevin B.; Yeager, Meredith; Wacholder, Sholom; Tucker, Margaret; Hoover, Robert N.; Thomas, Gilles D.; Chanock, Stephen J.; Chatterjee, Nilanjan] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Jacobs, Kevin B.] BioInformed LLC, Gaithersburg, MD USA; [Craig, David] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Paschal, Justin] NHGRI, Natl Ctr Biotechnol Informat, Natl Lib Med, NIH, Bethesda, MD 20892 USA; [Manolio, Teri A.] NHGRI, Off Populat Genom, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Translational Genomics Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Jacobs, KB (corresponding author), NCI, Core Genotyping Facil, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA.	jacobske@mail.nih.gov	Craig, David Wesley/K-6961-2019; Tucker, Margaret A/B-4297-2015; Yeager, Meredith/AAA-5322-2020	Craig, David Wesley/0000-0003-2040-1955; Jacobs, Kevin/0000-0002-4657-6473	Intramural NIH HHS [ZIA CP010187-05, ZIC CP010178-08] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	6	57	60	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2009	41	11					1253	U126		10.1038/ng.455	http://dx.doi.org/10.1038/ng.455			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19801980	Green Accepted			2022-12-25	WOS:000271247600021
J	Jones, CA; Nishiya, N; London, NR; Zhu, WQ; Sorensen, LK; Chan, AC; Lim, CJ; Chen, HY; Zhang, QS; Schultz, PG; Hayallah, AM; Thomas, KR; Famulok, M; Zhang, K; Ginsberg, MH; Li, DY				Jones, Christopher A.; Nishiya, Naoyuki; London, Nyall R.; Zhu, Weiquan; Sorensen, Lise K.; Chan, Aubrey C.; Lim, Chinten J.; Chen, Haoyu; Zhang, Qisheng; Schultz, Peter G.; Hayallah, Alaa M.; Thomas, Kirk R.; Famulok, Michael; Zhang, Kang; Ginsberg, Mark H.; Li, Dean Y.			Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity	NATURE CELL BIOLOGY			English	Article							REPULSIVE AXON GUIDANCE; RHO-GTPASES; ROUNDABOUT; SLIT; RECEPTORS; PAXILLIN; MIDLINE; ANGIOGENESIS; DROSOPHILA; EXPRESSION	Slit-Roundabout (Robo) signalling has a well-understood role in axon guidance(1-5). Unlike in the nervous system, however, Slit-dependent activation of an endothelial-specific Robo, Robo4, does not initiate a guidance program. Instead, Robo4 maintains the barrier function of the mature vascular network by inhibiting neovascular tuft formation and endothelial hyperpermeability induced by pro-angiogenic factors(6). In this study, we used cell biological and biochemical techniques to elucidate the molecular mechanism underlying the maintenance of vascular stability by Robo4. Here, we demonstrate that Robo4 mediates Slit2-dependent suppression of cellular protrusive activity through direct interaction with the intracellular adaptor protein paxillin and its paralogue, Hic-5. Formation of a Robo4-paxillin complex at the cell surface blocks activation of the small GTPase Arf6 and, consequently, Rac by recruitment of Arf-GAPs (ADP-ribosylation factor-directed GTPase-activating proteins) such as GIT1. Consistent with these in vitro studies, inhibition of Arf6 activity in vivo phenocopies Robo4 activation by reducing pathologic angiogenesis in choroidal and retinal vascular disease and VEGF-165 (vascular endothelial growth factor-165)-induced retinal hyperpermeability. These data reveal that a Slit2-Robo4-paxillin-GIT1 network inhibits the cellular protrusive activity underlying neovascularization and vascular leak, and identify a new therapeutic target for ameliorating diseases involving the vascular system.	[Jones, Christopher A.; London, Nyall R.; Zhu, Weiquan; Chan, Aubrey C.; Li, Dean Y.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, Christopher A.; London, Nyall R.; Zhu, Weiquan; Sorensen, Lise K.; Chan, Aubrey C.; Thomas, Kirk R.; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA; [Nishiya, Naoyuki; Lim, Chinten J.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chen, Haoyu; Zhang, Kang] Univ Utah, Dept Ophthalmol, Salt Lake City, UT 84112 USA; [Zhang, Qisheng] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA; [Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Schultz, Peter G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hayallah, Alaa M.; Famulok, Michael] Univ Bonn, LIMES Program, Unit Chem Biol & Med Chem, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; [Thomas, Kirk R.] Univ Utah, Div Haematol, Dept Med, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Univ Utah, Dept Med, Div Cardiol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute; Scripps Research Institute; University of Bonn; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Li, DY (corresponding author), Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	mhginsberg@ucsd.edu; dean.li@hmbg.utah.edu	Chen, Haoyu/A-7432-2013; Chu, Kai On/E-2325-2016; Lim, Chinten James/G-3777-2013; Zhang, Kang/Y-2740-2019	Chen, Haoyu/0000-0003-0676-4610; Lim, Chinten James/0000-0001-6381-7585; Zhang, Kang/0000-0002-4549-1697; Chan, Aubrey/0000-0002-9191-2173; Sorensen, Lise K./0000-0003-3250-4564; Zhang, Qisheng/0000-0001-9808-5038; Nishiya, Naoyuki/0000-0003-1575-9944	H. A. and Edna Benning Foundation, the Juvenile Diabetes Research Foundation, the American Heart Association, the Burroughs Wellcome Fund and the Department of Defense; National Heart Lung and Blood Institute; National Eye Institute; Deutsche Forschungsgemeinschaft [SFB 704]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Disease [AI065357]; US National Institutes of Health, Ruth L. Kirschstein National Research Service Award [T32-GM007464]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077671, R01HL068873, R01HL084516, R01HL065648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	H. A. and Edna Benning Foundation, the Juvenile Diabetes Research Foundation, the American Heart Association, the Burroughs Wellcome Fund and the Department of Defense(American Heart AssociationJuvenile Diabetes Research Foundation); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health, Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wythe for critical reading of the manuscript, and D. Lim for expert graphical assistance. J. Bonafacino provided the GST-GGA3 expression plasmid. This work was funded by grants from the H. A. and Edna Benning Foundation, the Juvenile Diabetes Research Foundation, the American Heart Association, the Burroughs Wellcome Fund and the Department of Defense (D.Y.L.); the National Heart Lung and Blood Institute (D.Y.L. and M. H. G.); the National Eye Institute (K.Z.); the Deutsche Forschungsgemeinschaft SFB 704 (M. F.); the National Institute of Arthritis and Musculoskeletal and Skin Diseases (M. H. G.); the National Institute of Allergy and Disease AI065357 (D.Y.L.) and by the US National Institutes of Health, Ruth L. Kirschstein National Research Service Award (N.R.L.) and training grant T32-GM007464 (A. C. C.).	Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; JONES CA, 2008, NATURE MED; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 2000, J CELL SCI, V113, P4139; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104	23	160	175	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1325	U146		10.1038/ncb1976	http://dx.doi.org/10.1038/ncb1976			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19855388	Green Accepted, Green Published			2022-12-25	WOS:000271425800012
J	Huys, I; Berthels, N; Matthijs, G; Van Overwalle, G				Huys, Isabelle; Berthels, Nele; Matthijs, Gert; Van Overwalle, Geertrui			Legal uncertainty in the area of genetic diagnostic testing	NATURE BIOTECHNOLOGY			English	Editorial Material							PATENTS	A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope.	[Huys, Isabelle; Berthels, Nele; Van Overwalle, Geertrui] Catholic Univ Louvain, Ctr Intellectual Property Rights, Fac Law, B-3000 Louvain, Belgium; [Matthijs, Gert] Catholic Univ Louvain, Ctr Human Genet, Fac Med, B-3000 Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Huys, I (corresponding author), Catholic Univ Louvain, Ctr Intellectual Property Rights, Fac Law, B-3000 Louvain, Belgium.	gert.matthijs@uz.kuleuven.be	Huys, Isabelle/M-8673-2016	Matthijs, Gert/0000-0001-6710-1912				Ayme S, 2008, EUR J HUM GENET, V16, P405, DOI 10.1038/sj.ejhg.5201929; Barton JH, 2006, NAT BIOTECHNOL, V24, P939, DOI 10.1038/nbt0806-939; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1091, DOI 10.1038/nbt0906-1091; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Gaisser S, 2009, NATURE, V458, P407, DOI 10.1038/458407a; GOLD R, 2008, NEW ERA INTELLECTUAL; Gold R., 2008, MYRIAD GENETICS EYE; Holman CM, 2008, SCIENCE, V322, P198, DOI 10.1126/science.1160687; HOLMAN CM, 2007, UMKC L REV, V76, P295; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Matthijs G, 2006, FAM CANCER, V5, P95, DOI 10.1007/s10689-005-2580-6; *MYR GEN INC, 1998, 298CV829 MYR GEN INC; *OECD, 2006, OECD GUID LIC GEN IN; Simmons WJ, 2009, NAT BIOTECHNOL, V27, P245, DOI 10.1038/nbt0309-245; Stott M, 2003, NAT BIOTECHNOL, V21, P729, DOI 10.1038/nbt0703-729; Van Overwalle G, 2006, NAT REV GENET, V7, P143, DOI 10.1038/nrg1765; Van Overwalle G., 2007, GENE PATENTS PUBLIC; VANZIMMEREN E, 2009, PATENT LICENSING MED; Verbeure B, 2006, EUR J HUM GENET, V14, P26, DOI 10.1038/sj.ejhg.5201503; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; US UTILITY PATENT EX; 1998, OFFICIAL J EPO L, V213; 2008, EPO NEWS        1119; 2005, OFFICIAL J EPO, V334; 2008, MANAGING IP, V17	26	48	48	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2009	27	10					903	909		10.1038/nbt1009-903	http://dx.doi.org/10.1038/nbt1009-903			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	515LO	19816443				2022-12-25	WOS:000271472500016
J	Lambert, JC; Heath, S; Even, G; Campion, D; Sleegers, K; Hiltunen, M; Combarros, O; Zelenika, D; Bullido, MJ; Tavernier, B; Letenneur, L; Bettens, K; Berr, C; Pasquier, F; Fievet, N; Barberger-Gateau, P; Engelborghs, S; De Deyn, P; Mateo, I; Franck, A; Helisalmi, S; Porcellini, E; Hanon, O; de Pancorbo, MM; Lendon, C; Dufouil, C; Jaillard, C; Leveillard, T; Alvarez, V; Bosco, P; Mancuso, M; Panza, F; Nacmias, B; Bossu, P; Piccardi, P; Annoni, G; Seripa, D; Galimberti, D; Hannequin, D; Licastro, F; Soininen, H; Ritchie, K; Blanche, H; Dartigues, JF; Tzourio, C; Gut, I; Van Broeckhoven, C; Alperovitch, A; Lathrop, M; Amouyel, P				Lambert, Jean-Charles; Heath, Simon; Even, Gael; Campion, Dominique; Sleegers, Kristel; Hiltunen, Mikko; Combarros, Onofre; Zelenika, Diana; Bullido, Maria J.; Tavernier, Beatrice; Letenneur, Luc; Bettens, Karolien; Berr, Claudine; Pasquier, Florence; Fievet, Nathalie; Barberger-Gateau, Pascale; Engelborghs, Sebastiaan; De Deyn, Peter; Mateo, Ignacio; Franck, Ana; Helisalmi, Seppo; Porcellini, Elisa; Hanon, Olivier; de Pancorbo, Marian M.; Lendon, Corinne; Dufouil, Carole; Jaillard, Celine; Leveillard, Thierry; Alvarez, Victoria; Bosco, Paolo; Mancuso, Michelangelo; Panza, Francesco; Nacmias, Benedetta; Bossu, Paola; Piccardi, Paola; Annoni, Giorgio; Seripa, Davide; Galimberti, Daniela; Hannequin, Didier; Licastro, Federico; Soininen, Hilkka; Ritchie, Karen; Blanche, Helene; Dartigues, Jean-Francois; Tzourio, Christophe; Gut, Ivo; Van Broeckhoven, Christine; Alperovitch, Annick; Lathrop, Mark; Amouyel, Philippe		European Alzheimers Dis Initiative	Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease	NATURE GENETICS			English	Article							AMYLOID-BETA-PEPTIDE; APOLIPOPROTEIN-J; GENETIC-HETEROGENEITY; PLAQUE-FORMATION; MOUSE MODEL; A-BETA; COMPLEMENT; CLUSTERIN; EXPRESSION; RISK	The gene encoding apolipoprotein E (APOE) on chromosome 19 is the only confirmed susceptibility locus for late-onset Alzheimer's disease. To identify other risk loci, we conducted a large genome-wide association study of 2,032 individuals from France with Alzheimer's disease (cases) and 5,328 controls. Markers outside APOE with suggestive evidence of association (P < 10(-5)) were examined in collections from Belgium, Finland, Italy and Spain totaling 3,978 Alzheimer's disease cases and 3,297 controls. Two loci gave replicated evidence of association: one within CLU (also called APOJ), encoding clusterin or apolipoprotein J, on chromosome 8 (rs11136000, OR = 0.86, 95% CI 0.81-0.90, P = 7.5 x 10(-9) for combined data) and the other within CR1, encoding the complement component (3b/4b) receptor 1, on chromosome 1 (rs6656401, OR = 1.21, 95% CI 1.14-1.29, P = 3.7 x 10(-9) for combined data). Previous biological studies support roles of CLU and CR1 in the clearance of. amyloid (A.) peptide, the principal constituent of amyloid plaques, which are one of the major brain lesions of individuals with Alzheimer's disease.	[Lambert, Jean-Charles; Even, Gael; Fievet, Nathalie; Amouyel, Philippe] INSERM, U744, F-59045 Lille, France; [Lambert, Jean-Charles; Even, Gael; Fievet, Nathalie; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Lambert, Jean-Charles; Pasquier, Florence; Amouyel, Philippe] Univ Lille Nord France, Lille, France; [Heath, Simon; Zelenika, Diana; Gut, Ivo; Lathrop, Mark] Commissariat Energie Atom, Ctr Natl Genotypage, Inst Genom, Evry, France; [Campion, Dominique; Hannequin, Didier] Fac Med & Pharm Rouen, U614, INSERM, Rouen, France; [Sleegers, Kristel; Bettens, Karolien; Van Broeckhoven, Christine] VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium; [Sleegers, Kristel; Bettens, Karolien; Engelborghs, Sebastiaan; De Deyn, Peter; Van Broeckhoven, Christine] Inst Born Bunge, Antwerp, Belgium; [Hiltunen, Mikko; Helisalmi, Seppo; Soininen, Hilkka] Univ Kuopio, Dept Neurol, FIN-70211 Kuopio, Finland; [Combarros, Onofre; Mateo, Ignacio] Univ Cantabria, Neurol Serv, Marques de Valdecilla Univ Hosp, E-39005 Santander, Spain; [Combarros, Onofre; Mateo, Ignacio] Univ Cantabria, CIBERNED, Marques de Valdecilla Univ Hosp, E-39005 Santander, Spain; [Bullido, Maria J.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain; [Bullido, Maria J.] Univ Autonoma Madrid, CIBERNED, Madrid, Spain; [Tavernier, Beatrice] Ctr Hosp Univ Dijon, Dept Geriatrie, Dijon, France; [Letenneur, Luc; Barberger-Gateau, Pascale; Dartigues, Jean-Francois] Victor Segalen Univ, INSERM, U897, Bordeaux, France; [Berr, Claudine; Ritchie, Karen] Hop La Colombiere, INSERM, U888, Montpellier, France; [Pasquier, Florence; Amouyel, Philippe] Ctr Hosp Reg Univ Lille, Lille, France; [Pasquier, Florence; Amouyel, Philippe] Ctr Hosp Reg Univ Lille, Lille, France; [Engelborghs, Sebastiaan; De Deyn, Peter] Ziekenhuisnetwerk Antwerpen Middelheim, Memory Clin, Antwerp, Belgium; [Engelborghs, Sebastiaan; De Deyn, Peter] Ziekenhuisnetwerk Antwerpen Middelheim, Dept Neurol, Antwerp, Belgium; [Franck, Ana] Univ Autonoma Madrid, Serv Neurol, Hosp Univ La Paz, Madrid, Spain; [Porcellini, Elisa; Licastro, Federico] Univ Bologna, Sch Med, Dept Expt Pathol, I-40126 Bologna, Italy; [Hanon, Olivier] Univ Paris 05, INSERM, U894, Fac Med, Paris, France; [de Pancorbo, Marian M.] Univ Basque Country, EHU, Banco ADN, Fac Farm, Vitoria, Spain; [Lendon, Corinne] Royal Brisbane Hosp, Mol Psychiat Lab, Queensland Inst Med Res, Brisbane, Qld, Australia; [Dufouil, Carole; Tzourio, Christophe; Alperovitch, Annick] INSERM, U708, Paris, France; [Jaillard, Celine; Leveillard, Thierry] Univ Paris 06, INSERM, Dept Genet, Inst Vis, Paris, France; [Alvarez, Victoria] Hosp Univ Cent Asturias, Mol Genet Unit, Oviedo, Spain; [Bosco, Paolo] Inst Res Mental Retardat & Brain Aging, IRCCS, Assoc Oasi Maria Santissima, Troina, Italy; [Mancuso, Michelangelo] Univ Pisa, Dept Neurosci, Neurol Clin, I-56100 Pisa, Italy; [Panza, Francesco] Univ Bari, Dept Geriatr, Ctr Aging Brain, Memory Unit, Bari, Italy; [Nacmias, Benedetta] Dept Neurol & Psychiat Sci, Florence, Italy; [Bossu, Paola] IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, Rome, Italy; [Piccardi, Paola] Univ Cagliari, Clin Pharmacol Sect, Dept Neurosci, Mol Genet Lab, I-09124 Cagliari, Italy; [Annoni, Giorgio] Univ Milano Bicocca, Dept Clin Med & Prevent, Monza, Italy; [Seripa, Davide] IRCCS Casa Sollievo Sofferenza, Geriatr Unit, Dept Med Sci, San Giovanni Rotondo, Italy; [Seripa, Davide] IRCCS Casa Sollievo Sofferenza, Gerontol Geriatr Res Lab, Dept Med Sci, San Giovanni Rotondo, Italy; [Galimberti, Daniela] Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, IRCCS Osped Maggiore Policlin, Milan, Italy; [Blanche, Helene; Lathrop, Mark] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Flanders Institute for Biotechnology (VIB); University of Eastern Finland; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBERNED; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; CIBERNED; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Autonomous University of Madrid; Hospital Universitario La Paz; University of Bologna; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Basque Country; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Central University Hospital Asturias; IRCCS Oasi Maria SS; University of Pisa; Universita degli Studi di Bari Aldo Moro; IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Cagliari; University of Milano-Bicocca; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Foundation Jean Dausset-CEPH	Amouyel, P (corresponding author), INSERM, U744, F-59045 Lille, France.	philippe.amouyel@pasteur-lille.fr	DARTIGUES, Jean François/T-4513-2019; Ritchie, Karen/G-3571-2013; LICEND, CEMND/F-1296-2015; Dufouil, Carole/F-5751-2014; Bossù, Paola/E-4832-2014; Tzourio, christophe/B-4015-2009; lambert, jean-charles/F-8787-2013; Sahel, Jose-Alain/F-3172-2017; Gut, Ivo/ABF-3188-2020; alvarez, victoria/GXV-1088-2022; Tzourio, christophe/L-6344-2019; Porcellini, Elisa/K-5346-2016; Van Broeckhoven, Christine/M-7853-2019; Alvarez, Maria/GZH-1345-2022; Deramecourt, Vincent/G-5504-2018; berr, Claudine/D-5238-2014; Panza, Francesco/M-6804-2017; Van Broeckhoven, Christine/G-8362-2017; Pasquier, Florence/F-1527-2017; García, Ana Frank/I-5159-2015; Galimberti, Daniela/N-7209-2019; alvarez, victoria/ABC-7891-2021; Seripa, Davide/AAK-1342-2021; Epelbaum, Jacques/B-2263-2013; LETENNEUR, Luc/T-4424-2019; Léveillard, Thierry/AAR-1804-2020; Hanon, Olivier/GWR-0220-2022; Dufouil, Carole/J-4968-2012; Heath, Simon C/J-4138-2012; Panza, Francesco/Y-2539-2019; Mancuso, Michelangelo/K-4170-2016; Bullido, maria j/C-8509-2014; Nacmias, Benedetta/J-5084-2018; Lambert, jean-charles/A-9553-2014; Scarpini, Elio/K-6547-2016; Seripa, Davide/B-9408-2017; Ferri, Raffaele/B-5439-2013	Ritchie, Karen/0000-0002-0688-8982; Dufouil, Carole/0000-0003-2442-4476; Bossù, Paola/0000-0002-1432-0078; Tzourio, christophe/0000-0002-6517-2984; lambert, jean-charles/0000-0003-0829-7817; Sahel, Jose-Alain/0000-0002-4831-1153; Gut, Ivo/0000-0001-7219-632X; alvarez, victoria/0000-0002-1916-2523; Tzourio, christophe/0000-0002-6517-2984; Porcellini, Elisa/0000-0003-3991-5294; Van Broeckhoven, Christine/0000-0003-0183-7665; Deramecourt, Vincent/0000-0001-9742-7833; berr, Claudine/0000-0001-5254-7655; Panza, Francesco/0000-0002-7220-0656; Van Broeckhoven, Christine/0000-0003-0183-7665; Pasquier, Florence/0000-0001-9880-9788; García, Ana Frank/0000-0003-3858-9116; Galimberti, Daniela/0000-0002-9284-5953; alvarez, victoria/0000-0002-1916-2523; LETENNEUR, Luc/0000-0002-3274-937X; Léveillard, Thierry/0000-0001-5692-8770; Heath, Simon C/0000-0002-9550-0897; Panza, Francesco/0000-0002-7220-0656; Mancuso, Michelangelo/0000-0003-2738-8562; Bullido, maria j/0000-0002-6477-1117; Nacmias, Benedetta/0000-0001-9338-9040; Lambert, jean-charles/0000-0003-0829-7817; MARTINEZ DE PANCORBO, MARIA DE LOS ANGELES/0000-0002-7408-6068; Scarpini, Elio/0000-0002-6395-2119; Brice, Alexis/0000-0002-0941-3990; M. de Pancorbo, Marian/0000-0002-8081-0702; Arosio, Beatrice/0000-0002-0615-3580; Amouyel, Philippe/0000-0001-9088-234X; Hanon, Olivier/0000-0002-4697-122X; sorbi, sandro/0000-0002-0380-6670; Seripa, Davide/0000-0001-7331-0470; Bishop, Tim/0000-0002-8752-8785; Ferri, Raffaele/0000-0001-6937-3065	National Foundation for Alzheimer's Disease and Related Disorders; Institut Pasteur de Lille; Centre National de Genotypage; Fondation pour la Recherche Medicale; Caisse Nationale d'Assurance Maladie des Travailleurs Salaries; Direction Generale de la Sante; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Aquitaine and Bourgogne Regional Councils; Fondation de France; French Ministry of Research/Inserm; Eisai; VIB Genetic Service Facility; Biobank of the Institute Born-Bunge; Research Fund of the University of Antwerp; Fund for Scientific Research-Flanders (FWO-V); Foundation for Alzheimer Research (SAO-FRMA); Belgian Federal Science Policy Office, Belgium; Health Research Council of the Academy of Finland; EVO [5772708]; Nordic Centre of Excellence in Neurodegeneration; Italian Ministry of research and University; Carimonte Foundation; Italian ministry of Health [RFPS-2006-7334858]; 'fondazione Monzino'; Ministerio de Educacion y Ciencia; Ministerio de Sanidad y Consumo; Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa	National Foundation for Alzheimer's Disease and Related Disorders; Institut Pasteur de Lille; Centre National de Genotypage; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Aquitaine and Bourgogne Regional Councils(Region Bourgogne-Franche-Comte); Fondation de France(Fondation de France); French Ministry of Research/Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)Ministry of Research, France); Eisai(Eisai Co Ltd); VIB Genetic Service Facility; Biobank of the Institute Born-Bunge; Research Fund of the University of Antwerp; Fund for Scientific Research-Flanders (FWO-V)(FWO); Foundation for Alzheimer Research (SAO-FRMA); Belgian Federal Science Policy Office, Belgium(Belgian Federal Science Policy Office); Health Research Council of the Academy of Finland(Academy of Finland); EVO; Nordic Centre of Excellence in Neurodegeneration; Italian Ministry of research and University(Ministry of Education, Universities and Research (MIUR)); Carimonte Foundation; Italian ministry of Health(Ministry of Health, Italy); 'fondazione Monzino'; Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa	The work was made possible by the generous participation of the control subjects, the subjects with Alzheimer's disease, and their families. We thank A. Boland (Centre National de Genotypage) for her technical help in preparing the DNA samples for analyses. This work was supported by the National Foundation for Alzheimer's Disease and Related Disorders, the Institut Pasteur de Lille and the Centre National de Genotypage.; The Three-City Study was performed as part of a collaboration between the Institut National de la Sante et de la Recherche Medicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale d'Assurance Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale, Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/Inserm 'Cohortes et collections de donnees biologiques' programme. Lille Genopole received an unconditional grant from Eisai.; Belgium sample collection: the Antwerp site (CVB) was in part supported by the VIB Genetic Service Facility (http://www.vibgeneticservicefacility.be/) and the Biobank of the Institute Born-Bunge; the Special Research Fund of the University of Antwerp; the Fund for Scientific Research-Flanders (FWO-V); the Foundation for Alzheimer Research (SAO-FRMA); and the Interuniversity Attraction Poles (IAP) program P6/43 of the Belgian Federal Science Policy Office, Belgium; K. S. is a postdoctoral fellow and K. B. a PhD fellow of the FWO-V. Finnish sample collection: Financial support for this project was provided by the Health Research Council of the Academy of Finland, EVO grant 5772708 of Kuopio University Hospital, and the Nordic Centre of Excellence in Neurodegeneration. I; talian sample collection: the Bologna site (FL) obtained funds from the Italian Ministry of research and University as well as Carimonte Foundation. The Florence site was supported by a grant from the Italian ministry of Health (RFPS-2006-7334858). The Milan site was supported by a grant from the 'fondazione Monzino'. We appreciate the expert contribution of C. Romano.; Spanish sample collection: the Madrid site (MB) was supported by grants of the Ministerio de Educacion y Ciencia and the Ministerio de Sanidad y Consumo (Instituto de Salud Carlos III) and an institutional grant of the Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa. We thank I. Sastre and A. Martnez-Garc a for the preparation and control of the DNA collection and P. Gil and P. Coria for their cooperation in the recruitment of cases and controls. We are grateful to the Asociacion de Familiares de Alzheimer de Madrid (AFAL) for continuous encouragement and help.	Ashford JW, 2002, J ALZHEIMERS DIS, V4, P169, DOI 10.3233/JAD-2002-4307; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; BRESLOW NE, 1978, AM J EPIDEMIOL, V108, P299, DOI 10.1093/oxfordjournals.aje.a112623; Butler AW, 2009, NEUROBIOL AGING, V30, P1037, DOI 10.1016/j.neurobiolaging.2009.03.013; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Holtzman DM, 2004, J MOL NEUROSCI, V23, P247, DOI 10.1385/JMN:23:3:247; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; IIDA K, 1982, J EXP MED, V155, P1427, DOI 10.1084/jem.155.5.1427; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Kuo YM, 2000, BIOCHEM BIOPH RES CO, V268, P750, DOI 10.1006/bbrc.2000.2222; Lambert JC, 2007, PSYCHONEUROENDOCRINO, V32, pS62, DOI 10.1016/j.psyneuen.2007.05.015; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; MAY PC, 1992, TRENDS NEUROSCI, V15, P391, DOI 10.1016/0166-2236(92)90190-J; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Rogers J, 2006, NEUROBIOL AGING, V27, P1733, DOI 10.1016/j.neurobiolaging.2005.09.043; ROHEIM PS, 1979, P NATL ACAD SCI USA, V76, P4646, DOI 10.1073/pnas.76.9.4646; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Song WC, 2000, IMMUNOPHARMACOLOGY, V49, P187, DOI 10.1016/S0162-3109(00)80303-3; Tregouet DA, 2004, EUR J HUM GENET, V12, P971, DOI 10.1038/sj.ejhg.5201238; Webster S, 1997, J NEUROCHEM, V69, P388; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Zhou J, 2008, J NEUROCHEM, V106, P2080, DOI 10.1111/j.1471-4159.2008.05558.x; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	41	1795	1836	4	195	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1094	U68		10.1038/ng.439	http://dx.doi.org/10.1038/ng.439			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19734903	Green Published			2022-12-25	WOS:000270330400012
J	Pegoraro, G; Kubben, N; Wickert, U; Gohler, H; Hoffmann, K; Misteli, T				Pegoraro, Gianluca; Kubben, Nard; Wickert, Ute; Goehler, Heike; Hoffmann, Katrin; Misteli, Tom			Ageing-related chromatin defects through loss of the NURD complex	NATURE CELL BIOLOGY			English	Article							PROTEIN-INTERACTION NETWORK; TRANSCRIPTION; ENHANCER; GENOME; BREAKS; CAF-1	Physiological and premature ageing are characterized by multiple defects in chromatin structure and accumulation of persistent DNA damage. Here we identify the NURD chromatin remodelling complex as a key modulator of these ageing-associated chromatin defects. We demonstrate loss of several NURD components during premature and normal ageing and we find an ageing-associated reduction in HDAC1 activity. Silencing of individual NURD subunits recapitulated chromatin defects associated with ageing and we provide evidence that structural chromatin defects precede DNA damage accumulation. These results outline a molecular mechanism for chromatin defects during ageing.	[Pegoraro, Gianluca; Kubben, Nard; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Kubben, Nard] Maastricht Univ, Dept Expt & Mol Cardiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Wickert, Ute] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Goehler, Heike] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Hoffmann, Katrin] Humboldt Univ, Inst Med Genet, Charite Berlin, D-13353 Berlin, Germany; [Hoffmann, Katrin] Max Planck Inst Mol Genet Dev & Dis, D-14195 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maastricht University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Pegoraro, Gianluca/K-4233-2016	Pegoraro, Gianluca/0000-0003-2843-9464	Telethon Italy Foundation; Italian Association for Cancer Research (AIRC); Deutsche Forschungsgemeinschaft (DFG) [A4, Z2]; NIH; NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Telethon Italy Foundation(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Scaffidi and A. Marcello for critical reading of the manuscript, and P. Scaffidi for sharing data and providing numerous suggestions during the course of the experiments. Fluorescence imaging was performed with the assistance of T. Karpova at the NCI Fluorescence Imaging Microscopy Facility. FACS cell cycle acquisition and analysis was performed with the help of K. McKinnon at the NCI FACS facility. We also thank T. Jenuwein, B. Stillman and T. Dittmer for providing reagents. We thank H. Herrmann and E. Wanker for their support with the Y2H screening and subsequent confirmation studies. G. P. was partly supported by postdoctoral fellowships from the Telethon Italy Foundation and the Italian Association for Cancer Research (AIRC). K. H. and H. G. were supported by The Deutsche Forschungsgemeinschaft (DFG, SFB 577, projects A4 and Z2). This work was supported by an Intramural Research Program of the NIH, NCI, Center for Cancer Research.	Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Valgardsdottir R, 2008, NUCLEIC ACIDS RES, V36, P423, DOI 10.1093/nar/gkm1056; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	26	198	205	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1261	U251		10.1038/ncb1971	http://dx.doi.org/10.1038/ncb1971			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19734887	Green Accepted			2022-12-25	WOS:000270382000017
J	Persson, H; Kvist, A; Vallon-Christersson, J; Medstrand, P; Borg, A; Rovira, C				Persson, Helena; Kvist, Anders; Vallon-Christersson, Johan; Medstrand, Patrik; Borg, Ake; Rovira, Carlos			The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs	NATURE CELL BIOLOGY			English	Article							RIBONUCLEOPROTEIN PARTICLE; EXPRESSION; PROTEIN; YEAST	Vault particles are conserved organelles implicated in multidrug resistance and intracellular transport. They contain three different proteins and non-coding vault RNAs (vRNAs). Here we show that human vRNAs produce several small RNAs (svRNAs) by mechanisms different from those in the canonical microRNA (miRNA) pathway. At least one of these svRNAs, svRNAb, associates with Argonaute proteins to guide sequence-specific cleavage and regulate gene expression similarly to miRNAs. We demonstrate that svRNAb downregulates CYP3A4, a key enzyme in drug metabolism. Our findings expand the repertoire of small regulatory RNAs and assign, for the first time, a function to vRNAs that may help explain the association between vault particles and drug resistance.	[Persson, Helena; Kvist, Anders; Vallon-Christersson, Johan; Borg, Ake; Rovira, Carlos] Lund Univ, Dept Oncol, BMC, S-22184 Lund, Sweden; [Persson, Helena; Kvist, Anders; Vallon-Christersson, Johan; Borg, Ake; Rovira, Carlos] Lund Univ, CREATE Hlth Strateg Ctr Clin Canc Res, BMC, S-22184 Lund, Sweden; [Medstrand, Patrik] Lund Univ, Dept Expt Med Sci, BMC, S-22184 Lund, Sweden; [Vallon-Christersson, Johan; Borg, Ake; Rovira, Carlos] Lund Univ, BMC, SCIBLU Genom, S-22184 Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Rovira, C (corresponding author), Lund Univ, Dept Oncol, BMC, S-22184 Lund, Sweden.	carlos.rovira@med.lu.se	Persson, Helena/ABE-5003-2020	Vallon-Christersson, Johan/0000-0002-2195-0385; Kvist, Anders/0000-0002-1358-0695; Persson, Helena/0000-0002-5187-6446	Royal Physiographic Society in Lund; Berta Kamprad Foundation; Lund Center for Stem Cell Biology and Cell Therapy; Swedish Cancer Society; Swedish Knowledge Foundation	Royal Physiographic Society in Lund; Berta Kamprad Foundation; Lund Center for Stem Cell Biology and Cell Therapy; Swedish Cancer Society(Swedish Cancer Society); Swedish Knowledge Foundation(General Electric)	This work was supported by grants from The Royal Physiographic Society in Lund, the Berta Kamprad Foundation, the Lund Center for Stem Cell Biology and Cell Therapy, and the Swedish Cancer Society. We thank M. Siomi and H. Siomi for the gift of the Ago antibodies, and A. Brun and C. Welinder for technical advice. HP was supported by the Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at the Strategy and Development Office at the Karolinska Institute.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Duncan DD, 2006, ANAL BIOCHEM, V359, P268, DOI 10.1016/j.ab.2006.08.022; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; Izquierdo MA, 1996, AM J PATHOL, V148, P877; KEDERSHA NL, 1990, J CELL BIOL, V110, P895, DOI 10.1083/jcb.110.4.895; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; Kickhoefer VA, 1998, J BIOL CHEM, V273, P8971, DOI 10.1074/jbc.273.15.8971; Kitazono M, 2001, INT J CANCER, V91, P126, DOI 10.1002/1097-0215(20010101)91:1<126::AID-IJC1018>3.0.CO;2-8; Kitazono M, 1999, JNCI-J NATL CANCER I, V91, P1647, DOI 10.1093/jnci/91.19.1647; Kong LB, 2000, RNA, V6, P890, DOI 10.1017/S1355838200000157; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Mossink MH, 2003, ONCOGENE, V22, P7458, DOI 10.1038/sj.onc.1206947; Saal LH, 2002, GENOME BIOL, V3; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siva AC, 2001, INT J CANCER, V92, P195, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1168>3.0.CO;2-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Zon A, 2001, J BIOL CHEM, V276, P37715, DOI 10.1074/jbc.M106055200; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Yang IV, 2002, GENOME BIOL, V3	28	121	127	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1268	U265		10.1038/ncb1972	http://dx.doi.org/10.1038/ncb1972			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19749744				2022-12-25	WOS:000270382000018
J	Eminli, S; Foudi, A; Stadtfeld, M; Maherali, N; Ahfeldt, T; Mostoslavsky, G; Hock, H; Hochedlinger, K				Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Ahfeldt, Tim; Mostoslavsky, Gustavo; Hock, Hanno; Hochedlinger, Konrad			Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells	NATURE GENETICS			English	Article							HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; PROGENITOR CELLS; NUCLEAR TRANSFER; MATURE B; GENERATION; INDUCTION; SYSTEM; OCT4; EXPRESSION	The reprogramming of somatic cells into induced pluripotent stem (iPS) cells upon overexpression of the transcription factors Oct4, Sox2, Klf4 and cMyc is inefficient. It has been assumed that the somatic differentiation state provides a barrier for efficient reprogramming; however, direct evidence for this notion is lacking. Here, we tested the potential of mouse hematopoietic cells at different stages of differentiation to be reprogrammed into iPS cells. We show that hematopoietic stem and progenitor cells give rise to iPS cells up to 300 times more efficiently than terminally differentiated B and T cells do, yielding reprogramming efficiencies of up to 28%. Our data provide evidence that the differentiation stage of the starting cell has a critical influence on the efficiency of reprogramming into iPS cells. Moreover, we identify hematopoietic progenitors as an attractive cell type for applications of iPS cell technology in research and therapy.	[Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Ahfeldt, Tim; Hock, Hanno; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Ahfeldt, Tim; Hock, Hanno; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA USA; [Eminli, Sarah; Stadtfeld, Matthias; Maherali, Nimet; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Hock, Hanno; Hochedlinger, Konrad] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Eminli, Sarah] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Maherali, Nimet] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol 2, Hamburg, Germany; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Gastroenterol Sect, Dept Med, Boston, MA 02118 USA; [Mostoslavsky, Gustavo] Boston Univ, Ctr Regenerat Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Free University of Berlin; Harvard University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Boston University; Boston University	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	hock.hanno@mgh.harvard.edu; khochedlinger@helix.mgh.harvard.edu	Ahfeldt, Tim/E-2935-2017; Foudi, Adlen/L-7251-2018	Foudi, Adlen/0000-0001-5002-5490; Ahfeldt, Tim/0000-0001-6377-7376; Stadtfeld, Matthias/0000-0002-5852-9906; Mostoslavsky, Gustavo/0000-0002-0784-2169	Ellison Foundation to Massachusetts General Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Ellison Foundation to Massachusetts General Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Xie for sharing the C/ EBPa overexpression vector, R. Mostoslavsky for critical reading of the manuscript, L. Prickett and K. Folz- Donahue for help with FACS and P. Follett for help with blastocyst injections. A. F. was the recipient of the Lady Tata Memorial Trust Award. A Postdoctoral Fellowship from Schering Foundation supported M. S. This work was supported by a contribution from the Ellison Foundation to Massachusetts General Hospital start- up funds for H. H., by an American Society of Hematology ( ASH) Scholar Award to H. H. and by the Harvard Stem Cell Institute. Support to K. H. came from the US National Institutes of Health ( NIH) Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation and the V Foundation.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2007, NAT GENET, V39, P136, DOI 10.1038/ng0207-136; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; RAMSDELL F, 2006, CURR PROTOC IMMUNOL, V71; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	51	314	333	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					968	U29		10.1038/ng.428	http://dx.doi.org/10.1038/ng.428			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19668214	Green Accepted			2022-12-25	WOS:000269382100007
J	Wetzel, S; Klein, K; Renner, S; Rauh, D; Oprea, TI; Mutzel, P; Waldmann, H				Wetzel, Stefan; Klein, Karsten; Renner, Steffen; Rauh, Daniel; Oprea, Tudor I.; Mutzel, Petra; Waldmann, Herbert			Interactive exploration of chemical space with Scaffold Hunter	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-PRODUCTS; CLASSIFICATION; DISCOVERY; LIBRARIES	We describe Scaffold Hunter, a highly interactive computer-based tool for navigation in chemical space that fosters intuitive recognition of complex structural relationships associated with bioactivity. The program reads compound structures and bioactivity data, generates compound scaffolds, correlates them in a hierarchical tree-like arrangement, and annotates them with bioactivity. Brachiation along tree branches from structurally complex to simple scaffolds allows identification of new ligand types. We provide proof of concept for pyruvate kinase.	[Wetzel, Stefan; Renner, Steffen; Waldmann, Herbert] Max Planck Inst Mol Physiol, D-44139 Dortmund, Germany; [Klein, Karsten; Mutzel, Petra] Tech Univ Dortmund, Dept Comp Sci, Chair Algorithm Engn, Dortmund, Germany; [Rauh, Daniel] Max Planck Soc, Chem Genom Ctr, Dortmund, Germany; [Oprea, Tudor I.] Univ New Mexico, Sch Med, Div Biocomput, Albuquerque, NM 87131 USA	Max Planck Society; Dortmund University of Technology; Max Planck Society; University of New Mexico	Waldmann, H (corresponding author), Max Planck Inst Mol Physiol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	herbert.waldmann@mpi-dortmund.mpg.de	Renner, Steffen/C-3400-2009; Oprea, Tudor I/A-5746-2011; Waldmann, Herbert/B-7406-2017; Rauh, Daniel/G-1595-2013	Renner, Steffen/0000-0002-0720-5629; Oprea, Tudor I/0000-0002-6195-6976; Waldmann, Herbert/0000-0002-9606-7247; Rauh, Daniel/0000-0002-1970-7642; Mutzel, Petra/0000-0001-7621-971X	Max Planck Society; State of North-Rhine Westphalia; European Union Fonds for Regional Development; German Federal Ministry for Education and Research; BMBF [01GS08102]; US National Institutes of Health [1U54MH084690]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); State of North-Rhine Westphalia; European Union Fonds for Regional Development; German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the members of the project group PG504-namely A. B. Ahmed, A. Arndt, P. Budenbender, V. Bembenek, A. Gorecki, N. Kriege, S. Rakov, M. Rex, G. Schrader, H. Wagner, A. Wiesniewski and C. Yucel - for their enthusiasm and commitment. This work was supported by the Max Planck Society, the State of North-Rhine Westphalia, the European Union Fonds for Regional Development, and the German Federal Ministry for Education and Research through the German National Genome Research Network- Plus (NGFN-Plus, grant number BMBF 01GS08102 to D. R. and H. W.). Part of this work was supported by US National Institutes of Health grant 1U54MH084690 (to T.I.O.). Software was generously supplied by Openeye (OEChem) and Accelrys/SciTegic (PipelinePilot). S. W. is grateful to Novartis for a PhD scholarship.	Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Koch MA, 2005, P NATL ACAD SCI USA, V102, P17272, DOI 10.1073/pnas.0503647102; Larsson J, 2005, J NAT PROD, V68, P985, DOI 10.1021/np049655u; Larsson J, 2007, J NAT PROD, V70, P789, DOI 10.1021/np070002y; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Noren-Muller A, 2006, P NATL ACAD SCI USA, V103, P10606, DOI 10.1073/pnas.0601490103; OLAH M, 2007, CHEM BIOL SMALL MOL, V2, P760; Oprea TI, 2001, J COMB CHEM, V3, P157, DOI 10.1021/cc0000388; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Roberts G, 2000, J CHEM INF COMP SCI, V40, P1302, DOI 10.1021/ci0000631; Schuffenhauer A, 2007, J CHEM INF MODEL, V47, P47, DOI 10.1021/ci600338x; Schulz W., 1996, CHEM ENG NEWS, V74, P43; Verheij HJ, 2006, MOL DIVERS, V10, P377, DOI 10.1007/s11030-006-9040-6	15	174	175	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					581	583		10.1038/nchembio.187	http://dx.doi.org/10.1038/nchembio.187			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19561620	Green Submitted			2022-12-25	WOS:000268209200016
J	Kirchner, H; Gutierrez, JA; Solenberg, PJ; Pfluger, PT; Czyzyk, TA; Willency, JA; Schurmann, A; Joost, HG; Jandacek, RJ; Hale, JE; Heiman, ML; Tschop, MH				Kirchner, Henriette; Gutierrez, Jesus A.; Solenberg, Patricia J.; Pfluger, Paul T.; Czyzyk, Traci A.; Willency, Jill A.; Schuermann, Annette; Joost, Hans-Georg; Jandacek, Ronald J.; Hale, John E.; Heiman, Mark L.; Tschoep, Matthias H.			GOAT links dietary lipids with the endocrine control of energy balance	NATURE MEDICINE			English	Article							CHAIN FATTY-ACIDS; FOOD-INTAKE; GHRELIN; HORMONE; IDENTIFICATION; METABOLISM; SECRETION; PEPTIDE	Central nervous system nutrient sensing and afferent endocrine signaling have been established as parallel systems communicating metabolic status and energy availability in vertebrates. The only afferent endocrine signal known to require modification with a fatty acid side chain is the orexigenic hormone ghrelin. We find that the ghrelin O-acyl transferase (GOAT), which is essential for ghrelin acylation, is regulated by nutrient availability, depends on specific dietary lipids as acylation substrates and links ingested lipids to energy expenditure and body fat mass. These data implicate the ghrelin-GOAT system as a signaling pathway that alerts the central nervous system to the presence of dietary calories, rather than to their absence as is commonly accepted.	[Kirchner, Henriette; Pfluger, Paul T.; Jandacek, Ronald J.; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45221 USA; [Kirchner, Henriette; Pfluger, Paul T.; Jandacek, Ronald J.; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Dept Med, Obes Res Ctr, Cincinnati, OH USA; [Kirchner, Henriette; Pfluger, Paul T.; Jandacek, Ronald J.; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Genome Res Inst, Cincinnati, OH USA; [Kirchner, Henriette; Schuermann, Annette; Joost, Hans-Georg; Tschoep, Matthias H.] German Inst Human Nutr, Dept Pharmacol, Potsdam, Germany; [Gutierrez, Jesus A.; Solenberg, Patricia J.; Czyzyk, Traci A.; Willency, Jill A.; Hale, John E.; Heiman, Mark L.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eli Lilly	Tschop, MH (corresponding author), Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45221 USA.	matthias.tschoep@uc.edu	Kirchner, Henriette/D-6699-2011; Pfluger, Paul T/A-3770-2019; Joost, Hans-Georg/J-4462-2013; Pfluger, Paul/B-4889-2010; Tschoep, Matthias H/I-5443-2014	Pfluger, Paul T/0000-0002-8118-7588; Joost, Hans-Georg/0000-0002-5860-606X; Tschoep, Matthias/0000-0002-4744-371X; Schurmann, Annette/0000-0002-4113-4377; Czyzyk, Traci/0000-0002-3888-8338	Leibniz Graduate College; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK069987]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077975, R01DK069987, P01DK056863] Funding Source: NIH RePORTER	Leibniz Graduate College; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank J.E. Baker, B. Berger and J. Holland for their outstanding technical support. This manuscript was supported by the Leibniz Graduate College ( H. K.) and by the US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK069987 ( to M. H. T.).	Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; DOLE VP, 1961, J LIPID RES, V2, P90; Drazen DL, 2006, ENDOCRINOLOGY, V147, P23, DOI 10.1210/en.2005-0973; Gauna C, 2007, AM J PHYSIOL-ENDOC M, V293, pE697, DOI 10.1152/ajpendo.00219.2007; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Liu JH, 2008, J CLIN ENDOCR METAB, V93, P1980, DOI 10.1210/jc.2007-2235; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Pfluger PT, 2008, AM J PHYSIOL-GASTR L, V294, pG610, DOI 10.1152/ajpgi.00321.2007; PRIOR IA, 1981, AM J CLIN NUTR, V34, P1552, DOI 10.1093/ajcn/34.8.1552; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; ZURIER RB, 1966, NEW ENGL J MED, V274, P490, DOI 10.1056/NEJM196603032740904	20	301	312	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					741	745		10.1038/nm.1997	http://dx.doi.org/10.1038/nm.1997			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19503064	Green Accepted			2022-12-25	WOS:000267806900025
J	Osborne, EA; Dudoit, S; Rine, J				Osborne, Erin A.; Dudoit, Sandrine; Rine, Jasper			The establishment of gene silencing at single-cell resolution	NATURE GENETICS			English	Article							DOMAIN-CONTAINING PROTEINS; MATING-TYPE LOCI; SACCHAROMYCES-CEREVISIAE; HISTONE H3; DNA-REPLICATION; TELOMERIC HETEROCHROMATIN; NUCLEOSOME CORE; ADP-RIBOSE; YEAST; METHYLATION	The establishment of silencing in Saccharomyces cerevisiae is similar to heterochromatin formation in multicellular eukaryotes. Previous batch culture studies determined that the de novo establishment of silencing initiates during S phase and continues for up to five cell divisions for completion. To track silencing phenotypically, we developed an assay that introduces Sir3 protein into individual sir3 Delta mutant cells synchronously and then detects the onset of silencing with single-cell resolution. Silencing was completed within the first one to two cell divisions in most cells queried. Moreover, we uncovered unexpected complexity in the contributions of a histone acetyltransferase (Sas2), two histone methytransferases (Dot1 and Set1) and one histone demethylase (Jhd2) to the dynamics of silencing. Our findings showed that removal of methyl modifications at H3K4 and H3K79 were important steps in silent chromatin formation and that Jhd2 and Set1 had competing roles in the process.	[Dudoit, Sandrine; Rine, Jasper] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Rine, Jasper] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Osborne, Erin A.] Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA; [Dudoit, Sandrine] Univ Calif Berkeley, Div Biostat, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rine, J (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	jrine@berkeley.edu		Osborne Nishimura, Erin/0000-0002-4313-4573	National Institute of Health [GM31105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031105, R37GM031105] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Li, C. Hale, O. Zill, M. Gartenberg and K. Struhl for helpful contributions and wonderful discussions. Also, thanks to O. Zill, J. Kuei, J. Babiarz and L. Lombardi for strains and reagents. Finally, thanks to J. O for her hard work and contributions. This work was supported by a National Science Foundation Pre-Doctoral Fellowship to E. A. Osborne and by grants from the National Institute of Health (GM31105 to J. R.).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Bantignies F, 2006, CURR OPIN CELL BIOL, V18, P275, DOI 10.1016/j.ceb.2006.04.003; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; FRIENDLY M, 1994, J AM STAT ASSOC, V89, P190, DOI DOI 10.2307/2291215; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ingvarsdottir K, 2007, MOL CELL BIOL, V27, P7856, DOI 10.1128/MCB.00801-07; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; KLAR AJS, 1979, GENETICS, V93, P37; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lynch PJ, 2009, MOL CELL BIOL, V29, P43, DOI 10.1128/MCB.00983-08; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; R Core Development Team, 2008, R LANG ENV STAT COMP; RINE J, 1979, GENETICS, V93, P877; RINE J, 1987, GENETICS, V116, P9; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Singer MS, 1998, GENETICS, V150, P613; STRATHERN JN, 1979, CELL, V17, P371, DOI 10.1016/0092-8674(79)90163-6; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; van Welsem T, 2008, MOL CELL BIOL, V28, P3861, DOI 10.1128/MCB.02050-07; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yang B, 2008, J MOL BIOL, V381, P826, DOI 10.1016/j.jmb.2008.06.059	61	54	54	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					800	U54		10.1038/ng.402	http://dx.doi.org/10.1038/ng.402			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19543267	Green Accepted, Green Submitted			2022-12-25	WOS:000267786200009
J	Ellis, T; Wang, X; Collins, JJ				Ellis, Tom; Wang, Xiao; Collins, James J.			Diversity-based, model-guided construction of synthetic gene networks with predicted functions	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; ESCHERICHIA-COLI; FEEDFORWARD LOOP; EXPRESSION; PROMOTER; CIRCUIT; YEAST; SWITCH; BACTERIOPHAGE	Engineering artificial gene networks from modular components is a major goal of synthetic biology. However, the construction of gene networks with predictable functions remains hampered by a lack of suitable components and the fact that assembled networks often require extensive, iterative retrofitting to work as intended. Here we present an approach that couples libraries of diversified components ( synthesized with randomized nonessential sequence) with in silico modeling to guide predictable gene network construction without the need for post hoc tweaking. We demonstrate our approach in Saccharomyces cerevisiae by synthesizing regulatory promoter libraries and using them to construct feed-forward loop networks with different predicted input-output characteristics. We then expand our method to produce a synthetic gene network acting as a predictable timer, modifiable by component choice. We use this network to control the timing of yeast sedimentation, illustrating how the plug-and-play nature of our design can be readily applied to biotechnology.	[Ellis, Tom; Wang, Xiao; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Ellis, Tom; Wang, Xiao; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [Ellis, Tom; Wang, Xiao; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu	Wang, Xiao/A-8414-2008; Ellis, Tom/A-3062-2010	Wang, Xiao/0000-0002-4056-0155; Ellis, Thomas/0000-0001-5392-976X	National Institutes of Health (NIH) through the NIH Director's Pioneer Award Program [DP1 OD003644]; National Science Foundation Frontiers in Integrative Biological Research program; Howard Hughes Medical Institute; Engineering and Physical Sciences Research Council [EP/G036004/1] Funding Source: researchfish; EPSRC [EP/G036004/1] Funding Source: UKRI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the NIH Director's Pioneer Award Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Frontiers in Integrative Biological Research program(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. R. Jensen for advice on promoter library synthesis methods, K. Verstrepen for guidance and materials relating to yeast flocculation and H. H. Lee for valuable ideas in genetic device construction. This work was supported by the National Institutes of Health (NIH) through the NIH Director's Pioneer Award Program, grant number DP1 OD003644, the National Science Foundation Frontiers in Integrative Biological Research program and the Howard Hughes Medical Institute.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Entus Robert, 2007, Syst Synth Biol, V1, P119, DOI 10.1007/s11693-007-9008-6; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Grilly C, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100168; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Jensen PR, 1998, BIOTECHNOL BIOENG, V58, P191, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<191::AID-BIT11>3.0.CO;2-G; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Marguet P, 2007, J R SOC INTERFACE, V4, P607, DOI 10.1098/rsif.2006.0206; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rosenfeld N, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100185; SCHIRMAIER F, 1984, EMBO J, V3, P3311, DOI 10.1002/j.1460-2075.1984.tb02295.x; Scrable H, 1997, GENETICS, V147, P297; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Withers ST, 2007, APPL MICROBIOL BIOT, V73, P980, DOI 10.1007/s00253-006-0593-1; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	50	338	363	1	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2009	27	5					465	471		10.1038/nbt.1536	http://dx.doi.org/10.1038/nbt.1536			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	444KS	19377462	Green Accepted			2022-12-25	WOS:000265980500026
J	Faulkner, GJ; Kimura, Y; Daub, CO; Wani, S; Plessy, C; Irvine, KM; Schroder, K; Cloonan, N; Steptoe, AL; Lassmann, T; Waki, K; Hornig, N; Arakawa, T; Takahashi, H; Kawai, J; Forrest, ARR; Suzuki, H; Hayashizaki, Y; Hume, DA; Orlando, V; Grimmond, SM; Carninci, P				Faulkner, Geoffrey J.; Kimura, Yasumasa; Daub, Carsten O.; Wani, Shivangi; Plessy, Charles; Irvine, Katharine M.; Schroder, Kate; Cloonan, Nicole; Steptoe, Anita L.; Lassmann, Timo; Waki, Kazunori; Hornig, Nadine; Arakawa, Takahiro; Takahashi, Hazuki; Kawai, Jun; Forrest, Alistair R. R.; Suzuki, Harukazu; Hayashizaki, Yoshihide; Hume, David A.; Orlando, Valerio; Grimmond, Sean M.; Carninci, Piero			The regulated retrotransposon transcriptome of mammalian cells	NATURE GENETICS			English	Article							SMALL INTERFERING RNAS; ANTISENSE PROMOTER; L1 RETROTRANSPOSITION; GENE-EXPRESSION; ELEMENTS; IDENTIFICATION; DISCOVERY; INSIGHTS; SITES; MAPS	Although repetitive elements pervade mammalian genomes, their overall contribution to transcriptional activity is poorly defined. Here, as part of the FANTOM4 project, we report that 6-30% of cap-selected mouse and human RNA transcripts initiate within repetitive elements. Analysis of approximately 250,000 retrotransposon-derived transcription start sites shows that the associated transcripts are generally tissue specific, coincide with gene-dense regions and form pronounced clusters when aligned to full-length retrotransposon sequences. Retrotransposons located immediately 5' of protein-coding loci frequently function as alternative promoters and/or express noncoding RNAs. More than a quarter of RefSeqs possess a retrotransposon in their 3' UTR, with strong evidence for the reduced expression of these transcripts relative to retrotransposon-free transcripts. Finally, a genome-wide screen identifies 23,000 candidate regulatory regions derived from retrotransposons, in addition to more than 2,000 examples of bidirectional transcription. We conclude that retrotransposon transcription has a key influence upon the transcriptional output of the mammalian genome.	[Hornig, Nadine; Orlando, Valerio] IRCCS Fondazione Santa Lucia EBRI, Dulbecco Telethon Inst, Rome, Italy; [Faulkner, Geoffrey J.; Wani, Shivangi; Cloonan, Nicole; Steptoe, Anita L.; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Express Genom Lab, Brisbane, Qld 4072, Australia; [Kimura, Yasumasa; Daub, Carsten O.; Plessy, Charles; Lassmann, Timo; Waki, Kazunori; Arakawa, Takahiro; Takahashi, Hazuki; Kawai, Jun; Forrest, Alistair R. R.; Suzuki, Harukazu; Hayashizaki, Yoshihide; Carninci, Piero] RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan; [Irvine, Katharine M.; Schroder, Kate] Univ Queensland, Inst Mol Biosci, Cooperat Res Ctr Chron Inflammatory Dis, Brisbane, Qld, Australia; [Irvine, Katharine M.; Schroder, Kate] Univ Queensland, Inst Mol Biosci, Special Res Ctr Funct & Appl Genom, Brisbane, Qld, Australia; [Hornig, Nadine] IGB CNR, Dulbecco Telethon Inst, Naples, Italy; [Forrest, Alistair R. R.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Queensland; RIKEN; University of Queensland; University of Queensland; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Griffith University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Orlando, V (corresponding author), IRCCS Fondazione Santa Lucia EBRI, Dulbecco Telethon Inst, Rome, Italy.	vorlando@dti.telethon.it; s.grimmond@imb.uq.edu.au; carninci@riken.jp	Hornig, Nadine/AAO-2648-2021; Carninci, Piero/K-1568-2014; Forrest, Alistair/A-6597-2008; Lassmann, Timo/HCH-4313-2022; Suzuki, Harukazu/N-9553-2015; Grimmond, Sean M/J-5304-2016; Daub, Carsten O/A-7436-2010; Grimmond, Sean/K-3246-2019; Irvine, Katharine M/A-5559-2011; Hayashizaki, Yoshihide/N-6590-2015; Kawai, Jun/A-6451-2016; Cloonan, Nicole/B-5272-2008; Plessy, Charles/N-5054-2015; Faulkner, Geoffrey J/M-3168-2014; Hume, David A/C-7695-2013; Lassmann, Timo/A-8271-2008; Kimura, Yasumasa/M-9720-2013; Schroder, Kate/C-6132-2008; Waki, Kazunori/T-6444-2019; Takahashi, Hazuki/F-9007-2017	Carninci, Piero/0000-0001-7202-7243; Forrest, Alistair/0000-0003-4543-1675; Lassmann, Timo/0000-0002-0138-2691; Suzuki, Harukazu/0000-0002-8087-0836; Grimmond, Sean M/0000-0002-8102-7998; Daub, Carsten O/0000-0002-3295-8729; Grimmond, Sean/0000-0002-8102-7998; Irvine, Katharine M/0000-0002-6716-1605; Cloonan, Nicole/0000-0001-7802-6647; Plessy, Charles/0000-0001-7410-6295; Faulkner, Geoffrey J/0000-0001-5769-4494; Lassmann, Timo/0000-0002-0138-2691; Schroder, Kate/0000-0001-9261-3805; Waki, Kazunori/0000-0001-7311-7208; Takahashi, Hazuki/0000-0001-7315-7349; Hume, David/0000-0002-2615-1478	Australian Postgraduate Award through the Australian government Department of Education, Training and Youth Affairs; CJ Martin Fellowship from the Australian NHMRC [ID 428261]; MEXT; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; ARC Special Research Centre for Functional and Applied Genomics; NHMRC; Australian NHMRC; UQ postdoctoral research fellowship; Telethon Foundation [TCP00094]; Associazione Italiana Ricerca sul Cancro (AIRC); Fondazione Compagnia di San Paolo; EMBO long-term fellowship; Medical Research Council [G9900991B] Funding Source: researchfish	Australian Postgraduate Award through the Australian government Department of Education, Training and Youth Affairs; CJ Martin Fellowship from the Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ARC Special Research Centre for Functional and Applied Genomics(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); UQ postdoctoral research fellowship; Telethon Foundation(Fondazione Telethon); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Compagnia di San Paolo(Compagnia di San Paolo); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	G.J.F. is supported by an Australian Postgraduate Award through the Australian government Department of Education, Training and Youth Affairs (DETYA). A.RR.F. is funded by a CJ Martin Fellowship from the Australian NHMRC (ID 428261). K. S. and K. M. I. are members of the CRC for Chronic Inflammatory Diseases. P. C. and Y.H. are supported by the National Project on Protein Structural and Functional Analysis from MEXT and the National Project on Genome Network Analysis and the RIKEN Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government. D. A. H. acknowledges the funding of the ARC Special Research Centre for Functional and Applied Genomics and the NHMRC. S. M. G. holds a Senior Research Fellowship with the Australian NHMRC. N.C. is supported by a UQ postdoctoral research fellowship. V.O. is supported by Telethon Foundation (TCP00094), Associazione Italiana Ricerca sul Cancro (AIRC) and Fondazione Compagnia di San Paolo, and N. H. is supported by an EMBO long-term fellowship.	Babushok DV, 2007, CELL MOL LIFE SCI, V64, P542, DOI 10.1007/s00018-006-6453-4; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Jurka J, 2004, CURR OPIN GENET DEV, V14, P603, DOI 10.1016/j.gde.2004.08.008; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P3354, DOI 10.1073/pnas.0408539102; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; MCCLINTOCK B, 1956, COLD SPRING HARB SYM, V21, P197, DOI 10.1101/SQB.1956.021.01.017; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; NILSSON M, 1994, J VIROL, V68, P276, DOI 10.1128/JVI.68.1.276-288.1994; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Olivarius S, 2009, BIOTECHNIQUES, V46, P130, DOI 10.2144/000113066; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schmitt S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-218; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Shibata K, 2000, GENOME RES, V10, P1757, DOI 10.1101/gr.152600; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Ustyugova SV, 2006, GENETICA, V128, P261, DOI 10.1007/s10709-005-5967-2; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	50	565	580	1	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					563	571		10.1038/ng.368	http://dx.doi.org/10.1038/ng.368			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19377475				2022-12-25	WOS:000265575600017
J	Kelly, RC; Bolitho, ME; Higgins, DA; Lu, WY; Ng, WL; Jeffrey, PD; Rabinowitz, JD; Semmelhack, MF; Hughson, FM; Bassler, BL				Kelly, Robert C.; Bolitho, Megan E.; Higgins, Douglas A.; Lu, Wenyun; Ng, Wai-Leung; Jeffrey, Philip D.; Rabinowitz, Joshua D.; Semmelhack, Martin F.; Hughson, Frederick M.; Bassler, Bonnie L.			The Vibrio cholerae quorum-sensing autoinducer CAI-1: analysis of the biosynthetic enzyme CqsA	NATURE CHEMICAL BIOLOGY			English	Article							S-RIBOSYLHOMOCYSTEINASE LUXS; 8-AMINO-7-OXONONANOATE SYNTHASE; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; MECHANISM; VIRULENCE; SIGNAL; IDENTIFICATION; COMMUNICATION; REFINEMENT	Vibrio cholerae, the bacterium that causes the disease cholera, controls virulence factor production and biofilm development in response to two extracellular quorum-sensing molecules, called autoinducers. The strongest autoinducer, called CAI-1 ( for cholera autoinducer-1), was previously identified as (S)-3-hydroxytridecan-4-one. Biosynthesis of CAI-1 requires the enzyme CqsA. Here, we determine the CqsA reaction mechanism, identify the CqsA substrates as (S)-2-aminobutyrate and decanoyl coenzyme A, and demonstrate that the product of the reaction is 3-aminotridecan-4-one, dubbed amino-CAI-1. CqsA produces amino-CAI-1 by a pyridoxal phosphate-dependent acyl-CoA transferase reaction. Amino-CAI-1 is converted to CAI-1 in a subsequent step via a CqsA-independent mechanism. Consistent with this, we find cells release >= 100 times more CAI-1 than amino-CAI-1. Nonetheless, V. cholerae responds to amino-CAI-1 as well as CAI-1, whereas other CAI-1 variants do not elicit a quorum-sensing response. Thus, both CAI-1 and amino-CAI-1 have potential as lead molecules in the development of an anticholera treatment.	[Kelly, Robert C.; Higgins, Douglas A.; Ng, Wai-Leung; Jeffrey, Philip D.; Hughson, Frederick M.; Bassler, Bonnie L.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Bolitho, Megan E.; Lu, Wenyun; Rabinowitz, Joshua D.; Semmelhack, Martin F.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Lu, Wenyun; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD USA	Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	bbassler@princeton.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Jeffrey, Philip/0000-0002-4351-5341; Bassler, Bonnie/0000-0002-0043-746X	Howard Hughes Medical Institute; US National Institutes of Health [AI054442, GM065859, AI069326]; US National Science Foundation [MCB-0639855]; Cephalon Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054442, R21AI069326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065859, R01GM065859] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Cephalon Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of the National Synchrotron Light Source beamline X29 for assistance with X-ray data collection; N. Ruiz and A. Arnaudo (Princeton University) for strains; and J. Kirsch for insightful discussions. This work was supported by the Howard Hughes Medical Institute; US National Institutes of Health grants AI054442, GM065859 and AI069326; US National Science Foundation grant MCB-0639855; and a Dr. Horst Witzel Fellowship from Cephalon Corporation (to M. E. B.).	Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gopishetty B, 2009, J AM CHEM SOC, V131, P1243, DOI 10.1021/ja808206w; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; IZUMI Y, 1973, AGR BIOL CHEM TOKYO, V37, P1327, DOI 10.1080/00021369.1973.10860848; Jahan N, 2009, J MOL BIOL, V392, P763, DOI 10.1016/j.jmb.2009.07.042; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Pei DH, 2004, CURR OPIN CHEM BIOL, V8, P492, DOI 10.1016/j.cbpa.2004.08.003; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	26	86	97	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					891	895		10.1038/nchembio.237	http://dx.doi.org/10.1038/nchembio.237			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19838203	Green Accepted			2022-12-25	WOS:000271756900011
J	Lin, AC; Seeto, BL; Bartoszko, JM; Khoury, MA; Whetstone, H; Ho, L; Hsu, C; Ali, AS; Alman, BA				Lin, Alvin C.; Seeto, Brian L.; Bartoszko, Justyna M.; Khoury, Michael A.; Whetstone, Heather; Ho, Louisa; Hsu, Claire; Ali, Amanda S.; Alman, Benjamin A.			Modulating hedgehog signaling can attenuate the severity of osteoarthritis	NATURE MEDICINE			English	Article							SMALL-MOLECULE INHIBITOR; INDIAN-HEDGEHOG; CHONDROCYTE DIFFERENTIATION; ARTICULAR-CARTILAGE; II COLLAGEN; HUMAN ADAMTS-5; BONE-FORMATION; GROWTH-PLATE; EXPRESSION; DEGRADATION	Osteoarthritis is associated with the irreversible degeneration of articular cartilage. Notably, in this condition, articular cartilage chondrocytes undergo phenotypic and gene expression changes that are reminiscent of their end-stage differentiation in the growth plate during skeletal development(1,2). Hedgehog (Hh) signaling regulates normal chondrocyte growth and differentiation(3-8); however, the role of Hh signaling in chondrocytes in osteoarthritis is unknown. Here we examine human osteoarthritic samples and mice in which osteoarthritis was surgically induced and find that Hh signaling is activated in osteoarthritis. Using several genetically modified mice, we found that higher levels of Hh signaling in chondrocytes cause a more severe osteoarthritic phenotype. Furthermore, we show in mice and in human cartilage explants that pharmacological or genetic inhibition of Hh signaling reduces the severity of osteoarthritis and that runt-related transcription factor-2 (RUNX2) potentially mediates this process by regulating a disintegrin and metalloproteinase with thrombospondin type 1 motif-5 (ADAMTS5) expression. Together, these findings raise the possibility that Hh blockade can be used as a therapeutic approach to inhibit articular cartilage degeneration.	[Lin, Alvin C.; Seeto, Brian L.; Bartoszko, Justyna M.; Khoury, Michael A.; Whetstone, Heather; Ho, Louisa; Hsu, Claire; Ali, Amanda S.; Alman, Benjamin A.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Lin, Alvin C.; Hsu, Claire; Ali, Amanda S.; Alman, Benjamin A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Lin, Alvin C.; Ho, Louisa; Hsu, Claire; Ali, Amanda S.; Alman, Benjamin A.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Alman, Benjamin A.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Alman, Benjamin A.] Univ Toronto, Div Orthopaed Surg, Toronto, ON, Canada; [Alman, Benjamin A.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Alman, BA (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	benjamin.alman@sickkids.ca		Khoury, Michael/0000-0001-6112-6860; Ali, Shabana/0000-0002-4339-9467	Canadian Institutes of Health Research [FRN: 79436]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We wish to thank D. Backstein and A. Gross (Mount Sinai Hospital, Toronto) for assistance obtaining human cartilage samples, T. Mak (University Health Network, Toronto) for assistance obtaining the hedgehog blocking agent, L. Morikawa for assistance with sectioning and histology, P. Roughley (McGill University) for providing the COL2-rtTA-Cre mice and R. Ward and C.-C. Hui for their assistance with the Ptch1+/-mice. The Canada Research Chair program supports B. A. A. A. C. L. and C. H. are supported by Canadian Institutes of Health Research studentships; L. H. and A. S. A. are supported by Ontario graduate scholarships. This work was supported by the Canadian Institutes of Health Research grant FRN: 79436.	ADAMS ME, 1995, J RHEUMATOL, V22, P94; Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Arai M, 2004, OSTEOARTHR CARTILAGE, V12, P599, DOI 10.1016/j.joca.2004.05.001; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Everts V, 2008, METHODS, V45, P86, DOI 10.1016/j.ymeth.2008.01.009; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grover J, 2006, MATRIX BIOL, V25, P158, DOI 10.1016/j.matbio.2005.11.003; Hilton MJ, 2007, DEV BIOL, V308, P93, DOI 10.1016/j.ydbio.2007.05.011; Ho L, 2009, CANCER CELL, V16, P126, DOI 10.1016/j.ccr.2009.05.013; Hopyan S, 2005, J PATHOL, V206, P143, DOI 10.1002/path.1761; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Li Y, 2004, TISSUE ENG, V10, P575, DOI 10.1089/107632704323061933; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Ng TCS, 2006, FRONT BIOSCI-LANDMRK, V11, P943; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Sarangi A, 2009, ONCOGENE, V28, P3468, DOI 10.1038/onc.2009.208; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Slagboom E, 2008, NAT CLIN PRACT RHEUM, V4, P563, DOI 10.1038/ncprheum0935; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; Takamoto M, 2003, J ENDOCRINOL, V177, P413, DOI 10.1677/joe.0.1770413; Taniguchi H, 2007, J PATHOL, V213, P131, DOI 10.1002/path.2216; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Thirunavukkarasu K, 2007, MOL BIOL REP, V34, P225, DOI 10.1007/s11033-006-9037-3; Tiet TD, 2006, AM J PATHOL, V168, P321, DOI 10.2353/ajpath.2006.050001; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	41	233	252	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2009	15	12					1421	U11		10.1038/nm.2055	http://dx.doi.org/10.1038/nm.2055			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	527YS	19915594	Green Submitted			2022-12-25	WOS:000272407800023
J	Hassel, D; Dahme, T; Erdmann, J; Meder, B; Huge, A; Stoll, M; Just, S; Hess, A; Ehlermann, P; Weichenhan, D; Grimmler, M; Liptau, H; Hetzer, R; Regitz-Zagrosek, V; Fischer, C; Nurnberg, P; Schunkert, H; Katus, HA; Rottbauer, W				Hassel, David; Dahme, Tillman; Erdmann, Jeanette; Meder, Benjamin; Huge, Andreas; Stoll, Monika; Just, Steffen; Hess, Alexander; Ehlermann, Philipp; Weichenhan, Dieter; Grimmler, Matthias; Liptau, Henrike; Hetzer, Roland; Regitz-Zagrosek, Vera; Fischer, Christine; Nuernberg, Peter; Schunkert, Heribert; Katus, Hugo A.; Rottbauer, Wolfgang			Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy	NATURE MEDICINE			English	Article							MECHANICAL STRETCH SENSOR; GENETIC-BASIS; HYPERTROPHIC CARDIOMYOPATHY; HEART; ZEBRAFISH; CONTRACTILITY; PHENOTYPES; PROTEIN; COMPONENT; DISEASE	Z-disks, the mechanical integration sites of heart and skeletal muscle cells, link anchorage of myofilaments to force reception and processing. The key molecules that enable the Z-disk to persistently withstand the extreme mechanical forces during muscle contraction have not yet been identified. Here we isolated nexilin (encoded by NEXN) as a novel Z-disk protein. Loss of nexilin in zebrafish led to perturbed Z-disk stability and heart failure. To evaluate the role of nexilin in human heart failure, we performed a genetic association study on individuals with dilated cardiomyopathy and found several mutations in NEXN associated with the disease. Nexilin mutation carriers showed the same cardiac Z-disk pathology as observed in nexilin-deficient zebrafish. Expression in zebrafish of nexilin proteins encoded by NEXN mutant alleles induced Z-disk damage and heart failure, demonstrating a dominant-negative effect and confirming the disease-causing nature of these mutations. Increasing mechanical strain aggravated Z-disk damage in nexilin-deficient skeletal muscle, implying a unique role of nexilin in protecting Z-disks from mechanical trauma.	[Hassel, David; Dahme, Tillman; Meder, Benjamin; Just, Steffen; Hess, Alexander; Ehlermann, Philipp; Weichenhan, Dieter; Katus, Hugo A.; Rottbauer, Wolfgang] Univ Heidelberg, Dept Med 3, Heidelberg, Germany; [Erdmann, Jeanette; Liptau, Henrike; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, Lubeck, Germany; [Huge, Andreas; Stoll, Monika] Univ Munster, Dept Genet Epidemiol Vasc Dis, Leibniz Inst Arteriosclerosis Res, Munster, Germany; [Grimmler, Matthias] Univ Wurzburg, Dept Biochem, Bioctr, Wurzburg, Germany; [Hetzer, Roland; Regitz-Zagrosek, Vera] German Heart Ctr, Berlin, Germany; [Regitz-Zagrosek, Vera] Charite, Cardiovasc Res Ctr, Berlin, Germany; [Fischer, Christine] Univ Heidelberg, Dept Human Genet, Heidelberg, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Munster; University of Wurzburg; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; University of Cologne	Rottbauer, W (corresponding author), Univ Heidelberg, Dept Med 3, Heidelberg, Germany.	wolfgang.rottbauer@med.uni-heidelberg.de	Erdmann, Jeanette/A-4417-2009; Dahme, Tillman/AAN-4511-2021; Erdmann, Jeanette/P-7513-2014	Dahme, Tillman/0000-0002-6211-7162; Erdmann, Jeanette/0000-0002-4486-6231; Grimmler, Matthias/0000-0003-2860-3391; Regitz-Zagrosek, Vera/0000-0002-3566-3467	Deutsche Forschungsgemeinschaft [Ro2173/1-1, Ro2173/2-1, Ro2173/2-2, Ro2173/3-1]; Bundesministerium fur Bildung und Forschung [01GS0108, 01GS0420, 01GS0836]; Postdoc-Fellowship YIA of the medical faculty of the University of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Postdoc-Fellowship YIA of the medical faculty of the University of Heidelberg	We thank S. Marquart, S. Weber, S. Kolb, H. Hosser, O. Mucke and S. Manthey as well as S. Wrobel for their excellent technical support. We thank B. Jurmann for human subject work-up and evaluation of clinical data and N. Frey (University of Heidelberg) for providing the calsarcin-specific antibody. We thank R. Knoll and L. Thierfelder for critical discussion of patient data. This work was supported by Deutsche Forschungsgemeinschaft Ro2173/1-1, Ro2173/2-1, Ro2173/2-2 and Ro2173/3-1 (W. R.), Bundesministerium fur Bildung und Forschung 01GS0108, 01GS0420 and 01GS0836 (W. R., B. M., D. W. and H. A. K.) and the Postdoc-Fellowship YIA of the medical faculty of the University of Heidelberg (T. D.). We are indebted to all probands for their participation. We thank M. C. Fishman for critical discussion of the manuscript.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Dahme T, 2009, DIS MODEL MECH, V2, P18, DOI 10.1242/dmm.000687; Erdmann J, 2001, J AM COLL CARDIOL, V38, P322, DOI 10.1016/S0735-1097(01)01387-0; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Goebel HH, 1997, CURR OPIN NEUROL, V10, P426, DOI 10.1097/00019052-199710000-00012; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce; Knoll R, 2003, J MOL MED, V81, P750, DOI 10.1007/s00109-003-0488-x; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ohtsuka T, 1998, J CELL BIOL, V143, P1227, DOI 10.1083/jcb.143.5.1227; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rottbauer W, 2005, GENE DEV, V19, P1624, DOI 10.1101/gad.1319405; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SHIMIZU T, 1985, J CELL BIOL, V101, P1115, DOI 10.1083/jcb.101.3.1115; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Zeller R, 2006, J MOL MED-JMM, V84, P682, DOI 10.1007/s00109-006-0056-2; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0	37	132	135	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1281	U78		10.1038/nm.2037	http://dx.doi.org/10.1038/nm.2037			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19881492				2022-12-25	WOS:000271543700016
J	Yamada, M; Yoshida, Y; Mori, D; Takitoh, T; Kengaku, M; Umeshima, H; Takao, K; Miyakawa, T; Sato, M; Sorimachi, H; Wynshaw-Boris, A; Hirotsune, S				Yamada, Masami; Yoshida, Yuko; Mori, Daisuke; Takitoh, Takako; Kengaku, Mineko; Umeshima, Hiroki; Takao, Keizo; Miyakawa, Tsuyoshi; Sato, Makoto; Sorimachi, Hiroyuki; Wynshaw-Boris, Anthony; Hirotsune, Shinji			Inhibition of calpain increases LIS1 expression and partially rescues in vivo phenotypes in a mouse model of lissencephaly	NATURE MEDICINE			English	Article							NEURONAL MIGRATION DEFECTS; CYCLIN-DEPENDENT KINASE-5; GENE-TRANSFER; SUBUNIT; CLEAVAGE; NDEL1; P35; PHOSPHORYLATION; DOUBLECORTIN; PROTEOLYSIS	Lissencephaly is a devastating neurological disorder caused by defective neuronal migration. LIS1 (official symbol PAFAH1B1, for platelet-activating factor acetylhydrolase, isoform 1b, subunit 1) was identified as the gene mutated in individuals with lissencephaly, and it was found to regulate cytoplasmic dynein function and localization. Here we show that inhibition or knockdown of calpains protects LIS1 from proteolysis, resulting in the augmentation of LIS1 amounts in Lis1(+/-) mouse embryonic fibroblast cells and rescue of the aberrant distribution of cytoplasmic dynein, mitochondria and beta-COP-positive vesicles. We also show that calpain inhibitors improve neuronal migration of Lis1(+/-) cerebellar granular neurons. Intraperitoneal injection of the calpain inhibitor ALLN to pregnant Lis1(+/-) dams rescued apoptotic neuronal cell death and neuronal migration defects in Lis1(+/-) offspring. Furthermore, in utero knockdown of calpain by short hairpin RNA rescued defective cortical layering in Lis1(+/-) mice. Thus, calpain inhibition is a potential therapeutic intervention for lissencephaly.	[Yamada, Masami; Yoshida, Yuko; Mori, Daisuke; Takitoh, Takako; Hirotsune, Shinji] Osaka City Univ, Grad Sch Med, Dept Genet Dis Res, Osaka 558, Japan; [Kengaku, Mineko; Umeshima, Hiroki] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Aichi, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Fac Med, Frontier Technol Ctr, Genet Engn & Funct Genom Grp,Sakyo Ku, Kyoto, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev & Core Res Evolut Sci, Kawaguchi, Saitama, Japan; [Sato, Makoto] Univ Fukui, Fac Med Sci, Dept Morphol & Physiol Sci, Div Cell Biol & Neurosci, Fukui 910, Japan; [Sato, Makoto] Univ Fukui, Fac Med Sci, Res & Educ Program Life Sci, Fukui 910, Japan; [Sorimachi, Hiroyuki] Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci Rinshoken, Dept Enzymat Regulat Cell Funct, Calpain Project,Setagaya Ku, Tokyo, Japan; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA USA	Osaka Metropolitan University; Kyoto University; Fujita Health University; Kyoto University; Japan Science & Technology Agency (JST); University of Fukui; University of Fukui; Tokyo Metropolitan Institute of Medical Science; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hirotsune, S (corresponding author), Osaka City Univ, Grad Sch Med, Dept Genet Dis Res, Asahi Machi, Osaka 558, Japan.	shinjih@med.osaka-cu.ac.jp	Takao, Keizo/B-9527-2008; Miyakawa, Tsuyoshi/A-7741-2008; Sorimachi, Hiroyuki/C-6448-2009; Sorimachi, Hiroyuki/Q-6956-2017; Mori, Daisuke/M-4952-2014	Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Sorimachi, Hiroyuki/0000-0001-9509-6727; Sorimachi, Hiroyuki/0000-0001-9509-6727; Mori, Daisuke/0000-0002-9072-2546; Umeshima, Hiroki/0000-0001-9957-1468	Ministry of Education, Science, Sports and Culture of Japan; Sagawa Foundation for Promotion of Cancer Research; The Cell Science Research Foundation; The Japan Spina Bifida & Hydrocephalus Research Foundation; Takeda Science Foundation; The Hoh-ansha Foundation; Knowledge Cluster Initiative (Stage-2) Research Foundation; US National Institutes of Health [NS41030, HD47380]; MEXT; Neuroinformatics Japan Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041030] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sagawa Foundation for Promotion of Cancer Research; The Cell Science Research Foundation(Cell Science Research Foundation, Japan); The Japan Spina Bifida & Hydrocephalus Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); The Hoh-ansha Foundation; Knowledge Cluster Initiative (Stage-2) Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Neuroinformatics Japan Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Kawashima (Tokyo Metropolitan Institute of Medical Science) for providing us with a calpain-specific antibody (1D10A7)<SUP>36</SUP>. We thank Y. Funae, H. Iwao, T. Yamauch, M. Muramatsu and Y. Nagai for generous support and encouragement. We also thank Y. Kira, Y. Yabunaka and R. Zako for technical support, H. Nishimura and K. Fujimoto for mouse breeding, T. Bando for in utero injection and K. Nakanishi for behavior study. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan from the Ministry of Education, Science, Sports and Culture of Japan to M. S. and S. H. This work was also supported by The Sagawa Foundation for Promotion of Cancer Research, The Cell Science Research Foundation, The Japan Spina Bifida & Hydrocephalus Research Foundation, Takeda Science Foundation, The Hoh-ansha Foundation and Knowledge Cluster Initiative (Stage-2) Research Foundation to Shinji Hirotsune and by US National Institutes of Health grants NS41030 and HD47380 to A.W.-B. This work was also supported by a Grant-in-Aid for Scientific Research on Priority Areas-Integrative Brain Research (Shien)-from MEXT and a Grant-in-Aid from Neuroinformatics Japan Center to T. M.	Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Bhatt A, 2002, J CELL SCI, V115, P3415; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gressens P, 2006, CURR OPIN NEUROL, V19, P135, DOI 10.1097/01.wco.0000218228.73678.e1; Hampton TG, 2004, PHYSIOL BEHAV, V82, P381, DOI 10.1016/j.physbeh.2004.04.006; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; KASAI Y, 1986, J BIOCHEM-TOKYO, V100, P183, DOI 10.1093/oxfordjournals.jbchem.a121691; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Patzke H, 2002, J BIOL CHEM, V277, P8054, DOI 10.1074/jbc.M109645200; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; Powell E, 1999, PHYSIOL BEHAV, V67, P819, DOI 10.1016/S0031-9384(99)00127-4; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Serrano K, 2004, CELL MOTIL CYTOSKEL, V58, P242, DOI 10.1002/cm.20011; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026	41	54	56	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1202	U132		10.1038/nm.2023	http://dx.doi.org/10.1038/nm.2023			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19734909	Green Accepted			2022-12-25	WOS:000270596400033
J	Aldinger, KA; Lehmann, OJ; Hudgins, L; Chizhikov, VV; Bassuk, AG; Ades, LC; Krantz, ID; Dobyns, WB; Millen, KJ				Aldinger, Kimberly A.; Lehmann, Ordan J.; Hudgins, Louanne; Chizhikov, Victor V.; Bassuk, Alexander G.; Ades, Lesley C.; Krantz, Ian D.; Dobyns, William B.; Millen, Kathleen J.			FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformation	NATURE GENETICS			English	Article							FORKHEAD TRANSCRIPTION FACTORS; SUBTELOMERIC DELETIONS; ENDOTHELIAL-CELLS; PROGENITOR CELLS; GRANULE NEURONS; SPINAL-CORD; HELIX GENE; EXPRESSION; MUTATIONS; MICE	Dandy-Walker malformation (DWM), the most common human cerebellar malformation, has only one characterized associated locus(1,2). Here we characterize a second DWM-linked locus on 6p25.3, showing that deletions or duplications encompassing FOXC1 are associated with cerebellar and posterior fossa malformations including cerebellar vermis hypoplasia (CVH), megacisterna magna (MCM) and DWM. Foxc1-null mice have embryonic abnormalities of the rhombic lip due to loss of mesenchyme-secreted signaling molecules with subsequent loss of Atoh1 expression in vermis. Foxc1 homozygous hypomorphs have CVH with medial fusion and foliation defects. Human FOXC1 heterozygous mutations are known to affect eye development, causing a spectrum of glaucoma-associated anomalies (Axenfeld-Rieger syndrome, ARS; MIM no. 601631). We report the first brain imaging data from humans with FOXC1 mutations and show that these individuals also have CVH. We conclude that alteration of FOXC1 function alone causes CVH and contributes to MCM and DWM. Our results highlight a previously unrecognized role for mesenchyme-neuroepithelium interactions in the mid-hindbrain during early embryogenesis.	[Aldinger, Kimberly A.; Millen, Kathleen J.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Lehmann, Ordan J.] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada; [Lehmann, Ordan J.] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Hudgins, Louanne] Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; [Chizhikov, Victor V.; Dobyns, William B.; Millen, Kathleen J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Div Neurol & Interdisciplinary, Grad Program Genet, Iowa City, IA 52242 USA; [Ades, Lesley C.] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; [Ades, Lesley C.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Dobyns, William B.; Millen, Kathleen J.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of Chicago; University of Alberta; University of Alberta; Stanford University; University of Chicago; University of Iowa; University of Sydney; University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Chicago	Millen, KJ (corresponding author), Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA.	kmillen@genetics.bsd.uchicago.edu	Aldinger, Kimberly/ABB-1561-2020; Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020	Aldinger, Kimberly/0000-0002-5406-8911; Dobyns, William/0000-0002-7681-2844; Bassuk, Alexander/0000-0002-4067-2157; Chizhikov, Victor/0000-0003-2338-1267; Millen, Kathleen/0000-0001-9978-675X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD054275] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048174, R01NS050375, R01NS050386] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014599, P30 CA014599-34S29010] Funding Source: Medline; NICHD NIH HHS [P30 HD054275-01A19002, P30 HD054275] Funding Source: Medline; NINDS NIH HHS [R01-NS050375, R01 NS050375, K08 NS048174-05, R01-NS050386, K08 NS048174, R01 NS050375-05, R01 NS050386-05A2, KO8-NS48174-01A, R01 NS050375-04, R01 NS050386] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Chanda B, 2008, HUM MOL GENET, V17, P3446, DOI 10.1093/hmg/ddn238; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Chizhikov VV, 2006, DEVELOPMENT, V133, P2793, DOI 10.1242/dev.02441; Chizhikov VV, 2004, DEVELOPMENT, V131, P2693, DOI 10.1242/dev.01139; Chizhikov VV, 2004, J NEUROSCI, V24, P5694, DOI 10.1523/JNEUROSCI.0758-04.2004; DeScipio C, 2005, AM J MED GENET A, V134A, P3, DOI 10.1002/ajmg.a.30573; DeScipio C, 2008, AM J MED GENET A, V146A, P730, DOI 10.1002/ajmg.a.32216; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Gould DB, 1997, AM J HUM GENET, V61, P765; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Hang HY, 2002, GENOMICS, V79, P487, DOI 10.1006/geno.2002.6737; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hong HK, 2001, GENESIS, V29, P163, DOI 10.1002/gene.1020; Krizhanovsky V, 2006, MECH DEVELOP, V123, P67, DOI 10.1016/j.mod.2005.09.005; Kume T, 2000, DEVELOPMENT, V127, P1387; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Lin RJ, 2005, AM J MED GENET A, V136A, P162, DOI 10.1002/ajmg.a.30784; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Maclean K, 2005, AM J MED GENET A, V132A, P381, DOI 10.1002/ajmg.a.30274; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Millen KJ, 2008, CURR OPIN NEUROBIOL, V18, P12, DOI 10.1016/j.conb.2008.05.010; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Ormestad M, 2004, DEV DYNAM, V229, P328, DOI 10.1002/dvdy.10426; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441; Rice R, 2005, DEV DYNAM, V233, P847, DOI 10.1002/dvdy.20430; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; SASAKI H, 1993, DEVELOPMENT, V118, P47; Selzer Y, 2005, NANO LETT, V5, P61, DOI 10.1021/nl048372j; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Sommer P, 2006, DEV GROWTH DIFFER, V48, P297, DOI 10.1111/j.1440-169x.2006.00866.x; Wang T, 2003, DEV BIOL, V259, P83, DOI 10.1016/S0012-1606(03)00176-3; Wilm B, 2004, DEV BIOL, V271, P176, DOI 10.1016/j.ydbio.2004.03.034; Wingate R, 2005, NEURON, V48, P1, DOI 10.1016/j.neuron.2005.09.012; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104	48	165	171	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1037	U116		10.1038/ng.422	http://dx.doi.org/10.1038/ng.422			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19668217	Green Accepted			2022-12-25	WOS:000269382100019
J	Bielas, SL; Silhavy, JL; Brancati, F; Kisseleva, MV; Al-Gazali, L; Laszlo, S; Bayoumi, RA; Zaki, MS; Abdel-Aleem, A; Rosti, RO; Kayserili, H; Swistun, D; Scott, LC; Bertini, E; Boltshauser, E; Fazzi, E; Travaglini, L; Field, SJ; Gayral, S; Jacoby, M; Schurmans, S; Dallapiccola, B; Majerus, PW; Valente, EM; Gleeson, JG				Bielas, Stephanie L.; Silhavy, Jennifer L.; Brancati, Francesco; Kisseleva, Marina V.; Al-Gazali, Lihadh; Laszlo Sztriha; Bayoumi, Riad A.; Zaki, Maha S.; Abdel-Aleem, Alice; Rosti, Rasim Ozgur; Kayserili, Hulya; Swistun, Dominika; Scott, Lesley C.; Bertini, Enrico; Boltshauser, Eugen; Fazzi, Elisa; Travaglini, Lorena; Field, Seth J.; Gayral, Stephanie; Jacoby, Monique; Schurmans, Stephane; Dallapiccola, Bruno; Majerus, Philip W.; Valente, Enza Maria; Gleeson, Joseph G.			Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies	NATURE GENETICS			English	Article							JOUBERT-SYNDROME; POLYPHOSPHATE 5-PHOSPHATASE; MEMBRANE; PROTEIN; 3-PHOSPHATE; CEP290; FORMS; RAB8	Phosphotidylinositol (PtdIns) signaling is tightly regulated both spatially and temporally by subcellularly localized PtdIns kinases and phosphatases that dynamically alter downstream signaling events(1). Joubert syndrome is characterized by a specific midbrain-hindbrain malformation ('molar tooth sign'), variably associated retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly(2) and is included in the newly emerging group of 'ciliopathies'. In individuals with Joubert disease genetically linked to JBTS1, we identified mutations in the INPP5E gene, encoding inositol polyphosphate-5- phosphatase E, which hydrolyzes the 5-phosphate of PtdIns(3,4,5) P3 and PtdIns(4,5) P2. Mutations clustered in the phosphatase domain and impaired 5-phosphatase activity, resulting in altered cellular PtdIns ratios. INPP5E localized to cilia in major organs affected by Joubert syndrome, and mutations promoted premature destabilization of cilia in response to stimulation. These data link PtdIns signaling to the primary cilium, a cellular structure that is becoming increasingly recognized for its role in mediating cell signals and neuronal function.	[Bielas, Stephanie L.; Silhavy, Jennifer L.; Swistun, Dominika; Scott, Lesley C.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci & Pediat, La Jolla, CA 92093 USA; [Brancati, Francesco; Travaglini, Lorena; Dallapiccola, Bruno; Valente, Enza Maria] Casa Sollievo Sofferenza Hosp, Casa Sollievo Sofferenza Mendel Inst, Rome, Italy; [Brancati, Francesco] G Annunzio Univ Fdn, Dept Biomed Sci, Ctr Studi Invecchiamento, Chieti, Italy; [Brancati, Francesco] G Annunzio Univ Fdn, Aging Res Ctr, Ctr Studi Invecchiamento, Chieti, Italy; [Kisseleva, Marina V.; Majerus, Philip W.] Washington Univ, Sch Med, Dept Internal Med, Div Hematol, St Louis, MO 63110 USA; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Laszlo Sztriha] Univ Szeged, Dept Pediat, Szeged, Hungary; [Bayoumi, Riad A.] Sultan Qaboos Univ, Coll Med, Al Khoud, Oman; [Zaki, Maha S.] Natl Res Ctr, Dept Clin Genet, Cairo, Egypt; [Abdel-Aleem, Alice] Natl Res Ctr, Med Mol Genet Dept, Human Genet & Genome Res Div, Cairo, Egypt; [Rosti, Rasim Ozgur; Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; [Bertini, Enrico] Bambino Gesu Childrens Res Hosp, Mol Med Unit, Dept Lab Med, Rome, Italy; [Boltshauser, Eugen] Univ Childrens Hosp Zurich, Dept Paediat Neurol, Zurich, Switzerland; [Fazzi, Elisa] Dept Child Neurol & Psychiat, Pavia, Italy; [Field, Seth J.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Gayral, Stephanie; Jacoby, Monique; Schurmans, Stephane] Univ Libre Bruxelles, IRIBHM, IBMM, Gosselies, Belgium; [Dallapiccola, Bruno] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Valente, Enza Maria] Univ Messina, Dept Med & Surg Paediat Sci, Messina, Italy	Howard Hughes Medical Institute; University of California System; University of California San Diego; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Washington University (WUSTL); United Arab Emirates University; United Arab Emirates University; Szeged University; Sultan Qaboos University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Istanbul University; IRCCS Bambino Gesu; University Children's Hospital Zurich; University of California System; University of California San Diego; Universite Libre de Bruxelles; Sapienza University Rome; University of Messina	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci & Pediat, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Travaglini, Lorena/AAA-6245-2020; Zaki, Maha S/B-9361-2013; Valente, Enza Maria/G-2942-2017; Fazzi, Elisa/J-6076-2016; Bayoumi, Riad/ABH-2732-2020; Bertini, Enrico/A-2284-2014; Bertini, Enrico/ABG-1278-2020; Kayserili, Hülya/AAA-5593-2021; Brancati, Francesco/AAC-3778-2022; Aleem, Alice Abdel/AAY-2598-2020; Dallapiccola, Bruno/K-8692-2016	Valente, Enza Maria/0000-0002-0600-6820; Fazzi, Elisa/0000-0003-4805-7906; Bertini, Enrico/0000-0001-9276-4590; Kayserili, Hülya/0000-0003-0376-499X; Brancati, Francesco/0000-0003-3624-2354; Abdel Aleem, Alice/0000-0001-5137-3382; Travaglini, Lorena/0000-0003-0142-6516; Gayral, Stephanie/0000-0001-6276-3917; Dallapiccola, Bruno/0000-0002-5031-1013; Bielas, Stephanie/0000-0003-0567-5632; Bayoumi, Riad/0000-0001-8177-8129; Zaki, Maha/0000-0001-7840-0002; Field, Seth/0000-0002-8893-4806	Italian Ministry of Health [RC2008]; Telethon Foundation Italy [GGP08145]; National Institutes of Health [HL 16634 (]; American Heart Association [0730350N]; National Institute of Neurological Disorder and Stroke; Burroughs Welcome Fund; March of Dimes and the Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA138676] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016634, R37HL016634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS052455, R13NS053097, P30NS047101] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004265] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); Telethon Foundation Italy(Fondazione Telethon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Burroughs Welcome Fund(Burroughs Wellcome Fund); March of Dimes and the Howard Hughes Medical Institute(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Marshfield Clinic Research Foundation, Center for Inherited Disease Research and University of California Los Angeles Microarray Core ( supported by the US National Heart, Lung, and Blood Institute and National Institutes of Health) for genotyping support. J. Meerloo at the University of California San Diego ( UCSD) Neuroscience Microscopy Imaging Core ( P30NS047101) provided imaging support. Ryan Anderson of the UCSD Material Sciences provided electron microscopy support. We thank members of the the Dixon lab ( UCSD) for suggestions and help with protein modeling, and members of the Mitchell lab ( Monash University) for reagents. This work was supported by the UCSD Neuroplasticity of Aging Training Grant ( to S. L. B.), the Italian Ministry of Health ( RC2008 to B. D., Ricerca Finalizzata 2006 to E. M. V.), the Telethon Foundation Italy ( GGP08145 to E. B. and E. M. V.), National Institutes of Health grant HL 16634 ( to P. W. M. and M. V. K.), American Heart Association grant 0730350N ( to M. V. K.), the National Institute of Neurological Disorder and Stroke, the Burroughs Welcome Fund, the March of Dimes and the Howard Hughes Medical Institute ( to J. G. G.).	Alieva I B, 1999, Membr Cell Biol, V12, P895; CALDWELL KK, 1991, J BIOL CHEM, V266, P18378; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gleeson JG, 2000, ANN NEUROL, V47, P265, DOI 10.1002/1531-8249(200002)47:2<265::AID-ANA22>3.3.CO;2-E; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rodriguez Luis G., 2004, V294, P23; Rohatgi R, 2008, SCIENCE, V320, P1726, DOI 10.1126/science.1160448; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Vandeput F, 2006, CELL SIGNAL, V18, P2193, DOI 10.1016/j.cellsig.2006.05.010; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Zhang XL, 1998, J BIOL CHEM, V273, P1574, DOI 10.1074/jbc.273.3.1574	33	291	297	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1032	U108		10.1038/ng.423	http://dx.doi.org/10.1038/ng.423			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19668216	Green Submitted, Green Accepted			2022-12-25	WOS:000269382100018
J	Clarke, L; van der Kooy, D				Clarke, Laura; van der Kooy, Derek			Inducing pluripotency	NATURE MEDICINE			English	Editorial Material							STEM-CELLS; GENERATION; FIBROBLASTS; INDUCTION		[Clarke, Laura; van der Kooy, Derek] Univ Toronto, Toronto, ON, Canada	University of Toronto	Clarke, L (corresponding author), Univ Toronto, Toronto, ON, Canada.	derek.van.der.kooy@utoronto.ca						Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	17	8	9	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1001	1002		10.1038/nm0909-1001	http://dx.doi.org/10.1038/nm0909-1001			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19734874				2022-12-25	WOS:000269979200017
J	Minamino, T; Orimo, M; Shimizu, I; Kunieda, T; Yokoyama, M; Ito, T; Nojima, A; Nabetani, A; Oike, Y; Matsubara, H; Ishikawa, F; Komuro, I				Minamino, Tohru; Orimo, Masayuki; Shimizu, Ippei; Kunieda, Takeshige; Yokoyama, Masataka; Ito, Takashi; Nojima, Aika; Nabetani, Akira; Oike, Yuichi; Matsubara, Hisahiro; Ishikawa, Fuyuki; Komuro, Issei			A crucial role for adipose tissue p53 in the regulation of insulin resistance	NATURE MEDICINE			English	Article							ACID-BINDING PROTEIN; CELLULAR SENESCENCE; MICE LACKING; LIFE-SPAN; FAT-BODY; KAPPA-B; TELOMERASE; OBESITY; CELLS; RECEPTOR	Various stimuli, such as telomere dysfunction and oxidative stress, can induce irreversible cell growth arrest, which is termed 'cellular senescence'(1,2). This response is controlled by tumor suppressor proteins such as p53 and pRb. There is also evidence that senescent cells promote changes related to aging or age-related diseases(3-6). Here we show that p53 expression in adipose tissue is crucially involved in the development of insulin resistance, which underlies age-related cardiovascular and metabolic disorders. We found that excessive calorie intake led to the accumulation of oxidative stress in the adipose tissue of mice with type 2 diabetes-like disease and promoted senescence-like changes, such as increased activity of senescence-associated beta-galactosidase, increased expression of p53 and increased production of proinflammatory cytokines. Inhibition of p53 activity in adipose tissue markedly ameliorated these senescence-like changes, decreased the expression of proinflammatory cytokines and improved insulin resistance in mice with type 2 diabetes-like disease. Conversely, upregulation of p53 in adipose tissue caused an inflammatory response that led to insulin resistance. Adipose tissue from individuals with diabetes also showed senescence-like features. Our results show a previously unappreciated role of adipose tissue p53 expression in the regulation of insulin resistance and suggest that cellular aging signals in adipose tissue could be a new target for the treatment of diabetes.	[Minamino, Tohru; Orimo, Masayuki; Shimizu, Ippei; Kunieda, Takeshige; Yokoyama, Masataka; Ito, Takashi; Nojima, Aika; Komuro, Issei] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba, Japan; [Minamino, Tohru; Oike, Yuichi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Nabetani, Akira; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Kyoto, Japan; [Oike, Yuichi] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Mol Genet, Kumamoto, Japan; [Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chuo Ku, Chiba, Japan; [Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan	Chiba University; Japan Science & Technology Agency (JST); Kyoto University; Kumamoto University; Chiba University; Osaka University	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba, Japan.	komuro-tky@umin.ac.jp	Minamino, Tohru/P-8145-2018; Ishikawa, Fuyuki/AAU-4056-2021	Minamino, Tohru/0000-0003-1627-6151; Ishikawa, Fuyuki/0000-0002-5580-2305; Shimizu, Ippei/0000-0003-3333-8131	Ministry of Education, Science, Sports and Culture and Health and Labor Sciences Research Grants; Ministry of Education, Culture, Sports, Science and Technology of Japan; Suzuken Memorial Foundation; Japan Diabetes Foundation; Ichiro Kanehara Foundation; Tokyo Biochemical Research Foundation; Takeda Science Foundation; Cell Science Research Foundation; Japan Foundation of Applied Enzymology; Grants-in-Aid for Scientific Research [21390237] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture and Health and Labor Sciences Research Grants; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Suzuken Memorial Foundation; Japan Diabetes Foundation; Ichiro Kanehara Foundation; Tokyo Biochemical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Karagiri for discussion, W. C. Greene ( University of California) and T. Fujita ( The Tokyo Metropolitan Institute of Medical Science) for expression vector encoding constitutively active I.B and p55-A2-Luc ( luciferase reporter vector containing the kappa B binding sites), respectively, A. Berns ( The Netherlands Cancer Institute) for floxed Trp53 mice, and E. Fujita, Y. Ishiyama, R. Kobayashi and Y. Ishikawa for their excellent technical assistance. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture and Health and Labor Sciences Research Grants ( to I. K.); a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and grants from the Suzuken Memorial Foundation, the Japan Diabetes Foundation, the Ichiro Kanehara Foundation, the Tokyo Biochemical Research Foundation, the Takeda Science Foundation, the Cell Science Research Foundation and the Japan Foundation of Applied Enzymology ( to T. M.).	Benoit V, 2006, ONCOGENE, V25, P5708, DOI 10.1038/sj.onc.1209579; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Marino S, 2000, GENE DEV, V14, P994; Minamino T, 2008, NAT CLIN PRACT CARD, V5, P637, DOI 10.1038/ncpcardio1324; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x	31	564	579	6	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1082	U140		10.1038/nm.2014	http://dx.doi.org/10.1038/nm.2014			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19718037				2022-12-25	WOS:000269979200031
J	Rossi, AM; Riley, AM; Tovey, SC; Rahman, T; Dellis, O; Taylor, EJA; Veresov, VG; Potter, BVL; Taylor, CW				Rossi, Ana M.; Riley, Andrew M.; Tovey, Stephen C.; Rahman, Taufiq; Dellis, Olivier; Taylor, Emily J. A.; Veresov, Valery G.; Potter, Barry V. L.; Taylor, Colin W.			Synthetic partial agonists reveal key steps in IP3 receptor activation	NATURE CHEMICAL BIOLOGY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; POLY(ETHYLENE GLYCOL)-LINKED DIMERS; PROTEIN-PROTEIN DOCKING; LIGAND-BINDING SITE; CONFORMATIONAL-CHANGES; SUPPRESSOR DOMAIN; TRISPHOSPHATE; TYPE-1; CHANNELS; AFFINITY	Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) are ubiquitous intracellular Ca2+ channels. IP3 binding to the IP3-binding core (IBC) near the N terminus initiates conformational changes that lead to opening of a pore. The mechanisms underlying this process are unresolved. We synthesized 2-O-modified IP3 analogs that are partial agonists of IP3R. These are similar to IP3 in their interactions with the IBC, but they are less effective than IP3 in rearranging the relationship between the IBC and the N-terminal suppressor domain (SD), and they open the channel at slower rates. IP3R with a mutation in the SD occupying a position similar to the 2-O substituent of the partial agonists has a reduced open probability that is similar for full and partial agonists. Bulky or charged substituents from either the ligand or the SD therefore block obligatory coupling of the IBC and the SD. Analysis of. G for ligand binding shows that IP3 is recognized by the IBC and conformational changes then propagate entirely via the SD to the pore.	[Rossi, Ana M.; Tovey, Stephen C.; Rahman, Taufiq; Dellis, Olivier; Taylor, Emily J. A.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Riley, Andrew M.; Potter, Barry V. L.] Univ Bath, Dept Pharm & Pharmacol, Wolfson Lab Med Chem, Bath BA2 7AY, Avon, England; [Veresov, Valery G.] Natl Acad Sci Belarus, Inst Biophys & Cell Engn, Dept Cell Biophys, Minsk, BELARUS	University of Cambridge; University of Bath; National Academy of Sciences of Belarus (NASB); Institute of Biophysics & Cell Engineering of the National Academy of Sciences of Belarus	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	b.v.l.potter@bath.ac.uk; cwt1000@cam.ac.uk	rahman, taufiq/GON-8210-2022; Potter, Barry/AAX-4781-2020; Potter, Barry VL/A-1845-2012; Riley, Andrew M/F-3526-2013; Dellis, Olivier/E-8501-2011; rahman, taufiq/E-9806-2013; Taylor, Colin/G-2447-2010	rahman, taufiq/0000-0003-3830-5160; Riley, Andrew M/0000-0001-9003-3540; Dellis, Olivier/0000-0003-0377-9163; rahman, taufiq/0000-0003-3830-5160; Taylor, Colin/0000-0001-7771-1044; Taylor, Emily/0000-0001-7974-1538; Rossi, Ana Maria/0000-0001-8743-1089	Wellcome Trust; Biotechnology and Biological Sciences Research Council; Queens' College, Cambridge, UK; Biotechnology and Biological Sciences Research Council [BB/E004660/1] Funding Source: researchfish; BBSRC [BB/E004660/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Queens' College, Cambridge, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Dedos, P. da Fonseca, A. Burgen, S. Otto and M. Garcia Alai for helpful comments, and T. Woodman for advice on NMR spectroscopy. This work was supported by grants from the Wellcome Trust (to C. W. T., A. M. Riley and B. V. L. P.) and the Biotechnology and Biological Sciences Research Council (to C. W. T.). A. M. Rossi holds a Junior Research Fellowship at Queens' College, Cambridge, UK.	Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Bosanac I, 2004, BBA-MOL CELL RES, V1742, P89, DOI 10.1016/j.bbamcr.2004.09.016; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; BURGEN ASV, 1981, FED PROC, V40, P2723; Cardy TJA, 1997, BIOCHEM J, V328, P785, DOI 10.1042/bj3280785; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1971, LECTURES BIOSTATISTI, P279; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Jiang QX, 2002, EMBO J, V21, P3575, DOI 10.1093/emboj/cdf380; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; MacKinnon R, 2004, ANGEW CHEM INT EDIT, V43, P4265, DOI 10.1002/anie.200400662; Marwood RD, 2000, TETRAHEDRON-ASYMMETR, V11, P397, DOI 10.1016/S0957-4166(99)00491-7; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Poinas A, 2005, CHEMBIOCHEM, V6, P1449, DOI 10.1002/cbic.200400443; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; POTTER BVL, 1995, ANGEW CHEM INT EDIT, V34, P1933, DOI 10.1002/anie.199519331; Riley AM, 2004, BIOCHEM BIOPH RES CO, V318, P444, DOI 10.1016/j.bbrc.2004.04.051; Riley AM, 2004, BIOCONJUGATE CHEM, V15, P278, DOI 10.1021/bc034214s; Riley AM, 2002, J BIOL CHEM, V277, P40290, DOI 10.1074/jbc.M206925200; Riley AM, 2001, J MED CHEM, V44, P2108, DOI 10.1021/jm0005499; Riley AM, 1998, J ORG CHEM, V63, P295, DOI 10.1021/jo9714425; Riley AM, 2000, CHEM COMMUN, P983, DOI 10.1039/b002312o; Riley AM, 2006, CHEMBIOCHEM, V7, P1114, DOI 10.1002/cbic.200600037; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szlufcik K, 2006, CELL CALCIUM, V39, P325, DOI 10.1016/j.ceca.2005.11.007; TAKAHASHI M, 1994, J BIOL CHEM, V269, P369; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wagenknecht T, 2002, FRONT BIOSCI, V7, pD1464, DOI 10.2741/wagen; Williams DH, 2006, J MOL BIOL, V355, P760, DOI 10.1016/j.jmb.2005.11.015; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yoshikawa F, 1999, BIOCHEM BIOPH RES CO, V257, P792, DOI 10.1006/bbrc.1999.0498	50	55	55	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					631	639		10.1038/nchembio.195	http://dx.doi.org/10.1038/nchembio.195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19668195	Green Accepted, Green Submitted			2022-12-25	WOS:000269093000011
J	Suriben, R; Kivimae, S; Fisher, DAC; Moon, RT; Cheyette, BNR				Suriben, Rowena; Kivimaee, Saul; Fisher, Daniel A. C.; Moon, Randall T.; Cheyette, Benjamin N. R.			Posterior malformations in Dact1 mutant mice arise through misregulated Vangl2 at the primitive streak	NATURE GENETICS			English	Article							PLANAR-CELL-POLARITY; NEURAL-TUBE DEFECTS; BETA-CATENIN; EMBRYONIC-DEVELOPMENT; WNT SIGNALS; LOOP-TAIL; GASTRULATION MOVEMENTS; CONVERGENT EXTENSION; PRESOMITIC MESODERM; MOUSE EMBRYOS	Mice homozygous for mutations in Dact1 (also called Dapper or Frodo) phenocopy human malformations involving the spine, genitourinary system and distal digestive tract. We traced this phenotype to disrupted germ-layer morphogenesis at the primitive streak. Notably, heterozygous mutation of Vangl2, a transmembrane component of the planar cell polarity (PCP) pathway, rescued recessive Dact1 phenotypes, whereas loss of Dact1 reciprocally rescued semidominant Vangl2 phenotypes. We show that Dact1, an intracellular protein, forms a complex with Vangl2. In Dact1 mutants, Vangl2 was increased at the primitive streak, where cells ordinarily undergo an epithelial-mesenchymal transition. This is associated with abnormal E-cadherin distribution and changes in biochemical measures of the PCP pathway. We conclude that Dact1 contributes to morphogenesis at the primitive streak by regulating Vangl2 upstream of cell adhesion and the PCP pathway.	[Suriben, Rowena; Kivimaee, Saul; Fisher, Daniel A. C.; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Suriben, Rowena; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Grad Program Dev Biol, San Francisco, CA 94143 USA; [Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Cheyette, Benjamin N. R.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Cheyette, BNR (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	benjamin.cheyette@ucsf.edu	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019; Cheyette, Benjamin/K-5535-2014	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Cheyette, Benjamin/0000-0001-9934-7941	NICHD NIH HHS [R01 HD055300-01, R01 HD055300, R01HD055300, R01 HD055300-03, R01 HD055300-02] Funding Source: Medline; NIMH NIH HHS [K08 MH001750-05, K08MH001750, K08 MH001750-04, K08 MH001750-03] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001750] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; COPP AJ, 1994, DEV BIOL, V165, P20, DOI 10.1006/dbio.1994.1230; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Duesterhoeft SM, 2007, AM J MED GENET A, V143A, P3175, DOI 10.1002/ajmg.a.32028; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hunter NL, 2006, DEV DYNAM, V235, P279, DOI 10.1002/dvdy.20609; Hyenne V, 2005, DEV BIOL, V287, P180, DOI 10.1016/j.ydbio.2005.09.004; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; Klingensmith J, 1996, MECH DEVELOP, V58, P15, DOI 10.1016/S0925-4773(96)00549-7; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Le Douarin NM, 1998, INT J DEV BIOL, V42, P909; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; MANZONI GA, 1987, J UROLOGY, V138, P1065, DOI 10.1016/S0022-5347(17)43503-8; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park E, 2006, DEV BIOL, V292, P344, DOI 10.1016/j.ydbio.2006.01.011; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; PAULI RM, 1994, AM J MED GENET, V50, P154, DOI 10.1002/ajmg.1320500206; Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; STEVENSON RE, 1986, PEDIATRICS, V78, P451; Suriben R, 2006, DEV DYNAM, V235, P3177, DOI 10.1002/dvdy.20968; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; TAM PPL, 1986, J EMBRYOL EXP MORPH, V92, P269; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Vandenberg AL, 2009, DEVELOPMENT, V136, P1559, DOI 10.1242/dev.034066; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	50	62	66	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					977	U40		10.1038/ng.435	http://dx.doi.org/10.1038/ng.435			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19701191	Green Submitted, Green Accepted			2022-12-25	WOS:000269382100008
J	Singh, RK; Kabbaj, MHM; Paik, J; Gunjan, A				Singh, Rakesh Kumar; Kabbaj, Marie-Helene Miquel; Paik, Johanna; Gunjan, Akash			Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-CONJUGATING ENZYMES; MITOTIC CHROMOSOME TRANSMISSION; SACCHAROMYCES-CEREVISIAE; S-PHASE; DNA-SYNTHESIS; CELL-CYCLE; RAD53 KINASE; H3 VARIANT; IN-VIVO; YEAST	Histone levels are tightly regulated to prevent harmful effects such as genomic instability and hypersensitivity to DNA-damaging agents due to the accumulation of these highly basic proteins when DNA replication slows down or stops. Although chromosomal histones are stable, excess (non-chromatin bound) histones are rapidly degraded in a Rad53 (radiation sensitive 53) kinase-dependent manner in Saccharomyces cerevisiae. Here we demonstrate that excess histones associate with Rad53 in vivo and seem to undergo modifications such as tyrosine phosphorylation and polyubiquitylation, before their proteolysis by the proteasome. We have identified the Tyr 99 residue of histone H3 as being critical for the efficient ubiquitylation and degradation of this histone. We have also identified the ubiquitin conjugating enzymes (E2) Ubc4 and Ubc5, as well as the ubiquitin ligase (E3) Tom1 (temperature dependent organization in mitotic nucleus 1), as enzymes involved in the ubiquitylation of excess histones. Regulated histone proteolysis has major implications for the maintenance of epigenetic marks on chromatin, genomic stability and the packaging of sperm DNA.	[Singh, Rakesh Kumar; Kabbaj, Marie-Helene Miquel; Paik, Johanna; Gunjan, Akash] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Gunjan, A (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, 1115 W Call St, Tallahassee, FL 32306 USA.	akash.gunjan@med.fsu.edu		Gunjan, Akash/0000-0001-8478-3978	Florida Department of Health [07BN-02]; NIH [R15GM079678-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM079678] Funding Source: NIH RePORTER	Florida Department of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Diffley, D. Finley, M. Hochstrasser, S. Jentsch, N. Lowndes, C. Mann, H. Masumoto, M. A. Osley, R. Rothstein, D. Stern, D. Stillman, J. Svejstrup, A. Verreault and Y. Wang for strains and reagents, A. Verreault and D. Brown for critical reading of this manuscript, M. Abdul-Rauf for construction of the pYES2-HTH and pYES2-HTH-HHT2 plasmids, as well as the H4 mutants used in the Supplementary Information and undergraduate students S. Eckley and M. Gonzalez for technical assistance with the collection of many litres of yeast cultures for our experiments. We thank M. Blaber for assistance with the structural modelling of the Y 99 residue of histone H3, shown in Supplementary Information, Fig. S8. Research in AG's laboratory is supported by a Bankhead-Coley Cancer Research Program grant (07BN-02) from the Florida Department of Health and research in JP's laboratory is funded by a NIH grant (R15GM079678-01).	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; BONNER WM, 1988, BIOCHEMISTRY-US, V27, P6542, DOI 10.1021/bi00417a052; Chen HY, 1998, J BIOL CHEM, V273, P13165, DOI 10.1074/jbc.273.21.13165; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; DAVIE JR, 1985, ANAL BIOCHEM, V144, P522, DOI 10.1016/0003-2697(85)90149-6; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Eriksson PR, 2005, MOL CELL BIOL, V25, P9127, DOI 10.1128/MCB.25.20.9127-9137.2005; Geng FQ, 2008, MOL BIOL CELL, V19, P3616, DOI 10.1091/mbc.E08-01-0050; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Gunjan A, 2006, CURR OPIN GENET DEV, V16, P112, DOI 10.1016/j.gde.2006.02.010; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HILT W, 1993, J BIOL CHEM, V268, P3479; Kaygun H, 2005, MOL CELL BIOL, V25, P6879, DOI 10.1128/MCB.25.16.6879-6888.2005; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LI W, 1993, BIOCHEM J, V296, P737, DOI 10.1042/bj2960737; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matuschewski K, 1996, J BIOL CHEM, V271, P2789, DOI 10.1074/jbc.271.5.2789; Mayor T, 2005, MOL CELL PROTEOMICS, V4, P741, DOI 10.1074/mcp.M400220-MCP200; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Meistrich M., 1989, HISTONES OTHER BASIC, P165; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Rajapurohitam V, 1999, DEV BIOL, V212, P217, DOI 10.1006/dbio.1999.9342; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Saleh A, 1998, J MOL BIOL, V282, P933, DOI 10.1006/jmbi.1998.2036; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SHAN XY, 1994, J CELL BIOL, V126, P853, DOI 10.1083/jcb.126.4.853; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; SPENCER F, 1990, GENETICS, V124, P237; Steger DJ, 1999, METHODS, V19, P410, DOI 10.1006/meth.1999.0877; STERN DF, 1991, MOL CELL BIOL, V11, P987, DOI 10.1128/MCB.11.2.987; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; TSVETKOV S, 1989, EXP CELL RES, V180, P94, DOI 10.1016/0014-4827(89)90215-2; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Utsugi T, 1999, GENE, V234, P285, DOI 10.1016/S0378-1119(99)00197-3; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wing SS, 1996, MOL CELL BIOL, V16, P4064; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; WUNSCH AM, 1989, J CELL PHYSIOL, V141, P97, DOI 10.1002/jcp.1041410115; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	65	144	147	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					925	U40		10.1038/ncb1903	http://dx.doi.org/10.1038/ncb1903			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19578373	Green Accepted			2022-12-25	WOS:000268593200005
J	Zalatan, JG; Herschlag, D				Zalatan, Jesse G.; Herschlag, Daniel			The far reaches of enzymology	NATURE CHEMICAL BIOLOGY			English	Article							MECHANISTIC ASPECTS; ENZYME; CATALYSIS; RNA; REPLICATION; PROMISCUITY; EVOLUTION; COMPLEX	The scope of enzymology has expanded rapidly over the last century, from an early focus on the chemical and catalytic mechanisms of individual enzymes to more recent efforts to understand enzyme action in the context of dynamic, functional biological systems consisting of many interacting enzymes and proteins. Continuing progress in probing the link between molecular structure and function now promises to pave the way for a deeper understanding of the evolution and behavior of the complex biological systems that govern cellular behavior.	[Zalatan, Jesse G.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Zalatan, JG (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	zalatan@cmp.ucsf.edu; herschla@stanford.edu		Zalatan, Jesse/0000-0002-1458-0654				Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; BELL RM, 1971, SCIENCE, V172, P1253, DOI 10.1126/science.172.3989.1253; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BRUICE TC, 1971, P NATL ACAD SCI USA, V68, P658, DOI 10.1073/pnas.68.3.658; BRUICE TC, 1966, BIOORGANIC MECH; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FISHER HF, 1953, J BIOL CHEM, V202, P687; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JENCKS WP, 1989, METHOD ENZYMOL, V171, P145; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; KOKESH FC, 1971, J AM CHEM SOC, V93, P7270, DOI 10.1021/ja00755a025; KORNBERG A, 1990, METHOD ENZYMOL, V182, P1; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Narlikar GJ, 1997, ANNU REV BIOCHEM, V66, P19, DOI 10.1146/annurev.biochem.66.1.19; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polanyi M, 1921, Z ELKTROCHEM ANGEW P, V27, P142; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; STORM DR, 1970, P NATL ACAD SCI USA, V66, P445, DOI 10.1073/pnas.66.2.445; TISELIUS AWK, 1964, NOBEL LECTURES CHEM, P195; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VOET JG, 1970, J BIOL CHEM, V245, P1020; WOLFENDEN R, 1976, ANNU REV BIOPHYS BIO, V5, P271, DOI 10.1146/annurev.bb.05.060176.001415	30	19	20	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					516	520		10.1038/nchembio0809-516	http://dx.doi.org/10.1038/nchembio0809-516			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19620986				2022-12-25	WOS:000268209200002
J	Cai, S; O'Connell, CB; Khodjakov, A; Walczak, CE				Cai, Shang; O'Connell, Christopher B.; Khodjakov, Alexey; Walczak, Claire E.			Chromosome congression in the absence of kinetochore fibres	NATURE CELL BIOLOGY			English	Article							NEWT LUNG-CELLS; CENP-E; MICROTUBULE ATTACHMENT; MAMMALIAN-CELLS; SPINDLE; MECHANISMS; CAPTURE; PROTEIN; METAPHASE; INSTABILITY	Proper chromosome congression (the process of aligning chromosomes on the spindle) contributes to accurate and faithful chromosome segregation. It is widely accepted that congression requires kinetochore fibres (K-fibres), microtubule bundles that extend from the kinetochores to spindle poles(1,2). Here, we demonstrate that chromosomes in human cells co-depleted of HSET (human kinesin-14)(3,4) and hNuf2 (human Ndc80/Hec1-complex component) 5 can congress to the metaphase plate in the absence of K-fibres. However, the chromosomes are not stably maintained at the metaphase plate under these conditions. Chromosome congression in HSET + hNuf2 co-depleted cells required the plus-end directed motor CENP-E (centromere protein E; kinesin-7 family member) 6, which has been implicated in the gliding of mono-oriented kinetochores alongside adjacent K-fibres(7). Thus, proper end-on attachment of kinetochores to microtubules is not necessary for chromosome congression. Instead, our data support the idea that congression allows unattached chromosomes to move to the middle of the spindle where they have a higher probability of establishing connections with both spindle poles. These bi-oriented connections are also used to maintain stable chromosome alignment at the spindle equator.	[Walczak, Claire E.] Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA; [Cai, Shang] Indiana Univ, Biochem Program, Bloomington, IN 47405 USA; [O'Connell, Christopher B.; Khodjakov, Alexey] New York State Dept Hlth, Div Mol Med, Wadsworth Ctr, Albany, NY 12201 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; State University of New York (SUNY) System; Wadsworth Center	Walczak, CE (corresponding author), Indiana Univ, Med Sci Program, Myers Hall 262,915 E 3rd St, Bloomington, IN 47405 USA.	cwalczak@indiana.edu		Cai, Shang/0000-0003-0630-7719	NIH [GM59618, GM59363, GM077911]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059618, R01GM059363, F32GM077911] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ems-McClung and J. Powers for discussions and critical comments on the manuscript, G. Fang for HURP antibodies, D. Compton for HSET constructs, B. Sullivan for the GFP-CENP A construct and T. Yen for the CENP-E antibody. S. C. is grateful to members of the Marine Biological Laboratory Physiology course for instruction in imaging and many thoughtful discussions. The Indiana University Bloomington Light Microscopy Imaging Center and Wadsworth Center's electron microscopy Core facility provided microscopy resources. This work was supported by NIH grants (GM59618) to C. E. W. and (GM59363) A. K; C. B. O. was supported by a Kirschstein- National Research Service Award post-doctoral fellowship (GM077911).	Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Heald Rebecca, 2009, P231, DOI 10.1007/978-0-387-69076-6_8; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; KIRSCHNER MW, 1986, NATURE, V324, P621, DOI 10.1038/324621a0; Maiato H, 2004, CHROMOSOME RES, V12, P585, DOI 10.1023/B:CHRO.0000036587.26566.81; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; NICKLAS RB, 1992, J CELL SCI, V102, P681; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1999, METHOD CELL BIOL, V61, P297; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Rodriguez A, 1999, ANAL BIOCHEM, V272, P171, DOI 10.1006/abio.1999.4156; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Vorozhko VV, 2008, CHROMOSOMA, V117, P169, DOI 10.1007/s00412-007-0135-3; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	30	118	120	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					832	U118		10.1038/ncb1890	http://dx.doi.org/10.1038/ncb1890			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525938	Green Accepted			2022-12-25	WOS:000267603100011
J	Tang, Y; Wu, XW; Lei, WQ; Pang, LJ; Wan, C; Shi, ZQ; Zhao, L; Nagy, TR; Peng, XY; Hu, JB; Feng, X; Van Hul, W; Wan, M; Cao, X				Tang, Yi; Wu, Xiangwei; Lei, Weiqi; Pang, Lijuan; Wan, Chao; Shi, Zhenqi; Zhao, Ling; Nagy, Timothy R.; Peng, Xinyu; Hu, Junbo; Feng, Xu; Van Hul, Wim; Wan, Mei; Cao, Xu			TGF-beta 1-induced migration of bone mesenchymal stem cells couples bone resorption with formation	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; CAMURATI-ENGELMANN-DISEASE; LATENCY-ASSOCIATED PEPTIDE; DOMAIN-SPECIFIC MUTATIONS; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; DIFFERENT POPULATIONS; ACTIVATION; COMPLEX; MATRIX	Bone remodeling depends on the precise coordination of bone resorption and subsequent bone formation. Disturbances of this process are associated with skeletal diseases, such as Camurati-Engelmann disease (CED). We show using in vitro and in vivo models that active TGF-beta 1 released during bone resorption coordinates bone formation by inducing migration of bone marrow stromal cells, also known as bone mesenchymal stem cells, to the bone resorptive sites and that this process is mediated through a SMAD signaling pathway. Analyzing mice carrying a CED-derived mutant TGFB1 (encoding TGF-beta 1), which show the typical progressive diaphyseal dysplasia seen in the human disease, we found high levels of active TGF-beta 1 in the bone marrow. Treatment with a TGF-beta type I receptor inhibitor partially rescued the uncoupled bone remodeling and prevented the fractures. Thus, as TGF-beta 1 functions to couple bone resorption and formation, modulation of TGF-beta 1 activity could be an effective treatment for bone remodeling diseases.	[Tang, Yi; Wu, Xiangwei; Lei, Weiqi; Pang, Lijuan; Wan, Chao; Shi, Zhenqi; Zhao, Ling; Feng, Xu; Wan, Mei; Cao, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Wu, Xiangwei; Hu, Junbo] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Wu, Xiangwei; Peng, Xinyu] Shihezi Univ, Sch Med, Affiliated Hosp 1, Shihezi, Xinjiang, Peoples R China; [Pang, Lijuan] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Nagy, Timothy R.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Van Hul, Wim] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium	University of Alabama System; University of Alabama Birmingham; Huazhong University of Science & Technology; Shihezi University; Shihezi University; University of Alabama System; University of Alabama Birmingham; University of Antwerp	Cao, X (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	cao@uab.edu	Wan, Chao/J-9277-2013; zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022; Sui, Yanwei/AAH-9928-2021	Wan, Chao/0000-0001-6780-2006; Nagy, Tim/0000-0002-2371-7114; Van Hul, Wim/0000-0002-5065-7858	US National Institutes of Health [AR 053973, DK057501]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057501, Z01DK057501] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank F. Hunter and T. Clemens for critical review and discussion of the manuscript and H. L. Moses (Vanderbilt University), C. Deng (US National Institutes of Health), J. Murphy-Ullrich (University of Alabama at Birmingham) and W. Xiong (Medical College of Georgia) for reagents. We thank the UAB Center for Metabolic Bone Disease Cores for mouse phenotyping, histomorphometry and molecular analyses. This research was supported by US National Institutes of Health grants AR 053973 and DK057501.	Atti E, 2002, BONE, V31, P675, DOI 10.1016/S8756-3282(02)00905-5; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bismar H, 1999, BONE, V24, P565, DOI 10.1016/S8756-3282(99)00082-4; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; DALLAS SL, 1994, J BIOL CHEM, V269, P6815; Dennis JE, 2002, CELLS TISSUES ORGANS, V170, P73, DOI 10.1159/000046182; Engle SJ, 2002, CANCER RES, V62, P6362; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hecht JT, 2001, CLIN GENET, V59, P198, DOI 10.1034/j.1399-0004.2001.590310.x; Hill P A, 1998, Br J Orthod, V25, P101; Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; HUGHES FJ, 1992, BONE MINER, V19, P63, DOI 10.1016/0169-6009(92)90844-4; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Janssens K, 2003, J BIOL CHEM, V278, P7718, DOI 10.1074/jbc.M208857200; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Leucht P, 2007, BONE, V40, P919, DOI 10.1016/j.bone.2006.10.027; Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; MARTIN TJ, 1993, GROWTH REGULAT, V3, P209; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Mirmalek-Sani SH, 2006, STEM CELLS, V24, P1042, DOI 10.1634/stemcells.2005-0368; MUNDY GR, 1994, RHEUM DIS CLIN N AM, V20, P577; OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2; OWEN M, 1988, CIBA F SYMP, V136, P42; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pedrozo HA, 1999, ENDOCRINOLOGY, V140, P5806, DOI 10.1210/en.140.12.5806; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P825; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P49, DOI 10.1002/jbmr.5650050109; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; ROBERTS AB, 1983, FED PROC, V42, P2621; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saito T, 2001, J BIOL CHEM, V276, P11469, DOI 10.1074/jbc.C000859200; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zink AR, 2005, JAMA-J AM MED ASSOC, V293, P40, DOI 10.1001/jama.293.1.40-c	57	774	817	8	190	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					757	U9		10.1038/nm.1979	http://dx.doi.org/10.1038/nm.1979			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19584867	Green Accepted			2022-12-25	WOS:000267806900028
J	Mencia, A; Modamio-Hoybjor, S; Redshaw, N; Morin, M; Mayo-Merino, F; Olavarrieta, L; Aguirre, LA; del Castillo, I; Steel, KP; Dalmay, T; Moreno, F; Moreno-Pelayo, MA				Mencia, Angeles; Modamio-Hoybjor, Silvia; Redshaw, Nick; Morin, Matias; Mayo-Merino, Fernando; Olavarrieta, Leticia; Aguirre, Luis A.; del Castillo, Ignacio; Steel, Karen P.; Dalmay, Tamas; Moreno, Felipe; Angel Moreno-Pelayo, Miguel			Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss	NATURE GENETICS			English	Article							GENE; EXPRESSION; MICRORNAS; TARGET; MIRNA; SITE; RNA	MicroRNAs (miRNAs) bind to complementary sites in their target mRNAs to mediate post-transcriptional repression(1,2), with the specificity of target recognition being crucially dependent on the miRNA seed region(3). Impaired miRNA target binding resulting from SNPs within mRNA target sites has been shown to lead to pathologies associated with dysregulated gene expression(4-7). However, no pathogenic mutations within the mature sequence of a miRNA have been reported so far. Here we show that point mutations in the seed region of miR-96, a miRNA expressed in hair cells of the inner ear(8), result in autosomal dominant, progressive hearing loss. This is the first study implicating a miRNA in a mendelian disorder. The identified mutations have a strong impact on miR-96 biogenesis and result in a significant reduction of mRNA targeting. We propose that these mutations alter the regulatory role of miR-96 in maintaining gene expression profiles in hair cells required for their normal function.	[Mencia, Angeles; Modamio-Hoybjor, Silvia; Morin, Matias; Mayo-Merino, Fernando; Olavarrieta, Leticia; Aguirre, Luis A.; del Castillo, Ignacio; Moreno, Felipe; Angel Moreno-Pelayo, Miguel] Hosp Ramon & Cajal, Unidad Genet Mol, E-28034 Madrid, Spain; [Mencia, Angeles; Modamio-Hoybjor, Silvia; Morin, Matias; Mayo-Merino, Fernando; Olavarrieta, Leticia; Aguirre, Luis A.; del Castillo, Ignacio; Moreno, Felipe; Angel Moreno-Pelayo, Miguel] ISCIII, CIBERER, Madrid, Spain; [Redshaw, Nick; Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Steel, Karen P.] Wellcome Trust Sanger Inst, Cambridge, England	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of East Anglia; Wellcome Trust Sanger Institute	Moreno-Pelayo, MA (corresponding author), Hosp Ramon & Cajal, Unidad Genet Mol, E-28034 Madrid, Spain.	mmoreno.hrc@salud.madrid.org	Pérez, Luis Augusto Aguirre/J-2175-2015; Mencia, Angeles/H-8688-2017; Aguirre, Luis/ABD-8789-2021; Dalmay, Tamas/E-1377-2011; MORIN, MATIAS/H-5411-2011; Olavarrieta, Leticia/GYQ-5751-2022; Mencia, Angeles/AAE-4134-2021; del Castillo, Ignacio/B-4314-2013	Pérez, Luis Augusto Aguirre/0000-0003-0903-9385; Dalmay, Tamas/0000-0003-1492-5429; MORIN, MATIAS/0000-0002-7985-592X; del Castillo, Ignacio/0000-0003-1188-3665; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098; Mayo-Merino, Fernando/0000-0001-5714-4003	L'Oreal-UNESCO "for women in Science''; Spanish Ministerio de Ciencia y Tecnologia; Spanish Ministerio de Ciencia y Tecnologia [SAF2005-06355]; Spanish Fondo de Investigaciones anitarias [FIS CP03/00014, PI08/0045, PI-051942, G03/203]; European Commission [LSHG-CT-2006-037900, LSHG-CT-2004-512063]; Deafness Research UK; Wellcome Trust; MRC [G0300212, MC_qA137918] Funding Source: UKRI; Medical Research Council [G0300212, MC_qA137918] Funding Source: researchfish; RNID [G41] Funding Source: researchfish	L'Oreal-UNESCO "for women in Science''(L'Oreal Group); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Fondo de Investigaciones anitarias(Instituto de Salud Carlos III); European Commission(European CommissionEuropean Commission Joint Research Centre); Deafness Research UK; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID	We thank members of the Spanish families whose participation made this study possible. We also express our gratitude to A. Fatica and I. Bozzoni (Universita di Roma "La Sapienza'') for the donation of the microRNA expression vector and to P. Morales (Hospital 12 de Octubre) for providing control DNAs. S. M.-H. is recipient of a fellowship from L'Oreal-UNESCO "for women in Science''. A. M. is recipient of a contract from the Centre for Biomedical Research on Rare Diseases (CIBERER) and M. M. is recipient of a contract from the EuroHear project. F. M.-M. is a fellow from the Spanish Ministerio de Ciencia y Tecnologia. This work was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (SAF2005-06355 to F. M.), Spanish Fondo de Investigaciones anitarias (FIS CP03/00014 and PI08/0045 to M. A. M.-P; PI-051942; G03/203), the European Commission (FP6 Integrated Projects: SIROCCO LSHG-CT-2006-037900 to T. D.; EUROHEAR, LSHG-CT-2004-512063), Deafness Research UK and the Wellcome Trust.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; Denti MA, 2004, MOL THER, V10, P191, DOI 10.1016/j.ymthe.2004.04.008; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Enright AJ, 2004, GENOME BIOL, V5; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; JENSEN KP, MOL PSYCHIATR, DOI DOI 10.1038/MP.2008.15; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Modamio-Hoybjor S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012500; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	381	432	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					609	613		10.1038/ng.355	http://dx.doi.org/10.1038/ng.355			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19363479				2022-12-25	WOS:000265575600024
J	Chen, YG; Kowtoniuk, WE; Agarwal, I; Shen, YH; Liu, DR				Chen, Y. Grace; Kowtoniuk, Walter E.; Agarwal, Isha; Shen, Yinghua; Liu, David R.			LC/MS analysis of cellular RNA reveals NAD-linked RNA	NATURE CHEMICAL BIOLOGY			English	Article							DNA; COENZYMES; LIBRARY; GENE; COA	We developed a general method to detect cellular small molecule-RNA conjugates that does not rely on the reactivity of the small molecule. This technique revealed NAD-linked RNA in Escherichia coli and Streptomyces venezuelae. Subsequent characterization showed that NAD is a 5' modification of RNA, cannot be installed in vitro through aberrant transcriptional initiation, is only found among smaller cellular RNAs and is present at a surprisingly high abundance of similar to 3,000 copies per cell.	[Chen, Y. Grace; Kowtoniuk, Walter E.; Agarwal, Isha; Shen, Yinghua; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Chen, Y. Grace; Kowtoniuk, Walter E.; Agarwal, Isha; Shen, Yinghua; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Liu, DR (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022		Howard Hughes Medical Institute; US National Institute of General Medical Sciences, National Institutes of Health [R01GM065865]; US National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute and the US National Institute of General Medical Sciences, National Institutes of Health (R01GM065865). Y. G. C. and W. E. K. gratefully acknowledge US National Science Foundation Graduate Research Fellowships.	BREAKER RR, 1995, J MOL EVOL, V40, P551, DOI 10.1007/BF00160500; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; FURUICHI Y, 1975, NATURE, V253, P374, DOI 10.1038/253374a0; Gartner ZJ, 2004, SCIENCE, V305, P1601, DOI 10.1126/science.1102629; Grosjean H, 2005, TOP CURR GENET, V12, P1, DOI 10.1007/b106848; Hiley SL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni002; HOAGLAND MB, 1958, J BIOL CHEM, V231, P241; Huang FQ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng008; JAKUBOWSKI H, 1984, J BACTERIOL, V158, P769, DOI 10.1128/JB.158.3.769-776.1984; Kowtoniuk WE, 2009, P NATL ACAD SCI USA, V106, P7768, DOI 10.1073/pnas.0900528106; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Romier C, 1998, PROTEINS, V32, P414, DOI 10.1002/(SICI)1097-0134(19980901)32:4<414::AID-PROT2>3.3.CO;2-5; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Tse BN, 2008, J AM CHEM SOC, V130, P15611, DOI 10.1021/ja805649f; Tsukiji S, 2004, J AM CHEM SOC, V126, P5044, DOI 10.1021/ja0495213; VISSER CM, 1978, J MOL EVOL, V11, P163, DOI 10.1007/BF01733891; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; WYATT GR, 1950, NATURE, V166, P237, DOI 10.1038/166237b0	25	120	127	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					879	881		10.1038/nchembio.235	http://dx.doi.org/10.1038/nchembio.235			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19820715	Green Accepted, Green Submitted			2022-12-25	WOS:000271756900007
J	Benyamin, B; Ferreira, MAR; Willemsen, G; Gordon, S; Middelberg, RPS; McEvoy, BP; Hottenga, JJ; Henders, AK; Campbell, MJ; Wallace, L; Frazer, IH; Heath, AC; de Geus, EJC; Nyholt, DR; Visscher, PM; Penninx, BW; Boomsma, DI; Martin, NG; Montgomery, GW; Whitfield, JB				Benyamin, Beben; Ferreira, Manuel A. R.; Willemsen, Gonneke; Gordon, Scott; Middelberg, Rita P. S.; McEvoy, Brian P.; Hottenga, Jouke-Jan; Henders, Anjali K.; Campbell, Megan J.; Wallace, Leanne; Frazer, Ian H.; Heath, Andrew C.; de Geus, Eco J. C.; Nyholt, Dale R.; Visscher, Peter M.; Penninx, Brenda W.; Boomsma, Dorret I.; Martin, Nicholas G.; Montgomery, Grant W.; Whitfield, John B.			Common variants in TMPRSS6 are associated with iron status and erythrocyte volume	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MATRIPTASE-2 TMPRSS6; HEPCIDIN EXPRESSION; SERINE-PROTEASE; DISORDER; HFE	We report a genome-wide association study to iron status. We identify an association of SNPs in TPMRSS6 to serum iron (rs855791, combined P = 1.5 x 10(-20)), transferrin saturation (combined P = 2.2 x 10(-23)) and erythrocyte mean cell volume (MCV, combined P = 1.1 x 10(-10)). We also find suggestive evidence of association with blood hemoglobin levels (combined P = 5.3 x 10(-7)). These findings demonstrate the involvement of TMPRSS6 in control of iron homeostasis and in normal erythropoiesis.	[Benyamin, Beben; Ferreira, Manuel A. R.; Gordon, Scott; Middelberg, Rita P. S.; McEvoy, Brian P.; Henders, Anjali K.; Campbell, Megan J.; Wallace, Leanne; Nyholt, Dale R.; Visscher, Peter M.; Martin, Nicholas G.; Montgomery, Grant W.; Whitfield, John B.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Willemsen, Gonneke; Hottenga, Jouke-Jan; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Frazer, Ian H.] Univ Queensland, Princess Alexandra Hosp, Ctr Immunol & Canc Res, Brisbane, Qld, Australia; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Heath, Andrew C.] Midwest Alcoholism Res Ctr, St Louis, MO USA; [Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands	QIMR Berghofer Medical Research Institute; Vrije Universiteit Amsterdam; University of Queensland; Washington University (WUSTL); Vrije Universiteit Amsterdam	Benyamin, B (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	bebenB@qimr.edu.au	Wallace, Leanne/V-2097-2018; Boomsma, Dorret I/AAX-4470-2020; Nyholt, Dale Robert/J-3174-2017; Benyamin, Beben/D-9195-2012; Ferreira, Manuel A R/D-3609-2013; Visscher, Peter/ABB-6151-2020; Montgomery, Grant W/B-7148-2008; de Geus, Eco J.C./M-9318-2015; Penninx, Brenda WJH/S-7627-2017; Frazer, Ian/A-1137-2007; Henders, Anjali/E-3126-2017	Wallace, Leanne/0000-0003-4310-7572; Nyholt, Dale Robert/0000-0001-7159-3040; Benyamin, Beben/0000-0001-5608-2293; Ferreira, Manuel A R/0000-0001-9059-1825; Visscher, Peter/0000-0002-2143-8760; Montgomery, Grant W/0000-0002-4140-8139; de Geus, Eco J.C./0000-0001-6022-2666; Penninx, Brenda WJH/0000-0001-7779-9672; Campbell, Megan/0000-0002-6056-6140; Frazer, Ian/0000-0002-8002-4680; Willemsen, Gonneke/0000-0003-3755-0236; Martin, Nicholas/0000-0003-4069-8020; Whitfield, John/0000-0002-1103-0876; Henders, Anjali/0000-0003-3672-1451	Australian National Health and Medical Research Council (NHMRC) [241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485]; US National Institutes of Health (NIH) [AA07535, AA10248, AA014041]; Australian Research Council (ARC) [DP0770096]; Netherlands Society for Scientific Research [NWO 904-61-090, 904-61-193, 480-04-004, 400-05-717, SPI 56-464-14192]; Center for Medical Systems Biology (NWO Genomics); ZonMW [10-000-1002]; universities and mental health care institutes involved in NESDA (GGZ Buitenamstel-Geestgronden, Rivierduinen, University Medical Center Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe); Centre for Neurogenomics and Cognitive Research VU University (CNCR-VU); European Science Foundation [EU/QLRT-2001-01254]; NIMH [R01 MH059160]; NTR; NESDA; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health; GAIN; National Institute of Mental Health [MH081802]; NHMRC [5524983]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081802, R01MH059160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007535, R01AA014041, R01AA010249] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC)(Australian Research Council); Netherlands Society for Scientific Research; Center for Medical Systems Biology (NWO Genomics); ZonMW(Netherlands Organization for Health Research and Development); universities and mental health care institutes involved in NESDA (GGZ Buitenamstel-Geestgronden, Rivierduinen, University Medical Center Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe); Centre for Neurogenomics and Cognitive Research VU University (CNCR-VU); European Science Foundation(European Science Foundation (ESF)European Commission); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NTR; NESDA; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GAIN; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We are grateful to the twins and their families for their generous participation in these studies. We would like to thank staff at the Queensland Institute of Medical Research: D. Statham, A. Eldridge and M. Grace for the Australian sample collection; L. Bowdler, S. Crooks and staff of the Molecular Epidemiology Laboratory for sample processing and preparation; D. Smyth and H. Beeby for IT support; M. Wright for supervision and A. McRae and S. Medland for discussion. For the Australian study, we acknowledge funding from the Australian National Health and Medical Research Council (NHMRC grants 241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739 and 552485), US National Institutes of Health (NIH grants AA07535, AA10248 and AA014041) and the Australian Research Council (ARC grant DP0770096). For the Netherlands Twin Registry (NTR) and the Netherlands Study of Depression and Anxiety (NESDA) samples, we acknowledge support from The Netherlands Society for Scientific Research (NWO 904-61-090; 904-61-193; 480-04-004; 400-05-717; SPI 56-464-14192), Center for Medical Systems Biology (NWO Genomics); Geestkracht program of ZonMW (10-000-1002); matching funds from universities and mental health care institutes involved in NESDA (GGZ Buitenamstel-Geestgronden, Rivierduinen, University Medical Center Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe); Centre for Neurogenomics and Cognitive Research VU University (CNCR-VU); European Science Foundation (EU/QLRT-2001-01254); NIMH (R01 MH059160); and matching funds from participating institutes in NTR and NESDA. Genotyping of NTR and NESDA samples was funded by the Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health, and analysis was supported by grants from GAIN and the National Institute of Mental Health (MH081802). B. B. is the recipient of an NHMRC Biomedical Postdoctoral Fellowship (552498). D. R. N., G. W. M and P. M. V. are supported by the NHMRC Fellowship Scheme.	Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Muckenthaler MU, 2008, CELL METAB, V8, P1, DOI 10.1016/j.cmet.2008.06.009; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862	12	191	201	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2009	41	11					1173	1175		10.1038/ng.456	http://dx.doi.org/10.1038/ng.456			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19820699	Green Published, Green Accepted			2022-12-25	WOS:000271247600007
J	Cheng, ZY; Guo, SD; Copps, K; Dong, XC; Kollipara, R; Rodgers, JT; Depinho, RA; Puigserver, P; White, MF				Cheng, Zhiyong; Guo, Shaodong; Copps, Kyle; Dong, Xiaochen; Kollipara, Ramya; Rodgers, Joseph T.; Depinho, Ronald A.; Puigserver, Pere; White, Morris F.			Foxo1 integrates insulin signaling with mitochondrial function in the liver	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCOSE-PRODUCTION; HUMAN SKELETAL-MUSCLE; DYSFUNCTION; RECEPTOR; ALPHA; EXPRESSION; RESISTANCE; INDUCTION; OXIDATION	Type 2 diabetes is a complex disease that is marked by the dysfunction of glucose and lipid metabolism. Hepatic insulin resistance is especially pathogenic in type 2 diabetes, as it dysregulates fasting and postprandial glucose tolerance and promotes systemic dyslipidemia and nonalcoholic fatty liver disease(1,2). Mitochondrial dysfunction is closely associated with insulin resistance and might contribute to the progression of diabetes(3,4). Here we used previously generated mice(5) with hepatic insulin resistance owing to the deletion of the genes encoding insulin receptor substrate-1 (Irs-1) and Irs-2 (referred to here as double-knockout (DKO) mice) to establish the molecular link between dysregulated insulin action and mitochondrial function. The expression of several forkhead box O1 (Foxo1) target genes increased in the DKO liver, including heme oxygenase-1 (Hmox1), which disrupts complex III and IV of the respiratory chain and lowers the NAD(+)/NADH ratio and ATP production. Although peroxisome proliferator-activated receptor-gamma coactivator-1 gamma (Ppargc-1 alpha) was also upregulated in DKO liver, it was acetylated and failed to promote compensatory mitochondrial biogenesis or function. Deletion of hepatic Foxo1 in DKO liver normalized the expression of Hmox1 and the NAD(+)/NADH ratio, reduced Ppargc-1 alpha acetylation and restored mitochondrial oxidative metabolism and biogenesis. Thus, Foxo1 integrates insulin signaling with mitochondrial function, and inhibition of Foxo1 can improve hepatic metabolism during insulin resistance and the metabolic syndrome.	[Cheng, Zhiyong; Guo, Shaodong; Copps, Kyle; Dong, Xiaochen; White, Morris F.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Div Endocrinol,Childrens Hosp Boston, Boston, MA 02115 USA; [Kollipara, Ramya; Depinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Dept Med Oncol,Belfer Inst Appl Canc Sci, Boston, MA USA; [Kollipara, Ramya; Depinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Rodgers, Joseph T.; Puigserver, Pere] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol,Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	White, MF (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Div Endocrinol,Childrens Hosp Boston, Boston, MA 02115 USA.	morris.white@childrens.harvard.edu	Guo, Shaodong/W-5552-2019	Rodgers, Joseph/0000-0002-6598-5520; Cheng, Zhiyong/0000-0001-7615-9788; DePinho, Ronald/0000-0002-5625-577X	US National Institutes of Health [DK38712, DK55326]; American Diabetes Association [7-08-MN-63, JF-7-07-27]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043808, R01DK038712, R29DK038712, K99DK077505, R01DK055326, R55DK038712] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Spiegelman and L. M. Rohas for help with respiration assays, S. Orkin for help with fluorescent assays and R. de Cabo for the communication on flow cytometric assay. We are also grateful to Y. Long for his valuable comments and discussion. This project was supported by US National Institutes of Health grants DK38712 and DK55326 (M. F. W.), American Diabetes Association Mentor-Based Postdoctoral Fellowship 7-08-MN-63 (M. F. W. and Z.C.) and American Diabetes Association Junior Faculty Grant JF-7-07-27 (S. G.).	ALAM J, 1994, J BIOL CHEM, V269, P1001; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Converso DP, 2006, FASEB J, V20, P1236, DOI 10.1096/fj.05-4204fje; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Edgerton DS, 2009, FRONT BIOSCI-LANDMRK, V14, P1169, DOI 10.2741/3301; Friedman JR, 2004, P NATL ACAD SCI USA, V101, P12986, DOI 10.1073/pnas.0402875101; GONZALEZHALPHEN D, 1988, BIOCHEMISTRY-US, V27, P7021, DOI 10.1021/bi00418a053; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kamei Y, 2008, ENDOCRINOLOGY, V149, P2293, DOI 10.1210/en.2007-1461; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; KUNZ WS, 1988, BIOCHIM BIOPHYS ACTA, V932, P8, DOI 10.1016/0005-2728(88)90134-X; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; LUMENG L, 1976, J BIOL CHEM, V251, P277; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Taille C, 2004, J BIOL CHEM, V279, P28681, DOI 10.1074/jbc.M310661200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	34	213	220	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1307	U105		10.1038/nm.2049	http://dx.doi.org/10.1038/nm.2049			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19838201	Green Accepted			2022-12-25	WOS:000271543700019
J	Hatzakis, NS; Bhatia, VK; Larsen, J; Madsen, KL; Bolinger, PY; Kunding, AH; Castillo, J; Gether, U; Hedegard, P; Stamou, D				Hatzakis, Nikos S.; Bhatia, Vikram K.; Larsen, Jannik; Madsen, Kenneth L.; Bolinger, Pierre-Yves; Kunding, Andreas H.; Castillo, John; Gether, Ulrik; Hedegard, Per; Stamou, Dimitrios			How curved membranes recruit amphipathic helices and protein anchoring motifs	NATURE CHEMICAL BIOLOGY			English	Article							CURVATURE; MECHANISMS; PEPTIDES; VESICLES; DOMAINS; THERMODYNAMICS; LOCALIZATION; ORGANIZATION; TRANSITION; FISSION	Lipids and several specialized proteins are thought to be able to sense the curvature of membranes (MC). Here we used quantitative fluorescence microscopy to measure curvature-selective binding of amphipathic motifs on single liposomes 50-700 nm in diameter. Our results revealed that sensing is predominantly mediated by a higher density of binding sites on curved membranes instead of higher affinity. We proposed a model based on curvature-induced defects in lipid packing that related these findings to lipid sorting and accurately predicted the existence of a new ubiquitous class of curvature sensors: membrane-anchored proteins. The fact that unrelated structural motifs such as alpha-helices and alkyl chains sense MC led us to propose that MC sensing is a generic property of curved membranes rather than a property of the anchoring molecules. We therefore anticipate that MC will promote the redistribution of proteins that are anchored in membranes through other types of hydrophobic moieties.	[Hatzakis, Nikos S.; Bhatia, Vikram K.; Larsen, Jannik; Bolinger, Pierre-Yves; Kunding, Andreas H.; Castillo, John; Stamou, Dimitrios] Univ Copenhagen, Bionanotechnol Lab, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Hatzakis, Nikos S.; Bhatia, Vikram K.; Larsen, Jannik; Bolinger, Pierre-Yves; Kunding, Andreas H.; Castillo, John; Stamou, Dimitrios] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Madsen, Kenneth L.; Gether, Ulrik] Univ Copenhagen, Mol Neuropharmacol Grp, Copenhagen, Denmark; [Madsen, Kenneth L.; Gether, Ulrik] Univ Copenhagen, Panum Inst, Ctr Pharmacogenom, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Hedegard, Per] Univ Copenhagen, Niels Bohr Inst, Nanosci Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Niels Bohr Institute	Stamou, D (corresponding author), Univ Copenhagen, Bionanotechnol Lab, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	stamou@nano.ku.dk	Stamou, Dimitrios/D-5042-2016; Kunding, Andreas/C-9730-2012; Hatzakis, Nikos S/C-2715-2015; Larsen, Jannik/M-7950-2015; Larsen, Jannik/AAE-4195-2020; Hatzakis, Nikos/P-3865-2019; leon, john castillo/K-7894-2013; Castillo, John/C-5138-2012; Madsen, Kenneth/C-7778-2012; Hedegård, Per/C-1954-2015	Stamou, Dimitrios/0000-0001-8456-8995; Kunding, Andreas/0000-0002-7952-395X; Hatzakis, Nikos S/0000-0003-4202-0328; Larsen, Jannik/0000-0003-4754-2803; Larsen, Jannik/0000-0003-4754-2803; Hatzakis, Nikos/0000-0003-4202-0328; Madsen, Kenneth/0000-0001-9274-6691; Hedegård, Per/0000-0002-6328-7462; Gether, Ulrik/0000-0002-0020-3807; Kunding, Andreas/0000-0003-4071-1862; castillo, john/0000-0002-6751-2305	Danish Councils for Scientific and Strategic Research; European Union [FP6-2004-IST-4]	Danish Councils for Scientific and Strategic Research(Danske Strategiske Forskningsrad (DSF)); European Union(European Commission)	We thank H. Wennerstrom, T. Heimburg and T. Bjornholm for critically reading the manuscript; J.-B. Perez and K. L. Martinez for help with data treatment; N. Kirkby (University of Copenhagen Hospital, Rigshospitalet, Department of Clinical Microbiology) for providing palmitoylated ovalbumin; J.L. Baneres (Institut des Biomolecules Max Mousseron, University of Montpellier) for the generous contribution of G beta<INF>1</INF>gamma<INF>2</INF> and H. McMahon (MRC Laboratory of Molecular Biology) for kindly providing the plasmid for rat endophilin A1. This work was supported by the Danish Councils for Scientific and Strategic Research and partly by the European Union FP6-2004-IST-4 program NEMOSLAB.	Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bendix PM, 2009, P NATL ACAD SCI USA, V106, P12341, DOI 10.1073/pnas.0903052106; BHATIA VK, EMBO J IN PRESS; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Chan YHM, 2007, P NATL ACAD SCI USA, V104, P18913, DOI 10.1073/pnas.0706114104; Christensen SM, 2007, SOFT MATTER, V3, P828, DOI 10.1039/b702849k; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gazzara JA, 1997, J LIPID RES, V38, P2147; HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; KOZASA T, 1999, CRC METH SIG TRANS, P23; Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819; Kuyper CL, 2006, J AM CHEM SOC, V128, P3233, DOI 10.1021/ja057349c; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Manneville JB, 2008, P NATL ACAD SCI USA, V105, P16946, DOI 10.1073/pnas.0807102105; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; Muddana HS, 2009, BIOPHYS J, V96, p197A, DOI 10.1016/j.bpj.2008.12.1060; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Parthasarathy R, 2007, SOFT MATTER, V3, P24, DOI 10.1039/b608631d; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stamou D, 2003, ANGEW CHEM INT EDIT, V42, P5580, DOI 10.1002/anie.200351866; TAYLOR KMP, 1995, BIOCHEMISTRY-US, V34, P3841, DOI 10.1021/bi00011a042; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Wieprecht T, 2002, BIOPHYS CHEM, V96, P191, DOI 10.1016/S0301-4622(02)00025-X; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	50	300	301	3	163	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2009	5	11					835	841		10.1038/nchembio.213	http://dx.doi.org/10.1038/nchembio.213			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	508FQ	19749743				2022-12-25	WOS:000270915000013
J	Keren, K; Yam, PT; Kinkhabwala, A; Mogilner, A; Theriot, JA				Keren, Kinneret; Yam, Patricia T.; Kinkhabwala, Anika; Mogilner, Alex; Theriot, Julie A.			Intracellular fluid flow in rapidly moving cells	NATURE CELL BIOLOGY			English	Article							MIGRATING CELLS; MYOSIN-II; ANOMALOUS DIFFUSION; WATER PERMEABILITY; LEADING-EDGE; MONTE-CARLO; ACTIN; MOTILITY; KERATOCYTES; TRACKING	Cytosolic fluid dynamics have been implicated in cell motility(1-5) because of the hydrodynamic forces they induce and because of their influence on transport of components of the actin machinery to the leading edge. To investigate the existence and the direction of fluid flow in rapidly moving cells, we introduced inert quantum dots into the lamellipodia of fish epithelial keratocytes and analysed their distribution and motion. Our results indicate that fluid flow is directed from the cell body towards the leading edge in the cell frame of reference, at about 40% of cell speed. We propose that this forward-directed flow is driven by increased hydrostatic pressure generated at the rear of the cell by myosin contraction, and show that inhibition of myosin II activity by blebbistatin reverses the direction of fluid flow and leads to a decrease in keratocyte speed. We present a physical model for fluid pressure and flow in moving cells that quantitatively accounts for our experimental data.	[Keren, Kinneret; Yam, Patricia T.; Theriot, Julie A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Keren, Kinneret; Yam, Patricia T.; Theriot, Julie A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Keren, Kinneret] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Keren, Kinneret] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Yam, Patricia T.] Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Kinkhabwala, Anika] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Theriot, Julie A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Technion Israel Institute of Technology; Technion Israel Institute of Technology; McGill University; Stanford University; University of California System; University of California Davis; University of California System; University of California Davis; Stanford University	Keren, K (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	kinneret@ph.technion.ac.il	Kinkhabwala, Anika/A-8214-2010; Theriot, Julie/HHN-2034-2022; Mogilner, Alex/A-3135-2008	Yam, Patricia/0000-0002-3631-3151; Keren, Kinneret/0000-0002-2962-6977; Theriot, Julie/0000-0002-2334-2535	Damon Runyon Postdoctoral Fellowship; Technion; Israel Council for Higher Education; Israel Science Foundation; Wolfson Foundation; European Research Council; National Institutes of Health; National Science Foundation; American Heart Association and the Howard Hughes Medical Institute; Howard Hughes Medical Institute; Stanford Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	Damon Runyon Postdoctoral Fellowship; Technion; Israel Council for Higher Education; Israel Science Foundation(Israel Science Foundation); Wolfson Foundation; European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association and the Howard Hughes Medical Institute(Howard Hughes Medical InstituteAmerican Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stanford Graduate Fellowship(Stanford University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Theresa Harper and Marcel Bruchez from Quantum Dot Corporation (Molecular Probes, Invitrogen) for providing the quantum dot probes; W. E. Moerner for advice on the single-particle tracking experiments; Paul Wiseman, Ben Hebert and Lia Gracey for their contributions to the initial phase of this project; Michael Saxton and Cyrus Wilson for useful discussions; and Boris Slepchenko for help with Virtual Cell. K. K. was supported by a Damon Runyon Postdoctoral Fellowship, a Horev fellowship from the Technion, an Allon Fellowship from the Israel Council for Higher Education, and by grants from the Morasha Program of the Israel Science Foundation, the Converging Technologies Program of The Israel Council for Higher Education, the Wolfson Foundation, and a European Research Council Starting Grant. A. M. was supported by grants from the National Institutes of Health and the National Science Foundation. J. A. T. was supported by grants from the National Institutes of Health, the American Heart Association and the Howard Hughes Medical Institute. P. T. Y. was supported by a Howard Hughes Medical Institute Predoctoral Fellowship and Stanford Graduate Fellowship.	Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; ALLEN RD, 1978, ANNU REV BIOPHYS BIO, V7, P469, DOI 10.1146/annurev.bb.07.060178.002345; Anderson KI, 2000, CURR BIOL, V10, P253, DOI 10.1016/S0960-9822(00)00357-2; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Galbraith CG, 1999, J CELL BIOL, V147, P1313, DOI 10.1083/jcb.147.6.1313; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Iwasaki T, 2008, BIOPHYS J, V94, pL35, DOI 10.1529/biophysj.107.124479; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Khan S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041915; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Laurent VM, 2005, BIOPHYS J, V89, P667, DOI 10.1529/biophysj.104.052316; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Loitto VM, 2009, CELL MOTIL CYTOSKEL, V66, P237, DOI 10.1002/cm.20357; Loitto VM, 2002, J LEUKOCYTE BIOL, V71, P212; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Metzler R, 2000, PHYS REV E, V61, P6308, DOI 10.1103/PhysRevE.61.6308; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Olbrich K, 2000, BIOPHYS J, V79, P321, DOI 10.1016/S0006-3495(00)76294-1; Oliver T, 1999, J CELL BIOL, V145, P589, DOI 10.1083/jcb.145.3.589; OSTER GF, 1987, J CELL SCI, P35; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rubinstein B, 2005, MULTISCALE MODEL SIM, V3, P413, DOI 10.1137/04060370X; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Savin T, 2005, BIOPHYS J, V88, P623, DOI 10.1529/biophysj.104.04245; Saxton MJ, 2007, BIOPHYS J, V92, P1178, DOI 10.1529/biophysj.106.092619; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schaub S, 2007, MOL BIOL CELL, V18, P3723, DOI 10.1091/mbc.E06-09-0859; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Verkman AS, 2000, J MEMBRANE BIOL, V173, P73, DOI 10.1007/s002320001009; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Weisswange I, 2005, J CELL SCI, V118, P4375, DOI 10.1242/jcs.02551; WILSON CA, 2006, THESIS STANFORD U; WILSON CA, 2006, THESIS STANFORD U, P1; Wong IY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178101; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	50	135	136	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1219	U137		10.1038/ncb1965	http://dx.doi.org/10.1038/ncb1965			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767741	Green Accepted			2022-12-25	WOS:000270382000011
J	Plum, L; Lin, HV; Dutia, R; Tanaka, J; Aizawa, KS; Matsumoto, M; Kim, AJ; Cawley, NX; Paik, JH; Loh, YP; DePinho, RA; Wardlaw, SL; Accili, D				Plum, Leona; Lin, Hua V.; Dutia, Roxanne; Tanaka, Jun; Aizawa, Kumiko S.; Matsumoto, Michihiro; Kim, Andrea J.; Cawley, Niamh X.; Paik, Ji-Hye; Loh, Y. Peng; DePinho, Ronald A.; Wardlaw, Sharon L.; Accili, Domenico			The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake	NATURE MEDICINE			English	Article							PROTHYROTROPIN-RELEASING HORMONE; PROHORMONE CONVERTASES; BETA-ENDORPHIN; BODY-WEIGHT; CPE(FAT)/CPE(FAT) MICE; STIMULATING HORMONE; ENERGY HOMEOSTASIS; LEPTIN; PEPTIDE; INSULIN	Reduced food intake brings about an adaptive decrease in energy expenditure that contributes to the recidivism of obesity after weight loss. Insulin and leptin inhibit food intake through actions in the central nervous system that are partly mediated by the transcription factor FoxO1. We show that FoxO1 ablation in pro-opiomelanocortin (Pomc)-expressing neurons in mice (here called Pomc-Foxo1(-/-) mice) increases Carboxypeptidase E (Cpe) expression, resulting in selective increases of alpha-melanocyt-estimulating hormone (alpha-Msh) and carboxy-cleaved beta-endorphin, the products of Cpe-dependent processing of Pomc. This neuropeptide profile is associated with decreased food intake and normal energy expenditure in Pomc-Foxo1(-/-) mice. We show that Cpe expression is downregulated by diet-induced obesity and that FoxO1 deletion offsets the decrease, protecting against weight gain. Moreover, moderate Cpe overexpression in the arcuate nucleus phenocopies features of the FoxO1 mutation. The dissociation of food intake from energy expenditure in Pomc-Foxo1(-/-) mice represents a model for therapeutic intervention in obesity and raises the possibility of targeting Cpe to develop weight loss medications.	[Plum, Leona; Lin, Hua V.; Dutia, Roxanne; Tanaka, Jun; Aizawa, Kumiko S.; Matsumoto, Michihiro; Kim, Andrea J.; Wardlaw, Sharon L.; Accili, Domenico] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA; [Plum, Leona; Lin, Hua V.; Dutia, Roxanne; Tanaka, Jun; Aizawa, Kumiko S.; Matsumoto, Michihiro; Kim, Andrea J.; Wardlaw, Sharon L.; Accili, Domenico] Columbia Univ, Dept Med, New York, NY USA; [Matsumoto, Michihiro] Int Med Ctr Japan, Dept Clin Pharmacol, Tokyo, Japan; [Cawley, Niamh X.; Loh, Y. Peng] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurosci, Cellular Neurobiol Sect, Bethesda, MD USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA	Columbia University; Columbia University; National Center for Global Health & Medicine - Japan; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Accili, D (corresponding author), Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA.	da230@columbia.edu	Plum-Mörschel, Leona/W-9413-2019	Plum-Mörschel, Leona/0000-0002-1907-761X; DePinho, Ronald/0000-0002-5625-577X; Lin, Hua/0000-0001-5001-5567	Deutsche Forschungsgemeinschaft [PL542/1-1]; US National Institutes of Health [DK57539, DK58282, DK80003, DK63608]; Robert A. and Renee E. Belfer Family Institute for Innovative Cancer Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058282, R01DK058282, R01DK080003, R01DK064819, R01DK057539, P30DK063608] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. and Renee E. Belfer Family Institute for Innovative Cancer Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Deutsche Forschungsgemeinschaft PL542/1-1 (L.P.), US National Institutes of Health DK57539 and DK58282 (D.A.), DK80003 (S.L.W.) and DK63608 (Columbia Diabetes and Endocrinology Research Center). We thank R. Leibel for insightful discussions, L. Zeltser and S. Padilla for help with in situ hybridization, N. Seidah (Clinical Research Institute of Montreal) and D. Good (University of Massachusetts) for plasmids encoding pCsk1, A. White (University of Manchester) for neuropeptide antisera, and M. Low (Oregon Health Sciences University) for Pomc-Gfp transgenic mice, Y. Liu for technical assistance and members of the Accili and Wardlaw laboratories for stimulating discussions. R.A.D. is an American Cancer Society Research Professor and an Ellison Medical Foundation Senior Scholar and is supported by the Robert A. and Renee E. Belfer Family Institute for Innovative Cancer Science.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Allen RG, 2001, J NEUROSCI, V21, P5864, DOI 10.1523/JNEUROSCI.21-16-05864.2001; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; Benoit SC, 2002, J NEUROSCI, V22, P9048; Berman Y, 2001, J BIOL CHEM, V276, P1466, DOI 10.1074/jbc.M008499200; Brakch N, 1997, BIOCHEMISTRY-US, V36, P16309, DOI 10.1021/bi9714767; Bray GA, 2008, J CLIN ENDOCR METAB, V93, pS81, DOI 10.1210/jc.2008-1294; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Chen MS, 2001, ASIA PAC J OPER RES, V18, P131; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; Fox DL, 2008, MOL ENDOCRINOL, V22, P1438, DOI 10.1210/me.2008-0010; Fukuda M, 2008, J NEUROSCI, V28, P13640, DOI 10.1523/JNEUROSCI.4023-08.2008; Furuta M, 2001, J BIOL CHEM, V276, P27197, DOI 10.1074/jbc.M103362200; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; JAFFE SB, 1994, BRAIN RES, V648, P24, DOI 10.1016/0006-8993(94)91900-3; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; MCGOWAN MK, 1993, PHYSIOL BEHAV, V54, P1031, DOI 10.1016/0031-9384(93)90320-F; Miller R, 2003, J NEUROCHEM, V86, P556, DOI 10.1046/j.1471-4159.2003.01856.x; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; NICOLAS P, 1985, P NATL ACAD SCI USA, V82, P3178, DOI 10.1073/pnas.82.10.3178; Nilaweera KN, 2003, NEUROSCIENCE, V119, P713, DOI 10.1016/S0306-4522(02)00869-2; Nillni EA, 2007, ENDOCRINOLOGY, V148, P4191, DOI 10.1210/en.2007-0173; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Papadopoulos AD, 1999, J NEUROENDOCRINOL, V11, P315; Perone MJ, 1996, BIOCHEM SOC T, V24, pS497, DOI 10.1042/bst024497s; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Pritchard LE, 2007, ENDOCRINOLOGY, V148, P4201, DOI 10.1210/en.2006-1686; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Sanchez VC, 2004, J CLIN INVEST, V114, P357, DOI 10.1172/jci200421620; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; TSIGOS C, 1993, J CLIN ENDOCR METAB, V76, P620, DOI 10.1210/jc.76.3.620; Viale A, 1999, J BIOL CHEM, V274, P6536, DOI 10.1074/jbc.274.10.6536; WARDLAW SL, 1986, ENDOCRINOLOGY, V119, P19, DOI 10.1210/endo-119-1-19; Wertz-Lutz AE, 2008, J ANIM SCI, V86, P564, DOI 10.2527/jas.2007-0556; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yanagita K, 2008, NEUROSCI LETT, V442, P140, DOI 10.1016/j.neulet.2008.07.018; Zhu X, 1996, P NATL ACAD SCI USA, V93, P4919, DOI 10.1073/pnas.93.10.4919; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	55	120	123	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1195	U125		10.1038/nm.2026	http://dx.doi.org/10.1038/nm.2026			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19767734	Green Accepted			2022-12-25	WOS:000270596400032
J	Reversade, B; Escande-Beillard, N; Dimopoulou, A; Fischer, B; Chng, SC; Li, Y; Shboul, M; Tham, PY; Kayserili, H; Al-Gazali, L; Shahwan, M; Brancati, F; Lee, H; O'Connor, BD; Schmidt-von Kegler, M; Merriman, B; Nelson, SF; Masri, A; Alkazaleh, F; Guerra, D; Ferrari, P; Nanda, A; Rajab, A; Markie, D; Gray, M; Nelson, J; Grix, A; Sommer, A; Savarirayan, R; Janecke, AR; Steichen, E; Sillence, D; Hausser, I; Budde, B; Nurnberg, G; Nurnberg, P; Seemann, P; Kunkel, D; Zambruno, G; Dallapiccola, B; Schuelke, M; Robertson, S; Hamamy, H; Wollnik, B; Van Maldergem, L; Mundlos, S; Kornak, U				Reversade, Bruno; Escande-Beillard, Nathalie; Dimopoulou, Aikaterini; Fischer, Bjoern; Chng, Serene C.; Li, Yun; Shboul, Mohammad; Tham, Puay-Yoke; Kayserili, Huelya; Al-Gazali, Lihadh; Shahwan, Monzer; Brancati, Francesco; Lee, Hane; O'Connor, Brian D.; Schmidt-von Kegler, Mareen; Merriman, Barry; Nelson, Stanley F.; Masri, Amira; Alkazaleh, Fawaz; Guerra, Deanna; Ferrari, Paola; Nanda, Arti; Rajab, Anna; Markie, David; Gray, Mary; Nelson, John; Grix, Arthur; Sommer, Annemarie; Savarirayan, Ravi; Janecke, Andreas R.; Steichen, Elisabeth; Sillence, David; Hausser, Ingrid; Budde, Birgit; Nuernberg, Gudrun; Nuernberg, Peter; Seemann, Petra; Kunkel, Desiree; Zambruno, Giovanna; Dallapiccola, Bruno; Schuelke, Markus; Robertson, Stephen; Hamamy, Hanan; Wollnik, Bernd; Van Maldergem, Lionel; Mundlos, Stefan; Kornak, Uwe			Mutations in PYCR1 cause cutis laxa with progeroid features	NATURE GENETICS			English	Article							GERODERMIA OSTEODYSPLASTICA; REDUCED ORNITHINE; SKIN SYNDROME; PROLINE; HYPERAMMONEMIA; GLYCOSYLATION; MITOCHONDRIA; CITRULLINE; ARGININE; OPA1	Autosomal recessive cutis laxa (ARCL) describes a group of syndromal disorders that are often associated with a progeroid appearance, lax and wrinkled skin, osteopenia and mental retardation(1-3). Homozygosity mapping in several kindreds with ARCL identified a candidate region on chromosome 17q25. By high- throughput sequencing of the entire candidate region, we detected disease-causing mutations in the gene PYCR1. We found that the gene product, an enzyme involved in proline metabolism, localizes to mitochondria. Altered mitochondrial morphology, membrane potential and increased apoptosis rate upon oxidative stress were evident in fibroblasts from affected individuals. Knockdown of the orthologous genes in Xenopus and zebrafish led to epidermal hypoplasia and blistering that was accompanied by a massive increase of apoptosis. Our findings link mutations in PYCR1 to altered mitochondrial function and progeroid changes in connective tissues.	[Dimopoulou, Aikaterini; Fischer, Bjoern; Schmidt-von Kegler, Mareen; Mundlos, Stefan; Kornak, Uwe] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Reversade, Bruno; Escande-Beillard, Nathalie; Chng, Serene C.; Shboul, Mohammad; Tham, Puay-Yoke] ASTAR, Inst Med Biol, Singapore, Singapore; [Li, Yun; Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Kayserili, Huelya] Istanbul Univ, Dept Med Genet, Istanbul Fac Med, Istanbul, Turkey; [Al-Gazali, Lihadh] United Arab Emirates Univ, Dept Paediat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Shahwan, Monzer; Hamamy, Hanan] Natl Ctr Diabet Endocrinol & Genet, Amman, Jordan; [Brancati, Francesco; Dallapiccola, Bruno] Osped Casa Sollievo Sofferenza, Rome, Italy; [Brancati, Francesco; Dallapiccola, Bruno] Ist CSS Mendel, Rome, Italy; [Brancati, Francesco] Gabriele Annunzio Univ, CeSI, Dept Biomed Sci, Chieti, Italy; [Lee, Hane; O'Connor, Brian D.; Merriman, Barry; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Schmidt-von Kegler, Mareen; Seemann, Petra; Mundlos, Stefan; Kornak, Uwe] Max Planck Inst Mol Genet, Berlin, Germany; [Masri, Amira; Alkazaleh, Fawaz] Univ Jordan, Fac Med, Dept Pediat, Amman, Jordan; [Masri, Amira; Alkazaleh, Fawaz] Univ Jordan, Fac Med, Dept Obstet & Gynecol, Amman, Jordan; [Guerra, Deanna] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Ferrari, Paola] Univ Modena & Reggio Emilia, Dept Pediat, Modena, Italy; [Nanda, Arti] Al Sabah Hosp, Asad Al Hamad Dermatol Ctr, Kuwait, Kuwait; [Rajab, Anna] Minist Hlth, Genet Unit, Directorate Gen Hlth Affairs, Muscat, Oman; [Markie, David; Gray, Mary] Univ Otago, Dept Pathol, Dunedin, New Zealand; [Nelson, John] King Edward Mem Hosp Women, Genet Serv Western Australia, Perth, WA, Australia; [Grix, Arthur] Permanente Med Grp Inc, Sacramento, CA USA; [Sommer, Annemarie] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Sommer, Annemarie] Nationwide Childrens Hosp, Columbus, OH USA; [Savarirayan, Ravi] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Savarirayan, Ravi] Genet Hlth Serv Victoria, Parkville, Vic, Australia; [Janecke, Andreas R.] Innsbruck Med Univ, Div Clin Genet, Innsbruck, Austria; [Steichen, Elisabeth] Univ Innsbruck, Klin Kinder & Jugendheilkunde, A-6020 Innsbruck, Austria; [Sillence, David] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; [Hausser, Ingrid] Univ Hautklin Heidelberg, Heidelberg, Germany; [Budde, Birgit; Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-5000 Cologne 41, Germany; [Seemann, Petra; Kunkel, Desiree] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Zambruno, Giovanna] Ist Ricovero & Cura Carattere Sci, Lab Mol & Cell Biol, Ist Dermopat Immacolata, Rome, Italy; [Schuelke, Markus] Charite, Dept Neuropediat & NeuroCure, Clin Res Ctr, D-13353 Berlin, Germany; [Robertson, Stephen] Univ Otago, Dept Paediat & Child Hlth, Dunedin, New Zealand; [Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Wollnik, Bernd] Univ Cologne, Inst Human Genet, Cologne, Germany; [Van Maldergem, Lionel] Univ Liege, Ctr Genet Humaine, Ctr Hosp Univ Sart Tilman, Liege, Belgium	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Cologne; Istanbul University; United Arab Emirates University; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; G d'Annunzio University of Chieti-Pescara; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Max Planck Society; University of Jordan; University of Jordan; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Al Sabah Hospital; University of Otago; King Edward Memorial Hospital; University of Western Australia; Permanente Medical Groups; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Medical University of Innsbruck; University of Innsbruck; University of Sydney; Ruprecht Karls University Heidelberg; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Otago; University of Cologne; University of Cologne; University of Liege	Mundlos, S (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	stefan.mundlos@charite.de	Zambruno, Giavanna/K-2933-2018; Seemann, Petra/G-3606-2011; Gray, Mary/J-9669-2014; Van Maldergem, Lionel/O-3242-2019; Wollnik, Bernd/GRY-6062-2022; Fischer-Zirnsak, Björn/D-7487-2013; Markie, David/I-7893-2019; Brancati, Francesco/AAC-3778-2022; Nanda, Arti/H-8565-2019; Janecke, Andreas/AAA-5227-2019; masri, amira/C-4570-2015; Nelson, Stanley F/D-4771-2009; Mundlos, Stefan/ABH-9585-2020; Van Maldergem, Lionel/G-9849-2017; Dallapiccola, Bruno/K-8692-2016	Seemann, Petra/0000-0002-6056-6669; Gray, Mary/0000-0003-1610-0674; Van Maldergem, Lionel/0000-0001-8880-5214; Wollnik, Bernd/0000-0003-2589-0364; Fischer-Zirnsak, Björn/0000-0002-1075-7571; Brancati, Francesco/0000-0003-3624-2354; masri, amira/0000-0001-6103-8713; Nelson, Stanley F/0000-0002-2082-3114; Van Maldergem, Lionel/0000-0001-8880-5214; Mundlos, Stefan/0000-0002-9788-3166; Escande-Beillard, Nathalie/0000-0002-7706-1608; Budde, Birgit/0000-0001-9385-4168; Schuelke, Markus/0000-0003-2824-3891; Dallapiccola, Bruno/0000-0002-5031-1013; Robertson, Stephen/0000-0002-5181-7809; Janecke, Andreas/0000-0001-7155-0315; Markie, David/0000-0001-5452-9194; REVERSADE, Bruno/0000-0002-4070-7997; Chng, Serene C/0000-0003-0500-8792; shahwan, moyad/0000-0001-8367-4841; Zambruno, Giovanna/0000-0002-1295-056X; Nanda, Arti/0000-0002-1223-3181	German Federal Ministry of Education and Research ( BMBF) [01GM0623]; Deutsche Forschungsgemeinschaft [01GM0880, 01GM0801]	German Federal Ministry of Education and Research ( BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	J. Common and B. Lane for advice and help with primary cultures. J. Gautier for TUNEL protocol. K. Rogers and S. Rogers for their help and advice on histology. This study was supported by the German Federal Ministry of Education and Research ( BMBF) by grant 01GM0623 ( SKELNET) to U. K. and S. M. and grants 01GM0880 and 01GM0801 to B. W., a grant from the Deutsche Forschungsgemeinschaft ( Collaborative Research Centre 577) to U. K. and P. N., and by A* STAR and the Branco Weiss Foundation to B. R.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Al-Gazali LI, 2001, AM J MED GENET, V101, P213, DOI 10.1002/ajmg.1352; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baumgartner MR, 2000, HUM MOL GENET, V9, P2853, DOI 10.1093/hmg/9.19.2853; Baumgartner MR, 2005, EUR J PEDIATR, V164, P31, DOI 10.1007/s00431-004-1545-3; Bicknell LS, 2008, EUR J HUM GENET, V16, P1176, DOI 10.1038/ejhg.2008.91; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Guerra D, 2004, J CUTAN PATHOL, V31, P616, DOI 10.1111/j.0303-6987.2004.00241.x; HAGEDORN CH, 1983, ARCH BIOCHEM BIOPHYS, V225, P95, DOI 10.1016/0003-9861(83)90010-3; Hamamy H, 2005, CLIN EXP DERMATOL, V30, P590, DOI 10.1111/j.1365-2230.2005.01825.x; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KUNZE J, 1985, EUR J PEDIATR, V144, P348, DOI 10.1007/BF00441776; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Meng ZH, 2006, J MOL BIOL, V359, P1364, DOI 10.1016/j.jmb.2006.04.053; Mitsubuchi H, 2008, J NUTR, V138, p2016S, DOI 10.1093/jn/138.10.2016S; Morava E, 2008, EUR J HUM GENET, V16, P28, DOI 10.1038/sj.ejhg.5201947; Nanda A, 2008, PEDIATR DERMATOL, V25, P66, DOI 10.1111/j.1525-1470.2007.00586.x; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; Rajab A, 2008, AM J MED GENET A, V146A, P965, DOI 10.1002/ajmg.a.32143; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Sommer A, 2007, AM J MED GENET C, V145C, P291, DOI 10.1002/ajmg.c.30146; Teramoto S, 1999, JPN J PHARMACOL, V79, P33, DOI 10.1254/jjp.79.33; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Van Maldergem L, 2008, NEUROLOGY, V71, P1602, DOI 10.1212/01.wnl.0000327822.52212.c7; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	35	164	175	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1016	U88		10.1038/ng.413	http://dx.doi.org/10.1038/ng.413			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19648921				2022-12-25	WOS:000269382100015
J	Mureev, S; Kovtun, O; Nguyen, UTT; Alexandrov, K				Mureev, Sergei; Kovtun, Oleksiy; Nguyen, Uyen T. T.; Alexandrov, Kirill			Species-independent translational leaders facilitate cell-free expression	NATURE BIOTECHNOLOGY			English	Article							FREE PROTEIN-SYNTHESIS; CROSS-CORRELATION SPECTROSCOPY; MESSENGER-RNAS; LEISHMANIA-TARENTOLAE; INITIATION-FACTORS; SYNTHESIS SYSTEM; COMPLEX; VIRUS; MECHANISM; SELECTION	Cell-free protein synthesis enables the rapid production and engineering of recombinant proteins. Existing cell-free systems differ substantially from each other with respect to efficiency, scalability and the ability to produce functional eukaryotic proteins. Here we describe species-independent translational sequences (SITS) that mediate efficient cell-free protein synthesis in multiple prokaryotic and eukaryotic systems, presumably through bypassing the early translation initiation factors. We use these leaders in combination with targeted suppression of the endogenous Leishmania tarentolae mRNAs to create a cell-free system based on this protozoan. The system can be directly programmed with unpurified PCR products, enabling rapid generation of large protein libraries and protein variants. L. tarentolae extract can produce up to 300 mu g/ml of recombinant protein in 2 h. We further demonstrate that protein-protein and protein-small molecule interactions can be quantitatively analyzed directly in the translation mixtures using fluorescent (cross-) correlation spectroscopy.	[Mureev, Sergei; Kovtun, Oleksiy; Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Mureev, Sergei; Kovtun, Oleksiy; Alexandrov, Kirill] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Nguyen, Uyen T. T.; Alexandrov, Kirill] Max Planck Inst Mol Physiol, D-44139 Dortmund, Germany	University of Queensland; University of Queensland; Max Planck Society	Alexandrov, K (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	k.alexandrov@uq.edu.au	mureev, sergey/K-3521-2014; Alexandrov, Kirill/A-5830-2013; Kovtun, Oleksiy/F-7443-2015; Mureev, Sergey/ABB-4757-2020; Kovtun, Oleksiy/AAE-5397-2019	mureev, sergey/0000-0001-9999-3150; Alexandrov, Kirill/0000-0002-0957-6511; Kovtun, Oleksiy/0000-0001-6374-7863; Kovtun, Oleksiy/0000-0001-6374-7863				AHN BY, 1989, J VIROL, V63, P226, DOI 10.1128/JVI.63.1.226-232.1989; BABLANIAN R, 1991, J VIROL, V65, P4449, DOI 10.1128/JVI.65.8.4449-4460.1991; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Berestovskaya NG, 1999, ANAL BIOCHEM, V268, P72, DOI 10.1006/abio.1998.3051; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Ezure T, 2006, BIOTECHNOL PROGR, V22, P1570, DOI 10.1021/bp060110v; Fritsche C, 2008, J BASIC MICROB, V48, P488, DOI 10.1002/jobm.200700389; He MY, 2007, BIOMOL ENG, V24, P375, DOI 10.1016/j.bioeng.2007.05.002; Kamura N, 2005, BIOORG MED CHEM LETT, V15, P5402, DOI 10.1016/j.bmcl.2005.09.013; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Keese M, 2007, DIFFERENTIATION, V75, P809, DOI 10.1111/j.1432-0436.2007.00186.x; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000; McCallum CD, 2000, J CELL BIOL, V149, P591, DOI 10.1083/jcb.149.3.591; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Nguyen UTT, 2007, CHEMBIOCHEM, V8, P408, DOI 10.1002/cbic.200600440; Niculae A, 2006, PROTEIN EXPRES PURIF, V48, P167, DOI 10.1016/j.pep.2006.04.006; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; Oyama R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl477; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; RUDOLF R, 1993, P SOC PHOTO-OPT INS, V1921, P239; Sawasaki Tatsuya, 2007, V375, P95; Shaloiko LA, 2004, BIOTECHNOL BIOENG, V88, P730, DOI 10.1002/bit.20267; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Yakhnin AV, 1998, PROTEIN EXPRES PURIF, V14, P382, DOI 10.1006/prep.1998.0981	35	104	108	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2009	27	8					747	U98		10.1038/nbt.1556	http://dx.doi.org/10.1038/nbt.1556			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	480YY	19648909				2022-12-25	WOS:000268774500025
J	Butler, LC; Blanchard, GB; Kabla, AJ; Lawrence, NJ; Welchman, DP; Mahadevan, L; Adams, RJ; Sanson, B				Butler, Lucy C.; Blanchard, Guy B.; Kabla, Alexandre J.; Lawrence, Nicola J.; Welchman, David P.; Mahadevan, L.; Adams, Richard J.; Sanson, Benedicte			Cell shape changes indicate a role for extrinsic tensile forces in Drosophila germ-band extension	NATURE CELL BIOLOGY			English	Article							EPITHELIAL MORPHOGENESIS; GASTRULATION; INTERCALATION; REARRANGEMENT; INVAGINATION; MELANOGASTER; ELONGATION; DIVISIONS; NOTOCHORD; POLARITY	Drosophila germ-band extension (GBE) is an example of the convergence and extension movements that elongate and narrow embryonic tissues. To understand the collective cell behaviours underlying tissue morphogenesis, we have continuously quantified cell intercalation and cell shape change during GBE. We show that the fast, early phase of GBE depends on cell shape change in addition to cell intercalation. In antero-posterior patterning mutants such as those for the gap gene Kruppel, defective polarized cell intercalation is compensated for by an increase in antero-posterior cell elongation, such that the initial rate of extension remains the same. Spatio-temporal patterns of cell behaviours indicate that an antero-posterior tensile force deforms the germ band, causing the cells to change shape passively. The rate of anteroposterior cell elongation is reduced in twist mutant embryos, which lack mesoderm. We propose that cell shape change contributing to germ-band extension is a passive response to mechanical forces caused by the invaginating mesoderm.	[Butler, Lucy C.; Blanchard, Guy B.; Adams, Richard J.; Sanson, Benedicte] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Kabla, Alexandre J.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Lawrence, Nicola J.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Welchman, David P.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Cambridge; University of Cambridge; University of Cambridge; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Harvard University; Harvard Medical School	Sanson, B (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	bs251@cam.ac.uk	Kabla, Alexandre/AAF-3993-2019	Kabla, Alexandre/0000-0002-0280-3531; Blanchard, Guy/0000-0002-3689-0522; Adams, Richard/0000-0003-0280-0901; Sanson, Benedicte/0000-0002-2782-4195; Lawrence, Nicola/0000-0001-9773-2360	Human Frontier Science Program; Wellcome Trust; Medical Research Council; Harvard-National Science Foundation; MRC [G0400709] Funding Source: UKRI; Medical Research Council [G0400709] Funding Source: researchfish	Human Frontier Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Harvard-National Science Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Claire Lye, Bruno Monier and Daniel St Johnston for comments on the manuscript and discussions. We thank the Bloomington Drosophila Stock Centre for fly strains. This work was supported by a Human Frontier Science Program grant to B. S., a Wellcome Trust studentship to L. C. B., a Medical Research Council grant to R. J. A. and a Harvard-National Science Foundation Materials Research Science and Engineering Center award to M. L.	Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Costa Michael, 1993, P425; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; HARTENSTEIN V, 1985, ROUX ARCH DEV BIOL, V194, P181; IRVINE KD, 1994, DEVELOPMENT, V120, P827; KAM Z, 1991, DEVELOPMENT, V112, P365; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; KELLER RE, 1987, DEV BIOL, V120, P12, DOI 10.1016/0012-1606(87)90099-6; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Munro EM, 2002, DEVELOPMENT, V129, P13; Oda H, 2001, J CELL SCI, V114, P493; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pope KL, 2008, DEVELOPMENT, V135, P2227, DOI 10.1242/dev.019802; Pouille PA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015005; *R RES DEV TEAM, 2008, R LANG ENV STAT COMP; Seher TC, 2007, MECH DEVELOP, V124, P167, DOI 10.1016/j.mod.2006.12.004; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; SWEETON D, 1991, DEVELOPMENT, V112, P775; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; Vincent A, 1997, DEVELOPMENT, V124, P3747; Weaire DL., 2001, PHYS FOAMS; WELIKY M, 1990, DEVELOPMENT, V109, P373; WICKHAM H, 2008, R PACKAGE VERSION 0; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	31	166	166	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					859	U181		10.1038/ncb1894	http://dx.doi.org/10.1038/ncb1894			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19503074				2022-12-25	WOS:000267603100015
J	Karner, CM; Chirumamilla, R; Aoki, S; Igarashi, P; Wallingford, JB; Carroll, TJ				Karner, Courtney M.; Chirumamilla, Rani; Aoki, Shigehisa; Igarashi, Peter; Wallingford, John B.; Carroll, Thomas J.			Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis	NATURE GENETICS			English	Article							DROSOPHILA TRACHEAL MORPHOGENESIS; CONVERGENT EXTENSION MOVEMENTS; BETA-CATENIN GENE; TUBE-SIZE CONTROL; CYSTIC KIDNEY; ZEBRAFISH GASTRULATION; TISSUE POLARITY; XENOPUS-LAEVIS; PRIMARY CILIUM; URETERAL BUD	Although many vertebrate organs, such as kidneys, lungs and liver, are composed of epithelial tubules, little is known of the mechanisms that establish the length or diameter of these tubules. In the kidney, defects in the establishment or maintenance of tubule diameter are associated with one of the most common inherited human disorders, polycystic kidney disease. Here we show that attenuation of Wnt9b signaling during kidney morphogenesis affects the planar cell polarity of the epithelium and leads to tubules with significantly increased diameter. Although previous studies showed that polarized cell divisions maintain the diameter of postnatal kidney tubules, we find that cell divisions are randomly oriented during embryonic development. Our data suggest that diameter is established during early morphogenetic stages by convergent extension processes and maintained by polarized cell divisions. Wnt9b, signaling through the non-canonical Rho/Jnk branch of the Wnt pathway, is necessary for both of these processes.	[Karner, Courtney M.; Chirumamilla, Rani; Aoki, Shigehisa; Igarashi, Peter; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA; [Karner, Courtney M.; Chirumamilla, Rani; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Aoki, Shigehisa] Saga Univ, Pathol & Biodef Fac Med, Saga 840, Japan; [Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Wallingford, John B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Saga University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Austin	Carroll, TJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA.	thomas.carroll@utsouthwestern.edu	Aoki, Shigehisa/AFQ-9927-2022	Aoki, Shigehisa/0000-0002-1778-8944; Karner, Courtney/0000-0003-0387-4486; Igarashi, Peter/0000-0001-8698-1185	American Society for Nephrology; American Heart Association [0730236N]; Polycystic Kidney Disease Research Foundation; UAB ARPKD Center [5P30DK07403802]; US National Institutes of Health [1R01DK080004]; University of Texas Southwestern O'Brien Kidney Research Core Center [NIH P30DK079328]; National Institute for General Medical Sciences; March of Dimes; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080004, P30DK074038, R37DK042921, P30DK079328] Funding Source: NIH RePORTER	American Society for Nephrology; American Heart Association(American Heart Association); Polycystic Kidney Disease Research Foundation; UAB ARPKD Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern O'Brien Kidney Research Core Center; National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank O. Cleaver for reading and commenting on this manuscript, L. Avery for help with statistical analysis, J. Zhou (Brigham and Women's and Harvard Medical School) for providing us with antibodies to Pc-1 and Pc-2 and the Pkd1 mutant kidneys, M. Taketo (Kyoto University) for providing the beta-catenin exon 3 flox mice, O. Cabello (J. H. Quillen College of Medicine, East Tennessee State University) for providing us with the Invs mutant kidneys, B. Adams, E. Small, J. Shelton and the Molecular Pathology Core for technical assistance and L. James and M. Princena for the urine albumin studies. This work was supported by grants from the American Society for Nephrology, the American Heart Association (0730236N), the Polycystic Kidney Disease Research Foundation, the UAB ARPKD Center (5P30DK07403802) and the US National Institutes of Health (1R01DK080004) to T. J. C. The work was also supported by the University of Texas Southwestern O'Brien Kidney Research Core Center (NIH P30DK079328). J. B. W. was supported by grants from the National Institute for General Medical Sciences, the March of Dimes and the Burroughs Wellcome Fund.	Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Benzing T, 2007, J AM SOC NEPHROL, V18, P1389, DOI 10.1681/ASN.2006121355; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Concha ML, 1998, DEVELOPMENT, V125, P983; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Djiane A, 2000, DEVELOPMENT, V127, P3091; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goto T, 2005, CURR BIOL, V15, P787, DOI 10.1016/j.cub.2005.03.040; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Ibraghimov-Beskrovnaya O, 2007, CELL CYCLE, V6, P776, DOI 10.4161/cc.6.7.4047; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Jung AC, 2006, CURR BIOL, V16, P1224, DOI 10.1016/j.cub.2006.04.048; Karner C, 2006, SEMIN CELL DEV BIOL, V17, P194, DOI 10.1016/j.semcdb.2006.05.003; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Menezes LFC, 2004, KIDNEY INT, V66, P1345, DOI 10.1111/j.1523-1755.2004.00844.x; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Meyer TN, 2006, DIFFERENTIATION, V74, P638, DOI 10.1111/j.1432-0436.2006.00102.x; Michael L, 2005, KIDNEY INT, V68, P2010, DOI 10.1111/j.1523-1755.2005.00655.x; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; SHIH J, 1992, DEVELOPMENT, V116, P901; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tada M, 2000, DEVELOPMENT, V127, P2227; Thomson RB, 1999, AM J PHYSIOL-RENAL, V277, pF146, DOI 10.1152/ajprenal.1999.277.1.F146; Tong X, 2008, DEV BIOL, V317, P225, DOI 10.1016/j.ydbio.2008.02.040; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2001, INT J DEV BIOL, V45, P225; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	71	258	266	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					793	U46		10.1038/ng.400	http://dx.doi.org/10.1038/ng.400			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19543268	Green Accepted			2022-12-25	WOS:000267786200008
J	Viswanathan, SR; Powers, JT; Einhorn, W; Hoshida, Y; Ng, TL; Toffanin, S; O'Sullivan, M; Lu, J; Phillips, LA; Lockhart, VL; Shah, SP; Tanwar, PS; Mermel, CH; Beroukhim, R; Azam, M; Teixeira, J; Meyerson, M; Hughes, TP; Llovet, JM; Radich, J; Mullighan, CG; Golub, TR; Sorensen, PH; Daley, GQ				Viswanathan, Srinivas R.; Powers, John T.; Einhorn, William; Hoshida, Yujin; Ng, Tony L.; Toffanin, Sara; O'Sullivan, Maureen; Lu, Jun; Phillips, Letha A.; Lockhart, Victoria L.; Shah, Samar P.; Tanwar, Pradeep S.; Mermel, Craig H.; Beroukhim, Rameen; Azam, Mohammad; Teixeira, Jose; Meyerson, Matthew; Hughes, Timothy P.; Llovet, Josep M.; Radich, Jerald; Mullighan, Charles G.; Golub, Todd R.; Sorensen, Poul H.; Daley, George Q.			Lin28 promotes transformation and is associated with advanced human malignancies	NATURE GENETICS			English	Article							MICRORNA EXPRESSION; GENE-EXPRESSION; LUNG-CANCER; LET-7; TUMOR; LIN-28; REGION; MYC; DIFFERENTIATION; T(5/6)(Q21,Q21)	Multiple members of the let-7 family of miRNAs are often repressed in human cancers(1,2), thereby promoting oncogenesis by derepressing targets such as HMGA2, K-Ras and c-Myc(3,4). However, the mechanism by which let-7 miRNAs are coordinately repressed is unclear. The RNA-binding proteins LIN28 and LIN28B block let-7 precursors from being processed to mature nmiRNAs(5-8), suggesting that their overexpression might promote malignancy through repression of let-7. Here we show that LIN28 and LIN28B are overexpressed in primary human tumors and human cancer cell lines (overall frequency B15%), and that overexpression is linked to repression of let-7 family miRNAs and derepression of let-7 targets. LIN28 and LIN28b facilitate cellular transformation in vitro, and overexpression is associated with advanced disease across multiple tumor types. Our work provides a mechanism for the coordinate repression of let-7 miRNAs observed in a subset of human cancers, and associates activation of LIN28 and LIN28B with poor clinical prognosis.	[Viswanathan, Srinivas R.; Powers, John T.; Einhorn, William; Shah, Samar P.; Azam, Mohammad; Daley, George Q.] Harvard Univ, Childrens Hosp, Dept Biol Chem & Mol Pharmacol, Med Sch,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Hoshida, Yujin; Golub, Todd R.; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Cambridge, MA USA; [Hoshida, Yujin; Golub, Todd R.; Daley, George Q.] Dana Farber Canc Inst, Cambridge, MA USA; [Hoshida, Yujin; Lu, Jun; Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew; Golub, Todd R.] MIT & Harvard, Broad Inst, Canc Program, Cambridge, MA USA; [Hoshida, Yujin; Lu, Jun; Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hoshida, Yujin; Lu, Jun; Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Ng, Tony L.; Sorensen, Poul H.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Ng, Tony L.; Sorensen, Poul H.] BC Canc Res Ctr, Dept Mol Oncol, Vancouver, BC, Canada; [Toffanin, Sara; Llovet, Josep M.] Mt Sinai Sch Med, Div Liver Dis, Mt Sinai Liver Canc Program, New York, NY USA; [Toffanin, Sara] IRCSS Fdn, Natl Canc Inst, Gastrointestinal Surg & Liver Transplantat Unit, Milan, Italy; [O'Sullivan, Maureen] Our Ladys Childrens Hosp, Dept Pathol, Dublin, Ireland; [O'Sullivan, Maureen] Trinity Coll Dublin, Dept Pathol, Dublin, Ireland; [Phillips, Letha A.; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Lockhart, Victoria L.; Radich, Jerald] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Tanwar, Pradeep S.; Teixeira, Jose] Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Hughes, Timothy P.] Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia; [Llovet, Josep M.] Hosp Clin Barcelona, HCC Translat Res Lab, Barcelona Clin Liver Canc Grp,CIBERehd, Liver Unit,Inst Invest Biomed August Pi & Sunyer, Catalonia, Spain; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Catalonia, Spain; [Golub, Todd R.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of British Columbia; British Columbia Cancer Agency; Icahn School of Medicine at Mount Sinai; Fondazione IRCCS Istituto Nazionale Tumori Milan; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; St Jude Children's Research Hospital; Fred Hutchinson Cancer Center; Harvard University; Massachusetts General Hospital; Institute Medical & Veterinary Science Australia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Daley, GQ (corresponding author), Harvard Univ, Childrens Hosp, Dept Biol Chem & Mol Pharmacol, Med Sch,Harvard Stem Cell Inst, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Llovet, Josep M/ABB-6264-2021; Tanwar, Pradeep/AAU-6831-2020; Mullighan, Charles/H-3253-2011; Viswanathan, Srinivas/ABA-6316-2021; Meyerson, Matthew L/E-7123-2012; Powers, John/AAO-1018-2020; Hughes, Tim/AAO-9975-2021; Mermel, Craig/AAZ-7322-2020; Hoshida, Yujin/R-7513-2019; Llovet, Josep M/D-4340-2014; Teixeira, Jose/P-2542-2014	Llovet, Josep M/0000-0003-0547-2667; Mullighan, Charles/0000-0002-1871-1850; Viswanathan, Srinivas/0000-0003-1856-3023; Mermel, Craig/0000-0002-0816-3395; Llovet, Josep M/0000-0003-0547-2667; O'Sullivan, Maureen/0000-0001-5838-1609; Teixeira, Jose/0000-0002-6438-5064; Hughes, Timothy/0000-0002-0910-3730	ICREA Funding Source: Custom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052701] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [T32-HL 66987] Funding Source: Medline; NICHD NIH HHS [R01 HD052701-02, R01 HD052701] Funding Source: Medline; NIDDK NIH HHS [1 R01 DK076986-01, R01 DK076986] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NIH HHS [DP1 OD000256-01, DP1 OD000256] Funding Source: Medline	ICREA(ICREA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bruce CK, 2003, CANCER GENET CYTOGEN, V141, P106, DOI 10.1016/S0165-4608(02)00669-6; Bruecher-Encke B, 2001, LEUKEMIA, V15, P1424, DOI 10.1038/sj.leu.2402214; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; ENGELMAN A, 1990, MOL CELL BIOL, V10, P4365, DOI 10.1128/MCB.10.8.4365; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fernandez CV, 2001, CANCER GENET CYTOGEN, V129, P165, DOI 10.1016/S0165-4608(01)00445-9; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hoban PR, 1997, J MED GENET, V34, P343, DOI 10.1136/jmg.34.4.343; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Inamura K, 2007, LUNG CANCER, V58, P392, DOI 10.1016/j.lungcan.2007.07.013; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; KEATH EJ, 1984, CELL, V39, P339, DOI 10.1016/0092-8674(84)90012-6; Korshunov A, 2007, AM J CLIN PATHOL, V127, P585, DOI 10.1309/DE4LNX3YMACCC1ER; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meyer B, 2007, LEUKEMIA LYMPHOMA, V48, P2008, DOI 10.1080/10428190701559116; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Summersgill B, 1998, BRIT J CANCER, V77, P305, DOI 10.1038/bjc.1998.47; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang L, 2007, NAT MED, V13, P1060, DOI 10.1038/nm1621	55	625	651	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					843	U109		10.1038/ng.392	http://dx.doi.org/10.1038/ng.392			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19483683	Green Accepted			2022-12-25	WOS:000267786200018
J	Yamayoshi, S; Yamashita, Y; Li, JF; Hanagata, N; Minowa, T; Takemura, T; Koike, S				Yamayoshi, Seiya; Yamashita, Yasuko; Li, Jifen; Hanagata, Nobutaka; Minowa, Takashi; Takemura, Taro; Koike, Satoshi			Scavenger receptor B2 is a cellular receptor for enterovirus 71	NATURE MEDICINE			English	Article							MOUTH-DISEASE; POLIOVIRUS RECEPTOR; MEMBRANE-PROTEINS; PUBLIC-HEALTH; INFECTION; OUTBREAK; SYSTEM; FOOT; HAND; EVOLUTION	Enterovirus 71 (EV71) belongs to human enterovirus species A of the genus Enterovirus within the family Picornaviridae(1). EV71, together with coxsackievirus A16 (CVA16), are most frequently associated with hand, foot and mouth disease (HFMD)(1). Although HFMD is considered a mild exanthematous infection, infections involving EV71, but not CVA16, can progress to severe neurological disease, including fatal encephalitis, aseptic meningitis and acute flaccid paralysis(2). In recent years, epidemic and sporadic outbreaks of neurovirulent EV71 infections have been reported in Taiwan, Malaysia, Singapore, Japan and China(3-7). Here, we show that human scavenger receptor class B, member 2 (SCARB2, also known as lysosomal integral membrane protein II or CD36b like-2) is a receptor for EV71. EV71 binds soluble SCARB2 or cells expressing SCARB2, and the binding is inhibited by an antibody to SCARB2. Expression of human SCARB2 enables normally unsusceptible cell lines to support EV71 propagation and develop cytopathic effects. EV71 infection is hampered by the antibody to SCARB2 and soluble SCARB2. SCARB2 also supports the infection of the milder pathogen CVA16. The identification of SCARB2 as an EV71 and CVA16 receptor contributes to a better understanding of the pathogenicity of these viruses.	[Yamayoshi, Seiya; Yamashita, Yasuko; Li, Jifen; Koike, Satoshi] Tokyo Metropolitan Org Med Res, Dept Microbiol & Immunol, Tokyo Metropolitan Inst Neurosci, Tokyo, Japan; [Yamayoshi, Seiya] Japan Hlth Sci Fdn, Tokyo, Japan; [Hanagata, Nobutaka; Minowa, Takashi; Takemura, Taro] Natl Inst Mat Sci, Nanotechnol Innovat Ctr, Ibaraki, Japan; [Hanagata, Nobutaka] Natl Inst Mat Sci, Ctr Biomat, Ibaraki, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; National Institute for Materials Science; National Institute for Materials Science	Koike, S (corresponding author), Tokyo Metropolitan Org Med Res, Neurovirol Project, Tokyo Metropolitan Inst Med Sci, Tokyo, Japan.	koike-st@igakuken.or.jp	Yamayoshi, Seiya/C-1982-2013; Yamayoshi, Seiya/Y-7430-2019	Yamayoshi, Seiya/0000-0001-7768-5157; Yamayoshi, Seiya/0000-0001-7768-5157; Hanagata, Nobutaka/0000-0001-6079-3426	Japan Society for the Promotion of Science [20590243]; Ministry of Health, Labour and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	We thank H. Shimizu (Japan National Institute of Infectious Diseases) for providing us with all viruses used in this report and critical reading of this manuscript, Y. Kawaoka (University of Tokyo) for providing us with pCAGGS-PUR, Y. Yanagi for critical reading of this manuscript and Y. Matsumoto and K. Kohyama for supporting flow cytometry. This work was supported in part by a grant-in-aid for Scientific Research (C) (20590243) from the Japan Society for the Promotion of Science and in part by a grant-in-aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour and Welfare, Japan.	Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; CALVO D, 1995, GENOMICS, V25, P100, DOI 10.1016/0888-7543(95)80114-2; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gamp AC, 2003, HUM MOL GENET, V12, P631, DOI 10.1093/hmg/ddg062; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Nagata N, 2002, J MED VIROL, V67, P207, DOI 10.1002/jmv.2209; Pallansch M., 2006, FIELDS VIROLOGY, VVolume 1, P839; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Yamayoshi S, 2008, CELL HOST MICROBE, V3, P168, DOI 10.1016/j.chom.2008.02.001; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Yanagiya A, 2005, J VIROL, V79, P1523, DOI 10.1128/JVI.79.3.1523-1532.2005	18	370	428	6	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					798	U15		10.1038/nm.1992	http://dx.doi.org/10.1038/nm.1992			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19543282				2022-12-25	WOS:000267806900034
J	Barrett, JC; Clayton, DG; Concannon, P; Akolkar, B; Cooper, JD; Erlich, HA; Julier, C; Morahan, G; Nerup, J; Nierras, C; Plagnol, V; Pociot, F; Schuilenburg, H; Smyth, DJ; Stevens, H; Todd, JA; Walker, NM; Rich, SS				Barrett, Jeffrey C.; Clayton, David G.; Concannon, Patrick; Akolkar, Beena; Cooper, Jason D.; Erlich, Henry A.; Julier, Cecile; Morahan, Grant; Nerup, Jorn; Nierras, Concepcion; Plagnol, Vincent; Pociot, Flemming; Schuilenburg, Helen; Smyth, Deborah J.; Stevens, Helen; Todd, John A.; Walker, Neil M.; Rich, Stephen S.		Type 1 Diabet Genetics Consortium	Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCUS; CHROMOSOME; DISEASE; REGION; GENES; HLA; VARIANTS; MELLITUS; PTPN22; TESTS	Type 1 diabetes (T1D) is a common autoimmune disorder that arises from the action of multiple genetic and environmental risk factors. We report the findings of a genome-wide association study of T1D, combined in a meta-analysis with two previously published studies. The total sample set included 7,514 cases and 9,045 reference samples. Forty-one distinct genomic locations provided evidence for association with T1D in the meta-analysis (P < 10(-6)). After excluding previously reported associations, we further tested 27 regions in an independent set of 4,267 cases, 4,463 controls and 2,319 affected sib-pair (ASP) families. Of these, 18 regions were replicated (P < 0.01; overall P < 5 x 10(-8)) and 4 additional regions provided nominal evidence of replication (P < 0.05). The many new candidate genes suggested by these results include IL10, IL19, IL20, GLIS3, CD69 and IL27.	[Clayton, David G.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Barrett, Jeffrey C.; Clayton, David G.; Cooper, Jason D.; Plagnol, Vincent; Schuilenburg, Helen; Smyth, Deborah J.; Stevens, Helen; Todd, John A.; Walker, Neil M.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res,Juvenile Diabet Res Fdn, Dept Med Genet,Wellcom Trust Diabet & Inflammat L, Cambridge CB2 2QQ, England; [Concannon, Patrick; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Akolkar, Beena] NIDDK, Div Diabet Endocrinol & Metab Dis, NIH, Bethesda, MD USA; [Erlich, Henry A.] Roche Mol Syst, Pleasanton, CA USA; [Julier, Cecile] INSERM, U958, Ctr Natl Genotypage, Evry, France; [Morahan, Grant] Western Australia Inst Med Res, Ctr Diabet Res, Perth, WA, Australia; [Morahan, Grant] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [Nerup, Jorn; Pociot, Flemming] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Nerup, Jorn; Pociot, Flemming] Hagedorn Res Inst, Gentofte, Denmark; [Nierras, Concepcion] Juvenile Diabet Res Fdn, New York, NY USA; [Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA USA	University of Virginia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Roche Holding; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Western Australia; Steno Diabetes Center; Novo Nordisk; Hagedorn Research Institute; University of Virginia	Concannon, P (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	patcon@virginia.edu	Cameron, Fergus J/N-9535-2015; Plagnol, Vincent/A-5667-2011; Skrha, Jan/C-3095-2017; Vázquez, Federico/AAF-9825-2021; Morahan, Grant/T-7501-2019; Briggs, Farren/Q-2164-2019; Li, Dawei/A-3466-2011; Roep, Bart/AAD-7609-2021; Tillmann, Vallo/G-8118-2012; Altshuler, David M/A-4476-2009; Ludvigsson, Johnny/AAI-2051-2020; de Bakker, Paul IW/B-8730-2009; Boehm, Bernhard Otto/F-8750-2015; JULIER, Cécile/M-9824-2017; Mauricio, Didac/B-7951-2009; Argente, Jesús/K-1167-2014; Hernández, Marta/U-9874-2017; Kockum, Ingrid/O-8781-2018; Paterson, Andrew/A-4088-2011; Urbanavicius, Vaidotas/D-4907-2016; Kretowski, Adam/U-6299-2018; Doria, Alessandro/H-9157-2018; Todd, John/A-3542-2010	Skrha, Jan/0000-0001-8012-8802; Vázquez, Federico/0000-0001-6493-2374; Briggs, Farren/0000-0003-0903-1359; Tillmann, Vallo/0000-0002-5279-4493; Altshuler, David M/0000-0002-7250-4107; Ludvigsson, Johnny/0000-0003-1695-5234; de Bakker, Paul IW/0000-0001-7735-7858; JULIER, Cécile/0000-0002-1538-0240; Mauricio, Didac/0000-0002-2868-0250; Argente, Jesús/0000-0001-5826-0276; Hernández, Marta/0000-0003-1237-298X; Kockum, Ingrid/0000-0002-0867-4726; Concannon, Patrick/0000-0002-5801-1859; Paterson, Andrew/0000-0002-9169-118X; Hall, Mark A./0000-0001-6277-144X; Rich, Stephen/0000-0003-3872-7793; Schuilenburg, Helen/0000-0002-0040-6591; Urbanavicius, Vaidotas/0000-0002-8601-4563; Castano, Luis/0000-0003-0437-9401; Pociot, Flemming/0000-0003-3274-5448; smyth, deborah/0000-0002-6330-2669; Metzger, Daniel/0000-0002-1715-4319; Li, Xiaoying/0000-0002-9383-5757; McLaren, William/0000-0001-6218-1116; Walker, Neil/0000-0001-9796-7688; Cinek, Ondrej/0000-0002-0526-8714; Corripio, Raquel/0000-0003-3344-8269; Burren, Oliver/0000-0002-3388-5760; Abdul Ghani, Rohana/0000-0002-3520-8472; Knip, Mikael/0000-0003-0474-0033; Kretowski, Adam/0000-0002-4522-4978; Doria, Alessandro/0000-0002-3830-4304; Van der Auwera, Bart/0000-0003-4133-2565; Brodnicki, Thomas/0000-0003-2294-315X; Schofield, Ellen/0000-0003-0648-1418; Colman, Peter/0000-0001-8718-6175; Plagnol, Vincent/0000-0002-5597-9215; Dunger, Professor David/0000-0002-2566-9304; Couper, Jennifer/0000-0003-4448-8629; Todd, John/0000-0003-2740-8148; Battelino, Tadej/0000-0002-0273-4732; Willis, Jinny/0000-0001-7215-0655; Nicholson, Ian/0000-0001-6654-2548; Willi, Steven/0000-0002-4910-2425; Johannesen, Jesper/0000-0003-2772-2567; Wagner, Ana M/0000-0002-7663-9308; CUCCA, Francesco/0000-0002-7414-1995; Simpson, Angela/0000-0003-2733-6666; Pirags, Valdis/0000-0002-3650-7394; vandiedonck, claire/0000-0002-6669-6923; , Silvana/0000-0001-6873-0198; Ampudia Blasco, Francisco Javier/0000-0003-0221-0901	Medical Research Council [G0000934] Funding Source: Medline; NIDDK NIH HHS [R01 DK046635, U01 DK062418-06, K08 DK002876-06, U01 DK062418, R01 DK046635-15, K08 DK002876, DK46635] Funding Source: Medline; NIMH NIH HHS [MH059571, R01 MH061675, MH59587, MH60870, MH 63420, MH59566, R01 MH059566, R01 MH060879, R01 MH060870, MH060879, R01 MH059586, R01 MH059571, R01 MH059565, MH067257, R01 MH067257, R01 MH059587, MH059565, MH059588, R01 MH063420, MH061675, R01 MH059588, MH59586] Funding Source: Medline; Wellcome Trust [076113, 061858] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002876, U01DK062418, R01DK046635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060879, R01MH059586, R01MH063420, R01MH059571, R01MH059587, R01MH061675, R01MH059565, R01MH067257, R01MH060870, R01MH059566, R01MH059588] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0508-10274, NF-SI-0508-10275] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bjornvold M, 2008, DIABETOLOGIA, V51, P589, DOI 10.1007/s00125-008-0932-0; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; COOPER JD, GENES IMMUN IN PRESS; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Mueller PW, 2006, J AM SOC NEPHROL, V17, P1782, DOI 10.1681/ASN.2005080822; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	29	1210	1243	2	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					703	707		10.1038/ng.381	http://dx.doi.org/10.1038/ng.381			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19430480	Green Accepted			2022-12-25	WOS:000266411700019
J	Mates, L; Chuah, MKL; Belay, E; Jerchow, B; Manoj, N; Acosta-Sanchez, A; Grzela, DP; Schmitt, A; Becker, K; Matrai, J; Ma, L; Samara-Kuko, E; Gysemans, C; Pryputniewicz, D; Miskey, C; Fletcher, B; VandenDriessche, T; Ivics, Z; Izsvak, Z				Mates, Lajos; Chuah, Marinee K. L.; Belay, Eyayu; Jerchow, Boris; Manoj, Namitha; Acosta-Sanchez, Abel; Grzela, Dawid P.; Schmitt, Andrea; Becker, Katja; Matrai, Janka; Ma, Ling; Samara-Kuko, Ermira; Gysemans, Conny; Pryputniewicz, Diana; Miskey, Csaba; Fletcher, Bradley; VandenDriessche, Thierry; Ivics, Zoltan; Izsvak, Zsuzsanna			Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates	NATURE GENETICS			English	Article							EXPRESSION IN-VIVO; HUMAN-CELLS; LENTIVIRAL VECTORS; STEM-CELLS; FACTOR-IX; TRANSGENE EXPRESSION; MUTATIONAL ANALYSIS; HEMOPHILIC MICE; NOD/SCID MICE; INTEGRATION	The Sleeping Beauty (SB) transposon is a promising technology platform for gene transfer in vertebrates; however, its efficiency of gene insertion can be a bottleneck in primary cell types. A large-scale genetic screen in mammalian cells yielded a hyperactive transposase (SB100X) with B100-fold enhancement in efficiency when compared to the first-generation transposase. SB100X supported 35-50% stable gene transfer in human CD34(+) cells enriched in hematopoietic stem or progenitor cells. Transplantation of gene-marked CD34(+) cells in immunodeficient mice resulted in long-term engraftment and hematopoietic reconstitution. In addition, SB100X supported sustained (> 1 year) expression of physiological levels of factor IX upon transposition in the mouse liver in vivo. Finally, SB100X reproducibly resulted in 45% stable transgenesis frequencies by pronuclear microinjection into mouse zygotes. The newly developed transposase yields unprecedented stable gene transfer efficiencies following nonviral gene delivery that compare favorably to stable transduction efficiencies with integrating viral vectors and is expected to facilitate widespread applications in functional genomics and gene therapy.	[Chuah, Marinee K. L.; Belay, Eyayu; Acosta-Sanchez, Abel; Matrai, Janka; Ma, Ling; Samara-Kuko, Ermira; VandenDriessche, Thierry] Katholieke Univ Leuven VIB, Vesalius Res Ctr, Louvain, Belgium; [Mates, Lajos; Jerchow, Boris; Manoj, Namitha; Grzela, Dawid P.; Schmitt, Andrea; Becker, Katja; Pryputniewicz, Diana; Miskey, Csaba; Ivics, Zoltan; Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, Berlin, Germany; [Gysemans, Conny] Katholieke Univ Leuven, Lab Expt Transplantat, Dept Expt Med, Louvain, Belgium; [Fletcher, Bradley] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Izsvak, Zsuzsanna] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary	Flanders Institute for Biotechnology (VIB); KU Leuven; Helmholtz Association; Max Delbruck Center for Molecular Medicine; KU Leuven; State University System of Florida; University of Florida; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	VandenDriessche, T (corresponding author), Katholieke Univ Leuven VIB, Vesalius Res Ctr, Louvain, Belgium.	thierry.vandendriessche@med.kuleuven.be; zizsvak@mdc-berlin.de	Grzela, Dawid P/G-6395-2015; Miskey, Csaba/U-3473-2017; Wilson, Matthew H/K-3193-2013	Grzela, Dawid P/0000-0002-0667-6488; Izsvak, Zsuzsanna/0000-0002-2053-2384; Vandendriessche, Thierry/0000-0003-4230-745X; Mates, Lajos/0000-0002-0058-470X; Chuah, Marinee/0000-0001-8569-0175; gysemans, conny/0000-0003-3559-6089; Jerchow, Boris-Alexander/0000-0002-7031-8730	Volkswagen Stiftung [EU FP5, EU FP6, EU FP7]; Bundesministerium fur Bildung und Forschung [NGFN-2]; FWO [G.0632.07];  [VIB GOA/2004/09]	Volkswagen Stiftung(Volkswagen); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); FWO(FWO); 	We thank C. Judis, V. Gillijns and M. Shrahna for technical assistance. Z. Izsvak is an EURYI Awardee. We acknowledge the financial support of EU FP5 ( JUMPY), EU FP6 (INTHER) and EU FP7 ( PERSIST), grants from the Volkswagen Stiftung and from the Bundesministerium fur Bildung und Forschung (NGFN-2), VIB GOA/2004/09 and FWO ( G.0632.07). We thank E. Zeira, E. Galun ( Goldyne Savad Institute of Gene Therapy) and M. Rhee ( Chunguam University of Korea) for providing the pT2/CAGGS-GFP and the pcGlobin2 constructs, respectively. We further thank M. J. Fraser ( University of Notre Dame) and A. Bradley ( Sanger Centre) for providing the pXL-BacII and codon-optimized piggyBac transposase constructs, respectively, and A. Leutz and N. Rajewsky for critical reading of the manuscript. A. Schmitt is affiliated with Medical Faculty of Charite, Berlin.	Baus J, 2005, MOL THER, V12, P1148, DOI 10.1016/j.ymthe.2005.06.484; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Conneally E, 1998, BLOOD, V91, P3487, DOI 10.1182/blood.V91.9.3487.3487_3487_3493; CONNER DA, 2004, CURR PROTOC MOL BIOL, pCH23; Dalsgaard T, 2009, MOL THER, V17, P121, DOI 10.1038/mt.2008.224; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Geurts AM, 2006, PLOS GENET, V2, P1413, DOI 10.1371/journal.pgen.0020156; Hollis RP, 2006, EXP HEMATOL, V34, P1333, DOI 10.1016/j.exphem.2006.05.023; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2007, MOL THER, V15, P1137, DOI 10.1038/sj.mt.6300169; Ivics Z, 2006, CURR GENE THER, V6, P593, DOI 10.2174/156652306778520647; Izsvak Z, 2004, MOL THER, V9, P147, DOI 10.1016/j.ymthe.2003.11.009; Kitada K, 2007, NAT METHODS, V4, P131, DOI 10.1038/nmeth1002; Liu GY, 2005, J MOL BIOL, V346, P161, DOI 10.1016/j.jmb.2004.09.086; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mates L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S1; Miao CH, 2000, MOL THER, V1, P522, DOI 10.1006/mthe.2000.0075; Mikkelsen JG, 2003, MOL THER, V8, P654, DOI 10.1016/S1525-0016(03)00216-8; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Moore JC, 1997, J MOL BIOL, V272, P336, DOI 10.1006/jmbi.1997.1252; Nagy A., 2003, MANIPULATING MOUSE E; Ohlfest JR, 2005, BLOOD, V105, P2691, DOI 10.1182/blood-2004-09-3496; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; Salmon P, 2000, BLOOD, V96, P3392; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; VandenDriessche T, 2002, BLOOD, V100, P813, DOI 10.1182/blood.V100.3.813; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Walisko O, 2008, MOL THER, V16, P359, DOI 10.1038/sj.mt.6300366; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yant SR, 2004, MOL CELL BIOL, V24, P9239, DOI 10.1128/MCB.24.20.9239-9247.2004; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089; Yusa K, 2004, MOL CELL BIOL, V24, P4004, DOI 10.1128/MCB.24.9.4004-4018.2004; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	46	576	629	6	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					753	761		10.1038/ng.343	http://dx.doi.org/10.1038/ng.343			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19412179				2022-12-25	WOS:000266411700028
J	Ye, SX; Huber, T; Vogel, R; Sakmar, TP				Ye, Shixin; Huber, Thomas; Vogel, Reiner; Sakmar, Thomas P.			FTIR analysis of GPCR activation using azido probes	NATURE CHEMICAL BIOLOGY			English	Article							SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACID; PROTEIN-COUPLED-RECEPTORS; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; GENETIC-CODE; RHODOPSIN; DISCOVERY; OPSIN	We demonstrate the site-directed incorporation of an IR-active amino acid, p-azido-L-phenylalanine (azidoF, 1), into the G protein-coupled receptor rhodopsin using amber codon suppression technology. The antisymmetric stretch vibration of the azido group absorbs at similar to 2,100 cm(-1) in a clear spectral window and is sensitive to its electrostatic environment. We used FTIR difference spectroscopy to monitor the azido probe and show that the electrostatic environments of specific interhelical networks change during receptor activation.	[Ye, Shixin; Huber, Thomas; Sakmar, Thomas P.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; [Vogel, Reiner] Univ Freiburg, Biophys Sect, Inst Mol Med & Cell Res, Freiburg, Germany	Rockefeller University; University of Freiburg	Sakmar, TP (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA.	sakmar@rockefeller.edu	Huber, Thomas/A-8016-2008; Sakmar, Thomas P/D-1833-2015	Huber, Thomas/0000-0002-1844-262X; Sakmar, Thomas P/0000-0002-2836-8953; Ye, Shixin/0000-0002-9254-9409	Deutsche Forschungsgemeinschaft [Vo 811/4-1]; C. H. Li Memorial Scholar Award; NATIONAL EYE INSTITUTE [R01EY012049, R01EY018891] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); C. H. Li Memorial Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Banerjee, T. Haines, U. L. RajBhandary, C. Kohrer and M. S. Sagredo for invaluable discussions. We are also grateful to the Proteomic Resource Center at The Rockefeller University for providing technical resources. Financial support was provided by the Deutsche Forschungsgemeinschaft (grant Vo 811/4-1 to R. V.) and by a C. H. Li Memorial Scholar Award (to S. Y.).	Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Huber T, 2004, BIOPHYS J, V86, P2078, DOI 10.1016/S0006-3495(04)74268-X; Huber T, 2008, BIOCHEMISTRY-US, V47, P11013, DOI 10.1021/bi800891r; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Ohno S, 2007, J BIOCHEM, V141, P335, DOI 10.1093/jb/mvm036; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schultz KC, 2006, J AM CHEM SOC, V128, P13984, DOI 10.1021/ja0636690; Silverman LN, 2007, J PHYS CHEM B, V111, P11611, DOI 10.1021/jp0750912; Suydam IT, 2006, SCIENCE, V313, P200, DOI 10.1126/science.1127159; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200	25	141	143	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					397	399		10.1038/nchembio.167	http://dx.doi.org/10.1038/nchembio.167			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19396177	Green Accepted			2022-12-25	WOS:000266383800012
J	Cho, YS; Go, MJ; Kim, YJ; Heo, JY; Oh, JH; Ban, HJ; Yoon, D; Lee, MH; Kim, DJ; Park, M; Cha, SH; Kim, JW; Han, BG; Min, H; Ahn, Y; Park, MS; Han, HR; Jang, HY; Cho, EY; Lee, JE; Cho, NH; Shin, C; Park, T; Park, JW; Lee, JK; Cardon, L; Clarke, G; McCarthy, MI; Lee, JY; Lee, JK; Oh, B; Kim, HL				Cho, Yoon Shin; Go, Min Jin; Kim, Young Jin; Heo, Jee Yeon; Oh, Ji Hee; Ban, Hyo-Jeong; Yoon, Dankyu; Lee, Mi Hee; Kim, Dong-Joon; Park, Miey; Cha, Seung-Hun; Kim, Jun-Woo; Han, Bok-Ghee; Min, Haesook; Ahn, Younjhin; Park, Man Suk; Han, Hye Ree; Jang, Hye-Yoon; Cho, Eun Young; Lee, Jong-Eun; Cho, Nam H.; Shin, Chol; Park, Taesung; Park, Ji Wan; Lee, Jong-Keuk; Cardon, Lon; Clarke, Geraldine; McCarthy, Mark I.; Lee, Jong-Young; Lee, Jong-Koo; Oh, Bermseok; Kim, Hyung-Lae			A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits	NATURE GENETICS			English	Article							PLASMA-MEMBRANE; CELLS; OBESITY; HEIGHT; MASS; EXPRESSION; VARIANTS; PROTEINS; ARRAYS; LOCI	To identify genetic factors influencing quantitative traits of biomedical importance, we conducted a genome-wide association study in 8,842 samples from population-based cohorts recruited in Korea. For height and body mass index, most variants detected overlapped those reported in European samples. For the other traits examined, replication of promising GWAS signals in 7,861 independent Korean samples identified six previously unknown loci. For pulse rate, signals reaching genome-wide significance mapped to chromosomes 1q32 (rs12731740, P = 2.9 x 10(-9)) and 6q22 (rs12110693, P = 1.6 x 10(-9)), with the latter similar to 400 kb from the coding sequence of GJA1. For systolic blood pressure, the most compelling association involved chromosome 12q21 and variants near the ATP2B1 gene (rs17249754, P = 1.3 x 10(-7)). For waist-hip ratio, variants on chromosome 12q24 (rs2074356, P = 7.8 x 10(-12)) showed convincing associations, although no regional transcript has strong biological candidacy. Finally, we identified two loci influencing bone mineral density at multiple sites. On chromosome 7q31, rs7776725 (within the FAM3C gene) was associated with bone density at the radius (P = 1.0 x 10(-11)), tibia (P = 1.6 x 10(-6)) and heel (P = 1.9 x 10(-10)). On chromosome 7p14, rs1721400 (mapping close to SFRP4, a frizzled protein gene) showed consistent associations at the same three sites (P = 2.2 x 10(-3), P = 1.4 x 10(-7) and P = 6.0 x 10(-4), respectively). This large-scale GWA analysis of well-characterized Korean population-based samples highlights previously unknown biological pathways.	[Cho, Yoon Shin; Go, Min Jin; Kim, Young Jin; Heo, Jee Yeon; Oh, Ji Hee; Ban, Hyo-Jeong; Lee, Mi Hee; Kim, Dong-Joon; Park, Miey; Cha, Seung-Hun; Kim, Jun-Woo; Han, Bok-Ghee; Min, Haesook; Ahn, Younjhin; Park, Man Suk; Han, Hye Ree; Lee, Jong-Keuk; Oh, Bermseok; Kim, Hyung-Lae] Natl Inst Hlth, Ctr Genome Sci, Seoul, South Korea; [Yoon, Dankyu; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Han, Hye Ree; Jang, Hye-Yoon; Cho, Eun Young] DNA Link, Seoul, South Korea; [Cho, Nam H.] Ajou Univ, Sch Med, Dept Prevent Med, Suwon 441749, South Korea; [Shin, Chol] Korea Univ, Ansan Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Ansan, South Korea; [Park, Taesung] Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul 151742, South Korea; [Park, Ji Wan] Hallym Univ, Coll Med, Dept Med Genet, Chunchon, South Korea; [Lee, Jong-Keuk] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea; [Cardon, Lon] GlaxoSmithKline Inc, Philadelphia, PA USA; [Clarke, Geraldine; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Lee, Jong-Koo] Korea Ctr Dis Control & Prevent, Seoul, South Korea; [Oh, Bermseok] Kyung Hee Univ, Sch Med, Dept Biomed Engn, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Seoul National University (SNU); DNA Link, Inc.; Ajou University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Hallym University; University of Ulsan; GlaxoSmithKline; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Korea Centers for Disease Control & Prevention (KCDC); Kyung Hee University	Kim, HL (corresponding author), Natl Inst Hlth, Ctr Genome Sci, Seoul, South Korea.	ohbs@khu.ac.kr; hyung505@nih.go.kr	LEE, Jong-koo/E-4166-2012; Kim, Young-jin/GSD-3168-2022; Lee, Jong-Young/M-6319-2013; Lee, JongGu/B-7384-2013; McCarthy, Mark/M-3763-2015	Lee, Jong-Young/0000-0002-0092-9958; Park, Ji Wan/0000-0003-0840-1696; McCarthy, Mark/0000-0002-4393-0510	Ministry for Health, Welfare and Family Affairs, Republic of Korea [4845-301-430-260-00]; Korea National Institute of Health, Korea Center for Disease Control, Republic of Korea [4845-301-430-210-13]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea National Institute of Health, Korea Center for Disease Control, Republic of Korea	This work was supported by a grant from the Ministry for Health, Welfare and Family Affairs, Republic of Korea (4845-301-430-260-00), and an intramural grant from the Korea National Institute of Health, Korea Center for Disease Control, Republic of Korea (4845-301-430-210-13).	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; Cho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Dooley DC, 2004, STEM CELLS, V22, P556, DOI 10.1634/stemcells.22-4-556; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; Howarth FC, 2007, MOL CELL BIOCHEM, V305, P145, DOI 10.1007/s11010-007-9537-z; HUI L, 2008, CURR PROTOC HUM GENE; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Nakanishi R, 2006, J BONE MINER RES, V21, P1713, DOI 10.1359/JBMR.060719; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Pati N, 2004, J BIOCHEM BIOPH METH, V60, P1, DOI 10.1016/j.jbbm.2003.11.005; Peters NS, 1996, CLIN SCI, V90, P447, DOI 10.1042/cs0900447; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569	28	743	818	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					527	534		10.1038/ng.357	http://dx.doi.org/10.1038/ng.357			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19396169				2022-12-25	WOS:000265575600013
J	Imielinski, M; Baldassano, RN; Griffiths, A; Russell, RK; Annese, V; Dubinsky, M; Kugathasan, S; Bradfield, JP; Walters, TD; Sleiman, P; Kim, CE; Muise, A; Wang, K; Glessner, JT; Saeed, S; Zhang, HT; Frackelton, EC; Hou, CP; Flory, JH; Otieno, G; Chiavacci, RM; Grundmeier, R; Castro, M; Latiano, A; Dallapiccola, B; Stempak, J; Abrams, DJ; Taylor, K; McGovern, D; Heyman, MB; Ferry, GD; Kirschner, B; Lee, J; Essers, J; Grand, R; Stephens, M; Levine, A; Piccoli, D; Van Limbergen, J; Cucchiara, S; Monos, DS; Guthery, SL; Denson, L; Wilson, DC; Grant, SFA; Daly, M; Silverberg, MS; Satsangi, J; Hakonarson, H				Imielinski, Marcin; Baldassano, Robert N.; Griffiths, Anne; Russell, Richard K.; Annese, Vito; Dubinsky, Marla; Kugathasan, Subra; Bradfield, Jonathan P.; Walters, Thomas D.; Sleiman, Patrick; Kim, Cecilia E.; Muise, Aleixo; Wang, Kai; Glessner, Joseph T.; Saeed, Shehzad; Zhang, Haitao; Frackelton, Edward C.; Hou, Cuiping; Flory, James H.; Otieno, George; Chiavacci, Rosetta M.; Grundmeier, Robert; Castro, Massimo; Latiano, Anna; Dallapiccola, Bruno; Stempak, Joanne; Abrams, Debra J.; Taylor, Kent; McGovern, Dermot; Heyman, Melvin B.; Ferry, George D.; Kirschner, Barbara; Lee, Jessica; Essers, Jonah; Grand, Richard; Stephens, Michael; Levine, Arie; Piccoli, David; Van Limbergen, Johan; Cucchiara, Salvatore; Monos, Dimitri S.; Guthery, Stephen L.; Denson, Lee; Wilson, David C.; Grant, Struan F. A.; Daly, Mark; Silverberg, Mark S.; Satsangi, Jack; Hakonarson, Hakon		Western Reg Res Alliance Pediat IB; Int IBD Genetics Consortium	Common variants at five new loci associated with early-onset inflammatory bowel disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; SEQUENCE VARIANTS; GENE; EXPRESSION; CONTRIBUTE; AUTOPHAGY; MULTIPLE; HISTORY	The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis are common causes of morbidity in children and young adults in the western world. Here we report the results of a genome-wide association study in early-onset IBD involving 3,426 affected individuals and 11,963 genetically matched controls recruited through international collaborations in Europe and North America, thereby extending the results from a previous study of 1,011 individuals with early-onset IBD1. We have identified five new regions associated with early-onset IBD susceptibility, including 16p11 near the cytokine gene IL27 (rs8049439, P = 2.41 x 10(-9)), 22q12 (rs2412973, P = 1.55 x 10(-9)), 10q22 (rs1250550, P = 5.63 x 10(-9)), 2q37 (rs4676410, P = 3.64 x 10(-8)) and 19q13.11 (rs10500264, P = 4.26 x 10(-10)). Our scan also detected associations at 23 of 32 loci previously implicated in adult-onset Crohn's disease and at 8 of 17 loci implicated in adult-onset ulcerative colitis, highlighting the close pathogenetic relationship between early- and adult-onset IBD.	[Imielinski, Marcin; Bradfield, Jonathan P.; Sleiman, Patrick; Kim, Cecilia E.; Wang, Kai; Glessner, Joseph T.; Zhang, Haitao; Frackelton, Edward C.; Hou, Cuiping; Flory, James H.; Otieno, George; Chiavacci, Rosetta M.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Baldassano, Robert N.; Grundmeier, Robert; Piccoli, David; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Baldassano, Robert N.; Abrams, Debra J.; Piccoli, David] Childrens Hosp Philadelphia, Div Gastroenterol, Philadelphia, PA 19104 USA; [Griffiths, Anne; Walters, Thomas D.; Muise, Aleixo] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Russell, Richard K.] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; [Annese, Vito] CSS, IRCCS, Dept Med Sci, Gastroenterol Unit, San Giovanni Rotondo, Italy; [Dubinsky, Marla] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Dubinsky, Marla; Taylor, Kent; McGovern, Dermot] Cedars Sinai Med Ctr, Dept Common Dis Genet, Los Angeles, CA 90048 USA; [Kugathasan, Subra] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Kugathasan, Subra] Childrens Hlth Care Atlanta, Atlanta, GA USA; [Saeed, Shehzad] Univ Alabama, Dept Pediat, Birmingham, AL USA; [Grundmeier, Robert] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Castro, Massimo; Latiano, Anna] Bambino Gesu Pediat Hosp, Gastroenterol Unit, Rome, Italy; [Dallapiccola, Bruno] Univ Roma La Sapienza, Mendel Inst, IRCCS, CSS Hosp, San Giovanni Rotondo, Italy; [Stempak, Joanne; Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, Ctr Inflammatory Bowel Dis, Toronto, ON M5G 1X5, Canada; [Heyman, Melvin B.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ferry, George D.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Kirschner, Barbara] Univ Chicago, Comer Childrens Hosp, Chicago, IL 60637 USA; [Lee, Jessica; Essers, Jonah; Grand, Richard] Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Stephens, Michael] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Levine, Arie] Tel Aviv Univ, Wolfson Med Ctr, Pediat Gastroenterol Unit, IL-69978 Tel Aviv, Israel; [Van Limbergen, Johan; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Div Med Sci,Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Cucchiara, Salvatore] Univ Roma La Sapienza, Pediat Gastroenterol & Liver Unit, Rome, Italy; [Monos, Dimitri S.] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Guthery, Stephen L.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Guthery, Stephen L.] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; [Denson, Lee] Cincinnati Childrens Hosp, Med Ctr, Div Gastroenterol, Ctr Inflammatory Bowel Dis, Cincinnati, OH USA; [Wilson, David C.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Daly, Mark] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Glasgow; IRCCS Casa Sollievo Della Sofferenza; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Emory University; Children's Healthcare of Atlanta (CHOA); University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; IRCCS Bambino Gesu; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of California System; University of California San Francisco; Baylor College of Medicine; University of Chicago; Harvard University; Boston Children's Hospital; Medical College of Wisconsin; Tel Aviv University; University of Edinburgh; Sapienza University Rome; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utah System of Higher Education; University of Utah; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Massachusetts General Hospital	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Van Limbergen, Johan/L-1855-2019; Saeed, Shehzad/R-8534-2019; Duerr, Richard H/B-4188-2009; Daly, Mark J/B-2453-2017; Annese, Vito/AGW-4200-2022; Rioux, John D/A-9599-2015; Silverberg, Mark/B-4183-2008; Latiano, Anna/R-1965-2016; Prescott, Natalie J/F-6490-2011; Saeed, Shehzad/AGD-6642-2022; Cucchiara, Salvatore/K-1628-2016; Dallapiccola, Bruno/K-8692-2016	Van Limbergen, Johan/0000-0001-5822-4371; Duerr, Richard H/0000-0001-6586-3905; Daly, Mark J/0000-0002-0949-8752; Annese, Vito/0000-0002-0082-892X; Rioux, John D/0000-0001-7560-8326; Latiano, Anna/0000-0003-3719-2061; Prescott, Natalie J/0000-0002-5901-7371; Cucchiara, Salvatore/0000-0002-2939-9698; Parkes, Miles/0000-0002-6467-0631; Schumm, Phil/0000-0002-3050-2429; Grant, Struan/0000-0003-2025-5302; Dallapiccola, Bruno/0000-0002-5031-1013; Hugot, Jean-Pierre/0000-0002-8446-6056; Glessner, Joseph/0000-0001-5131-2811; Laukens, Debby/0000-0002-1984-5850; Kirschner, Barbara/0000-0003-4640-2438; Georges, Michel/0000-0003-4124-2375	Children's Hospital of Philadelphia; Primary Children's Medical Center Foundation; National Center for Research Resources [DK069513, M01-RR00064, M01 RR002172-26, C06-RR11234]; NIH/NIDDK [DK062423]; Gale and Graham Wright Research Chair in Digestive Diseases; Canadian Association of Gastroenterology (CAG); Crohn's Colitis Foundation of Canada (CCFC); Canadian Institutes of Health Research (CIHR); Astra-Zeneca; CCFC/CAG/CIHR Transition Award; Canadian Child Health Clinician Scientist Program (CCHCSP); Children's Hospital Boston; NIDDK [DK069513, T32 DK007477]; NCRR [M01-RR00064, C06-RR11234]; Action Medical Research; Gay-Ramsay-SteelMaitland or Stafford Trust; Hazel M Wood Charitable Trust; Medical Research Council Patient Cohorts Research Initiative award [G0800675]; Wellcome Trust Programme Grant [072789/Z/03/Z]; Chief Scientist Office of the Scottish Government Health Department; University of Edinburgh Medical Faculty Fellowship; GI/Nutrition Research Fund; Child Life and Health; University of Edinburgh; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172, C06RR011234, M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, K23DK069513, K24DK060617, T32DK007477, U01DK062423, U01DK062413, P30DK043351, U01DK062420] Funding Source: NIH RePORTER; Medical Research Council [G0800675, G0600329, G0800759] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish; MRC [G0600329, G0800675, G0800759] Funding Source: UKRI	Children's Hospital of Philadelphia; Primary Children's Medical Center Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Gale and Graham Wright Research Chair in Digestive Diseases; Canadian Association of Gastroenterology (CAG); Crohn's Colitis Foundation of Canada (CCFC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Astra-Zeneca(AstraZeneca); CCFC/CAG/CIHR Transition Award(Canadian Institutes of Health Research (CIHR)); Canadian Child Health Clinician Scientist Program (CCHCSP); Children's Hospital Boston; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Action Medical Research; Gay-Ramsay-SteelMaitland or Stafford Trust; Hazel M Wood Charitable Trust; Medical Research Council Patient Cohorts Research Initiative award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme Grant(Wellcome Trust); Chief Scientist Office of the Scottish Government Health Department; University of Edinburgh Medical Faculty Fellowship; GI/Nutrition Research Fund; Child Life and Health; University of Edinburgh; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all participating subjects and families. We thank the medical assistants, nursing staff and clinicians at CHOP who assisted with the recruitment of control subjects, which made this work possible; and members of the International HapMap and Wellcome Trust Case Control Consortiums for publicly providing data that were critically important for part of our analyses. The following physicians of the SIGENP (Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition) contributed by providing DNA samples and clinical information from their patients: A. Andriulli, M. R. Valvano, O. Palmieri, F. Bossa, E. Colombo, M. Pastore, M. D'Altilia, O. Borrelli, C. Bascietto, A. Ferraris, B. Papadatou, A. Diamanti, P. Lionetti, E. Pozzi, A. Barabino, A. Calvi, G. L. de' Angelis, G. Guariso, V. Lodde, G. Vieni, C. Sferlazzas, S. Accomando, G. Iacono, E. Berni Canani, A. M. Staiano, V. Rutigliano, D. De Venuto, C. Romano, G. Lombardi, S. Nobile, C. Catassi and A. Campanozzi. The following physicians of SPGHANG (Scottish Pediatric Gastroenterology, Hepatology and Nutrition Group) contributed by providing DNA samples and clinical information from their patients: W. M. Bisset, P. M. Gillett, G. Mahdi and P. McGrogan. This research was supported by the Children's Hospital of Philadelphia, the Primary Children's Medical Center Foundation and grants DK069513, M01-RR00064, M01 RR002172-26 and C06-RR11234 from the National Center for Research Resources. All genomewide genotyping was funded by an Institute Development Award from the Children's Hospital of Philadelphia. M. S. is funded by NIH/NIDDK grant DK062423 and the Gale and Graham Wright Research Chair in Digestive Diseases. T. W. received fellowship funding support jointly from the Canadian Association of Gastroenterology (CAG), Crohn's Colitis Foundation of Canada (CCFC), Canadian Institutes of Health Research (CIHR) and Astra-Zeneca. A. M. received a CCFC/CAG/CIHR Transition Award and Canadian Child Health Clinician Scientist Program (CCHCSP) Award for training. J. L. received Junior Faculty Development Award from Children's Hospital Boston. J. E. is supported by a Training grant (T32 DK007477) from NIDDK. S. L. G. received support from the Primary Children's Medical Center Foundation, NIDDK (DK069513) and NCRR (M01-RR00064 and C06-RR11234). J. V. L. was funded by a Research Training Fellowship from Action Medical Research, the Gay-Ramsay-SteelMaitland or Stafford Trust and the Hazel M Wood Charitable Trust. D. C. W. is the holder of a Medical Research Council Patient Cohorts Research Initiative award (G0800675). Financial assistance was also provided by a Wellcome Trust Programme Grant (072789/Z/03/Z), the Chief Scientist Office of the Scottish Government Health Department, a University of Edinburgh Medical Faculty Fellowship and the GI/Nutrition Research Fund, Child Life and Health, University of Edinburgh.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Vernier-Massouille G, 2008, GASTROENTEROLOGY, V135, P1106, DOI 10.1053/j.gastro.2008.06.079	24	364	373	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1335	U107		10.1038/ng.489	http://dx.doi.org/10.1038/ng.489			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19915574	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000272144900017
J	Song, H; Payne, S; Gray, M; You, LC				Song, Hao; Payne, Stephen; Gray, Meagan; You, Lingchong			Spatiotemporal modulation of biodiversity in a synthetic chemical-mediated ecosystem	NATURE CHEMICAL BIOLOGY			English	Article							ECOLOGICAL CONSEQUENCES; PREDATORY PROKARYOTES; BACTERIAL CHEMOTAXIS; COMMUNICATION; INTERKINGDOM; PERSPECTIVE; DIVERSITY; PROMOTES	Biodiversity, or the relative abundance of species, measures the persistence of an ecosystem. To better understand its modulation, we analyzed the spatial and temporal dynamics of a synthetic, chemical-mediated ecosystem that consisted of two engineered Escherichia coli populations. Depending on the specific experimental conditions implemented, the dominant interaction between the two populations could be competition for nutrients or predation due to engineered communication. While the two types of interactions resulted in different spatial patterns, they demonstrated a common trend in terms of the modulation of biodiversity. Specifically, biodiversity decreased with increasing cellular motility if the segregation distance between the two populations was comparable to the length scale of the chemical-mediated interaction. Otherwise, biodiversity was insensitive to cellular motility. Our results suggested a simple criterion for predicting the modulation of biodiversity by habitat partitioning and cellular motility in chemical-mediated ecosystems.	[You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Duke University	You, LC (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	you@duke.edu	Song, Hao/G-6207-2010	Song, Hao/0000-0001-5553-2539; Payne, Stephen/0000-0001-9727-7409	US National Institutes of Health [5R01CA118486]; David and Lucile Packard Fellowship; DuPont Young Professor Award; US National Institute of General Medical Sciences Biotechnology Predoctoral Center for Biomolecular and Tissue Engineering Fellowship; Duke University Pratt Fellowship; NATIONAL CANCER INSTITUTE [R01CA118486] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); DuPont Young Professor Award; US National Institute of General Medical Sciences Biotechnology Predoctoral Center for Biomolecular and Tissue Engineering Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Duke University Pratt Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank F. Yuan for access to a Kodak fluorescence image station and software (Comsol Multiphysics); F. Arnold (California Institute of Technology) and C. Collins (Rensselaer Polytechnic Institute) for sharing genetic constructs; D. Schaeffer for suggestions on modeling; C. Tan for commenting on the manuscript; and other You lab members for discussions. This study was supported by the US National Institutes of Health (5R01CA118486), a David and Lucile Packard Fellowship (L. Y.), a DuPont Young Professor Award (L. Y.), a US National Institute of General Medical Sciences Biotechnology Predoctoral Center for Biomolecular and Tissue Engineering Fellowship (to S. P.) and a Duke University Pratt Fellowship for undergraduate research (to M. G.). We thank the anonymous reviewers for critical and constructive suggestions.	Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Battin TJ, 2007, NAT REV MICROBIOL, V5, P76, DOI 10.1038/nrmicro1556; Berleman JE, 2006, J BACTERIOL, V188, P5888, DOI 10.1128/JB.00559-06; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dicke M, 1988, FUNCT ECOL, V2, P131, DOI 10.2307/2389687; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; ESTEVE I, 1992, FEMS MICROBIOL ECOL, V86, P205, DOI 10.1016/0378-1097(92)90783-K; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; GUERRERO R, 1986, P NATL ACAD SCI USA, V83, P2138, DOI 10.1073/pnas.83.7.2138; HART BA, 1966, J BACTERIOL, V92, P1632, DOI 10.1128/JB.92.6.1632-1637.1966; HASTINGS A, 1977, THEOR POPUL BIOL, V12, P37, DOI 10.1016/0040-5809(77)90034-X; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Ianora A, 2006, ESTUAR COAST, V29, P531, DOI 10.1007/BF02784281; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; JURKEVITCH E, 2007, MICROBE, V2, P67; Kareiva, 1997, SPATIAL ECOLOGY; KELLER EF, 1971, J THEOR BIOL, V30, P235, DOI 10.1016/0022-5193(71)90051-8; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; KELLY FX, 1988, MICROBIAL ECOL, V16, P115, DOI 10.1007/BF02018908; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; KOSINSKI MJ, 1992, APPL MICROBIOL BIOT, V36, P782; Lambert C, 2006, CURR OPIN MICROBIOL, V9, P639, DOI 10.1016/j.mib.2006.10.002; LAUFFENBURGER DA, 1991, MICROB ECOL, V22, P175, DOI 10.1007/BF02540222; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Martin MO, 2002, J MOL MICROB BIOTECH, V4, P467; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; Pham VD, 2005, MICROBIOL-SGM, V151, P1865, DOI 10.1099/mic.0.27824-0; Pohnert G, 2007, TRENDS ECOL EVOL, V22, P198, DOI 10.1016/j.tree.2007.01.005; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Staley JT, 2001, BIODIVERSITY MICROBI; Stolp H., 1988, MICROBIAL ECOLOGY OR; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Weissburg MJ, 2002, J CHEM ECOL, V28, P1953, DOI 10.1023/A:1020741710060; WHITTAKER RH, 1971, SCIENCE, V171, P757, DOI 10.1126/science.171.3973.757; WOODWARD DE, 1995, BIOPHYS J, V68, P2181	50	66	68	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					929	935		10.1038/nchembio.244	http://dx.doi.org/10.1038/nchembio.244			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19915540	Green Accepted			2022-12-25	WOS:000271756900016
J	Broske, AM; Vockentanz, L; Kharazi, S; Huska, MR; Mancini, E; Scheller, M; Kuhl, C; Enns, A; Prinz, M; Jaenisch, R; Nerlov, C; Leutz, A; Andrade-Navarro, MA; Jacobsen, SEW; Rosenbauer, F				Broeske, Ann-Marie; Vockentanz, Lena; Kharazi, Shabnam; Huska, Matthew R.; Mancini, Elena; Scheller, Marina; Kuhl, Christiane; Enns, Andreas; Prinz, Marco; Jaenisch, Rudolf; Nerlov, Claus; Leutz, Achim; Andrade-Navarro, Miguel A.; Jacobsen, Sten Eirik W.; Rosenbauer, Frank			DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; EPIGENETIC REGULATION; TRANSCRIPTION FACTORS; B-CELLS; PROGENITOR; MICE; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; CANCER	DNA methylation is a dynamic epigenetic mark that undergoes extensive changes during differentiation of self-renewing stem cells. However, whether these changes are the cause or consequence of stem cell fate remains unknown. Here, we show that alternative functional programs of hematopoietic stem cells (HSCs) are governed by gradual differences in methylation levels. Constitutive methylation is essential for HSC self-renewal but dispensable for homing, cell cycle control and suppression of apoptosis. Notably, HSCs from mice with reduced DNA methyltransferase 1 activity cannot suppress key myeloerythroid regulators and thus can differentiate into myeloerythroid, but not lymphoid, progeny. A similar methylation dosage effect controls stem cell function in leukemia. These data identify DNA methylation as an essential epigenetic mechanism to protect stem cells from premature activation of predominant differentiation programs and suggest that methylation dynamics determine stem cell functions in tissue homeostasis and cancer.	[Broeske, Ann-Marie; Vockentanz, Lena; Huska, Matthew R.; Scheller, Marina; Kuhl, Christiane; Enns, Andreas; Leutz, Achim; Andrade-Navarro, Miguel A.; Rosenbauer, Frank] Max Delbruck Ctr Mol Med, Berlin, Germany; [Kharazi, Shabnam; Jacobsen, Sten Eirik W.] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Hematopoiet Stem Cell Lab, Lund, Sweden; [Mancini, Elena; Nerlov, Claus] Mouse Biol Unit, European Mol Biol Lab, Monterotondo, Italy; [Prinz, Marco] Univ Freiburg, Dept Neuropathol, Freiburg, Germany; [Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford OX3 9DU, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Lund University; European Molecular Biology Laboratory (EMBL); University of Freiburg; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Oxford	Rosenbauer, F (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	f.rosenbauer@mdc-berlin.de	Andrade, Miguel A/B-6565-2008; Leutz, Achim/K-9643-2013; Jacobsen, Sten Eirik W/D-3974-2018	Andrade, Miguel A/0000-0001-6650-1711; Leutz, Achim/0000-0001-8259-927X; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Rosenbauer, Frank/0000-0001-7977-9421; Scheller, Marina/0000-0001-6108-0831; Huska, Matthew/0000-0002-0912-745X; Broske, Ann-Marie/0000-0002-2529-6317	German Research Foundation; German Cancer Aid (Mildred Scheel); Helmholtz Association of German Research Centers; UK Medical Research Council; MRC [G0701761, G0801073, G0501838] Funding Source: UKRI; Medical Research Council [G0801073, G0501838, G0701761] Funding Source: researchfish	German Research Foundation(German Research Foundation (DFG)); German Cancer Aid (Mildred Scheel)(Deutsche Krebshilfe); Helmholtz Association of German Research Centers(Helmholtz Association); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank V. Malchin, C. Graubmann and J. F. Zinke for their excellent technical assistance; J. Schoenheit for his help with real-time PCR; H. P. Rahn and Z. Ma for assistance with high-speed cell sorting; M. L. Cleary (Stanford University School of Medicine), S. Fillatreau (Deutsches Rheuma-Forschungszentrum), A. Muller (University of Wurzburg), K. Rajewsky (Harvard Medical School), M. Rehli (University of Regensburg), M. Tomasson (Washington University School of Medicine), B. L. Kee (University of Chicago) and T. Somervaille (Stanford University School of Medicine) for reagents; members of the Rosenbauer lab for discussions; D. G. Tenen for support during the initial phase of this study; and C. Plass, C. Muller-Tidow, C. Bonifer and D. G. Tenen for advice on the manuscript. This work was supported by grants from the German Research Foundation, the German Cancer Aid (Mildred Scheel) and the Helmholtz Association of German Research Centers to F. R. S. E. W. J. is the recipient of a strategic appointment grant from the UK Medical Research Council.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Bottardi S, 2007, CELL CYCLE, V6, P1035, DOI 10.4161/cc.6.9.4208; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Domen Jos, 1998, Blood, V91, P2272; Ehlers A, 2008, LEUKEMIA, V22, P835, DOI 10.1038/leu.2008.12; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; FIOTHO C, 2009, LEUKEMIA, V23, P1019; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KAIHO SI, 1985, ANAL BIOCHEM, V149, P117, DOI 10.1016/0003-2697(85)90483-X; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Landgrebe J, 2002, GENOME BIOL, V3; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Ushijima T, 1997, P NATL ACAD SCI USA, V94, P2284, DOI 10.1073/pnas.94.6.2284; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	49	340	347	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1207	1215		10.1038/ng.463	http://dx.doi.org/10.1038/ng.463			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19801979				2022-12-25	WOS:000271247600013
J	Ge, B; Pokholok, DK; Kwan, T; Grundberg, E; Morcos, L; Verlaan, DJ; Le, J; Koka, V; Lam, KCL; Gagne, V; Dias, J; Hoberman, R; Montpetit, A; Joly, MM; Harvey, EJ; Sinnett, D; Beaulieu, P; Hamon, R; Graziani, A; Dewar, K; Harmsen, E; Majewski, J; Goring, HHH; Naumova, AK; Blanchette, M; Gunderson, KL; Pastinen, T				Ge, Bing; Pokholok, Dmitry K.; Kwan, Tony; Grundberg, Elin; Morcos, Lisanne; Verlaan, Dominique J.; Le, Jennie; Koka, Vonda; Lam, Kevin C. L.; Gagne, Vincent; Dias, Joana; Hoberman, Rose; Montpetit, Alexandre; Joly, Marie-Michele; Harvey, Edward J.; Sinnett, Daniel; Beaulieu, Patrick; Hamon, Robert; Graziani, Alexandru; Dewar, Ken; Harmsen, Eef; Majewski, Jacek; Goering, Harald H. H.; Naumova, Anna K.; Blanchette, Mathieu; Gunderson, Kevin L.; Pastinen, Tomi			Global patterns of cis variation in human cells revealed by high-density allelic expression analysis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HUMAN GENE-EXPRESSION; REGULATORY VARIATION; HUMAN HAPLOTYPES; DISEASE; DISCOVERY; VARIANTS; LOCI	Cis-acting variants altering gene expression are a source of phenotypic differences. The cis-acting components of expression variation can be identified through the mapping of differences in allelic expression (AE), which is the measure of relative expression between two allelic transcripts. We generated a map of AE associated SNPs using quantitative measurements of AE on Illumina Human1M BeadChips. In 53 lymphoblastoid cell lines derived from donors of European descent, we identified common cis variants affecting 30% (2935/9751) of the measured RefSeq transcripts at 0.001 permutation significance. The pervasive influence of cis-regulatory variants, which explain >50% of population variation in AE, extend to full-length transcripts and their isoforms as well as to unannotated transcripts. These strong effects facilitate fine mapping of cis-regulatory SNPs, as demonstrated by dissection of heritable control of transcripts in the systemic lupus erythematosus-associated C8orf13-BLK region in chromosome 8. The dense collection of associations will facilitate large-scale isolation of cis-regulatory SNPs.	[Grundberg, Elin; Morcos, Lisanne; Verlaan, Dominique J.; Dewar, Ken; Majewski, Jacek; Pastinen, Tomi] McGill Univ, McGill Univ Hlth Ctr, Dept Human Genet, Montreal, PQ, Canada; [Ge, Bing; Kwan, Tony; Grundberg, Elin; Morcos, Lisanne; Verlaan, Dominique J.; Koka, Vonda; Lam, Kevin C. L.; Dias, Joana; Montpetit, Alexandre; Joly, Marie-Michele; Dewar, Ken; Harmsen, Eef; Majewski, Jacek; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Pokholok, Dmitry K.; Le, Jennie; Gunderson, Kevin L.] Illumina Inc, San Diego, CA USA; [Grundberg, Elin; Morcos, Lisanne; Verlaan, Dominique J.; Dewar, Ken; Majewski, Jacek; Naumova, Anna K.; Pastinen, Tomi] McGill Univ, McGill Univ Hlth Ctr, Dept Med Genet, Montreal, PQ, Canada; [Gagne, Vincent; Sinnett, Daniel; Beaulieu, Patrick; Hamon, Robert; Graziani, Alexandru; Blanchette, Mathieu] Univ Montreal, Hop St Justine, Montreal, PQ H3T 1C5, Canada; [Hoberman, Rose] Univ Montreal, Sch Comp Sci, Montreal, PQ, Canada; [Harvey, Edward J.] Univ Montreal, Div Orthopaed Surg, McGill Univ Hlth Ctr, Montreal, PQ, Canada; [Goering, Harald H. H.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; [Naumova, Anna K.] McGill Univ, Dept Obstet & Gynecol, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ H3A 2T5, Canada	McGill University; Illumina; McGill University; Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; Texas Biomedical Research Institute; McGill University	Pastinen, T (corresponding author), McGill Univ, McGill Univ Hlth Ctr, Dept Human Genet, Montreal, PQ, Canada.	tomi.pastinen@mcgill.ca	sinnett, daniel/S-4589-2017	sinnett, daniel/0000-0003-3625-6676; Naumova, Anna K./0000-0001-8481-5765; Le, Jennie/0000-0002-1791-6109; harvey, edward/0000-0003-3934-8920	National Center for Research Resources [C06 RR017515]; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017515] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Genome Canada, Genome Quebec and Illumina, Inc. T. P. holds a Canada Research Chair. H. H. H. G. carried out work in facilities constructed with support from Research Facilities Improvement Program Grant Number C06 RR017515 from the National Center for Research Resources, National Institutes of Health and a gift from the SBC Foundation.	Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2008, AM J HUM GENET, V82, P1357, DOI 10.1016/j.ajhg.2008.05.003; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hoberman R, 2009, GENOME RES, V19, P1542, DOI 10.1101/gr.092072.109; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Maynard ND, 2008, NAT METHODS, V5, P307, DOI [10.1038/NMETH.1194, 10.1038/nmeth.1194]; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tao H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000697; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Wang HY, 2008, P NATL ACAD SCI USA, V105, P6362, DOI 10.1073/pnas.0711774105; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	29	172	175	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1216	U78		10.1038/ng.473	http://dx.doi.org/10.1038/ng.473			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19838192				2022-12-25	WOS:000271247600014
J	Lopez, RG; Garcia-Silva, S; Moore, SJ; Bereshchenko, O; Martinez-Cruz, AB; Ermakova, O; Kurz, E; Paramio, JM; Nerlov, C				Lopez, Rodolphe G.; Garcia-Silva, Susana; Moore, Susan J.; Bereshchenko, Oksana; Martinez-Cruz, Ana B.; Ermakova, Olga; Kurz, Elke; Paramio, Jesus M.; Nerlov, Claus			C/EBP alpha and beta couple interfollicular keratinocyte proliferation arrest to commitment and terminal differentiation	NATURE CELL BIOLOGY			English	Article							CCAAT/ENHANCER-BINDING-PROTEINS; TRANSCRIPTION FACTORS C/EBP; STEM-CELLS; GENE-EXPRESSION; BARRIER FUNCTION; HAIR FOLLICLE; LIGASE ITCH; IN-VIVO; SKIN; P63	The transcriptional regulators that couple interfollicular basal keratinocyte proliferation arrest to commitment and differentiation are yet to be identified. Here we report that the basic region leucine zipper transcription factors C/EBP alpha and C/EBP beta are co-expressed in basal keratinocytes, and are coordinately upregulated as keratinocytes exit the basal layer and undergo terminal differentiation. Mice lacking both C/EBP alpha and beta in the epidermis showed increased proliferation of basal keratinocytes and impaired commitment to differentiation. This led to ectopic expression of keratin 14 (K14) and Delta Np63 in suprabasal cells, decreased expression of spinous and granular layer proteins, parakeratosis and defective epidermal water barrier function. Knock-in mutagenesis revealed that C/EBP-E2F interaction was required for control of interfollicular epidermis (IFE) keratinocyte proliferation, but not for induction of spinous and granular layer markers, whereas C/EBP DNA binding was required for Delta Np63 downregulation and K1/K10 induction. Finally, loss of C/EBP alpha/beta induced stem cell gene expression signatures in the epidermis. C/EBPs, therefore, couple basal keratinocyte cell cycle exit to commitment to differentiation through E2F repression and DNA binding, respectively, and may act to restrict the epidermal stem cell compartment.	[Lopez, Rodolphe G.; Garcia-Silva, Susana; Moore, Susan J.; Bereshchenko, Oksana; Ermakova, Olga; Kurz, Elke; Nerlov, Claus] EMBL Mouse Biol Unit, I-00016 Monterotondo, Italy; [Martinez-Cruz, Ana B.; Paramio, Jesus M.] CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain; [Nerlov, Claus] Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH8 9YL, Midlothian, Scotland; [Nerlov, Claus] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH8 9YL, Midlothian, Scotland	European Molecular Biology Laboratory (EMBL); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; University of Edinburgh; University of Edinburgh	Nerlov, C (corresponding author), EMBL Mouse Biol Unit, I-00016 Monterotondo, Italy.	cnerlov@staffmail.ed.ac.uk	Garcia-Silva, Susana/AAW-8528-2021; Ermakova, Olga/Z-2037-2018; Ermakova, Olga/K-5712-2019; Paramio, Jesus M/M-8482-2014	Garcia-Silva, Susana/0000-0003-1065-0245; Ermakova, Olga/0000-0001-8365-4904; Ermakova, Olga/0000-0001-8365-4904; Paramio, Jesus M/0000-0001-7520-3177; Bereshchenko, Oxana/0000-0002-2772-6042	MRC [G0701761] Funding Source: UKRI; Medical Research Council [G0701761] Funding Source: Medline; Medical Research Council [G0700711B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bull JJ, 2002, J INVEST DERMATOL, V118, P17, DOI 10.1046/j.0022-202x.2001.01629.x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Di-Poi N, 2005, J BIOL CHEM, V280, P38700, DOI 10.1074/jbc.M507782200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elias PM, 2004, J INVEST DERMATOL, V122, P314, DOI 10.1046/j.1523-1747.2003.22258.x; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Maytin EV, 1999, DEV BIOL, V216, P164, DOI 10.1006/dbio.1999.9460; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oberst A, 2007, P NATL ACAD SCI USA, V104, P11280, DOI 10.1073/pnas.0701773104; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Rounbehler RJ, 2001, ONCOGENE, V20, P5341, DOI 10.1038/sj.onc.1204691; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Vidal VPI, 2008, J CUTAN PATHOL, V35, P373, DOI 10.1111/j.1600-0560.2007.00815.x; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	58	86	89	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1181	U40		10.1038/ncb1960	http://dx.doi.org/10.1038/ncb1960			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19749746				2022-12-25	WOS:000270382000006
J	Lacefield, S; Lau, DTC; Murray, AW				Lacefield, Soni; Lau, Derek T. C.; Murray, Andrew W.			Recruiting a microtubule-binding complex to DNA directs chromosome segregation in budding yeast	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; PRECOCIOUS SEPARATION; PLASMID SEGREGATION; CENTROMERE FUNCTION; KINETOCHORE; SPINDLE; BIORIENTATION; ATTACHMENT; CHROMATIN; MITOSIS	Accurate chromosome segregation depends on the kinetochore, which is the complex of proteins that link microtubules to centromeric DNA(1). The kinetochore of the budding yeast Saccharomyces cerevisiae consists of more than 80 proteins assembled on a 125-bp region of DNA(1). We studied the assembly and function of kinetochore components by fusing individual kinetochore proteins to the lactose repressor (LacI) and testing their ability to improve segregation of a plasmid carrying tandem repeats of the lactose operator (LacO). Targeting Ask1, a member of the Dam1-DASH microtubule-binding complex, creates a synthetic kinetochore that performs many functions of a natural kinetochore: it can replace an endogenous kinetochore on a chromosome, bi-orient sister kinetochores at metaphase during the mitotic cycle, segregate sister chromatids, and repair errors in chromosome attachment. We show the synthetic kinetochore functions do not depend on the DNA-binding components of the natural kinetochore but do require other kinetochore proteins. We conclude that tethering a single kinetochore protein to DNA triggers assembly of the complex structure that directs mitotic chromosome segregation.	[Lacefield, Soni; Lau, Derek T. C.; Murray, Andrew W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Murray, AW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	amurray@mcb.harvard.edu			US National Institutes of Health (NIH) National Research Service Award [GM043987]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043987, R01GM043987] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Greg Lang, Joana Gonyalves-Sa, John Koschwanez, Gregg Wildenberg and Dai Tsuchiya for technical advice; Charles Asbury, Ted Salmon, Steve Elledge, Ajit Joglekar, Frank Solomon, Amy Rowat and members of the Murray lab for critical reading of the manuscript; and Steve Elledge, John Kilmartin and Sue Biggins for strains. This work was supported by a US National Institutes of Health (NIH) National Research Service Award fellowship to S.L. and an NIH grant to A.W.M. (GM043987).	Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; GAUDET A, 1987, MOL CELL BIOL, V7, P68, DOI 10.1128/MCB.7.1.68; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; HABER JE, 1984, GENETICS, V106, P207; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hajra S, 2006, J CELL BIOL, V174, P779, DOI 10.1083/jcb.200603042; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Joglekar AP, 2008, METHOD CELL BIOL, V85, P127, DOI 10.1016/S0091-679X(08)85007-8; Kiermaier E, 2009, NAT CELL BIOL, V11, P1109, DOI 10.1038/ncb1924; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Li YM, 2003, CELL CYCLE, V2, P143, DOI 10.4161/cc.2.2.336; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; Sherman F, 1979, METHODS YEAST GENETI; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Velmurugan S, 2000, J CELL BIOL, V149, P553, DOI 10.1083/jcb.149.3.553; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019	36	43	43	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1116	U150		10.1038/ncb1925	http://dx.doi.org/10.1038/ncb1925			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684576	Green Accepted, Green Submitted			2022-12-25	WOS:000269482500013
J	Li, QX; Lin, SY; Wang, X; Lian, GL; Lu, ZL; Guo, HL; Ruan, K; Wang, YH; Ye, ZY; Han, JH; Lin, SC				Li, Qinxi; Lin, Shuyong; Wang, Xuan; Lian, Guili; Lu, Zailian; Guo, Huiling; Ruan, Ka; Wang, Yanhai; Ye, Zhiyun; Han, Jiahuai; Lin, Sheng-Cai			Axin determines cell fate by controlling the p53 activation threshold after DNA damage	NATURE CELL BIOLOGY			English	Article							INTERACTING PROTEIN KINASE-2; APOPTOSIS; DEGRADATION; HIPK2; WNT; PATHWAY; LIGASE; PHOSPHORYLATION; ACETYLATION; INHIBITOR	Cells can undergo either cell-cycle arrest or apoptosis after genotoxic stress, based on p53 activity(1-6). Here we show that cellular fate commitment depends on Axin forming distinct complexes with Pirh2, Tip60, HIPK2 and p53. In cells treated with sublethal doses of ultra-violet (UV) radiation or doxorubicin (Dox), Pirh2 abrogates Axin-induced p53 phosphorylation at Ser 46 catalysed by HIPK2, by competing with HIPK2 for binding to Axin. However, on lethal treatment, Tip60 interacts with Axin and abrogates Pirh2-Axin binding, forming an Axin-Tip60-HIPK2-p53 complex that allows maximal p53 activation to trigger apoptosis. We also provide evidence that the ATM/ATR pathway mediates the Axin-Tip60 complex assembly. An axin mutation promotes carcinogenesis in Axin(Fu)/+ (Axin-Fused) mice, consistent with a dominant-negative role for Axin(Fu) in p53 activation. Thus, Axin is a critical determinant in p53-dependent tumour suppression in which Pirh2 and Tip60 have different roles in triggering cell-cycle arrest or apoptosis depending on the severity of genotoxic stress.	[Li, Qinxi; Lin, Shuyong; Wang, Xuan; Lian, Guili; Lu, Zailian; Guo, Huiling; Ruan, Ka; Wang, Yanhai; Ye, Zhiyun; Han, Jiahuai; Lin, Sheng-Cai] Xiamen Univ, Key Lab Cell Biol & Tumor Cell Engn, Minist Educ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China	Xiamen University	Lin, SC (corresponding author), Xiamen Univ, Key Lab Cell Biol & Tumor Cell Engn, Minist Educ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	linsc@xmu.edu.cn	Lin, Shu-Yong/B-7726-2012; Han, J/G-4671-2010; Lin, SC/G-4666-2010; Li, QX/G-4669-2010	Lin, Shu-Yong/0000-0002-4419-1713; Wang, Yanhai/0000-0002-0002-2467	973 Program and 863 Program [2007CB914602, 2006CB503900, 2006AA02A303]; National Natural Science Foundation of China [30730025, 30871280, 30770454]; Ministry of Education of China [705030, B06016]; National Basic Research Program of the Ministry of Science and Technology; National Science Foundation of Fujian Province [2009J06021]	973 Program and 863 Program(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); National Basic Research Program of the Ministry of Science and Technology(National Basic Research Program of China); National Science Foundation of Fujian Province	This work was supported by grants from the 973 Program and 863 Program (2007CB914602, 2006CB503900 and 2006AA02A303), the National Natural Science Foundation of China (30730025, 30871280 and 30770454), the Ministry of Education of China (705030 and B06016), the National Basic Research Program of the Ministry of Science and Technology and the National Science Foundation of Fujian Province (2009J06021). We thank H. You for commenting on the manuscript.	Beitel LK, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290041; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Lu ZL, 2008, J BIOL CHEM, V283, P13132, DOI 10.1074/jbc.M710595200; MASHA V, 2006, GENE DEV, V20, P125; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	29	65	70	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1128	U184		10.1038/ncb1927	http://dx.doi.org/10.1038/ncb1927			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19731416				2022-12-25	WOS:000269482500015
J	Konski, AF; Spielthenner, DJF				Konski, Antoinette F.; Spielthenner, Doris J. F.			Stem cell patents: a landscape analysis	NATURE BIOTECHNOLOGY			English	Editorial Material									[Konski, Antoinette F.] Foley & Lardner, Palo Alto, CA USA; [Spielthenner, Doris J. F.] IDU Consult, Melbourne, Vic, Australia		Konski, AF (corresponding author), Foley & Lardner, Palo Alto, CA USA.	akonski@foley.com; doris.spielthenner@idu-consult.com						[Anonymous], 2008, STEM CELL RES; BATAGELJ V, 2007, CLASSIFICATION DATA, P141; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Hall BH, 2005, RAND J ECON, V36, P16; Obama Barack, 2009, REMOVING BARRIERS RE; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; WONG KM, 2009, CELL STEM CELL, V4, P95; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; 2009, PRESIDENTIAL OBAMA I; 2009, NEWS CIRM       0618; 2008, STATE FUNDING EMBRYO	11	10	12	4	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2009	27	8					722	727		10.1038/nbt0809-722	http://dx.doi.org/10.1038/nbt0809-722			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	480YY	19668176				2022-12-25	WOS:000268774500018
J	Lim, E; Vaillant, F; Wu, D; Forrest, NC; Pal, B; Hart, AH; Asselin-Labat, ML; Gyorki, DE; Ward, T; Partanen, A; Feleppa, F; Huschtscha, LI; Thorne, HJ; Fox, SB; Yan, M; French, JD; Brown, MA; Smyth, GK; Visvader, JE; Lindeman, GJ				Lim, Elgene; Vaillant, Francois; Wu, Di; Forrest, Natasha C.; Pal, Bhupinder; Hart, Adam H.; Asselin-Labat, Marie-Liesse; Gyorki, David E.; Ward, Teresa; Partanen, Audrey; Feleppa, Frank; Huschtscha, Lily I.; Thorne, Heather J.; Fox, Stephen B.; Yan, Max; French, Juliet D.; Brown, Melissa A.; Smyth, Gordon K.; Visvader, Jane E.; Lindeman, Geoffrey J.			Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers	NATURE MEDICINE			English	Article							MAMMARY EPITHELIAL-CELLS; REDUCING SALPINGO-OOPHORECTOMY; HUMAN BREAST-TUMORS; ADULT HUMAN BREAST; STEM-CELLS; CANCER SUSCEPTIBILITY; MICE; DIFFERENTIATION; GLAND; RISK	Basal-like breast cancers arising in women carrying mutations in the BRCA1 gene, encoding the tumor suppressor protein BRCA1, are thought to develop from the mammary stem cell. To explore early cellular changes that occur in BRCA1 mutation carriers, we have prospectively isolated distinct epithelial subpopulations from normal mammary tissue and preneoplastic specimens from individuals heterozygous for a BRCA1 mutation. We describe three epithelial subsets including basal stem/progenitor, luminal progenitor and mature luminal cells. Unexpectedly, we found that breast tissue from BRCA1 mutation carriers harbors an expanded luminal progenitor population that shows factor-independent growth in vitro. Moreover, gene expression profiling revealed that breast tissue heterozygous for a BRCA1 mutation and basal breast tumors were more similar to normal luminal progenitor cells than any other subset, including the stem cell-enriched population. The c-KIT tyrosine kinase receptor (encoded by KIT) emerged as a key marker of luminal progenitor cells and was more highly expressed in BRCA1-associated preneoplastic tissue and tumors. Our findings suggest that an aberrant luminal progenitor population is a target for transformation in BRCA1-associated basal tumors.	[Lim, Elgene; Vaillant, Francois; Wu, Di; Forrest, Natasha C.; Pal, Bhupinder; Asselin-Labat, Marie-Liesse; Gyorki, David E.; Ward, Teresa; Smyth, Gordon K.; Visvader, Jane E.; Lindeman, Geoffrey J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Lim, Elgene; Wu, Di; Gyorki, David E.] Univ Melbourne, Parkville, Vic 3052, Australia; [Hart, Adam H.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Partanen, Audrey; Feleppa, Frank; Lindeman, Geoffrey J.] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Huschtscha, Lily I.] Childrens Med Res Inst, Westmead, NSW, Australia; [Thorne, Heather J.; Fox, Stephen B.; Yan, Max] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [French, Juliet D.; Brown, Melissa A.] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Monash University; Royal Melbourne Hospital; Children's Medical Research Institute - Australia; Peter Maccallum Cancer Center; University of Queensland	Visvader, JE (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	visvader@wehi.edu.au; lindeman@wehi.edu.au	Pal, Bhupinder/AAF-4011-2020; Wu, Di/AAB-7566-2021; French, Juliet D/A-4982-2011; Lim, Elgene/AAS-7280-2020; Brown, Melissa A/F-1451-2010; McKay, Michael/ABA-9029-2021; Smyth, Gordon/B-5276-2008; Hart, Adam/C-1196-2011; French, Juliet/AAV-4435-2020; Fox, Stephen/G-9719-2016	Wu, Di/0000-0001-8331-2357; Lim, Elgene/0000-0001-8065-8838; Smyth, Gordon/0000-0001-9221-2892; Hart, Adam/0000-0001-8129-3877; French, Juliet/0000-0002-9770-0198; Brown, Melissa/0000-0002-2830-9259; Pal, Bhupinder/0000-0002-3684-4331; Thorne, Heather/0000-0003-3610-2511; Lindeman, Geoffrey/0000-0001-9386-2416; Fox, Stephen/0000-0002-7648-8896				Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Bouwman P, 2008, CELL CYCLE, V7, P2647, DOI 10.4161/cc.7.17.6266; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; DEOME KB, 1959, CANCER RES, V19, P515; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Ganesan S, 2005, COLD SH Q B, V70, P93, DOI 10.1101/sqb.2005.70.045; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kauff ND, 2008, J CLIN ONCOL, V26, P1331, DOI 10.1200/JCO.2007.13.9626; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; LAIDLAW IJ, 1995, ENDOCRINOLOGY, V136, P164, DOI 10.1210/en.136.1.164; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Michaud J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-363; NAGLE RB, 1986, J HISTOCHEM CYTOCHEM, V34, P869, DOI 10.1177/34.7.2423579; Narod SA, 2006, ONCOGENE, V25, P5832, DOI 10.1038/sj.onc.1209870; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; ROMIJN HJ, 1984, NEUROSCI BIOBEHAV R, V8, P301, DOI 10.1016/0149-7634(84)90055-1; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Simon R, 2004, CLIN CANCER RES, V10, P178, DOI 10.1158/1078-0432.CCR-0597-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	44	954	976	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					907	913		10.1038/nm.2000	http://dx.doi.org/10.1038/nm.2000			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19648928				2022-12-25	WOS:000268770400035
J	Shan, SW; Lee, DY; Deng, ZQ; Shatseva, T; Jeyapalan, Z; Du, WW; Zhang, Y; Xuan, JW; Yee, SP; Siragam, V; Yang, BB				Shan, Sze Wan; Lee, Daniel Y.; Deng, Zhaoqun; Shatseva, Tatiana; Jeyapalan, Zina; Du, William W.; Zhang, Yaou; Xuan, Jim W.; Yee, Siu-Pok; Siragam, Vinayakumar; Yang, Burton B.			MicroRNA MiR-17 retards tissue growth and represses fibronectin expression	NATURE CELL BIOLOGY			English	Article							CELL-PROLIFERATION; LUNG CANCERS; CLUSTER; VERSICAN; DIFFERENTIATION; ANGIOGENESIS; APOPTOSIS; SURVIVAL; FAMILY; ROLES	MicroRNAs (miRNAs) are single-stranded regulatory RNAs, frequently expressed as clusters. Previous studies have demonstrated that the six-miRNA cluster miR-17 similar to 92 has important roles in tissue development and cancers. However, the precise role of each miRNA in the cluster is unknown. Here we show that overexpression of miR-17 results in decreased cell adhesion, migration and proliferation. Transgenic mice overexpressing miR-17 showed overall growth retardation, smaller organs and greatly reduced haematopoietic cell lineages. We found that fibronectin and the fibronectin type-III domain containing 3A (FNDC3A) are two targets that have their expression repressed by miR-17, both in vitro and in transgenic mice. Several lines of evidence support the notion that miR-17 causes cellular defects through its repression of fibronectin expression. Our single miRNA expression assay may be evolved to allow the manipulation of individual miRNA functions in vitro and in vivo. We anticipate that this could serve as a model for studying gene regulation by miRNAs in the development of gene therapy.	[Shan, Sze Wan; Lee, Daniel Y.; Deng, Zhaoqun; Shatseva, Tatiana; Jeyapalan, Zina; Du, William W.; Siragam, Vinayakumar; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Zhang, Yaou] Grad Sch, Div Life Sci, Shenzhen, Peoples R China; [Xuan, Jim W.] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada; [Yee, Siu-Pok] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Yee, Siu-Pok] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Shan, Sze Wan; Lee, Daniel Y.; Jeyapalan, Zina; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto	Yang, BB (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, 2075 Bayview Ave, Toronto, ON, Canada.	byang@sri.utoronto.ca		SHAN, SW/0000-0001-6876-9914	Heart and Stroke Foundation of Ontario [CI 5958]; Canadian Institutes of Health Research; National Natural Science Foundation of China; Canada Graduate Scholarship;  [NA 6282]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canada Graduate Scholarship; 	We thank J. Ma for assistance in real-time PCR experiments, G. Knowles for flow cytometry analysis at the Core Facilities of Sunnybrook Research Institute, S. Gatchell and K. Green for the generation and maintenance of transgenic mice at UWO, D. Wei for technical assistance in molecular cloning, and J. Yang for editing the manuscript. This work was supported by a grant (NA 6282) and a Career Investigator Award (CI 5958) from Heart and Stroke Foundation of Ontario to B. B. Y. and a China-Canada Joint Health Research Grant (from Canadian Institutes of Health Research and the National Natural Science Foundation of China to B. B. Y. and Y. Z.). D. Y. L. is the recipient of a Canada Graduate Scholarship.	Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; GeorgesLabouesse EN, 1996, DEV DYNAM, V207, P145, DOI 10.1002/(SICI)1097-0177(199610)207:2<145::AID-AJA3>3.0.CO;2-H; GREGORY PA, 2008, NATURE CELL BIOL; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Karaulanov EE, 2006, EMBO REP, V7, P283, DOI 10.1038/sj.embor.7400614; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Rifes P, 2007, DEVELOPMENT, V134, P3155, DOI 10.1242/dev.003665; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	38	177	182	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1031	U278		10.1038/ncb1917	http://dx.doi.org/10.1038/ncb1917			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19633662				2022-12-25	WOS:000268593200019
J	Siepe, D; Jentsch, S				Siepe, Dirk; Jentsch, Stefan			Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR; P53; UBIQUITIN; ISOMERIZATION; DEGRADATION; MECHANISM; PROTEIN; MDM2; MULTIUBIQUITYLATION; LOCALIZATION	Pin1, a conserved eukaryotic peptidyl-prolyl cis/trans isomerase, has important roles in cellular regulation(1,2). Because of its activity to switch the conformation of peptidyl-proline bonds in polypeptide chains, Pin1 operates as a binary switch, often in fate-determining pathways. Pin1 activity is usually controlled by substrate phosphorylation(1,2), but how Pin1 switches protein fates has been unclear. Here we show that Pin1 controls the degree of substrate ubiquitylation and thereby protein functions. We found that yeast Pin1 (Ess1) is essential for viability because it controls the NF-kappa B-related Spt23 transcription factor involved in unsaturated fatty-acid synthesis(3). High Pin1 activity results in low ubiquitylation of Spt23, which triggers Spt23 precursor processing and hence transcription factor activation. By contrast, decreased Pin1 activity leads to robust Spt23 polyubiquitylation and subsequent proteasomal degradation. Inhibition of Pin1 in mammalian cells changes the ubiquitylation status of the tumour suppressor protein p53 from oligoubiquitylation, which is known to trigger nuclear export(4), to polyubiquitylation, which causes nuclear p53 degradation. This suggests that the Pin1 activity is often translated into a fate-determining ubiquitylation switch, and that Pin1 may affect the degree of substrate ubiquitylation in other pathways as well.	[Siepe, Dirk; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de			Max Planck Society; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank T. Ammon, A. Buchberger, M. Kalocsay, S. Muller, W. Piwko and C. Pohl for discussions, and M. Kalocsay for the pOLE1 reporter construct. S. J. is supported by the Max Planck Society, the Center for Integrated Protein Science Munich, the RUBICON EU Network of Excellence, and Fonds der Chemischen Industrie.	Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Coutts AS, 2009, DNA REPAIR, V8, P483, DOI 10.1016/j.dnarep.2009.01.008; Gietz RD, 1997, MOL CELL BIOCHEM, V172, P67, DOI 10.1023/A:1006859319926; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hsu T, 2001, NAT CELL BIOL, V3, P538, DOI 10.1038/35078508; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	36	44	45	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					967	U127		10.1038/ncb1908	http://dx.doi.org/10.1038/ncb1908			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597489				2022-12-25	WOS:000268593200010
J	Thoma, CR; Toso, A; Gutbrodt, KL; Reggi, SP; Frew, IJ; Schraml, P; Hergovich, A; Moch, H; Meraldi, P; Krek, W				Thoma, Claudio R.; Toso, Alberto; Gutbrodt, Katrin L.; Reggi, Sabina P.; Frew, Ian J.; Schraml, Peter; Hergovich, Alexander; Moch, Holger; Meraldi, Patrick; Krek, Wilhelm			VHL loss causes spindle misorientation and chromosome instability	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR; HELA-CELLS; PVHL; PROTEINS; ACTIVATION; CHECKPOINT; EXPRESSION; ANEUPLOIDY; MUTATIONS; STABILITY	Error-free mitosis depends on fidelity-monitoring checkpoint systems that ensure correct temporal and spatial coordination of chromosome segregation by the microtubule spindle apparatus. Defects in these checkpoint systems can lead to genomic instability, an important aspect of tumorigenesis. Here we show that the von Hippel-Lindau (VHL) tumour suppressor protein, pVHL, which is inactivated in hereditary and sporadic forms of renal cell carcinoma, localizes to the mitotic spindle in mammalian cells and its functional inactivation provokes spindle misorientation, spindle checkpoint weakening and chromosomal instability. Spindle misorientation is linked to unstable astral microtubules and is supressed by the restoration of wild-type pVHL in pVHL-deficient cells, but not in naturally-occurring VHL disease mutants that are defective in microtubule stabilization. Impaired spindle checkpoint function and chromosomal instability are the result of reduced Mad2 (mitotic arrest deficient 2) levels actuated by pVHL-inactivation and are rescued by re-expression of either Mad2 or pVHL in VHL-defective cells. An association between VHL inactivation, reduced Mad2 levels and increased aneuploidy was also found in human renal cancer, implying that the newly identified functions of pVHL in promoting proper spindle orientation and chromosomal stability probably contribute to tumour suppression.	[Thoma, Claudio R.; Gutbrodt, Katrin L.; Frew, Ian J.; Hergovich, Alexander; Krek, Wilhelm] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Toso, Alberto; Reggi, Sabina P.; Meraldi, Patrick] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Schraml, Peter; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Krek, W (corresponding author), ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.	patrick.meraldi@bc.biol.ethz.ch; wilhelm.krek@cell.biol.ethz.ch	Meraldi, Patrick/D-6190-2013	Hergovich, Alexander/0000-0001-7018-5635; Frew, Ian/0000-0003-2735-5509; Meraldi, Patrick/0000-0001-9742-8756	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank all members of our laboratories for helpful discussions. The authors are grateful to P. Sorger and A. Musacchio for their generous gifts of reagents, R. Carazo Salas and M. Bortfeld-Miller for helping with microtubule assays, C. Azzalin and M. Patil for helping with chromosome spreads, the Light Microscopy Centre ETH Zurich, in particular G. Csucs and J. Kusch, for help with microscopy, M. Storz and S. Behnke for preparing the tissue array and the immunostaining and J. Schelldorfer for advise in statistical data analysis. C. R. T. and A. T. are members of the Life Science Zurich Graduate School Zurich, Program in Molecular Life Sciences. P. M. is recipient of a SNF Assistant Professorship and is supported by the Swiss National Science Foundation. W. K. is supported by a grant from the Swiss National Science Foundation.	Abou-Rebyeh H, 2001, CANCER-AM CANCER SOC, V92, P2280, DOI 10.1002/1097-0142(20011101)92:9<2280::AID-CNCR1574>3.0.CO;2-2; Dalquen P, 1997, VIRCHOWS ARCH, V431, P173, DOI 10.1007/s004280050085; DE AA, 2005, CURR BIOL, V15, P214; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Frew IJ, 2008, MOL CELL BIOL, V28, P4536, DOI 10.1128/MCB.02132-07; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Lolkema MP, 2007, FEBS LETT, V581, P4571, DOI 10.1016/j.febslet.2007.08.050; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Mertz KD, 2008, INT J CANCER, V123, P569, DOI 10.1002/ijc.23565; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pepe S, 2000, CANCER, V89, P1065, DOI 10.1002/1097-0142(20000901)89:5<1065::AID-CNCR16>3.0.CO;2-T; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Salinas S, 2005, J NEUROCHEM, V95, P1411, DOI 10.1111/j.1471-4159.2005.03472.x; SOLOMON D, 1988, HUM PATHOL, V19, P1072, DOI 10.1016/S0046-8177(88)80089-3; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003	27	119	119	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					994	U200		10.1038/ncb1912	http://dx.doi.org/10.1038/ncb1912			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19620968				2022-12-25	WOS:000268593200014
J	Tyo, KEJ; Ajikumar, PK; Stephanopoulos, G				Tyo, Keith E. J.; Ajikumar, Parayil Kumaran; Stephanopoulos, Gregory			Stabilized gene duplication enables long-term selection-free heterologous pathway expression	NATURE BIOTECHNOLOGY			English	Article							PLASMID COPY NUMBER; RECOMBINANT ESCHERICHIA-COLI; HAMSTER OVARY CELLS; STRAINS; POLY(3-HYDROXYBUTYRATE); BIOSYNTHESIS; SEQUENCES; SYNTHASE; CLONING; DNA	Engineering robust microbes for the biotech industry typically requires high-level, genetically stable expression of heterologous genes and pathways. Although plasmids have been used for this task, fundamental issues concerning their genetic stability have not been adequately addressed. Here we describe chemically inducible chromosomal evolution (CIChE), a plasmid-free, high gene copy expression system for engineering Escherichia coli. CIChE uses E. coli recA homologous recombination to evolve a chromosome with similar to 40 consecutive copies of a recombinant pathway. Pathway copy number is stabilized by recA knockout, and the resulting engineered strain requires no selection markers and is unaffected by plasmid instabilities. Comparison of CIChE-engineered strains with equivalent plasmids revealed that CIChE improved genetic stability approximately tenfold and growth phase-specific productivity approximately fourfold for a strain producing the high metabolic burden-biopolymer poly-3-hydroxybutyrate. We also increased the yield of the nutraceutical lycopene by 60%. CIChE should be applicable in many organisms, as it only requires having targeted genomic integration methods and a recA homolog.	[Tyo, Keith E. J.; Ajikumar, Parayil Kumaran; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu	Tyo, Keith/D-1817-2009; Tyo, Keith/AAM-4543-2020; Tyo, Keith/H-6227-2012	Tyo, Keith/0000-0002-2342-0687	National Science Foundation [CBET-0730238]; Singapore-MIT Alliance; Harvard Medical School [BW26,547]; (Massachusetts Institute of Technology (MIT)) [pAGL20]	National Science Foundation(National Science Foundation (NSF)); Singapore-MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Harvard Medical School; (Massachusetts Institute of Technology (MIT))	We would like to acknowledge National Science Foundation grant CBET-0730238 and the Singapore-MIT Alliance for funding. We thank H. Alper for cloning advice and J. Young for model calculations advice. Lysogens and transfer strains were kindly provided by D. Boyd and J. Beckwith (Harvard Medical School). BW26,547 was received from B. Sauer (Massachusetts Institute of Technology (MIT)). pAGL20 is a gift from A. Sinskey (MIT).	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; BENTLEY WE, 1993, BIOTECHNOL BIOENG, V42, P222, DOI 10.1002/bit.260420210; Borth N, 2000, BIOTECHNOL BIOENG, V71, P266, DOI 10.1002/1097-0290(2000)71:4<266::AID-BIT1016>3.0.CO;2-2; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Hiszczynska-Sawicka E, 1997, PLASMID, V38, P174, DOI 10.1006/plas.1997.1307; Hong SH, 2003, BIOTECHNOL BIOENG, V83, P854, DOI 10.1002/bit.10733; ISHII K, 1978, PLASMID, V1, P435, DOI 10.1016/0147-619X(78)90002-1; IVANOV IG, 1987, ANAL BIOCHEM, V165, P137, DOI 10.1016/0003-2697(87)90211-9; Keasling JD, 1999, TRENDS BIOTECHNOL, V17, P452, DOI 10.1016/S0167-7799(99)01376-1; Kim NS, 1998, BIOTECHNOL BIOENG, V60, P679, DOI 10.1002/(SICI)1097-0290(19981220)60:6<679::AID-BIT5>3.0.CO;2-Q; Klein-Marcuschamer D, 2007, TRENDS BIOTECHNOL, V25, P417, DOI 10.1016/j.tibtech.2007.07.006; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Lawrence AG, 2005, BIOMACROMOLECULES, V6, P2113, DOI 10.1021/bm0501048; LEE SY, 1994, BIOTECHNOL BIOENG, V44, P1337, DOI 10.1002/bit.260441110; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Nakanishi F, 1999, ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 10, P259; NOVICK RP, 1978, PLASMID, V1, P421, DOI 10.1016/0147-619X(78)90001-X; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; Olson P, 1998, PROTEIN EXPRES PURIF, V14, P160, DOI 10.1006/prep.1998.0973; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Pont-Kingdon Genevieve, 2003, Methods Mol Biol, V226, P511; Pronk JT, 2002, APPL ENVIRON MICROB, V68, P2095, DOI 10.1128/AEM.68.5.2095-2100.2002; Snell KD, 1996, J AM CHEM SOC, V118, P5605, DOI 10.1021/ja9538041; Tyo KE, 2006, APPL ENVIRON MICROB, V72, P3412, DOI 10.1128/AEM.72.5.3412-3417.2006; Wang Duan-hao, 2008, Shengwu Jiagong Guocheng, V6, P33; Wang FL, 1997, APPL ENVIRON MICROB, V63, P4765, DOI 10.1128/AEM.63.12.4765-4769.1997; Wang XH, 1996, BIOTECHNOL BIOENG, V49, P45, DOI 10.1002/(SICI)1097-0290(19960105)49:1<45::AID-BIT6>3.0.CO;2-T; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	40	217	232	6	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2009	27	8					760	U115		10.1038/nbt.1555	http://dx.doi.org/10.1038/nbt.1555			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	480YY	19633654				2022-12-25	WOS:000268774500027
J	Sun, SY; Chao, DY; Li, XM; Shi, M; Gao, JP; Zhu, MZ; Yang, HQ; Luan, S; Lin, HX				Sun, Shi-Yong; Chao, Dai-Yin; Li, Xin-Min; Shi, Min; Gao, Ji-Ping; Zhu, Mei-Zhen; Yang, Hong-Quan; Luan, Sheng; Lin, Hong-Xuan			OsHAL3 mediates a new pathway in the light-regulated growth of rice	NATURE CELL BIOLOGY			English	Article							COENZYME-A BIOSYNTHESIS; SALT TOLERANCE; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; INHIBITORY SUBUNIT; GENE; PROTEIN; OVEREXPRESSION; 4'-PHOSPHOPANTOTHENOYLCYSTEINE; 4'-PHOSPHOPANTETHEINE	Plants show distinct morphologies in different light conditions through a process called photomorphogenesis. A predominant feature of photomorphogenesis is the reduced growth of seedlings under light conditions compared with darkness. For this adaptive event, the most well-known molecular mechanism involves photoreceptor-mediated inhibition of cell elongation(1-4). However, it is not known whether additional pathways exist. Here, we describe a newly discovered pathway of light-modulated plant growth mediated by the halotolerance protein HAL3, a flavin mononucleotide (FMN)-binding protein involved in cell division(5-8). We found that light, especially blue light, suppresses growth of rice seedlings by reducing the activity of Oryza sativa (Os) HAL3. Both in vitro and in vivo studies showed that OsHAL3 is structurally inactivated by light through photo-oxidation and by direct interaction with photons. In addition, the transcriptional expression of OsHAL3 is synergistically regulated by different light conditions. Further investigation suggested that OsHAL3 promotes cell division by recruiting a ubiquitin system, rather than by its 4'-phosphopantothenoylcysteine (PPC) decarboxylase activity. Our results uncover a new mechanism for light-regulated plant growth, namely, light not only inhibits cell elongation but also suppresses cell division through HAL3 and E3 ubiquitin ligase. This study thus brings new insights into our understanding of plant photomorphogenesis.	[Sun, Shi-Yong; Chao, Dai-Yin; Li, Xin-Min; Shi, Min; Gao, Ji-Ping; Zhu, Mei-Zhen; Yang, Hong-Quan; Lin, Hong-Xuan] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Luan, Sheng; Lin, Hong-Xuan] Chinese Acad Sci, SIBS, SIBS UC Berkeley Ctr Mol Life Sci, Shanghai 200032, Peoples R China; [Luan, Sheng] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Lin, HX (corresponding author), Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	hxlin@sibs.ac.cn	Zhang, Ning/F-1387-2014; Chao, Dai-Yin/H-1357-2012; Chao, Daiyin/A-5213-2013; Lin, Hong-Xuan/AEQ-6607-2022	Lin, Hong-Xuan/0000-0002-2818-023X; ?, ??/0000-0003-2832-4800; Gao, Ji-Ping/0000-0002-8968-4423; Yang, Hong-Quan/0000-0001-6215-2665	Ministry of Science and Technology of China [2006CB100100, 2006AA10A102]; Chinese Academy of Sciences [KSCX2-YW-N-011]; National Natural Science Foundation of China [30730058, 30821004]; Ministry of Agriculture of China [2009EX08009-0678]; Shanghai Science and Technology Development Fund	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Shanghai Science and Technology Development Fund	We thank Q..-H. Yao for providing a rice cDNA library and T. G. Sors for revising the manuscript. This work was supported by grants from the Ministry of Science and Technology of China (2006CB100100 and 2006AA10A102), the Chinese Academy of Sciences (KSCX2-YW-N-011), the National Natural Science Foundation of China (30730058 and 30821004), the Ministry of Agriculture of China (2009EX08009-0678) and the Shanghai Science and Technology Development Fund.	Albert A, 2000, STRUCTURE, V8, P961, DOI 10.1016/S0969-2126(00)00187-8; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Clotet J, 1999, MOL CELL BIOL, V19, P2408; de Nadal E, 1998, P NATL ACAD SCI USA, V95, P7357, DOI 10.1073/pnas.95.13.7357; DICOMO CJ, 1995, GENETICS, V139, P95; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; Hernandez-Acosta P, 2002, J BIOL CHEM, V277, P20490, DOI 10.1074/jbc.M201557200; HIEL Y, 1994, PLANT J, V6, P271; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Karsai A, 2002, BIOTECHNIQUES, V32, P790, DOI 10.2144/02324st05; Kupke T, 2003, J BIOL CHEM, V278, P38229, DOI 10.1074/jbc.M306321200; Kupke T, 2001, J BIOL CHEM, V276, P19190, DOI 10.1074/jbc.M100776200; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Mei Chuansheng, 2007, Methods Mol Biol, V354, P161; Munoz I, 2004, J BIOL CHEM, V279, P42619, DOI 10.1074/jbc.M405656200; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Rios G, 1997, YEAST, V13, P515, DOI 10.1002/(SICI)1097-0061(199705)13:6<515::AID-YEA102>3.0.CO;2-X; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rodriguez PL, 1996, YEAST, V12, P1321, DOI 10.1002/(SICI)1097-0061(199610)12:13<1321::AID-YEA27>3.0.CO;2-6; Rubio S, 2006, PLANT PHYSIOL, V140, P830, DOI 10.1104/pp.105.072066; Ruiz A, 2004, J BIOL CHEM, V279, P34421, DOI 10.1074/jbc.M400572200; Sang Y, 2005, PLANT CELL, V17, P1569, DOI 10.1105/tpc.104.029645; Steinbacher S, 2003, J MOL BIOL, V327, P193, DOI 10.1016/S0022-2836(03)00092-5; vonArnim A, 1996, ANNU REV PLANT PHYS, V47, P215, DOI 10.1146/annurev.arplant.47.1.215; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920; Yonamine I, 2004, J EXP BOT, V55, P387, DOI 10.1093/jxb/erh043; Zhang N, 2009, BIOCHEMISTRY-MOSCOW+, V74, P61, DOI 10.1134/S000629790901009X; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	32	29	44	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					845	U148		10.1038/ncb1892	http://dx.doi.org/10.1038/ncb1892			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543273				2022-12-25	WOS:000267603100013
J	Liutkeviciute, Z; Lukinavicius, G; Masevicius, V; Daujotyte, D; Klimasauskas, S				Liutkeviciute, Zita; Lukinavicius, Grazvydas; Masevicius, Viktoras; Daujotyte, Dalia; Klimasauskas, Saulius			Cytosine-5-methyltransferases add aldehydes to DNA	NATURE CHEMICAL BIOLOGY			English	Article							METHYLTRANSFERASE; FORMALDEHYDE; 5-METHYLCYTOSINE; DEMETHYLATION; METHYLATION; DEAMINATION; MECHANISM; ENZYMES; HELIX; BASE	Targeted methylation of cytosine residues by S-adenosylmethionine-dependent DNA methyltransferases modulates gene expression in vertebrates. Here we show that cytosine-5-methyltransferases catalyze reversible covalent addition of exogenous aliphatic aldehydes to their target residues in DNA, thus yielding corresponding 5-alpha-hydroxyalkylcytosines. Such atypical enzymatic reactions with non-cofactor-like substrates open new ways for sequence-specific derivatization of DNA and demonstrate enzymatic exchange of 5-hydroxymethyl groups on cytosine in support of an oxidative mechanism of DNA demethylation.	[Liutkeviciute, Zita; Lukinavicius, Grazvydas; Masevicius, Viktoras; Daujotyte, Dalia; Klimasauskas, Saulius] Inst Biotechnol, Lab Biol DNA Modificat, Vilnius, Lithuania; [Masevicius, Viktoras] Vilnius State Univ, Dept Chem, Vilnius, Lithuania	Vilnius University; Vilnius University	Klimasauskas, S (corresponding author), Inst Biotechnol, Lab Biol DNA Modificat, Vilnius, Lithuania.	klimasau@ibt.lt	Klimasauskas, Saulius/M-3053-2016; Lukinavicius, Grazvydas/H-9799-2017; Lukinavicius, Grazvydas/B-8061-2013	Klimasauskas, Saulius/0000-0002-1395-2030; Lukinavicius, Grazvydas/0000-0002-7176-1793; Lukinavicius, Grazvydas/0000-0002-7176-1793	Lithuanian State Science and Study Foundation; Ministry of Education and Science of Lithuania	Lithuanian State Science and Study Foundation(Research Council of Lithuania (LMTLT)); Ministry of Education and Science of Lithuania	We thank S. Morera (Laboratoire d'Enzymologie et Biochimie Structurales) and L. C. Sowers (Loma Linda University) for the gift of an hmC-containing oligonucleotide, G. Vilkaitis (Institute of Biotechnology) for a sample of mouse Dnmt1, and M. Petrusyte (Fermentas) for M. HpaII. Thanks are due to L. Peil for HR-MS analysis of modified nucleosides, M. Kreneviciene for NMR spectra and E. Weinhold for valuable discussions. This work was supported by grants from the Lithuanian State Science and Study Foundation and the Ministry of Education and Science of Lithuania.	Bornscheuer UT, 2004, ANGEW CHEM INT EDIT, V43, P6032, DOI 10.1002/anie.200460416; Bujnicki JM, 2004, NUCLEIC ACIDS RES, V32, P2453, DOI 10.1093/nar/gkh564; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Chittaboina S, 2005, TETRAHEDRON LETT, V46, P2331, DOI 10.1016/j.tetlet.2005.01.175; Daujotyte D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn200; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; GOMMERSAMPT JH, 1995, FASEB J, V9, P1034, DOI 10.1096/fasebj.9.11.7649402; GRAVES KL, 1992, BIOCHEMISTRY-US, V31, P10315, DOI 10.1021/bi00157a020; Hamm S, 2008, BIOORG MED CHEM LETT, V18, P1046, DOI 10.1016/j.bmcl.2007.12.027; Heck HD, 2004, REGUL TOXICOL PHARM, V40, P92, DOI 10.1016/j.yrtph.2004.05.001; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; KLIMASAUSKAS S, 2008, WILEY ENCY CHEM BIOL, pCH335; Klimasauskas S, 2007, TRENDS BIOTECHNOL, V25, P99, DOI 10.1016/j.tibtech.2007.01.006; KRIAUCIONIS S, 2009, SCIENCE         0416, DOI DOI 10.1126/SCIENCE.1169786; KUSMIEREK JT, 1982, BIOCHEMISTRY-US, V21, P5717, DOI 10.1021/bi00265a050; Lukinavicius G, 2007, J AM CHEM SOC, V129, P2758, DOI 10.1021/ja0691876; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; TAHILIANI M, 2009, SCIENCE         0416, DOI DOI 10.1126/SCIENCE.1170116; Wang MY, 2007, CHEM RES TOXICOL, V20, P1141, DOI 10.1021/tx700189c; WU JC, 1987, J BIOL CHEM, V262, P4778; Zingg JM, 1996, NUCLEIC ACIDS RES, V24, P3267, DOI 10.1093/nar/24.16.3267	26	111	118	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2009	5	6					400	402		10.1038/nchembio.172	http://dx.doi.org/10.1038/nchembio.172			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	450EM	19430486				2022-12-25	WOS:000266383800013
J	Taft, RJ; Glazov, EA; Cloonan, N; Simons, C; Stephen, S; Faulkner, GJ; Lassmann, T; Forrest, ARR; Grimmond, SM; Schroder, K; Irvine, K; Arakawa, T; Nakamura, M; Kubosaki, A; Hayashida, K; Kawazu, C; Murata, M; Nishiyori, H; Fukuda, S; Kawai, J; Daub, CO; Hume, DA; Suzuki, H; Orlando, V; Carninci, P; Hayashizaki, Y; Mattick, JS				Taft, Ryan J.; Glazov, Evgeny A.; Cloonan, Nicole; Simons, Cas; Stephen, Stuart; Faulkner, Geoffrey J.; Lassmann, Timo; Forrest, Alistair R. R.; Grimmond, Sean M.; Schroder, Kate; Irvine, Katharine; Arakawa, Takahiro; Nakamura, Mari; Kubosaki, Atsutaka; Hayashida, Kengo; Kawazu, Chika; Murata, Mitsuyoshi; Nishiyori, Hiromi; Fukuda, Shiro; Kawai, Jun; Daub, Carsten O.; Hume, David A.; Suzuki, Harukazu; Orlando, Valerio; Carninci, Piero; Hayashizaki, Yoshihide; Mattick, John S.			Tiny RNAs associated with transcription start sites in animals	NATURE GENETICS			English	Article							ANALYSIS GENE-EXPRESSION; POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; DNA METHYLATION; FACTOR TFIIS; HUMAN-CELLS; GENOME; INITIATION; CLEAVAGE	It has been reported that relatively short RNAs of heterogeneous sizes are derived from sequences near the promoters of eukaryotic genes. In conjunction with the FANTOM4 project, we have identified tiny RNAs with a modal length of 18 nt that map within -60 to +120 nt of transcription start sites (TSSs) in human, chicken and Drosophila. These transcription initiation RNAs (tiRNAs) are derived from sequences on the same strand as the TSS and are preferentially associated with G+C-rich promoters. The 5' ends of tiRNAs show peak density 10-30 nt downstream of TSSs, indicating that they are processed. tiRNAs are generally, although not exclusively, associated with highly expressed transcripts and sites of RNA polymerase II binding. We suggest that tiRNAs may be a general feature of transcription in metazoa and possibly all eukaryotes.	[Lassmann, Timo; Forrest, Alistair R. R.; Arakawa, Takahiro; Nakamura, Mari; Kubosaki, Atsutaka; Hayashida, Kengo; Kawazu, Chika; Murata, Mitsuyoshi; Nishiyori, Hiromi; Fukuda, Shiro; Kawai, Jun; Daub, Carsten O.; Suzuki, Harukazu; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan; [Taft, Ryan J.; Cloonan, Nicole; Simons, Cas; Stephen, Stuart; Faulkner, Geoffrey J.; Grimmond, Sean M.; Schroder, Kate; Irvine, Katharine; Hume, David A.; Mattick, John S.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Glazov, Evgeny A.] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [Forrest, Alistair R. R.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Orlando, Valerio] IRCCS Santa Lucia EBRI, Dulbecco Telethon Inst, Rome, Italy; [Orlando, Valerio] IGB CNR, Dulbecco Telethon Inst, Naples, Italy	RIKEN; University of Queensland; University of Queensland; Griffith University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI)	Hayashizaki, Y (corresponding author), RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan.	yosihide@gsc.riken.jp; j.mattick@imb.uq.edu.au	Grimmond, Sean M/J-5304-2016; Grimmond, Sean/K-3246-2019; Carninci, Piero/K-1568-2014; Lassmann, Timo/A-8271-2008; Faulkner, Geoffrey J/M-3168-2014; Taft, Ryan/B-2945-2010; Mattick, John S/I-7789-2012; Cloonan, Nicole/B-5272-2008; Daub, Carsten O/A-7436-2010; Suzuki, Harukazu/N-9553-2015; Hayashizaki, Yoshihide/N-6590-2015; Kawai, Jun/A-6451-2016; Simons, Cas/A-7905-2011; Stuart, Stephen/I-3380-2012; Mattick, John/ABH-6130-2020; Hume, David A/C-7695-2013; Forrest, Alistair/A-6597-2008; Lassmann, Timo/HCH-4313-2022; Schroder, Kate/C-6132-2008; Irvine, Katharine M/A-5559-2011; Glazov, Evgeny A/F-9951-2010	Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Carninci, Piero/0000-0001-7202-7243; Lassmann, Timo/0000-0002-0138-2691; Faulkner, Geoffrey J/0000-0001-5769-4494; Mattick, John S/0000-0002-7680-7527; Cloonan, Nicole/0000-0001-7802-6647; Daub, Carsten O/0000-0002-3295-8729; Suzuki, Harukazu/0000-0002-8087-0836; Simons, Cas/0000-0003-3147-8042; Stuart, Stephen/0000-0001-5141-640X; Mattick, John/0000-0002-7680-7527; Forrest, Alistair/0000-0003-4543-1675; Lassmann, Timo/0000-0002-0138-2691; Schroder, Kate/0000-0001-9261-3805; Irvine, Katharine M/0000-0002-6716-1605; Hume, David/0000-0002-2615-1478; Fukuda, Shiro/0000-0002-0065-662X	US National Science Foundation Graduate Research Fellowship; University of Queensland Postdoctoral Research Fellowship; Australian National Health and Medical Research Council [ID 428261]; Australian NHMRC Fellowship [455857]; Telethon [TCP00094]; Associazione Italiana Riecrca sul Cancro (AIRC); Compagnia San Paolo; Australian Research Council Federation Fellowship [ID FF0561986]; University of Queensland and the Queensland State Government; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; RIKEN Frontier Research System, Functional RNA Research Program; Medical Research Council [G9900991B] Funding Source: researchfish	US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Queensland Postdoctoral Research Fellowship(University of Queensland); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Telethon(Fondazione Telethon); Associazione Italiana Riecrca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia San Paolo(Compagnia di San Paolo); Australian Research Council Federation Fellowship(Australian Research Council); University of Queensland and the Queensland State Government; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Frontier Research System, Functional RNA Research Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Hasegawa, F. Hori, H. Sano for technical assistance. R. J. T. is supported by a US National Science Foundation Graduate Research Fellowship. N. C. is supported by a University of Queensland Postdoctoral Research Fellowship. A. R. R. F. is supported by a CJ Martin Fellowship from the Australian National Health and Medical Research Council (ID 428261). S. M. G. is supported by Australian NH&MRC Fellowship grant no. 455857. V.O. is supported by Telethon TCP00094, Associazione Italiana Riecrca sul Cancro (AIRC), Compagnia San Paolo. J. S. M. is supported by an Australian Research Council Federation Fellowship (ID FF0561986), the University of Queensland and the Queensland State Government. This work was also supported by grants for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Y.H.), and Research Grant for the RIKEN Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government, the RIKEN Frontier Research System, Functional RNA Research Program (Y.H.). We thank the reviewers for their insights and suggestions.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; FROMONTRACINE M, 1993, NUCLEIC ACIDS RES, V21, P1683, DOI 10.1093/nar/21.7.1683; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lagonigro MS, 2004, PIGM CELL RES, V17, P312; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mellor J, 2008, CURR OPIN GENET DEV, V18, P116, DOI 10.1016/j.gde.2007.12.005; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Pal M, 2001, MOL CELL BIOL, V21, P5815, DOI 10.1128/MCB.21.17.5815-5825.2001; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Prather DA, 2005, MOL CELL BIOL, V25, P2650, DOI 10.1128/MCB.25.7.2650-2659.2005; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tews B, 2007, ONCOGENE, V26, P5010, DOI 10.1038/sj.onc.1210297; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200	47	265	294	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					572	578		10.1038/ng.312	http://dx.doi.org/10.1038/ng.312			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19377478				2022-12-25	WOS:000265575600018
J	Pant, S; Sharma, M; Patel, K; Caplan, S; Carr, CM; Grant, BD				Pant, Saumya; Sharma, Mahak; Patel, Kruti; Caplan, Steve; Carr, Chavela M.; Grant, Barth D.			AMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd1 in endocytic recycling	NATURE CELL BIOLOGY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; EARLY ENDOSOMAL TRANSPORT; CAENORHABDITIS-ELEGANS; EH-DOMAIN; DROSOPHILA AMPHIPHYSIN; MEDIATED ENDOCYTOSIS; MEMBRANE FISSION; SH3 DOMAIN; C-ELEGANS; DYNAMIN	RME-1/EHD1 (receptor mediated endocytosis/Eps15 homology-domain containing 1) family proteins are key residents of the recycling endosome, which are required for endosome-to-plasma membrane transport in Caenorhabditis elegans and mammals. Recent studies suggest similarities between the RME-1/EHD proteins and the Dynamin GTPase superfamily of mechanochemical pinchases, which promote membrane fission. Here we show that endogenous C. elegans AMPH-1, the only C. elegans member of the Amphiphysin/ BIN1 family of BAR (Bin1-Amphiphysin-Rvs161p/167p)-domain-containing proteins, colocalizes with RME-1 on recycling endosomes in vivo, that amph-1-deletion mutants are defective in recycling endosome morphology and function, and that binding of AMPH-1 Asn-Pro-Phe(Asp/Glu) sequences to the RME-1 EH-domain promotes the recycling of transmembrane cargo. We also show a requirement for human BIN1 ( also known as Amphiphysin 2) in EHD1-regulated endocytic recycling. In vitro, we find that purified recombinant AMPH-1-RME-1 complexes produce short, coated membrane tubules that are qualitatively distinct from those produced by either protein alone. Our results indicate that AMPH-1 and RME-1 cooperatively regulate endocytic recycling, probably through functions required for the production of cargo carriers that exit the recycling endosome for the cell surface.	[Pant, Saumya; Patel, Kruti; Grant, Barth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Carr, Chavela M.] Univ Med & Dent New Jersey, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA; [Sharma, Mahak; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Nebraska System; University of Nebraska Medical Center	Grant, BD (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	grant@biology.rutgers.edu	Sharma, Mahak/AAE-9071-2019	Sharma, Mahak/0000-0002-4117-4790; Grant, Barth/0000-0002-5943-8336	NIH [GM67237, GM074876]; NJCSCR [06-2915-SCR-E-0]; Anne B. and James B. Leathem Fellowship; McCallum Fund Fellowship; American Heart Association; Rutgers Summer Undergraduate Research Fellowship (SURF);  [R24RR22234]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR022234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067237, R01GM074876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NJCSCR; Anne B. and James B. Leathem Fellowship; McCallum Fund Fellowship; American Heart Association(American Heart Association); Rutgers Summer Undergraduate Research Fellowship (SURF); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. McPherson, Z. Zhou, B. Kay, G. Prandergast and S. Mitani for important reagents. The monoclonal against RME- 1 was made at Washington University School of Medicine and funded by Grant R24RR22234 ( PI M. L. Nonet). We also thank C. Martin, P. Yurchenco, D. Winkelman, F. Matsumura, S. Yamashiro and S. H. deGregori for sharing their instruments, reagents and protocols; A. Shi for the construction and gift of the GFP-SDPN-1 strain; R. Patel and V. Starovoytov for expert assistance with electron microscopy protocols and Z. Pan for usage of the confocal microscopy facility; O. Daumke and T. Pucadyil for discussions and advice on liposome tubulation experiments; P. Schweinsberg for technical assistance. This work was supported by NIH Grants GM67237 to B. D. G and GM074876 to S. C., a NJCSCR Graduate Fellowship 06-2915-SCR-E-0, an Anne B. and James B. Leathem Fellowship, a McCallum Fund Fellowship Grant to S. P., an American Heart Association student fellowship to M. S. and a Rutgers Summer Undergraduate Research Fellowship (SURF) to K. P.	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BASHKIROV PV, 2008, CELL; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; BRENNER S, 1974, GENETICS, V77, P71; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Choi JY, 1996, J BIOL CHEM, V271, P3581; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Farsad K, 2003, NEUROPHARMACOLOGY, V45, P787, DOI 10.1016/S0028-3908(03)00306-X; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Grant B, 1997, DEVELOPMENT, V124, P637; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; GRANT BD, 2008, TRAFFIC; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Leventis PA, 2001, TRAFFIC, V2, P839; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Olesen LE, 2008, J BIOL CHEM, V283, P5099, DOI 10.1074/jbc.M708621200; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Praitis V, 2001, GENETICS, V157, P1217; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2008, CELL, V135, P1163, DOI 10.1016/j.cell.2008.12.003; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sato K, 2009, P NATL ACAD SCI USA, V106, P1139, DOI 10.1073/pnas.0809541106; Sever S, 2002, CURR OPIN CELL BIOL, V14, P463, DOI 10.1016/S0955-0674(02)00347-2; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Takei K, 2001, METHOD ENZYMOL, V329, P478; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Zelhof AC, 2001, DEVELOPMENT, V128, P5005; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x	50	138	142	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1399	U38		10.1038/ncb1986	http://dx.doi.org/10.1038/ncb1986			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19915558	Green Accepted			2022-12-25	WOS:000272251300005
J	Li, XD; Zhang, XX; Leathers, R; Makino, A; Huang, CQ; Parsa, P; Macias, J; Yuan, JXJ; Jamieson, SW; Thistlethwaite, PA				Li, Xiaodong; Zhang, Xiaoxue; Leathers, Robin; Makino, Ayako; Huang, Chengqun; Parsa, Pouria; Macias, Jesus; Yuan, Jason X-J; Jamieson, Stuart W.; Thistlethwaite, Patricia A.			Notch3 signaling promotes the development of pulmonary arterial hypertension	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; TGF-BETA; INTRACELLULAR DOMAIN; NEOINTIMAL FORMATION; CROSS-TALK; RECEPTOR; EXPRESSION; PROLIFERATION; DIFFERENTIATION; MUTATIONS	Notch receptor signaling is implicated in controlling smooth muscle cell proliferation and in maintaining smooth muscle cells in an undifferentiated state. Pulmonary arterial hypertension is characterized by excessive vascular resistance, smooth muscle cell proliferation in small pulmonary arteries, leading to elevation of pulmonary vascular resistance, right ventricular failure and death. Here we show that human pulmonary hypertension is characterized by overexpression of NOTCH3 in small pulmonary artery smooth muscle cells and that the severity of disease in humans and rodents correlates with the amount of NOTCH3 protein in the lung. We further show that mice with homozygous deletion of Notch3 do not develop pulmonary hypertension in response to hypoxic stimulation and that pulmonary hypertension can be successfully treated in mice by administration of N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT), a gamma-secretase inhibitor that blocks activation of Notch3 in smooth muscle cells. We show a mechanistic link from NOTCH3 receptor signaling through the Hairy and enhancer of Split-5 (HES-5) protein to smooth muscle cell proliferation and a shift to an undifferentiated smooth muscle cell phenotype. These results suggest that the NOTCH3-HES-5 signaling pathway is crucial for the development of pulmonary arterial hypertension and provide a target pathway for therapeutic intervention.	[Li, Xiaodong; Zhang, Xiaoxue; Leathers, Robin; Huang, Chengqun; Parsa, Pouria; Jamieson, Stuart W.; Thistlethwaite, Patricia A.] Univ Calif San Diego, Div Cardiothorac Surg, La Jolla, CA 92093 USA; [Makino, Ayako; Yuan, Jason X-J] Univ Calif San Diego, Div Pulm & Crit Care Med, La Jolla, CA 92093 USA; [Macias, Jesus] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Thistlethwaite, PA (corresponding author), Univ Calif San Diego, Div Cardiothorac Surg, La Jolla, CA 92093 USA.	pthistlethwaite@ucsd.edu			US National Institutes of Health [2R01HL70852]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070852] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank T. Gridley (The Jackson Laboratory) for providing the Notch3-knockout mice strain used in this study. This work was supported by a grant from the US National Institutes of Health (2R01HL70852 to P. A. T.).	Alva JA, 2004, CURR OPIN HEMATOL, V11, P278, DOI 10.1097/01.moh.0000130309.44976.ad; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Broughton BRS, 2008, AM J PHYSIOL-LUNG C, V294, pL797, DOI 10.1152/ajplung.00253.2007; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; CHANTEMELE EJ, 2008, ARTERIOSCLER THROMB, V28, P2216; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; HAUSMANN G, 2008, J CLIN INVEST, V118, P1846; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hyduk Alexandra, 2005, Morbidity and Mortality Weekly Report, V54, P1; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kluppel M, 2005, BIOESSAYS, V27, P115, DOI 10.1002/bies.20187; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Lin Q, 2006, J BIOL CHEM, V281, P30678, DOI 10.1074/jbc.C600120200; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Sakata Y, 2004, ARTERIOSCL THROM VAS, V24, P2069, DOI 10.1161/01.ATV.0000143936.77094.a4; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Sullivan CC, 2003, P NATL ACAD SCI USA, V100, P12331, DOI 10.1073/pnas.1933740100; Thomas M, 2009, AM J PATHOL, V174, P380, DOI 10.2353/ajpath.2009.080565; Tuchscherer HA, 2007, J BIOMECH, V40, P993, DOI 10.1016/j.jbiomech.2006.03.023; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yuan JXJ, 2005, CIRCULATION, V111, P534, DOI 10.1161/01.CIR.0000156326.48823.55; Zhang LZ, 2008, J BIOL CHEM, V283, P4304, DOI 10.1074/jbc.M708673200	40	241	273	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1289	U89		10.1038/nm.2021	http://dx.doi.org/10.1038/nm.2021			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19855400	Green Accepted			2022-12-25	WOS:000271543700017
J	Lancaster, MA; Louie, CM; Silhavy, JL; Sintasath, L; DeCambre, M; Nigam, SK; Willert, K; Gleeson, JG				Lancaster, Madeline A.; Louie, Carrie M.; Silhavy, Jennifer L.; Sintasath, Louis; DeCambre, Marvalyn; Nigam, Sanjay K.; Willert, Karl; Gleeson, Joseph G.			Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy	NATURE MEDICINE			English	Article							FINGER PROTEIN GLIS2; JOUBERT-SYNDROME; CEREBELLAR DEVELOPMENT; NEGATIVE REGULATOR; EPITHELIAL-CELLS; COLON-CARCINOMA; MOUSE KIDNEY; CANCER-CELLS; AHI1 GENE; DISEASE	Cystic kidney disease represents a major cause of end-stage renal disease, yet the molecular mechanisms of pathogenesis remain largely unclear. Recent emphasis has been placed on a potential role for canonical Wnt signaling, but investigation of this pathway in adult renal homeostasis is lacking. Here we provide evidence of a previously unidentified canonical Wnt activity in adult mammalian kidney homeostasis, the loss of which leads to cystic kidney disease. Loss of the Jouberin (Jbn) protein in mouse leads to the cystic kidney disease nephronophthisis, owing to an unexpected decrease in endogenous Wnt activity. Jbn interacts with and facilitates beta-catenin nuclear accumulation, resulting in positive modulation of downstream transcription. Finally, we show that Jbn is required in vivo for a Wnt response to injury and renal tubule repair, the absence of which triggers cystogenesis.	[Lancaster, Madeline A.; Louie, Carrie M.; Silhavy, Jennifer L.; Nigam, Sanjay K.; Gleeson, Joseph G.] Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA; [Lancaster, Madeline A.; Louie, Carrie M.; Silhavy, Jennifer L.; DeCambre, Marvalyn; Nigam, Sanjay K.; Gleeson, Joseph G.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Lancaster, Madeline A.; Louie, Carrie M.; Silhavy, Jennifer L.; Nigam, Sanjay K.; Gleeson, Joseph G.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Sintasath, Louis; Nigam, Sanjay K.; Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [DeCambre, Marvalyn] Univ Calif San Diego, Rady Childrens Hosp, Dept Urol, La Jolla, CA 92093 USA; [DeCambre, Marvalyn] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Pediat, La Jolla, CA 92093 USA; [Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu		Lancaster, Madeline/0000-0003-2324-8853	US National Institutes of Health-National Institute of General Medical Sciences [T32 GM08666]; US National Institutes of Health; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS048453, R01NS052455] Funding Source: NIH RePORTER	US National Institutes of Health-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to members of the Gleeson lab for technical expertise and feedback and the Nigam lab for helpful kidney-related discussions and reagents, as well as B. Brinkman and the UCSD Neuroscience Microscopy Core. We also thank the K. Kaushansky, M. Karin, and P. L. Mellon labs, as well as E. L. Stone for technical expertise. We are grateful to S. Piccolo at the Departments of Histology, Microbiology and Medical Biotechnologies, University of Padua, for the BATGAL mice. We thank S. Pleasure at the Department of Neurology, University of California-San Francisco, for Lrp6-mutant mice. We also thank M. G. Rosenfeld at the School of Medicine, UCSD, for the beta-cat Delta N construct and R. T. Moon at the Department of Pharmacology, University of Washington, for the Super Topflash construct. M. A. L. and C. M. L received support from the US National Institutes of Health-National Institute of General Medical Sciences-funded UCSD Genetics Training Program (T32 GM08666). This work was supported by the US National Institutes of Health and the Burroughs Wellcome Fund in Translational Research (J. G. G.). J. G. G. is an investigator with Howard Hughes Medical Institute.	Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Calvet J P, 1994, Curr Opin Nephrol Hypertens, V3, P340, DOI 10.1097/00041552-199405000-00017; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Davison AMA, 2005, OXFORD TXB CLIN NEPH; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Eley L, 2008, KIDNEY INT, V74, P1139, DOI 10.1038/ki.2008.377; FARAGGIANA T, 1982, J HISTOCHEM CYTOCHEM, V30, P451, DOI 10.1177/30.5.7077075; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Harris PC, 2002, CURR OPIN NEPHROL HY, V11, P309, DOI 10.1097/00041552-200205000-00007; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Iglesias DM, 2007, AM J PHYSIOL-RENAL, V293, pF494, DOI 10.1152/ajprenal.00416.2006; Jauregui AR, 2008, J CELL BIOL, V180, P973, DOI 10.1083/jcb.200707090; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim YS, 2008, MOL CELL BIOL, V28, P2358, DOI 10.1128/MCB.01722-07; Kim YS, 2007, FEBS LETT, V581, P858, DOI 10.1016/j.febslet.2007.01.058; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krishnan R, 2008, KIDNEY BLOOD PRESS R, V31, P152, DOI 10.1159/000129648; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Meldrum KK, 2002, AM J PHYSIOL-HEART C, V282, pH540, DOI 10.1152/ajpheart.00072.2001; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Weiss DJ, 1999, HISTOCHEM J, V31, P231, DOI 10.1023/A:1003642025421; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Zhang K, 2007, CELL BIOCHEM FUNCT, V25, P767, DOI 10.1002/cbf.1417; Zheng R, 2008, CELL BIOL INT, V32, P427, DOI 10.1016/j.cellbi.2007.12.014	58	130	131	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1046	U101		10.1038/nm.2010	http://dx.doi.org/10.1038/nm.2010			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19718039	Green Accepted			2022-12-25	WOS:000269979200025
J	Rodier, F; Coppe, JP; Patil, CK; Hoeijmakers, WAM; Munoz, DP; Raza, SR; Freund, A; Campeau, E; Davalos, AR; Campisi, J				Rodier, Francis; Coppe, Jean-Philippe; Patil, Christopher K.; Hoeijmakers, Wieteke A. M.; Munoz, Denise P.; Raza, Saba R.; Freund, Adam; Campeau, Eric; Davalos, Albert R.; Campisi, Judith			Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion	NATURE CELL BIOLOGY			English	Article							ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; HUMAN FIBROBLASTS; GROWTH-FACTOR; HUMAN-CELLS; P53; CANCER; TUMORIGENESIS; BARRIER; ROLES	Cellular senescence suppresses cancer by stably arresting the proliferation of damaged cells(1). Paradoxically, senescent cells also secrete factors that alter tissue microenvironments(2). The pathways regulating this secretion are unknown. We show that damaged human cells develop persistent chromatin lesions bearing hallmarks of DNA double-strand breaks (DSBs), which initiate increased secretion of inflammatory cytokines such as interleukin-6 (IL-6). Cytokine secretion occurred only after establishment of persistent DNA damage signalling, usually associated with senescence, not after transient DNA damage responses (DDRs). Initiation and maintenance of this cytokine response required the DDR proteins ATM, NBS1 and CHK2, but not the cell-cycle arrest enforcers p53 and pRb. ATM was also essential for IL-6 secretion during oncogene-induced senescence and by damaged cells that bypass senescence. Furthermore, DDR activity and IL-6 were elevated in human cancers, and ATM-depletion suppressed the ability of senescent cells to stimulate IL-6-dependent cancer cell invasiveness. Thus, in addition to orchestrating cell-cycle checkpoints and DNA repair, a new and important role of the DDR is to allow damaged cells to communicate their compromised state to the surrounding tissue.	[Rodier, Francis; Coppe, Jean-Philippe; Patil, Christopher K.; Hoeijmakers, Wieteke A. M.; Raza, Saba R.; Freund, Adam; Campeau, Eric; Davalos, Albert R.; Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Rodier, Francis; Munoz, Denise P.; Campisi, Judith] Buck Inst Age Res, Novato, CA 94545 USA; [Freund, Adam] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging; University of California System; University of California Berkeley	Campisi, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	jcampisi@lbl.gov	Raza, Rizwan/B-4526-2012; Hoeijmakers, Wieteke/E-4022-2012	Raza, Rizwan/0000-0003-0599-3630; Rodier, Francis/0000-0003-2523-309X	National Institutes of Health [AG017242, AG025708]; CABCRP [11IB-0153]; Larry L. Hillblom Foundation; Netherlands Organization for International Cooperation in Higher Education [HSP-TP 06/78]; Dutch Cancer Society; Department of Energy [DE-AC03-76SF00098]; NATIONAL INSTITUTE ON AGING [P30AG025708, P01AG017242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CABCRP; Larry L. Hillblom Foundation; Netherlands Organization for International Cooperation in Higher Education; Dutch Cancer Society(KWF Kankerbestrijding); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Beausejour (grant CIHR # MPO-79317) for help in the design of a modified lentiviral expression system, R. Teachenor, V. Chu and G. Tang for valuable technical assistance, and P. Desprez for insightful comments on the manuscript. This work was supported by National Institutes of Health grants AG017242 (J.C.) and AG025708 (Buck Institute), a CABCRP grant 11IB-0153 (A. R. D.), a Larry L. Hillblom Foundation fellowship (C. K. P.), the Netherlands Organization for International Cooperation in Higher Education (Nuffic, HSP-TP 06/78), the Dutch Cancer Society (W. A. M. H.), and the Department of Energy under contract DE-AC03-76SF00098 to the University of California.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Beliveau A, 2007, P NATL ACAD SCI USA, V104, P4431, DOI 10.1073/pnas.0700260104; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Caruso C, 2004, ANN NY ACAD SCI, V1028, P1, DOI 10.1196/annals.1322.001; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	31	1359	1400	5	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					973	U142		10.1038/ncb1909	http://dx.doi.org/10.1038/ncb1909			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597488	Green Accepted			2022-12-25	WOS:000268593200011
J	Bogdanov, AM; Mishin, AS; Yampolsky, IV; Belousov, VV; Chudakov, DM; Subach, FV; Verkhusha, VV; Lukyanov, S; Lukyanov, KA				Bogdanov, Alexey M.; Mishin, Alexander S.; Yampolsky, Ilia V.; Belousov, Vsevolod V.; Chudakov, Dmitriy M.; Subach, Fedor V.; Verkhusha, Vladislav V.; Lukyanov, Sergey; Lukyanov, Konstantin A.			Green fluorescent proteins are light-induced electron donors	NATURE CHEMICAL BIOLOGY			English	Article							GFP; CHROMOPHORE; EVOLUTION; RED; PHOTOACTIVATION; DIVERSITY; ZOANTHUS; FAMILY; CORAL	Proteins of the green fluorescent protein (GFP) family are well known owing to their unique biochemistry and extensive use as in vivo markers. We discovered that GFPs of diverse origins can act as light-induced electron donors in photochemical reactions with various electron acceptors, including biologically relevant ones. Moreover, via green-to-red GFP photoconversion, this process can be observed in living cells without additional treatment.	[Bogdanov, Alexey M.; Mishin, Alexander S.; Yampolsky, Ilia V.; Belousov, Vsevolod V.; Chudakov, Dmitriy M.; Lukyanov, Sergey; Lukyanov, Konstantin A.] Shemiakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Subach, Fedor V.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Subach, Fedor V.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Lukyanov, KA (corresponding author), Shemiakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	kluk@ibch.ru	Chudakov, Dmitriy M/G-7741-2014; Yampolsky, Ilia V/R-6798-2016; Verkhusha, Vladislav/AAU-7784-2020; Belousov, Vsevolod V/G-5562-2016; Bogdanov, Alexey M/S-2759-2018; Lukyanov, Sergey/F-9140-2014; Lukyanov, Konstantin A/D-4030-2013; Subach, Fedor/K-7080-2014; Mishin, Alexander/L-9420-2014; Bogdanov, Alexey/Q-7926-2019; Subach, Fedor/AAA-5320-2021	Chudakov, Dmitriy M/0000-0003-0430-790X; Yampolsky, Ilia V/0000-0003-2558-2476; Verkhusha, Vladislav/0000-0002-2083-8121; Bogdanov, Alexey M/0000-0002-5346-789X; Lukyanov, Konstantin A/0000-0001-9845-2088; Mishin, Alexander/0000-0002-4935-7030; Bogdanov, Alexey/0000-0002-5346-789X; Subach, Fedor/0000-0003-2720-7821	Russian Academy of Sciences; Russian Federal Agency for Science and Innovations [02.513.12.3013]; Howard Hughes Medical Institute [55005618]; European Commission Sixth Framework Programme [LSHG-CT-2003-50325]; Russian Foundation [07-04-12189-ofi, 09-0400356- a]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073913] Funding Source: NIH RePORTER	Russian Academy of Sciences(Russian Academy of Sciences); Russian Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Commission Sixth Framework Programme(European CommissionEuropean Commission Joint Research Centre); Russian Foundation(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the MCB program of the Russian Academy of Sciences, the Russian Federal Agency for Science and Innovations (grant 02.513.12.3013), Howard Hughes Medical Institute (grant 55005618), the European Commission Sixth Framework Programme (LSHG-CT-2003-503259), the Russian Foundation for Basic Research (grants 07-04-12189-ofi and 09-0400356- a),	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Elowitz MB, 1997, CURR BIOL, V7, P809, DOI 10.1016/S0960-9822(06)00342-3; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Jakobs S, 2003, FEBS LETT, V554, P194, DOI 10.1016/S0014-5793(03)01170-0; Kiseleva Iu V, 2008, Bioorg Khim, V34, P711; KRASNOVSKII AA, 1948, DOKL AKAD NAUK SSSR+, V60, P421; KRASNOVSKY AA, 1960, ANNU REV PLANT PHYS, V11, P363, DOI 10.1146/annurev.pp.11.060160.002051; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Pettigrew, 1990, CYTOCHROME C EVOLUTI; Pletneva N, 2006, ACTA CRYSTALLOGR D, V62, P527, DOI 10.1107/S0907444906007852; Remington SJ, 2005, BIOCHEMISTRY-US, V44, P202, DOI 10.1021/bi048383r; Sawin KE, 1997, CURR BIOL, V7, pR606, DOI 10.1016/S0960-9822(06)00313-7; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Takahashi E, 2006, AM J PHYSIOL-CELL PH, V291, pC781, DOI 10.1152/ajpcell.00067.2006; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943	25	149	156	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					459	461		10.1038/nchembio.174	http://dx.doi.org/10.1038/nchembio.174			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19396176	Green Accepted			2022-12-25	WOS:000267266100009
J	Kato, M; Putta, S; Wang, M; Yuan, H; Lanting, L; Nair, I; Gunn, A; Nakagawa, Y; Shimano, H; Todorov, I; Rossi, JJ; Natarajan, R				Kato, Mitsuo; Putta, Sumanth; Wang, Mei; Yuan, Hang; Lanting, Linda; Nair, Indu; Gunn, Amanda; Nakagawa, Yoshimi; Shimano, Hitoshi; Todorov, Ivan; Rossi, John J.; Natarajan, Rama			TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; DIABETIC KIDNEY-DISEASE; FIBRONECTIN PRODUCTION; EXPRESSION; HYPERTROPHY; NEPHROPATHY; PATHWAY; TRANSCRIPTION; CELLS; TFE3	Akt kinase is activated by transforming growth factor-beta 1 (TGF-beta) in diabetic kidneys, and has important roles in fibrosis, hypertrophy and cell survival in glomerular mesangial cells(1-11). However, the mechanisms of Akt activation by TGF-beta are not fully understood. Here we show that TGF-beta activates Akt in glomerular mesangial cells by inducing the microRNAs (miRNAs) miR-216a and miR-217, both of which target PTEN (phosphatase and tensin homologue), an inhibitor of Akt activation. These miRNAs are located within the second intron of a non-coding RNA (RP23-298H6.1-001). The RP23 promoter was activated by TGF-beta and miR-192 through E-box-regulated mechanisms, as shown previously(3). Akt activation by these miRs led to glomerular mesangial cell survival and hypertrophy, which were similar to the effects of activation by TGF-beta. These studies reveal a mechanism of Akt activation through PTEN downregulation by two miRs, which are regulated by upstream miR-192 and TGF-beta. Due to the diversity of PTEN function(12,13), this miR-amplifying circuit may have key roles, not only in kidney disorders, but also in other diseases.	[Kato, Mitsuo; Putta, Sumanth; Wang, Mei; Yuan, Hang; Lanting, Linda; Nair, Indu; Todorov, Ivan; Natarajan, Rama] City Hope Natl Med Ctr, Beckman Res Inst, Gonda Diabet Ctr, Duarte, CA 91010 USA; [Putta, Sumanth; Gunn, Amanda; Rossi, John J.; Natarajan, Rama] City Hope Natl Med Ctr, Beckman Res Inst, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Rossi, John J.] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Biol, Duarte, CA 91010 USA; [Nakagawa, Yoshimi; Shimano, Hitoshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Metab & Endocrinol, Tsukuba, Ibaraki 3058575, Japan	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Tsukuba	Natarajan, R (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Gonda Diabet Ctr, Duarte, CA 91010 USA.	mkato@coh.org; rnatarajan@coh.org	Kato, Mitsuo/D-5411-2009; Shimano, Hitoshi/V-1761-2019; Shimano, Hitoshi/AAI-5648-2020; putta, sumanth/E-3933-2010	Shimano, Hitoshi/0000-0002-5562-5572; Kato, Mitsuo/0000-0002-1783-1084	NIH; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081705, R21DK076669] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH-National Institute of Diabetes and Digestive and Kidney Diseases and the Juvenile Diabetes Research Foundation (to RN). We are grateful to M.C.-T. Hu for a generous gift of plasmids (pFRE-Luc and FoxO3a-GFP), L. Wang and J. Arizala for technical assistance and S. DaCosta for editing the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gou D, 2007, PHYSIOL GENOMICS, V31, P554, DOI 10.1152/physiolgenomics.00005.2007; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Omori K, 2007, AM J TRANSPLANT, V7, P1224, DOI 10.1111/j.1600-6143.2007.01741.x; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200	34	481	508	5	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					881	U263		10.1038/ncb1897	http://dx.doi.org/10.1038/ncb1897			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543271	Green Accepted			2022-12-25	WOS:000267603100018
J	Capasso, M; Devoto, M; Hou, CP; Asgharzadeh, S; Glessner, JT; Attiyeh, EF; Mosse, YP; Kim, C; Diskin, SJ; Cole, KA; Bosse, K; Diamond, M; Laudenslager, M; Winter, C; Bradfield, JP; Scott, RH; Jagannathan, J; Garris, M; McConville, C; London, WB; Seeger, RC; Grant, SFA; Li, HZ; Rahman, N; Rappaport, E; Hakonarson, H; Maris, JM				Capasso, Mario; Devoto, Marcella; Hou, Cuiping; Asgharzadeh, Shahab; Glessner, Joseph T.; Attiyeh, Edward F.; Mosse, Yael P.; Kim, Cecilia; Diskin, Sharon J.; Cole, Kristina A.; Bosse, Kristopher; Diamond, Maura; Laudenslager, Marci; Winter, Cynthia; Bradfield, Jonathan P.; Scott, Richard H.; Jagannathan, Jayanti; Garris, Maria; McConville, Carmel; London, Wendy B.; Seeger, Robert C.; Grant, Struan F. A.; Li, Hongzhe; Rahman, Nazneen; Rappaport, Eric; Hakonarson, Hakon; Maris, John M.			Common variations in BARD1 influence susceptibility to high-risk neuroblastoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER SUSCEPTIBILITY; PREDISPOSITION; IDENTIFICATION; CHEMOTHERAPY; CYS557SER; BRCA1; GENE	We conducted a SNP-based genome-wide association study (GWAS) focused on the high-risk subset of neuroblastoma(1). As our previous unbiased GWAS showed strong association of common 6p22 SNP alleles with aggressive neuroblastoma(2), we restricted our analysis here to 397 high-risk cases compared to 2,043 controls. We detected new significant association of six SNPs at 2q35 within the BARD1 locus (P-allelic = 2.35 x 10(-9)-2.25 x 10(-8)). We confirmed each SNP association in a second series of 189 high-risk cases and 1,178 controls (P-allelic = 7.90 x 10(-7)-2.77 x 10(-4)). We also tested the two most significant SNPs (rs6435862, rs3768716) in two additional independent high-risk neuroblastoma case series, yielding combined allelic odds ratios of 1.68 each (P = 8.65 x 10(-18)and 2.74 x 10(-16), respectively). We also found significant association with known BARD1 nonsynonymous SNPs. These data show that common variation in BARD1 contributes to the etiology of the aggressive and most clinically relevant subset of human neuroblastoma.	[Capasso, Mario; Devoto, Marcella; Attiyeh, Edward F.; Mosse, Yael P.; Diskin, Sharon J.; Cole, Kristina A.; Bosse, Kristopher; Diamond, Maura; Laudenslager, Marci; Winter, Cynthia; Grant, Struan F. A.; Rappaport, Eric; Hakonarson, Hakon; Maris, John M.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Capasso, Mario; Devoto, Marcella; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Capasso, Mario] Univ Naples Federico 2, CEINGE Biotecnol Avanzate, Naples, Italy; [Devoto, Marcella; Li, Hongzhe] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Hou, Cuiping; Glessner, Joseph T.; Kim, Cecilia; Bradfield, Jonathan P.; Garris, Maria; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90033 USA; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90033 USA; [Attiyeh, Edward F.; Mosse, Yael P.; Diskin, Sharon J.; Cole, Kristina A.; Bosse, Kristopher; Diamond, Maura; Laudenslager, Marci; Winter, Cynthia; Jagannathan, Jayanti; Rappaport, Eric; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Attiyeh, Edward F.; Mosse, Yael P.; Diskin, Sharon J.; Cole, Kristina A.; Bosse, Kristopher; Diamond, Maura; Laudenslager, Marci; Winter, Cynthia; Jagannathan, Jayanti; Rappaport, Eric; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Scott, Richard H.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [McConville, Carmel] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [London, Wendy B.] Univ Florida, Ctr Data, Gainesville, FL USA; [London, Wendy B.] Univ Florida, Childrens Oncol Grp Stat, Gainesville, FL USA; [Maris, John M.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Pennsylvania; Pennsylvania Medicine; Sapienza University Rome; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; Institute of Cancer Research - UK; University of Birmingham; State University System of Florida; University of Florida; Children's Oncology Group (COG); State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine	Devoto, M (corresponding author), Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	devoto@chop.edu; hakonarson@chop.edu; maris@chop.edu	London, Wendy Beth/ABA-8948-2021; Pinheiro, Maísa/E-7424-2012; Rappaport, Eric/GRO-4051-2022; Cole, Kristina/M-3922-2015; Devoto, Marcella/AAP-7595-2021; London, Wendy/ABD-4624-2021; Capasso, Mario/D-1617-2014; Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	London, Wendy Beth/0000-0003-3571-6538; Rahman, Nazneen/0000-0003-4376-0440; Glessner, Joseph/0000-0001-5131-2811; Asgharzadeh, Shahab/0000-0002-0510-3848; DEVOTO, MARCELLA/0000-0002-4431-5114; Capasso, Mario/0000-0003-3306-1259; Grant, Struan/0000-0003-2025-5302	Fondazione Italiana per la Ricerca sul Cancro, FIRC; Howard Hughes Medical Institute Research Training Fellowship; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Andrew's Army Foundation; Evan Dunbar Foundation; Abramson Family Cancer Research Institute; Center for Applied Genomics; Joseph Stokes Research Institute;  [R01-CA124709]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA124709] Funding Source: NIH RePORTER	Fondazione Italiana per la Ricerca sul Cancro, FIRC(Fondazione AIRC per la ricerca sul cancro); Howard Hughes Medical Institute Research Training Fellowship(Howard Hughes Medical Institute); Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Andrew's Army Foundation; Evan Dunbar Foundation; Abramson Family Cancer Research Institute; Center for Applied Genomics; Joseph Stokes Research Institute; ; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the Children's Oncology Group for providing neuroblastoma specimens. M. C. is supported in part by Fondazione Italiana per la Ricerca sul Cancro, FIRC, and K. B. is supported by the Howard Hughes Medical Institute Research Training Fellowship. This work was supported in part by R01-CA124709 (J. M. M.), the Giulio D'Angio Endowed Chair (J. M. M.), the Alex's Lemonade Stand Foundation (J. M. M.), Andrew's Army Foundation (J. M. M.), the Rally Foundation (J. M. M.), the Evan Dunbar Foundation (J. M. M.), the Abramson Family Cancer Research Institute (J. M. M.) and the Center for Applied Genomics (H. H.) at the Joseph Stokes Research Institute.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berthold F, 2005, LANCET ONCOL, V6, P649, DOI 10.1016/S1470-2045(05)70291-6; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Irminger-Finger I, 2006, NAT REV CANCER, V6, P382, DOI 10.1038/nrc1878; JOHNATTY SE, BREAST CANC IN PRESS; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Nickerson HJ, 2000, J CLIN ONCOL, V18, P477, DOI 10.1200/JCO.2000.18.3.477; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stacey SN, 2006, PLOS MED, V3, P1103, DOI 10.1371/journal.pmed.0030217; Vahteristo P, 2006, EUR J HUM GENET, V14, P167, DOI 10.1038/sj.ejhg.5201542; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430	19	223	228	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					718	723		10.1038/ng.374	http://dx.doi.org/10.1038/ng.374			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19412175	Green Accepted			2022-12-25	WOS:000266411700022
J	Hallmayer, J; Faraco, J; Lin, L; Hesselson, S; Winkelmann, J; Kawashima, M; Mayer, G; Plazzi, G; Nevsimalova, S; Bourgin, P; Hong, SSC; Honda, Y; Honda, M; Hogl, B; Longstreth, WT; Montplaisir, J; Kemlink, D; Einen, M; Chen, J; Musone, SL; Akana, M; Miyagawa, T; Duan, J; Desautels, A; Erhardt, C; Hesla, PE; Poli, F; Frauscher, B; Jeong, JH; Lee, SP; Ton, TGN; Kvale, M; Kolesar, L; Dobrovolna, M; Nepom, GT; Salomon, D; Wichmann, HE; Rouleau, GA; Gieger, C; Levinson, DF; Gejman, PV; Meitinger, T; Young, T; Peppard, P; Tokunaga, K; Kwok, PY; Risch, N; Mignot, E				Hallmayer, Joachim; Faraco, Juliette; Lin, Ling; Hesselson, Stephanie; Winkelmann, Juliane; Kawashima, Minae; Mayer, Geert; Plazzi, Giuseppe; Nevsimalova, Sona; Bourgin, Patrice; Hong, Sheng Seung-Chul; Honda, Yutaka; Honda, Makoto; Hoegl, Birgit; Longstreth, William T., Jr.; Montplaisir, Jacques; Kemlink, David; Einen, Mali; Chen, Justin; Musone, Stacy L.; Akana, Matthew; Miyagawa, Taku; Duan, Jubao; Desautels, Alex; Erhardt, Christine; Hesla, Per Egil; Poli, Francesca; Frauscher, Birgit; Jeong, Jong-Hyun; Lee, Sung-Pil; Ton, Thanh G. N.; Kvale, Mark; Kolesar, Libor; Dobrovolna, Marie; Nepom, Gerald T.; Salomon, Dan; Wichmann, H-Erich; Rouleau, Guy A.; Gieger, Christian; Levinson, Douglas F.; Gejman, Pablo V.; Meitinger, Thomas; Young, Terry; Peppard, Paul; Tokunaga, Katsushi; Kwok, Pui-Yan; Risch, Neil; Mignot, Emmanuel			Narcolepsy is strongly associated with the T-cell receptor alpha locus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFORMATION; EVOLUTION; MUTATION; REGION; GENE	Narcolepsy with cataplexy, characterized by sleepiness and rapid onset into REM sleep, affects 1 in 2,000 individuals(1,2). Narcolepsy was first shown to be tightly associated with HLA-DR2 (ref. 3) and later sublocalized to DQB1*0602 (ref. 4). Following studies in dogs(5) and mice(6), a 95% loss of hypocretin-producing cells in postmortem hypothalami from narcoleptic individuals was reported(7,8). Using genome-wide association (GWA) in Caucasians with replication in three ethnic groups, we found association between narcolepsy and polymorphisms in the TRA@ (T-cell receptor alpha) locus, with highest significance at rs1154155 (average allelic odds ratio 1.69, genotypic odds ratios 1.94 and 2.55, P < 10(-21), 1,830 cases, 2,164 controls). This is the first documented genetic involvement of the TRA@ locus, encoding the major receptor for HLA-peptide presentation, in any disease. It is still unclear how specific HLA alleles confer susceptibility to over 100 HLA-associated disorders(9); thus, narcolepsy will provide new insights on how HLA-TCR interactions contribute to organ-specific autoimmune targeting and may serve as a model for over 100 other HLA-associated disorders(9).	[Hallmayer, Joachim; Faraco, Juliette; Lin, Ling; Kawashima, Minae; Einen, Mali; Mignot, Emmanuel] Stanford Univ, Sch Med, Ctr Sleep Sci, Palo Alto, CA 94304 USA; [Hallmayer, Joachim; Faraco, Juliette; Lin, Ling; Kawashima, Minae; Einen, Mali; Levinson, Douglas F.; Mignot, Emmanuel] Stanford Univ, Sch Med, Dept Psychiat, Palo Alto, CA 94304 USA; [Hesselson, Stephanie; Chen, Justin; Musone, Stacy L.; Akana, Matthew; Kvale, Mark; Kwok, Pui-Yan; Risch, Neil] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA USA; [Winkelmann, Juliane; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkelmann, Juliane; Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, Munich, Germany; [Kawashima, Minae; Miyagawa, Taku; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Tokyo, Japan; [Mayer, Geert] Hephata Klin, Schwalmstadt, Germany; [Mayer, Geert] Univ Marburg, Dept Neurol, Marburg, Germany; [Plazzi, Giuseppe; Poli, Francesca] Univ Bologna, Bologna, Italy; [Nevsimalova, Sona; Kemlink, David] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Nevsimalova, Sona; Kemlink, David] Gen Teaching Hosp, Prague, Czech Republic; [Bourgin, Patrice; Erhardt, Christine] Univ Strasbourg, Hop Civil, Sleep Clin, Strasbourg, France; [Hong, Sheng Seung-Chul; Jeong, Jong-Hyun; Lee, Sung-Pil] Catholic Univ Korea, St Vincents Hosp, Dept Neuropsychiat, Suwon, South Korea; [Honda, Yutaka; Honda, Makoto] Tokyo Inst Psychiat, Tokyo, Japan; [Hoegl, Birgit; Frauscher, Birgit] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Longstreth, William T., Jr.; Ton, Thanh G. N.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Longstreth, William T., Jr.; Ton, Thanh G. N.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Montplaisir, Jacques; Desautels, Alex] Univ Montreal, Sleep Disorders Ctr, Montreal, PQ, Canada; [Duan, Jubao; Gejman, Pablo V.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat, Evanston, IL USA; [Hesla, Per Egil] Coliseum Majorstua Clin, Oslo, Norway; [Kolesar, Libor] Inst Clin & Expt Med, Dept Immunogenet, Prague, Czech Republic; [Dobrovolna, Marie] Inst Hematol & Blood Transfus, Natl Reference Lab DNA Diagnost, HLA Typing Lab, CR-12820 Prague, Czech Republic; [Nepom, Gerald T.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Salomon, Dan] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Wichmann, H-Erich; Gieger, Christian] Helmholtz Zentrum Munchen, Inst Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Montreal, PQ, Canada; [Gejman, Pablo V.] N Shore Univ HlthSyts, Evanston, IL USA; [Young, Terry; Peppard, Paul] Univ Wisconsin, Sch Med, Dept Populat Hlth Sci, Madison, WI USA; [Risch, Neil] Kaiser Permanente No Calif Div Res, Oakland, CA USA; [Mignot, Emmanuel] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Tokyo; Philipps University Marburg; University of Bologna; Charles University Prague; General University Hospital Prague; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Catholic University of Korea; Tokyo Institute of Psychiatry; Medical University of Innsbruck; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universite de Montreal; Northwestern University; Feinberg School of Medicine; Institute for Clinical & Experimental Medicine (IKEM); Institute of Hematology Prague; Benaroya Research Institute; Virginia Mason Medical Center; Scripps Research Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Universite de Montreal; University of Wisconsin System; University of Wisconsin Madison; Kaiser Permanente; Howard Hughes Medical Institute; Stanford University	Mignot, E (corresponding author), Stanford Univ, Sch Med, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Meitinger, Thomas/O-1318-2015; Salomon, Daniel/E-9380-2012; Plazzi, Giuseppe/AAB-9627-2020; Kemlink, David/Q-3019-2019; Wichmann, Heinz Erich/AAA-5695-2022; Nevšímalová, Soňa/H-3533-2017; Kwok, Pui-Yan/F-7725-2014; Kemlink, David/F-9567-2017	Nevšímalová, Soňa/0000-0003-0083-3742; Kwok, Pui-Yan/0000-0002-5087-3059; Kemlink, David/0000-0003-1398-5796; Winkelmann, Juliane/0000-0003-2667-9691; Chen, Justin/0000-0002-1661-4547; Gieger, Christian/0000-0001-6986-9554; Jeong, Jong-Hyun/0000-0003-3570-7607; Meitinger, Thomas/0000-0002-8838-8403; Hogl, Birgit/0000-0003-1894-7641; Plazzi, Giuseppe/0000-0002-1051-0472; Nepom, Gerald/0000-0002-8063-1464	US National Institutes of Neurological Disease and Stroke [P50 NS2372]; National Institutes of Mental Health [R01 MH080957]; Czech Ministry of Education [MSM0021620849, MZO 0002373601]; National institutes of Allergic and Infectious diseases [5U19 AI063603]; National Institute of Neurological Disorders and Stroke [R01 NS38523]; MIUR PRIN [2005065029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH079470, U01MH079469, R01MH080957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038523, P50NS023724, R37NS033797] Funding Source: NIH RePORTER	US National Institutes of Neurological Disease and Stroke; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); National institutes of Allergic and Infectious diseases; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are most indebted to all the participants of the study, most notably the subjects with narcolepsy. This study was supported primarily by the US National Institutes of Neurological Disease and Stroke grant P50 NS2372. Additional funding included National Institutes of Mental Health R01 MH080957 to E. M., 5U01 MH079470 to D. F. L., 5U01 MH079469-02 to P. V. G., R01 HL62252 to T. Y. Czech Ministry of Education MSM0021620849 and MZO 0002373601 to S. N., National institutes of Allergic and Infectious diseases 5U19 AI063603 to D. S., National Institute of Neurological Disorders and Stroke R01 NS38523 to W. T. L., MIUR PRIN Grant 2005065029 to G. P. and a grant from Grants-in-Aid for Scientific Research on Comprehensive Genomics from the Ministry of Education, Culture, Sports, Science and Technology of Japan to K. T. G. A. R. is supported by the Canadian Institutes of Health Research. Grant MGC 77493 to J. Montplaisir. E. M. is an HHMI supported investigator. We are also grateful to GAIN (the Genetic Association Information Network, NIH) and KORA (Kooperative Gesundheitsforschung in der Region Augsburg, Germany). The KORA research platform was initiated and financed by the German Federal Ministry of Education and Research and by the State of Bavaria. The authors extend their thanks to E. Wan, C. Chu, C. Ha, J. Zhang and A. Voros for technical assistance, and C. Grumet for brainstorming and constant support.	Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuschiotti P, 2007, MOL IMMUNOL, V44, P3380, DOI 10.1016/j.molimm.2007.02.017; Garcia KC, 1998, CURR OPIN BIOTECH, V9, P338, DOI 10.1016/S0958-1669(98)80004-9; Haynes MR, 2004, IMMUNOGENETICS, V56, P470, DOI 10.1007/s00251-004-0706-x; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Overeem S, 2008, SLEEP MED REV, V12, P95, DOI 10.1016/j.smrv.2007.07.010; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scammell TE, 2006, SLEEP, V29, P601, DOI 10.1093/sleep/29.5.601; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1	25	333	340	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					708	711		10.1038/ng.372	http://dx.doi.org/10.1038/ng.372			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19412176	Green Accepted			2022-12-25	WOS:000266411700020
J	Huffaker, SJ; Chen, JS; Nicodemus, KK; Sambataro, F; Yang, F; Mattay, V; Lipska, BK; Hyde, TM; Song, J; Rujescu, D; Giegling, I; Mayilyan, K; Proust, MJ; Soghoyan, A; Caforio, G; Callicott, JH; Bertolino, A; Meyer-Lindenberg, A; Chang, J; Ji, YJ; Egan, MF; Goldberg, TE; Kleinman, JE; Lu, B; Weinberger, DR				Huffaker, Stephen J.; Chen, Jingshan; Nicodemus, Kristin K.; Sambataro, Fabio; Yang, Feng; Mattay, Venkata; Lipska, Barbara K.; Hyde, Thomas M.; Song, Jian; Rujescu, Dan; Giegling, Ina; Mayilyan, Karine; Proust, Morgan J.; Soghoyan, Armen; Caforio, Grazia; Callicott, Joseph H.; Bertolino, Alessandro; Meyer-Lindenberg, Andreas; Chang, Jay; Ji, Yuanyuan; Egan, Michael F.; Goldberg, Terry E.; Kleinman, Joel E.; Lu, Bai; Weinberger, Daniel R.			A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia	NATURE MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE-PHENOTYPE ASSOCIATIONS; DORSOLATERAL PREFRONTAL CORTEX; GENETIC ASSOCIATIONS; WORKING-MEMORY; RELATIVE RISK; K+ CHANNELS; HERG; SIBLINGS; OSCILLATIONS	Organized neuronal firing is crucial for cortical processing and is disrupted in schizophrenia. Using rapid amplification of 5' complementary DNA ends in human brain, we identified a primate-specific isoform (3.1) of the ether-a-go-go-related K+ channel KCNH2 that modulates neuronal firing. KCNH2-3.1 messenger RNA levels are comparable to full-length KCNH2 (1A) levels in brain but three orders of magnitude lower in heart. In hippocampus from individuals with schizophrenia, KCNH2-3.1 expression is 2.5-fold greater than KCNH2-1A expression. A meta-analysis of five clinical data sets (367 families, 1,158 unrelated cases and 1,704 controls) shows association of single nucleotide polymorphisms in KCNH2 with schizophrenia. Risk-associated alleles predict lower intelligence quotient scores and speed of cognitive processing, altered memory-linked functional magnetic resonance imaging signals and increased KCNH2-3.1 mRNA levels in postmortem hippocampus. KCNH2-3.1 lacks a domain that is crucial for slow channel deactivation. Overexpression of KCNH2-3.1 in primary cortical neurons induces a rapidly deactivating K+ current and a high-frequency, nonadapting firing pattern. These results identify a previously undescribed KCNH2 channel isoform involved in cortical physiology, cognition and psychosis, providing a potential new therapeutic drug target.	[Huffaker, Stephen J.; Chen, Jingshan; Nicodemus, Kristin K.; Sambataro, Fabio; Mattay, Venkata; Lipska, Barbara K.; Hyde, Thomas M.; Song, Jian; Proust, Morgan J.; Callicott, Joseph H.; Meyer-Lindenberg, Andreas; Egan, Michael F.; Goldberg, Terry E.; Kleinman, Joel E.; Weinberger, Daniel R.] NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA; [Huffaker, Stephen J.; Chen, Jingshan; Nicodemus, Kristin K.; Sambataro, Fabio; Mattay, Venkata; Lipska, Barbara K.; Hyde, Thomas M.; Song, Jian; Meyer-Lindenberg, Andreas; Chang, Jay; Goldberg, Terry E.; Kleinman, Joel E.; Lu, Bai; Weinberger, Daniel R.] NIMH, Genes Cognit & Psychosis Program, Bethesda, MD 20892 USA; [Yang, Feng; Chang, Jay; Ji, Yuanyuan; Lu, Bai] NICHD, Sect Neural Dev & Plast, Bethesda, MD USA; [Rujescu, Dan; Giegling, Ina] Univ Munich, Dept Psychiat, D-8000 Munich, Germany; [Mayilyan, Karine; Soghoyan, Armen] Yerevan State Med Univ, Dept Psychiat & Med Psychol, Hlth Minist Armenian, Yerevan, Armenia; [Caforio, Grazia; Bertolino, Alessandro] Univ Bari, Dept Neurol & Psychiat Sci, Sect Mental Disorders, Psychiat Neurosci Grp, Bari, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Munich; Yerevan State Medical University; Universita degli Studi di Bari Aldo Moro	Weinberger, DR (corresponding author), NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA.	weinberd@mail.nih.gov	Lu, Bai/A-4018-2012; Sambataro, Fabio/E-3426-2010; Lipska, Barbara K/E-4569-2017; Yang, Feng/C-9530-2011; Callicott, Joseph H/AAE-7243-2022; Bertolino, Alessandro/O-6352-2016; Callicott, Joseph H/C-9102-2009; Giegling, Ina/ABA-3677-2021; Rujescu, Dan/GRS-3875-2022; Meyer-Lindenberg, Andreas/H-1076-2011	Sambataro, Fabio/0000-0003-2102-416X; Bertolino, Alessandro/0000-0002-1251-1380; Callicott, Joseph H/0000-0003-1298-3334; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Lu, Bai/0000-0001-5418-9759; Mayilyan, Karine R/0000-0001-9712-4939	US National Institutes of Health/Cambridge University Health Science; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002903, ZIAMH002399, ZIAMH002904, ZIAMH002716, ZIAMH002734, ZICMH002905] Funding Source: NIH RePORTER	US National Institutes of Health/Cambridge University Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Hardy, J. Duckworth and P. Momeni for technical assistance with high G-C content sequencing. We also thank J. Hardy, D. Goldman, A. Law and W. Chen for their very helpful review of the manuscript. We thank R. Straub and M. Mayhew for their input on statistical genetics analysis, M. Barenboim for help with bioinformatics and M. Herman and S. Mitkus for their help with postmortem tissue. We are extremely grateful for the assistance of G. Liu and S. Chen in the cloning and sequencing of KCNH2-3.1. We also would like to thank H.-J. Moller, P. Muglia and coworkers at the Department of Psychiatry, Ludwig Maximilians University for their help with subject recruitment and evaluation. S. J. Huffaker was partially supported by the US National Institutes of Health/Cambridge University Health Science Scholars and Medical Scientist Training Programs. Recruitment of the individuals with schizophrenia at Ludwig Maximilians University was supported by GlaxoSmithKline. Human fetal tissue was obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Bracci E, 1999, J NEUROSCI, V19, P8104; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Cannon TD, 2000, AM J HUM GENET, V67, P369, DOI 10.1086/303006; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Cloninger CR, 1998, AM J MED GENET, V81, P275, DOI 10.1002/(SICI)1096-8628(19980710)81:4<275::AID-AJMG1>3.3.CO;2-U; Davachi L, 2001, J NEUROPHYSIOL, V85, P2590, DOI 10.1152/jn.2001.85.6.2590; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Egan G, 2003, P NATL ACAD SCI USA, V100, P15241, DOI 10.1073/pnas.2136650100; Egan MF, 2001, BIOL PSYCHIAT, V50, P98, DOI 10.1016/S0006-3223(01)01133-7; Egan MF, 2000, AM J PSYCHIAT, V157, P1309, DOI 10.1176/appi.ajp.157.8.1309; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Genderson MR, 2007, SCHIZOPHR RES, V94, P231, DOI 10.1016/j.schres.2006.12.031; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Guasti L, 2005, J COMP NEUROL, V491, P157, DOI 10.1002/cne.20721; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hariri AR, 2003, BRIT MED BULL, V65, P259, DOI 10.1093/bmb/65.1.259; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Honea RA, 2008, BIOL PSYCHIAT, V63, P465, DOI 10.1016/j.biopsych.2007.05.027; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kongsamut S, 2002, EUR J PHARMACOL, V450, P37, DOI 10.1016/S0014-2999(02)02074-5; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Nicodemus KK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-130; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Peirce TR, 2006, ARCH GEN PSYCHIAT, V63, P18, DOI 10.1001/archpsyc.63.1.18; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Sacco T, 2003, J NEUROPHYSIOL, V90, P1817, DOI 10.1152/jn.00104.2003; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Straub RE, 2006, BIOL PSYCHIAT, V60, P81, DOI 10.1016/j.biopsych.2006.06.002; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Talkowski ME, 2006, SCHIZOPHRENIA BULL, V32, P203, DOI 10.1093/schbul/sbj058; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weinberger DR, 2001, BIOL PSYCHIAT, V50, P825, DOI 10.1016/S0006-3223(01)01252-5; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Wimmers S, 2002, PFLUG ARCH EUR J PHY, V445, P423, DOI 10.1007/s00424-002-0936-4; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490; Witchel HJ, 2003, BRIT J PSYCHIAT, V182, P171, DOI 10.1192/bjp.182.2.171-a	57	195	199	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2009	15	5					509	518		10.1038/nm.1962	http://dx.doi.org/10.1038/nm.1962			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19412172	Green Accepted			2022-12-25	WOS:000265889300029
J	Shoelson, SE; Goldfine, AB				Shoelson, Steven E.; Goldfine, Allison B.			Fanning the flames of obesity-induced inflammation	NATURE MEDICINE			English	Editorial Material							INDUCED INSULIN-RESISTANCE; DIABETES-MELLITUS; IKK-BETA; DISEASE; EXPRESSION		[Shoelson, Steven E.; Goldfine, Allison B.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Shoelson, Steven E.; Goldfine, Allison B.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Shoelson, SE (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA.	steven.shoelson@joslin.harvard.edu		Goldfine, Allison/0000-0002-0345-1048	NCRR NIH HHS [M01 RR001032, M01 RR002635] Funding Source: Medline; NHLBI NIH HHS [P50 HL083813] Funding Source: Medline; NIDDK NIH HHS [U01 DK074556, R37 DK051729, RC4 DK090792, R01 DK051729, R01 DK043123, R01 DK045943, P30 DK036836, R01 DK073547, R01 DK095327] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032, M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051729, P30DK036836, R01DK073547, R01DK095327, R01DK043123, R37DK051729, R01DK045943, U01DK074556, RC4DK090792] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	14	77	79	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2009	15	4					373	374		10.1038/nm0409-373	http://dx.doi.org/10.1038/nm0409-373			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19350009	Green Accepted			2022-12-25	WOS:000264937200019
J	da Costa, CA; Sunyach, C; Giaime, E; West, A; Corti, O; Brice, A; Safe, S; Abou-Sleiman, PM; Wood, NW; Takahashi, H; Goldberg, MS; Shen, J; Checler, F				da Costa, Cristine Alves; Sunyach, Claire; Giaime, Emilie; West, Andrew; Corti, Olga; Brice, Alexis; Safe, Stephen; Abou-Sleiman, Patrick M.; Wood, Nicholas W.; Takahashi, Hitoshi; Goldberg, Mathew S.; Shen, Jie; Checler, Frederic			Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-PROTEIN LIGASE; GENE-EXPRESSION; LOCALIZATION; CELLS; SOLUBILITY; ACTIVATION; PROMOTES; SURVIVAL; PRODUCT; NEURONS	Mutations of the ubiquitin ligase parkin account for most autosomal recessive forms of juvenile Parkinson's disease (AR-JP). Several studies have suggested that parkin possesses DNA-binding and transcriptional activity. We report here that parkin is a p53 transcriptional repressor. First, parkin prevented 6-hydroxydopamine-induced caspase-3 activation in a p53-dependent manner. Concomitantly, parkin reduced p53 expression and activity, an effect abrogated by familial parkin mutations known to either abolish or preserve its ligase activity. ChIP experiments indicate that overexpressed and endogenous parkin interact physically with the p53 promoter and that pathogenic mutations abolish DNA binding to and promoter transactivation of p53. Parkin lowered p53 mRNA levels and repressed p53 promoter transactivation through its Ring1 domain. Conversely, parkin depletion enhanced p53 expression and mRNA levels in fibroblasts and mouse brains, and increased cellular p53 activity and promoter transactivation in cells. Finally, familial parkin missense and deletion mutations enhanced p53 expression in human brains affected by AR-JP. This study reveals a ubiquitin ligase-independent function of parkin in the control of transcription and a functional link between parkin and p53 that is altered by AR-JP mutations.	[da Costa, Cristine Alves; Sunyach, Claire; Giaime, Emilie; Checler, Frederic] UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, Equipe Labellisee,Fdn Rech Med,UMR6097, F-06560 Valbonne, France; [da Costa, Cristine Alves; Sunyach, Claire; Giaime, Emilie; Checler, Frederic] UNSA, CNRS, Inst NeuroMed Mol, Equipe Labellisee,Fdn Rech Med,UMR6097, F-06560 Valbonne, France; [West, Andrew] Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21287 USA; [Corti, Olga; Brice, Alexis] Hop La Pitie Salpetriere, INSERM, U679, F-75013 Paris, France; [Safe, Stephen] Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX USA; [Abou-Sleiman, Patrick M.; Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Niigata 9518585, Japan; [Goldberg, Mathew S.; Shen, Jie] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Niigata University; Harvard University; Harvard Medical School	da Costa, CA (corresponding author), UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, Equipe Labellisee,Fdn Rech Med,UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	acosta@ipmc.cnrs.fr; checler@ipmc.cnrs.fr	Goldberg, Matthew/T-7827-2019; Wood, Nicholas W/C-2505-2009; Checler, Frederic/C-1241-2009; Shen, Jie/GXH-9449-2022; da Costa, Cristine Alves/G-8075-2011; Corti, Olga/I-4981-2016; Corti, Olga/AAC-3160-2019; Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	Wood, Nicholas W/0000-0002-9500-3348; Checler, Frederic/0000-0003-2098-1750; da Costa, Cristine Alves/0000-0002-7777-005X; Corti, Olga/0000-0003-2093-7389; brice, alexis/0000-0002-0941-3990; West, Andrew/0000-0002-3034-4061; Goldberg, Matthew/0000-0002-5172-9841	Fondation pour la Recherche Medicale; MRC [G0400000] Funding Source: UKRI; Medical Research Council [G0400000] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Amanda Patel for helpful discussion concerning gel shift analyses. We wish to thank M. Oren, B. Vogelstein and T. Dawson for providing us with the p53 promoter, PG13 and parkin-deleted constructs. M. Roussel and T. Dawson are thanked for providing the p19<SUP>Arf-1-/-</SUP> and p19<SUP>Arf-1-/-</SUP>p53<SUP>-/-</SUP> and parkin knockout cells, and parkin-deletion constructs, respectively. We thank J. C. Bourdon for providing polyclonal p53-directed antibodies. We wish to thank F. Brau for help in confocal analysis and F. Aguila for artwork. This work was supported by the Fondation pour la Recherche Medicale.	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; BERTOLIAVELLA AM, 2004, MOV DISORD; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Coleman JE, 2003, PHYSIOL GENOMICS, V12, P221, DOI 10.1152/physiolgenomics.00135.2002; Cookson MR, 2003, HUM MOL GENET, V12, P2957, DOI 10.1093/hmg/ddg328; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi S, 2000, MOVEMENT DISORD, V15, P884, DOI 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Horowitz JM, 2001, DEV BRAIN RES, V126, P31, DOI 10.1016/S0165-3806(00)00133-4; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Qin CH, 2002, MOL ENDOCRINOL, V16, P1793, DOI 10.1210/me.2002-0006; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Tatehata A, 1998, INORG CHEM COMMUN, V1, P392, DOI 10.1016/S1387-7003(98)00105-1; Unschuld PG, 2006, MOL BIOL REP, V33, P13, DOI 10.1007/s11033-005-3961-5; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; West A, 2002, AM J MED GENET, V114, P584, DOI 10.1002/ajmg.10525; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016	36	150	154	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1370	U255		10.1038/ncb1981	http://dx.doi.org/10.1038/ncb1981			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19801972	Green Accepted			2022-12-25	WOS:000271425800018
J	Mukundan, L; Odegaard, JI; Morel, CR; Heredia, JE; Mwangi, JW; Ricardo-Gonzalez, RR; Goh, YPS; Eagle, AR; Dunn, SE; Awakuni, JUH; Nguyen, KD; Steinman, L; Michie, SA; Chawla, A				Mukundan, Lata; Odegaard, Justin I.; Morel, Christine R.; Heredia, Jose E.; Mwangi, Julia W.; Ricardo-Gonzalez, Roberto R.; Goh, Y. P. Sharon; Eagle, Alex Red; Dunn, Shannon E.; Awakuni, Jennifer U. H.; Nguyen, Khoa D.; Steinman, Lawrence; Michie, Sara A.; Chawla, Ajay			PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance	NATURE MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACTIVATED RECEPTOR-DELTA; PHOSPHATIDYLSERINE RECEPTOR; INSULIN-RESISTANCE; NUCLEAR RECEPTORS; BALB/C MICE; GLOMERULONEPHRITIS; AUTOANTIBODIES; PHAGOCYTOSIS; DEFICIENCY	Macrophages rapidly engulf apoptotic cells to limit the release of noxious cellular contents and to restrict autoimmune responses against self antigens. Although factors participating in recognition and engulfment of apoptotic cells have been identified, the transcriptional basis for the sensing and the silent disposal of apoptotic cells is unknown. Here we show that peroxisome proliferator-activated receptor-delta (PPAR-delta) is induced when macrophages engulf apoptotic cells and functions as a transcriptional sensor of dying cells. Genetic deletion of PPAR-delta decreases expression of opsonins such as complement component-1qb (C1qb), resulting in impairment of apoptotic cell clearance and reduction in anti-inflammatory cytokine production. This increases autoantibody production and predisposes global and macrophage-specific Ppard(-/-) mice to autoimmune kidney disease, a phenotype resembling the human disease systemic lupus erythematosus. Thus, PPAR-delta has a pivotal role in orchestrating the timely disposal of apoptotic cells by macrophages, ensuring that tolerance to self is maintained.	[Mukundan, Lata; Odegaard, Justin I.; Morel, Christine R.; Heredia, Jose E.; Mwangi, Julia W.; Ricardo-Gonzalez, Roberto R.; Goh, Y. P. Sharon; Eagle, Alex Red; Awakuni, Jennifer U. H.; Nguyen, Khoa D.; Chawla, Ajay] Stanford Univ, Dept Med, Sch Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA; [Odegaard, Justin I.; Michie, Sara A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Morel, Christine R.] Baylor Univ, Baylor Inst Immunol Res, Grad Program Biomed Sci, Dallas, TX USA; [Ricardo-Gonzalez, Roberto R.; Goh, Y. P. Sharon; Nguyen, Khoa D.; Chawla, Ajay] Stanford Univ, Sch Med, Grad Program Immunol, Stanford, CA 94305 USA; [Eagle, Alex Red] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Dunn, Shannon E.; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Studies, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Baylor Scott & White Health; Baylor University; Stanford University; Stanford University; Stanford University	Chawla, A (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA.	achawla@stanford.edu		Ricardo-Gonzalez, Roberto/0000-0002-6135-4035; Nguyen, Khoa/0000-0002-6720-2470; Steinman, Lawrence/0000-0002-2437-2250	US National Institutes of Health [DK062386, HL076746, DK081405, DK67592, DE14385, AI066402]; Rita Allen Foundation; US National Multiple Sclerosis Society; Stanford Medical Scientist Training Program; American Heart Association; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI066402, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK062386, R01DK081405, R01DK076760, R01DK067592] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; US National Multiple Sclerosis Society(National Multiple Sclerosis Society); Stanford Medical Scientist Training Program; American Heart Association(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Chawla lab for valuable comment and C. H. Lee and A. Loh for critique on the manuscript. This work was supported by grants made available to A. C. (US National Institutes of Health (DK062386, HL076746 and DK081405) and Rita Allen Foundation), to L. S. (US National Multiple Sclerosis Society) and to S. A. M. (US National Institutes of Health (DK67592 and DE14385)). Support was provided by Stanford Medical Scientist Training Program (J.I.O. and A. R. E.), American Heart Association (J.I.O.), Dean's Fellowship (J.E.H.), Howard Hughes Medical Institute Gilliam fellowship (A. R. E.) and US National Institutes of Health AI066402 (R.R.R.-G.).	Armbrust T, 1997, HEPATOLOGY, V26, P98; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Breitkopf K, 2005, GUT, V54, P673, DOI 10.1136/gut.2004.042911; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fadok VA, 1999, J MAMMARY GLAND BIOL, V4, P203, DOI 10.1023/A:1011384009787; GONZALEZ N, 2009, IMMUNITY, V31, P245, DOI DOI 10.1016/J.IMMUNI.2009.06.018; Graham RR, 2009, J INTERN MED, V265, P680, DOI 10.1111/j.1365-2796.2009.02096.x; GUNNIA UB, 1991, KIDNEY INT, V39, P882, DOI 10.1038/ki.1991.111; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Harley JB, 2006, SPRINGER SEMIN IMMUN, V28, P119, DOI 10.1007/s00281-006-0040-5; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Hess KL, 1997, CYTOMETRY, V27, P145; Hicks J, 2006, ULTRASTRUCT PATHOL, V30, P345, DOI 10.1080/01913120600932677; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; KELLEY VE, 1985, CLIN IMMUNOL IMMUNOP, V37, P220, DOI 10.1016/0090-1229(85)90153-9; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morel L, 1996, MAMM GENOME, V7, P335, DOI 10.1007/s003359900098; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Petry F, 2001, J IMMUNOL, V167, P4033, DOI 10.4049/jimmunol.167.7.4033; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Slingsby JH, 1996, ARTHRITIS RHEUM, V39, P663, DOI 10.1002/art.1780390419; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600	45	267	273	4	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1266	U59		10.1038/nm.2048	http://dx.doi.org/10.1038/nm.2048			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19838202	Green Accepted			2022-12-25	WOS:000271543700014
J	Gudmundsson, J; Sulem, P; Gudbjartsson, DF; Blondal, T; Gylfason, A; Agnarsson, BA; Benediktsdottir, KR; Magnusdottir, DN; Orlygsdottir, G; Jakobsdottir, M; Stacey, SN; Sigurdsson, A; Wahlfors, T; Tammela, T; Breyer, JP; McReynolds, KM; Bradley, KM; Saez, B; Godino, J; Navarrete, S; Fuertes, F; Murillo, L; Polo, E; Aben, KK; van Oort, IM; Suarez, BK; Helfand, BT; Kan, DH; Zanon, C; Frigge, ML; Kristjansson, K; Gulcher, JR; Einarsson, GV; Jonsson, E; Catalona, WJ; Mayordomo, JI; Kiemeney, LA; Smith, JR; Schleutker, J; Barkardottir, RB; Kong, A; Thorsteinsdottir, U; Rafnar, T; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Blondal, Thorarinn; Gylfason, Arnaldur; Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Magnusdottir, Droplaug N.; Orlygsdottir, Gudbjorg; Jakobsdottir, Margret; Stacey, Simon N.; Sigurdsson, Asgeir; Wahlfors, Tiina; Tammela, Teuvo; Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Saez, Berta; Godino, Javier; Navarrete, Sebastian; Fuertes, Fernando; Murillo, Laura; Polo, Eduardo; Aben, Katja K.; van Oort, Inge M.; Suarez, Brian K.; Helfand, Brian T.; Kan, Donghui; Zanon, Carlo; Frigge, Michael L.; Kristjansson, Kristleifur; Gulcher, Jeffrey R.; Einarsson, Gudmundur V.; Jonsson, Eirikur; Catalona, William J.; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Smith, Jeffrey R.; Schleutker, Johanna; Barkardottir, Rosa B.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari			Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility	NATURE GENETICS			English	Article							SEQUENCE VARIANTS; COLORECTAL-CANCER; MULTIPLE LOCI; RISK; GENE; 8Q24; SCAN	We report a prostate cancer genome-wide association follow-on study. We discovered four variants associated with susceptibility to prostate cancer in several European populations: rs10934853[A] (OR = 1.12, P = 2.9 x 10(-10)) on 3q21.3; two moderately correlated (r(2) = 0.07) variants, rs16902094[G] (OR = 1.21, P = 6.2 x 10(-15)) and rs445114[T] (OR = 1.14, P = 4.7 x 10(-1)0), on 8q24.21; and rs8102476[C] (OR = 1.12, P = 1.6 x 10(-11)) on 19q13.2. We also refined a previous association signal on 11q13 with the SNP rs11228565[A] (OR = 1.23, P = 6.7 x 10(-12)). In a multivariate analysis using 22 prostate cancer risk variants typed in the Icelandic population, we estimated that carriers in the top 1.3% of the risk distribution are at a 2.5 times greater risk of developing the disease than members of the general population.	[Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Blondal, Thorarinn; Gylfason, Arnaldur; Magnusdottir, Droplaug N.; Orlygsdottir, Gudbjorg; Jakobsdottir, Margret; Stacey, Simon N.; Sigurdsson, Asgeir; Zanon, Carlo; Frigge, Michael L.; Kristjansson, Kristleifur; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Barkardottir, Rosa B.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Wahlfors, Tiina; Schleutker, Johanna] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Wahlfors, Tiina; Schleutker, Johanna] Tampere Univ Hosp, Tampere, Finland; [Tammela, Teuvo] Univ Tampere, Dept Urol, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Smith, Jeffrey R.] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Saez, Berta; Godino, Javier; Mayordomo, Jose I.] Hlth Sci Inst Aragon, Zaragoza, Spain; [Saez, Berta; Mayordomo, Jose I.] Nanotechnol Inst Aragon, Zaragoza, Spain; [Navarrete, Sebastian; Fuertes, Fernando] Univ Zaragoza, Div Radiat Oncol, Lozano Blesa Univ Hosp, Zaragoza, Spain; [Murillo, Laura] Reina Sofia Hosp, Div Med Oncol, Tudela, Spain; [Polo, Eduardo] Ernest Lluch Hosp, Div Med Oncol, Calatayud, Spain; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Aben, Katja K.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol Biostat & Hlth Technol Assessment, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Oort, Inge M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Suarez, Brian K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Helfand, Brian T.; Kan, Donghui; Catalona, William J.] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zanon, Carlo] Univ Turin, Mol Genet Lab, Inst Canc Res & Treatment, Sch Med, Candiolo, Italy; [Einarsson, Gudmundur V.; Jonsson, Eirikur] Landspitali Univ Hosp, Dept Urol, Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Zaragoza, Div Med Oncol, Univ Hosp, Zaragoza, Spain; [Smith, Jeffrey R.] Vet Affairs Tennessee Valley Healthcare Syst, Med Res Serv, Nashville, TN USA	Landspitali National University Hospital; University of Iceland; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Vanderbilt University; Lozano Blesa University Clinical Hospital; University of Zaragoza; Servicio Navarro de Salud - Osasunbidea; Radboud University Nijmegen; Radboud University Nijmegen; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Landspitali National University Hospital; Miguel Servet University Hospital; University of Zaragoza; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Stefansson, K (corresponding author), deCODE Genet, Reykjavik, Iceland.	julius@decode.is; kstefans@decode.is	Aben, Katja KH/G-9686-2016; Kiemeney, Lambertus A./D-3357-2009; van Oort, Inge/AAD-1197-2020; van Oort, Inge/L-4554-2015; Stefansson, Kari/AAE-7187-2019; Godino, Javier/M-3753-2018; Smith, Jeff/C-3484-2012; Mayordomo, Jose/K-3453-2013; Wahlfors, Tiina/U-7635-2018	Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; van Oort, Inge/0000-0002-8002-1869; van Oort, Inge/0000-0002-8002-1869; Godino, Javier/0000-0002-5653-2722; Gudbjartsson, Daniel/0000-0002-5222-9857; Smith, Jeffrey/0000-0001-8424-910X; Saez, Berta/0000-0003-0753-1165; Kong, Augustine/0000-0001-8193-5438; Wahlfors, Tiina/0000-0002-3910-796X; Schleutker, Johanna/0000-0002-1863-0305; Zanon, Carlo/0000-0003-2539-7238	European Union [202059, 218071]; V Foundation; US Department of Veterans Affairs; Academy of Finland; Sigrid Juselius Foundation; Pirkanmaa Hospital District, Tampere University Hospital; NATIONAL CANCER INSTITUTE [P50CA090386] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	European Union(European Commission); V Foundation; US Department of Veterans Affairs(US Department of Veterans Affairs); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Pirkanmaa Hospital District, Tampere University Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the individuals who participated in the study and whose contribution made this work possible. This project was funded in part by contract number 202059 PROMARK) from the Seventh Framework Program of the European Union to deCODE Genetics T. R. and L. A. K.), in part by FP7-MC-IAPP Grant agreement no. 218071 CancerGene) to deCODE Genetics, in part by a V Foundation award and US Department of Veterans Affairs grants to J. R. S., and in part by Academy of Finland, Sigrid Juselius Foundation, Finnish Cancer Organisations and the Competitive Research Funding of the Pirkanmaa Hospital District, Tampere University Hospital, to J. S.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; KOTEJARAI Z, 2008, CANCER EPIDEM BIOMAR, V17, P2901; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	31	264	284	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1122	U104		10.1038/ng.448	http://dx.doi.org/10.1038/ng.448			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19767754	Green Accepted			2022-12-25	WOS:000270330400017
J	Sankararaman, S; Obozinski, G; Jordan, MI; Halperin, E				Sankararaman, Sriram; Obozinski, Guillaume; Jordan, Michael I.; Halperin, Eran			Genomic privacy and limits of individual detection in a pool	NATURE GENETICS			English	Article							WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; METAANALYSIS	Recent studies have demonstrated that statistical methods can be used to detect the presence of a single individual within a study group based on summary data reported from genomewide association studies (GWAS). We present an analytical and empirical study of the statistical power of such methods. We thereby aim to provide quantitative guidelines for researchers wishing to make a limited number of SNPs available publicly without compromising subjects' privacy.	[Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA; [Sankararaman, Sriram; Jordan, Michael I.] Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; [Obozinski, Guillaume; Jordan, Michael I.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Halperin, Eran] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Halperin, Eran] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Tel Aviv University; Tel Aviv University	Halperin, E (corresponding author), Int Comp Sci Inst, Berkeley, CA 94704 USA.	heran@icsi.berkeley.edu	Jordan, Michael I/C-5253-2013	Jordan, Michael/0000-0001-8935-817X	US National Science Foundation [IIS- 0713254]; NIH/ NIGMS [GM071749]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071749] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); NIH/ NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H. was supported by US National Science Foundation grant IIS- 0713254. E. H. is a faculty fellow of the Edmond J. Safra Bioinformatics program at Tel- Aviv University. M. I. J., S. S. and G. O. were supported by NIH/ NIGMS R01 grant GM071749. This study makes use of data generated by the Wellcome Trust Case Control Consortium; a full list of the investigators who contributed to the generation of the data is available from http:// www. wtccc. org. uk. Funding for the project was provided by the Wellcome Trust under award 076113.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; GILBERT N, 2008, NATURE          0904, DOI DOI 10.1038/NEWS.2008.1083; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	7	98	107	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					965	967		10.1038/ng.436	http://dx.doi.org/10.1038/ng.436			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19701190				2022-12-25	WOS:000269382100006
J	Wong, SY; Seol, AD; So, PL; Ermilov, AN; Bichakjian, CK; Epstein, EH; Dlugosz, AA; Reiter, JF				Wong, Sunny Y.; Seol, Allen D.; So, Po-Lin; Ermilov, Alexandre N.; Bichakjian, Christopher K.; Epstein, Ervin H., Jr.; Dlugosz, Andrzej A.; Reiter, Jeremy F.			Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis	NATURE MEDICINE			English	Article							BASAL-CELL CARCINOMAS; PRIMITIVE NEUROECTODERMAL TUMORS; SONIC-HEDGEHOG; INTRAFLAGELLAR TRANSPORT; REPRESSOR FUNCTIONS; MOUSE MODEL; STEM-CELLS; SKIN; EXPRESSION; GLI2	Primary cilia are present on most mammalian cells and are implicated in transducing Hedgehog (Hh) signals during development; however, the prevalence of cilia on human tumors remains unclear, and the role of cilia in cancer has not been examined. Here we show that human basal cell carcinomas (BCCs) are frequently ciliated, and we test the role of cilia in BCC by conditionally deleting Kif3a (encoding kinesin family member 3A) or Ift88 (encoding intraflagellar transport protein 88), genes required for ciliogenesis, in two Hh pathway-dependent mouse tumor models. Ciliary ablation strongly inhibited BCC-like tumors induced by an activated form of Smoothened. In contrast, removal of cilia accelerated tumors induced by activated Gli2, a transcriptional effector of Hh signaling. These seemingly paradoxical effects are consistent with a dual role for cilia in mediating both the activation and the repression of the Hh signaling pathway. Our findings demonstrate that cilia function as unique signaling organelles that can either mediate or suppress tumorigenesis depending on the nature of the oncogenic initiating event.	[Wong, Sunny Y.; Seol, Allen D.; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [So, Po-Lin; Epstein, Ervin H., Jr.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Ermilov, Alexandre N.; Bichakjian, Christopher K.; Dlugosz, Andrzej A.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of Michigan System; University of Michigan	Reiter, JF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	jeremy.reiter@ucsf.edu			US National Institutes of Health [RO1AR054396, RO1CA087837]; Burroughs Wellcome Fund; Packard Foundation; Sandler Family Supporting Foundation; A.P. Giannini Foundation; Herbert W. Boyer Fund; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA087837, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396, R01AR045973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); Sandler Family Supporting Foundation; A.P. Giannini Foundation; Herbert W. Boyer Fund; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Hanahan, O. Nolan-Stevaux, G. Evan and the members of the Reiter lab for critical reading of this manuscript; K. Thorn and the UCSF Nikon Imaging Center for assistance with confocal microscopy; C. Miller and J. D. Fish for assistance with histology; and R. T. Bronson for help with pathology. We thank T. Li, Harvard Medical School, for rabbit antibody to rootletin; K. V. Anderson, Sloan-Kettering Institute, for Ift172<SUP>-/-</SUP> MEFs; S. Scales, Genentech, for mouse antibody to Gli3; J. T. Eggenschwiler, Princeton University, for guinea pig antibody to Gli2; B. Yoder, University of Alabama at Birmingham, for Ift88<SUP>flox</SUP> mice; L. Goldstein, University of California, San Diego, for Kif3a<SUP>flox</SUP>-knockout mice; and L. V. Goodrich, Harvard Medical School, for Ptch1 riboprobe plasmid. This work was funded by grants from the US National Institutes of Health (RO1AR054396), the Burroughs Wellcome Fund, the Packard Foundation and the Sandler Family Supporting Foundation to J. F. R. A. A. D. acknowledges the support of the US National Institutes of Health ( RO1CA087837). S. Y. W. acknowledges the support of the A.P. Giannini Foundation, the Herbert W. Boyer Fund and the American Cancer Society.	Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Lehman JM, 2009, J INVEST DERMATOL, V129, P438, DOI 10.1038/jid.2008.279; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Reifenberger J, 1998, CANCER RES, V58, P1798; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Tojo M, 2003, BRIT J DERMATOL, V148, P892, DOI 10.1046/j.1365-2133.2003.05284.x; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; WILSON RB, 1963, LAB INVEST, V12, P242; Wolter M, 1997, CANCER RES, V57, P2581; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	40	323	342	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1055	U109		10.1038/nm.2011	http://dx.doi.org/10.1038/nm.2011			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19701205	Green Accepted			2022-12-25	WOS:000269979200026
J	Miura, K; Okada, Y; Aoi, T; Okada, A; Takahashi, K; Okita, K; Nakagawa, M; Koyanagi, M; Tanabe, K; Ohnuki, M; Ogawa, D; Ikeda, E; Okano, H; Yamanaka, S				Miura, Kyoko; Okada, Yohei; Aoi, Takashi; Okada, Aki; Takahashi, Kazutoshi; Okita, Keisuke; Nakagawa, Masato; Koyanagi, Michiyo; Tanabe, Koji; Ohnuki, Mari; Ogawa, Daisuke; Ikeda, Eiji; Okano, Hideyuki; Yamanaka, Shinya			Variation in the safety of induced pluripotent stem cell lines	NATURE BIOTECHNOLOGY			English	Article							GENERATION; FIBROBLASTS; MOUSE; MYC	We evaluated the teratoma-forming propensity of secondary neurospheres (SNS) generated from 36 mouse induced pluripotent stem (iPS) cell lines derived in 11 different ways. Teratoma-formation of SNS from embryonic fibroblast-derived iPS cells was similar to that of SNS from embryonic stem (ES) cells. In contrast, SNS from iPS cells derived from different adult tissues varied substantially in their teratoma-forming propensity, which correlated with the persistence of undifferentiated cells.	[Miura, Kyoko; Okada, Yohei; Ogawa, Daisuke; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Miura, Kyoko; Aoi, Takashi; Okada, Aki; Takahashi, Kazutoshi; Okita, Keisuke; Nakagawa, Masato; Koyanagi, Michiyo; Tanabe, Koji; Ohnuki, Mari; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Miura, Kyoko; Nakagawa, Masato; Tanabe, Koji; Ohnuki, Mari; Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto, Japan; [Miura, Kyoko; Aoi, Takashi; Takahashi, Kazutoshi; Okita, Keisuke; Nakagawa, Masato; Koyanagi, Michiyo; Tanabe, Koji; Ohnuki, Mari; Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama, Japan; [Okada, Yohei] Keio Univ, Sch Med, Kanrinmaru Project, Tokyo 160, Japan; [Ikeda, Eiji] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Keio University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Keio University; Keio University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan.	hidokano@sc.itc.keio.ac.jp; yamanaka@frontier.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020; Okada, Yohei/L-1662-2013; Okano, Hideyuki/I-7584-2019; Miura, Kyoko/L-1750-2013	Takahashi, Kazutoshi/0000-0002-5329-8395; Miura, Kyoko/0000-0003-2208-149X; Okita, Keisuke/0000-0001-5806-1090				Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	23	650	725	2	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2009	27	8					743	745		10.1038/nbt.1554	http://dx.doi.org/10.1038/nbt.1554			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	480YY	19590502	Green Submitted			2022-12-25	WOS:000268774500024
J	Zhou, YG; Schmitz, KM; Mayer, C; Yuan, XJ; Akhtar, A; Grummt, I				Zhou, Yonggang; Schmitz, Kerstin-Maike; Mayer, Christine; Yuan, Xuejun; Akhtar, Asifa; Grummt, Ingrid			Reversible acetylation of the chromatin remodelling complex NoRC is required for non-coding RNA-dependent silencing	NATURE CELL BIOLOGY			English	Article							RIBOSOMAL GENE-TRANSCRIPTION; DROSOPHILA MSL COMPLEX; DOSAGE COMPENSATION; HISTONE H4; EPIGENETIC STATE; MOF; ACETYLTRANSFERASE; RDNA; LYSINE-16; PROMOTER	The SNF2h (sucrose non-fermenting protein 2 homologue)-containing chromatin-remodelling complex NoRC silences a fraction of ribosomal RNA genes (rDNA) by establishing a heterochromatic structure at the rDNA promoter(1-3). Here we show that the acetyltransferase MOF (males absent on the first) acetylates TIP5, the largest subunit of NoRC, at a single lysine residue, K633, adjacent to the TIP5 RNA-binding domain, and that the NAD(+)-dependent deacetylase SIRT1 (sirtuin-1) removes the acetyl group from K633. Acetylation regulates the interaction of NoRC with promoter-associated RNA (pRNA), which in turn affects heterochromatin formation, nucleosome positioning and rDNA silencing. Significantly, NoRC acetylation is responsive to the intracellular energy status and fluctuates during S phase. Activation of SIRT1 on glucose deprivation leads to deacetylation of K633, enhanced pRNA binding and an increase in heterochromatic histone marks. These results suggest a mechanism that links the epigenetic state of rDNA to cell metabolism and reveal another layer of epigenetic control that involves post-translational modification of a chromatin remodelling complex.	[Zhou, Yonggang; Schmitz, Kerstin-Maike; Mayer, Christine; Yuan, Xuejun; Grummt, Ingrid] DKFZ ZMBH Alliance, Div Mol Biol Cell 2, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Akhtar, Asifa] European Mol Biol Lab, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)	Grummt, I (corresponding author), DKFZ ZMBH Alliance, Div Mol Biol Cell 2, German Canc Res Ctr, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	i.grummt@dkfz.de		Mayer, Christine/0000-0003-3936-7670				Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Buscaino A, 2003, MOL CELL, V11, P1265, DOI 10.1016/S1097-2765(03)00140-0; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Grummt I, 2008, CELL, V133, P577, DOI 10.1016/j.cell.2008.04.026; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li JW, 2006, EMBO J, V25, P5735, DOI 10.1038/sj.emboj.7601454; Li JW, 2005, EMBO J, V24, P120, DOI 10.1038/sj.emboj.7600492; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	28	85	90	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1010	U229		10.1038/ncb1914	http://dx.doi.org/10.1038/ncb1914			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19578370				2022-12-25	WOS:000268593200016
J	Chen, YY; Hu, YG; Zhang, HJ; Peng, C; Li, SG				Chen, Yaoyu; Hu, Yiguo; Zhang, Haojian; Peng, Cong; Li, Shaoguang			Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia	NATURE GENETICS			English	Article							SELF-RENEWAL; BCR-ABL; CANCER; 5-LIPOXYGENASE; PATHWAYS; MICE; IDENTIFICATION; PROGENITORS; EXPRESSION; GROWTH	Targeting of cancer stem cells is believed to be essential for curative therapy of cancers, but supporting evidence is limited. Few selective target genes in cancer stem cells have been identified. Here we identify the arachidonate 5-lipoxygenase (5-LO) gene (Alox5) as a critical regulator for leukemia stem cells (LSCs) in BCR-ABL-induced chronic myeloid leukemia (CML). In the absence of Alox5, BCR-ABL failed to induce CML in mice. This Alox5 deficiency caused impairment of the function of LSCs but not normal hematopoietic stem cells (HSCs) through affecting differentiation, cell division and survival of long-term LSCs (LT-LSCs), consequently causing a depletion of LSCs and a failure of CML development. Treatment of CML mice with a 5-LO inhibitor also impaired the function of LSCs similarly by affecting LT-LSCs, and prolonged survival. These results demonstrate that a specific target gene can be found in cancer stem cells and its inhibition can completely inhibit the function of these stem cells.	[Chen, Yaoyu; Zhang, Haojian; Peng, Cong; Li, Shaoguang] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Li, SG (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01605 USA.	Shaoguang.Li@umassmed.edu	chen, yaoyu/A-4236-2011; Zhang, Haojian/H-7897-2013; zhang, haojian/D-5370-2012; Peng, Cong/H-2286-2011; Peng, Cong/D-6302-2011	Hu, Yiguo/0000-0002-3973-2140	Leukemia & Lymphoma Society; National Institutes of Health [R01-CA122142, R01-CA114199]; NATIONAL CANCER INSTITUTE [R01CA114199, R01CA122142] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants from the Leukemia & Lymphoma Society and the National Institutes of Health (R01-CA122142, R01-CA114199) to S. L. S. L. is a Scholar of the Leukemia & Lymphoma Society.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson KM, 1995, LEUKEMIA RES, V19, P789, DOI 10.1016/0145-2126(95)00043-7; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Catalano A, 2005, EMBO J, V24, P170, DOI 10.1038/sj.emboj.7600502; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; KNAPP HR, 1990, NEW ENGL J MED, V323, P1745, DOI 10.1056/NEJM199012203232506; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Marley SB, 2000, EXP HEMATOL, V28, P551, DOI 10.1016/S0301-472X(00)00142-9; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Singh SK, 2003, CANCER RES, V63, P5821; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; STENKE L, 1987, EXP HEMATOL, V15, P203; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Taylor PM, 2002, ONCOGENE, V21, P5765, DOI 10.1038/sj.onc.1205702; Tornhamre S, 2003, EXP HEMATOL, V31, P122, DOI 10.1016/S0301-472X(02)01026-3; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	45	238	245	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					783	U37		10.1038/ng.389	http://dx.doi.org/10.1038/ng.389			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19503090	Green Submitted, Green Accepted			2022-12-25	WOS:000267786200007
J	De Jager, PL; Jia, XM; Wang, J; de Bakker, PIW; Ottoboni, L; Aggarwal, NT; Piccio, L; Raychaudhuri, S; Tran, D; Aubin, C; Briskin, R; Romano, S; Baranzini, SE; McCauley, JL; Pericak-Vance, MA; Haines, JL; Gibson, RA; Naeglin, Y; Uitdehaag, B; Matthews, PM; Kappos, L; Polman, C; McArdle, WL; Strachan, DP; Evans, D; Cross, AH; Daly, MJ; Compston, A; Sawcer, SJ; Weiner, HL; Hauser, SL; Hafler, DA; Oksenberg, JR				De Jager, Philip L.; Jia, Xiaoming; Wang, Joanne; de Bakker, Paul I. W.; Ottoboni, Linda; Aggarwal, Neelum T.; Piccio, Laura; Raychaudhuri, Soumya; Tran, Dong; Aubin, Cristin; Briskin, Rebeccah; Romano, Susan; Baranzini, Sergio E.; McCauley, Jacob L.; Pericak-Vance, Margaret A.; Haines, Jonathan L.; Gibson, Rachel A.; Naeglin, Yvonne; Uitdehaag, Bernard; Matthews, Paul M.; Kappos, Ludwig; Polman, Chris; McArdle, Wendy L.; Strachan, David P.; Evans, Denis; Cross, Anne H.; Daly, Mark J.; Compston, Alastair; Sawcer, Stephen J.; Weiner, Howard L.; Hauser, Stephen L.; Hafler, David A.; Oksenberg, Jorge R.		Int MS Genetics Consortium	Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERIPHERAL-BLOOD CELLS; WIDE ASSOCIATION; PERIODIC-SYNDROME; R92Q MUTATION; RHEUMATOID-ARTHRITIS; HAPLOTYPE MAP; INTERFERON; DISEASE; RISK	We report the results of a meta-analysis of genome-wide association scans for multiple sclerosis (MS) susceptibility that includes 2,624 subjects with MS and 7,220 control subjects. Replication in an independent set of 2,215 subjects with MS and 2,116 control subjects validates new MS susceptibility loci at TNFRSF1A (combined P = 1.59 x 10(-11)), IRF8 (P = 3.73 x 10(-9)) and CD6 (P = 3.79 x 10(-9)). TNFRSF1A harbors two independent susceptibility alleles: rs1800693 is a common variant with modest effect (odds ratio 1.2), whereas rs4149584 is a nonsynonymous coding polymorphism of low frequency but with stronger effect (allele frequency 0.02; odds ratio 1.6). We also report that the susceptibility allele near IRF8, which encodes a transcription factor known to function in type I interferon signaling, is associated with higher mRNA expression of interferon-response pathway genes in subjects with MS.	[De Jager, Philip L.; Ottoboni, Linda; Romano, Susan; Weiner, Howard L.; Hafler, David A.] Brigham & Womens Hosp, Div Mol Immunol, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA; [De Jager, Philip L.; Ottoboni, Linda; Briskin, Rebeccah] Partners Ctr Personalized Genet Med, Boston, MA USA; [De Jager, Philip L.; de Bakker, Paul I. W.; Ottoboni, Linda; Raychaudhuri, Soumya; Tran, Dong; Aubin, Cristin; Daly, Mark J.; Hafler, David A.] Harvard Univ, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02138 USA; [De Jager, Philip L.; de Bakker, Paul I. W.; Ottoboni, Linda; Raychaudhuri, Soumya; Tran, Dong; Aubin, Cristin; Daly, Mark J.; Hafler, David A.] MIT, Cambridge, MA 02139 USA; [Jia, Xiaoming; de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Wang, Joanne; Baranzini, Sergio E.; Hauser, Stephen L.; Oksenberg, Jorge R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Wang, Joanne; Hauser, Stephen L.; Oksenberg, Jorge R.] Univ Calif San Francisco, Inst Human Genet, Sch Med, San Francisco, CA 94143 USA; [Aggarwal, Neelum T.; Evans, Denis] Rush Univ, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Aggarwal, Neelum T.; Evans, Denis] Rush Univ, Dept Neurol Sci, Chicago, IL 60612 USA; [Piccio, Laura; Cross, Anne H.] Washington Univ, Dept Neurol, St Louis, MO USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Immunol Allergy & Rheumatol, Boston, MA 02115 USA; [McCauley, Jacob L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33136 USA; [Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Gibson, Rachel A.; Matthews, Paul M.] Univ London Imperial Coll Sci Technol & Med, Dept Clin Neurosci, London SW7 2AZ, England; [Gibson, Rachel A.; Matthews, Paul M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, GlaxoSmithKline Clin Imaging Ctr, London SW7 2AZ, England; [Naeglin, Yvonne; Kappos, Ludwig] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Uitdehaag, Bernard; Polman, Chris] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Compston, Alastair; Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rush University; Rush University; Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; University of Miami; Vanderbilt University; Imperial College London; GlaxoSmithKline; Imperial College London; University of Basel; Vrije Universiteit Amsterdam; University of Bristol; University of London; Harvard University; Massachusetts General Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	De Jager, PL (corresponding author), Brigham & Womens Hosp, Div Mol Immunol, Ctr Neurol Dis, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	pdejager@rics.bwh.harvard.edu	Piccio, Laura/AAE-1706-2020; de Bakker, Paul IW/B-8730-2009; Baranzini, Sergio/A-9422-2013; Hauser, Stephen L/J-2978-2016; Ottoboni, Linda/AAC-4508-2022; Haines, Jonathan/C-3374-2012; Daly, Mark J/B-2453-2017	Piccio, Laura/0000-0002-8760-109X; de Bakker, Paul IW/0000-0001-7735-7858; Baranzini, Sergio/0000-0003-0067-194X; Ottoboni, Linda/0000-0001-5412-7785; Haines, Jonathan/0000-0002-4351-4728; Daly, Mark J/0000-0002-0949-8752; Matthews, Paul M/0000-0002-1619-8328; Raychaudhuri, Soumya/0000-0002-1901-8265; Cross, Anne/0000-0003-0829-7569; Gibson, Rachel/0000-0002-1338-1290; Jia, Xiaoming/0000-0002-5104-5431; Uitdehaag, Bernard/0000-0002-9226-7364	Medical Research Council [MC_qA137934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish; MRC [MC_qA137934, G0000934] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477, K08NS046341, R01NS046630] Funding Source: NIH RePORTER; Medical Research Council [MC_QA137934, G0000934] Funding Source: Medline; NIAID NIH HHS [P01 AI039671] Funding Source: Medline; NIAMS NIH HHS [K08 AR055688, K08 AR055688-01A1] Funding Source: Medline; NINDS NIH HHS [K08 NS046341, K08 NS46341, R01 NS046630, R01 NS049477] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust)		Aksentijevich I, 2001, AM J HUM GENET, V69, P301, DOI 10.1086/321976; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bienias JL, 2003, J ALZHEIMERS DIS, V5, P349, DOI 10.3233/JAD-2003-5501; Castro MAA, 2007, J IMMUNOL, V178, P4351, DOI 10.4049/jimmunol.178.7.4351; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; De Jager PL, 2008, NEUROLOGY, V70, P1113, DOI 10.1212/01.wnl.0000294325.63006.f8; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; DEGRE M, 1976, ACTA NEUROL SCAND, V53, P152, DOI 10.1111/j.1600-0404.1976.tb04333.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauthier SA, 2006, AUTOIMMUN REV, V5, P532, DOI 10.1016/j.autrev.2006.02.012; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; HAFLER DA, 1986, NEUROLOGY, V36, P777, DOI 10.1212/WNL.36.6.777; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hoffmann LA, 2008, NEUROLOGY, V70, P1155, DOI 10.1212/01.wnl.0000296279.98236.8a; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jenne DE, 2007, ANN RHEUM DIS, V66, P1266, DOI 10.1136/ard.2006.065987; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kumpfel T, 2007, ARTHRITIS RHEUM, V56, P2774, DOI 10.1002/art.22795; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Miller D, 2005, LANCET NEUROL, V4, P341, DOI 10.1016/S1474-4422(05)70095-8; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pedchenko TV, 2005, AM J PHYSIOL-LUNG C, V289, pL429, DOI 10.1152/ajplung.00046.2005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Siddigui MAA, 2006, BIODRUGS, V20, P67, DOI 10.2165/00063030-200620010-00008; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Wildemann B, 2007, NEUROLOGY, V68, P1742, DOI 10.1212/01.wnl.0000260226.21010.2b; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063	48	610	619	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2009	41	7					776	U26		10.1038/ng.401	http://dx.doi.org/10.1038/ng.401			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19525953	Green Accepted			2022-12-25	WOS:000267786200006
J	Gregersen, PK; Amos, CI; Lee, AT; Lu, Y; Remmers, EF; Kastner, DL; Seldin, MF; Criswell, LA; Plenge, RM; Holers, VM; Mikuls, TR; Sokka, T; Moreland, LW; Bridges, SL; Xie, G; Begovich, AB; Siminovitch, KA				Gregersen, Peter K.; Amos, Chistopher I.; Lee, Annette T.; Lu, Yue; Remmers, Elaine F.; Kastner, Daniel L.; Seldin, Michael F.; Criswell, Lindsey A.; Plenge, Robert M.; Holers, V. Michael; Mikuls, Ted R.; Sokka, Tuulikki; Moreland, Larry W.; Bridges, S. Louis, Jr.; Xie, Gang; Begovich, Ann B.; Siminovitch, Katherine A.			REL, encoding a member of the NF-kappa B family of transcription factors, is a newly defined risk locus for rheumatoid arthritis	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-REL; INCEPTION COHORT; CELLS; ASSOCIATION; EXPRESSION; VARIANTS; ITGAM	We conducted a genome-wide association study of rheumatoid arthritis in 2,418 cases and 4,504 controls from North America and identified an association at the REL locus, encoding c-Rel, on chromosome 2p13 (rs13031237, P = 6.01 x 10(-10)). Replication in independent case-control datasets comprising 2,604 cases and 2,882 controls confirmed this association, yielding an allelic OR 1.25 (P = 3.08 x 10(-14)) for marker rs13031237 and an allelic OR 1.21 (P = 2.60 x 10(-11)) for marker rs13017599 in the combined dataset. The combined dataset also provides definitive support for associations at both CTLA4 (rs231735; OR = 0.85; P = 6.25 x 10(-9)) and BLK (rs2736340; OR = 1.19; P = 5.69 x 10(-9)). c-Rel is an NF-kappa B family member with distinct functional properties in hematopoietic cells, and its association with rheumatoid arthritis suggests disease pathways that involve other recently identified rheumatoid arthritis susceptibility genes including CD40, TRAF1, TNFAIP3 and PRKCQ(1,2).	[Gregersen, Peter K.; Lee, Annette T.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Amos, Chistopher I.; Lu, Yue] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Remmers, Elaine F.; Kastner, Daniel L.] NIAMSD, Genet & Genom Branch, NIH, Bethesda, MD 20892 USA; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Holers, V. Michael] Univ Colorado, Denver Sch Med, Denver, CO 80202 USA; [Sokka, Tuulikki] Univ Nebraska, Med Ctr, Omaha, NE USA; [Sokka, Tuulikki] Jyvaskyla Cent Hosp, Jyvaskyla, Finland; [Moreland, Larry W.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Bridges, S. Louis, Jr.] Univ Alabama Birmingham, Birmingham, AL USA; [Xie, Gang; Siminovitch, Katherine A.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Xie, Gang; Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON M5G 1X5, Canada; [Begovich, Ann B.] Celera, Alameda, CA USA	Northwell Health; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of California System; University of California Davis; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Nebraska System; University of Nebraska Medical Center; Central Finland Central Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gregersen, PK (corresponding author), N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA.	peterg@nshs.edu; ksimin@mshri.on.ca	Siminovitch, Katherine/K-1475-2013	Remmers, Elaine F/0000-0002-9522-1249; Moreland, Larry/0000-0003-4483-0359	US National Institutes of Health [NO1-AR-2-2263, RO1 AR44422]; Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the Muriel Fusfeld Foundation; Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes for Health Research [MOP79321]; Ontario Research Fund [RE01061]; Canada Research Chair; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041139, N01AR022263, R01AR044422] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the Muriel Fusfeld Foundation; Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the US National Institutes of Health NO1-AR-2-2263 (P. K. G.), RO1 AR44422 (P. K. G.) and by the Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the Muriel Fusfeld Foundation. The work was also supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and by grants from the Canadian Institutes for Health Research (MOP79321) and Ontario Research Fund (RE01061) and a Canada Research Chair to K. A. S.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Coenen MJH, 2009, GENES IMMUN, V10, P101, DOI 10.1038/gene.2008.77; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Fries JF, 2002, ARTHRITIS RHEUM, V46, P2320, DOI 10.1002/art.10485; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Lu KT, 2006, BLOOD, V108, P3769, DOI 10.1182/blood-2006-03-008839; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Pennisi E, 2008, SCIENCE, V322, P842, DOI 10.1126/science.322.5903.842; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Sokka T, 2005, CLIN EXP RHEUMATOL, V23, pS178; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; TRYNKA G, 2009, GUT             0224, DOI DOI 10.1136/GUT.2008.169052; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Weisman MH, 2003, ARTHRITIS RHEUM, V48, pS119; Wolfe F, 2003, ARTHRITIS RHEUM, V48, P1530, DOI 10.1002/art.11024; Zhou HJ, 2007, BLOOD, V110, P2121, DOI 10.1182/blood-2007-02-073080	30	270	277	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					820	U77		10.1038/ng.395	http://dx.doi.org/10.1038/ng.395			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19503088	Green Accepted			2022-12-25	WOS:000267786200013
J	Hancock, SM; Rich, JR; Caines, MEC; Strynadka, NCJ; Withers, SG				Hancock, Susan M.; Rich, Jamie R.; Caines, Matthew E. C.; Strynadka, Natalie C. J.; Withers, Stephen G.			Designer enzymes for glycosphingolipid synthesis by directed evolution	NATURE CHEMICAL BIOLOGY			English	Article							OLIGOSACCHARIDE SYNTHESIS; UTERINE ENDOMETRIUM; ESCHERICHIA-COLI; MENSTRUAL-CYCLE; GLYCOSYNTHASES; BINDING; GLYCOSYLTRANSFERASES; LACTOSYLCERAMIDE; TESTOSTERONE; GLYCOSIDASES	Though glycosphingolipids have great potential as therapeutics for cancer, HIV, neurodegenerative diseases and auto-immune diseases, both extensive study of their biological roles and development as pharmaceuticals are limited by difficulties in their synthesis, especially on large scales. Here we addressed this restriction by expanding the synthetic scope of a glycosphingolipid-synthesizing enzyme through a combination of rational mutagenesis and directed evolution with an ELISA-based screening strategy. We targeted both a low-level promiscuous substrate activity and the overall catalytic efficiency of the catalyst, and we identified several mutants with enhanced activities. These new catalysts, which are capable of producing a broad range of homogeneous samples, represent a significant advance toward the facile, large-scale synthesis of glycosphingolipids and demonstrate the general utility of this approach toward the creation of designer glycosphingolipid-synthesizing enzymes.	[Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	withers@chem.ubc.ca			Royal Society (UK); Government of Canada; Natural Sciences and Engineering Research Council of Canada; Neose Technologies Ltd	Royal Society (UK)(Royal Society of London); Government of Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Neose Technologies Ltd	The authors thank the Royal Society (UK) and the Government of Canada for postdoctoral fellowships (S. M. H.), the Natural Sciences and Engineering Research Council of Canada and Neose Technologies Ltd. for funding, and W. Hol (University of Washington) for providing the recombinant gene for cholera toxin B subunit.	Aharoni A, 2006, NAT METHODS, V3, P609, DOI 10.1038/NMETH899; Angstrom J, 1998, GLYCOBIOLOGY, V8, P297, DOI 10.1093/glycob/8.4.297; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Backhed F, 2002, J BIOL CHEM, V277, P18198, DOI 10.1074/jbc.M111640200; Ben-David A, 2008, CHEM BIOL, V15, P546, DOI 10.1016/j.chembiol.2008.05.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caines MEC, 2007, J BIOL CHEM, V282, P14300, DOI 10.1074/jbc.M611455200; DAHIYA R, 1989, BIOCHEM CELL BIOL, V67, P42, DOI 10.1139/o89-006; DAHIYA R, 1990, BIOMED BIOCHIM ACTA, V49, P1195; De Rosa M, 2008, BBA-GEN SUBJECTS, V1780, P347, DOI 10.1016/j.bbagen.2007.10.016; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; GROSS SK, 1994, MOL CELL BIOCHEM, V137, P25, DOI 10.1007/BF00926036; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Hancock SM, 2008, ANAL BIOCHEM, V382, P48, DOI 10.1016/j.ab.2008.07.023; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; ITO M, 1986, J BIOL CHEM, V261, P14278; Jansson L, 2006, INFECT IMMUN, V74, P3488, DOI 10.1128/IAI.02006-05; Kim YW, 2004, J BIOL CHEM, V279, P42787, DOI 10.1074/jbc.M406890200; Lin HN, 2004, J AM CHEM SOC, V126, P15051, DOI 10.1021/ja046238v; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; Mayer C, 2001, CHEM BIOL, V8, P437, DOI 10.1016/S1074-5521(01)00022-9; MIKAMI M, 1992, BIOCHIM BIOPHYS ACTA, V1125, P104, DOI 10.1016/0005-2760(92)90162-O; Morales-Serna JA, 2007, CARBOHYD RES, V342, P1595, DOI 10.1016/j.carres.2007.03.028; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; SHUKLA GS, 1991, J NEUROCHEM, V56, P2125, DOI 10.1111/j.1471-4159.1991.tb03475.x; STROMBERG N, 1988, FEBS LETT, V232, P193, DOI 10.1016/0014-5793(88)80415-0; TAKAMATSU K, 1992, BIOCHIM BIOPHYS ACTA, V1165, P177; Vankar YD, 2000, CHEM SOC REV, V29, P201, DOI 10.1039/a900943d; Vaughan MD, 2006, J AM CHEM SOC, V128, P6300, DOI 10.1021/ja058469n; Williams GJ, 2007, NAT CHEM BIOL, V3, P657, DOI 10.1038/nchembio.2007.28; Wu D, 2008, BIOORGAN MED CHEM, V16, P1073, DOI 10.1016/j.bmc.2007.10.026	32	60	62	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					508	514		10.1038/nchembio.191	http://dx.doi.org/10.1038/nchembio.191			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19525967				2022-12-25	WOS:000267266100017
J	Hert, J; Irwin, JJ; Laggner, C; Keiser, MJ; Shoichet, BK				Hert, Jerome; Irwin, John J.; Laggner, Christian; Keiser, Michael J.; Shoichet, Brian K.			Quantifying biogenic bias in screening libraries	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-PRODUCTS; CHEMICAL SPACE; MOLECULAR DESCRIPTORS; VIRTUAL EXPLORATION; GUIDING PRINCIPLES; DRUGS; UNIVERSE; CLASSIFICATION; COLLECTIONS; CHEMISTRY	In lead discovery, libraries of 106 molecules are screened for biological activity. Given the over 1060 drug-like molecules thought possible, such screens might never succeed. The fact that they do, even occasionally, implies a biased selection of library molecules. We have developed a method to quantify the bias in screening libraries toward biogenic molecules. With this approach, we consider what is missing from screening libraries and how they can be optimized.	[Hert, Jerome; Irwin, John J.; Laggner, Christian; Keiser, Michael J.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	shoichet@cgl.ucsf.edu	Hert, Jerome/A-8158-2008; Keiser, Michael J./F-2825-2016	Keiser, Michael J./0000-0002-1240-2192; Irwin, John/0000-0002-1195-6417; Hert/0000-0003-3062-8029	Max Kade Foundation; US National Institutes of Health [GM59957]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059957] Funding Source: NIH RePORTER	Max Kade Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grant GM59957 to B. K. S. J.H. was supported by a Marie Curie fellowship from the 6th Framework Program of the European Commission; M. J. K. was supported by a US National Science Foundation graduate fellowship; C. L. was supported by a fellowship from the Max Kade Foundation.	Arve L, 2006, QSAR COMB SCI, V25, P449, DOI 10.1002/qsar.200540213; Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.3.CO;2-D; Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879; Buckingham J., 2008, DICT NATURAL PRODUCT; Ertl P, 2008, J CHEM INF MODEL, V48, P68, DOI 10.1021/ci700286x; Ertl P, 2006, J MED CHEM, V49, P4568, DOI 10.1021/jm060217p; Fink T, 2005, ANGEW CHEM INT EDIT, V44, P1504, DOI 10.1002/anie.200462457; Fink T, 2007, J CHEM INF MODEL, V47, P342, DOI 10.1021/ci600423u; Fox S, 2004, J BIOMOL SCREEN, V9, P354, DOI 10.1177/1087057104265290; Glen RC, 2006, IDRUGS, V9, P199; Good AC, 2007, J CHEM INF MODEL, V47, P110, DOI 10.1021/ci6003493; Gregori-Puigjane E, 2008, CURR OPIN CHEM BIOL, V12, P359, DOI 10.1016/j.cbpa.2008.03.015; Gupta S, 2007, MOL DIVERS, V11, P23, DOI 10.1007/s11030-006-9054-0; Haggarty SJ, 2004, COMB CHEM HIGH T SCR, V7, P669; Hert J, 2004, ORG BIOMOL CHEM, V2, P3256, DOI 10.1039/b409865j; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koch MA, 2005, P NATL ACAD SCI USA, V102, P17272, DOI 10.1073/pnas.0503647102; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Macarron R, 2006, DRUG DISCOV TODAY, V11, P277, DOI 10.1016/j.drudis.2006.02.001; Martin YC, 2001, J COMB CHEM, V3, P231, DOI 10.1021/cc000073e; MORGAN HL, 1965, J CHEM DOC, V5, P107, DOI 10.1021/c160017a018; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Pereira DA, 2007, BRIT J PHARMACOL, V152, P53, DOI 10.1038/sj.bjp.0707373; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Sadowski J, 1998, J MED CHEM, V41, P3325, DOI 10.1021/jm9706776; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Shang S, 2005, CURR OPIN CHEM BIOL, V9, P248, DOI 10.1016/j.cbpa.2005.03.006; Spencer RW, 1998, BIOTECHNOL BIOENG, V61, P61, DOI 10.1002/(SICI)1097-0290(199824)61:1<61::AID-BIT11>3.0.CO;2-C; Wester MJ, 2008, J CHEM INF MODEL, V48, P1311, DOI 10.1021/ci700342h; Wetzel S, 2007, CHIMIA, V61, P355, DOI 10.2533/chimia.2007.355; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	34	174	175	2	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2009	5	7					479	483		10.1038/nchembio.180	http://dx.doi.org/10.1038/nchembio.180			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461KQ	19483698	Green Submitted, Green Accepted			2022-12-25	WOS:000267266100013
J	Lyons, DA; Naylor, SG; Scholze, A; Talbot, WS				Lyons, David A.; Naylor, Stephen G.; Scholze, Anja; Talbot, William S.			Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons	NATURE GENETICS			English	Article							BASIC-PROTEIN; MULTIPLE-SCLEROSIS; TUMOR-SUPPRESSOR; CNS MYELIN; ZEBRAFISH; TRANSPORT; KINESIN; MECHANISMS; MUTATION; DATABASE	The kinesin motor protein Kif1b has previously been implicated in the axonal transport of mitochondria and synaptic vesicles(1,2). More recently, KIF1B has been associated with susceptibility to multiple sclerosis (MS)(3). Here we show that Kif1b is required for the localization of mbp (myelin basic protein) mRNA to processes of myelinating oligodendrocytes in zebrafish. We observe the ectopic appearance of myelin-like membrane in kif1b mutants, coincident with the ectopic localization of myelin proteins in kif1b mutant oligodendrocyte cell bodies. These observations suggest that oligodendrocytes localize certain mRNA molecules, namely those encoding small basic proteins such as MBP, to prevent aberrant effects of these proteins elsewhere in the cell. We also find that Kif1b is required for outgrowth of some of the longest axons in the peripheral and central nervous systems. Our data demonstrate previously unknown functions of kif1b in vivo and provide insights into its possible roles in MS.	[Lyons, David A.; Naylor, Stephen G.; Scholze, Anja; Talbot, William S.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University	Talbot, WS (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	william.talbot@stanford.edu		, William/0000-0002-2048-7472; Lyons, David/0000-0003-1166-4454	US National Institutes of Health [NS050223]; National Multiple Sclerosis Society [RG 3943-A-2]; Muscular Dystrophy Association [MDA4061]; Biotechnology and Biological Sciences Research Council, UK; BBSRC [BB/F023243/1] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050223, R56NS050223] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F023243/1] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Muscular Dystrophy Association(Muscular Dystrophy Association); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank I. Middendorf, T. Reyes and C. Hill for technical support and fish care. We thank H. Okamoto, B. Appel, G. Jeserich and M. Meyer for sharing reagents. We thank B. Barres, P. Brophy and members of our laboratory for comments on the manuscript. This work was supported by grants from the US National Institutes of Health (NS050223, W. S. T.) and the National Multiple Sclerosis Society (RG 3943-A-2, W. S. T.), a postdoctoral fellowship from the Muscular Dystrophy Association (MDA4061, D. A. L.) and a David Phillips Fellowship from the Biotechnology and Biological Sciences Research Council, UK (D. A. L.).	AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Gould RM, 1999, J NEUROCHEM, V73, P1913; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Lambracht-Washington D, 2007, J NEUROIMMUNOL, V186, P164, DOI 10.1016/j.jneuroim.2007.03.002; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Lyons DA, 2008, DEVELOPMENT, V135, P599, DOI 10.1242/dev.012377; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Meinl E, 2002, CLIN EXP IMMUNOL, V128, P395, DOI 10.1046/j.1365-2249.2002.01879.x; Morris JK, 2004, GLIA, V45, P378, DOI 10.1002/glia.10338; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Pogoda HM, 2006, DEV BIOL, V298, P118, DOI 10.1016/j.ydbio.2006.06.021; Rispoli P, 2007, BIOPHYS J, V93, P1999, DOI 10.1529/biophysj.106.103820; Sato T, 2006, GENESIS, V44, P136, DOI 10.1002/gene.20196; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Song J, 2003, MOL CELL NEUROSCI, V24, P926, DOI 10.1016/S1044-7431(03)00254-9; Yeh IT, 2008, HUM GENET, V124, P279, DOI 10.1007/s00439-008-0553-1; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	28	121	123	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					854	U121		10.1038/ng.376	http://dx.doi.org/10.1038/ng.376			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19503091	Green Accepted			2022-12-25	WOS:000267786200020
J	Kottgen, A; Glazer, NL; Dehghan, A; Hwang, SJ; Katz, R; Li, M; Yang, Q; Gudnason, V; Launer, LJ; Harris, TB; Smith, AV; Arking, DE; Astor, BC; Boerwinkle, E; Ehret, GB; Ruczinski, I; Scharpf, RB; Chen, YDI; de Boer, IH; Haritunians, T; Lumley, T; Sarnak, M; Siscovick, D; Benjamin, EJ; Levy, D; Upadhyay, A; Aulchenko, YS; Hofman, A; Rivadeneira, F; Uitterlinden, AG; van Duijn, CM; Chasman, DI; Pare, G; Ridker, PM; Kao, WHL; Witteman, JC; Coresh, J; Shlipak, MG; Fox, CS				Koettgen, Anna; Glazer, Nicole L.; Dehghan, Abbas; Hwang, Shih-Jen; Katz, Ronit; Li, Man; Yang, Qiong; Gudnason, Vilmundur; Launer, Lenore J.; Harris, Tamara B.; Smith, Albert V.; Arking, Dan E.; Astor, Brad C.; Boerwinkle, Eric; Ehret, Georg B.; Ruczinski, Ingo; Scharpf, Robert B.; Chen, Yii-Der Ida; de Boer, Ian H.; Haritunians, Talin; Lumley, Thomas; Sarnak, Mark; Siscovick, David; Benjamin, Emelia J.; Levy, Daniel; Upadhyay, Ashish; Aulchenko, Yurii S.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Chasman, Daniel I.; Pare, Guillaume; Ridker, Paul M.; Kao, W. H. Linda; Witteman, Jacqueline C.; Coresh, Josef; Shlipak, Michael G.; Fox, Caroline S.			Multiple loci associated with indices of renal function and chronic kidney disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SERUM CREATININE; CARDIOVASCULAR-DISEASE; POOLED ANALYSIS; RISK-FACTOR; HEART; GFR; STANNIOCALCIN-1; EPIDEMIOLOGY; HERITABILITY	Chronic kidney disease (CKD) has a heritable component and is an important global public health problem because of its high prevalence and morbidity(1). We conducted genome-wide association studies (GWAS) to identify susceptibility loci for glomerular filtration rate, estimated by serum creatinine (eGFRcrea) and cystatin C (eGFRcys), and CKD (eGFRcrea < 60ml/min/1.73 m(2)) in European-ancestry participants of four population-based cohorts (ARIC, CHS, FHS, RS; n = 19,877; 2,388 CKD cases), and tested for replication in 21,466 participants (1,932 CKD cases). We identified significant SNP associations (P < 5 x 10(-8)) with CKD at the UMOD locus, with eGFRcrea at UMOD, SHROOM3 and GATM-SPATA5L1, and with eGFRcys at CST and STC1. UMOD encodes the most common protein in human urine, Tamm-Horsfall protein(2), and rare mutations in UMOD cause mendelian forms of kidney disease(3). Our findings provide new insights into CKD pathogenesis and underscore the importance of common genetic variants influencing renal function and disease.	[Hwang, Shih-Jen; Levy, Daniel; Fox, Caroline S.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Hwang, Shih-Jen; Levy, Daniel; Fox, Caroline S.] Ctr Populat Studies, Framingham, MA USA; [Koettgen, Anna; Li, Man; Astor, Brad C.; Kao, W. H. Linda; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Glazer, Nicole L.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, DC USA; [Siscovick, David] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Dehghan, Abbas; Aulchenko, Yurii S.; Hofman, Albert; van Duijn, Cornelia M.; Witteman, Jacqueline C.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Katz, Ronit; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Yang, Qiong] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Gudnason, Vilmundur; Smith, Albert V.] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Arking, Dan E.; Ehret, Georg B.] Johns Hopkins Med Inst, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX USA; [Ehret, Georg B.] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland; [Ruczinski, Ingo; Scharpf, Robert B.; Coresh, Josef] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Chen, Yii-Der Ida; Haritunians, Talin] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [de Boer, Ian H.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Sarnak, Mark] Tufts Univ New England Med Ctr, Boston, MA USA; [Siscovick, David] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Upadhyay, Ashish] Boston Med Ctr, Renal Sect, Boston, MA USA; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Chasman, Daniel I.; Pare, Guillaume; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Shlipak, Michael G.] Univ Calif San Francisco, San Francisco VA Med Ctr, Gen Internal Med Div, San Francisco, CA 94143 USA; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Boston, MA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Boston University; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Geneva; Johns Hopkins University; Cedars Sinai Medical Center; University of Washington; University of Washington Seattle; Tufts Medical Center; University of Washington; University of Washington Seattle; Boston University; Boston University; Boston Medical Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Fox, CS (corresponding author), Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA.	j.witteman@erasmusmc.nl; coresh@jhu.edu; michael.shlipak@ucsf.edu; foxca@nhlbi.nih.gov	Yang, Qiong/G-5438-2014; Aulchenko, Yurii/M-8270-2013; Katz, Ronit/ABA-1880-2021; Launer, Lenore J/A-8218-2010; de Boer, Ian/GYJ-3282-2022; EHRET, Georg B/A-9532-2009; Rivadeneira, Fernando/O-5385-2015; Levy, Daniel/ABF-6873-2021; Kottgen, Anna/D-2920-2012; Gudnason, Vilmundur/AAE-7126-2019; Li, Man/AAX-3400-2020; Smith, Albert Vernon/K-5150-2015; Dehghan, Abbas/ABE-7377-2020; Levy, Daniel/ABB-2752-2021; Pare, Guillaume/T-9631-2018; Hwang, Shih-Jen/HGU-5826-2022; Gudnason, Vilmundur/K-6885-2015; Benjamin, Emelia/E-7103-2011; Dehghan, Abbas/B-9896-2008	Aulchenko, Yurii/0000-0002-7899-1575; EHRET, Georg B/0000-0002-5730-0675; Rivadeneira, Fernando/0000-0001-9435-9441; Levy, Daniel/0000-0003-1843-8724; Gudnason, Vilmundur/0000-0001-5696-0084; Li, Man/0000-0002-3839-0281; Smith, Albert Vernon/0000-0003-1942-5845; Pare, Guillaume/0000-0002-6795-4760; Gudnason, Vilmundur/0000-0001-5696-0084; Glazer, Nicole/0000-0002-6397-609X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Benjamin, Emelia/0000-0003-4076-2336; Dehghan, Abbas/0000-0001-6403-016X; Van Duijn, Cornelia/0000-0002-2374-9204; Johnson, Andrew/0000-0001-6369-5178; Ballantyne, Christie/0000-0002-6432-1730; Upadhyay, Ashish/0000-0002-0536-5776	Intramural NIH HHS Funding Source: Medline; NCATS NIH HHS [UL1 TR000423] Funding Source: Medline; NCI NIH HHS [R01 CA047988, CA 047988] Funding Source: Medline; NCRR NIH HHS [M01RR00069, UL1 RR025005-01, UL1RR025005, UL1 RR025005, KL2 RR025015, M01 RR000069, KL2 RR025015-03] Funding Source: Medline; NHGRI NIH HHS [U01HG004402, U01 HG004402-01, U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [N01 HC055019, N01-HC-85085, R01HL59367, R01 HL059367-02, N01-HC-85082, N01 HC085086, N01 HC055022, N01-HC-25195, N02-HL-6-4278, R01 HL043851-09, N01 HC055021, N01-HC-55019, N01-HC-55015, N01HC55015, N01 HC055222, N01-HC-55222, N01-HC-85086, N01-HC-55021, N01-HC-85083, N01-HC-75150, N01-HC-55020, N01HC85086, N01-HC-85080, N01HC55016, N01 HC055015, N01HC55018, R01HL087641, N01-HC-85081, N01 HC075150, R01 HL043851, R01 HL059367, N01 HC015103, N01-HC-55016, N01 HC055018, R01HL086694, N01-HC-85084, N01 HC055016, N01 HC025195, N01HC55222, N01HC55019, N01HC75150, N01HC55020, N01 HC045133, R01 HL086694-01A1, N01HC55022, R01 HL087652, R01 HL087652-01, N02 HL64278, U01 HL080295-01, N01HC25195, R01 HL087641-01, N01-HC-85079, N01 HC055020, N01-HC-55018, R01 HL086694, N01HC55021, R01 HL087641, N01HC85079, N01 HC085079, U01 HL080295, HL 043851, N01 HC035129, N01-HC-55022] Funding Source: Medline; NIA NIH HHS [R01 AG027002, N01 AG012100, R01 AG027002-01, N01AG12100] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491-05, P30 DK063491-019004, R01 DK076770, K01 DK067207, K01 DK067207-01A1, DK063491, K01DK067207, P30 DK063491] Funding Source: Medline; PHS HHS [HHSN268200625226C] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [N01HC55021, ZIAHL006001, ZIAHL006094] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANAD F, 1990, J MED GENET, V27, P729, DOI 10.1136/jmg.27.12.729; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Benetti E, 2009, AM J KIDNEY DIS, V53, P327, DOI 10.1053/j.ajkd.2008.08.020; Bochud M, 2005, KIDNEY INT, V67, P61, DOI 10.1111/j.1523-1755.2005.00055.x; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Freedman BI, 2000, CURR OPIN NEPHROL HY, V9, P273, DOI 10.1097/00041552-200005000-00011; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hsu CC, 2005, JAMA-J AM MED ASSOC, V293, P2892, DOI 10.1001/jama.293.23.2892; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; Hwang SJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S10; Langefeld CD, 2004, AM J KIDNEY DIS, V43, P796, DOI 10.1053/j.ajkd.2003.12.043; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; *NIH, 2008, US REN DAT SYST USRD; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Yoshiko Y, 2004, PEPTIDES, V25, P1663, DOI 10.1016/j.peptides.2004.04.015; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	30	447	463	3	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					712	717		10.1038/ng.377	http://dx.doi.org/10.1038/ng.377			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19430482	Green Accepted, Green Submitted			2022-12-25	WOS:000266411700021
J	Esparza-Gordillo, J; Weidinger, S; Folster-Holst, R; Bauerfeind, A; Ruschendorf, F; Patone, G; Rohde, K; Marenholz, I; Schulz, F; Kerscher, T; Hubner, N; Wahn, U; Schreiber, S; Franke, A; Vogler, R; Heath, S; Baurecht, H; Novak, N; Rodriguez, E; Illig, T; Lee-Kirsch, MA; Ciechanowicz, A; Kurek, M; Piskackova, T; Macek, M; Lee, YA; Ruether, A				Esparza-Gordillo, Jorge; Weidinger, Stephan; Foelster-Holst, Regina; Bauerfeind, Anja; Ruschendorf, Franz; Patone, Giannino; Rohde, Klaus; Marenholz, Ingo; Schulz, Florian; Kerscher, Tamara; Hubner, Norbert; Wahn, Ulrich; Schreiber, Stefan; Franke, Andre; Vogler, Rainer; Heath, Simon; Baurecht, Hansjoerg; Novak, Natalija; Rodriguez, Elke; Illig, Thomas; Lee-Kirsch, Min-Ae; Ciechanowicz, Andrzej; Kurek, Michael; Piskackova, Tereza; Macek, Milan; Lee, Young-Ae; Ruether, Andreas			A common variant on chromosome 11q13 is associated with atopic dermatitis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; FILAGGRIN MUTATIONS; ULCERATIVE-COLITIS; COMPLEX; ASTHMA; ECZEMA; GENES; EXPRESSION; CHILDREN	We conducted a genome-wide association study in 939 individuals with atopic dermatitis and 975 controls as well as 270 complete nuclear families with two affected siblings. SNPs consistently associated with atopic dermatitis in both discovery sets were then investigated in two additional independent replication sets totalling 2,637 cases and 3,957 controls. Highly significant association was found with allele A of rs7927894 on chromosome 11q13.5, located 38 kb downstream of C11orf30 (P-combined = 7.6 x 10(-10)). Approximately 13% of individuals of European origin are homozygous for rs7927894[A], and their risk of developing atopic dermatitis is 1.47 times that of noncarriers.	[Esparza-Gordillo, Jorge; Marenholz, Ingo; Schulz, Florian; Kerscher, Tamara; Wahn, Ulrich; Lee, Young-Ae] Charite, D-13353 Berlin, Germany; [Esparza-Gordillo, Jorge; Bauerfeind, Anja; Ruschendorf, Franz; Patone, Giannino; Rohde, Klaus; Marenholz, Ingo; Schulz, Florian; Kerscher, Tamara; Hubner, Norbert; Lee, Young-Ae] Max Delbruck Ctr Mol Med, Berlin, Germany; [Weidinger, Stephan; Rodriguez, Elke] Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Weidinger, Stephan; Baurecht, Hansjoerg; Rodriguez, Elke] Tech Univ Munich, Ctr Allergy & Environm, ZAUM, Munich, Germany; [Weidinger, Stephan; Baurecht, Hansjoerg; Rodriguez, Elke] Tech Univ Munich, Helmholtz Zentrum Munich, Div Environm Dermatol & Allergy, Munich, Germany; [Foelster-Holst, Regina] Univ Hosp Schleswig Holstein, Clin Dermatol Venerol & Allergol, Kiel, Germany; [Franke, Andre; Ruether, Andreas] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan; Vogler, Rainer] Univ Kiel, POPGEN Biobank Project, Kiel, Germany; [Heath, Simon] Ctr Natl Genotypage, Evry, France; [Baurecht, Hansjoerg] Tech Univ Munich, IMSE, Munich, Germany; [Novak, Natalija] Univ Bonn, Dept Dermatol & Allergy, D-5300 Bonn, Germany; [Lee-Kirsch, Min-Ae] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Dept Epidemiol, Neuherberg, Germany; [Lee-Kirsch, Min-Ae] Tech Univ Dresden, Klin Kinder & Jugendmed, Dresden, Germany; [Ciechanowicz, Andrzej] Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, Szczecin, Poland; [Kurek, Michael] Pomeranian Med Univ, Dept Clin Allergol, Szczecin, Poland; [Piskackova, Tereza; Macek, Milan] Charles Univ Prague, Med Sch & Fac 2, Dept Biol & Med Genet, Prague, Czech Republic	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel; CEA; UDICE-French Research Universities; Universite Paris Saclay; Technical University of Munich; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Pomeranian Medical University; Pomeranian Medical University; Charles University Prague	Lee, YA (corresponding author), Charite, D-13353 Berlin, Germany.	yolee@mdc-berlin.de	Lee-Kirsch, Min Ae/C-5769-2018; Ciechanowicz, Andrzej/W-8594-2018; Heath, Simon C/J-4138-2012; Weidinger, Stephan/C-8461-2011; Baurecht, Hansjorg/C-4035-2013	Ciechanowicz, Andrzej/0000-0002-3804-440X; Heath, Simon C/0000-0002-9550-0897; Weidinger, Stephan/0000-0003-3944-252X; Rodriguez, Elke/0000-0003-3692-3950; Baurecht, Hansjorg/0000-0002-9265-5594	German Ministry of Education and Research (BMBF) through the Clinical Research Group for Allergy at Charite Berlin; National Genome Research Network (NGFN); PopGen biobank and infrastructure support through the DFG cluster of excellence "Inflammation at Interfaces'; EMBO long-term fellowship [522-2006]; Marie Curie EIF fellowship [039868]; German Research Council [DFG NO454/1-4, NO454/2-4, NO454/5-2, SFB704 TPA4]; BONFOR grants of the University of Bonn; University Hospital Rechts der Isar [KKF-07/04, KKF-27/05]; Technische Universitat Munchen; Wilhelm-Vaillant-Stiftung and a Heisenberg fellowship [DFG WE 2678/4-1]; German Research Council;  [VZFNM00064203]	German Ministry of Education and Research (BMBF) through the Clinical Research Group for Allergy at Charite Berlin(Federal Ministry of Education & Research (BMBF)); National Genome Research Network (NGFN); PopGen biobank and infrastructure support through the DFG cluster of excellence "Inflammation at Interfaces'; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Marie Curie EIF fellowship(European Commission); German Research Council(German Research Foundation (DFG)); BONFOR grants of the University of Bonn; University Hospital Rechts der Isar; Technische Universitat Munchen; Wilhelm-Vaillant-Stiftung and a Heisenberg fellowship; German Research Council(German Research Foundation (DFG)); 	We thank all subjects with eczema, families and physicians for their participation. We thank I. v. Gwinner-Buhring, F. Kussebi, C. Ockeloen, T. Schilling and I. Schulz for subject evaluation. We are grateful to C. Flachmeier, S. Kolberg, M. Schwarz, I. Szangolies, S. Blachut, G. Born, S. Schmidt, C. v. d. Lancken, T. Henke, B. Fedders and T. Wesse for technical assistance, and to M. Wittig for database management. We thank L. Ghys and M. De Longueville (UCB Pharma) and the following EPAAC and ETAC investigators for providing case samples: O. Rybnicek (Brno, Czech Republic), J. Chladkova, T. Chyba (Hradec Kralove, Czech Republic), F. Kopriva (Olomouc, Czech Republic), O. S. kopkova, V. Balcarek (Ostrava, Czech Republic), H. Honomichlova, P. Honomichlova-Houdkova, P. Honomichl (Plzen Lochotin, Czech Republic), M. Spicakova, S. Kynclova, V. Petru, A. Carbolova, K. Kopecka, P. Pohunek, T. Svobodova, V. S. picak, K. Kopecka, M. Maltulka (Praha, Czech Republic), M. Kaczmarski, B. Cudowska, J. Wasilewska, E. Matuszfewska (Bialystok, Poland), T. Malaczynska, B. Klajna-Kraluk (Gdansk, Poland), J. Sokalska, E. Masnica-Wasylkowska, I. Biegun-Awramineko, M. Chlon (Gliwice Poland), T. Latos, E. Pomaranska, G. Gaszczyk, B. Makuch, J. Stanisz, J. Bokiej (Karpacz, Poland), G. Lis, E. Cichocka-Jarosz, I. Glodzik, T. Szczerbinski (Krakow, Poland), D. Chlebna-Sokol, A. Stanczyk, J. Wlazlowski, I. Ligenza, B. Kamer, K. Pyziak, R. Pasowska, J. Zwaigzne-Raczynska (Lodz, Poland), A. Emeryk, H. Milanowska, G. Zywicka, M. Bartkowiak-Emeryk, E. Chojna (Lublin, Poland), A. Swiatly, A. SzczawinskaPoplonyk, M. Kulesza-Kazecka, J. Alkiewicz, A. Breborowicz (Poznan, Poland), R. Kurzawa, A. Wojcik, U. Jedrys-Klucjasz, E. Urbanek-Jozwik (Rabka Zdroj, Poland), L. Dymek, A. Dymek, A. Bozek (Strzelce opolskie, Poland), D. Chmielewska-Szewczyk, J. Lange, J. Peradzynska, M. Kulus, E. Najberg, E. Nowicka, A. Chrupek (Warszawa, Poland), A. Boznanski, E. Willak-Janc, A. Latkowska, E. Sikorska, M. T. Jarlinska (Wroclaw, Poland). The study was funded by the German Ministry of Education and Research (BMBF) through the Clinical Research Group for Allergy at Charite Berlin, the National Genome Research Network (NGFN), by the PopGen biobank and infrastructure support through the DFG cluster of excellence "Inflammation at Interfaces''. This work was supported by an EMBO long-term fellowship (522-2006) and by a Marie Curie EIF fellowship (039868) to J. E. G. N. N. was supported by grants from the German Research Council (DFG NO454/1-4, NO454/2-4, NO454/5-2, SFB704 TPA4) and BONFOR grants of the University of Bonn. S. W. was supported by research grants KKF-07/04 and KKF-27/05 of the University Hospital Rechts der Isar, Technische Universitat Munchen, a grant from the Wilhelm-Vaillant-Stiftung and a Heisenberg fellowship (DFG WE 2678/4-1) from the German Research Council. M. M. was supported by research grant VZFNM00064203.	[Anonymous], 1932, STAT METHODS RES WOR; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Chen WM, 2001, GENET EPIDEMIOL, V21, P53, DOI 10.1002/gepi.1018; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; HAMMER B, 1968, GUT, V9, P17, DOI 10.1136/gut.9.1.17; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Hill DJ, 2008, CLIN EXP ALLERGY, V38, P161, DOI 10.1111/j.1365-2222.2007.02861.x; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; LARSEN FS, 1993, J AM ACAD DERMATOL, V28, P719, DOI 10.1016/0190-9622(93)70099-F; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Morar N, 2007, J INVEST DERMATOL, V127, P1667, DOI 10.1038/sj.jid.5700739; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Nomura T, 2007, J ALLERGY CLIN IMMUN, V119, P434, DOI 10.1016/j.jaci.2006.12.646; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Petitti D, 1994, METAANALYSIS DECISIO; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; PUGH SM, 1979, CLIN ALLERGY, V9, P221, DOI 10.1111/j.1365-2222.1979.tb01545.x; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; TAYLOR B, 1984, LANCET, V2, P1255, DOI 10.1016/S0140-6736(84)92805-8; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Warner JO, 1998, PEDIATR ALLERGY IMMU, V9, P116; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x	30	229	243	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					596	601		10.1038/ng.347	http://dx.doi.org/10.1038/ng.347			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19349984				2022-12-25	WOS:000265575600022
J	Hotchkiss, RS; Coopersmith, CM; McDunn, JE; Ferguson, TA				Hotchkiss, Richard S.; Coopersmith, Craig M.; McDunn, Jonathan E.; Ferguson, Thomas A.			Tilting toward immunosuppression	NATURE MEDICINE			English	Editorial Material							SEPSIS; APOPTOSIS		[Hotchkiss, Richard S.; Coopersmith, Craig M.; McDunn, Jonathan E.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med & Surg, St Louis, MO 63110 USA; [Coopersmith, Craig M.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Ferguson, Thomas A.] Washington Univ, Sch Med, Dept Ophthalmol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	hotch@wustl.edu	McDunn, Jonathan/A-6816-2009	McDunn, Jonathan/0000-0001-8792-828X	NATIONAL EYE INSTITUTE [R01EY006765, P30EY002687, R01EY015570] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015570, R01 EY006765, P30 EY002687] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; CHOILEAIN NN, 2006, J IMMUNOL, V176, P225, DOI 10.4049/jimmunol.176.1.225; Deans KJ, 2005, J TRAUMA, V58, P867, DOI 10.1097/01.TA.0000158244.69179.94; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Schwulst SJ, 2006, J IMMUNOL, V177, P557, DOI 10.4049/jimmunol.177.1.557; Stewart TJ, 2008, ONCOGENE, V27, P5894, DOI 10.1038/onc.2008.268; [No title captured]	15	416	441	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2009	15	5					496	497		10.1038/nm0509-496	http://dx.doi.org/10.1038/nm0509-496			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19424209	Bronze, Green Accepted			2022-12-25	WOS:000265889300026
J	Vanneste, E; Voet, T; Le Caignec, C; Ampe, M; Konings, P; Melotte, C; Debrock, S; Amyere, M; Vikkula, M; Schuit, F; Fryns, JP; Verbeke, G; D'Hooghe, T; Moreau, Y; Vermeesch, JR				Vanneste, Evelyne; Voet, Thierry; Le Caignec, Cedric; Ampe, Michele; Konings, Peter; Melotte, Cindy; Debrock, Sophie; Amyere, Mustapha; Vikkula, Miikka; Schuit, Frans; Fryns, Jean-Pierre; Verbeke, Geert; D'Hooghe, Thomas; Moreau, Yves; Vermeesch, Joris R.			Chromosome instability is common in human cleavage-stage embryos	NATURE MEDICINE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; UNIPARENTAL DISOMY UPD; PREIMPLANTATION EMBRYOS; SPONTANEOUS-ABORTIONS; TERMINAL DELETIONS; SINGLE CELLS; YOUNG-WOMEN; ARRAY-CGH; ANEUPLOIDY; ABNORMALITIES	Chromosome instability is a hallmark of tumorigenesis. This study establishes that chromosome instability is also common during early human embryogenesis. A new array-based method allowed screening of genome-wide copy number and loss of heterozygosity in single cells. This revealed not only mosaicism for whole-chromosome aneuploidies and uniparental disomies in most cleavage-stage embryos but also frequent segmental deletions, duplications and amplifications that were reciprocal in sister blastomeres, implying the occurrence of breakage-fusion-bridge cycles. This explains the low human fecundity and identifies post-zygotic chromosome instability as a leading cause of constitutional chromosomal disorders.	[Vanneste, Evelyne; Voet, Thierry; Le Caignec, Cedric; Melotte, Cindy; Fryns, Jean-Pierre; Vermeesch, Joris R.] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Vanneste, Evelyne; Debrock, Sophie; D'Hooghe, Thomas] Univ Hosp Gasthuisberg, Leuven Univ Fertil Ctr, B-3000 Leuven, Belgium; [Le Caignec, Cedric] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Le Caignec, Cedric] Inst Natl Sante & Rech Med, Inst Thorax, Nantes, France; [Ampe, Michele; Verbeke, Geert] Katholieke Univ Leuven, Interuniv Inst Biostat & Stat Bioinformat, Leuven, Belgium; [Konings, Peter; Moreau, Yves] Katholieke Univ Leuven, ESAT SISTA, Heverlee, Belgium; [Amyere, Mustapha; Vikkula, Miikka] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Schuit, Frans] Univ Hosp Gasthuisberg, Gene Express Grp, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Hasselt University; KU Leuven; KU Leuven; Universite Catholique Louvain; KU Leuven; University Hospital Leuven	Vermeesch, JR (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium.	joris.vermeesch@uz.kuleuven.be	Voet, Thierry/E-8877-2017; Le Caignec, Cedric/K-8467-2015; Melotte, Cindy/GXV-5465-2022; Vikkula, Miikka/Q-1038-2018; Verbeke, Geert/I-5587-2015	Voet, Thierry/0000-0003-1204-9963; Le Caignec, Cedric/0000-0002-0598-653X; Vikkula, Miikka/0000-0002-6236-338X; Verbeke, Geert/0000-0001-8430-7576; Moreau, Yves/0000-0002-4647-6560; Konings, Peter/0000-0002-8637-5916; Vermeesch, Joris/0000-0002-3071-1191	Institute for the Promotion of Innovation through Science and Technology (IWT-Flanders) [SBO-60848, GOA/2006/12]; Research Council K. U. Leuven [EF/05/007]; Fonds de la Recherche Scientifique; Institute for the Promotion of Innovation through Science and Technology in Flanders	Institute for the Promotion of Innovation through Science and Technology (IWT-Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Council K. U. Leuven(KU Leuven); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	We thank all families who participated in the study, the Leuven University Fertility Center for technical assistance and S. Jackmaert for her help with the SNP arrays. We are also grateful to the Mapping Core and Map finishing groups of the Wellcome Trust Sanger Institute for initial BAC clone supply and verification and to the microarray facility of the Flanders Interuniversity Institute for Biotechnology for their help in spotting the arrays. We would like to thank C. Spiessens, E. Legius, T. de Ravel de l'Argentiere, H. van Esch and K. Devriendt for the critical reading of the manuscript. This work was made possible by grants from the Institute for the Promotion of Innovation through Science and Technology (IWT-Flanders) (SBO-60848) and GOA/2006/12 and Center of Excellence SymBioSys (Research Council K. U. Leuven EF/05/007) to J. R. V. and Fonds de la Recherche Scientifique to M. V. E. V. was supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Ballif BC, 2006, PRENATAL DIAG, V26, P333, DOI 10.1002/pd.1411; Ballif BC, 2003, HUM MOL GENET, V12, P2153, DOI 10.1093/hmg/ddg231; Benkhalifa M, 2005, PRENATAL DIAG, V25, P894, DOI 10.1002/pd.1230; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Daphnis DD, 2008, MOL HUM REPROD, V14, P117, DOI 10.1093/molehr/gam087; Delhanty JDA, 2005, CYTOGENET GENOME RES, V111, P237, DOI 10.1159/000086894; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; Fritz B, 2001, EUR J HUM GENET, V9, P539, DOI 10.1038/sj.ejhg.5200669; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Harper JC, 2008, HUM REPROD, V23, P741, DOI 10.1093/humrep/dem354; Harper J, 2008, HUM REPROD, V23, P478, DOI 10.1093/humrep/dem424; Iwamoto K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001306; Kotzot D, 1999, AM J MED GENET, V82, P265, DOI 10.1002/(SICI)1096-8628(19990129)82:3<265::AID-AJMG14>3.3.CO;2-Y; Kotzot D, 2001, J MED GENET, V38, P497, DOI 10.1136/jmg.38.8.497; Le Caignec C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl336; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li M, 2005, FERTIL STERIL, V84, P1395, DOI 10.1016/j.fertnstert.2005.04.068; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Munne S, 1997, HUM REPROD, V12, P780, DOI 10.1093/humrep/12.4.780; Munne S, 2004, PRENATAL DIAG, V24, P638, DOI 10.1002/pd.957; Munne S, 2005, FERTIL STERIL, V84, P1328, DOI 10.1016/j.fertnstert.2005.06.025; Perry J, 2004, CHROMOSOME RES, V12, P627, DOI 10.1023/B:CHRO.0000036594.38997.59; Pflueger SMV, 1999, PRINCIPLES OF CLINICAL CYTOGENETICS, P317; Pipiras E, 1998, EMBO J, V17, P325, DOI 10.1093/emboj/17.1.325; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Rossi E, 2008, J MED GENET, V45, P147, DOI 10.1136/jmg.2007.054007; Rubio C, 2003, HUM REPROD, V18, P182, DOI 10.1093/humrep/deg015; Schinzel A., 2001, CATALOGUE UNBALANCED; Staessen C, 2004, HUM REPROD, V19, P2849, DOI 10.1093/humrep/deh536; Voullaire L, 2000, HUM GENET, V106, P210, DOI 10.1007/s004390051030; Weghofer A, 2008, HUM REPROD, V23, P499, DOI 10.1093/humrep/dem412; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558	38	560	595	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2009	15	5					577	583		10.1038/nm.1924	http://dx.doi.org/10.1038/nm.1924			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19396175				2022-12-25	WOS:000265889300038
J	Orti, L; Carbajo, RJ; Pieper, U; Eswar, N; Maurer, SM; Rai, AK; Taylor, G; Todd, MH; Pineda-Lucena, A; Sali, A; Marti-Renom, MA				Orti, Leticia; Carbajo, Rodrigo J.; Pieper, Ursula; Eswar, Narayanan; Maurer, Stephen M.; Rai, Arti K.; Taylor, Ginger; Todd, Matthew H.; Pineda-Lucena, Antonio; Sali, Andrej; Marti-Renom, Marc A.			A kernel for the Tropical Disease Initiative	NATURE BIOTECHNOLOGY			English	Letter							DRUG DISCOVERY; TARGETS; BINDING		[Orti, Leticia; Marti-Renom, Marc A.] Ctr Invest Principe Felipe, Struct Genom Unit, Bioinformat & Genom Dept, Valencia, Spain; [Orti, Leticia; Carbajo, Rodrigo J.; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Struct Biol Lab, Dept Med Chem, Valencia, Spain; [Pieper, Ursula; Eswar, Narayanan; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Pieper, Ursula; Eswar, Narayanan; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Pieper, Ursula; Eswar, Narayanan; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Maurer, Stephen M.] Univ So Calif, Gould Sch Law, Los Angeles, CA USA; [Rai, Arti K.] Duke Univ, Sch Law, Durham, NC 27706 USA; [Taylor, Ginger] Synapt Leap, San Ramon, CA USA; [Todd, Matthew H.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	Prince Felipe Research Center; Prince Felipe Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; Duke University; University of Sydney	Orti, L (corresponding author), Ctr Invest Principe Felipe, Struct Genom Unit, Bioinformat & Genom Dept, Valencia, Spain.	sali@salilab.org; mmarti@cipf.es	Marti-Renom, Marc A./Y-8803-2019; Pieper, Ursula/E-4444-2010; Marti-Renom, Marc/A-1836-2010; Pineda-Lucena, Antonio/B-1320-2014	Marti-Renom, Marc A./0000-0002-0151-4279; Marti-Renom, Marc/0000-0002-0151-4279; Pineda-Lucena, Antonio/0000-0002-3532-8781; Pieper, Ursula/0000-0002-3168-8122	NIAID NIH HHS [P01 AI035707-05, P01 AI035707] Funding Source: Medline; NIGMS NIH HHS [U54 GM074945, R01 GM054762, P01 GM71790, P01 GM071790-01, P01 GM071790, R01 GM054762-09, U54 GM074945-01, R01 GM54762] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071790, U54GM074945, R01GM054762] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Kepler TB, 2006, AUST J CHEM, V59, P291, DOI 10.1071/CH06095; Marti-Renom MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S4; Maurer SM, 2004, PLOS MED, V1, P183, DOI 10.1371/journal.pmed.0010056; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Munos B, 2006, NAT REV DRUG DISCOV, V5, P723, DOI 10.1038/nrd2131; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Singh S, 2008, CELL, V133, P201, DOI 10.1016/j.cell.2008.04.003; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958	12	4	4	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2009	27	4					320	321		10.1038/nbt0409-320	http://dx.doi.org/10.1038/nbt0409-320			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	430EO	19352362	Green Accepted			2022-12-25	WOS:000264971800011
J	Lefevre, S; Knedla, A; Tennie, C; Kampmann, A; Wunrau, C; Dinser, R; Korb, A; Schnaker, EM; Tarner, IH; Robbins, PD; Evans, CH; Sturz, H; Steinmeyer, J; Gay, S; Scholmerich, J; Pap, T; Muller-Ladner, U; Neumann, E				Lefevre, Stephanie; Knedla, Anette; Tennie, Christoph; Kampmann, Andreas; Wunrau, Christina; Dinser, Robert; Korb, Adelheid; Schnaeker, Eva-Maria; Tarner, Ingo H.; Robbins, Paul D.; Evans, Christopher H.; Stuerz, Henning; Steinmeyer, Juergen; Gay, Steffen; Schoelmerich, Juergen; Pap, Thomas; Mueller-Ladner, Ulf; Neumann, Elena			Synovial fibroblasts spread rheumatoid arthritis to unaffected joints	NATURE MEDICINE			English	Article							ENDOTHELIAL-CELL ADHESION; GENE-TRANSFER; IN-VITRO; CARTILAGE; MIGRATION; DESTRUCTION; OSTEOARTHRITIS; PROLIFERATION; SYNOVIOCYTES; PATHOGENESIS	Active rheumatoid arthritis originates from few joints but subsequently affects the majority of joints. Thus far, the pathways of the progression of the disease are largely unknown. As rheumatoid arthritis synovial fibroblasts (RASFs) which can be found in RA synovium are key players in joint destruction and are able to migrate in vitro, we evaluated the potential of RASFs to spread the disease in vivo. To simulate the primary joint of origin, we implanted healthy human cartilage together with RASFs subcutaneously into severe combined immunodeficient (SCID) mice. At the contralateral flank, we implanted healthy cartilage without cells. RASFs showed an active movement to the naive cartilage via the vasculature independent of the site of application of RASFs into the SCID mouse, leading to a marked destruction of the target cartilage. These findings support the hypothesis that the characteristic clinical phenomenon of destructive arthritis spreading between joints is mediated, at least in part, by the transmigration of activated RASFs.	[Lefevre, Stephanie; Knedla, Anette; Tennie, Christoph; Kampmann, Andreas; Dinser, Robert; Tarner, Ingo H.; Mueller-Ladner, Ulf; Neumann, Elena] Univ Giessen, Dept Internal Med & Rheumatol, Kerckhoff Clin, Bad Nauheim, Germany; [Wunrau, Christina; Pap, Thomas] Univ Hosp Muenster, Inst Expt Musculoskeletal Med, Munster, Germany; [Korb, Adelheid] Univ Hosp Muenster, Dept Internal Med Nephrol & Rheumatol D, Munster, Germany; [Schnaeker, Eva-Maria] Univ Hosp Muenster, Dept Dermatol, Munster, Germany; [Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Evans, Christopher H.] Harvard Univ, Sch Med, Ctr Mol Orthoped, Boston, MA USA; [Stuerz, Henning] Univ Hosp Giessen & Marburg, Dept Orthoped & Orthoped Surg, Giessen, Germany; [Steinmeyer, Juergen] Univ Hosp Giessen & Marburg, Dept Orthoped & Expt Orthoped, Giessen, Germany; [Gay, Steffen] USZ, Zurich Ctr Integrat Human Physiol, Ctr Expt Rheumatol, Zurich, Switzerland; [Schoelmerich, Juergen] Univ Regensburg, Dept Internal Med 1, Regensburg, Germany	Justus Liebig University Giessen; Kerckhoff Clinic; University of Munster; University of Munster; University of Munster; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Regensburg	Neumann, E (corresponding author), Univ Giessen, Dept Internal Med & Rheumatol, Kerckhoff Clin, Bad Nauheim, Germany.	e.neumann@kerckhoff-klinik.de	Neumann, Elena/A-1418-2011	Steinmeyer, Juergen/0000-0002-4053-503X	German Society of Rheumatology; German Research Foundation (Deutsche Forschungsgemeinschaft) [NE1174/3-1, MU1383/14-1, FOR 696]; Swiss National Fond [32000-116842]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051456] Funding Source: NIH RePORTER	German Society of Rheumatology; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Swiss National Fond(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by a start-up grant of the German Society of Rheumatology, by research grants of the German Research Foundation (Deutsche Forschungsgemeinschaft: NE1174/3-1, MU1383/14-1, FOR 696), by the Swiss National Fond 32000-116842 and by the Sixth Framework Programme Autocure and Seventh Framework Programme Masterswitch of the EU initiatives. We wish to thank S. Benninghoff, B. Riepl, S. Bruckmann and C. Schreiyack for technical assistance.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bresnihan B, 1999, J RHEUMATOL, V26, P717; BROMLEY M, 1985, ANN RHEUM DIS, V44, P676, DOI 10.1136/ard.44.10.676; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Clark RAF, 2003, J INVEST DERMATOL, V121, P695, DOI 10.1046/j.1523-1747.2003.12484.x; Clements KM, 2001, OSTEOARTHR CARTILAGE, V9, P499, DOI 10.1053/joca.2000.0417; Davidson ENB, 2007, ARTHRITIS RHEUM, V56, P4065, DOI 10.1002/art.23034; ElGabalawy H, 1996, ARTHRITIS RHEUM-US, V39, P1913, DOI 10.1002/art.1780391119; Felix R, 1996, J CELL PHYSIOL, V166, P311, DOI 10.1002/(SICI)1097-4652(199602)166:2<311::AID-JCP9>3.0.CO;2-S; Garcia-Vicuna R, 2004, ARTHRITIS RHEUM-US, V50, P3866, DOI 10.1002/art.20615; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Hajiioannou JK, 2006, ARCH OTOLARYNGOL, V132, P1363, DOI 10.1001/archotol.132.12.1363; Hall H, 2004, MICROVASC RES, V68, P169, DOI 10.1016/j.mvr.2004.07.001; Hashimoto Atsushi, 2007, Mod Rheumatol, V17, P185; HUBBELL JA, 2007, SWISS MED WKLY S155, V137, pS75; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; ISHIKAWA H, 1984, RHEUMATOL INT, V4, P1, DOI 10.1007/BF00683876; Judex M, 2004, METH MOLEC MED, V101, P93; Judex M, 2001, Mod Rheumatol, V11, P145, DOI 10.3109/s101650170027; Karouzakis E, 2006, IMMUNOL LETT, V106, P8, DOI 10.1016/j.imlet.2006.04.011; Knedla A, 2009, ANN RHEUM DIS, V68, P124, DOI 10.1136/ard.2007.086116; Lechman ER, 1999, J IMMUNOL, V163, P2202; Lechner S, 2003, GUT, V52, P1148, DOI 10.1136/gut.52.8.1148; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; Looney RJ, 2006, DRUGS, V66, P625, DOI 10.2165/00003495-200666050-00004; Ma YY, 2005, CURR PHARM DESIGN, V11, P569, DOI 10.2174/1381612053381927; MORALESDUCRET J, 1992, J IMMUNOL, V149, P1424; Muller-Ladner U, 2005, NAT CLIN PRACT RHEUM, V1, P102, DOI 10.1038/ncprheum0047; Muller-Ladner U, 1999, ARTHRITIS RHEUM, V42, P490, DOI 10.1002/1529-0131(199904)42:3<490::AID-ANR14>3.0.CO;2-L; MullerLadner U, 1996, AM J PATHOL, V149, P1607; MullerLadner U, 1997, J IMMUNOL, V158, P3492; MullerLadner U, 1997, J RHEUMATOL, V24, P1873; Neumann E, 2002, GENE THER, V9, P1508, DOI 10.1038/sj.gt.3301811; Neumann E, 2002, ARTHRITIS RHEUM-US, V46, P52, DOI 10.1002/1529-0131(200201)46:1<52::AID-ART10048>3.0.CO;2-1; NICOSIA RF, 1994, J CELL BIOL, V124, P183, DOI 10.1083/jcb.124.1.183; OWSIANIK WDJ, 1980, ANN RHEUM DIS, V39, P508, DOI 10.1136/ard.39.5.508; Pap T, 2005, ANN RHEUM DIS, V64, P52, DOI 10.1136/ard.2005.042424; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Saint-Geniez M, 2009, INVEST OPHTH VIS SCI, V50, P311, DOI 10.1167/iovs.08-2461; Schedel J, 2004, SCAND J IMMUNOL, V60, P514, DOI 10.1111/j.0300-9475.2004.01507.x; Skapenko A, 2005, ARTHRITIS RES THER, V7, pS4, DOI 10.1186/ar1703; Takahara K, 2004, HUM PATHOL, V35, P150, DOI 10.1016/j.humpath.2003.11.010; van Beurden HE, 2003, WOUND REPAIR REGEN, V11, P55, DOI 10.1046/j.1524-475X.2003.11109.x; Van der Laan WH, 2000, ARTHRITIS RHEUM, V43, P1710, DOI 10.1002/1529-0131(200008)43:8<1710::AID-ANR6>3.0.CO;2-Y; Woods JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1999; Yasuda Tadashi, 2006, Mod Rheumatol, V16, P197; Zak J, 2000, PFLUG ARCH EUR J PHY, V440, P179, DOI 10.1007/s004240000282	50	424	446	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2009	15	12					1414	U10		10.1038/nm.2050	http://dx.doi.org/10.1038/nm.2050			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	527YS	19898488	Green Accepted			2022-12-25	WOS:000272407800022
J	Baleux, F; Loureiro-Morais, L; Hersant, Y; Clayette, P; Arenzana-Seisdedos, F; Bonnaffe, D; Lortat-Jacob, H				Baleux, Francoise; Loureiro-Morais, Latino; Hersant, Yael; Clayette, Pascal; Arenzana-Seisdedos, Fernando; Bonnaffe, David; Lortat-Jacob, Hugues			A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry	NATURE CHEMICAL BIOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS GP120; HEPARAN-SULFATE; BINDING; RECEPTOR; PROTEOGLYCANS; V3; RETROVIRUS; ANTIBODIES; COFACTOR; EPITOPES	The HIV-1 envelope, gp120, which features the binding determinants for both CD4 and coreceptor recognition, is key for virus entry and represents an attractive pharmacological target. However, critical domains for entry (coreceptor and CD4 binding sites) are either cryptic or located in partially occluded cavities. Here we developed a chemical approach to synthesize a CD4-mimetic peptide linked to a heparan sulfate dodecasaccharide. This molecule binds to gp120, induces the exposure of the coreceptor binding domain and renders it available for interaction with the oligosaccharide. The linkage between the CD4 mimetic and the heparan sulfate derivative provides strong cooperative effects, resulting in low-nanomolar antiviral activity toward both CCR5- and CXCR4-tropic HIV-1 strains. This compound, which has the unique ability to simultaneously target two critical and highly conserved regions of gp120, establishes a new type of inhibitor and suggests a general concept for the inhibition of numerous other biological systems.	[Lortat-Jacob, Hugues] Univ Grenoble 1, CNRS, Inst Biol Struct, UMR 5075,Commissariat Energie Atom, Grenoble, France; [Baleux, Francoise] Inst Pasteur, Unite Chim Biomol, Unite Rech Assoc 2128, CNRS, Paris, France; [Loureiro-Morais, Latino; Hersant, Yael; Bonnaffe, David] Univ Paris 11, CNRS, UMR 8182,Lab Chim Organ Multifonct, Inst Chim Mol & Mat Orsay,Equipe Glycochim Mol &, F-91405 Orsay, France; [Clayette, Pascal] Commissariat Energie Atom, SPI bio, Lab Neurovirol, Fontenay Aux Roses, France; [Arenzana-Seisdedos, Fernando] Inst Pasteur, INSERM, Lab Pathogenie Virale, U819, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lortat-Jacob, H (corresponding author), Univ Grenoble 1, CNRS, Inst Biol Struct, UMR 5075,Commissariat Energie Atom, Grenoble, France.	hugues.lortat-jacob@ibs.fr	Arenzana-Seisdedos, Fernando/E-5835-2016	Baleux, Francoise/0000-0003-4926-1060	US National Institutes of Health	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Klemm, C. Rogez-Kreuz, R. Yousfi and V.I. Iuyot for technical assistance and R. R. Vives for stimulating discussions. This work was supported by the Agence Nationale de la Recherche sur le Syndrome d'Immunodeficience Acquise. Soluble CD4 and monoclonal antibodies 17b and E51 were obtained through the US National Institutes of Health AIDS Research and Reference Reagent Program from S. Iyer and J. Robinson. Infectious HIV-1 proviral clones pNL4-3 Luc were a gift from J. Alcami (Unidad de Inmunopatolog a del Sida, Instituto de Salud Carlos III).	Adibekian A, 2007, CHEM-EUR J, V13, P4510, DOI 10.1002/chem.200700141; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Argyris EG, 2003, J VIROL, V77, P12140, DOI 10.1128/JVI.77.22.12140-12151.2003; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chan WC, 2000, FMOC SOLID PHASE PEP; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen WZ, 2008, P NATL ACAD SCI USA, V105, P17121, DOI 10.1073/pnas.0805297105; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Endress T, 2008, EUR BIOPHYS J BIOPHY, V37, P1291, DOI 10.1007/s00249-008-0322-z; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lubineau A, 2004, CHEM-EUR J, V10, P4265, DOI 10.1002/chem.200306063; Moncunill G, 2008, AIDS, V22, P23, DOI 10.1097/QAD.0b013e3282f303e6; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; RIDER CC, 1994, BIOCHEMISTRY-US, V33, P6974, DOI 10.1021/bi00188a029; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Roisin A, 2004, J BIOL CHEM, V279, P9208, DOI 10.1074/jbc.M311594200; Saidi H, 2007, VIROLOGY, V358, P55, DOI 10.1016/j.virol.2006.07.029; Shafer RW, 2008, AIDS REV, V10, P67; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959	37	97	103	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					743	748		10.1038/nchembio.207	http://dx.doi.org/10.1038/nchembio.207			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19734912				2022-12-25	WOS:000270039900012
J	Ferrandon, S; Feinstein, TN; Castro, M; Wang, B; Bouley, R; Potts, JT; Gardella, TJ; Vilardaga, JP				Ferrandon, Sebastien; Feinstein, Timothy N.; Castro, Marian; Wang, Bin; Bouley, Richard; Potts, John T.; Gardella, Thomas J.; Vilardaga, Jean-Pierre			Sustained cyclic AMP production by parathyroid hormone receptor endocytosis	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATION; TRAFFICKING; SELECTIVITY; INFUSION; KINETICS; BINDING; SWITCH; PTHRP	Cell signaling mediated by the G protein-coupled parathyroid hormone receptor type 1 (PTHR) is fundamental to bone and kidney physiology. It has been unclear how the two ligand systems-PTH, endocrine and homeostatic, and PTH-related peptide (PTHrP), paracrine-can effectively operate with only one receptor and trigger different durations of the cAMP responses. Here we analyze the ligand response by measuring the kinetics of activation and deactivation for each individual reaction step along the PTHR signaling cascade. We found that during the time frame of G protein coupling and cAMP production, PTHrP(1-36) action was restricted to the cell surface, whereas PTH1-34 had moved to internalized compartments where it remained associated with the PTHR and G alpha(s), potentially as a persistent and active ternary complex. Such marked differences suggest a mechanism by which PTH and PTHrP induce differential responses, and these results indicate that the central tenet that cAMP production originates exclusively at the cell membrane must be revised.	[Ferrandon, Sebastien; Castro, Marian; Potts, John T.; Gardella, Thomas J.; Vilardaga, Jean-Pierre] Massachusetts Gen Hosp, Dept Med, Program Membrane Biol, Endocrine Unit, Boston, MA 02114 USA; [Ferrandon, Sebastien; Bouley, Richard; Vilardaga, Jean-Pierre] Massachusetts Gen Hosp, Dept Med, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA; [Ferrandon, Sebastien; Castro, Marian; Potts, John T.; Gardella, Thomas J.; Vilardaga, Jean-Pierre] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Endocrine Unit, Boston, MA 02114 USA; [Ferrandon, Sebastien; Bouley, Richard; Vilardaga, Jean-Pierre] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Ctr Syst Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; [Feinstein, Timothy N.; Wang, Bin; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vilardaga, JP (corresponding author), Massachusetts Gen Hosp, Dept Med, Program Membrane Biol, Endocrine Unit, Boston, MA 02114 USA.	jpv@pitt.edu	Feinstein, Timothy/G-3110-2011; Castro, Marián/K-5747-2014	Castro, Marián/0000-0002-4732-1966; Wang, Bin/0000-0002-5396-6111; Feinstein, Timothy/0000-0002-9801-9708; Vilardaga, Jean-Pierre/0000-0002-1217-1435	Department of Medicine, Massachusetts General Hospital; Department of Pharmacology and Chemical Biology, University of Pittsburgh; Xunta de Galicia (Spain); US National Institutes of Health [DK38451]; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087688, R29DK038451] Funding Source: NIH RePORTER	Department of Medicine, Massachusetts General Hospital; Department of Pharmacology and Chemical Biology, University of Pittsburgh(University of Pittsburgh); Xunta de Galicia (Spain)(Xunta de Galicia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	J.-P. V. thanks M. J. Lohse (University of Wuerzburg) and N.O. Nikolaev (University of Wuerzburg) for generously sharing their plasmid encoding Epac-CFP/YFP, C. Berlot (Weis Center for Research) for the plasmid encoding G alpha<INF>s</INF>-CFP, M. Buemann (University of Wuerzburg) for the G gamma<INF>2</INF>-CFP construct and A. Bisello (University of Pittsburgh) for Dyn K44A. The authors thank D. Altschuler for the use of his FRET imaging microscope. This work was supported by start-up funds from the Department of Medicine, Massachusetts General Hospital, and the Department of Pharmacology and Chemical Biology, University of Pittsburgh (to J.-P. V.). M. C. is at the Department of Pharmacology, School of Pharmacy, University of Santiago de Compostella (Spain) and received a fellowship from the Xunta de Galicia (Spain) for a research sabbatical at the J.-P. V. laboratory at the Endocrine Unit of the Massachusetts General Hospital. R. B. was supported by US National Institutes of Health grant DK38451 and received an investigator award from the National Kidney Foundation. J.-P. V. thanks P. Friedman and G. Romero for critically commenting on the manuscript.	Berlot CH, 2002, J BIOL CHEM, V277, P21080, DOI 10.1074/jbc.M201330200; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chauvin S, 2002, MOL ENDOCRINOL, V16, P2720, DOI 10.1210/me.2002-0049; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P1603, DOI 10.1210/jc.2002-020773; Horwitz MJ, 2005, J BONE MINER RES, V20, P1792, DOI 10.1359/JBMR.050602; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Syme CA, 2005, J BIOL CHEM, V280, P11281, DOI 10.1074/jbc.M413393200; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	22	373	380	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					734	742		10.1038/nchembio.206	http://dx.doi.org/10.1038/nchembio.206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19701185	Green Accepted			2022-12-25	WOS:000270039900011
J	Melixetian, M; Klein, DK; Sorensen, CS; Helin, K				Melixetian, Marina; Klein, Ditte Kjaersgaard; Sorensen, Claus Storgaard; Helin, Kristian			NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint	NATURE CELL BIOLOGY			English	Article							S-PHASE; BETA-TRCP; CHK1; PHOSPHORYLATION; KINASE; BRCA1; INHIBITION; EVENTS; ATR	DNA damage-induced cell-cycle checkpoints have a critical role in maintaining genomic stability(1,2). A key target of the checkpoints is the CDC25A (cell division cycle 25 homologue A) phosphatase, which is essential for the activation of cyclin-dependent kinases and cell-cycle progression(3-5). To identify new genes involved in the G2/M checkpoint we performed a large-scale short hairpin RNA (shRNA) library screen. We show that NIMA (never in mitosis gene A)-related kinase 11 (NEK11) is required for DNA damage-induced G2/M arrest. Depletion of NEK11 prevents proteasome-dependent degradation of CDC25A, both in unperturbed and DNA-damaged cells. We show that NEK11 directly phosphorylates CDC25A on residues whose phosphorylation is required for beta-TrCP (beta-transducin repeat-containing protein)-mediated polyubiquitylation and degradation of CDC25A. Furthermore, we demonstrate that CHK1 (checkpoint kinase 1) directly activates NEK11 by phosphorylating it on Ser 273, indicating that CHK1 and NEK11 operate in a single pathway that controls proteolysis of CDC25A. Taken together, these results demonstrate that NEK11 is an important component of the pathway enforcing the G2/M checkpoint, suggesting that genetic mutations in NEK11 may contribute to the development of human cancer.	[Klein, Ditte Kjaersgaard; Sorensen, Claus Storgaard; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Melixetian, Marina; Helin, Kristian] European Inst Oncol, Dept Expt Oncol, I-20135 Milan, Italy	University of Copenhagen; University of Copenhagen; IRCCS European Institute of Oncology (IEO)	Sorensen, CS (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	claus.storgaard@bric.ku.dk; kristian.helin@bric.ku.dk	Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022; Melixetian, Marine/AAR-1524-2020	Helin, Kristian/0000-0003-1975-6097; Melixetian, Marine/0000-0002-8454-8262; Sorensen, Claus/0000-0001-6022-9710	EU-framework 6; Danish Cancer Society; Novo Nordisk Foundation; Danish National Research Foundation	EU-framework 6; Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank R. Bernards for the NKI shRNA library, M. Donzelli and L. Busino for reagents and helpful discussions, G. Ossolengo for purification of the antibodies, S. Ronzoni for FACS sorting, S. Bossi for recombinant NEK11 production and P. G. Pelicci for his continuous support. This work was supported by grants from the EU-framework 6 program to INTACT, the Danish Cancer Society, the Novo Nordisk Foundation and the Danish National Research Foundation.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Donzelli M, 2004, CELL CYCLE, V3, P469; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kohn EA, 2003, CANCER RES, V63, P31; Liu QH, 2000, GENE DEV, V14, P1448; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200; Noguchi K, 2002, J BIOL CHEM, V277, P39655, DOI 10.1074/jbc.M204599200; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Syljuasen RG, 2004, CANCER RES, V64, P9035, DOI 10.1158/0008-5472.CAN-04-2434; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	24	94	100	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1247	U212		10.1038/ncb1969	http://dx.doi.org/10.1038/ncb1969			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19734889				2022-12-25	WOS:000270382000015
J	Murakami, T; Saito, A; Hino, SI; Kondo, S; Kanemoto, S; Chihara, K; Sekiya, H; Tsumagari, K; Ochiai, K; Yoshinaga, K; Saitoh, M; Nishimura, R; Yoneda, T; Kou, I; Furuichi, T; Ikegawa, S; Ikawa, M; Okabe, M; Wanaka, A; Imaizumi, K				Murakami, Tomohiko; Saito, Atsushi; Hino, Shin-ichiro; Kondo, Shinichi; Kanemoto, Soshi; Chihara, Kazuyasu; Sekiya, Hiroshi; Tsumagari, Kenji; Ochiai, Kimiko; Yoshinaga, Kazuya; Saitoh, Masahiro; Nishimura, Riko; Yoneda, Toshiyuki; Kou, Ikuyo; Furuichi, Tatsuya; Ikegawa, Shiro; Ikawa, Masahito; Okabe, Masaru; Wanaka, Akio; Imaizumi, Kazunori			Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR OASIS; OSTEOBLAST DIFFERENTIATION; ER STRESS; OSTEOGENESIS IMPERFECTA; COLLAGEN PROMOTER; CREB/ATF-FAMILY; TRANSGENIC MICE; I COLLAGEN; EXPRESSION; ASTROCYTES	Eukaryotic cells have signalling pathways from the endoplasmic reticulum (ER) to cytosol and nuclei, to avoid excess accumulation of unfolded proteins in the ER. We previously identified a new type of ER stress transducer, OASIS, a bZIP (basic leucine zipper) transcription factor, which is a member of the CREB/ATF family and has a transmembrane domain(1-6). OASIS is processed by regulated intramembrane proteolysis (RIP) in response to ER stress, and is highly expressed in osteoblasts. OASIS(-/-) mice exhibited severe osteopenia, involving a decrease in type I collagen in the bone matrix and a decline in the activity of osteoblasts, which showed abnormally expanded rough ER, containing of a large amount of bone matrix proteins. Here we identify the gene for type 1 collagen, Col1a1, as a target of OASIS, and demonstrate that OASIS activates the transcription of Col1a1 through an unfolded protein response element (UPRE)-like sequence in the osteoblast-specific Col1a1 promoter region. Moreover, expression of OASIS in osteoblasts is induced by BMP2 (bone morphogenetic protein 2), the signalling of which is required for bone formation. Additionally, RIP of OASIS is accelerated by BMP2 signalling, which causes mild ER stress. Our studies show that OASIS is critical for bone formation through the transcription of Col1a1 and the secretion of bone matrix proteins, and they reveal a new mechanism by which ER stress-induced signalling mediates bone formation.	[Murakami, Tomohiko; Saito, Atsushi; Hino, Shin-ichiro; Kondo, Shinichi; Kanemoto, Soshi; Chihara, Kazuyasu; Sekiya, Hiroshi; Tsumagari, Kenji; Ochiai, Kimiko; Imaizumi, Kazunori] Miyazaki Univ, Div Mol & Cellular Biol, Dept Anat, Fac Med, Miyazaki 8891692, Japan; [Yoshinaga, Kazuya] Kumamoto Univ, Sch Hlth Sci, Dept Anat & Pathol, Kumamoto 8620976, Japan; [Saitoh, Masahiro; Nishimura, Riko; Yoneda, Toshiyuki] Osaka Univ, Dept Mol & Cellular Biochem, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Kou, Ikuyo; Furuichi, Tatsuya; Ikegawa, Shiro] RIKEN SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Wanaka, Akio] Nara Med Univ, Dept Anat & Neurosci, Nara 6348521, Japan	University of Miyazaki; Kumamoto University; Osaka University; RIKEN; Osaka University; Osaka University; Nara Medical University	Imaizumi, K (corresponding author), Miyazaki Univ, Div Mol & Cellular Biol, Dept Anat, Fac Med, 5200 Kihara, Miyazaki 8891692, Japan.	imaizumi@med.miyazaki-u.ac.jp	Wanaka, Akio/GPW-8926-2022; ikawa, masahito/A-5315-2009; Wanaka, Akio/ABE-4671-2020; Ikegawa, Shiro/N-6895-2015; Wanaka, Akio/AAC-9754-2019; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Ikegawa, Shiro/0000-0003-0316-2147; Wanaka, Akio/0000-0001-9951-9862; Nishimura, Riko/0000-0001-7279-8363; Okabe, Masaru/0000-0002-0803-9044	Japan Society for the Promotion of Science KAKENHI [20059028, 21790184, 20890175, 21790323, 21700410]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Takeda Medical Research Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Medical Research Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis)	We thank G. Karsenty (Columbia University) for providing plasmids (Col1a1 and Osteocalcin as probes for in situ hybridization, and pCMV-ATF4), G. Xiao (University of Pittsburgh, PA, USA) for providing a plasmid (pCMV-Runx2) and L. W. Fisher (National Institutes of Health, USA) for providing an LF41 antibody, M. Tohyama and S. Shiosaka for helpful discussions and critical reading of the manuscript, E. Nishida for technical advice and H. Yamato, H. Murayama,. W. Soma, M. Shimbara, I. Tsuchimochi, T. Kawanami, A. Ikeda, A. Kawai, and Y. Maruyama for technical support. This work was partly supported by grants from the Japan Society for the Promotion of Science KAKENHI (# 20059028, # 21790184, # 20890175, # 21790323, # 21700410), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Takeda Medical Research Foundation and NOVARTIS Foundation (Japan) for the Promotion of Science.	Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; DOMENICUCCI C, 1988, BIOCHEM J, V253, P139, DOI 10.1042/bj2530139; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Nagamori I, 2006, GENES CELLS, V11, P1161, DOI 10.1111/j.1365-2443.2006.01013.x; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nikaido T, 2001, HISTOCHEM CELL BIOL, V116, P141; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Rossert JA, 1996, P NATL ACAD SCI USA, V93, P1027, DOI 10.1073/pnas.93.3.1027; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	32	243	251	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1205	U90		10.1038/ncb1963	http://dx.doi.org/10.1038/ncb1963			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767743				2022-12-25	WOS:000270382000009
J	Brown, HA; Murphy, RC				Brown, H. Alex; Murphy, Robert C.			Working towards an exegesis for lipids in biology	NATURE CHEMICAL BIOLOGY			English	Article							IONIZATION MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; GAS CHROMATOGRAPHY; COMPUTER SYSTEM; SEPARATION; EXTRACTS; IMMUNITY	As a field, lipidomics is in its infancy, yet it has already begun to influence lipid biochemistry in myriad ways. As with other omic technologies, the field is driven by advances in analytical chemistry, particularly by mass spectrometry. At the heart of a renaissance in lipid biochemistry, systems biology is being used to define the cellular lipome, build a comprehensive picture of metabolic interconnections, discover new molecular species and determine how lipids modulate biological functions.	[Brown, H. Alex] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Murphy, Robert C.] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO USA	Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus	Brown, HA (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	alex.brown@vanderbilt.edu	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM069338, GM 069338] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS B, 1929, MOL BIOL CELL, P115; Austin MB, 2008, NAT CHEM BIOL, V4, P217, DOI 10.1038/nchembio0408-217; Berry KAZ, 2006, ANAL BIOCHEM, V349, P118, DOI 10.1016/j.ab.2005.11.020; Callender HL, 2007, ANAL CHEM, V79, P263, DOI 10.1021/ac061083q; Carado A, 2008, ANAL CHEM, V80, P7921, DOI 10.1021/ac801712s; Cooley M, 2008, CHEM BIOL, V15, P1141, DOI 10.1016/j.chembiol.2008.10.010; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; FONTELL KRISTER, 1960, JOUR LIPID RES, V1, P391; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hankin JA, 2007, J AM SOC MASS SPECTR, V18, P1646, DOI 10.1016/j.jasms.2007.06.010; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; HITES RA, 1968, ANAL CHEM, V40, P1217, DOI 10.1021/ac60264a013; Hutchins PM, 2008, J LIPID RES, V49, P804, DOI 10.1194/jlr.M700521-JLR200; JAMES AT, 1956, BIOCHEM J, V63, P144, DOI 10.1042/bj0630144; Koch W, 1906, J BIOL CHEM, V1, P203; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; McAnoy AM, 2005, J AM SOC MASS SPECTR, V16, P1498, DOI 10.1016/j.jasms.2005.04.017; McLean JA, 2007, J MASS SPECTROM, V42, P1099, DOI 10.1002/jms.1254; MURPHY RC, 1969, SCIENCE, V165, P695, DOI 10.1126/science.165.3894.695; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; Rouzer CA, 2006, BIOCHEMISTRY-US, V45, P14795, DOI 10.1021/bi061723j; RYHAGE RAGNAR, 1960, JOUR LIPID RES, V1, P361; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Thomas MC, 2007, ANAL CHEM, V79, P5013, DOI 10.1021/ac0702185; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786	34	102	104	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					602	606		10.1038/nchembio0909-602	http://dx.doi.org/10.1038/nchembio0909-602			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19690530	Green Accepted			2022-12-25	WOS:000269093000002
J	Horie, A; Tomita, T; Saiki, A; Kono, H; Taka, H; Mineki, R; Fujimura, T; Nishiyama, C; Kuzuyama, T; Nishiyama, M				Horie, Akira; Tomita, Takeo; Saiki, Asako; Kono, Hidetoshi; Taka, Hikari; Mineki, Reiko; Fujimura, Tsutomu; Nishiyama, Chiharu; Kuzuyama, Tomohisa; Nishiyama, Makoto			Discovery of proteinaceous N-modification in lysine biosynthesis of Thermus thermophilus	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-AMINOADIPATE AMINOTRANSFERASE; FATTY-ACID SYNTHASE; GENOME SEQUENCE; ARGININE-BIOSYNTHESIS; CARRIER PROTEIN; BACTERIUM; GENE; PATHWAY; CRENARCHAEON; EVOLUTION	Although the latter portion of lysine biosynthesis, the conversion of alpha-aminoadipate (AAA) to lysine, in Thermus thermophilus is similar to the latter portion of arginine biosynthesis, enzymes homologous to ArgA and ArgJ are absent from the lysine pathway. Because ArgA and ArgJ are known to modify the amino group of glutamate to avoid intramolecular cyclization of intermediates, their absence suggests that the pathway includes an alternative N-modification system. We reconstituted the conversion of AAA to lysine and found that the amino group of AAA is modified by attachment to the gamma-carboxyl group of the C-terminal Glu54 of a small protein, LysW; that the side chain of AAA is converted to the lysyl side chain while still attached to LysW; and that lysine is subsequently liberated from the LysW-lysine fusion. The fact that biosynthetic enzymes recognize the acidic globular domain of LysW indicates that LysW acts as a carrier protein or protein scaffold for the biosynthetic enzymes. This study thus reveals the previously unknown function of a small protein in primary metabolism.	[Kono, Hidetoshi] Japan Atom Energy Agcy, Computat Biol Grp, Quantum Beam Sci Directorate, Kyoto, Japan; [Kono, Hidetoshi] Japan Atom Energy Agcy, Quantum Bioinformat Team, Ctr Computat Sci & E Syst, Kyoto, Japan; [Taka, Hikari; Mineki, Reiko; Fujimura, Tsutomu] Juntendo Univ, Sch Med, Cent Lab Med Sci, Ctr Biochem Anal,Bunkyo Ku, Tokyo 113, Japan; [Nishiyama, Chiharu] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 113, Japan; [Nishiyama, Makoto] RIKEN, SPring Ctr 8, Sayo, Hyogo, Japan; [Horie, Akira; Tomita, Takeo; Saiki, Asako; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan	Japan Atomic Energy Agency; Japan Atomic Energy Agency; Juntendo University; Juntendo University; RIKEN; University of Tokyo	Nishiyama, M (corresponding author), Kirin Holdings Co, Cent Labs Frontier Technol, Yokohama, Kanagawa, Japan.	umanis@mail.ecc.u-tokyo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022	Kono, Hidetoshi/0000-0001-5729-8707; Kuzuyama, Tomohisa/0000-0002-7221-5858; Fujimura, Tsutomu/0000-0003-1744-7725; Nishiyama, Makoto/0000-0001-8143-8052	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nagase Science and Technology Foundation; Asahi Glass Foundation; Charitable Trust	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagase Science and Technology Foundation; Asahi Glass Foundation; Charitable Trust	We thank H. Satsu for technical help with amino acid analysis. This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, from the Nagase Science and Technology Foundation, from the Asahi Glass Foundation and from the Charitable Trust Araki Medical and Biochemistry Memorial Research Promotion Fund.	Baetens M, 1998, MICROBIOL-SGM, V144, P479, DOI 10.1099/00221287-144-2-479; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Broquist HP., 1971, METHODS ENZYMOL, V17B, P112; BUCHLI R, 1995, J BIOL CHEM, V270, P29330, DOI 10.1074/jbc.270.49.29330; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Iwasaki T, 2005, J BIOL CHEM, V280, P9129, DOI 10.1074/jbc.M414051200; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Jia YH, 2006, BIOCHEM J, V396, P479, DOI 10.1042/BJ20051711; KANG WK, 1989, MOL GEN GENET, V217, P281, DOI 10.1007/BF02464894; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; LEISINGER T, 1975, J BIOL CHEM, V250, P1690; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; MAJERUS PW, 1964, P NATL ACAD SCI USA, V51, P1231, DOI 10.1073/pnas.51.6.1231; MARTIN PR, 1992, J BACTERIOL, V174, P2694, DOI 10.1128/jb.174.8.2694-2701.1992; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Miyazaki J, 2002, FEBS LETT, V512, P269, DOI 10.1016/S0014-5793(02)02290-1; Miyazaki J, 2001, J BACTERIOL, V183, P5067, DOI 10.1128/JB.183.17.5067-5073.2001; Miyazaki T, 2004, MICROBIOL-SGM, V150, P2327, DOI 10.1099/mic.0.27037-0; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Robb FT, 2001, METHOD ENZYMOL, V330, P134; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; SNOKE JE, 1955, J BIOL CHEM, V213, P813; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06; Zhao QF, 2008, CHEM BIOL, V15, P693, DOI 10.1016/j.chembiol.2008.05.021	36	37	45	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					673	679		10.1038/nchembio.198	http://dx.doi.org/10.1038/nchembio.198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19620981				2022-12-25	WOS:000269093000016
J	Geu-Flores, F; Nielsen, MT; Nafisi, M; Moldrup, ME; Olsen, CE; Motawia, MS; Halkier, BA				Geu-Flores, Fernando; Nielsen, Morten Thrane; Nafisi, Majse; Moldrup, Morten Emil; Olsen, Carl Erik; Motawia, Mohammed Saddik; Halkier, Barbara Ann			Glucosinolate engineering identifies gamma-glutamyl peptidase	NATURE CHEMICAL BIOLOGY			English	Article							MYROSINASE SYSTEM; CANCER; SULFORAPHANE; GLUTATHIONE; PATHWAY	Consumption of cruciferous vegetables is associated with reduced risk of developing cancer, a phenomenon attributed to glucosinolates, which are characteristic of these vegetables. We report production of the bioactive benzylglucosinolate in the noncruciferous plant Nicotiana benthamiana through metabolic engineering. The study includes identification of gamma-glutamyl peptidase 1 (GGP1), which substantially increased glucosinolate production by metabolizing an accumulating glutathione conjugate, an activity not previously described for glucosinolate biosynthesis or for proteins containing glutamine amidotransferase domains.	[Geu-Flores, Fernando; Nielsen, Morten Thrane; Nafisi, Majse; Moldrup, Morten Emil; Motawia, Mohammed Saddik; Halkier, Barbara Ann] Univ Copenhagen, Fac Life Sci, Dept Plant Biol, Plant Biochem Lab, Frederiksberg, Denmark; [Geu-Flores, Fernando; Nielsen, Morten Thrane; Nafisi, Majse; Moldrup, Morten Emil; Olsen, Carl Erik; Motawia, Mohammed Saddik; Halkier, Barbara Ann] Univ Copenhagen, Fac Life Sci, Dept Plant Biol, VKR Res Ctr Proactive Plants, Frederiksberg, Denmark; [Olsen, Carl Erik] Univ Copenhagen, Fac Life Sci, Dept Nat Sci, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Halkier, BA (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Plant Biol, Plant Biochem Lab, Frederiksberg, Denmark.	bah@life.ku.dk	Halkier, Barbara A/H-3196-2014; Geu-Flores, Fernando/B-2737-2015; Olsen, Carl E/H-3031-2014	Halkier, Barbara A/0000-0002-3742-702X; Geu-Flores, Fernando/0000-0002-5735-9810; Olsen, Carl E/0000-0002-2275-0596; Motawia, Mohammed Saddik/0000-0001-5582-9463	Danish International Developmental Agency [91175]; Villum Kann Rasmussen Fond	Danish International Developmental Agency; Villum Kann Rasmussen Fond	We thank the Danish International Developmental Agency for a PhD stipend to F. G,- F. (DANIDA project no. 91175) and the Villum Kann Rasmussen Fond for its support to the VKR Research Centre for Pro-Active Plants. We also thank Novozymes for the Novo Scholarship to M. T, N and M. E. M.	Charron CS, 2005, J SCI FOOD AGR, V85, P671, DOI 10.1002/jsfa.1880; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Geu-Flores F, 2009, PLANTA, V229, P261, DOI 10.1007/s00425-008-0825-y; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; *INT AG RES CANC W, 2004, CRUC VEG IS IND; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kleinwachter M, 2008, J AGR FOOD CHEM, V56, P11165, DOI 10.1021/jf802053n; Kurihara S, 2006, FEMS MICROBIOL LETT, V256, P318, DOI 10.1111/j.1574-6968.2006.00137.x; Martin MN, 2007, PLANT PHYSIOL, V144, P1715, DOI 10.1104/pp.106.094409; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; SCHWIMMER S, 1960, BIOCHIM BIOPHYS ACTA, V42, P316, DOI 10.1016/0006-3002(60)90795-2; Traka M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002568; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x	19	110	115	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					575	577		10.1038/nchembio.185	http://dx.doi.org/10.1038/nchembio.185			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19483696				2022-12-25	WOS:000268209200014
J	Schwartz, SD; Schramm, VL				Schwartz, Steven D.; Schramm, Vern L.			Enzymatic transition states and dynamic motion in barrier crossing	NATURE CHEMICAL BIOLOGY			English	Article							PURINE NUCLEOSIDE PHOSPHORYLASE; REACTION COORDINATE; CATALYTIC PROFICIENCY; PROMOTING VIBRATIONS; ESCHERICHIA-COLI; REMOTE MUTATIONS; DISTAL MUTATIONS; HYDRIDE TRANSFER; COUPLED MOTIONS; ATOMIC DETAIL	What are the atomic motions at enzymatic catalytic sites on the timescale of chemical change? Combined experimental and computational chemistry approaches take advantage of transition-state analogs to reveal dynamic motions linked to transition-state formation. QM/MM transition path sampling from reactive complexes provides both temporal and dynamic information for barrier crossing. Fast (femtosecond to picosecond) dynamic motions provide essential links to enzymatic barrier crossing by local or promoting-mode dynamic searches through bond-vibrational space. Transition-state lifetimes are within the femtosecond timescales of bond vibrations and show no manifestations of stabilized, equilibrated complexes. The slow binding and protein conformational changes (microsecond to millisecond) also required for catalysis are temporally decoupled from the fast dynamic motions forming the transition state. According to this view of enzymatic catalysis, transition states are formed by fast, coincident dynamic excursions of catalytic site elements, while the binding of transition-state analogs is the conversion of the dynamic excursions to equilibrated states.	[Schwartz, Steven D.; Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Schwartz, Steven D.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Schwartz, SD (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	vern@aecom.yu.edu	Schwartz, Steven/H-4899-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068036] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM068036, P01 GM068036-040002, P01 GM068036-01A10002, P01 GM068036-06S17594, P01 GM068036-030002, P01 GM068036-020002, P01 GM068036-06S17592, P01 GM068036-050002] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Alexandrova AN, 2008, J AM CHEM SOC, V130, P15907, DOI 10.1021/ja804040s; Bandaria JN, 2008, J AM CHEM SOC, V130, P22, DOI 10.1021/ja077599o; Basner JE, 2005, J AM CHEM SOC, V127, P13822, DOI 10.1021/ja043320h; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bianchet MA, 2003, BIOCHEMISTRY-US, V42, P12455, DOI 10.1021/bi035372+; BIGELEISEN J, 1958, ADV CHEM PHYS, V1, P15; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bruice TC, 2002, ACCOUNTS CHEM RES, V35, P139, DOI 10.1021/ar0001665; Caratzoulas S, 2001, J CHEM PHYS, V114, P2910, DOI 10.1063/1.1342817; CHATFIELD DC, 1992, J PHYS CHEM-US, V96, P2414, DOI 10.1021/j100185a007; Chopra M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2980043; Cleland WW, 2005, ARCH BIOCHEM BIOPHYS, V433, P2, DOI 10.1016/j.abb.2004.08.027; Crehuet R, 2007, J PHYS CHEM B, V111, P5708, DOI 10.1021/jp067629u; Dellago C, 1998, J CHEM PHYS, V108, P9236, DOI 10.1063/1.476378; Deng H, 2004, J AM CHEM SOC, V126, P9516, DOI 10.1021/ja049296p; Deng H, 2008, BIOPHYS J, V95, P804, DOI 10.1529/biophysj.108.128884; Deng H, 2006, J AM CHEM SOC, V128, P7765, DOI 10.1021/ja0570281; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Gao JL, 2006, CHEM REV, V106, P3188, DOI 10.1021/cr050293k; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Gutierrez JA, 2007, ACS CHEM BIOL, V2, P725, DOI 10.1021/cb700166z; Gutierrez JA, 2009, NAT CHEM BIOL, V5, P251, DOI 10.1038/nchembio.153; Hammes-Schiffer S, 2002, BIOCHEMISTRY-US, V41, P13335, DOI 10.1021/bi0267137; Hammes-Schiffer S, 2006, ISOTOPE EFFECTS CHEM, P499; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hatcher E, 2004, J AM CHEM SOC, V126, P5763, DOI 10.1021/ja039606o; Hay S, 2008, CHEMPHYSCHEM, V9, P1875, DOI 10.1002/cphc.200800303; Hay S, 2009, ANGEW CHEM INT EDIT, V48, P1452, DOI 10.1002/anie.200805502; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; HORENSTEIN BA, 1993, BIOCHEMISTRY-US, V32, P20658; Hu J, 2008, P NATL ACAD SCI USA, V105, P4615, DOI 10.1073/pnas.0708058105; JENCKS WP, 1980, ACCOUNTS CHEM RES, V13, P161, DOI 10.1021/ar50150a001; Johannissen LO, 2008, J R SOC INTERFACE, V5, pS225, DOI 10.1098/rsif.2008.0068.focus; Juraszek J, 2008, BIOPHYS J, V95, P4246, DOI 10.1529/biophysj.108.136267; Kanaan N, 2009, J PHYS CHEM A, V113, P2176, DOI 10.1021/jp810548d; Karsten W. E., 2006, ISOTOPE EFFECTS CHEM, P793; KLINE PC, 1993, BIOCHEMISTRY-US, V32, P13212, DOI 10.1021/bi00211a033; Klinman JP, 2009, CHEM PHYS LETT, V471, P179, DOI 10.1016/j.cplett.2009.01.038; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Lewis CA, 2008, P NATL ACAD SCI USA, V105, P17328, DOI 10.1073/pnas.0809838105; Liu HB, 2007, BIOCHEMISTRY-US, V46, P6011, DOI 10.1021/bi700201w; Liu Q, 2008, CHEM BIOL, V15, P1068, DOI 10.1016/j.chembiol.2008.08.007; Luo M, 2008, BIOCHEMISTRY-US, V47, P2565, DOI 10.1021/bi702133x; Ma L, 2007, J AM CHEM SOC, V129, P10261, DOI 10.1021/ja073059f; MARCUS RA, 2006, J CHEM PHYS, V124; Miller BG, 2002, ANNU REV BIOCHEM, V71, P847, DOI 10.1146/annurev.biochem.71.110601.135446; MILLER WH, 1974, J CHEM PHYS, V61, P1823, DOI 10.1063/1.1682181; Murkin AS, 2008, BIOORG MED CHEM LETT, V18, P5900, DOI 10.1016/j.bmcl.2008.08.047; Murkin AS, 2008, J AM CHEM SOC, V130, P2166, DOI 10.1021/ja7104398; Murkin AS, 2007, BIOCHEMISTRY-US, V46, P5038, DOI 10.1021/bi700147b; Nunez S, 2004, J AM CHEM SOC, V126, P15720, DOI 10.1021/ja0457563; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; PECHUKAS P, 1973, J CHEM PHYS, V58, P1622, DOI 10.1063/1.1679404; Pool R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2741513; Quaytman SL, 2007, P NATL ACAD SCI USA, V104, P12253, DOI 10.1073/pnas.0704304104; Ringia EAT, 2006, J AM CHEM SOC, V128, P7126, DOI 10.1021/ja081403n; Roca M, 2006, J AM CHEM SOC, V128, P6186, DOI 10.1021/ja058826u; Ruiz-Pernia JJ, 2008, J AM CHEM SOC, V130, P7477, DOI 10.1021/ja801156y; Saen-oon S, 2008, P NATL ACAD SCI USA, V105, P16543, DOI 10.1073/pnas.0808413105; Saen-Oon S, 2008, BIOPHYS J, V94, P4078, DOI 10.1529/biophysj.107.121913; SCHOWEN RL, 2006, ISOTOPE EFFECTS CHEM, P765; Schramm VL, 2007, J BIOL CHEM, V282, P28297, DOI 10.1074/jbc.R700018200; Schramm VL, 2005, CURR OPIN STRUC BIOL, V15, P604, DOI 10.1016/j.sbi.2005.10.017; Schramm VL, 1998, ANNU REV BIOCHEM, V67, P693, DOI 10.1146/annurev.biochem.67.1.693; Schramm VL, 2005, ARCH BIOCHEM BIOPHYS, V433, P13, DOI 10.1016/j.abb.2004.08.035; Singh V, 2005, BIOCHEMISTRY-US, V44, P11647, DOI 10.1021/bi050863a; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Watney JB, 2006, J PHYS CHEM B, V110, P10130, DOI 10.1021/jp0605956; WOLFENDE.R, 1969, NATURE, V223, P704, DOI 10.1038/223704a0; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102; Xu Y, 2004, BIOORGAN MED CHEM, V12, P5247, DOI 10.1016/j.bmc.2004.03.077; Zhang XY, 2005, ACCOUNTS CHEM RES, V38, P379, DOI 10.1021/ar040257s; [No title captured]	84	198	199	0	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					552	559		10.1038/nchembio.202	http://dx.doi.org/10.1038/nchembio.202			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19620996	Green Accepted			2022-12-25	WOS:000268209200011
J	Wrensch, M; Jenkins, RB; Chang, JS; Yeh, RF; Xiao, YY; Decker, PA; Ballman, KV; Berger, M; Buckner, JC; Chang, S; Giannini, C; Halder, C; Kollmeyer, TM; Kosel, ML; LaChance, DH; McCoy, L; O'Neill, BP; Patoka, J; Pico, AR; Prados, M; Quesenberry, C; Rice, T; Rynearson, AL; Smirnov, I; Tihan, T; Wiemels, J; Yang, P; Wiencke, JK				Wrensch, Margaret; Jenkins, Robert B.; Chang, Jeffrey S.; Yeh, Ru-Fang; Xiao, Yuanyuan; Decker, Paul A.; Ballman, Karla V.; Berger, Mitchel; Buckner, Jan C.; Chang, Susan; Giannini, Caterina; Halder, Chandralekha; Kollmeyer, Thomas M.; Kosel, Matthew L.; LaChance, Daniel H.; McCoy, Lucie; O'Neill, Brian P.; Patoka, Joe; Pico, Alexander R.; Prados, Michael; Quesenberry, Charles; Rice, Terri; Rynearson, Amanda L.; Smirnov, Ivan; Tihan, Tarik; Wiemels, Joe; Yang, Ping; Wiencke, John K.			Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility	NATURE GENETICS			English	Article							TELOMERASE ACTIVITY; GENOME; LOCUS; TUMOR; EPIDEMIOLOGY; P15(INK4B); TRAITS; GROWTH; LENGTH; MYC	The causes of glioblastoma and other gliomas remain obscure(1,2). To discover new candidate genes influencing glioma susceptibility, we conducted a principal component adjusted(3) genome-wide association study (GWAS) of 275,895 autosomal variants among 692 adult high-grade glioma cases (622 from the San Francisco Adult Glioma Study (AGS) and 70 from the Cancer Genome Atlas (TCGA))(4) and 3,992 controls (602 from AGS and 3,390 from Illumina iControlDB (iControls)). For replication, we analyzed the 13 SNPs with P < 10(-6) using independent data from 176 high-grade glioma cases and 174 controls from the Mayo Clinic. On 9p21, rs1412829 near CDKN2B had discovery P = 3.4 x 10(-8), replication P = 0.0038 and combined P = 1.85 x 10(-10). On 20q13.3, rs6010620 intronic to RTEL1 had discovery P = 1.5 x 10(-7), replication P = 0.00035 and combined P = 3.40 x 10(-9) . For both SNPs, the direction of association was the same in discovery and replication phases.	[Wrensch, Margaret; Berger, Mitchel; Chang, Susan; McCoy, Lucie; Patoka, Joe; Prados, Michael; Rice, Terri; Smirnov, Ivan; Wiencke, John K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Wrensch, Margaret; Wiemels, Joe; Wiencke, John K.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Jenkins, Robert B.; Giannini, Caterina; Halder, Chandralekha; Kollmeyer, Thomas M.; Rynearson, Amanda L.] Mayo Clin, Dept Expt Pathol, Rochester, MN USA; [Chang, Jeffrey S.; Yeh, Ru-Fang; Xiao, Yuanyuan; Wiemels, Joe] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Decker, Paul A.; Ballman, Karla V.; Kosel, Matthew L.] Mayo Clin, Div Biostat, Rochester, MN USA; [Buckner, Jan C.] Mayo Clin, Dept Oncol, Rochester, MN USA; [LaChance, Daniel H.; O'Neill, Brian P.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Pico, Alexander R.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Quesenberry, Charles] Kaiser Permanente, Div Res, Oakland, CA USA; [Tihan, Tarik] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Yang, Ping] Mayo Clin, Div Epidemiol, Rochester, MN USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; University of California System; University of California San Francisco; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of California System; University of California San Francisco; The J David Gladstone Institutes; Kaiser Permanente; University of California System; University of California San Francisco; Mayo Clinic	Wrensch, M (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	margaret.wrensch@ucsf.edu	Pico, Alexander/HCH-4305-2022; Tihan, Tarik/AAU-6371-2021; Giannini, Caterina/AAB-7551-2022; Prados, Michael/N-5220-2019; Chang, Jeffrey Shu-Ming/B-1092-2010; Chang, Jeffrey Shu-Ming/AAR-4161-2020; Rice, Terri/J-6071-2014; Buckner, Jan/AAE-6388-2019	Chang, Jeffrey Shu-Ming/0000-0002-3236-6205; Ballman, Karla/0000-0002-4492-0357; Tihan, Tarik/0000-0003-4551-2555; Pico, Alexander/0000-0001-5706-2163	NCI NIH HHS [P50 CA097257, P30 CA15083, R01 CA052689-19, P50 CA108961, R25 CA 112355, R01CA52689, P50CA097257, R25 CA112355, P30 CA015083, R01 CA052689] Funding Source: Medline; NINDS NIH HHS [RC1 NS068222-01, RC1 NS068222] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA015083, P50CA097257, P50CA108961, R01CA052689, R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068222] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bahuau M, 1998, CANCER RES, V58, P2298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; *CBTRUS, 2008, PRIM BRAIN TUM US ST; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Davis FG, 2008, CANCER EPIDEM BIOMAR, V17, P484, DOI 10.1158/1055-9965.EPI-07-0725; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Falchetti ML, 2006, NEUROL RES, V28, P532, DOI 10.1179/016164106X116818; Felini MJ, 2009, CANCER CAUSE CONTROL, V20, P87, DOI 10.1007/s10552-008-9220-z; Fuxe J, 2000, CELL GROWTH DIFFER, V11, P373; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Lemmens R, 2009, EUR J HUM GENET, V17, P1287, DOI 10.1038/ejhg.2009.42; Maes L, 2007, ONCOL REP, V18, P1571; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mohlke KL, 2008, HUM MOL GENET, V17, pR102, DOI 10.1093/hmg/ddn275; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pico AR, 2009, NUCLEIC ACIDS RES, V37, pD803, DOI 10.1093/nar/gkn756; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Schaefer AS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000378; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shervington A, 2006, MOL CELL BIOCHEM, V283, P1, DOI 10.1007/s11010-006-2495-z; Wrensch M, 2007, CLIN CANCER RES, V13, P197, DOI 10.1158/1078-0432.CCR-06-1199	28	392	397	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					905	U61		10.1038/ng.408	http://dx.doi.org/10.1038/ng.408			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19578366	Green Accepted			2022-12-25	WOS:000268432900015
J	Schweizerhof, M; Stosser, S; Kurejova, M; Njoo, C; Gangadharan, V; Agarwal, N; Schmelz, M; Bali, KK; Michalski, CW; Brugger, S; Dickenson, A; Simone, DA; Kuner, R				Schweizerhof, Matthias; Stoesser, Sebastian; Kurejova, Martina; Njoo, Christian; Gangadharan, Vijayan; Agarwal, Nitin; Schmelz, Martin; Bali, Kiran Kumar; Michalski, Christoph W.; Brugger, Stefan; Dickenson, Anthony; Simone, Donald A.; Kuner, Rohini			Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain	NATURE MEDICINE			English	Article							FACTOR GM-CSF; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR; FUNCTIONAL INTERACTIONS; PANCREATIC-CANCER; PERIPHERAL-NERVE; HUMAN MONOCYTES; MURINE MODEL; EXPRESSION; PROTEIN	Pain is one of the most severe and debilitating symptoms associated with several forms of cancer(1,2). Various types of carcinomas and sarcomas metastasize to skeletal bones and cause spontaneous bone pain and hyperalgesia, which is accompanied by bone degradation and remodeling of peripheral nerves(2). Despite recent advances, the molecular mechanisms underlying the development and maintenance of cancer-evoked pain are not well understood(2). Several types of non-hematopoietic tumors secrete hematopoietic colony-stimulating factors that act on myeloid cells(3) and tumor cells(4). Here we report that receptors and signaling mediators of granulocyte-and granulocyte-macrophage colony-stimulating factors (G-CSF and GM-CSF)(3) are also functionally expressed on sensory nerves. GM-CSF sensitized nerves to mechanical stimuli in vitro and in vivo, potentiated CGRP release and caused sprouting of sensory nerve endings in the skin. Interruption of G-CSF and GM-CSF signaling in vivo led to reduced tumor growth and nerve remodeling, and abrogated bone cancer pain. The key significance of GM-CSF signaling in sensory neurons was revealed by an attenuation of tumor-evoked pain following a sensory nerve-specific knockdown of GM-CSF receptors. These results show that G-CSF and GM-CSF are important in tumor-nerve interactions and suggest that their receptors on primary afferent nerve fibers constitute potential therapeutic targets in cancer pain.	[Schweizerhof, Matthias; Stoesser, Sebastian; Kurejova, Martina; Njoo, Christian; Gangadharan, Vijayan; Agarwal, Nitin; Bali, Kiran Kumar; Michalski, Christoph W.; Brugger, Stefan; Kuner, Rohini] Heidelberg Univ, Inst Pharmacol, D-6900 Heidelberg, Germany; [Schmelz, Martin] Heidelberg Univ, Dept Anesthesiol & Intens Care Med, Med Fac Mannheim, D-6800 Mannheim, Germany; [Michalski, Christoph W.] Heidelberg Univ, Dept Surg, D-6900 Heidelberg, Germany; [Dickenson, Anthony] UCL, Dept Pharmacol, London, England; [Simone, Donald A.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities	Kuner, R (corresponding author), Heidelberg Univ, Inst Pharmacol, D-6900 Heidelberg, Germany.	rohini.kuner@pharma.uni-heidelberg.de	Michalski, Christoph/U-9167-2019; Schmelz, Martin/A-9327-2013; Bali, Kiran/F-6828-2013; Kuner, Rohini/AGU-0204-2022	Schmelz, Martin/0000-0002-9736-7241; Bali, Kiran/0000-0002-9503-1402; Gangadharan, Vijayan/0000-0002-2385-045X	Association of International Cancer Research; Landesstiftung Baden-Wurttemberg; US National Institutes of Health [DA11471, CA91007]; NATIONAL CANCER INSTITUTE [R01CA091007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011471] Funding Source: NIH RePORTER	Association of International Cancer Research; Landesstiftung Baden-Wurttemberg; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank H.-J. Wrede, C. Harding-Rose and D. Baumgartl-Ahlert for technical assistance and R. LeFaucheur for secretarial help. This work was supported by grants from the Association of International Cancer Research and the Landesstiftung Baden-Wurttemberg (Program RNAi) to R. K. and by US National Institutes of Health grants DA11471 and CA91007 to D. A. S.	Angst MS, 2008, PAIN, V139, P15, DOI 10.1016/j.pain.2008.02.028; Cain DM, 2001, J NEUROSCI, V21, P9367, DOI 10.1523/JNEUROSCI.21-23-09367.2001; Carvalho B, 2008, J PAIN, V9, P650, DOI 10.1016/j.jpain.2008.02.004; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; DANIS VA, 1991, CLIN EXP IMMUNOL, V85, P143; Davar G, 2001, PAIN MED, V2, P24, DOI 10.1046/j.1526-4637.2001.002001024.x; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; DEDHAR S, 1988, P NATL ACAD SCI USA, V85, P9253, DOI 10.1073/pnas.85.23.9253; Giron-Michel J, 2003, J EXP MED, V197, P763, DOI 10.1084/jem.20020150; Glatzel W, 2000, P NATL ACAD SCI USA, V97, P442, DOI 10.1073/pnas.97.1.442; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Honore P, 2000, PAIN MED, V1, P303, DOI 10.1046/j.1526-4637.2000.00047.x; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kasper B, 1997, BLOOD, V90, P2839, DOI 10.1182/blood.V90.7.2839.2839_2839_2840; Khasabova IA, 2007, J NEUROSCI, V27, P10289, DOI 10.1523/JNEUROSCI.2851-07.2007; Lehtonen A, 2002, J LEUKOCYTE BIOL, V71, P511; LINDEMANN A, 1989, BLOOD, V74, P2644; Lindsay TH, 2005, PAIN, V119, P233, DOI 10.1016/j.pain.2005.10.019; McIntyre GJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-1; Monfardini C, 1998, J BIOL CHEM, V273, P7657, DOI 10.1074/jbc.273.13.7657; Owen JL, 2005, CELL IMMUNOL, V235, P122, DOI 10.1016/j.cellimm.2005.08.032; Portenoy RK, 1999, LANCET, V353, P1695, DOI 10.1016/S0140-6736(99)01310-0; Salh B, 1998, IMMUNOLOGY, V95, P473, DOI 10.1046/j.1365-2567.1998.00614.x; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Tachibana M, 1998, CYTOKINES CELL MOL T, V4, P113; Tigue CC, 2007, BONE MARROW TRANSPL, V40, P185, DOI 10.1038/sj.bmt.1705722; VADHANRAJ S, 1987, NEW ENGL J MED, V317, P1545, DOI 10.1056/NEJM198712173172501; Wacnik PW, 2005, NEUROSCIENCE, V132, P479, DOI 10.1016/j.neuroscience.2004.12.035; Wacnik PW, 2001, J NEUROSCI, V21, P9355, DOI 10.1523/JNEUROSCI.21-23-09355.2001; Waller EK, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S2-22; Zhu ZW, 1999, J CLIN ONCOL, V17, P2419, DOI 10.1200/JCO.1999.17.8.2419	34	151	162	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2009	15	7					802	U122		10.1038/nm.1976	http://dx.doi.org/10.1038/nm.1976			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	468HE	19525966				2022-12-25	WOS:000267806900035
J	Ong, KK; Elks, CE; Li, SX; Zhao, JH; Luan, J; Andersen, LB; Bingham, SA; Brage, S; Smith, GD; Ekelund, U; Gillson, CJ; Glaser, B; Golding, J; Hardy, R; Khaw, KT; Kuh, D; Luben, R; Marcus, M; McGeehin, MA; Ness, AR; Northstone, K; Ring, SM; Rubin, C; Sims, MA; Song, K; Strachan, DP; Vollenweider, P; Waeber, G; Waterworth, DM; Wong, A; Deloukas, P; Barroso, I; Mooser, V; Loos, RJ; Wareham, NJ				Ong, Ken K.; Elks, Cathy E.; Li, Shengxu; Zhao, Jing Hua; Luan, Jian'an; Andersen, Lars B.; Bingham, Sheila A.; Brage, Soren; Smith, George Davey; Ekelund, Ulf; Gillson, Christopher J.; Glaser, Beate; Golding, Jean; Hardy, Rebecca; Khaw, Kay-Tee; Kuh, Diana; Luben, Robert; Marcus, Michele; McGeehin, Michael A.; Ness, Andrew R.; Northstone, Kate; Ring, Susan M.; Rubin, Carol; Sims, Matthew A.; Song, Kijoung; Strachan, David P.; Vollenweider, Peter; Waeber, Gerard; Waterworth, Dawn M.; Wong, Andrew; Deloukas, Panagiotis; Barroso, Ines; Mooser, Vincent; Loos, Ruth J.; Wareham, Nicholas J.			Genetic variation in LIN28B is associated with the timing of puberty	NATURE GENETICS			English	Article							EPIC-NORFOLK; IDENTIFICATION; RISK; AGE	The timing of puberty is highly variable(1). We carried out a genome-wide association study for age at menarche in 4,714 women and report an association in LIN28B on chromosome 6 (rs314276, minor allele frequency (MAF) = 0.33, P = 1.5 x 10(-8)). In independent replication studies in 16,373 women, each major allele was associated with 0.12 years earlier menarche (95% CI = 0.08-0.16; P = 2.8 x 10(-10); combined P = 3.6 x 10(-16)). This allele was also associated with earlier breast development in girls (P = 0.001; N = 4,271); earlier voice breaking (P = 0.006, N = 1,026) and more advanced pubic hair development in boys (P = 0.01; N = 4,588); a faster tempo of height growth in girls (P = 0.00008; N = 4,271) and boys (P = 0.03; N = 4,588); and shorter adult height in women (P = 3.6 x 10(-7); N = 17,274) and men (P = 0.006; N = 9,840) in keeping with earlier growth cessation. These studies identify variation in LIN28B, a potent and specific regulator of microRNA processing(2), as the first genetic determinant regulating the timing of human pubertal growth and development.	[Ong, Ken K.; Elks, Cathy E.; Li, Shengxu; Zhao, Jing Hua; Luan, Jian'an; Brage, Soren; Ekelund, Ulf; Gillson, Christopher J.; Sims, Matthew A.; Loos, Ruth J.; Wareham, Nicholas J.] Addenbrookes Hosp, MRC, Epidemiol Unit, Cambridge, England; [Ong, Ken K.; Elks, Cathy E.; Li, Shengxu; Zhao, Jing Hua; Luan, Jian'an; Brage, Soren; Ekelund, Ulf; Gillson, Christopher J.; Sims, Matthew A.; Loos, Ruth J.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, Cambridge, England; [Ong, Ken K.] Univ Cambridge, Dept Paediat, Cambridge, England; [Andersen, Lars B.] Univ So Denmark, Inst Sport Sci & Clin Biomech, Odense, Denmark; [Bingham, Sheila A.] MRC Dunn Human Nutr Unit, Cambridge, England; [Bingham, Sheila A.] MRC Ctr Nutr Epidemiol Canc Prevent & Survival, Cambridge, England; [Smith, George Davey; Glaser, Beate] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Ekelund, Ulf] Univ Orebro, Sch Med & Hlth Sci, Orebro, Sweden; [Golding, Jean] Univ Bristol, Dept Community Based Med, ALSPAC, Bristol, Avon, England; [Hardy, Rebecca; Kuh, Diana; Wong, Andrew] MRC Unit Lifelong Hlth & Ageing, London, England; [Khaw, Kay-Tee; Luben, Robert] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Marcus, Michele; McGeehin, Michael A.; Rubin, Carol] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Marcus, Michele] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Marcus, Michele] Emory Univ, Rollins Sch Publ Hlth, Dept Environm & Occupat Hlth, Atlanta, GA 30322 USA; [Ness, Andrew R.] Univ Bristol, Dept Oral & Dent Sci, Bristol, Avon, England; [Northstone, Kate; Ring, Susan M.] Univ Bristol, Dept Social Med, ALSPAC, Bristol, Avon, England; [Song, Kijoung; Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline, Div Genet, King Of Prussia, PA USA; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Vollenweider, Peter; Waeber, Gerard] BH10 CHUV, Dept Internal Med, Lausanne, Switzerland; [Deloukas, Panagiotis; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Southern Denmark; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of Bristol; Orebro University; University of Bristol; University of Cambridge; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University of Bristol; University of Bristol; GlaxoSmithKline; University of London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Wellcome Trust Sanger Institute	Ong, KK (corresponding author), Addenbrookes Hosp, MRC, Epidemiol Unit, Cambridge, England.	ken.ong@mrc-epid.cam.ac.uk; ruth.loos@mrc-epid.cam.ac.uk	Berryman, Katie/J-4236-2014; Brage, Soren/C-6415-2013; Ness, Andy R/M-7612-2013; Hardy, Rebecca/AFR-1989-2022; Wong, Andrew/M-8899-2016; Luben, Robert N/H-5519-2015; Marcus, Michele/J-2746-2015; Loos, Ruth/GON-5877-2022; Davey Smith, George/A-7407-2013; Wong, Andrew/AAE-6995-2019; Kuh, Diana/L-6019-2014; Loos, Ruth J F/Q-2862-2016; Deloukas, Panos/B-2922-2013; St Pourcain, Beate/K-8004-2017; Khaw, Kay-Tee/AAZ-3209-2021; Ekelund, Ulf/AAE-8471-2019; Northstone, Kate/A-8165-2011; Colaus, PsyColaus/K-6607-2013	Brage, Soren/0000-0002-1265-7355; Ness, Andy R/0000-0003-3548-9523; Wong, Andrew/0000-0003-2079-4779; Luben, Robert N/0000-0002-5088-6343; Davey Smith, George/0000-0002-1407-8314; Wong, Andrew/0000-0003-2079-4779; Kuh, Diana/0000-0001-7386-2857; Loos, Ruth J F/0000-0002-8532-5087; Deloukas, Panos/0000-0001-9251-070X; St Pourcain, Beate/0000-0002-4680-3517; Ekelund, Ulf/0000-0003-2115-9267; Northstone, Kate/0000-0002-0602-1983; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Waeber, Gerard/0000-0003-4193-788X; Barroso, Ines/0000-0001-5800-4520; Golding, Jean/0000-0003-2826-3307; Hardy, Rebecca/0000-0001-9949-0799; s, hema/0000-0002-3440-9475	UK Medical Research Council; Wellcome Trust; University of Bristol; Faculty of Biology and Medicine of Lausanne, Switzerland; GlaxoSmithKline; Medical Research Council [MC_U106179472, G9815508, MC_U123092721, G0701863, MC_U105630924, G0600717B, MC_U106179471, MC_U123092720, G0401527, G0000934, MC_U106179473, MC_U106188470] Funding Source: researchfish; MRC [G0000934, MC_U106188470, MC_U106179473, MC_U123092720, G0701863, MC_U106179472, MC_U123092721, MC_U105630924] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Faculty of Biology and Medicine of Lausanne, Switzerland; GlaxoSmithKline(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to all of the participants in each of the studies contributing to this effort. Full acknowledgments can be found in the Supplementary Note. Support for this research was provided by: the UK Medical Research Council; the Wellcome Trust; University of Bristol; the Faculty of Biology and Medicine of Lausanne, Switzerland; and GlaxoSmithKline.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Day N, 1999, BRIT J CANCER, V80, P95; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Gajdos ZKZ, 2009, CURR OPIN ENDOCRINOL, V16, P16, DOI 10.1097/MED.0b013e328320253c; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Harries MLL, 1997, ARCH DIS CHILD, V77, P445, DOI 10.1136/adc.77.5.445; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wehkalampi K, 2008, AM J HUM BIOL, V20, P417, DOI 10.1002/ajhb.20748; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	15	234	244	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					729	733		10.1038/ng.382	http://dx.doi.org/10.1038/ng.382			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19448623	Green Accepted, Green Published			2022-12-25	WOS:000266411700024
J	Plutzky, J				Plutzky, Jorge			The mighty, mighty fatty acid	NATURE MEDICINE			English	Editorial Material							ADIPOSE-TISSUE; INSULIN-RESISTANCE; OBESITY; METABOLISM; CONTRIBUTE; MICE		Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Plutzky, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA.	jplutzky@rics.bwh.harvard.edu	Plutzky, Jorge/V-3410-2019		NHLBI NIH HHS [P01 HL048743] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Eleftheriadou I, 2008, CURR DIABETES REV, V4, P340, DOI 10.2174/157339908786241133; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9; Speakman J, 2008, LAB ANIM-UK, V42, P413, DOI 10.1258/la.2007.006067; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	19	10	10	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2009	15	6					618	619		10.1038/nm0609-618	http://dx.doi.org/10.1038/nm0609-618			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19498375	Green Accepted			2022-12-25	WOS:000266731600019
J	Satoh, K; Nigro, P; Matoba, T; O'Dell, MR; Cui, ZQ; Shi, X; Mohan, A; Yan, C; Abe, J; Illig, KA; Berk, BC				Satoh, Kimio; Nigro, Patrizia; Matoba, Tetsuya; O'Dell, Michael R.; Cui, Zhaoqiang; Shi, Xi; Mohan, Amy; Yan, Chen; Abe, Jun-ichi; Illig, Karl A.; Berk, Bradford C.			Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; MATRIX METALLOPROTEINASES; INDUCED ATHEROSCLEROSIS; RHO-KINASE; PATHOGENESIS; MMP-2; GENE; HYPERTENSION; ACTIVATION	Inflammation and oxidative stress are pathogenic mediators of many diseases, but molecules that could be therapeutic targets remain elusive. Inflammation and matrix degradation in the vasculature are crucial for abdominal aortic aneurysm (AAA) formation. Cyclophilin A (CypA, encoded by Ppia) is highly expressed in vascular smooth muscle cells (VSMCs), is secreted in response to reactive oxygen species (ROS) and promotes inflammation. Using the angiotensin II (AngII)-induced AAA model in Apoe(-/-) mice, we show that Apoe(-/-) Ppia(-/-) mice are completely protected from AngII-induced AAA formation, in contrast to Apoe(-/-) Ppia(+/+) mice. Apoe(-/-) Ppia(-/-) mice show decreased inflammatory cytokine expression, elastic lamina degradation and aortic expansion. These features were not altered by reconstitution of bone marrow cells from Ppia(+/+) mice. Mechanistic studies showed that VSMC-derived intracellular and extracellular CypA are required for ROS generation and matrix metalloproteinase-2 activation. These data define a previously undescribed role for CypA in AAA formation and suggest CypA as a new target for treating cardiovascular disease.	[Satoh, Kimio; Nigro, Patrizia; Matoba, Tetsuya; O'Dell, Michael R.; Cui, Zhaoqiang; Shi, Xi; Mohan, Amy; Yan, Chen; Abe, Jun-ichi; Berk, Bradford C.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA; [Satoh, Kimio; Nigro, Patrizia; Matoba, Tetsuya; O'Dell, Michael R.; Cui, Zhaoqiang; Shi, Xi; Mohan, Amy; Yan, Chen; Abe, Jun-ichi; Berk, Bradford C.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY USA; [Illig, Karl A.] Univ Rochester, Sch Med & Dent, Div Vasc Surg, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester	Berk, BC (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA.	bradford_berk@urmc.rochester.edu	Matoba, Tetsuya/M-1920-2013; Satoh, Kimio/O-7794-2019	Nigro, Patrizia/0000-0003-0182-4346; Berk, Bradford/0000-0002-2767-4115; Yan, Chen/0000-0002-1397-6358; Matoba, Tetsuya/0000-0003-4563-304X	US National Institutes of Health grant [HL49192]; Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049192] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by US National Institutes of Health grant HL49192 (to B. C. B.) and Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad (to K. S.). We are grateful to the Aab Cardiovascular Research Institute members for useful suggestions and R. Winterkorn, M. A. Georger and A. T. Paxhia for technical assistance.	Bharadwaj U, 2005, J SURG RES, V127, P29, DOI 10.1016/j.jss.2005.02.020; Browatzki M, 2005, J VASC RES, V42, P415, DOI 10.1159/000087451; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Castier Y, 2005, CIRC RES, V97, P533, DOI 10.1161/01.RES.0000181759.63239.21; CHEN XF, 2008, IN VITRO CLIN SCI LO, DOI DOI 10.1042/CS20080235; Chen XL, 1998, CIRC RES, V83, P952; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Eagleton MJ, 2006, J SURG RES, V135, P345, DOI 10.1016/j.jss.2006.03.026; Ejiri J, 2003, CARDIOVASC RES, V59, P988, DOI 10.1016/S0008-6363(03)00523-6; Gavazzi G, 2007, HYPERTENSION, V50, P189, DOI 10.1161/HYPERTENSIONAHA.107.089706; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Guo HM, 1998, GENE, V220, P99, DOI 10.1016/S0378-1119(98)00400-4; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Haug C, 2004, ARTERIOSCL THROM VAS, V24, P1823, DOI 10.1161/01.ATV.0000142806.59283.11; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Khromykh LM, 2007, CELL IMMUNOL, V249, P46, DOI 10.1016/j.cellimm.2007.11.002; Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Luchtefeld M, 2005, BIOCHEM BIOPH RES CO, V328, P183, DOI 10.1016/j.bbrc.2004.12.152; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; McCormick ML, 2007, ARTERIOSCL THROM VAS, V27, P461, DOI 10.1161/01.ATV.0000257552.94483.14; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Satoh K, 2006, CIRCULATION, V113, P1442, DOI 10.1161/CIRCULATIONAHA.105.583732; Satoh K, 2008, CIRCULATION, V117, P3088, DOI 10.1161/CIRCULATIONAHA.107.756106; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Thomas M, 2006, CIRCULATION, V114, P404, DOI 10.1161/CIRCULATIONAHA.105.607168; Thompson RW, 1999, ANN NY ACAD SCI, V878, P159, DOI 10.1111/j.1749-6632.1999.tb07682.x; Valentin F, 2005, FUND CLIN PHARMACOL, V19, P661, DOI 10.1111/j.1472-8206.2005.00371.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200	46	295	311	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					649	U144		10.1038/nm.1958	http://dx.doi.org/10.1038/nm.1958			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19430489	Green Accepted			2022-12-25	WOS:000266731600024
J	Yao, CC; Sakata, D; Esaki, Y; Li, YX; Matsuoka, T; Kuroiwa, K; Sugimoto, Y; Narumiya, S				Yao, Chengcan; Sakata, Daiji; Esaki, Yoshiyasu; Li, Youxian; Matsuoka, Toshiyuki; Kuroiwa, Kenji; Sugimoto, Yukihiko; Narumiya, Shuh			Prostaglandin E-2-EP4 signaling promotes immune inflammation through T(H)1 cell differentiation and T(H)17 cell expansion	NATURE MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; BOWEL-DISEASE; TH17 CELLS; MULTIPLE-SCLEROSIS; T-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; CROHN-DISEASE; E-2; ACTIVATION	Two distinct helper T (T-H) subsets, T(H)1 and T(H)17, mediate tissue damage and inflammation in animal models of various immune diseases such as multiple sclerosis, rheumatoid arthritis, inflammatory bowel diseases and allergic skin disorders. These experimental findings, and the implication of these TH subsets in human diseases, suggest the need for pharmacological measures to manipulate these TH subsets. Here we show that prostaglandin E-2 (PGE(2)) acting on its receptor EP4 on T cells and dendritic cells not only facilitates T(H)1 cell differentiation but also amplifies interleukin-23-mediated T(H)17 cell expansion in vitro. Administration of an EP4-selective antagonist in vivo decreases accumulation of both T(H)1 and T(H)17 cells in regional lymph nodes and suppresses the disease progression in mice subjected to experimental autoimmune encephalomyelitis or contact hypersensitivity. Thus, PGE(2)-EP4 signaling promotes immune inflammation through T(H)1 differentiation and T(H)17 expansion, and EP4 antagonism may be therapeutically useful for various immune diseases.	[Yao, Chengcan; Sakata, Daiji; Esaki, Yoshiyasu; Li, Youxian; Matsuoka, Toshiyuki; Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; [Kuroiwa, Kenji; Sugimoto, Yukihiko] Kyoto Univ, Fac Pharmaceut Sci, Dept Physiol Chem, Kyoto 606, Japan	Kyoto University; Kyoto University	Narumiya, S (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Sugimoto, Yukihiko/AAV-6470-2021	Sugimoto, Yukihiko/0000-0001-6973-932X; Yao, Chengcan/0000-0003-3754-2842; Li, Youxian/0000-0003-3213-1358				Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Betti M, 2006, ANN ONCOL, V17, P235; BETZ M, 1991, J IMMUNOL, V146, P108; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chemnitz JM, 2006, CANCER RES, V66, P1114, DOI 10.1158/0008-5472.CAN-05-3252; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fassbender K, 1998, NEUROLOGY, V51, P753, DOI 10.1212/WNL.51.3.753; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; GOLD KN, 1994, ARTHRITIS RHEUM, V37, P925, DOI 10.1002/art.1780370623; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; HASLER F, 1983, J IMMUNOL, V131, P768; Herve M, 2003, EUR J IMMUNOL, V33, P2764, DOI 10.1002/eji.200324143; HILKENS CMU, 1995, EUR J IMMUNOL, V25, P59, DOI 10.1002/eji.1830250112; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Moldovan IR, 2003, J NEUROIMMUNOL, V141, P132, DOI 10.1016/S0165-5728(03)00221-2; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Nagamachi M, 2007, J EXP MED, V204, P2865, DOI 10.1084/jem.20070773; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Narumiya S, 2001, J CLIN INVEST, V108, P25, DOI 10.1172/JCI200113455; Narumiya S, 2007, P JPN ACAD B-PHYS, V83, P296, DOI [10.2183/pjab.83.296, 10.2183/pjab/83.296]; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; Nurieva R, 2009, J IMMUNOL, V182, P2565, DOI 10.4049/jimmunol.0803931; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	57	414	431	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					633	U141		10.1038/nm.1968	http://dx.doi.org/10.1038/nm.1968			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19465928	Green Submitted			2022-12-25	WOS:000266731600022
J	Zou, K; Yuan, Z; Yang, ZJ; Luo, HC; Sun, KJ; Zhou, L; Xiang, J; Shi, LJ; Yu, QS; Zhang, Y; Hou, RY; Wu, J				Zou, Kang; Yuan, Zhe; Yang, Zhaojuan; Luo, Huacheng; Sun, Kejing; Zhou, Li; Xiang, Jie; Shi, Lingjun; Yu, Qingsheng; Zhang, Yong; Hou, Ruoyu; Wu, Ji			Production of offspring from a germline stem cell line derived from neonatal ovaries	NATURE CELL BIOLOGY			English	Article							PB-CADHERIN; MOUSE; EXPRESSION; PROTEIN; GENE; VASA; HOMOLOG; OOCYTES; GENERATION; GONOCYTES	The idea that females of most mammalian species have lost the capacity for oocyte production at birth(1-5) has been challenged recently by the finding that juvenile and adult mouse ovaries possess mitotically active germ cells(6). However, the existence of female germline stem cells (FGSCs) in postnatal mammalian ovaries still remains a controversial issue among reproductive biologists and stem cell researchers(6-10). We have now established a neonatal mouse FGSC line, with normal karyotype and high telomerase activity, by immunomagnetic isolation and culture for more than 15 months. FGSCs from adult mice were isolated and cultured for more than 6 months. These FGSCs were infected with GFP virus and transplanted into ovaries of infertile mice. Transplanted cells underwent oogenesis and the mice produced offspring that had the GFP transgene. These findings contribute to basic research into oogenesis and stem cell self-renewal and open up new possibilities for use of FGSCs in biotechnology and medicine.	[Zou, Kang; Yuan, Zhe; Yang, Zhaojuan; Luo, Huacheng; Sun, Kejing; Zhou, Li; Xiang, Jie; Shi, Lingjun; Yu, Qingsheng; Zhang, Yong; Hou, Ruoyu; Wu, Ji] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University	Wu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China.	jiwu@sjtu.edu.cn	Hou, Ruoyu/B-4661-2008; yuan, zhe/GYE-0922-2022; Zou, Kang/ABB-2412-2020; Yuan, Zhe/H-1169-2018; Zou, Kang/R-6626-2019; yu, qing/HGC-4611-2022	Hou, Ruoyu/0000-0002-9891-8834; Yuan, Zhe/0000-0002-8674-9287; Zou, Kang/0000-0002-1253-1816; 	Key Program of National Natural Scientific Foundation of China [30630012]; Shanghai Pujiang Program, China [06PJ14058]; Shanghai Leading Academic Discipline [B205]	Key Program of National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program, China(Shanghai Pujiang Program); Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project)	The authors would like to thank Il-Hoan Oh for providing the MSCV-PGK-GFP vector used in this study. This work was supported by Key Program of National Natural Scientific Foundation of China (No. 30630012), and sponsored by Shanghai Pujiang Program, China (No. 06PJ14058) and Shanghai Leading Academic Discipline Project (No. B205).	Anderson L D, 1992, Md Med J, V41, P614; Bortvin Alex, 2004, BMC Developmental Biology, V4; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gosden RG, 2004, HUM REPROD UPDATE, V10, P193, DOI 10.1093/humupd/dmh023; Honda A, 2007, P NATL ACAD SCI USA, V104, P12389, DOI 10.1073/pnas.0703787104; HU B, 2008, AM J PHYSIOL-GASTR L, V295, P45; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; PETERS H, 1970, PHILOS T R SOC B, V259, P91, DOI 10.1098/rstb.1970.0048; Ravindranath N, 1997, ENDOCRINOLOGY, V138, P4026, DOI 10.1210/en.138.9.4026; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SHIROMIZU K, 1984, PEDIATR PHARMACOL, V4, P213; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Telfer EE, 2005, CELL, V122, P821, DOI 10.1016/j.cell.2005.09.004; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Wu J, 2005, DEV BIOL, V284, P437, DOI 10.1016/j.ydbio.2005.05.042; Wu J, 2003, J ENDOCRINOL, V176, P381, DOI 10.1677/joe.0.1760381; Wu J, 2008, CELL SIGNAL, V20, P1052, DOI 10.1016/j.cellsig.2008.01.011; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Xu J, 2008, J MOL BIOL, V377, P28, DOI 10.1016/j.jmb.2007.12.038; Yang ZJ, 2008, DNA CELL BIOL, V27, P479, DOI 10.1089/dna.2008.0752; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63	37	426	476	5	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					631	U424		10.1038/ncb1869	http://dx.doi.org/10.1038/ncb1869			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19363485				2022-12-25	WOS:000265640000022
J	June, C; Moore, JP; von Laer, D				June, Carl; Moore, John P.; von Laer, Dorothee			Bone marrow transplant muffles HIV	NATURE MEDICINE			English	Editorial Material									[June, Carl] Univ Penn, Philadelphia, PA 19104 USA; [Moore, John P.] Weill Cornell Med Coll, New York, NY USA; [von Laer, Dorothee] Georg Speyer Haus, Appl Virol & Gene Therapy, Frankfurt, Germany	University of Pennsylvania; Cornell University; Octapharma	June, C (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.							Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Rapoport AP, 2005, NAT MED, V11, P1230, DOI 10.1038/nm1310; von Laer D, 2006, J GENE MED, V8, P658, DOI 10.1002/jgm.908	4	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2009	15	4					371	371		10.1038/nm0409-371	http://dx.doi.org/10.1038/nm0409-371			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	429RG	19350007				2022-12-25	WOS:000264937200017
J	Cegelski, L; Pinkner, JS; Hammer, ND; Cusumano, CK; Hung, CS; Chorell, E; Aberg, V; Walker, JN; Seed, PC; Almqvist, F; Chapman, MR; Hultgren, SJ				Cegelski, Lynette; Pinkner, Jerome S.; Hammer, Neal D.; Cusumano, Corinne K.; Hung, Chia S.; Chorell, Erik; Aberg, Veronica; Walker, Jennifer N.; Seed, Patrick C.; Almqvist, Fredrik; Chapman, Matthew R.; Hultgren, Scott J.			Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation	NATURE CHEMICAL BIOLOGY			English	Article							URINARY-TRACT-INFECTIONS; BLADDER EPITHELIAL-CELLS; PILUS BIOGENESIS; CURLI PRODUCTION; GENETIC-ANALYSIS; TYPE-1 PILI; PATHOGENESIS; CELLULOSE; BACTERIA; IDENTIFICATION	Curli are functional extracellular amyloid fibers produced by uropathogenic Escherichia coli (UPEC) and other Enterobacteriaceae. Ring-fused 2-pyridones, such as FN075 and BibC6, inhibited curli biogenesis in UPEC and prevented the in vitro polymerization of the major curli subunit protein CsgA. The curlicides FN075 and BibC6 share a common chemical lineage with other ring-fused 2-pyridones termed pilicides. Pilicides inhibit the assembly of type 1 pili, which are required for pathogenesis during urinary tract infection. Notably, the curlicides retained pilicide activities and inhibited both curli-dependent and type 1-dependent biofilms. Furthermore, pretreatment of UPEC with FN075 significantly attenuated virulence in a mouse model of urinary tract infection. Curli and type 1 pili exhibited exclusive and independent roles in promoting UPEC biofilms, and curli provided a fitness advantage in vivo. Thus, the ability of FN075 to block the biogenesis of both curli and type 1 pili endows unique anti-biofilm and anti-virulence activities on these compounds.	[Chorell, Erik; Aberg, Veronica; Almqvist, Fredrik] Umea Univ, Dept Chem, Umea, Sweden; [Cegelski, Lynette; Pinkner, Jerome S.; Cusumano, Corinne K.; Hung, Chia S.; Walker, Jennifer N.; Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Cegelski, Lynette] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Hammer, Neal D.; Chapman, Matthew R.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Seed, Patrick C.] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; [Seed, Patrick C.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA	Umea University; Washington University (WUSTL); Stanford University; University of Michigan System; University of Michigan; Duke University; Duke University	Almqvist, F (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	fredrik.almqvist@chem.umu.se; chapmanm@umich.edu; hultgren@borcim.wustl.edu	Hung, Chia-Suei/G-6167-2010	Almqvist, Fredrik/0000-0002-0504-4446; Chapman, Matthew/0000-0002-2645-1294; Hammer, Neal/0000-0001-6148-7850; Hung, Chia-Suei/0000-0001-9844-9954	Swedish Natural Science Research Council; Knut and Alice Wallenberg Foundation; US National Institutes of Health [AI02549, AI048689, AI049950, P50 DK64540, AI073847, K12HD00850, K08DK074443, T32A107172]; Burroughs Wellcome Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049950, R01AI073847, R01AI048689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK074443, P50DK064540] Funding Source: NIH RePORTER	Swedish Natural Science Research Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge the expertise of W. Beatty (Imaging Facility, Washington University School of Medicine) and of A. Olofsson (Umea Centre for Molecular Pathogenesis, Umea University). This study was supported in part by the Swedish Natural Science Research Council and the Knut and Alice Wallenberg Foundation. The authors acknowledge funding from the US National Institutes of Health to S. J. H. (AI02549, AI048689, AI049950 and P50 DK64540), M. R. C. (AI073847),P. C. S. (K12HD00850 and K08DK074443) and L. C. (T32A107172). L. C. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Aberg V, 2005, ORG BIOMOL CHEM, V3, P2817, DOI 10.1039/b503294f; Aberg V, 2007, ORG BIOMOL CHEM, V5, P1827, DOI 10.1039/b702397a; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; CEGELSKI L, 2009, ENCY MICROBIOLOGY, P1; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dhakal BK, 2009, J BIOL CHEM, V284, P446, DOI 10.1074/jbc.M805010200; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Emtenas H, 2001, J ORG CHEM, V66, P6756, DOI 10.1021/jo015794u; Emtenas H, 2003, MOL DIVERS, V7, P165, DOI 10.1023/B:MODI.0000006800.46154.99; Garofalo CK, 2007, INFECT IMMUN, V75, P52, DOI 10.1128/IAI.01123-06; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Hammer ND, 2008, J ALZHEIMERS DIS, V13, P407; Hung DL, 1998, J STRUCT BIOL, V124, P201, DOI 10.1006/jsbi.1998.4049; JONES CH, 1993, P NATL ACAD SCI USA, V90, P8397, DOI 10.1073/pnas.90.18.8397; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Lloyd AL, 2009, J BACTERIOL, V191, P3469, DOI 10.1128/JB.01717-08; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; OLSEN A, 1993, INFECT AGENT DIS, V2, P272; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Rosen DA, 2008, INFECT IMMUN, V76, P3346, DOI 10.1128/IAI.00340-08; Ryu JH, 2005, APPL ENVIRON MICROB, V71, P247, DOI 10.1128/AEM.71.1.247-254.2005; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; Terada N, 2009, CELL TISSUE RES, V337, P91, DOI 10.1007/s00441-009-0804-z; Uhlich GA, 2006, APPL ENVIRON MICROB, V72, P2564, DOI 10.1128/AEM.72.4.2564-2572.2006; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	50	298	309	0	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					913	919		10.1038/nchembio.242	http://dx.doi.org/10.1038/nchembio.242			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19915538	Green Accepted			2022-12-25	WOS:000271756900014
J	Raychaudhuri, S; Thomson, BP; Remmers, EF; Eyre, S; Hinks, A; Guiducci, C; Catanese, JJ; Xie, G; Stahl, EA; Chen, R; Alfredsson, L; Amos, CI; Ardlie, KG; Barton, A; Bowes, J; Burtt, NP; Chang, M; Coblyn, J; Costenbader, KH; Criswell, LA; Crusius, JBA; Cui, J; De Jager, PL; Ding, B; Emery, P; Flynn, E; Harrison, P; Hocking, LJ; Huizinga, TWJ; Kastner, DL; Ke, XY; Kurreeman, FAS; Lee, AT; Liu, XD; Li, YH; Martin, P; Morgan, AW; Padyukov, L; Reid, DM; Seielstad, M; Seldin, MF; Shadick, NA; Steer, S; Tak, PP; Thomson, W; van der Helm-van Mil, AHM; van der Horst-Bruinsma, IE; Weinblatt, ME; Wilson, AG; Wolbink, GJ; Wordsworth, P; Altshuler, D; Karlson, EW; Toes, REM; de Vries, N; Begovich, AB; Siminovitch, KA; Worthington, J; Klareskog, L; Gregersen, PK; Daly, MJ; Plenge, RM				Raychaudhuri, Soumya; Thomson, Brian P.; Remmers, Elaine F.; Eyre, Stephen; Hinks, Anne; Guiducci, Candace; Catanese, Joseph J.; Xie, Gang; Stahl, Eli A.; Chen, Robert; Alfredsson, Lars; Amos, Christopher I.; Ardlie, Kristin G.; Barton, Anne; Bowes, John; Burtt, Noel P.; Chang, Monica; Coblyn, Jonathan; Costenbader, Karen H.; Criswell, Lindsey A.; Crusius, J. Bart A.; Cui, Jing; De Jager, Phillip L.; Ding, Bo; Emery, Paul; Flynn, Edward; Harrison, Pille; Hocking, Lynne J.; Huizinga, Tom W. J.; Kastner, Daniel L.; Ke, Xiayi; Kurreeman, Fina A. S.; Lee, Annette T.; Liu, Xiangdong; Li, Yonghong; Martin, Paul; Morgan, Ann W.; Padyukov, Leonid; Reid, David M.; Seielstad, Mark; Seldin, Michael F.; Shadick, Nancy A.; Steer, Sophia; Tak, Paul P.; Thomson, Wendy; van der Helm-van Mil, Annette H. M.; van der Horst-Bruinsma, Irene E.; Weinblatt, Michael E.; Wilson, Anthony G.; Wolbink, Gert Jan; Wordsworth, Paul; Altshuler, David; Karlson, Elizabeth W.; Toes, Rene E. M.; de Vries, Niek; Begovich, Ann B.; Siminovitch, Katherine A.; Worthington, Jane; Klareskog, Lars; Gregersen, Peter K.; Daly, Mark J.; Plenge, Robert M.		BIRAC Consortium; Consortium, Y	Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISM; MULTIPLE-SCLEROSIS; SUSCEPTIBILITY LOCI; CELIAC-DISEASE; PTPN22; REPLICATION; PTPRC; CD45; MUTATION	To discover new rheumatoid arthritis (RA) risk loci, we systematically examined 370 SNPs from 179 independent loci with P < 0.001 in a published meta-analysis of RA genome-wide association studies (GWAS) of 3,393 cases and 12,462 controls(1). We used Gene Relationships Across Implicated Loci (GRAIL)(2), a computational method that applies statistical text mining to PubMed abstracts, to score these 179 loci for functional relationships to genes in 16 established RA disease loci(1,3-11). We identified 22 loci with a significant degree of functional connectivity. We genotyped 22 representative SNPs in an independent set of 7,957 cases and 11,958 matched controls. Three were convincingly validated: CD2-CD58 (rs11586238, P = 1 x 10(-6) replication, P = 1 x 10(-9) overall), CD28 (rs1980422, P = 5 x 10(-6) replication, P = 1 x 10(-9) overall) and PRDM1 (rs548234, P = 1 x 10(-5) replication, P = 2 x 10(-8) overall). An additional four were replicated (P < 0.0023): TAGAP (rs394581, P = 0.0002 replication, P = 4 x 10(-7) overall), PTPRC (rs10919563, P = 0.0003 replication, P = 7 x 10(-7) overall), TRAF6-RAG1 (rs540386, P = 0.0008 replication, P = 4 x 10(-6) overall) and FCGR2A (rs12746613, P = 0.0022 replication, P = 2 x 10(-5) overall). Many of these loci are also associated to other immunologic diseases.	[Raychaudhuri, Soumya; Stahl, Eli A.; Chen, Robert; Coblyn, Jonathan; Costenbader, Karen H.; Cui, Jing; Kurreeman, Fina A. S.; Shadick, Nancy A.; Weinblatt, Michael E.; Karlson, Elizabeth W.; Plenge, Robert M.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Thomson, Brian P.; Guiducci, Candace; Ardlie, Kristin G.; Burtt, Noel P.; De Jager, Phillip L.; Altshuler, David; Daly, Mark J.; Plenge, Robert M.] Broad Inst, Cambridge, MA USA; [Raychaudhuri, Soumya; Altshuler, David; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Remmers, Elaine F.; Kastner, Daniel L.] NIAMSD, Genet & Genom Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Eyre, Stephen; Hinks, Anne; Barton, Anne; Bowes, John; Flynn, Edward; Ke, Xiayi; Martin, Paul; Thomson, Wendy; Worthington, Jane] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester, Lancs, England; [Catanese, Joseph J.; Chang, Monica; Li, Yonghong; Begovich, Ann B.] Celera, Alameda, CA USA; [Xie, Gang; Liu, Xiangdong; Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Xie, Gang; Liu, Xiangdong; Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON, Canada; [Alfredsson, Lars; Ding, Bo] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA USA; [Crusius, J. Bart A.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Immunogenet Lab, Amsterdam, Netherlands; [De Jager, Phillip L.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Emery, Paul; Morgan, Ann W.] Univ Leeds, Leeds Inst Mol Med, Natl Inst Hlth Res, Leeds Musculoskeletal Biomed Res Unit, Leeds LS2 9JT, W Yorkshire, England; [Harrison, Pille; Wordsworth, Paul] Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Oxford, England; [Hocking, Lynne J.; Reid, David M.] Univ Aberdeen, Div Appl Med, Musculoskeletal & Genet Sect, Aberdeen AB9 1FX, Scotland; [Huizinga, Tom W. J.; Kurreeman, Fina A. S.; van der Helm-van Mil, Annette H. M.; Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Lee, Annette T.; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Padyukov, Leonid; Klareskog, Lars] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Seielstad, Mark] Genome Inst Singapore, Singapore, Singapore; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Steer, Sophia] Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, London, England; [Tak, Paul P.; de Vries, Niek] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van der Horst-Bruinsma, Irene E.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Wilson, Anthony G.] Univ Sheffield, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Wolbink, Gert Jan] Jan van Breemen Inst, Amsterdam, Netherlands; [Wolbink, Gert Jan] Univ Amsterdam, Acad Med Ctr, Sanquin Res Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Begovich, Ann B.] Roche Diagnost, Pleasanton, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Manchester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Karolinska Institutet; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Vrije Universiteit Amsterdam; Harvard University; Brigham & Women's Hospital; University of Leeds; University of Oxford; University of Aberdeen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Northwell Health; Karolinska Institutet; Karolinska University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California Davis; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Sheffield; University of Amsterdam; Academic Medical Center Amsterdam; Roche Holding	Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.	soumya@broad.mit.edu; rplenge@partners.org	Seielstad, Mark/T-7841-2019; Hinks, Anne/E-1853-2015; Ke, Xiayi/C-7674-2009; emery, paul/B-3560-2013; van der Horst-Bruinsma, Irene/AAC-7744-2022; Crusius, Jakob Bart/AAE-9051-2019; Barton, Anne/N-2053-2014; eyre, stephen/K-3776-2017; Worthington, Jane/M-9770-2014; Siminovitch, Katherine/K-1475-2013; de Vries, Niek/J-9348-2013; Bowes, John/B-3472-2015; Daly, Mark J/B-2453-2017; Alfredsson, Lars/AAC-9007-2019; Altshuler, David M/A-4476-2009; Ng, Wan-Fai/R-8083-2016; Padyukov, Leonid/A-4890-2009	Hinks, Anne/0000-0001-8843-3967; van der Horst-Bruinsma, Irene/0000-0002-8086-9915; Crusius, Jakob Bart/0000-0001-9046-0155; Barton, Anne/0000-0003-3316-2527; eyre, stephen/0000-0002-1251-6974; Worthington, Jane/0000-0003-0544-042X; de Vries, Niek/0000-0002-6257-8604; Bowes, John/0000-0003-4659-031X; Daly, Mark J/0000-0002-0949-8752; Alfredsson, Lars/0000-0003-1688-6697; Altshuler, David M/0000-0002-7250-4107; Klareskog, Lars/0000-0001-9601-6186; Li, Yonghong/0000-0001-7326-0717; Morgan, Ann/0000-0003-1109-624X; Conaghan, Philip/0000-0002-3478-5665; Hyrich, Kimme/0000-0001-8242-9262; van der Helm - van Mil, Annette/0000-0001-8572-1437; Ng, Wan-Fai/0000-0002-5539-388X; Remmers, Elaine F/0000-0002-9522-1249; Packham, Jon/0000-0001-5531-1680; Thomson, Wendy/0000-0002-9022-5179; Young-Min, Steven/0000-0001-8270-6207; Wolbink, Gerrit Jan/0000-0003-1924-7460; Martin, Paul/0000-0002-1016-6851; Hocking, Lynne J/0000-0002-2414-2826; Padyukov, Leonid/0000-0003-2950-5670; Seielstad, Mark/0000-0001-5783-1401; McInnes, Iain/0000-0002-6462-4280; Raychaudhuri, Soumya/0000-0002-1901-8265; Wilson, Anthony Gerard/0000-0003-4855-3926; Toes, Rene/0000-0002-9618-6414; Harrison, Pille/0000-0003-4117-6910; Hensor, Elizabeth/0000-0002-5245-4755	US National Institutes of Health (NIH) Career Development Award [1K08AR055688-01A1]; American College of Rheumatology Bridge Grant; NIH [AI55314-3, U01 HG004171, DK62432, R01 DK083756-1, DK64869, NO1-AR-2-2263, RO1 AR44422]; Fox Trot Fund; William Randolph Hearst Fund of Harvard University; Burroughs Wellcome Fund; National Center for Research Resources [U54 RR020278]; Millennium Pharmaceuticals; Intramural Research Program of the National Institute of Arthritis; Musculoskeletal and Skin Diseases of the NIH; Canadian Institutes for Health Research [MOP79321, IIN-84042]; Ontario Research Fund [RE01061]; Canada Research Chair; Biogen-Idec; National Heart, Lung, and Blood Institute's (STAMPEED);  [R01HL087676]; National Institute for Health Research [NF-SI-0508-10299] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688, N01AR022263, R01AR056768, R01AR044422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083756, R01DK064869, U01DK062432] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Bridge Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Trot Fund; William Randolph Hearst Fund of Harvard University; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Intramural Research Program of the National Institute of Arthritis; Musculoskeletal and Skin Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Biogen-Idec(Biogen); National Heart, Lung, and Blood Institute's (STAMPEED); ; National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	S. R. is supported by a US National Institutes of Health (NIH) Career Development Award (1K08AR055688-01A1) and an American College of Rheumatology Bridge Grant. R. M. P. is supported by a K08 grant from the NIH (AI55314-3), a private donation from the Fox Trot Fund, the William Randolph Hearst Fund of Harvard University, the American College of Rheumatology 'Within Our Reach' campaign and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. M. J. D. is supported by NIH grants through the U01 (HG004171, DK62432) and R01 (DK083756-1, DK64869) mechanisms. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. The Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study (BRASS) Registry is supported by a grant from Millennium Pharmaceuticals and Biogen-Idec. The North American Rheumatoid Arthritis Consortium (NARAC) is supported by the NIH (NO1-AR-2-2263 and RO1 AR44422). This research was also supported in part by the Intramural Research Program of the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the NIH. This research was also supported in part by grants to KAS from the Canadian Institutes for Health Research (MOP79321 and IIN-84042) and the Ontario Research Fund (RE01061) and by a Canada Research Chair. We acknowledge the help of C. E. van der Schoot for healthy control samples for the Genetics Network Rheumatology Amsterdam (GENRA) and the help of B. A. C. Dijkmans, D. van Schaardenburg, A. S. Pe a, P. L. Klarenbeek, Z. Zhang, M. T. Nurmohammed, W. F. Lems, R. R. J. van de Stadt, W. H. Bos, J. Ursum, M. G. M. Bartelds, D. M. Gerlag, M. G. H. van der Sande, C. A. Wijbrandts and M. M. J. Herenius in gathering GENRA patient samples and data. We thank the Myocardial Infarction Genetics Consortium (MIGen) study for the use of genotype data from their healthy controls in our study. The MIGen study was funded by the US NIH and National Heart, Lung, and Blood Institute's SNP Typing for Association with Multiple Phenotypes from Existing Epidemiologic Data (STAMPEED) genomics research program R01HL087676 and a grant from the National Center for Research Resources. We thank the Johanna Seddon Progression of AMD Study, AMD Registry Study, Family Study of AMD, The US Twin Study of AMD and the Age-Related Eye Disease Study (AREDS) for use of genotype data from their healthy controls in our study. We thank D. Hafler and the Multiple Sclerosis collaborative for use of genotype data from their healthy controls recruited at Brigham and Women's Hospital.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barcellos LF, 2001, NAT GENET, V29, P23, DOI 10.1038/ng722; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Costenbader KH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2421; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Duits AJ, 1995, ARTHRITIS RHEUM, V38, P1832, DOI 10.1002/art.1780381217; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Maddison PJ, 2004, OXFORD TXB RHEUMATOL, P1185; Nielen MMJ, 2005, ANN RHEUM DIS, V64, P1199, DOI 10.1136/ard.2004.029389; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raychaudhuri S., 2006, COMPUTATIONAL TEXT A; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Sato M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1921; SCHRAVEN B, 1990, NATURE, V345, P71, DOI 10.1038/345071a0; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Tchilian EZ, 2001, J IMMUNOL, V166, P6144, DOI 10.4049/jimmunol.166.10.6144; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Vorechovsky I, 2001, NAT GENET, V29, P22, DOI 10.1038/ng723; Wesoly J, 2005, ARTHRITIS RHEUM-US, V52, P2948, DOI 10.1002/art.21294; WIJBRANDTS CA, 2007, ANN RHEUM DIS; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	43	271	278	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2009	41	12					1313	U76		10.1038/ng.479	http://dx.doi.org/10.1038/ng.479			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19898481	Green Accepted			2022-12-25	WOS:000272144900013
J	Simon-Sanchez, J; Schulte, C; Bras, JM; Sharma, M; Gibbs, JR; Berg, D; Paisan-Ruiz, C; Lichtner, P; Scholz, SW; Hernandez, DG; Kruger, R; Federoff, M; Klein, C; Goate, A; Perlmutter, J; Bonin, M; Nalls, MA; Illig, T; Gieger, C; Houlden, H; Steffens, M; Okun, MS; Racette, BA; Cookson, MR; Foote, KD; Fernandez, HH; Traynor, BJ; Schreiber, S; Arepalli, S; Zonozi, R; Gwinn, K; van der Brug, M; Lopez, G; Chanock, SJ; Schatzkin, A; Park, Y; Hollenbeck, A; Gao, JJ; Huang, XM; Wood, NW; Lorenz, D; Deuschl, G; Chen, HL; Riess, O; Hardy, JA; Singleton, AB; Gasser, T				Simon-Sanchez, Javier; Schulte, Claudia; Bras, Jose M.; Sharma, Manu; Gibbs, J. Raphael; Berg, Daniela; Paisan-Ruiz, Coro; Lichtner, Peter; Scholz, Sonja W.; Hernandez, Dena G.; Krueger, Rejko; Federoff, Monica; Klein, Christine; Goate, Alison; Perlmutter, Joel; Bonin, Michael; Nalls, Michael A.; Illig, Thomas; Gieger, Christian; Houlden, Henry; Steffens, Michael; Okun, Michael S.; Racette, Brad A.; Cookson, Mark R.; Foote, Kelly D.; Fernandez, Hubert H.; Traynor, Bryan J.; Schreiber, Stefan; Arepalli, Sampath; Zonozi, Ryan; Gwinn, Katrina; van der Brug, Marcel; Lopez, Grisel; Chanock, Stephen J.; Schatzkin, Arthur; Park, Yikyung; Hollenbeck, Albert; Gao, Jianjun; Huang, Xuemei; Wood, Nick W.; Lorenz, Delia; Deuschl, Guenther; Chen, Honglei; Riess, Olaf; Hardy, John A.; Singleton, Andrew B.; Gasser, Thomas			Genome-wide association study reveals genetic risk underlying Parkinson's disease	NATURE GENETICS			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; LINKAGE DISEQUILIBRIUM; TAU GENE; HAPLOTYPE; MUTATIONS; SYSTEM; SNCA	We performed a genome-wide association study (GWAS) in 1,713 individuals of European ancestry with Parkinson's disease (PD) and 3,978 controls. After replication in 3,361 cases and 4,573 controls, we observed two strong association signals, one in the gene encoding a-synuclein (SNCA; rs2736990, OR = 1.23, P = 2.24 x 10(-16)) and another at the MAPT locus (rs393152, OR = 0.77, P = 1.95 x 10(-16)). We exchanged data with colleagues performing a GWAS in Japanese PD cases. Association to PD at SNCA was replicated in the Japanese GWAS1, confirming this as a major risk locus across populations. We replicated the effect of a new locus detected in the Japanese cohort (PARK16, rs823128, OR = 0.66, P = 7.29 x 10(-8)) and provide supporting evidence that common variation around LRRK2 modulates risk for PD (rs1491923, OR = 1.14, P = 1.55 x 10(-5)). These data demonstrate an unequivocal role for common genetic variants in the etiology of typical PD and suggest population-specific genetic heterogeneity in this disease.	[Schulte, Claudia; Sharma, Manu; Berg, Daniela; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Simon-Sanchez, Javier; Bras, Jose M.; Gibbs, J. Raphael; Scholz, Sonja W.; Hernandez, Dena G.; Federoff, Monica; Nalls, Michael A.; Cookson, Mark R.; Traynor, Bryan J.; Arepalli, Sampath; Zonozi, Ryan; van der Brug, Marcel; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Simon-Sanchez, Javier] Vrije Univ Amsterdam Med Ctr, Sect Med Genom, Dept Clin Genet, Amsterdam, Netherlands; [Schulte, Claudia; Sharma, Manu; Berg, Daniela; Gasser, Thomas] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Bras, Jose M.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Gibbs, J. Raphael; Paisan-Ruiz, Coro; Scholz, Sonja W.; Hernandez, Dena G.; Houlden, Henry; Wood, Nick W.; Hardy, John A.] UCL, Dept Mol Neurosci, Inst Neurol, London, England; [Gibbs, J. Raphael; Paisan-Ruiz, Coro; Scholz, Sonja W.; Hernandez, Dena G.; Houlden, Henry; Wood, Nick W.; Hardy, John A.] UCL, Reta Lila Weston Labs, Inst Neurol, London, England; [Lichtner, Peter] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Klein, Christine] Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany; [Goate, Alison; Perlmutter, Joel; Racette, Brad A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Goate, Alison; Perlmutter, Joel; Racette, Brad A.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Bonin, Michael; Riess, Olaf] Univ Tubingen, Inst Human Genet, Dept Med Genet, Tubingen, Germany; [Illig, Thomas; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Steffens, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Okun, Michael S.; Foote, Kelly D.; Fernandez, Hubert H.] Univ Florida, Movement Disorders Ctr, Gainesville, FL USA; [Schreiber, Stefan] Univ Kiel, Inst Klin Mol Biol, D-24098 Kiel, Germany; [Gwinn, Katrina] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [van der Brug, Marcel] Scripps Res Inst, Dept Neurosci, Scripps, FL USA; [Lopez, Grisel] NINDS, Parkinsons Dis Clin, NIH, Bethesda, MD 20892 USA; [Chanock, Stephen J.; Schatzkin, Arthur; Park, Yikyung] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hollenbeck, Albert] AARP, Washington, DC USA; [Gao, Jianjun; Chen, Honglei] Natl Inst Environm Hlth Sci, Epidemiol Branch, NIH, Res Triangle Pk, NC USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Pharmacol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Kinesiol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Bioengn, Hershey, PA 17033 USA; [Lorenz, Delia; Deuschl, Guenther] Univ Kiel, Neurol Klin, Univ Klinikum Schleswig Holstein, D-2300 Kiel, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Universidade de Coimbra; University of London; University College London; University of London; University College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Lubeck; Washington University (WUSTL); Washington University (WUSTL); Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; State University System of Florida; University of Florida; University of Kiel; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Kiel; Schleswig Holstein University Hospital	Gasser, T (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany.	singleta@mail.nih.gov; thomas.gasser@uni-tuebingen.de	Gasser, Thomas/GNH-5293-2022; Singleton, Andrew B/C-3010-2009; Scholz, Sonja W./R-5524-2017; Wood, Nicholas W/C-2505-2009; Ruiz, Coro Paisán/C-2912-2009; Deuschl, Gunther/A-7986-2010; Houlden, Henry J/C-1532-2008; Cookson, Mark/AAW-2516-2021; Hardy, John/C-2451-2009; Gwinn, Katrina A/C-2508-2009; Klein, Christine/AGK-8003-2022; Bras, Jose MT/A-1428-2011; Traynor, Bryan J/G-5690-2010; Sharma, Manu/AAX-2594-2020; Berg, Daniela/A-8728-2019; Hollenbeck, Albert/AAG-9461-2020; Gibbs, J. Raphael/A-3984-2010; Scholz, Sonja/AAN-6601-2021	Gasser, Thomas/0000-0002-1069-1146; Scholz, Sonja W./0000-0002-6623-0429; Wood, Nicholas W/0000-0002-9500-3348; Deuschl, Gunther/0000-0002-4176-9196; Houlden, Henry J/0000-0002-2866-7777; Cookson, Mark/0000-0002-1058-3831; Hardy, John/0000-0002-3122-0423; Berg, Daniela/0000-0001-5796-5442; Gibbs, J. Raphael/0000-0002-6985-0658; Scholz, Sonja/0000-0002-6623-0429; Park, Yikyung/0000-0002-6281-489X; Goate, Alison/0000-0002-0576-2472; Simon Sanchez, Javier/0000-0001-5141-5829; Steffens, Michael/0000-0002-6445-8593; Okun, Michael/0000-0002-6247-9358; Klein, Christine/0000-0003-2102-3431; Krueger, Rejko/0000-0003-4258-6241; Gwinn, Katrina/0000-0002-8277-651X; Gieger, Christian/0000-0001-6986-9554; Foote, Kelly/0000-0002-2436-4138; Chen, Honglei/0000-0003-3446-7779; Bras, Jose/0000-0001-8186-0333; Afifa, Sayyidah/0000-0002-1151-9583; Schulte, Claudia/0000-0003-4006-1265	Intramural Research Programs of the National Institute on Aging; National Institute of Neurological Disorders and Stroke; National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; Department of Health and Human Services [Z01 AG000949-02, Z01-ES101986]; Forschungszentrum fur Umwelt und Gesundheit (GSF); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German National Genome Network [01GS08134]; German Ministry for Education and Research; German Federal Ministry of Education and Research (BMBF) NGFN [01GR0468]; National Institutes of Health NINDS [P30NS05710]; Clinical Sciences Translational Award [RR024992]; Medical Research Council, UK; Medical Research Council [G108/638, G0400000, G0701075] Funding Source: researchfish; Parkinson&quot;s UK [G-0907, G-0909, J-0804] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986, Z01ES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041509, R01NS058714, R01NS050425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000949, ZIAAG000947, Z01AG000949] Funding Source: NIH RePORTER; MRC [G108/638, G0701075, G0400000] Funding Source: UKRI	Intramural Research Programs of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Forschungszentrum fur Umwelt und Gesundheit (GSF); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German National Genome Network; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF) NGFN(Federal Ministry of Education & Research (BMBF)); National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Clinical Sciences Translational Award; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the subjects involved in this study whose contribution made this work possible. This work used samples and clinical data from the US National Institute of Neurological Disorders and Stroke (NINDS) Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds). This work was supported in part by the Intramural Research Programs of the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the National Institute of Environmental Health Sciences, the National Cancer Institute, National Institutes of Health and the Department of Health and Human Services; project numbers Z01 AG000949-02 and Z01-ES101986. The KORA research platform (KORA: Cooperative Research in the Region of Augsburg; http://www.gsf.de/KORA) was initiated and financed by the Forschungszentrum fur Umwelt und Gesundheit (GSF), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria.; The study was additionally funded by the German National Genome Network (NGFNplus #01GS08134; German Ministry for Education and Research) and in addition by the German Federal Ministry of Education and Research (BMBF) NGFN (01GR0468). This work also was supported by the National Institutes of Health NINDS P30NS05710 (Neuroscience Blueprint Grant) and Clinical Sciences Translational Award RR024992 to Washington University in St. Louis and the Greater St. Louis Chapter of the American Parkinson Disease Association. Authors received support from the Medical Research Council, UK.	Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutton M, 2001, NEUROLOGY, V56, pS21, DOI 10.1212/WNL.56.suppl_4.S21; Johansson A, 2005, NEURODEGENER DIS, V2, P28, DOI 10.1159/000086428; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	22	1398	1432	3	199	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1308	U68		10.1038/ng.487	http://dx.doi.org/10.1038/ng.487			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19915575	Green Accepted			2022-12-25	WOS:000272144900012
J	Gaster, RS; Hall, DA; Nielsen, CH; Osterfeld, SJ; Yu, H; Mach, KE; Wilson, RJ; Murmann, B; Liao, JC; Gambhir, SS; Wang, SX				Gaster, Richard S.; Hall, Drew A.; Nielsen, Carsten H.; Osterfeld, Sebastian J.; Yu, Heng; Mach, Kathleen E.; Wilson, Robert J.; Murmann, Boris; Liao, Joseph C.; Gambhir, Sanjiv S.; Wang, Shan X.			Matrix-insensitive protein assays push the limits of biosensors in medicine	NATURE MEDICINE			English	Article							SPIN-VALVE SENSORS; OVARIAN-CANCER; SUPERPARAMAGNETIC NANOPARTICLES; BIOLOGICAL APPLICATIONS; DNA DETECTION; MICROARRAYS; LACTOFERRIN; BIOMARKER	Advances in biosensor technologies for in vitro diagnostics have the potential to transform the practice of medicine. Despite considerable work in the biosensor field, there is still no general sensing platform that can be ubiquitously applied to detect the constellation of biomolecules in diverse clinical samples (for example, serum, urine, cell lysates or saliva) with high sensitivity and large linear dynamic range. A major limitation confounding other technologies is signal distortion that occurs in various matrices due to heterogeneity in ionic strength, pH, temperature and autofluorescence. Here we present a magnetic nanosensor technology that is matrix insensitive yet still capable of rapid, multiplex protein detection with resolution down to attomolar concentrations and extensive linear dynamic range. The matrix insensitivity of our platform to various media demonstrates that our magnetic nanosensor technology can be directly applied to a variety of settings such as molecular biology, clinical diagnostics and biodefense.	[Hall, Drew A.; Murmann, Boris; Wang, Shan X.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Gaster, Richard S.; Gambhir, Sanjiv S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gaster, Richard S.] Stanford Univ, Med Scientist Training Program, Stanford, CA 94305 USA; [Nielsen, Carsten H.; Gambhir, Sanjiv S.] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Nielsen, Carsten H.] Rigshosp, Dept Clin Physiol Nucl Med & Positron Emiss Tomog, Copenhagen, Denmark; [Nielsen, Carsten H.] Univ Copenhagen, DK-1168 Copenhagen, Denmark; [Nielsen, Carsten H.] Tech Univ Denmark, Dept Elect Engn, Sect Biomed Engn, Lyngby, Denmark; [Osterfeld, Sebastian J.; Wilson, Robert J.; Wang, Shan X.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Osterfeld, Sebastian J.; Yu, Heng] MagArray Inc, Sunnyvale, CA USA; [Mach, Kathleen E.; Liao, Joseph C.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Liao, Joseph C.; Gambhir, Sanjiv S.; Wang, Shan X.] Stanford Univ, Biox Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Technical University of Denmark; Stanford University; Stanford University; Stanford University	Wang, SX (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.	sgambhir@stanford.edu; sxwang@stanford.edu	Hall, Drew A/C-6068-2012	Hall, Drew A/0000-0003-0674-074X; Liao, Joseph/0000-0003-2448-5463; Osterfeld, Sebastian/0000-0003-2822-990X; Murmann, Boris/0000-0003-3417-8782	US National Cancer Institute [1U54CA119367, N44CM-2009-00011]; US National Science Foundation [ECCS-0801385-000]; US Defense Threat Reduction Agency [HDTRA1-07-1-0030-P00005]; US Defense Advanced Research Projects Agency/Navy [N00014-02-1-0807]; NCI ICMIC [P50 CA114747]; US Department of Veterans Affairs Merit Review [B4872]; Canary Foundation; The National Semiconductor Corporation; Stanford Medical School Medical Scientist Training Program; National Science Foundation; Denmark-American Foundation; Lundbeck Foundation; NATIONAL CANCER INSTITUTE [P50CA114747, U54CA119367] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Science Foundation(National Science Foundation (NSF)); US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); US Defense Advanced Research Projects Agency/Navy(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NCI ICMIC; US Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); Canary Foundation; The National Semiconductor Corporation; Stanford Medical School Medical Scientist Training Program; National Science Foundation(National Science Foundation (NSF)); Denmark-American Foundation; Lundbeck Foundation(Lundbeckfonden); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by US National Cancer Institute grants 1U54CA119367 and N44CM-2009-00011, US National Science Foundation grant ECCS-0801385-000, US Defense Threat Reduction Agency grant HDTRA1-07-1-0030-P00005, the US Defense Advanced Research Projects Agency/Navy Grant N00014-02-1-0807, NCI ICMIC P50 CA114747, the US Department of Veterans Affairs Merit Review B4872, the Canary Foundation and The National Semiconductor Corporation. R. S. G. acknowledges financial support from Stanford Medical School Medical Scientist Training Program and a National Science Foundation graduate research fellowship. C. H. N. acknowledges financial support from the Denmark-American Foundation and the Lundbeck Foundation.	Arao S, 1999, J CLIN MICROBIOL, V37, P553, DOI 10.1128/JCM.37.3.553-557.1999; BARNAS J, 1990, PHYS REV B, V42, P8110, DOI 10.1103/PhysRevB.42.8110; Baselt DR, 1998, BIOSENS BIOELECTRON, V13, P731, DOI 10.1016/S0956-5663(98)00037-2; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Chen Z, 2008, NAT BIOTECHNOL, V26, P1285, DOI 10.1038/nbt.1501; Cheng MMC, 2006, CURR OPIN CHEM BIOL, V10, P11, DOI 10.1016/j.cbpa.2006.01.006; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Ghosh S, 2003, SCIENCE, V299, P1042, DOI 10.1126/science.1079080; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Graham DL, 2002, J APPL PHYS, V91, P7786, DOI 10.1063/1.1451898; Heath JR, 2008, ANNU REV MED, V59, P251, DOI 10.1146/annurev.med.59.061506.185523; Ji HF, 2008, ANALYST, V133, P434, DOI 10.1039/b713330h; Li GX, 2006, SENSOR ACTUAT A-PHYS, V126, P98, DOI 10.1016/j.sna.2005.10.001; Li GX, 2003, J APPL PHYS, V93, P7557, DOI 10.1063/1.1540176; Lopez MF, 2007, CLIN CHEM, V53, P1067, DOI 10.1373/clinchem.2006.080721; Millen RL, 2005, ANAL CHEM, V77, P6581, DOI 10.1021/ac0509049; Mitchell P, 2002, NAT BIOTECHNOL, V20, P225, DOI 10.1038/nbt0302-225; Mukherjee S, 1997, BIOL TRACE ELEM RES, V57, P1, DOI 10.1007/BF02803864; Osterfeld SJ, 2008, P NATL ACAD SCI USA, V105, P20637, DOI 10.1073/pnas.0810822105; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Schotter J, 2004, BIOSENS BIOELECTRON, V19, P1149, DOI 10.1016/j.bios.2003.11.007; Shingyoji M, 2005, TALANTA, V67, P472, DOI 10.1016/j.talanta.2005.06.064; Srinivas PR, 2001, CLIN CHEM, V47, P1901; Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Xu L, 2008, BIOSENS BIOELECTRON, V24, P99, DOI 10.1016/j.bios.2008.03.030; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138; Zheng YY, 2007, CLIN CANCER RES, V13, P6984, DOI 10.1158/1078-0432.CCR-07-1409; ZIMMERMAN R, 1980, CANCER-AM CANCER SOC, V46, P1802, DOI 10.1002/1097-0142(19801015)46:8<1802::AID-CNCR2820460818>3.0.CO;2-5	33	302	317	7	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1327	U130		10.1038/nm.2032	http://dx.doi.org/10.1038/nm.2032			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19820717	Green Accepted			2022-12-25	WOS:000271543700023
J	Goriely, A; Hansen, RMS; Taylor, IB; Olesen, IA; Jacobsen, GK; McGowan, SJ; Pfeifer, SP; McVean, GAT; Rajpert-De Meyts, E; Wilkie, AOM				Goriely, Anne; Hansen, Ruth M. S.; Taylor, Indira B.; Olesen, Inge A.; Jacobsen, Grete Krag; McGowan, Simon J.; Pfeifer, Susanne P.; McVean, Gilean A. T.; Rajpert-De Meyts, Ewa; Wilkie, Andrew O. M.			Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; GERM-CELL TUMORS; THANATOPHORIC DYSPLASIA; PATERNAL AGE; SPERMATOCYTIC SEMINOMA; ACANTHOSIS NIGRICANS; SELECTIVE ADVANTAGE; COSTELLO-SYNDROME; NOONAN-SYNDROME; BLADDER-CANCER	Genes mutated in congenital malformation syndromes are frequently implicated in oncogenesis(1,2), but the causative germline and somatic mutations occur in separate cells at different times of an organism's life. Here we unify these processes to a single cellular event for mutations arising in male germ cells that show a paternal age effect(3). Screening of 30 spermatocytic seminomas(4,5) for oncogenic mutations in 17 genes identified 2 mutations in FGFR3 (both 1948A>G, encoding K650E, which causes thanatophoric dysplasia in the germline)(6) and 5 mutations in HRAS. Massively parallel sequencing of sperm DNA showed that levels of the FGFR3 mutation increase with paternal age and that the mutation spectrum at the Lys650 codon is similar to that observed in bladder cancer(7,8). Most spermatocytic seminomas show increased immunoreactivity for FGFR3 and/or HRAS. We propose that paternal age-effect mutations activate a common 'selfish' pathway supporting proliferation in the testis, leading to diverse phenotypes in the next generation including fetal lethality, congenital syndromes and cancer predisposition.	[Goriely, Anne; Hansen, Ruth M. S.; Taylor, Indira B.; Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Olesen, Inge A.; Rajpert-De Meyts, Ewa] Univ Copenhagen Hosp, Rigshosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Jacobsen, Grete Krag] Univ Copenhagen Hosp, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [McGowan, Simon J.] Univ Oxford, Computat Biol Res Grp, Oxford, England; [Pfeifer, Susanne P.; McVean, Gilean A. T.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oxford; University of Oxford	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	awilkie@hammer.imm.ox.ac.uk	Olesen, Inge/B-7812-2014; Goriely, Anne/AAR-1133-2020; Rajpert-De Meyts, Ewa/H-6526-2019; Wilkie, Andrew/AAC-3820-2020	Rajpert-De Meyts, Ewa/0000-0002-5946-7559; Wilkie, Andrew/0000-0002-2972-5481; McGowan, Simon/0000-0001-9720-1914; Goriely, Anne/0000-0001-9229-7216; Pfeifer, Susanne/0000-0003-1378-2913	Danish Cancer Society [DP08147]; Wellcome Trust [078666]	Danish Cancer Society(Danish Cancer Society); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the Oxford Fertility Clinic and anonymous sperm donors for help with obtaining samples; L. Andersen, T. Chin-A-Woeng, K. Clark, K. Cook, A. Fenwick, A. Herlihy, H. Kistrup, J. Lim, J.-E. Nielsen, L. Thompson and N. Ward for expert technical support and advice; associates of the Rajpert-De Meyts and Wilkie labs for discussions; staff in numerous pathology departments in Denmark and Lund (Sweden), and G. Turner and I. Roberts, for histopathological support and samples; L. Legeai-Mallet for providing control genomic samples; G. Spagnoli for the MAGE-A4 antibody; M. de Gobbi for information on TaqMan primers for DNA quantification; and S. Robertson for comments on the manuscript. This work was funded by the Danish Cancer Society (DP08147 to E. R.-D. M.) and the Wellcome Trust (078666 to A. O. M. W.).	Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Arnheim N, 2009, NAT REV GENET, V10, P478, DOI 10.1038/nrg2529; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bohm J, 2006, AM J MED GENET A, V140A, P1904, DOI 10.1002/ajmg.a.31383; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; Castro-Feijoo L, 2008, EUR J ENDOCRINOL, V159, P243, DOI 10.1530/EJE-08-0393; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Choi SK, 2008, P NATL ACAD SCI USA, V105, P10143, DOI 10.1073/pnas.0801267105; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Dym M, 2009, BIRTH DEFECTS RES C, V87, P27, DOI 10.1002/bdrc.20141; EBLE JN, 1994, HUM PATHOL, V25, P1035, DOI 10.1016/0046-8177(94)90062-0; Friedman JM, 1997, AM J HUM GENET, V60, P469; Giudicelli MD, 2008, FERTIL STERIL, V89, P1651, DOI 10.1016/j.fertnstert.2007.04.037; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Hafner C, 2007, J INVEST DERMATOL, V127, P1883, DOI 10.1038/sj.jid.5700804; Hansen RM, 2005, J PATHOL, V207, P27, DOI 10.1002/path.1816; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; Iwata T, 2001, HUM MOL GENET, V10, P1255, DOI 10.1093/hmg/10.12.1255; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Juul A, 2007, HUM REPROD, V22, P1907, DOI 10.1093/humrep/dem126; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Nachman MW, 2000, GENETICS, V156, P297; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; ORIOLI IM, 1995, AM J MED GENET, V59, P209, DOI 10.1002/ajmg.1320590218; Ota S, 2009, HUM MOL GENET, V18, P2609, DOI 10.1093/hmg/ddp195; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Qin J, 2007, PLOS BIOL, V5, P1912, DOI 10.1371/journal.pbio.0050224; Rajpert-De Meyts E, 2003, HISTOPATHOLOGY, V42, P217, DOI 10.1046/j.1365-2559.2003.01587.x; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Sol-Church K, 2006, HUM MUTAT, V27, P736, DOI 10.1002/humu.20381; SRIVASTAVA SK, 1985, P NATL ACAD SCI USA, V82, P38, DOI 10.1073/pnas.82.1.38; Tartaglia M, 2004, AM J HUM GENET, V75, P492, DOI 10.1086/423493; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Waller DK, 2008, AM J MED GENET A, V146A, P2385, DOI 10.1002/ajmg.a.32485; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; Yoon SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000558; Zampino G, 2007, HUM MUTAT, V28, P265, DOI 10.1002/humu.20431; Zankl A, 2008, AM J MED GENET A, V146A, P212, DOI 10.1002/ajmg.a.32085	60	146	152	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1247	U119		10.1038/ng.470	http://dx.doi.org/10.1038/ng.470			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19855393	Green Accepted			2022-12-25	WOS:000271247600020
J	Gumireddy, K; Li, AP; Gimotty, PA; Klein-Szanto, AJ; Showe, LC; Katsaros, D; Coukos, G; Zhang, L; Huang, QH				Gumireddy, Kiranmai; Li, Anping; Gimotty, Phyllis A.; Klein-Szanto, Andres J.; Showe, Louise C.; Katsaros, Dionyssios; Coukos, George; Zhang, Lin; Huang, Qihong			KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer	NATURE CELL BIOLOGY			English	Article							FUNCTIONAL GENOMIC ANALYSIS; ID PROTEINS; TRANSCRIPTIONAL REGULATOR; MAMMARY-TUMOR; GENES; SUPPRESSOR; GROWTH; CELLS; RNA; SUBPOPULATIONS	Metastasis is a complex multistep process, which requires the concerted action of many genes and is the primary cause of cancer death. Both pathways that regulate metastasis enhancement and those that regulate its suppression contribute to the tumour dissemination process. To identify new metastasis suppressors, we set up a forward genetic screen in a mouse model. We transduced a genome-wide RNA interference (RNAi) library into the non-metastatic 168FARN breast cancer cell line and orthotopically transplanted the cells into mouse mammary fat pads. We then selected cells that could metastasize to the lung and identified an RNAi for the KLF17 gene. Conversely, we demonstrate that ectopic expression of KLF17 in a highly metastatic 4T1 breast cancer cell line inhibits the ability of cells to metastasize from the mammary fat pad to the lung. We also show that suppression of KLF17 expression promotes breast cancer cell invasion and epithelial-mesenchymal transition (EMT), and that KLF17 protein functions by directly binding to the promoter region of Id1 (which encodes a key metastasis regulator in breast cancer) to inhibit its transcription. Finally, we demonstrate that KLF17 expression is significantly downregulated in primary human breast cancer samples and that the combined expression pattern of KLF17 and Id1 can serve as a potential biomarker for lymph node metastasis in breast cancer.	[Gumireddy, Kiranmai; Li, Anping; Showe, Louise C.; Huang, Qihong] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Gimotty, Phyllis A.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Katsaros, Dionyssios] Univ Turin, Dept Obstet & Gynecol, Turin, Italy; [Coukos, George; Zhang, Lin] Univ Penn, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; Fox Chase Cancer Center; University of Turin; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Huang, QH (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	qhuang@wistar.org	Gimotty, Phyllis/GWZ-4136-2022; Coukos, George/ABG-7389-2020; Zhang, Lin/K-8478-2012	Gimotty, Phyllis/0000-0002-3850-9799; Coukos, George/0000-0001-8813-7367	Breast Cancer Alliance; Pardee Foundation; V Foundation; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health (PA DOH) [P30 CA10815, SAP 4100020718]; NCI ovarian SPORE [P50-CA83638]; Ovarian Cancer Research Fund; Mary Kay Ash Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA148759, P50CA083638] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059478] Funding Source: NIH RePORTER	Breast Cancer Alliance; Pardee Foundation; V Foundation; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health (PA DOH); NCI ovarian SPORE; Ovarian Cancer Research Fund; Mary Kay Ash Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank F. Miller for providing 168FARN and 4T1 cells, R. Weinberg for providing the HMEL cell line, J. Price for providing the MDA-MB-435 cell line, C. Chang and W. Horng for assistance with microarray analysis and J. Hayden and F. Keeney for assistance with microscopy. Q. H. is supported by the Breast Cancer Alliance, Pardee Foundation, V Foundation. Q. H. and L. C. S. are supported by the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health (PA DOH; P30 CA10815) and L. C. S. is supported by a PA DOH grant (SAP 4100020718). G. C. and L. Z. are supported by NCI ovarian SPORE (P50-CA83638), Ovarian Cancer Research Fund and Mary Kay Ash Charitable Foundation.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; ASLAKSON CJ, 1991, INT J CANCER, V47, P466, DOI 10.1002/ijc.2910470327; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; DEXTER DL, 1978, CANCER RES, V38, P3174; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Foster KW, 2000, CANCER RES, V60, P6488; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Grimm S, 2004, NAT REV GENET, V5, P179, DOI 10.1038/nrg1291; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iavarone A, 2006, TRENDS MOL MED, V12, P588, DOI 10.1016/j.molmed.2006.10.007; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kataoka M, 1998, CANCER RES, V58, P4761; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Lin CQ, 2000, CANCER RES, V60, P1332; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; McAllister SD, 2007, MOL CANCER THER, V6, P2921, DOI 10.1158/1535-7163.MCT-07-0371; Miller Fred, 2004, Breast Dis, V20, P43; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; PERKINS AC, 1995, NATURE, V375, P318; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; VLIET JV, 2005, GENOMICS, V87, P474; Yan W, 2002, MECH DEVELOP, V118, P233, DOI 10.1016/S0925-4773(02)00258-7; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshida BA, 2000, JNCI-J NATL CANCER I, V92, P1717, DOI 10.1093/jnci/92.21.1717; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	55	153	163	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1297	U69		10.1038/ncb1974	http://dx.doi.org/10.1038/ncb1974			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19801974	Green Accepted			2022-12-25	WOS:000271425800009
J	Hindie, V; Stroba, A; Zhang, H; Lopez-Garcia, LA; Idrissova, L; Zeuzem, S; Hirschberg, D; Schaeffer, F; Jorgensen, TJD; Engel, M; Alzari, PM; Biondi, RM				Hindie, Valerie; Stroba, Adriana; Zhang, Hua; Lopez-Garcia, Laura A.; Idrissova, Leila; Zeuzem, Stefan; Hirschberg, Daniel; Schaeffer, Francis; Jorgensen, Thomas J. D.; Engel, Matthias; Alzari, Pedro M.; Biondi, Ricardo M.			Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1	NATURE CHEMICAL BIOLOGY			English	Article							HYDROPHOBIC MOTIF PHOSPHORYLATION; PIF-BINDING POCKET; IN-VIVO ROLE; CRYSTAL-STRUCTURE; DOCKING-SITE; GROWTH-FACTOR; MAXIMUM-LIKELIHOOD; AGC KINASES; AMP-PNP; DOMAIN	Protein phosphorylation transduces a large set of intracellular signals. One mechanism by which phosphorylation mediates signal transduction is by prompting conformational changes in the target protein or interacting proteins. Previous work described an allosteric site mediating phosphorylation-dependent activation of AGC kinases. The AGC kinase PDK1 is activated by the docking of a phosphorylated motif from substrates. Here we present the crystallography of PDK1 bound to a rationally developed low-molecular-weight activator and describe the conformational changes induced by small compounds in the crystal and in solution using a fluorescence-based assay and deuterium exchange experiments. Our results indicate that the binding of the compound produces local changes at the target site, the PIF binding pocket, and also allosteric changes at the ATP binding site and the activation loop. Altogether, we present molecular details of the allosteric changes induced by small compounds that trigger the activation of PDK1 through mimicry of phosphorylation-dependent conformational changes.	[Hindie, Valerie; Zhang, Hua; Lopez-Garcia, Laura A.; Idrissova, Leila; Zeuzem, Stefan; Biondi, Ricardo M.] Univ Frankfurt Klinikum, Dept Internal Med 1, Res Grp PhosphoSites, D-6000 Frankfurt, Germany; [Hindie, Valerie; Schaeffer, Francis; Alzari, Pedro M.] Inst Pasteur, Struct Biochem Unit, Paris, France; [Stroba, Adriana; Engel, Matthias] Univ Saarland, Dept Pharmaceut & Med Chem, Res Grp PhosphoSites, D-6600 Saarbrucken, Germany; [Hirschberg, Daniel; Jorgensen, Thomas J. D.] Univ So Denmark, Dept Biochem & Mol Biol, Odense M, Denmark	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Saarland University; University of Southern Denmark	Biondi, RM (corresponding author), Univ Frankfurt Klinikum, Dept Internal Med 1, Res Grp PhosphoSites, D-6000 Frankfurt, Germany.	biondi@med.uni-frankfurt.de	Hirschberg, Daniel/J-3133-2014; Zeuzem, Stefan/AAE-7435-2019	Hirschberg, Daniel/0000-0002-1136-9802; Biondi, Ricardo/0000-0002-8873-7167; Jorgensen, Thomas J.D./0000-0002-7149-316X; Alzari, Pedro/0000-0002-4233-1903	Europrofession Foundation; Deutsche Krebshilfe [107875]; Deutsche Forschungsgemeinschaft [BI 1044/2-2]; Bundesministerium fur Bildung und Forschung (Go-Bio)	Europrofession Foundation; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Go-Bio)(Federal Ministry of Education & Research (BMBF))	We acknowledge A. Haouz for help with the crystallization screening, F. Saul for crystallography advice, J. Imig for help setting up the conditions for the TNP-ATP assay and I. Adrian for excellent technical assistance. We give special thanks to R. W. Hartmann, R. Zimmermann and R. Bernhardt (University of Saarland), and to A. Scheidig (University of Kiel) for support for our research project. We acknowledge the financial support of the Europrofession Foundation (Saarbrucken, Germany), the Deutsche Krebshilfe (107875), Deutsche Forschungsgemeinschaft (BI 1044/2-2) and Bundesministerium fur Bildung und Forschung (Go-Bio). We are grateful to N. Huntington for careful reading of the manuscript.	Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Collins BJ, 2003, EMBO J, V22, P4202, DOI 10.1093/emboj/cdg407; Collins BJ, 2005, J CELL SCI, V118, P5023, DOI 10.1242/jcs.02617; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel M, 2006, EMBO J, V25, P5469, DOI 10.1038/sj.emboj.7601416; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Parker PJ, 2001, BIOCHEM SOC T, V29, P860, DOI 10.1042/0300-5127:0290860; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pearl LH, 2002, CURR OPIN STRUC BIOL, V12, P761, DOI 10.1016/S0959-440X(02)00386-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Smith KJ, 2004, STRUCTURE, V12, P1067, DOI 10.1016/j.str.2004.02.040; Stroba A, 2009, J MED CHEM, V52, P4683, DOI 10.1021/jm9001499; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhao B, 2007, PROTEIN SCI, V16, P2761, DOI 10.1110/ps.073161707	38	112	125	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					758	764		10.1038/nchembio.208	http://dx.doi.org/10.1038/nchembio.208			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19718043				2022-12-25	WOS:000270039900014
J	Alvarado-Kristensson, M; Rodriguez, MJ; Silio, V; Valpuesta, JM; Carrera, AC				Alvarado-Kristensson, Maria; Josefa Rodriguez, Maria; Silio, Virginia; Valpuesta, Jose M.; Carrera, Ana C.			SADB phosphorylation of gamma-tubulin regulates centrosome duplication	NATURE CELL BIOLOGY			English	Article							MICROTUBULE NUCLEATION; CELL-CYCLE; CENTRIOLE DUPLICATION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; BUDDING YEAST; RING COMPLEX; PROTEIN; KINASE; RECRUITMENT	Symmetrical cell division requires duplication of DNA and protein content to generate two daughter cells. Centrosomes also duplicate during cell division, but the mechanism controlling this process is incompletely understood. We describe an alternative splice form of SadB encoding a short SADB Ser/Thr kinase whose activity fluctuates during the cell cycle, localizes to centrosomes, and controls centrosome duplication. Reduction of endogenous SADB levels diminished centrosome numbers, whereas enhanced SADB expression induced centrosome amplification. SADB exerted this action through phosphorylation of gamma-tubulin on Ser 131, as expression of a phosphomimetic Ser 131-to-Asp gamma-tubulin mutant alone increased centrosome numbers, whereas non-phosphorylatable Ala 131-gamma-tubulin impaired centrosome duplication. We propose that SADB kinase activity controls centrosome homeostasis by regulating phosphorylation of gamma-tubulin.	[Alvarado-Kristensson, Maria; Silio, Virginia; Carrera, Ana C.] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain; [Josefa Rodriguez, Maria; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, Dept Macromol Struct, E-28049 Madrid, Spain; [Alvarado-Kristensson, Maria] Lund Univ, Malmoe Univ Hosp, Dept Lab Med, Ctr Mol Pathol, S-22100 Lund, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Lund University	Alvarado-Kristensson, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Darwin 3, E-28049 Madrid, Spain.	maria.alvarado-kristensson@med.lu.se; acarrera@cnb.csic.es	Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017; Alvarado-Kristensson, Maria T./C-4543-2014	Valpuesta, José M/0000-0001-7468-8053; Carrera, Ana/0000-0002-3999-5434; Alvarado Kristensson, Maria Teresa/0000-0003-0598-7986; Silio, Virginia/0000-0002-3169-336X	Spanish Ministry of Science and Innovation [SAF200405955, 200763624, CSD 2006-00023]; Spanish Association against Cancer; Spanish Ministry of Health [PI050964]; Royal Physiographic Society in Lund; Ake Wibergs, Thelma Zoegas, OE och Edla Johanssons; U-MAS Cancer Research Found; Teggers Fond, EMBO; Swedish Society for Medical Research	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Association against Cancer; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Royal Physiographic Society in Lund; Ake Wibergs, Thelma Zoegas, OE och Edla Johanssons; U-MAS Cancer Research Found; Teggers Fond, EMBO(European Molecular Biology Organization (EMBO)); Swedish Society for Medical Research	We thank York-Dieter Stierhof and Dagmar Ripper for their generous help with electron microscopy. We thank Y. Shi, M. van de Wetering, M. Marques, M. Bornens and T. Strearns for reagents, J. Sanes and B. Lilley for SADB-deficient cells and comments, L. Kremer and L. Gomez for antibody production, C. Hernandez for help in biochemistry assays, C. Mark and R. Hartong for editorial assistance. This work was supported by the Spanish Ministry of Science and Innovation (SAF200405955, 200763624 to ACC, CSD 2006-00023 to JMV), the Spanish Association against Cancer, the Spanish Ministry of Health (PI050964), the Royal Physiographic Society in Lund, the Ake Wibergs, Thelma Zoegas, OE och Edla Johanssons and U-MAS Cancer Research Found, and fellowships from Teggers Fond, EMBO and the Swedish Society for Medical Research.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Barbosa V, 2000, GENE DEV, V14, P3126, DOI 10.1101/gad.182800; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cuschieri L, 2006, MOL BIOL CELL, V17, P4420, DOI 10.1091/mbc.E06-03-0245; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; FELIX MA, 1994, J CELL BIOL, V124, P19, DOI 10.1083/jcb.124.1.19; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; HESSE J, 1987, J BIOL CHEM, V262, P15472; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Kim HK, 2005, J CELL BIOL, V169, P719, DOI 10.1083/jcb.200410052; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lew DJ, 2000, CURR OPIN GENET DEV, V10, P47, DOI 10.1016/S0959-437X(99)00051-9; Lu R, 2004, J BIOL CHEM, V279, P31164, DOI 10.1074/jbc.M404728200; Marques M, 2008, MOL CELL BIOL, V28, P2803, DOI 10.1128/MCB.01786-07; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Ruiz F, 1999, CURR BIOL, V9, P43, DOI 10.1016/S0960-9822(99)80045-1; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wu J, 2008, J CELL BIOL, V181, P475, DOI 10.1083/jcb.200710127; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	41	64	67	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1081	U86		10.1038/ncb1921	http://dx.doi.org/10.1038/ncb1921			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19648910				2022-12-25	WOS:000269482500009
J	Miller, PM; Folkmann, AW; Maia, ARR; Efimova, N; Efimov, A; Kaverina, I				Miller, Paul M.; Folkmann, Andrew W.; Maia, Ana R. R.; Efimova, Nadia; Efimov, Andrey; Kaverina, Irina			Golgi-derived CLASP-dependent microtubules control Golgi organization and polarized trafficking in motile cells	NATURE CELL BIOLOGY			English	Article							RIBBON FORMATION; TRANS-GOLGI; COMPLEX; DYNAMICS; DYNEIN; APPARATUS; SITES; MORPHOGENESIS; CENTROSOMES; MECHANISMS	Microtubules are indispensable for Golgi complex assembly and maintenance, which are integral parts of cytoplasm organization during interphase in mammalian cells. Here, we show that two discrete microtubule subsets drive two distinct, yet simultaneous, stages of Golgi assembly. In addition to the radial centrosomal microtubule array, which positions the Golgi in the centre of the cell, we have identified a role for microtubules that form at the Golgi membranes in a manner dependent on the microtubule regulators CLASPs. These Golgi-derived microtubules draw Golgi ministacks together in tangential fashion and are crucial for establishing continuity and proper morphology of the Golgi complex. We propose that specialized functions of these two microtubule arrays arise from their specific geometries. Further, we demonstrate that directional post-Golgi trafficking and cell migration depend on Golgi-associated CLASPs, suggesting that correct organization of the Golgi complex by microtubules is essential for cell polarization and motility.	[Miller, Paul M.; Folkmann, Andrew W.; Maia, Ana R. R.; Efimova, Nadia; Efimov, Andrey; Kaverina, Irina] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Maia, Ana R. R.] Univ Porto, Inst Mol & Cell Biol, P-4150180 Oporto, Portugal	Vanderbilt University; Universidade do Porto	Kaverina, I (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	irina.kaverina@vanderbilt.edu			NIH NIGMS [1R01GM078373-01]; NIH NCI GI SPORE [P50CA095103]; Fundacao Para a Ciencia e Tecnologia [SFRH/BD/32976/2006]; Fundacao Para a Ciencia e a Tecnologia of Portugal [PTDC/SAU-OBD/66113/2006]; American Heart Predoctoral [09PRE2260729]; NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078373] Funding Source: NIH RePORTER	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NCI GI SPORE; Fundacao Para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); American Heart Predoctoral; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Goldenring, Mathew Tyska and Ryoma Ohi for helpful discussions, and Anna Akhmanova, Laura A. Lee and Steven K. Hanks for critical reading of the manuscript. This study was funded by NIH NIGMS grant 1R01GM078373-01 to I.K. and a pilot project to LK. from NIH NCI GI SPORE grant P50CA095103. A.R.R.M. was supported by Fundacao Para a Ciencia e Tecnologia fellowship SFRH/BD/32976/2006 and by grant PTDC/SAU-OBD/66113/2006 from Fundacao Para a Ciencia e a Tecnologia of Portugal. P.M.M. was supported by American Heart Predoctoral grant 09PRE2260729.	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; BRUUN A, 1986, HISTOCHEMISTRY, V86, P135, DOI 10.1007/BF00493378; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Burkhardt JK, 1998, BBA-MOL CELL RES, V1404, P113, DOI 10.1016/S0167-4889(98)00052-4; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cytrynbaum EN, 2004, J CELL SCI, V117, P1381, DOI 10.1242/jcs.00919; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Faire K, 1999, J CELL SCI, V112, P4243; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; KARSENTI E, 1984, J CELL BIOL, V98, P1730, DOI 10.1083/jcb.98.5.1730; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Linstedt AD, 2004, CELL, V118, P271, DOI 10.1016/j.cell.2004.07.015; Lippincott-Schwartz J, 1998, TRENDS CELL BIOL, V8, P16, DOI 10.1016/S0962-8924(97)01199-9; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Patel H, 2008, J CELL SCI, V121, P1159, DOI 10.1242/jcs.021725; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2005, CURR OPIN CELL BIOL, V17, P369, DOI 10.1016/j.ceb.2005.06.006; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Rios RM, 2004, CELL, V118, P323; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Roghi C, 1999, J CELL SCI, V112, P4673; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Storrie B, 1998, BBA-MOL CELL RES, V1404, P127, DOI 10.1016/S0167-4889(98)00053-6; Tang DM, 2008, J BIOL CHEM, V283, P6085, DOI 10.1074/jbc.M707715200; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Thomas JH, 2004, DEVELOPMENT, V131, P863, DOI 10.1242/dev.00989; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201	43	220	225	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1069	U69		10.1038/ncb1920	http://dx.doi.org/10.1038/ncb1920			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19701196	Green Accepted			2022-12-25	WOS:000269482500008
J	Braun, M; Drummond, DR; Cross, RA; McAinsh, AD				Braun, Marcus; Drummond, Douglas R.; Cross, Robert A.; McAinsh, Andrew D.			The kinesin-14 Klp2 organizes microtubules into parallel bundles by an ATP-dependent sorting mechanism	NATURE CELL BIOLOGY			English	Article							SELF-ORGANIZATION; INTERPHASE MICROTUBULES; NCD TAIL; FISSION; ARRAYS; TUBULIN; DYNAMICS; BINDING; MOTORS; HEAD	The dynamic organization of microtubules into parallel arrays allows interphase cells to set up multi-lane highways for intracellular transport and M-phase cells to build the mitotic and meiotic spindles. Here we show that a minimally reconstituted system composed of Klp2, a kinesin-14 from the fission yeast Schizosaccharomyces pombe, together with microtubules assembled from purified S. pombe tubulin, autonomously assembles bundles of parallel microtubules. Bundles form by an ATP-dependent sorting mechanism that requires the full-length Klp2 motor. By this mechanism, antiparallel-overlapped microtubules slide over one another until they dissociate from the bundles, whereas parallel-overlapped microtubules are selectively trapped by an energy-dissipating force-balance mechanism. Klp2-driven microtubule sorting provides a robust pathway for the organization of microtubules into parallel arrays. In vivo evidence indicates that Klp2 is required for the proper organization of S. pombe interphase microtubules into bipolar arrays of parallel-overlapped microtubules(1-4), suggesting that kinesin-14-dependent microtubule sorting may have wide biological importance.	[Braun, Marcus; McAinsh, Andrew D.] Marie Curie Res Inst, Chromosome Segregat Lab, Surrey RH8 0TL, England; [Drummond, Douglas R.; Cross, Robert A.] Marie Curie Res Inst, Mol Motors Lab, Surrey RH8 0TL, England		McAinsh, AD (corresponding author), Marie Curie Res Inst, Chromosome Segregat Lab, Surrey RH8 0TL, England.	a.mcainsh@mcri.ac.uk	McAinsh, Andrew/C-6438-2012; Cross, Robert A/F-1798-2011; Braun, Marcus/L-8931-2018	Cross, Robert A/0000-0002-0004-7832; Braun, Marcus/0000-0003-2026-2238; Drummond, Douglas/0000-0003-4155-3747; McAinsh, Andrew/0000-0001-6808-0711	Marie Curie Cancer Care; Medical Research Council; MRC [G0200542] Funding Source: UKRI; Medical Research Council [G0200542] Funding Source: researchfish	Marie Curie Cancer Care; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Joe Howard for the full-length Drosophila kinesin-1 construct and Michael Osei for purification of S. pombe tubulin and EGFP-tubulin. This work was supported by Marie Curie Cancer Care (A. D. M. and R. A. C.) and the Medical Research Council (R. A. C.).	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Brunner D, 2000, PHILOS T ROY SOC B, V355, P873, DOI 10.1098/rstb.2000.0622; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; DAVIS A, 1993, BIOCHEMISTRY-US, V32, P8823, DOI 10.1021/bi00085a013; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; HACKNEY DD, 1995, BIOPHYS J, V68, pS267; Hagan IM, 1998, J CELL SCI, V111, P1603; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; LOCKHART A, 1994, EMBO J, V13, P751, DOI 10.1002/j.1460-2075.1994.tb06317.x; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Nedelec F, 2003, CURR OPIN CELL BIOL, V15, P118, DOI 10.1016/S0955-0674(02)00014-5; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wendt T, 2003, J MOL BIOL, V333, P541, DOI 10.1016/j.jmb.2003.08.051	27	87	87	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					724	U55		10.1038/ncb1878	http://dx.doi.org/10.1038/ncb1878			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19430466				2022-12-25	WOS:000266503700017
J	Mille, F; Thibert, C; Fombonne, J; Rama, N; Guix, C; Hayashi, H; Corset, V; Reed, JC; Mehlen, P				Mille, Frederic; Thibert, Chantal; Fombonne, Joanna; Rama, Nicolas; Guix, Catherine; Hayashi, Hideki; Corset, Veronique; Reed, John C.; Mehlen, Patrick			The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex	NATURE CELL BIOLOGY			English	Article							PRODUCT INDUCES APOPTOSIS; SONIC HEDGEHOG; CASPASE ACTIVATION; NEURONAL DEATH; CELL-DEATH; KAPPA-B; PROTEIN; GENE; MECHANISM; INHIBITION	Sonic hedgehog (Shh) and its main receptor, Patched (Ptc), are implicated in both neural development and tumorigenesis(1,2). Besides its classic morphogenic activity, Shh is also a survival factor(3,4). Along this line, Ptc has been shown to function as a dependence receptor; it induces apoptosis in the absence of Shh, whereas its pro-apoptotic activity is blocked in the presence of Shh(5). Here we show that, in the absence of its ligand, Ptc interacts with the adaptor protein DRAL (downregulated in rhabdomyosarcoma LIM-domain protein; also known as FHL2). DRAL is required for the pro-apoptotic activity of Ptc both in immortalized cells and during neural tube development in chick embryos. We demonstrate that, in the absence of Shh, Ptc recruits a protein complex that includes DRAL, one of the caspase recruitment (CARD)-domain containing proteins TUCAN (family member, 8) or NALP1 (NLR family, pyrin domain containing 1) and apical caspase-9. Ptc triggers caspase-9 activation and enhances cell death through a caspase-9-dependent mechanism. Thus, we propose that in the absence of its ligand Shh the dependence receptor Ptc serves as the anchor for a caspase-activating complex that includes DRAL, and caspase-9.	[Mille, Frederic; Thibert, Chantal; Fombonne, Joanna; Rama, Nicolas; Guix, Catherine; Corset, Veronique; Mehlen, Patrick] Univ Lyon, CNRS, UMR5238,Apoptosis Canc & Dev Lab, Equipe Labellisee La Ligue,Ctr Leon Berard, F-69008 Lyon, France; [Hayashi, Hideki; Reed, John C.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Leon Berard; Sanford Burnham Prebys Medical Discovery Institute	Mehlen, P (corresponding author), Univ Lyon, CNRS, UMR5238,Apoptosis Canc & Dev Lab, Equipe Labellisee La Ligue,Ctr Leon Berard, F-69008 Lyon, France.	mehlen@lyon.fnclcc.fr	Hideki, Hayashi/AAW-9081-2021; THIBERT, Chantal/N-1828-2013; Thibert, Chantal/D-4367-2019	Thibert, Chantal/0000-0002-1516-5671; Rama, Nicolas/0000-0003-1614-7755; Hayashi, Hideki/0000-0003-4585-6542	Ligue Contre le Cancer; Agence Nationale de la Recherche; Institut National du Cancer; Rhone-Alpes Region; Centre National de la Recherche Scientifique; EU; NIH [NS45093, AI56324]; Rhone-Alpes Region fellowship; Association pour la Recherche sur le Cancer fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045093] Funding Source: NIH RePORTER	Ligue Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhone-Alpes Region fellowship(Region Auvergne-Rhone-Alpes); Association pour la Recherche sur le Cancer fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Briscoe and N. Le Douarin for advice and reagents, B. W. Schafer, C. Sardet and R. Sadoul for reagents, K. Cywinska for technical work on immunoprecipitation experiments and L. Kremer for the 5e1 hybridoma cell line (protein tools service at the Centro Nacional de Biotecnologia of Madrid). This work was supported by the Ligue Contre le Cancer, the Agence Nationale de la Recherche, the Institut National du Cancer, the Rhone-Alpes Region, the Centre National de la Recherche Scientifique, the EU grants Hermione and APO-SYS, NIH grants to P. M. (NS45093) and J. C. R. (AI56324), and a Rhone-Alpes Region fellowship and an Association pour la Recherche sur le Cancer fellowship to F. M.	Bartholin L, 2007, GENE, V393, P153, DOI 10.1016/j.gene.2007.02.007; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bredesen DE, 2004, PHYSIOL REV, V84, P411, DOI 10.1152/physrev.00027.2003; Charrier JB, 1999, DEVELOPMENT, V126, P4771; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Furne C, 2006, P NATL ACAD SCI USA, V103, P4128, DOI 10.1073/pnas.0507864103; Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105; Furne C, 2009, BBA-MOL CELL RES, V1793, P231, DOI 10.1016/j.bbamcr.2008.09.009; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Liu F, 2004, CELL SIGNAL, V16, P1013, DOI 10.1016/j.cellsig.2004.02.006; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Scholl FA, 2000, J CELL BIOL, V151, P495, DOI 10.1083/jcb.151.3.495; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Trioulier Y, 2004, J BIOL CHEM, V279, P2046, DOI 10.1074/jbc.M309243200; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	39	100	103	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					739	U93		10.1038/ncb1880	http://dx.doi.org/10.1038/ncb1880			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465923	Green Submitted, Green Accepted			2022-12-25	WOS:000266503700019
J	Siegel, G; Obernosterer, G; Fiore, R; Oehmen, M; Bicker, S; Christensen, M; Khudayberdiev, S; Leuschner, PF; Busch, CJL; Kane, C; Hubel, K; Dekker, F; Hedberg, C; Rengarajan, B; Drepper, C; Waldmann, H; Kauppinen, S; Greenberg, ME; Draguhn, A; Rehmsmeier, M; Martinez, J; Schratt, GM				Siegel, Gabriele; Obernosterer, Gregor; Fiore, Roberto; Oehmen, Martin; Bicker, Silvia; Christensen, Mette; Khudayberdiev, Sharof; Leuschner, Philipp F.; Busch, Clara J. L.; Kane, Christina; Huebel, Katja; Dekker, Frank; Hedberg, Christian; Rengarajan, Balamurugan; Drepper, Carsten; Waldmann, Herbert; Kauppinen, Sakari; Greenberg, Michael E.; Draguhn, Andreas; Rehmsmeier, Marc; Martinez, Javier; Schratt, Gerhard M.			A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis	NATURE CELL BIOLOGY			English	Article							NEURONAL RNA GRANULES; PROTEIN-SYNTHESIS; POSTTRANSCRIPTIONAL REGULATION; MOLECULAR-MECHANISMS; MICRORNAS; EXPRESSION; BRAIN; CELLS; PALMITOYLATION; POLYRIBOSOMES	The microRNA pathway has been implicated in the regulation of synaptic protein synthesis and ultimately in dendritic spine morphogenesis, a phenomenon associated with long-lasting forms of memory. However, the particular microRNAs (miRNAs) involved are largely unknown. Here we identify specific miRNAs that function at synapses to control dendritic spine structure by performing a functional screen. One of the identified miRNAs, miR-138, is highly enriched in the brain, localized within dendrites and negatively regulates the size of dendritic spines in rat hippocampal neurons. miR-138 controls the expression of acyl protein thioesterase 1 (APT1), an enzyme regulating the palmitoylation status of proteins that are known to function at the synapse, including the alpha(13) subunits of G proteins (G alpha(13)). RNA-interference-mediated knockdown of APT1 and the expression of membrane-localized G alpha(13) both suppress spine enlargement caused by inhibition of miR-138, suggesting that APT1-regulated depalmitoylation of G alpha(13) might be an important downstream event of miR-138 function. Our results uncover a previously unknown miRNA-dependent mechanism in neurons and demonstrate a previously unrecognized complexity of miRNA-dependent control of dendritic spine morphogenesis.	[Leuschner, Philipp F.; Busch, Clara J. L.; Martinez, Javier] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Siegel, Gabriele; Obernosterer, Gregor; Fiore, Roberto; Bicker, Silvia; Christensen, Mette; Khudayberdiev, Sharof; Schratt, Gerhard M.] Heidelberg Univ, Interdisziplinares Zentrum Neurowissensch, Jr Grp SFB488, D-69120 Heidelberg, Germany; [Siegel, Gabriele; Obernosterer, Gregor; Fiore, Roberto; Bicker, Silvia; Christensen, Mette; Khudayberdiev, Sharof; Schratt, Gerhard M.] Univ Klinikum Heidelberg, Inst Neuroanat, D-69120 Heidelberg, Germany; [Oehmen, Martin; Draguhn, Andreas] Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; [Christensen, Mette; Kauppinen, Sakari] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Cph N, Denmark; [Kane, Christina; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Huebel, Katja; Dekker, Frank; Rengarajan, Balamurugan; Waldmann, Herbert] Max Planck Inst Mol Physiol, Abt Chem Biol, D-44227 Dortmund, Germany; [Huebel, Katja; Dekker, Frank; Rengarajan, Balamurugan; Waldmann, Herbert] Tech Univ Dortmund, Fak Chem, D-44227 Dortmund, Germany; [Drepper, Carsten; Rehmsmeier, Marc] Univ Bielefeld, Ctr Biotechnol CeBiTec, D-33594 Bielefeld, Germany; [Kauppinen, Sakari] Santaris Pharma, DK-2970 Horsholm, Denmark	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Copenhagen; Harvard University; Harvard Medical School; Max Planck Society; Dortmund University of Technology; University of Bielefeld	Martinez, J (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at; schratt@ana.uni-heidelberg.de	Rehmsmeier, Marc/A-4982-2013; Waldmann, Herbert/B-7406-2017; Dekker, Frank J./H-2544-2014; Drepper, Carsten/GSN-2009-2022	Waldmann, Herbert/0000-0002-9606-7247; Dekker, Frank J./0000-0001-7217-9300; Drepper, Carsten/0000-0002-7883-6479; Siegel, Gabriele/0000-0002-9501-7061; Khudayberdiev, Sharof/0000-0003-0349-116X; Martinez, Javier/0000-0001-9152-7323	Deutsche Forschungsgemeinschaft [SFB488]; Human Frontier Science Program; National Institute on Drug Abuse [1R21DA025102-01]; National Institutes of Health [NS045500]; Bioinformatics Initiative; Austrian Academy of Sciences; Austrian Government; GEN-AU initiative; Alexander von Humboldt foundation; Netherlands Organization for Scientific Research (NWO); European Union; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025102] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bioinformatics Initiative; Austrian Academy of Sciences; Austrian Government; GEN-AU initiative; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank O. Rocks and P. Wedegaertner for providing reagents; R. Heinen for suggestions on the luciferase reporter assays; T. Wust for technical assistance; and M. Alenius and A. Keene for critically reading the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (SFB488; to G. M. S.), the Human Frontier Science Program (Career Development Award; to G. M. S.), the National Institute on Drug Abuse (1R21DA025102-01; to G. M. S.), the National Institutes of Health (NS045500; to M. E. G.) the Bioinformatics Initiative (to C. D. and M. R.), the Austrian Academy of Sciences (to J.M. and S. B. (DOC-fFORTE-fellowship)) and the Austrian Government, GEN-AU initiative (to G. O.). C. H. acknowledges the Alexander von Humboldt foundation for a postdoctoral fellowship. F. D. is a recipient of a TALENT-stipendium from the Netherlands Organization for Scientific Research (NWO)and a Marie-Curie fellowship from the European Union.	AEL DE, 2002, CELL, V108, P849; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Etournay R, 2005, J CELL SCI, V118, P2891, DOI 10.1242/jcs.02424; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; RAO A, 1991, J NEUROSCI, V11, P2881; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	52	371	389	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					705	U36		10.1038/ncb1876	http://dx.doi.org/10.1038/ncb1876			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465924	Green Accepted			2022-12-25	WOS:000266503700015
J	Suzuki, H; Forrest, ARR; van Nimwegen, E; Daub, CO; Balwierz, PJ; Irvine, KM; Lassmann, T; Ravasi, T; Hasegawa, Y; de Hoon, MJL; Katayama, S; Schroder, K; Carninci, P; Tomaru, Y; Kanamori-Katayama, M; Kubosaki, A; Akalin, A; Ando, Y; Arner, E; Asada, M; Asahara, H; Bailey, T; Bajic, VB; Bauer, D; Beckhouse, AG; Bertin, N; Bjorkegren, J; Brombacher, F; Bulger, E; Chalk, AM; Chiba, J; Cloonan, N; Dawe, A; Dostie, J; Engstrom, PG; Essack, M; Faulkner, GJ; Fink, JL; Fredman, D; Fujimori, K; Furuno, M; Gojobori, T; Gough, J; Grimmond, SM; Gustafsson, M; Hashimoto, M; Hashimoto, T; Hatakeyama, M; Heinzel, S; Hide, W; Hofmann, O; Hornquist, M; Huminiecki, L; Ikeo, K; Imamoto, N; Inoue, S; Inoue, Y; Ishihara, R; Iwayanagi, T; Jacobsen, A; Kaur, M; Kawaji, H; Kerr, MC; Kimura, R; Kimura, S; Kimura, Y; Kitano, H; Koga, H; Kojima, T; Kondo, S; Konno, T; Krogh, A; Kruger, A; Kumar, A; Lenhard, B; Lennartsson, A; Lindow, M; Lizio, M; MacPherson, C; Maeda, N; Maher, CA; Maqungo, M; Mar, J; Matigian, NA; Matsuda, H; Mattick, JS; Meier, S; Miyamoto, S; Miyamoto-Sato, E; Nakabayashi, K; Nakachi, Y; Nakano, M; Nygaard, S; Okayama, T; Okazaki, Y; Okuda-Yabukami, H; Orlando, V; Otomo, J; Pachkov, M; Petrovsky, N; Plessy, C; Quackenbush, J; Radovanovic, A; Rehli, M; Saito, R; Sandelin, A; Schmeier, S; Schonbach, C; Schwartz, AS; Semple, CA; Sera, M; Severin, J; Shirahige, K; Simons, C; Laurent, GS; Suzuki, M; Suzuki, T; Sweet, MJ; Taft, RJ; Takeda, S; Takenaka, Y; Tan, K; Taylor, MS; Teasdale, RD; Tegner, J; Teichmann, S; Valen, E; Wahlestedt, C; Waki, K; Waterhouse, A; AWells, C; Winther, O; Wu, L; Yamaguchi, K; Yanagawa, H; Yasuda, J; Zavolan, M; Hume, DA; Arakawa, T; Fukuda, S; Imamura, K; Kai, C; Kaiho, A; Kawashima, T; Kawazu, C; Kitazume, Y; Kojima, M; Miura, H; Murakami, K; Murata, M; Ninomiya, N; Nishiyori, H; Noma, S; Ogawa, C; Sano, T; Simon, C; Tagami, M; Takahashi, Y; Kawai, J; Hayashizaki, Y				Suzuki, Harukazu; Forrest, Alistair R. R.; van Nimwegen, Erik; Daub, Carsten O.; Balwierz, Piotr J.; Irvine, Katharine M.; Lassmann, Timo; Ravasi, Timothy; Hasegawa, Yuki; de Hoon, Michiel J. L.; Katayama, Shintaro; Schroder, Kate; Carninci, Piero; Tomaru, Yasuhiro; Kanamori-Katayama, Mutsumi; Kubosaki, Atsutaka; Akalin, Altuna; Ando, Yoshinari; Arner, Erik; Asada, Maki; Asahara, Hiroshi; Bailey, Timothy; Bajic, Vladimir B.; Bauer, Denis; Beckhouse, Anthony G.; Bertin, Nicolas; Bjorkegren, Johan; Brombacher, Frank; Bulger, Erika; Chalk, Alistair M.; Chiba, Joe; Cloonan, Nicole; Dawe, Adam; Dostie, Josee; Engstrom, Par G.; Essack, Magbubah; Faulkner, Geoffrey J.; Fink, J. Lynn; Fredman, David; Fujimori, Ko; Furuno, Masaaki; Gojobori, Takashi; Gough, Julian; Grimmond, Sean M.; Gustafsson, Mika; Hashimoto, Megumi; Hashimoto, Takehiro; Hatakeyama, Mariko; Heinzel, Susanne; Hide, Winston; Hofmann, Oliver; Hornquist, Michael; Huminiecki, Lukasz; Ikeo, Kazuho; Imamoto, Naoko; Inoue, Satoshi; Inoue, Yusuke; Ishihara, Ryoko; Iwayanagi, Takao; Jacobsen, Anders; Kaur, Mandeep; Kawaji, Hideya; Kerr, Markus C.; Kimura, Ryuichiro; Kimura, Syuhei; Kimura, Yasumasa; Kitano, Hiroaki; Koga, Hisashi; Kojima, Toshio; Kondo, Shinji; Konno, Takeshi; Krogh, Anders; Kruger, Adele; Kumar, Ajit; Lenhard, Boris; Lennartsson, Andreas; Lindow, Morten; Lizio, Marina; MacPherson, Cameron; Maeda, Norihiro; Maher, Christopher A.; Maqungo, Monique; Mar, Jessica; Matigian, Nicholas A.; Matsuda, Hideo; Mattick, John S.; Meier, Stuart; Miyamoto, Sei; Miyamoto-Sato, Etsuko; Nakabayashi, Kazuhiko; Nakachi, Yutaka; Nakano, Mika; Nygaard, Sanne; Okayama, Toshitsugu; Okazaki, Yasushi; Okuda-Yabukami, Haruka; Orlando, Valerio; Otomo, Jun; Pachkov, Mikhail; Petrovsky, Nikolai; Plessy, Charles; Quackenbush, John; Radovanovic, Aleksandar; Rehli, Michael; Saito, Rintaro; Sandelin, Albin; Schmeier, Sebastian; Schonbach, Christian; Schwartz, Ariel S.; Semple, Colin A.; Sera, Miho; Severin, Jessica; Shirahige, Katsuhiko; Simons, Cas; Laurent, George St.; Suzuki, Masanori; Suzuki, Takahiro; Sweet, Matthew J.; Taft, Ryan J.; Takeda, Shizu; Takenaka, Yoichi; Tan, Kai; Taylor, Martin S.; Teasdale, Rohan D.; Tegner, Jesper; Teichmann, Sarah; Valen, Eivind; Wahlestedt, Claes; Waki, Kazunori; Waterhouse, Andrew; AWells, Christine; Winther, Ole; Wu, Linda; Yamaguchi, Kazumi; Yanagawa, Hiroshi; Yasuda, Jun; Zavolan, Mihaela; Hume, David A.; Arakawa, Takahiro; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Kaiho, Ai; Kawashima, Tsugumi; Kawazu, Chika; Kitazume, Yayoi; Kojima, Miki; Miura, Hisashi; Murakami, Kayoko; Murata, Mitsuyoshi; Ninomiya, Noriko; Nishiyori, Hiromi; Noma, Shohei; Ogawa, Chihiro; Sano, Takuma; Simon, Christophe; Tagami, Michihira; Takahashi, Yukari; Kawai, Jun; Hayashizaki, Yoshihide		FANTOM Consortium; Riken Omics Sci Ctr	The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line	NATURE GENETICS			English	Article							SERUM RESPONSE FACTOR; MONOCYTE-MACROPHAGE MATURATION; MESSENGER-RNA EXPRESSION; FACTOR-BINDING-SITES; GENE-EXPRESSION; SIGNALING PATHWAYS; STEM-CELLS; GENOME; PHOSPHORYLATION; PROLIFERATION	Using deep sequencing (deepCAGE), the FANTOM4 study measured the genome-wide dynamics of transcription-start-site usage in the human monocytic cell line THP-1 throughout a time course of growth arrest and differentiation. Modeling the expression dynamics in terms of predicted cis-regulatory sites, we identified the key transcription regulators, their time-dependent activities and target genes. Systematic siRNA knockdown of 52 transcription factors confirmed the roles of individual factors in the regulatory network. Our results indicate that cellular states are constrained by complex networks involving both positive and negative regulatory interactions among substantial numbers of transcription factors and that no single transcription factor is both necessary and sufficient to drive the differentiation process.	[Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Suzuki, Harukazu; Forrest, Alistair R. R.; Daub, Carsten O.; Lassmann, Timo; Hasegawa, Yuki; de Hoon, Michiel J. L.; Katayama, Shintaro; Carninci, Piero; Tomaru, Yasuhiro; Kanamori-Katayama, Mutsumi; Kubosaki, Atsutaka; Ando, Yoshinari; Arner, Erik; Bertin, Nicolas; Bulger, Erika; Furuno, Masaaki; Hashimoto, Takehiro; Ishihara, Ryoko; Kawaji, Hideya; Kimura, Yasumasa; Kondo, Shinji; Lennartsson, Andreas; Lizio, Marina; Maeda, Norihiro; Nakano, Mika; Okuda-Yabukami, Haruka; Plessy, Charles; Severin, Jessica; Suzuki, Masanori; Suzuki, Takahiro; Waki, Kazunori; Waterhouse, Andrew; Yamaguchi, Kazumi; Yasuda, Jun] RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan; [Forrest, Alistair R. R.; Beckhouse, Anthony G.; Chalk, Alistair M.; Matigian, Nicholas A.; AWells, Christine] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [van Nimwegen, Erik; Balwierz, Piotr J.; Pachkov, Mikhail; Zavolan, Mihaela] Univ Basel, Bioctr, CH-4056 Basel, Switzerland; [van Nimwegen, Erik; Balwierz, Piotr J.; Pachkov, Mikhail; Zavolan, Mihaela] Swiss Inst Bioinformat, Basel, Switzerland; [Irvine, Katharine M.; Schroder, Kate; Bailey, Timothy; Bauer, Denis] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Ravasi, Timothy; Schwartz, Ariel S.; Tan, Kai] Univ Calif San Diego, Jacobs Sch Engn, Dept Bioengn, La Jolla, CA 92093 USA; [Akalin, Altuna; Engstrom, Par G.; Fredman, David; Lenhard, Boris] Bergen Ctr Computat Sci, Bergen, Norway; [Asada, Maki; Asahara, Hiroshi; Hashimoto, Megumi] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Bajic, Vladimir B.; Dawe, Adam; Essack, Magbubah; Hide, Winston; Hofmann, Oliver; Kaur, Mandeep; Kruger, Adele; MacPherson, Cameron; Maqungo, Monique; Meier, Stuart; Radovanovic, Aleksandar; Schmeier, Sebastian; AWells, Christine] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Bjorkegren, Johan; Tegner, Jesper] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Computat Med Grp,Atherosclerosis Res Unit,Ctr Mol, Stockholm, Sweden; [Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, IIDMM, Observatory, South Africa; [Chiba, Joe; Kimura, Ryuichiro; Nakabayashi, Kazuhiko] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 162, Japan; [Cloonan, Nicole; Faulkner, Geoffrey J.; Grimmond, Sean M.; Mattick, John S.; Simons, Cas; Taft, Ryan J.] Univ Queensland, Inst Mol Biosci, Special Res Ctr Funct & Appl Genom, ARC, St Lucia, Qld, Australia; [Dostie, Josee] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Fink, J. Lynn; Kerr, Markus C.; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, Ctr Excellence Bioinformat, ARC, St Lucia, Qld, Australia; [Fujimori, Ko] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Osaka 580, Japan; [Gojobori, Takashi; Ikeo, Kazuho; Konno, Takeshi; Miyamoto, Sei; Okayama, Toshitsugu; Sera, Miho] Natl Inst Genet, Res Org Informat & Syst, Ctr Informat Biol, Shizuoka, Japan; [Gojobori, Takashi; Ikeo, Kazuho; Konno, Takeshi; Miyamoto, Sei; Okayama, Toshitsugu; Sera, Miho] Natl Inst Genet, DDBJ, Shizuoka, Japan; [Gough, Julian] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Gustafsson, Mika; Hornquist, Michael] Linkoping Univ, Dept Sci & Technol, Norrkoping, Sweden; [Hatakeyama, Mariko; Kojima, Toshio] RIKEN, Yokohama Inst, Genom Sci Ctr, Computat & Expt Syst Biol Grp, Kanagawa, Japan; [Heinzel, Susanne; Petrovsky, Nikolai] Flinders Univ & Med Ctr, Dept Endocrinol & Diabet, Adelaide, SA, Australia; [Hide, Winston; Hofmann, Oliver] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Huminiecki, Lukasz] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Imamoto, Naoko] RIKEN, Wako Inst, Discovery & Res Inst, Cellular Dynam Lab, Saitama, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Inoue, Satoshi] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Inoue, Yusuke] Gunma Univ, Fac Engn, Dept Biol & Chem Engn, Gunma, Japan; [Iwayanagi, Takao] Hitachi Ltd, Res & Dev Grp, R&D Solut Ctr, Tokyo, Japan; [Jacobsen, Anders; Krogh, Anders; Lindow, Morten; Nygaard, Sanne; Sandelin, Albin; Valen, Eivind; Winther, Ole] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Jacobsen, Anders; Krogh, Anders; Lindow, Morten; Nygaard, Sanne; Sandelin, Albin; Valen, Eivind; Winther, Ole] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Kimura, Syuhei] Tottori Univ, Fac Engn, Dept Informat & Knowledge Engn, Tottori 680, Japan; [Kitano, Hiroaki] Syst Biol Inst, Shibuya Ku, Tokyo, Japan; [Koga, Hisashi] Kazusa DNA Res Inst, Dept Human Gene Res, Chiba, Japan; [Kumar, Ajit; Laurent, George St.] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Mar, Jessica; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Matsuda, Hideo; Takenaka, Yoichi] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan; [Miyamoto-Sato, Etsuko; Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Sch, Res Ctr Genom Med, Div Funct Genom & Syst Med, Saitama, Japan; [Orlando, Valerio] IRCCS Fdn Santa Lucia EBRI, Dulbecco Telethon Inst, Rome, Italy; [Orlando, Valerio] IGB CNR, Naples, Italy; [Otomo, Jun; Takeda, Shizu] Hitachi Ltd, Cent Res Labs, Tokyo, Japan; [Rehli, Michael] Univ Regensburg, Dept Hematol & Oncol, Regensburg, Germany; [Saito, Rintaro] Keio Univ, Fac Environm & Informat Studies, Kanagawa, Japan; [Schonbach, Christian] Nanyang Technol Univ, Div Genom & Genet, Sch Biol Sci, Singapore, Singapore; [Semple, Colin A.] Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Shirahige, Katsuhiko] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Comp Sci, Tokyo 152, Japan; [Sweet, Matthew J.] Univ Queensland, CRC Chron Inflammatory Dis, Sch Mol & Microbial Sci, Inst Mol Biosci, St Lucia, Qld, Australia; [Taylor, Martin S.] EMBL European Bioinformat Inst, Cambridge, England; [Tegner, Jesper] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Teichmann, Sarah] MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 2QH, England; [Wahlestedt, Claes] Scripps Res Inst, Jupiter, FL USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; RIKEN; Griffith University; University of Basel; Swiss Institute of Bioinformatics; University of Queensland; University of California System; University of California San Diego; National Center for Child Health & Development - Japan; South African National Biodiversity Institute; University of the Western Cape; Karolinska Institutet; Karolinska University Hospital; University of Cape Town; Tokyo University of Science; University of Queensland; McGill University; University of Queensland; Osaka University of Pharmaceutical Sciences; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Bristol; Linkoping University; RIKEN; Flinders University South Australia; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; RIKEN; University of Tokyo; University of Tokyo; Gunma University; Hitachi Limited; University of Copenhagen; University of Copenhagen; Tottori University; Kazusa DNA Research Institute; George Washington University; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Osaka University; Keio University; Saitama Medical University; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Hitachi Limited; University of Regensburg; Keio University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Edinburgh; Tokyo Institute of Technology; University of Queensland; European Molecular Biology Laboratory (EMBL); Linkoping University; MRC Laboratory Molecular Biology; Scripps Research Institute	Hume, DA (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	david.hume@roslin.ed.ac.uk; yosihide@gsc.riken.jp	Schmeier, Sebastian/D-4731-2011; Nygaard, Sanne/M-2569-2014; Forrest, Alistair/A-6597-2008; de Hoon, Michiel/A-6443-2013; Radovanovic, Aleksandar/M-3687-2019; Lennartsson, Andreas/E-7823-2011; Suzuki, Harukazu/N-9553-2015; Rehli, Michael/E-9093-2011; Inoue, Yusuke/O-6207-2018; Sandelin, Albin/G-2881-2011; Simons, Cas/A-7905-2011; AKALIN, ALTUNA/A-4424-2012; Hide, Winston Hide/C-7217-2009; Dawe, Adam/C-5295-2009; Petrovsky, Nikolai/P-1912-2017; Arner, Erik/A-1895-2010; Bauer, Denis/C-3903-2009; Irvine, Katharine M/A-5559-2011; Bertin, Nicolas/O-9602-2019; Hayashizaki, Yoshihide/N-6590-2015; Kawaji, Hideya/N-5116-2015; Daub, Carsten O/A-7436-2010; Severin, Jessica/AAQ-2723-2020; Ravasi, Timothy/B-8777-2008; Wells, Christine A/A-5071-2010; Hofmann, Oliver M/F-1800-2013; Fink, Lynn/C-2031-2008; Hume, David A/C-7695-2013; Valen, Eivind/A-8617-2011; Sweet, Matthew J/F-2229-2011; Essack, Magbubah/G-5008-2013; Imamoto, Naoko/A-7458-2015; Suzuki, Takahiro/AAW-8509-2020; Tomic, Nevena/AAA-2135-2021; Katayama, Shintaro/F-2958-2010; Hide, Winston/R-3815-2019; Matigian, Nicholas/AAF-9390-2020; Schroder, Kate/C-6132-2008; Ando, Yoshinari/AAK-5668-2020; van Nimwegen, Erik/ABF-1085-2021; Kimura, Yasumasa/M-9720-2013; Cloonan, Nicole/B-5272-2008; Teasdale, Rohan/AAD-6698-2019; Kerr, Markus C/A-9864-2014; Mattick, John S/I-7789-2012; Taylor, Martin S/C-3825-2009; Grimmond, Sean M/J-5304-2016; Teasdale, Rohan D/B-2538-2009; Nakachi, Yutaka/M-2446-2013; Lassmann, Timo/A-8271-2008; Matigian, Nicholas A/A-4935-2009; Fredman, David J/H-3566-2013; Zavolan, Mihaela/S-3888-2016; Plessy, Charles/N-5054-2015; Radovanovic, Aleksandar/D-1313-2012; Chalk, Alistair/O-3522-2019; Mattick, John/ABH-6130-2020; Carninci, Piero/K-1568-2014; Hide, Winston A/V-2727-2017; Skanderup, Anders Jacobsen/K-1081-2013; Faulkner, Geoffrey J/M-3168-2014; Beckhouse, Anthony G/A-2601-2010; Essack, Magbubah/R-2773-2019; Schönbach, Christian/B-1998-2009; tegner, jesper N/R-5095-2017; Taft, Ryan/B-2945-2010; Fujimori, Ko/AAD-5428-2021; Grimmond, Sean/K-3246-2019; Lassmann, Timo/HCH-4313-2022; Semple, Colin A M/A-5613-2009; Okada, Mariko/N-6933-2015; Kawai, Jun/A-6451-2016; Kaur, Mandeep/N-4550-2015; Bajic, Vladimir/D-2810-2009; Bertin, Nicolas/C-3025-2008; Krogh, Anders/M-1541-2014; Waki, Kazunori/T-6444-2019	Schmeier, Sebastian/0000-0002-3947-8226; Nygaard, Sanne/0000-0002-3002-6047; Forrest, Alistair/0000-0003-4543-1675; Radovanovic, Aleksandar/0000-0002-8749-7608; Suzuki, Harukazu/0000-0002-8087-0836; Rehli, Michael/0000-0003-3992-932X; Inoue, Yusuke/0000-0002-9710-7482; Sandelin, Albin/0000-0002-7109-7378; Simons, Cas/0000-0003-3147-8042; AKALIN, ALTUNA/0000-0002-0468-0117; Hide, Winston Hide/0000-0002-8621-3271; Petrovsky, Nikolai/0000-0002-1580-5245; Arner, Erik/0000-0003-1225-4908; Bauer, Denis/0000-0001-8033-9810; Irvine, Katharine M/0000-0002-6716-1605; Kawaji, Hideya/0000-0002-0575-0308; Daub, Carsten O/0000-0002-3295-8729; Severin, Jessica/0000-0003-1274-208X; Wells, Christine A/0000-0003-3133-3628; Hofmann, Oliver M/0000-0002-7738-1513; Fink, Lynn/0000-0003-2912-6048; Sweet, Matthew J/0000-0002-0406-8139; Essack, Magbubah/0000-0003-2709-5356; Imamoto, Naoko/0000-0002-2886-3022; Suzuki, Takahiro/0000-0002-0972-6911; Katayama, Shintaro/0000-0001-7581-5157; Hide, Winston/0000-0002-8621-3271; Matigian, Nicholas/0000-0001-7735-9415; Schroder, Kate/0000-0001-9261-3805; Ando, Yoshinari/0000-0002-8128-6201; van Nimwegen, Erik/0000-0001-6338-1312; Cloonan, Nicole/0000-0001-7802-6647; Teasdale, Rohan/0000-0001-7455-5269; Mattick, John S/0000-0002-7680-7527; Taylor, Martin S/0000-0001-7656-330X; Grimmond, Sean M/0000-0002-8102-7998; Teasdale, Rohan D/0000-0001-7455-5269; Nakachi, Yutaka/0000-0003-1964-2495; Lassmann, Timo/0000-0002-0138-2691; Matigian, Nicholas A/0000-0001-7735-9415; Fredman, David J/0000-0003-3507-0554; Plessy, Charles/0000-0001-7410-6295; Radovanovic, Aleksandar/0000-0002-8749-7608; Chalk, Alistair/0000-0002-9630-6236; Mattick, John/0000-0002-7680-7527; Carninci, Piero/0000-0001-7202-7243; Hide, Winston A/0000-0002-8621-3271; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Faulkner, Geoffrey J/0000-0001-5769-4494; Beckhouse, Anthony G/0000-0002-5141-8250; Schönbach, Christian/0000-0002-0693-7617; tegner, jesper N/0000-0002-9568-5588; Fujimori, Ko/0000-0002-2506-0769; Grimmond, Sean/0000-0002-8102-7998; Lassmann, Timo/0000-0002-0138-2691; Semple, Colin A M/0000-0003-1765-4118; Kaur, Mandeep/0000-0002-9757-4048; de Hoon, Michiel/0000-0003-0489-2352; Yasuda, Jun/0000-0002-3887-6871; Okazaki, Yasushi/0000-0003-3241-5502; Tan, Kai/0000-0002-9104-5567; Zavolan, Mihaela/0000-0002-8832-2041; Ando, Yukio/0000-0001-7115-9105; Ravasi, Timothy/0000-0002-9950-465X; Engstrom, Par/0000-0001-5265-2121; Hume, David/0000-0002-2615-1478; Winther, Ole/0000-0002-1966-3205; MacPherson, Cameron/0000-0002-8945-9736; Lennartsson, Andreas/0000-0002-3272-2505; Quackenbush, John/0000-0002-2702-5879; Bajic, Vladimir/0000-0001-5435-4750; Huminiecki, Lukasz/0000-0003-1943-4450; Bertin, Nicolas/0000-0002-9835-9606; Lenhard, Boris/0000-0002-1114-1509; Matsuda, Hideo/0000-0002-4701-3779; Krogh, Anders/0000-0002-5147-6282; Teichmann, Sarah/0000-0002-6294-6366; Mar, Jessica/0000-0002-5147-9299; Valen, Eivind/0000-0003-1840-6108; Waki, Kazunori/0000-0001-7311-7208; Heinzel, Susanne/0000-0001-9524-2835	Ministry of Education, Culture, Sports, Science and Technology, Japan; RIKEN Frontier Research System, Functional RNA research program; Australian National Health and Medical Research Council [ID 428261]; SNF [SNF 3100A0-118318]; Medical Research Council [G9900991B, MC_U105161047] Funding Source: researchfish; MRC [MC_U105161047] Funding Source: UKRI; Fondazione Telethon Funding Source: Custom; Grants-in-Aid for Scientific Research [21570151] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Frontier Research System, Functional RNA research program; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); SNF; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondazione Telethon(Fondazione Telethon); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Ambesi, H. Atsui, M. Bansal, V. Belcastro, H. Daub, D. di Bernardo, M. Furuya, A. Hasegawa, K. Hayashida, A. Hirakiyama, F. Hori, K. Koseki, S. Kuhara, N. Miyamoto, S. Miyano, M. Nishikawa, C. Ohinata, M. Persson, S. Saihara, C. Sakaba, H. Sano, E. Shibazaki, T. Takagi, K. Toyoda, Y. Tsujimura and M. Yamamoto for discussion, encouragement and technical assistance. We thank M. Muramatsu, T. Ogawa, Y. Sakaki and A. Wada for support and encouragement. This work was mainly supported by grants for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Y. H.), Research Grant for the RIKEN Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (Y. H.) and the RIKEN Frontier Research System, Functional RNA research program (Y. H.). A. R. R. F. is supported by a CJ Martin Fellowship from the Australian National Health and Medical Research Council (ID 428261). E. v. N. acknowledges support from SNF grant SNF # 3100A0-118318.	ABRINK M, 1994, LEUKEMIA, V8, P1579; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Biggs JR, 1998, CELL GROWTH DIFFER, V9, P667; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Carey JO, 1996, BLOOD, V87, P4316, DOI 10.1182/blood.V87.10.4316.bloodjournal87104316; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Das D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100067; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fleige A, 2007, J BIOL CHEM, V282, P24320, DOI 10.1074/jbc.M703119200; Foster N, 2007, J LEUKOCYTE BIOL, V81, P893, DOI 10.1189/jlb.0206086; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; Kauffman S.A., 1993, ORIGINS ORDER; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Krishnaraju K, 1998, BLOOD, V92, P1957, DOI 10.1182/blood.V92.6.1957.418k24_1957_1966; Martino V, 2006, ONCOL REP, V15, P207; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; Odero MD, 2000, GENE CHROMOSOME CANC, V29, P333, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1040>3.3.CO;2-Q; Pession A, 2003, ONCOGENE, V22, P8671, DOI 10.1038/sj.onc.1207125; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; REDDY MA, 1994, J EXP MED, V180, P2309, DOI 10.1084/jem.180.6.2309; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Schmitz G, 2008, REV PHYSIOL BIOCH P, V160, P93, DOI 10.1007/112_2008_802; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TREJO J, 1994, J BIOL CHEM, V269, P21682; TSUCHIYA S, 1982, CANCER RES, V42, P1530; van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507	49	341	347	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					553	562		10.1038/ng.375	http://dx.doi.org/10.1038/ng.375			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19377474	Green Accepted			2022-12-25	WOS:000265575600016
J	Fitt, R				Fitt, Robert			New guidance on the patentability of embryonic stem cell patents in Europe	NATURE BIOTECHNOLOGY			English	Editorial Material								The European Patent Office rules in the latest installment of the prosecution of the WARF patents.	Bristows, Life Sci Grp, London, England		Fitt, R (corresponding author), Bristows, Life Sci Grp, London, England.	robert.fitt@bristows.com						[Anonymous], European Patent, Patent No. [EP0770125, 0770125, 96903521.1]; *WI AL RES FDN, 2008, G000206 WISC AL RES; 2009, UKIPO PRACTICE NOTIC	3	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2009	27	4					338	340		10.1038/nbt0409-338	http://dx.doi.org/10.1038/nbt0409-338			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	430EO	19352367				2022-12-25	WOS:000264971800015
J	Garnett, MJ; Mansfeld, J; Godwin, C; Matsusaka, T; Wu, JH; Russell, P; Pines, J; Venkitaraman, AR				Garnett, Mathew J.; Mansfeld, Joerg; Godwin, Colin; Matsusaka, Takahiro; Wu, Jiahua; Russell, Paul; Pines, Jonathon; Venkitaraman, Ashok R.			UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITOR; CHROMOSOME ALIGNMENT; CONJUGATING ENZYME; FISSION YEAST; KINESIN EG5; CYCLIN-A; ANAPHASE; DESTRUCTION; MITOSIS	The anaphase-promoting complex (APC/C), a ubiquitin ligase, is the target of the spindle-assembly checkpoint (SAC), and it ubiquitylates protein substrates whose degradation regulates progress through mitosis(1-3). The identity of the ubiquitin-conjugating (E2) enzymes that work with the APC/C is unclear. In an RNA interference (RNAi) screen for factors that modify release from drug-induced SAC activation, we identified the E2 enzyme UBE2S as an APC/C auxiliary factor that promotes mitotic exit. UBE2S is dispensable in a normal mitosis, but its depletion prolongs drug-induced mitotic arrest and suppresses mitotic slippage. In vitro, UBE2S elongates ubiquitin chains initiated by the E2 enzymes UBCH10 and UBCH5, enhancing the degradation of APC/C substrates by the proteasome. Indeed, following release from SAC-induced mitotic arrest, UBE2S-depleted cells neither degrade crucial APC/C substrates, nor silence this checkpoint, whereas bypassing the SAC through BUBR1 depletion or Aurora-B inhibition negates the requirement for UBE2S. Thus, UBE2S functions with the APC/C in a two-step mechanism to control substrate ubiquitylation that is essential for mitotic exit after prolonged SAC activation, providing a new model for APC/C function in human cells.	[Garnett, Mathew J.; Godwin, Colin; Wu, Jiahua; Russell, Paul; Venkitaraman, Ashok R.] Univ Cambridge, Dept Oncol, Cambridge CB2 0XZ, England; [Garnett, Mathew J.; Godwin, Colin; Wu, Jiahua; Russell, Paul; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, Med Res Council, Canc Cell Unit, Cambridge CB2 0XZ, England; [Mansfeld, Joerg; Matsusaka, Takahiro; Pines, Jonathon] Wellcome Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Mansfeld, Joerg; Matsusaka, Takahiro; Pines, Jonathon] Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Garnett, MJ (corresponding author), Univ Cambridge, Dept Oncol, Hills Rd, Cambridge CB2 0XZ, England.	arv22@cam.ac.uk	Mansfeld, Joerg/B-4154-2014	Pines, Jonathon/0000-0002-5227-6004; Mansfeld, Jorg/0000-0002-0562-8206	Newton Trust; Canadian Institute of Health Research; FEBS; Churchill Foundation Scholarship; UK Medical Research Council (MRC); Wellcome Trust; Cancer Research UK; MRC [G0600332, G0700651, G9900064, MC_U105359877] Funding Source: UKRI; Medical Research Council [G0700651, G9900064, MC_U105359877, G0600332] Funding Source: researchfish	Newton Trust; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); FEBS; Churchill Foundation Scholarship; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Lehner (Cambridge Institute of Medical Research) for providing the ubiquitin-proteasome siRNA library, the Newton Trust for funding its purchase, and L. Passmore for helpful discussions. M.J.G. was supported by a Canadian Institute of Health Research fellowship, J.M., by a FEBS fellowship and C. G., by a Churchill Foundation Scholarship. M.J.G., C. G. and P. R. were also supported by a UK Medical Research Council (MRC) grant to A. R. V., and J.W. and by a Wellcome Trust grant to A. R. V. Work in J.P.'s laboratory is supported by Cancer Research UK, and in A.R.V.'s, by the MRC.	Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Brito DA, 2008, J CELL BIOL, V182, P623, DOI 10.1083/jcb.200805072; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; CHOI E, 2009, EMBO J; DeBonis S, 2004, MOL CANCER THER, V3, P1079; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gartner M, 2005, CHEMBIOCHEM, V6, P1173, DOI 10.1002/cbic.200500005; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Mathe E, 2004, CURR BIOL, V14, P1723, DOI 10.1016/j.cub.2004.09.023; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Osaka F, 1997, MOL CELL BIOL, V17, P3388, DOI 10.1128/MCB.17.6.3388; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Walker A, 2008, J CELL SCI, V121, P2319, DOI 10.1242/jcs.031591; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4	32	192	211	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1363	U241		10.1038/ncb1983	http://dx.doi.org/10.1038/ncb1983			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19820702	Green Accepted			2022-12-25	WOS:000271425800017
J	Sun, YL; Jiang, XF; Xu, Y; Ayrapetov, MK; Moreau, LA; Whetstine, JR; Price, BD				Sun, Yingli; Jiang, Xiaofeng; Xu, Ye; Ayrapetov, Marina K.; Moreau, Lisa A.; Whetstine, Johnathan R.; Price, Brendan D.			Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; ATM ACTIVATION; CHROMATIN; ACETYLATION; BINDING; GENE; PROTEINS; REPAIR	DNA double-strand break (DSB) repair involves complex interactions between chromatin and repair proteins, including Tip60, a tumour suppressor(1). Tip60 is an acetyltransferase that acetylates both histones(2-5) and ATM (ataxia telangiectasia mutated) kinase(6,7). Inactivation of Tip60 leads to defective DNA repair(2-4) and increased cancer risk(8-11). However, how DNA damage activates the acetyltransferase activity of Tip60 is not known. Here, we show that direct interaction between the chromodomain of Tip60 and histone H3 trimethylated on lysine 9 (H3K9me3) at DSBs activates the acetyltransferase activity of Tip60. Depletion of intracellular H3K9me3 blocks activation of the acetyltransferase activity of Tip60, resulting in defective ATM activation and widespread defects in DSB repair. In addition, the ability of Tip60 to access H3K9me3 is dependent on the DNA damage-induced displacement of HP1 beta (heterochromatin protein 1 beta) from H3K9me3. Finally, we demonstrate that the Mre11-Rad50-Nbs1 (MRN) complex targets Tip60 to H3K9me3, and is required to activate the acetyltransferase activity of Tip60. These results reveal a new function for H3K9me3 in coordinating activation of Tip60-dependent DNA repair pathways, and imply that aberrant patterns of histone methylation may contribute to cancer by altering the efficiency of DSB repair.	[Sun, Yingli; Jiang, Xiaofeng; Xu, Ye; Ayrapetov, Marina K.; Moreau, Lisa A.; Price, Brendan D.] Harvard Univ, Sch Med, Div Genom Stabil & DNA Repair, Dept Radiat Oncol,Dana Farber Canc Inst, Boston, MA 02115 USA; [Whetstine, Johnathan R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital	Price, BD (corresponding author), Harvard Univ, Sch Med, Div Genom Stabil & DNA Repair, Dept Radiat Oncol,Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	brendan_price@dfci.harvard.edu			NCI [CA64585, CA93602]; DOD Breast Cancer Program; NIAID [U19AI067751];  [T32 CA09078]; NATIONAL CANCER INSTITUTE [R01CA064585, T32CA009078, R01CA093602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067751] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD Breast Cancer Program(United States Department of Defense); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Jenuwein for providing Suv39h1/2 cells, D. Ferguson for providing Rad50-deficient HCT116 cells, and H. Chan, J. Cote, D. Chowdhury and A. D'Andrea for critical discussions and reading of the manuscript. This work was supported by grants from the NCI (CA64585 and CA93602) and the DOD Breast Cancer Program to B. D. P., and by NCI training grants to Y.S. and M. K. A. (T32 CA09078). Y.X. is supported by a U19 Center grant from NIAID (U19AI067751).	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUSCH T, 2004, SCIENCE; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lleonart ME, 2006, ONCOL REP, V16, P603; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pethe K, 2002, P NATL ACAD SCI USA, V99, P10759, DOI 10.1073/pnas.162246899; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; SQUATRITO M, 2006, TRENDS CELL BIOL; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302	38	310	320	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1376	U273		10.1038/ncb1982	http://dx.doi.org/10.1038/ncb1982			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19783983	Green Accepted			2022-12-25	WOS:000271425800019
J	Merico, D; Gfeller, D; Bader, GD				Merico, Daniele; Gfeller, David; Bader, Gary D.			How to visually interpret biological data using networks	NATURE BIOTECHNOLOGY			English	Article							YEAST; MODULES; CELL	Networks in biology can appear complex and difficult to decipher. We illustrate how to interpret biological networks with the help of frequently used visualization and analysis patterns.	[Merico, Daniele] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Toronto, ON, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada	University of Toronto; University of Toronto	Merico, D (corresponding author), Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Toronto, ON, Canada.	gary.bader@utoronto.ca	Bader, Gary/C-1176-2009; gfeller, david/D-3395-2009; Gfeller, David/A-6493-2019	Bader, Gary/0000-0003-0185-8861; gfeller, david/0000-0002-3952-0930; Gfeller, David/0000-0002-3952-0930; Merico, Daniele/0000-0002-3728-4401	NIGMS NIH HHS [R01 GM070743] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070743] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Fukuda K, 2001, BIOINFORMATICS, V17, P829, DOI 10.1093/bioinformatics/17.9.829; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hu ZJ, 2007, NUCLEIC ACIDS RES, V35, pW625, DOI 10.1093/nar/gkm295; Hu ZJ, 2007, NAT BIOTECHNOL, V25, P547, DOI 10.1038/nbt1304; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447	18	64	70	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2009	27	10					921	924		10.1038/nbt.1567	http://dx.doi.org/10.1038/nbt.1567			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	515LO	19816451	Green Accepted			2022-12-25	WOS:000271472500022
J	Yuan, J; Johnson, RL; Huang, RL; Wichterman, J; Jiang, HY; Hayton, K; Fidock, DA; Wellems, TE; Inglese, J; Austin, CP; Su, XZ				Yuan, Jing; Johnson, Ronald L.; Huang, Ruili; Wichterman, Jennifer; Jiang, Hongying; Hayton, Karen; Fidock, David A.; Wellems, Thomas E.; Inglese, James; Austin, Christopher P.; Su, Xin-zhuan			Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum	NATURE CHEMICAL BIOLOGY			English	Article							CHLOROQUINE RESISTANCE; MALARIA PARASITES; DRUG-RESISTANCE; FOLIC-ACID; GENOME; IDENTIFICATION; TRIAMTERENE; ANTIMALARIALS; PYRIMETHAMINE; SENSITIVITY	Studies of gene function and molecular mechanisms in Plasmodium falciparum are hampered by difficulties in characterizing and measuring phenotypic differences between individual parasites. We screened seven parasite lines for differences in responses to 1,279 bioactive chemicals. Hundreds of compounds were active in inhibiting parasite growth; 607 differential chemical phenotypes, defined as pairwise IC50 differences of fivefold or more between parasite lines, were cataloged. We mapped major determinants for three differential chemical phenotypes between the parents of a genetic cross, and we identified target genes by fine mapping and testing the responses of parasites in which candidate genes were genetically replaced with mutant alleles. Differential sensitivity to dihydroergotamine methanesulfonate (1), a serotonin receptor antagonist, was mapped to a gene encoding the homolog of human P-glycoprotein (PfPgh-1). This study identifies new leads for antimalarial drugs and demonstrates the utility of a high-throughput chemical genomic strategy for studying malaria traits.	[Yuan, Jing; Jiang, Hongying; Hayton, Karen; Wellems, Thomas E.; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Johnson, Ronald L.; Huang, Ruili; Wichterman, Jennifer; Inglese, James; Austin, Christopher P.] NHGRI, NIH, Chem Genom Ctr, Bethesda, MD 20892 USA; [Fidock, David A.] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); Columbia University	Su, XZ (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	xsu@niaid.nih.gov		Yuan, Jing/0000-0002-8907-9143; Fidock, David/0000-0001-6753-8938; Su, Xinzhuan/0000-0003-3246-3248	Divisions of Intramural Research at the National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, ZIAAI000483] Funding Source: NIH RePORTER	Divisions of Intramural Research at the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Divisions of Intramural Research at the National Institute of Allergy and Infectious Diseases, and by the National Human Genome Research Institute and the NIH Roadmap for Medical Research, all at the US National Institutes of Health. We thank J. Sa, J. Mu, L. Jiang, D. Raj and M. J. Lopez Barragan for help in drug assays; P. Shinn and D. VanLeer for compound management; D. Leja for assistance in artworks and NIAID intramural editor B. R. Marshall for assistance.	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Busch AE, 1996, PFLUG ARCH EUR J PHY, V432, P760, DOI 10.1007/s004240050196; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Cowman Alan F., 1993, Seminars in Cell Biology, V4, P29, DOI 10.1006/scel.1993.1004; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hayton K., 2004, Current Drug Targets - Infectious Disorders, V4, P1, DOI 10.2174/1568005043480925; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Liu SF, 2008, AM J TROP MED HYG, V79, P178, DOI 10.4269/ajtmh.2008.79.178; Mehrotra S, 2008, N-S ARCH PHARMACOL, V378, P371, DOI 10.1007/s00210-008-0322-7; Montalar M, 2003, J DRUG TARGET, V11, P215, DOI 10.1080/10611860310001615947; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; POLLOCK LOUIS A., 1949, ANN WESTERN MED AND SURG, V3, P388; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Schaerlinger B, 2003, BRIT J PHARMACOL, V140, P277, DOI 10.1038/sj.bjp.0705437; SCHALHORN A, 1981, EUR J CLIN PHARMACOL, V20, P219, DOI 10.1007/BF00544601; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Su XZ, 2004, MOL MICROBIOL, V53, P1573, DOI 10.1111/j.1365-2958.2004.04270.x; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; WELLEMS TE, 1988, REV BRAS GENET, V11, P813; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921; ZIMMERMAN J, 1986, J LAB CLIN MED, V108, P272	45	54	56	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					765	771		10.1038/nchembio.215	http://dx.doi.org/10.1038/nchembio.215			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19734910	Green Accepted			2022-12-25	WOS:000270039900015
J	Dansen, TB; Smits, LMM; van Triest, MH; de Keizer, PLJ; van Leenen, D; Koerkamp, MG; Szypowska, A; Meppelink, A; Brenkman, AB; Yodoi, J; Holstege, FCP; Burgering, BMT				Dansen, Tobias B.; Smits, Lydia M. M.; van Triest, Miranda H.; de Keizer, Peter L. J.; van Leenen, Dik; Koerkamp, Marian Groot; Szypowska, Anna; Meppelink, Amanda; Brenkman, Arjan B.; Yodoi, Junji; Holstege, Frank C. P.; Burgering, Boudewijn M. T.			Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity	NATURE CHEMICAL BIOLOGY			English	Article							FORKHEAD TRANSCRIPTION FACTORS; LIFE-SPAN; BINDING; STRESS; SIRT1; PHOSPHORYLATION; ACTIVATION; MECHANISMS; LONGEVITY; SEQUENCE	Cellular damage invoked by reactive oxygen species plays a key role in the pathobiology of cancer and aging. Forkhead box class O (FoxO) transcription factors are involved in various cellular processes including cell cycle regulation, apoptosis and resistance to reactive oxygen species, and studies in animal models have shown that these transcription factors are of vital importance in tumor suppression, stem cell maintenance and lifespan extension. Here we report that the activity of FoxO in human cells is directly regulated by the cellular redox state through a unique mechanism in signal transduction. We show that reactive oxygen species induce the formation of cysteine-thiol disulfide-dependent complexes of FoxO and the p300/CBP acetyltransferase, and that modulation of FoxO biological activity by p300/CBP-mediated acetylation is fully dependent on the formation of this redox-dependent complex. These findings directly link cellular redox status to the activity of the longevity protein FoxO.	[Dansen, Tobias B.; Smits, Lydia M. M.; van Triest, Miranda H.; de Keizer, Peter L. J.; van Leenen, Dik; Koerkamp, Marian Groot; Szypowska, Anna; Meppelink, Amanda; Brenkman, Arjan B.; Holstege, Frank C. P.; Burgering, Boudewijn M. T.] Univ Med Ctr Utrecht, Ctr Biomed Genet, Dept Physiol Chem, Utrecht, Netherlands; [Brenkman, Arjan B.] Univ Med Ctr Utrecht, Canc Genom Ctr, Utrecht, Netherlands; [Yodoi, Junji] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 606, Japan	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Kyoto University	Dansen, TB (corresponding author), Univ Med Ctr Utrecht, Ctr Biomed Genet, Dept Physiol Chem, Utrecht, Netherlands.	t.b.dansen@umcutrecht.nl; b.m.t.burgering@umcutrecht.nl	de+Keizer, Peter/AAD-5320-2020; Holstege, Frank/AAM-9944-2021	de+Keizer, Peter/0000-0002-6948-925X; Dansen, Tobias/0000-0001-5259-8815; Groot Koerkamp, Marian JA/0000-0002-0867-0821	The Netherlands Science Organization (NWO, Vici); KWF (Dutch Cancer Foundation); Center for Biomedical Genetics (CBG); Cancer Genomics Center (CGC)	The Netherlands Science Organization (NWO, Vici)(Netherlands Organization for Scientific Research (NWO)); KWF (Dutch Cancer Foundation)(KWF Kankerbestrijding); Center for Biomedical Genetics (CBG); Cancer Genomics Center (CGC)	We thank G.J.P.L. Kops and M.B. Toledano for critically reading the manuscript, M. Putker and I. van Zutphen for experimental support, E. Kalkhoven (University Medical Center Utrecht) for reagents and our colleagues for discussions and suggestions. This work was supported by grants from The Netherlands Science Organization (NWO, Vici), KWF (Dutch Cancer Foundation), the Center for Biomedical Genetics (CBG) and the Cancer Genomics Center (CGC).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bjelakovic G, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004183.PUB2; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Brenkman AB, 2008, CANCER RES, V68, P7597, DOI 10.1158/0008-5472.CAN-08-1059; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Mahmud DL, 2002, ONCOGENE, V21, P1556, DOI 10.1038/sj.onc.1205230; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Obsilova V, 2005, BIOCHEMISTRY-US, V44, P11608, DOI 10.1021/bi050618r; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang YD, 2004, CANCER RES, V64, P1902, DOI 10.1158/0008-5472.CAN-03-3361	44	150	154	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2009	5	9					664	672		10.1038/nchembio.194	http://dx.doi.org/10.1038/nchembio.194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	485AP	19648934				2022-12-25	WOS:000269093000015
J	Rafei, M; Hsieh, J; Zehntner, S; Li, MY; Forner, K; Birman, E; Boivin, MN; Young, YK; Perreault, C; Galipeau, J				Rafei, Moutih; Hsieh, Jeremy; Zehntner, Simone; Li, MengYang; Forner, Kathy; Birman, Elena; Boivin, Marie-Noelle; Young, Yoon Kow; Perreault, Claude; Galipeau, Jacques			A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLACEBO-CONTROLLED TRIAL; REMITTING MULTIPLE-SCLEROSIS; T-CELLS; DOUBLE-BLIND; INTERFERON BETA-1B; GLATIRAMER ACETATE; PROGRESSIVE MS; PROTECTS MICE; IN-VIVO	We have previously shown that a granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-15 (IL-15) 'fusokine' (GIFT15) exerts immune suppression via aberrant signaling through the IL-15 receptor on lymphomyeloid cells. We show here that ex vivo GIFT15 treatment of mouse splenocytes generates suppressive regulatory cells of B cell ontogeny (hereafter called GIFT15 B-reg cells). Arising from CD19(+) B cells, GIFT15 B-reg cells express major histocompatibility complex class I (MHCI) and MHCII, surface IgM and IgD, and secrete IL-10, akin to previously described B10 and T2-MZP B-reg cells, but lose expression of the transcription factor PAX5, coupled to upregulation of CD138 and reciprocal suppression of CD19. Mice with experimental autoimmune encephalomyelitis went into complete remission after intravenous infusion of GIFT15 B-reg cells paralleled by suppressed neuroinflammation. The clinical effect was abolished when GIFT15 B-reg cells were derived from m mu MT (lacking B cells), MHCII-knockout, signal transducer and activator of transcription-6 (STAT-6)-knockout, IL-10-knockout or allogeneic splenocytes, consistent with a pivotal role for MHCII and IL-10 by sygeneic B cells for the observed therapeutic effect. We propose that autologous GIFT15 B-reg cells may serve as a new treatment for autoimmune ailments.	[Rafei, Moutih; Hsieh, Jeremy; Li, MengYang; Forner, Kathy; Birman, Elena; Boivin, Marie-Noelle; Young, Yoon Kow; Galipeau, Jacques] McGill Univ, Jewish Gen Hosp, Montreal Ctr Expt Therapeut Canc, Montreal, PQ H3T 1E2, Canada; [Zehntner, Simone] McGill Univ, Mol Oncol Lab, Montreal, PQ H3T 1E2, Canada; [Zehntner, Simone] McGill Univ, Neuroimmunol Grp, Montreal Neurol Inst, Montreal, PQ H3T 1E2, Canada; [Perreault, Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Galipeau, Jacques] McGill Univ, Jewish Gen Hosp, Div Hematol Oncol, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University; Universite de Montreal; McGill University	Galipeau, J (corresponding author), McGill Univ, Jewish Gen Hosp, Montreal Ctr Expt Therapeut Canc, Montreal, PQ H3T 1E2, Canada.	jacques.galipeau@mcgill.ca	Galipeau, Jacques/R-9909-2019; Perreault, Claude/A-7220-2008	Galipeau, Jacques/0000-0002-9374-1996; Perreault, Claude/0000-0001-9453-7383	Canadian Institute of Health Research [MOP-15017]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	M. R. is a recipient of a Fonds de Recherches en Sante du Quebec Scholarship, and J. G. is a Fonds de Recherches en Sante du Quebec chercheur-boursier senior. C. P. holds a Canada Research Chair in Immunobiology. This work was supported by the Canadian Institute of Health Research grant MOP-15017.	Arnold DL, 2008, J NEUROL, V255, P1473, DOI 10.1007/s00415-008-0911-x; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Brummel R, 2005, J IMMUNOL, V174, P2429, DOI 10.4049/jimmunol.174.4.2429; Dhib-Jalbut S, 2002, MULT SCLER, V8, P485, DOI 10.1191/1352458502ms862oa; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fornek JL, 2006, BLOOD, V107, P1085, DOI 10.1182/blood-2005-07-2871; Giorgini A, 2007, J LEUKOCYTE BIOL, V82, P1053, DOI 10.1189/jlb.0407227; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Jamin C, 2008, ARTHRITIS RHEUM-US, V58, P1900, DOI 10.1002/art.23487; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Karim M, 2005, BLOOD, V105, P4871, DOI 10.1182/blood-2004-10-3888; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kozak T, 2002, J NEUROL, V249, P1088, DOI 10.1007/s00415-002-0800-7; Krapf H, 2005, NEUROLOGY, V65, P690, DOI 10.1212/01.wnl.0000174439.70369.7a; Kuhlmann T, 2006, AM J PATHOL, V169, P584, DOI 10.2353/ajpath.2006.051086; Lau AWT, 2008, J IMMUNOL, V180, P3889, DOI 10.4049/jimmunol.180.6.3889; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mauri C, 2000, NAT MED, V6, P673, DOI 10.1038/76251; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; O'Connor KC, 2001, J CLIN IMMUNOL, V21, P81, DOI 10.1023/A:1011064007686; Panitch H, 2004, NEUROLOGY, V63, P1788; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Rafei M, 2007, BLOOD, V109, P2234, DOI 10.1182/blood-2006-07-037473; Rafei M, 2009, J IMMUNOL, V182, P2620, DOI 10.4049/jimmunol.0803495; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Singh A, 2008, J IMMUNOL, V180, P7318, DOI 10.4049/jimmunol.180.11.7318; Stern JNH, 2008, P NATL ACAD SCI USA, V105, P5172, DOI 10.1073/pnas.0712131105; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	35	94	100	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2009	15	9					1038	U91		10.1038/nm.2003	http://dx.doi.org/10.1038/nm.2003			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	496MT	19668193				2022-12-25	WOS:000269979200024
J	Benjamin, EJ; Rice, KM; Arking, DE; Pfeufer, A; van Noord, C; Smith, AV; Schnabel, RB; Bis, JC; Boerwinkle, E; Sinner, MF; Dehghan, A; Lubitz, SA; D'Agostino, RB; Lumley, T; Ehret, GB; Heeringa, J; Aspelund, T; Newton-Cheh, C; Larson, MG; Marciante, KD; Soliman, EZ; Rivadeneira, F; Wang, TJ; Eiriksdottir, G; Levy, D; Psaty, BM; Li, M; Chamberlain, AM; Hofman, A; Vasan, RS; Harris, TB; Rotter, JI; Kao, WHL; Agarwal, SK; Stricker, BHC; Wang, K; Launer, LJ; Smith, NL; Chakravarti, A; Uitterlinden, AG; Wolf, PA; Sotoodehnia, N; Kottgen, A; van Duijn, CM; Meitinger, T; Mueller, M; Perz, S; Steinbeck, G; Wichmann, HE; Lunetta, KL; Heckbert, SR; Gudnason, V; Alonso, A; Kaab, S; Ellinor, PT; Witteman, JCM				Benjamin, Emelia J.; Rice, Kenneth M.; Arking, Dan E.; Pfeufer, Arne; van Noord, Charlotte; Smith, Albert V.; Schnabel, Renate B.; Bis, Joshua C.; Boerwinkle, Eric; Sinner, Moritz F.; Dehghan, Abbas; Lubitz, Steven A.; D'Agostino, Ralph B., Sr.; Lumley, Thomas; Ehret, Georg B.; Heeringa, Jan; Aspelund, Thor; Newton-Cheh, Christopher; Larson, Martin G.; Marciante, Kristin D.; Soliman, Elsayed Z.; Rivadeneira, Fernando; Wang, Thomas J.; Eiriksdottir, Gudny; Levy, Daniel; Psaty, Bruce M.; Li, Man; Chamberlain, Alanna M.; Hofman, Albert; Vasan, Ramachandran S.; Harris, Tamara B.; Rotter, Jerome I.; Kao, W. H. Linda; Agarwal, Sunil K.; Stricker, Bruno H. Ch; Wang, Ke; Launer, Lenore J.; Smith, Nicholas L.; Chakravarti, Aravinda; Uitterlinden, Andre G.; Wolf, Philip A.; Sotoodehnia, Nona; Koettgen, Anna; van Duijn, Cornelia M.; Meitinger, Thomas; Mueller, Martina; Perz, Siegfried; Steinbeck, Gerhard; Wichmann, H-Erich; Lunetta, Kathryn L.; Heckbert, Susan R.; Gudnason, Vilmundur; Alonso, Alvaro; Kaeaeb, Stefan; Ellinor, Patrick T.; Witteman, Jacqueline C. M.			Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR ATBF1; LIFETIME RISK; DIFFERENTIATION; PREVALENCE	We conducted meta-analyses of genome-wide association studies for atrial fibrillation (AF) in participants from five community-based cohorts. Meta-analyses of 896 prevalent (15,768 referents) and 2,517 incident (21,337 referents) AF cases identified a new locus for AF (ZFHX3, rs2106261, risk ratio RR = 1.19; P = 2.3 x 10(-7)). We replicated this association in an independent cohort from the German AF Network (odds ratio = 1.44; P = 1.6 x 10(-11); combined RR = 1.25; combined P = 1.8 x 10(-15)).	[Benjamin, Emelia J.; Schnabel, Renate B.; D'Agostino, Ralph B., Sr.; Newton-Cheh, Christopher; Larson, Martin G.; Wang, Thomas J.; Levy, Daniel; Vasan, Ramachandran S.; Wolf, Philip A.; Lunetta, Kathryn L.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Benjamin, Emelia J.; Levy, Daniel; Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Benjamin, Emelia J.; Levy, Daniel; Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Prevent Med Sect, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Rice, Kenneth M.; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Arking, Dan E.; Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Human Genet, D-8000 Munich, Germany; [Pfeufer, Arne] German Natl Res Ctr Environm Hlth, Helmholtz Ctr Munich, Dept Human Genet, Munich, Germany; [van Noord, Charlotte; Dehghan, Abbas; Heeringa, Jan; Rivadeneira, Fernando; Hofman, Albert; Stricker, Bruno H. Ch; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Noord, Charlotte] Dutch Med Evaluat Board, The Hague, Netherlands; [van Noord, Charlotte; Witteman, Jacqueline C. M.] Netherlands Consortium Healthy Aging, Leiden, Netherlands; [Smith, Albert V.; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Schnabel, Renate B.] Johannes Gutenberg Univ Mainz, Gutenberg Heart Study, Med Clin Cardiol 2, Mainz, Germany; [Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX USA; [Sinner, Moritz F.; Mueller, Martina; Steinbeck, Gerhard; Kaeaeb, Stefan] Univ Munich, Klinikum Grosshadern, Dept Med 1, D-8000 Munich, Germany; [Lubitz, Steven A.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Lubitz, Steven A.; Newton-Cheh, Christopher; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [D'Agostino, Ralph B., Sr.; Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Marciante, Kristin D.; Psaty, Bruce M.; Sotoodehnia, Nona] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Marciante, Kristin D.] Univ Washington, Dept Gen Internal Med, Seattle, WA 98195 USA; [Soliman, Elsayed Z.] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Rivadeneira, Fernando; Stricker, Bruno H. Ch; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Psaty, Bruce M.; Smith, Nicholas L.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.; Heckbert, Susan R.] Ctr Hlth Studies, Grp Hlth, Washington, DC USA; [Li, Man; Kao, W. H. Linda; Koettgen, Anna] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Chamberlain, Alanna M.; Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Harris, Tamara B.; Launer, Lenore J.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Agarwal, Sunil K.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Stricker, Bruno H. Ch] Inspectorate Hlth Care, The Hague, Netherlands; [Wang, Ke; Lunetta, Kathryn L.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Smith, Nicholas L.] Seattle Epidemiol Res & Informat Ctr, Dept Vet Affairs, Off Res & Dev, Seattle, WA USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Sotoodehnia, Nona] Univ Washington, Div Cardiol, Seattle, WA 98195 USA; [Mueller, Martina; Wichmann, H-Erich] Deutsch Forschungszentrum Gesundheit & Umwelt, Inst Epidemiol, Helmholtz Zentrum Munchen, Munich, Germany; [Perz, Siegfried] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Med Informat, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Ellinor, Patrick T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiac Arrhythmia Serv, Boston, MA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; University of Washington; University of Washington Seattle; Johns Hopkins University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; Icelandic Heart Association; Johannes Gutenberg University of Mainz; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Boston University; University of Iceland; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest Baptist Medical Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Boston University; Erasmus University Rotterdam; Erasmus MC; Boston University; University of Washington; University of Washington Seattle; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Harvard University; Harvard Medical School; Massachusetts General Hospital	Benjamin, EJ (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA USA.	emelia@bu.edu; j.witteman@erasmusmc.nl	Wichmann, Heinz Erich/AAA-5695-2022; Kaab, Stefan/H-3915-2012; Müller-Nurasyid, Martina/I-8735-2018; Aspelund, Thor/F-4826-2011; Alonso, Alvaro/A-4917-2010; Meitinger, Thomas/O-1318-2015; Schnabel, Renate B/F-6527-2014; Soliman, Elsayed/D-8124-2011; Rivadeneira, Fernando/O-5385-2015; Schnabel, Renate B/ABE-6668-2021; Gudnason, Vilmundur/K-6885-2015; Li, Man/AAX-3400-2020; Rotter, Jerome/AAY-6598-2021; EHRET, Georg B/A-9532-2009; Levy, Daniel/ABF-6873-2021; Sinner, Moritz/AAW-5043-2020; Launer, Lenore J/A-8218-2010; Gudnason, Vilmundur/AAE-7126-2019; Rice, Kenneth M/A-4150-2013; Soliman, Elsayed Z/AAD-7135-2020; Kottgen, Anna/D-2920-2012; Pfeufer, Arne/B-6634-2013; Smith, Albert Vernon/K-5150-2015; Aspelund, Thor/K-7022-2019; Aspelund, Thor/C-5983-2008; Dehghan, Abbas/ABE-7377-2020; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011; Dehghan, Abbas/B-9896-2008	Müller-Nurasyid, Martina/0000-0003-3793-5910; Alonso, Alvaro/0000-0002-2225-8323; Soliman, Elsayed/0000-0001-5632-8150; Rivadeneira, Fernando/0000-0001-9435-9441; Schnabel, Renate B/0000-0001-7170-9509; Gudnason, Vilmundur/0000-0001-5696-0084; Li, Man/0000-0002-3839-0281; EHRET, Georg B/0000-0002-5730-0675; Levy, Daniel/0000-0003-1843-8724; Gudnason, Vilmundur/0000-0001-5696-0084; Rice, Kenneth M/0000-0001-5779-4495; Soliman, Elsayed Z/0000-0001-5632-8150; Smith, Albert Vernon/0000-0003-1942-5845; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; Ramachandran, Vasan/0000-0001-7357-5970; Chamberlain, Alanna/0000-0003-1888-9584; Meitinger, Thomas/0000-0002-8838-8403; Wang, Thomas/0000-0003-4063-6508; Benjamin, Emelia/0000-0003-4076-2336; Ballantyne, Christie/0000-0002-6432-1730; Van Duijn, Cornelia/0000-0002-2374-9204; Lunetta, Kathryn/0000-0002-9268-810X; Dehghan, Abbas/0000-0001-6403-016X; Ellinor, Patrick/0000-0002-2067-0533; Larson, Martin/0000-0002-9631-1254; Wolf, Philip/0000-0002-3628-301X	NCRR NIH HHS [UL1 RR025005, M01 RR000425-30S1, M01 RR000069] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402-01, U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [N01HC85086, N01HC55015, R01 HL086694-01A1, N01HC55222, N01HC55022, R01 HL076784, R01 HL087652, R01 HL087652-01, N01 HC085085, N02 HL64278, R01 HL080124-01, N01 HC085081, N01 HC055222, N01HC55016, U01 HL080295-01, R01 HL086694, N01 HC055021, N01 HC055020, T32 HL007575, N01 HC025195, N01 HC055018, N01 HC085083, R01 HL088456, N01 HC055019, N01 HC085082, N01 HC085080, R01 HL086694-02, N01 HC035129, R01 HL076784-01, N01 HC085079, N01HC85079, R01 HL087641, N01HC55020, N01HC55021, R01 HL080124, R01 HL087641-01, N01HC25195, N01 HC055015, R01 HL092577-01A1, N01HC75150, N01 HC085084, N01 HC015103, R01 HL059367, R01 HL092577, R01 HL104156, N01 HC075150, U01 HL080295, N01 HC045133, R01 HL093328-01, N01HC55018, T32 HL007575-23, R01 HL088456-01, N01 HC055016, R01 HL059367-02, N01 HC085086, N01 HC055022, R01 HL093328, N01HC55019] Funding Source: Medline; NIA NIH HHS [N01 AG012100, R01 AG028321-01, R01 AG028321, N01AG12100] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491, P30 DK063491-05, P30 DK063491-029004, R01 DK033651, P30 DK063491-039004, P30 DK063491-049004, P30 DK063491-06, P30 DK063491-019004] Funding Source: Medline; NINDS NIH HHS [R01 NS017950-23, R01 NS017950] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [N01HC55021, ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Ellinor PT, 2005, HUM GENET, V118, P179, DOI 10.1007/s00439-005-0034-8; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Ido A, 1996, GENE, V168, P227, DOI 10.1016/0378-1119(95)00740-7; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528	14	288	295	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2009	41	8					879	881		10.1038/ng.416	http://dx.doi.org/10.1038/ng.416			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19597492	Green Accepted, Green Submitted			2022-12-25	WOS:000268432900008
J	Langemeijer, SMC; Kuiper, RP; Berends, M; Knops, R; Aslanyan, MG; Massop, M; Stevens-Linders, E; van Hoogen, P; van Kessel, AG; Raymakers, RAP; Kamping, EJ; Verhoef, GE; Verburgh, E; Hagemeijer, A; Vandenberghe, P; de Witte, T; van der Reijden, BA; Jansen, JH				Langemeijer, Saskia M. C.; Kuiper, Roland P.; Berends, Marieke; Knops, Ruth; Aslanyan, Mariam G.; Massop, Marion; Stevens-Linders, Ellen; van Hoogen, Patricia; van Kessel, Ad Geurts; Raymakers, Reinier A. P.; Kamping, Eveline J.; Verhoef, Gregor E.; Verburgh, Estelle; Hagemeijer, Anne; Vandenberghe, Peter; de Witte, Theo; van der Reijden, Bert A.; Jansen, Joop H.			Acquired mutations in TET2 are common in myelodysplastic syndromes	NATURE GENETICS			English	Article							COPY NUMBER; UNIPARENTAL DISOMY; ARRAYS; GENOME; RPS14; MDS	Myelodysplastic syndromes (MDS) represent a heterogeneous group of neoplastic hematopoietic disorders(1). Several recurrent chromosomal aberrations have been associated with MDS, but the genes affected have remained largely unknown. To identify relevant genetic lesions involved in the pathogenesis of MDS, we conducted SNP array-based genomic profiling and genomic sequencing in 102 individuals with MDS and identified acquired deletions and missense and nonsense mutations in the TET2 gene in 26% of these individuals. Using allele-specific assays, we detected TET2 mutations in most of the bone marrow cells (median 96%). In addition, the mutations were encountered in various lineages of differentiation including CD34(+) progenitor cells, suggesting that TET2 mutations occur early during disease evolution. In healthy tissues, TET2 expression was shown to be elevated in hematopoietic cells with highest expression in granulocytes, in line with a function in myelopoiesis. We conclude that TET2 is the most frequently mutated gene in MDS known so far.	[Langemeijer, Saskia M. C.; Berends, Marieke; Knops, Ruth; Aslanyan, Mariam G.; Massop, Marion; Stevens-Linders, Ellen; van Hoogen, Patricia; Raymakers, Reinier A. P.; de Witte, Theo; van der Reijden, Bert A.; Jansen, Joop H.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands; [Langemeijer, Saskia M. C.; Berends, Marieke; Knops, Ruth; Aslanyan, Mariam G.; Massop, Marion; Stevens-Linders, Ellen; van Hoogen, Patricia; Raymakers, Reinier A. P.; de Witte, Theo; van der Reijden, Bert A.; Jansen, Joop H.] Radboud Univ Nijmegen, Med Ctr, Cent Hematol Lab, NL-6525 ED Nijmegen, Netherlands; [Kuiper, Roland P.; van Kessel, Ad Geurts; Kamping, Eveline J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Kuiper, Roland P.; van Kessel, Ad Geurts; Kamping, Eveline J.] Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands; [Verhoef, Gregor E.; Verburgh, Estelle] Univ Hosp Leuven, Dept Internal, Leuven, Belgium; [Hagemeijer, Anne; Vandenberghe, Peter] Univ Hosp Leuven, Ctr Human Genet, Lab Genet Malignant Disorders, Leuven, Belgium	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Jansen, JH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands.	j.jansen@chl.umcn.nl	Kuiper, Roland/A-9646-2014; van der Reijden, Bert A/A-3543-2014; Stevens-Linders, Ellen/H-1050-2016; de Witte, T.J.M./L-4762-2015; Kamping, Eveline J/E-9530-2016; van Hoogen, Patricia/G-4717-2016; Knops, Ruth G.H.J.N./F-5280-2016; van Kessel, Ad Geurts/A-2810-2010; Jansen, J.H./H-8054-2014; Aslanyan, Mariam/GYU-7303-2022	Jansen, J.H./0000-0001-9459-568X; Vandenberghe, Peter/0000-0003-4719-1935; Verburgh, Estelle Ramona/0000-0003-4657-7318				DELHOMMEAU F, 2008, BLOOD, P112; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Gondek LP, 2008, BLOOD, V111, P1534, DOI 10.1182/blood-2007-05-092304; Gondek LP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001225; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; List Alan F, 2004, Hematology Am Soc Hematol Educ Program, P297; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Nolte F, 2008, ANN HEMATOL, V87, P777, DOI 10.1007/s00277-008-0502-z; PEDERSENBJERGAARD J, 1995, BLOOD, V86, P3542, DOI 10.1182/blood.V86.9.3542.bloodjournal8693542; Pellagatti A, 2008, BRIT J HAEMATOL, V142, P57, DOI 10.1111/j.1365-2141.2008.07178.x; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735; Viguie F, 2005, LEUKEMIA, V19, P1411, DOI 10.1038/sj.leu.2403818; Wang L, 2008, HAEMATOL-HEMATOL J, V93, P994, DOI 10.3324/haematol.12603	18	577	611	0	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					838	U102		10.1038/ng.391	http://dx.doi.org/10.1038/ng.391			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19483684				2022-12-25	WOS:000267786200017
J	Stolk, L; Zhai, G; van Meurs, JBJ; Verbiest, MMPJ; Visser, JA; Estrada, K; Rivadeneira, F; Williams, FM; Cherkas, L; Deloukas, P; Soranzo, N; de Keyzer, JJ; Pop, VJM; Lips, P; Lebrun, CEI; van der Schouw, YT; Grobbee, DE; Witteman, J; Hofman, A; Pols, HAP; Laven, JSE; Spector, TD; Uitterlinden, AG				Stolk, Lisette; Zhai, Guangju; van Meurs, Joyce B. J.; Verbiest, Michael M. P. J.; Visser, Jenny A.; Estrada, Karol; Rivadeneira, Fernando; Williams, Frances M.; Cherkas, Lynn; Deloukas, Panos; Soranzo, Nicole; de Keyzer, Jules J.; Pop, Victor J. M.; Lips, Paul; Lebrun, Corinne E. I.; van der Schouw, Yvonne T.; Grobbee, Diederick E.; Witteman, Jacqueline; Hofman, Albert; Pols, Huibert A. P.; Laven, Joop S. E.; Spector, Tim D.; Uitterlinden, Andre G.			Loci at chromosomes 13, 19 and 20 influence age at natural menopause	NATURE GENETICS			English	Article							ASSOCIATION; HERITABILITY	We conducted a genome-wide association study for age at natural menopause in 2,979 European women and identified six SNPs in three loci associated with age at natural menopause: chromosome 19q13.4 (rs1172822; -0.4 year per T allele (39%); P = 6.3 x 10(-11)), chromosome 20p12.3 (rs236114; +0.5 year per A allele (21%); P = 9.7 x 10(-11)) and chromosome 13q34 (rs7333181; +0.5 year per A allele (12%); P = 2.5 x 10(-8)). These common genetic variants regulate timing of ovarian aging, an important risk factor for breast cancer, osteoporosis and cardiovascular disease.	[Stolk, Lisette; van Meurs, Joyce B. J.; Verbiest, Michael M. P. J.; Visser, Jenny A.; Estrada, Karol; Rivadeneira, Fernando; Lebrun, Corinne E. I.; Pols, Huibert A. P.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Stolk, Lisette; Rivadeneira, Fernando; Witteman, Jacqueline; Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Stolk, Lisette; van Meurs, Joyce B. J.; Witteman, Jacqueline; Hofman, Albert; Uitterlinden, Andre G.] NGI NCHA, Rotterdam, Netherlands; [Zhai, Guangju; Williams, Frances M.; Cherkas, Lynn; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Soranzo, Nicole] Wellcome Trust Sanger Inst, Hinxton, England; [de Keyzer, Jules J.] Ctr Diagnost Eindhoven, Res Unit, Eindhoven, Netherlands; [Pop, Victor J. M.] Tilburg Univ, Dept Clin & Hlth Psychol, NL-5000 LE Tilburg, Netherlands; [Lips, Paul] Vrije Univ Amsterdam, Med Ctr, Endocrine Sect, Dept Internal Med, Amsterdam, Netherlands; [Lebrun, Corinne E. I.; van der Schouw, Yvonne T.; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Laven, Joop S. E.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; Wellcome Trust Sanger Institute; Tilburg University; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	Uitterlinden, AG (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	a.g.uitterlinden@erasmusmc.nl	Visser, Jenny A./F-8156-2011; Deloukas, Panos/B-2922-2013; van der Schouw, Yvonne T./F-8327-2014; Rivadeneira, Fernando/O-5385-2015; Grobbee, Diederick/C-7651-2014	Deloukas, Panos/0000-0001-9251-070X; van der Schouw, Yvonne T./0000-0002-4605-435X; Rivadeneira, Fernando/0000-0001-9435-9441; Grobbee, Diederick/0000-0003-4472-4468; Soranzo, Nicole/0000-0003-1095-3852; van Meurs, Joyce/0000-0001-6245-2123; Williams, Frances/0000-0002-2998-2744	Wellcome Trust [077011] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Burger HG, 1996, BAILLIERE CLIN OB GY, V10, P347, DOI 10.1016/S0950-3552(96)80019-8; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Kok HS, 2005, HUM REPROD, V20, P536, DOI 10.1093/humrep/deh600; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Murabito JM, 2005, J CLIN ENDOCR METAB, V90, P3427, DOI 10.1210/jc.2005-0181; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; te Velde ER, 1998, MATURITAS, V30, P103, DOI 10.1016/S0378-5122(98)00067-X; van Asselt KM, 2004, FERTIL STERIL, V82, P1348, DOI 10.1016/j.fertnstert.2004.04.047; Weel AEAM, 1999, J CLIN ENDOCR METAB, V84, P3146, DOI 10.1210/jc.84.9.3146	10	119	121	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					645	647		10.1038/ng.387	http://dx.doi.org/10.1038/ng.387			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19448619	Green Accepted			2022-12-25	WOS:000266411700010
J	Ward, PA				Ward, Peter A.			Seeking a heart salve	NATURE MEDICINE			English	Editorial Material							SEPSIS; DYSFUNCTION; ENDOTOXIN		Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@med.umich.edu						Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; Fernandes CJ, 2008, SHOCK, V30, P14, DOI 10.1097/SHK.0b013e3181818617; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Johnston GR, 2009, BRIT J ANAESTH, V102, P453, DOI 10.1093/bja/aep037; LORTS A, 2008, SHOCK           1222; Opal SM, 2007, CONTRIB NEPHROL, V156, P220; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Soriano FG, 2006, CRIT CARE MED, V34, P1073, DOI 10.1097/01.CCM.0000206470.47721.8D	13	28	30	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2009	15	5					497	499		10.1038/nm0509-497	http://dx.doi.org/10.1038/nm0509-497			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19424210				2022-12-25	WOS:000265889300027
J	Doi, A; Park, IH; Wen, B; Murakami, P; Aryee, MJ; Irizarry, R; Herb, B; Ladd-Acosta, C; Rho, JS; Loewer, S; Miller, J; Schlaeger, T; Daley, GQ; Feinberg, AP				Doi, Akiko; Park, In-Hyun; Wen, Bo; Murakami, Peter; Aryee, Martin J.; Irizarry, Rafael; Herb, Brian; Ladd-Acosta, Christine; Rho, Junsung; Loewer, Sabine; Miller, Justine; Schlaeger, Thorsten; Daley, George Q.; Feinberg, Andrew P.			Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts	NATURE GENETICS			English	Article								Induced pluripotent stem (iPS) cells are derived by epigenetic reprogramming, but their DNA methylation patterns have not yet been analyzed on a genome-wide scale. Here, we find substantial hypermethylation and hypomethylation of cytosine-phosphate-guanine (CpG) island shores in nine human iPS cell lines as compared to their parental fibroblasts. The differentially methylated regions (DMRs) in the reprogrammed cells (denoted R-DMRs) were significantly enriched in tissue-specific (T-DMRs; 2.6-fold, P < 10(-4)) and cancer-specific DMRs (C-DMRs; 3.6-fold, P < 10(-4)). Notably, even though the iPS cells are derived from fibroblasts, their R-DMRs can distinguish between normal brain, liver and spleen cells and between colon cancer and normal colon cells. Thus, many DMRs are broadly involved in tissue differentiation, epigenetic reprogramming and cancer. We observed colocalization of hypomethylated R-DMRs with hypermethylated C-DMRs and bivalent chromatin marks, and colocalization of hypermethylated R-DMRs with hypomethylated C-DMRs and the absence of bivalent marks, suggesting two mechanisms for epigenetic reprogramming in iPS cells and cancer.	[Park, In-Hyun; Rho, Junsung; Loewer, Sabine; Miller, Justine; Schlaeger, Thorsten; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Doi, Akiko; Wen, Bo; Murakami, Peter; Herb, Brian; Ladd-Acosta, Christine; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD USA; [Doi, Akiko; Wen, Bo; Murakami, Peter; Herb, Brian; Ladd-Acosta, Christine; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Park, In-Hyun; Rho, Junsung; Loewer, Sabine; Miller, Justine; Schlaeger, Thorsten; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Aryee, Martin J.; Irizarry, Rafael] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Aryee, Martin J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	George.Daley@childrens.harvard.edu; afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020; Wen, Bo/P-5332-2019; Gonçalves, Helen/P-2381-2018; Hallal, Pedro C/A-3249-2011; Aryee, Martin/AAC-8113-2020; Menezes, Ana MB/G-7266-2012	Wen, Bo/0000-0003-0394-7366; Hallal, Pedro C/0000-0003-1470-6461; Menezes, Ana MB/0000-0002-2996-9427; Schlaeger, Thorsten/0000-0002-1599-9908; Feinberg, Andrew/0000-0002-8364-1991	US National Institutes of Health; NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health (A. P. F. and G. Q. D.). G. Q. D affiliations include the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; the Division of Hematology, Brigham and Women's Hospital; Harvard Stem Cell Institute; and the Manton Center for Orphan Disease Research.	Ball MP, 2009, NAT BIOTECHNOL, V27, P485, DOI 10.1038/nbt0509-485b; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	15	866	899	1	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1350	U123		10.1038/ng.471	http://dx.doi.org/10.1038/ng.471			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19881528	Green Accepted			2022-12-25	WOS:000272144900020
J	Roberts, BE; Duennwald, ML; Wang, H; Chung, C; Lopreiato, NP; Sweeny, EA; Knight, MN; Shorter, J				Roberts, Blake E.; Duennwald, Martin L.; Wang, Huan; Chung, Chan; Lopreiato, Nicholas P.; Sweeny, Elizabeth A.; Knight, M. Noelle; Shorter, James			A synergistic small-molecule combination directly eradicates diverse prion strain structures	NATURE CHEMICAL BIOLOGY			English	Article							SPECIES BARRIERS; AMYLOID FIBRILS; YEAST; INHIBITORS; DISEASE; HSP104; MODELS; PSI+; 4,5-DIANILINOPHTHALIMIDE; CONFORMATIONS	Safely eradicating prions, amyloids and preamyloid oligomers may ameliorate several fatal neurodegenerative disorders. Yet whether small-molecule drugs can directly antagonize the entire spectrum of distinct amyloid structures or 'strains' that underlie distinct disease states is unclear. Here, we investigated this issue using the yeast prion protein Sup35. We have established how epigallocatechin-3-gallate (EGCG) blocks synthetic Sup35 prionogenesis, eliminates preformed Sup35 prions and disrupts inter- and intramolecular prion contacts. Unexpectedly, these direct activities were strain selective, altered the repertoire of accessible infectious forms and facilitated emergence of a new prion strain that configured original, EGCG-resistant intermolecular contacts. In vivo, EGCG cured and prevented induction of susceptible, but not resistant strains, and elicited switching from susceptible to resistant forms. Importantly, 4,5-bis-(4-methoxyanilino)phthalimide directly antagonized EGCG-resistant prions and synergized with EGCG to eliminate diverse Sup35 prion strains. Thus, synergistic small-molecule combinations that directly eradicate complete strain repertoires likely hold considerable therapeutic potential.	[Roberts, Blake E.; Wang, Huan; Lopreiato, Nicholas P.; Sweeny, Elizabeth A.; Knight, M. Noelle; Shorter, James] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Duennwald, Martin L.; Chung, Chan] Boston Biomed Res Inst, Watertown, MA USA	University of Pennsylvania; Boston Biomedical Research Institute	Shorter, J (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	duennwald@bbri.org; jshorter@mail.med.upenn.edu	Shorter, James/E-8207-2011; Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Sweeny, Elizabeth/0000-0001-7818-9112; Chung, Chan/0000-0003-0510-8996	US National Institutes of Health (NIH) [2T32GM008275-21, DP2OD002177]; Ellison Medical Foundation New Scholar in Aging Award; American Heart Association; University of Pennsylvania Institute on Aging and Alzheimer's Disease Core Center pilots; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation New Scholar in Aging Award(Lawrence Ellison Foundation); American Heart Association(American Heart Association); University of Pennsylvania Institute on Aging and Alzheimer's Disease Core Center pilots; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Hennessy (Massachusetts Institute of Technology), S. Buchwald (Massachusetts Institute of Technology), R. Krishnan (Whitehead Institute for Biomedical Research), S. Lindquist ( Whitehead Institute for Biomedical Research), J. Weissman (University of California San Francisco), R. Wetzel (University of Pittsburgh School of Medicine) and C. Glabe (University of California Irvine) for generous provision of reagents; J. Chan for preliminary in vivo experiments; and M. Lemmon, A. Gitler, S. B. Cullinan, N. Bonini and S. W. Englander for comments on the manuscript. This work was supported by US National Institutes of Health (NIH) training grant 2T32GM008275-21 (E. A. S), an NIH Director's New Innovator Award (DP2OD002177), an Ellison Medical Foundation New Scholar in Aging Award, an American Heart Association Scientist Development Grant, and University of Pennsylvania Institute on Aging and Alzheimer's Disease Core Center pilots (J. S.).	Aguzzi A, 2008, NAT NEUROSCI, V11, P1239, DOI 10.1038/nn1108-1239; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Derkatch IL, 1996, GENETICS, V144, P1375; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hennessy EJ, 2005, J ORG CHEM, V70, P7371, DOI 10.1021/jo051096o; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Kocisko DA, 2005, NEUROSCI LETT, V388, P106, DOI 10.1016/j.neulet.2005.06.053; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li J, 2004, CHEM BIOL, V11, P1513, DOI 10.1016/j.chembiol.2004.08.025; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roberts BE, 2008, NAT STRUCT MOL BIOL, V15, P544, DOI 10.1038/nsmb0608-544; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheibel T, 2004, P NATL ACAD SCI USA, V101, P2287, DOI 10.1073/pnas.0308754101; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Scheibel T, 2001, NAT STRUCT BIOL, V8, P958, DOI 10.1038/nsb1101-958; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Tribouillard D, 2007, PRION, V1, P48, DOI 10.4161/pri.1.1.4053; TRINKS U, 1994, J MED CHEM, V37, P1015, DOI 10.1021/jm00033a019; Wang H, 2008, P NATL ACAD SCI USA, V105, P7159, DOI 10.1073/pnas.0801934105; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	50	81	85	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2009	5	12					936	946		10.1038/nchembio.246	http://dx.doi.org/10.1038/nchembio.246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	519HV	19915541	Green Accepted			2022-12-25	WOS:000271756900017
J	Lee, JS; Li, QL; Lee, JY; Lee, SH; Jeong, JH; Lee, HR; Chang, H; Zhou, FC; Gao, SJ; Liang, CY; Jung, JU				Lee, Jong-Soo; Li, Qinglin; Lee, June-Yong; Lee, Sun-Hwa; Jeong, Joseph H.; Lee, Hye-Ra; Chang, Heesoon; Zhou, Fu-Chun; Gao, Shou-Jiang; Liang, Chengyu; Jung, Jae U.			FLIP-mediated autophagy regulation in cell death control	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; CRYSTAL-STRUCTURE; CONJUGATION SYSTEMS; MOLECULAR-MECHANISM; IN-VIVO; INHIBITION; ACTIVATION; APOPTOSIS; LYMPHOMAS; PROTEINS	Autophagy is an active homeostatic degradation process for the removal or turnover of cytoplasmic components wherein the LC3 ubiquitin-like protein undergoes an Atg7 E1-like enzyme/Atg3 E2-like enzyme-mediated conjugation process to induce autophagosome biogenesis(1-4). Besides its cytoprotecive role, autophagy acts on cell death when it is abnormally upregulated. Thus, the autophagy pathway requires tight regulation to ensure that this degradative process is well balanced. Two death effector domains (DED1/2) containing cellular FLICE-like inhibitor protein (cFLIP) and viral FLIP (vFLIP) of Kaposi's sarcoma-associated herpesvirus (KSHV), Herpesvirus saimiri (HVS), and Molluscum contagiosum virus (MCV) protect cells from apoptosis mediated by death receptors(5,6). Here, we report that cellular and viral FLIPs suppress autophagy by preventing Atg3 from binding and processing LC3. Consequently, FLIP expression effectively represses cell death with autophagy, as induced by rapamycin, an mTor inhibitor and an effective anti-tumour drug against KSHV-induced Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL)(7,8). Remarkably, either a DED1 alpha 2-helix ten amino-acid (alpha 2) peptide or a DED2 alpha 4-helix twelve amino-acid (alpha 4) peptide of FLIP is individually sufficient for binding FLIP itself and Atg3, with the peptide interactions effectively suppressing Atg3-FLIP interaction without affecting Atg3-LC3 interaction, resulting in robust cell death with autophagy. Our study thus identifies a checkpoint of the autophagy pathway where cellular and viral FLIPs limit the Atg3-mediated step of LC3 conjugation to regulate autophagosome biogenesis. Furthermore, the FLIP-derived short peptides induce growth suppression and cell death with autophagy, representing biologically active molecules for potential anti-cancer therapies.	[Lee, Jong-Soo; Lee, June-Yong; Lee, Sun-Hwa; Jeong, Joseph H.; Lee, Hye-Ra; Chang, Heesoon; Liang, Chengyu; Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90033 USA; [Lee, Jong-Soo; Li, Qinglin; Lee, Hye-Ra; Chang, Heesoon; Liang, Chengyu; Jung, Jae U.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, New England Primate Res Ctr, Southborough, MA 01772 USA; [Lee, Jong-Soo; Li, Qinglin; Lee, Hye-Ra; Chang, Heesoon; Liang, Chengyu; Jung, Jae U.] Harvard Univ, Sch Med, Div Tumor Virol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Zhou, Fu-Chun; Gao, Shou-Jiang] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA	University of Southern California; Harvard University; Harvard University; University of Texas System; University of Texas Health San Antonio	Jung, JU (corresponding author), Univ So Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Harlyne J Norris Canc Res Tower,1450 Biggy St, Los Angeles, CA 90033 USA.	jaeujung@usc.edu	Li, Qinglin/K-2570-2015; Gao, Shou-Jiang/B-8641-2012	Li, Qinglin/0000-0002-4125-1944; Lee, Jong-Soo/0000-0001-5119-0711; LIANG, CHENGYU/0000-0001-6082-2143; Gao, Shou-Jiang/0000-0001-6194-1742; Lee, June-Yong/0000-0002-4476-725X	US. Public Health Service [CA82057, CA91819, CA31363, CA115284, AI073099, RR00168]; Hastings Foundation; Korean GRL Program [K20815000001]; Lymphoma and Leukemia Society of USA; Wright Foundation; Baxter Foundation;  [AI083841];  [CA140964]; NATIONAL CANCER INSTITUTE [R01CA124332, R01CA091819, R01CA096512, R01CA115284, R01CA082057, R01CA140964, R01CA132637, R01CA031363] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073099, R21AI083841] Funding Source: NIH RePORTER	US. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Hastings Foundation; Korean GRL Program; Lymphoma and Leukemia Society of USA; Wright Foundation; Baxter Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by US. Public Health Service grants CA82057, CA91819, CA31363, CA115284, AI073099, RR00168, Hastings Foundation, Korean GRL Program K20815000001 (J.J.), AI083841, CA140964, the Lymphoma and Leukemia Society of USA, the Wright Foundation, and the Baxter Foundation (C.L.). We thank Don Ganem, Noboru Mizushima, Preet Chaudhary and Jeff Cohen for reagents, Ernesto Barron for EM analysis, and Steven Lee for manuscript preparation. Finally, we thank all of J.J.'s lab members for their discussions.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Guasparri I, 2006, EMBO REP, V7, P114, DOI 10.1038/sj.embor.7400580; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hotchkiss RS, 2006, J IMMUNOL, V176, P5471, DOI 10.4049/jimmunol.176.9.5471; Izzedine H, 2005, NEW ENGL J MED, V353, P2088, DOI 10.1056/NEJM200511103531922; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakamura H, 2007, ATHEROSCLEROSIS SUPP, V8, P13, DOI 10.1016/j.atherosclerosissup.2007.02.003; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wu W, 2005, LEUKEMIA RES, V29, P545, DOI 10.1016/j.leukres.2004.11.010; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07	32	294	309	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1355	U225		10.1038/ncb1980	http://dx.doi.org/10.1038/ncb1980			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838173	Green Accepted			2022-12-25	WOS:000271425800016
J	Rumjantseva, V; Grewal, PK; Wandall, HH; Josefsson, EC; Sorensen, AL; Larson, G; Marth, JD; Hartwig, JH; Hoffmeister, KM				Rumjantseva, Viktoria; Grewal, Prabhjit K.; Wandall, Hans H.; Josefsson, Emma C.; Sorensen, Anne Louise; Larson, Goran; Marth, Jamey D.; Hartwig, John H.; Hoffmeister, Karin M.			Dual roles for hepatic lectin receptors in the clearance of chilled platelets	NATURE MEDICINE			English	Article							VON-WILLEBRAND-FACTOR; GLYCOPROTEIN-IB; ASIALOGLYCOPROTEIN RECEPTOR; BLOOD-PLATELETS; IN-VITRO; CARBOHYDRATE MOIETY; GLYCOCALICIN; MEMBRANES; BINDING; ALPHA	Rapid chilling causes glycoprotein-Ib (GPIb) receptors to cluster on blood platelets. Hepatic macrophage beta(2) integrin binding to beta-N-acetylglucosamine (beta-GlcNAc) residues in the clusters leads to rapid clearance of acutely chilled platelets after transfusion. Although capping the beta-GlcNAc moieties by galactosylation prevents clearance of short-term-cooled platelets, this strategy is ineffective after prolonged refrigeration. We report here that prolonged refrigeration increased the density and concentration of exposed galactose residues on platelets such that hepatocytes, through Ashwell-Morell receptor binding, become increasingly involved in platelet removal. Macrophages rapidly removed a large fraction of transfused platelets independent of their storage conditions. With prolonged platelet chilling, hepatocyte-dependent clearance further diminishes platelet recovery and survival after transfusion. Inhibition of chilled platelet clearance by both beta(2) integrin and Ashwell-Morell receptors may afford a potentially simple method for storing platelets in the cold.	[Rumjantseva, Viktoria; Wandall, Hans H.; Josefsson, Emma C.; Sorensen, Anne Louise; Hartwig, John H.; Hoffmeister, Karin M.] Brigham & Womens Hosp, Dept Med, Div Translat Med, Boston, MA 02115 USA; [Rumjantseva, Viktoria; Wandall, Hans H.; Josefsson, Emma C.; Sorensen, Anne Louise; Hartwig, John H.; Hoffmeister, Karin M.] Harvard Univ, Sch Med, Boston, MA USA; [Rumjantseva, Viktoria; Larson, Goran] Sahlgrens Univ Hosp, Inst Lab Med, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Grewal, Prabhjit K.; Marth, Jamey D.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Grewal, Prabhjit K.; Marth, Jamey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Sorensen, Anne Louise] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Copenhagen, Denmark	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Sahlgrenska University Hospital; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Copenhagen	Hoffmeister, KM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Translat Med, 75 Francis St, Boston, MA 02115 USA.	khoffmeister@rics.bwh.harvard.edu	Josefsson, Emma/CAF-4970-2022; Larson, Göran/AAF-3404-2019; Sørensen, Anne Louise Tølbøll/AAA-3211-2022	Sørensen, Anne Louise Tølbøll/0000-0003-4537-2505; Wandall, Hans H./0000-0003-0240-9232; Josefsson, Emma/0000-0001-6478-5204	US National Institutes of Health [PO1 HL056949, HL089224]; The Pew Scholars Award; Howard Hughes Medical Institute; The Swedish Medical Research Council; Goteborg University Jubileums; ZymeQuest, Inc;  [PO1HL57345]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949, P01HL057345, R01HL089224] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Pew Scholars Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); The Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Goteborg University Jubileums; ZymeQuest, Inc; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Nayeb-Hashemi for excellent technical assistance, H. Clausen for helpful discussions and F. Maignen for statistical expertise. This work was supported by US National Institutes of Health grant PO1 HL056949 (to J.H.H. and K. M. H.) and grant HL089224 (to K. M. H.); The Pew Scholars Award to K. M. H.; PO1HL57345 (to J.D.M.); Howard Hughes Medical Institute to J. D. M.; and The Swedish Medical Research Council, Goteborg University Jubileums stipend to V. R. and K. M. H. V. R. and H. H. W. received sponsored research support form ZymeQuest, Inc. We obtained macros for K-function analysis from J. Hancock at the Institute for Molecular Bioscience, University of Queensland.	Alves-Rosa F, 2003, BRIT J HAEMATOL, V121, P130, DOI 10.1046/j.1365-2141.2003.04259.x; BARBER AJ, 1971, BIOCHIM BIOPHYS ACTA, V252, P533, DOI 10.1016/0304-4165(71)90156-5; BAUVOIS B, 1981, FEBS LETT, V125, P277, DOI 10.1016/0014-5793(81)80737-5; BECKER GA, 1973, TRANSFUSION, V13, P61, DOI 10.1111/j.1537-2995.1973.tb05442.x; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; Blajchman MA, 2001, TRANSFUS APHER SCI, V24, P245, DOI 10.1016/S1473-0502(01)00063-5; Crowe JH, 2003, CHEM PHYS LIPIDS, V122, P41, DOI 10.1016/S0009-3084(02)00177-9; Denis CV, 2008, THROMB HAEMOSTASIS, V99, P271, DOI 10.1160/TH07-10-0629; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; EZZELL RM, 1988, J BIOL CHEM, V263, P13303; Gousset K, 2004, BBA-BIOMEMBRANES, V1660, P7, DOI 10.1016/j.bbamem.2003.09.009; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Hoffmeister KM, 2003, SCIENCE, V301, P1531, DOI 10.1126/science.1085322; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Hoffmeister KM, 2001, J BIOL CHEM, V276, P24751, DOI 10.1074/jbc.M011642200; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Josefsson EC, 2005, J BIOL CHEM, V280, P18025, DOI 10.1074/jbc.M501178200; KOLBBACHOFEN V, 1984, BIOL CELL, V51, P219, DOI 10.1111/j.1768-322X.1984.tb00302.x; KORREL SAM, 1988, FEBS LETT, V228, P321, DOI 10.1016/0014-5793(88)80024-3; KORREL SAM, 1984, EUR J BIOCHEM, V140, P571, DOI 10.1111/j.1432-1033.1984.tb08140.x; Kuehnert MJ, 2001, TRANSFUSION, V41, P1493, DOI 10.1046/j.1537-2995.2001.41121493.x; Leidy C, 2004, CELL BIOCHEM BIOPHYS, V40, P123, DOI 10.1385/CBB:40:2:123; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; MCCULLOUGH J, 2003, TRANSFUSION MED 2011; MCGILL M, 1978, J LAB CLIN MED, V92, P971; McGill M, 1978, Prog Clin Biol Res, V28, P119; MURPHY S, 1969, NEW ENGL J MED, V280, P1094, DOI 10.1056/NEJM196905152802004; OZAKI K, 1995, GLYCOCONJUGATE J, V12, P268, DOI 10.1007/BF00731329; Prior I. A., 2003, SCI STKE, V2003, pPL9; Reimers H J, 1977, Adv Exp Med Biol, V82, P231; Rensen PCN, 2001, J BIOL CHEM, V276, P37577, DOI 10.1074/jbc.M101786200; SCHLEPPERSCHAFER J, 1986, EXP CELL RES, V165, P494, DOI 10.1016/0014-4827(86)90602-6; Soukharev S, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e21; SULLIVAN MT, 2001, TRANSFUSION, V3; TSUJI T, 1987, J BIOCHEM-TOKYO, V101, P241, DOI 10.1093/oxfordjournals.jbchem.a121897; TSUJI T, 1983, J BIOL CHEM, V258, P6335; Valeri CR, 2002, VOX SANG, V83, P347, DOI 10.1046/j.1423-0410.2002.00229.x; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; VANROOIJEN N, 1984, CELL TISSUE RES, V238, P355, DOI 10.1007/BF00217308; Wahrenbrock MG, 2006, CANCER RES, V66, P2433, DOI 10.1158/0008-5472.CAN-05-3851; Wandall HH, 2008, BLOOD, V111, P3249, DOI 10.1182/blood-2007-06-097295; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; Webert KE, 2008, TRANSFUS MED REV, V22, P1, DOI 10.1016/j.tmrv.2007.09.001	46	151	164	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1273	U68		10.1038/nm.2030	http://dx.doi.org/10.1038/nm.2030			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19783995	Green Accepted, Green Submitted			2022-12-25	WOS:000271543700015
J	Veith, H; Southall, N; Huang, RL; James, T; Fayne, D; Artemenko, N; Shen, M; Inglese, J; Austin, CP; Lloyd, DG; Auld, DS				Veith, Henrike; Southall, Noel; Huang, Ruili; James, Tim; Fayne, Darren; Artemenko, Natalia; Shen, Min; Inglese, James; Austin, Christopher P.; Lloyd, David G.; Auld, Douglas S.			Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries	NATURE BIOTECHNOLOGY			English	Article							IN-VITRO INHIBITION; DRUG-LIKE PROPERTIES; LIVER-MICROSOMES; STATISTICAL PARAMETER; PROBE SELECTION; CYP ENZYMES; ASSAYS; DISCOVERY; P450; IDENTIFICATION	The cytochrome P450 (CYP) gene family catalyzes drug metabolism and bioactivation and is therefore relevant to drug development. We determined potency values for 17,143 compounds against five recombinant CYP isozymes (1A2, 2C9, 2C19, 2D6 and 3A4) using an in vitro bioluminescent assay. The compounds included libraries of US Food and Drug Administration (FDA)-approved drugs and screening libraries. We observed cross-library isozyme inhibition (30-78%) with important differences between libraries. Whereas only 7% of the typical screening library was inactive against all five isozymes, 33% of FDA-approved drugs were inactive, reflecting the optimized pharmacological properties of the latter. Our results suggest that low CYP 2C isozyme activity is a common property of drugs, whereas other isozymes, such as CYP 2D6, show little discrimination between drugs and unoptimized compounds found in screening libraries. We also identified chemical substructures that differentiated between the five isozymes. The pharmacological compendium described here should further the understanding of CYP isozymes.	[Veith, Henrike; Southall, Noel; Huang, Ruili; Shen, Min; Inglese, James; Austin, Christopher P.; Auld, Douglas S.] NIH, Chem Genom Ctr, Bethesda, MD 20892 USA; [James, Tim; Fayne, Darren; Artemenko, Natalia; Lloyd, David G.] Trinity Coll Dublin, Sch Biochem & Immunol, Mol Design Grp, Dublin, Ireland	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Trinity College Dublin	Auld, DS (corresponding author), NIH, Chem Genom Ctr, Bldg 10, Bethesda, MD 20892 USA.	dauld@mail.nih.gov	Southall, Noel T/H-8991-2012; Lloyd, David/E-9152-2013	Southall, Noel T/0000-0003-4500-880X; Lloyd, David/0000-0003-0658-8995; Fayne, Darren/0000-0003-2417-5406	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research; National Human Genome Research Institute; Enterprise Ireland; Chemical Computing Group; OpenEye Scientific; Accelrys; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Enterprise Ireland; Chemical Computing Group; OpenEye Scientific; Accelrys; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research and the Intramural Research Program of the National Human Genome Research Institute. Work in Trinity College Dublin was supported by Enterprise Ireland, the Chemical Computing Group, OpenEye Scientific and Accelrys. We thank S. Jefferies and G. Carta for helpful discussions, S. Michael and C. Klumpp for help with robotic automation of the assays and P. Shinn for preparation of compound dilutions and library plates.	Arimoto R, 2005, J BIOMOL SCREEN, V10, P197, DOI 10.1177/1087057104274091; Auld DS, 2009, J MED CHEM, V52, P1450, DOI 10.1021/jm8014525; Cali JJ, 2006, EXPERT OPIN DRUG MET, V2, P629, DOI 10.1517/17425255.2.4.629; Chauret N, 1999, ANAL BIOCHEM, V276, P215, DOI 10.1006/abio.1999.4348; Cohen LH, 2003, DRUG METAB DISPOS, V31, P1005, DOI 10.1124/dmd.31.8.1005; Davis RE, 2007, ASSAY DRUG DEV TECHN, V5, P85, DOI 10.1089/adt.2006.048; de Graaf C, 2005, J MED CHEM, V48, P2725, DOI 10.1021/jm040180d; de Graaf C, 2005, J MED CHEM, V48, P2308, DOI 10.1021/jm049650u; Di L, 2005, CURR OPIN DRUG DISC, V8, P495; Eagling VA, 1998, BRIT J CLIN PHARMACO, V45, P107, DOI 10.1046/j.1365-2125.1998.00679.x; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Ekins S, 2001, DRUG METAB DISPOS, V29, P936; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Foti RS, 2008, DRUG METAB DISPOS, V36, P523, DOI 10.1124/dmd.107.019265; Fox T, 2007, ANN REP COMP CHEM, V3, P63, DOI 10.1016/S1574-1400(07)03005-8; Goode DR, 2008, J MED CHEM, V51, P2346, DOI 10.1021/jm701583b; Hansch C, 2004, DRUG METAB REV, V36, P105, DOI 10.1081/DMR-120028428; Hansch C, 2004, BIOORGAN MED CHEM, V12, P3391, DOI 10.1016/j.bmc.2003.11.037; Hollenberg PF, 2002, DRUG METAB REV, V34, P17, DOI 10.1081/DMR-120001387; Huang R, 2008, CHEM RES TOXICOL, V21, P659, DOI 10.1021/tx700365e; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Kenworthy KE, 1999, BRIT J CLIN PHARMACO, V48, P716; Kohonen T, 1998, NEUROCOMPUTING, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; KOHONEN T, 1987, SCIENCE, V235, P1227; Kohonen T, 2006, NEURAL NETWORKS, V19, P723, DOI 10.1016/j.neunet.2006.05.001; Kumar V, 2006, DRUG METAB DISPOS, V34, P1966, DOI 10.1124/dmd.106.010926; Lewis D. F. V., 2001, GUIDE CYTOCHROME P45; Lewis DFV, 2008, EXPERT OPIN DRUG MET, V4, P1181, DOI 10.1517/17425255.4.9.1181 ; Lewis DFV, 1998, CHEM-BIOL INTERACT, V115, P175, DOI 10.1016/S0009-2797(98)00068-4; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Nath A, 2008, DRUG METAB DISPOS, V36, P2151, DOI 10.1124/dmd.108.022061; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; PORTER TD, 1991, J BIOL CHEM, V266, P13469; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Schulz M, 2003, PHARMAZIE, V58, P447; Shimada T, 1997, ARCH TOXICOL, V71, P401, DOI 10.1007/s002040050403; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; Shukla SJ, 2009, ASSAY DRUG DEV TECHN, V7, P143, DOI 10.1089/adt.2009.193; Sigel A., 2007, UBIQUITOUS ROLES CYT, V3; vonMoltke LL, 1996, PSYCHOPHARMACOLOGY, V128, P398, DOI 10.1007/s002130050149; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104; Zlokarnik G, 2005, DRUG DISCOV TODAY, V10, P1443, DOI 10.1016/S1359-6446(05)03580-4	50	106	108	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2009	27	11					1050	U123		10.1038/nbt.1581	http://dx.doi.org/10.1038/nbt.1581			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	516EM	19855396	Green Accepted			2022-12-25	WOS:000271524700027
J	Xu, J; Zhang, XM; Pelayo, R; Monestier, M; Ammollo, CT; Semeraro, F; Taylor, FB; Esmon, NL; Lupu, F; Esmon, CT				Xu, Jun; Zhang, Xiaomei; Pelayo, Rosana; Monestier, Marc; Ammollo, Concetta T.; Semeraro, Fabrizio; Taylor, Fletcher B.; Esmon, Naomi L.; Lupu, Florea; Esmon, Charles T.			Extracellular histones are major mediators of death in sepsis	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-C; INFLAMMATION; TRAPS; MICE	Hyperinflammatory responses can lead to a variety of diseases, including sepsis(1). We now report that extracellular histones released in response to inflammatory challenge contribute to endothelial dysfunction, organ failure and death during sepsis. They can be targeted pharmacologically by antibody to histone or by activated protein C (APC). Antibody to histone reduced the mortality of mice in lipopolysaccharide (LPS), tumor necrosis factor (TNF) or cecal ligation and puncture models of sepsis. Extracellular histones are cytotoxic toward endothelium in vitro and are lethal in mice. In vivo, histone administration resulted in neutrophil margination, vacuolated endothelium, intra-alveolar hemorrhage and macro- and microvascular thrombosis. We detected histone in the circulation of baboons challenged with Escherichia coli, and the increase in histone levels was accompanied by the onset of renal dysfunction. APC cleaves histones and reduces their cytotoxicity. Co-infusion of APC with E. coli in baboons or histones in mice prevented lethality. Blockade of protein C activation exacerbated sublethal LPS challenge into lethality, which was reversed by treatment with antibody to histone. We conclude that extracellular histones are potential molecular targets for therapeutics for sepsis and other inflammatory diseases.	[Xu, Jun; Ammollo, Concetta T.; Semeraro, Fabrizio; Taylor, Fletcher B.; Esmon, Naomi L.; Lupu, Florea; Esmon, Charles T.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Zhang, Xiaomei; Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma City, OK USA; [Pelayo, Rosana] Oklahoma Med Res Fdn, Immunol & Canc Res Program, Oklahoma City, OK 73104 USA; [Monestier, Marc] Temple Univ, Sch Med, Dept Microbiol & Immunol, Temple Autoimmun Ctr, Philadelphia, PA 19122 USA	Oklahoma Medical Research Foundation; Howard Hughes Medical Institute; Oklahoma Medical Research Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Esmon, CT (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA.	esmonc@omrf.org	Lupu, Florea/C-3162-2009; Lupu, Florea/AAV-3257-2021	Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278	US National Institutes of Health [R01GM037704]; University of Bari, Italy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037704] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Bari, Italy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Jackson for protein sequencing and identification; A. Matveev for preparing liposomes; C. J. Edgell, University of North Carolina, Chapel Hill, for providing EA.hy926 cells; G. Kinasewitz, University of Oklahoma Health Science Center, for providing plasma samples from humans with sepsis; K. Deatherage for preparing the manuscript; and P. Kincade for reviewing the original manuscript. C. T. E. is an investigator of the Howard Hughes Medical Institute. F. L. and F. B. T. are supported by US National Institutes of Health grant R01GM037704. C. T. A. and F. S. are supported by fellowships from the University of Bari, Italy.	Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BEUTLER B, 1988, BIOCHEMISTRY-US, V27, P7575, DOI 10.1021/bi00420a001; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Lay AJ, 2007, BLOOD, V109, P1984, DOI 10.1182/blood-2006-07-037945; LUPU F, 1993, ARTERIOSCLER THROMB, V13, P1090, DOI 10.1161/01.ATV.13.7.1090; Macias WL, 2004, CRIT CARE MED, V32, pS223, DOI 10.1097/01.CCM.0000126120.49367.AC; MONESTIER M, 1993, MOL IMMUNOL, V30, P1069, DOI 10.1016/0161-5890(93)90153-3; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Xu J, 1999, J BIOL CHEM, V274, P6704, DOI 10.1074/jbc.274.10.6704; Xu J, 2009, J THROMB HAEMOST, V7, P851, DOI 10.1111/j.1538-7836.2009.03333.x; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95	21	982	1061	7	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2009	15	11					1318	U117		10.1038/nm.2053	http://dx.doi.org/10.1038/nm.2053			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	516LM	19855397	Green Accepted			2022-12-25	WOS:000271543700021
J	Kortylewski, M; Swiderski, P; Herrmann, A; Wang, L; Kowolik, C; Kujawski, M; Lee, H; Scuto, A; Liu, Y; Yang, CM; Deng, JH; Soifer, HS; Raubitschek, A; Forman, S; Rossi, JJ; Pardoll, DM; Jove, R; Yu, H				Kortylewski, Marcin; Swiderski, Piotr; Herrmann, Andreas; Wang, Lin; Kowolik, Claudia; Kujawski, Maciej; Lee, Heehyoung; Scuto, Anna; Liu, Yong; Yang, Chunmei; Deng, Jiehui; Soifer, Harris S.; Raubitschek, Andrew; Forman, Stephen; Rossi, John J.; Pardoll, Drew M.; Jove, Richard; Yu, Hua			In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses	NATURE BIOTECHNOLOGY			English	Article							BACTERIAL-DNA; TUMOR MICROENVIRONMENT; STAT3 ACTIVATION; DENDRITIC CELLS; INNATE IMMUNITY; CPG MOTIFS; CANCER; INFLAMMATION; MICE; IMMUNOTHERAPY	Efficient delivery of small interfering (si)RNA to specific cell populations in vivo remains a formidable challenge to its successful therapeutic application. We show that siRNA synthetically linked to a CpG oligonucleotide agonist of toll-like receptor (TLR)9 targets and silences genes in TLR9(+) myeloid cells and B cells, both of which are key components of the tumor microenvironment. When a CpG-conjugated siRNA that targets the immune suppressor gene Stat3 is injected in mice either locally at the tumor site or intravenously, it enters tumor-associated dendritic cells, macrophages and B cells. Silencing of Stat3 leads to activation of tumor-associated immune cells and ultimately to potent antitumor immune responses. Our findings demonstrate the potential of TLR agonist-siRNA conjugates for targeted gene silencing coupled with TLR stimulation and immune activation in the tumor microenvironment.	[Kortylewski, Marcin; Herrmann, Andreas; Wang, Lin; Kujawski, Maciej; Lee, Heehyoung; Liu, Yong; Yang, Chunmei; Deng, Jiehui; Raubitschek, Andrew; Yu, Hua] Beckman Res Inst City Hope, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA; [Swiderski, Piotr; Kowolik, Claudia; Scuto, Anna; Jove, Richard] Beckman Res Inst City Hope, Dept Mol Med, Duarte, CA USA; [Soifer, Harris S.; Rossi, John J.] Beckman Res Inst City Hope, Dept Mol Biol, Duarte, CA USA; [Forman, Stephen] Beckman Res Inst City Hope, Dept Hematopoiet Cell Transplant, Duarte, CA USA; [Pardoll, Drew M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Johns Hopkins University	Yu, H (corresponding author), Beckman Res Inst City Hope, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA.	hyu@coh.org	Liu, Yong/A-2031-2013; Kortylewski, Marcin/H-8052-2019	Kortylewski, Marcin/0000-0002-6003-1816; YU, Hua/0000-0003-0931-1000; Deng, Jiehui/0000-0001-7986-8643	board of governors for City of Hope Medical Center; Harry Lloyd Charitable Trust; Keck Foundation; National Institutes of Health [R01CA122976, R01CA115815, R01CA115674, P50CA107399]; NATIONAL CANCER INSTITUTE [R01CA122976, P50CA107399, R01CA115815, R01CA115674] Funding Source: NIH RePORTER	board of governors for City of Hope Medical Center; Harry Lloyd Charitable Trust; Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the Light Microscopy Imaging and Flow Cytometry Cores and Animal Facilities of Beckman Research Institute at City of Hope Medical Center for technical support and assistance and X. Li of the Department of Biomedical Informatics for consultation on statistical analyses. We thank C. H. Contag of Stanford University School of Medicine for providing the original luciferase mice. Mouse dendritic DC2.4 cells were originally from K. Rock (University of Massachusetts Medical School). The highly metastatic clone of K1735 melanoma (C4) was kindly provided by S. Huang and J. Fidler of M. D. Anderson Cancer Center. The stably transduced A20-Luc cell line was provided by D. Zheng ( City of Hope). This work is funded in part by grants from the board of governors for City of Hope Medical Center, Harry Lloyd Charitable Trust and Keck Foundation, in addition to National Institutes of Health grants (R01CA122976, R01CA115815, R01CA115674, P50CA107399).	Barchet W, 2008, CURR OPIN IMMUNOL, V20, P389, DOI 10.1016/j.coi.2008.07.007; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; Bui JD, 2006, CANCER RES, V66, P7301, DOI 10.1158/0008-5472.CAN-06-0556; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Clarke P, 1998, CANCER RES, V58, P1469; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Klinman D, 2008, J LEUKOCYTE BIOL, V84, P958, DOI 10.1189/jlb.1107775; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Kortylewski M, 2009, CANCER RES, V69, P2497, DOI 10.1158/0008-5472.CAN-08-3031; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Krieg AM, 2008, ONCOGENE, V27, P161, DOI 10.1038/sj.onc.1210911; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Samarasinghe R, 2006, J INTERF CYTOK RES, V26, P893, DOI 10.1089/jir.2006.26.893; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Spaner DE, 2008, ONCOGENE, V27, P208, DOI 10.1038/sj.onc.1210905; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	50	292	305	3	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2009	27	10					925	U88		10.1038/nbt.1564	http://dx.doi.org/10.1038/nbt.1564			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	515LO	19749770	Green Accepted			2022-12-25	WOS:000271472500023
J	Dendrou, CA; Plagnol, V; Fung, E; Yang, JHM; Downes, K; Cooper, JD; Nutland, S; Coleman, G; Himsworth, M; Hardy, M; Burren, O; Healy, B; Walker, NM; Koch, K; Ouwehand, WH; Bradley, JR; Wareham, NJ; Todd, JA; Wicker, LS				Dendrou, Calliope A.; Plagnol, Vincent; Fung, Erik; Yang, Jennie H. M.; Downes, Kate; Cooper, Jason D.; Nutland, Sarah; Coleman, Gillian; Himsworth, Matthew; Hardy, Matthew; Burren, Oliver; Healy, Barry; Walker, Neil M.; Koch, Kerstin; Ouwehand, Willem H.; Bradley, John R.; Wareham, Nicholas J.; Todd, John A.; Wicker, Linda S.			Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource	NATURE GENETICS			English	Article							REGULATORY T-CELLS; NOD MICE; DIABETES-MELLITUS; ALLELIC VARIANTS; HUMAN IMMUNOLOGY; RNA-SEQ; INTERLEUKIN-2; IL-2; RECEPTOR; DISEASE	Genome-wide association studies (GWAS) have identified over 300 regions associated with more than 70 common diseases(1). However, identifying causal genes within an associated region remains a major challenge(1,2). One approach to resolving causal genes is through the dissection of gene-phenotype correlations. Here we use polychromatic flow cytometry to show that differences in surface expression of the human interleukin-2 (IL-2) receptor alpha (IL2RA, or CD25) protein are restricted to particular immune cell types and correlate with several haplotypes in the IL2RA region that have previously been associated with two autoimmune diseases, type 1 diabetes (T1D) and multiple sclerosis(2-4). We confirm our strongest gene-phenotype correlation at the RNA level by allele-specific expression (ASE). We also define key parameters for the design and implementation of post-GWAS gene-phenotype investigations and demonstrate the usefulness of a large bioresource of genotype-selectable normal donors from whom fresh, primary cells can be analyzed.	[Dendrou, Calliope A.; Plagnol, Vincent; Fung, Erik; Yang, Jennie H. M.; Downes, Kate; Cooper, Jason D.; Nutland, Sarah; Coleman, Gillian; Himsworth, Matthew; Hardy, Matthew; Burren, Oliver; Healy, Barry; Walker, Neil M.; Todd, John A.; Wicker, Linda S.] Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2QQ, England; [Koch, Kerstin; Ouwehand, Willem H.] Univ Cambridge & NHS Blood & Transplant Cambridge, Dept Haematol, Cambridge, England; [Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [Bradley, John R.] Univ Cambridge, Addenbrookes Hosp, Div Resp Med, Dept Med,Sch Clin Med, Cambridge CB2 2QQ, England; [Bradley, John R.] Univ Cambridge, Dept Med, Div Resp Med, Papworth Hosp,Sch Clin Med, Cambridge CB2 2QQ, England; [Wareham, Nicholas J.] Addenbrookes Hosp, Med Res Council Epidemiol Unit, Inst Metab Sci, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge	Wicker, LS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Hills Rd, Cambridge CB2 2QQ, England.	linda.wicker@cimr.cam.ac.uk	Plagnol, Vincent/A-5667-2011; Wicker, Linda S/F-7384-2010; Todd, John/A-3542-2010	Todd, John/0000-0003-2740-8148; Burren, Oliver/0000-0002-3388-5760; Dendrou, Calliope/0000-0003-1179-4021; Bradley, John/0000-0002-7774-8805; Walker, Neil/0000-0001-9796-7688; Plagnol, Vincent/0000-0002-5597-9215; Hardy, Matthew/0000-0001-6420-1715	Medical Research Council; Wellcome Trust [079895]; Juvenile Diabetes Research Foundation (JDRF) International [4-2007-1003]; National Institute for Health Research Cambridge Biomedical Research Centre; National Institutes of Health (USA) [P01 AI39671]; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Juvenile Diabetes Research Foundation (JDRF) International(Juvenile Diabetes Research Foundation); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge the participation of all Cambridge BioResource subjects. We thank R. Bailey, P. Clarke, H. Stevens, S. Duley, D. Harrison, M. Maisuria, T. Mistry and N. Taylor for DNA sample preparation and D. Smyth for genotype double scoring. We thank J. Casey, W. Herring, K. Hodge, H. Lloyd- Jones, R. Walker and M. Wiesner for donor coordination and blood sample obtainment and J. Clark for help with immunostaining. We thank T. Attwood for his contribution to sample management. We thank the other members of the Cambridge BioResource Management Committee: D. Dunger, S. O'Rahilly, D. Savage, J. Sambrook, A. Calder, W. Marslen- Wilson, K. Chatterjee and C. Saunders. We acknowledge use of the DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council and Wellcome Trust. We thank the Avon Longitudinal Study of Parents and Children laboratory in Bristol and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton, for preparing and providing the control DNA samples. We also thank the Wellcome Trust, the Juvenile Diabetes Research Foundation (JDRF) International and the National Institute for Health Research Cambridge Biomedical Research Centre for funding. This work was also supported by a National Institutes of Health (USA) grant P01 AI39671 and a grant from the JDRF UK Centre for Diabetes Genes, Autoimmunity and Prevention (D-GAP; 4-2007-1003). The Cambridge Institute for Medical Research is the recipient of a Wellcome Trust Strategic Award (079895). L. S. W. is a Juvenile Diabetes Research Foundation/ Wellcome Trust Principal Research Fellow.	Baecher-Allan C, 2005, CLIN IMMUNOL, V115, P10, DOI 10.1016/j.clim.2005.02.018; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Dendrou CA, 2008, J CLIN IMMUNOL, V28, P685, DOI 10.1007/s10875-008-9237-9; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hayday AC, 2008, NAT IMMUNOL, V9, P575, DOI 10.1038/ni0608-575; KAYE WA, 1986, NEW ENGL J MED, V315, P920, DOI 10.1056/NEJM198610093151502; KNIEP EM, 1992, IMMUNOLOGY, V75, P299; Lenardo MJ, 1996, J EXP MED, V183, P721, DOI 10.1084/jem.183.3.721; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; McKarns SC, 2008, J IMMUNOL, V181, P1272, DOI 10.4049/jimmunol.181.2.1272; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pearson T, 2004, DIABETES, V53, P1972, DOI 10.2337/diabetes.53.8.1972; Rainbow DB, 2008, BIOCHEM SOC T, V36, P312, DOI 10.1042/BST0360312; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sgouroudis E, 2008, J IMMUNOL, V181, P6283, DOI 10.4049/jimmunol.181.9.6283; Smith Kendall A, 2004, Med Immunol, V3, P3, DOI 10.1186/1476-9433-3-3; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Tkaczuk J, 2002, AM J TRANSPLANT, V2, P31, DOI 10.1034/j.1600-6143.2002.020107.x; Tree TIM, 2004, ANN NY ACAD SCI, V1037, P26, DOI 10.1196/annals.1337.005; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; URDAL DL, 1984, P NATL ACAD SCI-BIOL, V81, P6481, DOI 10.1073/pnas.81.20.6481; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; ZIER KS, 1984, DIABETES, V33, P552, DOI 10.2337/diabetes.33.6.552	30	212	216	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1011	U80		10.1038/ng.434	http://dx.doi.org/10.1038/ng.434			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19701192	Green Accepted			2022-12-25	WOS:000269382100014
J	Jones, MR; Quinton, LJ; Blahna, MT; Neilson, JR; Fu, SN; Ivanov, AR; Wolf, DA; Mizgerd, JP				Jones, Matthew R.; Quinton, Lee J.; Blahna, Matthew T.; Neilson, Joel R.; Fu, Suneng; Ivanov, Alexander R.; Wolf, Dieter A.; Mizgerd, Joseph P.			Zcchc11-dependent uridylation of microRNA directs cytokine expression	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC POLY(A) POLYMERASE; MESSENGER-RNA; MECHANISMS; FAMILY; MIRNA; IDENTIFICATION; DETERMINANTS; INVOLVEMENT; INHIBITION; PROTEINS	Mounting an effective host immune response without incurring inflammatory injury requires the precise regulation of cytokine expression(1,2). To achieve this, cytokine mRNAs are post-transcriptionally regulated by diverse RNA-binding proteins and microRNAs (miRNAs) targeting their 3' untranslated regions (UTRS)(3,4). Zcchc11 (zinc-finger, CCHC domain-containing protein 11) contains RNA-interacting motifs(5), and has been implicated in signalling pathways involved in cytokine expression(6). The nature of the Zcchc11 protein and how it influences cytokine expression are unknown. Here we show that Zcchc11 directs cytokine expression by uridylating cytokine-targeting miRNAs. Zcchc11 is a ribonucleotidyltransferase with a preference for uridine and is essential for maintaining the poly(A) tail length and stability of transcripts for interleukin-6 (IL-6) and other specific cytokines. The miR-26 family of miRNAs targets IL-6, and the addition of terminal uridines to the miR-26 3' end abrogates IL-6 repression. Whereas 78% of miR-26a sequences in control cells contained 1-3 uridines on their 3' ends, less than 0.1% did so in Zcchc11-knockdown cells. Thus, Zcchc11 fine tunes IL-6 production by uridylating miR-26a, which we propose is an enzymatic modification of the terminal nucleotide sequence of mature miRNA as a means to regulate gene expression.	[Jones, Matthew R.; Quinton, Lee J.; Blahna, Matthew T.; Mizgerd, Joseph P.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Fu, Suneng; Ivanov, Alexander R.; Wolf, Dieter A.] Harvard Univ, Sch Publ Hlth, Dept Genet, Boston, MA 02115 USA; [Fu, Suneng; Ivanov, Alexander R.; Wolf, Dieter A.] Harvard Univ, Sch Publ Hlth, Complex Dis & NIEHS Ctr, Prote Facil, Boston, MA 02115 USA; [Neilson, Joel R.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Massachusetts Institute of Technology (MIT)	Mizgerd, JP (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	jmizgerd@bu.edu	Mizgerd, Joseph/GRY-6369-2022; Wolf, Dieter/AAE-5890-2021; Blahna, Matthew T/F-3172-2013	Wolf, Dieter/0000-0002-3761-1070; Quinton, Lee/0000-0003-1938-2507; Jones, Matthew/0000-0003-4647-2962; Neilson, Joel R./0000-0002-3408-608X; Mizgerd, Joseph/0000-0002-4042-3169	NATIONAL CANCER INSTITUTE [P01CA042063, K99CA131474] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019028] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL092956, R01HL068153, R01HL079392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059780] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA042063-249002, K99 CA131474-02, P01 CA42063, P01 CA042063, K99 CA131474] Funding Source: Medline; NCRR NIH HHS [S10 RR019028] Funding Source: Medline; NHLBI NIH HHS [R01 HL079392, R01 HL068153-06, R01 HL068153, R01 HL079392-04, K99 HL092956, K99 HL092956-02] Funding Source: Medline; NIEHS NIH HHS [P01 ES00002, P30 ES000002] Funding Source: Medline; NIGMS NIH HHS [R01 GM059780] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103	40	233	253	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1157	U258		10.1038/ncb1931	http://dx.doi.org/10.1038/ncb1931			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19701194	Green Accepted			2022-12-25	WOS:000269482500019
J	Renner, S; van Otterlo, WAL; Seoane, MD; Mocklinghoff, S; Hofmann, B; Wetzel, S; Schuffenhauer, A; Ertl, P; Oprea, TI; Steinhilber, D; Brunsveld, L; Rauh, D; Waldmann, H				Renner, Steffen; van Otterlo, Willem A. L.; Seoane, Marta Dominguez; Moecklinghoff, Sabine; Hofmann, Bettina; Wetzel, Stefan; Schuffenhauer, Ansgar; Ertl, Peter; Oprea, Tudor I.; Steinhilber, Dieter; Brunsveld, Luc; Rauh, Daniel; Waldmann, Herbert			Bioactivity-guided mapping and navigation of chemical space	NATURE CHEMICAL BIOLOGY			English	Article							BIOLOGICAL-ACTIVITY; DISCOVERY; INHIBITORS; MECHANISM; DESIGN	The structure- and chemistry-based hierarchical organization of library scaffolds in tree-like arrangements provides a valid, intuitive means to map and navigate chemical space. We demonstrate that scaffold trees built using bioactivity as the key selection criterion for structural simplification during tree construction allow efficient and intuitive mapping, visualization and navigation of the chemical space defined by a given library, which in turn allows correlation of this chemical space with the investigated bioactivity and further compound design. Brachiation along the branches of such trees from structurally complex to simple scaffolds with retained yet varying bioactivity is feasible at high frequency for the five major pharmaceutically relevant target classes and allows for the identification of new inhibitor types for a given target. We provide proof of principle by identifying new active scaffolds for 5-lipoxygenase and the estrogen receptor ER alpha.	[Renner, Steffen; van Otterlo, Willem A. L.; Wetzel, Stefan; Waldmann, Herbert] Max Planck Inst Mol Physiol, Abt Chem Biol, D-44139 Dortmund, Germany; [Renner, Steffen; Wetzel, Stefan; Waldmann, Herbert] Tech Univ Dortmund, Fak Chem, Dortmund, Germany; [van Otterlo, Willem A. L.] Univ Witwatersrand, Sch Chem, Inst Mol Sci, Johannesburg, South Africa; [Seoane, Marta Dominguez; Moecklinghoff, Sabine; Brunsveld, Luc; Rauh, Daniel] Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany; [Hofmann, Bettina; Steinhilber, Dieter] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Ctr Drug Res Dev & Safety, Frankfurt, Germany; [Schuffenhauer, Ansgar; Ertl, Peter] Novartis Inst BioMed Res, Basel, Switzerland; [Oprea, Tudor I.] Univ New Mexico, Sch Med, Div Biocomp, Albuquerque, NM 87131 USA; [Brunsveld, Luc] Tech Univ Eindhoven, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands	Max Planck Society; Dortmund University of Technology; University of Witwatersrand; Max Planck Society; Goethe University Frankfurt; Novartis; University of New Mexico; Eindhoven University of Technology	Waldmann, H (corresponding author), Max Planck Inst Mol Physiol, Abt Chem Biol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	herbert.waldmann@mpi-dortmund.mpg.de	Waldmann, Herbert/B-7406-2017; van Otterlo, Willem A.L./AAJ-8542-2021; Oprea, Tudor I/A-5746-2011; Dominguez, Marta/AAA-2084-2019; Steinhilber, Dieter/J-3221-2012; Renner, Steffen/C-3400-2009; Rauh, Daniel/G-1595-2013	Waldmann, Herbert/0000-0002-9606-7247; Oprea, Tudor I/0000-0002-6195-6976; Renner, Steffen/0000-0002-0720-5629; van Otterlo, Willem/0000-0002-3300-6463; Rauh, Daniel/0000-0002-1970-7642; Ertl, Peter/0000-0001-6496-4448; Dominguez Seoane, Marta/0000-0003-4569-8011; Brunsveld, Luc/0000-0001-5675-511X	Max-Planck-Gesellschaft; Fonds der Chemischen Industrie; US National Institutes of Health [1R01CA127731, 1U54MH084690]; German Federal Ministry for Education and Research; BMBF [01GS08102]; Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [R01CA127731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	Max-Planck-Gesellschaft(Max Planck Society); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Max-Planck-Gesellschaft and the Fonds der Chemischen Industrie. Part of this work was supported by US National Institutes of Health grants 1R01CA127731 and 1U54MH084690 (to T.I.O.) and by the German Federal Ministry for Education and Research through the German National Genome Research NetworkPlus (grant number BMBF 01GS08102, to D. R. and H. W.). W.A.L.v.O. thanks the Alexander von Humboldt Foundation for a Georg Forster Research Fellowship for Experienced Researchers.	Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Chesworth R, 2004, BIOORG MED CHEM LETT, V14, P2729, DOI 10.1016/j.bmcl.2004.03.077; Clark AM, 2009, J MED CHEM, V52, P469, DOI 10.1021/jm801098a; DUCHARME Y, 1994, J MED CHEM, V37, P512, DOI 10.1021/jm00030a010; Ersmark K, 2008, ANGEW CHEM INT EDIT, V47, P1202, DOI 10.1002/anie.200605219; Fattori D, 2004, DRUG DISCOV TODAY, V9, P229, DOI 10.1016/S1359-6446(03)03007-1; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hoekstra WJ, 2005, J MED CHEM, V48, P2243, DOI 10.1021/jm040154f; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Johnson M.A., 1990, CONCEPTS APPL MOL SI; Kaiser M, 2008, CELL MOL LIFE SCI, V65, P1186, DOI 10.1007/s00018-007-7492-1; Kingston DGI, 2007, PHYTOCHEMISTRY, V68, P1844, DOI 10.1016/j.phytochem.2006.11.009; Koch MA, 2005, P NATL ACAD SCI USA, V102, P17272, DOI 10.1073/pnas.0503647102; Loewi O, 1936, PFLUG ARCH GES PHYS, V214, P689; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Noren-Muller A, 2008, ANGEW CHEM INT EDIT, V47, P5973, DOI 10.1002/anie.200801566; Noren-Muller A, 2006, P NATL ACAD SCI USA, V103, P10606, DOI 10.1073/pnas.0601490103; OLAH M, 2004, CHEMOINFORMATICS DRU, P223; Olah M., 2007, CHEM BIOL SMALL MOL, P760; Sadler BR, 1998, J MED CHEM, V41, P2261, DOI 10.1021/jm9705521; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schuffenhauer A, 2007, J CHEM INF MODEL, V47, P325, DOI 10.1021/ci6004004; Schuffenhauer A, 2007, J CHEM INF MODEL, V47, P47, DOI 10.1021/ci600338x; Schulz W., 1996, CHEM ENG NEWS, V74, P43; Siegel MG, 2007, DRUG DISCOV TODAY, V12, P71, DOI 10.1016/j.drudis.2006.11.011; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Wiley MR, 1997, EXPERT OPIN THER PAT, V7, P1265, DOI 10.1517/13543776.7.11.1265	30	105	105	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					585	592		10.1038/nchembio.188	http://dx.doi.org/10.1038/nchembio.188			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19561619				2022-12-25	WOS:000268209200017
J	Skibola, CF; Bracci, PM; Halperin, E; Conde, L; Craig, DW; Agana, L; Iyadurai, K; Becker, N; Brooks-Wilson, A; Curry, JD; Spinelli, JJ; Holly, EA; Riby, J; Zhang, LP; Nieters, A; Smith, MT; Brown, KM				Skibola, Christine F.; Bracci, Paige M.; Halperin, Eran; Conde, Lucia; Craig, David W.; Agana, Luz; Iyadurai, Kelly; Becker, Nikolaus; Brooks-Wilson, Angela; Curry, John D.; Spinelli, John J.; Holly, Elizabeth A.; Riby, Jacques; Zhang, Luoping; Nieters, Alexandra; Smith, Martyn T.; Brown, Kevin M.			Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma	NATURE GENETICS			English	Article							NON-HODGKIN-LYMPHOMA; GENOME-WIDE ASSOCIATION; POLYMORPHISMS	We conducted genome-wide association studies of non-Hodgkin lymphoma using Illumina HumanHap550 BeadChips to identify subtype-specific associations in follicular, diffuse large B-cell and chronic lymphocytic leukemia/small lymphocytic lymphomas. We found that rs6457327 on 6p21.33 was associated with susceptibility to follicular lymphoma (FL; N = 189 cases, 592 controls) with validation in another 456 FL cases and 2,785 controls (combined allelic P = 4.7 x 10(-11)). The region of strongest association overlapped C6orf15 (STG), located near psoriasis susceptibility region 1 (PSORS1).	[Skibola, Christine F.; Conde, Lucia; Agana, Luz; Curry, John D.; Riby, Jacques; Zhang, Luoping; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Bracci, Paige M.; Holly, Elizabeth A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA; [Craig, David W.; Iyadurai, Kelly; Brown, Kevin M.] Translat Genom Res Inst, Phoenix, AZ USA; [Becker, Nikolaus; Nieters, Alexandra] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Brooks-Wilson, Angela] Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Spinelli, John J.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Nieters, Alexandra] Univ Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Translational Genomics Research Institute; Helmholtz Association; German Cancer Research Center (DKFZ); British Columbia Cancer Agency; University of Freiburg	Skibola, CF (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	chrisfs@berkeley.edu	Brooks-Wilson, Angela/E-9399-2012; Conde, Lucia/D-9295-2011; Craig, David Wesley/K-6961-2019; Spinelli, John J./B-6210-2013	Brooks-Wilson, Angela/0000-0003-1009-6408; Craig, David Wesley/0000-0003-2040-1955; Spinelli, John J./0000-0002-9119-3287; Conde, Lucia/0000-0001-5180-543X	US National Institutes of Health [CA122663, CA104862, CA45614, CA89745, CA87014, HL086528]; American Cancer Society [IRG-07-06401]; Stardust Foundation; Canadian Cancer Society and National Cancer Institute of Canada; Canadian Institutes of Health Research; German Jose Carreras Leukemia Foundation [DJCLS R04/08, R07/26]; NATIONAL CANCER INSTITUTE [R01CA045614, R03CA089745, R01CA087014, R01CA122663, R01CA104682] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL086528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Stardust Foundation; Canadian Cancer Society and National Cancer Institute of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); German Jose Carreras Leukemia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Leach, J. Schuetz and A. MacArthur for assistance. This work was supported by US National Institutes of Health grants CA122663 (C. F. S.), CA104862 (M. T. S.), and CA45614, CA89745 and CA87014 (E. A. H.); the American Cancer Society (IRG-07-06401), the US National Institutes of Health (HL086528) and a charitable donation by Sylvia Chase (K. M. B.); the Stardust Foundation (D. W. C.); the Canadian Cancer Society and National Cancer Institute of Canada, and the Canadian Institutes of Health Research (J. J. S. and A. B.-W.); and the German Jose Carreras Leukemia Foundation (DJCLS R04/ 08 and R07/ 26f; A. N.).	Becker N, 2004, LEUKEMIA RES, V28, P713, DOI 10.1016/j.leukres.2003.11.010; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Homer N, 2008, BIOINFORMATICS, V24, P1896, DOI 10.1093/bioinformatics/btn333; Morton LM, 2008, BLOOD, V112, P5150, DOI 10.1182/blood-2008-01-133587; Nair B, 2007, AM J HEMATOL, V82, P1022, DOI 10.1002/ajh.20926; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Skibola CF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002816; Spinelli JJ, 2007, INT J CANCER, V121, P2767, DOI 10.1002/ijc.23005; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199	12	116	118	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					873	875		10.1038/ng.419	http://dx.doi.org/10.1038/ng.419			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19620980	Green Accepted			2022-12-25	WOS:000268432900006
J	Thangaraj, H; van Dolleweerd, CJ; McGowan, EG; Ma, JKC				Thangaraj, Harry; van Dolleweerd, Craig J.; McGowan, Edward G.; Ma, Julian K-C			Dynamics of global disclosure through patent and journal publications for biopharmaceutical products	NATURE BIOTECHNOLOGY			English	Editorial Material								Examining the relationships between invention disclosure type in industry and academia and geographical disclosure trends, using plant-made pharmaceuticals as a single-sector model for the biopharmaceutical industry.	[Thangaraj, Harry; van Dolleweerd, Craig J.; McGowan, Edward G.; Ma, Julian K-C] Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med, Mol Immunol Unit, London SW17 0RE, England	St Georges University London; University of London; University College London; UCL Medical School	Thangaraj, H (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med, Mol Immunol Unit, Cranmer Terrace, London SW17 0RE, England.	hthangar@sgul.ac.uk		van Dolleweerd, Craig/0000-0002-1380-6930; Ma, Julian/0000-0003-0767-0042				Crespi RS, 1998, TRENDS BIOTECHNOL, V16, P450, DOI 10.1016/S0167-7799(98)01228-1; *EPO, 2004, R BERG MARK RES EUR; Geuna A, 2006, RES POLICY, V35, P790, DOI 10.1016/j.respol.2006.04.005; HALL S, 2008, SCIENTIST        AUG, P30; JENSEN PH, 2008, 0108 IPRIA; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; *MARKS CLERK, 2007, AC OUTP CORP BIOT EU; Parida DK, 2008, NAT BIOTECHNOL, V26, P763, DOI 10.1038/nbt0708-763; ROYLE M, 2008, GEN ENG NEWS    SEP; *THOMS TEUT, 2008, AN GLOB PAT ACT US S; Thursby JG, 2003, SCIENCE, V301, P1052, DOI 10.1126/science.1087473; von Gabain A, 2003, EMBO REP, V4, P642, DOI 10.1038/sj.embor.embor891; WEBSTER P, 2005, INNOVATIONS PHARM TE; World Intellectual Property Organization, 2008, WORLD PAT REP STAT R; Yiannaka A, 2006, INT J IND ORGAN, V24, P177, DOI 10.1016/j.ijindorg.2005.06.001; 2008, INVESTORS CHRON 0711, P16	16	10	10	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2009	27	7					614	619		10.1038/nbt0709-614	http://dx.doi.org/10.1038/nbt0709-614			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	469OF	19587663				2022-12-25	WOS:000267908500015
J	Jallow, M; Teo, YY; Small, KS; Rockett, KA; Deloukas, P; Clark, TG; Kivinen, K; Bojang, KA; Conway, DJ; Pinder, M; Sirugo, G; Sisay-Joof, F; Usen, S; Auburn, S; Bumpstead, SJ; Campino, S; Coffey, A; Dunham, A; Fry, AE; Green, A; Gwilliam, R; Hunt, SE; Inouye, M; Jeffreys, AE; Mendy, A; Palotie, A; Potter, S; Ragoussis, J; Rogers, J; Rowlands, K; Somaskantharajah, E; Whittaker, P; Widden, C; Donnelly, P; Howie, B; Marchini, J; Morris, A; SanJoaquin, M; Achidi, EA; Agbenyega, T; Allen, A; Amodu, O; Corran, P; Djimde, A; Dolo, A; Doumbo, OK; Drakeley, C; Dunstan, S; Evans, J; Farrar, J; Fernando, D; Hien, TT; Horstmann, RD; Ibrahim, M; Karunaweera, N; Kokwaro, G; Koram, KA; Lemnge, M; Makani, J; Marsh, K; Michon, P; Modiano, D; Molyneux, ME; Mueller, I; Parker, M; Peshu, N; Plowe, CV; Puijalon, O; Reeder, J; Reyburn, H; Riley, EM; Sakuntabhai, A; Singhasivanon, P; Sirima, S; Tall, A; Taylor, TE; Thera, M; Troye-Blomberg, M; Williams, TN; Wilson, M; Kwiatkowski, DP				Jallow, Muminatou; Teo, Yik Ying; Small, Kerrin S.; Rockett, Kirk A.; Deloukas, Panos; Clark, Taane G.; Kivinen, Katja; Bojang, Kalifa A.; Conway, David J.; Pinder, Margaret; Sirugo, Giorgio; Sisay-Joof, Fatou; Usen, Stanley; Auburn, Sarah; Bumpstead, Suzannah J.; Campino, Susana; Coffey, Alison; Dunham, Andrew; Fry, Andrew E.; Green, Angela; Gwilliam, Rhian; Hunt, Sarah E.; Inouye, Michael; Jeffreys, Anna E.; Mendy, Alieu; Palotie, Aarno; Potter, Simon; Ragoussis, Jiannis; Rogers, Jane; Rowlands, Kate; Somaskantharajah, Elilan; Whittaker, Pamela; Widden, Claire; Donnelly, Peter; Howie, Bryan; Marchini, Jonathan; Morris, Andrew; SanJoaquin, Miguel; Achidi, Eric Akum; Agbenyega, Tsiri; Allen, Angela; Amodu, Olukemi; Corran, Patrick; Djimde, Abdoulaye; Dolo, Amagana; Doumbo, Ogobara K.; Drakeley, Chris; Dunstan, Sarah; Evans, Jennifer; Farrar, Jeremy; Fernando, Deepika; Hien, Tran Tinh; Horstmann, Rolf D.; Ibrahim, Muntaser; Karunaweera, Nadira; Kokwaro, Gilbert; Koram, Kwadwo A.; Lemnge, Martha; Makani, Julie; Marsh, Kevin; Michon, Pascal; Modiano, David; Molyneux, Malcolm E.; Mueller, Ivo; Parker, Michael; Peshu, Norbert; Plowe, Christopher V.; Puijalon, Odile; Reeder, John; Reyburn, Hugh; Riley, Eleanor M.; Sakuntabhai, Anavaj; Singhasivanon, Pratap; Sirima, Sodiomon; Tall, Adama; Taylor, Terrie E.; Thera, Mahamadou; Troye-Blomberg, Marita; Williams, Thomas N.; Wilson, Michael; Kwiatkowski, Dominic P.		Wellcome Trust Case Control Consor; Malaria Genomic Epidemiology Netwo	Genome-wide and fine-resolution association analysis of malaria in West Africa	NATURE GENETICS			English	Article							BETA-GLOBIN GENE; LINKAGE DISEQUILIBRIUM; NATURAL-SELECTION; HEMOGLOBIN-C; POPULATION; CHILDREN; POWER; INDICATORS; COVERAGE; ORIGIN	We report a genome-wide association (GWA) study of severe malaria in The Gambia. The initial GWA scan included 2,500 children genotyped on the Affymetrix 500K GeneChip, and a replication study included 3,400 children. We used this to examine the performance of GWA methods in Africa. We found considerable population stratification, and also that signals of association at known malaria resistance loci were greatly attenuated owing to weak linkage disequilibrium (LD). To investigate possible solutions to the problem of low LD, we focused on the HbS locus, sequencing this region of the genome in 62 Gambian individuals and then using these data to conduct multipoint imputation in the GWA samples. This increased the signal of association, from P = 4 x 10(-7) to P = 4 x 10(-14), with the peak of the signal located precisely at the HbS causal variant. Our findings provide proof of principle that fine-resolution multipoint imputation, based on population-specific sequencing data, can substantially boost authentic GWA signals and enable fine mapping of causal variants in African populations.	[Teo, Yik Ying; Small, Kerrin S.; Rockett, Kirk A.; Clark, Taane G.; Auburn, Sarah; Campino, Susana; Fry, Andrew E.; Green, Angela; Jeffreys, Anna E.; Mendy, Alieu; Ragoussis, Jiannis; Rogers, Jane; Rowlands, Kate; Donnelly, Peter; Marchini, Jonathan; Morris, Andrew; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Jallow, Muminatou; Bojang, Kalifa A.; Conway, David J.; Pinder, Margaret; Sirugo, Giorgio; Sisay-Joof, Fatou; Usen, Stanley] MRC Labs, Banjul, Gambia; [Rockett, Kirk A.; Deloukas, Panos; Clark, Taane G.; Kivinen, Katja; Auburn, Sarah; Bumpstead, Suzannah J.; Campino, Susana; Coffey, Alison; Dunham, Andrew; Gwilliam, Rhian; Hunt, Sarah E.; Inouye, Michael; Palotie, Aarno; Potter, Simon; Somaskantharajah, Elilan; Whittaker, Pamela; Widden, Claire; SanJoaquin, Miguel; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Donnelly, Peter; Howie, Bryan; Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [SanJoaquin, Miguel; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Achidi, Eric Akum] Univ Buea, Buea, South West Prov, Cameroon; [Agbenyega, Tsiri; Evans, Jennifer] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Allen, Angela; Michon, Pascal; Mueller, Ivo; Reeder, John] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Allen, Angela] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Amodu, Olukemi] Univ Ibadan, Coll Med, Inst Child Hlth, Ibadan, Nigeria; [Corran, Patrick] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Djimde, Abdoulaye; Dolo, Amagana; Doumbo, Ogobara K.; Thera, Mahamadou] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Drakeley, Chris; Reyburn, Hugh; Riley, Eleanor M.] London Sch Hyg & Trop Med, London WC1, England; [Drakeley, Chris; Reyburn, Hugh; Riley, Eleanor M.] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Dunstan, Sarah; Farrar, Jeremy; Hien, Tran Tinh] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Evans, Jennifer; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany; [Fernando, Deepika; Karunaweera, Nadira] Univ Colombo, Fac Med, Colombo, Sri Lanka; [Ibrahim, Muntaser] Univ Khartoum, Inst Endem Dis, Khartoum, Sudan; [Kokwaro, Gilbert; Marsh, Kevin; Peshu, Norbert; Williams, Thomas N.] Kenyan Med Res Inst KEMRI, Wellcome Trust Programme, Kilifi, Kenya; [Koram, Kwadwo A.; Wilson, Michael] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Lemnge, Martha] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Makani, Julie] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Modiano, David] Univ Roma La Sapienza, Rome, Italy; [Parker, Michael] Univ Oxford, Dept Publ Hlth & Primary Hlth Care, Ethox Ctr, Oxford, England; [Plowe, Christopher V.; Taylor, Terrie E.] Blantyre Malaria Project, Blantyre 3, Malawi; [Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Puijalon, Odile; Sakuntabhai, Anavaj] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Sirima, Sodiomon] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Tall, Adama] Inst Pasteur, Dakar, Senegal; [Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; [Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden	University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; University of Oxford; University of Malawi; Kwame Nkrumah University Science & Technology; PNG Institute Of Medical Research; University of Oxford; University of Ibadan; National Institute for Biological Standards & Control; University of Bamako; University of London; London School of Hygiene & Tropical Medicine; Kilimanjaro Christian Medical Centre; University of Oxford; Bernhard Nocht Institut fur Tropenmedizin; University of Colombo; University of Khartoum; Kenya Medical Research Institute; University of Ghana; National Institute of Medical Research; Muhimbili University of Health & Allied Sciences; Sapienza University Rome; University of Oxford; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Michigan State University; Michigan State University College of Osteopathic Medicine; Stockholm University	Kwiatkowski, DP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	dominic@sanger.ac.uk	Marchini, Jonathan/ABE-9024-2020; Clark, Taane G./AAM-2570-2020; Mueller, Ivo/C-7251-2013; Sirugo, Giorgio/N-9056-2019; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Makani, Julie/E-8525-2017; Dominiczak, Anna F/P-9390-2017; Makani, Julie/N-9370-2013; Riley, Eleanor/AAL-1382-2020; Troye-Blomberg, Marita/B-9210-2016; Campino, Susana/AAM-2577-2020; Farrar, Jeremy J./HGA-7610-2022; Fry, Andrew/AAN-2730-2020; eyre, stephen/K-3776-2017; Dunstan, Sarah/AAO-9597-2020; mangano, valentina/I-2456-2012; Mead, Daniel/AAE-6629-2019; Fry, Andrew/AFK-7448-2022; Sirugo, Giorgio/L-1628-2016; Breen, Gerome D/A-5540-2010; Deloukas, Panos/B-2922-2013; Riley, Eleanor M/C-8960-2013; Ragoussis, Ioannis/AAD-9790-2022; Breen, Gerome/Y-2706-2019; Auburn, Sarah/N-2266-2013	Marchini, Jonathan/0000-0003-0610-8322; Clark, Taane G./0000-0001-8985-9265; Mueller, Ivo/0000-0001-6554-6889; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Makani, Julie/0000-0002-4801-6250; Dominiczak, Anna F/0000-0003-4913-3608; Makani, Julie/0000-0002-4801-6250; Riley, Eleanor/0000-0003-3447-3570; Troye-Blomberg, Marita/0000-0002-2804-0325; Campino, Susana/0000-0003-1403-6138; Fry, Andrew/0000-0001-9778-6924; eyre, stephen/0000-0002-1251-6974; Mead, Daniel/0000-0001-7717-4330; Fry, Andrew/0000-0001-9778-6924; Breen, Gerome D/0000-0003-2053-1792; Deloukas, Panos/0000-0001-9251-070X; Riley, Eleanor M/0000-0003-3447-3570; Breen, Gerome/0000-0003-2053-1792; Auburn, Sarah/0000-0002-4638-536X; Walton, Robert/0000-0001-7700-1907; Hart, Lee/0000-0002-6473-0964; Karunaweera, Nadira/0000-0003-3985-1817; Hunt, Sarah/0000-0002-8350-1235; Kivinen, Katja/0000-0002-1135-7625; Inouye, Michael/0000-0001-9413-6520; Apinjoh, Tobias/0000-0001-9889-7271; Kwiatkowski, Dominic/0000-0002-5023-0176; Donnelly, Peter/0000-0001-9495-3408; Bojang, Kalifa/0000-0001-7506-0938; Mangano, Valentina D/0000-0002-2021-6162; Munroe, Patricia/0000-0002-4176-2947; Weedon, Michael/0000-0002-6174-6135; Ragoussis, Ioannis/0000-0002-8515-0934; Farrar, Jeremy/0000-0002-2700-623X; Small, Kerrin/0000-0003-4566-0005; Oluoch, Tom/0000-0001-9621-5900; Ishengoma, Deus/0000-0003-2040-3416; Maslen, Gareth/0000-0001-7318-3678; Reeder, John/0000-0003-1395-1289; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Lees, Charlie/0000-0002-0732-8215; Manske, Magnus/0000-0001-5916-0947; Singhasivanon, Pratap/0000-0002-9759-1702; Palotie, Aarno/0000-0002-2527-5874; Conway, David/0000-0002-8711-3037; Amodu, Olukemi/0000-0003-1477-4229; Dunger, Professor David/0000-0002-2566-9304; Hattersley, Andrew/0000-0001-5620-473X; Newport, Melanie/0000-0002-8946-7525; Thera, Mahamadou A/0000-0002-2679-035X; Dunstan, Sarah/0000-0001-7873-933X; Moyes, Catherine/0000-0002-8028-4079; Lango Allen, Hana/0000-0002-7803-8688; Zeggini, Eleftheria/0000-0003-4238-659X	Wellcome Trust [077383/Z/05/Z]; Bill & Melinda Gates Foundation; Foundation for the National Institutes of Health [566]; Medical Research Council [G0600230]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065683] Funding Source: NIH RePORTER; MRC [G0800759, G19/9, G0800675, MC_U190081993, G9828345, MC_U190081977, G0600718, G0600230, G0600329] Funding Source: UKRI; Medical Research Council [MC_U190081977, G0800675, G0600718, G9828345, G0800759, G19/9, G0600329, MC_U190081993] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	We thank the Gambian children and their parents and guardians who made this study possible; and the doctors, nurses and fieldworkers at the Royal Victoria Hospital, Banjul and other health clinics who assisted with this work. MalariaGEN's primary funding is from the Wellcome Trust (grant number 077383/Z/05/Z) and from the Bill & Melinda Gates Foundation, through the Foundation for the National Institutes of Health (grant number 566) as part of the Grand Challenges in Global Health initiative. The Wellcome Trust (Sanger Institute core funding) and the Medical Research Council (grant number G0600230) provide additional support for genotyping, bioinformatics and analysis. The MalariaGEN Resource Centre is part of the European Union Network of Excellence on the Biology and Pathology of Malaria Parasites.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Hanchard N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-52; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Modiano D, 2008, HUM MOL GENET, V17, P789, DOI 10.1093/hmg/ddm350; MOLYNEUX ME, 1989, Q J MED, V71, P441; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Romans P, 1999, AM J TROP MED HYG, V60, P22, DOI 10.4269/ajtmh.1999.60.22; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313	38	275	277	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					657	665		10.1038/ng.388	http://dx.doi.org/10.1038/ng.388			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19465909	Green Accepted, Green Published			2022-12-25	WOS:000266411700014
J	Schinke, T; Schilling, AF; Baranowsky, A; Seitz, S; Marshall, RP; Linn, T; Blaeker, M; Huebner, AK; Schulz, A; Simon, R; Gebauer, M; Priemel, M; Kornak, U; Perkovic, S; Barvencik, F; Beil, FT; Del Fattore, A; Frattini, A; Streichert, T; Pueschel, K; Villa, A; Debatin, KM; Rueger, JM; Teti, A; Zustin, J; Sauter, G; Amling, M				Schinke, Thorsten; Schilling, Arndt F.; Baranowsky, Anke; Seitz, Sebastian; Marshall, Robert P.; Linn, Tilman; Blaeker, Michael; Huebner, Antje K.; Schulz, Ansgar; Simon, Ronald; Gebauer, Matthias; Priemel, Matthias; Kornak, Uwe; Perkovic, Sandra; Barvencik, Florian; Beil, F. Timo; Del Fattore, Andrea; Frattini, Annalisa; Streichert, Thomas; Pueschel, Klaus; Villa, Anna; Debatin, Klaus-Michael; Rueger, Johannes M.; Teti, Anna; Zustin, Jozef; Sauter, Guido; Amling, Michael			Impaired gastric acidification negatively affects calcium homeostasis and bone mass	NATURE MEDICINE			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; VACUOLAR PROTON PUMP; TARGETED DISRUPTION; MICE; SUBUNIT; MUTATIONS; DISEASE; LEADS; DEFICIENCY; ABSORPTION	Activation of osteoclasts and their acidification-dependent resorption of bone is thought to maintain proper serum calcium levels. Here we show that osteoclast dysfunction alone does not generally affect calcium homeostasis. Indeed, mice deficient in Src, encoding a tyrosine kinase critical for osteoclast activity, show signs of osteopetrosis, but without hypocalcemia or defects in bone mineralization. Mice deficient in Cckbr, encoding a gastrin receptor that affects acid secretion by parietal cells, have the expected defects in gastric acidification but also secondary hyperparathyroidism and osteoporosis and modest hypocalcemia. These results suggest that alterations in calcium homeostasis can be driven by defects in gastric acidification, especially given that calcium gluconate supplementation fully rescues the phenotype of the Cckbr-mutant mice. Finally, mice deficient in Tcirg1, encoding a subunit of the vacuolar proton pump specifically expressed in both osteoclasts and parietal cells, show hypocalcemia and osteopetrorickets. Although neither Src- nor Cckbr-deficient mice have this latter phenotype, the combined deficiency of both genes results in osteopetrorickets. Thus, we find that osteopetrosis and osteopetrorickets are distinct phenotypes, depending on the site or sites of defective acidification.	[Schinke, Thorsten; Schilling, Arndt F.; Baranowsky, Anke; Seitz, Sebastian; Marshall, Robert P.; Linn, Tilman; Huebner, Antje K.; Gebauer, Matthias; Priemel, Matthias; Perkovic, Sandra; Barvencik, Florian; Beil, F. Timo; Rueger, Johannes M.; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Ctr Biomech & Skeletal Biol, Hamburg, Germany; [Blaeker, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany; [Schulz, Ansgar; Debatin, Klaus-Michael] Univ Med Ctr Ulm, Dept Pediat, Ulm, Germany; [Simon, Ronald; Zustin, Jozef; Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Kornak, Uwe] Charite Univ Med Ctr, Inst Med Genet, Berlin, Germany; [Del Fattore, Andrea; Teti, Anna] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Frattini, Annalisa; Villa, Anna] CNR, Italian Natl Res Council, Ist Tecnol Biomed, Human Genome Dept, Segrate, Italy; [Frattini, Annalisa; Villa, Anna] IRCCS, Ist Clin Humanitas, Rozzano, Italy; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendrof, Inst Clin Chem, Hamburg, Germany; [Pueschel, Klaus] Univ Med Ctr Hamburg Eppendrof, Inst Forens Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); IRCCS Humanitas Research Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Amling, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Ctr Biomech & Skeletal Biol, Hamburg, Germany.	amling@uke.uni-hamburg.de	Del Fattore, Andrea/H-4409-2015; Debatin, Klaus-Michael/J-9704-2014; Del Fattore, Andrea/AAP-2045-2020; Frattini, Annalisa/B-7684-2015; Marshall, Robert Percy/AAD-5269-2022	Del Fattore, Andrea/0000-0003-3848-412X; Debatin, Klaus-Michael/0000-0002-8397-1886; Del Fattore, Andrea/0000-0003-3848-412X; Frattini, Annalisa/0000-0002-1166-3091; Marshall, Robert Percy/0000-0003-4247-1006; Simon, Ronald/0000-0003-0158-4258; Teti, Anna Maria/0000-0002-5887-4419; Villa, Anna/0000-0003-4428-9013	Deutsche Forschungsgemeinschaft [AM103/14-1, BL423/4-3]; Deutsches Zentrum fur Luft- und Raumfahrt; Telethon [GGP06119]; NOBEL	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)); Telethon(Fondazione Telethon); NOBEL	This work was supported by grants from the Deutsche Forschungsgemeinschaft to M. A. (AM103/14-1) and M. B. (BL423/4-3), from the Deutsches Zentrum fur Luft- und Raumfahrt within the framework of the E-Rare JTC 2007 to M. A., A. S., U. K., A. T. and A. V., from Telethon to A. T. (GGP06119) and by the NOBEL program from Fondazione Cariplo to A. V.	Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; Aoki K, 2005, ANN EPIDEMIOL, V15, P598, DOI 10.1016/j.annepidem.2004.11.002; BANCO R, 1985, CLIN ORTHOP RELAT R, P238; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Del Fattore A, 2006, J MED GENET, V43, P315, DOI 10.1136/jmg.2005.036673; Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029; Driessen GJA, 2003, BONE MARROW TRANSPL, V32, P657, DOI 10.1038/sj.bmt.1704194; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hoff AO, 2002, J CLIN INVEST, V110, P1849, DOI 10.1172/JCI200214218; Huebner AK, 2006, J BONE MINER RES, V21, P1924, DOI 10.1359/JBMR.060820; Jacobson BC, 2003, AM J GASTROENTEROL, V98, P51, DOI 10.1111/j.1572-0241.2003.07186.x; KAPLAN FS, 1993, CLIN ORTHOP RELAT R, P64; Karaplis A C, 2000, Rev Endocr Metab Disord, V1, P331, DOI 10.1023/A:1026526703898; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KASSARJIAN Z, 1989, ANNU REV NUTR, V9, P271, DOI 10.1146/annurev.nu.09.070189.001415; Kirubakaran C, 2004, J TROP PEDIATRICS, V50, P185, DOI 10.1093/tropej/50.3.185; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Langhans N, 1997, GASTROENTEROLOGY, V112, P280, DOI 10.1016/S0016-5085(97)90000-7; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; MARKS SC, 1985, J HERED, V76, P171, DOI 10.1093/oxfordjournals.jhered.a110059; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; O'Connell MB, 2005, AM J MED, V118, P778, DOI 10.1016/j.amjmed.2005.02.007; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; RECKER RR, 1985, NEW ENGL J MED, V313, P70, DOI 10.1056/NEJM198507113130202; Schmidt K, 2005, J CELL BIOL, V168, P899, DOI 10.1083/jcb.200408013; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Seitz S, 2009, J BONE MINER RES, V24, P62, DOI 10.1359/JBMR.080907; Simon R, 2004, BIOTECHNIQUES, V36, P98, DOI 10.2144/04361RV01; SLY WS, 1985, NEW ENGL J MED, V313, P139, DOI 10.1056/NEJM198507183130302; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Straub DA, 2007, NUTR CLIN PRACT, V22, P286, DOI 10.1177/0115426507022003286; TAKAGI H, 1992, J CLIN INVEST, V90, P1161, DOI 10.1172/JCI115936; Taranta A, 2003, AM J PATHOL, V162, P57, DOI 10.1016/S0002-9440(10)63798-4; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Wilson CJ, 2000, ARCH DIS CHILD, V83, P449, DOI 10.1136/adc.83.5.449; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947	45	140	144	1	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2009	15	6					674	U111		10.1038/nm.1963	http://dx.doi.org/10.1038/nm.1963			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	455BS	19448635				2022-12-25	WOS:000266731600027
J	Huang, SW; Li, RQ; Zhang, ZH; Li, L; Gu, XF; Fan, W; Lucas, WJ; Wang, XW; Xie, BY; Ni, PX; Ren, YY; Zhu, HM; Li, J; Lin, K; Jin, WW; Fei, ZJ; Li, GC; Staub, J; Kilian, A; van der Vossen, EAG; Wu, Y; Guo, J; He, J; Jia, ZQ; Ren, Y; Tian, G; Lu, Y; Ruan, J; Qian, WB; Wang, MW; Huang, QF; Li, B; Xuan, ZL; Cao, JJ; Asan; Wu, ZG; Zhang, JB; Cai, QL; Bai, YQ; Zhao, BW; Han, YH; Li, Y; Li, XF; Wang, SH; Shi, QX; Liu, SQ; Cho, WK; Kim, JY; Xu, Y; Heller-Uszynska, K; Miao, H; Cheng, ZC; Zhang, SP; Wu, J; Yang, YH; Kang, HX; Li, M; Liang, HQ; Ren, XL; Shi, ZB; Wen, M; Jian, M; Yang, HL; Zhang, GJ; Yang, ZT; Chen, R; Liu, SF; Li, JW; Ma, LJ; Liu, H; Zhou, Y; Zhao, J; Fang, XD; Li, GQ; Fang, L; Li, YR; Liu, DY; Zheng, HK; Zhang, Y; Qin, N; Li, Z; Yang, GH; Yang, S; Bolund, L; Kristiansen, K; Zheng, HC; Li, SC; Zhang, XQ; Yang, HM; Wang, J; Sun, RF; Zhang, BX; Jiang, SZ; Wang, J; Du, YC; Li, SG				Huang, Sanwen; Li, Ruiqiang; Zhang, Zhonghua; Li, Li; Gu, Xingfang; Fan, Wei; Lucas, William J.; Wang, Xiaowu; Xie, Bingyan; Ni, Peixiang; Ren, Yuanyuan; Zhu, Hongmei; Li, Jun; Lin, Kui; Jin, Weiwei; Fei, Zhangjun; Li, Guangcun; Staub, Jack; Kilian, Andrzej; van der Vossen, Edwin A. G.; Wu, Yang; Guo, Jie; He, Jun; Jia, Zhiqi; Ren, Yi; Tian, Geng; Lu, Yao; Ruan, Jue; Qian, Wubin; Wang, Mingwei; Huang, Quanfei; Li, Bo; Xuan, Zhaoling; Cao, Jianjun; Asan; Wu, Zhigang; Zhang, Juanbin; Cai, Qingle; Bai, Yinqi; Zhao, Bowen; Han, Yonghua; Li, Ying; Li, Xuefeng; Wang, Shenhao; Shi, Qiuxiang; Liu, Shiqiang; Cho, Won Kyong; Kim, Jae-Yean; Xu, Yong; Heller-Uszynska, Katarzyna; Miao, Han; Cheng, Zhouchao; Zhang, Shengping; Wu, Jian; Yang, Yuhong; Kang, Houxiang; Li, Man; Liang, Huiqing; Ren, Xiaoli; Shi, Zhongbin; Wen, Ming; Jian, Min; Yang, Hailong; Zhang, Guojie; Yang, Zhentao; Chen, Rui; Liu, Shifang; Li, Jianwen; Ma, Lijia; Liu, Hui; Zhou, Yan; Zhao, Jing; Fang, Xiaodong; Li, Guoqing; Fang, Lin; Li, Yingrui; Liu, Dongyuan; Zheng, Hongkun; Zhang, Yong; Qin, Nan; Li, Zhuo; Yang, Guohua; Yang, Shuang; Bolund, Lars; Kristiansen, Karsten; Zheng, Hancheng; Li, Shaochuan; Zhang, Xiuqing; Yang, Huanming; Wang, Jian; Sun, Rifei; Zhang, Baoxi; Jiang, Shuzhi; Wang, Jun; Du, Yongchen; Li, Songgang			The genome of the cucumber, Cucumis sativus L.	NATURE GENETICS			English	Article							RICE GENOME; ETHYLENE BIOSYNTHESIS; ARABIDOPSIS-THALIANA; GENE; SEQUENCE; RESISTANCE; PLANTS; PHLOEM; EXPRESSION; DIVERSITY	Cucumber is an economically important crop as well as a model system for sex determination studies and plant vascular biology. Here we report the draft genome sequence of Cucumis sativus var. sativus L., assembled using a novel combination of traditional Sanger and next-generation Illumina GA sequencing technologies to obtain 72.2-fold genome coverage. The absence of recent whole-genome duplication, along with the presence of few tandem duplications, explains the small number of genes in the cucumber. Our study establishes that five of the cucumber's seven chromosomes arose from fusions of ten ancestral chromosomes after divergence from Cucumis melo. The sequenced cucumber genome affords insight into traits such as its sex expression, disease resistance, biosynthesis of cucurbitacin and 'fresh green' odor. We also identify 686 gene clusters related to phloem function. The cucumber genome provides a valuable resource for developing elite cultivars and for studying the evolution and function of the plant vascular system.	[Huang, Sanwen; Zhang, Zhonghua; Gu, Xingfang; Wang, Xiaowu; Xie, Bingyan; He, Jun; Jia, Zhiqi; Ren, Yi; Li, Ying; Li, Xuefeng; Wang, Shenhao; Shi, Qiuxiang; Liu, Shiqiang; Miao, Han; Cheng, Zhouchao; Zhang, Shengping; Wu, Jian; Yang, Yuhong; Kang, Houxiang; Li, Man; Sun, Rifei; Zhang, Baoxi; Jiang, Shuzhi; Du, Yongchen] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Sino Dutch Joint Lab Hort Genom Technol, Minist Agr,Key Lab Hort Crops Genet Improvement, Beijing, Peoples R China; [Li, Ruiqiang; Li, Li; Fan, Wei; Ni, Peixiang; Ren, Yuanyuan; Zhu, Hongmei; Li, Jun; Tian, Geng; Lu, Yao; Ruan, Jue; Qian, Wubin; Wang, Mingwei; Huang, Quanfei; Li, Bo; Xuan, Zhaoling; Cao, Jianjun; Asan; Wu, Zhigang; Zhang, Juanbin; Cai, Qingle; Bai, Yinqi; Liang, Huiqing; Ren, Xiaoli; Shi, Zhongbin; Wen, Ming; Jian, Min; Yang, Hailong; Zhang, Guojie; Yang, Zhentao; Chen, Rui; Liu, Shifang; Li, Jianwen; Ma, Lijia; Liu, Hui; Zhou, Yan; Zhao, Jing; Fang, Xiaodong; Li, Guoqing; Fang, Lin; Li, Yingrui; Liu, Dongyuan; Zheng, Hongkun; Zhang, Yong; Qin, Nan; Li, Zhuo; Yang, Guohua; Yang, Shuang; Bolund, Lars; Zheng, Hancheng; Li, Shaochuan; Zhang, Xiuqing; Yang, Huanming; Wang, Jian; Wang, Jun; Li, Songgang] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Ruiqiang; Zheng, Hongkun] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Lucas, William J.] Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA; [Lin, Kui; Wu, Yang; Guo, Jie] Beijing Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Jin, Weiwei; Han, Yonghua] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Genet Improvement & Genome, Natl Maize Improvement Ctr China,Minist Agr, Beijing 100094, Peoples R China; [Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Fei, Zhangjun] Cornell Univ, USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA; [Li, Guangcun] Shandong Acad Agr Sci, High Tech Res Ctr, Jinan, Peoples R China; [Staub, Jack] Univ Wisconsin, Dept Hort, USDA ARS, Vegetable Crops Res Unit, Madison, WI 53706 USA; [Kilian, Andrzej; Heller-Uszynska, Katarzyna] Divers Arrays Technol, Canberra, ACT, Australia; [van der Vossen, Edwin A. G.] Wageningen UR Plant Breeding, Wageningen, Netherlands; [Ruan, Jue; Zhang, Guojie; Ma, Lijia; Li, Yingrui] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhao, Bowen] Renmin Univ China, High Sch, Beijing, Peoples R China; [Cho, Won Kyong; Kim, Jae-Yean] Gyeongsang Natl Univ, Div Appl Life Sci, BK21 & WCU Program, PMBBRC, Jinju, South Korea; [Cho, Won Kyong; Kim, Jae-Yean] Gyeongsang Natl Univ, EB NCRC, Jinju, South Korea; [Xu, Yong] Natl Engn Res Ctr Vegetables, Beijing, Peoples R China; [Bolund, Lars] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Zheng, Hancheng; Li, Shaochuan] S China Univ Technol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); University of Southern Denmark; University of California System; University of California Davis; Beijing Normal University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; United States Department of Agriculture (USDA); Shandong Academy of Agricultural Sciences; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Wageningen University & Research; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Renmin University of China; Gyeongsang National University; Gyeongsang National University; Beijing Academy of Agriculture & Forestry; Aarhus University; University of Copenhagen; South China University of Technology	Du, YC (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Sino Dutch Joint Lab Hort Genom Technol, Minist Agr,Key Lab Hort Crops Genet Improvement, Beijing, Peoples R China.	huangsanwen@caas.net.cn; wangj@genomics.org.cn; yongchen.du@mail.caas.net.cn; lisg@genomics.org.cn	Kristiansen, Karsten/J-5148-2014; Wang, Jun/A-7261-2013; Fang, Xiaodong/K-6743-2018; Lin, Kui/P-4492-2015; Fei, Zhangjun/H-5152-2012; Zhang, Guojie/J-7273-2019; Zhang, Guojie/B-6188-2014; yang, hailong/GXH-9625-2022; He, Jun/ABC-9997-2021; Li, Yingrui/K-1064-2015; Huang, Sanwen/ABE-9053-2020; Cho, Won Kyong/I-5098-2012; Wang, Xiaowu/L-2579-2019; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Kristiansen, Karsten/0000-0002-6024-0917; Fang, Xiaodong/0000-0001-7061-3337; Lin, Kui/0000-0002-5993-1972; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; He, Jun/0000-0003-3733-0241; Huang, Sanwen/0000-0002-8547-5309; Cho, Won Kyong/0000-0002-8416-5173; Wang, Jun/0000-0002-8540-8931; Fan, Wei/0000-0001-5036-8733; Wang, Jun/0000-0002-2113-5874; Kilian, Andrzej/0000-0002-2730-7462; zhang, zhonghua/0000-0002-1034-227X; Li, Jun/0000-0001-7218-429X; Ruan, Jue/0000-0003-3713-3192	Chinese Ministry of Agriculture (948 program); Ministry of Science and Technology [2006DFA32140, 2007CB815701, 2007CB815703, 2007CB815705]; Ministry of Finance [1251610601001]; National Natural Science Foundation of China [30871707, 30725008]; Chinese Academy of Agricultural Sciences; Chinese Academy of Science [GJHZ0701-6, KSCX2-YWN-023]; US Department of Agriculture; National Research Initiative [2006-35304-17346]; National Science Foundation [IOS-07-15513]; Korea Science and Engineering Foundation-Ministry of Education, Science and Technology [WCU R33-10002, BK21]; Environmental Biotechnology National Core Research Center [R15-2003-012-01003-0]; National Research Laboratory [2009-0066339]; Shenzhen Municipal and Yantian District Governments; Society of Entrepreneurs Ecology	Chinese Ministry of Agriculture (948 program)(Ministry of Agriculture & Rural Affairs); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Finance; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Agricultural Sciences; Chinese Academy of Science(Chinese Academy of Sciences); US Department of Agriculture(United States Department of Agriculture (USDA)); National Research Initiative(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Korea Science and Engineering Foundation-Ministry of Education, Science and Technology; Environmental Biotechnology National Core Research Center(Korea Science and Engineering Foundation); National Research Laboratory(Korea Science and Engineering Foundation); Shenzhen Municipal and Yantian District Governments; Society of Entrepreneurs Ecology	We thank L. Goodman for assistance in editing the manuscript and R. Quatrano, L. Kochian, L. Comai, V. Sundaresan, S. Kamoun and S. Renner for critical readings of the manuscript. This work was funded by the Chinese Ministry of Agriculture (948 program), Ministry of Science and Technology (2006DFA32140, 2007CB815701, 2007CB815703 and 2007CB815705) and Ministry of Finance (1251610601001); the National Natural Science Foundation of China (30871707 and 30725008); the Chinese Academy of Agricultural Sciences (seed grant to S. H.); the Chinese Academy of Science (GJHZ0701-6 and KSCX2-YWN-023); the US Department of Agriculture (National Research Initiative grant 2006-35304-17346 to W. J. L.); the National Science Foundation (grant IOS-07-15513 to W. J. L.); and the Korea Science and Engineering Foundation-Ministry of Education, Science and Technology (WCU R33-10002 and BK21 grants to J.-Y.K.). WKC was partly supported by grants from the Environmental Biotechnology National Core Research Center (R15-2003-012-01003-0) and National Research Laboratory (2009-0066339). This work was also supported by the Shenzhen Municipal and Yantian District Governments and the Society of Entrepreneurs & Ecology. D. Qu and Z. Fang of the Chinese Academy of Agricultural Sciences provided management support for this work.	Aki T, 2008, PLANT CELL PHYSIOL, V49, P767, DOI 10.1093/pcp/pcn049; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Balkema-Boomstra AG, 2003, J CHEM ECOL, V29, P225, DOI 10.1023/A:1021945101308; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Buescher RH, 2001, J FOOD SCI, V66, P357, DOI 10.1111/j.1365-2621.2001.tb11346.x; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Cho MJ, 2004, J FOOD PROTECT, V67, P1014, DOI 10.4315/0362-028X-67.5.1014; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; DACOSTA CP, 1971, SCIENCE, V172, P1145, DOI 10.1126/science.172.3988.1145; Darwin C., 1875, MOVEMENTS HABITS CLI; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; Dinant S, 2003, PLANT PHYSIOL, V131, P114, DOI 10.1104/pp.013086; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fernandez-Silva I, 2008, THEOR APPL GENET, V118, P139, DOI 10.1007/s00122-008-0883-3; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; GALUN E, 1959, CELL MOL LIFE SCI, V15, P184; Giavalisco P, 2006, PROTEOMICS, V6, P896, DOI 10.1002/pmic.200500155; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim SJ, 2007, PHYTOCHEMISTRY, V68, P1957, DOI 10.1016/j.phytochem.2007.02.032; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lange T, 1997, P NATL ACAD SCI USA, V94, P6553, DOI 10.1073/pnas.94.12.6553; Li H, 2005, J COMPUT SCI TECH-CH, V20, P446, DOI 10.1007/s11390-005-0446-x; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li RQ, 2005, PLOS COMPUT BIOL, V1, P313, DOI 10.1371/journal.pcbi.0010043; Li Z, 2009, GENETICS, V182, P1381, DOI 10.1534/genetics.109.104737; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Lin MK, 2009, MOL CELL PROTEOMICS, V8, P343, DOI 10.1074/mcp.M800420-MCP200; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Matsui K, 2000, FEBS LETT, V481, P183, DOI 10.1016/S0014-5793(00)01997-9; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Nieto C, 2006, PLANT J, V48, P452, DOI 10.1111/j.1365-313X.2006.02885.x; Pelissier HC, 2008, PLANT CELL PHYSIOL, V49, P1699, DOI 10.1093/pcp/pcn141; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; Pirrung MC, 1999, ACCOUNTS CHEM RES, V32, P711, DOI 10.1021/ar960003+; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; RUDICH J, 1972, PLANT PHYSIOL, V49, P998, DOI 10.1104/pp.49.6.998; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schaefer H, 2009, P ROY SOC B-BIOL SCI, V276, P843, DOI 10.1098/rspb.2008.1447; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Shibuya M, 2004, TETRAHEDRON, V60, P6995, DOI 10.1016/j.tet.2004.04.088; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Staub JE, 1999, GENET RESOUR CROP EV, V46, P297, DOI 10.1023/A:1008663225896; STEPANOVA AN, 2005, SCI STKE, pCM3; TAKAHASHI H, 1984, PHYTON-INT J EXP BOT, V44, P81; Taler D, 2004, PLANT CELL, V16, P172, DOI 10.1105/tpc.016352; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; WAI T, 1995, THEOR APPL GENET, V91, P699, DOI 10.1007/BF00223299; Wang J, 2002, GENOME RES, V12, P824, DOI 10.1101/gr.165102; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yamagami T, 2003, J BIOL CHEM, V278, P49102, DOI 10.1074/jbc.M308297200; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	78	1013	1180	19	381	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1275	U29		10.1038/ng.475	http://dx.doi.org/10.1038/ng.475			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19881527	Bronze			2022-12-25	WOS:000272144900007
J	Patwardhan, RP; Lee, C; Litvin, O; Young, DL; Pe'er, D; Shendure, J				Patwardhan, Rupali P.; Lee, Choli; Litvin, Oren; Young, David L.; Pe'er, Dana; Shendure, Jay			High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; PROMOTER	We present a method that harnesses massively parallel DNA synthesis and sequencing for the high-throughput functional analysis of regulatory sequences at single-nucleotide resolution. As a proof of concept, we quantitatively assayed the effects of all possible single-nucleotide mutations for three bacteriophage promoters and three mammalian core promoters in a single experiment per promoter. The method may also serve as a rapid screening tool for regulatory element engineering in synthetic biology.	[Patwardhan, Rupali P.; Lee, Choli; Young, David L.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Litvin, Oren; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Litvin, Oren; Pe'er, Dana] Columbia Univ, Inst Computat Biol & Bioinformat, New York, NY USA	University of Washington; University of Washington Seattle; Columbia University; Columbia University	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	rpatward@u.washington.edu; shendure@u.washington.edu	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865; Pe'er, Dana/0000-0002-9259-8817	Burroughs Wellcome Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to thank M. G. Surette (Univ. of Calgary) for the generous gift of the pCS26 plasmid used for the luciferase assays; E. LeProust and W. Woo (Agilent Technologies) for array- derived oligonucleotides libraries and E. Turner, J. B. Hiatt, S. Ng, J. Kitzman, R. Monnat, B. Stone, A. Dudley and N. Goddard for helpful discussions. D. P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Baliga Nitin S., 2001, Biological Procedures Online, V3, P64, DOI 10.1251/bpo24; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Jin VX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-114; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kinkhabwala A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002030; Leach KM, 2003, NUCLEIC ACIDS RES, V31, P1292, DOI 10.1093/nar/gkg209; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Shin I, 2000, P NATL ACAD SCI USA, V97, P3890, DOI 10.1073/pnas.97.8.3890; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859	16	207	217	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1173	1175		10.1038/nbt.1589	http://dx.doi.org/10.1038/nbt.1589			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	19915551	Green Accepted			2022-12-25	WOS:000272708300034
J	Finetti, F; Paccani, SR; Riparbelli, MG; Giacomello, E; Perinetti, G; Pazour, GJ; Rosenbaum, JL; Baldari, CT				Finetti, Francesca; Paccani, Silvia Rossi; Riparbelli, Maria Giovanna; Giacomello, Emiliana; Perinetti, Giuseppe; Pazour, Gregory J.; Rosenbaum, Joel L.; Baldari, Cosima T.			Intraflagellar transport is required for polarized recycling of the TCR/CD3 complex to the immune synapse	NATURE CELL BIOLOGY			English	Article							T-CELL-ACTIVATION; ANTIGEN; RECEPTOR; CILIUM; TCR; INTERNALIZATION; MECHANISMS; PROTEIN; IFT20	Most eukaryotic cells have a primary cilium which functions as a sensory organelle(1). Cilia are assembled by intraflagellar transport (IFT), a process mediated by multimeric IFT particles and molecular motors(2). Here we show that lymphoid and myeloid cells, which lack primary cilia, express IFT proteins. IFT20, an IFT component essential for ciliary assembly(3,4), was found to colocalize with both the microtubule organizing centre (MTOC) and Golgi and post-Golgi compartments in T-lymphocytes. In antigen-specific conjugates, IFT20 translocated to the immune synapse. IFT20 knockdown resulted in impaired T-cell receptor/CD3 (TCR/CD3) clustering and signalling at the immune synapse, due to defective polarized recycling. Moreover, IFT20 was required for the inducible assembly of a complex with other IFT components (IFT57 and IFT88) and the TCR. The results identify IFT20 as a new regulator of immune synapse assembly in T cells and provide the first evidence to implicate IFT in membrane trafficking in cells lacking primary cilia, thereby introducing a new perspective on IFT function beyond its role in ciliogenesis.	[Finetti, Francesca; Paccani, Silvia Rossi; Riparbelli, Maria Giovanna; Baldari, Cosima T.] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; [Perinetti, Giuseppe] Univ Trieste, Dept Biomed, I-34138 Trieste, Italy; [Pazour, Gregory J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Rosenbaum, Joel L.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	University of Siena; University of Trieste; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Baldari, CT (corresponding author), Univ Siena, Dept Evolutionary Biol, Via Aldo Moro 2, I-53100 Siena, Italy.	baldari@unisi.it	Finetti, Francesca/T-3788-2019; Giacomello, Emiliana/E-3080-2018	Finetti, Francesca/0000-0002-3421-1637; Pazour, Gregory/0000-0002-6285-8796; Giacomello, Emiliana/0000-0003-3329-6269; Perinetti, Giuseppe/0000-0002-7226-5134; Baldari, Cosima/0000-0002-4414-6744	AIRC; National Institutes of Health [GM060992, GM-14,642]; FIRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM014642, R01GM060992] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors want to thank G. Callaini for invaluable help with fluorescence microscopy, S. Grassini for technical assistance, A. Alcover, S. Valitutti, P. Lupetti, A. Luini, A. Colanzi, A. De Matteis and C. Mencarelli for useful discussions and J. L Telford and A. Alcover for critical reading of the manuscript. This work was supported by grants from AIRC (to C. T. B.) and the National Institutes of Health (GM060992 to G. J. P. and GM-14,642 to J. L. R.). F. F. is the recipient of a FIRC fellowship.	Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Cemerski S, 2006, CURR OPIN IMMUNOL, V18, P298, DOI 10.1016/j.coi.2006.03.011; D'Oro U, 2002, J IMMUNOL, V169, P6269, DOI 10.4049/jimmunol.169.11.6269; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Dustin ML, 2006, CURR OPIN IMMUNOL, V18, P512, DOI 10.1016/j.coi.2006.05.017; Esquerre M, 2008, P NATL ACAD SCI USA, V105, P2550, DOI 10.1073/pnas.0708350105; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; OHAVER TC, 1979, CLIN CHEM, V25, P1548; Pacini S, 1998, J BIOL CHEM, V273, P20487, DOI 10.1074/jbc.273.32.20487; Patrussi L, 2005, ONCOGENE, V24, P2218, DOI 10.1038/sj.onc.1208384; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Perinetti G, 2009, TRAFFIC, V10, P379, DOI [10.1111/j.1600-0854.2009.00875.x, 10.1111/j.1600-0854.2008.00875.x]; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Wulfing C, 2002, IMMUNOL REV, V189, P64, DOI 10.1034/j.1600-065X.2002.18907.x	28	238	240	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1332	U163		10.1038/ncb1977	http://dx.doi.org/10.1038/ncb1977			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19855387	Green Accepted			2022-12-25	WOS:000271425800013
J	Huggett, B				Huggett, Brady			How Tysabri survived	NATURE BIOTECHNOLOGY			English	Editorial Material							RELAPSING MULTIPLE-SCLEROSIS; NATALIZUMAB	Most drugs withdrawn from the market because of serious toxicities never make it back. But Biogen Idec succeeded in getting its multiple sclerosis (MS) drug Tysabri reintroduced in less than 16 months.										Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396	2	5	5	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2009	27	11					986	986		10.1038/nbt1109-986	http://dx.doi.org/10.1038/nbt1109-986			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	516EM	19898447	Bronze			2022-12-25	WOS:000271524700014
J	Oney, S; Lam, RTS; Bompiani, KM; Blake, CM; Quick, G; Heidel, JD; Liu, JYC; Mack, BC; Davis, ME; Leong, KW; Sullenger, BA				Oney, Sabah; Lam, Ruby T. S.; Bompiani, Kristin M.; Blake, Charlene M.; Quick, George; Heidel, Jeremy D.; Liu, Joanna Yi-Ching; Mack, Brendan C.; Davis, Mark E.; Leong, Kam W.; Sullenger, Bruce A.			Development of universal antidotes to control aptamer activity	NATURE MEDICINE			English	Article							VON-WILLEBRAND-FACTOR; ADVERSE DRUG EVENTS; RNA APTAMERS; PROTAMINE; NANOPARTICLES; ANGIOGENESIS; COAGULATION; TECHNOLOGY; GENERATION; DELIVERY	With an ever increasing number of people taking numerous medications, the need to safely administer drugs and limit unintended side effects has never been greater. Antidote control remains the most direct means to counteract acute side effects of drugs, but, unfortunately, it has been challenging and cost prohibitive to generate antidotes for most therapeutic agents. Here we describe the development of a set of antidote molecules that are capable of counteracting the effects of an entire class of therapeutic agents based upon aptamers. These universal antidotes exploit the fact that, when systemically administered, aptamers are the only free extracellular oligonucleotides found in circulation. We show that protein- and polymer-based molecules that capture oligonucleotides can reverse the activity of several aptamers in vitro and counteract aptamer activity in vivo. The availability of universal antidotes to control the activity of any aptamer suggests that aptamers may be a particularly safe class of therapeutics.	[Oney, Sabah; Bompiani, Kristin M.; Blake, Charlene M.; Quick, George; Sullenger, Bruce A.] Duke Univ, Med Ctr, Duke Translat Res Inst, Durham, NC 27706 USA; [Oney, Sabah; Bompiani, Kristin M.; Blake, Charlene M.; Sullenger, Bruce A.] Duke Univ, Univ Program Genet & Genom, Durham, NC USA; [Oney, Sabah; Bompiani, Kristin M.; Blake, Charlene M.; Sullenger, Bruce A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Lam, Ruby T. S.; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Heidel, Jeremy D.; Liu, Joanna Yi-Ching] Calando Pharmaceut, Pasadena, CA USA; [Mack, Brendan C.; Davis, Mark E.] CALTECH, Dept Chem Engn, Pasadena, CA 91125 USA	Duke University; Duke University; Duke University; Duke University; California Institute of Technology	Sullenger, BA (corresponding author), Duke Univ, Med Ctr, Duke Translat Res Inst, Durham, NC 27706 USA.	bruce.sullenger@duke.edu	Leong, Kam W/A-7270-2009; Leong, Kam/O-9302-2019	Leong, Kam W/0000-0002-8133-4955; Leong, Kam/0000-0002-8133-4955	US National Institutes of Health [HL065222]; American Heart Association [0615443U]; US National Cancer Institute [CA 119347]; NATIONAL CANCER INSTITUTE [U54CA119347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065222] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S.M. Nimjee and J. Layzer for helpful discussions and Calando Pharmaceuticals for providing the CDP and CDP-Im polymers. This work was supported by a grant from the US National Institutes of Health (HL065222 to B.A.S.), a predoctoral fellowship from the American Heart Association (0615443U to S.O.) and a grant from the US National Cancer Institute (CA 119347 to M.E.D).	Anderson J, 2007, MOL THER, V15, P1182, DOI 10.1038/sj.mt.6300157; Becker RC, 2005, THROMB HAEMOSTASIS, V93, P1014, DOI 10.1160/TH04-12-0790; Carr JA, 1999, J CARDIOVASC SURG, V40, P659; Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fanikos J, 2007, AM J CARDIOL, V100, P1465, DOI 10.1016/j.amjcard.2007.06.041; Fish G, 2003, OPHTHALMOLOGY, V110, P979, DOI 10.1016/S0161-6420(03)00085-X; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Gonzalez H, 1999, BIOCONJUGATE CHEM, V10, P1068, DOI 10.1021/bc990072j; Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; HIRD RB, 1995, CIRCULATION, V92, P433, DOI 10.1161/01.CIR.92.9.433; Joachimi A, 2007, J AM CHEM SOC, V129, P3036, DOI 10.1021/ja0677822; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lee JH, 2005, P NATL ACAD SCI USA, V102, P18902, DOI 10.1073/pnas.0509069102; Mao HQ, 2005, ADV GENET, V53, P275, DOI 10.1016/S0065-2660(05)53011-6; Martin DF, 2002, RETINA-J RET VIT DIS, V22, P143; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752; Nimjee SM, 2006, MOL THER, V14, P408, DOI 10.1016/j.ymthe.2006.04.006; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Nirnjee SM, 2005, TRENDS CARDIOVAS MED, V15, P41, DOI 10.1016/j.tcm.2005.01.002; Oney S, 2007, OLIGONUCLEOTIDES, V17, P265, DOI 10.1089/oli.2007.0089; Porsche R, 1999, HEART LUNG, V28, P418, DOI 10.1016/S0147-9563(99)70031-2; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Rusconi CP, 2000, THROMB HAEMOSTASIS, V84, P841; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Shigeta O, 1999, J THORAC CARDIOV SUR, V118, P354, DOI 10.1016/S0022-5223(99)70227-8; STANKER LH, 1993, MOL IMMUNOL, V30, P1633, DOI 10.1016/0161-5890(93)90436-F; SULLENGER BA, 1990, CELL, V63, P601, DOI 10.1016/0092-8674(90)90455-N; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Welsby IJ, 2005, ANESTHESIOLOGY, V102, P308, DOI 10.1097/00000542-200502000-00011; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	89	95	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2009	15	10					1224	U157		10.1038/nm.1990	http://dx.doi.org/10.1038/nm.1990			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	504EC	19801990	Green Accepted, Green Published			2022-12-25	WOS:000270596400037
J	Pavlova, M; Klvana, M; Prokop, Z; Chaloupkova, R; Banas, P; Otyepka, M; Wade, RC; Tsuda, M; Nagata, Y; Damborsky, J				Pavlova, Martina; Klvana, Martin; Prokop, Zbynek; Chaloupkova, Radka; Banas, Pavel; Otyepka, Michal; Wade, Rebecca C.; Tsuda, Masataka; Nagata, Yuji; Damborsky, Jiri			Redesigning dehalogenase access tunnels as a strategy for degrading an anthropogenic substrate	NATURE CHEMICAL BIOLOGY			English	Article							SPHINGOMONAS-PAUCIMOBILIS UT26; HALOALKANE DEHALOGENASE; DIRECTED EVOLUTION; CYTOCHROME P450S; HETEROLOGOUS EXPRESSION; XENOBIOTIC COMPOUNDS; CATALYTIC MECHANISM; ESCHERICHIA-COLI; ENZYME; SPECIFICITY	Engineering enzymes to degrade anthropogenic compounds efficiently is challenging. We obtained Rhodococcus rhodochrous haloalkane dehalogenase mutants with up to 32-fold higher activity than wild type toward the toxic, recalcitrant anthropogenic compound 1,2,3-trichloropropane (TCP) using a new strategy. We identified key residues in access tunnels connecting the buried active site with bulk solvent by rational design and randomized them by directed evolution. The most active mutant has large aromatic residues at two out of three randomized positions and two positions modified by site-directed mutagenesis. These changes apparently enhance activity with TCP by decreasing accessibility of the active site for water molecules, thereby promoting activated complex formation. Kinetic analyses confirmed that the mutations improved carbon-halogen bond cleavage and shifted the rate-limiting step to the release of products. Engineering access tunnels by combining computer-assisted protein design with directed evolution may be a valuable strategy for refining catalytic properties of enzymes with buried active sites.	[Pavlova, Martina; Klvana, Martin; Prokop, Zbynek; Chaloupkova, Radka; Damborsky, Jiri] Masaryk Univ, Fac Sci, Loschmidt Labs, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Pavlova, Martina; Klvana, Martin; Prokop, Zbynek; Chaloupkova, Radka; Damborsky, Jiri] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic; [Banas, Pavel; Otyepka, Michal] Palacky Univ, Dept Phys Chem, CR-77147 Olomouc, Czech Republic; [Banas, Pavel; Otyepka, Michal] Palacky Univ, Ctr Biomol & Complex Mol Syst, CR-77147 Olomouc, Czech Republic; [Wade, Rebecca C.] EML Res gGmbH, Mol & Cellular Modeling Grp, Heidelberg, Germany; [Tsuda, Masataka; Nagata, Yuji] Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Sendai, Miyagi 980, Japan	Masaryk University Brno; Masaryk University Brno; Palacky University Olomouc; Palacky University Olomouc; Tohoku University	Damborsky, J (corresponding author), Masaryk Univ, Fac Sci, Loschmidt Labs, Inst Expt Biol, CS-61137 Brno, Czech Republic.	jiri@chemi.muni.cz	Prokop, Zbynek/H-5707-2012; Otyepka, Michal/A-5922-2008; Damborsky, Jiri/H-3799-2012; Wade, Rebecca/L-1489-2019; Otyepka, Michal/D-1220-2017; Tsuda, Masataka/AAC-3657-2019; Banas, Pavel/E-8074-2010; Klvana, Martin/B-1299-2015; Chaloupkova, Radka/M-5565-2016	Prokop, Zbynek/0000-0001-9358-4081; Otyepka, Michal/0000-0002-1066-5677; Damborsky, Jiri/0000-0002-7848-8216; Wade, Rebecca/0000-0001-5951-8670; Otyepka, Michal/0000-0002-1066-5677; Tsuda, Masataka/0000-0002-5388-663X; Klvana, Martin/0000-0002-5076-4936; Chaloupkova, Radka/0000-0002-3539-7445	Japan Society for Promotion of Science; Ministry of Education of the Czech Republic [LC06010, MSM0021622412]; Czech Republic [201/07/0927, 203/08/0114]; Czech Academy of Sciences [IAA401630901]; North Atlantic Treaty Organization [EST.CLG.980504]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Agriculture, Forestry, and Fisheries, Japan	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Republic(Czech Republic Government); Czech Academy of Sciences(Czech Academy of Sciences); North Atlantic Treaty Organization(NATO (North Atlantic Treaty Organisation)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry, and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	We thank V. de Lorenzo (Centro Nacional de Biotecnologia, Spain) and U. Bornscheuer (University Greifswald, Germany) for critical reading of this manuscript. R. C. W. gratefully acknowledges the support of the Klaus Tschira Foundation and M. P. acknowledges a scholarship from the Japan Society for Promotion of Science. We acknowledge financial support from the Ministry of Education of the Czech Republic (LC06010 and MSM0021622412), the Grant Agency of the Czech Republic (201/07/0927 and 203/08/0114), the Grant Agency of the Czech Academy of Sciences (IAA401630901), the North Atlantic Treaty Organization (EST.CLG.980504), and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and the Ministry of Agriculture, Forestry, and Fisheries, Japan. We acknowledge the Supercomputing Centre Brno for computational resources.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Banas P, 2006, J COMPUT AID MOL DES, V20, P375, DOI 10.1007/s10822-006-9071-1; Bartsch S, 2008, ANGEW CHEM INT EDIT, V47, P1508, DOI 10.1002/anie.200704606; Bosma T, 2003, BIOCHEMISTRY-US, V42, P8047, DOI 10.1021/bi026907m; Bosma T, 2002, APPL ENVIRON MICROB, V68, P3582, DOI 10.1128/AEM.68.7.3582-3587.2002; Bosma T, 1999, APPL ENVIRON MICROB, V65, P4575; Carmichael AB, 2001, EUR J BIOCHEM, V268, P3117, DOI 10.1046/j.1432-1327.2001.02212.x; Chaloupkova R, 2003, J BIOL CHEM, V278, P52622, DOI 10.1074/jbc.M306762200; Chovancova E, 2007, PROTEINS, V67, P305, DOI 10.1002/prot.21313; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Devi-Kesavan LS, 2003, J AM CHEM SOC, V125, P1532, DOI 10.1021/ja026955u; Doyle SA, 2000, BIOCHEMISTRY-US, V39, P14348, DOI 10.1021/bi001458g; Fedorov R, 2004, P NATL ACAD SCI USA, V101, P5892, DOI 10.1073/pnas.0306588101; Feingersch R, 2008, APPL ENVIRON MICROB, V74, P1555, DOI 10.1128/AEM.01849-07; Fishman A, 2004, BIOTECHNOL BIOENG, V87, P779, DOI 10.1002/bit.20185; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Gray KA, 2001, ADV SYNTH CATAL, V343, P607, DOI 10.1002/1615-4169(200108)343:6/7<607::AID-ADSC607>3.3.CO;2-D; Hur S, 2003, P NATL ACAD SCI USA, V100, P2215, DOI 10.1073/pnas.242721799; IWASAKI I, 1952, B CHEM SOC JPN, V25, P226, DOI 10.1246/bcsj.25.226; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; JANSSEN DB, 1988, EUR J BIOCHEM, V171, P67, DOI 10.1111/j.1432-1033.1988.tb13759.x; Kotik M, 2007, J BIOTECHNOL, V132, P8, DOI 10.1016/j.jbiotec.2007.08.014; Kulakova AN, 1997, MICROBIOL-SGM, V143, P109, DOI 10.1099/00221287-143-1-109; Lauble H, 2002, PROTEIN SCI, V11, P65, DOI 10.1110/ps.ps.33702; Marek J, 2000, BIOCHEMISTRY-US, V39, P14082, DOI 10.1021/bi001539c; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Newman J, 1999, BIOCHEMISTRY-US, V38, P16105, DOI 10.1021/bi9913855; Neylon C, 2004, NUCLEIC ACIDS RES, V32, P1448, DOI 10.1093/nar/gkh315; Olsson MHM, 2004, J AM CHEM SOC, V126, P15167, DOI 10.1021/ja047151c; Otyepka M, 2002, PROTEIN SCI, V11, P1206, DOI 10.1110/ps.ps3830102; Pavelka A, 2009, NUCLEIC ACIDS RES, V37, pW376, DOI 10.1093/nar/gkp410; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Poelarends GJ, 1998, APPL ENVIRON MICROB, V64, P2931; Prokop Z, 2003, J BIOL CHEM, V278, P45094, DOI 10.1074/jbc.M307056200; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; SALLIS PJ, 1990, J GEN MICROBIOL, V136, P115, DOI 10.1099/00221287-136-1-115; Schanstra JP, 1996, BIOCHEMISTRY-US, V35, P5624, DOI 10.1021/bi952904g; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Schmitt J, 2002, PROTEIN ENG, V15, P595, DOI 10.1093/protein/15.7.595; STUCKI G, 1995, ENVIRON SCI TECHNOL, V29, P2339, DOI 10.1021/es00009a028; Swanson PE, 1999, CURR OPIN BIOTECH, V10, P365, DOI 10.1016/S0958-1669(99)80066-4; VANDERMEER JR, 1992, MICROBIOL REV, V56, P677, DOI 10.1128/MMBR.56.4.677-694.1992; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; Whittle E, 2001, J BIOL CHEM, V276, P21500, DOI 10.1074/jbc.M102129200; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Woycechowsky Kenneth J., 2007, V75, P241; Wymer N, 2001, STRUCTURE, V9, P1, DOI 10.1016/S0969-2126(00)00555-4; YOKOTA T, 1987, J BACTERIOL, V169, P4049, DOI 10.1128/jb.169.9.4049-4054.1987; YUJING M, 2001, PHYS CHEM CHEM PHYS, V3, P2614	50	201	204	4	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					727	733		10.1038/nchembio.205	http://dx.doi.org/10.1038/nchembio.205			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19701186				2022-12-25	WOS:000270039900010
J	Zhang, YX; Erdmann, F; Fischer, G				Zhang, Yixin; Erdmann, Frank; Fischer, Gunter			Augmented photoswitching modulates immune signaling	NATURE CHEMICAL BIOLOGY			English	Article							CYCLOSPORINE-A; CRYSTAL-STRUCTURE; CALCINEURIN; CONFORMATION; AZOBENZENE; INHIBITORS; PEPTIDES; TARGET; COMMON	Reversible and non-invasive photoswitching of the immunosuppressive effect of a drug would be a very valuable tool for precisely regulating the immune system. Using a combination of protein borrowing and two-photon photoisomerization, we designed and synthesized derivatives of cyclosporin A. Here we demonstrate photoswitching of the local conformation within small molecules, which we used to modulate inhibitory potencies for cyclophilin, influence ternary and quaternary complex formations and regulate T-cell transcriptional activation in situ.	[Zhang, Yixin; Erdmann, Frank; Fischer, Gunter] Max Planck Res Unit Enzymol Prot Folding, Halle, Germany	Max Planck Society	Fischer, G (corresponding author), Max Planck Res Unit Enzymol Prot Folding, Halle, Germany.	fischer@enzyme-halle.mpg.de	Erdmann, Frank/AAF-1091-2021	Erdmann, Frank/0000-0001-5261-0984				Baumgrass R, 2004, J BIOL CHEM, V279, P2470, DOI 10.1074/jbc.M304754200; Behrendt R, 1999, ANGEW CHEM INT EDIT, V38, P2771, DOI 10.1002/(SICI)1521-3773(19990917)38:18<2771::AID-ANIE2771>3.0.CO;2-W; Boulegue C, 2007, CHEMBIOCHEM, V8, P591, DOI 10.1002/cbic.200600495; Briesewitz R, 1999, P NATL ACAD SCI USA, V96, P1953, DOI 10.1073/pnas.96.5.1953; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Churikov VM, 2002, OPT COMMUN, V209, P451, DOI 10.1016/S0030-4018(02)01677-2; Fanghanel J, 2003, BIOPHYS CHEM, V100, P351, DOI 10.1016/S0301-4622(02)00292-2; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kullertz G, 1998, CLIN CHEM, V44, P502; Kumita JR, 2000, P NATL ACAD SCI USA, V97, P3803, DOI 10.1073/pnas.97.8.3803; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu JO, 1999, CHEM BIOL, V6, pR213, DOI 10.1016/S1074-5521(99)80080-5; van Besouw N M, 1996, Transpl Int, V9 Suppl 1, pS345; van Besouw NM, 2000, TRANSPLANTATION, V70, P136; Vollmer MS, 1999, ANGEW CHEM INT EDIT, V38, P1598, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1598::AID-ANIE1598>3.0.CO;2-J; WAELKENS E, 1984, BIOCHEM BIOPH RES CO, V120, P397, DOI 10.1016/0006-291X(84)91267-1; WESTMARK PR, 1993, J AM CHEM SOC, V115, P3416, DOI 10.1021/ja00062a003; Zhang YX, 2005, J BIOL CHEM, V280, P4842, DOI 10.1074/jbc.M409178200	25	25	25	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2009	5	10					724	726		10.1038/nchembio.214	http://dx.doi.org/10.1038/nchembio.214			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	497EV	19734911				2022-12-25	WOS:000270039900009
J	de Vries, PJ				de Vries, Petrus J.			Genetics and neuropsychiatric disorders: Genome-wide, yet narrow	NATURE MEDICINE			English	Editorial Material							AUTISM; MUTATIONS		[de Vries, Petrus J.] Cambridgeshire & Peterborough NHS Fdn Trust, Neurodev Serv, Cambridge, England; [de Vries, Petrus J.] Univ Cambridge, Dev Psychiat Sect, Cambridge, England	University of Cambridge	de Vries, PJ (corresponding author), Cambridgeshire & Peterborough NHS Fdn Trust, Neurodev Serv, Cambridge, England.	pd215@cam.ac.uk						Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Bolton PF, 2002, BRAIN, V125, P1247, DOI 10.1093/brain/awf124; de Vries PJ, 2007, TRENDS MOL MED, V13, P319, DOI 10.1016/j.molmed.2007.06.003; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Holden C, 2009, SCIENCE, V324, P1628, DOI 10.1126/science.324_1628; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999	12	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2009	15	8					850	851		10.1038/nm0809-850	http://dx.doi.org/10.1038/nm0809-850			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19661990				2022-12-25	WOS:000268770400024
J	Ehninger, D; Silva, AJ				Ehninger, Dan; Silva, Alcino J.			Genetics and neuropsychiatric disorders: Treatment during adulthood	NATURE MEDICINE			English	Editorial Material							FRAGILE-X-SYNDROME; NEUROFIBROMATOSIS TYPE-1; MOUSE MODEL; DEFICITS; RESCUE; TRIAL; MICE		[Ehninger, Dan; Silva, Alcino J.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Ehninger, Dan; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Ehninger, Dan; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Ehninger, Dan; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Ehninger, D (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494				Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701; Berry-Kravis E, 2008, J DEV BEHAV PEDIATR, V29, P293, DOI 10.1097/DBP.0b013e31817dc447; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Krab LC, 2008, JAMA-J AM MED ASSOC, V300, P287, DOI 10.1001/jama.300.3.287; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004	12	18	18	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2009	15	8					849	850		10.1038/nm0809-849	http://dx.doi.org/10.1038/nm0809-849			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	480XK	19661989				2022-12-25	WOS:000268770400023
J	Murga, M; Bunting, S; Montana, MF; Soria, R; Mulero, F; Canamero, M; Lee, Y; McKinnon, PJ; Nussenzweig, A; Fernandez-Capetillo, O				Murga, Matilde; Bunting, Samuel; Montana, Maria F.; Soria, Rebeca; Mulero, Francisca; Canamero, Marta; Lee, Youngsoo; McKinnon, Peter J.; Nussenzweig, Andre; Fernandez-Capetillo, Oscar			A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging	NATURE GENETICS			English	Article							HEMATOPOIETIC STEM-CELLS; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; CHROMOSOME INSTABILITY; DEFICIENT MICE; GENE ATR; CHECKPOINT; AGE; LEADS; P53	Although DNA damage is considered a driving force for aging, the nature of the damage that arises endogenously remains unclear. Replicative stress, a source of endogenous DNA damage, is prevented primarily by the ATR kinase. We have developed a mouse model of Seckel syndrome characterized by a severe deficiency in ATR. Seckel mice show high levels of replicative stress during embryogenesis, when proliferation is widespread, but this is reduced to marginal amounts in postnatal life. In spite of this decrease, adult Seckel mice show accelerated aging, which is further aggravated in the absence of p53. Together, these results support a model whereby replicative stress, particularly in utero, contributes to the onset of aging in postnatal life, and this is balanced by the replicative stress-limiting role of the checkpoint proteins ATR and p53.	[Murga, Matilde; Montana, Maria F.; Soria, Rebeca; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid, Spain; [Bunting, Samuel; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Mulero, Francisca] CNIO, Mol Imaging Unit, Madrid, Spain; [Canamero, Marta] CNIO, Comparat Pathol Unit, Madrid, Spain; [Lee, Youngsoo; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); St Jude Children's Research Hospital	Murga, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid, Spain.	mmurga@cnio.es; ofernandez@cnio.es	/AAI-3238-2021; Murga, Matilde/B-3499-2018; Mulero, Francisca/R-2387-2019; Fernandez-Capetillo, Oscar/H-3508-2015; Mulero, Francisca M/M-3289-2014	Mulero, Francisca/0000-0001-9584-4211; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Mulero, Francisca M/0000-0001-9584-4211; Lee, Youngsoo/0000-0003-4773-6464	Spanish Ministry of Science [RYC-2003-002731, CSD200700017, SAF2008-01596]; Fondo de Investigaciones Sanitarias [PI080220]; European Molecular Biology Organization Young Investigator Programme; European Research Council [ERC-210520]; Epigenome Network of Excellence; NATIONAL CANCER INSTITUTE [ZICBC009255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); European Molecular Biology Organization Young Investigator Programme(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission); Epigenome Network of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Serrano and A. Ramiro for critical comments on the manuscript. We also thank S. P. Jackson for his help with the PIKK inhibitors and A. Garcia for cytometry. M. M. is supported by a Ramon y Cajal contract from the Spanish Ministry of Science (RYC-2003-002731) and from a grant from Fondo de Investigaciones Sanitarias (PI080220). Work in O. F.-C.' s laboratory is supported by grants from the Spanish Ministry of Science (RYC-2003-002731, CSD200700017 and SAF2008-01596), European Molecular Biology Organization Young Investigator Programme, European Research Council (ERC-210520) and Epigenome Network of Excellence.	Arnold SR, 1999, PEDIATR DEVEL PATHOL, V2, P180, DOI 10.1007/s100249900107; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bobabilla-Morales L, 2003, AM J MED GENET A, V123A, P148, DOI 10.1002/ajmg.a.20341; BOSCHERINI B, 1981, EUR J PEDIATR, V137, P237, DOI 10.1007/BF00441325; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; BUTLER MG, 1987, AM J MED GENET, V27, P645, DOI 10.1002/ajmg.1320270318; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Casper AM, 2004, AM J HUM GENET, V75, P654, DOI 10.1086/422701; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; EL DW, 1993, CELL, V75, P817; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; FATHIZADEH A, 1979, J AM ACAD DERMATOL, V1, P52, DOI 10.1016/S0190-9622(79)70004-1; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Goodship J, 2000, AM J HUM GENET, V67, P498, DOI 10.1086/303023; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Liu QH, 2000, GENE DEV, V14, P1448; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lombardi G, 2005, J Endocrinol Invest, V28, P99; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; MURPHY DP, 1928, SURG GYNECOL OBSTET, V47, P201; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; SCHMIDT SL, 1987, J COMP NEUROL, V264, P193, DOI 10.1002/cne.902640205; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; SECKEL H, 1960, STUDIES DEV ANTHR IN; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shanske A, 1997, AM J MED GENET, V70, P155, DOI 10.1002/(SICI)1096-8628(19970516)70:2<155::AID-AJMG10>3.0.CO;2-I; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Syrrou M., 1995, Genetic Counseling, V6, P37; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401	50	257	260	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					891	U46		10.1038/ng.420	http://dx.doi.org/10.1038/ng.420			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19620979	Green Accepted			2022-12-25	WOS:000268432900012
J	Nagel, ZD; Klinman, JP				Nagel, Zachary D.; Klinman, Judith P.			A 21(st) century revisionist's view at a turning point in enzymology	NATURE CHEMICAL BIOLOGY			English	Article							DIHYDROFOLATE-REDUCTASE CATALYSIS; THERMOPHILIC ALCOHOL-DEHYDROGENASE; ENZYME-SUBSTRATE COMPLEX; TRANSITION-STATE THEORY; SOYBEAN LIPOXYGENASE-1; PROTEIN DYNAMICS; HYDRIDE TRANSFER; MORPHINONE REDUCTASE; DIRECTED EVOLUTION; GLUCOSE-OXIDASE	Despite the fact that the number of publications associated with the keyword 'enzyme' increases every year, the precise origin of enzyme catalysis has remained unresolved. Because of sustained intensive research efforts from an increasing number of laboratories, detailed information regarding the physics, chemistry and kinetics of enzymes is accumulating rapidly. The growing body of data contains many examples of kinetic behavior that are incompatible with a static view of enzyme catalysis. As a result, numerous laboratories are approaching the consensus that protein motion plays an essential role in enzyme catalysis. A model that incorporates nuclear quantum tunneling together with two classes of protein motion termed conformational sampling (pre-organization) and reorganization-is recommended as a means of understanding the large body of data for enzyme-catalyzed hydrogen transfers. It should also serve as a vehicle for future efforts in the development of potent enzyme inhibitors and the de novo design of all classifications of enzymes.	[Nagel, Zachary D.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Nagel, ZD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu						Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; Bell R P, 1980, TUNNELING EFFECT CHE; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Boehr DD, 2008, BIOCHEMISTRY-US, V47, P9227, DOI 10.1021/bi801102e; CHA Y, 1989, SCIENCE, V243, P1325, DOI 10.1126/science.2646716; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fan F, 2007, BIOCHEMISTRY-US, V46, P6402, DOI 10.1021/bi700255v; GARRETT BC, 1979, J CHEM PHYS, V70, P1593, DOI 10.1063/1.437698; GERHART JC, 1968, BIOCHEMISTRY-US, V7, P538, DOI 10.1021/bi00842a600; GLICKMAN MH, 1995, BIOCHEMISTRY-US, V34, P14077, DOI 10.1021/bi00043a013; Griffiths AD, 2000, CURR OPIN BIOTECH, V11, P338, DOI 10.1016/S0958-1669(00)00109-9; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Harris RJ, 2000, BIOCHEMISTRY-US, V39, P1189, DOI 10.1021/bi991941v; HASLETT JW, 1973, AM J PHYS, V41, P445, DOI 10.1119/1.1987257; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Heyes DJ, 2009, J BIOL CHEM, V284, P3762, DOI 10.1074/jbc.M808548200; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Hothi P, 2008, CHEMBIOCHEM, V9, P2839, DOI 10.1002/cbic.200800408; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Jencks W. P., 1969, CATALYSIS CHEM ENZYM; KAPTEIN R, 1985, J MOL BIOL, V182, P179, DOI 10.1016/0022-2836(85)90036-1; Klinman JP, 2009, CHEM PHYS LETT, V471, P179, DOI 10.1016/j.cplett.2009.01.038; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kohen A, 1997, BIOCHEMISTRY-US, V36, P2603, DOI 10.1021/bi962492r; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Limbach HH, 2006, PHILOS T R SOC B, V361, P1399, DOI 10.1098/rstb.2006.1872; Lin HN, 2004, J AM CHEM SOC, V126, P15051, DOI 10.1021/ja046238v; Liu HB, 2007, J PHYS CHEM B, V111, P7852, DOI 10.1021/jp070938f; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Maglia G, 2003, J AM CHEM SOC, V125, P13372, DOI 10.1021/ja035692g; MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MCCAMMON J, 1987, DYNAMICS PROTEIN NUC, V234; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; MELANDER L, 1987, REACTION RATES ISOTO, V331; Meyer MP, 2008, P NATL ACAD SCI USA, V105, P1146, DOI 10.1073/pnas.0710643105; Meyer MP, 2005, CHEM PHYS, V319, P283, DOI 10.1016/j.chemphys.2005.05.017; Min W, 2008, J PHYS CHEM B, V112, P454, DOI 10.1021/jp076533c; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nesheim JC, 1996, BIOCHEMISTRY-US, V35, P10240, DOI 10.1021/bi960596w; Pang JY, 2008, J AM CHEM SOC, V130, P7092, DOI 10.1021/ja800471f; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; Pudney CR, 2007, J AM CHEM SOC, V129, P13949, DOI 10.1021/ja074463h; Radkiewicz JL, 2000, J AM CHEM SOC, V122, P225, DOI 10.1021/ja9913838; Roca M, 2008, P NATL ACAD SCI USA, V105, P13877, DOI [10.1073/pnas.0803405105, 10.1073/pnas.080340S105]; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Saen-oon S, 2008, P NATL ACAD SCI USA, V105, P16543, DOI 10.1073/pnas.0808413105; Saen-Oon S, 2008, BIOPHYS J, V94, P4078, DOI 10.1529/biophysj.107.121913; Schnell JR, 2004, BIOCHEMISTRY-US, V43, P374, DOI 10.1021/bi035464z; Schramm VL, 2005, ARCH BIOCHEM BIOPHYS, V433, P13, DOI 10.1016/j.abb.2004.08.035; Seymour SL, 2002, BIOCHEMISTRY-US, V41, P8747, DOI 10.1021/bi020054g; SWAIN CG, 1958, J AM CHEM SOC, V80, P5885, DOI 10.1021/ja01554a077; Taylor SV, 2001, ANGEW CHEM INT EDIT, V40, P3310, DOI 10.1002/1521-3773(20010917)40:18<3310::AID-ANIE3310>3.0.CO;2-P; Truhlar DG, 2004, INT J QUANTUM CHEM, V100, P1136, DOI 10.1002/qua.20205; Tsai SC, 2001, BIOCHEMISTRY-US, V40, P2303, DOI 10.1021/bi002075l; Voigt CA, 2000, J MOL BIOL, V299, P789, DOI 10.1006/jmbi.2000.3758; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; Wang L, 2006, PHILOS T R SOC B, V361, P1307, DOI 10.1098/rstb.2006.1871; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P2764, DOI 10.1073/pnas.0400091101	66	246	248	3	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2009	5	8					543	550		10.1038/nchembio.204	http://dx.doi.org/10.1038/nchembio.204			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473LV	19620995				2022-12-25	WOS:000268209200010
J	Carroll, CW; Silva, MCC; Godek, KM; Jansen, LET; Straight, AF				Carroll, Christopher W.; Silva, Mariana C. C.; Godek, Kristina M.; Jansen, Lars E. T.; Straight, Aaron F.			Centromere assembly requires the direct recognition of CENP-A nucleosomes by CENP-N	NATURE CELL BIOLOGY			English	Article							HUMAN-CELLS; KINETOCHORE; CHROMATIN; COMPLEX; DOMAIN; DNA; PATHWAYS	Centromeres are specialized chromosomal domains that direct kinetochore assembly during mitosis. CENP-A (centromere protein A), a histone H3-variant present exclusively in centromeric nucleosomes, is thought to function as an epigenetic mark that specifies centromere identity. Here we identify the essential centromere protein CENP-N as the first protein to selectively bind CENP-A nucleosomes but not H3 nucleosomes. CENP-N bound CENP-A nucleosomes in a DNA sequence-independent manner, but did not bind soluble CENP-A-H4 tetramers. Mutations in CENP-N that reduced its affinity for CENP-A nucleosomes caused defects in CENP-N localization and had dominant effects on the recruitment of CENP-H, CENP-I and CENP-K to centromeres. Depletion of CENP-N using siRNA (short interfering RNA) led to similar centromere assembly defects and resulted in reduced assembly of nascent CENP-A into centromeric chromatin. These data suggest that CENP-N interprets the information encoded within CENP-A nucleosomes and recruits other proteins to centromeric chromatin that are required for centromere function and propagation.	[Carroll, Christopher W.; Godek, Kristina M.; Straight, Aaron F.] Stanford Univ, Sch Med, Beckman Ctr, Dept Biochem, Palo Alto, CA 94503 USA; [Silva, Mariana C. C.; Jansen, Lars E. T.] Inst Gulbenkian Ciencias, Lab Epigenet Mech, P-2780156 Oeiras, Portugal	Stanford University; Instituto Gulbenkian de Ciencia	Straight, AF (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Biochem, Room 409,279 Campus Dr, Palo Alto, CA 94503 USA.	astraigh@stanford.edu		Godek, Kristina/0000-0002-2512-9295; Straight, Aaron/0000-0001-5885-7881; Coelho Correia da Silva, Mariana/0000-0003-0532-4998; Jansen, Lars/0000-0002-2158-0345	Helen Hay Whitney Foundation; National Science Foundation; NIH [T32GM007276, R01GM074728]; Damon Runyon Cancer Research Foundation; Funda ao para a Cincia e a Tecnologia [SFRH/ BD33219/2007]; EU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R01GM074728] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Funda ao para a Cincia e a Tecnologia; EU(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank members of the Straight Lab for helpful comments and support, J. Minshull and DNA2.0 (CA, USA) for gene synthesis, S. H. Hanissian for the CENP-U(50) cDNA, J. Yang, G. Narlikar, M. Resch, K. Luger and J. Hansen for reagents and help with nucleosome reconstitution, S.- T. Liu for the CENP-H and CENP-I antibodies and D. Herschlag for advice. C. W. C. was supported by a postdoctoral fellowship from the Helen Hay Whitney Foundation. K. G. was supported by a predoctoral fellowship from the National Science Foundation and by a NIH grant (T32GM007276). A. F. S. is a Gordon Family Scholar supported by the Damon Runyon Cancer Research Foundation, and this work was supported by a NIH grant (R01GM074728). M. C. C. S. is supported by the Funda ao para a Cincia e a Tecnologia (FCT; SFRH/ BD33219/2007). LETJ is supported by the FCT, Funda ao Calouste Gulbenkian and the EU Seventh Framework Programme.	Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; CHEESEMAN IM, 2007, MOL BIOL CELL; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Luger K, 1999, METHOD ENZYMOL, V304, P3; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Trazzi S, 2002, J STRUCT BIOL, V140, P39, DOI 10.1016/S1047-8477(02)00506-3; Yang CH, 1996, MOL CELL BIOL, V16, P3576	24	207	213	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					896	U297		10.1038/ncb1899	http://dx.doi.org/10.1038/ncb1899			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543270	Green Accepted			2022-12-25	WOS:000267603100020
J	MacDiarmid, JA; Amaro-Mugridge, NB; Madrid-Weiss, J; Sedliarou, I; Wetzel, S; Kochar, K; Brahmbhatt, VN; Phillips, L; Pattison, ST; Petti, C; Stillman, B; Graham, RM; Brahmbhatt, H				MacDiarmid, Jennifer A.; Amaro-Mugridge, Nancy B.; Madrid-Weiss, Jocelyn; Sedliarou, Ilya; Wetzel, Stefanie; Kochar, Kartini; Brahmbhatt, Vatsala N.; Phillips, Leo; Pattison, Scott T.; Petti, Carlotta; Stillman, Bruce; Graham, Robert M.; Brahmbhatt, Himanshu			Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug	NATURE BIOTECHNOLOGY			English	Article							SMALL INTERFERING RNA; EPIDERMAL-GROWTH-FACTOR; MULTIDRUG-RESISTANCE; CONTAINING NANOPARTICLES; SYSTEMIC DELIVERY; ESCHERICHIA-COLI; FACTOR RECEPTOR; IN-VIVO; CANCER; INHIBITORS	The dose-limiting toxicity of chemotherapeutics, heterogeneity and drug resistance of cancer cells, and difficulties of targeted delivery to tumors all pose daunting challenges to effective cancer therapy. We report that small interfering RNA ( siRNA) duplexes readily penetrate intact bacterially derived minicells previously shown to cause tumor stabilization and regression when packaged with chemotherapeutics. When targeted via antibodies to tumor-cell-surface receptors, minicells can specifically and sequentially deliver to tumor xenografts first siRNAs or short hairpin RNA (shRNA)-encoding plasmids to compromise drug resistance by knocking down a multidrug resistance protein. Subsequent administration of targeted minicells containing cytotoxic drugs eliminate formerly drug-resistant tumors. The two waves of treatment, involving minicells loaded with both types of payload, enable complete survival without toxicity in mice with tumor xenografts, while involving several thousandfold less drug, siRNA and antibody than needed for conventional systemic administration of cancer therapies.	[MacDiarmid, Jennifer A.; Amaro-Mugridge, Nancy B.; Madrid-Weiss, Jocelyn; Sedliarou, Ilya; Wetzel, Stefanie; Kochar, Kartini; Brahmbhatt, Vatsala N.; Phillips, Leo; Pattison, Scott T.; Petti, Carlotta; Brahmbhatt, Himanshu] EnGeneIC Pty Ltd, Sydney, NSW, Australia; [Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Graham, Robert M.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Graham, Robert M.] Univ New S Wales, Kensington, NSW 2033, Australia	Cold Spring Harbor Laboratory; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Brahmbhatt, H (corresponding author), EnGeneIC Pty Ltd, Sydney, NSW, Australia.	hbrahmbhatt@engeneic.com	Brahmbhatt, Himanshu/AAY-9997-2020	Stillman, Bruce/0000-0002-9453-4091; Sedliarou, Ilya/0000-0002-0001-2568				Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Bartlett DW, 2008, BIOTECHNOL BIOENG, V99, P975, DOI 10.1002/bit.21668; Bartlett DW, 2007, BIOCONJUGATE CHEM, V18, P456, DOI 10.1021/bc0603539; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CUMMINGS J, 1985, J CHROMATOGR, V341, P401, DOI 10.1016/S0378-4347(00)84053-0; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; El-Rayes BF, 2004, BRIT J CANCER, V91, P418, DOI 10.1038/sj.bjc.6601921; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Heidel JD, 2007, CLIN CANCER RES, V13, P2207, DOI 10.1158/1078-0432.CCR-06-2218; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Itoh T, 2004, J PHARM PHARM SCI, V7, P13; Kaszubiak A, 2007, INT J ONCOL, V31, P419; Kawakami S, 2007, DRUG METAB PHARMACOK, V22, P142, DOI 10.2133/dmpk.22.142; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; Larson Rodney R, 2003, Appl Occup Environ Hyg, V18, P109; MacDiarmid JA, 2007, CELL CYCLE, V6, P2099, DOI 10.4161/cc.6.17.4648; MacDiarmid JA, 2007, CANCER CELL, V11, P431, DOI 10.1016/j.ccr.2007.03.012; Mamot C, 2003, CANCER RES, V63, P3154; Mayer LD, 2001, CANCER METAST REV, V20, P87, DOI 10.1023/A:1013108524062; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Meade BR, 2008, ADV DRUG DELIVER REV, V60, P530, DOI 10.1016/j.addr.2007.10.004; MEAGHER RB, 1977, CELL, V10, P521, DOI 10.1016/0092-8674(77)90039-3; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pirollo KF, 2008, CANCER RES, V68, P1247, DOI 10.1158/0008-5472.CAN-07-5810; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Reilly RM, 2000, J NUCL MED, V41, P903; Robbins M, 2008, HUM GENE THER, V19, P991, DOI 10.1089/hum.2008.131; Sambrook J, 2001, MOL CLONING LAB MANU; Sato J D, 1983, Mol Biol Med, V1, P511; Sharma A, 1997, INT J CANCER, V71, P103, DOI 10.1002/(SICI)1097-0215(19970328)71:1<103::AID-IJC17>3.0.CO;2-J; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Sorensen DR, 2003, J MOL BIOL, V327, P761, DOI 10.1016/S0022-2836(03)00181-5; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sun JZ, 1999, CANCER RES, V59, P4919; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Villares GJ, 2008, CANCER RES, V68, P9078, DOI 10.1158/0008-5472.CAN-08-2397; Weil A, 2002, BIOTECHNIQUES, V33, P1244, DOI 10.2144/02336st01; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998; Wu H, 2003, CANCER RES, V63, P1515; YUAN F, 1994, CANCER RES, V54, P3352; Zheng JH, 2001, AAPS PHARMSCI, V3	45	197	241	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2009	27	7					643	U97		10.1038/nbt.1547	http://dx.doi.org/10.1038/nbt.1547			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	469OF	19561595				2022-12-25	WOS:000267908500021
J	Galban, CJ; Chenevert, TL; Meyer, CR; Tsien, C; Lawrence, TS; Hamstra, DA; Junck, L; Sundgren, PC; Johnson, TD; Ross, DJ; Rehemtulla, A; Ross, BD				Galban, Craig J.; Chenevert, Thomas L.; Meyer, Charles R.; Tsien, Christina; Lawrence, Theodore S.; Hamstra, Daniel A.; Junck, Larry; Sundgren, Pia C.; Johnson, Timothy D.; Ross, David J.; Rehemtulla, Alnawaz; Ross, Brian D.			The parametric response map is an imaging biomarker for early cancer treatment outcome	NATURE MEDICINE			English	Article							FUNCTIONAL DIFFUSION MAP; CONTRAST-ENHANCED MRI; ADVANCED SOLID TUMORS; HIGH-GRADE GLIOMAS; PHASE-I; ANGIOGENESIS INHIBITOR; HISTOGRAM ANALYSIS; LIVER METASTASES; PROSTATE-CANCER; BREAST-TUMORS	Here we describe the parametric response map (PRM), a voxel-wise approach for image analysis and quantification of hemodynamic alterations during treatment for 44 patients with high-grade glioma. Relative cerebral blood volume (rCBV) and flow (rCBF) maps were acquired before treatment and after 1 and 3 weeks of therapy. We compared the standard approach using region-of-interest analysis for change in rCBV or rCBF to the change in perfusion parameters on the basis of PRM (PRMrCBV and PRMrCBF) for their accuracy in predicting overall survival. Neither the percentage change of rCBV or rCBF predicted survival, whereas the regional response evaluations made on the basis of PRM were highly predictive of survival. Even when accounting for baseline rCBV, which is prognostic, PRMrCBV proved more predictive of overall survival.	[Galban, Craig J.; Chenevert, Thomas L.; Meyer, Charles R.; Sundgren, Pia C.; Rehemtulla, Alnawaz; Ross, Brian D.] Univ Michigan, Ctr Mol Imaging, Dept Radiol, Ann Arbor, MI 48109 USA; [Tsien, Christina; Lawrence, Theodore S.; Hamstra, Daniel A.; Ross, David J.; Rehemtulla, Alnawaz] Univ Michigan, Ctr Mol Imaging, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Junck, Larry] Univ Michigan, Ctr Mol Imaging, Dept Neurol, Ann Arbor, MI 48109 USA; [Johnson, Timothy D.] Univ Michigan, Ctr Mol Imaging, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ross, BD (corresponding author), Univ Michigan, Ctr Mol Imaging, Dept Radiol, Ann Arbor, MI 48109 USA.	bdross@umich.edu		Chenevert, Thomas/0000-0003-1476-4274; Sundgren, Pia/0000-0001-9237-1236	US National Institutes of Health [P01CA085878, U24CA083099, P50CA093990]; NATIONAL CANCER INSTITUTE [U24CA083099, R24CA083099, P50CA093990, P01CA085878] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Institutes of Health research grants P01CA085878, U24CA083099 and P50CA093990.	Brix G, 2004, MAGNET RESON MED, V52, P420, DOI 10.1002/mrm.20161; Cao Y, 2006, INT J RADIAT ONCOL, V64, P876, DOI 10.1016/j.ijrobp.2005.09.001; Chan JL, 2002, J CLIN ONCOL, V20, P1635, DOI 10.1200/JCO.20.6.1635; Degani H, 1997, NAT MED, V3, P780, DOI 10.1038/nm0797-780; Eyal E, 2009, NMR BIOMED, V22, P40, DOI 10.1002/nbm.1221; Galbraith SM, 2002, NMR BIOMED, V15, P132, DOI 10.1002/nbm.731; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; HOFFMANN U, 1995, MAGNET RESON MED, V33, P506, DOI 10.1002/mrm.1910330408; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Kiessling F, 2007, CURR MED CHEM, V14, P77, DOI 10.2174/092986707779313516; Law M, 2007, AM J NEURORADIOL, V28, P761; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Lee KC, 2007, NEOPLASIA, V9, P1003, DOI 10.1593/neo.07954; Lee KC, 2007, CANCER RES, V67, P3524, DOI 10.1158/0008-5472.CAN-06-4236; Liu G, 2005, J CLIN ONCOL, V23, P5464, DOI 10.1200/JCO.2005.04.143; Meyer C R, 1997, Med Image Anal, V1, P195, DOI 10.1016/S1361-8415(97)85010-4; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Morgan B, 2003, J CLIN ONCOL, V21, P3955, DOI 10.1200/JCO.2003.08.092; Mross K, 2005, EUR J CANCER, V41, P1291, DOI 10.1016/j.ejca.2005.03.005; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; O'Donnell A, 2005, BRIT J CANCER, V93, P876, DOI 10.1038/sj.bjc.6602797; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Rugo HS, 2005, J CLIN ONCOL, V23, P5474, DOI 10.1200/JCO.2005.04.192; Thomas AL, 2005, J CLIN ONCOL, V23, P4162, DOI 10.1200/JCO.2005.09.034; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Wedam SB, 2006, J CLIN ONCOL, V24, P769, DOI 10.1200/JCO.2005.03.4645; Xiong HQ, 2004, INVEST NEW DRUG, V22, P459, DOI 10.1023/B:DRUG.0000036688.96453.8d; Young R, 2007, J MAGN RESON IMAGING, V26, P1053, DOI 10.1002/jmri.21064; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9	32	156	166	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2009	15	5					572	576		10.1038/nm.1919	http://dx.doi.org/10.1038/nm.1919			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	443DB	19377487	Green Accepted			2022-12-25	WOS:000265889300037
J	Garinis, GA; Uittenboogaard, LM; Stachelscheid, H; Fousteri, M; van Ijcken, W; Breit, TM; van Steeg, H; Mullenders, LHF; van der Horst, GTJ; Bruning, JC; Niessen, CM; Hoeijmakers, JHJ; Schumacher, B				Garinis, George A.; Uittenboogaard, Lieneke M.; Stachelscheid, Heike; Fousteri, Maria; van Ijcken, Wilfred; Breit, Timo M.; van Steeg, Harry; Mullenders, Leon H. F.; van der Horst, Gijsbertus T. J.; Bruening, Jens C.; Niessen, Carien M.; Hoeijmakers, Jan H. J.; Schumacher, Bjoern			Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevity	NATURE CELL BIOLOGY			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; OXIDATIVE STRESS; GENE-EXPRESSION; LIFE-SPAN; DAMAGE; HORMONE; MICE	The accumulation of stochastic DNA damage throughout an organism's lifespan is thought to contribute to ageing. Conversely, ageing seems to be phenotypically reproducible and regulated through genetic pathways such as the insulin-like growth factor-1 (IGF-1) and growth hormone (GH) receptors, which are central mediators of the somatic growth axis. Here we report that persistent DNA damage in primary cells from mice elicits changes in global gene expression similar to those occurring in various organs of naturally aged animals. We show that, as in ageing animals, the expression of IGF-1 receptor and GH receptor is attenuated, resulting in cellular resistance to IGF-1. This cell-autonomous attenuation is specifically induced by persistent lesions leading to stalling of RNA polymerase II in proliferating, quiescent and terminally differentiated cells; it is exacerbated and prolonged in cells from progeroid mice and confers resistance to oxidative stress. Our findings suggest that the accumulation of DNA damage in transcribed genes in most if not all tissues contributes to the ageing-associated shift from growth to somatic maintenance that triggers stress resistance and is thought to promote longevity.	[Garinis, George A.; Uittenboogaard, Lieneke M.; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan H. J.; Schumacher, Bjoern] Erasmus MC, Ctr Biomed Genet, MGC Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; [Garinis, George A.] FORTH, Inst Mol Biol & Biotechnol, GR-70013 Iraklion, Greece; [Stachelscheid, Heike; Niessen, Carien M.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Stachelscheid, Heike; Bruening, Jens C.] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Fousteri, Maria; Mullenders, Leon H. F.] LUMC, Dept Toxicogenet, NL-2300 RC Leiden, Netherlands; [van Ijcken, Wilfred] Erasmus MC, Erasmus Ctr Biom, NL-3000 DR Rotterdam, Netherlands; [Breit, Timo M.] Univ Amsterdam, Fac Sci, Inst Informat, Integrat Bioinformat Unit, NL-1098 SM Amsterdam, Netherlands; [van Steeg, Harry] Natl Inst Publ Hlth & Environm RIVM, Lab Toxicol Pathol & Genet TOX, NL-3720 BA Bilthoven, Netherlands; [Bruening, Jens C.; Niessen, Carien M.; Schumacher, Bjoern] Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Niessen, Carien M.] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany	Erasmus University Rotterdam; Erasmus MC; Foundation for Research & Technology - Hellas (FORTH); University of Cologne; University of Cologne; Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Netherlands National Institute for Public Health & the Environment; University of Cologne; University of Cologne	Schumacher, B (corresponding author), Erasmus MC, Ctr Biomed Genet, MGC Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	bjoern.schumacher@uni-koeln.de	van der Horst, Gijsbertus TJ/E-3661-2015; van ijcken, willem/N-9805-2018; Schumacher, Björn/I-4829-2013; Garinis, George A./B-2943-2012; Fousteri, Maria/M-2312-2017; Hoeijmakers, Jan/AAX-6972-2021	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; van ijcken, willem/0000-0002-0421-8301; Schumacher, Björn/0000-0001-6097-5238; Garinis, George A./0000-0002-3200-5004; Fousteri, Maria/0000-0003-1729-5899; Niessen, Carien M./0000-0002-4892-9391	Netherlands Organization for Scientific Research (NWO); Netherlands Genomics Initiative [NGI/NWO 05040202]; SenterNovem IOP-Genomics [IGE03009]; NIH [1PO1 AG17242]; National Institute of Environmental Health Sciences [1UO1 ES011044]; EC [QRTL-1999-02002]; Dutch Cancer Society [EUR 99-2004]; Cancer Genomics Centre; EMBO long-term, Marie Curie Intra-European; NWO; Deutsche Forschungsgemeinschaft [SFB829]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; SenterNovem IOP-Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EC(European CommissionEuropean Commission Joint Research Centre); Dutch Cancer Society(KWF Kankerbestrijding); Cancer Genomics Centre; EMBO long-term, Marie Curie Intra-European(European Molecular Biology Organization (EMBO)); NWO(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Christel Kockx, Zeliha Ozgur and Anja Raams for technical assistance, Casper Hoogenraad for neuron cultures, and Anton Gartner and Francis Barr for comments on the manuscript. This research was supported by the Netherlands Organization for Scientific Research (NWO) and the Netherlands Genomics Initiative (NGI; NGI/NWO 05040202), SenterNovem IOP-Genomics (IGE03009), the NIH (1PO1 AG17242), the National Institute of Environmental Health Sciences (NIEHS; 1UO1 ES011044), the EC (QRTL-1999-02002) and the Dutch Cancer Society (EUR 99-2004). G. G. acknowledges support from the Cancer Genomics Centre and B. S. from EMBO long-term, Marie Curie Intra-European fellowships, Veni grant of the NWO and the Deutsche Forschungsgemeinschaft (CECAD and SFB829).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bonkowski MS, 2006, J GERONTOL A-BIOL, V61, P562, DOI 10.1093/gerona/61.6.562; Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x; Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; Daitoku H, 2007, J BIOCHEM, V141, P769, DOI 10.1093/jb/mvm104; DARDEVET D, 1994, ENDOCRINOLOGY, V134, P1475, DOI 10.1210/en.134.3.1475; Dianou GL, 2007, DNA REPAIR, V6, P454, DOI 10.1016/j.dnarep.2006.10.009; Dibiase SJ, 2000, CANCER RES, V60, P1245; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Essers J, 2005, MOL BIOL CELL, V16, P769, DOI 10.1091/mbc.e04-10-0876; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gems D, 2000, BIOGERONTOLOGY, V1, P289, DOI 10.1023/A:1026546719091; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hartog H, 2007, EUR J CANCER, V43, P1895, DOI 10.1016/j.ejca.2007.05.021; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Jaspers NGJ, 2002, DNA REPAIR, V1, P1027, DOI 10.1016/S1568-7864(02)00166-0; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KIRKWOOD TBL, 1982, HUM GENET, V60, P101, DOI 10.1007/BF00569695; Kirkwood TBL, 1981, REPAIR ITS EVOLUTION, P165; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Li MH, 2003, MECH AGEING DEV, V124, P771, DOI 10.1016/S0047-6374(03)00124-6; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Masternak MM, 2005, EXP GERONTOL, V40, P679, DOI 10.1016/j.exger.2005.06.003; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Murakami S, 2006, EXP GERONTOL, V41, P1014, DOI 10.1016/j.exger.2006.06.061; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nunez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Paci A, 2006, DRUG METAB DISPOS, V34, P1918, DOI 10.1124/dmd.106.010512; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piwien-Pilipuk G, 2002, J PEDIATR ENDOCR MET, V15, P771; Ramirez CL, 2007, CELL MOL LIFE SCI, V64, P155, DOI 10.1007/s00018-006-6349-3; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Riou L, 2004, CANCER RES, V64, P889, DOI 10.1158/0008-5472.CAN-03-2070; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; Verma AK, 2006, MOL CARCINOGEN, V45, P381, DOI 10.1002/mc.20230; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200	71	104	107	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					604	U370		10.1038/ncb1866	http://dx.doi.org/10.1038/ncb1866			215	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19363488	Green Accepted			2022-12-25	WOS:000265640000019
J	Huang, C; Rajfur, Z; Yousefi, N; Chen, ZZ; Jacobson, K; Ginsberg, MH				Huang, Cai; Rajfur, Zenon; Yousefi, Nima; Chen, Zaozao; Jacobson, Ken; Ginsberg, Mark H.			Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; INTEGRIN ACTIVATION; NEURONAL MIGRATION; STRUCTURAL BASIS; ADHESION; DOMAIN; MOTILITY; BINDING; CONTRACTILITY; DEGRADATION	Cell migration is a dynamic process that requires temporal and spatial regulation of integrin activation and focal adhesion assembly/disassembly(1). Talin, an actin and beta-integrin tail-binding protein, is essential for integrin activation and focal adhesion formation(2,3). Calpain-mediated cleavage of talin has a key role in focal adhesion turnover(3); however, the talin head domain, one of the two cleavage products, stimulates integrin activation, localizes to focal adhesions and maintains cell edge protrusions(2,4,5), suggesting that other steps, downstream of talin proteolysis, are required for focal adhesion disassembly. Here we show that talin head binds Smurf1, an E3 ubiquitin ligase involved in cell polarity and migration(6,7), more tightly than full-length talin does and that this interaction leads to talin head ubiquitylation and degradation. We found that talin head is a substrate for Cdk5, a cyclin-dependent protein kinase that is essential for cell migration, synaptic transmission and cancer metastasis(8-11). Cdk5 phosphorylated talin head at Ser 425, inhibiting its binding to Smurf1, thus preventing talin head ubiquitylation and degradation. Expression of the mutant tal(S425A), which resists Cdk5 phosphorylation thereby increasing its susceptibility to Smurf1-mediated ubiqitylation, resulted in extensive focal adhesion turnover and inhibited cell migration. Thus, talin head produced by calpain-induced cleavage of talin is degraded through Smurf1-mediated ubiquitylation; moreover, phosphorylation by Cdk5 regulates the binding of Smurf1 to talin head, controlling talin head turnover, adhesion stability and ultimately, cell migration.	[Huang, Cai; Rajfur, Zenon; Chen, Zaozao; Jacobson, Ken] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Jacobson, Ken] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Huang, Cai; Yousefi, Nima; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego	Jacobson, K (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	frap@med.unc.edu; mhginsberg@ucsd.edu	Chen, Zaozao/AAS-6111-2021; Rajfur, Zenon/H-2506-2013; , UNC Flow Cytometry Core/AGU-9839-2022	Rajfur, Zenon/0000-0003-1265-6480	National Institutes of Health; Cell Migration Consortium; NIH [GM64346]; Ruth L. Kirschstein National Research Service [1F32 HL08321]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL083215, P01HL031950, F32HL008321, P01HL057900, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Migration Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Burridge for critical reading of this manuscript, M. Schaller for critical reading of this manuscript and supporting of phosphorylation assays, A. Huttenlocher for the pEGFP-talin plasmid, L.-H. Tsai for the Cdk5 and p35 plasmids, D. Cyr for the HA-ubiquitin plasmid, E1 and Ubc5 alpha, and M. Kerber for assistance with TIRF imaging. Supported by National Institutes of Health grants to M. H. G., a Cell Migration Consortium grant (NIH GM64346) to M. H. G. and K. J. and a Ruth L. Kirschstein National Research Service Award (1F32 HL08321) to C. H.	Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Borowsky ML, 1998, J CELL BIOL, V143, P429, DOI 10.1083/jcb.143.2.429; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chen F, 2001, BLOOD, V97, P3763, DOI 10.1182/blood.V97.12.3763; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Lazaro JB, 1997, J CELL SCI, V110, P1251; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Negash S, 2002, J CELL SCI, V115, P2109; NUCKOLLS GH, 1992, J CELL SCI, V102, P753; NUCKOLLS GH, 1990, J CELL BIOL, V110, P1635, DOI 10.1083/jcb.110.5.1635; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tsai LH, 2001, FASEB J, V15, pA2; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	35	159	159	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					624	U404		10.1038/ncb1868	http://dx.doi.org/10.1038/ncb1868			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19363486	Green Submitted, Green Accepted			2022-12-25	WOS:000265640000021
